,Entry,Entry name,Gene names,Gene names  (primary ),Gene names  (synonym ),Gene names  (ordered locus ),Gene names  (ORF ),Organism,Organism ID,Protein names,Proteomes,Taxonomic lineage (ALL),Taxonomic lineage IDs,Virus hosts,Sequence,Length,Mass,Gene encoded by,Alternative products (isoforms),Erroneous gene model prediction,Erroneous initiation,Erroneous termination,Erroneous translation,Frameshift,Mass spectrometry,Polymorphism,RNA editing,Sequence caution,Alternative sequence,Natural variant,Non-adjacent residues,Non-standard residue,Non-terminal residue,Sequence conflict,Sequence uncertainty,Version (sequence),Domains,Domain count,Domain [CC],Sequence similarities,Coiled coil,Compositional bias,Domain [FT],Motif,Region,Repeat,Zinc finger,EC number,Absorption,Catalytic activity,Cofactor,General annotation (ENZYME REGULATION),Function [CC],Kinetics,Pathway,Redox potential,Temperature dependence,pH dependence,Active site,Binding site,DNA binding,Metal binding,Nucleotide binding,Site,Gene ontology (GO),Gene ontology (biological process),Gene ontology (molecular function),Gene ontology (cellular component),Gene ontology IDs,InterPro,Interacts with,Subunit structure [CC],PubMed ID,Mapped PubMed ID,Date of creation,Date of last modification,Date of last sequence modification,Version (entry),3D,Beta strand,Helix,Turn,Subcellular location,Intramembrane,Topological domain,Transmembrane,Annotation,Features,Caution,Tissue specificity,Miscellaneous [CC],Keywords,Protein existence,Status,Sequence annotation (Features),Protein families,Version,Comments,Cross-reference (null),Keyword ID,Pathway.1,Allergenic properties,Biotechnological use,Disruption phenotype,Involvement in disease,Pharmaceutical use,Toxic dose,Post-translational modification,Chain,Cross-link,Disulfide bond,Glycosylation,Initiator methionine,Lipidation,Modified residue,Peptide,Propeptide,Signal peptide,Transit peptide,Taxonomic lineage (all),Taxonomic lineage (SUPERKINGDOM),Taxonomic lineage (KINGDOM),Taxonomic lineage (SUBKINGDOM),Taxonomic lineage (SUPERPHYLUM),Taxonomic lineage (PHYLUM),Taxonomic lineage (SUBPHYLUM),Taxonomic lineage (SUPERCLASS),Taxonomic lineage (CLASS),Taxonomic lineage (SUBCLASS),Taxonomic lineage (INFRACLASS),Taxonomic lineage (SUPERORDER),Taxonomic lineage (ORDER),Taxonomic lineage (SUBORDER),Taxonomic lineage (INFRAORDER),Taxonomic lineage (PARVORDER),Taxonomic lineage (SUPERFAMILY),Taxonomic lineage (FAMILY),Taxonomic lineage (SUBFAMILY),Taxonomic lineage (TRIBE),Taxonomic lineage (SUBTRIBE),Taxonomic lineage (GENUS),Taxonomic lineage (SUBGENUS),Taxonomic lineage (SPECIES GROUP),Taxonomic lineage (SPECIES SUBGROUP),Taxonomic lineage (SPECIES),Taxonomic lineage (SUBSPECIES),Taxonomic lineage (VARIETAS),Taxonomic lineage (FORMA),Taxonomic lineage IDs (all),Taxonomic lineage IDs (SUPERKINGDOM),Taxonomic lineage IDs (KINGDOM),Taxonomic lineage IDs (SUBKINGDOM),Taxonomic lineage IDs (SUPERPHYLUM),Taxonomic lineage IDs (PHYLUM),Taxonomic lineage IDs (SUBPHYLUM),Taxonomic lineage IDs (SUPERCLASS),Taxonomic lineage IDs (CLASS),Taxonomic lineage IDs (SUBCLASS),Taxonomic lineage IDs (INFRACLASS),Taxonomic lineage IDs (SUPERORDER),Taxonomic lineage IDs (ORDER),Taxonomic lineage IDs (SUBORDER),Taxonomic lineage IDs (INFRAORDER),Taxonomic lineage IDs (PARVORDER),Taxonomic lineage IDs (SUPERFAMILY),Taxonomic lineage IDs (FAMILY),Taxonomic lineage IDs (SUBFAMILY),Taxonomic lineage IDs (TRIBE),Taxonomic lineage IDs (SUBTRIBE),Taxonomic lineage IDs (GENUS),Taxonomic lineage IDs (SUBGENUS),Taxonomic lineage IDs (SPECIES GROUP),Taxonomic lineage IDs (SPECIES SUBGROUP),Taxonomic lineage IDs (SPECIES),Taxonomic lineage IDs (SUBSPECIES),Taxonomic lineage IDs (VARIETAS),Taxonomic lineage IDs (FORMA),Cross-reference (db_abbrev),Cross-reference (EMBL)
0,O14576,DC1I1_HUMAN,DYNC1I1 DNCI1 DNCIC1,DYNC1I1,DNCI1 DNCIC1,,,Homo sapiens (Human),9606,"Cytoplasmic dynein 1 intermediate chain 1 (Cytoplasmic dynein intermediate chain 1) (Dynein intermediate chain 1, cytosolic) (DH IC-1)",UP000005640: Chromosome 7,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSDKSDLKAELERKKQRLAQIREEKKRKEEERKKKEADMQQKKEPVQDDSDLDRKRRETEALLQSIGISPEPPLVQPLHFLTWDTCYFHYLVPTPMSPSSKSVSTPSEAGSQDSGDLGPLTRTLQWDTDPSVLQLQSDSELGRRLHKLGVSKVTQVDFLPREVVSYSKETQTPLATHQSEEDEEDEEMVESKVGQDSELENQDKKQEVKEAPPRELTEEEKQQILHSEEFLIFFDRTIRVIERALAEDSDIFFDYSGRELEEKDGDVQAGANLSFNRQFYDEHWSKHRVVTCMDWSLQYPELMVASYNNNEDAPHEPDGVALVWNMKFKKTTPEYVFHCQSSVMSVCFARFHPNLVVGGTYSGQIVLWDNRSHRRTPVQRTPLSAAAHTHPVYCVNVVGTQNAHNLITVSTDGKMCSWSLDMLSTPQESMELVYNKSKPVAVTGMAFPTGDVNNFVVGSEEGTVYTACRHGSKAGIGEVFEGHQGPVTGINCHMAVGPIDFSHLFVTSSFDWTVKLWTTKHNKPLYSFEDNADYVYDVMWSPVHPALFACVDGMGRLDLWNLNNDTEVPTASVAIEGASALNRVRWAQAGKEVAVGDSEGRIWVYDVGELAVPHNDEWTRFARTLVEIRANRADSEEEGTVELSA,645,"72,955",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=5;  Name=1; IsoId=O14576-1; Sequence=Displayed; Name=2; IsoId=O14576-2; Sequence=VSP_001332; Name=3; IsoId=O14576-3; Sequence=VSP_001332, VSP_001333; Name=4; IsoId=O14576-4; Sequence=VSP_001332, VSP_001333, VSP_054766; Note=No experimental confirmation available.; Name=5; IsoId=O14576-5; Sequence=VSP_001333; Note=No experimental confirmation available.; ",,,,,,,,,,"VAR_SEQ 74 90 Missing (in isoform 2, isoform 3 and isoform 4). {ECO:0000303|PubMed:14702039, ECO:0000303|Ref.2}. /FTId=VSP_001332.; VAR_SEQ 123 142 Missing (in isoform 3, isoform 4 and isoform 5). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334, ECO:0000303|Ref.2}. /FTId=VSP_001333.; VAR_SEQ 610 645 LAVPHNDEWTRFARTLVEIRANRADSEEEGTVELSA -> GLAMLPGWSQNSWTQAILLCWPPKVLGLQT (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_054766.",VARIANT 373 373 H -> L (found in a renal cell carcinoma case; somatic mutation). {ECO:0000269|PubMed:21248752}. /FTId=VAR_064709.; VARIANT 582 582 N -> T (in dbSNP:rs35077523). /FTId=VAR_048905.,,,,CONFLICT 254 254 D -> G (in Ref. 3; BAG59855). {ECO:0000305}.; CONFLICT 517 517 W -> C (in Ref. 6; AAH22540). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the dynein intermediate chain family. {ECO:0000305}.,,,,,REGION 2 123 Interaction with DCTN1. {ECO:0000250}.; REGION 147 163 Interaction with DYNLT1. {ECO:0000269|PubMed:27502274}.,REPEAT 285 334 WD 1.; REPEAT 338 378 WD 2.; REPEAT 387 428 WD 3.; REPEAT 437 477 WD 4.; REPEAT 482 527 WD 5.; REPEAT 530 570 WD 6.; REPEAT 576 615 WD 7.,,,,,,,FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. The intermediate chains mediate the binding of dynein to dynactin via its 150 kDa component (p150-glued) DCNT1. May play a role in mediating the interaction of cytoplasmic dynein with membranous organelles and kinetochores.,,,,,,,,,,,,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; spectrin binding [GO:0030507]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; microtubule-based movement [GO:0007018]; vesicle transport along microtubule [GO:0047496],antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; microtubule-based movement [GO:0007018]; vesicle transport along microtubule [GO:0047496],dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; spectrin binding [GO:0030507],condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; vesicle [GO:0031982],GO:0000776; GO:0000777; GO:0000922; GO:0003774; GO:0003777; GO:0005634; GO:0005737; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0008017; GO:0019886; GO:0030286; GO:0030507; GO:0031982; GO:0036464; GO:0045503; GO:0045504; GO:0047496; GO:0048471; GO:0055037,IPR025956; IPR015943; IPR001680; IPR017986; IPR036322; ,Q9CZA6,"SUBUNIT: Homodimer (By similarity). The cytoplasmic dynein 1 complex consists of two catalytic heavy chains (HCs) and a number of non-catalytic subunits presented by intermediate chains (ICs), light intermediate chains (LICs) and light chains (LCs); the composition seems to vary in respect to the IC, LIC and LC composition. The heavy chain homodimer serves as a scaffold for the probable homodimeric assembly of the respective non-catalytic subunits. The ICs and LICs bind directly to the HC dimer and the LCs assemble on the IC dimer. Interacts with DYNC1H1. Interacts with DYNLT1 and DYNLT3. Interacts with DCNT1 (By similarity). {ECO:0000250, ECO:0000269|PubMed:27502274}.",10049579; 14702039; 12853948; 15489334; 19229290; 19690332; 27502274; 21248752,10049579; 14702039; 12853948; 15489334; 19229290; 19690332; 27502274; 21248752; 10036229; 10559986; 10562278; 10679020; 10903204; 11035033; 11081627; 11181178; 11285137; 11306556; 11461920; 11483508; 11509732; 11804586; 12006501; 12006665; 12194817; 12198549; 12401177; 12447383; 14730319; 15085137; 15121898; 15339662; 15483056; 15591061; 15632110; 15723797; 15728195; 15737063; 15824131; 15878873; 16189514; 16362039; 16541025; 16616141; 16622419; 16622420; 16723730; 17030981; 17129783; 17139249; 17274799; 17283181; 17827179; 18046453; 18086915; 18097444; 18664496; 18716626; 19564404; 19927128; 19965387; 20038533; 20048338; 20195357; 20201926; 20360680; 21397845; 21763495; 21767414; 21878504; 21900206; 21987589; 22885700; 23487458; 23783758; 23839779; 23960070; 24459211; 24806965; 24891604; 25015291; 25231166; 25233431; 25453831; 7691276; 8642258; 8909537; 8991093; 9150144; 9288971; 9323141; 9380700; 9490716; 9671725,2000-05-30,2019-02-13,1999-05-01,172,,,,,,,,,5 out of 5,Alternative sequence (3); Chain (1); Initiator methionine (1); Modified residue (11); Mutagenesis (10); Natural variant (2); Region (2); Repeat (7); Sequence conflict (2),,,,Acetylation;Alternative splicing;Centromere;Chromosome;Complete proteome;Cytoplasm;Cytoskeleton;Dynein;Kinetochore;Microtubule;Motor protein;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transport;WD repeat,Evidence at protein level,reviewed,,Dynein intermediate chain family,172,Alternative products (1); Caution (2); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0007; KW-0025; KW-0137; KW-0158; KW-0181; KW-0206; KW-0243; KW-0493; KW-0505; KW-0597; KW-0621; KW-0677; KW-0813; KW-0853; KW-0963; KW-0995; KW-1185,,,,,,,,,CHAIN 2 645 Cytoplasmic dynein 1 intermediate chain 1. /FTId=PRO_0000114652.,,,,INIT_MET 1 1 Removed. {ECO:0000250|UniProtKB:Q13409}.,,MOD_RES 2 2 N-acetylserine. {ECO:0000250|UniProtKB:Q13409}.; MOD_RES 50 50 Phosphoserine. {ECO:0000250|UniProtKB:O88485}.; MOD_RES 100 100 Phosphoserine. {ECO:0000250|UniProtKB:Q62871}.; MOD_RES 105 105 Phosphothreonine. {ECO:0000250|UniProtKB:Q13409}.; MOD_RES 107 107 Phosphoserine. {ECO:0000250|UniProtKB:Q13409}.; MOD_RES 111 111 Phosphoserine. {ECO:0000250|UniProtKB:O88485}.; MOD_RES 114 114 Phosphoserine. {ECO:0000250|UniProtKB:O88485}.; MOD_RES 176 176 Phosphothreonine. {ECO:0000250|UniProtKB:O88485}.; MOD_RES 179 179 Phosphoserine. {ECO:0000250|UniProtKB:O88485}.; MOD_RES 197 197 Phosphoserine. {ECO:0000250|UniProtKB:O88485}.; MOD_RES 635 635 Phosphoserine. {ECO:0000244|PubMed:19690332}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF063228;AF123074;AK091339;AK297427;AC002452;AC002540;CH471091;BC022540;
0,O43293,DAPK3_HUMAN,DAPK3 ZIPK,DAPK3,ZIPK,,,Homo sapiens (Human),9606,Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSTFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSGRKPERRRLKTTRLKEYTIKSHSSLPPNNSYADFERFSKVLEEAAAAEEGLRELQRSRRLCHEDVEALAAIYEEKEAWYREESDSLGQDLRRLRQELLKTEALKRQAQEEAKGALLGTSGLKRRFSRLENRYEALAKQVASEMRFVQDLVRALEQEKLQGVECGLR,454,"52,536",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; Synonyms=ZIPK-L; IsoId=O43293-1; Sequence=Displayed; Name=2; Synonyms=ZIPK-S; IsoId=O43293-2; Sequence=VSP_042059, VSP_042060; Note=The internal splice site between exon 8 and the 3' UTR, which yields this truncated isoform, is non-canonical.; ",,,,,,,,,,VAR_SEQ 313 322 LPPNNSYADF -> ASPIVAPVDA (in isoform 2). {ECO:0000303|PubMed:17126281}. /FTId=VSP_042059.; VAR_SEQ 323 454 Missing (in isoform 2). {ECO:0000303|PubMed:17126281}. /FTId=VSP_042060.,"VARIANT 112 112 T -> M (in a colorectal adenocarcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation and cell survival). {ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:21487036}. /FTId=VAR_040438.; VARIANT 161 161 D -> N (in an ovarian mucinous carcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation and cell survival). {ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:21487036}. /FTId=VAR_040439.; VARIANT 216 216 P -> S (in a lung neuroendocrine carcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation, cell adhesion and cell survival). {ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:21487036}. /FTId=VAR_040440.",,,,,,1,,0,,SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. DAP kinase subfamily. {ECO:0000305}.,,,DOMAIN 13 275 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,REGION 161 204 Activation segment. {ECO:0000250|UniProtKB:O96017}.; REGION 427 441 Leucine-zipper. {ECO:0000303|PubMed:9488481}.,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10356987, ECO:0000269|PubMed:11384979, ECO:0000269|PubMed:11781833, ECO:0000269|PubMed:15096528, ECO:0000269|PubMed:17126281, ECO:0000269|PubMed:18995835}; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10356987, ECO:0000269|PubMed:11384979, ECO:0000269|PubMed:11781833, ECO:0000269|PubMed:15096528, ECO:0000269|PubMed:17126281, ECO:0000269|PubMed:18995835};",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:10356987}; ,,"FUNCTION: Serine/threonine kinase which is involved in the regulation of apoptosis, autophagy, transcription, translation and actin cytoskeleton reorganization. Involved in the regulation of smooth muscle contraction. Regulates both type I (caspase-dependent) apoptotic and type II (caspase-independent) autophagic cell deaths signal, depending on the cellular setting. Involved in regulation of starvation-induced autophagy. Regulates myosin phosphorylation in both smooth muscle and non-muscle cells. In smooth muscle, regulates myosin either directly by phosphorylating MYL12B and MYL9 or through inhibition of smooth muscle myosin phosphatase (SMPP1M) via phosphorylation of PPP1R12A; the inhibition of SMPP1M functions to enhance muscle responsiveness to Ca(2+) and promote a contractile state. Phosphorylates MYL12B in non-muscle cells leading to reorganization of actin cytoskeleton. Isoform 2 can phosphorylate myosin, PPP1R12A and MYL12B. Overexpression leads to condensation of actin stress fibers into thick bundles. Involved in actin filament focal adhesion dynamics. The function in both reorganization of actin cytoskeleton and focal adhesion dissolution is modulated by RhoD. Positively regulates canonical Wnt/beta-catenin signaling through interaction with NLK and TCF7L2. Phosphorylates RPL13A on 'Ser-77' upon interferon-gamma activation which is causing RPL13A release from the ribosome, RPL13A association with the GAIT complex and its subsequent involvement in transcript-selective translation inhibition. Enhances transcription from AR-responsive promoters in a hormone- and kinase-dependent manner. Involved in regulation of cell cycle progression and cell proliferation. May be a tumor suppressor. {ECO:0000269|PubMed:10356987, ECO:0000269|PubMed:11384979, ECO:0000269|PubMed:11781833, ECO:0000269|PubMed:12917339, ECO:0000269|PubMed:15096528, ECO:0000269|PubMed:15367680, ECO:0000269|PubMed:16219639, ECO:0000269|PubMed:17126281, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:18084323, ECO:0000269|PubMed:18995835, ECO:0000269|PubMed:21169990, ECO:0000269|PubMed:21408167, ECO:0000269|PubMed:21454679, ECO:0000269|PubMed:21487036, ECO:0000269|PubMed:23454120}.",BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=12 uM for myosin (isoform 2) {ECO:0000269|PubMed:17126281}; KM=6.2 uM for myosin (isoform 1) {ECO:0000269|PubMed:17126281}; KM=73 uM for MYL12B (isoform 2) {ECO:0000269|PubMed:17126281}; KM=10.4 uM for MYL12B (isoform 1) {ECO:0000269|PubMed:17126281}; Vmax=248 nmol/min/mg enzyme toward myosin (isoform 2) {ECO:0000269|PubMed:17126281}; Vmax=120 nmol/min/mg enzyme toward myosin (isoform 1) {ECO:0000269|PubMed:17126281}; Vmax=1.3 umol/min/mg enzyme toward MYL12B (isoform 2) {ECO:0000269|PubMed:17126281}; Vmax=271 nmol/min/mg enzyme toward MYL12B (isoform 1) {ECO:0000269|PubMed:17126281}; ,,,,,"ACT_SITE 139 139 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 42 42 ATP. {ECO:0000305}.; BINDING 94 94 Inhibitor. {ECO:0000269|PubMed:18239682}.; BINDING 96 96 Inhibitor. {ECO:0000269|PubMed:18239682}.,,,NP_BIND 19 27 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,"actin filament [GO:0005884]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-gamma [GO:0071346]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of focal adhesion assembly [GO:0051893]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of myosin II filament organization [GO:0043519]; regulation of smooth muscle contraction [GO:0006940]; regulation of transcription, DNA-templated [GO:0006355]","apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-gamma [GO:0071346]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of focal adhesion assembly [GO:0051893]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of myosin II filament organization [GO:0043519]; regulation of smooth muscle contraction [GO:0006940]; regulation of transcription, DNA-templated [GO:0006355]",ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048],actin filament [GO:0005884]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; PML body [GO:0016605],GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005884; GO:0006325; GO:0006355; GO:0006468; GO:0006915; GO:0006940; GO:0007088; GO:0007346; GO:0008022; GO:0008140; GO:0008360; GO:0010506; GO:0016605; GO:0017048; GO:0017148; GO:0030182; GO:0030335; GO:0035556; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0043519; GO:0043522; GO:0045121; GO:0046777; GO:0051893; GO:0071346; GO:0090263; GO:0097190; GO:2000145; GO:2000249; GO:2001241,IPR011009; IPR000719; IPR017441; IPR008271; ,Itself; Q9UBE8; O14974; Q10728; Q8TDR4,"SUBUNIT: Homooligomer in its kinase-active form (homotrimers and homodimers are reported); monomeric in its kinase-inactive form. Homodimerization is required for activation segment autophosphorylation (Probable). Isoform 1 and isoform 2 interact with myosin and PPP1R12A; interaction of isoform 1 with PPP1R12A is inhibited by RhoA dominant negative form. Interacts with NLK, DAXX, STAT3, RHOD (GTP-bound form) and TCP10L. Interacts with PAWR; the interaction is reported conflictingly: according to PubMed:17953487 does not interact with PAWR. Interacts with ULK1; may be a substrate of ULK1. {ECO:0000269|PubMed:12917339, ECO:0000269|PubMed:15292222, ECO:0000269|PubMed:15910542, ECO:0000269|PubMed:16219639, ECO:0000269|PubMed:17126281, ECO:0000269|PubMed:18239682, ECO:0000269|PubMed:21169990, ECO:0000269|PubMed:21408167, ECO:0000269|PubMed:21454679, ECO:0000269|PubMed:23454120, ECO:0000303|PubMed:18239682}.",9488481; 10356987; 14702039; 15489334; 17126281; 11384979; 11781833; 12917339; 15292222; 15096528; 15367680; 16219639; 15910542; 15611134; 16756490; 17158456; 17953487; 18995835; 18084323; 21487036; 20854903; 21169990; 21454679; 21408167; 23454120; 23186163; 18239682; 17344846,9488481; 10356987; 14702039; 15489334; 17126281; 11384979; 11781833; 12917339; 15292222; 15096528; 15367680; 16219639; 15910542; 15611134; 16756490; 17158456; 17953487; 18995835; 18084323; 21487036; 20854903; 21169990; 21454679; 21408167; 23454120; 23186163; 18239682; 17344846; 12577067; 15729359; 16325270; 18515077; 19117059; 20085750; 21988832; 22136433; 22939624; 23146908; 24633547; 25036637; 25304685; 25503649; 25723491; 25769953; 26117336; 26486226; 26496610; 26638075; 26748242; 27126362; 27133022; 27573465; 28011458; 28075459; 28731173; 30033129,2003-11-28,2019-02-13,1998-06-01,180,X-ray crystallography (7),STRAND 13 21 {ECO:0000244|PDB:3BHY}.; STRAND 23 32 {ECO:0000244|PDB:3BHY}.; STRAND 38 46 {ECO:0000244|PDB:3BHY}.; STRAND 53 56 {ECO:0000244|PDB:3BHY}.; STRAND 79 84 {ECO:0000244|PDB:3BHY}.; STRAND 86 94 {ECO:0000244|PDB:3BHY}.; STRAND 145 148 {ECO:0000244|PDB:3BHY}.; STRAND 150 154 {ECO:0000244|PDB:3BHY}.; STRAND 157 159 {ECO:0000244|PDB:3BHY}.,HELIX 9 12 {ECO:0000244|PDB:3BHY}.; HELIX 49 51 {ECO:0000244|PDB:2J90}.; HELIX 58 70 {ECO:0000244|PDB:3BHY}.; HELIX 101 108 {ECO:0000244|PDB:3BHY}.; HELIX 113 132 {ECO:0000244|PDB:3BHY}.; HELIX 142 144 {ECO:0000244|PDB:3BHY}.; HELIX 171 175 {ECO:0000244|PDB:5A6N}.; HELIX 176 178 {ECO:0000244|PDB:5A6O}.; HELIX 181 183 {ECO:0000244|PDB:3BHY}.; HELIX 186 189 {ECO:0000244|PDB:3BHY}.; HELIX 197 212 {ECO:0000244|PDB:3BHY}.; HELIX 222 230 {ECO:0000244|PDB:3BHY}.; HELIX 238 241 {ECO:0000244|PDB:3BHY}.; HELIX 246 253 {ECO:0000244|PDB:3BHY}.; HELIX 260 262 {ECO:0000244|PDB:3BHY}.; HELIX 266 271 {ECO:0000244|PDB:3BHY}.; HELIX 273 280 {ECO:0000244|PDB:3BHY}.,TURN 33 35 {ECO:0000244|PDB:3BHY}.,,,,,5 out of 5,Active site (1); Alternative sequence (2); Beta strand (9); Binding site (3); Chain (1); Domain (1); Helix (17); Modified residue (11); Mutagenesis (12); Natural variant (3); Nucleotide binding (1); Region (2); Turn (1),,"TISSUE SPECIFICITY: Widely expressed. Isoform 1 and isoform 2 are expressed in the bladder smooth muscle. {ECO:0000269|PubMed:15292222, ECO:0000269|PubMed:17126281}.",,3D-structure;ATP-binding;Activator;Alternative splicing;Apoptosis;Chromatin regulator;Complete proteome;Cytoplasm;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Translation regulation;Tumor suppressor,Evidence at protein level,reviewed,,"Protein kinase superfamily, CAMK Ser/Thr protein kinase family, DAP kinase subfamily",180,Activity regulation (1); Alternative products (1); Catalytic activity (2); Caution (1); Cofactor (1); Function (1); Kinetics (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (3); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0010; KW-0025; KW-0043; KW-0053; KW-0067; KW-0156; KW-0181; KW-0418; KW-0539; KW-0547; KW-0597; KW-0621; KW-0723; KW-0804; KW-0805; KW-0808; KW-0810; KW-0963; KW-1185,,,,,,,,"PTM: The phosphorylation status is critical for kinase activity, oligomerization and intracellular localization. Phosphorylation at Thr-180, Thr-225 and Thr-265 is essential for activity. The phosphorylated form is localized in the cytoplasm promoted by phosphorylation at Thr-299; nuclear translocation or retention is maximal when it is not phosphorylated. Phosphorylation increases the trimeric form, and its dephosphorylation favors a kinase-inactive monomeric form. Both isoform 1 and isoform 2 can undergo autophosphorylation. {ECO:0000269|PubMed:15367680, ECO:0000269|PubMed:15611134, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:20854903}.",CHAIN 1 454 Death-associated protein kinase 3. /FTId=PRO_0000085914.,,,,,,"MOD_RES 50 50 Phosphoserine; by autocatalysis. {ECO:0000269|PubMed:18239682}.; MOD_RES 180 180 Phosphothreonine. {ECO:0000269|PubMed:15611134, ECO:0000269|PubMed:17158456}.; MOD_RES 225 225 Phosphothreonine. {ECO:0000269|PubMed:15611134}.; MOD_RES 265 265 Phosphothreonine; by autocatalysis and ROCK1. {ECO:0000269|PubMed:15611134, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:18239682}.; MOD_RES 299 299 Phosphothreonine; by autocatalysis, DAPK1 and ROCK1. {ECO:0000269|PubMed:15367680, ECO:0000269|PubMed:15611134, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:20854903}.; MOD_RES 306 306 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:15611134}.; MOD_RES 309 309 Phosphoserine; by DAPK1. {ECO:0000269|PubMed:15367680}.; MOD_RES 311 311 Phosphoserine; by autocatalysis and DAPK1. {ECO:0000269|PubMed:15367680, ECO:0000269|PubMed:15611134}.; MOD_RES 312 312 Phosphoserine; by DAPK1. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:15367680}.; MOD_RES 318 318 Phosphoserine; by DAPK1. {ECO:0000269|PubMed:15367680}.; MOD_RES 326 326 Phosphoserine; by DAPK1. {ECO:0000269|PubMed:15367680}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB007144;AB022341;AK074799;BC126430;BC126432;AB265224;
0,O75935,DCTN3_HUMAN,DCTN3 DCTN22,DCTN3,DCTN22,,,Homo sapiens (Human),9606,Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22),UP000005640: Chromosome 9,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAGLTDLQRLQARVEELERWVYGPGGARGSRKVADGLVKVQVALGNISSKRERVKILYKKIEDLIKYLDPEYIDRIAIPDASKLQFILAEEQFILSQVALLEQVNALVPMLDSAHIKAVPEHAARLQRLAQIHIQQQDQCVEITEESKALLEEYNKTTMLLSKQFVQWDELLCQLEAATQVKPAEE,186,"21,119",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1 {ECO:0000269|PubMed:9722614}; IsoId=O75935-1; Sequence=Displayed; Name=2 {ECO:0000269|PubMed:15164053}; IsoId=O75935-2; Sequence=VSP_051964; Note=No experimental confirmation available. {ECO:0000305}; Name=3 {ECO:0000305}; IsoId=O75935-3; Sequence=VSP_051961; Note=No experimental confirmation available. {ECO:0000305}; ,SEQUENCE CAUTION:  Sequence=CAI14178.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; ,SEQUENCE CAUTION:  Sequence=CAI13144.1; Type=Erroneous initiation; Evidence={ECO:0000305};  Sequence=CAI14180.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 90 117 Missing (in isoform 3). {ECO:0000305}. /FTId=VSP_051961.; VAR_SEQ 138 186 DQCVEITEESKALLEEYNKTTMLLSKQFVQWDELLCQLEAATQVKPAEE -> APWGVGVRDEAGSLVEDVGFAQFLSVLHFGPTGPVCGNH (in isoform 2). {ECO:0000303|PubMed:15164053, ECO:0000303|PubMed:15489334}. /FTId=VSP_051964.",,,,,,,1,,0,,SIMILARITY: Belongs to the dynactin subunit 3 family. {ECO:0000305}.,COILED 135 157 {ECO:0000255}.,,,,,,,,,,,,FUNCTION: Together with dynein may be involved in spindle assembly and cytokinesis. {ECO:0000269|PubMed:9722614}.,,,,,,,,,,,,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; structural molecule activity [GO:0005198]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoskeleton-dependent cytokinesis [GO:0061640]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoskeleton-dependent cytokinesis [GO:0061640]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],structural molecule activity [GO:0005198],centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819],GO:0000086; GO:0000278; GO:0000777; GO:0005198; GO:0005730; GO:0005813; GO:0005819; GO:0005829; GO:0005869; GO:0005874; GO:0006888; GO:0007017; GO:0010389; GO:0019886; GO:0030496; GO:0032154; GO:0048471; GO:0061640; GO:0097711,IPR009991; ,,"SUBUNIT: Subunit of dynactin, a multiprotein complex associated with dynein.",9722614; 14702039; 15164053; 15489334; 21269460; 22814378,9722614; 14702039; 15164053; 15489334; 21269460; 22814378; 10036229; 10559986; 10562278; 10679020; 10903204; 11035033; 11076968; 11285137; 11306556; 11461920; 11483508; 11956313; 12198549; 12207013; 12221128; 12401177; 12447383; 12852856; 13678582; 14580337; 14667819; 15483056; 15498487; 15591061; 15632110; 15705883; 15728195; 15878873; 16357211; 16462731; 16713569; 16723730; 16890155; 17274799; 17283181; 17574030; 17646400; 17719545; 17827179; 18037885; 18046453; 18086915; 18566290; 18615013; 18664496; 18694559; 19004860; 19564404; 19940019; 20038533; 20230748; 20360068; 20399632; 20558667; 20711500; 21273506; 21347367; 21422230; 21548880; 21565611; 21620453; 21725307; 21792235; 21900206; 22094468; 22179047; 22653444; 23141531; 23141541; 23253480; 23348840; 23400999; 23416715; 23530209; 23747070; 23769972; 23783758; 23789104; 23839779; 23921553; 24053599; 24089205; 24231678; 24469809; 24806965; 24891604; 24982133; 25047611; 25233431; 25313408; 25453831; 25532896; 26638075; 26954557; 7691276; 7769006; 7790358; 8642258; 8838651; 8909537; 8991093; 9150144; 9288971; 9323141; 9380700; 9490716; 9671725,2006-03-07,2019-02-13,1998-11-01,156,,,,,,,,,5 out of 5,Alternative sequence (2); Chain (1); Coiled coil (1); Erroneous gene model prediction (1); Erroneous initiation (2); Initiator methionine (1); Modified residue (1),,TISSUE SPECIFICITY: Ubiquitously expressed. Highly expressed in muscle and pancreas and detected at lower levels in brain. {ECO:0000269|PubMed:9722614}.,,Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Kinetochore;Mitosis;Reference proteome,Evidence at protein level,reviewed,,Dynactin subunit 3 family,156,Alternative products (1); Caution (2); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0007; KW-0025; KW-0131; KW-0132; KW-0137; KW-0158; KW-0175; KW-0181; KW-0206; KW-0498; KW-0903; KW-0963; KW-0995; KW-1185,,,,,,,,,CHAIN 2 186 Dynactin subunit 3. /FTId=PRO_0000225603.,,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378}.,,MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF082513;CR541889;AK314730;AL160270;AL450283;AL160270;AL450283;AL160270;AL450283;AL450283;AL450283;AL160270;AL450283;AL160270;AL450283;AL160270;CH471071;CH471071;BC000319;BC003004;BC107697;
0,P23258,TBG1_HUMAN,TUBG1 TUBG,TUBG1,TUBG,,,Homo sapiens (Human),9606,Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1),UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPREIITLQLGQCGNQIGFEFWKQLCAEHGISPEGIVEEFATEGTDRKDVFFYQADDEHYIPRAVLLDLEPRVIHSILNSPYAKLYNPENIYLSEHGGGAGNNWASGFSQGEKIHEDIFDIIDREADGSDSLEGFVLCHSIAGGTGSGLGSYLLERLNDRYPKKLVQTYSVFPNQDEMSDVVVQPYNSLLTLKRLTQNADCVVVLDNTALNRIATDRLHIQNPSFSQINQLVSTIMSASTTTLRYPGYMNNDLIGLIASLIPTPRLHFLMTGYTPLTTDQSVASVRKTTVLDVMRRLLQPKNVMVSTGRDRQTNHCYIAILNIIQGEVDPTQVHKSLQRIRERKLANFIPWGPASIQVALSRKSPYLPSAHRVSGLMMANHTSISSLFERTCRQYDKLRKREAFLEQFRKEDMFKDNFDEMDTSREIVQQLIDEYHAATRPDYISWGTQEQ,451,"51,170",,,,,,,,MASS SPECTROMETRY: Mass=51197.98; Method=MALDI; Range=1-451; Evidence={ECO:0000269|PubMed:11840567};,,,,,VARIANT 92 92 Y -> C (in CDCBM4; dbSNP:rs398123046). {ECO:0000269|PubMed:23603762}. /FTId=VAR_070577.; VARIANT 331 331 T -> P (in CDCBM4; dbSNP:rs398123047). {ECO:0000269|PubMed:23603762}. /FTId=VAR_070578.; VARIANT 387 387 L -> P (in CDCBM4; the chaperonin-dependent folding and hence the yield of monomeric gamma-tubulin is compromised; dbSNP:rs398123045). {ECO:0000269|PubMed:23603762}. /FTId=VAR_070579.; VARIANT 413 413 M -> V (in dbSNP:rs13663). /FTId=VAR_052674.,,,,CONFLICT 35 35 G -> A (in Ref. 1; AAA52620). {ECO:0000305}.; CONFLICT 202 202 V -> L (in Ref. 1; AAA52620). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the tubulin family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Tubulin is the major constituent of microtubules. The gamma chain is found at microtubule organizing centers (MTOC) such as the spindle poles or the centrosome. Pericentriolar matrix component that regulates alpha/beta chain minus-end nucleation, centrosome duplication and spindle formation.",,,,,,,,,,NP_BIND 142 148 GTP. {ECO:0000255}.,,apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200],apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819],GO:0000070; GO:0000086; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0005874; GO:0005881; GO:0007017; GO:0007020; GO:0007052; GO:0010389; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0045177; GO:0055037; GO:0097711; GO:0097730,IPR002454; IPR008280; IPR000217; IPR018316; IPR037103; IPR036525; IPR023123; IPR017975; IPR003008; ,Itself; O15169; Q96L34; Q08AG7; Q6NZ67; Q9UGJ1-2,"SUBUNIT: Interacts with TUBGCP2 and TUBGCP3 (PubMed:9566969, PubMed:9566969). Interacts with B9D2 (By similarity). Interacts with CDK5RAP2; the interaction is leading to centrosomal localization of TUBG1 and CDK5RAP2 (PubMed:17959831). Interacts with PIFO (PubMed:20643351). Interacts with SAS6 and NUP62 at the centrosome (PubMed:24107630). {ECO:0000250|UniProtKB:P83887, ECO:0000269|PubMed:17959831, ECO:0000269|PubMed:20643351, ECO:0000269|PubMed:24107630, ECO:0000269|PubMed:9566967, ECO:0000269|PubMed:9566969}.",1904010; 14702039; 15489334; 11840567; 9566967; 9566969; 14654843; 17959831; 20643351; 21269460; 24107630; 23603762,1904010; 14702039; 15489334; 11840567; 9566967; 9566969; 14654843; 17959831; 20643351; 21269460; 24107630; 23603762; 11076968; 11163258; 11956313; 12207013; 12221128; 12812986; 12852856; 13678582; 14580337; 14594945; 14676191; 15498487; 15705883; 15917813; 16357211; 16462731; 16890155; 17102634; 17139249; 17314511; 17406983; 17574030; 17646400; 17719545; 17853893; 18037885; 18316369; 18388201; 18566290; 18615013; 18621829; 18694559; 18847512; 19004860; 19215229; 19242490; 19299467; 19390532; 19509060; 19536135; 19543530; 19648910; 19940019; 20056645; 20224777; 20230748; 20360068; 20399632; 20467437; 20508983; 20558667; 20577264; 21273506; 21347367; 21422230; 21465471; 21473851; 21548880; 21565611; 21620453; 21725307; 21792235; 21795687; 21951856; 22094468; 22179047; 22653444; 22806905; 22818914; 23141531; 23141541; 23253480; 23348840; 23400999; 23530209; 23747070; 23769972; 23789104; 23921553; 23966160; 24053599; 24089205; 24231678; 24469809; 24620973; 24725412; 24942739; 24982133; 25031076; 25047611; 25313408; 25532896; 25542213; 25609649; 25830658; 26496610; 26556314; 28119396; 29339327; 7769006; 7790358; 8838651,1991-11-01,2019-02-13,2002-05-02,199,X-ray crystallography (3),STRAND 5 10 {ECO:0000244|PDB:3CB2}.; STRAND 33 35 {ECO:0000244|PDB:1Z5V}.; STRAND 52 54 {ECO:0000244|PDB:3CB2}.; STRAND 60 62 {ECO:0000244|PDB:3CB2}.; STRAND 64 71 {ECO:0000244|PDB:3CB2}.; STRAND 91 93 {ECO:0000244|PDB:3CB2}.; STRAND 134 144 {ECO:0000244|PDB:3CB2}.; STRAND 164 172 {ECO:0000244|PDB:3CB2}.; STRAND 200 206 {ECO:0000244|PDB:3CB2}.; STRAND 244 247 {ECO:0000244|PDB:3CB2}.; STRAND 248 250 {ECO:0000244|PDB:1Z5V}.; STRAND 262 265 {ECO:0000244|PDB:1Z5V}.; STRAND 268 274 {ECO:0000244|PDB:3CB2}.; STRAND 303 305 {ECO:0000244|PDB:3CB2}.; STRAND 317 327 {ECO:0000244|PDB:3CB2}.; STRAND 350 352 {ECO:0000244|PDB:1Z5V}.; STRAND 356 361 {ECO:0000244|PDB:3CB2}.; STRAND 374 381 {ECO:0000244|PDB:3CB2}.,HELIX 11 28 {ECO:0000244|PDB:3CB2}.; HELIX 48 50 {ECO:0000244|PDB:3CB2}.; HELIX 72 79 {ECO:0000244|PDB:3CB2}.; HELIX 88 90 {ECO:0000244|PDB:3CB2}.; HELIX 104 127 {ECO:0000244|PDB:3CB2}.; HELIX 145 160 {ECO:0000244|PDB:3CB2}.; HELIX 184 197 {ECO:0000244|PDB:3CB2}.; HELIX 207 216 {ECO:0000244|PDB:3CB2}.; HELIX 225 239 {ECO:0000244|PDB:3CB2}.; HELIX 253 260 {ECO:0000244|PDB:3CB2}.; HELIX 290 296 {ECO:0000244|PDB:3CB2}.; HELIX 300 302 {ECO:0000244|PDB:3CB2}.; HELIX 330 342 {ECO:0000244|PDB:3CB2}.; HELIX 382 384 {ECO:0000244|PDB:3CB2}.; HELIX 385 400 {ECO:0000244|PDB:3CB2}.; HELIX 406 409 {ECO:0000244|PDB:3CB2}.; HELIX 412 414 {ECO:0000244|PDB:3CB2}.; HELIX 419 437 {ECO:0000244|PDB:3CB2}.; HELIX 441 443 {ECO:0000244|PDB:3CB2}.,TURN 81 85 {ECO:0000244|PDB:3CB2}.; TURN 240 243 {ECO:0000244|PDB:3CB2}.,,,,,5 out of 5,Beta strand (18); Chain (1); Helix (19); Mass spectrometry (1); Modified residue (1); Natural variant (4); Nucleotide binding (1); Sequence conflict (2); Turn (2),,,,3D-structure;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;GTP-binding;Lissencephaly;Microtubule;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,Tubulin family,199,Function (1); Involvement in disease (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0181; KW-0206; KW-0225; KW-0342; KW-0451; KW-0493; KW-0547; KW-0597; KW-0621; KW-0963; KW-1185,,,,,"DISEASE: Cortical dysplasia, complex, with other brain malformations 4 (CDCBM4) [MIM:615412]: A disorder of aberrant neuronal migration and disturbed axonal guidance. Clinical features include early-onset seizures, microcephaly, spastic tetraplegia, and various malformations of cortical development, such as agyria, posterior or frontal pachygyria, thick cortex, and subcortical band heterotopia and thin corpus callosum in some patients. {ECO:0000269|PubMed:23603762}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Phosphorylation at Ser-131 by BRSK1 regulates centrosome duplication, possibly by mediating relocation of gamma-tubulin and its associated proteins from the cytoplasm to the centrosome. {ECO:0000250}.",CHAIN 1 451 Tubulin gamma-1 chain. /FTId=PRO_0000048465.,,,,,,MOD_RES 131 131 Phosphoserine; by BRSK1. {ECO:0000250|UniProtKB:P83887}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M61764;BT019931;CR407642;AK313339;BC000619;
0,P27361,MK03_HUMAN,MAPK3 ERK1 PRKM3,MAPK3,ERK1 PRKM3,,,Homo sapiens (Human),9606,Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1),UP000005640: Chromosome 16,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAAAAAQGGGGGEPRRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQPGVLEAP,379,"43,136",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=P27361-1; Sequence=Displayed; Name=2; IsoId=P27361-2; Sequence=VSP_041906; Name=3; Synonyms=ERK1b; IsoId=P27361-3; Sequence=VSP_041907; ,,,,,,,,,,VAR_SEQ 259 302 Missing (in isoform 2). {ECO:0000303|Ref.3}. /FTId=VSP_041906.; VAR_SEQ 340 379 PVAEEPFTFAMELDDLPKERLKELIFQETARFQPGVLEAP -> VGQSPAAVGLGAGEQGGT (in isoform 3). {ECO:0000303|Ref.2}. /FTId=VSP_041907.,VARIANT 323 323 E -> K (in dbSNP:rs55859133). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042253.,,,,CONFLICT 174 174 I -> S (in Ref. 1; CAA42744 and 2; AAK52329). {ECO:0000305}.,,4,,0,DOMAIN: The TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases. {ECO:0000269|PubMed:10521408}.,SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily. {ECO:0000305}.,,,DOMAIN 42 330 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,MOTIF 202 204 TXY.,,,,2.7.11.24,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.24; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.24;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; ,,"FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade plays also a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1) and a variety of other signaling-related molecules (like ARHGEF2, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. {ECO:0000269|PubMed:10393181, ECO:0000269|PubMed:10617468, ECO:0000269|PubMed:12110590, ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:12974390, ECO:0000269|PubMed:15788397, ECO:0000269|PubMed:15952796, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:8325880, ECO:0000269|PubMed:9155018, ECO:0000269|PubMed:9480836}.",,,,,,"ACT_SITE 166 166 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 71 71 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 48 56 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; cardiac neural crest cell development involved in heart development [GO:0061308]; cartilage development [GO:0051216]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to dopamine [GO:1903351]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; decidualization [GO:0046697]; DNA damage induced protein phosphorylation [GO:0006975]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung morphogenesis [GO:0060425]; MAPK cascade [GO:0000165]; negative regulation of apolipoprotein binding [GO:2000657]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of cellular pH [GO:0030641]; regulation of cellular response to heat [GO:1900034]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; stress-activated MAPK cascade [GO:0051403]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; transcription initiation from RNA polymerase I promoter [GO:0006361]; viral process [GO:0016032],activation of MAPK activity [GO:0000187]; aging [GO:0007568]; apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; cardiac neural crest cell development involved in heart development [GO:0061308]; cartilage development [GO:0051216]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to dopamine [GO:1903351]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; decidualization [GO:0046697]; DNA damage induced protein phosphorylation [GO:0006975]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung morphogenesis [GO:0060425]; MAPK cascade [GO:0000165]; negative regulation of apolipoprotein binding [GO:2000657]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of cyclase activity [GO:0031281]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of xenophagy [GO:1904417]; protein-containing complex assembly [GO:0065003]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cellular response to heat [GO:1900034]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; stress-activated MAPK cascade [GO:0051403]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; transcription initiation from RNA polymerase I promoter [GO:0006361]; viral process [GO:0016032],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143],GO:0000165; GO:0000187; GO:0001784; GO:0001934; GO:0002741; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006361; GO:0006468; GO:0006915; GO:0006975; GO:0007049; GO:0007411; GO:0007568; GO:0008543; GO:0009636; GO:0010468; GO:0010628; GO:0010759; GO:0014066; GO:0016032; GO:0016301; GO:0016310; GO:0018105; GO:0019233; GO:0019369; GO:0019902; GO:0030168; GO:0030278; GO:0030509; GO:0030641; GO:0030878; GO:0031143; GO:0031281; GO:0031663; GO:0032212; GO:0032872; GO:0032991; GO:0033129; GO:0034198; GO:0034614; GO:0035066; GO:0035556; GO:0038083; GO:0038095; GO:0038096; GO:0042473; GO:0042802; GO:0043330; GO:0045727; GO:0045944; GO:0046697; GO:0048538; GO:0051090; GO:0051216; GO:0051403; GO:0051493; GO:0051973; GO:0060020; GO:0060324; GO:0060425; GO:0060440; GO:0061308; GO:0065003; GO:0070371; GO:0070374; GO:0070498; GO:0070849; GO:0071260; GO:0071276; GO:0071310; GO:0071356; GO:0072584; GO:0090170; GO:0097110; GO:1900034; GO:1903351; GO:1904355; GO:1904417; GO:1905050; GO:2000641; GO:2000657,IPR011009; IPR003527; IPR008349; IPR000719; IPR017441; IPR008271; ,Itself; P53355; P49366; P28562; P19419; Q08509; Q60793; Q02750; P28482; Q16539; Q9EPI6; Q15121; P14618-1; Q8N490; P23467; Q12913; Q62132; Q15349; Q14160,"SUBUNIT: Binds both upstream activators and downstream substrates in multimolecular complexes. Found in a complex with at least BRAF, HRAS, MAP2K1/MEK1, MAPK3 and RGS14 (By similarity). Interacts with ADAM15, ARRB2, CANX, DAPK1 (via death domain), HSF4, IER3, MAP2K1/MEK1, MORG1, NISCH, and SGK1. Interacts with PEA15 and MKNK2 (By similarity). MKNK2 isoform 1 binding prevents from dephosphorylation and inactivation (By similarity). Interacts with TPR. Interacts with CDKN2AIP. Interacts with HSF1 (via D domain and preferentially with hyperphosphorylated form); this interaction occurs upon heat shock (PubMed:10747973). Interacts with CAVIN4 (By similarity). {ECO:0000250|UniProtKB:P21708, ECO:0000250|UniProtKB:Q63844, ECO:0000269|PubMed:10393181, ECO:0000269|PubMed:10521408, ECO:0000269|PubMed:10747973, ECO:0000269|PubMed:11912194, ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:15616583, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:18296648, ECO:0000269|PubMed:18435604, ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:19060905, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:24825908}.; SUBUNIT: (Microbial infection) Binds to HIV-1 Nef through its SH3 domain. This interaction inhibits its tyrosine-kinase activity. {ECO:0000269|PubMed:8794306}.",7687743; 15616553; 15489334; 1540184; 1319925; 8325880; 8794306; 9155018; 9480836; 10393181; 10224087; 10521408; 10617468; 10747973; 12356731; 11912194; 15526160; 15952796; 15616583; 12110590; 12974390; 15788397; 17081983; 16581800; 17274988; 18435604; 18296648; 18691976; 18794356; 18669648; 19413330; 19265199; 19494114; 19447520; 19369195; 19060905; 16393692; 19565474; 19690332; 20068231; 21269460; 21779493; 21406692; 22223895; 22814378; 23186163; 24825908; 18983981; 17344846,7687743; 15616553; 15489334; 1540184; 1319925; 8325880; 8794306; 9155018; 9480836; 10393181; 10224087; 10521408; 10617468; 10747973; 12356731; 11912194; 15526160; 15952796; 15616583; 12110590; 12974390; 15788397; 17081983; 16581800; 17274988; 18435604; 18296648; 18691976; 18794356; 18669648; 19413330; 19265199; 19494114; 19447520; 19369195; 19060905; 16393692; 19565474; 19690332; 20068231; 21269460; 21779493; 21406692; 22223895; 22814378; 23186163; 24825908; 18983981; 17344846; 10066421; 10209122; 10358095; 10409742; 10419510; 10508167; 10567369; 10725339; 10878576; 10891492; 11134045; 11238443; 11408587; 11546808; 11583024; 11698404; 11702783; 11739401; 11741541; 11741977; 11776327; 11782450; 11788588; 11792123; 11802164; 11802165; 11866540; 11884401; 11891214; 11923300; 11930938; 11937531; 11952164; 11960991; 11961297; 11971971; 12030372; 12032311; 12032872; 12068308; 12081892; 12082090; 12082091; 12134156; 12138104; 12183542; 12200131; 12218048; 12362243; 12408764; 12419216; 12441075; 12446729; 12456688; 12473660; 12479806; 12531514; 12538349; 12540563; 12555071; 12562867; 12582176; 12603851; 12606501; 12637339; 12637525; 12643788; 12663671; 12676937; 12682854; 12689928; 12690112; 12695496; 12727216; 12794156; 12810719; 12821662; 12832284; 12832465; 12840032; 12935895; 12937136; 12943720; 12960100; 14506247; 14515181; 14532121; 14575703; 14587029; 14602725; 14622970; 14634064; 14636584; 14651992; 14654779; 14671106; 14676217; 14701866; 14707138; 14711824; 14714552; 14729966; 14744867; 14960303; 14970219; 14985328; 15016620; 15030407; 15035987; 15040022; 15059773; 15064239; 15068691; 15078890; 15113754; 15118098; 15128760; 15143154; 15173068; 15210734; 15239952; 15243131; 15247230; 15247297; 15249224; 15256218; 15260967; 15292176; 15321994; 15322023; 15336571; 15347670; 15355986; 15356145; 15364926; 1545823; 15471881; 15509801; 15520807; 15542825; 15543157; 15545519; 15546878; 15547943; 15563472; 15572696; 15630448; 15642734; 15653554; 15657136; 15664191; 15671028; 15721302; 15728253; 15735702; 15739119; 15746430; 15757891; 15784503; 15809051; 15814736; 15879168; 15880942; 15890751; 15919053; 15923189; 15939799; 15967991; 15985432; 16009706; 16009940; 16047735; 16050810; 16081426; 16135787; 16139798; 16149052; 16153436; 16156742; 16209712; 16239230; 16253958; 16273281; 16278291; 16278684; 16280323; 16287813; 16291755; 16317051; 16321971; 16332685; 16364920; 16368546; 16373414; 16406609; 16407301; 16414009; 16428339; 16436515; 16456541; 16464493; 16484360; 16492667; 16508002; 16515552; 16533948; 16538383; 16556602; 16569214; 16574793; 16580177; 16585161; 16617096; 16624816; 16626623; 16644735; 16670094; 16676006; 16687572; 16705745; 16735500; 16794828; 16796978; 16813525; 16814113; 16814421; 16820412; 16820791; 16826196; 16844778; 16849642; 16879721; 16926156; 16941494; 16954218; 16990258; 16995340; 16998804; 17016429; 17035635; 17068339; 17068343; 17131384; 17142261; 17149612; 17178906; 17182854; 17192257; 17200115; 17202194; 17208316; 17212589; 17215072; 17237147; 17237423; 17267664; 17273789; 17274723; 17290218; 17294242; 17297454; 17303382; 17303384; 17311928; 17317670; 17322878; 17341442; 17351113; 17353931; 17382881; 17388789; 17406055; 17410437; 17427197; 17443665; 17453826; 17464174; 17478078; 17496912; 17496918; 17504381; 17510316; 17513610; 17519976; 17522999; 17525735; 17526808; 17543571; 17563371; 17565009; 17575262; 17581212; 17582224; 17583675; 17615382; 17620336; 17622743; 17634019; 17644078; 17652082; 17662006; 17662305; 17686614; 17695723; 17721511; 17765224; 17825787; 17850776; 17879163; 17881458; 17884340; 17889508; 17889855; 17921324; 17932312; 17936667; 17938255; 17942397; 17942603; 17967787; 17974977; 17991320; 17991743; 18006496; 18022816; 18034864; 18036343; 18055485; 18063683; 18065201; 18079194; 18079197; 18086557; 18086662; 18087676; 18095097; 18164958; 18165705; 18166657; 18174382; 18187448; 18189318; 18191226; 18210145; 18212269; 18224451; 18245089; 18245228; 18263590; 18266953; 18270969; 18271757; 18276593; 18280112; 18280482; 18280748; 18288130; 18292183; 18327407; 18328346; 18332145; 1835084; 18358530; 18365874; 18372245; 18378312; 18385516; 18387958; 18398416; 18405916; 18410277; 18414015; 18423386; 18424438; 18424783; 18426801; 18426913; 18433299; 18434089; 18434324; 18434598; 18448488; 18452557; 18463290; 18487214; 18488018; 18508903; 18516291; 18535203; 18559923; 18562239; 18563362; 18570890; 18572386; 18577518; 18593910; 18617556; 18617639; 18624398; 18632853; 18644434; 18660489; 18667434; 18682391; 18688042; 18691388; 18694962; 18703508; 18710790; 18711316; 18755896; 18771677; 18775330; 18775472; 18787043; 18787400; 18830271; 18853184; 18854640; 18949384; 18974108; 18981248; 18986987; 19008312; 19015316; 19020743; 19032445; 19035465; 19082454; 19091303; 19091959; 19097033; 19116345; 19147502; 19147767; 19153083; 19154323; 19160418; 19164129; 19164283; 19167335; 19184415; 19188252; 19197339; 19199380; 19206162; 19219045; 19242111; 19242545; 19266047; 19279408; 19298651; 19328461; 19363666; 19366876; 19367725; 19404844; 19407222; 19412549; 19414528; 19418584; 19428994; 19445727; 19453261; 19457236; 19477952; 19502238; 19502590; 19528227; 19574994; 19575782; 19588500; 19589780; 19597469; 19608729; 19610261; 19619936; 19631608; 19632304; 19643177; 19649722; 19651986; 19652666; 19656390; 19666073; 19672022; 19676104; 19684019; 19686845; 19690147; 19697705; 19713532; 19723095; 19729990; 19751964; 19776005; 19782465; 19801668; 19802003; 19805545; 19808666; 19815047; 19816090; 19816934; 19816936; 19819966; 19822148; 19823867; 19833733; 19834610; 19835659; 19847302; 19855431; 19858308; 19874574; 19892016; 19895547; 19910580; 19917255; 19917706; 19920141; 19926313; 19930715; 19933846; 19956840; 20009539; 20016498; 20028985; 20038816; 20069553; 20072648; 20074451; 20074637; 20074640; 20075392; 20083603; 20087064; 20097574; 20102637; 20103886; 20123980; 20126471; 20130576; 20141835; 20154642; 20155832; 20164223; 20174585; 20179103; 20179705; 20180987; 20189953; 20190820; 20201065; 20203690; 20225236; 20226096; 20231899; 20232314; 20232315; 20307589; 20335309; 20347885; 20351270; 20358251; 20359813; 20385094; 20386571; 20406097; 20429916; 20432452; 20451919; 20453075; 20463007; 20463008; 20463170; 20464500; 20483734; 20485667; 20490331; 20493910; 20501673; 20506264; 20509944; 20512084; 20519144; 20526349; 20534573; 20538278; 20562859; 20566577; 20616308; 20622900; 20637859; 20664595; 20671117; 20671123; 20674547; 20680465; 20693286; 20701626; 20716207; 20726858; 20729213; 20731749; 20735841; 20736304; 20737958; 20811691; 20811717; 20823131; 20823133; 20829350; 20837468; 20840867; 20853849; 20858867; 20868224; 20889506; 20889557; 20957203; 21029458; 21057728; 21070506; 21071439; 21076047; 21079800; 21084381; 21123621; 21126445; 21129151; 21135229; 21150201; 21159167; 21172820; 21185392; 21187008; 21199725; 21209852; 21210654; 21212994; 21228323; 21262199; 21262770; 21270289; 21273059; 21278199; 21285250; 21293101; 21321112; 21325048; 21335558; 21349701; 21354279; 21370247; 21413023; 21419341; 21424530; 21444628; 21448845; 21454500; 21474332; 21474333; 21487005; 21520151; 21537329; 21541441; 21551235; 21574189; 21596018; 21606674; 21607585; 21625939; 21635820; 21645924; 21669399; 21687944; 21708241; 21713404; 21730054; 21732279; 21742938; 21747041; 21750416; 21752354; 21760921; 21765462; 21768093; 21768115; 21772273; 21778192; 21779496; 21803177; 21816898; 21833774; 21840940; 21852536; 21871886; 21873423; 21873429; 21878648; 21898401; 21899882; 21900206; 21908610; 21910869; 21914806; 21917714; 21925842; 21952366; 21959954; 21960346; 22009749; 22024154; 22025613; 22028468; 22031842; 22039050; 22052014; 22076613; 22076920; 22090124; 22094458; 22096605; 22117074; 22121028; 22147898; 22158075; 22162761; 22171261; 22174934; 22177953; 22178882; 22222560; 22229442; 22238304; 22265030; 22277029; 22293503; 22344606; 22347457; 22370345; 22384111; 22388352; 22393163; 22396784; 22406505; 22447027; 22465663; 22502979; 22504224; 22510884; 22543708; 22551942; 22556124; 22560877; 22562654; 22563495; 22563497; 22564243; 22569528; 22574813; 22593617; 22610905; 22672288; 22683641; 22696230; 22712802; 22722337; 22731636; 22735594; 22745804; 22796164; 22808094; 22808266; 22815910; 22828925; 22837689; 22848708; 22865467; 22866973; 22869729; 22898922; 22902213; 22909302; 22914360; 22914643; 22917644; 22927430; 22935974; 22955917; 22995914; 23012423; 23024368; 23056203; 23076151; 23088735; 23166842; 23174997; 23222305; 23237355; 23247634; 23258237; 23265704; 23274199; 23306155; 23319595; 23332156; 23341459; 23349307; 23352452; 23353780; 23357054; 23360766; 23397142; 23408424; 23416715; 23424616; 23430108; 23441482; 23452857; 23455179; 23457635; 23468892; 23516513; 23538858; 23558220; 23569008; 23575685; 23576434; 23583981; 23585396; 23589880; 23601559; 23602568; 23613227; 23615537; 23618859; 23620784; 23621408; 23621870; 23640488; 23644655; 23645677; 23651922; 23671702; 23677697; 23684072; 23686305; 23698777; 23709326; 23754287; 23806693; 23812726; 23812841; 23827636; 23847209; 23867452; 23922976; 23954936; 23966319; 23977025; 23982477; 24040019; 24065881; 24074900; 24086495; 24119769; 24121020; 24121058; 24135138; 24161842; 24164897; 24166600; 24183461; 24199952; 24202393; 24204846; 24239461; 24244431; 24252614; 24269383; 24291038; 24300666; 24331979; 24332066; 24345643; 24345920; 24365237; 24370825; 24371145; 24384722; 24397597; 24434142; 24488174; 24501087; 24521094; 24530396; 24565681; 24587385; 24606918; 24619413; 24651010; 24651445; 24657322; 24657659; 24677094; 24682903; 24706358; 24714552; 24716848; 24768991; 24788939; 24789460; 24810160; 24818995; 24833778; 24853429; 24937142; 24957944; 24966925; 24966948; 25016365; 25048004; 25066297; 25085753; 25091805; 25108429; 25118288; 25120769; 25141921; 25142507; 25167778; 25179402; 25187541; 25188412; 25195011; 25204415; 25214430; 25217205; 25241249; 25241253; 25241761; 25247600; 25267105; 25270024; 25319474; 25341684; 25398317; 25414256; 25435214; 25449334; 25497010; 25561793; 25596700; 25605020; 25622783; 25647783; 25652124; 25655003; 25675421; 25697727; 25713071; 25722974; 25733818; 25738359; 25748447; 25770213; 25780035; 25796184; 25816226; 25816245; 25846811; 25849721; 25852190; 25865632; 25907612; 25937083; 25962735; 26004135; 26041434; 26041847; 26043921; 26044620; 26046303; 26046675; 26047699; 26051103; 26054744; 26096876; 26182292; 26204503; 26211551; 26234813; 26247533; 26253279; 26261493; 26261552; 26295469; 26324936; 26334722; 26336134; 26379399; 26385474; 26400984; 26408092; 26441204; 26464031; 26496610; 26499109; 26514924; 26519477; 26574555; 26580203; 26612919; 26617770; 26705127; 26711788; 26715278; 26716515; 26742423; 26767647; 26781754; 26782637; 26785721; 26795953; 26810068; 26823016; 26828872; 26858456; 26867010; 26879318; 26919095; 26930065; 26945151; 26945908; 26983806; 26988568; 27036313; 27054717; 27085460; 27098723; 27100626; 27107697; 27119567; 27133199; 27134571; 27152455; 27181591; 27216486; 27226339; 27259234; 27282353; 27293079; 27304216; 27305863; 27363268; 27366950; 27443255; 27456359; 27458015; 27492718; 27494841; 27498358; 27533246; 27564099; 27590109; 27591897; 27601158; 27613715; 27635110; 27665471; 27678294; 27721381; 27734226; 27780136; 27791265; 27876502; 27884160; 27901058; 27909249; 27927769; 27980400; 28061458; 28077802; 28096188; 28100259; 28106280; 28120452; 28147324; 28169830; 28178265; 28178656; 28180113; 28187762; 28188223; 28193911; 28196117; 28230290; 28247965; 28279977; 28285962; 28287251; 28295277; 28315433; 28316059; 28364380; 28389297; 28396058; 28396345; 28484053; 28533310; 28536097; 28557972; 28624624; 28630428; 28807789; 28844715; 28876465; 28912272; 28938400; 28986121; 29136244; 29198699; 29286066; 29383561; 29414775; 29475459; 29503347; 29729697; 30039885; 30106432; 30249660; 3287375; 7565670; 7565795; 7588608; 7588633; 7731720; 7739560; 7889942; 7929275; 7935411; 8013650; 8051079; 8157000; 8384717; 8388392; 8394845; 8444886; 8552081; 8626767; 8816480; 8946918; 9020159; 9604935; 9677429; 9687510; 9733512; 9792677; 9858547; 9924018; 9927426,1992-08-01,2019-02-13,2007-01-23,218,X-ray crystallography (2),STRAND 29 31 {ECO:0000244|PDB:4QTB}.; STRAND 34 36 {ECO:0000244|PDB:4QTB}.; STRAND 42 51 {ECO:0000244|PDB:4QTB}.; STRAND 54 61 {ECO:0000244|PDB:4QTB}.; STRAND 66 73 {ECO:0000244|PDB:4QTB}.; STRAND 105 107 {ECO:0000244|PDB:4QTB}.; STRAND 118 122 {ECO:0000244|PDB:4QTB}.; STRAND 126 128 {ECO:0000244|PDB:4QTB}.; STRAND 172 174 {ECO:0000244|PDB:4QTB}.; STRAND 180 182 {ECO:0000244|PDB:4QTB}.,HELIX 79 94 {ECO:0000244|PDB:4QTB}.; HELIX 129 135 {ECO:0000244|PDB:4QTB}.; HELIX 140 159 {ECO:0000244|PDB:4QTB}.; HELIX 169 171 {ECO:0000244|PDB:4QTB}.; HELIX 193 195 {ECO:0000244|PDB:4QTB}.; HELIX 208 210 {ECO:0000244|PDB:4QTB}.; HELIX 213 215 {ECO:0000244|PDB:4QTB}.; HELIX 225 240 {ECO:0000244|PDB:4QTB}.; HELIX 250 261 {ECO:0000244|PDB:4QTB}.; HELIX 266 269 {ECO:0000244|PDB:4QTB}.; HELIX 275 282 {ECO:0000244|PDB:4QTB}.; HELIX 292 295 {ECO:0000244|PDB:4QTB}.; HELIX 301 310 {ECO:0000244|PDB:4QTB}.; HELIX 315 317 {ECO:0000244|PDB:4QTB}.; HELIX 321 325 {ECO:0000244|PDB:4QTB}.; HELIX 328 330 {ECO:0000244|PDB:4QTB}.; HELIX 336 338 {ECO:0000244|PDB:4QTB}.; HELIX 350 354 {ECO:0000244|PDB:4QTB}.; HELIX 357 368 {ECO:0000244|PDB:4QTB}.; HELIX 369 371 {ECO:0000244|PDB:4QTB}.,TURN 39 41 {ECO:0000244|PDB:4QTB}.; TURN 62 65 {ECO:0000244|PDB:4QTB}.; TURN 112 114 {ECO:0000244|PDB:4QTB}.; TURN 216 218 {ECO:0000244|PDB:4QTB}.; TURN 331 333 {ECO:0000244|PDB:4QTB}.,,,,,5 out of 5,Active site (1); Alternative sequence (2); Beta strand (10); Binding site (1); Chain (1); Domain (1); Helix (20); Initiator methionine (1); Modified residue (5); Motif (1); Natural variant (1); Nucleotide binding (1); Sequence conflict (2); Turn (5),,,,3D-structure;ATP-binding;Acetylation;Alternative splicing;Apoptosis;Cell cycle;Complete proteome;Cytoplasm;Direct protein sequencing;Host-virus interaction;Kinase;Membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase,Evidence at protein level,reviewed,,"Protein kinase superfamily, CMGC Ser/Thr protein kinase family, MAP kinase subfamily",218,Activity regulation (1); Alternative products (1); Catalytic activity (2); Cofactor (1); Domain (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (2),,KW-0002; KW-0007; KW-0025; KW-0053; KW-0067; KW-0131; KW-0181; KW-0418; KW-0472; KW-0539; KW-0547; KW-0597; KW-0621; KW-0723; KW-0808; KW-0903; KW-0945; KW-0963; KW-1185,,,,,,,,"PTM: Phosphorylated upon KIT and FLT3 signaling (By similarity). Dually phosphorylated on Thr-202 and Tyr-204, which activates the enzyme. Ligand-activated ALK induces tyrosine phosphorylation. Dephosphorylated by PTPRJ at Tyr-204. {ECO:0000250, ECO:0000269|PubMed:17274988, ECO:0000269|PubMed:18983981, ECO:0000269|PubMed:19060905, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:19494114}.",CHAIN 2 379 Mitogen-activated protein kinase 3. /FTId=PRO_0000186251.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.8}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.8}.; MOD_RES 198 198 Phosphothreonine. {ECO:0000244|PubMed:19369195}.; MOD_RES 202 202 Phosphothreonine; by MAP2K1 and MAP2K2. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 204 204 Phosphotyrosine; by MAP2K1 and MAP2K2. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:18983981, ECO:0000269|PubMed:19494114}.; MOD_RES 207 207 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:19060905}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X60188;AY033607;DQ399291;EU332853;CH471238;CH471238;BC013992;M84490;Z11696;
0,P51955,NEK2_HUMAN,NEK2 NEK2A NLK1,NEK2,NEK2A NLK1,,,Homo sapiens (Human),9606,Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIADLVADEQRRNLERRGRQLGEPEKSQDSSPVLSELKLKEIQLQERERALKAREERLEQKEQELCVRERLAEDKLARAENLLKNYSLLKERKFLSLASNPELLNLPSSVIKKKVHFSGESKENIMRSENSESQLTSKSKCKDLKKRLHAAQLRAQALSDIEKNYQLKSRQILGMR,445,"51,763",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; Synonyms=Nek2A; IsoId=P51955-1; Sequence=Displayed; Name=2; Synonyms=Nek2B; IsoId=P51955-2; Sequence=VSP_015578, VSP_015579; Name=3; IsoId=P51955-3; Sequence=VSP_015576, VSP_015577; Name=4; Synonyms=Nek2C, Nek2A-T; IsoId=P51955-4; Sequence=VSP_041758; ",,,,,SEQUENCE CAUTION:  Sequence=AAH65932.1; Type=Frameshift; Positions=213; Evidence={ECO:0000305}; ,,,,,VAR_SEQ 323 326 REER -> KKKK (in isoform 3). {ECO:0000303|PubMed:15489334}. /FTId=VSP_015576.; VAR_SEQ 327 445 Missing (in isoform 3). {ECO:0000303|PubMed:15489334}. /FTId=VSP_015577.; VAR_SEQ 371 384 ELLNLPSSVIKKKV -> GMRINLVNRSWCYK (in isoform 2). {ECO:0000303|PubMed:11742531}. /FTId=VSP_015578.; VAR_SEQ 371 378 Missing (in isoform 4). {ECO:0000303|PubMed:15659832}. /FTId=VSP_041758.; VAR_SEQ 385 445 Missing (in isoform 2). {ECO:0000303|PubMed:11742531}. /FTId=VSP_015579.,"VARIANT 354 354 N -> S (in dbSNP:rs2230489). {ECO:0000269|PubMed:17344846, ECO:0000269|Ref.5}. /FTId=VAR_019990.; VARIANT 410 410 C -> Y (in dbSNP:rs56102977). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040907.",,,,CONFLICT 84 85 IV -> LY (in Ref. 8; CAA80912). {ECO:0000305}.; CONFLICT 325 325 E -> K (in Ref. 5; BAD97073). {ECO:0000305}.,,1,,0,DOMAIN: The leucine-zipper domain is required for its dimerization and activation. {ECO:0000269|PubMed:21669869}.,SIMILARITY: Belongs to the protein kinase superfamily. NEK Ser/Thr protein kinase family. NIMA subfamily. {ECO:0000305}.,COILED 303 362 {ECO:0000255}.; COILED 406 430 {ECO:0000255}.,,DOMAIN 8 271 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,REGION 264 445 Interaction with PCNT. {ECO:0000269|PubMed:20599736}.; REGION 301 445 Interaction with CEP85. {ECO:0000269|PubMed:26220856}.; REGION 306 334 Leucine-zipper.; REGION 329 445 Necessary for interaction with MAD1L1. {ECO:0000269|PubMed:14978040}.; REGION 333 370 Required for microtubule binding and for localization to the centrosomes.; REGION 403 439 Interaction with SAV1 and STK3/MST2. {ECO:0000269|PubMed:21076410}.,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ,,"FUNCTION: Protein kinase which is involved in the control of centrosome separation and bipolar spindle formation in mitotic cells and chromatin condensation in meiotic cells. Regulates centrosome separation (essential for the formation of bipolar spindles and high-fidelity chromosome separation) by phosphorylating centrosomal proteins such as CROCC, CEP250 and NINL, resulting in their displacement from the centrosomes. Regulates kinetochore microtubule attachment stability in mitosis via phosphorylation of NDC80. Involved in regulation of mitotic checkpoint protein complex via phosphorylation of CDC20 and MAD2L1. Plays an active role in chromatin condensation during the first meiotic division through phosphorylation of HMGA2. Phosphorylates: PPP1CC; SGO1; NECAB3 and NPM1. Essential for localization of MAD2L1 to kinetochore and MAPK1 and NPM1 to the centrosome. Phosphorylates CEP68 and CNTLN directly or indirectly (PubMed:24554434). NEK2-mediated phosphorylation of CEP68 promotes CEP68 dissociation from the centrosome and its degradation at the onset of mitosis (PubMed:25704143). Involved in the regulation of centrosome disjunction (PubMed:26220856). {ECO:0000269|PubMed:11742531, ECO:0000269|PubMed:12857871, ECO:0000269|PubMed:14978040, ECO:0000269|PubMed:15358203, ECO:0000269|PubMed:15388344, ECO:0000269|PubMed:17283141, ECO:0000269|PubMed:17621308, ECO:0000269|PubMed:17626005, ECO:0000269|PubMed:18086858, ECO:0000269|PubMed:18297113, ECO:0000269|PubMed:20034488, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:24554434, ECO:0000269|PubMed:25704143, ECO:0000269|PubMed:26220856}.; FUNCTION: Isoform 1: Phosphorylates and activates NEK11 in G1/S-arrested cells. {ECO:0000269|PubMed:15161910}.; FUNCTION: Isoform 2: Not present in the nucleolus and, in contrast to isoform 1, does not phosphorylate and activate NEK11 in G1/S-arrested cells. {ECO:0000269|PubMed:15161910}.",,,,,,"ACT_SITE 141 141 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 37 37 ATP.,,,NP_BIND 14 22 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; negative regulation of DNA binding [GO:0043392]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225],blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; negative regulation of DNA binding [GO:0043392]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674],centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922],GO:0000070; GO:0000086; GO:0000278; GO:0000776; GO:0000777; GO:0000794; GO:0000922; GO:0001824; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0005874; GO:0006468; GO:0007059; GO:0007088; GO:0010389; GO:0019903; GO:0030496; GO:0032212; GO:0032991; GO:0043392; GO:0046602; GO:0046777; GO:0046872; GO:0051225; GO:0051299; GO:0051301; GO:0051321; GO:0051973; GO:0051988; GO:0090307; GO:0097711; GO:1903126; GO:1904355,IPR011009; IPR000719; IPR008271; ,Q9UJX5; P30260; Q6GQ04; Q5T7B8; Q8NG66,"SUBUNIT: Isoform 1, isoform 2 and isoform 4 form homo- and heterodimers. Interacts with NECAB3 and HMGA2 (By similarity). Isoform 1 interacts with CDC20, CTNB1, MAD1L1, MAPK, NEK11, NPM1, NDC80, PCNT and SGO1 (PubMed:14978040, PubMed:15358203, PubMed:15388344, PubMed:15161910, PubMed:17621308, PubMed:18086858, PubMed:18297113, PubMed:20599736, PubMed:20034488). Isoform 1 interacts with STK3/MST2 (via SARAH domain) and SAV1 (via SARAH domain) (PubMed:21076410). Isoform 1 and isoform 2 interact with MAD2L1 (PubMed:20034488). Isoform 1 and isoform 4 interact with PPP1CA and PPP1CC (PubMed:15659832, PubMed:17283141). Interacts with CEP68; the interaction leads to phosphorylation of CEP68. Interacts with CNTLN; the interaction leads to phosphorylation of CNTLN (PubMed:24554434). Isoform 1 interacts with CEP85 (PubMed:26220856). {ECO:0000250|UniProtKB:O35942, ECO:0000269|PubMed:14978040, ECO:0000269|PubMed:15161910, ECO:0000269|PubMed:15358203, ECO:0000269|PubMed:15388344, ECO:0000269|PubMed:15659832, ECO:0000269|PubMed:17197699, ECO:0000269|PubMed:17283141, ECO:0000269|PubMed:17621308, ECO:0000269|PubMed:17626005, ECO:0000269|PubMed:18086858, ECO:0000269|PubMed:18297113, ECO:0000269|PubMed:20034488, ECO:0000269|PubMed:20599736, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:24554434, ECO:0000269|PubMed:26220856}.",7522034; 11742531; 16710414; 15489334; 8274451; 15659832; 14978040; 12857871; 14654843; 15358203; 15388344; 15161910; 17283141; 17621308; 17626005; 18086858; 18088087; 18691976; 18297113; 19941817; 19369195; 20599736; 20034488; 21076410; 21669869; 16280549; 23186163; 24043777; 24554434; 25704143; 26220856; 17197699; 17344846,7522034; 11742531; 16710414; 15489334; 8274451; 15659832; 14978040; 12857871; 14654843; 15358203; 15388344; 15161910; 17283141; 17621308; 17626005; 18086858; 18088087; 18691976; 18297113; 19941817; 19369195; 20599736; 20034488; 21076410; 21669869; 16280549; 23186163; 24043777; 24554434; 25704143; 26220856; 17197699; 17344846; 11076968; 11742988; 11956313; 12207013; 12221103; 12221128; 12386167; 12852856; 13678582; 14580337; 15387139; 15492258; 15498487; 15659651; 15705883; 15950749; 16084011; 16157594; 16357211; 16462731; 16648845; 16890155; 17535851; 17574030; 17646400; 17719545; 18037885; 18566290; 18615013; 18694559; 19004860; 19008095; 19038001; 19123481; 19124027; 19637314; 19940019; 20230748; 20360068; 20399632; 20508983; 20558667; 20581865; 20718755; 20734064; 20936789; 21102556; 21273506; 21347367; 21366329; 21382349; 21407176; 21422230; 21548880; 21565611; 21620453; 21723128; 21725307; 21792235; 21832156; 21900206; 22014044; 22094468; 22179047; 22234886; 22321011; 22404346; 22613497; 22653444; 22824957; 22879911; 23001753; 23141531; 23141541; 23253480; 23288039; 23291182; 23340795; 23348840; 23370767; 23400999; 23530209; 23708664; 23747070; 23769972; 23776583; 23789104; 23921553; 24046120; 24053599; 24089205; 24091727; 24163369; 24214971; 24231678; 24337664; 24389189; 24469809; 24501426; 24763826; 24797070; 24982133; 25043295; 25047611; 25230277; 25313354; 25313408; 25532896; 25673878; 25705694; 26290419; 26320076; 26337275; 26496610; 26638075; 26823916; 26851035; 27019372; 27108190; 27297360; 27349376; 27486244; 27509921; 27833088; 27925179; 28086949; 28101574; 28321704; 28400617; 28475000; 28737508; 28759960; 29141582; 29225051; 29399700; 7769006; 7790358; 8838651,1996-10-01,2019-02-13,1996-10-01,204,X-ray crystallography (25),STRAND 8 16 {ECO:0000244|PDB:2W5A}.; STRAND 18 27 {ECO:0000244|PDB:2W5A}.; STRAND 33 40 {ECO:0000244|PDB:2W5A}.; STRAND 70 76 {ECO:0000244|PDB:2W5A}.; STRAND 81 87 {ECO:0000244|PDB:2W5A}.; STRAND 147 149 {ECO:0000244|PDB:2W5A}.; STRAND 151 153 {ECO:0000244|PDB:2W5A}.; STRAND 155 157 {ECO:0000244|PDB:2W5A}.,HELIX 5 7 {ECO:0000244|PDB:2W5A}.; HELIX 41 43 {ECO:0000244|PDB:2XK3}.; HELIX 46 61 {ECO:0000244|PDB:2W5A}.; HELIX 77 79 {ECO:0000244|PDB:2W5A}.; HELIX 94 103 {ECO:0000244|PDB:2W5A}.; HELIX 110 130 {ECO:0000244|PDB:2W5A}.; HELIX 144 146 {ECO:0000244|PDB:2W5A}.; HELIX 162 165 {ECO:0000244|PDB:2W5A}.; HELIX 171 177 {ECO:0000244|PDB:2W5A}.; HELIX 180 182 {ECO:0000244|PDB:5M53}.; HELIX 185 189 {ECO:0000244|PDB:2W5A}.; HELIX 195 211 {ECO:0000244|PDB:2W5A}.; HELIX 221 230 {ECO:0000244|PDB:2W5A}.; HELIX 242 251 {ECO:0000244|PDB:2W5A}.; HELIX 256 258 {ECO:0000244|PDB:2W5A}.; HELIX 262 266 {ECO:0000244|PDB:2W5A}.,TURN 28 30 {ECO:0000244|PDB:2W5A}.,,,,,5 out of 5,Active site (1); Alternative sequence (5); Beta strand (8); Binding site (1); Chain (1); Coiled coil (2); Domain (1); Frameshift (1); Helix (16); Modified residue (17); Mutagenesis (12); Natural variant (2); Nucleotide binding (1); Region (6); Sequence conflict (2); Turn (1),,"TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in peripheral blood T-cells and a wide variety of transformed cell types. Isoform 1 and isoform 4 are expressed in the testis. Up-regulated in various cancer cell lines, as well as primary breast tumors. {ECO:0000269|PubMed:11742531, ECO:0000269|PubMed:15659832}.",,3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Kinase;Kinetochore;Magnesium;Meiosis;Metal-binding;Microtubule;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Retinitis pigmentosa;Serine/threonine-protein kinase;Transferase,Evidence at protein level,reviewed,,"Protein kinase superfamily, NEK Ser/Thr protein kinase family, NIMA subfamily",204,Activity regulation (1); Alternative products (1); Catalytic activity (2); Cofactor (1); Domain (1); Function (3); Induction (1); Involvement in disease (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (3); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0067; KW-0131; KW-0132; KW-0137; KW-0158; KW-0159; KW-0175; KW-0181; KW-0206; KW-0418; KW-0460; KW-0469; KW-0479; KW-0493; KW-0498; KW-0539; KW-0547; KW-0597; KW-0621; KW-0682; KW-0723; KW-0808; KW-0963; KW-0995; KW-1185,,,,,"DISEASE: Retinitis pigmentosa 67 (RP67) [MIM:615565]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:24043777}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Activated by autophosphorylation. Protein phosphatase 1 represses autophosphorylation and activation of isoform 1 by dephosphorylation. Phosphorylation by STK3/MST2 is necessary for its localization to the centrosome. {ECO:0000269|PubMed:17197699, ECO:0000269|PubMed:21076410}.",CHAIN 1 445 Serine/threonine-protein kinase Nek2. /FTId=PRO_0000086421.,,,,,,"MOD_RES 170 170 Phosphothreonine; by autocatalysis. {ECO:0000305|PubMed:17197699}.; MOD_RES 171 171 Phosphoserine; by autocatalysis. {ECO:0000244|PubMed:23186163, ECO:0000305|PubMed:17197699}.; MOD_RES 175 175 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:17197699}.; MOD_RES 179 179 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:17197699}.; MOD_RES 184 184 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 241 241 Phosphoserine; by autocatalysis. {ECO:0000269|PubMed:17197699}.; MOD_RES 296 296 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195}.; MOD_RES 300 300 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 356 356 Phosphoserine; by STK3/MST2. {ECO:0000269|PubMed:17197699, ECO:0000269|PubMed:21076410}.; MOD_RES 365 365 Phosphoserine; by STK3/MST2. {ECO:0000269|PubMed:21076410}.; MOD_RES 387 387 Phosphoserine. {ECO:0000269|PubMed:17197699}.; MOD_RES 390 390 Phosphoserine. {ECO:0000269|PubMed:17197699}.; MOD_RES 397 397 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000269|PubMed:17197699}.; MOD_RES 402 402 Phosphoserine. {ECO:0000269|PubMed:17197699}.; MOD_RES 406 406 Phosphoserine; by STK3/MST2. {ECO:0000269|PubMed:21076410}.; MOD_RES 428 428 Phosphoserine. {ECO:0000269|PubMed:17197699}.; MOD_RES 438 438 Phosphoserine; by STK3/MST2. {ECO:0000269|PubMed:21076410}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,Z29066;AY045701;U11050;BT019729;AK223353;BC043502;BC052807;BC065932;Z25425;AY863109;
0,P78527,PRKDC_HUMAN,PRKDC HYRC HYRC1,PRKDC,HYRC HYRC1,,,Homo sapiens (Human),9606,DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (p460),UP000005640: Chromosome 8,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAGSGAGVRCSLLRLQETLSAADRCGAALAGHQLIRGLGQECVLSSSPAVLALQTSLVFSRDFGLLVFVRKSLNSIEFRECREEILKFLCIFLEKMGQKIAPYSVEIKNTCTSVYTKDRAAKCKIPALDLLIKLLQTFRSSRLMDEFKIGELFSKFYGELALKKKIPDTVLEKVYELLGLLGEVHPSEMINNAENLFRAFLGELKTQMTSAVREPKLPVLAGCLKGLSSLLCNFTKSMEEDPQTSREIFNFVLKAIRPQIDLKRYAVPSAGLRLFALHASQFSTCLLDNYVSLFEVLLKWCAHTNVELKKAALSALESFLKQVSNMVAKNAEMHKNKLQYFMEQFYGIIRNVDSNNKELSIAIRGYGLFAGPCKVINAKDVDFMYVELIQRCKQMFLTQTDTGDDRVYQMPSFLQSVASVLLYLDTVPEVYTPVLEHLVVMQIDSFPQYSPKMQLVCCRAIVKVFLALAAKGPVLRNCISTVVHQGLIRICSKPVVLPKGPESESEDHRASGEVRTGKWKVPTYKDYVDLFRHLLSSDQMMDSILADEAFFSVNSSSESLNHLLYDEFVKSVLKIVEKLDLTLEIQTVGEQENGDEAPGVWMIPTSDPAANLHPAKPKDFSAFINLVEFCREILPEKQAEFFEPWVYSFSYELILQSTRLPLISGFYKLLSITVRNAKKIKYFEGVSPKSLKHSPEDPEKYSCFALFVKFGKEVAVKMKQYKDELLASCLTFLLSLPHNIIELDVRAYVPALQMAFKLGLSYTPLAEVGLNALEEWSIYIDRHVMQPYYKDILPCLDGYLKTSALSDETKNNWEVSALSRAAQKGFNKVVLKHLKKTKNLSSNEAISLEEIRIRVVQMLGSLGGQINKNLLTVTSSDEMMKSYVAWDREKRLSFAVPFREMKPVIFLDVFLPRVTELALTASDRQTKVAACELLHSMVMFMLGKATQMPEGGQGAPPMYQLYKRTFPVLLRLACDVDQVTRQLYEPLVMQLIHWFTNNKKFESQDTVALLEAILDGIVDPVDSTLRDFCGRCIREFLKWSIKQITPQQQEKSPVNTKSLFKRLYSLALHPNAFKRLGASLAFNNIYREFREEESLVEQFVFEALVIYMESLALAHADEKSLGTIQQCCDAIDHLCRIIEKKHVSLNKAKKRRLPRGFPPSASLCLLDLVKWLLAHCGRPQTECRHKSIELFYKFVPLLPGNRSPNLWLKDVLKEEGVSFLINTFEGGGCGQPSGILAQPTLLYLRGPFSLQATLCWLDLLLAALECYNTFIGERTVGALQVLGTEAQSSLLKAVAFFLESIAMHDIIAAEKCFGTGAAGNRTSPQEGERYNYSKCTVVVRIMEFTTTLLNTSPEGWKLLKKDLCNTHLMRVLVQTLCEPASIGFNIGDVQVMAHLPDVCVNLMKALKMSPYKDILETHLREKITAQSIEELCAVNLYGPDAQVDRSRLAAVVSACKQLHRAGLLHNILPSQSTDLHHSVGTELLSLVYKGIAPGDERQCLPSLDLSCKQLASGLLELAFAFGGLCERLVSLLLNPAVLSTASLGSSQGSVIHFSHGEYFYSLFSETINTELLKNLDLAVLELMQSSVDNTKMVSAVLNGMLDQSFRERANQKHQGLKLATTILQHWKKCDSWWAKDSPLETKMAVLALLAKILQIDSSVSFNTSHGSFPEVFTTYISLLADTKLDLHLKGQAVTLLPFFTSLTGGSLEELRRVLEQLIVAHFPMQSREFPPGTPRFNNYVDCMKKFLDALELSQSPMLLELMTEVLCREQQHVMEELFQSSFRRIARRGSCVTQVGLLESVYEMFRKDDPRLSFTRQSFVDRSLLTLLWHCSLDALREFFSTIVVDAIDVLKSRFTKLNESTFDTQITKKMGYYKILDVMYSRLPKDDVHAKESKINQVFHGSCITEGNELTKTLIKLCYDAFTENMAGENQLLERRRLYHCAAYNCAISVICCVFNELKFYQGFLFSEKPEKNLLIFENLIDLKRRYNFPVEVEVPMERKKKYIEIRKEAREAANGDSDGPSYMSSLSYLADSTLSEEMSQFDFSTGVQSYSYSSQDPRPATGRFRRREQRDPTVHDDVLELEMDELNRHECMAPLTALVKHMHRSLGPPQGEEDSVPRDLPSWMKFLHGKLGNPIVPLNIRLFLAKLVINTEEVFRPYAKHWLSPLLQLAASENNGGEGIHYMVVEIVATILSWTGLATPTGVPKDEVLANRLLNFLMKHVFHPKRAVFRHNLEIIKTLVECWKDCLSIPYRLIFEKFSGKDPNSKDNSVGIQLLGIVMANDLPPYDPQCGIQSSEYFQALVNNMSFVRYKEVYAAAAEVLGLILRYVMERKNILEESLCELVAKQLKQHQNTMEDKFIVCLNKVTKSFPPLADRFMNAVFFLLPKFHGVLKTLCLEVVLCRVEGMTELYFQLKSKDFVQVMRHRDDERQKVCLDIIYKMMPKLKPVELRELLNPVVEFVSHPSTTCREQMYNILMWIHDNYRDPESETDNDSQEIFKLAKDVLIQGLIDENPGLQLIIRNFWSHETRLPSNTLDRLLALNSLYSPKIEVHFLSLATNFLLEMTSMSPDYPNPMFEHPLSECEFQEYTIDSDWRFRSTVLTPMFVETQASQGTLQTRTQEGSLSARWPVAGQIRATQQQHDFTLTQTADGRSSFDWLTGSSTDPLVDHTSPSSDSLLFAHKRSERLQRAPLKSVGPDFGKKRLGLPGDEVDNKVKGAAGRTDLLRLRRRFMRDQEKLSLMYARKGVAEQKREKEIKSELKMKQDAQVVLYRSYRHGDLPDIQIKHSSLITPLQAVAQRDPIIAKQLFSSLFSGILKEMDKFKTLSEKNNITQKLLQDFNRFLNTTFSFFPPFVSCIQDISCQHAALLSLDPAAVSAGCLASLQQPVGIRLLEEALLRLLPAELPAKRVRGKARLPPDVLRWVELAKLYRSIGEYDVLRGIFTSEIGTKQITQSALLAEARSDYSEAAKQYDEALNKQDWVDGEPTEAEKDFWELASLDCYNHLAEWKSLEYCSTASIDSENPPDLNKIWSEPFYQETYLPYMIRSKLKLLLQGEADQSLLTFIDKAMHGELQKAILELHYSQELSLLYLLQDDVDRAKYYIQNGIQSFMQNYSSIDVLLHQSRLTKLQSVQALTEIQEFISFISKQGNLSSQVPLKRLLNTWTNRYPDAKMDPMNIWDDIITNRCFFLSKIEEKLTPLPEDNSMNVDQDGDPSDRMEVQEQEEDISSLIRSCKFSMKMKMIDSARKQNNFSLAMKLLKELHKESKTRDDWLVSWVQSYCRLSHCRSRSQGCSEQVLTVLKTVSLLDENNVSSYLSKNILAFRDQNILLGTTYRIIANALSSEPACLAEIEEDKARRILELSGSSSEDSEKVIAGLYQRAFQHLSEAVQAAEEEAQPPSWSCGPAAGVIDAYMTLADFCDQQLRKEEENASVIDSAELQAYPALVVEKMLKALKLNSNEARLKFPRLLQIIERYPEETLSLMTKEISSVPCWQFISWISHMVALLDKDQAVAVQHSVEEITDNYPQAIVYPFIISSESYSFKDTSTGHKNKEFVARIKSKLDQGGVIQDFINALDQLSNPELLFKDWSNDVRAELAKTPVNKKNIEKMYERMYAALGDPKAPGLGAFRRKFIQTFGKEFDKHFGKGGSKLLRMKLSDFNDITNMLLLKMNKDSKPPGNLKECSPWMSDFKVEFLRNELEIPGQYDGRGKPLPEYHVRIAGFDERVTVMASLRRPKRIIIRGHDEREHPFLVKGGEDLRQDQRVEQLFQVMNGILAQDSACSQRALQLRTYSVVPMTSRLGLIEWLENTVTLKDLLLNTMSQEEKAAYLSDPRAPPCEYKDWLTKMSGKHDVGAYMLMYKGANRTETVTSFRKRESKVPADLLKRAFVRMSTSPEAFLALRSHFASSHALICISHWILGIGDRHLNNFMVAMETGGVIGIDFGHAFGSATQFLPVPELMPFRLTRQFINLMLPMKETGLMYSIMVHALRAFRSDPGLLTNTMDVFVKEPSFDWKNFEQKMLKKGGSWIQEINVAEKNWYPRQKICYAKRKLAGANPAVITCDELLLGHEKAPAFRDYVAVARGSKDHNIRAQEPESGLSEETQVKCLMDQATDPNILGRTWEGWEPWM,4128,"469,089",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P78527-1; Sequence=Displayed; Name=2; IsoId=P78527-2; Sequence=VSP_004708; ,,,,,,,,,,VAR_SEQ 3799 3829 Missing (in isoform 2). {ECO:0000303|Ref.10}. /FTId=VSP_004708.,"VARIANT 6 6 A -> S (in dbSNP:rs8177999). {ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3}. /FTId=VAR_019179.; VARIANT 263 263 K -> N (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs758032015). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041602.; VARIANT 333 333 M -> I (in dbSNP:rs8178017). {ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3}. /FTId=VAR_019180.; VARIANT 420 420 V -> I (in dbSNP:rs55925466). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041603.; VARIANT 500 500 G -> S (in a metastatic melanoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041604.; VARIANT 605 605 T -> S (in dbSNP:rs8178033). {ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3}. /FTId=VAR_019181.; VARIANT 649 649 F -> L (in dbSNP:rs55811715). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041605.; VARIANT 680 680 I -> M (in dbSNP:rs8178040). {ECO:0000269|Ref.3}. /FTId=VAR_019182.; VARIANT 695 695 P -> S (in dbSNP:rs8178046). {ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3}. /FTId=VAR_019183.; VARIANT 1071 1071 N -> S (in dbSNP:rs8178070). {ECO:0000269|Ref.3}. /FTId=VAR_019184.; VARIANT 1136 1136 R -> H (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs781401034). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041606.; VARIANT 1190 1190 L -> V (in dbSNP:rs34598508). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041607.; VARIANT 1237 1237 A -> T (in dbSNP:rs191531119). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041608.; VARIANT 1279 1279 L -> F. {ECO:0000269|PubMed:17344846}. /FTId=VAR_041609.; VARIANT 1314 1314 G -> V (in dbSNP:rs8178090). {ECO:0000269|Ref.3}. /FTId=VAR_019185.; VARIANT 1447 1447 R -> M (in a lung squamous cell carcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041610.; VARIANT 1588 1588 D -> V (in dbSNP:rs8178104). {ECO:0000269|Ref.3}. /FTId=VAR_019186.; VARIANT 1603 1603 Q -> H (in dbSNP:rs8178106). {ECO:0000269|Ref.3}. /FTId=VAR_019187.; VARIANT 1619 1619 A -> G (in dbSNP:rs56182356). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041611.; VARIANT 1680 1680 A -> V (in a metastatic melanoma sample; somatic mutation; dbSNP:rs55735910). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041612.; VARIANT 2023 2023 S -> P (in dbSNP:rs56042895). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041613.; VARIANT 2095 2095 A -> V (in dbSNP:rs8178147). {ECO:0000269|Ref.3}. /FTId=VAR_019188.; VARIANT 2598 2598 R -> Q (in dbSNP:rs55923149). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041614.; VARIANT 2702 2702 K -> E (in dbSNP:rs8178178). {ECO:0000269|Ref.3}. /FTId=VAR_019189.; VARIANT 2810 2810 S -> N (in a metastatic melanoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041615.; VARIANT 2899 2899 R -> C (in dbSNP:rs4278157). {ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3}. /FTId=VAR_019190.; VARIANT 2941 2941 G -> A (in a lung neuroendocrine carcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041616.; VARIANT 3062 3062 L -> R (in IMD26; shows increased long palindromic (P)-nucleotide stretches in the immunoglobulin coding joints indicating a defect in hairpin opening and insufficient DCLRE1C activation; dbSNP:rs587777685). {ECO:0000269|PubMed:19075392}. /FTId=VAR_072569.; VARIANT 3085 3085 E -> D (in dbSNP:rs56135402). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041617.; VARIANT 3149 3149 G -> D (in dbSNP:rs8178208). {ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3}. /FTId=VAR_019191.; VARIANT 3198 3198 T -> S (in dbSNP:rs55793951). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041618.; VARIANT 3201 3201 P -> S (in dbSNP:rs8178216). {ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3}. /FTId=VAR_019192.; VARIANT 3404 3404 G -> E (in dbSNP:rs8178225). {ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3}. /FTId=VAR_019193.; VARIANT 3434 3434 I -> T (in dbSNP:rs7830743). {ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3}. /FTId=VAR_019194.; VARIANT 3459 3459 N -> S (in dbSNP:rs8178228). {ECO:0000269|Ref.3}. /FTId=VAR_019195.; VARIANT 3562 3562 L -> M (in dbSNP:rs8178232). {ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3}. /FTId=VAR_019196.; VARIANT 3574 3574 A -> V (in IMD26; shows impaired function in response to irradiation and a less severe defect in V(D)J end-joining suggesting that the missense mutation retained some functional capacity; consistent with a loss of function mutation; dbSNP:rs587777686). {ECO:0000269|PubMed:23722905}. /FTId=VAR_072570.; VARIANT 3584 3584 L -> F (in dbSNP:rs55866966). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041619.; VARIANT 3702 3702 P -> L (in dbSNP:rs8178236). /FTId=VAR_050534.; VARIANT 3800 3800 L -> I (in dbSNP:rs56216442). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041620.; VARIANT 3836 3836 P -> L (in dbSNP:rs8178245). {ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3}. /FTId=VAR_019197.; VARIANT 3932 3932 M -> V (in dbSNP:rs8178248). {ECO:0000269|Ref.3}. /FTId=VAR_019198.; VARIANT 3936 3936 G -> S (in dbSNP:rs55670423). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041621.; VARIANT 3937 3937 V -> M (in dbSNP:rs56090750). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041622.",,,,CONFLICT 405 405 D -> Y (in Ref. 2; AAC50210). {ECO:0000305}.; CONFLICT 1008 1008 A -> S (in Ref. 2; AAC50210). {ECO:0000305}.; CONFLICT 3660 3660 N -> T (in Ref. 8; AAA79184). {ECO:0000305}.; CONFLICT 3817 3817 L -> W (in Ref. 8; AAA79184). {ECO:0000305}.; CONFLICT 3862 3862 A -> P (in Ref. 8; AAA79184). {ECO:0000305}.; CONFLICT 4031 4031 I -> V (in Ref. 9; AAK40350). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the PI3/PI4-kinase family. {ECO:0000305}.,,,"DOMAIN 2883 3539 FAT. {ECO:0000255|PROSITE-ProRule:PRU00534}.; DOMAIN 3747 4015 PI3K/PI4K. {ECO:0000255|PROSITE-ProRule:PRU00269}.; DOMAIN 4096 4128 FATC. {ECO:0000255|PROSITE-ProRule:PRU00534, ECO:0000255|PROSITE-ProRule:PRU00535}.",,REGION 1503 1538 Interaction with C1D. {ECO:0000269|PubMed:9679063}.; REGION 1503 1538 Leucine-zipper.; REGION 2436 3212 KIP-binding.,REPEAT 288 323 HEAT 1.; REPEAT 1004 1040 HEAT 2.; REPEAT 1723 1756 TPR 1.; REPEAT 2920 2948 TPR 2.; REPEAT 2949 2982 TPR 3.,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",,,"FUNCTION: Serine/threonine-protein kinase that acts as a molecular sensor for DNA damage. Involved in DNA non-homologous end joining (NHEJ) required for double-strand break (DSB) repair and V(D)J recombination. Must be bound to DNA to express its catalytic properties. Promotes processing of hairpin DNA structures in V(D)J recombination by activation of the hairpin endonuclease artemis (DCLRE1C). The assembly of the DNA-PK complex at DNA ends is also required for the NHEJ ligation step. Required to protect and align broken ends of DNA. May also act as a scaffold protein to aid the localization of DNA repair proteins to the site of damage. Found at the ends of chromosomes, suggesting a further role in the maintenance of telomeric stability and the prevention of chromosomal end fusion. Also involved in modulation of transcription. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates 'Ser-139' of histone variant H2AX/H2AFX, thereby regulating DNA damage response mechanism. Phosphorylates DCLRE1C, c-Abl/ABL1, histone H1, HSPCA, c-jun/JUN, p53/TP53, PARP1, POU2F1, DHX9, SRF, XRCC1, XRCC1, XRCC4, XRCC5, XRCC6, WRN, MYC and RFA2. Can phosphorylate C1D not only in the presence of linear DNA but also in the presence of supercoiled DNA. Ability to phosphorylate p53/TP53 in the presence of supercoiled DNA is dependent on C1D. Contributes to the determination of the circadian period length by antagonizing phosphorylation of CRY1 'Ser-588' and increasing CRY1 protein stability, most likely through an indirect mechanism. Interacts with CRY1 and CRY2; negatively regulates CRY1 phosphorylation. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway. {ECO:0000269|PubMed:12649176, ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:15574326, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:9679063}.",,,,,,,,,,,SITE 2020 2021 Cleavage; by caspase-3. {ECO:0000305}.,"cytosol [GO:0005829]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription factor complex [GO:0005667]; ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; activation of innate immune response [GO:0002218]; B cell lineage commitment [GO:0002326]; brain development [GO:0007420]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; ectopic germ cell programmed cell death [GO:0035234]; heart development [GO:0007507]; immunoglobulin V(D)J recombination [GO:0033152]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of response to gamma radiation [GO:2001229]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of developmental growth [GO:0048639]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; pro-B cell differentiation [GO:0002328]; protein destabilization [GO:0031648]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of epithelial cell proliferation [GO:0050678]; regulation of smooth muscle cell proliferation [GO:0048660]; response to activity [GO:0014823]; response to gamma radiation [GO:0010332]; rhythmic process [GO:0048511]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]; somitogenesis [GO:0001756]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell receptor V(D)J recombination [GO:0033153]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]",activation of innate immune response [GO:0002218]; B cell lineage commitment [GO:0002326]; brain development [GO:0007420]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; ectopic germ cell programmed cell death [GO:0035234]; heart development [GO:0007507]; immunoglobulin V(D)J recombination [GO:0033152]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of response to gamma radiation [GO:2001229]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of developmental growth [GO:0048639]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; pro-B cell differentiation [GO:0002328]; protein destabilization [GO:0031648]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of epithelial cell proliferation [GO:0050678]; regulation of smooth muscle cell proliferation [GO:0048660]; response to activity [GO:0014823]; response to gamma radiation [GO:0010332]; rhythmic process [GO:0048511]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]; somitogenesis [GO:0001756]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell receptor V(D)J recombination [GO:0033153]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; thymus development [GO:0048538],ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134],"cytosol [GO:0005829]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription factor complex [GO:0005667]",GO:0000723; GO:0000784; GO:0001756; GO:0001933; GO:0002218; GO:0002326; GO:0002328; GO:0002360; GO:0002638; GO:0003690; GO:0003723; GO:0004672; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0005958; GO:0006302; GO:0006303; GO:0006464; GO:0006468; GO:0006974; GO:0007420; GO:0007507; GO:0008134; GO:0008630; GO:0010332; GO:0014823; GO:0016020; GO:0016233; GO:0016567; GO:0018105; GO:0019899; GO:0019904; GO:0031648; GO:0032481; GO:0032869; GO:0032991; GO:0032993; GO:0033077; GO:0033152; GO:0033153; GO:0035234; GO:0042752; GO:0043065; GO:0043066; GO:0045087; GO:0045944; GO:0048146; GO:0048511; GO:0048536; GO:0048538; GO:0048639; GO:0048660; GO:0050678; GO:0070419; GO:0072431; GO:0097681; GO:2000773; GO:2001229,IPR016024; IPR037706; IPR003152; IPR011009; IPR012582; IPR000403; IPR036940; IPR018936; IPR003151; IPR014009; ,O43918; P10275; Q96SD1; P14921; P50549; P09629; P17936; Q9BPZ7; Q96RI1-2; P10276; P17947; P13010; P12956; P25490,"SUBUNIT: DNA-PK is a heterotrimer of PRKDC and the Ku p70/YRCC6-p86/XRCC5 dimer. Formation of this complex may be promoted by interaction with ILF3. Associates with the DNA-bound Ku heterodimer, but it can also bind to and be activated by free DNA. The DNA-PK heterotrimer associates with the LIG4-XRCC4 complex to form the core of the non-homologous end joining (NHEJ) complex. Additional components of the NHEJ complex include NHEJ1/XLF and PAXX. Interacts with DNA-PKcs-interacting protein (KIP) with the region upstream the kinase domain. PRKDC alone also interacts with and phosphorylates DCLRE1C, thereby activating the latent endonuclease activity of this protein. Interacts with C1D. Interacts with TTI1 and TELO2. Interacts with CIB1. Interacts with SETX (PubMed:23149945). Interacts with NR4A3; the DNA-dependent protein kinase complex DNA-PK phosphorylates and activates NR4A3 and prevents NR4A3 ubiquitination and degradation (PubMed:25852083). Interacts with BRAT1. Part of the HDP-RNP complex composed of at least HEXIM1, PRKDC, XRCC5, XRCC6, paraspeckle proteins (SFPQ, NONO, PSPC1, RBM14, and MATR3) and NEAT1 RNA. {ECO:0000269|PubMed:11955432, ECO:0000269|PubMed:14744996, ECO:0000269|PubMed:15071507, ECO:0000269|PubMed:15456891, ECO:0000269|PubMed:15574326, ECO:0000269|PubMed:15758953, ECO:0000269|PubMed:15811628, ECO:0000269|PubMed:15936993, ECO:0000269|PubMed:20427287, ECO:0000269|PubMed:20801936, ECO:0000269|PubMed:20810650, ECO:0000269|PubMed:22977523, ECO:0000269|PubMed:23149945, ECO:0000269|PubMed:25574025, ECO:0000269|PubMed:25670504, ECO:0000269|PubMed:25852083, ECO:0000269|PubMed:25941166, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:9372844, ECO:0000269|PubMed:9442054, ECO:0000269|PubMed:9679063}.",7671312; 11418067; 9284934; 7638222; 7594449; 2507541; 2247066; 1597196; 8407951; 8464713; 8804412; 8917110; 9363941; 9372844; 9362500; 9139719; 9766667; 9679063; 9442054; 9435225; 10026262; 10467406; 12186630; 11955432; 12509254; 12231622; 11889123; 12649176; 14612514; 14627815; 15071507; 14744996; 15574326; 15456891; 14704337; 14734805; 16046194; 15811628; 15936993; 15758953; 17081983; 16397295; 15592499; 17525332; 18691976; 18669648; 19075392; 19369195; 19690332; 19608861; 20810650; 20801936; 20427287; 20068231; 21269460; 22977523; 21406692; 22002106; 23186163; 23149945; 24275569; 24979766; 25852083; 25941166; 25670504; 25944712; 25574025; 28712728; 17344846; 23722905,7671312; 11418067; 9284934; 7638222; 7594449; 2507541; 2247066; 1597196; 8407951; 8464713; 8804412; 8917110; 9363941; 9372844; 9362500; 9139719; 9766667; 9679063; 9442054; 9435225; 10026262; 10467406; 12186630; 11955432; 12509254; 12231622; 11889123; 12649176; 14612514; 14627815; 15071507; 14744996; 15574326; 15456891; 14704337; 14734805; 16046194; 15811628; 15936993; 15758953; 17081983; 16397295; 15592499; 17525332; 18691976; 18669648; 19075392; 19369195; 19690332; 19608861; 20810650; 20801936; 20427287; 20068231; 21269460; 22977523; 21406692; 22002106; 23186163; 23149945; 24275569; 24979766; 25852083; 25941166; 25670504; 25944712; 25574025; 28712728; 17344846; 23722905; 10572166; 10757784; 11702069; 11867762; 11904432; 12023295; 12065055; 12065431; 12077346; 12133833; 12379113; 12547193; 12577067; 12672807; 12750264; 12756247; 12897153; 14556663; 14561766; 14654699; 14743216; 14766968; 14966265; 15123719; 15140983; 15163725; 15177042; 15210742; 15258142; 15262962; 15279776; 15286704; 15313891; 15324660; 15353130; 15377652; 15381073; 15451442; 15493013; 15507430; 15520013; 15668230; 15668400; 15677476; 15698568; 15848144; 16000298; 16000400; 16001975; 16061182; 16093244; 16263121; 16281057; 16306936; 16314509; 16439204; 16439205; 16449650; 16510122; 16520097; 16566590; 16567133; 16600297; 16603769; 16713581; 16759233; 16785234; 16857680; 16874298; 16908529; 16914548; 17110338; 17158925; 17189255; 17196815; 17241822; 17287830; 17290226; 17308091; 17314511; 17389609; 17396150; 17400507; 17438073; 17441731; 17470781; 17526517; 17593081; 17626748; 17638905; 17714814; 17721511; 17764108; 17786318; 17786349; 17932067; 17963495; 17991316; 18026119; 18037521; 18046455; 18077418; 18097573; 18158334; 18160036; 18172300; 18246802; 18270197; 18397950; 18415044; 18422577; 18426604; 18449888; 18451257; 18505846; 18508926; 18550272; 18559621; 18644989; 18710952; 18728186; 18789131; 18799040; 18818105; 18922151; 18950845; 18952587; 18957425; 19021771; 19047373; 19071136; 19074885; 19092295; 19103741; 19144640; 19181665; 19198648; 19203584; 19224683; 19237606; 19244120; 19303849; 19341095; 19351595; 19367725; 19433799; 19444312; 19451221; 19463016; 19467273; 19505854; 19549901; 19573080; 19583974; 19589246; 19672258; 19697154; 19773279; 19776740; 19781633; 19805454; 19815090; 19833092; 19851285; 19893054; 19926846; 20003485; 20023628; 20065038; 20085707; 20111054; 20157594; 20204287; 20205745; 20219974; 20371770; 20379614; 20394854; 20467437; 20496165; 20522537; 20562859; 20590474; 20610542; 20618440; 20704701; 20711232; 20808282; 20813000; 20824055; 20878914; 20936779; 20966071; 21037379; 21042724; 21083655; 21108935; 21175350; 21182203; 21182205; 21188139; 21214942; 21300785; 21330363; 21390062; 21398614; 21450944; 21487018; 21559021; 21565611; 21567185; 21575865; 21576354; 21671477; 21679440; 21723633; 21731742; 21750982; 21773671; 21775006; 21888893; 21905307; 21907836; 21911578; 21941773; 21979916; 21985943; 22009179; 22040967; 22131882; 22139836; 22157815; 22189105; 22190034; 22190353; 22198295; 22267324; 22298787; 22310661; 22332739; 22343725; 22394562; 22404984; 22499342; 22529269; 22579474; 22592045; 22593156; 22596249; 22623428; 22634101; 22753480; 22815474; 22825692; 22841545; 22923485; 22972376; 23001845; 23012265; 23098447; 23098854; 23108991; 23178489; 23183621; 23184344; 23204796; 23251783; 23322783; 23325550; 23325849; 23337116; 23416715; 23449453; 23455922; 23505375; 23505488; 23603433; 23606334; 23678292; 23752268; 23775790; 23897887; 23902751; 23976954; 24013362; 24021630; 24085291; 24136149; 24166892; 24187467; 24189400; 24220101; 24236237; 24255178; 24282534; 24365180; 24429382; 24485452; 24500207; 24530422; 24535266; 24560620; 24635384; 24657168; 24662822; 24680878; 24819595; 24844881; 24952786; 25015719; 25046228; 25057768; 25078033; 25210793; 25223785; 25294801; 25303530; 25307264; 25332688; 25348361; 25480831; 25495526; 25503126; 25550082; 25609649; 25692509; 25749521; 25756210; 25771720; 25815686; 25818648; 25823795; 25841101; 25842288; 25852190; 25925375; 25944161; 26017556; 26049366; 26057167; 26065416; 26108997; 26166223; 26208712; 26212323; 26216882; 26221070; 26257651; 26320609; 26365377; 26381179; 26418254; 26464705; 26496610; 26514267; 26546606; 26578593; 26603896; 26652902; 26666690; 26716839; 26772202; 26774662; 26990988; 26992638; 27235137; 27255972; 27297111; 27412013; 27442243; 27468692; 27499034; 27629740; 27693638; 27733644; 27765904; 27811370; 27856181; 27988337; 28070830; 28109743; 28118114; 28154079; 28177883; 28300555; 28399576; 28448822; 28450160; 28498431; 28652322; 28668119; 28750002; 28840859; 28923836; 28970727; 29150048; 29344644; 29397516; 8422676; 9259561; 9430729; 9826654,2001-04-27,2019-02-13,2003-10-31,209,X-ray crystallography (1); Electron microscopy (2),,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Domain (3); Modified residue (26); Mutagenesis (6); Natural variant (44); Region (3); Repeat (5); Sequence conflict (6); Site (1),,,,3D-structure;ATP-binding;Acetylation;Alternative splicing;Biological rhythms;Complete proteome;DNA damage;DNA recombination;DNA repair;DNA-binding;Disease mutation;Immunity;Innate immunity;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SCID;Serine/threonine-protein kinase;TPR repeat;Transferase;Ubl conjugation,Evidence at protein level,reviewed,,PI3/PI4-kinase family,209,Activity regulation (1); Alternative products (1); Catalytic activity (2); Function (1); Involvement in disease (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0025; KW-0067; KW-0090; KW-0181; KW-0225; KW-0227; KW-0233; KW-0234; KW-0238; KW-0391; KW-0399; KW-0418; KW-0539; KW-0547; KW-0597; KW-0621; KW-0677; KW-0705; KW-0723; KW-0802; KW-0808; KW-0832; KW-1185,,,,,"DISEASE: Immunodeficiency 26 with or without neurologic abnormalities (IMD26) [MIM:615966]: A form of severe combined immunodeficiency characterized by reduced or absent T and B cells, recurrent candidiasis, and lower respiratory tract infections. Some patients show dysmorphic features, severe growth failure, microcephaly, seizures, and impaired neurological functions. {ECO:0000269|PubMed:19075392, ECO:0000269|PubMed:23722905}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Autophosphorylated on Ser-2056, Thr-2609, Thr-2638 and Thr-2647. Ser-2056 and Thr-2609 are DNA damage-inducible phosphorylation sites (inducible with ionizing radiation, IR) dephosphorylated by PPP5C. Autophosphorylation induces a conformational change that leads to remodeling of the DNA-PK complex, requisite for efficient end processing and DNA repair. {ECO:0000269|PubMed:10026262, ECO:0000269|PubMed:10467406, ECO:0000269|PubMed:11889123, ECO:0000269|PubMed:12186630, ECO:0000269|PubMed:12231622, ECO:0000269|PubMed:12509254, ECO:0000269|PubMed:14612514, ECO:0000269|PubMed:14627815, ECO:0000269|PubMed:14704337, ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:1597196, ECO:0000269|PubMed:16046194, ECO:0000269|PubMed:16397295, ECO:0000269|PubMed:2247066, ECO:0000269|PubMed:2507541, ECO:0000269|PubMed:8407951, ECO:0000269|PubMed:8464713, ECO:0000269|PubMed:8804412, ECO:0000269|PubMed:9139719, ECO:0000269|PubMed:9362500, ECO:0000269|PubMed:9363941}.; PTM: S-nitrosylated by GAPDH. {ECO:0000250}.; PTM: Polyubiquitinated by RNF144A, leading to proteasomal degradation. {ECO:0000269|PubMed:24979766}.",CHAIN 1 4128 DNA-dependent protein kinase catalytic subunit. /FTId=PRO_0000225598.,,,,,,"MOD_RES 117 117 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 511 511 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 687 687 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 828 828 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 841 841 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 893 893 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 1065 1065 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1209 1209 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 1970 1970 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 2056 2056 Phosphoserine; by autocatalysis. {ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:22977523}.; MOD_RES 2259 2259 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 2535 2535 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 2609 2609 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:12186630, ECO:0000269|PubMed:12231622, ECO:0000269|PubMed:14734805}.; MOD_RES 2612 2612 Phosphoserine; by autocatalysis. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:12186630}.; MOD_RES 2638 2638 Phosphothreonine; by autocatalysis. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:12186630}.; MOD_RES 2647 2647 Phosphothreonine; by autocatalysis. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:12186630}.; MOD_RES 2789 2789 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 3205 3205 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 3241 3241 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 3260 3260 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 3621 3621 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 3638 3638 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 3642 3642 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 3731 3731 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 3821 3821 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 4026 4026 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U47077;U34994;AY316117;U63630;U90415;L27425;AB052953;U35835;AY030284;AB208860;
0,P84243,H33_HUMAN,H3F3A H3.3A H3F3 PP781; H3F3B H3.3B,H3F3A; H3F3B,H3.3A H3F3; H3.3B,; ,PP781; ,Homo sapiens (Human),9606,Histone H3.3,"UP000005640: Chromosome 1, UP000005640: Chromosome 17","cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MARTKQTARKSTGGKAPRKQLATKAARKSAPSTGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSAAIGALQEASEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA,136,"15,328",,,,,,,,,,,,,"VARIANT 28 28 K -> M (in GLM; glioblastoma multiforme samples and diffuse intrinsic pontine glioma; somatic mutation; more prevalent in pediatric than adult malignancies; results in reduced allosteric activation of PRC2 causing a global decrease of H3K27me3 levels; has no effect on H3K4me3 or H3K36me3 levels; dbSNP:rs1057519903). {ECO:0000269|PubMed:22286061, ECO:0000269|PubMed:22286216, ECO:0000269|PubMed:23539183}. /FTId=VAR_079021.; VARIANT 35 35 G -> R (in GLM; glioblastoma multiforme samples; somatic mutation; also found in osteosarcoma samples; results in global decrease of H3K36me2 and H3K36me3 levels; has no effect on H3K27me3 levels). {ECO:0000269|PubMed:22286061, ECO:0000269|PubMed:23539183}. /FTId=VAR_079022.; VARIANT 35 35 G -> V (in GLM; glioblastoma multiforme samples; somatic mutation; affects regulation of gene expression and results in up-regulation of MYCN; results in global decrease of H3K36me2 and H3K36me3 levels; has no effect on H3K27me3 levels). {ECO:0000269|PubMed:22286061, ECO:0000269|PubMed:23539183, ECO:0000269|PubMed:23539269}. /FTId=VAR_079023.; VARIANT 35 35 G -> W (probable disease-associated mutation found in giant cell tumors of bone; somatic mutation). {ECO:0000269|PubMed:24162739}. /FTId=VAR_079024.; VARIANT 37 37 K -> M (probable disease-associated mutation found in chondroblastoma and clear cell chondrosarcoma; somatic mutation; also found in a subset of human papillomavirus-negative head and neck squamous cell carcinomas; results in global decrease of H3K36me2 and H3K36me3 levels and increased H3K27me3 levels). {ECO:0000269|PubMed:24162739, ECO:0000269|PubMed:27174990, ECO:0000269|PubMed:28067913}. /FTId=VAR_079025.",,,,CONFLICT 9 9 R -> L (in Ref. 7; AAH81561). {ECO:0000305}.,,2,,0,DOMAIN: Specific interaction of trimethylated form at 'Lys-36' (H3.3K36me3) with ZMYND11 is mediated by the encapsulation of Ser-32 residue with a composite pocket formed by the tandem bromo-PWWP domains. {ECO:0000269|PubMed:24590075}.,SIMILARITY: Belongs to the histone H3 family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Variant histone H3 which replaces conventional H3 in a wide range of nucleosomes in active genes. Constitutes the predominant form of histone H3 in non-dividing cells and is incorporated into chromatin independently of DNA synthesis. Deposited at sites of nucleosomal displacement throughout transcribed genes, suggesting that it represents an epigenetic imprint of transcriptionally active chromatin. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. {ECO:0000269|PubMed:14718166, ECO:0000269|PubMed:15776021, ECO:0000269|PubMed:16258499}.",,,,,,,,,,,SITE 32 32 Interaction with ZMYND11. {ECO:0000269|PubMed:24590075}.,"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nuclear nucleosome [GO:0000788]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; blood coagulation [GO:0007596]; cellular protein metabolic process [GO:0044267]; chromatin silencing at rDNA [GO:0000183]; DNA replication-independent nucleosome assembly [GO:0006336]; negative regulation of gene expression, epigenetic [GO:0045814]; nucleosome assembly [GO:0006334]; positive regulation of cell growth [GO:0030307]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; telomere organization [GO:0032200]","blood coagulation [GO:0007596]; cellular protein metabolic process [GO:0044267]; chromatin silencing at rDNA [GO:0000183]; DNA replication-independent nucleosome assembly [GO:0006336]; negative regulation of gene expression, epigenetic [GO:0045814]; nucleosome assembly [GO:0006334]; positive regulation of cell growth [GO:0030307]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; telomere organization [GO:0032200]",nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980],"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nuclear nucleosome [GO:0000788]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",GO:0000183; GO:0000228; GO:0000784; GO:0000786; GO:0000788; GO:0000979; GO:0000980; GO:0005576; GO:0005634; GO:0005654; GO:0006334; GO:0006336; GO:0007596; GO:0030307; GO:0031492; GO:0032200; GO:0032991; GO:0044267; GO:0045652; GO:0045814; GO:0046982; GO:0060964; GO:0070062,IPR009072; IPR007125; IPR000164; ,Q9NVP2; P45973; Q13111; Q9UER7; Q9UER7-1; Q9Y6K1; P62805; P49321-2; Q8IZL8; Q9VK33; Q5VWG9; Q8R5C8,"SUBUNIT: The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of DNA. Interacts with HIRA, a chaperone required for its incorporation into nucleosomes. Interacts with ZMYND11; when trimethylated at 'Lys-36' (H3.3K36me3). {ECO:0000269|PubMed:14718166, ECO:0000269|PubMed:24590075}.",2859593; 3031613; 8586426; 15498874; 17974005; 16710414; 15489334; 7309716; 16185088; 10464286; 11242053; 11856369; 12560483; 14718166; 15471871; 15525939; 15345777; 15776021; 15681610; 15684425; 15851689; 16258499; 16267050; 16457588; 16497732; 18079182; 16567635; 17194708; 17189264; 17898714; 18077460; 18066052; 19520870; 19783980; 19690332; 19608861; 20850016; 20228790; 21925322; 22387026; 22483618; 24275569; 24129315; 25944712; 27392148; 22389435; 22286216; 22286061; 23539269; 23415232; 24162739; 27735137; 27105113; 27105115; 24681537; 27016736; 28190768; 29211711; 30257210; 29480802; 24590075; 23603901; 23539183; 27174990; 28067913,2859593; 3031613; 8586426; 15498874; 17974005; 16710414; 15489334; 7309716; 16185088; 10464286; 11242053; 11856369; 12560483; 14718166; 15471871; 15525939; 15345777; 15776021; 15681610; 15684425; 15851689; 16258499; 16267050; 16457588; 16497732; 18079182; 16567635; 17194708; 17189264; 17898714; 18077460; 18066052; 19520870; 19783980; 19690332; 19608861; 20850016; 20228790; 21925322; 22387026; 22483618; 24275569; 24129315; 25944712; 27392148; 22389435; 22286216; 22286061; 23539269; 23415232; 24162739; 27735137; 27105113; 27105115; 24681537; 27016736; 28190768; 29211711; 30257210; 29480802; 24590075; 23603901; 23539183; 27174990; 28067913; 10373014; 10373562; 10436156; 10471499; 10551868; 10555141; 10567546; 10579975; 10644696; 10654609; 10679930; 10777502; 10940626; 11209945; 11254356; 11278854; 11336508; 11493525; 11498594; 11511348; 11544178; 11566863; 11583633; 11731253; 11784849; 11821381; 11823429; 11850414; 11891985; 12086618; 12123582; 12198165; 12208845; 12232854; 12351676; 12368916; 12385756; 12419248; 12435631; 12453418; 12481029; 12482716; 12483298; 12576332; 12591602; 12628190; 12649488; 12677454; 12725064; 12736215; 12798298; 12815623; 12954718; 1352886; 1360810; 1363091; 1423634; 14583461; 14610093; 14722118; 14969726; 14980219; 15033486; 15099518; 15105426; 15123803; 15138274; 15153943; 15158084; 15186775; 15262888; 15339660; 15340071; 15469825; 15509558; 15537652; 15563468; 15634700; 15654074; 15671018; 15750587; 15767661; 15799776; 1582411; 15861382; 15988529; 16026162; 16061184; 16079795; 16085498; 16166636; 16189514; 16274244; 16292313; 16307923; 16322561; 16357870; 16373483; 16431907; 16500889; 16510874; 16517599; 16544193; 16549775; 16603238; 16628190; 16630819; 16651411; 16678094; 16705743; 1673098; 16731913; 16735507; 16756492; 16757478; 1682218; 16829525; 16861263; 1693558; 16936726; 16999741; 17010333; 17030614; 17052464; 17079667; 17085592; 17113575; 17185360; 17200670; 17210787; 17314394; 17332741; 17344414; 17355984; 17403718; 17428788; 17478518; 17512414; 17525233; 17544230; 17620599; 17660710; 17663992; 17673620; 17687327; 17707230; 17713477; 17713478; 17761849; 17851529; 17875646; 17901401; 17906200; 17968314; 17994007; 18033247; 18164278; 18172012; 18172323; 18209087; 18227514; 18256527; 18302924; 18316480; 18318442; 18337721; 18367646; 18417536; 18485871; 18552846; 18579779; 18628788; 18632628; 18716661; 18772888; 18772889; 18772891; 18776137; 18787068; 18809715; 18850007; 18852463; 18945682; 18953329; 18974356; 19026781; 19104046; 19114653; 19115252; 19135889; 19232136; 19270680; 19340297; 19349354; 19363025; 19410545; 19451217; 19451218; 19462008; 19472184; 19477923; 19483677; 19494831; 19509293; 19557159; 19571010; 19575673; 19593370; 19622635; 19625767; 19633291; 19703992; 1972280; 19739128; 19747919; 1975088; 19782034; 19828451; 19834512; 19887624; 19998411; 20018712; 20018718; 20026581; 20035052; 20075857; 20085832; 20123894; 20133701; 20153629; 20171203; 20211137; 20223770; 20231276; 20385584; 20404089; 20448663; 20498303; 20525793; 20530532; 20587414; 20622854; 20630873; 20688500; 20699226; 20705812; 20711500; 20715035; 20816089; 20836077; 20838592; 20841325; 20841388; 20843831; 20929775; 20937877; 20952535; 20953165; 20966048; 20972224; 20974918; 20978174; 21047901; 21060806; 21062507; 21087926; 21115743; 21150319; 21151121; 21163940; 21163962; 21164480; 21170310; 21187428; 21228036; 21239496; 21242977; 21282660; 21310926; 21320481; 21324897; 21378119; 21427083; 21430779; 21451113; 21453398; 21489993; 21497760; 21498573; 21512140; 21566127; 21589992; 21606950; 21618588; 21636898; 21666679; 21706000; 21741597; 21777816; 21808299; 21808300; 21922516; 21926161; 21979949; 22012064; 22064703; 22064859; 22110697; 22178396; 22195966; 22323599; 22323818; 22325352; 22348533; 22445173; 22466170; 22569366; 22570494; 22661320; 22684280; 22705304; 22722852; 22761581; 22777353; 22810585; 22837395; 22872084; 22879880; 22961379; 23022729; 23079654; 23116151; 23142979; 23161542; 23260659; 23269674; 2330041; 23326524; 23354654; 23357850; 23414300; 23429371; 23431328; 23463006; 23534758; 23555303; 23630040; 23638021; 23660862; 23663978; 23667505; 23679895; 23723417; 23752590; 23758177; 23798402; 23897426; 23902751; 23955559; 24074865; 24086155; 24174538; 24183680; 24200965; 24209620; 24229707; 24242757; 24253042; 24285547; 24312487; 24368767; 24388755; 2444477; 2452725; 24586203; 24606918; 24722339; 24821725; 25101834; 25135475; 25263594; 25313066; 25383530; 25389051; 25408271; 25416956; 25417107; 25442495; 25479829; 25512564; 25538301; 25690891; 2570724; 2571087; 2571936; 25913784; 26167883; 26231952; 26399631; 26457357; 26551522; 26727948; 26933034; 27219822; 27338793; 27358293; 27474439; 27581705; 27694942; 28059095; 28137420; 28374988; 28505000; 28545165; 28717009; 28882701; 28899740; 2891503; 2898782; 29453713; 29529098; 29609578; 29894858; 30287617; 3210246; 3675579; 6577443; 7488013; 7501971; 7566114; 7710686; 7743939; 7831296; 7831297; 7901228; 7908827; 7914354; 7916164; 8033412; 8093325; 8093858; 8100763; 8674428; 8703472; 8710855; 8759021; 8895582; 8999919; 9053316; 9106661; 9144291; 9154799; 9218805; 9242495; 9272954; 9347914; 9360992; 9463349; 9463359; 9482740; 9501100; 9570764; 9662389; 9697850; 9789037; 9895323,1988-01-01,2019-02-13,2007-01-23,163,X-ray crystallography (42); NMR spectroscopy (2); Electron microscopy (7),STRAND 4 6 {ECO:0000244|PDB:3QL9}.; STRAND 16 18 {ECO:0000244|PDB:5DX0}.; STRAND 35 37 {ECO:0000244|PDB:5JLB}.; STRAND 45 47 {ECO:0000244|PDB:4H9N}.; STRAND 80 82 {ECO:0000244|PDB:5X7X}.; STRAND 84 86 {ECO:0000244|PDB:4H9N}.; STRAND 118 120 {ECO:0000244|PDB:5X7X}.,HELIX 8 10 {ECO:0000244|PDB:4GY5}.; HELIX 49 59 {ECO:0000244|PDB:4H9N}.; HELIX 65 79 {ECO:0000244|PDB:4H9N}.; HELIX 87 110 {ECO:0000244|PDB:4H9N}.; HELIX 122 132 {ECO:0000244|PDB:4H9N}.,,,,,,5 out of 5,Beta strand (7); Chain (1); Helix (5); Initiator methionine (1); Modified residue (87); Mutagenesis (1); Natural variant (5); Sequence conflict (1); Site (1),"CAUTION: The original paper reporting lysine deamination at Lys-5 by LOXL2 has been retracted due to inappropriate manipulation of figure data (PubMed:22483618, PubMed:27392148). However, this modification was confirmed in a subsequent publication (PubMed:27735137). {ECO:0000269|PubMed:27735137, ECO:0000305|PubMed:22483618, ECO:0000305|PubMed:27392148}.",,,3D-structure;ADP-ribosylation;Acetylation;Chromosome;Citrullination;Complete proteome;DNA-binding;Direct protein sequencing;Disease mutation;Hydroxylation;Methylation;Nucleosome core;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,Histone H3 family,163,Caution (1); Developmental stage (1); Domain (1); Function (1); Involvement in disease (2); Post-translational modification (11); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0013; KW-0158; KW-0164; KW-0181; KW-0225; KW-0238; KW-0379; KW-0488; KW-0539; KW-0544; KW-0597; KW-0832; KW-0903; KW-1185,,,,,"DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:22286061, ECO:0000269|PubMed:22286216, ECO:0000269|PubMed:23539269}. Note=The gene represented in this entry is involved in disease pathogenesis. H3F3A mutations affecting residues involved in post-translational modifications of histone H3.3 are recurrent in malignant, aggressive gliomas including glioblastoma multiforme (GBM) and diffuse intrinsic pontine glioma (DIPG) (PubMed:22286061, PubMed:22286216). The mechanism through which mutations lead to tumorigenesis involves altered histones methylation, impaired regulation of Polycomb repressive complex 2 (PRC2) activity, and aberrant epigenetic regulation of gene expression (PubMed:23539269, PubMed:23539183, PubMed:23603901). {ECO:0000269|PubMed:22286061, ECO:0000269|PubMed:22286216, ECO:0000269|PubMed:23539183, ECO:0000269|PubMed:23539269, ECO:0000269|PubMed:23603901}.; DISEASE: Note=H3F3A and H3F3B mutations affecting residues involved in post-translational modifications of histone H3.3 are implicated in the pathogenesis of some bone and cartilage neoplasms. Mutations have been found with high prevalence in chondroblastoma and giant cell tumors of bone, and with low frequency in osteosarcoma, conventional chondrosarcoma and clear cell chondrosarcoma. Chondroblastoma samples frequently carry a H3F3B mutation affecting residue Lys-37 (H3K36), although H3F3A is mutated in some cases. Most giant cell tumors of bone harbor H3F3A mutations affecting residue Gly-35 (H3G34). {ECO:0000269|PubMed:24162739}.",,,"PTM: Acetylation is generally linked to gene activation. Acetylation on Lys-10 (H3K9ac) impairs methylation at Arg-9 (H3R8me2s). Acetylation on Lys-19 (H3K18ac) and Lys-24 (H3K24ac) favors methylation at Arg-18 (H3R17me). Acetylation at Lys-123 (H3K122ac) by EP300/p300 plays a central role in chromatin structure: localizes at the surface of the histone octamer and stimulates transcription, possibly by promoting nucleosome instability. {ECO:0000269|PubMed:11242053, ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:15471871, ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:19520870, ECO:0000269|PubMed:23415232, ECO:0000269|PubMed:7309716}.; PTM: Citrullination at Arg-9 (H3R8ci) and/or Arg-18 (H3R17ci) by PADI4 impairs methylation and represses transcription. {ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:15471871, ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:16567635}.; PTM: Asymmetric dimethylation at Arg-18 (H3R17me2a) by CARM1 is linked to gene activation. Symmetric dimethylation at Arg-9 (H3R8me2s) by PRMT5 is linked to gene repression. Asymmetric dimethylation at Arg-3 (H3R2me2a) by PRMT6 is linked to gene repression and is mutually exclusive with H3 Lys-5 methylation (H3K4me2 and H3K4me3). H3R2me2a is present at the 3' of genes regardless of their transcription state and is enriched on inactive promoters, while it is absent on active promoters. {ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:15471871, ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:17898714, ECO:0000269|PubMed:18077460, ECO:0000269|PubMed:18079182}.; PTM: Specifically enriched in modifications associated with active chromatin such as methylation at Lys-5 (H3K4me), Lys-37 and Lys-80. Methylation at Lys-5 (H3K4me) facilitates subsequent acetylation of H3 and H4. Methylation at Lys-80 (H3K79me) is associated with DNA double-strand break (DSB) responses and is a specific target for TP53BP1. Methylation at Lys-10 (H3K9me) and Lys-28 (H3K27me), which are linked to gene repression, are underrepresented. Methylation at Lys-10 (H3K9me) is a specific target for HP1 proteins (CBX1, CBX3 and CBX5) and prevents subsequent phosphorylation at Ser-11 (H3S10ph) and acetylation of H3 and H4. Methylation at Lys-5 (H3K4me) and Lys-80 (H3K79me) require preliminary monoubiquitination of H2B at 'Lys-120'. Methylation at Lys-10 (H3K9me) and Lys-28 (H3K27me) are enriched in inactive X chromosome chromatin. Monomethylation at Lys-57 (H3K56me1) by EHMT2/G9A in G1 phase promotes interaction with PCNA and is required for DNA replication. {ECO:0000269|PubMed:10464286, ECO:0000269|PubMed:11242053, ECO:0000269|PubMed:11856369, ECO:0000269|PubMed:12560483, ECO:0000269|PubMed:15525939, ECO:0000269|PubMed:15681610, ECO:0000269|PubMed:15851689, ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:17189264, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:22387026, ECO:0000269|PubMed:7309716}.; PTM: Phosphorylated at Thr-4 (H3T3ph) by HASPIN during prophase and dephosphorylated during anaphase. Phosphorylation at Ser-11 (H3S10ph) by AURKB is crucial for chromosome condensation and cell-cycle progression during mitosis and meiosis. In addition phosphorylation at Ser-11 (H3S10ph) by RPS6KA4 and RPS6KA5 is important during interphase because it enables the transcription of genes following external stimulation, like mitogens, stress, growth factors or UV irradiation and result in the activation of genes, such as c-fos and c-jun. Phosphorylation at Ser-11 (H3S10ph), which is linked to gene activation, prevents methylation at Lys-10 (H3K9me) but facilitates acetylation of H3 and H4. Phosphorylation at Ser-11 (H3S10ph) by AURKB mediates the dissociation of HP1 proteins (CBX1, CBX3 and CBX5) from heterochromatin. Phosphorylation at Ser-11 (H3S10ph) is also an essential regulatory mechanism for neoplastic cell transformation. Phosphorylated at Ser-29 (H3S28ph) by MAP3K20 isoform 1, RPS6KA5 or AURKB during mitosis or upon ultraviolet B irradiation. Phosphorylation at Thr-7 (H3T6ph) by PRKCB is a specific tag for epigenetic transcriptional activation that prevents demethylation of Lys-5 (H3K4me) by LSD1/KDM1A. At centromeres, specifically phosphorylated at Thr-12 (H3T11ph) from prophase to early anaphase, by DAPK3 and PKN1. Phosphorylation at Thr-12 (H3T11ph) by PKN1 is a specific tag for epigenetic transcriptional activation that promotes demethylation of Lys-10 (H3K9me) by KDM4C/JMJD2C. Phosphorylation at Tyr-42 (H3Y41ph) by JAK2 promotes exclusion of CBX5 (HP1 alpha) from chromatin. Phosphorylation on Ser-32 (H3S31ph) is specific to regions bordering centromeres in metaphase chromosomes. {ECO:0000269|PubMed:10464286, ECO:0000269|PubMed:11242053, ECO:0000269|PubMed:11856369, ECO:0000269|PubMed:12560483, ECO:0000269|PubMed:15681610, ECO:0000269|PubMed:15684425, ECO:0000269|PubMed:15851689, ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:18066052, ECO:0000269|PubMed:19783980, ECO:0000269|PubMed:20228790, ECO:0000269|PubMed:20850016, ECO:0000269|PubMed:7309716}.; PTM: Ubiquitinated. Monoubiquitinated by RAG1 in lymphoid cells, monoubiquitination is required for V(D)J recombination (By similarity). {ECO:0000250|UniProtKB:P84245}.; PTM: Lysine deamination at Lys-5 (H3K4all) to form allysine is mediated by LOXL2. Allysine formation by LOXL2 only takes place on H3K4me3 and results in gene repression. {ECO:0000269|PubMed:27735137}.; PTM: Crotonylation (Kcr) is specifically present in male germ cells and marks testis-specific genes in post-meiotic cells, including X-linked genes that escape sex chromosome inactivation in haploid cells. Crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors. It is also associated with post-meiotically activated genes on autosomes. {ECO:0000269|PubMed:21925322}.; PTM: Butyrylation of histones marks active promoters and competes with histone acetylation. It is present during late spermatogenesis. {ECO:0000250|UniProtKB:P68433}.; PTM: Succinylation at Lys-80 (H3K79succ) by KAT2A takes place with a maximum frequency around the transcription start sites of genes (PubMed:29211711). It gives a specific tag for epigenetic transcription activation (PubMed:29211711). {ECO:0000269|PubMed:29211711}.; PTM: Serine ADP-ribosylation constitutes the primary form of ADP-ribosylation of proteins in response to DNA damage (PubMed:29480802). Serine ADP-ribosylation at Ser-11 (H3S10ADPr) is mutually exclusive with phosphorylation at Ser-11 (H3S10ph) and impairs acetylation at Lys-10 (H3K9ac) (PubMed:30257210). {ECO:0000269|PubMed:29480802, ECO:0000269|PubMed:30257210}.",CHAIN 2 136 Histone H3.3. /FTId=PRO_0000221247.,,,,INIT_MET 1 1 Removed. {ECO:0000305}.,,"MOD_RES 3 3 Asymmetric dimethylarginine; by PRMT6; alternate. {ECO:0000269|PubMed:17898714, ECO:0000269|PubMed:18077460, ECO:0000269|PubMed:18079182}.; MOD_RES 3 3 Citrulline; alternate. {ECO:0000269|PubMed:16567635}.; MOD_RES 4 4 Phosphothreonine; by HASPIN. {ECO:0000269|PubMed:15681610, ECO:0000269|PubMed:16185088}.; MOD_RES 5 5 Allysine; alternate. {ECO:0000269|PubMed:27735137}.; MOD_RES 5 5 N6,N6,N6-trimethyllysine; alternate. {ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708}.; MOD_RES 5 5 N6,N6-dimethyllysine; alternate. {ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708}.; MOD_RES 5 5 N6-(2-hydroxyisobutyryl)lysine; alternate. {ECO:0000269|PubMed:24681537}.; MOD_RES 5 5 N6-(beta-hydroxybutyryl)lysine; alternate. {ECO:0000269|PubMed:27105115}.; MOD_RES 5 5 N6-acetyllysine; alternate. {ECO:0000269|PubMed:17194708}.; MOD_RES 5 5 N6-crotonyllysine; alternate. {ECO:0000269|PubMed:21925322}.; MOD_RES 5 5 N6-methyllysine; alternate. {ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708}.; MOD_RES 7 7 Phosphothreonine; by PKC. {ECO:0000269|PubMed:20228790}.; MOD_RES 9 9 Citrulline; alternate. {ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:16567635}.; MOD_RES 9 9 Symmetric dimethylarginine; by PRMT5; alternate. {ECO:0000250|UniProtKB:P84244}.; MOD_RES 10 10 N6,N6,N6-trimethyllysine; alternate. {ECO:0000269|PubMed:11242053, ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716}.; MOD_RES 10 10 N6,N6-dimethyllysine; alternate. {ECO:0000269|PubMed:11242053, ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716}.; MOD_RES 10 10 N6-(2-hydroxyisobutyryl)lysine; alternate. {ECO:0000269|PubMed:24681537}.; MOD_RES 10 10 N6-(beta-hydroxybutyryl)lysine; alternate. {ECO:0000269|PubMed:27105115}.; MOD_RES 10 10 N6-acetyllysine; alternate. {ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:17194708}.; MOD_RES 10 10 N6-butyryllysine; alternate. {ECO:0000269|PubMed:27105113}.; MOD_RES 10 10 N6-crotonyllysine; alternate. {ECO:0000269|PubMed:21925322}.; MOD_RES 10 10 N6-methyllysine; alternate. {ECO:0000269|PubMed:11242053, ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716}.; MOD_RES 11 11 ADP-ribosylserine; alternate. {ECO:0000269|PubMed:28190768, ECO:0000269|PubMed:29480802}.; MOD_RES 11 11 Phosphoserine; alternate; by AURKB, AURKC, RPS6KA3, RPS6KA4 and RPS6KA5. {ECO:0000269|PubMed:10464286, ECO:0000269|PubMed:11856369, ECO:0000269|PubMed:12560483, ECO:0000269|PubMed:15681610, ECO:0000269|PubMed:15851689, ECO:0000269|PubMed:16185088}.; MOD_RES 12 12 Phosphothreonine; by PKC. {ECO:0000269|PubMed:12560483, ECO:0000269|PubMed:18066052}.; MOD_RES 15 15 N6-(2-hydroxyisobutyryl)lysine; alternate. {ECO:0000269|PubMed:24681537}.; MOD_RES 15 15 N6-(beta-hydroxybutyryl)lysine; alternate. {ECO:0000269|PubMed:27105115}.; MOD_RES 15 15 N6-acetyllysine; alternate. {ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716}.; MOD_RES 15 15 N6-succinyllysine; alternate. {ECO:0000269|PubMed:22389435}.; MOD_RES 18 18 Asymmetric dimethylarginine; by CARM1; alternate. {ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:15471871, ECO:0000269|PubMed:16497732}.; MOD_RES 18 18 Citrulline; alternate. {ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:16567635}.; MOD_RES 19 19 N6-(2-hydroxyisobutyryl)lysine; alternate. {ECO:0000269|PubMed:24681537}.; MOD_RES 19 19 N6-(beta-hydroxybutyryl)lysine; alternate. {ECO:0000269|PubMed:27105115}.; MOD_RES 19 19 N6-acetyllysine; alternate. {ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708}.; MOD_RES 19 19 N6-butyryllysine; alternate. {ECO:0000269|PubMed:27105113}.; MOD_RES 19 19 N6-crotonyllysine; alternate. {ECO:0000269|PubMed:21925322}.; MOD_RES 19 19 N6-methyllysine; alternate. {ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708}.; MOD_RES 24 24 N6-(2-hydroxyisobutyryl)lysine; alternate. {ECO:0000269|PubMed:24681537}.; MOD_RES 24 24 N6-(beta-hydroxybutyryl)lysine; alternate. {ECO:0000269|PubMed:27105115}.; MOD_RES 24 24 N6-acetyllysine; alternate. {ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716}.; MOD_RES 24 24 N6-butyryllysine; alternate. {ECO:0000269|PubMed:27105113}.; MOD_RES 24 24 N6-crotonyllysine; alternate. {ECO:0000269|PubMed:21925322}.; MOD_RES 24 24 N6-methyllysine; alternate. {ECO:0000269|PubMed:17194708}.; MOD_RES 27 27 Citrulline. {ECO:0000269|PubMed:16567635}.; MOD_RES 28 28 N6,N6,N6-trimethyllysine; alternate. {ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716}.; MOD_RES 28 28 N6,N6-dimethyllysine; alternate. {ECO:0000244|PubMed:24129315, ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716}.; MOD_RES 28 28 N6-(2-hydroxyisobutyryl)lysine; alternate. {ECO:0000269|PubMed:24681537}.; MOD_RES 28 28 N6-(beta-hydroxybutyryl)lysine; alternate. {ECO:0000269|PubMed:27105115}.; MOD_RES 28 28 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708}.; MOD_RES 28 28 N6-crotonyllysine; alternate. {ECO:0000269|PubMed:21925322}.; MOD_RES 28 28 N6-methyllysine; alternate. {ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716}.; MOD_RES 29 29 ADP-ribosylserine; alternate. {ECO:0000269|PubMed:28190768, ECO:0000269|PubMed:29480802}.; MOD_RES 29 29 Phosphoserine; alternate; by AURKB, AURKC and RPS6KA5. {ECO:0000269|PubMed:10464286, ECO:0000269|PubMed:11856369, ECO:0000269|PubMed:15681610, ECO:0000269|PubMed:15684425, ECO:0000269|PubMed:15851689, ECO:0000269|PubMed:16185088}.; MOD_RES 32 32 Phosphoserine. {ECO:0000269|PubMed:15851689, ECO:0000269|PubMed:16185088}.; MOD_RES 37 37 N6,N6,N6-trimethyllysine; alternate. {ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716}.; MOD_RES 37 37 N6,N6-dimethyllysine; alternate. {ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716}.; MOD_RES 37 37 N6-(2-hydroxyisobutyryl)lysine; alternate. {ECO:0000269|PubMed:24681537}.; MOD_RES 37 37 N6-acetyllysine; alternate. {ECO:0000269|PubMed:17189264, ECO:0000269|PubMed:17194708}.; MOD_RES 37 37 N6-methyllysine; alternate. {ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716}.; MOD_RES 38 38 N6-methyllysine. {ECO:0000250|UniProtKB:P68431}.; MOD_RES 42 42 Phosphotyrosine. {ECO:0000269|PubMed:19783980}.; MOD_RES 57 57 N6,N6,N6-trimethyllysine; alternate. {ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:22387026}.; MOD_RES 57 57 N6-(2-hydroxyisobutyryl)lysine; alternate. {ECO:0000269|PubMed:24681537}.; MOD_RES 57 57 N6-(beta-hydroxybutyryl)lysine; alternate. {ECO:0000269|PubMed:27105115}.; MOD_RES 57 57 N6-acetyllysine; alternate. {ECO:0000269|PubMed:17194708}.; MOD_RES 57 57 N6-crotonyllysine; alternate. {ECO:0000269|PubMed:21925322}.; MOD_RES 57 57 N6-methyllysine; by EHMT2; alternate. {ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:22387026}.; MOD_RES 57 57 N6-succinyllysine; alternate. {ECO:0000269|PubMed:22389435}.; MOD_RES 58 58 Phosphoserine. {ECO:0000269|PubMed:20850016}.; MOD_RES 65 65 N6-(2-hydroxyisobutyryl)lysine; alternate. {ECO:0000269|PubMed:24681537}.; MOD_RES 65 65 N6-methyllysine; alternate. {ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708}.; MOD_RES 80 80 N6,N6,N6-trimethyllysine; alternate. {ECO:0000250|UniProtKB:P84244}.; MOD_RES 80 80 N6,N6-dimethyllysine; alternate. {ECO:0000269|PubMed:15525939, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708}.; MOD_RES 80 80 N6-(2-hydroxyisobutyryl)lysine; alternate. {ECO:0000269|PubMed:24681537}.; MOD_RES 80 80 N6-(beta-hydroxybutyryl)lysine; alternate. {ECO:0000269|PubMed:27105115}.; MOD_RES 80 80 N6-acetyllysine; alternate. {ECO:0000269|PubMed:17194708}.; MOD_RES 80 80 N6-methyllysine; alternate. {ECO:0000269|PubMed:15525939, ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708}.; MOD_RES 80 80 N6-succinyllysine; alternate. {ECO:0000269|PubMed:22389435, ECO:0000269|PubMed:29211711}.; MOD_RES 81 81 Phosphothreonine. {ECO:0000269|PubMed:20850016}.; MOD_RES 87 87 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 108 108 Phosphothreonine. {ECO:0000250|UniProtKB:Q71DI3}.; MOD_RES 116 116 N6-acetyllysine. {ECO:0000269|PubMed:19520870}.; MOD_RES 123 123 N6-(2-hydroxyisobutyryl)lysine; alternate. {ECO:0000269|PubMed:24681537}.; MOD_RES 123 123 N6-(beta-hydroxybutyryl)lysine; alternate. {ECO:0000269|PubMed:27105115}.; MOD_RES 123 123 N6-acetyllysine; alternate. {ECO:0000269|PubMed:19520870, ECO:0000269|PubMed:23415232}.; MOD_RES 123 123 N6-methyllysine; alternate. {ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708}.; MOD_RES 123 123 N6-succinyllysine; alternate. {ECO:0000269|PubMed:22389435}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M11354;M11353;Z48950;X05855;X05856;X05857;AF218029;BX537379;BC001124;BC006497;BC012813;BC017558;BC029405;BC038989;BC081560;BC081561;BC095447;BC108701;
0,Q13409,DC1I2_HUMAN,DYNC1I2 DNCI2 DNCIC2,DYNC1I2,DNCI2 DNCIC2,,,Homo sapiens (Human),9606,"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)",UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSDKSELKAELERKKQRLAQIREEKKRKEEERKKKETDQKKEAVAPVQEESDLEKKRREAEALLQSMGLTPESPIVFSEYWVPPPMSPSSKSVSTPSEAGSQDSGDGAVGSRTLHWDTDPSVLQLHSDSDLGRGPIKLGMAKITQVDFPPREIVTYTKETQTPVMAQPKEDEEEDDDVVAPKPPIEPEEEKTLKKDEENDSKAPPHELTEEEKQQILHSEEFLSFFDHSTRIVERALSEQINIFFDYSGRDLEDKEGEIQAGAKLSLNRQFFDERWSKHRVVSCLDWSSQYPELLVASYNNNEDAPHEPDGVALVWNMKYKKTTPEYVFHCQSAVMSATFAKFHPNLVVGGTYSGQIVLWDNRSNKRTPVQRTPLSAAAHTHPVYCVNVVGTQNAHNLISISTDGKICSWSLDMLSHPQDSMELVHKQSKAVAVTSMSFPVGDVNNFVVGSEEGSVYTACRHGSKAGISEMFEGHQGPITGIHCHAAVGAVDFSHLFVTSSFDWTVKLWTTKNNKPLYSFEDNADYVYDVMWSPTHPALFACVDGMGRLDLWNLNNDTEVPTASISVEGNPALNRVRWTHSGREIAVGDSEGQIVIYDVGEQIAVPRNDEWARFGRTLAEINANRADAEEEAATRIPA,638,"71,457",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=6;  Name=2A; IsoId=Q13409-1; Sequence=Displayed; Name=2B; IsoId=Q13409-2; Sequence=VSP_001336; Name=2C; IsoId=Q13409-3; Sequence=VSP_001336, VSP_001337; Name=2E; IsoId=Q13409-5; Sequence=VSP_023011; Name=2F; IsoId=Q13409-6; Sequence=VSP_001336, VSP_001337, VSP_023011; Name=3; IsoId=Q13409-7; Sequence=VSP_054377, VSP_001337; Note=No experimental confirmation available.; ",,,,,,,,,SEQUENCE CAUTION:  Sequence=AAA89166.1; Type=Miscellaneous discrepancy; Note=Unlikely isoform. Several sequence problems.; Evidence={ECO:0000305}; ,"VAR_SEQ 76 81 VFSEYW -> AEQPLRVVTADTCLFHYL (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_054377.; VAR_SEQ 77 82 Missing (in isoform 2B, isoform 2C and isoform 2F). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005, ECO:0000303|Ref.1, ECO:0000303|Ref.2, ECO:0000303|Ref.3}. /FTId=VSP_001336.; VAR_SEQ 113 132 Missing (in isoform 2C, isoform 2F and isoform 3). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005, ECO:0000303|Ref.1, ECO:0000303|Ref.2, ECO:0000303|Ref.3}. /FTId=VSP_001337.; VAR_SEQ 602 602 Missing (in isoform 2E and isoform 2F). {ECO:0000303|Ref.2}. /FTId=VSP_023011.",,,,,CONFLICT 510 510 T -> S (in Ref. 1; AAP97254). {ECO:0000305}.; CONFLICT 525 525 D -> G (in Ref. 1; AAP97254). {ECO:0000305}.; CONFLICT 572 572 A -> G (in Ref. 8; AAI09376). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the dynein intermediate chain family. {ECO:0000305}.,,,,,,REPEAT 277 326 WD 1.; REPEAT 330 370 WD 2.; REPEAT 379 420 WD 3.; REPEAT 429 469 WD 4.; REPEAT 474 519 WD 5.; REPEAT 522 562 WD 6.; REPEAT 568 607 WD 7.,,,,,,,"FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. The intermediate chains mediate the binding of dynein to dynactin via its 150 kDa component (p150-glued) DCNT1. Involved in membrane-transport, such as Golgi apparatus, late endosomes and lysosomes.",,,,,,,,,,,,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; viral process [GO:0016032],antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; viral process [GO:0016032],dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982],GO:0000086; GO:0003777; GO:0005737; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0010389; GO:0016032; GO:0019886; GO:0030286; GO:0031982; GO:0045503; GO:0045504; GO:0097711,IPR025956; IPR015943; IPR001680; IPR017986; IPR036322; ,Q9NP97,"SUBUNIT: Homodimer (By similarity). The cytoplasmic dynein 1 complex consists of two catalytic heavy chains (HCs) and a number of non-catalytic subunits presented by intermediate chains (ICs), light intermediate chains (LICs) and light chains (LCs); the composition seems to vary in respect to the IC, LIC and LC composition. The heavy chain homodimer serves as a scaffold for the probable homodimeric assembly of the respective non-catalytic subunits. The ICs and LICs bind directly to the HC dimer and the LCs assemble on the IC dimer. Interacts with DYNLT1 and DYNLT3. Interacts with DCNT1 (By similarity). Interacts with BICD2 (By similarity). Interacts with SPEF2 (By similarity). {ECO:0000250|UniProtKB:O88487, ECO:0000250|UniProtKB:Q62871, ECO:0000269|PubMed:27502274}.; SUBUNIT: (Microbial infection) Interacts with human adenovirus 5 hexon protein; this interaction probably allows virus intracellular transport. {ECO:0000269|PubMed:20006841}.",14702039; 17974005; 15815621; 15489334; 8522607; 14654843; 16964243; 18669648; 19413330; 20006841; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 25944712; 27502274,14702039; 17974005; 15815621; 15489334; 8522607; 14654843; 16964243; 18669648; 19413330; 20006841; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 25944712; 27502274; 10036229; 10559986; 10562278; 10679020; 10903204; 11035033; 11076968; 11081627; 11181178; 11285137; 11306556; 11461920; 11483508; 11509732; 11804586; 11956313; 12006501; 12194817; 12198549; 12207013; 12221128; 12401177; 12447383; 12852856; 13678582; 14580337; 14730319; 15085137; 15339662; 15483056; 15498487; 15591061; 15632110; 15705883; 15723797; 15728195; 15737063; 15878873; 16189514; 16357211; 16462731; 16541025; 16622419; 16622420; 16723730; 16890155; 17030981; 17129783; 17274799; 17283181; 17353931; 17574030; 17646400; 17719545; 17827179; 18037885; 18046453; 18086915; 18097444; 18566290; 18615013; 18664496; 18694559; 18716626; 19004860; 19463016; 19540120; 19564404; 19940019; 19965387; 20038533; 20230748; 20360068; 20399632; 20558667; 21273506; 21347367; 21397845; 21422230; 21548880; 21565611; 21620453; 21725307; 21792235; 21878504; 21987589; 22094468; 22179047; 22190034; 22593156; 22653444; 22885700; 23141531; 23141541; 23253480; 23348840; 23400999; 23416715; 23530209; 23606334; 23747070; 23769972; 23783758; 23789104; 23839779; 23921553; 24053599; 24089205; 24189400; 24231678; 24469809; 24806965; 24891604; 24982133; 25015291; 25047611; 25233431; 25313408; 25416956; 25453831; 25532896; 25609649; 26638075; 29420470; 7691276; 7769006; 7790358; 8642258; 8838651; 8909537; 8991093; 9150144; 9288971; 9323141; 9380700; 9490716; 9671725,1997-11-01,2019-02-13,2002-09-19,194,NMR spectroscopy (1); Electron microscopy (5),STRAND 144 147 {ECO:0000244|PDB:5JPW}.; STRAND 219 221 {ECO:0000244|PDB:6F1Z}.; STRAND 289 293 {ECO:0000244|PDB:6F1U}.; STRAND 295 301 {ECO:0000244|PDB:6F1T}.; STRAND 306 308 {ECO:0000244|PDB:6F1T}.; STRAND 312 315 {ECO:0000244|PDB:6F1U}.; STRAND 326 330 {ECO:0000244|PDB:6F1U}.; STRAND 337 340 {ECO:0000244|PDB:6F1U}.; STRAND 347 351 {ECO:0000244|PDB:6F1U}.; STRAND 353 355 {ECO:0000244|PDB:6F1U}.; STRAND 358 361 {ECO:0000244|PDB:6F1U}.; STRAND 377 380 {ECO:0000244|PDB:6F1T}.; STRAND 384 389 {ECO:0000244|PDB:6F1U}.; STRAND 398 402 {ECO:0000244|PDB:6F1U}.; STRAND 405 410 {ECO:0000244|PDB:6F1U}.; STRAND 419 423 {ECO:0000244|PDB:6F1U}.; STRAND 427 429 {ECO:0000244|PDB:6F1U}.; STRAND 447 449 {ECO:0000244|PDB:6F1U}.; STRAND 452 454 {ECO:0000244|PDB:6F1U}.; STRAND 456 460 {ECO:0000244|PDB:6F1U}.; STRAND 467 472 {ECO:0000244|PDB:6F1U}.; STRAND 477 483 {ECO:0000244|PDB:6F1U}.; STRAND 488 490 {ECO:0000244|PDB:6F1U}.; STRAND 497 506 {ECO:0000244|PDB:6F1U}.; STRAND 517 522 {ECO:0000244|PDB:6F1T}.; STRAND 523 525 {ECO:0000244|PDB:6F1U}.; STRAND 530 532 {ECO:0000244|PDB:6F1U}.; STRAND 534 537 {ECO:0000244|PDB:6F1U}.; STRAND 540 542 {ECO:0000244|PDB:6F1U}.; STRAND 545 552 {ECO:0000244|PDB:6F1U}.; STRAND 558 560 {ECO:0000244|PDB:6F1U}.; STRAND 568 570 {ECO:0000244|PDB:6F1T}.; STRAND 575 578 {ECO:0000244|PDB:6F1U}.; STRAND 585 588 {ECO:0000244|PDB:6F1U}.; STRAND 590 592 {ECO:0000244|PDB:6F1U}.; STRAND 594 597 {ECO:0000244|PDB:6F1U}.; STRAND 600 602 {ECO:0000244|PDB:6F1T}.,HELIX 210 217 {ECO:0000244|PDB:6F1Z}.; HELIX 222 235 {ECO:0000244|PDB:6F1Z}.; HELIX 318 320 {ECO:0000244|PDB:6F1U}.; HELIX 610 619 {ECO:0000244|PDB:6F1U}.,TURN 274 276 {ECO:0000244|PDB:6F1U}.; TURN 362 365 {ECO:0000244|PDB:6F1U}.; TURN 393 395 {ECO:0000244|PDB:6F1U}.; TURN 511 513 {ECO:0000244|PDB:6F1T}.; TURN 554 556 {ECO:0000244|PDB:6F1U}.,,,,,5 out of 5,Alternative sequence (4); Beta strand (37); Chain (1); Helix (4); Initiator methionine (1); Modified residue (16); Repeat (7); Sequence caution (1); Sequence conflict (3); Turn (5),,,,3D-structure;Acetylation;Alternative splicing;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Dynein;Host-virus interaction;Microtubule;Motor protein;Phosphoprotein;Reference proteome;Repeat;Transport;WD repeat,Evidence at protein level,reviewed,,Dynein intermediate chain family,194,Alternative products (1); Caution (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (2),,KW-0002; KW-0007; KW-0025; KW-0181; KW-0206; KW-0243; KW-0493; KW-0505; KW-0597; KW-0677; KW-0813; KW-0853; KW-0903; KW-0945; KW-0963; KW-1185,,,,,,,,PTM: The phosphorylation status of Ser-90 appears to be involved in dynactin-dependent target binding. {ECO:0000250|UniProtKB:Q62871}.,CHAIN 2 638 Cytoplasmic dynein 1 intermediate chain 2. /FTId=PRO_0000114655.,,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378}.,,"MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:22814378}.; MOD_RES 51 51 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 90 90 Phosphoserine. {ECO:0000250|UniProtKB:Q62871}.; MOD_RES 95 95 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 97 97 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 101 101 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 104 104 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF134477;AF250307;AY037160;BT007130;AK055491;AK316119;AL137519;BX537412;AC068039;CH471058;CH471058;CH471058;CH471058;CH471058;CH471058;BC091498;BC109375;BC015038;U39575;
0,Q13561,DCTN2_HUMAN,DCTN2 DCTN50,DCTN2,DCTN50,,,Homo sapiens (Human),9606,Dynactin subunit 2 (50 kDa dynein-associated polypeptide) (Dynactin complex 50 kDa subunit) (DCTN-50) (p50 dynamitin),UP000005640: Chromosome 12,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MADPKYADLPGIARNEPDVYETSDLPEDDQAEFDAEELTSTSVEHIIVNPNAAYDKFKDKRVGTKGLDFSDRIGKTKRTGYESGEYEMLGEGLGVKETPQQKYQRLLHEVQELTTEVEKIKTTVKESATEEKLTPVLLAKQLAALKQQLVASHLEKLLGPDAAINLTDPDGALAKRLLLQLEATKNSKGGSGGKTTGTPPDSSLVTYELHSRPEQDKFSQAAKVAELEKRLTELETAVRCDQDAQNPLSAGLQGACLMETVELLQAKVSALDLAVLDQVEARLQSVLGKVNEIAKHKASVEDADTQSKVHQLYETIQRWSPIASTLPELVQRLVTIKQLHEQAMQFGQLLTHLDTTQQMIANSLKDNTTLLTQVQTTMRENLATVEGNFASIDERMKKLGK,401,"44,231",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=Q13561-1; Sequence=Displayed; Name=2; IsoId=Q13561-2; Sequence=VSP_040485; Name=3; IsoId=Q13561-3; Sequence=VSP_040486; ,,,,,SEQUENCE CAUTION:  Sequence=AAO34395.1; Type=Frameshift; Positions=381; Evidence={ECO:0000305}; ,,,,,"VAR_SEQ 35 35 A -> AFAQEL (in isoform 2). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:8647893}. /FTId=VSP_040485.; VAR_SEQ 35 35 A -> AEL (in isoform 3). {ECO:0000303|Ref.5}. /FTId=VSP_040486.",,,,,,,4,,0,,SIMILARITY: Belongs to the dynactin subunit 2 family. {ECO:0000305}.,COILED 99 132 {ECO:0000255}.; COILED 214 244 {ECO:0000255}.; COILED 379 399 {ECO:0000255}.,,,,,,,,,,,,"FUNCTION: Modulates cytoplasmic dynein binding to an organelle, and plays a role in prometaphase chromosome alignment and spindle organization during mitosis. Involved in anchoring microtubules to centrosomes. May play a role in synapse formation during brain development.",,,,,,,,,,,,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell population proliferation [GO:0008283]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; melanosome transport [GO:0032402]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; protein localization to centrosome [GO:0071539]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell population proliferation [GO:0008283]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; melanosome transport [GO:0032402]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; protein localization to centrosome [GO:0071539]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982],GO:0000086; GO:0000278; GO:0000776; GO:0003774; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0005874; GO:0006888; GO:0007052; GO:0008283; GO:0010389; GO:0016020; GO:0019886; GO:0019901; GO:0030286; GO:0030426; GO:0030507; GO:0031982; GO:0032402; GO:0042802; GO:0070062; GO:0071539; GO:0097711,IPR028133; ,Itself; Q9UL45; Q96GS4; P0C7W6; Q9C0F1; Q9NRI5; P24522; Q96CS2; P42858; Q9BVG8; Q9UPY8; O75340,"SUBUNIT: Subunit of dynactin, a multiprotein complex associated with dynein. Interacts with BICD2 and CEP135 (By similarity). Interacts with DYNAP (PubMed:20978158). Interacts with ECPAS (PubMed:20682791). Interacts with MAPRE1 (PubMed:10226031). {ECO:0000250|UniProtKB:Q99KJ8, ECO:0000269|PubMed:10226031, ECO:0000269|PubMed:20682791, ECO:0000269|PubMed:20978158}.",8647893; 14702039; 16541075; 15489334; 12665801; 10226031; 14654843; 15144186; 18669648; 19690332; 20682791; 20978158; 20068231; 21269460; 22905912; 22814378; 23186163; 24275569,8647893; 14702039; 16541075; 15489334; 12665801; 10226031; 14654843; 15144186; 18669648; 19690332; 20682791; 20978158; 20068231; 21269460; 22905912; 22814378; 23186163; 24275569; 10036229; 10559986; 10562278; 10679020; 10903204; 11035033; 11076968; 11285137; 11306556; 11461920; 11483508; 11956313; 12198549; 12207013; 12221128; 12401177; 12447383; 12852856; 13678582; 14580337; 14983524; 15483056; 15498487; 15580264; 15591061; 15632110; 15705883; 15728195; 15813749; 15878873; 16169070; 16189514; 16357211; 16369996; 16462731; 16723730; 16890155; 17043677; 17139249; 17274799; 17283181; 17353931; 17500595; 17574030; 17646400; 17719545; 17827179; 18037885; 18046453; 18086915; 18182012; 18566290; 18615013; 18664496; 18694559; 18782227; 19004860; 19367725; 19549727; 19564404; 19940019; 20029029; 20038533; 20230748; 20399632; 20463029; 20467437; 20558667; 20711500; 20936779; 21252941; 21273506; 21347367; 21422230; 21548880; 21565611; 21620453; 21725307; 21792235; 21900206; 21911577; 21988832; 22094468; 22179047; 22653444; 23141531; 23141541; 23253480; 23348840; 23374344; 23400999; 23416715; 23530209; 23606334; 23747070; 23769972; 23783758; 23789104; 23839779; 23853584; 23921553; 24053599; 24089205; 24231678; 24469809; 24806965; 24891604; 24982133; 25047611; 25088759; 25233431; 25313408; 25416956; 25453831; 25532896; 25604459; 25609649; 26496610; 26517670; 26638075; 7691276; 7769006; 7790358; 8642258; 8838651; 8909537; 8991093; 9150144; 9288971; 9323141; 9380700; 9490716; 9671725,1997-11-01,2019-02-13,2007-01-23,190,,,,,,,,,5 out of 5,Alternative sequence (2); Chain (1); Coiled coil (3); Frameshift (1); Initiator methionine (1); Modified residue (7),,,,Acetylation;Alternative splicing;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Dynein;Membrane;Microtubule;Phosphoprotein;Reference proteome,Evidence at protein level,reviewed,,Dynactin subunit 2 family,190,Alternative products (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0007; KW-0025; KW-0175; KW-0181; KW-0206; KW-0243; KW-0472; KW-0493; KW-0597; KW-0903; KW-0963; KW-1185,,,,,,,,,CHAIN 2 401 Dynactin subunit 2. /FTId=PRO_0000079821.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378, ECO:0000269|PubMed:12665801, ECO:0000269|Ref.7}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378, ECO:0000269|Ref.7}.; MOD_RES 6 6 Phosphotyrosine. {ECO:0000244|PubMed:15144186}.; MOD_RES 83 83 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 86 86 Phosphotyrosine. {ECO:0000250|UniProtKB:Q99KJ8}.; MOD_RES 134 134 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 198 198 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 320 320 Phosphoserine. {ECO:0000250|UniProtKB:Q99KJ8}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U50733;AK314705;BC000718;BC009468;BC014083;AY189155;
0,Q14203,DCTN1_HUMAN,DCTN1,DCTN1,,,,Homo sapiens (Human),9606,Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p135) (p150-glued),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAQSKRHVYSRTPSGSRMSAEASARPLRVGSRVEVIGKGHRGTVAYVGATLFATGKWVGVILDEAKGKNDGTVQGRKYFTCDEGHGIFVRQSQIQVFEDGADTTSPETPDSSASKVLKREGTDTTAKTSKLRGLKPKKAPTARKTTTRRPKPTRPASTGVAGASSSLGPSGSASAGELSSSEPSTPAQTPLAAPIIPTPVLTSPGAVPPLPSPSKEEEGLRAQVRDLEEKLETLRLKRAEDKAKLKELEKHKIQLEQVQEWKSKMQEQQADLQRRLKEARKEAKEALEAKERYMEEMADTADAIEMATLDKEMAEERAESLQQEVEALKERVDELTTDLEILKAEIEEKGSDGAASSYQLKQLEEQNARLKDALVRMRDLSSSEKQEHVKLQKLMEKKNQELEVVRQQRERLQEELSQAESTIDELKEQVDAALGAEEMVEMLTDRNLNLEEKVRELRETVGDLEAMNEMNDELQENARETELELREQLDMAGARVREAQKRVEAAQETVADYQQTIKKYRQLTAHLQDVNRELTNQQEASVERQQQPPPETFDFKIKFAETKAHAKAIEMELRQMEVAQANRHMSLLTAFMPDSFLRPGGDHDCVLVLLLMPRLICKAELIRKQAQEKFELSENCSERPGLRGAAGEQLSFAAGLVYSLSLLQATLHRYEHALSQCSVDVYKKVGSLYPEMSAHERSLDFLIELLHKDQLDETVNVEPLTKAIKYYQHLYSIHLAEQPEDCTMQLADHIKFTQSALDCMSVEVGRLRAFLQGGQEATDIALLLRDLETSCSDIRQFCKKIRRRMPGTDAPGIPAALAFGPQVSDTLLDCRKHLTWVVAVLQEVAAAAAQLIAPLAENEGLLVAALEELAFKASEQIYGTPSSSPYECLRQSCNILISTMNKLATAMQEGEYDAERPPSKPPPVELRAAALRAEITDAEGLGLKLEDRETVIKELKKSLKIKGEELSEANVRLSLLEKKLDSAAKDADERIEKVQTRLEETQALLRKKEKEFEETMDALQADIDQLEAEKAELKQRLNSQSKRTIEGLRGPPPSGIATLVSGIAGEEQQRGAIPGQAPGSVPGPGLVKDSPLLLQQISAMRLHISQLQHENSILKGAQMKASLASLPPLHVAKLSHEGPGSELPAGALYRKTSQLLETLNQLSTHTHVVDITRTSPAAKSPSAQLMEQVAQLKSLSDTVEKLKDEVLKETVSQRPGATVPTDFATFPSSAFLRAKEEQQDDTVYMGKVTFSCAAGFGQRHRLVLTQEQLHQLHSRLIS,1278,"141,695",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=6;  Name=p150; IsoId=Q14203-1; Sequence=Displayed; Name=p135; IsoId=Q14203-2; Sequence=VSP_000760; Name=3; IsoId=Q14203-3; Sequence=VSP_045392, VSP_045393, VSP_045394; Note=No experimental confirmation available.; Name=4; IsoId=Q14203-4; Sequence=VSP_045393, VSP_045394; Note=No experimental confirmation available.; Name=5; IsoId=Q14203-5; Sequence=VSP_000760, VSP_045394; Note=No experimental confirmation available.; Name=6; IsoId=Q14203-6; Sequence=VSP_047174; Note=No experimental confirmation available.; ",,,,,,,,,,"VAR_SEQ 1 138 MAQSKRHVYSRTPSGSRMSAEASARPLRVGSRVEVIGKGHRGTVAYVGATLFATGKWVGVILDEAKGKNDGTVQGRKYFTCDEGHGIFVRQSQIQVFEDGADTTSPETPDSSASKVLKREGTDTTAKTSKLRGLKPKK -> MMRQ (in isoform p135 and isoform 5). {ECO:0000303|PubMed:15489334}. /FTId=VSP_000760.; VAR_SEQ 1 17 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_045392.; VAR_SEQ 132 151 Missing (in isoform 3 and isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_045393.; VAR_SEQ 132 138 Missing (in isoform 6). {ECO:0000303|PubMed:8856662}. /FTId=VSP_047174.; VAR_SEQ 1066 1070 Missing (in isoform 3, isoform 4 and isoform 5). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334}. /FTId=VSP_045394.","VARIANT 52 52 F -> L (in PERRYS; mutation carriers either do not develop depression or they do develop it late in the disease course; dbSNP:rs886039227). {ECO:0000269|PubMed:24676999}. /FTId=VAR_071452.; VARIANT 59 59 G -> S (in HMN7B; reduced affinity for microtubules which has been suggested to impair axonal transport; the effect is identical to that of complete loss of the CAP-Gly domain; decreased interaction with MAPRE1; no effect on its interaction with TBCB; dbSNP:rs121909342). {ECO:0000269|PubMed:12627231, ECO:0000269|PubMed:16505168, ECO:0000269|PubMed:19136952, ECO:0000269|PubMed:19279216, ECO:0000269|PubMed:22777741}. /FTId=VAR_015850.; VARIANT 71 71 G -> A (in PERRYS; dbSNP:rs67586389). {ECO:0000269|PubMed:19136952}. /FTId=VAR_063867.; VARIANT 71 71 G -> E (in PERRYS; dbSNP:rs67586389). {ECO:0000269|PubMed:19136952}. /FTId=VAR_063868.; VARIANT 71 71 G -> R (in PERRYS; reduced microtubule binding; results in the accumulation of intracytoplasmic inclusions; loss of interaction with CLIP1; significant decrease in motility of dynein-dynactin complex along microtubules; dbSNP:rs72466485). {ECO:0000269|PubMed:19136952, ECO:0000269|PubMed:24881494, ECO:0000269|PubMed:25185702, ECO:0000269|PubMed:26972003}. /FTId=VAR_063869.; VARIANT 72 72 T -> P (in PERRYS; dbSNP:rs72466486). {ECO:0000269|PubMed:19136952}. /FTId=VAR_063870.; VARIANT 74 74 Q -> P (in PERRYS; diminishes microtubule binding and lead to intracytoplasmic inclusions; significant decrease in motility of dynein-dynactin complex along microtubules; defective in inhibiting microtubule catastrophe in neurons; dbSNP:rs72466487). {ECO:0000269|PubMed:19136952, ECO:0000269|PubMed:23874158, ECO:0000269|PubMed:25185702}. /FTId=VAR_063871.; VARIANT 78 78 Y -> C (in PERRYS; significantly reduced microtubule binding; dbSNP:rs886039229). {ECO:0000269|PubMed:24881494}. /FTId=VAR_071453.; VARIANT 163 163 A -> P. /FTId=VAR_001373.; VARIANT 196 196 I -> V (no effect of its interaction with TBCB; no loss of localization to microtubules; dbSNP:rs55862001). {ECO:0000269|PubMed:17824900, ECO:0000269|PubMed:22777741}. /FTId=VAR_076920.; VARIANT 287 287 L -> M (in dbSNP:rs13420401). /FTId=VAR_048677.; VARIANT 495 495 R -> Q (in dbSNP:rs17721059). {ECO:0000269|PubMed:17824900}. /FTId=VAR_048678.; VARIANT 571 571 M -> T (in ALS; associated with disease susceptibility; dbSNP:rs121909343). {ECO:0000269|PubMed:15326253}. /FTId=VAR_063872.; VARIANT 670 670 Y -> F (found in a patient with hereditary motor and sensory neuropathy; unknown pathological significance; dbSNP:rs765819985). {ECO:0000269|PubMed:24627108}. /FTId=VAR_073287.; VARIANT 785 785 R -> W (in ALS; associated with disease susceptibility; dbSNP:rs121909344). {ECO:0000269|PubMed:15326253}. /FTId=VAR_063873.; VARIANT 1101 1101 R -> K (in ALS; associated with disease susceptibility; dbSNP:rs121909345). {ECO:0000269|PubMed:16240349}. /FTId=VAR_063874.; VARIANT 1249 1249 T -> I (in ALS; unknown pathological significance; dbSNP:rs72466496). {ECO:0000269|PubMed:15326253, ECO:0000269|PubMed:17824900, ECO:0000269|PubMed:19506225}. /FTId=VAR_063875.",,,,CONFLICT 10 10 S -> N (in Ref. 7; CAA67333). {ECO:0000305}.; CONFLICT 257 257 Q -> R (in Ref. 2; BAG59757). {ECO:0000305}.; CONFLICT 349 349 K -> R (in Ref. 2; AK314352). {ECO:0000305}.; CONFLICT 368 368 A -> V (in Ref. 2; AK314352). {ECO:0000305}.; CONFLICT 526 526 H -> N (in Ref. 5; AAH71583). {ECO:0000305}.; CONFLICT 618 618 K -> R (in Ref. 5; AAH71583). {ECO:0000305}.; CONFLICT 712 712 D -> V (in Ref. 7; CAA67333). {ECO:0000305}.; CONFLICT 1081 1081 V -> M (in Ref. 9; AAP35404). {ECO:0000305}.; CONFLICT 1261 1261 R -> Q (in Ref. 2; BAG59757). {ECO:0000305}.; CONFLICT 1274 1274 S -> I (in Ref. 5; AAH71583). {ECO:0000305}.,,3,,0,"DOMAIN: The CAP-Gly domain is essential for interactions with microtubules and its binding partners and for its motion along the microtubules. Essential for its preferential binding to tyrosinated microtubules and for promoting the sustained interaction of the dynein motor with microtubules. {ECO:0000269|PubMed:25185702, ECO:0000269|PubMed:26968983, ECO:0000269|PubMed:26972003}.",SIMILARITY: Belongs to the dynactin 150 kDa subunit family. {ECO:0000305}.,COILED 213 547 {ECO:0000255}.; COILED 943 1049 {ECO:0000255}.; COILED 1182 1211 {ECO:0000255}.,COMPBIAS 164 191 Ser-rich.,DOMAIN 48 90 CAP-Gly. {ECO:0000255|PROSITE-ProRule:PRU00045}.,,REGION 911 1278 Interaction with HPS6. {ECO:0000269|PubMed:25189619}.,,,,,,,,"FUNCTION: Plays a key role in dynein-mediated retrograde transport of vesicles and organelles along microtubules by recruiting and tethering dynein to microtubules. Binds to both dynein and microtubules providing a link between specific cargos, microtubules and dynein. Essential for targeting dynein to microtubule plus ends, recruiting dynein to membranous cargos and enhancing dynein processivity (the ability to move along a microtubule for a long distance without falling off the track). Can also act as a brake to slow the dynein motor during motility along the microtubule (PubMed:25185702). Can regulate microtubule stability by promoting microtubule formation, nucleation and polymerization and by inhibiting microtubule catastrophe in neurons. Inhibits microtubule catastrophe by binding both to microtubules and to tubulin, leading to enhanced microtubule stability along the axon (PubMed:23874158). Plays a role in metaphase spindle orientation (PubMed:22327364). Plays a role in centriole cohesion and subdistal appendage organization and function. Its recruitement to the centriole in a KIF3A-dependent manner is essential for the maintenance of centriole cohesion and the formation of subdistal appendage. Also required for microtubule anchoring at the mother centriole (PubMed:23386061). Plays a role in primary cilia formation (PubMed:25774020). {ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23386061, ECO:0000269|PubMed:23874158, ECO:0000269|PubMed:25185702, ECO:0000269|PubMed:25774020}.",,,,,,,,,,,,"axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; intermediate filament cytoskeleton [GO:0045111]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; spindle pole [GO:0000922]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; IRE1-mediated unfolded protein response [GO:0036498]; maintenance of synapse structure [GO:0099558]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517]","antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; IRE1-mediated unfolded protein response [GO:0036498]; maintenance of synapse structure [GO:0099558]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517]",dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631],axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; intermediate filament cytoskeleton [GO:0045111]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; spindle pole [GO:0000922],GO:0000086; GO:0000132; GO:0000278; GO:0000776; GO:0000922; GO:0003774; GO:0005635; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005869; GO:0005874; GO:0005875; GO:0005938; GO:0006888; GO:0007399; GO:0007528; GO:0008017; GO:0010389; GO:0010457; GO:0010970; GO:0015631; GO:0016020; GO:0019886; GO:0019901; GO:0021517; GO:0030286; GO:0030424; GO:0031116; GO:0034454; GO:0035371; GO:0036498; GO:0042147; GO:0043005; GO:0043025; GO:0045111; GO:0048156; GO:0050905; GO:0051081; GO:0051301; GO:0060236; GO:0061744; GO:0070050; GO:0070840; GO:0090063; GO:0097711; GO:0099558; GO:0099738; GO:0120103; GO:1904398; GO:1905515; GO:1990535,IPR036859; IPR000938; IPR027663; IPR022157; ,P42025; Q96RK4; P30622-1; P54256; Q15691; P10636-8; Q9UNH7,"SUBUNIT: Monomer and homodimer (PubMed:23874158). Dynactin is a large macromolecular complex of at least 10 components; p150(glued) binds directly to microtubules and to cytoplasmic dynein. Interacts with the C-terminus of MAPRE1, MAPRE2 and MAPRE3. Interacts (via C-terminus) with SNX6. Interacts with CLN3, DYNAP, ECPAS and FBXL5. Interacts with MISP; this interaction regulates its distribution at the cell cortex. Interacts with CEP131. Interacts with CEP126 (PubMed:24867236). Interacts with CLIP1 (PubMed:17828275, PubMed:17828277, PubMed:26972003, PubMed:20679239). Interacts with dynein intermediate chain and dynein heavy chain (PubMed:25185702). Interacts with PLK1 (via POLO-box domain) (PubMed:20679239). Interacts with TBCB (PubMed:22777741). Binds preferentially to tyrosinated microtubules than to detyrosinated microtubules (PubMed:26972003, PubMed:26968983). Interacts with PARD6A (PubMed:20719959). Interacts with HPS6 (PubMed:25189619). Interacts with KIF3A. Interacts with BICD2 (By similarity). Interacts with DST (isoform 9) (By similarity). Interacts with DST (isoform 1) (By similarity). Identified in a complex with MREG and RILP (By similarity). Interacts with BCCIP (isoform 2/alpha) (PubMed:28394342). Interacts with DCDC1 (PubMed:22159412). {ECO:0000250|UniProtKB:O08788, ECO:0000269|PubMed:14514668, ECO:0000269|PubMed:16109370, ECO:0000269|PubMed:16505168, ECO:0000269|PubMed:16949363, ECO:0000269|PubMed:17532294, ECO:0000269|PubMed:17828275, ECO:0000269|PubMed:17828277, ECO:0000269|PubMed:19935774, ECO:0000269|PubMed:20679239, ECO:0000269|PubMed:20682791, ECO:0000269|PubMed:20719959, ECO:0000269|PubMed:20978158, ECO:0000269|PubMed:22159412, ECO:0000269|PubMed:22261744, ECO:0000269|PubMed:22777741, ECO:0000269|PubMed:22797915, ECO:0000269|PubMed:23509069, ECO:0000269|PubMed:23874158, ECO:0000269|PubMed:24867236, ECO:0000269|PubMed:25185702, ECO:0000269|PubMed:25189619, ECO:0000269|PubMed:26968983, ECO:0000269|PubMed:26972003, ECO:0000269|PubMed:28394342}.",9799602; 14702039; 15815621; 15489334; 8838327; 8856662; 9805007; 14514668; 14654843; 16964243; 17532294; 18669648; 19935774; 19690332; 20682791; 20719959; 20978158; 20679239; 21269460; 22159412; 22261744; 22797915; 22327364; 23386061; 23509069; 23186163; 23985322; 24867236; 25189619; 24275569; 25774020; 26968983; 28394342; 16109370; 16949363; 17828277; 17828275; 12627231; 15326253; 16240349; 16505168; 17824900; 19136952; 19506225; 19279216; 22777741; 23874158; 24627108; 24676999; 25185702; 24881494; 26972003,9799602; 14702039; 15815621; 15489334; 8838327; 8856662; 9805007; 14514668; 14654843; 16964243; 17532294; 18669648; 19935774; 19690332; 20682791; 20719959; 20978158; 20679239; 21269460; 22159412; 22261744; 22797915; 22327364; 23386061; 23509069; 23186163; 23985322; 24867236; 25189619; 24275569; 25774020; 26968983; 28394342; 16109370; 16949363; 17828277; 17828275; 12627231; 15326253; 16240349; 16505168; 17824900; 19136952; 19506225; 19279216; 22777741; 23874158; 24627108; 24676999; 25185702; 24881494; 26972003; 10036229; 10559986; 10562278; 10679020; 10903204; 11035033; 11076968; 11285137; 11306556; 11461920; 11483508; 11956313; 12024216; 12063394; 12198549; 12207013; 12221128; 12401177; 12447383; 12852856; 12857853; 13678582; 14580337; 15067220; 15107855; 15231748; 15375157; 15483056; 15498487; 15591061; 15632110; 15705883; 15728195; 15878873; 16169070; 16357211; 16362039; 16462731; 16539657; 16723730; 16772339; 16890155; 16902405; 17043677; 17139249; 17166838; 17274799; 17283181; 17344930; 17353931; 17574030; 17646400; 17719545; 17827179; 17932487; 18000879; 18037885; 18046453; 18081319; 18086915; 18094236; 18305234; 18364389; 18563468; 18566290; 18615013; 18615096; 18664496; 18694559; 18812314; 18922795; 19004860; 19564404; 19778315; 19940019; 20038533; 20195357; 20230748; 20360068; 20360680; 20399632; 20437543; 20467437; 20508983; 20518521; 20558667; 20664522; 20702129; 20936779; 21252941; 21273506; 21347367; 21422230; 21525035; 21548880; 21565611; 21620453; 21667337; 21725307; 21792235; 21900206; 21911577; 21915335; 21994455; 22094468; 22119847; 22179047; 22279557; 22321011; 22357949; 22373868; 22542187; 22653444; 22956769; 22987636; 23141531; 23141541; 23143281; 23253480; 23348840; 23400999; 23414517; 23530209; 23547029; 23747070; 23769972; 23783758; 23789104; 23839779; 23921553; 24053599; 24089205; 24231678; 24343258; 24469809; 24797316; 24806965; 24891604; 24909165; 24982133; 25047611; 25233431; 25313408; 25413345; 25453831; 25532896; 25558820; 25609649; 25763819; 26459637; 26496610; 26638075; 26662454; 26954557; 27132499; 27482052; 27573046; 28039481; 28625595; 28792508; 7691276; 7769006; 7790358; 8642258; 8838651; 8909537; 8991093; 9150144; 9288971; 9323141; 9361024; 9380700; 9490716; 9671725,1997-11-01,2019-02-13,2001-10-18,194,X-ray crystallography (8); NMR spectroscopy (1),STRAND 17 19 {ECO:0000244|PDB:2COY}.; STRAND 32 35 {ECO:0000244|PDB:1TXQ}.; STRAND 41 48 {ECO:0000244|PDB:1TXQ}.; STRAND 51 55 {ECO:0000244|PDB:1TXQ}.; STRAND 57 65 {ECO:0000244|PDB:1TXQ}.; STRAND 67 73 {ECO:0000244|PDB:1TXQ}.; STRAND 76 78 {ECO:0000244|PDB:1TXQ}.; STRAND 86 89 {ECO:0000244|PDB:1TXQ}.; STRAND 94 96 {ECO:0000244|PDB:1TXQ}.,HELIX 91 93 {ECO:0000244|PDB:1TXQ}.,TURN 36 38 {ECO:0000244|PDB:1TXQ}.; TURN 83 85 {ECO:0000244|PDB:2HQH}.,,,,,5 out of 5,Alternative sequence (5); Beta strand (9); Chain (1); Coiled coil (3); Compositional bias (1); Domain (1); Helix (1); Modified residue (6); Mutagenesis (8); Natural variant (17); Region (1); Sequence conflict (10); Turn (2),,TISSUE SPECIFICITY: Brain.,,3D-structure;Alternative splicing;Amyotrophic lateral sclerosis;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Dynein;Microtubule;Mitosis;Neurodegeneration;Neuropathy;Nucleus;Parkinsonism;Phosphoprotein;Polymorphism;Reference proteome;Transport;Ubl conjugation,Evidence at protein level,reviewed,,Dynactin 150 kDa subunit family,194,Alternative products (1); Caution (4); Domain (1); Function (1); Involvement in disease (3); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0036; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0243; KW-0493; KW-0498; KW-0523; KW-0539; KW-0597; KW-0621; KW-0622; KW-0813; KW-0832; KW-0908; KW-0963; KW-1185,,,,,"DISEASE: Neuronopathy, distal hereditary motor, 7B (HMN7B) [MIM:607641]: A neuromuscular disorder. Distal hereditary motor neuronopathies constitute a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs. {ECO:0000269|PubMed:12627231, ECO:0000269|PubMed:16505168, ECO:0000269|PubMed:19136952, ECO:0000269|PubMed:19279216, ECO:0000269|PubMed:22777741}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Amyotrophic lateral sclerosis (ALS) [MIM:105400]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:15326253, ECO:0000269|PubMed:16240349}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Perry syndrome (PERRYS) [MIM:168605]: A neuropsychiatric disorder characterized by mental depression not responsive to antidepressant drugs or electroconvulsive therapy, sleep disturbances, exhaustion and marked weight loss. Parkinsonism develops later and respiratory failure occurred terminally. {ECO:0000269|PubMed:19136952, ECO:0000269|PubMed:23874158, ECO:0000269|PubMed:24676999, ECO:0000269|PubMed:24881494, ECO:0000269|PubMed:25185702, ECO:0000269|PubMed:26972003}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Ubiquitinated by a SCF complex containing FBXL5, leading to its degradation by the proteasome. {ECO:0000269|PubMed:17532294}.; PTM: Phosphorylation by SLK at Thr-145, Thr-146 and Thr-147 targets DCTN1 to the centrosome. It is uncertain if SLK phosphorylates all three threonines or one or two of them. PLK1-mediated phosphorylation at Ser-179 is essential for its localization in the nuclear envelope, promotes its dissociation from microtubules during early mitosis and positively regulates nuclear envelope breakdown during prophase. {ECO:0000269|PubMed:20679239, ECO:0000269|PubMed:23985322}.",CHAIN 1 1278 Dynactin subunit 1. /FTId=PRO_0000083518.,,,,,,MOD_RES 108 108 Phosphothreonine. {ECO:0000244|PubMed:19690332}.; MOD_RES 145 145 Phosphothreonine; by SLK. {ECO:0000269|PubMed:23985322}.; MOD_RES 146 146 Phosphothreonine; by SLK. {ECO:0000269|PubMed:23985322}.; MOD_RES 147 147 Phosphothreonine; by SLK. {ECO:0000269|PubMed:23985322}.; MOD_RES 179 179 Phosphoserine; by PLK1. {ECO:0000269|PubMed:20679239}.; MOD_RES 212 212 Phosphoserine; by CDK1. {ECO:0000269|PubMed:20679239}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF064205;AF064203;AF064204;AF064205;AF064204;AK297286;CH471053;BC071583;X98801;AF086947;AF086927;AF086928;AF086929;AF086930;AF086931;AF086932;AF086933;AF086934;AF086935;AF086936;AF086937;AF086938;AF086939;AF086940;AF086941;AF086942;AF086943;AF086944;AF086945;AF086946;BT006758;
0,Q14204,DYHC1_HUMAN,DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325,DYNC1H1,DHC1 DNCH1 DNCL DNECL DYHC KIAA0325,,,Homo sapiens (Human),9606,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)",UP000005640: Chromosome 14,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSEPGGGGGEDGSAGLEVSAVQNVADVSVLQKHLRKLVPLLLEDGGEAPAALEAALEEKSALEQMRKFLSDPQVHTVLVERSTLKEDVGDEGEEEKEFISYNINIDIHYGVKSNSLAFIKRTPVIDADKPVSSQLRVLTLSEDSPYETLHSFISNAVAPFFKSYIRESGKADRDGDKMAPSVEKKIAELEMGLLHLQQNIEIPEISLPIHPMITNVAKQCYERGEKPKVTDFGDKVEDPTFLNQLQSGVNRWIREIQKVTKLDRDPASGTALQEISFWLNLERALYRIQEKRESPEVLLTLDILKHGKRFHATVSFDTDTGLKQALETVNDYNPLMKDFPLNDLLSATELDKIRQALVAIFTHLRKIRNTKYPIQRALRLVEAISRDLSSQLLKVLGTRKLMHVAYEEFEKVMVACFEVFQTWDDEYEKLQVLLRDIVKRKREENLKMVWRINPAHRKLQARLDQMRKFRRQHEQLRAVIVRVLRPQVTAVAQQNQGEVPEPQDMKVAEVLFDAADANAIEEVNLAYENVKEVDGLDVSKEGTEAWEAAMKRYDERIDRVETRITARLRDQLGTAKNANEMFRIFSRFNALFVRPHIRGAIREYQTQLIQRVKDDIESLHDKFKVQYPQSQACKMSHVRDLPPVSGSIIWAKQIDRQLTAYMKRVEDVLGKGWENHVEGQKLKQDGDSFRMKLNTQEIFDDWARKVQQRNLGVSGRIFTIESTRVRGRTGNVLKLKVNFLPEIITLSKEVRNLKWLGFRVPLAIVNKAHQANQLYPFAISLIESVRTYERTCEKVEERNTISLLVAGLKKEVQALIAEGIALVWESYKLDPYVQRLAETVFNFQEKVDDLLIIEEKIDLEVRSLETCMYDHKTFSEILNRVQKAVDDLNLHSYSNLPIWVNKLDMEIERILGVRLQAGLRAWTQVLLGQAEDKAEVDMDTDAPQVSHKPGGEPKIKNVVHELRITNQVIYLNPPIEECRYKLYQEMFAWKMVVLSLPRIQSQRYQVGVHYELTEEEKFYRNALTRMPDGPVALEESYSAVMGIVSEVEQYVKVWLQYQCLWDMQAENIYNRLGEDLNKWQALLVQIRKARGTFDNAETKKEFGPVVIDYGKVQSKVNLKYDSWHKEVLSKFGQMLGSNMTEFHSQISKSRQELEQHSVDTASTSDAVTFITYVQSLKRKIKQFEKQVELYRNGQRLLEKQRFQFPPSWLYIDNIEGEWGAFNDIMRRKDSAIQQQVANLQMKIVQEDRAVESRTTDLLTDWEKTKPVTGNLRPEEALQALTIYEGKFGRLKDDREKCAKAKEALELTDTGLLSGSEERVQVALEELQDLKGVWSELSKVWEQIDQMKEQPWVSVQPRKLRQNLDALLNQLKSFPARLRQYASYEFVQRLLKGYMKINMLVIELKSEALKDRHWKQLMKRLHVNWVVSELTLGQIWDVDLQKNEAIVKDVLLVAQGEMALEEFLKQIREVWNTYELDLVNYQNKCRLIRGWDDLFNKVKEHINSVSAMKLSPYYKVFEEDALSWEDKLNRIMALFDVWIDVQRRWVYLEGIFTGSADIKHLLPVETQRFQSISTEFLALMKKVSKSPLVMDVLNIQGVQRSLERLADLLGKIQKALGEYLERERSSFPRFYFVGDEDLLEIIGNSKNVAKLQKHFKKMFAGVSSIILNEDNSVVLGISSREGEEVMFKTPVSITEHPKINEWLTLVEKEMRVTLAKLLAESVTEVEIFGKATSIDPNTYITWIDKYQAQLVVLSAQIAWSENVETALSSMGGGGDAAPLHSVLSNVEVTLNVLADSVLMEQPPLRRRKLEHLITELVHQRDVTRSLIKSKIDNAKSFEWLSQMRFYFDPKQTDVLQQLSIQMANAKFNYGFEYLGVQDKLVQTPLTDRCYLTMTQALEARLGGSPFGPAGTGKTESVKALGHQLGRFVLVFNCDETFDFQAMGRIFVGLCQVGAWGCFDEFNRLEERMLSAVSQQVQCIQEALREHSNPNYDKTSAPITCELLNKQVKVSPDMAIFITMNPGYAGRSNLPDNLKKLFRSLAMTKPDRQLIAQVMLYSQGFRTAEVLANKIVPFFKLCDEQLSSQSHYDFGLRALKSVLVSAGNVKRERIQKIKREKEERGEAVDEGEIAENLPEQEILIQSVCETMVPKLVAEDIPLLFSLLSDVFPGVQYHRGEMTALREELKKVCQEMYLTYGDGEEVGGMWVEKVLQLYQITQINHGLMMVGPSGSGKSMAWRVLLKALERLEGVEGVAHIIDPKAISKDHLYGTLDPNTREWTDGLFTHVLRKIIDSVRGELQKRQWIVFDGDVDPEWVENLNSVLDDNKLLTLPNGERLSLPPNVRIMFEVQDLKYATLATVSRCGMVWFSEDVLSTDMIFNNFLARLRSIPLDEGEDEAQRRRKGKEDEGEEAASPMLQIQRDAATIMQPYFTSNGLVTKALEHAFQLEHIMDLTRLRCLGSLFSMLHQACRNVAQYNANHPDFPMQIEQLERYIQRYLVYAILWSLSGDSRLKMRAELGEYIRRITTVPLPTAPNIPIIDYEVSISGEWSPWQAKVPQIEVETHKVAAPDVVVPTLDTVRHEALLYTWLAEHKPLVLCGPPGSGKTMTLFSALRALPDMEVVGLNFSSATTPELLLKTFDHYCEYRRTPNGVVLAPVQLGKWLVLFCDEINLPDMDKYGTQRVISFIRQMVEHGGFYRTSDQTWVKLERIQFVGACNPPTDPGRKPLSHRFLRHVPVVYVDYPGPASLTQIYGTFNRAMLRLIPSLRTYAEPLTAAMVEFYTMSQERFTQDTQPHYIYSPREMTRWVRGIFEALRPLETLPVEGLIRIWAHEALRLFQDRLVEDEERRWTDENIDTVALKHFPNIDREKAMSRPILYSNWLSKDYIPVDQEELRDYVKARLKVFYEEELDVPLVLFNEVLDHVLRIDRIFRQPQGHLLLIGVSGAGKTTLSRFVAWMNGLSVYQIKVHRKYTGEDFDEDLRTVLRRSGCKNEKIAFIMDESNVLDSGFLERMNTLLANGEVPGLFEGDEYATLMTQCKEGAQKEGLMLDSHEELYKWFTSQVIRNLHVVFTMNPSSEGLKDRAATSPALFNRCVLNWFGDWSTEALYQVGKEFTSKMDLEKPNYIVPDYMPVVYDKLPQPPSHREAIVNSCVFVHQTLHQANARLAKRGGRTMAITPRHYLDFINHYANLFHEKRSELEEQQMHLNVGLRKIKETVDQVEELRRDLRIKSQELEVKNAAANDKLKKMVKDQQEAEKKKVMSQEIQEQLHKQQEVIADKQMSVKEDLDKVEPAVIEAQNAVKSIKKQHLVEVRSMANPPAAVKLALESICLLLGESTTDWKQIRSIIMRENFIPTIVNFSAEEISDAIREKMKKNYMSNPSYNYEIVNRASLACGPMVKWAIAQLNYADMLKRVEPLRNELQKLEDDAKDNQQKANEVEQMIRDLEASIARYKEEYAVLISEAQAIKADLAAVEAKVNRSTALLKSLSAERERWEKTSETFKNQMSTIAGDCLLSAAFIAYAGYFDQQMRQNLFTTWSHHLQQANIQFRTDIARTEYLSNADERLRWQASSLPADDLCTENAIMLKRFNRYPLIIDPSGQATEFIMNEYKDRKITRTSFLDDAFRKNLESALRFGNPLLVQDVESYDPVLNPVLNREVRRTGGRVLITLGDQDIDLSPSFVIFLSTRDPTVEFPPDLCSRVTFVNFTVTRSSLQSQCLNEVLKAERPDVDEKRSDLLKLQGEFQLRLRQLEKSLLQALNEVKGRILDDDTIITTLENLKREAAEVTRKVEETDIVMQEVETVSQQYLPLSTACSSIYFTMESLKQIHFLYQYSLQFFLDIYHNVLYENPNLKGVTDHTQRLSIITKDLFQVAFNRVARGMLHQDHITFAMLLARIKLKGTVGEPTYDAEFQHFLRGNEIVLSAGSTPRIQGLTVEQAEAVVRLSCLPAFKDLIAKVQADEQFGIWLDSSSPEQTVPYLWSEETPATPIGQAIHRLLLIQAFRPDRLLAMAHMFVSTNLGESFMSIMEQPLDLTHIVGTEVKPNTPVLMCSVPGYDASGHVEDLAAEQNTQITSIAIGSAEGFNQADKAINTAVKSGRWVMLKNVHLAPGWLMQLEKKLHSLQPHACFRLFLTMEINPKVPVNLLRAGRIFVFEPPPGVKANMLRTFSSIPVSRICKSPNERARLYFLLAWFHAIIQERLRYAPLGWSKKYEFGESDLRSACDTVDTWLDDTAKGRQNISPDKIPWSALKTLMAQSIYGGRVDNEFDQRLLNTFLERLFTTRSFDSEFKLACKVDGHKDIQMPDGIRREEFVQWVELLPDTQTPSWLGLPNNAERVLLTTQGVDMISKMLKMQMLEDEDDLAYAETEKKTRTDSTSDGRPAWMRTLHTTASNWLHLIPQTLSHLKRTVENIKDPLFRFFEREVKMGAKLLQDVRQDLADVVQVCEGKKKQTNYLRTLINELVKGILPRSWSHYTVPAGMTVIQWVSDFSERIKQLQNISLAAASGGAKELKNIHVCLGGLFVPEAYITATRQYVAQANSWSLEELCLEVNVTTSQGATLDACSFGVTGLKLQGATCNNNKLSLSNAISTALPLTQLRWVKQTNTEKKASVVTLPVYLNFTRADLIFTVDFEIATKEDPRSFYERGVAVLCTE,4646,"532,408",,,,SEQUENCE CAUTION:  Sequence=BAA20783.3; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,,"VARIANT 94 94 E -> K (found in a patient with spinal muscular atrophy; unknown pathological significance). {ECO:0000269|PubMed:25512093}. /FTId=VAR_073155.; VARIANT 129 129 K -> I (in MRD13). {ECO:0000269|PubMed:23603762}. /FTId=VAR_070580.; VARIANT 142 142 E -> A. {ECO:0000269|PubMed:23033978}. /FTId=VAR_069437.; VARIANT 264 264 R -> L (in SMALED1; slight increased BICD2-binding; dbSNP:rs713993043). {ECO:0000269|PubMed:25512093}. /FTId=VAR_073156.; VARIANT 306 306 H -> R (in CMT2O and SMALED1; dbSNP:rs387906738). {ECO:0000269|PubMed:21820100, ECO:0000269|PubMed:22847149}. /FTId=VAR_066651.; VARIANT 584 584 I -> L (in SMALED1; disrupts dynein complex stability and function; dbSNP:rs387906741). {ECO:0000269|PubMed:22459677}. /FTId=VAR_067820.; VARIANT 598 598 R -> C (in CMT2O and SMALED1; slight increased BICD2-binding; dbSNP:rs587780564). {ECO:0000269|PubMed:25484024, ECO:0000269|PubMed:25512093}. /FTId=VAR_073157.; VARIANT 659 662 Missing (in MRD13). {ECO:0000269|PubMed:23603762}. /FTId=VAR_070581.; VARIANT 671 671 K -> E (in SMALED1; dbSNP:rs387906742). {ECO:0000269|PubMed:22459677}. /FTId=VAR_067821.; VARIANT 776 776 P -> L (in SMALED1; dbSNP:rs1057518083). {ECO:0000269|PubMed:26846447}. /FTId=VAR_078241.; VARIANT 970 970 Y -> C (in SMALED1; dbSNP:rs387906743). {ECO:0000269|PubMed:22459677}. /FTId=VAR_067822.; VARIANT 1132 1132 G -> E (in SMALED1). {ECO:0000269|PubMed:28193117}. /FTId=VAR_078242.; VARIANT 1194 1194 Q -> R (in CMT2O; impairs function). {ECO:0000269|PubMed:24307404}. /FTId=VAR_072092.; VARIANT 1250 1250 V -> L (in dbSNP:rs369914512). {ECO:0000269|PubMed:23033978}. /FTId=VAR_069438.; VARIANT 1518 1518 E -> K (in MRD13; dbSNP:rs387906740). {ECO:0000269|PubMed:22368300, ECO:0000269|PubMed:23033978}. /FTId=VAR_067823.; VARIANT 1567 1567 R -> Q (in MRD13; dbSNP:rs797044901). {ECO:0000269|PubMed:23603762}. /FTId=VAR_070582.; VARIANT 1962 1962 R -> C (in MRD13; dbSNP:rs879253881). {ECO:0000269|PubMed:23603762}. /FTId=VAR_070583.; VARIANT 2247 2247 V -> M (in dbSNP:rs1064796963). {ECO:0000269|PubMed:23033978}. /FTId=VAR_069439.; VARIANT 3048 3048 E -> K (in CMT2O; impairs function). {ECO:0000269|PubMed:24307404}. /FTId=VAR_072093.; VARIANT 3241 3241 K -> T (in MRD13). {ECO:0000269|PubMed:23603762}. /FTId=VAR_070584.; VARIANT 3336 3336 K -> N (in MRD13; shows a substantial reduction in the microtubule binding affinity compared to the wild-type control protein; dbSNP:rs397509410). {ECO:0000269|PubMed:23603762}. /FTId=VAR_070585.; VARIANT 3344 3344 R -> Q (in MRD13; dbSNP:rs397509412). {ECO:0000269|PubMed:23603762}. /FTId=VAR_070586.; VARIANT 3384 3384 R -> Q (in MRD13; patients manifest malformations of cortical development; shows a substantial reduction in the microtubule binding affinity compared to the wild-type control protein; dbSNP:rs397509411). {ECO:0000269|PubMed:23603762, ECO:0000269|PubMed:28193117}. /FTId=VAR_070587.; VARIANT 3822 3822 H -> P (in MRD13; de novo mutation; dbSNP:rs387906739). {ECO:0000269|PubMed:21076407}. /FTId=VAR_065085.; VARIANT 3902 3902 D -> N (in dbSNP:rs17512818). {ECO:0000269|Ref.4}. /FTId=VAR_020889.; VARIANT 4029 4029 H -> Q (in dbSNP:rs10129889). {ECO:0000269|PubMed:9205841, ECO:0000269|Ref.4}. /FTId=VAR_020890.; VARIANT 4143 4143 R -> C (in dbSNP:rs1316357429). {ECO:0000269|PubMed:23033978}. /FTId=VAR_069440.; VARIANT 4285 4285 A -> S (in dbSNP:rs749486351). {ECO:0000269|PubMed:23033978}. /FTId=VAR_069441.; VARIANT 4421 4421 A -> T (in dbSNP:rs376492799). {ECO:0000269|PubMed:23033978}. /FTId=VAR_069442.; VARIANT 4507 4507 I -> S. {ECO:0000269|PubMed:23033978}. /FTId=VAR_069443.; VARIANT 4603 4603 S -> G. {ECO:0000269|PubMed:23033978}. /FTId=VAR_069444.",,,,CONFLICT 1778 1779 LH -> SD (in Ref. 5; AAB09727). {ECO:0000305}.; CONFLICT 1941 1941 M -> R (in Ref. 5; AAB09727). {ECO:0000305}.; CONFLICT 2025 2025 R -> N (in Ref. 5; AAB09727). {ECO:0000305}.,,5,,0,"DOMAIN: Dynein heavy chains probably consist of an N-terminal stem (which binds cargo and interacts with other dynein components), and the head or motor domain. The motor contains six tandemly-linked AAA domains in the head, which form a ring. A stalk-like structure (formed by two of the coiled coil domains) protrudes between AAA 4 and AAA 5 and terminates in a microtubule-binding site. A seventh domain may also contribute to this ring; it is not clear whether the N-terminus or the C-terminus forms this extra domain. There are four well-conserved and two non-conserved ATPase sites, one per AAA domain. Probably only one of these (within AAA 1) actually hydrolyzes ATP, the others may serve a regulatory function.",SIMILARITY: Belongs to the dynein heavy chain family. {ECO:0000305}.,COILED 181 202 {ECO:0000255}.; COILED 455 478 {ECO:0000255}.; COILED 543 566 {ECO:0000255}.; COILED 1171 1252 {ECO:0000255}.; COILED 1357 1373 {ECO:0000255}.; COILED 3189 3275 {ECO:0000255}.; COILED 3396 3500 {ECO:0000255}.; COILED 3737 3800 {ECO:0000255}.,,,,REGION 53 1867 Stem. {ECO:0000250}.; REGION 448 703 Interaction with DYNC1I2. {ECO:0000250}.; REGION 651 802 Interaction with DYNC1LI2. {ECO:0000250}.; REGION 1868 2099 AAA 1. {ECO:0000250}.; REGION 2180 2452 AAA 2. {ECO:0000250}.; REGION 2556 2805 AAA 3. {ECO:0000250}.; REGION 2899 3168 AAA 4. {ECO:0000250}.; REGION 3189 3500 Stalk. {ECO:0000250}.; REGION 3553 3782 AAA 5. {ECO:0000250}.; REGION 4005 4221 AAA 6. {ECO:0000250}.,,,,,,,,FUNCTION: Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Plays a role in mitotic spindle assembly and metaphase plate congression (PubMed:27462074). {ECO:0000269|PubMed:27462074}.,,,,,,,,,,NP_BIND 1906 1913 ATP. {ECO:0000255}.; NP_BIND 2224 2231 ATP. {ECO:0000255}.; NP_BIND 2595 2602 ATP. {ECO:0000255}.; NP_BIND 2937 2944 ATP. {ECO:0000255}.,,"azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; cytoplasmic mRNA processing body assembly [GO:0033962]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063]",antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; cytoplasmic mRNA processing body assembly [GO:0033962]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063],"ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]",azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874],GO:0000086; GO:0003723; GO:0005524; GO:0005576; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0007052; GO:0008569; GO:0010389; GO:0016020; GO:0019886; GO:0030175; GO:0030286; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0035578; GO:0043312; GO:0045503; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0070062; GO:0072382; GO:0090235; GO:0097711; GO:0120162; GO:1905832,IPR003593; IPR035699; IPR035706; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; ,Q9NRI5; P42858; P49810,"SUBUNIT: Homodimer. The cytoplasmic dynein 1 complex consists of two catalytic heavy chains (HCs) and a number of non-catalytic subunits presented by intermediate chains (ICs), light intermediate chains (LICs) and light chains (LCs); the composition seems to vary in respect to the IC, LIC and LC composition. The heavy chain homodimer serves as a scaffold for the probable homodimeric assembly of the respective non-catalytic subunits. The ICs and LICs bind directly to the HC dimer and dynein LCs assemble on the IC dimer. Interacts with DYNC1LI1; DYNC1LI1 and DYNC1LI2 bind mutually exclusive to DYNC1H1. Interacts with DYNC1LI2; DYNC1LI1 and DYNC1LI2 bind mutually exclusive to DYNC1H1. Interacts with DYNC1I2 (By similarity). Interacts with BICD2 (PubMed:25512093). {ECO:0000250|UniProtKB:P38650, ECO:0000269|PubMed:25512093}.",9205841; 8666668; 8227145; 15489334; 14654843; 17081983; 18669648; 19690332; 19608861; 20068231; 21269460; 22223895; 23186163; 24275569; 25944712; 27462074; 21076407; 21820100; 22368300; 22847149; 22459677; 23033978; 23603762; 25512093; 24307404; 25484024; 26846447; 28193117,9205841; 8666668; 8227145; 15489334; 14654843; 17081983; 18669648; 19690332; 19608861; 20068231; 21269460; 22223895; 23186163; 24275569; 25944712; 27462074; 21076407; 21820100; 22368300; 22847149; 22459677; 23033978; 23603762; 25512093; 24307404; 25484024; 26846447; 28193117; 10036229; 10559986; 10562278; 10679020; 10903204; 11035033; 11076968; 11081627; 11181178; 11285137; 11306556; 11461920; 11483508; 11509732; 11804586; 11956313; 12006501; 12194817; 12198549; 12207013; 12221128; 12401177; 12447383; 12852856; 13678582; 14580337; 14632200; 14730319; 14743216; 15085137; 15161933; 15231748; 15339662; 15483056; 15498487; 15591061; 15632110; 15705883; 15723797; 15728195; 15737063; 15878873; 16357211; 16462731; 16541025; 16546759; 16622419; 16622420; 16723730; 16890155; 17030981; 17043677; 17129783; 17274799; 17283181; 17314511; 17353931; 17500595; 17574030; 17620599; 17646400; 17719545; 17827179; 18037885; 18046453; 18086915; 18097444; 18566290; 18615013; 18664496; 18694559; 18716626; 19004860; 19020519; 19343720; 19367725; 19380743; 19463016; 19564404; 19738201; 19765186; 19805454; 19875381; 19940019; 19965387; 20029029; 20038533; 20195357; 20230748; 20360068; 20399632; 20467437; 20558667; 20562859; 20677014; 20711500; 21163940; 21273506; 21347367; 21397845; 21422230; 21525035; 21548880; 21565611; 21620453; 21723285; 21725307; 21792235; 21874239; 21878504; 21987589; 22094468; 22179047; 22190034; 22373868; 22593156; 22623428; 22653444; 22885700; 22956769; 23141531; 23141541; 23213255; 23253480; 23348840; 23389635; 23400999; 23416715; 23530209; 23583712; 23589491; 23742762; 23747070; 23769972; 23783758; 23789104; 23839779; 23921553; 24053599; 24089205; 24189400; 24231678; 24256283; 24469809; 24600008; 24751478; 24755273; 24806965; 24891604; 24982133; 25047611; 25185702; 25231297; 25233431; 25313408; 25355895; 25453831; 25479096; 25532896; 25604459; 25609649; 25609763; 26100331; 26496610; 26514267; 26638075; 27433848; 28196890; 28325891; 28455235; 28554554; 28602352; 29185983; 29420470; 29475948; 7691276; 7769006; 7790358; 8642258; 8692836; 8838651; 8909537; 8991093; 9150144; 9288971; 9323141; 9380700; 9490716; 9671725,1997-11-01,2019-02-13,2005-01-04,195,X-ray crystallography (1); Model (2); Electron microscopy (7),STRAND 42 47 {ECO:0000244|PDB:5OWO}.; STRAND 71 73 {ECO:0000244|PDB:6F1T}.; STRAND 76 85 {ECO:0000244|PDB:5OWO}.; STRAND 97 105 {ECO:0000244|PDB:5OWO}.; STRAND 113 124 {ECO:0000244|PDB:5OWO}.; STRAND 135 140 {ECO:0000244|PDB:5OWO}.; STRAND 229 232 {ECO:0000244|PDB:6F1U}.; STRAND 676 678 {ECO:0000244|PDB:6F1U}.; STRAND 826 828 {ECO:0000244|PDB:6F1V}.; STRAND 1021 1023 {ECO:0000244|PDB:6F1T}.,HELIX 27 41 {ECO:0000244|PDB:5OWO}.; HELIX 50 57 {ECO:0000244|PDB:5OWO}.; HELIX 59 70 {ECO:0000244|PDB:5OWO}.; HELIX 132 134 {ECO:0000244|PDB:5OWO}.; HELIX 145 155 {ECO:0000244|PDB:5OWO}.; HELIX 157 165 {ECO:0000244|PDB:5OWO}.; HELIX 178 199 {ECO:0000244|PDB:5OWO}.; HELIX 211 222 {ECO:0000244|PDB:6F1U}.; HELIX 233 235 {ECO:0000244|PDB:6F1U}.; HELIX 239 260 {ECO:0000244|PDB:6F1U}.; HELIX 271 293 {ECO:0000244|PDB:6F1U}.; HELIX 295 306 {ECO:0000244|PDB:6F1U}.; HELIX 310 318 {ECO:0000244|PDB:6F1U}.; HELIX 322 332 {ECO:0000244|PDB:6F1U}.; HELIX 342 345 {ECO:0000244|PDB:6F1U}.; HELIX 350 363 {ECO:0000244|PDB:6F1U}.; HELIX 364 366 {ECO:0000244|PDB:6F1T}.; HELIX 374 397 {ECO:0000244|PDB:6F1U}.; HELIX 406 440 {ECO:0000244|PDB:6F1U}.; HELIX 455 482 {ECO:0000244|PDB:6F1U}.; HELIX 519 533 {ECO:0000244|PDB:6F1U}.; HELIX 539 541 {ECO:0000244|PDB:6F1U}.; HELIX 542 574 {ECO:0000244|PDB:6F1U}.; HELIX 578 587 {ECO:0000244|PDB:6F1U}.; HELIX 590 593 {ECO:0000244|PDB:6F1U}.; HELIX 597 603 {ECO:0000244|PDB:6F1U}.; HELIX 605 624 {ECO:0000244|PDB:6F1U}.; HELIX 631 638 {ECO:0000244|PDB:6F1U}.; HELIX 643 669 {ECO:0000244|PDB:6F1U}.; HELIX 679 692 {ECO:0000244|PDB:6F1U}.; HELIX 696 706 {ECO:0000244|PDB:6F1U}.; HELIX 729 731 {ECO:0000244|PDB:6F1T}.; HELIX 742 755 {ECO:0000244|PDB:6F1U}.; HELIX 762 772 {ECO:0000244|PDB:6F1U}.; HELIX 775 796 {ECO:0000244|PDB:6F1U}.; HELIX 801 821 {ECO:0000244|PDB:6F1U}.; HELIX 830 862 {ECO:0000244|PDB:6F1V}.; HELIX 871 890 {ECO:0000244|PDB:6F1V}.; HELIX 896 925 {ECO:0000244|PDB:6F1V}.; HELIX 989 992 {ECO:0000244|PDB:6F1T}.; HELIX 994 997 {ECO:0000244|PDB:6F1T}.; HELIX 999 1002 {ECO:0000244|PDB:6F1T}.; HELIX 1033 1050 {ECO:0000244|PDB:6F1T}.,TURN 333 336 {ECO:0000244|PDB:6F1U}.; TURN 368 370 {ECO:0000244|PDB:6F1U}.; TURN 401 403 {ECO:0000244|PDB:6F1U}.; TURN 442 444 {ECO:0000244|PDB:6F1U}.; TURN 534 537 {ECO:0000244|PDB:6F1U}.; TURN 627 629 {ECO:0000244|PDB:6F1U}.; TURN 670 675 {ECO:0000244|PDB:6F1U}.; TURN 707 717 {ECO:0000244|PDB:6F1U}.; TURN 863 866 {ECO:0000244|PDB:6F1V}.; TURN 1009 1011 {ECO:0000244|PDB:6F1T}.; TURN 1024 1027 {ECO:0000244|PDB:6F1T}.,,,,,5 out of 5,Beta strand (10); Chain (1); Coiled coil (8); Erroneous initiation (1); Helix (43); Initiator methionine (1); Modified residue (9); Natural variant (31); Nucleotide binding (4); Region (10); Sequence conflict (3); Turn (11),,,,3D-structure;ATP-binding;Acetylation;Cell cycle;Cell division;Charcot-Marie-Tooth disease;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Dynein;Mental retardation;Microtubule;Mitosis;Motor protein;Neurodegeneration;Neuropathy;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transport,Evidence at protein level,reviewed,,Dynein heavy chain family,195,Domain (1); Function (1); Involvement in disease (3); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0067; KW-0131; KW-0132; KW-0144; KW-0175; KW-0181; KW-0206; KW-0225; KW-0243; KW-0493; KW-0498; KW-0505; KW-0523; KW-0547; KW-0597; KW-0621; KW-0622; KW-0677; KW-0813; KW-0963; KW-0991; KW-1185,,,,,"DISEASE: Charcot-Marie-Tooth disease 2O (CMT2O) [MIM:614228]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:21820100, ECO:0000269|PubMed:24307404, ECO:0000269|PubMed:25512093}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mental retardation, autosomal dominant 13 (MRD13) [MIM:614563]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD13 is associated with variable neuronal migration defects and mild dysmorphic features. Some patients may also show signs of peripheral neuropathy, such as abnormal gait and hyporeflexia. {ECO:0000269|PubMed:21076407, ECO:0000269|PubMed:22368300, ECO:0000269|PubMed:23033978, ECO:0000269|PubMed:23603762, ECO:0000269|PubMed:28193117}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600]: A form of spinal muscular atrophy, a neuromuscular disorder characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. SMALED1 is characterized by muscle weakness predominantly affecting the proximal lower extremities. {ECO:0000269|PubMed:22459677, ECO:0000269|PubMed:22847149, ECO:0000269|PubMed:25484024, ECO:0000269|PubMed:25512093, ECO:0000269|PubMed:26846447, ECO:0000269|PubMed:28193117}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 2 4646 Cytoplasmic dynein 1 heavy chain 1. /FTId=PRO_0000114627.,,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22223895}.,,"MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:22223895}.; MOD_RES 70 70 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1125 1125 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 1230 1230 Phosphoserine. {ECO:0000250|UniProtKB:Q9JHU4}.; MOD_RES 3480 3480 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 4162 4162 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 4283 4283 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 4366 4366 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 4368 4368 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB002323;AB290157;AY682080;U53530;L23958;BC021297;
0,Q15691,MARE1_HUMAN,MAPRE1,MAPRE1,,,,Homo sapiens (Human),9606,Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1) (EB1),UP000005640: Chromosome 20,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAVNVYSTSVTSDNLSRHDMLAWINESLQLNLTKIEQLCSGAAYCQFMDMLFPGSIALKKVKFQAKLEHEYIQNFKILQAGFKRMGVDKIIPVDKLVKGKFQDNFEFVQWFKKFFDANYDGKDYDPVAARQGQETAVAPSLVAPALNKPKKPLTSSSAAPQRPISTQRTAAAPKAGPGVVRKNPGVGNGDDEAAELMQQVNVLKLTVEDLEKERDFYFGKLRNIELICQENEGENDPVLQRIVDILYATDEGFVIPDEGGPQEEQEEY,268,"29,999",,,,,,,,,,,,,,,,,,,3,,0,DOMAIN: Composed of two functionally independent domains. The N-terminal domain forms a hydrophobic cleft involved in microtubule binding and the C-terminal is involved in the formation of mutually exclusive complexes with APC and DCTN1. {ECO:0000269|PubMed:12388762}.,SIMILARITY: Belongs to the MAPRE family. {ECO:0000305}.,,,DOMAIN 14 116 Calponin-homology (CH). {ECO:0000255|PROSITE-ProRule:PRU00044}.; DOMAIN 185 255 EB1 C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00576}.,,REGION 124 268 Interaction with MTUS2/TIP150. {ECO:0000269|PubMed:19543227}.; REGION 185 268 Interaction with CDK5RAP2. {ECO:0000269|PubMed:19553473}.; REGION 208 268 DCTN1-binding.; REGION 220 242 APC-binding.,,,,,,,,"FUNCTION: Plus-end tracking protein (+TIP) that binds to the plus-end of microtubules and regulates the dynamics of the microtubule cytoskeleton (PubMed:12388762, PubMed:16109370, PubMed:19632184, PubMed:21646404, PubMed:28726242, PubMed:28814570). Promotes cytoplasmic microtubule nucleation and elongation (PubMed:12388762, PubMed:16109370, PubMed:19632184, PubMed:21646404, PubMed:28726242, PubMed:28814570). May be involved in spindle function by stabilizing microtubules and anchoring them at centrosomes (PubMed:12388762). Also acts as a regulator of minus-end microtubule organization: interacts with the complex formed by AKAP9 and PDE4DIP, leading to recruit CAMSAP2 to the Golgi apparatus, thereby tethering non-centrosomal minus-end microtubules to the Golgi, an important step for polarized cell movement (PubMed:28814570). Promotes elongation of CAMSAP2-decorated microtubule stretches on the minus-end of microtubules (PubMed:28814570). Acts as a regulator of autophagosome transport via interaction with CAMSAP2 (PubMed:28726242). May play a role in cell migration (By similarity). {ECO:0000250|UniProtKB:Q61166, ECO:0000269|PubMed:12388762, ECO:0000269|PubMed:16109370, ECO:0000269|PubMed:19632184, ECO:0000269|PubMed:21646404, ECO:0000269|PubMed:28726242, ECO:0000269|PubMed:28814570}.",,,,,,,,,,,,cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; spindle midzone [GO:0051233]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of cell migration [GO:0030335]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of microtubule polymerization [GO:0031116]; protein localization [GO:0008104]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225],cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of cell migration [GO:0030335]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of microtubule polymerization [GO:0031116]; protein localization [GO:0008104]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225],cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723],cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; spindle midzone [GO:0051233],GO:0000086; GO:0003723; GO:0005794; GO:0005813; GO:0005815; GO:0005829; GO:0005874; GO:0005881; GO:0005925; GO:0008017; GO:0008022; GO:0008104; GO:0008283; GO:0010389; GO:0016477; GO:0019901; GO:0030335; GO:0030981; GO:0031110; GO:0031115; GO:0031116; GO:0031253; GO:0035371; GO:0035372; GO:0042802; GO:0045296; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:0097711; GO:1903033; GO:1904825,IPR001715; IPR036872; IPR004953; IPR036133; IPR027739; IPR027328; ,Itself; P25054; O95996; Q96GD4; O75122; P30622; P30622-1; P30622-2; Q14203; P15924; Q03001; Q8NHY3; Q99661; Q9Y448; P25791; Q15555; Q9UPY8; Q5JR59; Q5VU43; P56282; O60828; P25786; Q495Y8; P54274; Q12815,"SUBUNIT: Homodimer (PubMed:15616574). Heterodimer with MAPRE3 (PubMed:19255245). Interacts with DCTN1, DCTN2, TERF1 and dynein intermediate chain (PubMed:10226031, PubMed:11943150, PubMed:12388762, PubMed:14514668, PubMed:23874158, PubMed:16109370, PubMed:16949363). Interaction with DIAPH1 and DIAPH2 (By similarity). Interacts with APC (via C-terminal domain), CLASP2, DST, KIF2C and STIM1; probably required for their targeting to the growing microtubule plus ends (PubMed:7606712, PubMed:12388762, PubMed:14514668, PubMed:15631994, PubMed:19543227, PubMed:15616574, PubMed:19632184). Interacts with MTUS2; interaction is direct and probably targets MTUS2 to microtubules (PubMed:19543227). Interacts with APC2 (PubMed:10644998). Interacts with CLASP1 (PubMed:15631994). Interacts with CDK5RAP2 (PubMed:19553473). Interacts with MACF1 (By similarity). Interacts with RABL2/RABL2A; binds preferentially to GTP-bound RABL2 (By similarity). Interacts with KCNAB2 (By similarity). Interacts (via C-terminus) with CLIP1 (PubMed:17563362, PubMed:21646404). Interacts with SLAIN2 and SLAIN1 (PubMed:21646404). Interacts with KIF18B; this interaction is required for efficient accumulation of KIF18B at microtubule plus ends (PubMed:21820309). Interacts with MISP (PubMed:23509069). Interacts with KNSTRN (PubMed:23035123). Interacts with NCKAP5L (PubMed:26485573). Interacts with CAMSAP2 (PubMed:28726242). Interacts with PDE4DIP isoform 13/MMG8/SMYLE; this interaction is required for its recruitment to the Golgi apparatus (PubMed:25217626, PubMed:28814570). Forms a pericentrosomal complex with AKAP9, CDK5RAP2 and PDE4DIP isoform 13/MMG8/SMYLE; within this complex, MAPRE1 binding to CDK5RAP2 may be mediated by PDE4DIP (PubMed:29162697). {ECO:0000250|UniProtKB:Q61166, ECO:0000269|PubMed:10226031, ECO:0000269|PubMed:10644998, ECO:0000269|PubMed:11943150, ECO:0000269|PubMed:12388762, ECO:0000269|PubMed:14514668, ECO:0000269|PubMed:15616574, ECO:0000269|PubMed:15631994, ECO:0000269|PubMed:16109370, ECO:0000269|PubMed:16949363, ECO:0000269|PubMed:17563362, ECO:0000269|PubMed:19255245, ECO:0000269|PubMed:19543227, ECO:0000269|PubMed:19553473, ECO:0000269|PubMed:19632184, ECO:0000269|PubMed:21646404, ECO:0000269|PubMed:21820309, ECO:0000269|PubMed:23035123, ECO:0000269|PubMed:23509069, ECO:0000269|PubMed:23874158, ECO:0000269|PubMed:25217626, ECO:0000269|PubMed:26485573, ECO:0000269|PubMed:28726242, ECO:0000269|PubMed:28814570, ECO:0000269|PubMed:29162697, ECO:0000269|PubMed:7606712}.",7606712; 14702039; 11780052; 15489334; 9724749; 10226031; 10188731; 10644998; 11943150; 12388762; 14514668; 14654843; 15631994; 15592455; 17563362; 19413330; 19543227; 19255245; 19553473; 21269460; 21820309; 21646404; 23035123; 22223895; 22814378; 23509069; 23186163; 23874158; 25217626; 24275569; 26485573; 25944712; 28726242; 28814570; 29162697; 15616574; 12857735; 16109370; 16949363; 17889670; 19632184,7606712; 14702039; 11780052; 15489334; 9724749; 10226031; 10188731; 10644998; 11943150; 12388762; 14514668; 14654843; 15631994; 15592455; 17563362; 19413330; 19543227; 19255245; 19553473; 21269460; 21820309; 21646404; 23035123; 22223895; 22814378; 23509069; 23186163; 23874158; 25217626; 24275569; 26485573; 25944712; 28726242; 28814570; 29162697; 15616574; 12857735; 16109370; 16949363; 17889670; 19632184; 11076968; 11081627; 11181178; 11509732; 11701125; 11804586; 11956313; 12006501; 12194817; 12207013; 12221128; 12852856; 13678582; 14580337; 14730319; 15085137; 15339662; 15498487; 15699215; 15705883; 15723797; 15737063; 16030254; 16357211; 16455083; 16462731; 16541025; 16622419; 16622420; 16890155; 17030981; 17129783; 17353931; 17446270; 17574030; 17646400; 17719545; 17968321; 18037885; 18097444; 18477699; 18566290; 18615013; 18694559; 18716626; 18937283; 19004860; 19119138; 19126680; 19463016; 19738201; 19940019; 19965387; 20008324; 20230748; 20399632; 20465283; 20508983; 20558667; 20664522; 20696710; 20711500; 21273506; 21347367; 21397845; 21422230; 21548880; 21562367; 21565611; 21620453; 21725307; 21737685; 21737692; 21768326; 21792235; 21878504; 21987589; 21988832; 22094468; 22119847; 22123863; 22179047; 22277732; 22467876; 22543185; 22623428; 22653444; 22735596; 22748319; 22869553; 22885700; 22898821; 23001180; 23128140; 23141531; 23141541; 23236459; 23251535; 23253480; 23348840; 23400999; 23416715; 23455922; 23530209; 23595990; 23687376; 23747070; 23769972; 23789104; 23871111; 23900080; 23921553; 24040250; 24053599; 24089205; 24231678; 24462004; 24469809; 24478452; 24492008; 24552808; 24616220; 24725408; 24930764; 24982133; 25022754; 25047611; 25048701; 25160006; 25164813; 25225338; 25297623; 25313408; 25355949; 25416956; 25532896; 26150528; 26342024; 26496610; 26498358; 26638075; 26854759; 27208742; 27225956; 27462072; 27617931; 27698945; 27721984; 28039481; 28132723; 28320860; 28743637; 28777446; 29097501; 29484424; 7769006; 7790358; 8838651,2002-01-23,2019-02-13,2007-01-23,203,X-ray crystallography (27),,HELIX 17 28 {ECO:0000244|PDB:2QJZ}.; HELIX 35 40 {ECO:0000244|PDB:2QJZ}.; HELIX 42 51 {ECO:0000244|PDB:2QJZ}.; HELIX 58 60 {ECO:0000244|PDB:2QJZ}.; HELIX 68 85 {ECO:0000244|PDB:2QJZ}.; HELIX 93 96 {ECO:0000244|PDB:2QJZ}.; HELIX 101 118 {ECO:0000244|PDB:2QJZ}.; HELIX 126 129 {ECO:0000244|PDB:2QJZ}.; HELIX 192 230 {ECO:0000244|PDB:1WU9}.; HELIX 237 247 {ECO:0000244|PDB:1WU9}.; HELIX 251 253 {ECO:0000244|PDB:1WU9}.,TURN 97 99 {ECO:0000244|PDB:2R8U}.; TURN 231 233 {ECO:0000244|PDB:1WU9}.,,,,,5 out of 5,Chain (1); Domain (2); Helix (11); Initiator methionine (1); Modified residue (4); Mutagenesis (2); Region (4); Turn (2),,TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:10644998}.,,3D-structure;Acetylation;Cell cycle;Cell division;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Golgi apparatus;Microtubule;Mitosis;Phosphoprotein;Reference proteome,Evidence at protein level,reviewed,,MAPRE family,203,Domain (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0131; KW-0132; KW-0181; KW-0206; KW-0333; KW-0493; KW-0498; KW-0597; KW-0903; KW-0963; KW-1185,,,,,,,,,CHAIN 2 268 Microtubule-associated protein RP/EB family member 1. /FTId=PRO_0000213416.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.6}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.6}.; MOD_RES 124 124 Phosphotyrosine. {ECO:0000244|PubMed:15592455}.; MOD_RES 155 155 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 165 165 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U24166;AK312590;CH471077;CH471077;BC106068;BC109281;
0,Q5SW96,ARH_HUMAN,LDLRAP1 ARH,LDLRAP1,ARH,,,Homo sapiens (Human),9606,Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDALKSAGRALIRSPSLAKQSWGGGGRHRKLPENWTDTRETLLEGMLFSLKYLGMTLVEQPKGEELSAAAIKRIVATAKASGKKLQKVTLKVSPRGIILTDNLTNQLIENVSIYRISYCTADKMHDKVFAYIAQSQHNQSLECHAFLCTKRKMAQAVTLTVAQAFKVAFEFWQVSKEEKEKRDKASQEGGDVLGARQDCTPSLKSLVATGNLLDLEETAKAPLSTVSANTTNMDEVPRPQALSGSSVVWELDDGLDEAFSRLAQSRTNPQVLDTGLTAQDMHYAQCLSPVDWDKPDSSGTEQDDLFSF,308,"33,885",,,,,,,,,,,,,"VARIANT 56 56 T -> M (probable disease-associated mutation found in patients with hypercholesterolemia; dbSNP:rs752849346). {ECO:0000269|PubMed:20124734}. /FTId=VAR_076925.; VARIANT 202 202 S -> H (in ARH; Lebanon; requires 2 nucleotide substitutions; dbSNP:rs386629678). {ECO:0000269|PubMed:11326085}. /FTId=VAR_023320.; VARIANT 202 202 S -> P (in dbSNP:rs6687605). {ECO:0000269|PubMed:11326085, ECO:0000269|PubMed:12417523, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:20124734}. /FTId=VAR_028403.",,,,,,3,,0,"DOMAIN: The [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif mediates interaction the AP-2 complex subunit AP2B1. {ECO:0000269|PubMed:16516836}.; DOMAIN: The PID domain mediates interaction with the NPXY internalization motif of LDLR. {ECO:0000250|UniProtKB:D3ZAR1}.",,,COMPBIAS 23 26 Poly-Gly.,DOMAIN 42 196 PID. {ECO:0000255|PROSITE-ProRule:PRU00148}.,"MOTIF 212 216 Clathrin box. {ECO:0000269|PubMed:12221107}.; MOTIF 257 266 [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif. {ECO:0000269|PubMed:16516836}.",REGION 249 276 AP-2 complex binding. {ECO:0000269|PubMed:12221107}.,,,,,,,,"FUNCTION: Adapter protein (clathrin-associated sorting protein (CLASP)) required for efficient endocytosis of the LDL receptor (LDLR) in polarized cells such as hepatocytes and lymphocytes, but not in non-polarized cells (fibroblasts). May be required for LDL binding and internalization but not for receptor clustering in coated pits. May facilitate the endocytocis of LDLR and LDLR-LDL complexes from coated pits by stabilizing the interaction between the receptor and the structural components of the pits. May also be involved in the internalization of other LDLR family members. Binds to phosphoinositides, which regulate clathrin bud assembly at the cell surface. Required for trafficking of LRP2 to the endocytic recycling compartment which is necessary for LRP2 proteolysis, releasing a tail fragment which translocates to the nucleus and mediates transcriptional repression (By similarity). {ECO:0000250|UniProtKB:D3ZAR1, ECO:0000269|PubMed:15728179}.",,,,,,,,,,,,"axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; receptor signaling complex scaffold activity [GO:0030159]; signaling adaptor activity [GO:0035591]; amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]",amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076],"amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; receptor signaling complex scaffold activity [GO:0030159]; signaling adaptor activity [GO:0035591]",axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],GO:0001540; GO:0001784; GO:0005546; GO:0005769; GO:0005829; GO:0005883; GO:0005886; GO:0006898; GO:0008203; GO:0009898; GO:0009925; GO:0030159; GO:0030276; GO:0030301; GO:0030424; GO:0030665; GO:0031623; GO:0034383; GO:0035591; GO:0035612; GO:0035615; GO:0035650; GO:0042632; GO:0042982; GO:0043393; GO:0048260; GO:0050750; GO:0055037; GO:0061024; GO:0071345; GO:0090118; GO:0090205; GO:1903076; GO:1904707; GO:1905581; GO:1905602,IPR011993; IPR006020; ,P63010; P63010-2; P31273; Q9UPT6; Q8NDX1-2; Q9H668,"SUBUNIT: Interacts (via PID domain) with LDLR (via NPXY motif) (PubMed:12221107). Binds to soluble clathrin trimers (PubMed:12221107). Interacts with AP2B1; the interaction mediates the association with the AP-2 complex (PubMed:12221107). Interacts with VLDLR (By similarity). Interacts with LRP2 (By similarity). {ECO:0000250|UniProtKB:D3ZAR1, ECO:0000250|UniProtKB:Q8C142, ECO:0000269|PubMed:12221107}.",11326085; 12417523; 17974005; 16710414; 15489334; 12221107; 12451172; 15728179; 16903783; 18669648; 21269460; 22814378; 23186163; 16516836; 20124734,11326085; 12417523; 17974005; 16710414; 15489334; 12221107; 12451172; 15728179; 16903783; 18669648; 21269460; 22814378; 23186163; 16516836; 20124734; 10535736; 10542231; 10559861; 10559924; 10625686; 10766823; 11082044; 11231140; 11239472; 11247302; 11470803; 11517213; 11532990; 11577110; 11889126; 12057195; 12234931; 12464675; 12788851; 12944396; 12952949; 14528014; 14622578; 14622579; 15166224; 15252009; 15260957; 15318165; 15497461; 15502812; 15502813; 15599766; 15649145; 15703209; 15895077; 16103228; 16129683; 16179341; 16189514; 16215232; 16326391; 16410077; 16798879; 16870701; 16984970; 17018281; 17158794; 17512409; 17540576; 17609109; 17681954; 17686643; 17765681; 17978091; 18093523; 18388313; 18417616; 18790740; 18981233; 19081568; 19092055; 19296720; 19458185; 19477448; 19536138; 19575674; 19603039; 1968060; 19696796; 19841541; 19913121; 20033059; 20059951; 20231386; 20237496; 20428113; 20448150; 20467437; 20628086; 20826345; 20946875; 2115402; 21187331; 21278753; 21316588; 21444685; 21445324; 21482805; 21613550; 21778424; 21779028; 21841790; 21872251; 21915095; 21927000; 21927001; 21962517; 22099461; 221835; 22233676; 22505844; 23297414; 23510778; 23536704; 23564733; 23823722; 23861397; 23891661; 24186068; 24581490; 24789820; 24966051; 25107275; 25225128; 25331956; 25341920; 25416956; 26042225; 28958330; 6146630; 7877694; 8300609; 8524399; 8552632; 9092476; 9100026; 9427626; 9428629; 9635431; 9736607,2005-08-30,2019-02-13,2006-10-17,146,X-ray crystallography (1),,HELIX 256 266 {ECO:0000244|PDB:2G30}.,,,,,,5 out of 5,Chain (1); Compositional bias (1); Domain (1); Helix (1); Modified residue (4); Motif (2); Mutagenesis (7); Natural variant (3); Region (1),,"TISSUE SPECIFICITY: Expressed at high levels in the kidney, liver, and placenta, with lower levels detectable in brain, heart, muscle, colon, spleen, intestine, lung, and leukocytes.",,3D-structure;Acetylation;Atherosclerosis;Cholesterol metabolism;Complete proteome;Cytoplasm;Disease mutation;Endocytosis;Hyperlipidemia;Lipid metabolism;Phosphoprotein;Polymorphism;Reference proteome;Steroid metabolism;Sterol metabolism,Evidence at protein level,reviewed,,,146,Domain (2); Function (1); Involvement in disease (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0065; KW-0153; KW-0181; KW-0225; KW-0254; KW-0380; KW-0443; KW-0597; KW-0621; KW-0753; KW-0963; KW-1185; KW-1207,,,,,"DISEASE: Hypercholesterolemia, autosomal recessive (ARH) [MIM:603813]: A familial condition characterized by elevated circulating cholesterol contained in either low-density lipoproteins alone or also in very-low-density lipoproteins. {ECO:0000269|PubMed:11326085}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 308 Low density lipoprotein receptor adapter protein 1. /FTId=PRO_0000064675.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 14 14 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 186 186 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 202 202 Phosphoserine. {ECO:0000250|UniProtKB:Q8C142}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AY389348;AL117654;BC029770;
0,Q8N4N8,KIF2B_HUMAN,KIF2B,KIF2B,,,,Homo sapiens (Human),9606,Kinesin-like protein KIF2B,UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MASQFCLPESPCLSPLKPLKPHFGDIQEGIYVAIQRSDKRIHLAVVTEINRENYWVTVEWVEKAVKKGKKIDLETILLLNPALDSAEHPMPPPPLSPLALAPSSAIRDQRTATKWVAMIPQKNQTASGDSLDVRVPSKPCLMKQKKSPCLWEIQKLQEQREKRRRLQQEIRARRALDVNTRNPNYEIMHMIEEYRRHLDSSKISVLEPPQEHRICVCVRKRPLNQRETTLKDLDIITVPSDNVVMVHESKQKVDLTRYLQNQTFCFDHAFDDKASNELVYQFTAQPLVESIFRKGMATCFAYGQTGSGKTYTMGGDFSGTAQDCSKGIYALVAQDVFLLLRNSTYEKLDLKVYGTFFEIYGGKVYDLLNWKKKLQVLEDGNQQIQVVGLQEKEVCCVEEVLNLVEIGNSCRTSRQTPVNAHSSRSHAVFQIILKSGRIMHGKFSLVDLAGNERGADTTKASRKRQLEGAEINKSLLALKECILALGQNKPHTPFRASKLTLVLRDSFIGQNSSTCMIATISPGMTSCENTLNTLRYANRVKKLNVDVRPYHRGHYPIGHEAPRMLKSHIGNSEMSLQRDEFIKIPYVQSEEQKEIEEVETLPTLLGKDTTISGKGSSQWLENIQERAGGVHHDIDFCIARSLSILEQKIDALTEIQKKLKLLLADLHVKSKVE,673,"76,254",,,,,,,,,,,,,"VARIANT 112 112 A -> V (in dbSNP:rs3803824). {ECO:0000269|PubMed:14702039, ECO:0000269|Ref.1}. /FTId=VAR_028717.; VARIANT 128 128 G -> R (in dbSNP:rs9912492). /FTId=VAR_028718.; VARIANT 148 148 P -> S (in dbSNP:rs59657238). /FTId=VAR_061279.; VARIANT 417 417 P -> S (in dbSNP:rs4561518). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|Ref.1}. /FTId=VAR_028719.; VARIANT 437 437 R -> G (in dbSNP:rs4561519). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|Ref.1}. /FTId=VAR_028720.",,,,CONFLICT 32 32 V -> A (in Ref. 1; AAK20830). {ECO:0000305}.; CONFLICT 49 49 I -> T (in Ref. 2; BAB71406). {ECO:0000305}.; CONFLICT 93 93 P -> L (in Ref. 1; AAK20830). {ECO:0000305}.; CONFLICT 306 306 G -> R (in Ref. 1; AAK20830). {ECO:0000305}.; CONFLICT 313 313 M -> V (in Ref. 1; AAK20830). {ECO:0000305}.; CONFLICT 320 320 T -> K (in Ref. 2; BAB71406). {ECO:0000305}.; CONFLICT 500 500 T -> A (in Ref. 1; AAK20830). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family. MCAK/KIF2 subfamily. {ECO:0000255|PROSITE-ProRule:PRU00283}.,COILED 151 176 {ECO:0000255}.; COILED 640 666 {ECO:0000255}.,,DOMAIN 213 543 Kinesin motor. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,,,,,,,,,"FUNCTION: Plus end-directed microtubule-dependent motor required for spindle assembly and chromosome movement. Has microtubule depolymerization activity (PubMed:17538014). Plays a role in chromosome congression (PubMed:23891108). {ECO:0000269|PubMed:17538014, ECO:0000269|PubMed:23891108}.",,,,,,,,,,NP_BIND 303 310 ATP. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,"centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; regulation of chromosome segregation [GO:0051983]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; regulation of chromosome segregation [GO:0051983]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleus [GO:0005634],GO:0000777; GO:0003777; GO:0005524; GO:0005634; GO:0005730; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0007019; GO:0008017; GO:0015630; GO:0016887; GO:0019886; GO:0045171; GO:0051301; GO:0051310; GO:0051983; GO:0072686,IPR027640; IPR019821; IPR001752; IPR036961; IPR027417; ,,,14702039; 16625196; 15489334; 17538014; 22535524; 23891108,14702039; 16625196; 15489334; 17538014; 22535524; 23891108; 10036229; 11081627; 11181178; 11493604; 11509732; 11739780; 11804586; 12006501; 12194817; 12198549; 12368902; 12893827; 14504276; 14730319; 15029241; 15085137; 15272311; 15303970; 15326200; 15339662; 15723797; 15737063; 1607388; 16262723; 16541025; 16571679; 16622419; 16622420; 17030981; 17113389; 17129783; 17283181; 18046453; 18097444; 18716626; 19060894; 19116309; 19369418; 19564404; 19758564; 19965387; 20005805; 20136777; 20462495; 20534429; 20852589; 20950786; 21397845; 2142332; 21550981; 21878504; 21987589; 22013193; 22885700; 23087211; 2521221; 2522352; 25364732; 27982129; 7822426; 7844144; 7929562; 8602245; 8642258; 8909537,2006-10-17,2019-02-13,2010-10-05,144,,,,,,,,,5 out of 5,Chain (1); Coiled coil (2); Domain (1); Modified residue (2); Natural variant (5); Nucleotide binding (1); Sequence conflict (7),,"TISSUE SPECIFICITY: Highest level in lung. High level in ovary, moderate levels in heart, kidney, placenta, skeletal muscle and spleen (at protein level). Pancreas and spleen express a shorter isoform (at protein level). {ECO:0000269|PubMed:17538014}.","MISCELLANEOUS: Osteosarcoma cells (U2OS) lacking KIF2B show disorganised often monopolar mitotic spindles, severely reduced velocity of chromosome movement and blocked cytokinesis. Bipolar mitotic spindles can be restored by simultaneous depletion of KIF2B, KIFC1 and NUMA1.",ATP-binding;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Kinetochore;Microtubule;Mitosis;Motor protein;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family, MCAK/KIF2 subfamily",144,Function (1); Miscellaneous (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Tissue specificity (1),,KW-0067; KW-0131; KW-0132; KW-0137; KW-0158; KW-0175; KW-0181; KW-0206; KW-0493; KW-0498; KW-0505; KW-0547; KW-0597; KW-0621; KW-0963; KW-0995; KW-1185,,,,,,,,"PTM: Phosphorylation at Thr-125 by PLK1 is required for activity in the correction of kinetochore-microtubules attachment errors, while phosphorylation at Ser-204 also by PLK1 is required for the kinetochore localization and activity in prometaphase. {ECO:0000269|PubMed:22535524}.",CHAIN 1 673 Kinesin-like protein KIF2B. /FTId=PRO_0000253715.,,,,,,MOD_RES 125 125 Phosphothreonine; by PLK1. {ECO:0000269|PubMed:22535524}.; MOD_RES 204 204 Phosphoserine; by PLK1. {ECO:0000269|PubMed:22535524}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF333335;AK057272;BC033802;
0,Q8TF09,DLRB2_HUMAN,DYNLRB2 DNCL2B DNLC2B ROBLD2,DYNLRB2,DNCL2B DNLC2B ROBLD2,,,Homo sapiens (Human),9606,"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2)",UP000005640: Chromosome 16,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAEVEETLKRIQSHKGVIGTMVVNAEGIPIRTTLDNSTTVQYAGLLHHLTMKAKSTVRDIDPQNDLTFLRIRSKKHEIMVAPDKEYLLIVIQNPCE,96,"10,855",,,,,,,,,,,,,VARIANT 14 14 H -> R (in dbSNP:rs13332289). /FTId=VAR_049126.,,,,,,1,,0,,SIMILARITY: Belongs to the GAMAD family. {ECO:0000305}.,,,,,,,,,,,,,FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules.,,,,,,,,,,,,ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018],intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018],dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777],ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; outer dynein arm [GO:0036157],GO:0003777; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0035735; GO:0036157; GO:0045505; GO:0097542,IPR016561; IPR004942; ,,"SUBUNIT: Homodimer (Probable). The cytoplasmic dynein 1 complex consists of two catalytic heavy chains (HCs) and a number of non-catalytic subunits presented by intermediate chains (ICs), light intermediate chains (LICs) and light chains (LCs); the composition seems to vary in respect to the IC, LIC and LC composition. The heavy chain homodimer serves as a scaffold for the probable homodimeric assembly of the respective non-catalytic subunits. The ICs and LICs bind directly to the HC dimer and the LCs assemble on the IC dimer. Interacts with DYNC1I1 and DYNC1I2. Self-associates. Interacts with DYNLRB1. {ECO:0000269|PubMed:12077152, ECO:0000305}.",11750132; 12077152,11750132; 12077152; 10069812; 11285270; 15231740; 15269286; 15489852; 16049494; 16492809; 16782012; 17312020; 17574030; 18304522; 18852297; 19147001; 19384852; 19450523; 19711352; 19720863; 19805633; 19844255; 20379614; 20526328; 20530210; 20889716; 21427764; 21936775; 22118932; 22922713; 22992454; 23945166; 23990561; 24296415; 24596149; 24616010; 25205765; 25443296; 8516294; 8522608; 9114011; 9585416; 9585417; 9852153,2003-04-23,2019-02-13,2002-06-01,124,,,,,,,,,5 out of 5,Chain (1); Initiator methionine (1); Modified residue (1); Natural variant (1),,"TISSUE SPECIFICITY: High expression in heart, brain, placenta, skeletal muscle, prostate and small intestine; moderate in kidney, pancreas, spleen, testis, ovary and colon; low in lung, liver, thymus and leukocyte.",MISCELLANEOUS: Expression is significantly down-regulated in hepatocellular carcinoma (HCC) patients.,Acetylation;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Dynein;Microtubule;Motor protein;Polymorphism;Reference proteome;Transport,Evidence at protein level,reviewed,,GAMAD family,124,Function (1); Miscellaneous (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0007; KW-0181; KW-0206; KW-0243; KW-0493; KW-0505; KW-0621; KW-0813; KW-0903; KW-0963; KW-1185,,,,,,,,,CHAIN 2 96 Dynein light chain roadblock-type 2. /FTId=PRO_0000220958.,,,,INIT_MET 1 1 Removed. {ECO:0000269|Ref.2}.,,MOD_RES 2 2 N-acetylalanine. {ECO:0000269|Ref.2}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF125108;
0,Q96FJ2,DYL2_HUMAN,DYNLL2 DLC2,DYNLL2,DLC2,,,Homo sapiens (Human),9606,"Dynein light chain 2, cytoplasmic (8 kDa dynein light chain b) (DLC8b) (Dynein light chain LC8-type 2)",UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSDRKAVIKNADMSEDMQQDAVDCATQAMEKYNIEKDIAAYIKKEFDKKYNPTWHCIVGRNFGSYVTHETKHFIYFYLGQVAILLFKSG,89,"10,350",,,,,,,,,,,,,,,,,,,1,,0,,SIMILARITY: Belongs to the dynein light chain family. {ECO:0000305}.,,,,,,,,,,,,,FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in changing or maintaining the spatial distribution of cytoskeletal structures (By similarity). {ECO:0000250}.,,,,,,,,,,,SITE 41 41 Interaction with myosin V motor complex. {ECO:0000250}.,"centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intraciliary transport involved in cilium assembly [GO:0035735]; macroautophagy [GO:0016236]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]","antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intraciliary transport involved in cilium assembly [GO:0035735]; macroautophagy [GO:0016236]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]",dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069],GO:0003774; GO:0005634; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005886; GO:0005929; GO:0006888; GO:0014069; GO:0016020; GO:0016236; GO:0019886; GO:0030286; GO:0031475; GO:0035735; GO:0042803; GO:0045505; GO:0046982; GO:0051959; GO:0097110; GO:0097542; GO:0098794; GO:0098978; GO:2000582,IPR037177; IPR019763; IPR001372; ,P0C206; Q85601; Q96LC9; Q86WS4; Q8IYA8; O96015; Q6P1L5; Q6NT76; Q9NSC5; P50222; Q6PF18; Q8IV61; Q93073,"SUBUNIT: Homodimer. The cytoplasmic dynein 1 complex consists of two catalytic heavy chains (HCs) and a number of non-catalytic subunits which present intermediate chains (ICs), light intermediate chains (LICs) and light chains (LCs); the composition seems to vary in respect to the IC, LIC and LC composition. The heavy chain homodimer serves as a scaffold for the probable homodimeric assembly of the respective non-catalytic subunits. Dynein ICs and LICs bind directly to the HC dimer and the LCs assemble on the IC dimer. Interacts with DYNC1I1. Interacts with BMF. Component of the myosin V motor complex. Interacts with BCAS1. {ECO:0000250|UniProtKB:Q78P75, ECO:0000250|UniProtKB:Q9D0M5}.",14702039; 15489334; 21269460; 24275569; 25944712,14702039; 15489334; 21269460; 24275569; 25944712; 10036229; 10069812; 10559986; 10562278; 10679020; 10903204; 11035033; 11081627; 11181178; 11285137; 11285270; 11306556; 11461920; 11483508; 11509732; 11804586; 12006501; 12194817; 12198549; 12401177; 12447383; 12591950; 14730319; 15085137; 15231740; 15269286; 15339662; 15483056; 15489852; 15591061; 15632110; 15723797; 15728195; 15737063; 15878873; 16049494; 16189514; 16492809; 16541025; 16622419; 16622420; 16723730; 16782012; 17030981; 17129783; 17274799; 17283181; 17312020; 17353931; 17574030; 17827179; 18046453; 18086915; 18097444; 18304522; 18664496; 18716626; 18782753; 18852297; 19147001; 19384852; 19450523; 19564404; 19615732; 19720863; 19805633; 19965387; 20038533; 20064372; 20360068; 20526328; 20530210; 20889716; 20889982; 20921139; 21397845; 21427764; 21533121; 21878504; 21936775; 21987589; 21988832; 22118932; 22458338; 22575643; 22810585; 22885700; 22922713; 22992454; 23455922; 23602568; 23783758; 23839779; 23945166; 23990561; 24296415; 24366813; 24596149; 24616010; 24806965; 24891604; 25205765; 25233431; 25312846; 25416956; 25443296; 25453831; 26638075; 7691276; 8516294; 8522608; 8642258; 8909537; 8991093; 9114011; 9150144; 9288971; 9323141; 9380700; 9490716; 9585416; 9585417; 9671725; 9852153,2004-12-21,2019-02-13,2001-12-01,154,X-ray crystallography (3),STRAND 6 13 {ECO:0000244|PDB:2XQQ}.; STRAND 54 66 {ECO:0000244|PDB:2XQQ}.; STRAND 72 78 {ECO:0000244|PDB:2XQQ}.; STRAND 81 87 {ECO:0000244|PDB:2XQQ}.,HELIX 15 31 {ECO:0000244|PDB:2XQQ}.; HELIX 35 50 {ECO:0000244|PDB:2XQQ}.,TURN 1 3 {ECO:0000244|PDB:4D07}.,,,,,5 out of 5,Beta strand (4); Chain (1); Helix (2); Site (1); Turn (1),,,,3D-structure;Complete proteome;Cytoplasm;Cytoskeleton;Dynein;Microtubule;Motor protein;Reference proteome;Transport,Evidence at protein level,reviewed,,Dynein light chain family,154,Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0181; KW-0206; KW-0243; KW-0493; KW-0505; KW-0813; KW-0963; KW-1185,,,,,,,,,"CHAIN 1 89 Dynein light chain 2, cytoplasmic. /FTId=PRO_0000195132.",,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF112997;AK312125;CH471109;BC010744;
0,Q9HAU4,SMUF2_HUMAN,SMURF2,SMURF2,,,,Homo sapiens (Human),9606,E3 ubiquitin-protein ligase SMURF2 (hSMURF2) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2),UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSNPGGRRNGPVKLRLTVLCAKNLVKKDFFRLPDPFAKVVVDGSGQCHSTDTVKNTLDPKWNQHYDLYIGKSDSVTISVWNHKKIHKKQGAGFLGCVRLLSNAINRLKDTGYQRLDLCKLGPNDNDTVRGQIVVSLQSRDRIGTGGQVVDCSRLFDNDLPDGWEERRTASGRIQYLNHITRTTQWERPTRPASEYSSPGRPLSCFVDENTPISGTNGATCGQSSDPRLAERRVRSQRHRNYMSRTHLHTPPDLPEGYEQRTTQQGQVYFLHTQTGVSTWHDPRVPRDLSNINCEELGPLPPGWEIRNTATGRVYFVDHNNRTTQFTDPRLSANLHLVLNRQNQLKDQQQQQVVSLCPDDTECLTVPRYKRDLVQKLKILRQELSQQQPQAGHCRIEVSREEIFEESYRQVMKMRPKDLWKRLMIKFRGEEGLDYGGVAREWLYLLSHEMLNPYYGLFQYSRDDIYTLQINPDSAVNPEHLSYFHFVGRIMGMAVFHGHYIDGGFTLPFYKQLLGKSITLDDMELVDPDLHNSLVWILENDITGVLDHTFCVEHNAYGEIIQHELKPNGKSIPVNEENKKEYVRLYVNWRFLRGIEAQFLALQKGFNEVIPQHLLKTFDEKELELIICGLGKIDVNDWKVNTRLKHCTPDSNIVKWFWKAVEFFDEERRARLLQFVTGSSRVPLQGFKALQGAAGPRLFTIHQIDACTNNLPKAHTCFNRIDIPPYESYEKLYEKLLTAIEETCGFAVE,748,"86,196",,,,,,,,,,,,,,,,,CONFLICT 6 6 G -> R (in Ref. 2; AAG45422). {ECO:0000305}.,,1,,0,"DOMAIN: The second and third WW domains are responsible for interaction with the PY-motif of R-SMAD (SMAD1, SMAD2 and SMAD3).; DOMAIN: The C2 domain is involved in autoinhibition of the catalytic activity by interacting with the HECT domain.",,,,DOMAIN 1 98 C2. {ECO:0000255|PROSITE-ProRule:PRU00041}.; DOMAIN 157 190 WW 1. {ECO:0000255|PROSITE-ProRule:PRU00224}.; DOMAIN 251 284 WW 2. {ECO:0000255|PROSITE-ProRule:PRU00224}.; DOMAIN 297 330 WW 3. {ECO:0000255|PROSITE-ProRule:PRU00224}.; DOMAIN 414 748 HECT. {ECO:0000255|PROSITE-ProRule:PRU00104}.,,,,,2.3.2.26,,CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.26; Evidence={ECO:0000250|UniProtKB:Q9HCE7};,,,"FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Interacts with SMAD1 and SMAD7 in order to trigger their ubiquitination and proteasome-dependent degradation. In addition, interaction with SMAD7 activates autocatalytic degradation, which is prevented by interaction with SCYE1. Forms a stable complex with the TGF-beta receptor-mediated phosphorylated SMAD2 and SMAD3. In this way, SMAD2 may recruit substrates, such as SNON, for ubiquitin-mediated degradation. Enhances the inhibitory activity of SMAD7 and reduces the transcriptional activity of SMAD2. Coexpression of SMURF2 with SMAD1 results in considerable decrease in steady-state level of SMAD1 protein and a smaller decrease of SMAD2 level. {ECO:0000269|PubMed:11389444, ECO:0000269|PubMed:12717440}.",,PATHWAY: Protein modification; protein ubiquitination.,,,,ACT_SITE 716 716 Glycyl thioester intermediate. {ECO:0000255|PROSITE-ProRule:PRU00104}.,,,,,,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; BMP signaling pathway [GO:0030509]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","BMP signaling pathway [GO:0030509]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151],GO:0000122; GO:0000151; GO:0000209; GO:0004842; GO:0005160; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0016579; GO:0016607; GO:0017015; GO:0030509; GO:0030512; GO:0030514; GO:0030579; GO:0042802; GO:0043161; GO:0045121; GO:0045732; GO:0045892; GO:0046332; GO:0060071; GO:0061630; GO:0090263; GO:1901165,IPR000008; IPR035892; IPR024928; IPR000569; IPR035983; IPR001202; IPR036020; ,Itself; Q9WMX2; Q9H469; Q9Y3C5; Q15797; Q15796; P84022; O15105; P0CG47,"SUBUNIT: Interacts (via WW domains) with SMAD1. Interacts (via WW domains) with SMAD2 (via PY-motif). Interacts (via WW domains) with SMAD3 (via PY-motif). Interacts with SMAD6. Interacts with SMAD7 (via PY-motif) and TGFBR1; SMAD7 recruits SMURF2 to the TGF-beta receptor and regulates its degradation. Does not interact with SMAD4; SMAD4 lacks a PY-motif. Interacts with AIMP1. Interacts with STAMBP and RNF11. Interacts with NDFIP1 and NDFIP2 (Probable); this interaction activates the E3 ubiquitin-protein ligase. {ECO:0000269|PubMed:11163210, ECO:0000269|PubMed:11389444, ECO:0000269|PubMed:14562029, ECO:0000269|PubMed:14755250, ECO:0000269|PubMed:16061177, ECO:0000269|PubMed:16641086, ECO:0000269|PubMed:18448069}.",11163210; 11016919; 11158580; 15489334; 11389444; 12717440; 14562029; 14755250; 18448069; 19343052; 21572392; 16061177; 16641086; 17719543,11163210; 11016919; 11158580; 15489334; 11389444; 12717440; 14562029; 14755250; 18448069; 19343052; 21572392; 16061177; 16641086; 17719543; 10444327; 10458166; 10966113; 11027307; 11278251; 12123571; 12151385; 12646216; 12857866; 15138260; 15231748; 15300262; 15496141; 15574587; 15761153; 15862290; 15937478; 16954532; 16980583; 17318188; 17510063; 17591695; 17641202; 18052755; 18157088; 18181147; 18353873; 18514338; 18671942; 18729074; 18821706; 18842593; 18852296; 18927080; 18985028; 19028597; 19122240; 19155312; 19255252; 19379695; 19481076; 19489725; 19557001; 19805145; 19874575; 19898560; 20676133; 20819168; 20858899; 20937913; 21750651; 21945933; 21953463; 21967197; 21994455; 22045334; 22070932; 22378783; 22624557; 22921829; 23250956; 23455153; 23526793; 23725801; 23781096; 23902751; 24121673; 24302888; 24485087; 24709419; 24729608; 24803334; 24925320; 25051198; 25438670; 25524739; 26126536; 26166038; 26435193; 26679521; 26743567; 27086113; 27197155; 28169289; 28292929; 28387615; 28611047; 29100790; 29534682; 29964046; 9674432,2001-12-13,2019-02-13,2001-03-01,186,X-ray crystallography (2); NMR spectroscopy (4),STRAND 12 23 {ECO:0000244|PDB:2JQZ}.; STRAND 35 41 {ECO:0000244|PDB:2JQZ}.; STRAND 48 50 {ECO:0000244|PDB:2JQZ}.; STRAND 60 69 {ECO:0000244|PDB:2JQZ}.; STRAND 75 81 {ECO:0000244|PDB:2JQZ}.; STRAND 93 99 {ECO:0000244|PDB:2JQZ}.; STRAND 113 115 {ECO:0000244|PDB:2JQZ}.; STRAND 131 138 {ECO:0000244|PDB:2JQZ}.; STRAND 258 262 {ECO:0000244|PDB:2KXQ}.; STRAND 266 271 {ECO:0000244|PDB:2KXQ}.; STRAND 276 280 {ECO:0000244|PDB:2KXQ}.; STRAND 282 284 {ECO:0000244|PDB:2KXQ}.; STRAND 286 288 {ECO:0000244|PDB:2KXQ}.; STRAND 301 307 {ECO:0000244|PDB:2DJY}.; STRAND 309 311 {ECO:0000244|PDB:2DJY}.; STRAND 313 317 {ECO:0000244|PDB:2DJY}.; STRAND 322 326 {ECO:0000244|PDB:2DJY}.; STRAND 392 397 {ECO:0000244|PDB:1ZVD}.; STRAND 420 426 {ECO:0000244|PDB:1ZVD}.; STRAND 455 460 {ECO:0000244|PDB:1ZVD}.; STRAND 463 469 {ECO:0000244|PDB:1ZVD}.; STRAND 549 555 {ECO:0000244|PDB:1ZVD}.; STRAND 558 565 {ECO:0000244|PDB:1ZVD}.; STRAND 629 631 {ECO:0000244|PDB:1ZVD}.; STRAND 641 646 {ECO:0000244|PDB:1ZVD}.; STRAND 679 681 {ECO:0000244|PDB:1ZVD}.; STRAND 698 702 {ECO:0000244|PDB:1ZVD}.; STRAND 712 714 {ECO:0000244|PDB:1ZVD}.; STRAND 719 722 {ECO:0000244|PDB:1ZVD}.,HELIX 82 87 {ECO:0000244|PDB:2JQZ}.; HELIX 101 110 {ECO:0000244|PDB:2JQZ}.; HELIX 293 295 {ECO:0000244|PDB:2KXQ}.; HELIX 372 386 {ECO:0000244|PDB:1ZVD}.; HELIX 402 411 {ECO:0000244|PDB:1ZVD}.; HELIX 415 419 {ECO:0000244|PDB:1ZVD}.; HELIX 434 449 {ECO:0000244|PDB:1ZVD}.; HELIX 452 454 {ECO:0000244|PDB:1ZVD}.; HELIX 473 475 {ECO:0000244|PDB:1ZVD}.; HELIX 479 495 {ECO:0000244|PDB:1ZVD}.; HELIX 506 512 {ECO:0000244|PDB:1ZVD}.; HELIX 522 525 {ECO:0000244|PDB:1ZVD}.; HELIX 527 538 {ECO:0000244|PDB:1ZVD}.; HELIX 578 590 {ECO:0000244|PDB:1ZVD}.; HELIX 595 608 {ECO:0000244|PDB:1ZVD}.; HELIX 611 614 {ECO:0000244|PDB:1ZVD}.; HELIX 619 627 {ECO:0000244|PDB:1ZVD}.; HELIX 634 639 {ECO:0000244|PDB:1ZVD}.; HELIX 651 662 {ECO:0000244|PDB:1ZVD}.; HELIX 665 676 {ECO:0000244|PDB:1ZVD}.; HELIX 686 688 {ECO:0000244|PDB:1ZVD}.; HELIX 715 717 {ECO:0000244|PDB:1ZVD}.; HELIX 728 739 {ECO:0000244|PDB:1ZVD}.,TURN 42 44 {ECO:0000244|PDB:2JQZ}.; TURN 263 265 {ECO:0000244|PDB:2KXQ}.; TURN 272 275 {ECO:0000244|PDB:2KXQ}.; TURN 318 321 {ECO:0000244|PDB:2DJY}.; TURN 328 330 {ECO:0000244|PDB:2DJY}.; TURN 542 544 {ECO:0000244|PDB:1ZVD}.; TURN 574 577 {ECO:0000244|PDB:1ZVD}.; TURN 591 594 {ECO:0000244|PDB:1ZVD}.,,,,,5 out of 5,Active site (1); Beta strand (29); Chain (1); Domain (5); Helix (23); Mutagenesis (13); Sequence conflict (1); Turn (8),,TISSUE SPECIFICITY: Widely expressed.,,3D-structure;Cell membrane;Complete proteome;Cytoplasm;Membrane;Nucleus;Reference proteome;Repeat;Transferase;Ubl conjugation;Ubl conjugation pathway,Evidence at protein level,reviewed,,,186,Activity regulation (1); Catalytic activity (1); Domain (2); Function (1); Pathway (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0181; KW-0472; KW-0539; KW-0677; KW-0808; KW-0832; KW-0833; KW-0963; KW-1003; KW-1185,Protein modification; protein ubiquitination. ,,,,,,,"PTM: Auto-ubiquitinated and ubiquitinated in the presence of RNF11 and UBE2D1. Ubiquitinated by the SCF(FBXL15) complex, leading to its degradation by the proteasome. {ECO:0000269|PubMed:19343052, ECO:0000269|PubMed:21572392}.",CHAIN 1 748 E3 ubiquitin-protein ligase SMURF2. /FTId=PRO_0000120329.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF310676;AF301463;AY014180;BC093876;BC111945;
0,Q9NP97,DLRB1_HUMAN,DYNLRB1 BITH DNCL2A DNLC2A ROBLD1 HSPC162,DYNLRB1,BITH DNCL2A DNLC2A ROBLD1,,HSPC162,Homo sapiens (Human),9606,"Dynein light chain roadblock-type 1 (Bithoraxoid-like protein) (BLP) (Dynein light chain 2A, cytoplasmic) (Dynein-associated protein Km23) (Roadblock domain-containing protein 1)",UP000005640: Chromosome 20,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAEVEETLKRLQSQKGVQGIIVVNTEGIPIKSTMDNPTTTQYASLMHSFILKARSTVRDIDPQNDLTFLRIRSKKNEIMVAPDKDYFLIVIQNPTE,96,"10,922",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Comment=Additional isoforms seem to exist.; Name=1; IsoId=Q9NP97-1; Sequence=Displayed; Name=2; IsoId=Q9NP97-2; Sequence=VSP_007236, VSP_007237; Note=May result from the retention of an intron in the cDNA.; ",,,,,,,,,,VAR_SEQ 28 47 IPIKSTMDNPTTTQYASLMH -> GWEPLGHCGDRSRPPAQGCP (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_007236.; VAR_SEQ 48 96 Missing (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_007237.,VARIANT 13 13 S -> R (in dbSNP:rs1063616). /FTId=VAR_049124.; VARIANT 71 71 I -> F (in dbSNP:rs10036). /FTId=VAR_049125.,,,,,,3,,0,,SIMILARITY: Belongs to the GAMAD family. {ECO:0000305}.,,,,,,,,,,,,,FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules.,,,,,,,,,,,,centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; membrane [GO:0016020]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; visual behavior [GO:0007632],intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; visual behavior [GO:0007632],dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777],centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; membrane [GO:0016020]; microtubule [GO:0005874]; outer dynein arm [GO:0036157],GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0007632; GO:0016020; GO:0035735; GO:0036157; GO:0045505; GO:0097542,IPR016561; IPR004942; ,Q13409,"SUBUNIT: Homodimer. The cytoplasmic dynein 1 complex consists of two catalytic heavy chains (HCs) and a number of non-catalytic subunits presented by intermediate chains (ICs), light intermediate chains (LICs) and light chains (LCs); the composition seems to vary in respect to the IC, LIC and LC composition. The heavy chain homodimer serves as a scaffold for the probable homodimeric assembly of the respective non-catalytic subunits. The ICs and LICs bind directly to the HC dimer and the LCs assemble on the IC dimer. Self-associates. Interacts with DYNLRB2. Interacts with DYNC1I1 and DYNC1I2. Interacts with RAB6A isoform 1 (GTP-bound); the interaction is direct. Interacts with RAB6A isoform 2 (GDP-bound); the interaction is direct. Interacts with RAB6B (GDP-bound). {ECO:0000269|PubMed:12077152, ECO:0000269|PubMed:16083906, ECO:0000269|PubMed:16970917, ECO:0000269|PubMed:18044744}.",11750132; 11042152; 11780052; 15489334; 12665801; 12077152; 18044744; 21269460; 25944712; 16083906; 16970917,11750132; 11042152; 11780052; 15489334; 12665801; 12077152; 18044744; 21269460; 25944712; 16083906; 16970917; 10069812; 10198631; 11285270; 15231740; 15231747; 15269286; 15489852; 16049494; 16189514; 16492809; 16778097; 16782012; 17312020; 17353931; 17556076; 17574030; 18304522; 18852297; 19147001; 19384852; 19450523; 19571232; 19711352; 19720863; 19805633; 20360068; 20526328; 20530210; 20711500; 20889716; 21150319; 21427764; 21936775; 22118932; 22637579; 22922713; 22992454; 23079622; 23333499; 23416715; 23755307; 23945166; 23990561; 24296415; 24596149; 24616010; 25205765; 25416956; 25443296; 26496610; 26638075; 29420470; 8516294; 8522608; 9114011; 9585416; 9585417; 9852153,2003-04-23,2019-02-13,2007-01-23,165,X-ray crystallography (1); NMR spectroscopy (3); Electron microscopy (4),STRAND 14 16 {ECO:0000244|PDB:6F1T}.; STRAND 17 23 {ECO:0000244|PDB:2HZ5}.; STRAND 25 27 {ECO:0000244|PDB:6F1Z}.; STRAND 29 34 {ECO:0000244|PDB:2HZ5}.; STRAND 66 75 {ECO:0000244|PDB:2HZ5}.; STRAND 77 81 {ECO:0000244|PDB:2HZ5}.; STRAND 87 92 {ECO:0000244|PDB:2HZ5}.,HELIX 6 12 {ECO:0000244|PDB:2HZ5}.; HELIX 36 60 {ECO:0000244|PDB:2HZ5}.,,,,,,5 out of 5,Alternative sequence (2); Beta strand (7); Chain (1); Helix (2); Initiator methionine (1); Modified residue (1); Natural variant (2),,"TISSUE SPECIFICITY: High expression in heart, liver, brain and pancreas; moderate in placenta, skeletal muscle and kidney; low in lung, prostate, testis, small intestine and colon. Isoform 1 expression is up-regulated in 64% hepatocellular carcinoma (HCC) patients. {ECO:0000269|PubMed:11750132}.",,3D-structure;Acetylation;Alternative splicing;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Dynein;Microtubule;Motor protein;Polymorphism;Reference proteome;Transport,Evidence at protein level,reviewed,,GAMAD family,165,Alternative products (1); Caution (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0181; KW-0206; KW-0243; KW-0493; KW-0505; KW-0621; KW-0813; KW-0903; KW-0963; KW-1185,,,,,,,,,CHAIN 2 96 Dynein light chain roadblock-type 1. /FTId=PRO_0000220955.,,,,"INIT_MET 1 1 Removed. {ECO:0000250|UniProtKB:P62628, ECO:0000269|PubMed:12665801}.",,MOD_RES 2 2 N-acetylalanine. {ECO:0000250|UniProtKB:P62628}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF132750;AF165516;AF178431;AY026513;AF161511;BC002481;
0,Q9UM13,APC10_HUMAN,ANAPC10 APC10,ANAPC10,APC10,,,Homo sapiens (Human),9606,Anaphase-promoting complex subunit 10 (APC10) (Cyclosome subunit 10),UP000005640: Chromosome 4,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MTTPNKTPPGADPKQLERTGTVREIGSQAVWSLSSCKPGFGVDQLRDDNLETYWQSDGSQPHLVNIQFRRKTTVKTLCIYADYKSDESYTPSKISVRVGNNFHNLQEIRQLELVEPSGWIHVPLTDNHKKPTRTFMIQIAVLANHQNGRDTHMRQIKIYTPVEESSIGKFPRCTTIDFMMYRSIR,185,"21,252",,,,,,,,,,,,,VARIANT 46 46 R -> Q (in dbSNP:rs35257136). {ECO:0000269|Ref.4}. /FTId=VAR_025200.,,,,CONFLICT 6 6 K -> R (in Ref. 1; AAD30527). {ECO:0000305}.; CONFLICT 134 134 T -> S (in Ref. 3; CAB45705). {ECO:0000305}.; CONFLICT 146 146 Q -> L (in Ref. 3; CAB45705). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the APC10 family. {ECO:0000305}.,,,DOMAIN 2 185 DOC. {ECO:0000255|PROSITE-ProRule:PRU00614}.,,,,,,,,,,"FUNCTION: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. {ECO:0000269|PubMed:18485873}.",,PATHWAY: Protein modification; protein ubiquitination.,,,,,,,,,,anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990],anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990],,anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],GO:0005654; GO:0005680; GO:0005829; GO:0007049; GO:0031145; GO:0051301; GO:0070979; GO:1901990,IPR016901; IPR004939; IPR008979; ,,"SUBUNIT: The mammalian APC/C is composed at least of 14 distinct subunits ANAPC1, ANAPC2, CDC27/APC3, ANAPC4, ANAPC5, CDC16/APC6, ANAPC7, CDC23/APC8, ANAPC10, ANAPC11, CDC26/APC12, ANAPC13, ANAPC15 and ANAPC16 that assemble into a complex of at least 19 chains with a combined molecular mass of around 1.2 MDa; APC/C interacts with FZR1 and FBXO5 (PubMed:26083744, PubMed:25043029). The C-terminus of APC10 binds to CDC27/APC3 (PubMed:11524682). Interacts with PIWIL1; interaction only takes place when PIWIL1 binds piRNA (By similarity). {ECO:0000250|UniProtKB:Q8K2H6, ECO:0000269|PubMed:11524682, ECO:0000269|PubMed:25043029, ECO:0000269|PubMed:26083744}.",10318877; 10498862; 11230166; 15489334; 18485873; 22814378; 23186163; 11524682; 16364912; 25043029; 26083744,10318877; 10498862; 11230166; 15489334; 18485873; 22814378; 23186163; 11524682; 16364912; 25043029; 26083744; 10548110; 10679238; 10733526; 10793135; 11114305; 11285280; 11340163; 11535616; 11742988; 11859075; 12070128; 12446569; 12646216; 14657031; 15014503; 15029244; 15678131; 15774718; 16413484; 16648845; 16954532; 17540176; 18411265; 18555777; 18555778; 19028597; 19489725; 19805069; 19874575; 20351173; 20360068; 20452968; 21186364; 21336306; 2183031; 21979375; 22084091; 22178396; 22575643; 2405250; 25609649; 25814554; 26496610; 27120157; 27259151; 27509861; 27522463; 8234276; 8413215; 8413306; 8617720,2003-08-29,2019-02-13,2000-05-01,160,X-ray crystallography (1); Electron microscopy (9),STRAND 21 24 {ECO:0000244|PDB:1JHJ}.; STRAND 29 34 {ECO:0000244|PDB:1JHJ}.; STRAND 58 74 {ECO:0000244|PDB:1JHJ}.; STRAND 76 82 {ECO:0000244|PDB:1JHJ}.; STRAND 90 101 {ECO:0000244|PDB:1JHJ}.; STRAND 106 112 {ECO:0000244|PDB:1JHJ}.; STRAND 117 123 {ECO:0000244|PDB:1JHJ}.; STRAND 129 144 {ECO:0000244|PDB:1JHJ}.; STRAND 155 161 {ECO:0000244|PDB:1JHJ}.; STRAND 166 170 {ECO:0000244|PDB:5G05}.,HELIX 13 18 {ECO:0000244|PDB:1JHJ}.; HELIX 26 28 {ECO:0000244|PDB:1JHJ}.; HELIX 43 46 {ECO:0000244|PDB:1JHJ}.; HELIX 83 86 {ECO:0000244|PDB:1JHJ}.; HELIX 87 89 {ECO:0000244|PDB:1JHJ}.; HELIX 145 147 {ECO:0000244|PDB:1JHJ}.; HELIX 176 180 {ECO:0000244|PDB:5G05}.,,,,,,5 out of 5,Beta strand (10); Chain (1); Domain (1); Helix (7); Initiator methionine (1); Modified residue (2); Natural variant (1); Sequence conflict (3),,,,3D-structure;Acetylation;Cell cycle;Cell division;Complete proteome;Mitosis;Polymorphism;Reference proteome;Ubl conjugation pathway,Evidence at protein level,reviewed,,APC10 family,160,Function (1); Pathway (1); Sequence similarities (1); Subunit structure (1),,KW-0002; KW-0007; KW-0131; KW-0132; KW-0181; KW-0498; KW-0621; KW-0833; KW-1185,Protein modification; protein ubiquitination. ,,,,,,,,CHAIN 2 185 Anaphase-promoting complex subunit 10. /FTId=PRO_0000174011.,,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378}.,,MOD_RES 2 2 N-acetylthreonine. {ECO:0000244|PubMed:22814378}.; MOD_RES 169 169 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8K2H6}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF132794;AB012109;AL080090;DQ304649;CH471056;CH471056;BC005217;
0,Q9Y6D9,MD1L1_HUMAN,MAD1L1 MAD1 TXBP181,MAD1L1,MAD1 TXBP181,,,Homo sapiens (Human),9606,Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181),UP000005640: Chromosome 7,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MEDLGENTMVLSTLRSLNNFISQRVEGGSGLDISTSAPGSLQMQYQQSMQLEERAEQIRSKSHLIQVEREKMQMELSHKRARVELERAASTSARNYEREVDRNQELLTRIRQLQEREAGAEEKMQEQLERNRQCQQNLDAASKRLREKEDSLAQAGETINALKGRISELQWSVMDQEMRVKRLESEKQELQEQLDLQHKKCQEANQKIQELQASQEARADHEQQIKDLEQKLSLQEQDAAIVKNMKSELVRLPRLERELKQLREESAHLREMRETNGLLQEELEGLQRKLGRQEKMQETLVGLELENERLLAKLQSWERLDQTMGLSIRTPEDLSRFVVELQQRELALKDKNSAVTSSARGLEKARQQLQEELRQVSGQLLEERKKRETHEALARRLQKRVLLLTKERDGMRAILGSYDSELTPAEYSPQLTRRMREAEDMVQKVHSHSAEMEAQLSQALEELGGQKQRADMLEMELKMLKSQSSSAEQSFLFSREEADTLRLKVEELEGERSRLEEEKRMLEAQLERRALQGDYDQSRTKVLHMSLNPTSVARQRLREDHSQLQAECERLRGLLRAMERGGTVPADLEAAAASLPSSKEVAELKKQVESAELKNQRLKEVFQTKIQEFRKACYTLTGYQIDITTENQYRLTSLYAEHPGDCLIFKATSPSGSKMQLLETEFSHTVGELIEVHLRRQDSIPAFLSSLTLELFSRQTVA,718,"83,067",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q9Y6D9-1; Sequence=Displayed; Name=2; IsoId=Q9Y6D9-3; Sequence=VSP_056160, VSP_056161; Note=No experimental confirmation available.; ",,,,,SEQUENCE CAUTION:  Sequence=AAC52059.1; Type=Frameshift; Positions=663; Evidence={ECO:0000305}; ,,,,,VAR_SEQ 1 65 MEDLGENTMVLSTLRSLNNFISQRVEGGSGLDISTSAPGSLQMQYQQSMQLEERAEQIRSKSHLI -> MLPARGCVRKRTVWPRLARVLIVTLLTLELSYAPLPCQLSGVPYNTGDPVGRWARPCIWPCPWHT (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_056160.; VAR_SEQ 66 157 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_056161.,"VARIANT 29 29 S -> L (in a lymphoid cancer cell line; somatic mutation). {ECO:0000269|PubMed:11423979}. /FTId=VAR_019707.; VARIANT 59 59 R -> C (in a prostate cancer cell line; somatic mutation; dbSNP:rs121908982). {ECO:0000269|PubMed:11423979}. /FTId=VAR_019708.; VARIANT 160 160 N -> S (in dbSNP:rs550573452). {ECO:0000269|PubMed:10597320}. /FTId=VAR_019709.; VARIANT 299 299 T -> A (in lung cancer cell line; somatic mutation). {ECO:0000269|PubMed:10597320}. /FTId=VAR_019710.; VARIANT 360 360 R -> Q (in a prostate cancer cell line; somatic mutation; dbSNP:rs769418574). {ECO:0000269|PubMed:11423979}. /FTId=VAR_019711.; VARIANT 500 500 T -> M (in dbSNP:rs193231481). {ECO:0000269|PubMed:10597320, ECO:0000269|PubMed:11423979}. /FTId=VAR_019712.; VARIANT 511 511 E -> K (in dbSNP:rs377555260). {ECO:0000269|PubMed:10597320}. /FTId=VAR_019713.; VARIANT 516 516 E -> K (in a breast cancer cell line; somatic mutation). {ECO:0000269|PubMed:11423979}. /FTId=VAR_019714.; VARIANT 556 556 R -> C (in a prostate cancer cell line; somatic mutation; dbSNP:rs371561369). {ECO:0000269|PubMed:11423979}. /FTId=VAR_019715.; VARIANT 556 556 R -> H (in one individual with lung cancer; dbSNP:rs755012008). {ECO:0000269|PubMed:10597320}. /FTId=VAR_019716.; VARIANT 558 558 R -> H (in a cancer cell line; dbSNP:rs1801368). {ECO:0000269|PubMed:10366450, ECO:0000269|PubMed:10597320, ECO:0000269|PubMed:11423979}. /FTId=VAR_019717.; VARIANT 569 569 E -> K (in a breast cancer cell line; somatic mutation; dbSNP:rs201951163). {ECO:0000269|PubMed:11423979}. /FTId=VAR_019718.; VARIANT 572 572 R -> H (in a cancer cell line; dbSNP:rs1801500). {ECO:0000269|PubMed:10366450}. /FTId=VAR_019719.",,,,CONFLICT 189 190 EL -> DV (in Ref. 1; AAC52059 and 3; AAD24498). {ECO:0000305}.; CONFLICT 260 260 K -> E (in Ref. 1; AAC52059 and 3; AAD24498). {ECO:0000305}.; CONFLICT 268 268 Missing (in Ref. 1; AAC52059). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the MAD1 family. {ECO:0000305}.,COILED 46 632 {ECO:0000255}.,,,,REGION 301 340 Important for interaction with IK. {ECO:0000269|PubMed:22351768}.; REGION 380 532 Necessary for interaction with NEK2. {ECO:0000269|PubMed:14978040}.; REGION 439 480 Important for interaction with IK. {ECO:0000269|PubMed:22351768}.,,,,,,,,"FUNCTION: Component of the spindle-assembly checkpoint that prevents the onset of anaphase until all chromosomes are properly aligned at the metaphase plate. May recruit MAD2L1 to unattached kinetochores. Has a role in the correct positioning of the septum. Required for anchoring MAD2L1 to the nuclear periphery. Binds to the TERT promoter and represses telomerase expression, possibly by interfering with MYC binding. {ECO:0000269|PubMed:10049595, ECO:0000269|PubMed:12837246, ECO:0000269|PubMed:20133940}.",,,,,,,,,,,,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538],attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538],identical protein binding [GO:0042802]; kinetochore binding [GO:0043515],centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922],GO:0000776; GO:0000777; GO:0000922; GO:0005635; GO:0005813; GO:0005819; GO:0005829; GO:0007093; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051301; GO:0051315; GO:0072686; GO:0090235,IPR008672; ,Itself; P09917; Q9UL15; Q8TD31-3; Q02224-2; Q2TBE0; Q96CS2; Q3ZCW2; Q13257; P55081; O76041; P25786; O76064; Q9UM82; P09493; P09493-10; P06753; Q5VU62; P12270; Q14134; Q99576-3; Q63HK5; Q9Y4E8; Q9BW85; I3L3J2,"SUBUNIT: Homodimer. Heterodimerizes with MAD2L1 in order to form a tetrameric MAD1L1-MAD2L1 core complex (PubMed:9546394, PubMed:18981471, PubMed:22351768, PubMed:12006501). Perturbation of the original MAD1L1-MAD2L1 structure by the spindle checkpoint may decrease MAD2L1 affinity for MAD1L1. CDC20 can compete with MAD1L1 for MAD2L1 binding, until the attachment and/or tension dampen the checkpoint signal, preventing further release of MAD2L1 on to CDC20. Also able to interact with the BUB1/BUB3 complex (PubMed:10198256). Interacts with NEK2 (PubMed:14978040). Interacts with TPR; the interactions occurs in a microtubule-independent manner (PubMed:18981471, PubMed:19273613, PubMed:20133940). Interacts with IK (PubMed:22351768). Interacts with the viral Tax protein (PubMed:9546394). {ECO:0000269|PubMed:10198256, ECO:0000269|PubMed:12006501, ECO:0000269|PubMed:14978040, ECO:0000269|PubMed:18981471, ECO:0000269|PubMed:19273613, ECO:0000269|PubMed:20133940, ECO:0000269|PubMed:22351768, ECO:0000269|PubMed:9546394}.",9546394; 10198256; 10049595; 14702039; 12853948; 15489334; 12837246; 14978040; 16964243; 17525332; 18981471; 18691976; 18669648; 19413330; 19273613; 19608861; 20133940; 20068231; 21269460; 22351768; 22223895; 22814378; 23186163; 25218447; 28112733; 12006501; 10366450; 10597320; 11423979,9546394; 10198256; 10049595; 14702039; 12853948; 15489334; 12837246; 14978040; 16964243; 17525332; 18981471; 18691976; 18669648; 19413330; 19273613; 19608861; 20133940; 20068231; 21269460; 22351768; 22223895; 22814378; 23186163; 25218447; 28112733; 12006501; 10366450; 10597320; 11423979; 11081627; 11181178; 11509732; 11804586; 11980658; 12194817; 12351790; 12876282; 14730319; 15085137; 15339662; 15723797; 15737063; 15782113; 15824131; 16189514; 16541025; 16622419; 16622420; 16713569; 16880273; 17030981; 17129783; 17333263; 17674037; 17998396; 18097444; 18318601; 18491369; 18692475; 18716626; 18922800; 19010891; 19224688; 19762557; 19965387; 20360068; 20379614; 20467437; 20516147; 20544396; 20624899; 20677014; 21327106; 21345218; 21394085; 21397845; 21516116; 21772247; 21878504; 21987589; 21988832; 22458338; 22493223; 22778409; 22810585; 22885700; 23099851; 23407047; 23459071; 23860928; 24095110; 24344181; 24374861; 24477933; 24581499; 24637323; 24695965; 24724894; 24728176; 24862574; 25036637; 25416956; 25447996; 25609649; 25898113; 26138747; 26183163; 26496610; 26499943; 26528791; 26752263; 27184339; 28072388; 29158164,2004-09-27,2019-02-13,2004-09-27,169,X-ray crystallography (2),STRAND 540 547 {ECO:0000244|PDB:1GO4}.; STRAND 638 644 {ECO:0000244|PDB:4DZO}.; STRAND 648 653 {ECO:0000244|PDB:4DZO}.; STRAND 663 667 {ECO:0000244|PDB:4DZO}.; STRAND 675 678 {ECO:0000244|PDB:4DZO}.,HELIX 487 492 {ECO:0000244|PDB:1GO4}.; HELIX 494 528 {ECO:0000244|PDB:1GO4}.; HELIX 549 575 {ECO:0000244|PDB:1GO4}.; HELIX 599 637 {ECO:0000244|PDB:4DZO}.; HELIX 683 685 {ECO:0000244|PDB:4DZO}.; HELIX 687 693 {ECO:0000244|PDB:4DZO}.; HELIX 700 715 {ECO:0000244|PDB:4DZO}.,TURN 537 539 {ECO:0000244|PDB:1GO4}.; TURN 580 582 {ECO:0000244|PDB:1GO4}.; TURN 645 647 {ECO:0000244|PDB:4DZO}.,,,,,5 out of 5,Alternative sequence (2); Beta strand (5); Chain (1); Coiled coil (1); Cross-link (1); Frameshift (1); Helix (7); Modified residue (5); Natural variant (13); Region (3); Sequence conflict (5); Turn (3),,TISSUE SPECIFICITY: Expressed weakly at G0/G1 and highly at late S and G2/M phase.,,3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Isopeptide bond;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,MAD1 family,169,Alternative products (1); Caution (1); Function (1); Induction (1); Involvement in disease (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0131; KW-0132; KW-0137; KW-0158; KW-0175; KW-0181; KW-0206; KW-0225; KW-0498; KW-0539; KW-0597; KW-0621; KW-0832; KW-0963; KW-0995; KW-1017; KW-1185,,,,,"DISEASE: Note=Defects in MAD1L1 are involved in the development and/or progression of various types of cancer. {ECO:0000269|PubMed:10597320, ECO:0000269|PubMed:11423979}.",,,"PTM: Phosphorylated; by BUB1. Become hyperphosphorylated in late S through M phases or after mitotic spindle damage. {ECO:0000269|PubMed:10198256, ECO:0000269|PubMed:9546394}.",CHAIN 1 718 Mitotic spindle assembly checkpoint protein MAD1. /FTId=PRO_0000213800.,"CROSSLNK 61 61 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:28112733}.",,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.; MOD_RES 16 16 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 61 61 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 214 214 Phosphoserine. {ECO:0000244|PubMed:17525332}.; MOD_RES 428 428 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U33822;AF123318;AF083811;AK090959;AC069288;AC104129;BC009964;
0,O15392,BIRC5_HUMAN,BIRC5 API4 IAP4,BIRC5,API4 IAP4,,,Homo sapiens (Human),9606,Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor 4) (Apoptosis inhibitor survivin),UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFKELEGWEPDDDPIEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD,142,"16,389",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=7;  Name=1; Synonyms=Alpha; IsoId=O15392-1; Sequence=Displayed; Name=2; Synonyms=2B, Beta; IsoId=O15392-2; Sequence=VSP_002454; Name=3; Synonyms=DeltaEx3; IsoId=O15392-3; Sequence=VSP_020338; Name=4; Synonyms=3B; IsoId=O15392-4; Sequence=VSP_020342; Name=5; Synonyms=SI; IsoId=O15392-5; Sequence=VSP_020341; Name=6; Synonyms=3 alpha; IsoId=O15392-6; Sequence=VSP_020339; Name=7; Synonyms=2 alpha; IsoId=O15392-7; Sequence=VSP_020340; ",,,,,,,,,,"VAR_SEQ 74 142 IEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD -> MQRKPTIRRKNLRKLRRKCAVPSSSWLPWIEASGRSCLVPEWLHHFQGLFPGATSLPVGPLAMS (in isoform 3). {ECO:0000303|PubMed:10626797}. /FTId=VSP_020338.; VAR_SEQ 74 142 IEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD -> MRELC (in isoform 6). {ECO:0000303|Ref.8}. /FTId=VSP_020339.; VAR_SEQ 74 142 IEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD -> M (in isoform 7). {ECO:0000303|Ref.7}. /FTId=VSP_020340.; VAR_SEQ 74 74 I -> IGPGTVAYACNTSTLGGRGGRITR (in isoform 2). {ECO:0000303|PubMed:10626797, ECO:0000303|Ref.6}. /FTId=VSP_002454.; VAR_SEQ 105 142 DRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD -> VRETLPPPRSFIR (in isoform 5). {ECO:0000303|PubMed:16329164}. /FTId=VSP_020341.; VAR_SEQ 114 142 AKETNNKKKEFEETAKKVRRAIEQLAAMD -> ERALLAE (in isoform 4). {ECO:0000303|PubMed:14741722}. /FTId=VSP_020342.","VARIANT 129 129 K -> E (loss of acetylation; localization primarily within the cytoplasm; increased likelihood of existing as monomer; stronger binding to XPO1/CRM1; dbSNP:rs2071214). {ECO:0000269|PubMed:16625196, ECO:0000269|PubMed:20826784}. /FTId=VAR_021071.",,,,CONFLICT 57 58 CF -> WV (in Ref. 5; AAW22624). {ECO:0000305}.; CONFLICT 58 58 F -> L (in Ref. 11; BAD97148). {ECO:0000305}.; CONFLICT 128 128 A -> V (in Ref. 9; CAG46540). {ECO:0000305}.,,3,,0,DOMAIN: The BIR repeat is necessary and sufficient for LAMTOR5 binding. {ECO:0000269|PubMed:12773388}.,SIMILARITY: Belongs to the IAP family. {ECO:0000305}.,,,,,,REPEAT 18 88 BIR.,,,,,,,"FUNCTION: Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis (PubMed:9859993, PubMed:21364656, PubMed:20627126). Component of a chromosome passage protein complex (CPC) which is essential for chromosome alignment and segregation during mitosis and cytokinesis (PubMed:16322459). Acts as an important regulator of the localization of this complex; directs CPC movement to different locations from the inner centromere during prometaphase to midbody during cytokinesis and participates in the organization of the center spindle by associating with polymerized microtubules (PubMed:20826784). Involved in the recruitment of CPC to centromeres during early mitosis via association with histone H3 phosphorylated at 'Thr-3' (H3pT3) during mitosis (PubMed:20929775). The complex with RAN plays a role in mitotic spindle formation by serving as a physical scaffold to help deliver the RAN effector molecule TPX2 to microtubules (PubMed:18591255). May counteract a default induction of apoptosis in G2/M phase (PubMed:9859993). The acetylated form represses STAT3 transactivation of target gene promoters (PubMed:20826784). May play a role in neoplasia (PubMed:10626797). Inhibitor of CASP3 and CASP7 (PubMed:21536684). Isoform 2 and isoform 3 do not appear to play vital roles in mitosis (PubMed:12773388, PubMed:16291752). Isoform 3 shows a marked reduction in its anti-apoptotic effects when compared with the displayed wild-type isoform (PubMed:10626797). {ECO:0000269|PubMed:10626797, ECO:0000269|PubMed:12773388, ECO:0000269|PubMed:16291752, ECO:0000269|PubMed:16322459, ECO:0000269|PubMed:18591255, ECO:0000269|PubMed:20627126, ECO:0000269|PubMed:20826784, ECO:0000269|PubMed:20929775, ECO:0000269|PubMed:21364656, ECO:0000269|PubMed:21536684, ECO:0000269|PubMed:9859993}.",,,,,,,,,"METAL 57 57 Zinc. {ECO:0000244|PDB:2QFA, ECO:0000269|PubMed:17956729}.; METAL 60 60 Zinc. {ECO:0000244|PDB:2QFA, ECO:0000269|PubMed:17956729}.; METAL 77 77 Zinc. {ECO:0000244|PDB:2QFA, ECO:0000269|PubMed:17956729}.; METAL 84 84 Zinc. {ECO:0000244|PDB:2QFA, ECO:0000269|PubMed:17956729}.",,,"centriole [GO:0005814]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; interphase microtubule organizing center [GO:0031021]; midbody [GO:0030496]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; chaperone binding [GO:0051087]; cobalt ion binding [GO:0050897]; cofactor binding [GO:0048037]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; Ran GTPase binding [GO:0008536]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; cytokine-mediated signaling pathway [GO:0019221]; establishment of chromosome localization [GO:0051303]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; protein-containing complex localization [GO:0031503]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]","apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; cytokine-mediated signaling pathway [GO:0019221]; establishment of chromosome localization [GO:0051303]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of mitotic cell cycle [GO:0045931]; protein-containing complex localization [GO:0031503]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]",chaperone binding [GO:0051087]; cobalt ion binding [GO:0050897]; cofactor binding [GO:0048037]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; Ran GTPase binding [GO:0008536]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],"centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; chromosome passenger complex [GO:0032133]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; interphase microtubule organizing center [GO:0031021]; midbody [GO:0030496]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]",GO:0000086; GO:0000228; GO:0000278; GO:0000281; GO:0000775; GO:0000777; GO:0004869; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005876; GO:0005881; GO:0006468; GO:0006915; GO:0007059; GO:0007094; GO:0007605; GO:0008017; GO:0008270; GO:0008284; GO:0008536; GO:0015631; GO:0019221; GO:0019899; GO:0030496; GO:0031021; GO:0031503; GO:0031536; GO:0032133; GO:0042802; GO:0042803; GO:0042981; GO:0043027; GO:0043066; GO:0043154; GO:0045892; GO:0045931; GO:0046872; GO:0046982; GO:0048037; GO:0050897; GO:0051087; GO:0051301; GO:0051303; GO:0090307,IPR001370; ,Itself; O14965; Q96GD4; Q9UQB9; Q14457; P55211; Q53HL2; P06493; Q9NR28; Q86XJ1; Q9NQS7; P62826; O14980,"SUBUNIT: Monomer or homodimer. Exists as a homodimer in the apo state and as a monomer in the CPC-bound state. The monomer protects cells against apoptosis more efficiently than the dimer. Only the dimeric form is capable of enhancing tubulin stability in cells. When phosphorylated, interacts with LAMTOR5/HBXIP; the resulting complex binds pro-CASP9, as well as active CASP9, but much less efficiently. Component of the chromosomal passenger complex (CPC) composed of at least BIRC5/survivin, CDCA8/borealin, INCENP, AURKB or AURKC; in the complex forms a triple-helix bundle-based subcomplex with INCENP and CDCA8 (PubMed:17956729). Interacts with JTB. Interacts (via BIR domain) with histone H3 phosphorylated at 'Thr-3' (H3pT3). Interacts with EVI5. Interacts with GTP-bound RAN in both the S and M phases of the cell cycle. Interacts with USP9X. Interacts with tubulin. Interacts with BIRC2/c-IAP1. The acetylated form at Lys-129 interacts with STAT3. The monomeric form deacetylated at Lys-129 interacts with XPO1/CRM1. The monomeric form interacts with XIAP/BIRC4. Both the dimeric and monomeric form can interact with DIABLO/SMAC. Interacts with BIRC6/bruce. {ECO:0000269|PubMed:12773388, ECO:0000269|PubMed:14610074, ECO:0000269|PubMed:15249581, ECO:0000269|PubMed:15665297, ECO:0000269|PubMed:16239925, ECO:0000269|PubMed:16291752, ECO:0000269|PubMed:16322459, ECO:0000269|PubMed:16427043, ECO:0000269|PubMed:16436504, ECO:0000269|PubMed:16764853, ECO:0000269|PubMed:17956729, ECO:0000269|PubMed:18329369, ECO:0000269|PubMed:18591255, ECO:0000269|PubMed:20826784, ECO:0000269|PubMed:21225229, ECO:0000269|PubMed:21536684}.",9256286; 10626797; 11084331; 14741722; 16329164; 14702039; 16625196; 15489334; 9859993; 11069302; 12773388; 14610074; 15249581; 15665297; 16344111; 16322459; 16762323; 16239925; 16427043; 16764853; 16291752; 16436504; 18329369; 17993464; 18691976; 18591255; 21364656; 20826784; 20627126; 20929775; 21252625; 21225229; 21536684; 24866247; 24793696; 27332895; 10949039; 10876248; 17956729; 19530738,9256286; 10626797; 11084331; 14741722; 16329164; 14702039; 16625196; 15489334; 9859993; 11069302; 12773388; 14610074; 15249581; 15665297; 16344111; 16322459; 16762323; 16239925; 16427043; 16764853; 16291752; 16436504; 18329369; 17993464; 18691976; 18591255; 21364656; 20826784; 20627126; 20929775; 21252625; 21225229; 21536684; 24866247; 24793696; 27332895; 10949039; 10876248; 17956729; 19530738; 10867011; 11024045; 11069780; 11081627; 11120780; 11181178; 11404481; 11509732; 11712083; 11714700; 11728454; 11773702; 11804586; 11821157; 11844831; 11861764; 11875736; 11877677; 11888845; 11925104; 12006501; 12073047; 12085263; 12115583; 12119561; 12133447; 12143224; 12168867; 12174930; 12194817; 12235242; 12363043; 12374680; 12388702; 12393476; 12419797; 12510154; 12517802; 12556969; 12569609; 12600988; 12609713; 12643601; 12654446; 12678716; 12709681; 12719470; 12794243; 12805209; 12833149; 12854136; 12883703; 12885482; 12926071; 12963850; 14523021; 14527689; 14581472; 14583779; 14597555; 14597622; 14614132; 14676801; 14699067; 14730319; 14734714; 14988404; 15077160; 15085137; 15126108; 15138717; 15139971; 15148334; 15149158; 15195112; 15280424; 15294091; 15309737; 15326475; 15334064; 15334693; 15339662; 15383173; 15456784; 15457550; 15477601; 15489959; 15512811; 15531913; 15541727; 15547736; 15569667; 15611790; 15623349; 15628841; 15637054; 15655550; 15670305; 15685548; 15688031; 15709157; 15723797; 15729715; 15735703; 15737063; 15743529; 15802787; 15809755; 15817155; 15829320; 15829330; 15831281; 15870931; 15882878; 15896468; 15916722; 15917996; 15923164; 15924721; 15928668; 15936846; 15938719; 15943789; 15950906; 15986442; 15991282; 16026775; 16048634; 16055565; 16108013; 16123317; 16142334; 16142363; 16171786; 16173017; 16202147; 16211215; 16211302; 16254145; 16364925; 16372125; 16375115; 16375117; 16397018; 16404364; 16407408; 16470228; 16510571; 16512495; 16516635; 16525632; 16525657; 16529600; 16534839; 16541025; 16552335; 16571674; 16595680; 16608879; 16622419; 16622420; 16644787; 16671090; 16714396; 16732934; 16761316; 16773218; 16807248; 16825985; 16826583; 16847054; 16850112; 16873289; 16950794; 17008426; 17012855; 17015676; 17018890; 17030981; 17038538; 17045968; 17077982; 17084966; 17087938; 17095626; 17098350; 17099693; 17108713; 17124585; 17127378; 17128412; 17129783; 17143520; 17167759; 17170079; 17203351; 17219991; 17225522; 17255535; 17274640; 17283539; 17285125; 17289902; 17304504; 17328950; 17337592; 17341657; 17353931; 17357516; 17361097; 17376603; 17393113; 17441339; 17451195; 17457057; 17464868; 17505517; 17509581; 17533050; 17534699; 17536304; 17543072; 17548900; 17559540; 17569112; 17582222; 17609820; 17612487; 17613533; 17616652; 17624454; 17633470; 17634026; 17635796; 17638911; 17641414; 17656368; 17666323; 17672950; 17680529; 17681274; 17687492; 17693049; 17704744; 17706282; 17714426; 17718383; 17785436; 17805549; 17828494; 17828496; 17828507; 17877643; 17879398; 17881355; 17905101; 17927889; 17943598; 17959540; 17961802; 17962949; 17965335; 17967504; 17982126; 18027854; 18032822; 18035418; 18048012; 18055328; 18057009; 18058462; 18069771; 18079751; 18089792; 18097444; 18154598; 18171606; 18181175; 18192073; 18206228; 18226337; 18227733; 18242580; 18243099; 18250050; 18251132; 18251156; 18251581; 18266976; 18278445; 18298903; 18301249; 18316606; 18327814; 18332262; 18334114; 18336724; 18336887; 18353781; 18364081; 18391576; 18393241; 18401527; 18425079; 18425331; 18426652; 18431086; 18438971; 18447642; 18451140; 18451232; 18476631; 18498065; 18510850; 18519556; 18539906; 18553460; 18563330; 18566409; 18574502; 18593915; 18593928; 18595518; 18599610; 18611860; 18630507; 18632631; 18642030; 18644974; 18652770; 18676762; 18687517; 18701842; 18704463; 18708766; 18712773; 18716626; 18716870; 18758234; 18815458; 18815881; 18818705; 18824294; 18825388; 18829549; 18839071; 18842333; 18856066; 18927499; 18928590; 18928599; 18946085; 18946675; 18949405; 18950577; 18998509; 19018856; 19018973; 19025652; 19032823; 19033926; 19034775; 19038421; 19074885; 19102934; 19112393; 19120021; 19130609; 19131553; 19134343; 19141860; 19144991; 19171073; 19173802; 19176119; 19207554; 19211844; 19218139; 19219613; 19242064; 19244345; 19247455; 19252483; 19258429; 19272817; 19280061; 19285711; 19287462; 19287963; 19293795; 19298527; 19320741; 19336448; 19347901; 19352701; 19361279; 19363521; 19366855; 19379562; 19397802; 19405109; 19421758; 19423183; 19428321; 19439469; 19451595; 19469654; 19472128; 19483728; 19497660; 19500507; 19506533; 19585499; 19605357; 19615253; 19621386; 19624872; 19628339; 19632843; 19636556; 19639203; 19664395; 19676105; 19679061; 19705503; 19716375; 19724852; 19728912; 19728914; 19729377; 19756737; 19763917; 19767411; 19778801; 19781773; 19787275; 19806913; 19832036; 19840459; 19885569; 19887369; 19895735; 19895744; 19903782; 19913527; 19921309; 19933689; 19939880; 19949374; 19951584; 19956893; 19965387; 20010504; 20011512; 20019839; 20027603; 20028510; 20041268; 20050981; 20056675; 20057973; 20072652; 20094073; 20100132; 20101202; 20104682; 20126979; 20128283; 20178473; 20181247; 20193113; 20193400; 20195727; 20235790; 20236666; 20306657; 20346215; 20357690; 20360068; 20367605; 20368071; 20372866; 20398291; 20401641; 20403046; 20406824; 20427271; 20430742; 20444731; 20453000; 20470195; 20493732; 20501415; 20503268; 20506498; 20515940; 20524087; 20551096; 20596624; 20597995; 20627293; 20638385; 20663916; 20668868; 20682707; 20698994; 20716114; 20717727; 20724919; 20728447; 20735270; 20735841; 20798131; 20800603; 20807887; 20819778; 20822926; 20842728; 20851637; 20862566; 20868995; 20881643; 20882051; 20929126; 20939430; 20957442; 20959405; 20978324; 20979750; 21034499; 21041181; 21048031; 21051298; 21055155; 21057000; 21062054; 21074309; 21082354; 21083600; 21092276; 21093004; 21106262; 21108736; 21130077; 21148584; 21154810; 21156966; 21158719; 21159887; 21161671; 21187067; 21198263; 21211287; 21215029; 21220185; 21223797; 21279308; 21292023; 21296634; 21304814; 21309483; 21312234; 21330050; 21342791; 21351527; 21355309; 21358596; 21362215; 21364662; 21367753; 21385904; 21397845; 21402055; 21415216; 21424389; 21431279; 21443519; 21447816; 21470426; 21516372; 21518489; 21526486; 21538024; 21552210; 21554500; 21565982; 21569999; 21572400; 21585553; 21611748; 21612579; 21613637; 21633298; 21634118; 21674243; 21689689; 21695980; 21705450; 21718681; 21729321; 21729543; 21729576; 21730069; 21737502; 21757750; 21765467; 21794903; 21826474; 21852011; 21855041; 21856925; 21861135; 21867615; 21874565; 21878504; 21878572; 21880190; 21897272; 21900948; 21910343; 21933669; 21979596; 21987589; 21988832; 22020290; 22032967; 22033156; 22035627; 22045227; 22052111; 22055399; 22056470; 22075159; 22076382; 22089920; 22103896; 22110249; 22126543; 22126788; 22152688; 22154363; 22159225; 22161156; 22161157; 22174091; 22182412; 22193624; 22199273; 22205702; 22214342; 22237452; 22244766; 22266808; 22274581; 22288915; 22293278; 22295057; 22311150; 22318371; 22325225; 22333553; 22334690; 22336533; 22340101; 22357620; 22389513; 22391172; 22407831; 22410464; 22416874; 22419576; 22426960; 22446832; 22459568; 22464730; 22491741; 22502701; 22503977; 22507272; 22513782; 22517713; 22528514; 22528517; 22550469; 22563025; 22568207; 22569715; 22581315; 22607367; 22645176; 22646166; 22680927; 22696161; 22711176; 22713668; 22723337; 22740207; 22749932; 22819074; 22848370; 22858571; 22885700; 22886454; 22925504; 22930255; 22935455; 22936565; 22957790; 22961763; 22968628; 22981350; 22996285; 23028610; 23030305; 23041974; 23042483; 23053158; 23065255; 23084269; 23087365; 23091600; 23097134; 23106581; 23124118; 23126236; 23131769; 23143666; 23146905; 23152437; 23161837; 23167185; 23168152; 23172665; 23176035; 23185410; 23219440; 23232114; 23244104; 23251006; 23254641; 23254909; 23258739; 23280017; 23281010; 23296940; 23310986; 23317219; 23323858; 23324341; 23325045; 23333752; 23338618; 23340171; 23358177; 23358691; 23368531; 23380758; 23405077; 23405201; 23414714; 23444076; 23449974; 23467576; 23477121; 23479154; 23494669; 23504337; 23564498; 23572266; 23580032; 23581553; 23611357; 23613251; 23618862; 23624914; 23640047; 23643942; 23645041; 23677479; 23690235; 23728352; 23729541; 23732815; 23747271; 23749114; 23755220; 23812937; 23826993; 23828577; 23847060; 23856250; 23858797; 23883402; 23898122; 23924925; 23936532; 23938875; 23948878; 23979427; 24077840; 24083380; 24096544; 24097101; 24117205; 24127439; 24128853; 24133585; 24165223; 24197699; 24199968; 24204662; 24213373; 24213518; 24223763; 24223792; 24233638; 24235270; 24239173; 24294379; 24303016; 24317109; 24325949; 24337012; 24338338; 24338523; 24386184; 24387108; 24425325; 24440709; 24448704; 24448706; 24460358; 24478433; 24495510; 24508259; 24519067; 24556686; 24563335; 24571573; 24596368; 24615109; 24618734; 24620748; 24636883; 24647137; 24648609; 24662134; 24676140; 24722794; 24726064; 24735609; 24743777; 24786601; 24793695; 24852427; 24852932; 24886358; 24886421; 24886669; 24891298; 24920238; 24930483; 24935470; 24945990; 24946930; 24961465; 24972968; 24996542; 25008566; 25018047; 25022384; 25028191; 25040987; 25046253; 25050620; 25069511; 25090821; 25106503; 25107550; 25129311; 25169544; 25177958; 25218447; 25241761; 25248821; 25261663; 25288231; 25294423; 25317803; 25333812; 25337230; 25344020; 25374237; 25392106; 25429620; 25471003; 25473903; 25480498; 25537090; 25577253; 25598934; 25605253; 25607650; 25635055; 25640185; 25661346; 25677909; 25701406; 25707849; 25726084; 25763854; 25769404; 25771974; 25778398; 25808836; 25810016; 25816072; 25824761; 25867400; 25875800; 25889770; 25890196; 25895606; 25896962; 25900794; 25910412; 25917317; 25928399; 25948791; 25964579; 25966084; 25973061; 26002465; 26016480; 26017879; 26022098; 26043753; 26080853; 26093789; 26112839; 26118178; 26122233; 26125713; 26148234; 26183563; 26191195; 26198101; 26227487; 26245993; 26261483; 26261647; 26268608; 26271669; 26318298; 26327128; 26352384; 26356696; 26392111; 26408642; 26419626; 26420684; 26442524; 26450645; 26470725; 26497847; 26540052; 26557682; 26595675; 26600399; 26614845; 26647806; 26648308; 26651826; 26677013; 26679694; 26681053; 26690822; 26708654; 26718331; 26718651; 26723509; 26755645; 26771605; 26815661; 26823716; 26828978; 26832409; 26896649; 26944315; 26969755; 26978233; 26995334; 27055667; 27079211; 27090386; 27097943; 27166029; 27177222; 27235693; 27246243; 27322712; 27350406; 27371848; 27372966; 27378628; 27399126; 27400093; 27411340; 27411378; 27420945; 27423588; 27430728; 27473264; 27489375; 27531889; 27539959; 27581819; 27602754; 27663628; 27715398; 27748828; 27764228; 27798120; 27803511; 27806337; 27865841; 27866460; 27915033; 27978829; 28011476; 28039474; 28095864; 28178644; 28193315; 28214203; 28260087; 28319412; 28319413; 28328831; 28337018; 28346726; 28365965; 28384094; 28446541; 28476028; 28476037; 28509321; 28518147; 28639913; 28713892; 28803837; 28845553; 28849238; 28852723; 28949095; 28950390; 28953948; 28981528; 29089085; 29204860; 29270761; 29277888; 29282022; 29311669; 29328641; 29391151; 29473241; 29491110; 29522718; 29578160; 29596838; 29605299; 29625788; 29631694; 29658609; 29678577; 29767242; 29795564; 29807222; 29848705; 29893319; 29901157; 29913237; 29956756; 29956779; 29961070; 29989646; 30061219; 30075571; 30086460; 30106446; 30205554; 30226700; 30241553; 30249893; 30275230; 30465472; 30537730; 7898939; 9874564,2000-05-30,2019-02-13,2012-03-21,216,X-ray crystallography (20); NMR spectroscopy (1),STRAND 31 33 {ECO:0000244|PDB:3UEC}.; STRAND 43 45 {ECO:0000244|PDB:2QFA}.; STRAND 49 51 {ECO:0000244|PDB:3UIG}.; STRAND 55 57 {ECO:0000244|PDB:2QFA}.; STRAND 63 65 {ECO:0000244|PDB:3UEC}.,HELIX 11 13 {ECO:0000244|PDB:2QFA}.; HELIX 15 20 {ECO:0000244|PDB:2QFA}.; HELIX 35 40 {ECO:0000244|PDB:2QFA}.; HELIX 73 80 {ECO:0000244|PDB:2QFA}.; HELIX 85 88 {ECO:0000244|PDB:2QFA}.; HELIX 93 95 {ECO:0000244|PDB:2QFA}.; HELIX 98 139 {ECO:0000244|PDB:2QFA}.,TURN 8 10 {ECO:0000244|PDB:2QFA}.; TURN 58 60 {ECO:0000244|PDB:2QFA}.; TURN 81 83 {ECO:0000244|PDB:1F3H}.,,,,,5 out of 5,Alternative sequence (6); Beta strand (5); Chain (1); Helix (7); Metal binding (4); Modified residue (11); Mutagenesis (20); Natural variant (1); Repeat (1); Sequence conflict (3); Turn (3),,"TISSUE SPECIFICITY: Expressed only in fetal kidney and liver, and to lesser extent, lung and brain (PubMed:10626797). Abundantly expressed in adenocarcinoma (lung, pancreas, colon, breast, and prostate) and in high-grade lymphomas (PubMed:14741722, PubMed:16329164). Also expressed in various renal cell carcinoma cell lines (PubMed:10626797). Expressed in cochlea including the organ of Corti, the lateral wall, the interdental cells of the Limbus as well as in Schwann cells and cells of the cochlear nerve and the spiral ganglions (at protein level). Not expressed in cells of the inner and outer sulcus or the Reissner's membrane (at protein level) (PubMed:21364656, PubMed:20627126). {ECO:0000269|PubMed:10626797, ECO:0000269|PubMed:14741722, ECO:0000269|PubMed:16329164, ECO:0000269|PubMed:20627126, ECO:0000269|PubMed:21364656}.",,3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Complete proteome;Cytoplasm;Cytoskeleton;Kinetochore;Metal-binding;Microtubule;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Protease inhibitor;Reference proteome;Repressor;Thiol protease inhibitor;Transcription;Transcription regulation;Ubl conjugation;Zinc,Evidence at protein level,reviewed,,IAP family,216,Alternative products (1); Developmental stage (1); Domain (1); Function (1); Induction (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0053; KW-0131; KW-0132; KW-0137; KW-0158; KW-0159; KW-0181; KW-0206; KW-0479; KW-0493; KW-0498; KW-0539; KW-0597; KW-0621; KW-0646; KW-0678; KW-0789; KW-0804; KW-0805; KW-0832; KW-0862; KW-0963; KW-0995; KW-1185,,,,,,,,"PTM: Ubiquitinated by the Cul9-RING ubiquitin-protein ligase complex, leading to its degradation. Ubiquitination is required for centrosomal targeting. {ECO:0000269|PubMed:16322459, ECO:0000269|PubMed:24793696}.; PTM: In vitro phosphorylation at Thr-117 by AURKB prevents interaction with INCENP and localization to mitotic chromosomes (PubMed:14610074). Phosphorylation at Thr-48 by CK2 is critical for its mitotic and anti-apoptotic activities (PubMed:21252625). Phosphorylation at Thr-34 by CDK15 is critical for its anti-apoptotic activity (PubMed:24866247). Phosphorylation at Ser-20 by AURKC is critical for regulation of proper chromosome alignment and segregation, and possibly cytokinesis. {ECO:0000269|PubMed:11069302, ECO:0000269|PubMed:14610074, ECO:0000269|PubMed:21252625, ECO:0000269|PubMed:24866247, ECO:0000269|PubMed:27332895}.; PTM: Acetylation at Lys-129 by CBP results in its homodimerization, while deacetylation promotes the formation of monomers which heterodimerize with XPO1/CRM1 which facilitates its nuclear export. The acetylated form represses STAT3 transactivation. The dynamic equilibrium between its acetylation and deacetylation at Lys-129 determines its interaction with XPO1/CRM1, its subsequent subcellular localization, and its ability to inhibit STAT3 transactivation. {ECO:0000269|PubMed:20826784}.",CHAIN 1 142 Baculoviral IAP repeat-containing protein 5. /FTId=PRO_0000122356.,,,,,,"MOD_RES 20 20 Phosphoserine; by AURKC. {ECO:0000269|PubMed:27332895}.; MOD_RES 23 23 N6-acetyllysine. {ECO:0000269|PubMed:20826784}.; MOD_RES 34 34 Phosphothreonine; by CDK1 and CDK15. {ECO:0000244|PubMed:18691976, ECO:0000269|PubMed:11069302, ECO:0000269|PubMed:24866247}.; MOD_RES 48 48 Phosphothreonine; by CK2; in vitro. {ECO:0000269|PubMed:21252625}.; MOD_RES 90 90 N6-acetyllysine. {ECO:0000269|PubMed:20826784}.; MOD_RES 110 110 N6-acetyllysine. {ECO:0000269|PubMed:20826784}.; MOD_RES 112 112 N6-acetyllysine. {ECO:0000269|PubMed:20826784}.; MOD_RES 115 115 N6-acetyllysine. {ECO:0000269|PubMed:20826784}.; MOD_RES 117 117 Phosphothreonine; by AURKB. {ECO:0000269|PubMed:14610074}.; MOD_RES 121 121 N6-acetyllysine. {ECO:0000269|PubMed:20826784}.; MOD_RES 129 129 N6-acetyllysine. {ECO:0000269|PubMed:20826784}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U75285;AF077350;AB154416;AY830084;AB028869;AY927772;DQ227257;DQ310375;DQ310376;DQ310377;DQ310378;DQ310379;CR541740;AK223428;AK311917;AY795969;CH471099;BC008718;BC034148;BC065497;
0,O43237,DC1L2_HUMAN,DYNC1LI2 DNCLI2 LIC2,DYNC1LI2,DNCLI2 LIC2,,,Homo sapiens (Human),9606,"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) (LIC-2) (LIC53/55)",UP000005640: Chromosome 16,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAPVGVEKKLLLGPNGPAVAAAGDLTSEEEEGQSLWSSILSEVSTRARSKLPSGKNILVFGEDGSGKTTLMTKLQGAEHGKKGRGLEYLYLSVHDEDRDDHTRCNVWILDGDLYHKGLLKFAVSAESLPETLVIFVADMSRPWTVMESLQKWASVLREHIDKMKIPPEKMRELERKFVKDFQDYMEPEEGCQGSPQRRGPLTSGSDEENVALPLGDNVLTHNLGIPVLVVCTKCDAVSVLEKEHDYRDEHLDFIQSHLRRFCLQYGAALIYTSVKEEKNLDLLYKYIVHKTYGFHFTTPALVVEKDAVFIPAGWDNEKKIAILHENFTTVKPEDAYEDFIVKPPVRKLVHDKELAAEDEQVFLMKQQSLLAKQPATPTRASESPARGPSGSPRTQGRGGPASVPSSSPGTSVKKPDPNIKNNAASEGVLASFFNSLLSKKTGSPGSPGAGGVQSTAKKSGQKTVLSNVQEELDRMTRKPDSMVTNSSTENEA,492,"54,099",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=O43237-1; Sequence=Displayed; Name=2; IsoId=O43237-2; Sequence=VSP_054663; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 100 177 DHTRCNVWILDGDLYHKGLLKFAVSAESLPETLVIFVADMSRPWTVMESLQKWASVLREHIDKMKIPPEKMRELERKF -> V (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_054663.,,,,,CONFLICT 458 458 K -> N (in Ref. 5; AAH25959). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the dynein light intermediate chain family. {ECO:0000305}.,,,,,,,,,,,,,FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in binding dynein to membranous organelles or chromosomes.,,,,,,,,,,NP_BIND 61 68 ATP. {ECO:0000255}.,,centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein homooligomerization [GO:0051260],antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; microtubule-based movement [GO:0007018]; microtubule cytoskeleton organization [GO:0000226]; protein homooligomerization [GO:0051260],ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; microtubule motor activity [GO:0003777],centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule [GO:0005874],GO:0000226; GO:0000776; GO:0003777; GO:0005524; GO:0005764; GO:0005770; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0016020; GO:0019886; GO:0045504; GO:0051260; GO:0051642; GO:1990090,IPR008467; IPR022780; IPR027417; ,,"SUBUNIT: Homodimer (By similarity). The cytoplasmic dynein 1 complex consists of two catalytic heavy chains (HCs) and a number of non-catalytic subunits presented by intermediate chains (ICs), light intermediate chains (LICs) and light chains (LCs); the composition seems to vary in respect to the IC, LIC and LC composition. The heavy chain homodimer serves as a scaffold for the probable homodimeric assembly of the respective non-catalytic subunits. The ICs and LICs bind directly to the HC dimer and the LCs assemble on the IC dimer. Self-associates. Interacts with DYNC1H1; DYNC1LI1 and DYNC1LI2 bind mutually exclusive to DYNC1H1 (By similarity). {ECO:0000250}.",14702039; 15616553; 15489334; 17081983; 16964243; 18691976; 18669648; 19413330; 20068231; 21269460; 21406692; 23186163; 24275569; 24129315,14702039; 15616553; 15489334; 17081983; 16964243; 18691976; 18669648; 19413330; 20068231; 21269460; 21406692; 23186163; 24275569; 24129315; 10036229; 10559986; 10562278; 10679020; 10903204; 11035033; 11081627; 11181178; 11285137; 11306556; 11461920; 11483508; 11509732; 11804586; 12006501; 12194817; 12198549; 12401177; 12447383; 14730319; 15085137; 15339662; 15483056; 15591061; 15632110; 15723797; 15728195; 15737063; 15878873; 16169070; 16541025; 16622419; 16622420; 16723730; 17030981; 17129783; 17274799; 17283181; 17827179; 18046453; 18086915; 18097444; 18664496; 18716626; 19463016; 19564404; 19965387; 20038533; 20214888; 20360068; 20467437; 20711500; 21169557; 21397845; 21878504; 21987589; 22593156; 22885700; 23416715; 23606334; 23783758; 23839779; 24189400; 24806965; 24891604; 25233431; 25422374; 25453831; 26496610; 26638075; 27433848; 27441562; 28003657; 29420470; 7691276; 8642258; 8909537; 8991093; 9150144; 9288971; 9323141; 9380700; 9490716; 9671725,1998-07-15,2019-02-13,1998-06-01,154,Electron microscopy (4),STRAND 55 60 {ECO:0000244|PDB:6F1Y}.; STRAND 83 85 {ECO:0000244|PDB:6F1Y}.; STRAND 89 93 {ECO:0000244|PDB:6F1Y}.; STRAND 96 98 {ECO:0000244|PDB:6F1Y}.; STRAND 102 106 {ECO:0000244|PDB:6F1Y}.; STRAND 128 135 {ECO:0000244|PDB:6F1Y}.; STRAND 139 141 {ECO:0000244|PDB:6F1Y}.; STRAND 164 166 {ECO:0000244|PDB:6F1Y}.; STRAND 184 186 {ECO:0000244|PDB:6F1Y}.; STRAND 225 230 {ECO:0000244|PDB:6F1Y}.; STRAND 303 307 {ECO:0000244|PDB:6F1Y}.; STRAND 326 328 {ECO:0000244|PDB:6F1Y}.,HELIX 39 45 {ECO:0000244|PDB:6F1Y}.; HELIX 67 74 {ECO:0000244|PDB:6F1Y}.; HELIX 116 120 {ECO:0000244|PDB:6F1Y}.; HELIX 142 163 {ECO:0000244|PDB:6F1Y}.; HELIX 169 181 {ECO:0000244|PDB:6F1Y}.; HELIX 237 243 {ECO:0000244|PDB:6F1Y}.; HELIX 248 265 {ECO:0000244|PDB:6F1Y}.; HELIX 280 288 {ECO:0000244|PDB:6F1Y}.; HELIX 319 323 {ECO:0000244|PDB:6F1Y}.; HELIX 336 339 {ECO:0000244|PDB:6F1Y}.; HELIX 362 370 {ECO:0000244|PDB:6F1Y}.,TURN 125 127 {ECO:0000244|PDB:6F1Y}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (12); Chain (1); Helix (11); Modified residue (7); Nucleotide binding (1); Sequence conflict (1); Turn (1),,,,3D-structure;ATP-binding;Alternative splicing;Complete proteome;Cytoplasm;Cytoskeleton;Dynein;Methylation;Microtubule;Motor protein;Nucleotide-binding;Phosphoprotein;Reference proteome;Transport,Evidence at protein level,reviewed,,Dynein light intermediate chain family,154,Alternative products (1); Caution (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0067; KW-0181; KW-0206; KW-0243; KW-0488; KW-0493; KW-0505; KW-0547; KW-0597; KW-0813; KW-0963; KW-1185,,,,,,,,,CHAIN 1 492 Cytoplasmic dynein 1 light intermediate chain 2. /FTId=PRO_0000114670.,,,,,,"MOD_RES 194 194 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 383 383 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 391 391 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 397 397 Omega-N-methylarginine. {ECO:0000244|PubMed:24129315}.; MOD_RES 441 441 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 443 443 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 446 446 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF035812;AK291766;AK303031;CH471092;BC025959;
0,P36873,PP1G_HUMAN,PPP1CC,PPP1CC,,,,Homo sapiens (Human),9606,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit),UP000005640: Chromosome 12,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MADLDKLNIDSIIQRLLEVRGSKPGKNVQLQENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVLGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPAEKKKPNATRPVTPPRGMITKQAKK,323,"36,984",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; Synonyms=PPPCC1, Gamma-1; IsoId=P36873-1; Sequence=Displayed; Name=2; Synonyms=PPPCC2, Gamma-2; IsoId=P36873-2; Sequence=VSP_005094; ",,,,,,,,,,VAR_SEQ 315 323 GMITKQAKK -> VASGLNPSIQKASNYRNNTVLYE (in isoform 2). {ECO:0000303|PubMed:8394140}. /FTId=VSP_005094.,VARIANT 152 152 F -> S (in dbSNP:rs11558237). /FTId=VAR_051734.,,,,,,1,,0,,SIMILARITY: Belongs to the PPP phosphatase family. PP-1 subfamily. {ECO:0000305}.,,,,,,,,3.1.3.16,,"CATALYTIC ACTIVITY: Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] + phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474, ChEBI:CHEBI:83421; EC=3.1.3.16; Evidence={ECO:0000269|PubMed:15280359}; CATALYTIC ACTIVITY: Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] + phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474, ChEBI:CHEBI:61977; EC=3.1.3.16; Evidence={ECO:0000269|PubMed:15280359};","COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:11535607, ECO:0000269|PubMed:15280359};  Note=Binds 2 manganese ions per subunit. {ECO:0000269|PubMed:11535607, ECO:0000269|PubMed:15280359};",,"FUNCTION: Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase 1 (PP1) is essential for cell division, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Dephosphorylates RPS6KB1. Involved in regulation of ionic conductances and long-term synaptic plasticity. May play an important role in dephosphorylating substrates such as the postsynaptic density-associated Ca(2+)/calmodulin dependent protein kinase II. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E. Dephosphorylates the 'Ser-418' residue of FOXP3 in regulatory T-cells (Treg) from patients with rheumatoid arthritis, thereby inactivating FOXP3 and rendering Treg cells functionally defective (PubMed:23396208). {ECO:0000269|PubMed:17936702, ECO:0000269|PubMed:20516061, ECO:0000269|PubMed:21712997, ECO:0000269|PubMed:23396208}.",,,,,,ACT_SITE 125 125 Proton donor. {ECO:0000269|PubMed:7500362}.,,,"METAL 64 64 Manganese 1. {ECO:0000269|PubMed:11535607, ECO:0000269|PubMed:15280359}.; METAL 66 66 Manganese 1. {ECO:0000269|PubMed:11535607, ECO:0000269|PubMed:15280359}.; METAL 92 92 Manganese 1. {ECO:0000269|PubMed:11535607, ECO:0000269|PubMed:15280359}.; METAL 92 92 Manganese 2. {ECO:0000269|PubMed:11535607, ECO:0000269|PubMed:15280359}.; METAL 124 124 Manganese 2. {ECO:0000269|PubMed:11535607, ECO:0000269|PubMed:15280359}.; METAL 173 173 Manganese 2. {ECO:0000269|PubMed:11535607, ECO:0000269|PubMed:15280359}.; METAL 248 248 Manganese 2. {ECO:0000269|PubMed:11535607, ECO:0000269|PubMed:15280359}.",,SITE 273 273 Inhibition by microcystin toxin binding.,cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; protein-containing complex [GO:0032991]; PTW/PP1 phosphatase complex [GO:0072357]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; neuron differentiation [GO:0030182]; positive regulation of glial cell proliferation [GO:0060252]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of nucleocytoplasmic transport [GO:0046822],cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; neuron differentiation [GO:0030182]; positive regulation of glial cell proliferation [GO:0060252]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of nucleocytoplasmic transport [GO:0046822],lamin binding [GO:0005521]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723],cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357],GO:0000164; GO:0000777; GO:0003723; GO:0004721; GO:0004722; GO:0005521; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0005925; GO:0005977; GO:0006470; GO:0007049; GO:0008022; GO:0008157; GO:0016607; GO:0016791; GO:0019901; GO:0019904; GO:0030182; GO:0030496; GO:0032154; GO:0032922; GO:0032991; GO:0042752; GO:0043153; GO:0043197; GO:0044877; GO:0046822; GO:0046872; GO:0047485; GO:0051301; GO:0060252; GO:0072357; GO:0098793; GO:0098978,IPR004843; IPR029052; IPR037981; IPR006186; IPR031675; ,A1DRY3; Q5JQC9; P38398; O95400; O08785; Q96S65; Q9H175; O15294; O60927; P41236; Q7Z5V6; Q9UQK1; Q15435; Q96SB3; Q96S59; Q14684; Q5JR98; P04637; Q13625; Q13625-3; O94763; O94763-1; O95405,"SUBUNIT: PP1 comprises a catalytic subunit, PPP1CA, PPP1CB or PPP1CC, which is folded into its native form by inhibitor 2 and glycogen synthetase kinase 3, and then complexed to one or several targeting or regulatory subunits. PPP1R12A, PPP1R12B and PPP1R12C mediate binding to myosin. PPP1R3A (in skeletal muscle), PPP1R3B (in liver), PPP1R3C, PPP1R3D and PPP1R3F (in brain) mediate binding to glycogen. Interacts with cyanobacterial toxin microcystin; disulfide-linked. Interacts with PPP1R3B and PPP1R7. Isoform 2 interacts with SPZ1 (By similarity). Interacts with CDCA2. PPP1R15A and PPP1R15B mediate binding to EIF2S1. Part of a complex containing PPP1R15B, PP1 and NCK1/2. Interacts with IKFZ1; the interaction targets PPP1CC to pericentromeric heterochromatin, dephosphorylates IKAROS, stabilizes it and prevents it from degradation. Interacts with PPP1R42; the interaction is direct (By similarity). Interacts with NOM1 and PPP1R8. Component of the PTW/PP1 phosphatase complex, composed of PPP1R10/PNUTS, TOX4, WDR82, and PPP1CA or PPP1CB or PPP1CC. Interacts with PPP1R8. Interacts with isoform 1 and isoform 4 NEK2. Interacts with URI1; the interaction is phosphorylation-dependent and occurs in a growth factor-dependent manner. Interacts with FOXP3. Interacts with TMEM225 (via RVxF motif) (By similarity). Interacts with MKI67 (PubMed:24867636). Interacts with RRP1B; this targets PPP1CC to the nucleolus (PubMed:20926688). Interacts with PPP1R2B (PubMed:23506001). Found in a complex with PPP1CA, PPP1CC, SHC1 and PEAK1 (PubMed:23846654). {ECO:0000250|UniProtKB:P63087, ECO:0000269|PubMed:11535607, ECO:0000269|PubMed:11564868, ECO:0000269|PubMed:11739654, ECO:0000269|PubMed:12226088, ECO:0000269|PubMed:15280359, ECO:0000269|PubMed:15659832, ECO:0000269|PubMed:16492807, ECO:0000269|PubMed:17283141, ECO:0000269|PubMed:17936702, ECO:0000269|PubMed:17965019, ECO:0000269|PubMed:20516061, ECO:0000269|PubMed:20926688, ECO:0000269|PubMed:23396208, ECO:0000269|PubMed:23506001, ECO:0000269|PubMed:23846654, ECO:0000269|PubMed:24867636, ECO:0000269|PubMed:7556599, ECO:0000269|PubMed:9414128}.",8394140; 15489334; 8111128; 7556599; 9414128; 11739654; 11564868; 12226088; 12529430; 15659832; 15705855; 16492807; 17283141; 17936702; 17965019; 18669648; 19377461; 21269460; 22814378; 23186163; 24275569; 24336203; 20516061; 20926688; 21712997; 23506001; 23846654; 23396208; 24867636; 25944712; 7500362; 11535607; 15280359,8394140; 15489334; 8111128; 7556599; 9414128; 11739654; 11564868; 12226088; 12529430; 15659832; 15705855; 16492807; 17283141; 17936702; 17965019; 18669648; 19377461; 21269460; 22814378; 23186163; 24275569; 24336203; 20516061; 20926688; 21712997; 23506001; 23846654; 23396208; 24867636; 25944712; 7500362; 11535607; 15280359; 10719897; 10790862; 10807923; 10848614; 10880350; 11081627; 11165242; 11181178; 11232563; 11509732; 11591712; 11779462; 11804586; 11856740; 11865049; 11875063; 12006501; 12015153; 12194817; 12221103; 12761178; 14701732; 14718519; 14730319; 14743216; 14750904; 15085137; 15231748; 15339662; 15723797; 15737063; 15767683; 15800623; 15817302; 15917222; 16131488; 16201749; 16343532; 16541025; 16622419; 16622420; 16826568; 16983144; 17022978; 17030981; 17129783; 17218255; 17274640; 17511879; 17996206; 18097444; 18400165; 18419299; 18448430; 18540044; 18716626; 18786386; 19074462; 19274088; 19303849; 19369647; 19805222; 19948962; 19965387; 20231380; 20562859; 20711500; 20948546; 21098020; 21397845; 21397856; 21516116; 21533037; 21723128; 21750233; 21878504; 21903422; 21987589; 21988832; 21998301; 22454514; 22623428; 22810585; 22885700; 23088536; 23176181; 23197154; 23414517; 23455153; 23499489; 23555304; 23606334; 23937259; 24196533; 24366813; 24502978; 24558042; 25012651; 25416956; 25609649; 25665578; 25852190; 25886518; 26496610; 26742780; 27572260; 27921263; 28678475; 9755872,1994-06-01,2019-02-13,1994-06-01,220,X-ray crystallography (9),STRAND 51 55 {ECO:0000244|PDB:5INB}.; STRAND 57 62 {ECO:0000244|PDB:5INB}.; STRAND 87 89 {ECO:0000244|PDB:5INB}.; STRAND 94 98 {ECO:0000244|PDB:5INB}.; STRAND 118 120 {ECO:0000244|PDB:5INB}.; STRAND 162 165 {ECO:0000244|PDB:5INB}.; STRAND 169 174 {ECO:0000244|PDB:5INB}.; STRAND 197 199 {ECO:0000244|PDB:5INB}.; STRAND 214 218 {ECO:0000244|PDB:5INB}.; STRAND 222 227 {ECO:0000244|PDB:5INB}.; STRAND 243 246 {ECO:0000244|PDB:5INB}.; STRAND 254 258 {ECO:0000244|PDB:5INB}.; STRAND 263 267 {ECO:0000244|PDB:5INB}.; STRAND 280 285 {ECO:0000244|PDB:5INB}.; STRAND 290 298 {ECO:0000244|PDB:5INB}.,HELIX 9 17 {ECO:0000244|PDB:5INB}.; HELIX 18 21 {ECO:0000244|PDB:5INB}.; HELIX 32 48 {ECO:0000244|PDB:5INB}.; HELIX 69 79 {ECO:0000244|PDB:5INB}.; HELIX 100 113 {ECO:0000244|PDB:5INB}.; HELIX 128 131 {ECO:0000244|PDB:5INB}.; HELIX 136 143 {ECO:0000244|PDB:5INB}.; HELIX 146 156 {ECO:0000244|PDB:5INB}.; HELIX 183 187 {ECO:0000244|PDB:5INB}.; HELIX 200 206 {ECO:0000244|PDB:5INB}.; HELIX 229 239 {ECO:0000244|PDB:5INB}.; HELIX 272 274 {ECO:0000244|PDB:5INB}.,TURN 115 117 {ECO:0000244|PDB:5INB}.; TURN 132 135 {ECO:0000244|PDB:4UT3}.; TURN 166 168 {ECO:0000244|PDB:5INB}.; TURN 259 262 {ECO:0000244|PDB:5INB}.,,,,,5 out of 5,Active site (1); Alternative sequence (1); Beta strand (15); Chain (1); Helix (12); Initiator methionine (1); Metal binding (7); Modified residue (3); Mutagenesis (2); Natural variant (1); Site (1); Turn (4),"CAUTION: Was originally thought to be part of the MLL5-L complex, at least composed of KMT2E, STK38, PPP1CA, PPP1CB, PPP1CC, HCFC1, ACTB and OGT (PubMed:19377461). However, the corresponding article has been retracted (PubMed:24336203). {ECO:0000269|PubMed:19377461, ECO:0000269|PubMed:24336203}.",,MISCELLANEOUS: Microcystin toxin is bound to Cys-273 through a thioether bond.,3D-structure;Acetylation;Alternative splicing;Biological rhythms;Carbohydrate metabolism;Cell cycle;Cell division;Centromere;Chromosome;Complete proteome;Cytoplasm;Direct protein sequencing;Disulfide bond;Glycogen metabolism;Hydrolase;Kinetochore;Manganese;Metal-binding;Mitochondrion;Nucleus;Phosphoprotein;Polymorphism;Protein phosphatase;Reference proteome,Evidence at protein level,reviewed,,"PPP phosphatase family, PP-1 subfamily",220,Activity regulation (1); Alternative products (1); Catalytic activity (2); Caution (1); Cofactor (1); Function (1); Induction (1); Miscellaneous (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0025; KW-0090; KW-0119; KW-0131; KW-0132; KW-0137; KW-0158; KW-0181; KW-0321; KW-0378; KW-0464; KW-0479; KW-0496; KW-0539; KW-0597; KW-0621; KW-0903; KW-0904; KW-0963; KW-0995; KW-1015; KW-1185,,,,,,,,PTM: Phosphorylated by NEK2. {ECO:0000269|PubMed:15659832}.,CHAIN 2 323 Serine/threonine-protein phosphatase PP1-gamma catalytic subunit. /FTId=PRO_0000058787.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|Ref.3, ECO:0000269|Ref.4}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|Ref.3, ECO:0000269|Ref.4}.; MOD_RES 307 307 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 311 311 Phosphothreonine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X74008;BC014073;L07395;
0,P49454,CENPF_HUMAN,CENPF,CENPF,,,,Homo sapiens (Human),9606,Centromere protein F (CENP-F) (AH antigen) (Kinetochore protein CENPF) (Mitosin),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSWALEEWKEGLPTRALQKIQELEGQLDKLKKEKQQRQFQLDSLEAALQKQKQKVENEKTEGTNLKRENQRLMEICESLEKTKQKISHELQVKESQVNFQEGQLNSGKKQIEKLEQELKRCKSELERSQQAAQSADVSLNPCNTPQKIFTTPLTPSQYYSGSKYEDLKEKYNKEVEERKRLEAEVKALQAKKASQTLPQATMNHRDIARHQASSSVFSWQQEKTPSHLSSNSQRTPIRRDFSASYFSGEQEVTPSRSTLQIGKRDANSSFFDNSSSPHLLDQLKAQNQELRNKINELELRLQGHEKEMKGQVNKFQELQLQLEKAKVELIEKEKVLNKCRDELVRTTAQYDQASTKYTALEQKLKKLTEDLSCQRQNAESARCSLEQKIKEKEKEFQEELSRQQRSFQTLDQECIQMKARLTQELQQAKNMHNVLQAELDKLTSVKQQLENNLEEFKQKLCRAEQAFQASQIKENELRRSMEEMKKENNLLKSHSEQKAREVCHLEAELKNIKQCLNQSQNFAEEMKAKNTSQETMLRDLQEKINQQENSLTLEKLKLAVADLEKQRDCSQDLLKKREHHIEQLNDKLSKTEKESKALLSALELKKKEYEELKEEKTLFSCWKSENEKLLTQMESEKENLQSKINHLETCLKTQQIKSHEYNERVRTLEMDRENLSVEIRNLHNVLDSKSVEVETQKLAYMELQQKAEFSDQKHQKEIENMCLKTSQLTGQVEDLEHKLQLLSNEIMDKDRCYQDLHAEYESLRDLLKSKDASLVTNEDHQRSLLAFDQQPAMHHSFANIIGEQGSMPSERSECRLEADQSPKNSAILQNRVDSLEFSLESQKQMNSDLQKQCEELVQIKGEIEENLMKAEQMHQSFVAETSQRISKLQEDTSAHQNVVAETLSALENKEKELQLLNDKVETEQAEIQELKKSNHLLEDSLKELQLLSETLSLEKKEMSSIISLNKREIEELTQENGTLKEINASLNQEKMNLIQKSESFANYIDEREKSISELSDQYKQEKLILLQRCEETGNAYEDLSQKYKAAQEKNSKLECLLNECTSLCENRKNELEQLKEAFAKEHQEFLTKLAFAEERNQNLMLELETVQQALRSEMTDNQNNSKSEAGGLKQEIMTLKEEQNKMQKEVNDLLQENEQLMKVMKTKHECQNLESEPIRNSVKERESERNQCNFKPQMDLEVKEISLDSYNAQLVQLEAMLRNKELKLQESEKEKECLQHELQTIRGDLETSNLQDMQSQEISGLKDCEIDAEEKYISGPHELSTSQNDNAHLQCSLQTTMNKLNELEKICEILQAEKYELVTELNDSRSECITATRKMAEEVGKLLNEVKILNDDSGLLHGELVEDIPGGEFGEQPNEQHPVSLAPLDESNSYEHLTLSDKEVQMHFAELQEKFLSLQSEHKILHDQHCQMSSKMSELQTYVDSLKAENLVLSTNLRNFQGDLVKEMQLGLEEGLVPSLSSSCVPDSSSLSSLGDSSFYRALLEQTGDMSLLSNLEGAVSANQCSVDEVFCSSLQEENLTRKETPSAPAKGVEELESLCEVYRQSLEKLEEKMESQGIMKNKEIQELEQLLSSERQELDCLRKQYLSENEQWQQKLTSVTLEMESKLAAEKKQTEQLSLELEVARLQLQGLDLSSRSLLGIDTEDAIQGRNESCDISKEHTSETTERTPKHDVHQICDKDAQQDLNLDIEKITETGAVKPTGECSGEQSPDTNYEPPGEDKTQGSSECISELSFSGPNALVPMDFLGNQEDIHNLQLRVKETSNENLRLLHVIEDRDRKVESLLNEMKELDSKLHLQEVQLMTKIEACIELEKIVGELKKENSDLSEKLEYFSCDHQELLQRVETSEGLNSDLEMHADKSSREDIGDNVAKVNDSWKERFLDVENELSRIRSEKASIEHEALYLEADLEVVQTEKLCLEKDNENKQKVIVCLEEELSVVTSERNQLRGELDTMSKKTTALDQLSEKMKEKTQELESHQSECLHCIQVAEAEVKEKTELLQTLSSDVSELLKDKTHLQEKLQSLEKDSQALSLTKCELENQIAQLNKEKELLVKESESLQARLSESDYEKLNVSKALEAALVEKGEFALRLSSTQEEVHQLRRGIEKLRVRIEADEKKQLHIAEKLKERERENDSLKDKVENLERELQMSEENQELVILDAENSKAEVETLKTQIEEMARSLKVFELDLVTLRSEKENLTKQIQEKQGQLSELDKLLSSFKSLLEEKEQAEIQIKEESKTAVEMLQNQLKELNEAVAALCGDQEIMKATEQSLDPPIEEEHQLRNSIEKLRARLEADEKKQLCVLQQLKESEHHADLLKGRVENLERELEIARTNQEHAALEAENSKGEVETLKAKIEGMTQSLRGLELDVVTIRSEKENLTNELQKEQERISELEIINSSFENILQEKEQEKVQMKEKSSTAMEMLQTQLKELNERVAALHNDQEACKAKEQNLSSQVECLELEKAQLLQGLDEAKNNYIVLQSSVNGLIQEVEDGKQKLEKKDEEISRLKNQIQDQEQLVSKLSQVEGEHQLWKEQNLELRNLTVELEQKIQVLQSKNASLQDTLEVLQSSYKNLENELELTKMDKMSFVEKVNKMTAKETELQREMHEMAQKTAELQEELSGEKNRLAGELQLLLEEIKSSKDQLKELTLENSELKKSLDCMHKDQVEKEGKVREEIAEYQLRLHEAEKKHQALLLDTNKQYEVEIQTYREKLTSKEECLSSQKLEIDLLKSSKEELNNSLKATTQILEELKKTKMDNLKYVNQLKKENERAQGKMKLLIKSCKQLEEEKEILQKELSQLQAAQEKQKTGTVMDTKVDELTTEIKELKETLEEKTKEADEYLDKYCSLLISHEKLEKAKEMLETQVAHLCSQQSKQDSRGSPLLGPVVPGPSPIPSVTEKRLSSGQNKASGKRQRSSGIWENGRGPTPATPESFSKKSKKAVMSGIHPAEDTEGTEFEPEGLPEVVKKGFADIPTGKTSPYILRRTTMATRTSPRLAAQKLALSPLSLGKENLAESSKPTAGGSRSQKVKVAQRSPVDSGTILREPTTKSVPVNNLPERSPTDSPREGLRVKRGRLVPSPKAGLESNGSENCKVQ,3114,"357,527",,,,,,,,,,,SEQUENCE CAUTION:  Sequence=AAA82889.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305}; ,,"VARIANT 250 250 Q -> L (in dbSNP:rs1050065). {ECO:0000269|PubMed:7542657}. /FTId=VAR_055049.; VARIANT 272 272 D -> G (in dbSNP:rs1050066). {ECO:0000269|PubMed:7542657}. /FTId=VAR_055050.; VARIANT 300 300 R -> C (in dbSNP:rs17023281). /FTId=VAR_034712.; VARIANT 494 494 H -> Q (in dbSNP:rs2070065). /FTId=VAR_034713.; VARIANT 701 701 M -> V (in dbSNP:rs3795524). /FTId=VAR_034714.; VARIANT 754 754 Q -> E (in dbSNP:rs3795523). /FTId=VAR_034715.; VARIANT 815 815 R -> H (in dbSNP:rs3795522). /FTId=VAR_034716.; VARIANT 1018 1018 Y -> D (in dbSNP:rs3795519). /FTId=VAR_034717.; VARIANT 1033 1033 G -> R (in dbSNP:rs3795518). /FTId=VAR_034718.; VARIANT 1105 1105 T -> I (in dbSNP:rs12067133). /FTId=VAR_034719.; VARIANT 1412 1412 L -> S (in dbSNP:rs3795517). /FTId=VAR_034720.; VARIANT 1768 1768 D -> N (in dbSNP:rs3748692). /FTId=VAR_055638.; VARIANT 1915 1915 E -> A (in dbSNP:rs3790647). /FTId=VAR_034723.; VARIANT 3106 3106 N -> K (in dbSNP:rs7289). {ECO:0000269|PubMed:7542657, ECO:0000269|PubMed:7612011, ECO:0000269|PubMed:7651420}. /FTId=VAR_014839.",,,,"CONFLICT 16 16 A -> T (in Ref. 1; AAA82889). {ECO:0000305}.; CONFLICT 48 48 L -> P (in Ref. 1; AAA82889 and 2; AAA82935). {ECO:0000305}.; CONFLICT 52 52 K -> T (in Ref. 1; AAA82889 and 2; AAA82935). {ECO:0000305}.; CONFLICT 611 611 Missing (in Ref. 2; AAA82935). {ECO:0000305}.; CONFLICT 1515 1515 A -> V (in Ref. 1; AAA82889). {ECO:0000305}.; CONFLICT 1715 1715 V -> L (in Ref. 2; AAA82935). {ECO:0000305}.; CONFLICT 2146 2147 ER -> DG (in Ref. 5; AAA86889). {ECO:0000305}.; CONFLICT 2239 2239 L -> Q (in Ref. 5; AAA86889). {ECO:0000305}.; CONFLICT 2396 2396 N -> D (in Ref. 1; AAA82889 and 5; AAA86889). {ECO:0000305}.; CONFLICT 2449 2465 ELNERVAALHNDQEACK -> SSMREWQPCIMTKKPVS (in Ref. 5; AAA86889). {ECO:0000305}.; CONFLICT 2943 2943 R -> G (in Ref. 1; AAA82889, 2; AAA82935 and 5; AAA86889). {ECO:0000305}.",,3,,0,,SIMILARITY: Belongs to the centromere protein F family. {ECO:0000305}.,COILED 13 131 {ECO:0000255}.; COILED 280 685 {ECO:0000255}.; COILED 899 989 {ECO:0000255}.; COILED 1196 1244 {ECO:0000255}.; COILED 1549 1646 {ECO:0000255}.; COILED 1890 2078 {ECO:0000255}.; COILED 2107 2891 {ECO:0000255}.,,,MOTIF 2919 2936 Nuclear localization signal. {ECO:0000255}.,REGION 1 481 Interaction with SNAP25 and required for localization to the cytoplasm. {ECO:0000250}.; REGION 2026 2351 Interaction with NDE1 and NDEL1. {ECO:0000269|PubMed:17600710}.; REGION 2111 2472 2 X 177 AA tandem repeats.; REGION 2392 3017 Sufficient for centromere localization.; REGION 2392 2829 Sufficient for self-association.; REGION 2831 3017 Sufficient for nuclear localization.,REPEAT 2111 2290 1.; REPEAT 2293 2472 2.,,,,,,,"FUNCTION: Required for kinetochore function and chromosome segregation in mitosis. Required for kinetochore localization of dynein, LIS1, NDE1 and NDEL1. Regulates recycling of the plasma membrane by acting as a link between recycling vesicles and the microtubule network though its association with STX4 and SNAP25. Acts as a potential inhibitor of pocket protein-mediated cellular processes during development by regulating the activity of RB proteins during cell division and proliferation. May play a regulatory or permissive role in the normal embryonic cardiomyocyte cell cycle and in promoting continued mitosis in transformed, abnormally dividing neonatal cardiomyocytes. Interaction with RB directs embryonic stem cells toward a cardiac lineage. Involved in the regulation of DNA synthesis and hence cell cycle progression, via its C-terminus. Has a potential role regulating skeletal myogenesis and in cell differentiation in embryogenesis. Involved in dendritic cell regulation of T-cell immunity against chlamydia. {ECO:0000269|PubMed:12974617, ECO:0000269|PubMed:17600710, ECO:0000269|PubMed:7542657, ECO:0000269|PubMed:7651420}.",,,,,,,,,,,,"axoneme [GO:0005930]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to drug [GO:0042493]; ventricular system development [GO:0021591]","cell differentiation [GO:0030154]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to drug [GO:0042493]; ventricular system development [GO:0021591]",chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134],"axoneme [GO:0005930]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]",GO:0000278; GO:0000775; GO:0000776; GO:0000922; GO:0000940; GO:0001822; GO:0003682; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005930; GO:0007059; GO:0007094; GO:0007517; GO:0008022; GO:0008134; GO:0008283; GO:0010389; GO:0015031; GO:0016202; GO:0016363; GO:0021591; GO:0030154; GO:0030496; GO:0036064; GO:0042493; GO:0042803; GO:0045120; GO:0045892; GO:0048471; GO:0051301; GO:0051310; GO:0051382; GO:0051726; GO:0070840; GO:0071897; GO:0097539,IPR018302; IPR019513; IPR018463; ,Q9GZM8; Q8WUM0,"SUBUNIT: Interacts with and STX4 (via C-terminus) (By similarity). Interacts (via N-terminus) with RBL1, RBL2 and SNAP25 (By similarity). Self-associates. Interacts with CENP-E and BUBR1 (via C-terminus). Interacts (via C-terminus) with NDE1, NDEL1 and RB1. {ECO:0000250, ECO:0000269|PubMed:17600710, ECO:0000269|PubMed:7642639, ECO:0000269|PubMed:7651420, ECO:0000269|PubMed:9763420}.",7542657; 7651420; 16710414; 15489334; 7612011; 7642639; 9763420; 10852915; 12974617; 17081983; 16964243; 17600710; 17924679; 17525332; 18220336; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 23186163; 25564561; 26820108,7542657; 7651420; 16710414; 15489334; 7612011; 7642639; 9763420; 10852915; 12974617; 17081983; 16964243; 17600710; 17924679; 17525332; 18220336; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 23186163; 25564561; 26820108; 11081627; 11181178; 11509732; 11804586; 12006501; 12154071; 12194817; 14720137; 14730319; 14968112; 15085137; 15339662; 15654331; 15677469; 15723797; 15737063; 15870278; 16219694; 16252009; 16456711; 16541025; 16601978; 16622419; 16622420; 16730941; 17030981; 17043677; 17129783; 17205517; 17353931; 17363900; 17617734; 17620599; 18097444; 18716626; 18847512; 19008095; 19102762; 19723035; 19965387; 20015195; 20053638; 20213041; 20309963; 20360068; 20398247; 20660191; 20828406; 20978035; 21282530; 21397845; 21613637; 21878504; 21987589; 21987812; 22885700; 22912832; 23075850; 23097494; 23163484; 24823640; 25609649; 25647485; 26101217; 26188054; 26259702; 26496610; 28301542; 28407396; 28701340; 29748388,1996-02-01,2019-02-13,2019-01-16,190,,,,,,,,,5 out of 5,Chain (1); Coiled coil (7); Lipidation (1); Modified residue (39); Motif (1); Natural variant (14); Propeptide (1); Region (6); Repeat (2); Sequence caution (1); Sequence conflict (16),,,,Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Ciliopathy;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;DNA synthesis;Developmental protein;Differentiation;Kinetochore;Lipoprotein;Methylation;Mitosis;Myogenesis;Nucleus;Phosphoprotein;Polymorphism;Prenylation;Primary ciliary dyskinesia;Reference proteome;Repeat,Evidence at protein level,reviewed,,Centromere protein F family,190,Developmental stage (1); Function (1); Involvement in disease (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0007; KW-0131; KW-0132; KW-0137; KW-0158; KW-0175; KW-0181; KW-0206; KW-0217; KW-0221; KW-0237; KW-0449; KW-0488; KW-0498; KW-0517; KW-0539; KW-0597; KW-0621; KW-0636; KW-0677; KW-0963; KW-0990; KW-0995; KW-1185; KW-1186,,,,,"DISEASE: Stromme syndrome (STROMS) [MIM:243605]: An autosomal recessive congenital disorder characterized by intestinal atresia, ocular anomalies, microcephaly, and renal and cardiac abnormalities in some patients. The disease has features of a ciliopathy, and lethality in early childhood is observed in severe cases. {ECO:0000269|PubMed:25564561, ECO:0000269|PubMed:26820108}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: Hyperphosphorylated during mitosis.,CHAIN 1 3111 Centromere protein F. /FTId=PRO_0000089477.,,,,,LIPID 3111 3111 S-farnesyl cysteine. {ECO:0000269|PubMed:10852915}.,"MOD_RES 106 106 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 144 144 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 151 151 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 154 154 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 158 158 Phosphotyrosine. {ECO:0000244|PubMed:20068231}.; MOD_RES 242 242 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 276 276 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 773 773 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 783 783 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 821 821 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 834 834 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 838 838 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 876 876 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1248 1248 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 1255 1255 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1259 1259 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 1651 1651 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1652 1652 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1654 1654 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1726 1726 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1862 1862 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1868 1868 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1892 1892 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 2416 2416 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 2417 2417 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 2779 2779 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 2900 2900 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231}.; MOD_RES 2911 2911 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231}.; MOD_RES 2922 2922 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 2936 2936 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 2949 2949 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 2952 2952 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 2998 2998 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 3023 3023 Phosphoserine. {ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 3026 3026 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 3054 3054 Phosphoserine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 3079 3079 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 3083 3083 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 3111 3111 Cysteine methyl ester. {ECO:0000305}.",,PROPEP 3112 3114 Removed in mature form. {ECO:0000305}. /FTId=PRO_0000396744.,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U19769;U30872;BC172232;U25725;
0,P53350,PLK1_HUMAN,PLK1 PLK,PLK1,PLK,,,Homo sapiens (Human),9606,Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13),UP000005640: Chromosome 16,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSAAVTAGKLARAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNKGLENPLPERPREKEEPVVRETGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS,603,"68,255",,,,,,,,,,,,,VARIANT 12 12 R -> L (in a lung squamous cell carcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041018.; VARIANT 261 261 L -> F (in dbSNP:rs35056440). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041019.; VARIANT 297 297 N -> D (in dbSNP:rs16972799). /FTId=VAR_051659.; VARIANT 332 332 L -> V (in dbSNP:rs45489499). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041020.; VARIANT 463 463 L -> H (in dbSNP:rs45569335). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041021.; VARIANT 518 518 R -> H (in dbSNP:rs56027600). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041022.; VARIANT 595 595 S -> L (in dbSNP:rs34001032). /FTId=VAR_051660.; VARIANT 599 599 R -> H (in dbSNP:rs34954545). /FTId=VAR_051661.,,,,CONFLICT 2 2 S -> T (in Ref. 1; AAA56634). {ECO:0000305}.; CONFLICT 11 11 A -> P (in Ref. 1; AAA56634). {ECO:0000305}.; CONFLICT 58 58 F -> L (in Ref. 1; AAA56634). {ECO:0000305}.; CONFLICT 60 60 G -> S (in Ref. 1; AAA56634). {ECO:0000305}.; CONFLICT 73 73 A -> V (in Ref. 2; AAA36659 and 7; AAB36946). {ECO:0000305}.; CONFLICT 123 123 N -> T (in Ref. 6; CAA62260). {ECO:0000305}.; CONFLICT 141 141 L -> P (in Ref. 4; CAA53536). {ECO:0000305}.; CONFLICT 227 227 G -> E (in Ref. 4; CAA53536). {ECO:0000305}.; CONFLICT 301 301 N -> G (in Ref. 2; AAA36659). {ECO:0000305}.; CONFLICT 495 495 A -> G (in Ref. 2; AAA36659). {ECO:0000305}.; CONFLICT 501 501 E -> Q (in Ref. 2; AAA36659). {ECO:0000305}.,,1,,0,"DOMAIN: The POLO box domains act as phosphopeptide-binding module that recognize and bind serine-[phosphothreonine/phosphoserine]-(proline/X) motifs. PLK1 recognizes and binds docking proteins that are already phosphorylated on these motifs, and then phosphorylates them. PLK1 can also create its own docking sites by mediating phosphorylation of serine-[phosphothreonine/phosphoserine]-(proline/X) motifs subsequently recognized by the POLO box domains. {ECO:0000269|PubMed:12939256, ECO:0000269|PubMed:14532005, ECO:0000269|PubMed:14734534, ECO:0000269|PubMed:17351640}.",SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. CDC5/Polo subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,DOMAIN 53 305 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.; DOMAIN 417 480 POLO box 1. {ECO:0000255|PROSITE-ProRule:PRU00154}.; DOMAIN 515 584 POLO box 2. {ECO:0000255|PROSITE-ProRule:PRU00154}.,MOTIF 337 340 D-box that targets the protein for proteasomal degradation in anaphase.,REGION 194 221 Activation loop.; REGION 493 507 Linker.; REGION 538 540 Important for interaction with phosphorylated proteins. {ECO:0000250}.,,,2.7.11.21,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.21; Evidence={ECO:0000269|PubMed:11202906, ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:21880710}; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.21; Evidence={ECO:0000269|PubMed:11202906, ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:21880710};",,,"FUNCTION: Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of anaphase-promoting complex/cyclosome (APC/C) inhibitors, and the regulation of mitotic exit and cytokinesis. Polo-like kinase proteins acts by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates BORA, BUB1B/BUBR1, CCNB1, CDC25C, CEP55, ECT2, ERCC6L, FBXO5/EMI1, FOXM1, KIF20A/MKLP2, CENPU, NEDD1, NINL, NPM1, NUDC, PKMYT1/MYT1, KIZ, PPP1R12A/MYPT1, PRC1, RACGAP1/CYK4, SGO1, STAG2/SA2, TEX14, TOPORS, p73/TP73, TPT1, WEE1 and HNRNPU. Plays a key role in centrosome functions and the assembly of bipolar spindles by phosphorylating KIZ, NEDD1 and NINL. NEDD1 phosphorylation promotes subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. Phosphorylation of NINL component of the centrosome leads to NINL dissociation from other centrosomal proteins. Involved in mitosis exit and cytokinesis by phosphorylating CEP55, ECT2, KIF20A/MKLP2, CENPU, PRC1 and RACGAP1. Recruited at the central spindle by phosphorylating and docking PRC1 and KIF20A/MKLP2; creates its own docking sites on PRC1 and KIF20A/MKLP2 by mediating phosphorylation of sites subsequently recognized by the POLO box domains. Phosphorylates RACGAP1, thereby creating a docking site for the Rho GTP exchange factor ECT2 that is essential for the cleavage furrow formation. Promotes the central spindle recruitment of ECT2. Plays a central role in G2/M transition of mitotic cell cycle by phosphorylating CCNB1, CDC25C, FOXM1, CENPU, PKMYT1/MYT1, PPP1R12A/MYPT1 and WEE1. Part of a regulatory circuit that promotes the activation of CDK1 by phosphorylating the positive regulator CDC25C and inhibiting the negative regulators WEE1 and PKMYT1/MYT1. Also acts by mediating phosphorylation of cyclin-B1 (CCNB1) on centrosomes in prophase. Phosphorylates FOXM1, a key mitotic transcription regulator, leading to enhance FOXM1 transcriptional activity. Involved in kinetochore functions and sister chromatid cohesion by phosphorylating BUB1B/BUBR1, FBXO5/EMI1 and STAG2/SA2. PLK1 is high on non-attached kinetochores suggesting a role of PLK1 in kinetochore attachment or in spindle assembly checkpoint (SAC) regulation. Required for kinetochore localization of BUB1B. Regulates the dissociation of cohesin from chromosomes by phosphorylating cohesin subunits such as STAG2/SA2. Phosphorylates SGO1: required for spindle pole localization of isoform 3 of SGO1 and plays a role in regulating its centriole cohesion function. Mediates phosphorylation of FBXO5/EMI1, a negative regulator of the APC/C complex during prophase, leading to FBXO5/EMI1 ubiquitination and degradation by the proteasome. Acts as a negative regulator of p53 family members: phosphorylates TOPORS, leading to inhibit the sumoylation of p53/TP53 and simultaneously enhance the ubiquitination and subsequent degradation of p53/TP53. Phosphorylates the transactivation domain of the transcription factor p73/TP73, leading to inhibit p73/TP73-mediated transcriptional activation and pro-apoptotic functions. Phosphorylates BORA, and thereby promotes the degradation of BORA. Contributes to the regulation of AURKA function. Also required for recovery after DNA damage checkpoint and entry into mitosis. Phosphorylates MISP, leading to stabilization of cortical and astral microtubule attachments required for proper spindle positioning (PubMed:8991084, PubMed:11202906, PubMed:12207013, PubMed:12447691, PubMed:12524548, PubMed:12738781, PubMed:12852856, PubMed:12939256, PubMed:14532005, PubMed:14734534, PubMed:15070733, PubMed:15148369, PubMed:15469984, PubMed:16198290, PubMed:16247472, PubMed:16980960, PubMed:17081991, PubMed:17351640, PubMed:17376779, PubMed:17617734, PubMed:18174154, PubMed:18331714, PubMed:18418051, PubMed:18477460, PubMed:18521620, PubMed:18615013, PubMed:19160488, PubMed:19351716, PubMed:19468300, PubMed:19468302, PubMed:19473992, PubMed:19509060, PubMed:19597481, PubMed:23455478, PubMed:23509069). Together with MEIKIN, acts as a regulator of kinetochore function during meiosis I: required both for mono-orientation of kinetochores on sister chromosomes and protection of centromeric cohesin from separase-mediated cleavage (By similarity). Phosphorylates CEP68 and is required for its degradation (PubMed:25503564). Regulates nuclear envelope breakdown during prophase by phosphorylating DCTN1 resulting in its localization in the nuclear envelope (PubMed:20679239). Phosphorylates the heat shock transcription factor HSF1, promoting HSF1 nuclear translocation upon heat shock (PubMed:15661742). Phosphorylates HSF1 also in the early mitotic period; this phosphorylation regulates HSF1 localization to the spindle pole, the recruitment of the SCF(BTRC) ubiquitin ligase complex induicing HSF1 degradation, and hence mitotic progression (PubMed:18794143). Regulates mitotic progression by phosphorylating RIOK2 (PubMed:21880710). {ECO:0000250|UniProtKB:Q5F2C3, ECO:0000269|PubMed:11202906, ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:12447691, ECO:0000269|PubMed:12524548, ECO:0000269|PubMed:12738781, ECO:0000269|PubMed:12852856, ECO:0000269|PubMed:12939256, ECO:0000269|PubMed:14532005, ECO:0000269|PubMed:14734534, ECO:0000269|PubMed:15070733, ECO:0000269|PubMed:15148369, ECO:0000269|PubMed:15469984, ECO:0000269|PubMed:15661742, ECO:0000269|PubMed:16198290, ECO:0000269|PubMed:16247472, ECO:0000269|PubMed:16980960, ECO:0000269|PubMed:17081991, ECO:0000269|PubMed:17351640, ECO:0000269|PubMed:17376779, ECO:0000269|PubMed:17617734, ECO:0000269|PubMed:18174154, ECO:0000269|PubMed:18331714, ECO:0000269|PubMed:18418051, ECO:0000269|PubMed:18477460, ECO:0000269|PubMed:18521620, ECO:0000269|PubMed:18615013, ECO:0000269|PubMed:18794143, ECO:0000269|PubMed:19160488, ECO:0000269|PubMed:19351716, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:19468302, ECO:0000269|PubMed:19473992, ECO:0000269|PubMed:19509060, ECO:0000269|PubMed:19597481, ECO:0000269|PubMed:20679239, ECO:0000269|PubMed:21880710, ECO:0000269|PubMed:23455478, ECO:0000269|PubMed:23509069, ECO:0000269|PubMed:25503564, ECO:0000269|PubMed:25986610, ECO:0000269|PubMed:8991084}.",,,,,,ACT_SITE 176 176 Proton acceptor. {ECO:0000269|PubMed:18615013}.,BINDING 82 82 ATP.; BINDING 131 131 ATP; via carbonyl oxygen.; BINDING 194 194 ATP.,,,NP_BIND 59 67 ATP.; NP_BIND 178 181 ATP.,,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]; anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell population proliferation [GO:0008283]; centrosome cycle [GO:0007098]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic nuclear envelope disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear envelope disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194],anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell population proliferation [GO:0008283]; centrosome cycle [GO:0007098]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic nuclear envelope disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear envelope disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194],anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795],GO:0000070; GO:0000086; GO:0000122; GO:0000278; GO:0000281; GO:0000287; GO:0000776; GO:0000785; GO:0000795; GO:0000922; GO:0000942; GO:0001578; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006468; GO:0007062; GO:0007077; GO:0007094; GO:0007098; GO:0007346; GO:0008017; GO:0008283; GO:0010389; GO:0010800; GO:0010997; GO:0015630; GO:0016301; GO:0016321; GO:0016567; GO:0018105; GO:0019901; GO:0030071; GO:0030496; GO:0031145; GO:0031648; GO:0032436; GO:0032465; GO:0034451; GO:0042802; GO:0043066; GO:0043393; GO:0045143; GO:0045184; GO:0045736; GO:0045862; GO:0051081; GO:0051233; GO:0051443; GO:0051726; GO:0070194; GO:0071168; GO:0072425; GO:0090435; GO:0097711; GO:1900182; GO:1901673; GO:1901990; GO:1902749; GO:1904668,IPR011009; IPR033702; IPR033701; IPR033695; IPR000959; IPR036947; IPR000719; IPR017441; IPR008271; ,Itself; Q99IB8; O14965; Q9Y2T1; Q9NR09; P54132; Q6PGQ7; P30307; Q99741; Q71F23-1; Q76N32; O96017; Q60838; P23588; Q2NKX8; O60447; Q13158; Q9NYZ3; P08107; O95251; P49736; P33993; Q00987; P23804; Q8TD19; O75665; Q8IXK0; Q9H0H5; Q8IY92; Q92844; P04637; Q12888; P70399-1,"SUBUNIT: Interacts with CEP170 and EVI5. Interacts and phosphorylates ERCC6L. Interacts with FAM29A. Interacts with SLX4/BTBD12 and TTDN1. Interacts with BUB1B. Interacts (via POLO-box domain) with the phosphorylated form of BUB1, CENPU and CDC25C. Interacts with isoform 3 of SGO1. Interacts with BORA, KIF2A and AURKA. Interacts with TOPORS and CYLD. Interacts with ECT2; the interaction is stimulated upon phosphorylation of ECT2 on 'Thr-444'. Interacts with PRC1. Interacts with KIF20A/MKLP2 (when phosphorylated), leading to the recruitment at the central spindle. Interacts (via POLO box domains) with PPP1R12A/MYPT1 (when previously phosphorylated by CDK1). Part of an astrin (SPAG5)-kinastrin (SKAP) complex containing KNSTRN, SPAG5, PLK1, DYNLL1 and SGO2. Interacts with BIRC6/bruce. Interacts with CDK1-phosphorylated FRY; this interaction occurs in mitotic cells, but not in interphase cells. FRY interaction facilitates AURKA-mediated PLK1 phosphorylation. Interacts with CDK1-phosphorylated DCTN6 during mitotic prometaphase; the interaction facilitates recruitment to kinetochores. Interacts with CEP68; the interaction phosphorylates CEP68 (PubMed:25503564). Interacts (via POLO-box domain) with DCTN1 (PubMed:20679239). Interacts with FOPNL in later G1, S, G2 and M phases of the cell cycle; this interaction recruits PLK1 to centrosomes, a step required for S phase progression (PubMed:24018379). Interacts with HSF1; this interaction increases upon heat shock but does not modulate neither HSF1 homotrimerization nor DNA-binding activities (PubMed:15661742, PubMed:18794143). Interacts with HNRNPU; this interaction induces phosphorylation of HNRNPU in mitosis (PubMed:25986610). Interacts (via its N-terminus) to RIOK2 (PubMed:21880710). Interacts with KLHL22 (PubMed:24067371, PubMed:23455478). {ECO:0000269|PubMed:12939256, ECO:0000269|PubMed:14532005, ECO:0000269|PubMed:14592974, ECO:0000269|PubMed:15616186, ECO:0000269|PubMed:15661742, ECO:0000269|PubMed:16247472, ECO:0000269|PubMed:16439210, ECO:0000269|PubMed:16760428, ECO:0000269|PubMed:17218258, ECO:0000269|PubMed:17307877, ECO:0000269|PubMed:17310276, ECO:0000269|PubMed:17495026, ECO:0000269|PubMed:18005335, ECO:0000269|PubMed:18329369, ECO:0000269|PubMed:18331714, ECO:0000269|PubMed:18391401, ECO:0000269|PubMed:18521620, ECO:0000269|PubMed:18662541, ECO:0000269|PubMed:18794143, ECO:0000269|PubMed:19029337, ECO:0000269|PubMed:19351716, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:19473992, ECO:0000269|PubMed:19596235, ECO:0000269|PubMed:19597481, ECO:0000269|PubMed:20679239, ECO:0000269|PubMed:21402792, ECO:0000269|PubMed:21880710, ECO:0000269|PubMed:22753416, ECO:0000269|PubMed:23455152, ECO:0000269|PubMed:23455478, ECO:0000269|PubMed:24018379, ECO:0000269|PubMed:24067371, ECO:0000269|PubMed:25503564, ECO:0000269|PubMed:25986610}.",8018557; 7902533; 7962193; 8127874; 15489334; 7478607; 9083047; 8991084; 11202906; 12207013; 12447691; 12442251; 12852856; 12639966; 12738781; 12939256; 12524548; 14654843; 14734534; 15469984; 15070733; 15148369; 16198290; 15661742; 15616186; 16439210; 16760428; 16980960; 16247472; 17081991; 16645325; 17981789; 17218258; 17617734; 17310276; 17376779; 17943598; 17351640; 17495026; 18794143; 18662541; 18329369; 18418051; 18521620; 18331714; 18477460; 18174154; 19029337; 18691976; 19160488; 18615013; 18669648; 19596235; 19473992; 19509060; 19351716; 19369195; 19468300; 19468302; 20671765; 20679239; 20068231; 21269460; 21880710; 21402792; 22753416; 22814378; 24067371; 24018379; 23455152; 23509069; 23186163; 23455478; 25986610; 25503564; 28112733; 14532005; 14592974; 17461553; 18005335; 17307877; 18391401; 19597481; 17344846,8018557; 7902533; 7962193; 8127874; 15489334; 7478607; 9083047; 8991084; 11202906; 12207013; 12447691; 12442251; 12852856; 12639966; 12738781; 12939256; 12524548; 14654843; 14734534; 15469984; 15070733; 15148369; 16198290; 15661742; 15616186; 16439210; 16760428; 16980960; 16247472; 17081991; 16645325; 17981789; 17218258; 17617734; 17310276; 17376779; 17943598; 17351640; 17495026; 18794143; 18662541; 18329369; 18418051; 18521620; 18331714; 18477460; 18174154; 19029337; 18691976; 19160488; 18615013; 18669648; 19596235; 19473992; 19509060; 19351716; 19369195; 19468300; 19468302; 20671765; 20679239; 20068231; 21269460; 21880710; 21402792; 22753416; 22814378; 24067371; 24018379; 23455152; 23509069; 23186163; 23455478; 25986610; 25503564; 28112733; 14532005; 14592974; 17461553; 18005335; 17307877; 18391401; 19597481; 17344846; 10395539; 10733526; 11076968; 11081627; 11181178; 11447294; 11509732; 11804586; 11854496; 11859075; 11897663; 11931760; 11956313; 12006501; 12034729; 12077309; 12082631; 12147700; 12194817; 12221128; 12364337; 12429910; 12446569; 12493754; 12592388; 12595692; 12679384; 12708489; 12732729; 12815053; 12839990; 12852857; 13678582; 14580337; 14654792; 14657031; 14730319; 14735186; 15015605; 15037762; 15085137; 15105433; 15125835; 15141022; 15176053; 15190079; 15199097; 15210710; 15280449; 15339662; 15350223; 15458642; 15498487; 15611664; 15654075; 15661849; 15664519; 15678101; 15678131; 15705883; 15713655; 15723797; 15737063; 15855824; 15876876; 15923617; 16079175; 16127294; 16129782; 16157594; 16169070; 16237758; 16260496; 16267267; 16357211; 16378098; 16413484; 16462731; 16469711; 16478733; 16541025; 16580887; 16582488; 16622419; 16622420; 16630118; 16648550; 16753148; 16837776; 16860740; 16865274; 16873548; 16890155; 16927022; 16930555; 16934469; 16966375; 17005603; 17030981; 17102638; 17121839; 17121863; 17129783; 17253180; 17265445; 17314511; 17351902; 17360533; 17434144; 17446864; 17476331; 17488623; 17574030; 17610829; 17623655; 17635521; 17646400; 17671160; 17719545; 17721511; 18037885; 18056432; 18062778; 18097444; 18171681; 18250300; 18278450; 18297112; 18298087; 18298903; 18353325; 18367646; 18378770; 18427546; 18547964; 18560274; 18566290; 18616938; 18625707; 18676680; 18694559; 18694934; 18695677; 18716626; 18820703; 18922800; 18950845; 18957422; 18980975; 19004025; 19004860; 19033445; 19124460; 19152411; 19170196; 19177004; 19383823; 19386263; 19400994; 19452252; 19458358; 19487276; 19503101; 19543530; 19546225; 19554017; 19572149; 19615732; 19625176; 19631697; 19668228; 19690138; 19692168; 19706541; 19725153; 19738611; 19739117; 19775446; 19804365; 19821153; 19822658; 19833129; 19855194; 19940019; 19965387; 20083603; 20089605; 20103597; 20130082; 20145140; 20146883; 20170163; 20198330; 20214750; 20230748; 20360068; 20373286; 20397705; 20399632; 20404504; 20427271; 20467437; 20470222; 20484576; 20508983; 20511645; 20534861; 20558667; 20562859; 20573420; 20577264; 20581060; 20581453; 20615875; 20624902; 20624918; 20656208; 20664522; 20819778; 20823832; 20860994; 20869364; 20890306; 20937827; 20962589; 21041660; 21051298; 21051833; 21078677; 21079244; 21148584; 21169242; 21170987; 21184800; 21242189; 21253604; 21271384; 21273506; 21330050; 21347367; 21397845; 21399492; 21407176; 21422230; 21436619; 21454580; 21470862; 21472932; 21480320; 21498573; 21507953; 21519187; 21522128; 21533207; 21548880; 21565611; 21576470; 21602893; 21610149; 21620453; 21635870; 21636267; 21640712; 21642957; 21690413; 21723128; 21725307; 21726628; 21750699; 21765407; 21768102; 21792235; 21813642; 21816470; 21818122; 21857030; 21857149; 21878504; 21887822; 21890624; 21900206; 21947279; 21953073; 21978935; 21987589; 21988832; 22000864; 22064247; 22070629; 22094468; 22108192; 22115795; 22120675; 22154349; 22179047; 22184120; 22184200; 22188812; 22192978; 22202082; 22249248; 22262171; 22281053; 22292814; 22309939; 22314839; 22325354; 22365832; 22390279; 22391203; 22391450; 22405092; 22427657; 22467873; 22535524; 22566210; 22609948; 22621898; 22641346; 22648245; 22653443; 22653444; 22686412; 22701722; 22726585; 22730171; 22753241; 22795848; 22818914; 22820163; 22826617; 22863584; 22869522; 22885700; 22890325; 22892842; 22908307; 22918237; 22961729; 23037713; 23045552; 23046929; 23063527; 23079597; 23105120; 23135290; 23141531; 23141541; 23144294; 23188630; 23253480; 23345402; 23348840; 23359173; 23397142; 23400999; 23494182; 23498919; 23520509; 23525475; 23530209; 23566315; 23574746; 23615397; 23643811; 23661607; 23664874; 23695676; 23713868; 23747070; 23750008; 23753023; 23757039; 23769972; 23770244; 23789104; 23790466; 23792639; 23804033; 23887393; 23902751; 23921553; 23977272; 24032677; 24053599; 24067368; 24076372; 24089205; 24152729; 24166892; 24196446; 24204733; 24205328; 24223211; 24231678; 24255178; 24271645; 24327015; 24338364; 24349352; 24397932; 24407240; 24407358; 24412650; 24413556; 24427308; 24451569; 24469809; 24482237; 24484936; 24498222; 24501426; 24510904; 24519995; 24626184; 24706748; 24722282; 24771642; 24777477; 24785407; 24844881; 24874015; 24876664; 24893992; 24931513; 24982133; 25036634; 25047611; 25047839; 25169932; 25245035; 25246616; 25283071; 25313408; 25347203; 25347426; 25398439; 25430493; 25480943; 25483079; 25483104; 25486482; 25501367; 25504441; 25505174; 25505268; 25524551; 25532896; 25537513; 25563361; 25592872; 25607646; 25609649; 25659891; 25666058; 25670858; 25697066; 25714006; 25737075; 25754767; 25826089; 25830382; 25852190; 25855382; 25917079; 25925375; 25965828; 25975351; 26012549; 26047016; 26057687; 26070557; 26090465; 26114094; 26119734; 26124292; 26152807; 26171916; 26192437; 26206521; 26242183; 26259146; 26291670; 26293378; 26302797; 26317649; 26318737; 26323689; 26406118; 26468278; 26493360; 26496610; 26503893; 26513691; 26549165; 26557691; 26576650; 26577686; 26595675; 26608325; 26638075; 26647647; 26745677; 26786872; 26794530; 26820885; 26876462; 26919439; 27002166; 27003818; 27043190; 27064522; 27068477; 27102712; 27127172; 27160062; 27219065; 27220401; 27238966; 27245623; 27398835; 27409838; 27498003; 27504491; 27538997; 27557660; 27558135; 27568005; 27603133; 27647547; 27662907; 27712975; 27721411; 27773673; 27793694; 27831827; 27861885; 27965426; 27979967; 28036269; 28102733; 28126323; 28169164; 28178660; 28184925; 28235541; 28267710; 28283778; 28286049; 28314279; 28341486; 28346135; 28351953; 28387346; 28430578; 28445592; 28512243; 28591578; 28607002; 28652654; 28708135; 28820331; 28973348; 29138396; 29154753; 29166606; 29191835; 29254517; 29295989; 29348559; 29393385; 29549256; 29565459; 29652009; 29749476; 29843122; 29913237; 30069007; 30174151; 30277841; 7769006; 7790358; 8703070; 8838651,1996-10-01,2019-02-13,1996-10-01,215,X-ray crystallography (61),STRAND 42 46 {ECO:0000244|PDB:2RKU}.; STRAND 51 62 {ECO:0000244|PDB:2RKU}.; STRAND 65 72 {ECO:0000244|PDB:2RKU}.; STRAND 78 85 {ECO:0000244|PDB:2RKU}.; STRAND 116 121 {ECO:0000244|PDB:2RKU}.; STRAND 123 131 {ECO:0000244|PDB:2RKU}.; STRAND 182 184 {ECO:0000244|PDB:2RKU}.; STRAND 190 192 {ECO:0000244|PDB:2RKU}.; STRAND 224 226 {ECO:0000244|PDB:2V5Q}.; STRAND 392 394 {ECO:0000244|PDB:3P34}.; STRAND 411 417 {ECO:0000244|PDB:4X9R}.; STRAND 422 427 {ECO:0000244|PDB:4X9R}.; STRAND 432 436 {ECO:0000244|PDB:4X9R}.; STRAND 441 444 {ECO:0000244|PDB:4X9R}.; STRAND 448 454 {ECO:0000244|PDB:4X9R}.; STRAND 460 464 {ECO:0000244|PDB:4X9R}.; STRAND 511 516 {ECO:0000244|PDB:4X9R}.; STRAND 518 525 {ECO:0000244|PDB:4X9R}.; STRAND 530 534 {ECO:0000244|PDB:4X9R}.; STRAND 540 544 {ECO:0000244|PDB:4X9R}.; STRAND 549 553 {ECO:0000244|PDB:4X9R}.; STRAND 559 563 {ECO:0000244|PDB:4X9R}.; STRAND 593 595 {ECO:0000244|PDB:4O56}.; STRAND 598 602 {ECO:0000244|PDB:4O56}.,HELIX 86 88 {ECO:0000244|PDB:2RKU}.; HELIX 92 106 {ECO:0000244|PDB:2RKU}.; HELIX 138 145 {ECO:0000244|PDB:2RKU}.; HELIX 150 169 {ECO:0000244|PDB:2RKU}.; HELIX 179 181 {ECO:0000244|PDB:2RKU}.; HELIX 220 223 {ECO:0000244|PDB:2RKU}.; HELIX 231 246 {ECO:0000244|PDB:2RKU}.; HELIX 256 264 {ECO:0000244|PDB:2RKU}.; HELIX 276 285 {ECO:0000244|PDB:2RKU}.; HELIX 290 292 {ECO:0000244|PDB:2RKU}.; HELIX 296 301 {ECO:0000244|PDB:2RKU}.; HELIX 303 306 {ECO:0000244|PDB:2RKU}.; HELIX 316 319 {ECO:0000244|PDB:2RKU}.; HELIX 367 370 {ECO:0000244|PDB:5J19}.; HELIX 374 386 {ECO:0000244|PDB:4X9R}.; HELIX 389 391 {ECO:0000244|PDB:4X9R}.; HELIX 397 400 {ECO:0000244|PDB:4X9R}.; HELIX 403 405 {ECO:0000244|PDB:4X9R}.; HELIX 470 472 {ECO:0000244|PDB:4X9R}.; HELIX 473 488 {ECO:0000244|PDB:4X9R}.; HELIX 564 570 {ECO:0000244|PDB:4X9R}.; HELIX 574 591 {ECO:0000244|PDB:4X9R}.,TURN 47 50 {ECO:0000244|PDB:2RKU}.; TURN 73 75 {ECO:0000244|PDB:2RKU}.; TURN 418 421 {ECO:0000244|PDB:4X9R}.; TURN 465 467 {ECO:0000244|PDB:3Q1I}.; TURN 493 496 {ECO:0000244|PDB:4X9R}.; TURN 503 505 {ECO:0000244|PDB:3P34}.; TURN 526 528 {ECO:0000244|PDB:4WHL}.; TURN 535 537 {ECO:0000244|PDB:4X9R}.; TURN 545 548 {ECO:0000244|PDB:4X9R}.,,,,,5 out of 5,Active site (1); Beta strand (24); Binding site (3); Chain (1); Cross-link (3); Domain (3); Helix (22); Initiator methionine (1); Modified residue (11); Motif (1); Mutagenesis (20); Natural variant (8); Nucleotide binding (2); Region (3); Sequence conflict (12); Turn (9),,TISSUE SPECIFICITY: Placenta and colon.,,3D-structure;ATP-binding;Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Complete proteome;Cytoplasm;Cytoskeleton;Isopeptide bond;Kinase;Kinetochore;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase;Ubl conjugation,Evidence at protein level,reviewed,,"Protein kinase superfamily, Ser/Thr protein kinase family, CDC5/Polo subfamily",215,Activity regulation (1); Catalytic activity (2); Developmental stage (1); Domain (1); Function (1); Induction (1); Involvement in disease (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0067; KW-0131; KW-0132; KW-0137; KW-0158; KW-0181; KW-0206; KW-0418; KW-0498; KW-0539; KW-0547; KW-0597; KW-0621; KW-0677; KW-0723; KW-0808; KW-0832; KW-0963; KW-0995; KW-1017; KW-1185,,,,,"DISEASE: Note=Defects in PLK1 are associated with some cancers, such as gastric, thyroid or B-cell lymphomas. Expression is cancer increased in tumor tissues with a poor prognosis, suggesting a role in malignant transformations and carcinogenesis.",,,"PTM: Catalytic activity is enhanced by phosphorylation of Thr-210. Phosphorylation at Thr-210 is first detected on centrosomes in the G2 phase of the cell cycle, peaks in prometaphase and gradually disappears from centrosomes during anaphase. Dephosphorylation at Thr-210 at centrosomes is probably mediated by protein phosphatase 1C (PP1C), via interaction with PPP1R12A/MYPT1. Autophosphorylation and phosphorylation of Ser-137 may not be significant for the activation of PLK1 during mitosis, but may enhance catalytic activity during recovery after DNA damage checkpoint. Phosphorylated in vitro by STK10. {ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:12442251, ECO:0000269|PubMed:12639966, ECO:0000269|PubMed:18477460, ECO:0000269|PubMed:18615013}.; PTM: Ubiquitinated by the anaphase promoting complex/cyclosome (APC/C) in anaphase and following DNA damage, leading to its degradation by the proteasome. Ubiquitination is mediated via its interaction with FZR1/CDH1. Ubiquitination and subsequent degradation prevents entry into mitosis and is essential to maintain an efficient G2 DNA damage checkpoint. Monoubiquitination at Lys-492 by the BCR(KLHL22) ubiquitin ligase complex does not lead to degradation: it promotes PLK1 dissociation from phosphoreceptor proteins and subsequent removal from kinetochores, allowing silencing of the spindle assembly checkpoint (SAC) and chromosome segregation. {ECO:0000269|PubMed:18662541, ECO:0000269|PubMed:23455478}.",CHAIN 2 603 Serine/threonine-protein kinase PLK1. /FTId=PRO_0000086556.,CROSSLNK 19 19 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin). {ECO:0000269|PubMed:18662541}.; CROSSLNK 338 338 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 492 492 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin). {ECO:0000269|PubMed:23455478}.,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378}.,,"MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:22814378}.; MOD_RES 6 6 Phosphothreonine. {ECO:0000244|PubMed:18691976}.; MOD_RES 103 103 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 137 137 Phosphoserine. {ECO:0000305|PubMed:12207013}.; MOD_RES 210 210 Phosphothreonine; by AURKA. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:18477460, ECO:0000269|PubMed:18615013}.; MOD_RES 214 214 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195}.; MOD_RES 269 269 Phosphoserine; by autocatalysis. {ECO:0000250}.; MOD_RES 335 335 Phosphoserine. {ECO:0000269|PubMed:12442251}.; MOD_RES 375 375 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 450 450 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 498 498 Phosphothreonine. {ECO:0000244|PubMed:18691976}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U01038;L19559;X73458;X75932;BC002369;BC003002;BC014846;X90725;U78073;
0,P62136,PP1A_HUMAN,PPP1CA PPP1A,PPP1CA,PPP1A,,,Homo sapiens (Human),9606,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16),UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSDSEKLNLDSIIGRLLEVQGSRPGKNVQLTENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVQGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPADKNKGKYGQFSGLNPGGRPITPPRNSAKAKK,330,"37,512",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=P62136-1; Sequence=Displayed; Name=2; IsoId=P62136-2; Sequence=VSP_043377; Note=No experimental confirmation available.; Name=3; IsoId=P62136-3; Sequence=VSP_046754; Note=No experimental confirmation available. Gene prediction based on EST data.; ,,,,,,,,,,VAR_SEQ 18 18 E -> EGSRVLTPHCAP (in isoform 2). {ECO:0000303|PubMed:8384581}. /FTId=VSP_043377.; VAR_SEQ 19 62 Missing (in isoform 3). {ECO:0000305}. /FTId=VSP_046754.,,,,,,,1,,0,,SIMILARITY: Belongs to the PPP phosphatase family. PP-1 subfamily. {ECO:0000305}.,,,,,,,,3.1.3.16,,"CATALYTIC ACTIVITY: Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] + phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474, ChEBI:CHEBI:83421; EC=3.1.3.16; Evidence={ECO:0000269|PubMed:26083323}; CATALYTIC ACTIVITY: Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] + phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474, ChEBI:CHEBI:61977; EC=3.1.3.16; Evidence={ECO:0000269|PubMed:26083323};",COFACTOR: Name=Fe cation; Xref=ChEBI:CHEBI:24875; Evidence={ECO:0000250};  Note=Binds 1 Fe cation per subunit. {ECO:0000250}; COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:18992256};  Note=Binds 2 manganese ions per subunit. {ECO:0000269|PubMed:18992256};,,"FUNCTION: Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase 1 (PP1) is essential for cell division, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Involved in regulation of ionic conductances and long-term synaptic plasticity. May play an important role in dephosphorylating substrates such as the postsynaptic density-associated Ca(2+)/calmodulin dependent protein kinase II. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. Regulates NEK2 function in terms of kinase activity and centrosome number and splitting, both in the presence and absence of radiation-induced DNA damage. Regulator of neural tube and optic fissure closure, and enteric neural crest cell (ENCCs) migration during development. In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E. Dephosphorylates the 'Ser-418' residue of FOXP3 in regulatory T-cells (Treg) from patients with rheumatoid arthritis, thereby inactivating FOXP3 and rendering Treg cells functionally defective (PubMed:23396208). Dephosphorylates CENPA (PubMed:25556658). Dephosphorylates the 'Ser-139' residue of ATG16L1 causing dissociation of ATG12-ATG5-ATG16L1 complex, thereby inhibiting autophagy (PubMed:26083323). {ECO:0000269|PubMed:17283141, ECO:0000269|PubMed:21712997, ECO:0000269|PubMed:23396208, ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:26083323}.",,,,,,ACT_SITE 125 125 Proton donor. {ECO:0000250}.,,,METAL 64 64 Manganese 1. {ECO:0000250}.; METAL 66 66 Manganese 1. {ECO:0000250}.; METAL 92 92 Manganese.; METAL 92 92 Manganese 1. {ECO:0000250}.; METAL 92 92 Manganese 2. {ECO:0000250}.; METAL 124 124 Manganese.; METAL 124 124 Manganese 2. {ECO:0000250}.; METAL 173 173 Manganese.; METAL 173 173 Manganese 2. {ECO:0000250}.; METAL 248 248 Manganese.; METAL 248 248 Manganese 2. {ECO:0000250}.,,,cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; ribonucleoprotein complex binding [GO:0043021]; beta-catenin destruction complex disassembly [GO:1904886]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; dephosphorylation [GO:0016311]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; negative regulation of protein binding [GO:0032091]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; regulation of translational initiation by eIF2 alpha dephosphorylation [GO:0036496]; response to lead ion [GO:0010288],beta-catenin destruction complex disassembly [GO:1904886]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; dephosphorylation [GO:0016311]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; negative regulation of protein binding [GO:0032091]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; regulation of translational initiation by eIF2 alpha dephosphorylation [GO:0036496]; response to lead ion [GO:0010288],cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; ribonucleoprotein complex binding [GO:0043021],cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357],GO:0000164; GO:0004721; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005913; GO:0005977; GO:0005979; GO:0005981; GO:0006470; GO:0007049; GO:0008157; GO:0010288; GO:0016311; GO:0016791; GO:0030324; GO:0032091; GO:0032922; GO:0035970; GO:0036496; GO:0042587; GO:0042752; GO:0043021; GO:0043153; GO:0043197; GO:0043204; GO:0046872; GO:0048754; GO:0051301; GO:0060828; GO:0070062; GO:0070262; GO:0072357; GO:0098641; GO:0098793; GO:0098978; GO:1904886; GO:2001241,IPR004843; IPR029052; IPR037979; IPR006186; IPR031675; ,P31749; O14727; O15169; P38398; O95400; Q99459; P12830; Q8TEP8; Q9NX63; O08785; Q6PJW8; Q96S65; Q9H175; Q92796; P55199; Q9BZS1; P36313; Q8NG31; Q5S007; O00566; Q76TK5; Q96QC0; Q96KQ4; Q8WUF5; O75807; Q5SWA1; Q6NYC8; P41236; Q5T8A7; Q86WC6; Q6NXS1; Q7Z5V6; O75864; Q86XI6; Q9UQK1; Q15435; Q12972; Q12972-1; Q12972-2; O35867; Q96SB3; O35274; P60484; P06400; Q5UIP0; Q14684; A8K8P3; Q562F6; Q9H788; Q8TEC5; P63208; Q7Z699; Q9HCH5; Q14C87; Q13625; Q4KMQ1; Q8TEL6; P49815; P55072; Q9Y2W2; Q9H4A3; P16989; P49750; Q9HBF4; O95405,"SUBUNIT: PP1 comprises a catalytic subunit, PPP1CA, PPP1CB or PPP1CC, which is folded into its native form by inhibitor 2 and glycogen synthetase kinase 3, and then complexed to one or several targeting or regulatory subunits. PPP1R12A, PPP1R12B and PPP1R12C mediate binding to myosin. PPP1R3A (in skeletal muscle), PPP1R3B (in liver), PPP1R3C, PPP1R3D and PPP1R3F (in brain) mediate binding to glycogen. Interacts with PPP1R39 (By similarity). Interacts with BTBD10 (By similarity). Interacts with KCTD20 (By similarity). Interacts with PPP1R9A and PPP1R9B. Part of a complex containing PPP1R15B, PP1 and NCK1/2. Interacts with PHACTR4; which acts as an activator of PP1 activity (By similarity). Interacts with PPP1R15A and PPP1R15B; the interactions mediate binding to EIF2S1. Interacts with PPP1R7. Interacts with YLPM1. Forms a complex with ILF2, ILF3, YLPM1, KHDRBS1, RBMX and NCOA5. Interacts with NOM1 and PPP1R8. Interacts with HHV-1 ICP34.5. Interacts with PPP1R16B. Interacts with RPSA only in the presence of PPP1R16B. Component of the PTW/PP1 phosphatase complex, composed of PPP1R10/PNUTS, TOX4, WDR82, and PPP1CA or PPP1CB or PPP1CC. Interacts with PPP1R10/PNUTS and PPP1R8. Interacts with WDR82 in the presence of PPP1R10/PNUTS. Interacts with TRIM28; the interaction dephosphorylates TRIM28 on 'Ser-824' and forms a complex at the p21 promoter site. Interacts with isoform 1 and isoform 4 of NEK2. Interacts with FER; this promotes phosphorylation at Thr-320. Interacts with DAB2; the interaction is mutually exclusive with the AXIN1:PPP1CA interaction. Interacts with FOXP3 (PubMed:23396208). Interacts with CENPA (PubMed:25556658). Interacts with ATG16L1 (PubMed:26083323). Found in a complex with PPP1CA, PPP1CC, SHC1 and PEAK1 (PubMed:23846654). {ECO:0000250|UniProtKB:P62137, ECO:0000250|UniProtKB:P62139, ECO:0000269|PubMed:11564868, ECO:0000269|PubMed:11739654, ECO:0000269|PubMed:12226088, ECO:0000269|PubMed:16263087, ECO:0000269|PubMed:16732323, ECO:0000269|PubMed:17283141, ECO:0000269|PubMed:17626005, ECO:0000269|PubMed:17890166, ECO:0000269|PubMed:17965019, ECO:0000269|PubMed:18992256, ECO:0000269|PubMed:19581931, ECO:0000269|PubMed:20305656, ECO:0000269|PubMed:20424263, ECO:0000269|PubMed:20516061, ECO:0000269|PubMed:23396208, ECO:0000269|PubMed:23846654, ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:26083323, ECO:0000269|PubMed:9023344}.",8392016; 8384581; 14702039; 16554811; 15489334; 2161401; 9023344; 11739654; 11564868; 12226088; 11839776; 16263087; 15705855; 16732323; 17890166; 17283141; 17626005; 17965019; 18088087; 18669648; 19377461; 20068231; 21269460; 22814378; 23186163; 24336203; 19581931; 20516061; 20424263; 21712997; 23846654; 23396208; 26083323; 25556658; 25944712; 18992256; 20305656,8392016; 8384581; 14702039; 16554811; 15489334; 2161401; 9023344; 11739654; 11564868; 12226088; 11839776; 16263087; 15705855; 16732323; 17890166; 17283141; 17626005; 17965019; 18088087; 18669648; 19377461; 20068231; 21269460; 22814378; 23186163; 24336203; 19581931; 20516061; 20424263; 21712997; 23846654; 23396208; 26083323; 25556658; 25944712; 18992256; 20305656; 10506210; 10719897; 10790862; 10807923; 10848614; 11165242; 11232563; 11320080; 11591712; 11779462; 11865049; 11875063; 12138106; 12202491; 12393858; 12434308; 12840032; 14633703; 14701732; 14718519; 14743216; 14750904; 15140983; 15231748; 15492829; 15767683; 15800623; 15817302; 15917222; 16550609; 16564677; 16619035; 16874461; 16983144; 17030510; 17202132; 17218255; 17274640; 17314511; 17318175; 17332742; 17435217; 17446270; 17511879; 17630778; 18068675; 18234856; 18400165; 18419299; 18483222; 18716057; 18755143; 18786386; 18842582; 18847512; 19074462; 19274088; 19364819; 19367725; 19389623; 19440292; 19463016; 19486527; 19622840; 19738201; 19805222; 19826001; 19919952; 19948962; 20186153; 20360068; 20467437; 20663907; 20694007; 21094159; 21106093; 21182205; 21189257; 21308747; 21331744; 21382349; 21427225; 21666598; 21706016; 21865402; 21909427; 21998301; 22220831; 22242915; 22284538; 22299668; 22311981; 22321011; 22360570; 22365833; 22479341; 22479519; 22623428; 22767595; 22810585; 22815811; 22940584; 22962028; 23176181; 23197154; 23277204; 23416715; 23455153; 23455922; 23499489; 23555304; 23606334; 23902751; 23937259; 24116158; 24255178; 24366813; 24574500; 24591642; 24939842; 25416956; 25474253; 25556058; 25604459; 25609649; 25852190; 25979969; 26033480; 26095357; 26116754; 26491017; 26496610; 26592247; 26636645; 26638075; 27105124; 27340655; 27469204; 27572260; 28202662; 28273463; 28296156; 28415748; 28576472; 28637872; 29156132; 29187447; 29257221; 30403291; 6087160; 9197238; 9755872,1988-08-01,2019-02-13,2004-06-21,167,X-ray crystallography (16),STRAND 51 55 {ECO:0000244|PDB:4MOV}.; STRAND 57 62 {ECO:0000244|PDB:4MOV}.; STRAND 87 89 {ECO:0000244|PDB:4MOV}.; STRAND 94 98 {ECO:0000244|PDB:4MOV}.; STRAND 118 120 {ECO:0000244|PDB:4MOV}.; STRAND 162 165 {ECO:0000244|PDB:4MOV}.; STRAND 169 171 {ECO:0000244|PDB:4MOV}.; STRAND 197 199 {ECO:0000244|PDB:4MOV}.; STRAND 214 218 {ECO:0000244|PDB:4MOV}.; STRAND 222 227 {ECO:0000244|PDB:4MOV}.; STRAND 242 246 {ECO:0000244|PDB:4MOV}.; STRAND 254 258 {ECO:0000244|PDB:4MOV}.; STRAND 263 267 {ECO:0000244|PDB:4MOV}.; STRAND 280 285 {ECO:0000244|PDB:4MOV}.; STRAND 291 296 {ECO:0000244|PDB:4MOV}.,HELIX 9 18 {ECO:0000244|PDB:4MOV}.; HELIX 32 48 {ECO:0000244|PDB:4MOV}.; HELIX 69 79 {ECO:0000244|PDB:4MOV}.; HELIX 100 113 {ECO:0000244|PDB:4MOV}.; HELIX 124 126 {ECO:0000244|PDB:6ALZ}.; HELIX 128 134 {ECO:0000244|PDB:4MOV}.; HELIX 136 143 {ECO:0000244|PDB:4MOV}.; HELIX 146 156 {ECO:0000244|PDB:4MOV}.; HELIX 184 187 {ECO:0000244|PDB:4MOV}.; HELIX 200 206 {ECO:0000244|PDB:4MOV}.; HELIX 229 239 {ECO:0000244|PDB:4MOV}.; HELIX 272 274 {ECO:0000244|PDB:4MOV}.,TURN 19 21 {ECO:0000244|PDB:4MOV}.; TURN 115 117 {ECO:0000244|PDB:4MOV}.; TURN 166 168 {ECO:0000244|PDB:4MOV}.; TURN 259 262 {ECO:0000244|PDB:4MOV}.,,,,,5 out of 5,Active site (1); Alternative sequence (2); Beta strand (15); Chain (1); Helix (12); Initiator methionine (1); Metal binding (11); Modified residue (7); Turn (4),"CAUTION: Was originally thought to be part of the MLL5-L complex, at least composed of KMT2E, STK38, PPP1CA, PPP1CB, PPP1CC, HCFC1, ACTB and OGT (PubMed:19377461). However, the corresponding article has been retracted (PubMed:24336203). {ECO:0000269|PubMed:19377461, ECO:0000269|PubMed:24336203}.",,,3D-structure;Acetylation;Alternative splicing;Carbohydrate metabolism;Cell cycle;Cell division;Complete proteome;Cytoplasm;Direct protein sequencing;Glycogen metabolism;Hydrolase;Manganese;Metal-binding;Nucleus;Phosphoprotein;Protein phosphatase;Reference proteome,Evidence at protein level,reviewed,,"PPP phosphatase family, PP-1 subfamily",167,Activity regulation (1); Alternative products (1); Catalytic activity (2); Caution (3); Cofactor (2); Function (1); Induction (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0025; KW-0119; KW-0131; KW-0132; KW-0181; KW-0321; KW-0378; KW-0464; KW-0479; KW-0539; KW-0597; KW-0903; KW-0904; KW-0963; KW-1185,,,,,,,,PTM: Phosphorylated. Dephosphorylated at Thr-320 in the presence of ionizing radiation. {ECO:0000269|PubMed:16732323}.,CHAIN 2 330 Serine/threonine-protein phosphatase PP1-alpha catalytic subunit. /FTId=PRO_0000058774.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378, ECO:0000269|Ref.8}.",,"MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:22814378, ECO:0000269|Ref.8}.; MOD_RES 2 2 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 22 22 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 305 305 N6-acetyllysine. {ECO:0000250|UniProtKB:P62137}.; MOD_RES 306 306 Phosphotyrosine. {ECO:0000250|UniProtKB:P62137}.; MOD_RES 320 320 Phosphothreonine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:16732323}.; MOD_RES 325 325 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X70848;S57501;M63960;AK313586;BT006629;BC001888;BC004482;BC008010;J04759;
0,P63167,DYL1_HUMAN,DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1,DYNLL1,DLC1 DNCL1 DNCLC1 HDLC1,,,Homo sapiens (Human),9606,"Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (DLC8) (Dynein light chain LC8-type 1) (Protein inhibitor of neuronal nitric oxide synthase) (PIN)",UP000005640: Chromosome 12,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MCDRKAVIKNADMSEEMQQDSVECATQALEKYNIEKDIAAHIKKEFDKKYNPTWHCIVGRNFGSYVTHETKHFIYFYLGQVAILLFKSG,89,"10,366",,,,,,,,,,,,,,,,,,,1,,0,,SIMILARITY: Belongs to the dynein light chain family. {ECO:0000305}.,,,,,REGION 67 89 Interaction with ESR1. {ECO:0000269|PubMed:15891768}.,,,,,,,,FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in changing or maintaining the spatial distribution of cytoskeletal structures.; FUNCTION: Binds and inhibits the catalytic activity of neuronal nitric oxide synthase.; FUNCTION: Promotes transactivation functions of ESR1 and plays a role in the nuclear localization of ESR1.; FUNCTION: Regulates apoptotic activities of BCL2L11 by sequestering it to microtubules. Upon apoptotic stimuli the BCL2L11-DYNLL1 complex dissociates from cytoplasmic dynein and translocates to mitochondria and sequesters BCL2 thus neutralizing its antiapoptotic activity.,,,,,,,,,,,,"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; ficolin-1-rich granule membrane [GO:0101003]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; enzyme binding [GO:0019899]; motor activity [GO:0003774]; nitric-oxide synthase regulator activity [GO:0030235]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; apoptotic process [GO:0006915]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; macroautophagy [GO:0016236]; motile cilium assembly [GO:0044458]; negative regulation of phosphorylation [GO:0042326]; neutrophil degranulation [GO:0043312]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spermatid development [GO:0007286]; substantia nigra development [GO:0021762]; viral process [GO:0016032]","antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; apoptotic process [GO:0006915]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; macroautophagy [GO:0016236]; motile cilium assembly [GO:0044458]; negative regulation of phosphorylation [GO:0042326]; neutrophil degranulation [GO:0043312]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spermatid development [GO:0007286]; substantia nigra development [GO:0021762]; viral process [GO:0016032]",dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; enzyme binding [GO:0019899]; motor activity [GO:0003774]; nitric-oxide synthase regulator activity [GO:0030235]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; ficolin-1-rich granule membrane [GO:0101003]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821],GO:0000086; GO:0000776; GO:0003774; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005886; GO:0005929; GO:0006888; GO:0006915; GO:0007286; GO:0008022; GO:0010389; GO:0016020; GO:0016032; GO:0016236; GO:0019886; GO:0019899; GO:0019904; GO:0021762; GO:0030235; GO:0030286; GO:0035721; GO:0035735; GO:0035774; GO:0042326; GO:0042803; GO:0043312; GO:0044458; GO:0045505; GO:0046982; GO:0051959; GO:0070821; GO:0072686; GO:0097110; GO:0097542; GO:0097711; GO:0101003; GO:1902857; GO:1904115; GO:2000582,IPR037177; IPR019763; IPR001372; ,Q9Y2J4-4; Q8IYA8; O96015; Q6P1L5; Q9NQX3; Q8NA54; Q63ZY3; P0CAP1; Q8TD19; P63244; P49901,"SUBUNIT: Homodimer. Monomer; the monomeric form is incapable of binding to target proteins. The cytoplasmic dynein 1 complex consists of two catalytic heavy chains (HCs) and a number of non-catalytic subunits presented by intermediate chains (ICs), light intermediate chains (LICs) and light chains (LCs); the composition seems to vary in respect to the IC, LIC and LC composition. The heavy chain homodimer serves as a scaffold for the probable homodimeric assembly of the respective non-catalytic subunits. The ICs and LICs bind directly to the HC dimer and the LCs assemble on the IC dimer. Interacts with TXNDC17. Interacts with WWC1 and ESR1. The WWC1-DYNLL1 interaction is mandatory for the recruitment and transactivation functions of ESR1 or DYNLL1 to the target chromatin. Interacts with BCL2L11 isoform 1 and isoform 2. Interacts with BCL2; the interaction is greatly enhanced in the nucleus and in mitochondria upon induction of apoptosis. Interacts with PAK1; the interaction requires dimeric DYNLL1. Interacts with MYZAP. Part of an astrin (SPAG5)-kinastrin (SKAP) complex containing KNSTRN, SPAG5, PLK1, DYNLL1 and SGO2. Interacts with ATMIN; this interaction inhibits ATMIN transcriptional activity and hence may play a role in a feedback loop whereby DYNLL1 inhibits transactivation of its own promoter by ATMIN. Interacts with NEK9 (not phosphorylated at 'Ser-944'). Interacts with BICD2 (By similarity). Interacts with BCAS1 (By similarity). {ECO:0000250|UniProtKB:P63168, ECO:0000250|UniProtKB:P63170, ECO:0000269|PubMed:10198631, ECO:0000269|PubMed:14607843, ECO:0000269|PubMed:15193260, ECO:0000269|PubMed:15891768, ECO:0000269|PubMed:16684779, ECO:0000269|PubMed:18084006, ECO:0000269|PubMed:18650427, ECO:0000269|PubMed:20412299, ECO:0000269|PubMed:21402792, ECO:0000269|PubMed:22167198, ECO:0000269|PubMed:23482567}.; SUBUNIT: (Microbial infection) Interacts with human spumaretrovirus Gag protein; this interaction is critical for intracellular microtubule-dependent viral genome transport toward the centrosome. {ECO:0000269|PubMed:12857789}.; SUBUNIT: (Microbial infection) Interacts with ebolavirus protein VP35; this interaction stabilizes VP35 N-terminal oligomerization domain and enhances viral RNA synthesis. {ECO:0000269|PubMed:25741013}.",8628263; 10198631; 12857789; 14654843; 15193260; 14607843; 15891768; 16684779; 18084006; 18650427; 19608861; 20412299; 21269460; 21402792; 22167198; 24275569; 25741013; 28112733; 10426949; 23482567,8628263; 10198631; 12857789; 14654843; 15193260; 14607843; 15891768; 16684779; 18084006; 18650427; 19608861; 20412299; 21269460; 21402792; 22167198; 24275569; 25741013; 28112733; 10426949; 23482567; 10036229; 10069812; 10559986; 10562278; 10679020; 10903204; 11035033; 11076968; 11081627; 11181178; 11285137; 11285270; 11306556; 11461920; 11483508; 11509732; 11804586; 11956313; 12006501; 12194817; 12198549; 12207013; 12221128; 12401177; 12447383; 12577067; 12591950; 12852856; 13678582; 14580337; 14730319; 15085137; 15231740; 15269286; 15339662; 15483056; 15489852; 15498487; 15504720; 15591061; 15611139; 15632110; 15705883; 15723797; 15728195; 15737063; 15878873; 16049494; 16098226; 16169070; 16357211; 16462731; 16492809; 16541025; 16622419; 16622420; 16723730; 16781079; 16782012; 16890155; 17012239; 17030981; 17129783; 17169380; 17274799; 17283181; 17312020; 17353931; 17446270; 17574030; 17646400; 17719545; 17827179; 18037885; 18046453; 18086915; 18097444; 18304522; 18420585; 18566290; 18579519; 18615013; 18664496; 18692162; 18694559; 18716626; 18767155; 18782753; 18850735; 18852297; 19004860; 19032974; 19147001; 19156129; 19289209; 19384852; 19450523; 19557173; 19564404; 19615732; 19720863; 19805633; 19863079; 19940019; 19965387; 20038533; 20230748; 20360068; 20379614; 20399632; 20444980; 20526328; 20530210; 20558667; 20562859; 20801876; 20889716; 20889982; 20921139; 20936810; 21094642; 21273506; 21347367; 21397845; 21422230; 21427764; 21454704; 21533121; 21548880; 21565611; 21620453; 21621319; 21725307; 21792235; 21878504; 21900206; 21936775; 21971545; 21987589; 21988832; 22094468; 22118932; 22179047; 22514732; 22653444; 22810585; 22885700; 22922713; 22965910; 22992454; 23027904; 23141531; 23141541; 23253480; 23293355; 23348840; 23400999; 23416715; 23455922; 23530209; 23589491; 23602568; 23650620; 23747070; 23769972; 23783758; 23789104; 23839779; 23853584; 23921553; 23945166; 23990561; 24053599; 24089205; 24189400; 24231678; 24255178; 24296415; 24366813; 24469809; 24596149; 24616010; 24806965; 24891604; 24982133; 25047611; 25205765; 25233431; 25272277; 25313408; 25416956; 25443296; 25453831; 25532896; 25568209; 25852190; 26157129; 26226419; 26496610; 26638075; 26652654; 26752685; 26923072; 27481317; 29240760; 30018294; 30261098; 7691276; 7769006; 7790358; 8516294; 8522608; 8642258; 8838651; 8909537; 8991093; 9114011; 9150144; 9288971; 9323141; 9380700; 9490716; 9585416; 9585417; 9671725; 9852153,2004-09-27,2019-02-13,2004-09-27,161,X-ray crystallography (5),STRAND 6 13 {ECO:0000244|PDB:6GZL}.; STRAND 32 34 {ECO:0000244|PDB:1CMI}.; STRAND 54 61 {ECO:0000244|PDB:6GZL}.; STRAND 63 69 {ECO:0000244|PDB:6GZL}.; STRAND 72 78 {ECO:0000244|PDB:6GZL}.; STRAND 81 87 {ECO:0000244|PDB:6GZL}.,HELIX 15 31 {ECO:0000244|PDB:6GZL}.; HELIX 35 50 {ECO:0000244|PDB:6GZL}.,,,,,,5 out of 5,Beta strand (6); Chain (1); Cross-link (1); Helix (2); Modified residue (2); Mutagenesis (3); Region (1),,TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:8628263}.,,3D-structure;Acetylation;Activator;Apoptosis;Complete proteome;Cytoplasm;Cytoskeleton;Dynein;Host-virus interaction;Isopeptide bond;Microtubule;Mitochondrion;Motor protein;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Transport;Ubl conjugation,Evidence at protein level,reviewed,,Dynein light chain family,161,Function (4); Induction (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (3); Tissue specificity (1),,KW-0002; KW-0007; KW-0010; KW-0053; KW-0181; KW-0206; KW-0243; KW-0493; KW-0496; KW-0505; KW-0539; KW-0597; KW-0804; KW-0805; KW-0813; KW-0832; KW-0945; KW-0963; KW-1017; KW-1185,,,,,,,,"PTM: Phosphorylation at Ser-88 appears to control the dimer-monomer transition. According to PubMed:15193260, it is phosphorylated at Ser-88 by PAK1, however, according to PubMed:18650427, the DYNLL1 dimer is not accessible for PAK1 and the phosphorylation could not be demonstrated in vitro. {ECO:0000269|PubMed:15193260}.","CHAIN 1 89 Dynein light chain 1, cytoplasmic. /FTId=PRO_0000195125.",CROSSLNK 43 43 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,,,MOD_RES 36 36 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 88 88 Phosphoserine. {ECO:0000269|PubMed:15193260}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U32944;CR407672;
0,Q8IZT6,ASPM_HUMAN,ASPM MCPH5,ASPM,MCPH5,,,Homo sapiens (Human),9606,Abnormal spindle-like microcephaly-associated protein (Abnormal spindle protein homolog) (Asp homolog),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MANRRVGRGCWEVSPTERRPPAGLRGPAAEEEASSPPVLSLSHFCRSPFLCFGDVLLGASRTLSLALDNPNEEVAEVKISHFPAADLGFSVSQRCFVLQPKEKIVISVNWTPLKEGRVREIMTFLVNDVLKHQAILLGNAEEQKKKKRSLWDTIKKKKISASTSHNRRVSNIQNVNKTFSVSQKVDRVRSPLQACENLAMNEGGPPTENNSLILEENKIPISPISPAFNECHGATCLPLSVRRSTTYSSLHASENRELLNVHSANVSKVSFNEKAVTETSFNSVNVNGQRGENSKLSLTPNCSSTLNITQSQIHFLSPDSFVNNSHGANNELELVTCLSSDMFMKDNSQPVHLESTIAHEIYQKILSPDSFIKDNYGLNQDLESESVNPILSPNQFLKDNMAYMCTSQQTCKVPLSNENSQVPQSPEDWRKSEVSPRIPECQGSKSPKAIFEELVEMKSNYYSFIKQNNPKFSAVQDISSHSHNKQPKRRPILSATVTKRKATCTRENQTEINKPKAKRCLNSAVGEHEKVINNQKEKEDFHSYLPIIDPILSKSKSYKNEVTPSSTTASVARKRKSDGSMEDANVRVAITEHTEVREIKRIHFSPSEPKTSAVKKTKNVTTPISKRISNREKLNLKKKTDLSIFRTPISKTNKRTKPIIAVAQSSLTFIKPLKTDIPRHPMPFAAKNMFYDERWKEKQEQGFTWWLNFILTPDDFTVKTNISEVNAATLLLGIENQHKISVPRAPTKEEMSLRAYTARCRLNRLRRAACRLFTSEKMVKAIKKLEIEIEARRLIVRKDRHLWKDVGERQKVLNWLLSYNPLWLRIGLETTYGELISLEDNSDVTGLAMFILNRLLWNPDIAAEYRHPTVPHLYRDGHEEALSKFTLKKLLLLVCFLDYAKISRLIDHDPCLFCKDAEFKASKEILLAFSRDFLSGEGDLSRHLGLLGLPVNHVQTPFDEFDFAVTNLAVDLQCGVRLVRTMELLTQNWDLSKKLRIPAISRLQKMHNVDIVLQVLKSRGIELSDEHGNTILSKDIVDRHREKTLRLLWKIAFAFQVDISLNLDQLKEEIAFLKHTKSIKKTISLLSCHSDDLINKKKGKRDSGSFEQYSENIKLLMDWVNAVCAFYNKKVENFTVSFSDGRVLCYLIHHYHPCYVPFDAICQRTTQTVECTQTGSVVLNSSSESDDSSLDMSLKAFDHENTSELYKELLENEKKNFHLVRSAVRDLGGIPAMINHSDMSNTIPDEKVVITYLSFLCARLLDLRKEIRAARLIQTTWRKYKLKTDLKRHQEREKAARIIQLAVINFLAKQRLRKRVNAALVIQKYWRRVLAQRKLLMLKKEKLEKVQNKAASLIQGYWRRYSTRQRFLKLKYYSIILQSRIRMIIAVTSYKRYLWATVTIQRHWRAYLRRKQDQQRYEMLKSSTLIIQSMFRKWKQRKMQSQVKATVILQRAFREWHLRKQAKEENSAIIIQSWYRMHKELRKYIYIRSCVVIIQKRFRCFQAQKLYKRRKESILTIQKYYKAYLKGKIERTNYLQKRAAAIQLQAAFRRLKAHNLCRQIRAACVIQSYWRMRQDRVRFLNLKKTIIKFQAHVRKHQQRQKYKKMKKAAVIIQTHFRAYIFAMKVLASYQKTRSAVIVLQSAYRGMQARKMYIHILTSVIKIQSYYRAYVSKKEFLSLKNATIKLQSTVKMKQTRKQYLHLRAAALFIQQCYRSKKIAAQKREEYMQMRESCIKLQAFVRGYLVRKQMRLQRKAVISLQSYFRMRKARQYYLKMYKAIIVIQNYYHAYKAQVNQRKNFLQVKKAATCLQAAYRGYKVRQLIKQQSIAALKIQSAFRGYNKRVKYQSVLQSIIKIQRWYRAYKTLHDTRTHFLKTKAAVISLQSAYRGWKVRKQIRREHQAALKIQSAFRMAKAQKQFRLFKTAALVIQQNFRAWTAGRKQCMEYIELRHAVLVLQSMWKGKTLRRQLQRQHKCAIIIQSYYRMHVQQKKWKIMKKAALLIQKYYRAYSIGREQNHLYLKTKAAVVTLQSAYRGMKVRKRIKDCNKAAVTIQSKYRAYKTKKKYATYRASAIIIQRWYRGIKITNHQHKEYLNLKKTAIKIQSVYRGIRVRRHIQHMHRAATFIKAMFKMHQSRISYHTMRKAAIVIQVRCRAYYQGKMQREKYLTILKAVKVLQASFRGVRVRRTLRKMQTAATLIQSNYRRYRQQTYFNKLKKITKTVQQRYWAMKERNIQFQRYNKLRHSVIYIQAIFRGKKARRHLKMMHIAATLIQRRFRTLMMRRRFLSLKKTAILIQRKYRAHLCTKHHLQFLQVQNAVIKIQSSYRRWMIRKRMREMHRAATFIQSTFRMHRLHMRYQALKQASVVIQQQYQANRAAKLQRQHYLRQRHSAVILQAAFRGMKTRRHLKSMHSSATLIQSRFRSLLVRRRFISLKKATIFVQRKYRATICAKHKLYQFLHLRKAAITIQSSYRRLMVKKKLQEMQRAAVLIQATFRMYRTYITFQTWKHASILIQQHYRTYRAAKLQRENYIRQWHSAVVIQAAYKGMKARQLLREKHKASIVIQSTYRMYRQYCFYQKLQWATKIIQEKYRANKKKQKVFQHNELKKETCVQAGFQDMNIKKQIQEQHQAAIIIQKHCKAFKIRKHYLHLRATVVSIQRRYRKLTAVRTQAVICIQSYYRGFKVRKDIQNMHRAATLIQSFYRMHRAKVDYETKKTAIVVIQNYYRLYVRVKTERKNFLAVQKSVRTIQAAFRGMKVRQKLKNVSEEKMAAIVNQSALCCYRSKTQYEAVQSEGVMIQEWYKASGLACSQEAEYHSQSRAAVTIQKAFCRMVTRKLETQKCAALRIQFFLQMAVYRRRFVQQKRAAITLQHYFRTWQTRKQFLLYRKAAVVLQNHYRAFLSAKHQRQVYLQIRSSVIIIQARSKGFIQKRKFQEIKNSTIKIQAMWRRYRAKKYLCKVKAACKIQAWYRCWRAHKEYLAILKAVKIIQGCFYTKLERTRFLNVRASAIIIQRKWRAILPAKIAHEHFLMIKRHRAACLIQAHYRGYKGRQVFLRQKSAALIIQKYIRAREAGKHERIKYIEFKKSTVILQALVRGWLVRKRFLEQRAKIRLLHFTAAAYYHLNAVRIQRAYKLYLAVKNANKQVNSVICIQRWFRARLQEKRFIQKYHSIKKIEHEGQECLSQRNRAASVIQKAVRHFLLRKKQEKFTSGIIKIQALWRGYSWRKKNDCTKIKAIRLSLQVVNREIREENKLYKRTALALHYLLTYKHLSAILEALKHLEVVTRLSPLCCENMAQSGAISKIFVLIRSCNRSIPCMEVIRYAVQVLLNVSKYEKTTSAVYDVENCIDILLELLQIYREKPGNKVADKGGSIFTKTCCLLAILLKTTNRASDVRSRSKVVDRIYSLYKLTAHKHKMNTERILYKQKKNSSISIPFIPETPVRTRIVSRLKPDWVLRRDNMEEITNPLQAIQMVMDTLGIPY,3477,"409,800",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q8IZT6-1; Sequence=Displayed; Name=2; IsoId=Q8IZT6-2; Sequence=VSP_010680; Note=No experimental confirmation available.; ,,SEQUENCE CAUTION:  Sequence=AAH34607.1; Type=Erroneous initiation; Evidence={ECO:0000305};  Sequence=BAA91676.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 1356 2940 Missing (in isoform 2). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:15972725}. /FTId=VSP_010680.","VARIANT 313 313 I -> V (in dbSNP:rs12025066). /FTId=VAR_047263.; VARIANT 430 430 R -> G (in dbSNP:rs6428388). /FTId=VAR_024369.; VARIANT 869 869 T -> S (in dbSNP:rs7551108). /FTId=VAR_046758.; VARIANT 1090 1090 S -> F (in dbSNP:rs16841081). {ECO:0000269|PubMed:15489334}. /FTId=VAR_046759.; VARIANT 2494 2494 Y -> H (in dbSNP:rs964201). {ECO:0000269|PubMed:12355089, ECO:0000269|PubMed:14704186, ECO:0000269|PubMed:16673149}. /FTId=VAR_046760.; VARIANT 2526 2526 N -> D (in dbSNP:rs587783267). {ECO:0000269|PubMed:16673149}. /FTId=VAR_071930.; VARIANT 2562 2562 S -> G (in dbSNP:rs41310927). {ECO:0000269|PubMed:14574646}. /FTId=VAR_019084.; VARIANT 2620 2620 Q -> H (in dbSNP:rs12138336). /FTId=VAR_046761.; VARIANT 2647 2647 L -> I (in dbSNP:rs3762271). {ECO:0000269|PubMed:14574646, ECO:0000269|PubMed:16673149, ECO:0000269|PubMed:18204051}. /FTId=VAR_019085.; VARIANT 3132 3132 L -> R (in dbSNP:rs36004306). {ECO:0000269|PubMed:14574646}. /FTId=VAR_019086.; VARIANT 3180 3180 Q -> P (in dbSNP:rs193251130). {ECO:0000269|PubMed:16673149, ECO:0000269|PubMed:27535533}. /FTId=VAR_071931.; VARIANT 3258 3258 H -> R (in dbSNP:rs7528827). /FTId=VAR_046762.",,,,CONFLICT 2355 2355 Q -> R (in Ref. 1; AAN40011 and 2; AAR12641). {ECO:0000305}.; CONFLICT 2977 2977 I -> V (in Ref. 7; BAA91676). {ECO:0000305}.; CONFLICT 3049 3049 F -> S (in Ref. 7; BAA91676). {ECO:0000305}.,,2,,0,,,COILED 1057 1078 {ECO:0000255}.,,DOMAIN 920 1056 Calponin-homology (CH) 1. {ECO:0000255|PROSITE-ProRule:PRU00044}.; DOMAIN 1110 1261 Calponin-homology (CH) 2. {ECO:0000255|PROSITE-ProRule:PRU00044}.; DOMAIN 1347 1378 IQ 1. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1393 1422 IQ 2. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1582 1613 IQ 3. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1632 1661 IQ 4. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1655 1684 IQ 5. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1728 1757 IQ 6. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1751 1782 IQ 7. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1801 1830 IQ 8. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1824 1853 IQ 9. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1874 1903 IQ 10. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1897 1928 IQ 11. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1947 1978 IQ 12. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1970 2001 IQ 13. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2020 2049 IQ 14. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2043 2074 IQ 15. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2093 2124 IQ 16. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2116 2147 IQ 17. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2166 2197 IQ 18. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2189 2218 IQ 19. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2239 2270 IQ 20. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2262 2293 IQ 21. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2311 2342 IQ 22. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2334 2365 IQ 23. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2384 2415 IQ 24. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2407 2438 IQ 25. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2457 2488 IQ 26. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2530 2561 IQ 27. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2624 2653 IQ 28. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2665 2696 IQ 29. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2688 2719 IQ 30. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2738 2767 IQ 31. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2859 2890 IQ 32. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2909 2938 IQ 33. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2932 2963 IQ 34. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 2954 2985 IQ 35. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 3029 3060 IQ 36. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 3079 3110 IQ 37. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 3181 3210 IQ 38. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 3204 3235 IQ 39. {ECO:0000255|PROSITE-ProRule:PRU00116}.,,REGION 308 409 Sufficient for interaction with KATNA1:KATNB1. {ECO:0000250|UniProtKB:Q8CJ27}.,,,,,,,,"FUNCTION: Involved in mitotic spindle regulation and coordination of mitotic processes. The function in regulating microtubule dynamics at spindle poles including spindle orientation, astral microtubule density and poleward microtubule flux seems to depend on the association with the katanin complex formed by KATNA1 and KATNB1. Enhances the microtubule lattice severing activity of KATNA1 by recruiting the katanin complex to microtubules. Can block microtubule minus-end growth and reversely this function can be enhanced by the katanin complex (PubMed:28436967). May have a preferential role in regulating neurogenesis. {ECO:0000269|PubMed:12355089, ECO:0000269|PubMed:15972725, ECO:0000269|PubMed:28436967}.",,,,,,,,,,,,apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle assembly involved in meiosis [GO:0090306]; spindle localization [GO:0051653]; spindle organization [GO:0007051],cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuronal stem cell population maintenance [GO:0097150]; neuron migration [GO:0001764]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle assembly involved in meiosis [GO:0090306]; spindle localization [GO:0051653]; spindle organization [GO:0007051],calmodulin binding [GO:0005516],apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634],GO:0001764; GO:0002052; GO:0005516; GO:0005634; GO:0005737; GO:0005813; GO:0007051; GO:0007283; GO:0008584; GO:0016324; GO:0021873; GO:0021987; GO:0030496; GO:0036449; GO:0045665; GO:0045769; GO:0048477; GO:0048589; GO:0051445; GO:0051653; GO:0051661; GO:0072687; GO:0090263; GO:0090306; GO:0097150; GO:0097431,IPR016024; IPR031549; IPR029955; IPR001715; IPR036872; IPR013783; IPR000048; IPR027417; ,,SUBUNIT: Interacts with KATNA1 and KATNB1; katanin complex formation KATNA1:KATNB1 is required for the association. {ECO:0000269|PubMed:28436967}.,12355089; 14704186; 15972725; 16710414; 15489334; 14702039; 14574646; 17081983; 18691976; 18669648; 19690332; 20068231; 22989186; 23186163; 28436967; 16673149; 18204051; 27535533,12355089; 14704186; 15972725; 16710414; 15489334; 14702039; 14574646; 17081983; 18691976; 18669648; 19690332; 20068231; 22989186; 23186163; 28436967; 16673149; 18204051; 27535533; 12571366; 15045028; 15355437; 16123590; 16141009; 16151010; 16687438; 17090670; 17220170; 17251122; 17353931; 17534152; 17566767; 17604569; 17849285; 18331833; 18452193; 18541031; 18636190; 18676753; 18728014; 19028728; 19332161; 19353628; 19770472; 19808985; 20080800; 20508983; 20694558; 21044324; 21150319; 21297427; 21633703; 21923303; 22529908; 22823409; 23300094; 23611254; 23887221; 23896173; 24830737; 24849541; 25796627; 26496610; 26691732; 27250695; 27562601; 27784895; 27876500; 27920410; 28004384; 28674240; 28883092; 29058117; 29431480,2004-07-05,2019-02-13,2008-11-25,162,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Coiled coil (1); Domain (41); Erroneous initiation (2); Modified residue (7); Natural variant (12); Region (1); Sequence conflict (4),,,,Alternative splicing;Calmodulin-binding;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Mental retardation;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Primary microcephaly;Reference proteome;Repeat,Evidence at protein level,reviewed,,,162,Alternative products (1); Caution (1); Function (1); Involvement in disease (1); Subcellular location (1); Subunit structure (1),,KW-0025; KW-0112; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0225; KW-0498; KW-0539; KW-0597; KW-0621; KW-0677; KW-0905; KW-0963; KW-0991; KW-1185,,,,,"DISEASE: Microcephaly 5, primary, autosomal recessive (MCPH5) [MIM:608716]: A disease defined as a head circumference more than 3 standard deviations below the age-related mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. Despite this marked reduction in size, the gyral pattern is relatively well preserved, with no major abnormality in cortical architecture. Affected individuals are mentally retarded. Primary microcephaly is further defined by the absence of other syndromic features or significant neurological deficits due to degenerative brain disorder. {ECO:0000269|PubMed:12355089, ECO:0000269|PubMed:14574646, ECO:0000269|PubMed:22989186}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 3477 Abnormal spindle-like microcephaly-associated protein. /FTId=PRO_0000191332.,,,,,,"MOD_RES 280 280 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 283 283 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 367 367 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 392 392 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231}.; MOD_RES 425 425 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 605 605 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1103 1103 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF509326;AY099890;AY099891;AY099892;AY099893;AY101201;AY367065;AY971956;CH471067;BC015396;BC034607;AK001411;
0,O00522,KRIT1_HUMAN,KRIT1 CCM1,KRIT1,CCM1,,,Homo sapiens (Human),9606,Krev interaction trapped protein 1 (Krev interaction trapped 1) (Cerebral cavernous malformations 1 protein),UP000005640: Chromosome 7,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGNPENIEDAYVAVIRPKNTASLNSREYRAKSYEILLHEVPIEGQKKKRKKVLLETKLQGNSEITQGILDYVVETTKPISPANQGIRGKRVVLMKKFPLDGEKMGREASLFIVPSVVKDNTKYTYTPGCPIFYCLQDIMRVCSESSTHFATLTARMLIALDKWLDERHAQSHFIPALFRPSPLERIKTNVINPAYATESGQTENSLHMGYSALEIKSKMLALEKADTCIYNPLFGSDLQYTNRVDKVVINPYFGLGAPDYSKIQIPKQEKWQRSMSSVTEDKERQWVDDFPLHRSACEGDSELLSRLLSERFSVNQLDSDHWAPIHYACWYGKVEATRILLEKGKCNPNLLNGQLSSPLHFAAGGGHAEIVQILLNHPETDRHITDQQGRSPLNICEENKQNNWEEAAKLLKEAINKPYEKVRIYRMDGSYRSVELKHGNNTTVQQIMEGMRLSQETQQYFTIWICSENLSLQLKPYHKPLQHVRDWPEILAELTNLDPQRETPQLFLRRDVRLPLEVEKQIEDPLAILILFDEARYNLLKGFYTAPDAKLITLASLLLQIVYGNYESKKHKQGFLNEENLKSIVPVTKLKSKAPHWTNRILHEYKNLSTSEGVSKEMHHLQRMFLQNCWEIPTYGAAFFTGQIFTKASPSNHKVIPVYVGVNIKGLHLLNMETKALLISLKYGCFMWQLGDTDTCFQIHSMENKMSFIVHTKQAGLVVKLLMKLNGQLMPTERNS,736,"84,348",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=O00522-1; Sequence=Displayed; Name=2; IsoId=O00522-2; Sequence=VSP_015800; Name=3; IsoId=O00522-3; Sequence=VSP_043327; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 1 207 Missing (in isoform 2). {ECO:0000303|PubMed:9285558}. /FTId=VSP_015800.; VAR_SEQ 283 330 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_043327.,VARIANT 97 97 F -> S (in CCM1). {ECO:0000269|PubMed:12172908}. /FTId=VAR_023573.; VARIANT 569 569 K -> E (in CCM1). {ECO:0000269|PubMed:12172908}. /FTId=VAR_023574.,,,,"CONFLICT 138 138 I -> T (in Ref. 5; AAQ94072). {ECO:0000305}.; CONFLICT 234 234 F -> G (in Ref. 1; AAB58582). {ECO:0000305}.; CONFLICT 731 731 P -> A (in Ref. 1; AAB58582, 2; AAG47774 and 5; AAQ94072). {ECO:0000305}.",,2,,0,"DOMAIN: The FERM domain mediates binding to RAP1A and RAP1B and is necessary for binding to phosphatidylinositol 4,5-bisphosphate (PIP2). {ECO:0000269|PubMed:23317506}.; DOMAIN: The N-terminal domain has structural similarity to the nudix hydrolase domain, despite the absence of a nudix box and low sequence similarity with nudix hydrolase domains. The N-terminus and the C-terminus part associate together via the NPAY binding motif and adopt a lose conformation that is disrupted by ITGB1BP1, but not by RAP1A. {ECO:0000269|PubMed:23317506}.; DOMAIN: Contains 4 ANK repeats that precede the FERM domain. {ECO:0000269|PubMed:26458359}.",,,,DOMAIN 420 734 FERM. {ECO:0000255|PROSITE-ProRule:PRU00084}.,,REGION 1 170 N-terminal domain similar to Nudix hydrolase domain.; REGION 172 195 Interaction with ITGB1BP1.; REGION 430 452 Interaction with RAP1B. {ECO:0000269|PubMed:22577140}.,REPEAT 287 316 ANK 1. {ECO:0000255}.; REPEAT 320 350 ANK 2. {ECO:0000255}.; REPEAT 354 383 ANK 3. {ECO:0000255}.; REPEAT 388 419 ANK 4. {ECO:0000255}.,,,,,,,"FUNCTION: Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity (By similarity). Negative regulator of angiogenesis. Inhibits endothelial proliferation, apoptosis, migration, lumen formation and sprouting angiogenesis in primary endothelial cells. Promotes AKT phosphorylation in a NOTCH-dependent and independent manner, and inhibits ERK1/2 phosphorylation indirectly through activation of the DELTA-NOTCH cascade. Acts in concert with CDH5 to establish and maintain correct endothelial cell polarity and vascular lumen and these effects are mediated by recruitment and activation of the Par polarity complex and RAP1B. Required for the localization of phosphorylated PRKCZ, PARD3, TIAM1 and RAP1B to the cell junction, and cell junction stabilization. Plays a role in integrin signaling via its interaction with ITGB1BP1; this prevents the interaction between ITGB1 and ITGB1BP1. Microtubule-associated protein that binds to phosphatidylinositol 4,5-bisphosphate (PIP2)-containing membranes in a GTP-bound RAP1-dependent manner. Plays an important role in the maintenance of the intracellular reactive oxygen species (ROS) homeostasis to prevent oxidative cellular damage. Regulates the homeostasis of intracellular ROS through an antioxidant pathway involving FOXO1 and SOD2. Facilitates the down-regulation of cyclin-D1 (CCND1) levels required for cell transition from proliferative growth to quiescence by preventing the accumulation of intracellular ROS through the modulation of FOXO1 and SOD2 levels. {ECO:0000250|UniProtKB:Q6S5J6, ECO:0000269|PubMed:11741838, ECO:0000269|PubMed:17916086, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:20616044, ECO:0000269|PubMed:20668652, ECO:0000269|PubMed:21633110, ECO:0000269|PubMed:23317506}.",,,,,,,,,,,,"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; GTPase regulator activity [GO:0030695]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; angiogenesis [GO:0001525]; cell redox homeostasis [GO:0045454]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; regulation of establishment of cell polarity [GO:2000114]; small GTPase mediated signal transduction [GO:0007264]",angiogenesis [GO:0001525]; cell redox homeostasis [GO:0045454]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; regulation of establishment of cell polarity [GO:2000114]; small GTPase mediated signal transduction [GO:0007264],"GTPase regulator activity [GO:0030695]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]",cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; microtubule [GO:0005874]; plasma membrane [GO:0005886],GO:0001525; GO:0001937; GO:0005546; GO:0005615; GO:0005737; GO:0005874; GO:0005886; GO:0005911; GO:0007264; GO:0008017; GO:0010596; GO:0016525; GO:0030695; GO:0044877; GO:0045454; GO:2000114; GO:2000352,IPR002110; IPR020683; IPR036770; IPR019749; IPR014352; IPR035963; IPR019748; IPR000299; IPR032022; IPR011993; ,Q9BSQ5; Q9BSQ5-1; Q9ULI3; O14713,"SUBUNIT: Interacts with CDH5 (PubMed:20332120). Found in a complex, at least composed of ITGB1BP1, KRIT1 and RAP1A. Interacts (via C-terminus FERM domain) with RAP1A (active GTP-bound form preferentially); the interaction does not induce the opening conformation of KRIT1. Interacts (via FERM domain) with RAP1B. Interacts (via N-terminus NPXY motif) with ITGB1BP1; the interaction induces the opening conformation of KRIT1 and competes with ITGB1 for ITGB1BP1 interaction. Interacts with HEG1 and CCM2; greatly facilitates CCM2-binding to HEG1. Associates (via N-terminus and C-terminus regions) with microtubules; the interaction is inhibited in presence of ITGB1BP1 and active GTP-bound RAP1A. {ECO:0000269|PubMed:11741838, ECO:0000269|PubMed:11854171, ECO:0000269|PubMed:17916086, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:21633110, ECO:0000269|PubMed:22577140, ECO:0000269|PubMed:23007647, ECO:0000269|PubMed:23317506, ECO:0000269|PubMed:9285558}.",9285558; 11161791; 11161805; 12172908; 14702039; 12853948; 15489334; 11342228; 11741838; 11854171; 17916086; 20332120; 20668652; 20616044; 21633110; 22577140; 23007647; 23317506; 26458359,9285558; 11161791; 11161805; 12172908; 14702039; 12853948; 15489334; 11342228; 11741838; 11854171; 17916086; 20332120; 20668652; 20616044; 21633110; 22577140; 23007647; 23317506; 26458359; 11831930; 11914398; 11941540; 12204286; 12682320; 12810002; 12877753; 15046662; 15079030; 15718512; 16239636; 16321204; 16373645; 16529293; 16712798; 16769843; 17043900; 17148043; 17290187; 17440989; 17657516; 17954608; 18300272; 18812969; 19088123; 19088124; 19092252; 19182478; 19199464; 19453802; 19454328; 19833796; 20306072; 20308363; 20379614; 20419355; 20689144; 20711500; 20798775; 20884211; 21029238; 22699465; 23485406; 23584803; 23695561; 23814056; 23872064; 24007869; 24058906; 24291398; 24466005; 24705002; 24714220; 25059659; 25086949; 25185960; 25203678; 25320085; 25413039; 25525273; 25707093; 25814554; 25923142; 26356566; 26643368; 27649701; 28000143; 28160210; 28255959; 28318403; 28867399; 28870584; 29169046,2001-04-27,2019-02-13,2005-10-11,179,X-ray crystallography (8),STRAND 9 17 {ECO:0000244|PDB:4DX8}.; STRAND 33 39 {ECO:0000244|PDB:4DX8}.; STRAND 54 57 {ECO:0000244|PDB:4DX8}.; STRAND 92 98 {ECO:0000244|PDB:4DX8}.; STRAND 107 114 {ECO:0000244|PDB:4DX8}.; STRAND 131 134 {ECO:0000244|PDB:4DX8}.; STRAND 186 191 {ECO:0000244|PDB:4JIF}.; STRAND 415 417 {ECO:0000244|PDB:5D68}.; STRAND 421 425 {ECO:0000244|PDB:4HDO}.; STRAND 431 435 {ECO:0000244|PDB:4HDO}.; STRAND 461 467 {ECO:0000244|PDB:4HDO}.; STRAND 470 473 {ECO:0000244|PDB:4HDO}.; STRAND 505 510 {ECO:0000244|PDB:4HDO}.; STRAND 572 574 {ECO:0000244|PDB:4HDO}.; STRAND 612 614 {ECO:0000244|PDB:3U7D}.; STRAND 638 645 {ECO:0000244|PDB:4HDO}.; STRAND 655 662 {ECO:0000244|PDB:4HDO}.; STRAND 664 671 {ECO:0000244|PDB:4HDO}.; STRAND 677 682 {ECO:0000244|PDB:4HDO}.; STRAND 685 690 {ECO:0000244|PDB:4HDO}.; STRAND 694 701 {ECO:0000244|PDB:4HDO}.; STRAND 706 711 {ECO:0000244|PDB:4HDO}.,HELIX 30 32 {ECO:0000244|PDB:4DX8}.; HELIX 64 75 {ECO:0000244|PDB:4DX8}.; HELIX 135 141 {ECO:0000244|PDB:4DX8}.; HELIX 151 170 {ECO:0000244|PDB:4DX8}.; HELIX 173 178 {ECO:0000244|PDB:4DX8}.; HELIX 182 185 {ECO:0000244|PDB:4JIF}.; HELIX 193 195 {ECO:0000244|PDB:4JIF}.; HELIX 291 297 {ECO:0000244|PDB:5D68}.; HELIX 301 309 {ECO:0000244|PDB:5D68}.; HELIX 324 330 {ECO:0000244|PDB:5D68}.; HELIX 334 342 {ECO:0000244|PDB:5D68}.; HELIX 358 364 {ECO:0000244|PDB:5D68}.; HELIX 368 376 {ECO:0000244|PDB:5D68}.; HELIX 392 399 {ECO:0000244|PDB:5D68}.; HELIX 404 412 {ECO:0000244|PDB:5D68}.; HELIX 439 441 {ECO:0000244|PDB:4HDO}.; HELIX 444 449 {ECO:0000244|PDB:4HDO}.; HELIX 455 458 {ECO:0000244|PDB:4HDO}.; HELIX 480 485 {ECO:0000244|PDB:4HDO}.; HELIX 487 494 {ECO:0000244|PDB:4HDO}.; HELIX 499 501 {ECO:0000244|PDB:4HDO}.; HELIX 516 519 {ECO:0000244|PDB:4HDO}.; HELIX 525 541 {ECO:0000244|PDB:4HDO}.; HELIX 548 563 {ECO:0000244|PDB:4HDO}.; HELIX 568 571 {ECO:0000244|PDB:4HDO}.; HELIX 578 581 {ECO:0000244|PDB:4HDO}.; HELIX 587 589 {ECO:0000244|PDB:4HDO}.; HELIX 594 596 {ECO:0000244|PDB:4HDO}.; HELIX 598 610 {ECO:0000244|PDB:4HDO}.; HELIX 618 629 {ECO:0000244|PDB:4HDO}.; HELIX 715 728 {ECO:0000244|PDB:4HDO}.,TURN 232 235 {ECO:0000244|PDB:4TKN}.; TURN 582 584 {ECO:0000244|PDB:4HDO}.; TURN 590 593 {ECO:0000244|PDB:4HDO}.; TURN 633 636 {ECO:0000244|PDB:4HDO}.; TURN 650 652 {ECO:0000244|PDB:4HDQ}.; TURN 672 674 {ECO:0000244|PDB:4HDO}.; TURN 702 705 {ECO:0000244|PDB:4HDO}.,,,,,5 out of 5,Alternative sequence (2); Beta strand (22); Chain (1); Domain (1); Helix (31); Mutagenesis (14); Natural variant (2); Region (3); Repeat (4); Sequence conflict (5); Turn (7),,TISSUE SPECIFICITY: Low levels in brain. Very weak expression found in heart and muscle. {ECO:0000269|PubMed:9285558}.,,3D-structure;ANK repeat;Alternative splicing;Angiogenesis;Cell junction;Cell membrane;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Membrane;Reference proteome;Repeat,Evidence at protein level,reviewed,,,179,Alternative products (1); Caution (1); Domain (3); Function (1); Involvement in disease (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0037; KW-0040; KW-0181; KW-0206; KW-0225; KW-0472; KW-0677; KW-0963; KW-0965; KW-1003; KW-1185,,,,,"DISEASE: Cerebral cavernous malformations 1 (CCM1) [MIM:116860]: A congenital vascular anomaly of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. The lesions are characterized by grossly enlarged blood vessels consisting of a single layer of endothelium and without any intervening neural tissue, ranging in diameter from a few millimeters to several centimeters. {ECO:0000269|PubMed:12172908}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 736 Krev interaction trapped protein 1. /FTId=PRO_0000067023.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U90268;U90269;AF310133;AF296765;AF388384;AY380057;AK055305;AC000120;BC094684;BC098442;AJ294850;AY993945;
0,O15066,KIF3B_HUMAN,KIF3B KIAA0359,KIF3B,KIAA0359,,,Homo sapiens (Human),9606,"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]",UP000005640: Chromosome 20,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSKLKSSESVRVVVRCRPMNGKEKAASYDKVVDVDVKLGQVSVKNPKGTAHEMPKTFTFDAVYDWNAKQFELYDETFRPLVDSVLQGFNGTIFAYGQTGTGKTYTMEGIRGDPEKRGVIPNSFDHIFTHISRSQNQQYLVRASYLEIYQEEIRDLLSKDQTKRLELKERPDTGVYVKDLSSFVTKSVKEIEHVMNVGNQNRSVGATNMNEHSSRSHAIFVITIECSEVGLDGENHIRVGKLNLVDLAGSERQAKTGAQGERLKEATKINLSLSALGNVISALVDGKSTHIPYRDSKLTRLLQDSLGGNAKTVMVANVGPASYNVEETLTTLRYANRAKNIKNKPRVNEDPKDALLREFQEEIARLKAQLEKRSIGRRKRREKRREGGGSGGGGEEEEEEGEEGEEEGDDKDDYWREQQEKLEIEKRAIVEDHSLVAEEKMRLLKEKEKKMEDLRREKDAAEMLGAKIKAMESKLLVGGKNIVDHTNEQQKILEQKRQEIAEQKRREREIQQQMESRDEETLELKETYSSLQQEVDIKTKKLKKLFSKLQAVKAEIHDLQEEHIKERQELEQTQNELTRELKLKHLIIENFIPLEEKSKIMNRAFFDEEEDHWKLHPITRLENQQMMKRPVSAVGYKRPLSQHARMSMMIRPEARYRAENIVLLELDMPSRTTRDYEGPAIAPKVQAALDAALQDEDEIQVDASSFESTANKKSKARPKSGRKSGSSSSSSGTPASQLYPQSRGLVPK,747,"85,125",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=O15066-1; Sequence=Displayed; Name=2; IsoId=O15066-2; Sequence=VSP_056489, VSP_056490; Note=No experimental confirmation available.; ",,SEQUENCE CAUTION:  Sequence=BAA20815.2; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 1 312 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_056489.; VAR_SEQ 375 436 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_056490.,,,,,,,1,,0,,SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family. Kinesin II subfamily. {ECO:0000255|PROSITE-ProRule:PRU00283}.,COILED 346 579 {ECO:0000255}.,COMPBIAS 386 393 Poly-Gly.; COMPBIAS 394 406 Poly-Glu.; COMPBIAS 723 730 Poly-Ser.,DOMAIN 9 340 Kinesin motor. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,REGION 580 747 Globular.,,,,,,,,FUNCTION: Involved in tethering the chromosomes to the spindle pole and in chromosome movement. Microtubule-based anterograde translocator for membranous organelles. Plus end-directed microtubule sliding activity in vitro (By similarity). {ECO:0000250}.,,,,,,,,,,NP_BIND 96 103 ATP.,,"axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]",axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819],GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0006890; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016887; GO:0016939; GO:0017048; GO:0019886; GO:0030496; GO:0032467; GO:0035735; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0120170; GO:1904115,IPR027640; IPR019821; IPR001752; IPR036961; IPR027417; ,O15013; P51795; Q92845,"SUBUNIT: Heterodimer of KIF3A and KIF3B. Interacts directly with IFT20 (By similarity). Interacts with the SMC3 subunit of the cohesin complex. {ECO:0000250|UniProtKB:Q61771, ECO:0000269|PubMed:9506951}.",9205841; 14702039; 11780052; 15489334; 9506951; 18669648; 22814378; 23186163; ,9205841; 14702039; 11780052; 15489334; 9506951; 18669648; 22814378; 23186163; 10036229; 10069812; 11285270; 11493604; 11739780; 12198549; 12368902; 12832475; 14504276; 15029241; 15231740; 15231748; 15269286; 15272311; 15326200; 15345558; 15489852; 16049494; 1607388; 16262723; 16298999; 16492809; 16571679; 16782012; 17008358; 17113389; 17283181; 17312020; 17574030; 18046453; 18304522; 18852297; 18957512; 19116309; 19147001; 19338388; 19339549; 19369418; 19384852; 19450523; 19564404; 19635168; 19720863; 19758564; 19805633; 19940036; 20005805; 20136777; 20462495; 20526328; 20530210; 20534429; 20889716; 2142332; 21427764; 21550981; 21871436; 21936775; 21988832; 22013193; 22118932; 22922713; 22992454; 23945166; 23990561; 24296415; 24368420; 24596149; 24616010; 25205765; 2521221; 2522352; 25364732; 25443296; 25588831; 26496610; 28161539; 28761002; 7528108; 7539720; 7559760; 7844144; 7929562; 8232586; 8516294; 8522608; 8602245; 8642258; 8710890; 8909537; 9114011; 9585416; 9585417; 9852153,1998-12-15,2019-02-13,1998-01-01,168,X-ray crystallography (1),STRAND 11 16 {ECO:0000244|PDB:3B6U}.; STRAND 32 35 {ECO:0000244|PDB:3B6U}.; STRAND 40 43 {ECO:0000244|PDB:3B6U}.; STRAND 55 58 {ECO:0000244|PDB:3B6U}.; STRAND 60 63 {ECO:0000244|PDB:3B6U}.; STRAND 90 97 {ECO:0000244|PDB:3B6U}.; STRAND 137 148 {ECO:0000244|PDB:3B6U}.; STRAND 151 154 {ECO:0000244|PDB:3B6U}.; STRAND 166 169 {ECO:0000244|PDB:3B6U}.; STRAND 173 176 {ECO:0000244|PDB:3B6U}.; STRAND 215 228 {ECO:0000244|PDB:3B6U}.; STRAND 235 245 {ECO:0000244|PDB:3B6U}.; STRAND 261 264 {ECO:0000244|PDB:3B6U}.; STRAND 307 317 {ECO:0000244|PDB:3B6U}.,HELIX 21 25 {ECO:0000244|PDB:3B6U}.; HELIX 69 75 {ECO:0000244|PDB:3B6U}.; HELIX 77 85 {ECO:0000244|PDB:3B6U}.; HELIX 102 106 {ECO:0000244|PDB:3B6U}.; HELIX 113 115 {ECO:0000244|PDB:3B6U}.; HELIX 118 131 {ECO:0000244|PDB:3B6U}.; HELIX 187 201 {ECO:0000244|PDB:3B6U}.; HELIX 208 213 {ECO:0000244|PDB:3B6U}.; HELIX 265 267 {ECO:0000244|PDB:3B6U}.; HELIX 270 283 {ECO:0000244|PDB:3B6U}.; HELIX 292 294 {ECO:0000244|PDB:3B6U}.; HELIX 296 300 {ECO:0000244|PDB:3B6U}.; HELIX 321 323 {ECO:0000244|PDB:3B6U}.; HELIX 324 337 {ECO:0000244|PDB:3B6U}.; HELIX 354 357 {ECO:0000244|PDB:3B6U}.,TURN 36 39 {ECO:0000244|PDB:3B6U}.; TURN 49 51 {ECO:0000244|PDB:3B6U}.; TURN 170 172 {ECO:0000244|PDB:3B6U}.; TURN 202 204 {ECO:0000244|PDB:3B6U}.; TURN 301 306 {ECO:0000244|PDB:3B6U}.,,,,,5 out of 5,Alternative sequence (2); Beta strand (14); Chain (2); Coiled coil (1); Compositional bias (3); Domain (1); Erroneous initiation (1); Helix (15); Initiator methionine (1); Modified residue (2); Nucleotide binding (1); Region (1); Turn (5),,,,3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell projection;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Microtubule;Motor protein;Nucleotide-binding;Reference proteome,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family, Kinesin II subfamily",168,Alternative products (1); Caution (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0025; KW-0067; KW-0175; KW-0181; KW-0206; KW-0493; KW-0505; KW-0547; KW-0963; KW-0966; KW-1185,,,,,,,,,"CHAIN 1 747 Kinesin-like protein KIF3B. /FTId=PRO_0000125395.; CHAIN 2 747 Kinesin-like protein KIF3B, N-terminally processed. /FTId=PRO_0000424495.",,,,INIT_MET 1 1 Removed; alternate. {ECO:0000244|PubMed:22814378}.,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 2 2 N-acetylserine; in Kinesin-like protein KIF3B, N-terminally processed. {ECO:0000244|PubMed:22814378}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB002357;AK299877;CH471077;CH471077;BC136310;BC136311;
0,O60447,EVI5_HUMAN,EVI5 NB4S,EVI5,NB4S,,,Homo sapiens (Human),9606,Ecotropic viral integration site 5 protein homolog (EVI-5) (Neuroblastoma stage 4S gene protein),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MVTNKMTAAFRNPSGKQVATDKVAEKLSSTLSWVKNTVSHTVSQMASQVASPSTSLHTTSSSTTLSTPALSPSSPSQLSPDDLELLAKLEEQNRLLETDSKSLRSVNGSRRNSGSSLVSSSSASSNLSHLEEDSWILWGRIVNEWEDVRKKKEKQVKELVHKGIPHHFRAIVWQLLCSAQSMPIKDQYSELLKMTSPCEKLIRRDIARTYPEHNFFKEKDSLGQEVLFNVMKAYSLVDREVGYCQGSAFIVGLLLMQMPEEEAFCVFVKLMQDYRLRELFKPSMAELGLCMYQFECMIQEHLPELFVHFQSQSFHTSMYASSWFLTIFLTTFPLPIATRIFDIFMSEGLEIVFRVGLALLQMNQAELMQLDMEGMLQHFQKVIPHQFDGVPDKLIQAAYQVKYNSKKMKKLEKEYTTIKTKEMEEQVEIKRLRTENRLLKQRIETLEKHKCSSNYNEDFVLQLEKELVQARLSEAESQCALKEMQDKVLDIEKRNNSLPDENNIARLQEELIAVKLREAEAIMGLKELRQQVKDLEEHWQRHLARTTGRWKDPPKKNAMNELQDELMTIRLREAETQAEIREIKQRMMEMETQNQINSNHLRRAEQEVISLQEKVQYLSAQNKGLLTQLSEAKRKQAEIECKNKEEVMAVRLREADSIAAVAELRQHIAELEIQKEEGKLQGQLNKSDSNQYIGELKDQIAELNHELRCLKGQRGFSGQPPFDGIHIVNHLIGDDESFHSSDEDFIDNSLQETGVGFPLHGKSGSMSLDPAVADGSESETEDSVLETRESNQVVQKERPPRRRESYSTTV,810,"92,949",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=O60447-1; Sequence=Displayed; Name=2; IsoId=O60447-2; Sequence=VSP_056828; ,,,,,,,,,,VAR_SEQ 448 448 K -> KESASLADRLIQ (in isoform 2). {ECO:0000303|PubMed:19077034}. /FTId=VSP_056828.,"VARIANT 82 82 D -> V (in dbSNP:rs1064580). {ECO:0000269|PubMed:19077034, ECO:0000269|PubMed:9618176}. /FTId=VAR_047753.; VARIANT 336 336 I -> V (in dbSNP:rs2391199). {ECO:0000269|PubMed:19077034, ECO:0000269|PubMed:9618176}. /FTId=VAR_028890.; VARIANT 612 612 Q -> H (in dbSNP:rs11808092). /FTId=VAR_028891.",,,,CONFLICT 94 94 R -> I (in Ref. 1; AAC16031 and 2; BAH16618). {ECO:0000305}.; CONFLICT 402 402 K -> Q (in Ref. 1; AAC16031). {ECO:0000305}.; CONFLICT 714 714 R -> K (in Ref. 1; AAC16031). {ECO:0000305}.,,3,,0,,,COILED 406 716 {ECO:0000255}.,COMPBIAS 28 128 Ser-rich.,DOMAIN 163 348 Rab-GAP TBC. {ECO:0000255|PROSITE-ProRule:PRU00163}.,,"REGION 1 483 Interaction with alpha-tubulin, gamma-tubulin, BIRC5 and FBXO5. {ECO:0000269|PubMed:16439210, ECO:0000269|PubMed:16764853}.; REGION 128 693 Dimerization.; REGION 377 810 Targeting to the centrosomes.; REGION 487 810 Interaction with AURKB and INCENP. {ECO:0000269|PubMed:16764853}.",,,,,,,,FUNCTION: Functions as a regulator of cell cycle progression by stabilizing the FBXO5 protein and promoting cyclin-A accumulation during interphase. May play a role in cytokinesis. {ECO:0000269|PubMed:16439210}.,,,,,,,,,,,SITE 594 594 Breakpoint for translocation to form EVI5-TRNG10 fusion protein.,"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular protein transport [GO:0006886]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]","activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular protein transport [GO:0006886]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]",GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819],GO:0005096; GO:0005634; GO:0005794; GO:0005815; GO:0005819; GO:0005829; GO:0006886; GO:0007049; GO:0017137; GO:0042147; GO:0043231; GO:0043547; GO:0051301; GO:0090630,IPR031214; IPR000195; IPR035969; ,Q12959; Q9UKT4; P53350; P62491,"SUBUNIT: Dimeric and monomeric. Interacts with alpha- and gamma-tubulin. Interacts with FBXO5. Interacts with the chromosome passenger complex (CPC) which is at least composed of AURKB/aurora-B, BIRC5/survivin, CDCA8/borealin and INCENP. {ECO:0000269|PubMed:16033705, ECO:0000269|PubMed:16439210, ECO:0000269|PubMed:16764853}.",9618176; 19077034; 16710414; 16033705; 16439210; 16764853; 18669648; 19413330; 23186163; 24275569,9618176; 19077034; 16710414; 16033705; 16439210; 16764853; 18669648; 19413330; 23186163; 24275569; 17229837; 18401352; 19506219; 19525955; 19834503; 19865102; 20008790; 20087403; 20711500; 23669355; 24130709; 25537516; 26433934; 26496610; 28765910; 29141798,2006-10-31,2019-02-13,2010-11-30,146,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (1); Domain (1); Modified residue (6); Natural variant (3); Region (4); Sequence conflict (4); Site (1),,"TISSUE SPECIFICITY: Expressed in various cell lines (at protein level). Expressed in a wide range of tissues including brain and adrenal. {ECO:0000269|PubMed:16033705, ECO:0000269|PubMed:9618176}.",MISCELLANEOUS: Depletion of EVI5 by RNAi causes cell cycle arrest and mitotic abnormalities.,Alternative splicing;Cell cycle;Cell division;Chromosomal rearrangement;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,,146,Alternative products (1); Function (1); Induction (1); Involvement in disease (1); Miscellaneous (1); Post-translational modification (2); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0131; KW-0132; KW-0160; KW-0175; KW-0181; KW-0206; KW-0539; KW-0597; KW-0621; KW-0832; KW-0963; KW-1185,,,,,DISEASE: Note=A chromosomal aberration involving EVI5 is found is a patient with stage 4S neuroblastoma. Translocation t(1;10)(p22;q21) that forms a EVI5-TRNG10 fusion protein. TRNG10 is a probable structural transcript which is normally not translated. {ECO:0000269|PubMed:9618176}.,,,PTM: Probably phosphorylated by PLK1; may be required for degradation during mitosis. {ECO:0000269|PubMed:16439210}.; PTM: Ubiquitinated. Degradation during prophase is ubiquitin-dependent. {ECO:0000269|PubMed:16439210}.,CHAIN 1 810 Ecotropic viral integration site 5 protein homolog. /FTId=PRO_0000256241.,,,,,,MOD_RES 102 102 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 113 113 Phosphoserine. {ECO:0000250|UniProtKB:P97366}.; MOD_RES 497 497 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 689 689 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 776 776 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 778 778 Phosphoserine. {ECO:0000250|UniProtKB:P97366}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF008915;AB449875;
0,O75154,RFIP3_HUMAN,RAB11FIP3 ARFO1 KIAA0665,RAB11FIP3,ARFO1 KIAA0665,,,Homo sapiens (Human),9606,Rab11 family-interacting protein 3 (FIP3-Rab11) (Rab11-FIP3) (Arfophilin-1) (EF hands-containing Rab-interacting protein) (Eferin) (MU-MB-17.148),UP000005640: Chromosome 16,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MASAPPASPPGSEPPGPDPEPGGPDGPGAAQLAPGPAELRLGAPVGGPDPQSPGLDEPAPGAAADGGARWSAGPAPGLEGGPRDPGPSAPPPRSGPRGQLASPDAPGPGPRSEAPLPELDPLFSWTEEPEECGPASCPESAPFRLQGSSSSHRARGEVDVFSPFPAPTAGELALEQGPGSPPQPSDLSQTHPLPSEPVGSQEDGPRLRAVFDALDGDGDGFVRIEDFIQFATVYGAEQVKDLTKYLDPSGLGVISFEDFYQGITAIRNGDPDGQCYGGVASAQDEEPLACPDEFDDFVTYEANEVTDSAYMGSESTYSECETFTDEDTSTLVHPELQPEGDADSAGGSAVPSECLDAMEEPDHGALLLLPGRPHPHGQSVITVIGGEEHFEDYGEGSEAELSPETLCNGQLGCSDPAFLTPSPTKRLSSKKVARYLHQSGALTMEALEDPSPELMEGPEEDIADKVVFLERRVLELEKDTAATGEQHSRLRQENLQLVHRANALEEQLKEQELRACEMVLEETRRQKELLCKMEREKSIEIENLQTRLQQLDEENSELRSCTPCLKANIERLEEEKQKLLDEIESLTLRLSEEQENKRRMGDRLSHERHQFQRDKEATQELIEDLRKQLEHLQLLKLEAEQRRGRSSSMGLQEYHSRARESELEQEVRRLKQDNRNLKEQNEELNGQIITLSIQGAKSLFSTAFSESLAAEISSVSRDELMEAIQKQEEINFRLQDYIDRIIVAIMETNPSILEVK,756,"82,440",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=O75154-1; Sequence=Displayed; Name=2; IsoId=O75154-2; Sequence=VSP_038664, VSP_038665; Note=No experimental confirmation available.; Name=3; IsoId=O75154-3; Sequence=VSP_038666; Note=No experimental confirmation available.; ",,SEQUENCE CAUTION:  Sequence=BAA31640.2; Type=Erroneous initiation; Evidence={ECO:0000305};  Sequence=BAG57098.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 1 296 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_038664.; VAR_SEQ 297 301 FVTYE -> MPFLK (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_038665.; VAR_SEQ 421 421 P -> PSTDPLAAKLHSILTDEAFEFYCSQCHKQINRLEDLSARLSDLEMN (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_038666.,,,,,,,1,,0,DOMAIN: The RBD-FIP domain mediates the interaction with Rab11 (RAB11A or RAB11B). {ECO:0000269|PubMed:17030804}.,,COILED 485 694 {ECO:0000255}.,COMPBIAS 5 197 Pro-rich.; COMPBIAS 148 151 Poly-Ser.; COMPBIAS 366 369 Poly-Leu.,DOMAIN 202 237 EF-hand 1. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 234 269 EF-hand 2. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 694 756 FIP-RBD. {ECO:0000255|PROSITE-ProRule:PRU00844}.,,REGION 484 588 ARF-binding domain (ABD).,,,,,,,,"FUNCTION: Acts as a regulator of endocytic traffic by participating in membrane delivery. Required for the abcission step in cytokinesis, possibly by acting as an 'address tag' delivering recycling endosome membranes to the cleavage furrow during late cytokinesis. Also required for the structural integrity of the endosomal recycling compartment during interphase. May play a role in breast cancer cell motility by regulating actin cytoskeleton. Acts as an adapter protein linking the dynein motor complex to various cargos and converts dynein from a non-processive to a highly processive motor in the presence of dynactin. Facilitates the interaction between dynein and dynactin and activates dynein processivity (the ability to move along a microtubule for a long distance without falling off the track) (PubMed:25035494). {ECO:0000269|PubMed:15601896, ECO:0000269|PubMed:17394487, ECO:0000269|PubMed:19327867, ECO:0000269|PubMed:25035494}.",,,,,,,,,,,,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; dynein light intermediate chain binding [GO:0051959]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; negative regulation of adiponectin secretion [GO:0070164]; protein localization to cilium [GO:0061512]; regulation of cytokinesis [GO:0032465]; vesicle-mediated transport [GO:0016192],cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; negative regulation of adiponectin secretion [GO:0070164]; protein localization to cilium [GO:0061512]; regulation of cytokinesis [GO:0032465]; vesicle-mediated transport [GO:0016192],ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; dynein light intermediate chain binding [GO:0051959]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137],centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],GO:0005509; GO:0005654; GO:0005768; GO:0005813; GO:0005815; GO:0005829; GO:0007049; GO:0016192; GO:0017137; GO:0030139; GO:0030306; GO:0030496; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0043231; GO:0045171; GO:0051301; GO:0051959; GO:0055037; GO:0055038; GO:0061512; GO:0070164,IPR011992; IPR002048; IPR037245; IPR019018; IPR032920; ,P18085; P62491; Q96QF0-2; Q9H0H5,"SUBUNIT: Homodimer. Forms a complex with Rab11 (RAB11A or RAB11B) and ARF6. Interacts with RAB11A; the interaction is direct. Interacts with RAB11B, RAB25 and RAB11FIP4. Interacts with ARF6; according to PubMed:16148947, it specifically interacts with ARF6 but not ARF5. Interacts with ARF6; according to PubMed:17030804 but not PubMed:16148947. Interacts with RACGAP1/MgcRacGAP; interaction takes place during late stage of cytokinesis and is required for recruitment to the midbody. Interacts with ASAP1 and EXOC7. Interacts with dynein intermediate chain and dynactin (DCTN1) (PubMed:25035494). {ECO:0000269|PubMed:11495908, ECO:0000269|PubMed:12470645, ECO:0000269|PubMed:15601896, ECO:0000269|PubMed:16148947, ECO:0000269|PubMed:17007872, ECO:0000269|PubMed:17030804, ECO:0000269|PubMed:17229837, ECO:0000269|PubMed:17628206, ECO:0000269|PubMed:18511905, ECO:0000269|PubMed:25035494}.",11481332; 9734811; 14702039; 11157797; 15616553; 15489334; 12800201; 11495908; 12470645; 15158446; 16148947; 15601896; 17628206; 17229837; 17394487; 18511905; 19327867; 22401586; 23186163; 25035494; 17007872; 17030804,11481332; 9734811; 14702039; 11157797; 15616553; 15489334; 12800201; 11495908; 12470645; 15158446; 16148947; 15601896; 17628206; 17229837; 17394487; 18511905; 19327867; 22401586; 23186163; 25035494; 17007872; 17030804; 12221131; 15158452; 16155582; 16431365; 17574030; 17646400; 18685082; 19017632; 19153612; 19297529; 19454479; 20083215; 20214888; 20308558; 20736163; 21273506; 21550243; 21565611; 22420621; 22433857; 22613832; 22983554; 23351793; 23567335; 24296415; 24591568; 24876499; 25673879; 26258637; 27154205; 28215104,2001-06-20,2019-02-13,1998-11-01,168,X-ray crystallography (5),,HELIX 704 709 {ECO:0000244|PDB:2HV8}.; HELIX 717 746 {ECO:0000244|PDB:2D7C}.; HELIX 750 753 {ECO:0000244|PDB:2D7C}.,,,,,,5 out of 5,Alternative sequence (3); Calcium binding (2); Chain (1); Coiled coil (1); Compositional bias (3); Domain (3); Erroneous initiation (2); Helix (3); Modified residue (8); Mutagenesis (5); Region (1),,,,3D-structure;Alternative splicing;Calcium;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Endosome;Membrane;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Transport,Evidence at protein level,reviewed,,,168,Alternative products (1); Caution (2); Domain (1); Function (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0106; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0472; KW-0479; KW-0597; KW-0677; KW-0813; KW-0963; KW-0967; KW-1185,,,,,,,,"PTM: Phosphorylated at Ser-102 by CDK1 during metaphase, and dephosphorylated as cells enter telophase. {ECO:0000269|PubMed:22401586}.",CHAIN 1 756 Rab11 family-interacting protein 3. /FTId=PRO_0000073879.,,,,,,"MOD_RES 52 52 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 102 102 Phosphoserine; by CDK1. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:22401586}.; MOD_RES 281 281 Phosphoserine. {ECO:0000269|PubMed:22401586}.; MOD_RES 348 348 Phosphoserine. {ECO:0000269|PubMed:22401586}.; MOD_RES 488 488 Phosphoserine. {ECO:0000269|PubMed:22401586}.; MOD_RES 538 538 Phosphoserine. {ECO:0000269|PubMed:22401586}.; MOD_RES 647 647 Phosphoserine. {ECO:0000269|PubMed:22401586}.; MOD_RES 648 648 Phosphoserine. {ECO:0000269|PubMed:22401586}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF395731;AB014565;AK293644;AK303061;AE006463;BC051360;AY130007;
0,O75410,TACC1_HUMAN,TACC1 KIAA1103,TACC1,KIAA1103,,,Homo sapiens (Human),9606,Transforming acidic coiled-coil-containing protein 1 (Gastric cancer antigen Ga55) (Taxin-1),UP000005640: Chromosome 8,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAFSPWQILSPVQWAKWTWSAVRGGAAGEDEAGGPEGDPEEEDSQAETKSLSFSSDSEGNFETPEAETPIRSPFKESCDPSLGLAGPGAKSQESQEADEQLVAEVVEKCSSKTCSKPSENEVPQQAIDSHSVKNFREEPEHDFSKISIVRPFSIETKDSTDISAVLGTKAAHGCVTAVSGKALPSSPPDALQDEAMTEGSMGVTLEASAEADLKAGNSCPELVPSRRSKLRKPKPVPLRKKAIGGEFSDTNAAVEGTPLPKASYHFSPEELDENTSPLLGDARFQKSPPDLKETPGTLSSDTNDSGVELGEESRSSPLKLEFDFTEDTGNIEARKALPRKLGRKLGSTLTPKIQKDGISKSAGLEQPTDPVARDGPLSQTSSKPDPSQWESPSFNPFGSHSVLQNSPPLSSEGSYHFDPDNFDESMDPFKPTTTLTSSDFCSPTGNHVNEILESPKKAKSRLITSGCKVKKHETQSLALDACSRDEGAVISQISDISNRDGHATDEEKLASTSCGQKSAGAEVKGEPEEDLEYFECSNVPVSTINHAFSSSEAGIEKETCQKMEEDGSTVLGLLESSAEKAPVSVSCGGESPLDGICLSESDKTAVLTLIREEIITKEIEANEWKKKYEETRQEVLEMRKIVAEYEKTIAQMIEDEQRTSMTSQKSFQQLTMEKEQALADLNSVERSLSDLFRRYENLKGVLEGFKKNEEALKKCAQDYLARVKQEEQRYQALKIHAEEKLDKANEEIAQVRTKAKAESAALHAGLRKEQMKVESLERALQQKNQEIEELTKICDELIAKLGKTD,805,"87,794",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=8;  Comment=Additional isoforms seem to exist.; Name=1; Synonyms=A, Long; IsoId=O75410-1; Sequence=Displayed; Name=2; Synonyms=F; IsoId=O75410-2; Sequence=VSP_012647; Name=3; Synonyms=E; IsoId=O75410-3; Sequence=VSP_012638; Name=4; Synonyms=D; IsoId=O75410-4; Sequence=VSP_012641, VSP_012642; Name=5; Synonyms=C; IsoId=O75410-5; Sequence=VSP_012639, VSP_012646; Name=6; Synonyms=Short; IsoId=O75410-6; Sequence=VSP_012644, VSP_012645; Name=7; IsoId=O75410-7; Sequence=VSP_012637, VSP_012643, VSP_012648; Name=8; IsoId=O75410-8; Sequence=VSP_012640; ",,,,,,,,,,"VAR_SEQ 1 651 Missing (in isoform 8). {ECO:0000303|Ref.3}. /FTId=VSP_012640.; VAR_SEQ 1 438 Missing (in isoform 5). {ECO:0000305}. /FTId=VSP_012639.; VAR_SEQ 1 426 Missing (in isoform 4). {ECO:0000305}. /FTId=VSP_012641.; VAR_SEQ 1 195 Missing (in isoform 3). {ECO:0000303|PubMed:12547166}. /FTId=VSP_012638.; VAR_SEQ 1 41 Missing (in isoform 7). {ECO:0000303|PubMed:15489334}. /FTId=VSP_012637.; VAR_SEQ 42 53 EDSQAETKSLSF -> MNNILKLK (in isoform 7). {ECO:0000303|PubMed:15489334}. /FTId=VSP_012643.; VAR_SEQ 54 54 S -> R (in isoform 6). {ECO:0000303|PubMed:15207008}. /FTId=VSP_012644.; VAR_SEQ 55 464 Missing (in isoform 6). {ECO:0000303|PubMed:15207008}. /FTId=VSP_012645.; VAR_SEQ 427 464 DPFKPTTTLTSSDFCSPTGNHVNEILESPKKAKSRLIT -> MGGSHSQTPRGREPAGERHPRPTETATTEQVKFLCFLL (in isoform 4). {ECO:0000305}. /FTId=VSP_012642.; VAR_SEQ 439 464 DFCSPTGNHVNEILESPKKAKSRLIT -> MGGSHSQTPRGREPAGERHPRPTETA (in isoform 5). {ECO:0000305}. /FTId=VSP_012646.; VAR_SEQ 464 464 T -> TTTEQVKFLCFLL (in isoform 2). {ECO:0000303|PubMed:10470851, ECO:0000303|PubMed:12087473}. /FTId=VSP_012647.; VAR_SEQ 525 553 Missing (in isoform 7). {ECO:0000303|PubMed:15489334}. /FTId=VSP_012648.",VARIANT 187 187 P -> L (in dbSNP:rs34235313). /FTId=VAR_053703.; VARIANT 243 243 I -> T (in dbSNP:rs6980553). /FTId=VAR_053704.; VARIANT 255 255 E -> G (in dbSNP:rs10107016). /FTId=VAR_053705.,,,,CONFLICT 291 291 L -> I (in Ref. 1; AAC32327). {ECO:0000305}.; CONFLICT 428 428 P -> H (in Ref. 6; AAH41391). {ECO:0000305}.; CONFLICT 588 588 G -> V (in Ref. 7; BAA83055). {ECO:0000305}.; CONFLICT 654 654 Missing (in Ref. 7; BAA83055). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the TACC family. {ECO:0000305}.,COILED 610 805,,DOMAIN 215 297 SPAZ 1.; DOMAIN 359 507 SPAZ 2.,MOTIF 226 241 Bipartite nuclear localization signal 1. {ECO:0000255}.; MOTIF 455 471 Bipartite nuclear localization signal 2. {ECO:0000255}.,REGION 2 55 Interaction with LSM7 and SNRPG. {ECO:0000269|PubMed:12165861}.; REGION 152 259 Interaction with TDRD7. {ECO:0000269|PubMed:14603251}.; REGION 206 427 Interaction with YEATS4. {ECO:0000269|PubMed:11903063}.; REGION 701 805 Interaction with CH-TOG.,,,,,,,,FUNCTION: Likely involved in the processes that promote cell division prior to the formation of differentiated tissues.,,,,,,,,,,,,cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052],cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052],,cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634],GO:0000226; GO:0005634; GO:0005737; GO:0005815; GO:0007052; GO:0008283; GO:0016020; GO:0021987; GO:0030496; GO:0051301,IPR039915; IPR007707; ,Q96GD4; A0A0S2Z507; B7Z3H4; Q9Y297; Q14008; P42858; Q9UK45; Q9Y316; Q9H788; P62308; Q13190; Q8NHU6; O43422; O95619,"SUBUNIT: Interacts with KIAA0097/CH-TOG and with the oncogenic transcription factor YEATS4. Interacts with AURKA, AURKB and AURKC. Interacts with LSM7, TDRD7 and SNRPG. Interacts with GCN5L2 and PCAF. {ECO:0000269|PubMed:11903063, ECO:0000269|PubMed:12165861, ECO:0000269|PubMed:14603251, ECO:0000269|PubMed:14767476, ECO:0000269|PubMed:15064709, ECO:0000269|PubMed:21531210}.",10435627; 15207008; 14702039; 15489334; 10470851; 12087473; 12547166; 11121038; 11903063; 12165861; 14603251; 14767476; 15064709; 15592455; 17081983; 17525332; 18669648; 19690332; 20068231; 21269460; 21531210; 23186163; 24275569; 25807930,10435627; 15207008; 14702039; 15489334; 10470851; 12087473; 12547166; 11121038; 11903063; 12165861; 14603251; 14767476; 15064709; 15592455; 17081983; 17525332; 18669648; 19690332; 20068231; 21269460; 21531210; 23186163; 24275569; 25807930; 12389629; 16496324; 17500595; 18984771; 20064372; 20078863; 20508983; 20711500; 20734064; 21516116; 21994455; 22837387; 23275563; 23354013; 23455924; 24358147; 25297519; 25416956; 26496610,2001-04-27,2019-02-13,2005-02-01,175,,,,,,,,,5 out of 5,Alternative sequence (12); Chain (1); Coiled coil (1); Domain (2); Initiator methionine (2); Lipidation (1); Modified residue (14); Motif (2); Mutagenesis (1); Natural variant (3); Region (4); Sequence conflict (4),,"TISSUE SPECIFICITY: Isoform 1, isoform 3 and isoform 5 are ubiquitous. Isoform 2 is strongly expressed in the brain, weakly detectable in lung and colon, and overexpressed in gastric cancer. Isoform 4 is not detected in normal tissues, but strong expression was found in gastric cancer tissues. Down-regulated in a subset of cases of breast cancer. {ECO:0000269|PubMed:12165861, ECO:0000269|PubMed:12547166}.",,Acetylation;Alternative splicing;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Lipoprotein;Membrane;Myristate;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat,Evidence at protein level,reviewed,,TACC family,175,Alternative products (1); Developmental stage (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (2); Subunit structure (1); Tissue specificity (1),,KW-0007; KW-0025; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0449; KW-0472; KW-0519; KW-0539; KW-0597; KW-0621; KW-0677; KW-0963; KW-1185,,,,,,,,"PTM: Isoform 1 is heavily phosphorylated; isoform 6 is not. {ECO:0000269|PubMed:12165861, ECO:0000269|PubMed:21531210}.",CHAIN 2 805 Transforming acidic coiled-coil-containing protein 1. /FTId=PRO_0000179986.,,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:20068231}.,,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:20068231}.; MOD_RES 4 4 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 10 10 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 44 44 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 147 147 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 153 153 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 228 228 Phosphoserine; by AURKC. {ECO:0000269|PubMed:21531210}.; MOD_RES 248 248 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 276 276 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 381 381 Phosphoserine. {ECO:0000250|UniProtKB:Q6Y685}.; MOD_RES 406 406 Phosphoserine. {ECO:0000250|UniProtKB:Q6Y685}.; MOD_RES 483 483 Phosphoserine. {ECO:0000250|UniProtKB:Q6Y685}.; MOD_RES 533 533 Phosphotyrosine. {ECO:0000244|PubMed:15592455}.; MOD_RES 591 591 Phosphoserine. {ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF049910;AY177411;AY139007;AK314620;CH471080;CH471080;CH471080;BC041391;AB029026;AY039239;AY072874;AY072875;AY072876;
0,O76070,SYUG_HUMAN,SNCG BCSG1 PERSYN PRSN,SNCG,BCSG1 PERSYN PRSN,,,Homo sapiens (Human),9606,Gamma-synuclein (Breast cancer-specific gene 1 protein) (Persyn) (Synoretin) (SR),UP000005640: Chromosome 10,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDVFKKGFSIAKEGVVGAVEKTKQGVTEAAEKTKEGVMYVGAKTKENVVQSVTSVAEKTKEQANAVSEAVVSSVNTVATKTVEEAENIAVTSGVVRKEDLRPSAPQQEGEASKEKEEVAEEAQSGGD,127,"13,331",,,,,,,,,,,,,"VARIANT 110 110 E -> V (in dbSNP:rs9864). {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9737786}. /FTId=VAR_007455.",,,,CONFLICT 13 13 E -> K (in Ref. 1; AAB64109). {ECO:0000305}.; CONFLICT 17 17 G -> D (in Ref. 4; AAL05870). {ECO:0000305}.; CONFLICT 68 68 E -> K (in Ref. 1; AAB64109). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the synuclein family. {ECO:0000305}.,,,,,REGION 20 67 4 X 11 AA tandem repeats of [EGSA]-K-T-K-[EQ]-[GQ]-V-X(4).,REPEAT 20 30 1.; REPEAT 31 41 2.; REPEAT 42 56 3; approximate.; REPEAT 57 67 4.,,,,,,,"FUNCTION: Plays a role in neurofilament network integrity. May be involved in modulating axonal architecture during development and in the adult. In vitro, increases the susceptibility of neurofilament-H to calcium-dependent proteases (By similarity). May also function in modulating the keratin network in skin. Activates the MAPK and Elk-1 signal transduction pathway (By similarity). {ECO:0000250}.",,,,,,,,,,,,axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; protein secretion [GO:0009306]; regulation of dopamine secretion [GO:0014059]; regulation of neurotransmitter secretion [GO:0046928]; synapse organization [GO:0050808],adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; protein secretion [GO:0009306]; regulation of dopamine secretion [GO:0014059]; regulation of neurotransmitter secretion [GO:0046928]; synapse organization [GO:0050808],,axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819],GO:0005737; GO:0005815; GO:0005819; GO:0007268; GO:0008344; GO:0009306; GO:0014059; GO:0030424; GO:0043025; GO:0046928; GO:0048471; GO:0050808; GO:0070062,IPR001058; IPR002462; ,P54274,SUBUNIT: May be a centrosome-associated protein. Interacts with MYOC; affects its secretion and its aggregation (By similarity). {ECO:0000250}.,9044857; 9700196; 9737786; 15489334; 10852916; 11746666; 18669648; 21269460,9044857; 9700196; 9737786; 15489334; 10852916; 11746666; 18669648; 21269460; 11585599; 11812782; 12072430; 12121974; 12559990; 12566312; 12783249; 12873981; 12970872; 14556204; 14576821; 15073123; 15591046; 15596044; 16596223; 16597821; 16786148; 16816827; 16821081; 16989287; 17016652; 17353931; 17369845; 17373700; 17534899; 17681534; 18498014; 18544996; 18728752; 18803290; 18849443; 19016751; 19351749; 19429025; 19706805; 19859996; 20043104; 20437261; 20577925; 20595634; 20604972; 20670935; 20697047; 21044950; 21117662; 21593311; 21740810; 21959308; 22015044; 22201822; 22294286; 22440249; 22905097; 23129765; 23242284; 23696021; 23696593; 23970348; 24040069; 24367999; 24431077; 24954510; 25142230; 25229320; 25400739; 25479371; 25499222; 25756178; 25956278; 25997706; 26191236; 26299756; 26496610; 26521046; 26976983; 27223068; 27655287; 27809878; 27926776; 28035067,1999-07-15,2019-02-13,2006-03-21,171,,,,,,,,,5 out of 5,Chain (1); Modified residue (3); Natural variant (1); Region (1); Repeat (4); Sequence conflict (3),,"TISSUE SPECIFICITY: Highly expressed in brain, particularly in the substantia nigra. Also expressed in the corpus callosum, heart, skeletal muscle, ovary, testis, colon and spleen. Weak expression in pancreas, kidney and lung.",,Complete proteome;Cytoplasm;Cytoskeleton;Phosphoprotein;Polymorphism;Reference proteome;Repeat,Evidence at protein level,reviewed,,Synuclein family,171,Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0181; KW-0206; KW-0597; KW-0621; KW-0677; KW-0963; KW-1185,,,,,,,,PTM: Phosphorylated. Phosphorylation by GRK5 appears to occur on residues distinct from the residue phosphorylated by other kinases. {ECO:0000269|PubMed:10852916}.,CHAIN 1 127 Gamma-synuclein. /FTId=PRO_0000184038.,,,,,,"MOD_RES 67 67 Phosphoserine. {ECO:0000250|UniProtKB:Q63544}.; MOD_RES 72 72 Phosphoserine. {ECO:0000250|UniProtKB:Q63544}.; MOD_RES 124 124 Phosphoserine; by BARK1, CaMK2 and CK2. {ECO:0000269|PubMed:10852916}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF010126;AF037207;AF017256;AF044311;AF411524;BC014098;
0,O76095,JTB_HUMAN,JTB HSPC222,JTB,,,HSPC222,Homo sapiens (Human),9606,Protein JTB (Jumping translocation breakpoint protein) (Prostate androgen-regulated protein) (PAR protein),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MLAGAGRPGLPQGRHLCWLLCAFTLKLCQAEAPVQEEKLSASTSNLPCWLVEEFVVAEECSPCSNFRAKTTPECGPTGYVEKITCSSSKRNEFKSCRSALMEQRLFWKFEGAVVCVALIFACLVIIRQRQLDRKALEKVRKQIESI,146,"16,358",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=O76095-1; Sequence=Displayed; Name=2; IsoId=O76095-2; Sequence=VSP_041400; ,,,,,,,,,,"VAR_SEQ 1 38 MLAGAGRPGLPQGRHLCWLLCAFTLKLCQAEAPVQEEK -> MAWGWHLSF (in isoform 2). {ECO:0000303|PubMed:11042152, ECO:0000303|PubMed:15489334}. /FTId=VSP_041400.",VARIANT 16 16 L -> F (in dbSNP:rs34686244). /FTId=VAR_033994.,,,,,,1,,0,,SIMILARITY: Belongs to the JTB family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Required for normal cytokinesis during mitosis. Plays a role in the regulation of cell proliferation. May be a component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Increases AURKB activity. Inhibits apoptosis induced by TGFB1 (By similarity). Overexpression induces swelling of mitochondria and reduces mitochondrial membrane potential (By similarity). {ECO:0000250, ECO:0000269|PubMed:21225229}.",,,,,,,,,,,,cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitochondrion [GO:0005739]; spindle [GO:0005819]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; positive regulation of protein kinase activity [GO:0045860],apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; positive regulation of protein kinase activity [GO:0045860],protein kinase binding [GO:0019901],cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitochondrion [GO:0005739]; spindle [GO:0005819],GO:0000278; GO:0000281; GO:0005737; GO:0005739; GO:0005815; GO:0005819; GO:0005887; GO:0006915; GO:0016020; GO:0019901; GO:0030496; GO:0045860,IPR008657; ,,"SUBUNIT: Interacts with AURKA, AURKB, BIRC5 and INCENP. May be a component of the CPC at least composed of BIRC5/survivin, CDCA8/borealin, INCENP and AURKB/Aurora-B. {ECO:0000269|PubMed:21225229}.",10321732; 10762645; 11042152; 14702039; 16710414; 15489334; 17369841; 21225229; 22079049,10321732; 10762645; 11042152; 14702039; 16710414; 15489334; 17369841; 21225229; 22079049; 12586295; 19487072; 19549727; 20711500; 21900206; 21988832; 22615844; 23297497,1999-07-15,2019-02-13,1998-11-01,146,NMR spectroscopy (1),STRAND 54 62 {ECO:0000244|PDB:2KJX}.; STRAND 79 85 {ECO:0000244|PDB:2KJX}.; STRAND 90 95 {ECO:0000244|PDB:2KJX}.,HELIX 65 70 {ECO:0000244|PDB:2KJX}.; HELIX 72 74 {ECO:0000244|PDB:2KJX}.; HELIX 98 101 {ECO:0000244|PDB:2KJX}.,TURN 49 51 {ECO:0000244|PDB:2KJX}.; TURN 75 77 {ECO:0000244|PDB:2KJX}.; TURN 86 89 {ECO:0000244|PDB:2KJX}.,,,TOPO_DOM 31 105 Extracellular. {ECO:0000255}.; TOPO_DOM 127 146 Cytoplasmic. {ECO:0000255}.,TRANSMEM 106 126 Helical. {ECO:0000255}.,5 out of 5,Alternative sequence (1); Beta strand (3); Chain (1); Helix (3); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"TISSUE SPECIFICITY: Ubiquitous. Expressed in all normal human tissues studied but overexpressed or underexpressed in many of their malignant counterparts. {ECO:0000269|PubMed:10321732, ECO:0000269|PubMed:10762645, ECO:0000269|PubMed:17369841, ECO:0000269|PubMed:21225229}.",,3D-structure;Alternative splicing;Apoptosis;Cell cycle;Cell division;Complete proteome;Cytoplasm;Cytoskeleton;Membrane;Mitochondrion;Mitosis;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix,Evidence at protein level,reviewed,,JTB family,146,Alternative products (1); Function (1); Induction (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0053; KW-0131; KW-0132; KW-0181; KW-0206; KW-0472; KW-0496; KW-0498; KW-0621; KW-0732; KW-0812; KW-0963; KW-1133; KW-1185,,,,,,,,,CHAIN 31 146 Protein JTB. /FTId=PRO_0000021535.,,,,,,,,,SIGNAL 1 30 {ECO:0000255}.,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB016492;AB016488;AB016493;AF115850;AF131797;AF151056;BT007285;CR456985;AK312106;CH471121;CH471121;CH471121;BC000499;BC000996;BC001363;BC001667;BC004239;BC019277;
0,O94806,KPCD3_HUMAN,PRKD3 EPK2 PRKCN,PRKD3,EPK2 PRKCN,,,Homo sapiens (Human),9606,Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSANNSPPSAQKSVLPTAIPAVLPAASPCSSPKTGLSARLSNGSFSAPSLTNSRGSVHTVSFLLQIGLTRESVTIEAQELSLSAVKDLVCSIVYQKFPECGFFGMYDKILLFRHDMNSENILQLITSADEIHEGDLVEVVLSALATVEDFQIRPHTLYVHSYKAPTFCDYCGEMLWGLVRQGLKCEGCGLNYHKRCAFKIPNNCSGVRKRRLSNVSLPGPGLSVPRPLQPEYVALPSEESHVHQEPSKRIPSWSGRPIWMEKMVMCRVKVPHTFAVHSYTRPTICQYCKRLLKGLFRQGMQCKDCKFNCHKRCASKVPRDCLGEVTFNGEPSSLGTDTDIPMDIDNNDINSDSSRGLDDTEEPSPPEDKMFFLDPSDLDVERDEEAVKTISPSTSNNIPLMRVVQSIKHTKRKSSTMVKEGWMVHYTSRDNLRKRHYWRLDSKCLTLFQNESGSKYYKEIPLSEILRISSPRDFTNISQGSNPHCFEIITDTMVYFVGENNGDSSHNPVLAATGVGLDVAQSWEKAIRQALMPVTPQASVCTSPGQGKDHKDLSTSISVSNCQIQENVDISTVYQIFADEVLGSGQFGIVYGGKHRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWREISGEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLREFETRIGERYITHESDDARWEIHAYTHNLVYPKHFIMAPNPDDMEEDP,890,"100,471",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=O94806-1; Sequence=Displayed; Name=2; IsoId=O94806-2; Sequence=VSP_029405, VSP_029406; ",,,,,,,,,,VAR_SEQ 595 611 HRKTGRDVAIKVIDKMR -> QLQPFAYCTHYFKNWKM (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_029405.; VAR_SEQ 612 890 Missing (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_029406.,VARIANT 42 42 N -> D (in dbSNP:rs11896614). /FTId=VAR_037147.; VARIANT 128 128 A -> T (in dbSNP:rs17852819). {ECO:0000269|PubMed:15489334}. /FTId=VAR_037148.; VARIANT 225 225 P -> S (in dbSNP:rs34280934). /FTId=VAR_050561.; VARIANT 445 445 L -> I (in dbSNP:rs55912911). /FTId=VAR_061532.; VARIANT 546 546 Q -> R (in dbSNP:rs17856887). {ECO:0000269|PubMed:15489334}. /FTId=VAR_037149.; VARIANT 716 716 V -> M (in a glioblastoma multiforme sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042336.,,,,,,1,,0,,SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. PKD subfamily. {ECO:0000305}.,,,DOMAIN 416 532 PH. {ECO:0000255|PROSITE-ProRule:PRU00145}.; DOMAIN 576 832 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,,ZN_FING 154 204 Phorbol-ester/DAG-type 1. {ECO:0000255|PROSITE-ProRule:PRU00226}.; ZN_FING 271 321 Phorbol-ester/DAG-type 2. {ECO:0000255|PROSITE-ProRule:PRU00226}.,2.7.11.13,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.13;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; ,,"FUNCTION: Converts transient diacylglycerol (DAG) signals into prolonged physiological effects, downstream of PKC. Involved in resistance to oxidative stress (By similarity). {ECO:0000250}.",,,,,,"ACT_SITE 699 699 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 605 605 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 582 590 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148],protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148],ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674],cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654],GO:0004674; GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007205; GO:0016020; GO:0016301; GO:0030148; GO:0046872; GO:0089700,IPR020454; IPR011009; IPR002219; IPR011993; IPR001849; IPR000719; IPR017441; IPR015727; IPR008271; ,P63027,,10231560; 15815621; 15489334; 16964243; 18076381; 18691976; 18669648; 19413330; 19369195; 20068231; 23186163; 17344846,10231560; 15815621; 15489334; 16964243; 18076381; 18691976; 18669648; 19413330; 19369195; 20068231; 23186163; 17344846; 12080077; 12506120; 12676944; 14743217; 15496505; 15824133; 16380377; 17196367; 17591919; 17889508; 18692497; 19264651; 19615732; 20621130; 20711500; 20813660; 20813663; 21900206; 21988832; 22893698; 22983445; 23393329; 23414517; 24265314; 24337579; 24606918; 24840177; 25136641; 25802335; 26253275; 26496610; 27662904; 28363424; 28656000,2001-01-11,2019-02-13,1999-05-01,177,NMR spectroscopy (1),STRAND 417 429 {ECO:0000244|PDB:2D9Z}.; STRAND 434 443 {ECO:0000244|PDB:2D9Z}.; STRAND 445 449 {ECO:0000244|PDB:2D9Z}.; STRAND 477 479 {ECO:0000244|PDB:2D9Z}.; STRAND 485 489 {ECO:0000244|PDB:2D9Z}.; STRAND 494 497 {ECO:0000244|PDB:2D9Z}.,HELIX 517 532 {ECO:0000244|PDB:2D9Z}.,TURN 462 464 {ECO:0000244|PDB:2D9Z}.; TURN 508 514 {ECO:0000244|PDB:2D9Z}.,,,,,5 out of 5,Active site (1); Alternative sequence (2); Beta strand (6); Binding site (1); Chain (1); Domain (2); Helix (1); Modified residue (18); Mutagenesis (8); Natural variant (6); Nucleotide binding (1); Turn (2); Zinc finger (2),,TISSUE SPECIFICITY: Ubiquitous.,,3D-structure;ATP-binding;Alternative splicing;Complete proteome;Cytoplasm;Kinase;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase;Zinc;Zinc-finger,Evidence at protein level,reviewed,,"Protein kinase superfamily, CAMK Ser/Thr protein kinase family, PKD subfamily",177,Activity regulation (1); Alternative products (1); Catalytic activity (2); Cofactor (1); Function (1); Sequence similarities (1); Subcellular location (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0067; KW-0181; KW-0418; KW-0460; KW-0472; KW-0479; KW-0547; KW-0597; KW-0621; KW-0677; KW-0723; KW-0808; KW-0862; KW-0863; KW-0963; KW-1185,,,,,,,,,CHAIN 1 890 Serine/threonine-protein kinase D3. /FTId=PRO_0000055717.,,,,,,"MOD_RES 6 6 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 27 27 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231}.; MOD_RES 37 37 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 41 41 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 44 44 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 213 213 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195}.; MOD_RES 216 216 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195}.; MOD_RES 364 364 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:23186163}.; MOD_RES 391 391 Phosphoserine. {ECO:0000250|UniProtKB:Q15139}.; MOD_RES 395 395 Phosphoserine. {ECO:0000250|UniProtKB:Q15139}.; MOD_RES 426 426 Phosphotyrosine. {ECO:0000250|UniProtKB:Q15139}.; MOD_RES 442 442 Phosphoserine. {ECO:0000250|UniProtKB:Q15139}.; MOD_RES 457 457 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9BZL6}.; MOD_RES 535 535 Phosphothreonine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195}.; MOD_RES 539 539 Phosphoserine. {ECO:0000250|UniProtKB:Q8K1Y2}.; MOD_RES 731 731 Phosphoserine; by PKC. {ECO:0000250|UniProtKB:Q15139}.; MOD_RES 735 735 Phosphoserine; by autocatalysis. {ECO:0000250|UniProtKB:Q15139}.; MOD_RES 742 742 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9BZL6}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB015982;AC007390;CH471053;CH471053;BC030706;
0,O95835,LATS1_HUMAN,LATS1 WARTS,LATS1,WARTS,,,Homo sapiens (Human),9606,Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts),UP000005640: Chromosome 6,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MKRSEKPEGYRQMRPKTFPASNYTVSSRQMLQEIRESLRNLSKPSDAAKAEHNMSKMSTEDPRQVRNPPKFGTHHKALQEIRNSLLPFANETNSSRSTSEVNPQMLQDLQAAGFDEDMVIQALQKTNNRSIEAAIEFISKMSYQDPRREQMAAAAARPINASMKPGNVQQSVNRKQSWKGSKESLVPQRHGPPLGESVAYHSESPNSQTDVGRPLSGSGISAFVQAHPSNGQRVNPPPPPQVRSVTPPPPPRGQTPPPRGTTPPPPSWEPNSQTKRYSGNMEYVISRISPVPPGAWQEGYPPPPLNTSPMNPPNQGQRGISSVPVGRQPIIMQSSSKFNFPSGRPGMQNGTGQTDFMIHQNVVPAGTVNRQPPPPYPLTAANGQSPSALQTGGSAAPSSYTNGSIPQSMMVPNRNSHNMELYNISVPGLQTNWPQSSSAPAQSSPSSGHEIPTWQPNIPVRSNSFNNPLGNRASHSANSQPSATTVTAITPAPIQQPVKSMRVLKPELQTALAPTHPSWIPQPIQTVQPSPFPEGTASNVTVMPPVAEAPNYQGPPPPYPKHLLHQNPSVPPYESISKPSKEDQPSLPKEDESEKSYENVDSGDKEKKQITTSPITVRKNKKDEERRESRIQSYSPQAFKFFMEQHVENVLKSHQQRLHRKKQLENEMMRVGLSQDAQDQMRKMLCQKESNYIRLKRAKMDKSMFVKIKTLGIGAFGEVCLARKVDTKALYATKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPESLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHPRQDSMDFSNEWGDPSSCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILFEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSASYIPKITHPTDTSNFDPVDPDKLWSDDNEEENVNDTLNGWYKNGKHPEHAFYEFTFRRFFDDNGYPYNYPKPIEYEYINSQGSEQQSDEDDQNTGSEIKNRDLVYV,1130,"126,870",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1 {ECO:0000269|PubMed:9988268}; IsoId=O95835-1; Sequence=Displayed; Name=2 {ECO:0000305}; IsoId=O95835-2; Sequence=VSP_051604, VSP_051605; Note=No experimental confirmation available. {ECO:0000305}; ",,,,,,,,,,VAR_SEQ 672 690 GLSQDAQDQMRKMLCQKES -> KPFKMSIFILNHLFAWCLF (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_051604.; VAR_SEQ 691 1130 Missing (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_051605.,VARIANT 96 96 R -> W (in dbSNP:rs55945045). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040660.; VARIANT 204 204 S -> G (in dbSNP:rs34793526). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040661.; VARIANT 237 237 P -> Q (in dbSNP:rs56149740). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040662.; VARIANT 370 370 R -> W (in dbSNP:rs56348064). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040663.; VARIANT 531 531 P -> S (in dbSNP:rs55874734). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040664.; VARIANT 641 641 F -> L (in dbSNP:rs35163691). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040665.; VARIANT 669 669 M -> I (in a lung adenocarcinoma sample; somatic mutation; dbSNP:rs1390558952). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040666.; VARIANT 806 806 R -> P (in a lung large cell carcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040667.; VARIANT 1000 1000 G -> S (in dbSNP:rs56412005). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040668.,,,,,,1,,0,,SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. {ECO:0000305}.,,,DOMAIN 100 141 UBA. {ECO:0000255|PROSITE-ProRule:PRU00212}.; DOMAIN 705 1010 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.; DOMAIN 1011 1090 AGC-kinase C-terminal.,MOTIF 373 376 PPxY motif 1.; MOTIF 556 559 PPxY motif 2.,REGION 526 655 Interaction with YAP1. {ECO:0000269|PubMed:18158288}.,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10518011, ECO:0000269|PubMed:15122335}; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10518011, ECO:0000269|PubMed:15122335};",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ,,"FUNCTION: Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. Acts as a tumor suppressor which plays a critical role in maintenance of ploidy through its actions in both mitotic progression and the G1 tetraploidy checkpoint. Negatively regulates G2/M transition by down-regulating CDK1 kinase activity. Involved in the control of p53 expression. Affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1. May also play a role in endocrine function. Plays a role in mammary gland epithelial cells differentiation, both through the Hippo signaling pathway and the intracellular estrogen receptor signaling pathway by promoting the degradation of ESR1 (PubMed:28068668). {ECO:0000269|PubMed:10518011, ECO:0000269|PubMed:10831611, ECO:0000269|PubMed:15122335, ECO:0000269|PubMed:15220930, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:19927127, ECO:0000269|PubMed:28068668}.",,,,,,"ACT_SITE 828 828 Proton acceptor. {ECO:0000250|UniProtKB:P22612, ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.","BINDING 734 734 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:15122335}.",,,"NP_BIND 711 719 ATP. {ECO:0000250|UniProtKB:P22612, ECO:0000255|PROSITE-ProRule:PRU00159}.",,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein complex assembly [GO:0043254]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819],cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein complex assembly [GO:0043254]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819],ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674],cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922],GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005815; GO:0005829; GO:0006468; GO:0009755; GO:0018105; GO:0019901; GO:0030216; GO:0030331; GO:0030833; GO:0033138; GO:0033146; GO:0034613; GO:0035329; GO:0035556; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051220; GO:0051301; GO:0060644; GO:0090090; GO:2000058,IPR000961; IPR011009; IPR028741; IPR000719; IPR008271; IPR015940; IPR009060; ,P06493; P24941; Q9Y4B6; P53667; Q9H8S9; Q7L9L4; P35240; P46662; O60285; O43255; Q15831; Q9GZV5; P46937; Q15942,"SUBUNIT: Complexes with CDK1 in early mitosis. LATS1-associated CDK1 has no mitotic cyclin partner and no apparent kinase activity. Binds phosphorylated ZYX, locating this protein to the mitotic spindle and suggesting a role for actin regulatory proteins during mitosis. Binds to and colocalizes with LIMK1 at the actomyosin contractile ring during cytokinesis. Interacts (via PPxY motif 2) with YAP1 (via WW domains). Interacts with MOB1A and MOB1B. Interacts with LIMD1, WTIP and AJUBA. Interacts with ESR1, DCAF1 and DCAF13; probably recruits DCAF1 and DCAF13 to ESR1 to promote ESR1 ubiquitination and ubiquitin-mediated proteasomal degradation (PubMed:28068668). Interacts with STK3/MST2; this interaction is inhibited in the presence of DLG5 (PubMed:28087714). Interacts with SCRIB in the presence of DLG5 (PubMed:28169360). {ECO:0000269|PubMed:10831611, ECO:0000269|PubMed:15220930, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:19739119, ECO:0000269|PubMed:20303269, ECO:0000269|PubMed:28068668, ECO:0000269|PubMed:28087714, ECO:0000269|PubMed:28169360, ECO:0000269|PubMed:9988268}.",9988268; 10518011; 15489334; 10831611; 15144186; 15122335; 15220930; 15688006; 17525332; 18158288; 18691976; 18669648; 19413330; 19369195; 19690332; 20303269; 19739119; 19927127; 23186163; 24275569; 28087714; 28068668; 28169360; 17344846,9988268; 10518011; 15489334; 10831611; 15144186; 15122335; 15220930; 15688006; 17525332; 18158288; 18691976; 18669648; 19413330; 19369195; 19690332; 20303269; 19739119; 19927127; 23186163; 24275569; 28087714; 28068668; 28169360; 17344846; 11278283; 12372621; 12379777; 12624101; 15746036; 16007220; 16061636; 17049657; 18328708; 18413746; 18640976; 19799973; 20048001; 20195357; 20412773; 20453000; 20508983; 20936779; 21212414; 21233212; 21383157; 21555462; 22078877; 22641346; 22863277; 22909338; 23230145; 23573293; 23885148; 24012335; 24026096; 24106267; 24225952; 24255178; 24356468; 24366813; 24682895; 25023289; 25026211; 25041856; 25044019; 25127217; 25218637; 25270913; 25283809; 25362852; 25393475; 25482410; 25618271; 25625370; 25658096; 25723520; 25743838; 25772246; 25786116; 25841306; 26045165; 26108669; 26116754; 26496610; 26638075; 26921249; 27335147; 27555231; 27786336; 27847303; 27886176; 27973704; 28075055; 28152516; 28259899; 28387539; 28434174; 28504812; 28720576; 28754671; 28893265; 28926138; 29362392; 29438698; 29730476; 29787761; 29850494; 29859193; 29901195; 30308519; 9545236,2004-09-27,2019-02-13,1999-05-01,184,X-ray crystallography (3),,HELIX 74 85 {ECO:0000244|PDB:4ZRK}.; HELIX 637 671 {ECO:0000244|PDB:5BRK}.; HELIX 675 697 {ECO:0000244|PDB:5BRK}.,,,,,,5 out of 5,Active site (1); Alternative sequence (2); Binding site (1); Chain (1); Domain (3); Helix (3); Modified residue (7); Motif (2); Mutagenesis (3); Natural variant (9); Nucleotide binding (1); Region (1),,TISSUE SPECIFICITY: Expressed in all adult tissues examined except for lung and kidney. {ECO:0000269|PubMed:10518011}.,,3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Complete proteome;Cytoplasm;Cytoskeleton;Kinase;Magnesium;Metal-binding;Mitosis;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Tumor suppressor,Evidence at protein level,reviewed,,"Protein kinase superfamily, AGC Ser/Thr protein kinase family",184,Alternative products (1); Catalytic activity (2); Caution (1); Cofactor (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0043; KW-0067; KW-0131; KW-0132; KW-0181; KW-0206; KW-0418; KW-0460; KW-0479; KW-0498; KW-0547; KW-0597; KW-0621; KW-0723; KW-0808; KW-0963; KW-1185,,,,,,,,"PTM: Autophosphorylated and phosphorylated during M-phase of the cell cycle. Phosphorylated by STK3/MST2 at Ser-909 and Thr-1079, which results in its activation. Phosphorylation at Ser-464 by NUAK1 and NUAK2 leads to decreased protein level and is required to regulate cellular senescence and cellular ploidy. {ECO:0000269|PubMed:10518011, ECO:0000269|PubMed:15688006, ECO:0000269|PubMed:19927127, ECO:0000269|PubMed:9988268}.",CHAIN 1 1130 Serine/threonine-protein kinase LATS1. /FTId=PRO_0000086232.,,,,,,"MOD_RES 246 246 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 278 278 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 464 464 Phosphoserine; by NUAK1 and NUAK2. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:19927127}.; MOD_RES 613 613 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 674 674 Phosphoserine. {ECO:0000244|PubMed:17525332}.; MOD_RES 909 909 Phosphoserine; by STK3/MST2. {ECO:0000269|PubMed:15688006}.; MOD_RES 1079 1079 Phosphothreonine; by STK3/MST2. {ECO:0000269|PubMed:15688006, ECO:0000269|PubMed:28087714}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF104413;AF164041;BC002767;
0,O96017,CHK2_HUMAN,CHEK2 CDS1 CHK2 RAD53,CHEK2,CDS1 CHK2 RAD53,,,Homo sapiens (Human),9606,Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2),UP000005640: Chromosome 22,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSRESDVEAQQSHGSSACSQPHGSVTQSQGSSSQSQGISSSSTSTMPNSSQSSHSSSGTLSSLETVSTQELYSIPEDQEPEDQEPEEPTPAPWARLWALQDGFANLECVNDNYWFGRDKSCEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAETTKRPAVCAAVL,543,"60,915",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=13;  Name=1; IsoId=O96017-1; Sequence=Displayed; Name=2; Synonyms=ins2; IsoId=O96017-2; Sequence=VSP_014564, VSP_014567, VSP_014568; Note=Lacks enzymatic activity.; Name=3; Synonyms=del2-12; IsoId=O96017-3; Sequence=VSP_014559; Name=4; Synonyms=del2-3; IsoId=O96017-4; Sequence=VSP_014558; Note=Lacks enzymatic activity.; Name=5; Synonyms=del4; IsoId=O96017-5; Sequence=VSP_014565, VSP_014566; Name=6; Synonyms=sub3; IsoId=O96017-6; Sequence=VSP_014562, VSP_014563; Name=7; Synonyms=del9-12; IsoId=O96017-7; Sequence=VSP_014572, VSP_014573; Note=Lacks enzymatic activity.; Name=8; Synonyms=del7; IsoId=O96017-8; Sequence=VSP_014569, VSP_014570; Name=9; Synonyms=insx; IsoId=O96017-9; Sequence=VSP_014557; Note=Retains low level of catalytic activity.; Name=10; Synonyms=iso2; IsoId=O96017-10; Sequence=VSP_014560, VSP_014561; Note=Lacks enzymatic activity.; Name=11; Synonyms=iso1; IsoId=O96017-11; Sequence=VSP_014556; Name=12; Synonyms=del9; IsoId=O96017-12; Sequence=VSP_014571; Note=Lacks enzymatic activity.; Name=13; IsoId=O96017-13; Sequence=VSP_045148; ",,,,,,,,,,"VAR_SEQ 1 221 Missing (in isoform 13). {ECO:0000303|PubMed:15498874}. /FTId=VSP_045148.; VAR_SEQ 75 392 Missing (in isoform 11). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014556.; VAR_SEQ 107 487 Missing (in isoform 3). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014559.; VAR_SEQ 107 197 Missing (in isoform 4). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014558.; VAR_SEQ 107 107 E -> ETESGHVTQSDLELLLSSDPPASASQSAGIRGVRHHPRPVCSLK (in isoform 9). {ECO:0000303|PubMed:15361853, ECO:0000303|PubMed:15461802}. /FTId=VSP_014557.; VAR_SEQ 131 147 KRTDKYRTYSKKHFRIF -> EFRSYSFYLP (in isoform 10). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014560.; VAR_SEQ 148 543 Missing (in isoform 10). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014561.; VAR_SEQ 150 165 VGPKNSYIAYIEDHSG -> ENLSCPYRIWFNFCLF (in isoform 6). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014562.; VAR_SEQ 166 543 Missing (in isoform 6). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014563.; VAR_SEQ 198 224 VFVFFDLTVDDQSVYPKALRDEYIMSK -> EKILKIYSLSRFSKIRRGAVAHVFNPS (in isoform 2). {ECO:0000303|PubMed:10097108, ECO:0000303|PubMed:15361853}. /FTId=VSP_014564.; VAR_SEQ 199 203 FVFFD -> VPVER (in isoform 5). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014565.; VAR_SEQ 204 543 Missing (in isoform 5). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014566.; VAR_SEQ 228 234 SGACGEV -> GRGWQIT (in isoform 2). {ECO:0000303|PubMed:10097108, ECO:0000303|PubMed:15361853}. /FTId=VSP_014567.; VAR_SEQ 235 543 Missing (in isoform 2). {ECO:0000303|PubMed:10097108, ECO:0000303|PubMed:15361853}. /FTId=VSP_014568.; VAR_SEQ 283 289 PCIIKIK -> DGRGRAV (in isoform 8). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014569.; VAR_SEQ 290 543 Missing (in isoform 8). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014570.; VAR_SEQ 337 365 Missing (in isoform 12). {ECO:0000303|PubMed:15361853, ECO:0000303|Ref.7}. /FTId=VSP_014571.; VAR_SEQ 337 339 YLH -> MKT (in isoform 7). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014572.; VAR_SEQ 340 543 Missing (in isoform 7). {ECO:0000303|PubMed:15361853}. /FTId=VSP_014573.","VARIANT 17 17 A -> S (in an osteogenic sarcoma sample; somatic mutation; might influence susceptibility to breast cancer; does not cause protein abrogation in familial colorectal cancer; dbSNP:rs137853008). {ECO:0000269|PubMed:11746983}. /FTId=VAR_019101.; VARIANT 59 59 T -> K (in multiple cancers; dbSNP:rs149991239). {ECO:0000269|PubMed:12052256}. /FTId=VAR_026630.; VARIANT 64 64 E -> K (in prostate cancer; somatic mutation; dbSNP:rs141568342). {ECO:0000269|PubMed:12533788}. /FTId=VAR_019107.; VARIANT 85 85 P -> L (in an osteogenic sarcoma sample; neutral allele among Ashkenazi Jewish women; dbSNP:rs17883862). {ECO:0000269|PubMed:11746983, ECO:0000269|PubMed:15649950, ECO:0000269|Ref.10}. /FTId=VAR_019102.; VARIANT 117 117 R -> G (in dbSNP:rs28909982). {ECO:0000269|PubMed:12454775, ECO:0000269|PubMed:12610780, ECO:0000269|PubMed:15818573}. /FTId=VAR_022461.; VARIANT 137 137 R -> Q (might influence susceptibility to breast cancer; does not cause protein abrogation in familial colorectal cancer; dbSNP:rs368570187). {ECO:0000269|PubMed:12454775, ECO:0000269|PubMed:15818573}. /FTId=VAR_022462.; VARIANT 145 145 R -> P (in prostate cancer; somatic mutation; dbSNP:rs587781667). {ECO:0000269|PubMed:12533788}. /FTId=VAR_019108.; VARIANT 145 145 R -> W (in colon cancer and LFS2; does not cause protein abrogation in familial colorectal cancer; loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation; dbSNP:rs137853007). {ECO:0000269|PubMed:10617473, ECO:0000269|PubMed:11298456, ECO:0000269|PubMed:11719428, ECO:0000269|PubMed:12610780, ECO:0000269|PubMed:15535844, ECO:0000269|PubMed:15818573}. /FTId=VAR_008554.; VARIANT 157 157 I -> T (might influence susceptibility to different types of cancer; does not cause protein abrogation in familial colorectal cancer; loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation; dbSNP:rs17879961). {ECO:0000269|PubMed:10617473, ECO:0000269|PubMed:11298456, ECO:0000269|PubMed:11461078, ECO:0000269|PubMed:12533788, ECO:0000269|PubMed:12610780, ECO:0000269|PubMed:14612911, ECO:0000269|PubMed:15087378, ECO:0000269|PubMed:15095295, ECO:0000269|PubMed:15239132, ECO:0000269|PubMed:15492928, ECO:0000269|PubMed:15535844, ECO:0000269|PubMed:15810020, ECO:0000269|PubMed:15818573, ECO:0000269|Ref.10}. /FTId=VAR_008555.; VARIANT 167 167 G -> R (in prostate cancer; somatic mutation; dbSNP:rs72552322). {ECO:0000269|PubMed:12533788}. /FTId=VAR_019109.; VARIANT 180 180 R -> C (in prostate cancer; somatic mutation; dbSNP:rs77130927). {ECO:0000269|PubMed:12533788, ECO:0000269|PubMed:21618645}. /FTId=VAR_019103.; VARIANT 180 180 R -> H (in prostate cancer; somatic mutation; dbSNP:rs137853009). {ECO:0000269|PubMed:12454775, ECO:0000269|PubMed:12533788, ECO:0000269|PubMed:15818573}. /FTId=VAR_019110.; VARIANT 181 181 R -> C (in prostate cancer; somatic mutation; dbSNP:rs137853010). {ECO:0000269|PubMed:12533788}. /FTId=VAR_019104.; VARIANT 181 181 R -> H (in prostate cancer; somatic mutation; dbSNP:rs121908701). {ECO:0000269|PubMed:12533788}. /FTId=VAR_019105.; VARIANT 239 239 E -> K (in prostate cancer; germline mutation; dbSNP:rs121908702). {ECO:0000269|PubMed:12533788}. /FTId=VAR_019106.; VARIANT 251 251 I -> F (in prostate cancer; germline mutation; dbSNP:rs587780189). {ECO:0000269|PubMed:12533788}. /FTId=VAR_019111.; VARIANT 318 318 R -> H (in prostate cancer; somatic mutation; dbSNP:rs143611747). {ECO:0000269|PubMed:12533788}. /FTId=VAR_019112.; VARIANT 323 323 T -> P (in prostate cancer; somatic mutation; dbSNP:rs750984976). {ECO:0000269|PubMed:12533788}. /FTId=VAR_019113.; VARIANT 327 327 Y -> C (in prostate cancer; somatic mutation; dbSNP:rs587780194). {ECO:0000269|PubMed:12533788}. /FTId=VAR_019114.; VARIANT 347 347 D -> N (in dbSNP:rs28909980). /FTId=VAR_029154.; VARIANT 371 371 H -> Y (confers a moderate risk of breast cancer; partially reduces kinase activity; dbSNP:rs531398630). {ECO:0000269|PubMed:21618645}. /FTId=VAR_066012.; VARIANT 390 390 Y -> C (in BC; does not phosphorylate p53/TP53; dbSNP:rs200928781). {ECO:0000269|PubMed:25619829}. /FTId=VAR_073020.; VARIANT 406 406 R -> H (in dbSNP:rs200649225). /FTId=VAR_024572.; VARIANT 428 428 S -> F (may increase breast cancer risk; dbSNP:rs137853011). {ECO:0000269|PubMed:15649950}. /FTId=VAR_022463.; VARIANT 436 436 L -> M (in dbSNP:rs17882922). {ECO:0000269|Ref.10}. /FTId=VAR_021117.; VARIANT 446 446 N -> K (in dbSNP:rs17880867). {ECO:0000269|Ref.10}. /FTId=VAR_021118.; VARIANT 447 447 F -> I (in dbSNP:rs17881473). {ECO:0000269|Ref.10}. /FTId=VAR_021119.; VARIANT 448 448 I -> S (in dbSNP:rs17886163). {ECO:0000269|Ref.10}. /FTId=VAR_021120.; VARIANT 476 476 T -> K (in prostate cancer; somatic mutation). {ECO:0000269|PubMed:12533788}. /FTId=VAR_019115.; VARIANT 500 500 S -> C (in dbSNP:rs28909981). /FTId=VAR_029155.; VARIANT 501 501 E -> K (in dbSNP:rs17883172). {ECO:0000269|Ref.10}. /FTId=VAR_021121.; VARIANT 512 512 L -> V (in dbSNP:rs17882942). {ECO:0000269|Ref.10}. /FTId=VAR_021122.",,,,,,1,,0,,SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. CHK2 subfamily. {ECO:0000305}.,,,DOMAIN 113 175 FHA. {ECO:0000255|PROSITE-ProRule:PRU00086}.; DOMAIN 220 486 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,REGION 368 394 T-loop/activation segment.,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ,,"FUNCTION: Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest, activation of DNA repair and apoptosis in response to the presence of DNA double-strand breaks. May also negatively regulate cell cycle progression during unperturbed cell cycles. Following activation, phosphorylates numerous effectors preferentially at the consensus sequence [L-X-R-X-X-S/T]. Regulates cell cycle checkpoint arrest through phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their activity. Inhibition of CDC25 phosphatase activity leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. May also phosphorylate NEK6 which is involved in G2/M cell cycle arrest. Regulates DNA repair through phosphorylation of BRCA2, enhancing the association of RAD51 with chromatin which promotes DNA repair by homologous recombination. Also stimulates the transcription of genes involved in DNA repair (including BRCA2) through the phosphorylation and activation of the transcription factor FOXM1. Regulates apoptosis through the phosphorylation of p53/TP53, MDM4 and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may alleviate inhibition by MDM2, leading to accumulation of active p53/TP53. Phosphorylation of MDM4 may also reduce degradation of p53/TP53. Also controls the transcription of pro-apoptotic genes through phosphorylation of the transcription factor E2F1. Tumor suppressor, it may also have a DNA damage-independent function in mitotic spindle assembly by phosphorylating BRCA1. Its absence may be a cause of the chromosomal instability observed in some cancer cells. Promotes the CCAR2-SIRT1 association and is required for CCAR2-mediated SIRT1 inhibition (PubMed:25361978). {ECO:0000250|UniProtKB:Q9Z265, ECO:0000269|PubMed:10097108, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11298456, ECO:0000269|PubMed:12402044, ECO:0000269|PubMed:12607004, ECO:0000269|PubMed:12717439, ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:16163388, ECO:0000269|PubMed:17101782, ECO:0000269|PubMed:17380128, ECO:0000269|PubMed:17715138, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:18644861, ECO:0000269|PubMed:18728393, ECO:0000269|PubMed:20364141, ECO:0000269|PubMed:25361978, ECO:0000269|PubMed:25619829, ECO:0000269|PubMed:9836640, ECO:0000269|PubMed:9889122}.",,,,,,ACT_SITE 347 347 Proton acceptor.,BINDING 249 249 ATP.; BINDING 368 368 ATP.,,,NP_BIND 227 234 ATP.; NP_BIND 302 308 ATP.; NP_BIND 351 352 ATP.,,"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]","cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625],cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],GO:0000077; GO:0000086; GO:0001302; GO:0001934; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0006978; GO:0008630; GO:0016301; GO:0016605; GO:0018105; GO:0019901; GO:0031625; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071157; GO:0071480; GO:0072428; GO:0090307; GO:0090399; GO:1901796; GO:1903416; GO:1903926; GO:2000002; GO:2000210,IPR000253; IPR011009; IPR000719; IPR008271; IPR008984; ,Itself; P27958; Q9NY61; Q9UQ88-1; Q96KN1; Q9Y248; Q13007; P56645; P53350; Q15172; Q15173; Q13362-1; Q13362-2; Q13362-3; Q16537; P06400; Q5VTR2; P06725; P55072; P18887,"SUBUNIT: Homodimer. Homodimerization is part of the activation process but the dimer may dissociate following activation. Interacts with PML. Interacts with TP53. Interacts with RB1; phosphorylates RB1. Interacts with BRCA1. Interacts (phosphorylated at Thr-68) with MDC1; requires ATM-mediated phosphorylation of CHEK2. Interacts with TP53BP1; modulates CHEK2 phosphorylation at Thr-68 in response to ionizing radiation. Interacts with CDC25A; phosphorylates CDC25A and mediates its degradation in response to ionizing radiation. Interacts with CUL1; mediates CHEK2 ubiquitination and regulation. Interacts with CDKN2AIP. Interacts (via protein kinase domain) with CCAR2 (via N-terminus). Interacts with SIRT1. {ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11298456, ECO:0000269|PubMed:12364621, ECO:0000269|PubMed:12607004, ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:16794575, ECO:0000269|PubMed:18644861, ECO:0000269|PubMed:24825908, ECO:0000269|PubMed:25361978}.",9836640; 9889122; 10097108; 15361853; 15461802; 14702039; 15498874; 10591208; 15489334; 10724175; 10973490; 11390408; 11298456; 12094328; 11901158; 12402044; 12364621; 12810724; 12717439; 12607004; 15279791; 15342622; 16163388; 16311512; 16481012; 17380128; 17715138; 17101782; 18728393; 18644861; 18317453; 19164942; 20364141; 21269460; 21618645; 22266820; 25361978; 12049740; 16794575; 19782031; 24825908; 10617473; 11461078; 11719428; 12052256; 12454775; 11746983; 12533788; 12610780; 14612911; 15492928; 15535844; 15087378; 15095295; 15239132; 15649950; 15810020; 15818573; 25619829,9836640; 9889122; 10097108; 15361853; 15461802; 14702039; 15498874; 10591208; 15489334; 10724175; 10973490; 11390408; 11298456; 12094328; 11901158; 12402044; 12364621; 12810724; 12717439; 12607004; 15279791; 15342622; 16163388; 16311512; 16481012; 17380128; 17715138; 17101782; 18728393; 18644861; 18317453; 19164942; 20364141; 21269460; 21618645; 22266820; 25361978; 12049740; 16794575; 19782031; 24825908; 10617473; 11461078; 11719428; 12052256; 12454775; 11746983; 12533788; 12610780; 14612911; 15492928; 15535844; 15087378; 15095295; 15239132; 15649950; 15810020; 15818573; 25619829; 10435585; 10570149; 10673500; 10673501; 10710310; 10744722; 11025670; 11085506; 11096068; 11438675; 11668173; 11751432; 11793476; 11821419; 11875739; 11967536; 11984555; 12024051; 12082606; 12111733; 12242661; 12386164; 12393693; 12447382; 12493754; 12529183; 12548019; 12551934; 12637545; 12654916; 12654917; 12676583; 12711320; 12766774; 12773400; 12805407; 12855706; 12897801; 12909615; 12917215; 14507240; 14514889; 14568168; 14648717; 14678969; 14681223; 14695167; 14701743; 14970866; 14970869; 14997059; 15024084; 15044452; 15048074; 15057041; 15122511; 15140942; 15192702; 15213307; 15322239; 15361830; 15361851; 15380617; 15385111; 15466005; 15467464; 15472904; 15488637; 15533933; 15601819; 15618221; 15647386; 15659650; 15668230; 15694385; 15700044; 15784679; 15803363; 15803365; 15852425; 15862297; 15876876; 15942682; 15963507; 15980987; 15987456; 16024600; 16043347; 16078115; 16150728; 16205633; 16239104; 16257342; 16317088; 16322218; 16337852; 16414312; 16437383; 16452051; 16456034; 16461339; 16478990; 16492927; 16539695; 16574953; 16596250; 16651405; 16671833; 16705183; 16732333; 16741947; 16758118; 16790090; 16798742; 16816021; 16828850; 16830057; 16835227; 16835864; 16858628; 16880452; 16883537; 16905549; 16914568; 16936775; 16940182; 16941491; 16943424; 16998498; 16998506; 17010071; 17026620; 17030982; 17040931; 17085682; 17106448; 17113724; 17132159; 17132695; 17145815; 17157788; 17164260; 17164383; 17169815; 17178848; 17214356; 17250914; 17317627; 17333333; 17333477; 17341484; 17363488; 17372254; 17380889; 17384638; 17409144; 17409195; 17428320; 17428325; 17464182; 17513615; 17517688; 17525332; 17544403; 17616632; 17634426; 17661168; 17663721; 17671118; 17684142; 17685927; 17694537; 17698850; 17705858; 17721994; 17876702; 17918154; 17940507; 18004398; 18024013; 18058223; 18085035; 18086781; 18086786; 18162465; 18167186; 18172190; 18175216; 18178638; 18239682; 18253122; 18281249; 18297428; 18321553; 18381420; 18381943; 18415014; 18482988; 18484200; 18538787; 18557994; 18566216; 18566483; 18571837; 18667510; 18676774; 18706089; 18725978; 18759107; 18762365; 18797466; 18802408; 18812180; 18833288; 18834326; 18930998; 18948271; 18950845; 18955500; 18957425; 18971944; 18985806; 18996005; 19001859; 19020308; 19021634; 19030985; 19062161; 19064572; 19116388; 19124502; 19124506; 19151762; 19176998; 19177012; 19177354; 19265784; 19330022; 19338682; 19338683; 19362748; 19372713; 19375317; 19377277; 19390600; 19399639; 19401704; 19411857; 19451272; 19453842; 19473886; 19480937; 19536092; 19548527; 19597488; 19609724; 19615254; 19656415; 19658174; 19666469; 19714462; 19741151; 19763819; 19768534; 19772467; 19789190; 19798429; 19840931; 19855918; 19863560; 19876921; 19881958; 19922265; 19996108; 20022510; 20023412; 20023427; 20080130; 20126263; 20159774; 20160490; 20200249; 20204303; 20305300; 20306497; 20360068; 20417869; 20424615; 20434834; 20442702; 20453000; 20462940; 20472656; 20496165; 20542099; 20581449; 20599567; 20637859; 20637980; 20643596; 20658728; 20668524; 20713355; 20722467; 20731661; 20875877; 21034966; 21070773; 21102523; 21118956; 21147465; 21156285; 21184685; 21186793; 21214517; 21239475; 21244692; 21310354; 21317874; 21338495; 21356067; 21390062; 21562711; 21614566; 21624128; 21701879; 21744992; 21765476; 21772273; 21787115; 21807500; 21876083; 21907711; 21924579; 21945852; 21956126; 21963792; 21988832; 22004065; 22058216; 22058428; 22071692; 22072393; 22099307; 22114986; 22158418; 22159226; 22160829; 22170260; 22201027; 22211259; 22294770; 22312557; 22355270; 22419737; 22420423; 22521562; 22586065; 22589537; 22623962; 22658458; 22770119; 22799331; 22808196; 22811390; 22901170; 22946335; 22994785; 23013471; 23058106; 23073808; 23107771; 23109706; 23150219; 23178491; 23269272; 23272087; 23296741; 23329222; 23333640; 23383325; 23415889; 23449389; 23598415; 23602568; 23666059; 23690919; 23705030; 23713947; 23776527; 23803109; 23806170; 23821772; 23855452; 23969480; 23977391; 24002546; 24021642; 24038392; 24065469; 24069304; 24153426; 24167195; 24190430; 24390236; 24415413; 24415942; 24480460; 24492479; 24498068; 24532427; 24553354; 24557336; 24599715; 24606918; 24657486; 24662822; 24713400; 24758542; 24764296; 24792164; 24798733; 24812435; 24844881; 24853623; 24879340; 24880342; 24882580; 24918820; 24976383; 24986639; 24998580; 25111195; 25355026; 25404613; 25414026; 25425972; 25449779; 25483076; 25527123; 25531207; 25535901; 25583358; 25609649; 25613496; 25629968; 25640309; 25743796; 25773391; 25842825; 25850293; 25872745; 25875766; 25884806; 25886177; 25895498; 25958056; 25962492; 26025911; 26041102; 26054341; 26061604; 26083025; 26084796; 26158765; 26333122; 26333361; 26416514; 26424751; 26441204; 26442630; 26447757; 26483394; 26485758; 26496610; 26506619; 26542114; 26553136; 26573794; 26577449; 26751069; 26751770; 26831064; 26919204; 26991782; 27001483; 27029031; 27039729; 27076856; 27125496; 27269948; 27438145; 27442652; 27464833; 27484185; 27510020; 27512067; 27595995; 27632928; 27711073; 27716909; 27751358; 27767095; 27792460; 27801830; 27838786; 27935866; 27964702; 27991505; 28038466; 28049532; 28087741; 28094252; 28103869; 28259974; 28360097; 28373435; 28418444; 28430840; 28498365; 28539821; 28608266; 28733865; 28874143; 29067458; 29082250; 29479983; 29486482; 29658237; 29761796; 29785007; 29804637; 29879026,2000-05-30,2019-02-13,1999-05-01,217,X-ray crystallography (38),STRAND 94 98 {ECO:0000244|PDB:1GXC}.; STRAND 100 103 {ECO:0000244|PDB:3I6U}.; STRAND 106 108 {ECO:0000244|PDB:1GXC}.; STRAND 110 118 {ECO:0000244|PDB:1GXC}.; STRAND 122 124 {ECO:0000244|PDB:1GXC}.; STRAND 144 150 {ECO:0000244|PDB:1GXC}.; STRAND 154 162 {ECO:0000244|PDB:1GXC}.; STRAND 168 170 {ECO:0000244|PDB:1GXC}.; STRAND 180 182 {ECO:0000244|PDB:1GXC}.; STRAND 187 193 {ECO:0000244|PDB:1GXC}.; STRAND 197 203 {ECO:0000244|PDB:1GXC}.; STRAND 220 228 {ECO:0000244|PDB:2YCF}.; STRAND 230 239 {ECO:0000244|PDB:2YCF}.; STRAND 244 251 {ECO:0000244|PDB:2YCF}.; STRAND 288 302 {ECO:0000244|PDB:2YCF}.; STRAND 307 309 {ECO:0000244|PDB:4BDD}.; STRAND 353 361 {ECO:0000244|PDB:2YCF}.; STRAND 364 366 {ECO:0000244|PDB:2YCF}.; STRAND 429 431 {ECO:0000244|PDB:2CN5}.,HELIX 128 132 {ECO:0000244|PDB:1GXC}.; HELIX 135 138 {ECO:0000244|PDB:1GXC}.; HELIX 209 211 {ECO:0000244|PDB:3I6U}.; HELIX 214 219 {ECO:0000244|PDB:2YCF}.; HELIX 253 256 {ECO:0000244|PDB:3I6U}.; HELIX 270 279 {ECO:0000244|PDB:2YCF}.; HELIX 310 313 {ECO:0000244|PDB:2YCF}.; HELIX 314 316 {ECO:0000244|PDB:2W7X}.; HELIX 321 340 {ECO:0000244|PDB:2YCF}.; HELIX 350 352 {ECO:0000244|PDB:2YCF}.; HELIX 369 371 {ECO:0000244|PDB:4BDE}.; HELIX 379 385 {ECO:0000244|PDB:2YCF}.; HELIX 388 390 {ECO:0000244|PDB:2WTJ}.; HELIX 393 398 {ECO:0000244|PDB:2YCF}.; HELIX 407 422 {ECO:0000244|PDB:2YCF}.; HELIX 436 442 {ECO:0000244|PDB:2YCF}.; HELIX 449 452 {ECO:0000244|PDB:2YCF}.; HELIX 457 466 {ECO:0000244|PDB:2YCF}.; HELIX 477 481 {ECO:0000244|PDB:2YCF}.; HELIX 484 486 {ECO:0000244|PDB:2YCF}.; HELIX 489 502 {ECO:0000244|PDB:2YCF}.,TURN 240 243 {ECO:0000244|PDB:2YCF}.; TURN 399 403 {ECO:0000244|PDB:2YCF}.; TURN 471 473 {ECO:0000244|PDB:2YCF}.; TURN 504 506 {ECO:0000244|PDB:2WTJ}.,,,,,5 out of 5,Active site (1); Alternative sequence (19); Beta strand (19); Binding site (2); Chain (1); Domain (2); Helix (21); Modified residue (7); Mutagenesis (8); Natural variant (32); Nucleotide binding (3); Region (1); Turn (4),,"TISSUE SPECIFICITY: High expression is found in testis, spleen, colon and peripheral blood leukocytes. Low expression is found in other tissues.",,3D-structure;ATP-binding;Alternative splicing;Apoptosis;Cell cycle;Cell division;Complete proteome;DNA damage;DNA repair;Disease mutation;Kinase;Li-Fraumeni syndrome;Magnesium;Metal-binding;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Tumor suppressor;Ubl conjugation,Evidence at protein level,reviewed,,"Protein kinase superfamily, CAMK Ser/Thr protein kinase family, CHK2 subfamily",217,Activity regulation (1); Alternative products (1); Catalytic activity (2); Caution (6); Cofactor (1); Function (1); Involvement in disease (4); Post-translational modification (2); Sequence similarities (1); Subcellular location (6); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0043; KW-0053; KW-0067; KW-0131; KW-0132; KW-0181; KW-0225; KW-0227; KW-0234; KW-0418; KW-0435; KW-0460; KW-0479; KW-0498; KW-0539; KW-0547; KW-0597; KW-0621; KW-0723; KW-0804; KW-0805; KW-0808; KW-0832; KW-1185,,,,,"DISEASE: Li-Fraumeni syndrome 2 (LFS2) [MIM:609265]: A highly penetrant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:11719428}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Prostate cancer (PC) [MIM:176807]: A malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. {ECO:0000269|PubMed:12533788}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Osteogenic sarcoma (OSRC) [MIM:259500]: A sarcoma originating in bone-forming cells, affecting the ends of long bones. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:12094328, ECO:0000269|PubMed:21618645, ECO:0000269|PubMed:25619829}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. {ECO:0000269|PubMed:12094328}.",,,"PTM: Phosphorylated. Phosphorylated at Ser-73 by PLK3 in response to DNA damage, promoting phosphorylation at Thr-68 by ATM and the G2/M transition checkpoint. Phosphorylation at Thr-68 induces homodimerization. Autophosphorylates at Thr-383 and Thr-387 in the T-loop/activation segment upon dimerization to become fully active and phosphorylate its substrates like for instance CDC25C. DNA damage-induced autophosphorylation at Ser-379 induces CUL1-mediated ubiquitination and regulates the pro-apoptotic function. Phosphorylation at Ser-456 also regulates ubiquitination. Phosphorylated by PLK4. {ECO:0000269|PubMed:10973490, ECO:0000269|PubMed:11390408, ECO:0000269|PubMed:15342622, ECO:0000269|PubMed:16311512, ECO:0000269|PubMed:16481012, ECO:0000269|PubMed:17715138, ECO:0000269|PubMed:18644861, ECO:0000269|PubMed:19164942}.; PTM: Ubiquitinated. CUL1-mediated ubiquitination regulates the pro-apoptotic function. Ubiquitination may also regulate protein stability. Ubiquitinated by RNF8 via 'Lys-48'-linked ubiquitination.",CHAIN 1 543 Serine/threonine-protein kinase Chk2. /FTId=PRO_0000085858.,,,,,,"MOD_RES 62 62 Phosphoserine; by PLK3. {ECO:0000269|PubMed:16481012}.; MOD_RES 68 68 Phosphothreonine; by ATM and MAP3K20. {ECO:0000269|PubMed:10973490, ECO:0000269|PubMed:15342622, ECO:0000269|PubMed:16311512, ECO:0000269|PubMed:16481012}.; MOD_RES 73 73 Phosphoserine; by PLK3. {ECO:0000269|PubMed:16481012}.; MOD_RES 379 379 Phosphoserine; by autocatalysis. {ECO:0000269|PubMed:18644861}.; MOD_RES 383 383 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:11390408}.; MOD_RES 387 387 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:11390408}.; MOD_RES 456 456 Phosphoserine. {ECO:0000269|PubMed:17715138}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF086904;AJ131197;AF096279;AY551295;AY551296;AY551297;AY551298;AY551299;AY551300;AY551301;AY551302;AY551303;AY551304;AY551305;CR456418;AF174135;AB040105;AK290754;AF217975;AY800241;CH471095;BC004207;
0,P02511,CRYAB_HUMAN,CRYAB CRYA2 HSPB5,CRYAB,CRYA2 HSPB5,,,Homo sapiens (Human),9606,Alpha-crystallin B chain (Alpha(B)-crystallin) (Heat shock protein beta-5) (HspB5) (Renal carcinoma antigen NY-REN-27) (Rosenthal fiber component),UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDIAIHHPWIRRPFFPFHSPSRLFDQFFGEHLLESDLFPTSTSLSPFYLRPPSFLRAPSWFDTGLSEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVLTVNGPRKQVSGPERTIPITREEKPAVTAAPKK,175,"20,159",,,,,,,,"MASS SPECTROMETRY: Mass=20201; Method=Electrospray; Range=1-175; Evidence={ECO:0000269|PubMed:10930324, ECO:0000269|PubMed:8175657}; MASS SPECTROMETRY: Mass=20281; Method=Electrospray; Range=1-175; Note=With 1 phosphate group.; Evidence={ECO:0000269|PubMed:10930324, ECO:0000269|PubMed:8175657}; MASS SPECTROMETRY: Mass=20360; Method=Electrospray; Range=1-175; Note=With 2 phosphate groups.; Evidence={ECO:0000269|PubMed:8175657}; MASS SPECTROMETRY: Mass=20199; Method=Electrospray; Range=1-175; Evidence={ECO:0000269|PubMed:10930324, ECO:0000269|PubMed:8175657}; MASS SPECTROMETRY: Mass=20278; Method=Electrospray; Range=1-175; Note=With 1 phosphate group.; Evidence={ECO:0000269|PubMed:10930324, ECO:0000269|PubMed:8175657};",,,,,"VARIANT 41 41 S -> Y (in dbSNP:rs2234703). /FTId=VAR_014607.; VARIANT 51 51 P -> L (in dbSNP:rs2234704). /FTId=VAR_014608.; VARIANT 109 109 D -> G (probable disease-associated mutation found in patients with restrictive cardiomyopathy; reduces CRYAB and DES localization at the Z-bands and the intercalated disk in the myocardium; cytoplasmic aggregations of CRYAB and DES; dbSNP:rs1114167341). {ECO:0000269|PubMed:28493373}. /FTId=VAR_079841.; VARIANT 109 109 D -> H (in MFM2; dbSNP:rs387907339). {ECO:0000269|PubMed:21920752}. /FTId=VAR_069528.; VARIANT 120 120 R -> G (in MFM2; decreased interactions with wild-type CRYAA and CRYAB but increased interactions with wild-type CRYBB2 and CRYGC; cytoplasmic aggregation; dbSNP:rs104894201). {ECO:0000269|PubMed:12601044, ECO:0000269|PubMed:28493373, ECO:0000269|PubMed:9731540}. /FTId=VAR_007899.; VARIANT 154 154 G -> S (in CMD1II; dbSNP:rs150516929). {ECO:0000269|PubMed:16793013}. /FTId=VAR_070035.; VARIANT 157 157 R -> H (in CMD1II; dbSNP:rs141638421). {ECO:0000269|PubMed:16483541}. /FTId=VAR_070036.",,,,CONFLICT 165 165 E -> K (in Ref. 4; AAC19161). {ECO:0000305}.; CONFLICT 175 175 K -> KKMPFLELHFLKQESFPTSE (in Ref. 4; AAC19161). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the small heat shock protein (HSP20) family. {ECO:0000255|PROSITE-ProRule:PRU00285}.,,,DOMAIN 56 164 sHSP. {ECO:0000255|PROSITE-ProRule:PRU00285}.,,,,,,,,,,"FUNCTION: May contribute to the transparency and refractive index of the lens. Has chaperone-like activity, preventing aggregation of various proteins under a wide range of stress conditions.",,,,,,,,,METAL 83 83 Zinc 1. {ECO:0000250}.; METAL 104 104 Zinc 2. {ECO:0000305}.; METAL 106 106 Zinc 2. {ECO:0000250}.; METAL 111 111 Zinc 1. {ECO:0000305}.; METAL 119 119 Zinc 1. {ECO:0000305}.,,SITE 48 48 Susceptible to oxidation.; SITE 60 60 Susceptible to oxidation.; SITE 68 68 Susceptible to oxidation.,actin filament bundle [GO:0032432]; axon [GO:0030424]; cardiac myofibril [GO:0097512]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; M band [GO:0031430]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; Z disc [GO:0030018]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; structural constituent of eye lens [GO:0005212]; unfolded protein binding [GO:0051082]; apoptotic process involved in morphogenesis [GO:0060561]; cellular response to gamma radiation [GO:0071480]; lens development in camera-type eye [GO:0002088]; microtubule polymerization or depolymerization [GO:0031109]; multicellular organism aging [GO:0010259]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular transport [GO:0032387]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; protein folding [GO:0006457]; protein homooligomerization [GO:0051260]; protein stabilization [GO:0050821]; regulation of cell death [GO:0010941]; regulation of cellular response to heat [GO:1900034]; response to estradiol [GO:0032355]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; stress-activated MAPK cascade [GO:0051403]; tubulin complex assembly [GO:0007021],apoptotic process involved in morphogenesis [GO:0060561]; cellular response to gamma radiation [GO:0071480]; lens development in camera-type eye [GO:0002088]; microtubule polymerization or depolymerization [GO:0031109]; multicellular organism aging [GO:0010259]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular transport [GO:0032387]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; protein folding [GO:0006457]; protein homooligomerization [GO:0051260]; protein stabilization [GO:0050821]; regulation of cell death [GO:0010941]; regulation of cellular response to heat [GO:1900034]; response to estradiol [GO:0032355]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; stress-activated MAPK cascade [GO:0051403]; tubulin complex assembly [GO:0007021],amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]; unfolded protein binding [GO:0051082],actin filament bundle [GO:0032432]; axon [GO:0030424]; cardiac myofibril [GO:0097512]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; M band [GO:0031430]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; Z disc [GO:0030018],GO:0001540; GO:0001666; GO:0002088; GO:0005212; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0006457; GO:0006936; GO:0007021; GO:0007517; GO:0008017; GO:0009986; GO:0010259; GO:0010629; GO:0010941; GO:0014069; GO:0015630; GO:0030018; GO:0030308; GO:0030424; GO:0031109; GO:0031430; GO:0032355; GO:0032387; GO:0032432; GO:0032463; GO:0042542; GO:0042802; GO:0042803; GO:0043066; GO:0043154; GO:0043197; GO:0043204; GO:0044877; GO:0046872; GO:0050821; GO:0051082; GO:0051260; GO:0051403; GO:0060561; GO:0070062; GO:0071480; GO:0097060; GO:0097512; GO:1900034; GO:1905907; GO:2000378,IPR002068; IPR037882; IPR001436; IPR003090; IPR031107; IPR008978; ,Itself; P02489; P05813; P07315; P22914; P04792; Q16082; Q9UJY1; Q3UBX0,"SUBUNIT: Heteropolymer composed of three CRYAA and one CRYAB subunits (PubMed:20836128). Aggregates with homologous proteins, including the small heat shock protein HSPB1, to form large heteromeric complexes (PubMed:10751411). Inter-subunit bridging via zinc ions enhances stability, which is crucial as there is no protein turn over in the lens (PubMed:22890888). Interacts with HSPBAP1 and TTN/titin (PubMed:14676215). Interacts with TMEM109 (PubMed:23542032). Interacts with DES; binds rapidly during early stages of DES filament assembly and a reduced binding seen in the later stages (PubMed:28470624). {ECO:0000269|PubMed:10751411, ECO:0000269|PubMed:14676215, ECO:0000269|PubMed:20836128, ECO:0000269|PubMed:22890888, ECO:0000269|PubMed:23542032, ECO:0000269|PubMed:28470624}.",838078; 2387586; 1407707; 14702039; 15489334; 1560006; 8999933; 7498159; 2539261; 8142454; 8175657; 10508479; 10930324; 10751411; 11577372; 11158243; 11369851; 14681890; 14676215; 19464326; 20836128; 21337604; 22120592; 22890888; 23542032; 24275569; 28470624; 28493373; 9731540; 12601044; 19646995; 16483541; 16793013; 21920752,838078; 2387586; 1407707; 14702039; 15489334; 1560006; 8999933; 7498159; 2539261; 8142454; 8175657; 10508479; 10930324; 10751411; 11577372; 11158243; 11369851; 14681890; 14676215; 19464326; 20836128; 21337604; 22120592; 22890888; 23542032; 24275569; 28470624; 28493373; 9731540; 12601044; 19646995; 16483541; 16793013; 21920752; 10217480; 11700327; 11771659; 11926998; 12095619; 12140279; 12468532; 12501218; 12600716; 12646227; 12837281; 12940843; 12965253; 14523008; 14532291; 14610128; 14743435; 15004872; 15117944; 15168732; 15236975; 15270074; 15284238; 15308659; 15339919; 15382236; 15388868; 15511225; 15639800; 15653686; 15817465; 15952936; 16049941; 16053447; 16142923; 16225851; 16274233; 16395408; 16480679; 16505043; 16581320; 16751613; 16760894; 16764341; 16817325; 16877416; 16893188; 17010329; 17022999; 17046756; 17056255; 17075130; 17081987; 17105203; 17216044; 17258947; 17260942; 17387692; 17487982; 17551579; 17568699; 17590381; 17601350; 17655279; 17662998; 17693254; 17723105; 17909943; 17916631; 17940610; 17968656; 18004741; 18061943; 18063749; 18095658; 18162431; 18164413; 18230612; 18334940; 18343237; 18343407; 18401461; 18543331; 18604737; 18639655; 18669646; 18685083; 18692065; 18712293; 18810322; 18941542; 18974385; 18977241; 18992912; 19041879; 19116904; 19140694; 19205872; 19238749; 19272359; 19282282; 19401464; 19451620; 19461931; 19498098; 19558454; 19597569; 19651604; 19680556; 19777343; 19799611; 20005263; 20064372; 20067552; 20104255; 20141356; 20378664; 20381070; 20440841; 20535031; 20587334; 20668689; 20711500; 20802487; 20804537; 20841355; 20863832; 21087083; 21152271; 21173272; 21224997; 21329698; 21357544; 21423662; 21423869; 21464278; 21768101; 21866213; 21884203; 21915251; 21980040; 21984182; 21988832; 22085609; 22090033; 22096479; 22143763; 22158051; 22210387; 22403391; 22417627; 22463677; 22537749; 22655036; 22815750; 22877753; 22972503; 22982407; 22993064; 23005341; 23049853; 23055712; 23074197; 23077034; 23159935; 23188086; 23194663; 23225306; 23231769; 23316005; 23340341; 23414517; 23508955; 23532854; 23559016; 23582651; 23590293; 23645685; 23929007; 23950959; 24023305; 24023879; 24072698; 24077282; 24132917; 24275510; 24307592; 24473683; 24589182; 24702231; 24711386; 24725344; 24817638; 24859470; 24880201; 24945100; 24985029; 24997049; 25048725; 25195561; 25261722; 25337251; 25450505; 25557022; 25564856; 25601468; 25609649; 25683516; 25684139; 25694240; 25962097; 26080000; 26116912; 26341790; 26351848; 26402864; 26415747; 26458046; 26464626; 26620801; 26657544; 26789112; 26878210; 26961874; 27129211; 27206651; 27226619; 27260392; 27587396; 27641668; 28007594; 28130664; 28337642; 28476624; 28640093; 28648665; 28796798; 28919577; 28939839; 29408057; 8455624,1986-07-21,2019-02-13,1990-01-01,221,X-ray crystallography (14); NMR spectroscopy (3); Electron microscopy (1),STRAND 68 70 {ECO:0000244|PDB:4M5S}.; STRAND 72 80 {ECO:0000244|PDB:4M5S}.; STRAND 82 84 {ECO:0000244|PDB:2N0K}.; STRAND 89 94 {ECO:0000244|PDB:4M5S}.; STRAND 97 109 {ECO:0000244|PDB:4M5S}.; STRAND 112 123 {ECO:0000244|PDB:4M5S}.; STRAND 134 137 {ECO:0000244|PDB:4M5S}.; STRAND 141 148 {ECO:0000244|PDB:4M5S}.; STRAND 157 159 {ECO:0000244|PDB:4M5T}.; STRAND 161 163 {ECO:0000244|PDB:4M5T}.,HELIX 86 88 {ECO:0000244|PDB:4M5S}.; HELIX 130 132 {ECO:0000244|PDB:4M5S}.,TURN 125 127 {ECO:0000244|PDB:2KLR}.,,,,,5 out of 5,Beta strand (10); Chain (1); Domain (1); Glycosylation (1); Helix (2); Mass spectrometry (5); Metal binding (5); Modified residue (6); Natural variant (7); Sequence conflict (2); Site (3); Turn (1),,"TISSUE SPECIFICITY: Lens as well as other tissues (PubMed:838078, PubMed:2387586). Expressed in myocardial tissue (PubMed:28493373). {ECO:0000269|PubMed:2387586, ECO:0000269|PubMed:28493373, ECO:0000269|PubMed:838078}.",,3D-structure;Acetylation;Cardiomyopathy;Cataract;Chaperone;Complete proteome;Cytoplasm;Direct protein sequencing;Disease mutation;Eye lens protein;Glycoprotein;Metal-binding;Myofibrillar myopathy;Nucleus;Oxidation;Phosphoprotein;Polymorphism;Reference proteome;Zinc,Evidence at protein level,reviewed,,Small heat shock protein (HSP20) family,221,Function (1); Involvement in disease (5); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0122; KW-0143; KW-0181; KW-0225; KW-0273; KW-0325; KW-0479; KW-0539; KW-0558; KW-0597; KW-0621; KW-0862; KW-0898; KW-0903; KW-0963; KW-1060; KW-1185,,,,,"DISEASE: Myopathy, myofibrillar, 2 (MFM2) [MIM:608810]: A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM2 is characterized by weakness of the proximal and distal limb muscles, weakness of the neck, velopharynx and trunk muscles, hypertrophic cardiomyopathy, and cataract in a subset of patients. {ECO:0000269|PubMed:12601044, ECO:0000269|PubMed:14681890, ECO:0000269|PubMed:21920752, ECO:0000269|PubMed:9731540}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cataract 16, multiple types (CTRCT16) [MIM:613763]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT16 includes posterior polar cataract, among others. Posterior polar cataract is a subcapsular opacity, usually disk-shaped, located at the back of the lens. {ECO:0000269|PubMed:11577372}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=CRYAB mutations may be involved in restrictive cardiomyopathy (RCM), a rare non-ischemic myocardial disease. RCM is characterized by restrictive ventricular-filling physiology in the presence of normal or reduced diastolic and/or systolic volumes (of 1 or both ventricles), biatrial enlargement, and normal ventricular wall thickness. {ECO:0000269|PubMed:28493373}.; DISEASE: Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related (MFMFIH-CRYAB) [MIM:613869]: A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFMFIH-CRYAB has onset in the first weeks of life after a normal neonatal period. Affected infants show rapidly progressive muscular rigidity of the trunk and limbs associated with increasing respiratory difficulty resulting in death before age 3 years. {ECO:0000269|PubMed:21337604}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1II (CMD1II) [MIM:615184]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:16483541, ECO:0000269|PubMed:16793013}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 175 Alpha-crystallin B chain. /FTId=PRO_0000125907.,,,CARBOHYD 170 170 O-linked (GlcNAc) threonine. {ECO:0000250}.,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000269|PubMed:8142454, ECO:0000269|PubMed:838078}.; MOD_RES 19 19 Phosphoserine. {ECO:0000269|PubMed:8175657}.; MOD_RES 45 45 Phosphoserine. {ECO:0000269|PubMed:11158243, ECO:0000269|PubMed:8175657}.; MOD_RES 59 59 Phosphoserine. {ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:11158243, ECO:0000269|PubMed:8175657}.; MOD_RES 92 92 N6-acetyllysine; partial. {ECO:0000269|PubMed:11369851, ECO:0000269|PubMed:22120592}.; MOD_RES 166 166 N6-acetyllysine. {ECO:0000269|PubMed:22120592}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M28638;S45630;AF007162;AK314029;BT006770;EF444955;CH471065;BC007008;M24906;
0,P04899,GNAI2_HUMAN,GNAI2 GNAI2B,GNAI2,GNAI2B,,,Homo sapiens (Human),9606,Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein),UP000005640: Chromosome 3,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGCTVSAEDKAAAERSKMIDKNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEDGYSEEECRQYRAVVYSNTIQSIMAIVKAMGNLQIDFADPSRADDARQLFALSCTAEEQGVLPDDLSGVIRRLWADHGVQACFGRSREYQLNDSAAYYLNDLERIAQSDYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSAYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKITHSPLTICFPEYTGANKYDEAASYIQSKFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF,355,"40,451",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=6;  Name=1; IsoId=P04899-1; Sequence=Displayed; Name=2; IsoId=P04899-2; Sequence=VSP_017497; Name=3; IsoId=P04899-3; Sequence=VSP_043473; Note=No experimental confirmation available.; Name=sGi2; Synonyms=sGalphai2; IsoId=P04899-4; Sequence=VSP_043903; Name=5; IsoId=P04899-5; Sequence=VSP_054789; Note=No experimental confirmation available.; Name=6; IsoId=P04899-6; Sequence=VSP_054788; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 1 52 Missing (in isoform 6). {ECO:0000303|PubMed:14702039}. /FTId=VSP_054788.; VAR_SEQ 1 39 MGCTVSAEDKAAAERSKMIDKNLREDGEKAAREVKLLLL -> MEYAGHLPASSAQGTILACTSCT (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_017497.; VAR_SEQ 1 39 MGCTVSAEDKAAAERSKMIDKNLREDGEKAAREVKLLLL -> MR (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_043473.; VAR_SEQ 1 39 MGCTVSAEDKAAAERSKMIDKNLREDGEKAAREVKLLLL -> MTEGVKTLGWTKQKGGCHWGRSE (in isoform 5). {ECO:0000303|PubMed:14702039}. /FTId=VSP_054789.; VAR_SEQ 332 355 NVQFVFDAVTDVIIKNNLKDCGLF -> SRKLFRETYLKLSGPDQHPHPSPAPAPPLSSDSVP (in isoform sGi2). {ECO:0000303|PubMed:17550964}. /FTId=VSP_043903.,,,,,,,3,,0,,SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily. {ECO:0000305}.,,,,,,,,,,,,,FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. The G(i) proteins are involved in hormonal regulation of adenylate cyclase: they inhibit the cyclase in response to beta-adrenergic stimuli. May play a role in cell division. {ECO:0000269|PubMed:17635935}.; FUNCTION: Isoform sGi2: Regulates the cell surface density of dopamine receptors DRD2 by sequestrating them as an intracellular pool. {ECO:0000269|PubMed:17550964}.,,,,,,,BINDING 327 327 GTP; via amide nitrogen. {ECO:0000250}.,,METAL 47 47 Magnesium. {ECO:0000250}.; METAL 182 182 Magnesium. {ECO:0000250}.,NP_BIND 40 47 GTP. {ECO:0000250|UniProtKB:P63096}.; NP_BIND 176 182 GTP. {ECO:0000250}.; NP_BIND 201 205 GTP. {ECO:0000250|UniProtKB:P63096}.; NP_BIND 270 273 GTP. {ECO:0000250|UniProtKB:P63096}.,,cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenosine receptor signaling pathway [GO:0001973]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein folding [GO:0006457]; regulation of calcium ion transport [GO:0051924]; response to nutrient [GO:0007584]; signal transduction [GO:0007165],adenosine receptor signaling pathway [GO:0001973]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; gamma-aminobutyric acid signaling pathway [GO:0007214]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein folding [GO:0006457]; regulation of calcium ion transport [GO:0051924]; response to nutrient [GO:0007584]; signal transduction [GO:0007165],G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872],cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],GO:0001664; GO:0001973; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005834; GO:0005886; GO:0006457; GO:0007049; GO:0007165; GO:0007186; GO:0007188; GO:0007189; GO:0007193; GO:0007194; GO:0007213; GO:0007214; GO:0007584; GO:0008283; GO:0008284; GO:0016020; GO:0030335; GO:0030425; GO:0030496; GO:0031683; GO:0032930; GO:0033864; GO:0035810; GO:0035815; GO:0044297; GO:0045121; GO:0045955; GO:0046628; GO:0046872; GO:0050805; GO:0051301; GO:0051924; GO:0070062; GO:0070374; GO:0140199; GO:1903561; GO:1903614; GO:1904707; GO:2000179; GO:2001234,IPR001408; IPR001019; IPR011025; IPR027417; ,P32302; Q9Y4H4; Q15323; Q6A162; P60410; Q99750; P14598; P19878; Q7Z3S9; P42866; O76081-6; Q15654,"SUBUNIT: G proteins are composed of 3 units; alpha, beta and gamma. The alpha chain contains the guanine nucleotide binding site. Interacts with GPSM1. Interacts with RGS12 and RGS14 (By similarity). Interacts with UNC5B. {ECO:0000250, ECO:0000269|PubMed:12359238}.",3100330; 3120178; 2834384; 17550964; 14702039; 16641997; 15489334; 2837412; 12359238; 17635935; 21269460; 22223895; 24141704; 24275569; 25255805; 25807930; 25944712,3100330; 3120178; 2834384; 17550964; 14702039; 16641997; 15489334; 2837412; 12359238; 17635935; 21269460; 22223895; 24141704; 24275569; 25255805; 25807930; 25944712; 10215864; 10480595; 11118617; 11196645; 11309201; 11786497; 11815450; 11815463; 11873862; 12058044; 12088413; 12202484; 12403834; 12624107; 12684222; 12887316; 1322796; 13549488; 14514350; 14613926; 14623802; 14676208; 14701866; 14743216; 15047060; 15126921; 15251452; 15331550; 15537656; 15572341; 15640523; 15889144; 15951850; 16099818; 16169070; 16189514; 16263121; 16352729; 16371464; 16373322; 16415903; 16443778; 1645720; 16565233; 1658606; 16714477; 16720719; 16782902; 16892066; 16923326; 1707501; 17095603; 17110338; 17215244; 17230639; 17502420; 17900700; 18162464; 1846707; 1849000; 18577758; 18854172; 18940181; 1898674; 19169048; 19188424; 19258039; 19282110; 19367581; 19542234; 19913121; 20043990; 20360068; 20628086; 21079996; 21856938; 21949112; 21988832; 22106087; 22333621; 22936789; 23071112; 23416715; 23430985; 23490066; 23606334; 23665327; 23773523; 24298018; 24423449; 24502978; 25078664; 25241761; 2534964; 25416956; 25675501; 25788576; 26496610; 26514267; 26662512; 2748346; 27811362; 28145731; 28722168; 29925945; 7556990; 7641683; 7859812; 7937899; 8015379; 8073283; 8099279; 8119955; 8208289; 8327893; 8521505; 8524874; 8554519; 8662784; 8997178; 9544801; 9760042; 9865521; 9914469,1987-08-13,2019-02-13,2007-01-23,213,Electron microscopy (1),,,,,,,,5 out of 5,Alternative sequence (5); Binding site (1); Chain (1); Initiator methionine (1); Lipidation (2); Metal binding (2); Modified residue (3); Nucleotide binding (4),,,,3D-structure;ADP-ribosylation;Alternative splicing;Cell cycle;Cell division;Cell membrane;Complete proteome;Cytoplasm;Cytoskeleton;GTP-binding;Lipoprotein;Magnesium;Membrane;Metal-binding;Myristate;Nucleotide-binding;Palmitate;Reference proteome;Transducer,Evidence at protein level,reviewed,,"G-alpha family, G(i/o/t/z) subfamily",213,Alternative products (1); Caution (3); Function (2); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0013; KW-0025; KW-0131; KW-0132; KW-0181; KW-0206; KW-0342; KW-0449; KW-0460; KW-0472; KW-0479; KW-0519; KW-0547; KW-0564; KW-0807; KW-0963; KW-1003; KW-1185,,,,,,,,"PTM: (Microbial infection) Deamidated at Gln-205 by Photorhabdus asymbiotica toxin PAU_02230, blocking GTP hydrolysis of heterotrimeric GNAQ or GNA11 and G-alphai (GNAI1, GNAI2 or GNAI3) proteins, thereby activating RhoA. {ECO:0000269|PubMed:24141704}.",CHAIN 2 355 Guanine nucleotide-binding protein G(i) subunit alpha-2. /FTId=PRO_0000203679.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22223895, ECO:0000269|PubMed:22223895, ECO:0000269|PubMed:25255805, ECO:0000269|PubMed:25807930}.","LIPID 2 2 N-myristoyl glycine. {ECO:0000269|PubMed:22223895, ECO:0000269|PubMed:25255805, ECO:0000269|PubMed:25807930}.; LIPID 3 3 S-palmitoyl cysteine. {ECO:0000250}.",MOD_RES 179 179 ADP-ribosylarginine; by cholera toxin. {ECO:0000250}.; MOD_RES 205 205 Deamidated glutamine; by Photorhabdus PAU_02230. {ECO:0000269|PubMed:24141704}.; MOD_RES 352 352 ADP-ribosylcysteine; by pertussis toxin. {ECO:0000250}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X04828;J03004;M20593;M20586;M20587;M20588;M20589;M20590;M20591;M20592;AY677118;AF493906;AK096299;AK096595;AK302330;AK304473;CH471055;CH471055;CH471055;BC012138;BC016995;X07854;
0,P08754,GNAI3_HUMAN,GNAI3,GNAI3,,,,Homo sapiens (Human),9606,Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGCTLSAEDKAAVERSKMIDRNLREDGEKAAKEVKLLLLGAGESGKSTIVKQMKIIHEDGYSEDECKQYKVVVYSNTIQSIIAIIRAMGRLKIDFGEAARADDARQLFVLAGSAEEGVMTPELAGVIKRLWRDGGVQACFSRSREYQLNDSASYYLNDLDRISQSNYIPTQQDVLRTRVKTTGIVETHFTFKDLYFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTETSIILFLNKKDLFEEKIKRSPLTICYPEYTGSNTYEEAAAYIQCQFEDLNRRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKECGLY,354,"40,532",,,,,,,,,,,,,VARIANT 40 40 G -> R (in ARCND1; dbSNP:rs387907178). {ECO:0000269|PubMed:22560091}. /FTId=VAR_068558.,,,,CONFLICT 21 21 R -> C (in Ref. 11; no nucleotide entry). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Heterotrimeric guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Signaling by an activated GPCR promotes GDP release and GTP binding. The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal. Both GDP release and GTP hydrolysis are modulated by numerous regulatory proteins (PubMed:8774883, PubMed:18434541, PubMed:19478087). Signaling is mediated via effector proteins, such as adenylate cyclase. Inhibits adenylate cyclase activity, leading to decreased intracellular cAMP levels (PubMed:19478087). Stimulates the activity of receptor-regulated K(+) channels (PubMed:2535845). The active GTP-bound form prevents the association of RGS14 with centrosomes and is required for the translocation of RGS14 from the cytoplasm to the plasma membrane. May play a role in cell division (PubMed:17635935). {ECO:0000269|PubMed:17635935, ECO:0000269|PubMed:18434541, ECO:0000269|PubMed:2535845, ECO:0000269|PubMed:8774883}.",,,,,,,"BINDING 326 326 GTP; via amide nitrogen. {ECO:0000244|PDB:2IHB, ECO:0000244|PDB:2ODE, ECO:0000244|PDB:2V4Z, ECO:0000244|PDB:4G5O, ECO:0000244|PDB:4G5R}.",,"METAL 47 47 Magnesium. {ECO:0000244|PDB:2V4Z, ECO:0000269|PubMed:19478087}.; METAL 181 181 Magnesium. {ECO:0000244|PDB:2V4Z, ECO:0000269|PubMed:19478087}.","NP_BIND 43 48 GTP. {ECO:0000244|PDB:2IHB, ECO:0000244|PDB:2ODE, ECO:0000244|PDB:2V4Z, ECO:0000244|PDB:4G5O, ECO:0000244|PDB:4G5R, ECO:0000244|PDB:4G5S}.; NP_BIND 150 151 GTP. {ECO:0000244|PDB:2V4Z, ECO:0000244|PDB:4G5O, ECO:0000244|PDB:4G5R, ECO:0000244|PDB:4G5S}.; NP_BIND 175 181 GTP. {ECO:0000244|PDB:2IHB, ECO:0000244|PDB:2ODE, ECO:0000244|PDB:2V4Z, ECO:0000244|PDB:4G5O, ECO:0000244|PDB:4G5R, ECO:0000244|PDB:4G5S}.; NP_BIND 200 204 GTP. {ECO:0000244|PDB:2V4Z, ECO:0000305|PubMed:19478087}.; NP_BIND 269 272 GTP. {ECO:0000244|PDB:2IHB, ECO:0000244|PDB:2ODE, ECO:0000244|PDB:2V4Z, ECO:0000244|PDB:4G5O, ECO:0000244|PDB:4G5R, ECO:0000244|PDB:4G5S}.",,centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell cycle [GO:0007049]; cell division [GO:0051301]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; GTP metabolic process [GO:0046039]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein folding [GO:0006457]; vesicle fusion [GO:0006906],adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell cycle [GO:0007049]; cell division [GO:0051301]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; GTP metabolic process [GO:0046039]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein folding [GO:0006457]; vesicle fusion [GO:0006906],GDP binding [GO:0019003]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904],centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588],GO:0001664; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005765; GO:0005794; GO:0005813; GO:0005834; GO:0005886; GO:0006457; GO:0006906; GO:0007049; GO:0007186; GO:0007188; GO:0007193; GO:0007194; GO:0007212; GO:0007420; GO:0016020; GO:0016239; GO:0019003; GO:0019904; GO:0030496; GO:0031683; GO:0031821; GO:0032794; GO:0032930; GO:0033864; GO:0042588; GO:0045121; GO:0046039; GO:0046872; GO:0051301; GO:0070062; GO:1904707; GO:2001234,IPR001408; IPR001019; IPR011025; IPR027417; ,Q9Y4H4; Q8IVA1; O43566; Q9UGC6,"SUBUNIT: Heterotrimeric G proteins are composed of 3 units; alpha, beta and gamma. The alpha subunit contains the guanine nucleotide binding site. GTP binding causes dissociation of the heterotrimer, liberating the individual subunits so that they can interact with downstream effector proteins. Interacts with GPSM1 (By similarity). Interacts (GDP-bound form) with GPSM2 (via GoLoco domains) (PubMed:22952234). Does not interact with RGS2 (PubMed:19478087). Interacts with RGS8 and RGS10; this strongly enhances the intrinsic GTPase activity (PubMed:8774883, PubMed:18434541). Interacts with RGS16; this strongly enhances the intrinsic GTPase activity (PubMed:19478087). Interacts with RGS12 (By similarity). Interacts (via active GTP- or inactive GDP-bound form) with RGS14 (By similarity). {ECO:0000250|UniProtKB:P08753, ECO:0000250|UniProtKB:Q9DC51, ECO:0000269|PubMed:18434541, ECO:0000269|PubMed:19478087, ECO:0000269|PubMed:22952234, ECO:0000305}.",3109953; 3120178; 2834384; 2452165; 3132707; 14702039; 15489334; 2440724; 2535845; 8774883; 16870394; 17635935; 21269460; 24141704; 25255805; 25944712; 18434541; 19478087; 22952234; 22560091,3109953; 3120178; 2834384; 2452165; 3132707; 14702039; 15489334; 2440724; 2535845; 8774883; 16870394; 17635935; 21269460; 24141704; 25255805; 25944712; 18434541; 19478087; 22952234; 22560091; 10215864; 11118617; 11196645; 11786497; 12058044; 12826607; 1322796; 13549488; 14743216; 15889144; 15951850; 16415903; 16511171; 1658606; 16892066; 16923326; 1707501; 17100651; 17215244; 17230639; 17353931; 1846707; 18577758; 18628988; 18663145; 19738201; 19808657; 20065032; 20125088; 20190146; 20360068; 20379614; 20562859; 20607800; 20711500; 21209316; 21795707; 21931697; 21988832; 22623428; 23389635; 23416715; 23606334; 25026904; 25078664; 25187647; 2534964; 25416956; 25444921; 25675501; 25977476; 26213104; 26391662; 26496610; 26514267; 27072656; 2748346; 27607449; 28223697; 28456783; 28484278; 7859812; 7937899; 8015379; 8073283; 8119955; 8208289; 8327893; 8521505; 8554519; 9544801; 9865521,1988-11-01,2019-02-13,2007-01-23,216,X-ray crystallography (6),STRAND 34 39 {ECO:0000244|PDB:2ODE}.; STRAND 183 191 {ECO:0000244|PDB:2ODE}.; STRAND 194 201 {ECO:0000244|PDB:2ODE}.; STRAND 219 226 {ECO:0000244|PDB:2ODE}.; STRAND 237 241 {ECO:0000244|PDB:2ODE}.; STRAND 262 269 {ECO:0000244|PDB:2ODE}.; STRAND 319 323 {ECO:0000244|PDB:2ODE}.,HELIX 46 57 {ECO:0000244|PDB:2ODE}.; HELIX 63 68 {ECO:0000244|PDB:2ODE}.; HELIX 70 91 {ECO:0000244|PDB:2ODE}.; HELIX 100 110 {ECO:0000244|PDB:2ODE}.; HELIX 121 131 {ECO:0000244|PDB:2ODE}.; HELIX 134 141 {ECO:0000244|PDB:2ODE}.; HELIX 142 145 {ECO:0000244|PDB:2ODE}.; HELIX 152 157 {ECO:0000244|PDB:2ODE}.; HELIX 159 162 {ECO:0000244|PDB:2ODE}.; HELIX 171 175 {ECO:0000244|PDB:2ODE}.; HELIX 205 214 {ECO:0000244|PDB:2ODE}.; HELIX 227 231 {ECO:0000244|PDB:2ODE}.; HELIX 242 254 {ECO:0000244|PDB:2ODE}.; HELIX 257 259 {ECO:0000244|PDB:2ODE}.; HELIX 271 278 {ECO:0000244|PDB:2ODE}.; HELIX 283 285 {ECO:0000244|PDB:2ODE}.; HELIX 296 308 {ECO:0000244|PDB:2ODE}.; HELIX 329 346 {ECO:0000244|PDB:2ODE}.,TURN 111 116 {ECO:0000244|PDB:2ODE}.; TURN 314 316 {ECO:0000244|PDB:2ODE}.,,,,,5 out of 5,Beta strand (7); Binding site (1); Chain (1); Helix (18); Initiator methionine (1); Lipidation (2); Metal binding (2); Modified residue (3); Natural variant (1); Nucleotide binding (5); Sequence conflict (1); Turn (2),,,,3D-structure;ADP-ribosylation;Cell cycle;Cell division;Cell membrane;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;GTP-binding;Lipoprotein;Magnesium;Membrane;Metal-binding;Myristate;Nucleotide-binding;Palmitate;Reference proteome;Transducer,Evidence at protein level,reviewed,,"G-alpha family, G(i/o/t/z) subfamily",216,Function (1); Involvement in disease (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0013; KW-0131; KW-0132; KW-0181; KW-0206; KW-0225; KW-0342; KW-0449; KW-0460; KW-0472; KW-0479; KW-0519; KW-0547; KW-0564; KW-0807; KW-0963; KW-1003; KW-1185,,,,,"DISEASE: Auriculocondylar syndrome 1 (ARCND1) [MIM:602483]: An autosomal dominant craniofacial malformation syndrome characterized by variable mandibular anomalies, including mild to severe micrognathia, temporomandibular joint ankylosis, cleft palate, and a characteristic ear malformation that consists of separation of the lobule from the external ear, giving the appearance of a question mark (question-mark ear). Other frequently described features include prominent cheeks, cupped and posteriorly rotated ears, preauricular tags, and microstomia. {ECO:0000269|PubMed:22560091}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: (Microbial infection) Deamidated at Gln-204 by Photorhabdus asymbiotica toxin PAU_02230, blocking GTP hydrolysis of heterotrimeric GNAQ or GNA11 and G-alphai (GNAI1, GNAI2 or GNAI3) proteins, thereby activating RhoA. {ECO:0000269|PubMed:24141704}.",CHAIN 2 354 Guanine nucleotide-binding protein G(k) subunit alpha. /FTId=PRO_0000203692.,,,,INIT_MET 1 1 Removed. {ECO:0000269|PubMed:25255805}.,LIPID 2 2 N-myristoyl glycine. {ECO:0000269|PubMed:25255805}.; LIPID 3 3 S-palmitoyl cysteine. {ECO:0000250}.,MOD_RES 178 178 ADP-ribosylarginine; by cholera toxin. {ECO:0000250}.; MOD_RES 204 204 Deamidated glutamine; by Photorhabdus PAU_02230. {ECO:0000269|PubMed:24141704}.; MOD_RES 351 351 ADP-ribosylcysteine; by pertussis toxin. {ECO:0000250}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M27543;J03005;M20604;M20597;M20598;M20599;M20600;M20601;M20602;M20603;J03198;J03238;AF493907;BT019973;BT019974;AK312252;CH471122;BC025285;
0,P11171,41_HUMAN,EPB41 E41P,EPB41,E41P,,,Homo sapiens (Human),9606,Protein 4.1 (P4.1) (4.1R) (Band 4.1) (EPB4.1),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MTTEKSLVTEAENSQHQQKEEGEEAINSGQQEPQQEESCQTAAEGDNWCEQKLKASNGDTPTHEDLTKNKERTSESRGLSRLFSSFLKRPKSQVSEEEGKEVESDKEKGEGGQKEIEFGTSLDEEIILKAPIAAPEPELKTDPSLDLHSLSSAETQPAQEELREDPDFEIKEGEGLEECSKIEVKEESPQSKAETELKASQKPIRKHRNMHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDYFGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDITRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYVSDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDLHKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIKIRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFRLTSTDTIPKSKFLALGSKFRYSGRTQAQTRQASALIDRPAPHFERTASKRASRSLDGAAAVDSADRSPRPTSAPAITQGQVAEGGVLDASAKKTVVPKAQKETVKAEVKKEDEPPEQAEPEPTEAWKVEKTHIEVTVPTSNGDQTQKLAEKTEDLIRMRKKKRERLDGENIYIRHSNLMLEDLDKSQEEIKKHHASISELKKNFMESVPEPRPSEWDKRLSTHSPFRTLNINGQIPTGEGPPLVKTQTVTISDNANAVKSEIPTKDVPIVHTETKTITYEAAQTDDNSGDLDPGVLLTAQTITSETPSSTTTTQITKTVKGGISETRIEKRIVITGDADIDHDQVLVQAIKEAKEQHPDMSVTKVVVHQETEIADE,864,"97,017",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=7;  Name=1; IsoId=P11171-1; Sequence=Displayed; Name=2; IsoId=P11171-2; Sequence=VSP_000470; Name=3; IsoId=P11171-3; Sequence=VSP_000468, VSP_000471; Name=4; Synonyms=Erythroid; IsoId=P11171-4; Sequence=VSP_000468, VSP_000470, VSP_000473; Name=5; Synonyms=Non-erythroid A; IsoId=P11171-5; Sequence=VSP_000469, VSP_000470, VSP_000472; Name=6; Synonyms=Non-erythroid B; IsoId=P11171-6; Sequence=VSP_000468, VSP_000469, VSP_000470, VSP_000472; Name=7; IsoId=P11171-7; Sequence=VSP_000471, VSP_012872, VSP_012873; ",,,,,,,,,,"VAR_SEQ 1 209 Missing (in isoform 3, isoform 4 and isoform 6). {ECO:0000303|PubMed:2022644, ECO:0000303|PubMed:3223413, ECO:0000303|PubMed:3375238, ECO:0000303|PubMed:3467321}. /FTId=VSP_000468.; VAR_SEQ 228 262 Missing (in isoform 5 and isoform 6). {ECO:0000303|PubMed:3223413, ECO:0000303|PubMed:3375238}. /FTId=VSP_000469.; VAR_SEQ 616 648 Missing (in isoform 2, isoform 4, isoform 5 and isoform 6). {ECO:0000303|PubMed:3223413, ECO:0000303|PubMed:3375238, ECO:0000303|PubMed:3467321}. /FTId=VSP_000470.; VAR_SEQ 635 648 Missing (in isoform 3 and isoform 7). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:2022644}. /FTId=VSP_000471.; VAR_SEQ 649 669 Missing (in isoform 5 and isoform 6). {ECO:0000303|PubMed:3223413, ECO:0000303|PubMed:3375238}. /FTId=VSP_000472.; VAR_SEQ 729 734 PPLVKT -> VSTLST (in isoform 7). {ECO:0000303|PubMed:15489334}. /FTId=VSP_012872.; VAR_SEQ 735 864 Missing (in isoform 7). {ECO:0000303|PubMed:15489334}. /FTId=VSP_012873.; VAR_SEQ 772 805 Missing (in isoform 4). {ECO:0000303|PubMed:3467321}. /FTId=VSP_000473.",VARIANT 214 214 V -> I (in dbSNP:rs111642750). {ECO:0000269|Ref.9}. /FTId=VAR_009122.,,,,CONFLICT 51 51 Q -> H (in Ref. 5; AAD42222). {ECO:0000305}.; CONFLICT 76 76 S -> N (in Ref. 5; AAD42222). {ECO:0000305}.; CONFLICT 168 168 F -> S (in Ref. 9; AAD42223). {ECO:0000305}.; CONFLICT 259 259 A -> T (in Ref. 5; AAD42222). {ECO:0000305}.; CONFLICT 665 665 N -> S (in Ref. 5; AAD42222). {ECO:0000305}.; CONFLICT 669 669 E -> K (in Ref. 10; no nucleotide entry). {ECO:0000305}.; CONFLICT 679 679 K -> E (in Ref. 5; AAD42222). {ECO:0000305}.; CONFLICT 802 802 Q -> K (in Ref. 2; no nucleotide entry and 3; AAA35793/AAA35794). {ECO:0000305}.; CONFLICT 852 852 K -> L (in Ref. 10; no nucleotide entry). {ECO:0000305}.; CONFLICT 863 863 D -> E (in Ref. 10; no nucleotide entry). {ECO:0000305}.,,4,,0,,,,,DOMAIN 210 491 FERM. {ECO:0000255|PROSITE-ProRule:PRU00084}.,,REGION 494 614 Hydrophilic.; REGION 615 713 Spectrin--actin-binding.; REGION 714 864 C-terminal (CTD).,,,,,,,,FUNCTION: Protein 4.1 is a major structural element of the erythrocyte membrane skeleton. It plays a key role in regulating membrane physical properties of mechanical stability and deformability by stabilizing spectrin-actin interaction. Recruits DLG1 to membranes. Required for dynein-dynactin complex and NUMA1 recruitment at the mitotic cell cortex during anaphase (PubMed:23870127). {ECO:0000269|PubMed:23870127}.,,,,,,,,,,,,cell cortex region [GO:0099738]; cell junction [GO:0030054]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin-associated cytoskeleton [GO:0014731]; 1-phosphatidylinositol binding [GO:0005545]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to cell cortex [GO:1904778]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360],actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to cell cortex [GO:1904778]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360],1-phosphatidylinositol binding [GO:0005545]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200],cell cortex region [GO:0099738]; cell junction [GO:0030054]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin-associated cytoskeleton [GO:0014731],GO:0003779; GO:0005200; GO:0005516; GO:0005545; GO:0005634; GO:0005829; GO:0005886; GO:0007049; GO:0008022; GO:0008360; GO:0009898; GO:0014069; GO:0014731; GO:0030036; GO:0030054; GO:0030507; GO:0030863; GO:0030866; GO:0031032; GO:0032092; GO:0032991; GO:0047485; GO:0051219; GO:0051301; GO:0065003; GO:0099738; GO:1904778,IPR008379; IPR019749; IPR021187; IPR000798; IPR014847; IPR014352; IPR035963; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; IPR029071; ,P54105; P57060; Q8TBK6,"SUBUNIT: Binds with a high affinity to glycophorin and with lower affinity to band III protein. Associates with the nuclear mitotic apparatus. Interacts with calmodulin (PubMed:10692436). Interacts with CENPJ (PubMed:11003675). Interacts with DLG1 (PubMed:7937897). Also found to associate with contractile apparatus and tight junctions. Interacts with NUMA1; this interaction is negatively regulated by CDK1 during metaphase and promotes anaphase-specific localization of NUMA1 in symmetrically dividing cells (PubMed:23870127). {ECO:0000269|PubMed:10692436, ECO:0000269|PubMed:11003675, ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:7937897}.",3467321; 3223413; 3375238; 2022644; 16710414; 15489334; 3194408; 2171679; 3531202; 2808371; 1647028; 7937897; 10692436; 11003675; 11432737; 12427749; 15525677; 18669648; 19690332; 20068231; 21269460; 21406692; 23870127; 23186163; 24275569; 25944712; 11017195,3467321; 3223413; 3375238; 2022644; 16710414; 15489334; 3194408; 2171679; 3531202; 2808371; 1647028; 7937897; 10692436; 11003675; 11432737; 12427749; 15525677; 18669648; 19690332; 20068231; 21269460; 21406692; 23870127; 23186163; 24275569; 25944712; 11017195; 11604393; 11737230; 12044158; 12130521; 12239178; 12522012; 12601556; 12807908; 12901833; 12960380; 15040429; 15184364; 15564380; 15611095; 15714879; 15731777; 15834631; 16060676; 16157202; 16254212; 16368534; 16537540; 16881872; 17087826; 17298666; 17353931; 17500595; 17715393; 18079699; 18212055; 18691159; 18952129; 19338061; 19367725; 19624891; 19729518; 19738201; 19794081; 20007969; 20711500; 20797695; 20863723; 21486941; 21750196; 21808284; 21848512; 22083953; 22197999; 22449961; 22731252; 23663475; 23902751; 23943871; 24607279; 24912669; 27453575; 27667160; 27981895; 28570402; 9660868,1989-07-01,2019-02-13,2006-03-07,216,X-ray crystallography (2); NMR spectroscopy (1),STRAND 211 215 {ECO:0000244|PDB:3QIJ}.; STRAND 221 225 {ECO:0000244|PDB:3QIJ}.; STRAND 251 258 {ECO:0000244|PDB:3QIJ}.; STRAND 261 264 {ECO:0000244|PDB:3QIJ}.; STRAND 281 288 {ECO:0000244|PDB:3QIJ}.; STRAND 356 358 {ECO:0000244|PDB:3QIJ}.; STRAND 399 404 {ECO:0000244|PDB:3QIJ}.; STRAND 410 415 {ECO:0000244|PDB:3QIJ}.; STRAND 417 424 {ECO:0000244|PDB:3QIJ}.; STRAND 427 433 {ECO:0000244|PDB:3QIJ}.; STRAND 437 443 {ECO:0000244|PDB:3QIJ}.; STRAND 446 451 {ECO:0000244|PDB:3QIJ}.; STRAND 454 458 {ECO:0000244|PDB:1GG3}.; STRAND 461 466 {ECO:0000244|PDB:3QIJ}.,HELIX 232 243 {ECO:0000244|PDB:3QIJ}.; HELIX 248 250 {ECO:0000244|PDB:3QIJ}.; HELIX 271 274 {ECO:0000244|PDB:3QIJ}.; HELIX 293 295 {ECO:0000244|PDB:3QIJ}.; HELIX 299 314 {ECO:0000244|PDB:3QIJ}.; HELIX 322 337 {ECO:0000244|PDB:3QIJ}.; HELIX 342 345 {ECO:0000244|PDB:3QIJ}.; HELIX 350 352 {ECO:0000244|PDB:1GG3}.; HELIX 361 372 {ECO:0000244|PDB:3QIJ}.; HELIX 379 390 {ECO:0000244|PDB:3QIJ}.; HELIX 434 436 {ECO:0000244|PDB:3QIJ}.; HELIX 470 486 {ECO:0000244|PDB:3QIJ}.,TURN 275 277 {ECO:0000244|PDB:1GG3}.; TURN 394 397 {ECO:0000244|PDB:3QIJ}.,,,,,5 out of 5,Alternative sequence (8); Beta strand (14); Chain (1); Domain (1); Helix (12); Modified residue (26); Mutagenesis (2); Natural variant (1); Region (3); Sequence conflict (12); Turn (2),,,,3D-structure;Actin-binding;Alternative splicing;Calmodulin-binding;Cell cycle;Cell division;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Elliptocytosis;Glycoprotein;Hereditary hemolytic anemia;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Pyropoikilocytosis;Reference proteome;Transport,Evidence at protein level,reviewed,,,216,Alternative products (1); Function (1); Involvement in disease (1); Post-translational modification (3); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0009; KW-0025; KW-0112; KW-0131; KW-0132; KW-0181; KW-0206; KW-0250; KW-0325; KW-0360; KW-0498; KW-0539; KW-0597; KW-0621; KW-0668; KW-0813; KW-0903; KW-0963; KW-1185,,,,,"DISEASE: Elliptocytosis 1 (EL1) [MIM:611804]: A Rhesus-linked form of hereditary elliptocytosis, a genetically heterogeneous, autosomal dominant hematologic disorder. It is characterized by variable hemolytic anemia and elliptical or oval red cell shape. {ECO:0000269|PubMed:3467321}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: Phosphorylated at multiple sites by different protein kinases and each phosphorylation event selectively modulates the protein's functions.; PTM: Phosphorylation on Tyr-660 reduces the ability of 4.1 to promote the assembly of the spectrin/actin/4.1 ternary complex. {ECO:0000269|PubMed:1647028}.; PTM: O-glycosylated; contains N-acetylglucosamine side chains in the C-terminal domain.,CHAIN 1 864 Protein 4.1. /FTId=PRO_0000219390.,,,,,,"MOD_RES 14 14 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 60 60 Phosphothreonine; by CDK1. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:15525677}.; MOD_RES 84 84 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 85 85 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 95 95 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 104 104 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 121 121 Phosphoserine. {ECO:0000250|UniProtKB:P48193}.; MOD_RES 149 149 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 151 151 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 152 152 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 188 188 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 191 191 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 222 222 Phosphotyrosine. {ECO:0000250|UniProtKB:P48193}.; MOD_RES 378 378 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 521 521 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 540 540 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:2171679}.; MOD_RES 542 542 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 555 555 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:24275569}.; MOD_RES 660 660 Phosphotyrosine; by EGFR. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:1647028}.; MOD_RES 664 664 Phosphoserine. {ECO:0000250|UniProtKB:P48193}.; MOD_RES 674 674 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 684 684 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 709 709 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:2171679}.; MOD_RES 712 712 Phosphoserine; by CDK1. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:15525677}.; MOD_RES 736 736 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 859 859 Phosphothreonine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M14993;J03796;J03796;M61733;AF156225;CH471059;CH471059;CH471059;CH471059;BC039079;AF156226;
0,P28482,MK01_HUMAN,MAPK1 ERK2 PRKM1 PRKM2,MAPK1,ERK2 PRKM1 PRKM2,,,Homo sapiens (Human),9606,Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2),UP000005640: Chromosome 22,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS,360,"41,390",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P28482-1; Sequence=Displayed; Name=2; IsoId=P28482-2; Sequence=VSP_047815; ,,SEQUENCE CAUTION:  Sequence=CAA77753.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 242 285 Missing (in isoform 2). {ECO:0000303|Ref.3}. /FTId=VSP_047815.,,,,,CONFLICT 91 91 R -> Q (in Ref. 2; CAA77752). {ECO:0000305}.,,3,,0,DOMAIN: The TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases.,SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily. {ECO:0000305}.,,COMPBIAS 2 9 Poly-Ala.,DOMAIN 25 313 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,MOTIF 185 187 TXY. {ECO:0000269|PubMed:18760948}.; MOTIF 318 322 Cytoplasmic retention motif. {ECO:0000269|PubMed:18760948}.; MOTIF 327 333 Nuclear translocation motif. {ECO:0000269|PubMed:18760948}.,REGION 105 108 Inhibitor-binding.; REGION 153 154 Inhibitor-binding.,,,2.7.11.24,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.24; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.24;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; ,,"FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade plays also a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1) and a variety of other signaling-related molecules (like ARHGEF2, DCC, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. Mediates phosphorylation of TPR in respons to EGF stimulation. May play a role in the spindle assembly checkpoint. Phosphorylates PML and promotes its interaction with PIN1, leading to PML degradation. Phosphorylates CDK2AP2 (By similarity). {ECO:0000250|UniProtKB:P63086, ECO:0000269|PubMed:10617468, ECO:0000269|PubMed:10637505, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:12110590, ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:12792650, ECO:0000269|PubMed:12794087, ECO:0000269|PubMed:12974390, ECO:0000269|PubMed:15184391, ECO:0000269|PubMed:15241487, ECO:0000269|PubMed:15616583, ECO:0000269|PubMed:15664191, ECO:0000269|PubMed:15788397, ECO:0000269|PubMed:15952796, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:19879846, ECO:0000269|PubMed:22033920, ECO:0000269|PubMed:7588608, ECO:0000269|PubMed:8622688, ECO:0000269|PubMed:9480836, ECO:0000269|PubMed:9596579, ECO:0000269|PubMed:9649500, ECO:0000269|PubMed:9687510, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:16393692, ECO:0000303|PubMed:19565474, ECO:0000303|PubMed:21779493}.; FUNCTION: Acts as a transcriptional repressor. Binds to a [GC]AAA[GC] consensus sequence. Repress the expression of interferon gamma-induced genes. Seems to bind to the promoter of CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and STAT1. Transcriptional activity is independent of kinase activity. {ECO:0000269|PubMed:19879846}.",,,,,,"ACT_SITE 149 149 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.","BINDING 54 54 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.; BINDING 54 54 Inhibitor. {ECO:0000269|PubMed:16139248, ECO:0000269|PubMed:16242327, ECO:0000269|PubMed:17194451, ECO:0000269|PubMed:17300186, ECO:0000269|PubMed:19827834, ECO:0000269|PubMed:9827991}.; BINDING 108 108 Inhibitor; via amide nitrogen and carbonyl oxygen. {ECO:0000269|PubMed:16139248, ECO:0000269|PubMed:16242327, ECO:0000269|PubMed:17194451, ECO:0000269|PubMed:17300186, ECO:0000269|PubMed:19827834, ECO:0000269|PubMed:9827991}.; BINDING 114 114 Inhibitor. {ECO:0000269|PubMed:16139248, ECO:0000269|PubMed:16242327, ECO:0000269|PubMed:17194451, ECO:0000269|PubMed:17300186, ECO:0000269|PubMed:19827834, ECO:0000269|PubMed:9827991}.; BINDING 154 154 Inhibitor. {ECO:0000269|PubMed:16139248, ECO:0000269|PubMed:16242327, ECO:0000269|PubMed:17194451, ECO:0000269|PubMed:17300186, ECO:0000269|PubMed:19827834, ECO:0000269|PubMed:9827991}.; BINDING 166 166 Inhibitor. {ECO:0000269|PubMed:16139248, ECO:0000269|PubMed:16242327, ECO:0000269|PubMed:17194451, ECO:0000269|PubMed:17300186, ECO:0000269|PubMed:19827834, ECO:0000269|PubMed:9827991}.; BINDING 167 167 Inhibitor. {ECO:0000269|PubMed:16139248, ECO:0000269|PubMed:16242327, ECO:0000269|PubMed:17194451, ECO:0000269|PubMed:17300186, ECO:0000269|PubMed:19827834, ECO:0000269|PubMed:9827991}.",DNA_BIND 259 277,,NP_BIND 31 39 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,"axon [GO:0030424]; azurophil granule lumen [GO:0035578]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; early endosome [GO:0005769]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chemical synaptic transmission [GO:0007268]; chemotaxis [GO:0006935]; cytosine metabolic process [GO:0019858]; decidualization [GO:0046697]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; learning or memory [GO:0007611]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; MAPK cascade [GO:0000165]; negative regulation of cell differentiation [GO:0045596]; neutrophil degranulation [GO:0043312]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cellular response to heat [GO:1900034]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to estrogen [GO:0043627]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; viral process [GO:0016032]","activation of MAPK activity [GO:0000187]; aging [GO:0007568]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chemical synaptic transmission [GO:0007268]; chemotaxis [GO:0006935]; cytosine metabolic process [GO:0019858]; decidualization [GO:0046697]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; learning or memory [GO:0007611]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; MAPK cascade [GO:0000165]; negative regulation of cell differentiation [GO:0045596]; neutrophil degranulation [GO:0043312]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cellular response to heat [GO:1900034]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of gene expression [GO:0010468]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to estrogen [GO:0043627]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; viral process [GO:0016032]",ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134],axon [GO:0030424]; azurophil granule lumen [GO:0035578]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; early endosome [GO:0005769]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143],GO:0000165; GO:0000187; GO:0001784; GO:0003690; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006468; GO:0006915; GO:0006935; GO:0006974; GO:0007049; GO:0007165; GO:0007268; GO:0007411; GO:0007568; GO:0007611; GO:0008134; GO:0008353; GO:0008543; GO:0010468; GO:0010628; GO:0010800; GO:0014066; GO:0014069; GO:0015966; GO:0016032; GO:0016301; GO:0018105; GO:0018107; GO:0019233; GO:0019858; GO:0019902; GO:0030168; GO:0030278; GO:0030335; GO:0030424; GO:0030641; GO:0030878; GO:0031143; GO:0031435; GO:0031647; GO:0031663; GO:0032212; GO:0032839; GO:0032872; GO:0032991; GO:0033598; GO:0034198; GO:0034614; GO:0035094; GO:0035556; GO:0035578; GO:0038095; GO:0038096; GO:0038127; GO:0042307; GO:0042473; GO:0042802; GO:0043204; GO:0043312; GO:0043330; GO:0043627; GO:0045596; GO:0045727; GO:0045893; GO:0046697; GO:0048538; GO:0050852; GO:0050853; GO:0051090; GO:0051403; GO:0051493; GO:0051973; GO:0060020; GO:0060045; GO:0060291; GO:0060324; GO:0060425; GO:0060440; GO:0060716; GO:0061308; GO:0070371; GO:0070849; GO:0071276; GO:0071310; GO:0071356; GO:0072584; GO:0072686; GO:0090170; GO:0097011; GO:1900034; GO:1903351; GO:1904355; GO:1904813; GO:2000641,IPR011009; IPR003527; IPR008349; IPR000719; IPR017441; IPR008271; ,Itself; P32121; P53004; Q9U1H0; Q7L5N1; P28562; Q05922; Q13115; Q16690; P14921; Q02750; Q16539-3; P27361; P02687; Q9BUB5; Q15121; P35813; P35236; Q12913; Q15256; Q15418; Q15349; P51812; P29353-2; Q9Y296; Q69559,"SUBUNIT: Binds both upstream activators and downstream substrates in multimolecular complexes. This interaction inhibits its tyrosine-kinase activity. Interacts with ADAM15, ARHGEF2, ARRB2, DAPK1 (via death domain), HSF4, IER3, IPO7, DUSP6, NISCH, SGK1, and isoform 1 of NEK2. Interacts (phosphorylated form) with CAV2 ('Tyr-19'-phosphorylated form); the interaction, promoted by insulin, leads to nuclear location and MAPK1 activation. Interacts with MORG1, PEA15 and MKNK2 (By similarity). MKNK2 isoform 1 binding prevents from dephosphorylation and inactivation (By similarity). Interacts with DCC (By similarity). The phosphorylated form interacts with PML (isoform PML-4). Interacts with STYX. Interacts with CDK2AP2. Interacts with CAVIN4 (By similarity). Interacts with DUSP7; the interaction enhances DUSP7 phosphatase activity (PubMed:9788880). {ECO:0000250|UniProtKB:P63085, ECO:0000250|UniProtKB:P63086, ECO:0000269|PubMed:11912194, ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:15358203, ECO:0000269|PubMed:15616583, ECO:0000269|PubMed:16139248, ECO:0000269|PubMed:16242327, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:17194451, ECO:0000269|PubMed:17300186, ECO:0000269|PubMed:18211802, ECO:0000269|PubMed:18296648, ECO:0000269|PubMed:18435604, ECO:0000269|PubMed:18760948, ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:19060905, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:19827834, ECO:0000269|PubMed:22033920, ECO:0000269|PubMed:23847209, ECO:0000269|PubMed:9596579, ECO:0000269|PubMed:9788880, ECO:0000269|PubMed:9827991}.; SUBUNIT: (Microbial infection) Interacts with HIV-1 Nef through its SH3 domain. {ECO:0000269|PubMed:8794306}.",1540184; 1319925; 10591208; 15489334; 12665801; 7588608; 8622688; 8794306; 9480836; 9687510; 9649500; 9788880; 9596579; 10224087; 10637505; 10617468; 11154262; 12110590; 12356731; 11912194; 12974390; 12794087; 12792650; 15358203; 15526160; 15184391; 15241487; 15952796; 15616583; 15788397; 15664191; 17081983; 18211802; 16581800; 17274988; 18435604; 18296648; 18691976; 18760948; 18794356; 18669648; 19413330; 19879846; 19265199; 19494114; 19447520; 19369195; 19060905; 16393692; 19565474; 19690332; 20068231; 21269460; 21779493; 22033920; 21406692; 22223895; 22814378; 23186163; 23847209; 24275569; 9827991; 16139248; 16242327; 17194451; 17300186; 19053285; 19827834,1540184; 1319925; 10591208; 15489334; 12665801; 7588608; 8622688; 8794306; 9480836; 9687510; 9649500; 9788880; 9596579; 10224087; 10637505; 10617468; 11154262; 12110590; 12356731; 11912194; 12974390; 12794087; 12792650; 15358203; 15526160; 15184391; 15241487; 15952796; 15616583; 15788397; 15664191; 17081983; 18211802; 16581800; 17274988; 18435604; 18296648; 18691976; 18760948; 18794356; 18669648; 19413330; 19879846; 19265199; 19494114; 19447520; 19369195; 19060905; 16393692; 19565474; 19690332; 20068231; 21269460; 21779493; 22033920; 21406692; 22223895; 22814378; 23186163; 23847209; 24275569; 9827991; 16139248; 16242327; 17194451; 17300186; 19053285; 19827834; 10066421; 10209122; 10358095; 10409742; 10415025; 10508167; 10567369; 10601328; 10608864; 10725339; 10818153; 10878576; 10891492; 11067847; 11134045; 11408587; 11546808; 11549292; 11583024; 11698404; 11702783; 11739401; 11741894; 11744690; 11756441; 11776327; 11782450; 11786537; 11802164; 11802165; 11805108; 11840291; 11840343; 11861509; 11866540; 11867630; 11878930; 11884401; 11891214; 11896055; 11914583; 11923300; 11930938; 11937531; 11943771; 11952164; 11960991; 11971971; 12030372; 12032311; 12032872; 12038794; 12058028; 12068308; 12076252; 12077112; 12079429; 12081892; 12081893; 12082090; 12082091; 12093745; 12095140; 12134156; 12140374; 12149431; 12149432; 12161424; 12183542; 12200131; 12206715; 12218048; 12220502; 12239215; 12356755; 12362243; 12391149; 12393542; 12408764; 12419216; 12435397; 12441075; 12444202; 12446729; 12450322; 12456688; 12460991; 12464620; 12473660; 12479806; 12505790; 12508271; 12529294; 12531514; 12536241; 12538349; 12540369; 12540563; 12555071; 12562867; 12576315; 12592337; 12592382; 12594221; 12603851; 12611773; 12618431; 12637339; 12637525; 12643788; 12663671; 12665513; 12676937; 12682854; 12690112; 12690113; 12695496; 12727980; 12774925; 12794004; 12794156; 12810719; 12821662; 12826588; 12832284; 12832465; 12832467; 12837293; 12840032; 12871860; 12894225; 12917419; 12935895; 12937136; 12937895; 12943720; 12947314; 12947325; 12957654; 12960100; 12963735; 12972603; 14500714; 14506247; 14511403; 14532121; 14551204; 14575703; 14587029; 14602725; 14620918; 14622970; 14634064; 14636584; 14636891; 14654779; 14655753; 14672918; 14676217; 14676843; 14691575; 14694183; 14701866; 14707138; 14711824; 14714552; 14715628; 14729966; 14742298; 14744867; 14762791; 14764702; 14766231; 14960303; 14970210; 14970219; 14985328; 14997206; 15016620; 15030407; 15033443; 15033452; 15035987; 15037631; 15040022; 15059773; 15064239; 15068691; 15069082; 15078890; 15096502; 15118098; 15128760; 15128788; 15143154; 15155723; 15173068; 15173174; 15187168; 15210734; 15225643; 15239952; 15243131; 15247230; 15247297; 15249224; 15260967; 15292226; 15292252; 15322023; 15347670; 15355986; 15358166; 1545823; 15485655; 15520807; 15529758; 15542825; 15543157; 15545519; 15546878; 15547943; 15563472; 15572696; 15610077; 15616014; 15630448; 15632082; 15653554; 15654082; 15655348; 15657136; 15659806; 15671028; 15713638; 15719130; 15721302; 15728253; 15735702; 15739119; 15746430; 15757891; 15777705; 15778391; 15809051; 15814736; 15851480; 15882975; 15890751; 15897893; 15923189; 15928037; 15967991; 15985432; 16038800; 16047735; 16051177; 16081426; 16135787; 16149052; 16153436; 16198290; 16198352; 16200835; 16209712; 16239230; 16242072; 16253958; 16273204; 16278291; 16278684; 16280323; 16283431; 16286470; 16287813; 16288922; 16291755; 16321971; 16364920; 16368546; 16373414; 16395709; 16406609; 16407301; 16414009; 16436515; 16456541; 16464493; 16492667; 16508002; 16533948; 16538383; 16556602; 16569214; 16574793; 16580177; 16611738; 16617096; 16624816; 16626623; 16635502; 16644735; 16670094; 16676006; 16687572; 16705745; 16723503; 16735500; 16753021; 16763222; 16794828; 16796978; 16813525; 16814421; 16820412; 16820791; 16820947; 16826196; 16848763; 16865246; 16879721; 16897432; 16912315; 16926156; 16941494; 16954218; 16980607; 16995340; 16998804; 17015027; 17016429; 17026958; 17035635; 17038630; 17068343; 17105191; 17128418; 17131384; 17142261; 17149612; 17178906; 17182854; 17200115; 17202194; 17208316; 17212589; 17215072; 17237147; 17255944; 17255949; 17267664; 17284251; 17284314; 17290218; 17294242; 17295209; 17297454; 17303382; 17303384; 17317670; 17317777; 17322878; 17341442; 17351113; 17353931; 17382881; 17397260; 17406055; 17410437; 17427197; 17443665; 17458890; 17464174; 17469127; 17486076; 17496912; 17496918; 17498346; 17502994; 17504381; 17510316; 17512500; 17513610; 17519976; 17522999; 17525735; 17526808; 17531530; 17543571; 17550972; 17563371; 17577579; 17581212; 17581316; 17582224; 17583675; 17602748; 17615382; 17620336; 17620599; 17623675; 17624368; 17631144; 17634019; 17646929; 17652082; 17652083; 17658605; 17662006; 17667937; 17686614; 17689925; 17693641; 17695723; 17697861; 17701086; 17721511; 17765224; 17825787; 17850776; 17879163; 17881458; 17883418; 17884340; 17889508; 17889855; 17921324; 17932312; 17933561; 17936667; 17938255; 17942397; 17942603; 17961162; 17974561; 17974977; 17991320; 17991734; 17991743; 18003605; 18022816; 18026817; 18034864; 18036343; 18055485; 18063683; 18065201; 18069631; 18070930; 18079194; 18079197; 18083711; 18086662; 18087676; 18095097; 18164958; 18165231; 18165705; 18171912; 18178562; 18182379; 18187448; 18189318; 18191226; 18212269; 18224451; 18245089; 18245228; 18256791; 18263590; 18266953; 18270969; 18271757; 18276593; 18280112; 18280482; 18280748; 18284542; 18292183; 18311544; 18327407; 18328346; 18332145; 18338817; 18358530; 18365874; 18372245; 18378228; 18378312; 18385516; 18400991; 18405916; 18410277; 18414015; 18423386; 18424438; 18424783; 18426801; 18426913; 18434089; 18434324; 18434598; 18450423; 18452557; 18456660; 18463290; 18477477; 18487214; 18488018; 18490749; 18508762; 18508903; 18509361; 18516291; 18535203; 18559923; 18562239; 18563362; 18565507; 18570890; 18572386; 18577518; 18587705; 18593910; 18594198; 18616943; 18617556; 18617639; 18624398; 18632853; 18644434; 18667434; 18682391; 18688042; 18694962; 18703508; 18710790; 18711316; 18715846; 18729074; 18755896; 18771677; 18775330; 18782768; 18787043; 18787400; 18798794; 18802359; 18813840; 18830271; 18848526; 18930812; 18949384; 18952847; 18959821; 18974108; 18977218; 18981248; 19001375; 19008312; 19015316; 19020743; 19032445; 19082453; 19082454; 19091303; 19091959; 19097033; 19147502; 19147767; 19151763; 19152186; 19154323; 19158277; 19164283; 19179479; 19184415; 19199380; 19206162; 19206164; 19211028; 19211765; 19219045; 19242111; 19249096; 19279408; 19319478; 19328461; 19363666; 19364816; 19366876; 19367725; 19385051; 19404844; 19407222; 19418584; 19433314; 19445727; 19457236; 19463016; 19475568; 19477272; 19477952; 19484147; 19496172; 19502238; 19502590; 19505457; 19524666; 19527712; 19528227; 19531493; 19543489; 19555684; 19575782; 19588500; 19589780; 19597469; 19610261; 19619936; 19628422; 19631649; 19632304; 19633425; 19643177; 19649722; 19650110; 19651986; 19652666; 19656390; 19672773; 19676104; 19684019; 19686046; 19686845; 19690147; 19697705; 19713532; 19720761; 19723095; 19729990; 19730683; 19751964; 19755487; 19776005; 19782465; 19801668; 19802003; 19805545; 19808666; 19815047; 19816090; 19816934; 19816936; 19819966; 19822148; 19823867; 19833733; 19835659; 19835973; 19855431; 19858308; 19861416; 19874574; 19880579; 19892016; 19901160; 19913121; 19917255; 19917706; 19919532; 19920141; 19926313; 19930715; 19933846; 19941816; 19956840; 20009539; 20038816; 20056178; 20072156; 20072648; 20074451; 20074637; 20074640; 20075392; 20083603; 20086178; 20087064; 20093341; 20097574; 20102637; 20118622; 20123980; 20130576; 20141835; 20155832; 20167130; 20174585; 20179103; 20179705; 20180987; 20189953; 20190820; 20201065; 20203690; 20225236; 20226009; 20232314; 20232315; 20307589; 20335309; 20351270; 20358251; 20359813; 20385094; 20386571; 20415541; 20432452; 20434207; 20451919; 20453075; 20455999; 20460375; 20463007; 20463008; 20463170; 20464500; 20467438; 20468064; 20483734; 20490331; 20493910; 20501673; 20506264; 20508983; 20519144; 20526349; 20534573; 20538278; 20541731; 20554783; 20616308; 20622900; 20623670; 20628086; 20628624; 20664595; 20665674; 20671117; 20671123; 20674547; 20677014; 20680465; 20693286; 20701626; 20716207; 20729213; 20731749; 20735357; 20735841; 20736304; 20737958; 20811691; 20811717; 20823131; 20823133; 20829350; 20832113; 20837468; 20840867; 20847405; 20853849; 20858867; 20889506; 20889557; 20936779; 20956553; 20965228; 21029458; 21029675; 21057728; 21070506; 21071439; 21076047; 21079800; 21084381; 21088106; 21098038; 21098700; 21123621; 21126445; 21135229; 21143918; 21150201; 21159167; 21164364; 21172820; 21177334; 21181091; 21199725; 21200133; 21205481; 21205837; 21212516; 21212994; 21224381; 21228323; 21251217; 21251657; 21262199; 21262770; 21264233; 21266192; 21278199; 21285250; 21293101; 21321112; 21325048; 21335558; 21349701; 21354100; 21354279; 21356304; 21370247; 21378396; 21388279; 21413023; 21415216; 21419341; 21424124; 21424530; 21444628; 21448845; 21454057; 21454500; 21454579; 21454676; 21454801; 21474333; 21487005; 21497119; 21520151; 21537329; 21541441; 21548882; 21551235; 21559503; 21562093; 21565167; 21574189; 21586573; 21606674; 21607585; 21618303; 21619869; 21625939; 21628073; 21635820; 21641389; 21645924; 21669399; 21680106; 21707777; 21708241; 21713404; 21715333; 21720547; 21729547; 21730285; 21732279; 21738699; 21742938; 21747041; 21747198; 21760921; 21762808; 21763495; 21765462; 21768093; 21768115; 21768338; 21778192; 21779496; 21803177; 21807114; 21808062; 21811066; 21821885; 21826244; 21833774; 21835307; 21840940; 21842857; 21849556; 21852536; 21865167; 21871886; 21873429; 21878648; 21896986; 21899882; 21908610; 21914806; 21917714; 21925842; 21952366; 21959954; 21959987; 21960346; 21961242; 21987775; 21988832; 21989417; 22009749; 22024154; 22025613; 22028468; 22039048; 22052014; 22075507; 22076613; 22084399; 22090124; 22094458; 22105580; 22117074; 22147898; 22158075; 22162761; 22171261; 22174934; 22177953; 22178882; 22200507; 22222560; 22229442; 22238304; 22239058; 22241220; 22243975; 22246186; 22262799; 22265030; 22277029; 22293503; 22344067; 22344606; 22345558; 22347375; 22354461; 22354961; 22370345; 22388352; 22393163; 22406505; 22447027; 22475145; 22475441; 22493490; 22502979; 22504224; 22504301; 22510884; 22521293; 22526456; 22529914; 22537555; 22543708; 22546605; 22551942; 22560877; 22562654; 22563495; 22563497; 22564243; 22569528; 22574813; 22575864; 22584435; 22593617; 22610905; 22623428; 22658382; 22659165; 22670315; 22672288; 22675204; 22682478; 22683641; 22696230; 22702503; 22712802; 22722337; 22731636; 22735594; 22745804; 22751131; 22778266; 22796164; 22808094; 22808218; 22808266; 22820249; 22825757; 22828925; 22837689; 22842575; 22848708; 22864777; 22865467; 22866973; 22869729; 22871965; 22898922; 22902213; 22914360; 22914643; 22917644; 22927430; 22935974; 22942770; 22955283; 22955917; 23012423; 23024368; 23039362; 23047924; 23048032; 23052192; 23066034; 23076151; 23088735; 23098854; 23115159; 23125486; 23174997; 23183114; 23196978; 23207287; 23222305; 23241949; 23247634; 23250869; 23258237; 23265704; 23282009; 23286773; 23306155; 23332156; 23338717; 23341459; 23349307; 23349819; 23352452; 23357054; 23360766; 23397142; 23416715; 23424616; 23430108; 23434428; 23441482; 23447674; 23455179; 23455922; 23457635; 23468369; 23468892; 23479736; 23516513; 23519423; 23535064; 23537502; 23538858; 23549785; 23555182; 23558220; 23560844; 23575685; 23576434; 23583981; 23584453; 23585396; 23589880; 23591790; 23601559; 23602568; 23606334; 23613227; 23615537; 23618859; 23620784; 23621408; 23621870; 23640488; 23644655; 23645677; 23650620; 23651922; 23671702; 23674093; 23677697; 23686311; 23698777; 23709326; 23727019; 23754287; 23806683; 23806693; 23812726; 23812841; 23820584; 23827636; 23845703; 23867452; 23867993; 23888996; 23923067; 23966319; 23982477; 23983265; 24024586; 24040019; 24074900; 24091658; 24119769; 24121058; 24128853; 24135138; 24161842; 24164897; 24166600; 24183461; 24199952; 24202393; 24204846; 24219282; 24252614; 24269383; 24270523; 24291038; 24300974; 24331979; 24332066; 24342355; 24345643; 24345920; 24348264; 24358311; 24365237; 24370825; 24371145; 24378749; 24382347; 24397597; 24434142; 24469069; 24488174; 24501087; 24509437; 24525621; 24530396; 24565681; 24587385; 24607276; 24619413; 24646717; 24651010; 24651445; 24657322; 24657659; 24677094; 24691442; 24706358; 24714552; 24716848; 24735981; 24752576; 24768991; 24780196; 24788939; 24789460; 24789704; 24813737; 24813998; 24821574; 24909688; 24923883; 24927687; 24929539; 24937142; 24951586; 24957944; 24966925; 24966948; 24984876; 25016365; 25055025; 25056917; 25065405; 25085753; 25091805; 25104643; 25108429; 25118288; 25120769; 25128071; 25141921; 25144187; 25150310; 25167778; 25182392; 25189770; 25195011; 25197063; 25204415; 25214430; 25217205; 25223800; 25230705; 25241249; 25241253; 25241761; 25247600; 25253956; 25265753; 25267105; 25296734; 25303530; 25319474; 25341684; 25374165; 25376373; 25421411; 25435214; 25497010; 25561793; 25581570; 25582918; 25583406; 25603482; 25605020; 25609649; 25615876; 25619389; 25619392; 25631750; 25634589; 25639353; 25647783; 25652124; 25655003; 25675421; 25678784; 25697727; 25699712; 25713071; 25715050; 25730857; 25738359; 25748447; 25770213; 25780035; 25796184; 25803100; 25816245; 25824786; 25831013; 25845399; 25846811; 25852190; 25855378; 25862896; 25865632; 25866182; 25874498; 25884419; 25889655; 25896662; 25903973; 25907612; 25913664; 25937083; 25948734; 25959126; 25962735; 25976462; 25977981; 26004135; 26041108; 26041434; 26041847; 26044620; 26046303; 26046675; 26047699; 26051103; 26054744; 26062551; 26095851; 26096876; 26117268; 26144345; 26151540; 26163656; 26176534; 26182292; 26204503; 26211551; 26234813; 26247533; 26253279; 26259804; 26261493; 26267534; 26267535; 26269597; 26299326; 26310353; 26320741; 26322419; 26324936; 26334722; 26336134; 26338362; 26346167; 26346493; 26385474; 26391660; 26408092; 26415877; 26464031; 26475474; 26475492; 26489621; 26499109; 26503828; 26510428; 26511315; 26519477; 26548627; 26552705; 26559845; 26574555; 26612919; 26617770; 26626456; 26644469; 26649298; 26657846; 26682012; 26686085; 26695150; 26705127; 26707272; 26718613; 26733474; 26742423; 26752685; 26767647; 26772530; 26773499; 26774343; 26782637; 26785721; 26795953; 26823699; 26828872; 26858456; 26867010; 26872057; 26879318; 26915336; 26930065; 26945151; 26988568; 26992219; 27004400; 27028853; 27036313; 27076520; 27083547; 27085460; 27098723; 27100626; 27107697; 27152455; 27167001; 27173611; 27181591; 27216486; 27223086; 27227380; 27259234; 27259691; 27281782; 27282353; 27293079; 27297874; 27305863; 27356628; 27358402; 27363268; 27366950; 27369075; 27385078; 27391062; 27395339; 27418173; 27423393; 27431267; 27443255; 27456359; 27458015; 27466485; 27486885; 27492718; 27494841; 27498358; 27564099; 27590109; 27591897; 27600951; 27613715; 27624978; 27635110; 27665471; 27667582; 27678294; 27706632; 27721381; 27734226; 27744428; 27760319; 27780136; 27780852; 27791265; 27821168; 27831567; 27835878; 27838300; 27846273; 27876502; 27894083; 27901058; 27907835; 27909249; 27909724; 27941878; 27980400; 28007785; 28030988; 28061458; 28077802; 28079888; 28096188; 28100259; 28114280; 28169830; 28178265; 28178421; 28180113; 28187762; 28188223; 28192403; 28193531; 28198034; 28230290; 28235709; 28241849; 28247965; 28254948; 28279977; 28285962; 28287251; 28295277; 28315433; 28316059; 28328092; 28364380; 28373581; 28376306; 28376477; 28389297; 28393232; 28396058; 28396345; 28396364; 28412413; 28418405; 28435071; 28444966; 28492138; 28494468; 28526294; 28533310; 28536097; 28548957; 28557972; 28569417; 28624624; 28630428; 28646091; 28689659; 28694028; 28730511; 28740606; 28744712; 28765918; 28807789; 28849117; 28869414; 28876465; 28887319; 28912272; 28933561; 28938400; 28978320; 28986121; 28990044; 28992617; 29039574; 29039608; 29071538; 29078142; 29090954; 29103983; 29115577; 29196260; 29198699; 29233917; 29286172; 29321092; 29326072; 29335299; 29355493; 29383561; 29466417; 29475459; 29488609; 29503347; 29550487; 29575240; 29666261; 29729706; 29767236; 29775310; 29901107; 29916542; 30015831; 30039885; 30126634; 30192113; 30249660; 30457858; 30568786; 3287375; 7565670; 7565795; 7588633; 7731720; 7739560; 7889942; 7929275; 7935411; 8013650; 8051079; 8131746; 8157000; 8381049; 8384717; 8388392; 8394845; 8552081; 8626452; 8626561; 8692836; 8816480; 8946918; 9013873; 9020159; 9604935; 9632734; 9677429; 9733512; 9858547; 9924018; 9927426,1992-12-01,2019-02-13,2007-01-23,222,X-ray crystallography (93),STRAND 12 14 {ECO:0000244|PDB:4QTA}.; STRAND 17 19 {ECO:0000244|PDB:4QTA}.; STRAND 25 34 {ECO:0000244|PDB:4ZZN}.; STRAND 37 44 {ECO:0000244|PDB:4ZZN}.; STRAND 49 56 {ECO:0000244|PDB:4ZZN}.; STRAND 59 61 {ECO:0000244|PDB:6G92}.; STRAND 81 83 {ECO:0000244|PDB:5AX3}.; STRAND 88 90 {ECO:0000244|PDB:4ZZN}.; STRAND 101 106 {ECO:0000244|PDB:4ZZN}.; STRAND 109 111 {ECO:0000244|PDB:4ZZN}.; STRAND 155 157 {ECO:0000244|PDB:4ZZN}.; STRAND 163 165 {ECO:0000244|PDB:4ZZN}.; STRAND 201 203 {ECO:0000244|PDB:5K4I}.; STRAND 280 282 {ECO:0000244|PDB:5NHO}.,HELIX 62 77 {ECO:0000244|PDB:4ZZN}.; HELIX 112 118 {ECO:0000244|PDB:4ZZN}.; HELIX 123 142 {ECO:0000244|PDB:4ZZN}.; HELIX 152 154 {ECO:0000244|PDB:4ZZN}.; HELIX 168 170 {ECO:0000244|PDB:3I5Z}.; HELIX 176 178 {ECO:0000244|PDB:4ZZN}.; HELIX 191 193 {ECO:0000244|PDB:4ZZN}.; HELIX 196 200 {ECO:0000244|PDB:4ZZN}.; HELIX 208 223 {ECO:0000244|PDB:4ZZN}.; HELIX 235 244 {ECO:0000244|PDB:4ZZN}.; HELIX 249 253 {ECO:0000244|PDB:4ZZN}.; HELIX 258 265 {ECO:0000244|PDB:4ZZN}.; HELIX 275 278 {ECO:0000244|PDB:4ZZN}.; HELIX 284 293 {ECO:0000244|PDB:4ZZN}.; HELIX 304 308 {ECO:0000244|PDB:4ZZN}.; HELIX 311 313 {ECO:0000244|PDB:4ZZN}.; HELIX 319 321 {ECO:0000244|PDB:4ZZN}.; HELIX 331 334 {ECO:0000244|PDB:5V62}.; HELIX 335 337 {ECO:0000244|PDB:5K4I}.; HELIX 340 351 {ECO:0000244|PDB:4ZZN}.; HELIX 352 354 {ECO:0000244|PDB:4ZZN}.,TURN 22 24 {ECO:0000244|PDB:4ZZN}.; TURN 45 48 {ECO:0000244|PDB:4ZZN}.; TURN 95 97 {ECO:0000244|PDB:4ZZN}.; TURN 159 161 {ECO:0000244|PDB:4IZ5}.; TURN 181 185 {ECO:0000244|PDB:2Y9Q}.; TURN 298 300 {ECO:0000244|PDB:4ZZN}.; TURN 314 316 {ECO:0000244|PDB:4ZZN}.; TURN 356 358 {ECO:0000244|PDB:1PME}.,,,,,5 out of 5,Active site (1); Alternative sequence (1); Beta strand (14); Binding site (7); Chain (1); Compositional bias (1); DNA binding (1); Domain (1); Erroneous initiation (1); Helix (21); Initiator methionine (1); Modified residue (8); Motif (3); Mutagenesis (8); Nucleotide binding (1); Region (2); Sequence conflict (1); Turn (8),,,,3D-structure;ATP-binding;Acetylation;Alternative splicing;Apoptosis;Cell cycle;Complete proteome;Cytoplasm;Cytoskeleton;DNA-binding;Direct protein sequencing;Host-virus interaction;Kinase;Membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Ubl conjugation,Evidence at protein level,reviewed,,"Protein kinase superfamily, CMGC Ser/Thr protein kinase family, MAP kinase subfamily",222,Activity regulation (1); Alternative products (1); Catalytic activity (2); Cofactor (1); Domain (1); Function (2); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (2),,KW-0002; KW-0007; KW-0025; KW-0053; KW-0067; KW-0131; KW-0181; KW-0206; KW-0238; KW-0418; KW-0472; KW-0539; KW-0547; KW-0597; KW-0678; KW-0723; KW-0804; KW-0805; KW-0808; KW-0832; KW-0903; KW-0945; KW-0963; KW-1185,,,,,,,,"PTM: Phosphorylated upon KIT and FLT3 signaling (By similarity). Dually phosphorylated on Thr-185 and Tyr-187, which activates the enzyme. Undergoes regulatory phosphorylation on additional residues such as Ser-246 and Ser-248 in the kinase insert domain (KID) These phosphorylations, which are probably mediated by more than one kinase, are important for binding of MAPK1/ERK2 to importin-7 (IPO7) and its nuclear translocation. In addition, autophosphorylation of Thr-190 was shown to affect the subcellular localization of MAPK1/ERK2 as well. Ligand-activated ALK induces tyrosine phosphorylation. Dephosphorylated by PTPRJ at Tyr-187. Phosphorylation on Ser-29 by SGK1 results in its activation by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. DUSP3 and DUSP6 dephosphorylate specifically MAPK1/ERK2 and MAPK3/ERK1 whereas DUSP9 dephosphorylates a broader range of MAPKs. Dephosphorylated by DUSP1 at Thr-185 and Tyr-187. {ECO:0000250, ECO:0000269|PubMed:17274988, ECO:0000269|PubMed:18760948, ECO:0000269|PubMed:19053285, ECO:0000269|PubMed:19060905, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:19494114}.; PTM: ISGylated. {ECO:0000250}.",CHAIN 2 360 Mitogen-activated protein kinase 1. /FTId=PRO_0000186247.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|PubMed:12665801}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|PubMed:12665801}.; MOD_RES 29 29 Phosphoserine; by SGK1. {ECO:0000269|PubMed:19447520}.; MOD_RES 185 185 Phosphothreonine; by MAP2K1 and MAP2K2. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 187 187 Phosphotyrosine; by MAP2K1 and MAP2K2. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:19053285, ECO:0000269|PubMed:19494114}.; MOD_RES 190 190 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:19060905}.; MOD_RES 246 246 Phosphoserine. {ECO:0000269|PubMed:18760948}.; MOD_RES 248 248 Phosphoserine. {ECO:0000269|PubMed:18760948}.; MOD_RES 284 284 Phosphoserine. {ECO:0000244|PubMed:19369195}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M84489;Z11694;Z11695;DQ399292;BC017832;
0,P35222,CTNB1_HUMAN,CTNNB1 CTNNB OK/SW-cl.35 PRO2286,CTNNB1,CTNNB,,OK/SW-cl.35 PRO2286,Homo sapiens (Human),9606,Catenin beta-1 (Beta-catenin),UP000005640: Chromosome 3,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL,781,"85,497",,,,SEQUENCE CAUTION:  Sequence=BAB93475.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,SEQUENCE CAUTION:  Sequence=AAG35511.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305}; ,,"VARIANT 23 23 S -> R (in hepatocellular carcinoma; no effect; dbSNP:rs1413975856). {ECO:0000269|PubMed:10435629, ECO:0000269|PubMed:12027456}. /FTId=VAR_017612.; VARIANT 25 33 Missing (in hepatocellular carcinoma). {ECO:0000269|PubMed:10435629}. /FTId=VAR_017613.; VARIANT 32 32 D -> A (in hepatocellular carcinoma; dbSNP:rs121913396). {ECO:0000269|PubMed:10435629}. /FTId=VAR_017614.; VARIANT 32 32 D -> G (in PTR and hepatocellular carcinoma; dbSNP:rs121913396). {ECO:0000269|PubMed:10192393, ECO:0000269|PubMed:10435629}. /FTId=VAR_017615.; VARIANT 32 32 D -> Y (in PTR, hepatoblastoma and hepatocellular carcinoma; dbSNP:rs28931588). {ECO:0000269|PubMed:10192393, ECO:0000269|PubMed:10435629, ECO:0000269|PubMed:11703283, ECO:0000269|PubMed:9927029}. /FTId=VAR_017616.; VARIANT 33 33 S -> F (in PTR, MDB and hepatocellular carcinoma; dbSNP:rs121913400). {ECO:0000269|PubMed:10192393, ECO:0000269|PubMed:10435629, ECO:0000269|PubMed:10666372}. /FTId=VAR_017617.; VARIANT 33 33 S -> L (in hepatocellular carcinoma). {ECO:0000269|PubMed:10435629}. /FTId=VAR_017618.; VARIANT 33 33 S -> Y (in colorectal cancer and PTR; enhances transactivation of target genes; dbSNP:rs121913400). {ECO:0000269|PubMed:10192393, ECO:0000269|PubMed:12027456, ECO:0000269|PubMed:9065402}. /FTId=VAR_017619.; VARIANT 34 34 G -> E (in PTR; dbSNP:rs28931589). {ECO:0000269|PubMed:10192393}. /FTId=VAR_017620.; VARIANT 34 34 G -> R (in hepatocellular carcinoma; dbSNP:rs121913399). {ECO:0000269|PubMed:10435629}. /FTId=VAR_017621.; VARIANT 34 34 G -> V (in hepatoblastoma; dbSNP:rs28931589). {ECO:0000269|PubMed:9927029}. /FTId=VAR_017622.; VARIANT 35 35 I -> S (in hepatocellular carcinoma). {ECO:0000269|PubMed:10435629}. /FTId=VAR_017623.; VARIANT 37 38 SG -> W (in hepatocellular carcinoma). {ECO:0000269|PubMed:10435629}. /FTId=VAR_017628.; VARIANT 37 37 S -> A (in MDB and hepatocellular carcinoma; enhances transactivation of target genes; dbSNP:rs121913228). {ECO:0000269|PubMed:10435629, ECO:0000269|PubMed:10666372, ECO:0000269|PubMed:12027456}. /FTId=VAR_017624.; VARIANT 37 37 S -> C (in PTR, hepatoblastoma and ovarian cancer; dbSNP:rs121913403). {ECO:0000269|PubMed:10192393, ECO:0000269|PubMed:10391090, ECO:0000269|PubMed:9927029}. /FTId=VAR_017625.; VARIANT 37 37 S -> F (in PTR; dbSNP:rs121913403). {ECO:0000269|PubMed:10192393}. /FTId=VAR_017626.; VARIANT 37 37 S -> Y (in hepatocellular carcinoma; dbSNP:rs121913403). {ECO:0000269|PubMed:10435629}. /FTId=VAR_017627.; VARIANT 41 41 T -> A (in hepatoblastoma and hepatocellular carcinoma; also in a desmoid tumor; strongly reduces phosphorylation and degradation; abolishes phosphorylation on Ser-33 and Ser-37 and enhances transactivation of target genes; dbSNP:rs121913412). {ECO:0000269|PubMed:10391090, ECO:0000269|PubMed:10398436, ECO:0000269|PubMed:10435629, ECO:0000269|PubMed:10655994, ECO:0000269|PubMed:12027456, ECO:0000269|PubMed:12051714, ECO:0000269|PubMed:9927029}. /FTId=VAR_017629.; VARIANT 41 41 T -> I (in PTR, hepatocellular carcinoma and ovarian cancer; dbSNP:rs121913413). {ECO:0000269|PubMed:10192393, ECO:0000269|PubMed:10391090, ECO:0000269|PubMed:10435629}. /FTId=VAR_017630.; VARIANT 45 45 S -> F (in hepatocellular carcinoma; dbSNP:rs121913409). {ECO:0000269|PubMed:10435629}. /FTId=VAR_017631.; VARIANT 45 45 S -> P (in hepatocellular carcinoma; dbSNP:rs121913407). {ECO:0000269|PubMed:10435629}. /FTId=VAR_017632.; VARIANT 45 45 Missing (in colorectal cancer). {ECO:0000269|PubMed:9065402}. /FTId=VAR_055430.; VARIANT 388 388 L -> P (in MRD19). {ECO:0000269|PubMed:25326669}. /FTId=VAR_072282.; VARIANT 558 781 Missing (in MRD19; the patient also manifest features of exudative vitreoretinopathy). {ECO:0000269|PubMed:28514307}. /FTId=VAR_079199.; VARIANT 688 688 M -> V (in dbSNP:rs4135384). {ECO:0000269|Ref.3}. /FTId=VAR_018954.; VARIANT 710 710 R -> C (in EVR7; unknown pathological significance; dbSNP:rs748653573). {ECO:0000269|PubMed:28575650}. /FTId=VAR_079200.",,,,,,1,,0,,SIMILARITY: Belongs to the beta-catenin family. {ECO:0000305}.,,,,,REGION 2 23 Interaction with VCL. {ECO:0000250}.; REGION 156 178 Interaction with BCL9. {ECO:0000269|PubMed:17052462}.; REGION 772 781 Interaction with SCRIB. {ECO:0000250}.,REPEAT 151 191 ARM 1.; REPEAT 193 234 ARM 2.; REPEAT 235 276 ARM 3.; REPEAT 277 318 ARM 4.; REPEAT 319 360 ARM 5.; REPEAT 361 389 ARM 6.; REPEAT 400 441 ARM 7.; REPEAT 442 484 ARM 8.; REPEAT 489 530 ARM 9.; REPEAT 531 571 ARM 10.; REPEAT 594 636 ARM 11.; REPEAT 637 666 ARM 12.,,,,,,,"FUNCTION: Key downstream component of the canonical Wnt signaling pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes. Involved in the regulation of cell adhesion, as component of an E-cadherin:catenin adhesion complex. Acts as a negative regulator of centrosome cohesion. Involved in the CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization. Blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating DAPK2. Disrupts PML function and PML-NB formation by inhibiting RANBP2-mediated sumoylation of PML (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:18957423, PubMed:21262353, PubMed:22647378, PubMed:22699938, PubMed:22155184). Promotes neurogenesis by maintaining sympathetic neuroblasts within the cell cycle (By similarity). {ECO:0000250|UniProtKB:Q02248, ECO:0000269|PubMed:17524503, ECO:0000269|PubMed:18077326, ECO:0000269|PubMed:18086858, ECO:0000269|PubMed:18957423, ECO:0000269|PubMed:21262353, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22647378, ECO:0000269|PubMed:22699938}.",,,,,,,,,,,,"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; intracellular [GO:0005622]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription factor complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; I-SMAD binding [GO:0070411]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; adherens junction assembly [GO:0034333]; androgen receptor signaling pathway [GO:0030521]; anterior/posterior axis specification [GO:0009948]; beta-catenin destruction complex disassembly [GO:1904886]; beta-catenin-TCF complex assembly [GO:1904837]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; entry of bacterium into host cell [GO:0035635]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon production [GO:0032481]; protein localization to cell surface [GO:0034394]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of euchromatin binding [GO:1904793]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","adherens junction assembly [GO:0034333]; androgen receptor signaling pathway [GO:0030521]; anterior/posterior axis specification [GO:0009948]; beta-catenin destruction complex disassembly [GO:1904886]; beta-catenin-TCF complex assembly [GO:1904837]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell fate specification [GO:0001708]; cell-matrix adhesion [GO:0007160]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal/ventral axis specification [GO:0009950]; dorsal root ganglion development [GO:1990791]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; entry of bacterium into host cell [GO:0035635]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung-associated mesenchyme development [GO:0060484]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein localization to cell surface [GO:0034394]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of euchromatin binding [GO:1904793]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]",alpha-catenin binding [GO:0045294]; androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; ion channel binding [GO:0044325]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134],"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF7L2 complex [GO:0070369]; beta-catenin-TCF complex [GO:1990907]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; intracellular [GO:0005622]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription factor complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]",GO:0000122; GO:0000578; GO:0000904; GO:0000922; GO:0001085; GO:0001102; GO:0001569; GO:0001658; GO:0001701; GO:0001702; GO:0001708; GO:0001711; GO:0001764; GO:0001837; GO:0001840; GO:0002052; GO:0002053; GO:0002089; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003700; GO:0003713; GO:0005622; GO:0005634; GO:0005654; GO:0005667; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005913; GO:0005916; GO:0005923; GO:0005925; GO:0005938; GO:0007155; GO:0007160; GO:0007223; GO:0007268; GO:0007398; GO:0007403; GO:0008022; GO:0008134; GO:0008285; GO:0009948; GO:0009950; GO:0009954; GO:0010718; GO:0010909; GO:0016020; GO:0016032; GO:0016055; GO:0016323; GO:0016328; GO:0016342; GO:0016525; GO:0016600; GO:0019827; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021819; GO:0022009; GO:0030018; GO:0030027; GO:0030054; GO:0030316; GO:0030331; GO:0030521; GO:0030539; GO:0030877; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031528; GO:0031641; GO:0032212; GO:0032331; GO:0032355; GO:0032481; GO:0032991; GO:0032993; GO:0033077; GO:0033234; GO:0034333; GO:0034394; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035257; GO:0035315; GO:0035635; GO:0036023; GO:0042129; GO:0042475; GO:0042493; GO:0042733; GO:0042734; GO:0043065; GO:0043066; GO:0043123; GO:0043410; GO:0043525; GO:0044325; GO:0044334; GO:0044336; GO:0045177; GO:0045202; GO:0045211; GO:0045294; GO:0045296; GO:0045453; GO:0045603; GO:0045669; GO:0045671; GO:0045743; GO:0045765; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0046332; GO:0046982; GO:0048096; GO:0048145; GO:0048469; GO:0048471; GO:0048489; GO:0048538; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048715; GO:0050681; GO:0050767; GO:0050808; GO:0051091; GO:0051145; GO:0051149; GO:0051571; GO:0051884; GO:0051973; GO:0060066; GO:0060070; GO:0060440; GO:0060441; GO:0060479; GO:0060484; GO:0060492; GO:0060742; GO:0060769; GO:0060789; GO:0060828; GO:0060916; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0070062; GO:0070369; GO:0070411; GO:0070491; GO:0070602; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072182; GO:0090279; GO:0097091; GO:0097718; GO:0098609; GO:0098685; GO:0098831; GO:0099092; GO:1903204; GO:1904501; GO:1904793; GO:1904798; GO:1904837; GO:1904886; GO:1904888; GO:1904948; GO:1904954; GO:1990138; GO:1990403; GO:1990791; GO:1990907; GO:1990909; GO:2000008; GO:2000017; GO:2000144; GO:2001234,IPR011989; IPR016024; IPR000225; IPR013284; ,P00519; O43707; Q5JTC6; P25054; P10275; O15169; O35625; Q9YGY0; Q9Y2T1; O00512; A1Z199; Q9Y297; P33724; Q6P1J9; P12830; P19022; P33151; Q92793; P35221; P26231; Q9NSA3; Q9NYF0; P26358; P18146; P50402; P29317; Q9UKB1; Q96AC1; P11362; P49789; P17948; Q08050; Q9BZE0; P49841; Q16665; P42858; P08069; P18012; P46940; O75564; P14923; Q14678; Q2LD37; Q9UJU2; P27782; Q8WVC0; Q9JHQ5; Q9GZQ8; P55197; Q92597; P19838; P29474; O00482-1; P49757; P49757-3; Q8TEW0; P16284; Q99697; P14618; P14618-1; Q03431; Q13308; P08575; P23470; Q12913; P49023; Q04206; Q13761; Q9Y265; Q01887; Q01826; P63208; Q9H6I2; P12931; P15884; P36402; Q9NQB0; O14746; Q9UKE5; P11388; Q13625; O95071; Q9GZV5; Q9EPK5; P46937; P46937-3,"SUBUNIT: Two separate complex-associated pools are found in the cytoplasm. The majority is present as component of an E-cadherin:catenin adhesion complex composed of at least E-cadherin/CDH1 and beta-catenin/CTNNB1, and possibly alpha-catenin/CTNNA1; the complex is located to adherens junctions. The stable association of CTNNA1 is controversial as CTNNA1 was shown not to bind to F-actin when assembled in the complex. Alternatively, the CTNNA1-containing complex may be linked to F-actin by other proteins such as LIMA1. Another cytoplasmic pool is part of a large complex containing AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. Wnt-dependent activation of DVL antagonizes the action of GSK3B. When GSK3B activity is inhibited the complex dissociates, CTNNB1 is dephosphorylated and is no longer targeted for destruction. The stabilized protein translocates to the nucleus, where it binds TCF/LEF-1 family members, TBP, BCL9, BCL9L and possibly also RUVBL1 and CHD8. Binds CTNNBIP and EP300. CTNNB1 forms a ternary complex with LEF1 and EP300 that is disrupted by CTNNBIP1 binding. Interacts with TAX1BP3 (via the PDZ domain); this interaction inhibits the transcriptional activity of CTNNB1. Interacts with AJAP1, BAIAP1, CARM1, CTNNA3, CXADR and PCDH11Y. Binds SLC9A3R1. Interacts with GLIS2 and MUC1. Interacts with SLC30A9. Interacts with XIRP1. Interacts directly with AXIN1; the interaction is regulated by CDK2 phosphorylation of AXIN1. Interacts with SCRIB. Interacts with RAPGEF2. Interacts with PTPRU (via the cytoplasmic juxtamembrane domain). Interacts with EMD. Interacts with TNIK and TCF7L2. Interacts with SESTD1 and TRPC4. Interacts with CAV1. Interacts with TRPV4. The TRPV4 and CTNNB1 complex can interact with CDH1. Interacts with VCL. Interacts with PTPRJ. Interacts with PKT7 and CDK2. Interacts with FAT1 (via the cytoplasmic domain). Interacts with NANOS1 and NDRG2. Interacts with isoform 1 of NEK2. Interacts with both isoform 1 and isoform 2 of CDK5. Interacts with PTK6. Interacts with SOX7; this interaction may lead to proteasomal degradation of active CTNNB1 and thus inhibition of Wnt/beta-catenin-stimulated transcription. Identified in a complex with HINT1 and MITF. Interacts with FHIT. The CTNNB1 and TCF7L2/TCF4 complex interacts with PML (isoform PML-4). Interacts with FERMT2. Identified in a complex with TCF7L2/TCF4 and FERMT2. Interacts with RORA. May interact with P-cadherin/CDH3. Interacts with RNF220 (PubMed:25266658). Interacts with CTNND2 (PubMed:25807484). Interacts (via the C-terminal region) with CBY1 (PubMed:12712206, PubMed:16424001). The complex composed, at least, of APC, CTNNB1 and GSK3B interacts with JPT1; the interaction requires the inactive form of GSK3B (phosphorylated at 'Ser-9') (PubMed:25169422). Interacts with DLG5 (By similarity). Interacts with FAM53B; promoting translocation to the nucleus (PubMed:25183871). Interacts with TMEM170B (PubMed:29367600). Interacts with AHI1 (PubMed:21623382). Interacts with GID8 (PubMed:28829046). Component of an cadherin:catenin adhesion complex composed of at least of CDH26, beta-catenin/CTNNB1, alpha-catenin/CTNNA1 and p120 catenin/CTNND1 (PubMed:28051089). Forms a complex comprising APPL1, RUVBL2, APPL2, HDAC1 and HDAC2 (PubMed:19433865). {ECO:0000250|UniProtKB:Q02248, ECO:0000269|PubMed:10966653, ECO:0000269|PubMed:11279024, ECO:0000269|PubMed:11389839, ECO:0000269|PubMed:11389840, ECO:0000269|PubMed:11590244, ECO:0000269|PubMed:11713475, ECO:0000269|PubMed:11713476, ECO:0000269|PubMed:11751639, ECO:0000269|PubMed:12077367, ECO:0000269|PubMed:12297051, ECO:0000269|PubMed:12370829, ECO:0000269|PubMed:12408824, ECO:0000269|PubMed:12420223, ECO:0000269|PubMed:12501215, ECO:0000269|PubMed:12712206, ECO:0000269|PubMed:12830000, ECO:0000269|PubMed:14595118, ECO:0000269|PubMed:16424001, ECO:0000269|PubMed:16858403, ECO:0000269|PubMed:17009320, ECO:0000269|PubMed:17047063, ECO:0000269|PubMed:17052462, ECO:0000269|PubMed:17289029, ECO:0000269|PubMed:17524503, ECO:0000269|PubMed:18077326, ECO:0000269|PubMed:18086858, ECO:0000269|PubMed:18378692, ECO:0000269|PubMed:18819930, ECO:0000269|PubMed:19433865, ECO:0000269|PubMed:19693690, ECO:0000269|PubMed:19816403, ECO:0000269|PubMed:19996314, ECO:0000269|PubMed:20026641, ECO:0000269|PubMed:20164195, ECO:0000269|PubMed:21132015, ECO:0000269|PubMed:21247902, ECO:0000269|PubMed:21262353, ECO:0000269|PubMed:21623382, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22647378, ECO:0000269|PubMed:22699938, ECO:0000269|PubMed:25169422, ECO:0000269|PubMed:25183871, ECO:0000269|PubMed:25266658, ECO:0000269|PubMed:25807484, ECO:0000269|PubMed:28051089, ECO:0000269|PubMed:28829046, ECO:0000269|PubMed:29367600, ECO:0000269|PubMed:29432739, ECO:0000269|PubMed:7982500}.; SUBUNIT: (Microbial infection) Interacts with herpes virus 8 protein vPK; this interaction inhibits the Wnt signaling pathway. {ECO:0000269|PubMed:29432739}.",7806582; 14702039; 16641997; 15489334; 12019147; 7982500; 9020842; 10029085; 10187801; 10966653; 11703283; 11751639; 11279024; 11590244; 11389839; 11389840; 11464291; 12501215; 12051714; 12297051; 12027456; 11834740; 12077367; 12370829; 12420223; 12830000; 10679188; 12640114; 12712206; 14595118; 16424001; 17047063; 17081983; 16858403; 17524503; 17289029; 17009320; 18077326; 18086858; 18220336; 18819930; 18378692; 18669648; 19816403; 18957423; 19433865; 19690332; 20307497; 20164195; 19996314; 19693690; 20026641; 20068231; 21269460; 21262353; 21132015; 21247902; 21623382; 21406692; 22647378; 22699938; 22155184; 23033978; 22814378; 25183871; 24342833; 24275569; 25266658; 24824780; 25169422; 25807484; 28829046; 28051089; 29432739; 29367600; 28575650; 11136974; 11713475; 11713476; 12408824; 17052462; 18334222; 9065402; 9927029; 10398436; 10391090; 10655994; 10192393; 10435629; 10666372; 25326669; 28514307,7806582; 14702039; 16641997; 15489334; 12019147; 7982500; 9020842; 10029085; 10187801; 10966653; 11703283; 11751639; 11279024; 11590244; 11389839; 11389840; 11464291; 12501215; 12051714; 12297051; 12027456; 11834740; 12077367; 12370829; 12420223; 12830000; 10679188; 12640114; 12712206; 14595118; 16424001; 17047063; 17081983; 16858403; 17524503; 17289029; 17009320; 18077326; 18086858; 18220336; 18819930; 18378692; 18669648; 19816403; 18957423; 19433865; 19690332; 20307497; 20164195; 19996314; 19693690; 20026641; 20068231; 21269460; 21262353; 21132015; 21247902; 21623382; 21406692; 22647378; 22699938; 22155184; 23033978; 22814378; 25183871; 24342833; 24275569; 25266658; 24824780; 25169422; 25807484; 28829046; 28051089; 29432739; 29367600; 28575650; 11136974; 11713475; 11713476; 12408824; 17052462; 18334222; 9065402; 9927029; 10398436; 10391090; 10655994; 10192393; 10435629; 10666372; 25326669; 28514307; 10023660; 10080941; 10198061; 10201372; 10318916; 10406800; 10421629; 10424823; 10473551; 10485845; 10487827; 10549281; 10581160; 10593980; 10601328; 10644691; 10698523; 10748026; 10769018; 10775268; 10801826; 10831834; 10898789; 10921899; 10921920; 10944533; 10987273; 11050151; 11080158; 11375957; 11401320; 11425858; 11429783; 11493532; 11532957; 11564718; 11691915; 11747475; 11790773; 11809808; 11809809; 11819825; 11831984; 11836379; 11836555; 11839663; 11856748; 11857309; 11893906; 11920497; 11921277; 11930117; 11934263; 11939410; 11940574; 11950845; 11953860; 11955436; 11955446; 11957146; 11967263; 11973335; 11988739; 12000790; 12037680; 12045208; 12047349; 12052822; 12060769; 12067995; 12086873; 12101426; 12111402; 12124804; 12127563; 12163411; 12169098; 12183361; 12209953; 12209999; 12219004; 12223464; 12234928; 12235125; 12297048; 12297840; 12389996; 12398896; 12408825; 12417018; 12421363; 12432063; 12439748; 12452049; 12474228; 12478897; 12482967; 12515622; 12532436; 12532469; 12540594; 12556497; 12556519; 12575848; 12587534; 12588987; 12592400; 12603528; 12606575; 12618757; 12634428; 12679314; 12692418; 12694354; 12700239; 12708483; 12729800; 12737446; 12740122; 12748295; 12771132; 12799363; 12810581; 12810642; 12820959; 12824925; 12839684; 12857869; 12883680; 12907143; 12917489; 12927518; 12937339; 12952940; 12969793; 12970740; 12972427; 14500351; 14517306; 14520463; 14563838; 14600025; 14633602; 14660579; 14695187; 14742711; 14766232; 14977843; 14981260; 14985333; 14993280; 1499644; 15057752; 15060161; 15064706; 15064718; 15077166; 15082903; 15102686; 15111320; 15121853; 15126105; 15132997; 15138556; 15149841; 15173161; 15194432; 15208637; 15215241; 15231748; 15239100; 15254684; 15279902; 15289833; 15294866; 15304487; 15306667; 15327768; 15327769; 15331612; 15371335; 15381698; 15381903; 15455387; 15492040; 15500294; 15514031; 15520370; 15523694; 15525529; 15572674; 15591320; 15652341; 15654359; 15660698; 15665104; 15668893; 15670774; 15684397; 15694380; 15695815; 15696778; 15698401; 15728254; 15737630; 15768032; 15781969; 15790758; 15791567; 15806138; 15817486; 15829968; 15832407; 15837931; 15853773; 15888491; 15893313; 15896469; 15905404; 15916880; 15921235; 15927956; 15930302; 15958533; 15972952; 15975091; 15987741; 16005293; 16012954; 16038041; 16082250; 16084063; 16114033; 16124054; 16126725; 16132582; 16133456; 16163548; 16169192; 16196383; 16199882; 16204054; 16204248; 16212417; 16219666; 16239965; 16254206; 16291872; 16306047; 16311123; 16328013; 16343437; 16344550; 16356174; 16371504; 16376880; 16378715; 16378739; 16382042; 16407829; 16428447; 16442529; 16462762; 16465411; 16474376; 16476742; 16496348; 16501564; 16507986; 16510874; 16513652; 16554443; 16565090; 16569639; 16574648; 16618120; 16621789; 16630820; 16644723; 16688229; 16696969; 16707106; 16712787; 16717102; 16724116; 16728727; 16730693; 16753179; 16756492; 16756720; 16760136; 16772034; 16786128; 16798748; 16815294; 16830381; 16843107; 16865250; 16890161; 16927799; 16930546; 16942611; 16945989; 16952352; 16953230; 16968744; 16990252; 16996060; 17018282; 17030184; 17050667; 17057644; 17060906; 17074887; 17087658; 17090192; 17090604; 17113272; 17121828; 17128412; 17129455; 17143292; 17143299; 17143483; 17160944; 17168211; 17172446; 17172473; 17183061; 17203186; 17218525; 17219201; 17220478; 17229887; 17240357; 17241872; 17242406; 17259169; 17260019; 17283121; 17284619; 17287208; 17318175; 17318191; 17341890; 17353931; 17377531; 17383052; 17393110; 17393422; 17412698; 17425782; 17428831; 17429067; 17458864; 17466258; 17500595; 17504383; 17505512; 17507638; 17510365; 17510384; 17513457; 17522055; 17526942; 17529994; 17551084; 17558858; 17569865; 17576040; 17579030; 17592150; 17595165; 17601350; 17601559; 17618275; 17621269; 17627624; 17637758; 17638895; 17641414; 17668445; 17673525; 17679465; 17693578; 17698607; 17710160; 17721184; 17724465; 17764657; 17785436; 17822871; 17851558; 17852416; 17854061; 17854394; 17875931; 17903198; 17905526; 17908501; 17914096; 17923689; 17927853; 17927863; 17927878; 17949810; 17952864; 17956661; 17956664; 17962810; 17977597; 17979146; 17979184; 17982235; 17983802; 17983804; 17992121; 17996206; 18006828; 18006853; 18008331; 18044981; 18048388; 18059161; 18070361; 18078131; 18078366; 18160704; 18161931; 18165946; 18199649; 18206728; 18218837; 18223684; 18223693; 18231728; 18242184; 18256147; 18276111; 18282277; 18284543; 18285264; 18287330; 18288545; 18295959; 18308950; 18309246; 18311776; 18313840; 18315906; 18316097; 18316596; 18320359; 18330089; 18330950; 18335551; 18339531; 18347063; 18353896; 18356165; 18376386; 18382662; 18384130; 18385740; 18391483; 18397460; 18404694; 18419788; 18422699; 18423204; 18439914; 18445113; 18445773; 18455580; 18456656; 18459111; 18460581; 18464243; 18466996; 18485479; 18486530; 18490349; 18490442; 18498752; 18500270; 18515080; 18538736; 18541010; 18552505; 18553167; 18560386; 18563180; 18566211; 18573912; 18586027; 18591935; 18592156; 18593713; 18593890; 18593917; 18598779; 18606139; 18609711; 18611862; 18615589; 18618575; 18619646; 18624796; 18632669; 18632682; 18646694; 18647815; 18653765; 18655368; 18662404; 18664491; 18667832; 18676680; 18676739; 18678706; 18685493; 18686607; 18720004; 18720887; 18757411; 18772112; 18787224; 18799618; 18805092; 18806787; 18807072; 18813944; 18832571; 18835279; 18837082; 18842495; 18932285; 18939887; 18949017; 18949395; 18958538; 18977241; 18979195; 18987336; 18992635; 19001871; 19003969; 19016843; 19018094; 19024596; 19047045; 19060929; 19061640; 19061838; 19064572; 19079338; 19082443; 19085831; 19094982; 19100874; 19101658; 19101982; 19104148; 19106159; 19107203; 19107227; 19118778; 19121846; 19124064; 19124205; 19124717; 19124718; 19126678; 19131506; 19137020; 19137776; 19141652; 19144919; 19145675; 19148484; 19148501; 19153669; 19166851; 19167335; 19169765; 19170196; 19174163; 19175984; 19184060; 19196958; 19197950; 19222307; 19234195; 19237556; 19238201; 19240121; 19244247; 19244314; 19244345; 19247180; 19251162; 19273195; 19274078; 19276972; 19290490; 19293931; 19298008; 19298526; 19303159; 19303846; 19324500; 19329935; 19336574; 19339270; 19351817; 19358846; 19364920; 19369584; 19372141; 19379556; 19383367; 19384065; 19389926; 19396152; 19401692; 19407222; 19413886; 19421142; 19423540; 19435525; 19440933; 19448414; 19448422; 19448592; 19453261; 19460168; 19461076; 19462446; 19463016; 19470755; 19475529; 19479054; 19487278; 19487454; 19492080; 19493659; 19495794; 19498322; 19501458; 19520846; 19526105; 19534622; 19536331; 19545383; 19556239; 19563778; 19564926; 19565571; 19571879; 19576224; 19581924; 19582367; 19607815; 19608668; 19609729; 19619488; 19620634; 19625176; 19628668; 19633358; 19633924; 19635198; 19639172; 19650189; 19652203; 19661031; 19664078; 19667122; 19675674; 19679059; 19679347; 19688824; 19690176; 19692168; 19703516; 19703993; 19704056; 19706825; 19711366; 19726098; 19727391; 19728763; 19729480; 19737400; 19745699; 19751190; 19755524; 19756656; 19777185; 19780202; 19781444; 19801982; 19810105; 19820688; 19826421; 19846673; 19850036; 19857041; 19887615; 19888426; 19898427; 19898734; 19900369; 19912361; 19913121; 19915524; 19923077; 19924227; 19928349; 19931509; 19940019; 19941816; 19952356; 19956716; 19958059; 19961258; 19966865; 19967550; 19996288; 20008139; 20019092; 20020146; 20028853; 20032304; 20033368; 20042714; 20056651; 20061390; 20074550; 20079187; 20086044; 20093106; 20097766; 20112731; 20122174; 20123964; 20126544; 20137080; 20141613; 20143187; 20160094; 20193114; 20195357; 20195621; 20197769; 20203130; 20208143; 20210255; 20224040; 20227366; 20232357; 20233054; 20236250; 20236666; 20302655; 20332102; 20332116; 20347502; 20348951; 20367250; 20369480; 20372837; 20395444; 20399743; 20406964; 20409609; 20419129; 20428811; 20438785; 20446815; 20453844; 20454507; 20459822; 20460486; 20474081; 20491588; 20503246; 20505989; 20508033; 20514474; 20519433; 20519507; 20527231; 20529814; 20529828; 20531388; 20532534; 20533307; 20544848; 20550535; 20561405; 20580720; 20589835; 20596253; 20596624; 20603606; 20613673; 20615089; 20625999; 20628086; 20631314; 20631633; 20634891; 20644561; 20646434; 20646651; 20660612; 20679491; 20693983; 20696077; 20699366; 20705583; 20711500; 20717765; 20736306; 20813688; 20818428; 20840015; 20840677; 20840813; 20856206; 20862283; 20870744; 20886225; 20933443; 20937153; 20943078; 20950152; 20959480; 20963515; 20974860; 21030215; 21031436; 21047397; 21050342; 21056029; 21057570; 21061181; 21073496; 21076461; 21084400; 21108734; 21112398; 21115917; 21118991; 21122409; 21151392; 21152425; 21165564; 21173432; 21179427; 21182203; 21183070; 21183076; 21189258; 21195420; 21196339; 21196815; 21207157; 21215703; 21225227; 21239045; 21240516; 21242974; 21252990; 21254927; 21259057; 21284870; 21292023; 21297666; 21297984; 21299429; 21299609; 21303971; 21317931; 21325624; 21331989; 21336184; 21344156; 21350711; 21352379; 21354309; 21355306; 21357396; 21357690; 21362399; 21368895; 21369691; 21376238; 21378377; 21383695; 21384147; 21385933; 21391741; 21399610; 21422242; 21423209; 21447180; 21448924; 21454805; 21457159; 21466614; 21494638; 21502434; 21505183; 21506126; 21521850; 21524889; 21527747; 21531001; 21532622; 21538055; 21545903; 21562161; 21565795; 21569306; 21575861; 21577209; 21584489; 21602666; 21612684; 21613219; 21617231; 21622533; 21625458; 21643019; 21649463; 21649464; 21654818; 21661417; 21665151; 21671177; 21677537; 21678082; 21691299; 21704588; 21726809; 21741601; 21743491; 21747169; 21751375; 21757651; 21761366; 21764279; 21769465; 21775056; 21781302; 21781452; 21781455; 21792768; 21803632; 21807967; 21812934; 21821917; 21822311; 21822615; 21829575; 21841793; 21849806; 21852086; 21852538; 21858114; 21858154; 21860425; 21875946; 21880956; 21881488; 21881870; 21884207; 21884214; 21885566; 21894439; 21901162; 21908588; 21911577; 21928230; 21935866; 21949247; 21952047; 21952639; 21963849; 21975680; 21980461; 21986938; 21992464; 21993766; 21994129; 21999200; 22007144; 22014042; 22014044; 22014570; 22020335; 22022540; 22023520; 22024040; 22034877; 22041457; 22049531; 22053859; 22056988; 22080244; 22081130; 22083140; 22083958; 22086512; 22093097; 22095489; 22095947; 22099930; 22100495; 22110128; 22115830; 22126602; 22133004; 22135721; 22139084; 22142772; 22152854; 22154485; 22156527; 22157815; 22158051; 22158061; 22166221; 22173096; 22174153; 22180573; 22186018; 22187462; 22190459; 22194818; 22198706; 22199277; 22201888; 22202456; 22209340; 22211293; 22213192; 22221700; 22230368; 22232518; 22234184; 22234612; 22246236; 22261717; 22276175; 22281980; 22287118; 22298898; 22298956; 22300273; 22303878; 22304920; 22307379; 22328737; 22333550; 22337891; 22350414; 22353711; 22369945; 22372443; 22383975; 22391162; 22392736; 22392999; 22406377; 22407433; 22425263; 22427053; 22438566; 22438981; 22454041; 22455883; 22456437; 22458737; 22459450; 22460269; 22466651; 22469663; 22470507; 22475572; 22480520; 22494971; 22505738; 22507326; 22509309; 22511927; 22516360; 22524844; 22526905; 22535304; 22540002; 22550094; 22558232; 22560296; 22571452; 22575643; 22576689; 22579815; 22609776; 22613727; 22614067; 22617422; 22622416; 22630347; 22653977; 22662165; 22662192; 22665063; 22668871; 22674979; 22682247; 22685558; 22692453; 22702043; 22704062; 22705350; 22713211; 22721621; 22723415; 22728435; 22734943; 22739727; 22766794; 22773187; 22773696; 22777005; 22800756; 22805760; 22815287; 22823957; 22846708; 22848100; 22855334; 22859221; 22864797; 22865883; 22905262; 22908324; 22912335; 22914623; 22915253; 22918686; 22919265; 22938416; 22945641; 22946055; 22952611; 22955108; 22956765; 22982193; 23009572; 23020601; 23029025; 23030478; 23032819; 23035229; 23042269; 23056515; 23056571; 23065461; 23067217; 23068095; 23068607; 23071338; 23086933; 23094073; 23099107; 23114888; 23117548; 23124878; 23138978; 23142810; 23152409; 23159080; 23168683; 23174221; 23178880; 23198873; 23208497; 23216017; 23220849; 23221384; 23222438; 23233089; 23235344; 23240619; 23243000; 23243217; 23245941; 23245942; 23246962; 23252868; 23256519; 23261982; 23268410; 23269799; 23273980; 23273993; 23274133; 23280187; 23280703; 23292837; 23295859; 23301872; 23307470; 23316072; 23317545; 23321667; 23325790; 23333633; 23337059; 23339186; 23349466; 23349811; 23355201; 23375645; 23386615; 23397142; 23399619; 23405266; 23406730; 23409032; 23416715; 23437103; 23447569; 23449499; 23452984; 23471552; 23483729; 23489693; 23490077; 23499736; 23504200; 23516071; 23516639; 23525311; 23559415; 23559584; 23576562; 23578392; 23579873; 23580348; 23582741; 23583404; 23583669; 23592333; 23598517; 23602568; 23603171; 23605563; 23613467; 23617586; 23624922; 23629955; 23640056; 23641195; 23661344; 23671189; 23677639; 23691015; 23702845; 23704310; 23708097; 23714193; 23717499; 23721711; 23727580; 23736261; 23743566; 23764002; 23765252; 23767804; 23767917; 23772632; 23784889; 23785285; 23787212; 23790492; 23796566; 23811937; 23826417; 23836524; 23837653; 23840677; 23840886; 23844214; 23887712; 23900566; 23904219; 23913621; 23936352; 23954158; 23960186; 23967107; 23983127; 23999248; 24003087; 24011952; 24012693; 24019458; 24021281; 24036252; 24042437; 24042511; 24055345; 24056964; 24061522; 24071572; 24073846; 24089139; 24096034; 24117889; 24123033; 24136289; 24145651; 24151146; 24157255; 24158438; 24158497; 24171719; 24182564; 24187464; 24189400; 24197976; 24255178; 24260469; 24261884; 24268141; 24276407; 24291232; 24303084; 24314188; 24317174; 24325610; 24333218; 24337587; 24339928; 24355586; 24358122; 24374017; 24398989; 24399733; 24401947; 24412473; 24413733; 24423919; 24424122; 24427347; 24431896; 24449884; 24457961; 24459012; 24476624; 24480807; 24481453; 24496450; 24498333; 24499657; 24501426; 24503442; 24511551; 24535143; 24535843; 24549785; 24556061; 24561119; 24562386; 24605829; 24608043; 24614104; 24622886; 24623448; 24624896; 24629143; 24634935; 24637293; 24651522; 24657339; 24658506; 24658583; 24661731; 24664543; 24695522; 24700283; 24700702; 24715106; 24715170; 24721736; 24722208; 24736394; 24743739; 24744147; 24746516; 24747551; 24748645; 24755523; 24778153; 24785374; 24788044; 24788118; 24798046; 24801904; 24821601; 24823909; 24832083; 24833089; 24837430; 24837480; 24846398; 24859161; 24862328; 24863942; 24888903; 24893577; 24895061; 24897117; 24930713; 24930890; 24931370; 24947187; 24952365; 24954509; 24961284; 24966918; 24969024; 24969559; 24976009; 24990246; 25001176; 25005144; 25005785; 25010141; 25012536; 25025452; 25025858; 25029241; 25029906; 25034524; 25041379; 25043295; 25045846; 25047762; 25058461; 25061104; 25061736; 25062958; 25073953; 25076298; 25090267; 25099011; 25120767; 25124581; 25130271; 25131138; 25135221; 25143352; 25143377; 25164010; 25175023; 25175499; 25193986; 25194164; 25211326; 25217103; 25218472; 25228302; 25232267; 25236602; 25241761; 25251028; 25257174; 25266063; 25270213; 25301365; 25311538; 25313256; 25326580; 25331950; 25333257; 25337242; 25339662; 25341748; 25343173; 25344320; 25348333; 25353218; 25359775; 25360740; 25361430; 25366337; 25374218; 25385294; 25386667; 25396757; 25400723; 25401330; 25401518; 25402006; 25420671; 25423132; 25430888; 25431235; 25435076; 25482924; 25490384; 25500543; 25503133; 25510422; 25517963; 25534855; 25536063; 25536643; 25538040; 25544258; 25544767; 25546293; 25552486; 25562153; 25579555; 25592970; 25596747; 25604686; 25605242; 25609649; 25632187; 25633614; 25636904; 25639486; 25645927; 25650440; 25658419; 25660024; 25660336; 25661872; 25667444; 25668519; 25670168; 25678599; 25681036; 25683913; 25691573; 25696004; 25697359; 25701229; 25732087; 25735793; 25738398; 25746001; 25749386; 25753001; 25771860; 25805023; 25820701; 25821199; 25823656; 25852190; 25857731; 25861021; 25862567; 25864182; 25869100; 25869879; 25873176; 25901368; 25909283; 25913412; 25921273; 25934477; 25942340; 25961922; 25966221; 25967717; 25968898; 25973035; 25980439; 26000787; 26004508; 26015066; 26026718; 26027441; 26034209; 26034868; 26037065; 26045816; 26045876; 26047573; 26047699; 26058972; 26059239; 26068882; 26078714; 26081897; 26088648; 26108805; 26113407; 26116705; 26122848; 26123998; 26129710; 26134785; 26153229; 26164002; 26165519; 26169834; 26171757; 26173102; 26175151; 26200099; 26213846; 26225651; 26246285; 26246473; 26252773; 26267535; 26268703; 26276776; 26284537; 26285011; 26290144; 26311355; 26311743; 26315281; 26317904; 26318035; 26322419; 26332075; 26337084; 26341700; 26359353; 26361959; 26363360; 26370090; 26373808; 26395974; 26397949; 26398277; 26398368; 26398662; 26408312; 26418878; 26422250; 26425687; 26429161; 26432349; 26450645; 26455321; 26477307; 26482209; 26483206; 26491150; 26496610; 26496941; 26497855; 26499380; 26506240; 26509276; 26509912; 26515729; 26521987; 26522223; 26526617; 26530498; 26538583; 26541651; 26552705; 26553052; 26565021; 26572152; 26614845; 26617938; 26628297; 26629686; 26631736; 26638075; 26645068; 26654598; 26657156; 26660958; 26663015; 26666421; 26676402; 26677174; 26681532; 26684358; 26700621; 26701804; 26707073; 26707164; 26708311; 26715559; 26717875; 26720485; 26721203; 26747727; 26755607; 26757261; 26776161; 26779651; 26787464; 26797284; 26804172; 26805761; 26808130; 26815163; 26823833; 26841865; 26841870; 26842923; 26843424; 26844272; 26844628; 26845447; 26849661; 26862060; 26868975; 26876206; 26888969; 26899563; 26905650; 26908451; 26910283; 26910375; 26912724; 26918728; 26921690; 26927026; 26932430; 26932501; 26935950; 26936013; 26942873; 26944016; 26945839; 26947016; 26956838; 26959414; 26960970; 26967979; 26968103; 26975630; 26984280; 26992487; 26996564; 26997628; 27003775; 27012187; 27014877; 27038679; 27052314; 27052477; 27067790; 27068743; 27069136; 27072961; 27081037; 27089389; 27092879; 27105607; 27107935; 27108064; 27125305; 27127145; 27137987; 27155323; 27177928; 27188501; 27188720; 27196759; 27206213; 27239797; 27247127; 27248172; 27259009; 27259010; 27272778; 27276713; 27281614; 27301468; 27302922; 27310371; 27310872; 27321956; 27321958; 27335344; 27363012; 27368802; 27374080; 27378242; 27378423; 27383156; 27384483; 27385092; 27389594; 27391060; 27391264; 27411103; 27411302; 27423571; 27431312; 27448298; 27448302; 27448963; 27449032; 27462866; 27465549; 27468715; 27472396; 27481517; 27485116; 27492069; 27499692; 27501523; 27529071; 27531891; 27543871; 27548498; 27551464; 27558955; 27559173; 27566565; 27567978; 27585692; 27586205; 27588407; 27592306; 27596264; 27596363; 27600761; 27600927; 27602769; 27602957; 27607135; 27619912; 27641329; 27643439; 27653698; 27655540; 27661004; 27661103; 27665868; 27692984; 27698922; 27709738; 27713156; 27713506; 27733866; 27765918; 27771714; 27773936; 27776341; 27780797; 27780915; 27782880; 27783990; 27783993; 27789284; 27793664; 27793695; 27798894; 27801786; 27809309; 27821172; 27824126; 27829235; 27835580; 27835587; 27835591; 27835604; 27835606; 27843945; 27852702; 27878263; 27879202; 27889473; 27890434; 27891591; 27902311; 27908728; 27910065; 27915094; 27924522; 27959422; 27977752; 27984126; 28010732; 28039460; 28052057; 28059452; 28075439; 28076327; 28076844; 28085114; 28088268; 28098905; 28099937; 28099945; 28102204; 28102846; 28112190; 28112375; 28117551; 28119087; 28122729; 28131747; 28132771; 28151479; 28160566; 28161440; 28163245; 28164117; 28178650; 28184024; 28191283; 28195086; 28199981; 28204871; 28209613; 28223148; 28223537; 28234922; 28240604; 28244647; 28259822; 28260015; 28274319; 28277542; 28277615; 28281553; 28295003; 28295012; 28296015; 28300597; 28320874; 28321124; 28328801; 28337019; 28348105; 28349057; 28370249; 28373572; 28416735; 28418353; 28418856; 28422983; 28425477; 28427939; 28438615; 28440436; 28440457; 28459354; 28468589; 28479420; 28498607; 28500561; 28501007; 28522609; 28533663; 28542126; 28547742; 28547961; 28551672; 28578348; 28583303; 28586066; 28602978; 28602980; 28612507; 28615299; 28618047; 28627514; 28627610; 28627792; 28631187; 28631286; 28639896; 28641114; 28645563; 28650464; 28651933; 28671020; 28677426; 28677753; 28684528; 28694190; 28705118; 28714363; 28733222; 28739741; 28741117; 28751540; 28754688; 28764862; 28782520; 28790108; 28796060; 28810144; 28810742; 28811707; 28817119; 28817830; 28844868; 28851389; 28858851; 28870805; 28882645; 28887323; 28889723; 28900081; 28921929; 28925399; 28943339; 28963373; 28965856; 28978671; 29033371; 29039569; 29045075; 29045831; 29048617; 29048651; 29048657; 29066512; 29066531; 29086002; 29101241; 29141249; 29146051; 29152645; 29164578; 29189991; 29224720; 29229887; 29249062; 29250652; 29268818; 29271667; 29286921; 29297710; 29310626; 29315835; 29317218; 29330435; 29331390; 29350680; 29402412; 29408512; 29496308; 29496310; 29562493; 29566950; 29577164; 29603045; 29625497; 29650531; 29660200; 29660231; 29792038; 29882937; 29901121; 29901167; 29901254; 29923144; 30009824; 30015971; 30077672; 30077727; 30082549; 30103006; 30130730; 30189871; 30193944; 30194792; 30226607; 30249289; 30396950; 30514931; 30534810; 3841689; 8601315; 8638126; 8672527; 8756721; 8757136; 8955148; 9118222; 9135132; 9152027; 9264463; 9391096; 9482734; 9488439; 9490669; 9501980; 9541017; 9694656; 9707618; 9727977; 9751710; 9819412; 9843967; 9990852,1994-02-01,2019-02-13,1994-02-01,233,X-ray crystallography (17); NMR spectroscopy (1),STRAND 473 475 {ECO:0000244|PDB:1JDH}.; STRAND 499 501 {ECO:0000244|PDB:4DJS}.; STRAND 550 552 {ECO:0000244|PDB:1QZ7}.; STRAND 554 557 {ECO:0000244|PDB:1QZ7}.; STRAND 561 563 {ECO:0000244|PDB:1T08}.; STRAND 778 780 {ECO:0000244|PDB:3DIW}.,HELIX 135 150 {ECO:0000244|PDB:1G3J}.; HELIX 152 160 {ECO:0000244|PDB:1JDH}.; HELIX 165 179 {ECO:0000244|PDB:1JDH}.; HELIX 182 189 {ECO:0000244|PDB:1JDH}.; HELIX 192 204 {ECO:0000244|PDB:1JDH}.; HELIX 208 221 {ECO:0000244|PDB:1JDH}.; HELIX 225 233 {ECO:0000244|PDB:1JDH}.; HELIX 236 243 {ECO:0000244|PDB:1JDH}.; HELIX 249 265 {ECO:0000244|PDB:1JDH}.; HELIX 269 276 {ECO:0000244|PDB:1JDH}.; HELIX 278 284 {ECO:0000244|PDB:1JDH}.; HELIX 285 287 {ECO:0000244|PDB:1JDH}.; HELIX 291 305 {ECO:0000244|PDB:1JDH}.; HELIX 309 317 {ECO:0000244|PDB:1JDH}.; HELIX 320 330 {ECO:0000244|PDB:1JDH}.; HELIX 334 347 {ECO:0000244|PDB:1JDH}.; HELIX 353 359 {ECO:0000244|PDB:1JDH}.; HELIX 362 367 {ECO:0000244|PDB:1JDH}.; HELIX 375 389 {ECO:0000244|PDB:1JDH}.; HELIX 399 408 {ECO:0000244|PDB:1JDH}.; HELIX 414 427 {ECO:0000244|PDB:1JDH}.; HELIX 432 440 {ECO:0000244|PDB:1JDH}.; HELIX 443 454 {ECO:0000244|PDB:1JDH}.; HELIX 458 471 {ECO:0000244|PDB:1JDH}.; HELIX 478 487 {ECO:0000244|PDB:1JDH}.; HELIX 491 496 {ECO:0000244|PDB:1JDH}.; HELIX 504 517 {ECO:0000244|PDB:1JDH}.; HELIX 521 523 {ECO:0000244|PDB:1JDH}.; HELIX 524 529 {ECO:0000244|PDB:1JDH}.; HELIX 532 547 {ECO:0000244|PDB:1JDH}.; HELIX 566 580 {ECO:0000244|PDB:1JDH}.; HELIX 584 592 {ECO:0000244|PDB:1JDH}.; HELIX 596 601 {ECO:0000244|PDB:1JDH}.; HELIX 602 604 {ECO:0000244|PDB:1JDH}.; HELIX 608 621 {ECO:0000244|PDB:1JDH}.; HELIX 625 633 {ECO:0000244|PDB:1JDH}.; HELIX 637 642 {ECO:0000244|PDB:1JDH}.; HELIX 643 645 {ECO:0000244|PDB:1JDH}.; HELIX 649 662 {ECO:0000244|PDB:1JDH}.; HELIX 668 682 {ECO:0000244|PDB:2Z6H}.; HELIX 688 690 {ECO:0000244|PDB:2Z6H}.,TURN 368 371 {ECO:0000244|PDB:1JDH}.; TURN 428 430 {ECO:0000244|PDB:1JDH}.; TURN 663 665 {ECO:0000244|PDB:2Z6H}.,,,,,5 out of 5,Beta strand (6); Chain (1); Erroneous initiation (1); Glycosylation (1); Helix (41); Initiator methionine (1); Modified residue (20); Mutagenesis (23); Natural variant (26); Region (3); Repeat (12); Sequence caution (1); Turn (3),,"TISSUE SPECIFICITY: Expressed in several hair follicle cell types: basal and peripheral matrix cells, and cells of the outer and inner root sheaths. Expressed in colon. Present in cortical neurons (at protein level). Expressed in breast cancer tissues (at protein level) (PubMed:29367600). {ECO:0000269|PubMed:11703283, ECO:0000269|PubMed:17009320, ECO:0000269|PubMed:17289029, ECO:0000269|PubMed:29367600}.",,3D-structure;Acetylation;Activator;Cell adhesion;Cell junction;Cell membrane;Cell projection;Chromosomal rearrangement;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Glycoprotein;Host-virus interaction;Membrane;Mental retardation;Neurogenesis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;S-nitrosylation;Synapse;Transcription;Transcription regulation;Ubl conjugation;Wnt signaling pathway,Evidence at protein level,reviewed,,Beta-catenin family,233,Function (1); Involvement in disease (9); Post-translational modification (5); Sequence similarities (1); Subcellular location (1); Subunit structure (2); Tissue specificity (1),,KW-0002; KW-0007; KW-0010; KW-0130; KW-0160; KW-0181; KW-0206; KW-0225; KW-0325; KW-0472; KW-0524; KW-0539; KW-0597; KW-0621; KW-0677; KW-0702; KW-0770; KW-0804; KW-0805; KW-0832; KW-0879; KW-0945; KW-0963; KW-0965; KW-0966; KW-0991; KW-1003; KW-1185,,,,,"DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. {ECO:0000269|PubMed:9065402}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Note=Activating mutations in CTNNB1 have oncogenic activity resulting in tumor development. Somatic mutations are found in various tumor types, including colon cancers, ovarian and prostate carcinomas, hepatoblastoma (HB), hepatocellular carcinoma (HCC). HBs are malignant embryonal tumors mainly affecting young children in the first three years of life.; DISEASE: Pilomatrixoma (PTR) [MIM:132600]: Common benign skin tumor. {ECO:0000269|PubMed:10192393, ECO:0000269|PubMed:11703283, ECO:0000269|PubMed:12027456}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Medulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. {ECO:0000269|PubMed:10666372, ECO:0000269|PubMed:12027456}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10391090}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving CTNNB1 is found in salivary gland pleiomorphic adenomas, the most common benign epithelial tumors of the salivary gland. Translocation t(3;8)(p21;q12) with PLAG1.; DISEASE: Mesothelioma, malignant (MESOM) [MIM:156240]: An aggressive neoplasm of the serosal lining of the chest. It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. {ECO:0000269|PubMed:11464291}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Mental retardation, autosomal dominant 19 (MRD19) [MIM:615075]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD19 features include severe intellectual disability with absent or very limited speech, microcephaly, and spasticity which severely impaired the ability to walk. {ECO:0000269|PubMed:23033978, ECO:0000269|PubMed:25326669, ECO:0000269|PubMed:28514307}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Vitreoretinopathy, exudative 7 (EVR7) [MIM:617572]: A form of exudative vitreoretinopathy, a disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. {ECO:0000269|PubMed:28575650}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Phosphorylation at Ser-552 by AMPK promotes stabilizion of the protein, enhancing TCF/LEF-mediated transcription (By similarity). Phosphorylation by GSK3B requires prior phosphorylation of Ser-45 by another kinase. Phosphorylation proceeds then from Thr-41 to Ser-37 and Ser-33. Phosphorylated by NEK2. EGF stimulates tyrosine phosphorylation. Phosphorylation on Tyr-654 decreases CDH1 binding and enhances TBP binding. Phosphorylated on Ser-33 and Ser-37 by HIPK2 and GSK3B, this phosphorylation triggers proteasomal degradation (PubMed:25169422). Phosphorylation on Ser-191 and Ser-246 by CDK5. Phosphorylation by CDK2 regulates insulin internalization. Phosphorylation by PTK6 at Tyr-64, Tyr-142, Tyr-331 and/or Tyr-333 with the predominant site at Tyr-64 is not essential for inhibition of transcriptional activity. {ECO:0000250, ECO:0000269|PubMed:10966653, ECO:0000269|PubMed:11279024, ECO:0000269|PubMed:12027456, ECO:0000269|PubMed:12051714, ECO:0000269|PubMed:12077367, ECO:0000269|PubMed:12640114, ECO:0000269|PubMed:17009320, ECO:0000269|PubMed:18086858, ECO:0000269|PubMed:20026641, ECO:0000269|PubMed:20307497, ECO:0000269|PubMed:21262353, ECO:0000269|PubMed:25169422}.; PTM: Ubiquitinated by the SCF(BTRC) E3 ligase complex when phosphorylated by GSK3B, leading to its degradation (PubMed:12077367). Ubiquitinated by a E3 ubiquitin ligase complex containing UBE2D1, SIAH1, CACYBP/SIP, SKP1, APC and TBL1X, leading to its subsequent proteasomal degradation (PubMed:11389839, PubMed:11389840). {ECO:0000269|PubMed:11389839, ECO:0000269|PubMed:11389840, ECO:0000269|PubMed:12077367}.; PTM: S-nitrosylation at Cys-619 within adherens junctions promotes VEGF-induced, NO-dependent endothelial cell permeability by disrupting interaction with E-cadherin, thus mediating disassembly adherens junctions. {ECO:0000250|UniProtKB:Q02248}.; PTM: O-glycosylation at Ser-23 decreases nuclear localization and transcriptional activity, and increases localization to the plasma membrane and interaction with E-cadherin CDH1. {ECO:0000269|PubMed:24342833}.; PTM: Deacetylated at Lys-49 by SIRT1. {ECO:0000269|PubMed:24824780}.",CHAIN 2 781 Catenin beta-1. /FTId=PRO_0000064271.,,,CARBOHYD 23 23 O-linked (GlcNAc) serine; alternate. {ECO:0000269|PubMed:24342833}.,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378}.,,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378}.; MOD_RES 23 23 Phosphoserine; by GSK3-beta; alternate. {ECO:0000269|PubMed:12027456}.; MOD_RES 29 29 Phosphoserine; by GSK3-beta. {ECO:0000269|PubMed:12027456}.; MOD_RES 33 33 Phosphoserine; by GSK3-beta and HIPK2. {ECO:0000269|PubMed:20307497, ECO:0000269|PubMed:25169422}.; MOD_RES 37 37 Phosphoserine; by GSK3-beta and HIPK2. {ECO:0000269|PubMed:20307497}.; MOD_RES 41 41 Phosphothreonine; by GSK3-beta. {ECO:0000269|PubMed:12027456}.; MOD_RES 45 45 Phosphoserine. {ECO:0000269|PubMed:12051714}.; MOD_RES 49 49 N6-acetyllysine. {ECO:0000269|PubMed:24824780}.; MOD_RES 64 64 Phosphotyrosine; by PTK6. {ECO:0000269|PubMed:20026641}.; MOD_RES 86 86 Phosphotyrosine; by CSK. {ECO:0000269|PubMed:11279024}.; MOD_RES 142 142 Phosphotyrosine; by FYN and PTK6. {ECO:0000269|PubMed:12640114, ECO:0000269|PubMed:20026641}.; MOD_RES 191 191 Phosphoserine; by CDK5. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:17009320}.; MOD_RES 246 246 Phosphoserine; by CDK5. {ECO:0000269|PubMed:17009320}.; MOD_RES 331 331 Phosphotyrosine; by PTK6. {ECO:0000269|PubMed:20026641}.; MOD_RES 333 333 Phosphotyrosine; by PTK6. {ECO:0000305|PubMed:20026641}.; MOD_RES 552 552 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 556 556 Phosphothreonine. {ECO:0000244|PubMed:18220336}.; MOD_RES 619 619 S-nitrosocysteine. {ECO:0000250|UniProtKB:Q02248}.; MOD_RES 654 654 Phosphotyrosine; by CSK. {ECO:0000269|PubMed:11279024}.; MOD_RES 675 675 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:20068231}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X87838;Z19054;AF130085;AY463360;AK289932;CH471055;BC058926;AY081165;AB062292;
0,P36405,ARL3_HUMAN,ARL3 ARFL3,ARL3,ARFL3,,,Homo sapiens (Human),9606,ADP-ribosylation factor-like protein 3,UP000005640: Chromosome 10,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGLLSILRKLKSAPDQEVRILLLGLDNAGKTTLLKQLASEDISHITPTQGFNIKSVQSQGFKLNVWDIGGQRKIRPYWKNYFENTDILIYVIDSADRKRFEETGQELAELLEEEKLSCVPVLIFANKQDLLTAAPASEIAEGLNLHTIRDRVWQIQSCSALTGEGVQDGMNWVCKNVNAKKK,182,"20,456",,,,,,,,,,,,,VARIANT 34 34 L -> M (in dbSNP:rs1141895). {ECO:0000269|Ref.4}. /FTId=VAR_014869.; VARIANT 149 149 R -> C (in JBTS35; dbSNP:rs776901858). {ECO:0000269|PubMed:30269812}. /FTId=VAR_081202.; VARIANT 149 149 R -> H (in JBTS35; decreased release of NPHP3 and INPP5E cargos to the cilium; dbSNP:rs770782663). {ECO:0000269|PubMed:30269812}. /FTId=VAR_081203.,,,,,,2,,0,,SIMILARITY: Belongs to the small GTPase superfamily. Arf family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Small GTP-binding protein which cycles between an inactive GDP-bound and an active GTP-bound form, and the rate of cycling is regulated by guanine nucleotide exchange factors (GEF) and GTPase-activating proteins (GAP) (PubMed:16525022, PubMed:18588884). Required for normal cytokinesis and cilia signaling (PubMed:22085962). Requires assistance from GTPase-activating proteins (GAPs) like RP2 and PDE6D, in order to cycle between inactive GDP-bound and active GTP-bound forms. Required for targeting proteins to the cilium, including myristoylated NPHP3 and prenylated INPP5E (PubMed:30269812). Targets NPHP3 to the ciliary membrane by releasing myristoylated NPHP3 from UNC119B cargo adapter into the cilium (PubMed:22085962). Required for PKD1:PKD2 complex targeting from the trans-Golgi network to the cilium (By similarity). {ECO:0000250|UniProtKB:Q9WUL7, ECO:0000269|PubMed:16525022, ECO:0000269|PubMed:18588884, ECO:0000269|PubMed:22085962}.",,,,,,,BINDING 48 48 GTP. {ECO:0000250}.; BINDING 70 70 GTP; via amide nitrogen. {ECO:0000250}.,,METAL 31 31 Magnesium. {ECO:0000250}.; METAL 48 48 Magnesium. {ECO:0000250}.,NP_BIND 24 31 GTP. {ECO:0000250}.; NP_BIND 67 71 GTP. {ECO:0000250}.; NP_BIND 126 129 GTP. {ECO:0000250}.; NP_BIND 159 161 GTP. {ECO:0000250}.,,centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; small GTPase mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224],cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; small GTPase mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224],GDP binding [GO:0019003]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017],centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876],GO:0000139; GO:0000281; GO:0000287; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0006892; GO:0006893; GO:0007224; GO:0007264; GO:0008017; GO:0015630; GO:0019003; GO:0030496; GO:0032391; GO:0032794; GO:0042073; GO:0042461; GO:0060271; GO:0061512; GO:0070062; GO:1903441,IPR027417; IPR005225; IPR006689; ,O43924; Q13432,"SUBUNIT: Found in a complex with ARL3, RP2 and UNC119 (or UNC119B); RP2 induces hydrolysis of GTP ARL3 in the complex, leading to the release of UNC119 (or UNC119B) (PubMed:11303027, PubMed:11847227, PubMed:18588884). Interacts with RP2; interaction is direct and stimulated with the activated GTP-bound form of ARL3 (PubMed:16472755). Interacts with SYS1 (PubMed:11303027, PubMed:11847227, PubMed:15077113). The GTP-bound form interacts with ARL2BP and PDE6D (PubMed:11303027, PubMed:11847227). Microtubule-associated protein (PubMed:11303027, PubMed:16525022). May interact with GOLGA4 (PubMed:11303027). Interacts with GGA1; the interaction recruits PKD1:PKD2 complex to trans-Golgi network and is required for ciliary targeting of PKD1:PKD2 complex (By similarity). {ECO:0000250|UniProtKB:Q9WUL7, ECO:0000269|PubMed:11303027, ECO:0000269|PubMed:11847227, ECO:0000269|PubMed:15077113, ECO:0000269|PubMed:16472755, ECO:0000269|PubMed:16525022, ECO:0000269|PubMed:18588884}.",8034651; 14702039; 15164054; 15489334; 10831612; 11303027; 12417528; 11847227; 15077113; 16525022; 16472755; 18588884; 20068231; 21269460; 22085962; 24275569; 25944712; 30269812,8034651; 14702039; 15164054; 15489334; 10831612; 11303027; 12417528; 11847227; 15077113; 16525022; 16472755; 18588884; 20068231; 21269460; 22085962; 24275569; 25944712; 30269812; 16169070; 16385451; 18376416; 20106869; 21285245; 22002721; 22389062; 22884633; 22960633; 23548655; 26936825; 27048653; 27481943; 27911709; 28487361; 30227171,1994-06-01,2019-02-13,1995-02-01,186,,,,,,,,,5 out of 5,Binding site (2); Chain (1); Initiator methionine (1); Lipidation (1); Metal binding (2); Modified residue (1); Mutagenesis (2); Natural variant (3); Nucleotide binding (4),,"TISSUE SPECIFICITY: Expressed in the retina. Strongly expressed in connecting cilium, the myoid region of the inner segments (IS) and in cone photoreceptors (at protein level). {ECO:0000269|PubMed:12417528}.",,Cell cycle;Cell division;Cell projection;Ciliopathy;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;GTP-binding;Golgi apparatus;Joubert syndrome;Lipoprotein;Magnesium;Membrane;Metal-binding;Myristate;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport,Evidence at protein level,reviewed,,"Small GTPase superfamily, Arf family",186,Function (1); Involvement in disease (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0131; KW-0132; KW-0181; KW-0206; KW-0225; KW-0333; KW-0342; KW-0449; KW-0460; KW-0472; KW-0479; KW-0519; KW-0539; KW-0547; KW-0597; KW-0621; KW-0653; KW-0813; KW-0903; KW-0963; KW-0966; KW-0979; KW-1185; KW-1186,,,,,"DISEASE: Joubert syndrome 35 (JBTS35) [MIM:618161]: A form of Joubert syndrome, a disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly. JBTS35 inheritance is autosomal recessive. {ECO:0000269|PubMed:30269812}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 2 182 ADP-ribosylation factor-like protein 3. /FTId=PRO_0000207456.,,,,INIT_MET 1 1 Removed. {ECO:0000255}.,LIPID 2 2 N-myristoyl glycine. {ECO:0000255}.,MOD_RES 5 5 Phosphoserine. {ECO:0000244|PubMed:20068231}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U07151;AF493889;AK312525;CR407637;BC009841;
0,P36507,MP2K2_HUMAN,MAP2K2 MEK2 MKK2 PRKMK2,MAP2K2,MEK2 MKK2 PRKMK2,,,Homo sapiens (Human),9606,Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MLARRKPVLPALTINPTIAEGPSPTSEGASEANLVDLQKKLEELELDEQQKKRLEAFLTQKAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLTNHTFIKRSEVEEVDFAGWLCKTLRLNQPGTPTRTAV,400,"44,424",,,,,,,,,,,,,VARIANT 57 57 F -> C (in CFC4; dbSNP:rs121434497). {ECO:0000269|PubMed:16439621}. /FTId=VAR_035095.; VARIANT 57 57 F -> V (in CFC4; dbSNP:rs121434498). {ECO:0000269|PubMed:18042262}. /FTId=VAR_069781.; VARIANT 128 128 P -> Q (in CFC4; results in increased kinase activity; dbSNP:rs267607230). {ECO:0000269|PubMed:20358587}. /FTId=VAR_069782.; VARIANT 134 134 Y -> H (in CFC4; dbSNP:rs121434499). {ECO:0000269|PubMed:18042262}. /FTId=VAR_069783.,,,,CONFLICT 56 56 A -> R (in Ref. 6; AA sequence). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase subfamily. {ECO:0000305}.,,COMPBIAS 266 315 Pro-rich.,DOMAIN 72 369 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,,,2.7.12.2,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.2; Evidence={ECO:0000269|PubMed:10409742}; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.12.2; Evidence={ECO:0000269|PubMed:10409742};",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:10409742}; ,,FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases (By similarity). {ECO:0000250}.,,,,,,"ACT_SITE 194 194 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 101 101 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 78 86 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,SITE 10 11 Cleavage; by anthrax lethal factor.,"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of gene expression [GO:0010629]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]","activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of gene expression [GO:0010629]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]",ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778],GO:0000165; GO:0000187; GO:0004674; GO:0004708; GO:0004712; GO:0004713; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005778; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0005911; GO:0005925; GO:0009898; GO:0010629; GO:0023014; GO:0030165; GO:0031098; GO:0032147; GO:0032872; GO:0036289; GO:0043539; GO:0045893; GO:0046872; GO:0048471; GO:0070371; GO:0071902; GO:0090170; GO:0097110; GO:1903800; GO:2000641,IPR011009; IPR000719; IPR017441; IPR008271; ,P10398; P15056; O95273; Q12959; Q8IVT5; P04049,"SUBUNIT: Interacts with MORG1 (By similarity). Interacts with SGK1 (PubMed:19447520). Interacts with KSR1 (PubMed:10409742). {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:10409742, ECO:0000269|PubMed:19447520}.",8388392; 15489334; 17116858; 9563949; 10409742; 11104681; 17081983; 18088087; 18691976; 18669648; 19413330; 19447520; 19369195; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 16439621; 18042262; 20358587,,1994-06-01,2019-02-13,1994-06-01,214,X-ray crystallography (2),STRAND 72 80 {ECO:0000244|PDB:1S9I}.; STRAND 85 91 {ECO:0000244|PDB:1S9I}.; STRAND 97 103 {ECO:0000244|PDB:1S9I}.; STRAND 133 148 {ECO:0000244|PDB:1S9I}.; STRAND 162 164 {ECO:0000244|PDB:1S9I}.; STRAND 200 202 {ECO:0000244|PDB:1S9I}.; STRAND 208 210 {ECO:0000244|PDB:1S9I}.,HELIX 69 71 {ECO:0000244|PDB:1S9I}.; HELIX 110 119 {ECO:0000244|PDB:1S9I}.; HELIX 120 122 {ECO:0000244|PDB:1S9I}.; HELIX 155 161 {ECO:0000244|PDB:1S9I}.; HELIX 167 186 {ECO:0000244|PDB:1S9I}.; HELIX 197 199 {ECO:0000244|PDB:1S9I}.; HELIX 217 222 {ECO:0000244|PDB:1S9I}.; HELIX 236 239 {ECO:0000244|PDB:1S9I}.; HELIX 246 262 {ECO:0000244|PDB:1S9I}.; HELIX 272 279 {ECO:0000244|PDB:1S9I}.; HELIX 318 327 {ECO:0000244|PDB:1S9I}.; HELIX 340 349 {ECO:0000244|PDB:1S9I}.; HELIX 360 364 {ECO:0000244|PDB:1S9I}.; HELIX 367 374 {ECO:0000244|PDB:1S9I}.; HELIX 379 386 {ECO:0000244|PDB:1S9I}.,TURN 92 94 {ECO:0000244|PDB:1S9I}.; TURN 335 337 {ECO:0000244|PDB:1S9I}.; TURN 354 356 {ECO:0000244|PDB:1S9I}.,,,,,5 out of 5,Active site (1); Beta strand (7); Binding site (1); Chain (1); Compositional bias (1); Domain (1); Helix (15); Modified residue (11); Natural variant (4); Nucleotide binding (1); Sequence conflict (1); Site (1); Turn (3),,,,3D-structure;ATP-binding;Acetylation;Cardiomyopathy;Complete proteome;Cytoplasm;Direct protein sequencing;Disease mutation;Ectodermal dysplasia;Kinase;Magnesium;Membrane;Mental retardation;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Tyrosine-protein kinase,Evidence at protein level,reviewed,,"Protein kinase superfamily, STE Ser/Thr protein kinase family, MAP kinase kinase subfamily",214,Catalytic activity (2); Cofactor (1); Function (1); Involvement in disease (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0038; KW-0067; KW-0122; KW-0181; KW-0225; KW-0418; KW-0460; KW-0472; KW-0479; KW-0547; KW-0597; KW-0723; KW-0808; KW-0829; KW-0903; KW-0963; KW-0991; KW-1185,,,,,"DISEASE: Cardiofaciocutaneous syndrome 4 (CFC4) [MIM:615280]: A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. {ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:18042262, ECO:0000269|PubMed:20358587}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: MAPKK is itself dependent on Ser/Thr phosphorylation for activity catalyzed by MAP kinase kinase kinases (RAF or MEKK1). Phosphorylated by MAP2K1/MEK1 (By similarity). {ECO:0000250}.; PTM: Acetylation of Ser-222 and Ser-226 by Yersinia yopJ prevents phosphorylation and activation, thus blocking the MAPK signaling pathway. {ECO:0000269|PubMed:17116858, ECO:0000269|Ref.3}.",CHAIN 1 400 Dual specificity mitogen-activated protein kinase kinase 2. /FTId=PRO_0000086372.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330}.; MOD_RES 23 23 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 222 222 O-acetylserine; by Yersinia yopJ; alternate. {ECO:0000269|PubMed:17116858}.; MOD_RES 222 222 Phosphoserine; by RAF; alternate. {ECO:0000269|PubMed:10409742, ECO:0000269|PubMed:17116858}.; MOD_RES 226 226 O-acetylserine; by Yersinia yopJ; alternate. {ECO:0000269|PubMed:17116858}.; MOD_RES 226 226 Phosphoserine; alternate. {ECO:0000269|PubMed:17116858}.; MOD_RES 293 293 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 295 295 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231}.; MOD_RES 306 306 Phosphoserine. {ECO:0000250|UniProtKB:Q02750}.; MOD_RES 394 394 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|Ref.3}.; MOD_RES 396 396 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,BC000471;BC018645;
0,P40121,CAPG_HUMAN,CAPG AFCP MCP,CAPG,AFCP MCP,,,Homo sapiens (Human),9606,Macrophage-capping protein (Actin regulatory protein CAP-G),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MYTAIPQSGSPFPGSVQDPGLHVWRVEKLKPVPVAQENQGVFFSGDSYLVLHNGPEEVSHLHLWIGQQSSRDEQGACAVLAVHLNTLLGERPVQHREVQGNESDLFMSYFPRGLKYQEGGVESAFHKTSTGAPAAIKKLYQVKGKKNIRATERALNWDSFNTGDCFILDLGQNIFAWCGGKSNILERNKARDLALAIRDSERQGKAQVEIVTDGEEPAEMIQVLGPKPALKEGNPEEDLTADKANAQAAALYKVSDATGQMNLTKVADSSPFALELLISDDCFVLDNGLCGKIYIWKGRKANEKERQAALQVAEGFISRMQYAPNTQVEILPQGHESPIFKQFFKDWK,348,"38,499",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P40121-1; Sequence=Displayed; Name=2; IsoId=P40121-2; Sequence=VSP_045538; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 207 221 Missing (in isoform 2). {ECO:0000303|Ref.2}. /FTId=VSP_045538.,"VARIANT 41 41 V -> I (in dbSNP:rs2229668). /FTId=VAR_047776.; VARIANT 198 198 R -> W (in dbSNP:rs11539103). /FTId=VAR_047777.; VARIANT 335 335 H -> R (in dbSNP:rs6886). {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21269460, ECO:0000269|PubMed:1322908, ECO:0000269|PubMed:15489334, ECO:0000269|Ref.2, ECO:0000269|Ref.4, ECO:0000269|Ref.7}. /FTId=VAR_047778.",,,,,,2,,0,,SIMILARITY: Belongs to the villin/gelsolin family. {ECO:0000305}.,,,,MOTIF 137 146 Nuclear localization signal. {ECO:0000255}.,,REPEAT 27 75 Gelsolin-like 1.; REPEAT 148 188 Gelsolin-like 2.; REPEAT 261 307 Gelsolin-like 3.,,,,,,,FUNCTION: Calcium-sensitive protein which reversibly blocks the barbed ends of actin filaments but does not sever preformed actin filaments. May play an important role in macrophage function. May play a role in regulating cytoplasmic and/or nuclear structures through potential interactions with actin. May bind DNA.,,,,,,,,,,,,centriole [GO:0005814]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; F-actin capping protein complex [GO:0008290]; Flemming body [GO:0090543]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; barbed-end actin filament capping [GO:0051016]; protein-containing complex assembly [GO:0065003],barbed-end actin filament capping [GO:0051016]; protein-containing complex assembly [GO:0065003],actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904],centriole [GO:0005814]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; F-actin capping protein complex [GO:0008290]; Flemming body [GO:0090543]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726],GO:0001726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0008290; GO:0019904; GO:0030027; GO:0042470; GO:0044877; GO:0045296; GO:0051015; GO:0051016; GO:0065003; GO:0070062; GO:0072686; GO:0090543,IPR029006; IPR029917; IPR007123; IPR007122; ,Q8IUQ4,SUBUNIT: Interacts with NUP62 (PubMed:18266911). Interacts with NUTF2 and RAN; involved in CAPG nuclear import (PubMed:18266911). {ECO:0000269|PubMed:18266911}.,1322908; 15815621; 15489334; 7851883; 17081065; 18266911; 19690332; 20068231; 24275569; 25944712; 7814409; 21269460,1322908; 15815621; 15489334; 7851883; 17081065; 18266911; 19690332; 20068231; 24275569; 25944712; 7814409; 21269460; 12637565; 15454578; 16767159; 16977317; 18059028; 18237446; 18461482; 18709641; 18938132; 19011242; 19166812; 19188659; 19242827; 19367725; 19439302; 20467437; 21768101; 21908955; 22155129; 22190510; 23085225; 23782053; 24804218; 25416956; 26466680; 26663173; 26757732; 28790116; 29970516; 30155403,1995-02-01,2019-02-13,2010-11-30,177,X-ray crystallography (2),STRAND 17 26 {ECO:0000244|PDB:1J72}.; STRAND 28 33 {ECO:0000244|PDB:1J72}.; STRAND 41 43 {ECO:0000244|PDB:1J72}.; STRAND 46 53 {ECO:0000244|PDB:1J72}.; STRAND 55 57 {ECO:0000244|PDB:1J72}.; STRAND 59 65 {ECO:0000244|PDB:1J72}.; STRAND 92 98 {ECO:0000244|PDB:1J72}.; STRAND 115 117 {ECO:0000244|PDB:1J72}.; STRAND 135 143 {ECO:0000244|PDB:1J72}.; STRAND 145 147 {ECO:0000244|PDB:1J72}.; STRAND 149 153 {ECO:0000244|PDB:1J72}.; STRAND 164 170 {ECO:0000244|PDB:1J72}.; STRAND 173 178 {ECO:0000244|PDB:1J72}.; STRAND 207 212 {ECO:0000244|PDB:1J72}.; STRAND 242 246 {ECO:0000244|PDB:1J72}.; STRAND 250 255 {ECO:0000244|PDB:1J72}.; STRAND 262 267 {ECO:0000244|PDB:1J72}.; STRAND 269 272 {ECO:0000244|PDB:1J72}.; STRAND 281 286 {ECO:0000244|PDB:1J72}.; STRAND 291 297 {ECO:0000244|PDB:1J72}.; STRAND 327 332 {ECO:0000244|PDB:1J72}.; STRAND 343 345 {ECO:0000244|PDB:1JHW}.,HELIX 71 87 {ECO:0000244|PDB:1J72}.; HELIX 104 107 {ECO:0000244|PDB:1J72}.; HELIX 157 159 {ECO:0000244|PDB:1J72}.; HELIX 184 198 {ECO:0000244|PDB:1J72}.; HELIX 218 224 {ECO:0000244|PDB:1J72}.; HELIX 274 276 {ECO:0000244|PDB:1J72}.; HELIX 288 290 {ECO:0000244|PDB:1J72}.; HELIX 303 320 {ECO:0000244|PDB:1J72}.,TURN 36 40 {ECO:0000244|PDB:1J72}.; TURN 88 90 {ECO:0000244|PDB:1J72}.; TURN 200 204 {ECO:0000244|PDB:1JHW}.; TURN 338 340 {ECO:0000244|PDB:1J72}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (22); Chain (1); Helix (8); Modified residue (2); Motif (1); Natural variant (3); Repeat (3); Turn (4),CAUTION: This protein was originally thought to be a DNA-binding protein with a helix-loop-helix domain. {ECO:0000305}.,TISSUE SPECIFICITY: Macrophages and macrophage-like cells.,,3D-structure;Acetylation;Actin capping;Actin-binding;Alternative splicing;Cell projection;Complete proteome;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat,Evidence at protein level,reviewed,,Villin/gelsolin family,177,Alternative products (1); Caution (2); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0009; KW-0025; KW-0117; KW-0181; KW-0539; KW-0597; KW-0621; KW-0677; KW-0903; KW-0963; KW-0966; KW-1185,,,,,,,,PTM: The N-terminus is blocked.,CHAIN 1 348 Macrophage-capping protein. /FTId=PRO_0000218753.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:25944712}.; MOD_RES 337 337 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M94345;AC062037;CH471053;CH471053;CH471053;CH471053;BC000728;BC014549;U12026;
0,P41236,IPP2_HUMAN,PPP1R2 IPP2,PPP1R2,IPP2,,,Homo sapiens (Human),9606,Protein phosphatase inhibitor 2 (IPP-2),UP000005640: Chromosome 3,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAASTASHRPIKGILKNKTSTTSSMVASAEQPRGNVDEELSKKSQKWDEMNILATYHPADKDYGLMKIDEPSTPYHSMMGDDEDACSDTEATEAMAPDILARKLAAAEGLEPKYRIQEQESSGEEDSDLSPEEREKKRQFEMKRKLHYNEGLNIKLARQLISKDLHDDDEDEEMLETADGESMNTEESNQGSTPSDQQQNKLRSS,205,"23,015",,,,,,,,,,,,,,,,,,,2,,0,,SIMILARITY: Belongs to the protein phosphatase inhibitor 2 family. {ECO:0000305}.,,,,,"REGION 12 17 Required for binding PPP1CC. {ECO:0000250}.; REGION 43 55 Required for binding PPP1CC. {ECO:0000250}.; REGION 147 150 Required for binding PPP1CC catalytic center, displacing metal ions and inhibition of PPP1CC catalytic activity. {ECO:0000250}.",,,,,,,,FUNCTION: Inhibitor of protein-phosphatase 1.,,,,,,,,,,,,protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966],generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966],protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865],,GO:0004864; GO:0004865; GO:0005977; GO:0006091; GO:0009966; GO:0043666,IPR007062; ,Q8IWU2; P62136; P36873; Q9BSI4,SUBUNIT: Heterodimer with PP1. {ECO:0000269|PubMed:18250156}.,7949733; 8119416; 9126490; 15489334; 12665801; 18220336; 18250156; 18669648; 19690332; 21269460; 23506001; 23186163,7949733; 8119416; 9126490; 15489334; 12665801; 18220336; 18250156; 18669648; 19690332; 21269460; 23506001; 23186163; 10807923; 11320080; 12221103; 12393858; 12697755; 12761178; 16627625; 16987514; 17353931; 18716057; 19036150; 20195357; 20360068; 21044950; 21382349; 21714498; 22321011; 23455922; 23602568; 24195737; 24366813; 25028520; 26496610; 26655089; 9405437,1995-02-01,2019-02-13,2007-01-23,173,,,,,,,,,5 out of 5,Chain (1); Initiator methionine (1); Modified residue (10); Region (3),,,,Acetylation;Carbohydrate metabolism;Complete proteome;Direct protein sequencing;Glycogen metabolism;Phosphoprotein;Protein phosphatase inhibitor;Reference proteome,Evidence at protein level,reviewed,,Protein phosphatase inhibitor 2 family,173,Function (1); Post-translational modification (1); Sequence similarities (1); Subunit structure (1),,KW-0007; KW-0119; KW-0181; KW-0321; KW-0597; KW-0650; KW-0903; KW-1185,,,,,,,,"PTM: Phosphorylation on Thr-73 by GSK3 activates PP1 by dissociating the PP1-PPP1R2 complex (By similarity). Phosphorylation on Ser-44 by ATM activates PP1 by dissociating the PP1-PPP1R2 complex. {ECO:0000250, ECO:0000269|PubMed:18250156, ECO:0000269|PubMed:23506001}.",CHAIN 2 205 Protein phosphatase inhibitor 2. /FTId=PRO_0000071481.,,,,"INIT_MET 1 1 Removed. {ECO:0000250|UniProtKB:P11845, ECO:0000269|PubMed:12665801}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000250|UniProtKB:P11845}.; MOD_RES 44 44 Phosphoserine; by ATM. {ECO:0000269|PubMed:18250156}.; MOD_RES 73 73 Phosphothreonine; by GSK3. {ECO:0000250|UniProtKB:P11845}.; MOD_RES 87 87 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 89 89 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 92 92 Phosphothreonine. {ECO:0000244|PubMed:18220336}.; MOD_RES 121 121 Phosphoserine. {ECO:0000269|PubMed:23506001}.; MOD_RES 122 122 Phosphoserine. {ECO:0000269|PubMed:23506001}.; MOD_RES 127 127 Phosphoserine. {ECO:0000269|PubMed:23506001}.; MOD_RES 130 130 Phosphoserine. {ECO:0000250|UniProtKB:Q9DCL8}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X78873;Z29646;U68111;U68106;U68107;U68108;U68109;U68110;AJ133812;AY063767;BC007655;
0,P49711,CTCF_HUMAN,CTCF,CTCF,,,,Homo sapiens (Human),9606,Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog),UP000005640: Chromosome 16,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MEGDAVEAIVEESETFIKGKERKTYQRRREGGQEEDACHLPQNQTDGGEVVQDVNSSVQMVMMEQLDPTLLQMKTEVMEGTVAPEAEAAVDDTQIITLQVVNMEEQPINIGELQLVQVPVPVTVPVATTSVEELQGAYENEVSKEGLAESEPMICHTLPLPEGFQVVKVGANGEVETLEQGELPPQEDPSWQKDPDYQPPAKKTKKTKKSKLRYTEEGKDVDVSVYDFEEEQQEGLLSEVNAEKVVGNMKPPKPTKIKKKGVKKTFQCELCSYTCPRRSNLDRHMKSHTDERPHKCHLCGRAFRTVTLLRNHLNTHTGTRPHKCPDCDMAFVTSGELVRHRRYKHTHEKPFKCSMCDYASVEVSKLKRHIRSHTGERPFQCSLCSYASRDTYKLKRHMRTHSGEKPYECYICHARFTQSGTMKMHILQKHTENVAKFHCPHCDTVIARKSDLGVHLRKQHSYIEQGKKCRYCDAVFHERYALIQHQKSHKNEKRFKCDQCDYACRQERHMIMHKRTHTGEKPYACSHCDKTFRQKQLLDMHFKRYHDPNFVPAAFVCSKCGKTFTRRNTMARHADNCAGPDGVEGENGGETKKSKRGRKRKMRSKKEDSSDSENAEPDLDDNEDEEEPAVEIEPEPEPQPVTPAPPPAKKRRGRPPGRTNQPKQNQPTAIIQVEDQNTGAIENIIVEVKKEPDAEPAEGEEEEAQPAATDAPNGDLTPEMILSMMDR,727,"82,785",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P49711-1; Sequence=Displayed; Name=2; IsoId=P49711-2; Sequence=VSP_045350; Note=No experimental confirmation available.; ,,SEQUENCE CAUTION:  Sequence=BAD93030.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 1 328 Missing (in isoform 2). {ECO:0000303|Ref.5}. /FTId=VSP_045350.,VARIANT 19 727 Missing (found in an endometrial carcinoma sample; unknown pathological significance). {ECO:0000269|PubMed:28319062}. /FTId=VAR_079374.; VARIANT 278 278 R -> C (found in an endometrial carcinoma sample; no effect on its nuclear localization; loss of its ability to inhibit cell proliferation; unknown pathological significance; dbSNP:rs1266478000). {ECO:0000269|PubMed:28319062}. /FTId=VAR_079375.; VARIANT 339 339 R -> W (in a Wilms' tumor; dbSNP:rs1243010179). {ECO:0000269|PubMed:11782357}. /FTId=VAR_013141.; VARIANT 342 342 R -> H (found in an endometrial carcinoma sample; no effect on its nuclear localization; loss of its ability to inhibit cell proliferation; unknown pathological significance). {ECO:0000269|PubMed:28319062}. /FTId=VAR_079376.; VARIANT 344 344 K -> E (in a breast tumor; dbSNP:rs1215280530). {ECO:0000269|PubMed:11782357}. /FTId=VAR_013142.; VARIANT 345 345 H -> R (in a prostate tumor). {ECO:0000269|PubMed:11782357}. /FTId=VAR_013143.; VARIANT 365 365 K -> T (found in an endometrial carcinoma sample; no effect on its nuclear localization; no loss of its ability to inhibit cell proliferation; unknown pathological significance). {ECO:0000269|PubMed:28319062}. /FTId=VAR_079377.; VARIANT 448 448 R -> Q (in a Wilms' tumor). {ECO:0000269|PubMed:11782357}. /FTId=VAR_013144.; VARIANT 567 567 R -> W (in MRD21; dbSNP:rs879255516). {ECO:0000269|PubMed:23746550}. /FTId=VAR_070776.,,,,,,1,,0,"DOMAIN: The 11 zinc fingers are highly conserved among vertebrates, exhibiting almost identical amino acid sequences. Different subsets or combination of individual zinc fingers gives the ability to CTCF to recognize multiple DNA target sites.",SIMILARITY: Belongs to the CTCF zinc-finger protein family. {ECO:0000305}.,,,,,,,ZN_FING 266 288 C2H2-type 1. {ECO:0000255|PROSITE-ProRule:PRU00042}.; ZN_FING 294 316 C2H2-type 2. {ECO:0000255|PROSITE-ProRule:PRU00042}.; ZN_FING 322 345 C2H2-type 3. {ECO:0000255|PROSITE-ProRule:PRU00042}.; ZN_FING 351 373 C2H2-type 4. {ECO:0000255|PROSITE-ProRule:PRU00042}.; ZN_FING 379 401 C2H2-type 5. {ECO:0000255|PROSITE-ProRule:PRU00042}.; ZN_FING 407 430 C2H2-type 6. {ECO:0000255|PROSITE-ProRule:PRU00042}.; ZN_FING 437 460 C2H2-type 7. {ECO:0000255|PROSITE-ProRule:PRU00042}.; ZN_FING 467 489 C2H2-type 8. {ECO:0000255|PROSITE-ProRule:PRU00042}.; ZN_FING 495 517 C2H2-type 9. {ECO:0000255|PROSITE-ProRule:PRU00042}.; ZN_FING 523 546 C2H2-type 10. {ECO:0000255|PROSITE-ProRule:PRU00042}.; ZN_FING 555 577 C2H2-type 11; atypical. {ECO:0000255|PROSITE-ProRule:PRU00042}.,,,,,,"FUNCTION: Chromatin binding factor that binds to DNA sequence specific sites. Involved in transcriptional regulation by binding to chromatin insulators and preventing interaction between promoter and nearby enhancers and silencers. Acts as transcriptional repressor binding to promoters of vertebrate MYC gene and BAG1 gene. Also binds to the PLK and PIM1 promoters. Acts as a transcriptional activator of APP. Regulates APOA1/C3/A4/A5 gene cluster and controls MHC class II gene expression. Plays an essential role in oocyte and preimplantation embryo development by activating or repressing transcription. Seems to act as tumor suppressor. Plays a critical role in the epigenetic regulation. Participates in the allele-specific gene expression at the imprinted IGF2/H19 gene locus. On the maternal allele, binding within the H19 imprinting control region (ICR) mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to IGF2. Plays a critical role in gene silencing over considerable distances in the genome. Preferentially interacts with unmethylated DNA, preventing spreading of CpG methylation and maintaining methylation-free zones. Inversely, binding to target sites is prevented by CpG methylation. Plays a important role in chromatin remodeling. Can dimerize when it is bound to different DNA sequences, mediating long-range chromatin looping. Mediates interchromosomal association between IGF2/H19 and WSB1/NF1 and may direct distant DNA segments to a common transcription factory. Causes local loss of histone acetylation and gain of histone methylation in the beta-globin locus, without affecting transcription. When bound to chromatin, it provides an anchor point for nucleosomes positioning. Seems to be essential for homologous X-chromosome pairing. May participate with Tsix in establishing a regulatable epigenetic switch for X chromosome inactivation. May play a role in preventing the propagation of stable methylation at the escape genes from X- inactivation. Involved in sister chromatid cohesion. Associates with both centromeres and chromosomal arms during metaphase and required for cohesin localization to CTCF sites. Regulates asynchronous replication of IGF2/H19. Plays a role in the recruitment of CENPE to the pericentromeric/centromeric regions of the chromosome during mitosis (PubMed:26321640). {ECO:0000269|PubMed:11743158, ECO:0000269|PubMed:16815976, ECO:0000269|PubMed:17827499, ECO:0000269|PubMed:18347100, ECO:0000269|PubMed:18413740, ECO:0000269|PubMed:18550811, ECO:0000269|PubMed:18654629, ECO:0000269|PubMed:19322193, ECO:0000269|PubMed:26321640, ECO:0000269|PubMed:8649389, ECO:0000269|PubMed:9591631}.",,,,,,,,,,,,"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]","chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]","chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]","chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",GO:0000122; GO:0000775; GO:0000793; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006306; GO:0006349; GO:0007059; GO:0008270; GO:0008285; GO:0010216; GO:0010628; GO:0016584; GO:0031060; GO:0035065; GO:0040029; GO:0040030; GO:0043035; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0070602; GO:0071459,IPR036236; IPR013087; ,Q00341; Q9UGL1; Q01860; Q5VZL5,"SUBUNIT: Interacts with CHD8 (PubMed:16949368). Interacts with LLPH (By similarity). Interacts with CENPE (PubMed:26321640). {ECO:0000250|UniProtKB:Q61164, ECO:0000269|PubMed:16949368, ECO:0000269|PubMed:26321640}.",8649389; 9591631; 11782357; 15616553; 15489334; 9407128; 12191639; 11743158; 16107875; 16595548; 16949368; 16815976; 17827499; 18413740; 18347100; 18654629; 18669648; 18550811; 19322193; 19690332; 19608861; 20068231; 21269460; 21406692; 22814378; 25218447; 26321640; 28112733; 23746550; 28319062,8649389; 9591631; 11782357; 15616553; 15489334; 9407128; 12191639; 11743158; 16107875; 16595548; 16949368; 16815976; 17827499; 18413740; 18347100; 18654629; 18669648; 18550811; 19322193; 19690332; 19608861; 20068231; 21269460; 21406692; 22814378; 25218447; 26321640; 28112733; 23746550; 28319062; 10579975; 10679930; 10734189; 11566863; 11971967; 11997516; 12099698; 12203779; 12524457; 12878173; 12960026; 14503807; 14645507; 14759373; 15084242; 15096508; 15158084; 15304340; 15471867; 15503857; 15670593; 15731119; 15941718; 15958555; 16140944; 16230345; 16731911; 16989720; 17185360; 17267480; 17583694; 17660710; 17663992; 17761849; 17851529; 18021171; 18164278; 18207574; 18219272; 18235444; 18237772; 18604514; 18923423; 19008940; 19056695; 19060911; 19074263; 19158269; 19247430; 19369356; 19450526; 19505873; 19513555; 19568426; 19584098; 19703992; 19737964; 19818655; 19922652; 19956589; 20038529; 20051228; 20101205; 20110362; 20133600; 20196073; 20231276; 20360068; 20404925; 20478995; 20584980; 20610384; 20711500; 20733034; 20877461; 20966046; 21087926; 21296871; 21325284; 21444719; 21451113; 21536749; 21550623; 21663659; 21884934; 21964334; 21970734; 22072770; 22110697; 22142239; 22247490; 22286186; 22347474; 22354964; 22422629; 22487828; 22538856; 22615834; 22791747; 22879976; 22952237; 23186133; 23192870; 23204437; 23553099; 23620300; 23706817; 23843455; 23874213; 23884423; 23902751; 23955559; 24023969; 24130125; 24174344; 24174538; 24257606; 24321385; 24335803; 24362533; 24393203; 24415941; 2444477; 24498324; 2452725; 24534946; 24561205; 24614316; 24659782; 24725430; 24794443; 24842653; 24901509; 24937458; 25101834; 25135475; 25299688; 25411781; 25416956; 25580597; 25592173; 25658338; 25665578; 25694598; 25703332; 25875106; 25881024; 25934638; 25936568; 26125810; 26154016; 26276636; 26302455; 26315019; 26321255; 26330387; 26376810; 26439501; 26478432; 26496610; 26549029; 26549033; 26578602; 26711177; 26747525; 26784546; 26802288; 26833217; 26929370; 26938874; 26953320; 26983574; 27019336; 27067545; 27089971; 27219007; 27226577; 27417714; 27490693; 27569350; 27582050; 27583466; 27762310; 27798106; 27848966; 27974201; 28045091; 28161276; 28262757; 28490592; 28529057; 28536180; 28560323; 28796949; 28848059; 28862757; 29076501; 29110030; 29157910; 29235471; 29437926; 29654311; 29698677; 29845264; 29956775; 29976663; 29981477; 30086769; 30310060; 7901228; 8100763; 8759021; 9272954; 9570764; 9895323,1996-10-01,2019-02-13,1996-10-01,192,X-ray crystallography (12); NMR spectroscopy (2),STRAND 297 300 {ECO:0000244|PDB:5T0U}.; STRAND 302 305 {ECO:0000244|PDB:5T0U}.; STRAND 325 327 {ECO:0000244|PDB:5YEF}.; STRAND 330 333 {ECO:0000244|PDB:5KKQ}.; STRAND 354 357 {ECO:0000244|PDB:5KKQ}.; STRAND 359 362 {ECO:0000244|PDB:5KKQ}.; STRAND 382 385 {ECO:0000244|PDB:5KKQ}.; STRAND 387 390 {ECO:0000244|PDB:5KKQ}.; STRAND 406 408 {ECO:0000244|PDB:2CT1}.; STRAND 415 418 {ECO:0000244|PDB:5KKQ}.; STRAND 437 439 {ECO:0000244|PDB:5KKQ}.; STRAND 444 448 {ECO:0000244|PDB:5KKQ}.; STRAND 460 468 {ECO:0000244|PDB:5YEF}.; STRAND 470 473 {ECO:0000244|PDB:5YEG}.; STRAND 475 478 {ECO:0000244|PDB:5YEG}.; STRAND 498 500 {ECO:0000244|PDB:5UND}.; STRAND 503 506 {ECO:0000244|PDB:5YEL}.; STRAND 526 529 {ECO:0000244|PDB:5YEL}.; STRAND 531 535 {ECO:0000244|PDB:5YEL}.; STRAND 558 560 {ECO:0000244|PDB:5YEL}.; STRAND 563 565 {ECO:0000244|PDB:1X6H}.,HELIX 306 316 {ECO:0000244|PDB:5T0U}.; HELIX 334 344 {ECO:0000244|PDB:5KKQ}.; HELIX 363 374 {ECO:0000244|PDB:5KKQ}.; HELIX 391 402 {ECO:0000244|PDB:5KKQ}.; HELIX 419 429 {ECO:0000244|PDB:5KKQ}.; HELIX 431 433 {ECO:0000244|PDB:5K5L}.; HELIX 449 459 {ECO:0000244|PDB:5KKQ}.; HELIX 479 486 {ECO:0000244|PDB:5YEG}.; HELIX 507 514 {ECO:0000244|PDB:5UND}.; HELIX 536 540 {ECO:0000244|PDB:5YEL}.; HELIX 541 545 {ECO:0000244|PDB:5YEL}.; HELIX 567 575 {ECO:0000244|PDB:5YEL}.,TURN 410 412 {ECO:0000244|PDB:5KKQ}.; TURN 440 443 {ECO:0000244|PDB:5KKQ}.; TURN 489 493 {ECO:0000244|PDB:5UND}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (21); Chain (1); Cross-link (4); Erroneous initiation (1); Helix (12); Modified residue (8); Natural variant (9); Turn (3); Zinc finger (11),,TISSUE SPECIFICITY: Ubiquitous. Absent in primary spermatocytes. {ECO:0000269|PubMed:9591631}.,MISCELLANEOUS: More than 13'00 CTCF-binding sites in potential insulators were identified in the human genome.,3D-structure;Acetylation;Activator;Alternative splicing;Centromere;Chromatin regulator;Chromosome;Chromosome partition;Complete proteome;DNA-binding;Direct protein sequencing;Disease mutation;Isopeptide bond;Mental retardation;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation;Zinc;Zinc-finger,Evidence at protein level,reviewed,,CTCF zinc-finger protein family,192,Alternative products (1); Caution (1); Domain (1); Function (1); Involvement in disease (1); Miscellaneous (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0010; KW-0025; KW-0043; KW-0137; KW-0156; KW-0158; KW-0159; KW-0181; KW-0225; KW-0238; KW-0479; KW-0539; KW-0597; KW-0621; KW-0677; KW-0678; KW-0804; KW-0805; KW-0832; KW-0862; KW-0863; KW-0903; KW-0991; KW-1017; KW-1185,,,,,"DISEASE: Mental retardation, autosomal dominant 21 (MRD21) [MIM:615502]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Additional MRD21 features include short stature, microcephaly, and developmental delay. {ECO:0000269|PubMed:23746550}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: Sumoylated on Lys-74 and Lys-689; sumoylation of CTCF contributes to the repressive function of CTCF on the MYC P2 promoter. {ECO:0000250|UniProtKB:Q61164}.,CHAIN 1 727 Transcriptional repressor CTCF. /FTId=PRO_0000047228.,"CROSSLNK 18 18 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 74 74 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO). {ECO:0000250}.; CROSSLNK 219 219 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 689 689 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:28112733}.",,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 289 289 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 317 317 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 374 374 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 402 402 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 609 609 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 610 610 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 612 612 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U25435;AF145477;AF145468;AF145469;AF145470;AF145471;AF145472;AF145473;AF145474;AF145475;AF145476;BT009915;AB209793;CH471092;BC014267;
0,P50395,GDIB_HUMAN,GDI2 RABGDIB,GDI2,RABGDIB,,,Homo sapiens (Human),9606,Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2),UP000005640: Chromosome 10,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MNEEYDVIVLGTGLTECILSGIMSVNGKKVLHMDRNPYYGGESASITPLEDLYKRFKIPGSPPESMGRGRDWNVDLIPKFLMANGQLVKMLLYTEVTRYLDFKVTEGSFVYKGGKIYKVPSTEAEALASSLMGLFEKRRFRKFLVYVANFDEKDPRTFEGIDPKKTTMRDVYKKFDLGQDVIDFTGHALALYRTDDYLDQPCYETINRIKLYSESLARYGKSPYLYPLYGLGELPQGFARLSAIYGGTYMLNKPIEEIIVQNGKVIGVKSEGEIARCKQLICDPSYVKDRVEKVGQVIRVICILSHPIKNTNDANSCQIIIPQNQVNRKSDIYVCMISFAHNVAAQGKYIAIVSTTVETKEPEKEIRPALELLEPIEQKFVSISDLLVPKDLGTESQIFISRTYDATTHFETTCDDIKNIYKRMTGSEFDFEEMKRKKNDIYGED,445,"50,663",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P50395-1; Sequence=Displayed; Name=2; IsoId=P50395-2; Sequence=VSP_043469; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 86 130 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_043469.,,,,,CONFLICT 2 2 N -> D (in Ref. 1; BAA03095). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the Rab GDI family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Regulates the GDP/GTP exchange reaction of most Rab proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them.",,,,,,,,,,,,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264],neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264],GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982],GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0031267; GO:0031982; GO:0034774; GO:0035578; GO:0043312; GO:0045202; GO:0051056; GO:0070062,IPR036188; IPR018203; IPR000806; ,Q8BMD2; Q8BMD2-1; P61027; P62820-1; P20338; P61007; P55258,SUBUNIT: Interacts with RHOH. {ECO:0000269|PubMed:11809807}.,9434952; 14702039; 15164054; 15489334; 10996854; 7543319; 11809807; 18669648; 19413330; 19608861; 20068231; 21269460; 23186163; 24275569; 25944712,,1996-10-01,2019-02-13,2001-04-27,178,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Modified residue (7); Sequence conflict (1),,TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:7543319}.,,Acetylation;Alternative splicing;Complete proteome;Cytoplasm;GTPase activation;Membrane;Phosphoprotein;Reference proteome,Evidence at protein level,reviewed,,Rab GDI family,178,Alternative products (1); Caution (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0007; KW-0025; KW-0181; KW-0343; KW-0472; KW-0597; KW-0963; KW-1185,,,,,,,,,CHAIN 1 445 Rab GDP dissociation inhibitor beta. /FTId=PRO_0000056679.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330}.; MOD_RES 57 57 N6-succinyllysine. {ECO:0000250|UniProtKB:Q61598}.; MOD_RES 61 61 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 112 112 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 130 130 Phosphoserine. {ECO:0000250|UniProtKB:P50399}.; MOD_RES 269 269 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 382 382 Phosphoserine. {ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,D13988;Y13286;Y13287;Y13288;Y13289;Y13290;Y13291;Y13292;Y13293;Y13294;Y13295;Y13296;Y13297;BT006868;AK297554;BC005145;AF144713;
0,P50570,DYN2_HUMAN,DNM2 DYN2,DNM2,DYN2,,,Homo sapiens (Human),9606,Dynamin-2 (EC 3.6.5.5),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGNRGMEELIPLVNKLQDAFSSIGQSCHLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLILQLIFSKTEHAEFLHCKSKKFTDFDEVRQEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLIDLPGITKVPVGDQPPDIEYQIKDMILQFISRESSLILAVTPANMDLANSDALKLAKEVDPQGLRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIEGKKDIRAALAAERKFFLSHPAYRHMADRMGTPHLQKTLNQQLTNHIRESLPALRSKLQSQLLSLEKEVEEYKNFRPDDPTRKTKALLQMVQQFGVDFEKRIEGSGDQVDTLELSGGARINRIFHERFPFELVKMEFDEKDLRREISYAIKNIHGVRTGLFTPDLAFEAIVKKQVVKLKEPCLKCVDLVIQELINTVRQCTSKLSSYPRLREETERIVTTYIREREGRTKDQILLLIDIEQSYINTNHEDFIGFANAQQRSTQLNKKRAIPNQGEILVIRRGWLTINNISLMKGGSKEYWFVLTAESLSWYKDEEEKEKKYMLPLDNLKIRDVEKGFMSNKHVFAIFNTEQRNVYKDLRQIELACDSQEDVDSWKASFLRAGVYPEKDQAENEDGAQENTFSMDPQLERQVETIRNLVDSYVAIINKSIRDLMPKTIMHLMINNTKAFIHHELLAYLYSSADQSSLMEESADQAQRRDDMLRMYHALKEALNIIGDISTSTVSTPVPPPVDDTWLQSASSHSPTPQRRPVSSIHPPGRPPAVRGPTPGPPLIPVPVGAAASFSAPPIPSRPGPQSVFANSDLFPAPPQIPSRPVRIPPGIPPGVPSRRPPAAPSRPTIIRPAEPSLLD,870,"98,064",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=5;  Name=1; IsoId=P50570-1; Sequence=Displayed; Name=2; IsoId=P50570-2; Sequence=VSP_001325; Name=3; IsoId=P50570-3; Sequence=VSP_044280, VSP_001325; Name=4; IsoId=P50570-4; Sequence=VSP_044280; Note=Gene prediction based on EST data.; Name=5; IsoId=P50570-5; Sequence=VSP_047534; Note=No experimental confirmation available.; ",,,,,,,,,,"VAR_SEQ 407 444 LAFEAIVKKQVVKLKEPCLKCVDLVIQELINTVRQCTS -> MAFEAIVKKQIVKLKEPSLKCVDLVVSELATVIKKCAE (in isoform 3 and isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_044280.; VAR_SEQ 516 519 Missing (in isoform 2 and isoform 3). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:7590285}. /FTId=VSP_001325.; VAR_SEQ 848 848 Missing (in isoform 5). {ECO:0000303|PubMed:14702039}. /FTId=VSP_047534.","VARIANT 263 263 P -> L (in dbSNP:rs3745674). /FTId=VAR_031961.; VARIANT 358 358 G -> R (in CMT2M; dbSNP:rs267606772). {ECO:0000269|PubMed:18560793}. /FTId=VAR_068425.; VARIANT 368 368 E -> K (in CNM1; dbSNP:rs121909092). {ECO:0000269|PubMed:16227997, ECO:0000269|PubMed:20227276}. /FTId=VAR_031962.; VARIANT 368 368 E -> Q (in CNM1). {ECO:0000269|PubMed:17825552}. /FTId=VAR_068365.; VARIANT 369 369 R -> Q (in CNM1; dbSNP:rs121909089). {ECO:0000269|PubMed:16227997}. /FTId=VAR_031963.; VARIANT 369 369 R -> W (in CNM1; reduced association with the centrosome; dbSNP:rs121909090). {ECO:0000269|PubMed:16227997}. /FTId=VAR_031964.; VARIANT 379 379 F -> V (in LCCS5; hypomorphic mutation impacting on endocytosis; dbSNP:rs397514735). {ECO:0000269|PubMed:23092955}. /FTId=VAR_070163.; VARIANT 465 465 R -> W (in CNM1; reduced association with the centrosome; COS7 cells show a reduced uptake of transferrin and low-density lipoprotein complex; dbSNP:rs121909091). {ECO:0000269|PubMed:16227997, ECO:0000269|PubMed:19623537, ECO:0000269|PubMed:20227276}. /FTId=VAR_031965.; VARIANT 522 522 R -> C (in CNM1). {ECO:0000269|PubMed:22396310}. /FTId=VAR_068366.; VARIANT 522 522 R -> H (in CNM1; dbSNP:rs587783595). {ECO:0000269|PubMed:20227276}. /FTId=VAR_068367.; VARIANT 523 523 R -> G (in CNM1; dbSNP:rs587783596). {ECO:0000269|PubMed:22396310}. /FTId=VAR_068368.; VARIANT 537 537 G -> C (in CMT2M; dbSNP:rs121909093). {ECO:0000269|PubMed:17636067}. /FTId=VAR_062574.; VARIANT 555 557 Missing (in CMTDIB; may affect binding to vesicles and membranes in favor of binding to microtubules; may affect receptor-mediated endocytosis). {ECO:0000269|PubMed:15731758}. /FTId=VAR_031966.; VARIANT 560 560 E -> K (in CNM1; dbSNP:rs879254086). {ECO:0000269|PubMed:19122038}. /FTId=VAR_068369.; VARIANT 562 562 K -> E (in CMTDIB; with neutropenia; COS7 cells show a reduced uptake of transferrin and low-density lipoprotein complex; dbSNP:rs121909088). {ECO:0000269|PubMed:15731758, ECO:0000269|PubMed:19623537}. /FTId=VAR_031967.; VARIANT 562 562 Missing (in CMTDIB). {ECO:0000269|PubMed:15731758}. /FTId=VAR_070164.; VARIANT 570 570 L -> H (in CMT2M; dbSNP:rs121909094). {ECO:0000269|PubMed:17636067}. /FTId=VAR_062575.; VARIANT 618 618 A -> D (in CNM1). {ECO:0000269|PubMed:19932619}. /FTId=VAR_068370.; VARIANT 618 618 A -> T (in CNM1; severe). {ECO:0000269|PubMed:17932957, ECO:0000269|PubMed:20227276}. /FTId=VAR_039041.; VARIANT 619 619 S -> L (in CNM1; severe; dbSNP:rs121909095). {ECO:0000269|PubMed:17932957, ECO:0000269|PubMed:20227276}. /FTId=VAR_039042.; VARIANT 619 619 S -> W (in CNM1; severe; dbSNP:rs121909095). {ECO:0000269|PubMed:17932957}. /FTId=VAR_039043.; VARIANT 621 621 L -> P (in CNM1; centronuclear myopathy with cataracts; dbSNP:rs587783597). {ECO:0000269|PubMed:19932620}. /FTId=VAR_068371.; VARIANT 625 625 Missing (in CNM1; severe; COS7 cells show a reduced uptake of transferrin and low-density lipoprotein complex). {ECO:0000269|PubMed:17932957, ECO:0000269|PubMed:19623537}. /FTId=VAR_039044.; VARIANT 627 627 P -> H (in CNM1). {ECO:0000269|PubMed:20227276}. /FTId=VAR_068372.; VARIANT 627 627 P -> R (in CNM1; dbSNP:rs587783598). {ECO:0000269|PubMed:22396310}. /FTId=VAR_068373.; VARIANT 650 650 E -> K (in CNM1; COS7 cells show a reduced uptake of transferrin and low-density lipoprotein complex). {ECO:0000269|PubMed:19623537}. /FTId=VAR_062576.",,,,CONFLICT 155 156 QI -> RV (in Ref. 1; AAA88025). {ECO:0000305}.; CONFLICT 207 207 L -> P (in Ref. 2; AK312260). {ECO:0000305}.; CONFLICT 316 316 N -> I (in Ref. 1; AAA88025). {ECO:0000305}.; CONFLICT 324 324 R -> P (in Ref. 1; AAA88025). {ECO:0000305}.; CONFLICT 475 475 I -> T (in Ref. 2; AK312260). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase superfamily. Dynamin/Fzo/YdjA family. {ECO:0000255|PROSITE-ProRule:PRU01055}.,,COMPBIAS 747 866 Pro-rich.,DOMAIN 28 294 Dynamin-type G. {ECO:0000255|PROSITE-ProRule:PRU01055}.; DOMAIN 519 625 PH. {ECO:0000255|PROSITE-ProRule:PRU00145}.; DOMAIN 653 744 GED. {ECO:0000255|PROSITE-ProRule:PRU00720}.,,REGION 38 45 G1 motif. {ECO:0000255|PROSITE-ProRule:PRU01055}.; REGION 64 66 G2 motif. {ECO:0000255|PROSITE-ProRule:PRU01055}.; REGION 136 139 G3 motif. {ECO:0000255|PROSITE-ProRule:PRU01055}.; REGION 205 208 G4 motif. {ECO:0000255|PROSITE-ProRule:PRU01055}.; REGION 235 238 G5 motif. {ECO:0000255|PROSITE-ProRule:PRU01055}.,,,3.6.5.5,,"CATALYTIC ACTIVITY: Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565, ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; EC=3.6.5.5;",,,"FUNCTION: Microtubule-associated force-producing protein involved in producing microtubule bundles and able to bind and hydrolyze GTP. Plays a role in the regulation of neuron morphology, axon growth and formation of neuronal growth cones (By similarity). Plays an important role in vesicular trafficking processes, in particular endocytosis. Involved in cytokinesis (PubMed:12498685). Regulates maturation of apoptotic cell corpse-containing phagosomes by recruiting PIK3C3 to the phagosome membrane (By similarity). {ECO:0000250|UniProtKB:P39052, ECO:0000250|UniProtKB:P39054, ECO:0000269|PubMed:12498685}.",,,,,,,,,,NP_BIND 38 46 GTP. {ECO:0000250|UniProtKB:O00429}.; NP_BIND 205 211 GTP. {ECO:0000250|UniProtKB:O00429}.; NP_BIND 236 239 GTP. {ECO:0000250|UniProtKB:O00429}.,,"axon [GO:0030424]; centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; endocytic vesicle membrane [GO:0030666]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; D2 dopamine receptor binding [GO:0031749]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; aorta development [GO:0035904]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; coronary vasculature development [GO:0060976]; endocytosis [GO:0006897]; G protein-coupled receptor internalization [GO:0002031]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi to plasma membrane transport [GO:0006893]; macropinocytosis [GO:0044351]; membrane organization [GO:0061024]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of sodium:potassium-exchanging ATPase activity [GO:1903408]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of Rac protein signal transduction [GO:0035020]; regulation of synapse structure or activity [GO:0050803]; regulation of transcription, DNA-templated [GO:0006355]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle transport [GO:0048489]; transferrin transport [GO:0033572]; ventricular septum development [GO:0003281]","antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; aorta development [GO:0035904]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; coronary vasculature development [GO:0060976]; endocytosis [GO:0006897]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi to plasma membrane transport [GO:0006893]; G protein-coupled receptor internalization [GO:0002031]; macropinocytosis [GO:0044351]; membrane organization [GO:0061024]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of sodium:potassium-exchanging ATPase activity [GO:1903408]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of Rac protein signal transduction [GO:0035020]; regulation of synapse structure or activity [GO:0050803]; regulation of transcription, DNA-templated [GO:0006355]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle transport [GO:0048489]; transferrin transport [GO:0033572]; ventricular septum development [GO:0003281]",D2 dopamine receptor binding [GO:0031749]; enzyme binding [GO:0019899]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699],"axon [GO:0030424]; centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; endocytic vesicle membrane [GO:0030666]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]",GO:0000086; GO:0000139; GO:0001891; GO:0001917; GO:0002031; GO:0003281; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005905; GO:0005925; GO:0006355; GO:0006893; GO:0006897; GO:0006898; GO:0006909; GO:0007165; GO:0007283; GO:0008017; GO:0009416; GO:0010592; GO:0014069; GO:0016020; GO:0016185; GO:0017124; GO:0019886; GO:0019899; GO:0019901; GO:0030027; GO:0030424; GO:0030426; GO:0030496; GO:0030512; GO:0030516; GO:0030666; GO:0030670; GO:0031410; GO:0031623; GO:0031749; GO:0032587; GO:0032991; GO:0033572; GO:0035020; GO:0035904; GO:0036312; GO:0042220; GO:0043065; GO:0043197; GO:0044327; GO:0044351; GO:0044877; GO:0045202; GO:0045211; GO:0045334; GO:0045429; GO:0045893; GO:0048471; GO:0048489; GO:0048812; GO:0050699; GO:0050766; GO:0050803; GO:0050998; GO:0050999; GO:0060976; GO:0061024; GO:0070062; GO:0071245; GO:0071481; GO:0071732; GO:0098793; GO:0098844; GO:0098884; GO:0098978; GO:0099092; GO:1900026; GO:1902856; GO:1903351; GO:1903358; GO:1903408; GO:1903526; GO:2000370,IPR027188; IPR000375; IPR001401; IPR019762; IPR022812; IPR030381; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; ,Q8N157; Q14247; P62993; Q15811; Q12965; Q9QPN3; P22392; Q9UNF0; Q9P0V3; Q99962; Q96B97; Q9Y5X1,"SUBUNIT: Interacts with MYOF (By similarity). Interacts with CTTN and ACTN1 (By similarity). Interacts with SHANK1, SHANK2, SH3BP4 and NOSTRIN. Interacts with SNX9. Interacts with SNX33 (via SH3 domain). Interacts with MYO1E (via SH3 domain). Interacts with PSTPIP1. Interacts with CTNND2 (PubMed:22022388). May interact with PIK3C3 (By similarity). May be a component of a complex composed of RAB5A (in GDP-bound form), DYN2 and PIK3C3 (By similarity). Interacts with BIN1 (PubMed:17676042). {ECO:0000250|UniProtKB:P39052, ECO:0000250|UniProtKB:P39054, ECO:0000269|PubMed:11583995, ECO:0000269|PubMed:15703209, ECO:0000269|PubMed:16234328, ECO:0000269|PubMed:16325581, ECO:0000269|PubMed:17257598, ECO:0000269|PubMed:17676042, ECO:0000269|PubMed:18353773, ECO:0000269|PubMed:18480402, ECO:0000269|PubMed:22022388}.",7590285; 14702039; 15057824; 15489334; 11583995; 12498685; 16325581; 16234328; 15703209; 17257598; 17676042; 18353773; 18480402; 18669648; 19690332; 19608861; 20068231; 21269460; 22022388; 24275569; 25944712; 15731758; 16227997; 17932957; 17636067; 17825552; 18560793; 19623537; 19122038; 19932620; 19932619; 20227276; 22396310; 23092955,7590285; 14702039; 15057824; 15489334; 11583995; 12498685; 16325581; 16234328; 15703209; 17257598; 17676042; 18353773; 18480402; 18669648; 19690332; 19608861; 20068231; 21269460; 22022388; 24275569; 25944712; 15731758; 16227997; 17932957; 17636067; 17825552; 18560793; 19623537; 19122038; 19932620; 19932619; 20227276; 22396310; 23092955; 10394364; 10480952; 10535736; 10542231; 10559861; 10559924; 10593899; 10625686; 10908605; 11082044; 11231140; 11470803; 11604418; 11782545; 11994746; 12029088; 12205083; 12668728; 12952949; 14622578; 14622579; 14731593; 15175163; 15231747; 15252009; 15260957; 15299020; 15318165; 15502812; 15502813; 15545517; 15749704; 15834155; 15895077; 16049137; 16103228; 16169070; 16314522; 16410077; 16467847; 16474900; 16551695; 16556602; 16636290; 16696976; 16722822; 16798879; 16807357; 17108328; 17158794; 17353931; 17412836; 17474147; 17500595; 17565002; 17626097; 17702744; 17702746; 17765681; 17978091; 18003703; 18093523; 18233961; 18236001; 18297073; 18388313; 18394888; 18817572; 18981119; 18981233; 19116150; 19126407; 19155218; 19367725; 19380743; 19463016; 19502294; 19528294; 19536138; 19575674; 19603039; 19833721; 20033059; 20059951; 20089652; 20397975; 20428113; 20467437; 20468064; 20508983; 20574164; 20711168; 20711500; 20822789; 20826345; 20889493; 21135248; 21150131; 2115402; 21195118; 2121367; 21220511; 21221624; 21278753; 21283621; 21316588; 21338326; 21411625; 21445324; 21482805; 21514436; 21525035; 21613550; 21706016; 21779028; 21841817; 21900206; 21927000; 21927001; 21962517; 21988832; 21996738; 22014111; 22078883; 22091729; 22096584; 22099461; 22158869; 22174845; 22233676; 22360420; 22505844; 22528500; 22574813; 22613877; 22623184; 22623428; 22665060; 22924779; 22959143; 23297414; 23374900; 23394783; 23414517; 23416715; 23537630; 23606334; 23823722; 23851497; 23861397; 23891661; 23986595; 24016602; 24145164; 24402972; 24581490; 24603492; 24809731; 24848261; 24891602; 24966051; 24970086; 25061227; 25107275; 25116793; 25232009; 25263585; 25336256; 25341920; 25471590; 25501959; 25957634; 25982272; 26042225; 26413867; 26475677; 26503427; 26517984; 26638075; 26791826; 26842864; 26908122; 27009360; 27572123; 27771248; 27885263; 28273099; 28366933; 28416666; 28676641; 28808055; 29044420; 30232666; 6146630; 7592972; 7650016; 7877694; 8397411; 8524399; 8552632; 8670264; 8939989; 9092476; 9100026; 9202021; 9427626; 9428629; 9497313; 9635431; 9651214; 9736607,1996-10-01,2019-02-13,2004-05-10,202,NMR spectroscopy (1),STRAND 522 530 {ECO:0000244|PDB:2YS1}.; STRAND 533 535 {ECO:0000244|PDB:2YS1}.; STRAND 540 545 {ECO:0000244|PDB:2YS1}.; STRAND 550 555 {ECO:0000244|PDB:2YS1}.; STRAND 560 565 {ECO:0000244|PDB:2YS1}.; STRAND 567 573 {ECO:0000244|PDB:2YS1}.; STRAND 585 590 {ECO:0000244|PDB:2YS1}.; STRAND 596 599 {ECO:0000244|PDB:2YS1}.; STRAND 601 606 {ECO:0000244|PDB:2YS1}.,HELIX 610 623 {ECO:0000244|PDB:2YS1}.,,,,,,5 out of 5,Alternative sequence (3); Beta strand (9); Chain (1); Compositional bias (1); Domain (3); Helix (1); Modified residue (6); Natural variant (26); Nucleotide binding (3); Region (5); Sequence conflict (5),,TISSUE SPECIFICITY: Ubiquitously expressed.,"MISCELLANEOUS: Overexpression of CNM- and CMT-related DNM2 mutants in COS7 cells, whatever the mutated domain, led to a reduction in clathrin-mediated receptor endocytosis associated with MAPK ERK-1 and ERK-2 impairment. The membrane trafficking impairment process may represent a common pathophysiological pathway in the autosomal forms of CNM DNM2-CMT neuropathy.",3D-structure;Acetylation;Alternative splicing;Cell junction;Cell membrane;Cell projection;Charcot-Marie-Tooth disease;Coated pit;Complete proteome;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Disease mutation;Endocytosis;GTP-binding;Hydrolase;Membrane;Microtubule;Motor protein;Neurodegeneration;Neuropathy;Nucleotide-binding;Phagocytosis;Phosphoprotein;Polymorphism;Postsynaptic cell membrane;Reference proteome;Synapse,Evidence at protein level,reviewed,,"TRAFAC class dynamin-like GTPase superfamily, Dynamin/Fzo/YdjA family",202,Alternative products (1); Catalytic activity (1); Caution (2); Function (1); Involvement in disease (4); Miscellaneous (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0144; KW-0168; KW-0181; KW-0206; KW-0225; KW-0254; KW-0342; KW-0378; KW-0472; KW-0493; KW-0505; KW-0523; KW-0547; KW-0581; KW-0597; KW-0621; KW-0622; KW-0628; KW-0770; KW-0963; KW-0965; KW-0966; KW-0968; KW-1003; KW-1185,,,,,"DISEASE: Myopathy, centronuclear, 1 (CNM1) [MIM:160150]: A congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers. {ECO:0000269|PubMed:16227997, ECO:0000269|PubMed:17825552, ECO:0000269|PubMed:17932957, ECO:0000269|PubMed:19122038, ECO:0000269|PubMed:19623537, ECO:0000269|PubMed:19932619, ECO:0000269|PubMed:19932620, ECO:0000269|PubMed:20227276, ECO:0000269|PubMed:22396310}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lethal congenital contracture syndrome 5 (LCCS5) [MIM:615368]: A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy and congenital non-progressive joint contractures. The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. {ECO:0000269|PubMed:23092955}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease, dominant, intermediate type, B (CMTDIB) [MIM:606482]: A form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. The dominant intermediate type B is characterized by clinical and pathologic features intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction velocities ranging from 25 to 45 m/sec. {ECO:0000269|PubMed:15731758, ECO:0000269|PubMed:19623537}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease 2M (CMT2M) [MIM:606482]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:17636067, ECO:0000269|PubMed:18560793}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Phosphorylation at Ser-764 by CDK1 is greatly increased upon mitotic entry. It regulates cytokinesis downstream of calcineurin, and does not affect clathrin-mediated endocytosis. Dephosphorylated by calcineurin/PP2 (By similarity). Phosphorylated on tyrosine residues after activation of SRC (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:P39052}.",CHAIN 1 870 Dynamin-2. /FTId=PRO_0000206570.,,,,,,MOD_RES 231 231 Phosphotyrosine. {ECO:0000250|UniProtKB:P39052}.; MOD_RES 299 299 N6-acetyllysine. {ECO:0000250|UniProtKB:P39054}.; MOD_RES 597 597 Phosphotyrosine. {ECO:0000250|UniProtKB:P39052}.; MOD_RES 598 598 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 755 755 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 764 764 Phosphoserine; by CDK1. {ECO:0000250|UniProtKB:P39052}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,L36983;AK289831;AC007229;BC039596;BC054501;
0,P50995,ANX11_HUMAN,ANXA11 ANX11,ANXA11,ANX11,,,Homo sapiens (Human),9606,Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50) (CAP-50),UP000005640: Chromosome 10,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSYPGYPPPPGGYPPAAPGGGPWGGAAYPPPPSMPPIGLDNVATYAGQFNQDYLSGMAANMSGTFGGANMPNLYPGAPGAGYPPVPPGGFGQPPSAQQPVPPYGMYPPPGGNPPSRMPSYPPYPGAPVPGQPMPPPGQQPPGAYPGQPPVTYPGQPPVPLPGQQQPVPSYPGYPGSGTVTPAVPPTQFGSRGTITDAPGFDPLRDAEVLRKAMKGFGTDEQAIIDCLGSRSNKQRQQILLSFKTAYGKDLIKDLKSELSGNFEKTILALMKTPVLFDIYEIKEAIKGVGTDEACLIEILASRSNEHIRELNRAYKAEFKKTLEEAIRSDTSGHFQRLLISLSQGNRDESTNVDMSLAQRDAQELYAAGENRLGTDESKFNAVLCSRSRAHLVAVFNEYQRMTGRDIEKSICREMSGDLEEGMLAVVKCLKNTPAFFAERLNKAMRGAGTKDRTLIRIMVSRSETDLLDIRSEYKRMYGKSLYHDISGDTSGDYRKILLKICGGND,505,"54,390",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P50995-1; Sequence=Displayed; Name=2; IsoId=P50995-2; Sequence=VSP_054553; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 1 33 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_054553.,VARIANT 38 38 G -> R (in ALS23; unknown pathological significance; changed cytoplasmic localization with decreased association with vesicle-like structures; increased interaction with S100A6; dbSNP:rs142083484). {ECO:0000269|PubMed:28469040}. /FTId=VAR_080653.; VARIANT 40 40 D -> G (in ALS23; forms cytoplasmic aggregates in patient tissues; no effect on nuclear and cytoplasmic localization; loss of interaction with S100A6; dbSNP:rs1247392012). {ECO:0000269|PubMed:28469040}. /FTId=VAR_080654.; VARIANT 175 175 G -> R (in ALS23; unknown pathological significance; dbSNP:rs754594235). {ECO:0000269|PubMed:28469040}. /FTId=VAR_080655.; VARIANT 189 189 G -> E (in ALS23; unknown pathological significance; no effect on aggregation; loss of interaction with S100A6; dbSNP:rs569546089). {ECO:0000269|PubMed:28469040}. /FTId=VAR_080656.; VARIANT 191 191 R -> Q (in dbSNP:rs2229554). /FTId=VAR_048259.; VARIANT 230 230 R -> C (in dbSNP:rs1049550). /FTId=VAR_012006.; VARIANT 235 235 R -> Q (in ALS23; unknown pathological significance; increased aggregation in the cytoplasm sequestering the wild-type protein in these aggregates; loss of interaction with S100A6; dbSNP:rs765489119). {ECO:0000269|PubMed:28469040}. /FTId=VAR_080657.; VARIANT 346 346 R -> C (in ALS23; unknown pathological significance; dbSNP:rs770574196). {ECO:0000269|PubMed:28469040}. /FTId=VAR_080658.; VARIANT 457 457 I -> V (in dbSNP:rs1802932). /FTId=VAR_012007.,,,,,,1,,0,DOMAIN: A pair of annexin repeats may form one binding site for calcium and phospholipid.,SIMILARITY: Belongs to the annexin family. {ECO:0000305}.,,,,,,REPEAT 209 269 Annexin 1.; REPEAT 281 341 Annexin 2.; REPEAT 365 425 Annexin 3.; REPEAT 440 500 Annexin 4.,,,,,,,"FUNCTION: Binds specifically to calcyclin in a calcium-dependent manner (By similarity). Required for midbody formation and completion of the terminal phase of cytokinesis. {ECO:0000250, ECO:0000269|PubMed:15197175}.",,,,,,,,,,,,azurophil granule [GO:0042582]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; specific granule [GO:0042581]; spindle [GO:0005819]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592],cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548],azurophil granule [GO:0042582]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; specific granule [GO:0042581]; spindle [GO:0005819],GO:0003723; GO:0005509; GO:0005544; GO:0005635; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006909; GO:0008429; GO:0016020; GO:0023026; GO:0030496; GO:0032506; GO:0042470; GO:0042581; GO:0042582; GO:0044548; GO:0045335; GO:0048306; GO:0051592; GO:0062023; GO:0070062,IPR001464; IPR018502; IPR018252; IPR037104; IPR008157; ,Q53EZ4; O75340; Q92734,"SUBUNIT: Interacts with S100A6 (PubMed:28469040). Interacts with PDCD6 in a calcium-dependent manner. Interacts with KIF23 during cytokinesis. {ECO:0000250, ECO:0000269|PubMed:11883939, ECO:0000269|PubMed:15197175, ECO:0000269|PubMed:18256029, ECO:0000269|PubMed:28469040}.",7508441; 11013079; 14702039; 15164054; 15489334; 11883939; 12601007; 12805373; 15197175; 17081065; 18256029; 19608861; 21269460; 24275569; 25944712; 28469040,7508441; 11013079; 14702039; 15164054; 15489334; 11883939; 12601007; 12805373; 15197175; 17081065; 18256029; 19608861; 21269460; 24275569; 25944712; 28469040; 12445460; 16169070; 16189514; 16385451; 19165924; 19345290; 19367725; 19484149; 20093723; 20093729; 20467437; 20711500; 20805159; 21239504; 21562576; 23151485; 23416715; 23579219; 24032725; 24508622; 24705354; 24955142; 25056970; 25540196; 25609649; 26496610; 27177629; 27537711; 28079857; 29306955; 29416296,1996-10-01,2019-02-13,1996-10-01,173,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Modified residue (3); Natural variant (9); Repeat (4),,,,Acetylation;Alternative splicing;Amyotrophic lateral sclerosis;Annexin;Calcium;Calcium/phospholipid-binding;Cell cycle;Cell division;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Neurodegeneration;Nucleus;Polymorphism;Reference proteome;Repeat,Evidence at protein level,reviewed,,Annexin family,173,Alternative products (1); Caution (1); Domain (1); Function (1); Involvement in disease (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0007; KW-0025; KW-0036; KW-0041; KW-0106; KW-0111; KW-0131; KW-0132; KW-0181; KW-0206; KW-0225; KW-0523; KW-0539; KW-0621; KW-0677; KW-0963; KW-1185,,,,,"DISEASE: Amyotrophic lateral sclerosis 23 (ALS23) [MIM:617839]: A form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. ALS23 is an autosomal dominant form with incomplete penetrance. {ECO:0000269|PubMed:28469040}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 505 Annexin A11. /FTId=PRO_0000067510.,,,,,,MOD_RES 248 248 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 255 255 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 479 479 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,L19605;AJ278463;AJ278464;AJ278465;AK301047;BC007564;
0,P51587,BRCA2_HUMAN,BRCA2 FACD FANCD1,BRCA2,FACD FANCD1,,,Homo sapiens (Human),9606,Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein),UP000005640: Chromosome 13,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPIGSKERPTFFEIFKTRCNKADLGPISLNWFEELSSEAPPYNSEPAEESEHKNNNYEPNLFKTPQRKPSYNQLASTPIIFKEQGLTLPLYQSPVKELDKFKLDLGRNVPNSRHKSLRTVKTKMDQADDVSCPLLNSCLSESPVVLQCTHVTPQRDKSVVCGSLFHTPKFVKGRQTPKHISESLGAEVDPDMSWSSSLATPPTLSSTVLIVRNEEASETVFPHDTTANVKSYFSNHDESLKKNDRFIASVTDSENTNQREAASHGFGKTSGNSFKVNSCKDHIGKSMPNVLEDEVYETVVDTSEEDSFSLCFSKCRTKNLQKVRTSKTRKKIFHEANADECEKSKNQVKEKYSFVSEVEPNDTDPLDSNVANQKPFESGSDKISKEVVPSLACEWSQLTLSGLNGAQMEKIPLLHISSCDQNISEKDLLDTENKRKKDFLTSENSLPRISSLPKSEKPLNEETVVNKRDEEQHLESHTDCILAVKQAISGTSPVASSFQGIKKSIFRIRESPKETFNASFSGHMTDPNFKKETEASESGLEIHTVCSQKEDSLCPNLIDNGSWPATTTQNSVALKNAGLISTLKKKTNKFIYAIHDETSYKGKKIPKDQKSELINCSAQFEANAFEAPLTFANADSGLLHSSVKRSCSQNDSEEPTLSLTSSFGTILRKCSRNETCSNNTVISQDLDYKEAKCNKEKLQLFITPEADSLSCLQEGQCENDPKSKKVSDIKEEVLAAACHPVQHSKVEYSDTDFQSQKSLLYDHENASTLILTPTSKDVLSNLVMISRGKESYKMSDKLKGNNYESDVELTKNIPMEKNQDVCALNENYKNVELLPPEKYMRVASPSRKVQFNQNTNLRVIQKNQEETTSISKITVNPDSEELFSDNENNFVFQVANERNNLALGNTKELHETDLTCVNEPIFKNSTMVLYGDTGDKQATQVSIKKDLVYVLAEENKNSVKQHIKMTLGQDLKSDISLNIDKIPEKNNDYMNKWAGLLGPISNHSFGGSFRTASNKEIKLSEHNIKKSKMFFKDIEEQYPTSLACVEIVNTLALDNQKKLSKPQSINTVSAHLQSSVVVSDCKNSHITPQMLFSKQDFNSNHNLTPSQKAEITELSTILEESGSQFEFTQFRKPSYILQKSTFEVPENQMTILKTTSEECRDADLHVIMNAPSIGQVDSSKQFEGTVEIKRKFAGLLKNDCNKSASGYLTDENEVGFRGFYSAHGTKLNVSTEALQKAVKLFSDIENISEETSAEVHPISLSSSKCHDSVVSMFKIENHNDKTVSEKNNKCQLILQNNIEMTTGTFVEEITENYKRNTENEDNKYTAASRNSHNLEFDGSDSSKNDTVCIHKDETDLLFTDQHNICLKLSGQFMKEGNTQIKEDLSDLTFLEVAKAQEACHGNTSNKEQLTATKTEQNIKDFETSDTFFQTASGKNISVAKESFNKIVNFFDQKPEELHNFSLNSELHSDIRKNKMDILSYEETDIVKHKILKESVPVGTGNQLVTFQGQPERDEKIKEPTLLGFHTASGKKVKIAKESLDKVKNLFDEKEQGTSEITSFSHQWAKTLKYREACKDLELACETIEITAAPKCKEMQNSLNNDKNLVSIETVVPPKLLSDNLCRQTENLKTSKSIFLKVKVHENVEKETAKSPATCYTNQSPYSVIENSALAFYTSCSRKTSVSQTSLLEAKKWLREGIFDGQPERINTADYVGNYLYENNSNSTIAENDKNHLSEKQDTYLSNSSMSNSYSYHSDEVYNDSGYLSKNKLDSGIEPVLKNVEDQKNTSFSKVISNVKDANAYPQTVNEDICVEELVTSSSPCKNKNAAIKLSISNSNNFEVGPPAFRIASGKIVCVSHETIKKVKDIFTDSFSKVIKENNENKSKICQTKIMAGCYEALDDSEDILHNSLDNDECSTHSHKVFADIQSEEILQHNQNMSGLEKVSKISPCDVSLETSDICKCSIGKLHKSVSSANTCGIFSTASGKSVQVSDASLQNARQVFSEIEDSTKQVFSKVLFKSNEHSDQLTREENTAIRTPEHLISQKGFSYNVVNSSAFSGFSTASGKQVSILESSLHKVKGVLEEFDLIRTEHSLHYSPTSRQNVSKILPRVDKRNPEHCVNSEMEKTCSKEFKLSNNLNVEGGSSENNHSIKVSPYLSQFQQDKQQLVLGTKVSLVENIHVLGKEQASPKNVKMEIGKTETFSDVPVKTNIEVCSTYSKDSENYFETEAVEIAKAFMEDDELTDSKLPSHATHSLFTCPENEEMVLSNSRIGKRRGEPLILVGEPSIKRNLLNEFDRIIENQEKSLKASKSTPDGTIKDRRLFMHHVSLEPITCVPFRTTKERQEIQNPNFTAPGQEFLSKSHLYEHLTLEKSSSNLAVSGHPFYQVSATRNEKMRHLITTGRPTKVFVPPFKTKSHFHRVEQCVRNINLEENRQKQNIDGHGSDDSKNKINDNEIHQFNKNNSNQAAAVTFTKCEEEPLDLITSLQNARDIQDMRIKKKQRQRVFPQPGSLYLAKTSTLPRISLKAAVGGQVPSACSHKQLYTYGVSKHCIKINSKNAESFQFHTEDYFGKESLWTGKGIQLADGGWLIPSNDGKAGKEEFYRALCDTPGVDPKLISRIWVYNHYRWIIWKLAAMECAFPKEFANRCLSPERVLLQLKYRYDTEIDRSRRSAIKKIMERDDTAAKTLVLCVSDIISLSANISETSSNKTSSADTQKVAIIELTDGWYAVKAQLDPPLLAVLKNGRLTVGQKIILHGAELVGSPDACTPLEAPESLMLKISANSTRPARWYTKLGFFPDPRPFPLPLSSLFSDGGNVGCVDVIIQRAYPIQWMEKTSSGLYIFRNEREEEKEAAKYVEAQQKRLEALFTKIQEEFEEHEENTTKPYLPSRALTRQQVRALQDGAELYEAVKNAADPAYLEGYFSEEQLRALNNHRQMLNDKKQAQIQLEIRKAMESAEQKEQGLSRDVTTVWKLRIVSYSKKEKDSVILSIWRPSSDLYSLLTEGKRYRIYHLATSKSKSKSERANIQLAATKKTQYQQLPVSDEILFQIYQPREPLHFSKFLDPDFQPSCSEVDLIGFVVSVVKKTGLAPFVYLSDECYNLLAIKFWIDLNEDIIKPHMLIAASNLQWRPESKSGLLTLFAGDFSVFSASPKEGHFQETFNKMKNTVENIDILCNEAENKLMHILHANDPKWSTPTKDCTSGPYTAQIIPGTGNKLLMSSPNCEIYYQSPLSLCMAKRKSVSTPVSAQMTSKSCKGEKEIDDQKNCKKRRALDFLSRLPLPPPVSPICTFVSPAAQKAFQPPRSCGTKYETPIKKKELNSPQMTPFKKFNEISLLESNSIADEELALINTQALLSGSTGEKQFISVSESTRTAPTSSEDYLRLKRRCTTSLIKEQESSQASTEECEKNKQDTITTKKYI,3418,"384,202",,,,,,,,,,,,,"VARIANT 25 25 G -> R (in BC; abolishes interaction with PALB2). {ECO:0000269|PubMed:16793542}. /FTId=VAR_028167.; VARIANT 31 31 W -> C (in BC; abolishes interaction with PALB2). {ECO:0000269|PubMed:16793542}. /FTId=VAR_028168.; VARIANT 31 31 W -> R (in BC; abolishes interaction with PALB2). {ECO:0000269|PubMed:16793542}. /FTId=VAR_028169.; VARIANT 32 32 F -> L (in BC). {ECO:0000269|PubMed:9609997}. /FTId=VAR_005085.; VARIANT 42 42 Y -> C (in BC and ovarian cancer; unknown pathological significance; dbSNP:rs4987046). {ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:14746861}. /FTId=VAR_020705.; VARIANT 53 53 K -> R (in BC). {ECO:0000269|PubMed:9609997}. /FTId=VAR_005086.; VARIANT 60 60 N -> S (in BC; unknown pathological significance). {ECO:0000269|PubMed:15026808}. /FTId=VAR_020706.; VARIANT 64 64 T -> I (in BC). {ECO:0000269|PubMed:15172753}. /FTId=VAR_032712.; VARIANT 75 75 A -> P (in ovarian cancer and renal cancer; unknown pathological significance; dbSNP:rs28897701). {ECO:0000269|PubMed:10486320}. /FTId=VAR_005087.; VARIANT 81 81 F -> L (in BC). {ECO:0000269|PubMed:9609997}. /FTId=VAR_005088.; VARIANT 108 108 N -> H. /FTId=VAR_008766.; VARIANT 118 118 R -> H (in one patient with esophageal carcinoma). {ECO:0000269|PubMed:11948123}. /FTId=VAR_032713.; VARIANT 192 192 M -> T (in one patient with pancreatic cancer). {ECO:0000269|PubMed:12097290}. /FTId=VAR_032714.; VARIANT 201 201 P -> R (in BC). {ECO:0000269|PubMed:9609997}. /FTId=VAR_005089.; VARIANT 211 211 V -> A (in BC). {ECO:0000269|PubMed:9609997}. /FTId=VAR_005090.; VARIANT 222 222 P -> S (in BC). {ECO:0000269|PubMed:9609997}. /FTId=VAR_005091.; VARIANT 225 225 T -> A (in one patient with BC; normal RNA expression and splicing). {ECO:0000269|PubMed:15300854}. /FTId=VAR_032715.; VARIANT 289 289 N -> H (common polymorphism; was originally thought to be linked to ovarian cancer; dbSNP:rs766173). {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:12552570, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|Ref.3}. /FTId=VAR_005092.; VARIANT 315 315 C -> S (in one patient with esophageal carcinoma; dbSNP:rs79483201). {ECO:0000269|PubMed:11948123}. /FTId=VAR_032716.; VARIANT 322 322 K -> Q (in dbSNP:rs11571640). {ECO:0000269|Ref.3}. /FTId=VAR_018908.; VARIANT 326 326 S -> R (in BC; dbSNP:rs28897706). {ECO:0000269|PubMed:10399947}. /FTId=VAR_032717.; VARIANT 327 327 K -> E (in BC; unknown pathological significance). /FTId=VAR_008767.; VARIANT 355 355 V -> L (in lung cancer). /FTId=VAR_005093.; VARIANT 372 372 N -> H (common polymorphism; may be associated with an increased risk of breast cancer; dbSNP:rs144848). {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11062481, ECO:0000269|PubMed:12552570, ECO:0000269|PubMed:15057823, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8665505, ECO:0000269|PubMed:8673091, ECO:0000269|Ref.3}. /FTId=VAR_005094.; VARIANT 405 405 G -> R (in BC; unknown pathological significance). {ECO:0000269|PubMed:15026808}. /FTId=VAR_020707.; VARIANT 431 431 T -> I (in BC; unknown pathological significance). {ECO:0000269|PubMed:12938098}. /FTId=VAR_020708.; VARIANT 448 448 R -> H (in BC; unknown pathological significance). {ECO:0000269|PubMed:15026808}. /FTId=VAR_020709.; VARIANT 462 462 E -> G (in BC; unknown pathological significance; dbSNP:rs56403624). {ECO:0000269|PubMed:12552570, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753}. /FTId=VAR_020710.; VARIANT 505 505 I -> T (in BC; dbSNP:rs28897708). {ECO:0000269|PubMed:11241844}. /FTId=VAR_032718.; VARIANT 513 513 K -> R (in dbSNP:rs28897709). /FTId=VAR_056751.; VARIANT 554 554 C -> W (in BC and pancreas cancer). {ECO:0000269|PubMed:9654203}. /FTId=VAR_005095.; VARIANT 582 582 T -> P (in dbSNP:rs80358457). {ECO:0000269|PubMed:12624724}. /FTId=VAR_008768.; VARIANT 598 598 T -> A (in dbSNP:rs28897710). {ECO:0000269|PubMed:12215251}. /FTId=VAR_020711.; VARIANT 599 599 S -> F (in dbSNP:rs1046984). {ECO:0000269|PubMed:8589730}. /FTId=VAR_035436.; VARIANT 606 606 P -> L. {ECO:0000269|PubMed:26566883}. /FTId=VAR_076440.; VARIANT 613 613 L -> R (in BC; unknown pathological significance). {ECO:0000269|PubMed:12442275}. /FTId=VAR_020712.; VARIANT 630 630 T -> I (in ovarian cancer). /FTId=VAR_005096.; VARIANT 707 707 D -> Y (in dbSNP:rs80358487). /FTId=VAR_008769.; VARIANT 728 728 D -> A (in BC). /FTId=VAR_005097.; VARIANT 729 729 I -> M (in BC). {ECO:0000269|PubMed:10978364}. /FTId=VAR_032719.; VARIANT 784 784 M -> V (in dbSNP:rs11571653). {ECO:0000269|PubMed:15365993, ECO:0000269|Ref.3}. /FTId=VAR_008770.; VARIANT 886 886 N -> I. /FTId=VAR_008771.; VARIANT 929 929 L -> S (in dbSNP:rs2227943). {ECO:0000269|Ref.3}. /FTId=VAR_018909.; VARIANT 935 935 D -> N (in BC; unknown pathological significance; dbSNP:rs28897716). /FTId=VAR_008772.; VARIANT 976 976 S -> F (in dbSNP:rs11571656). {ECO:0000269|Ref.3}. /FTId=VAR_018910.; VARIANT 982 982 I -> L (in dbSNP:rs28897717). /FTId=VAR_056752.; VARIANT 987 987 N -> I (in dbSNP:rs2227944). {ECO:0000269|Ref.3}. /FTId=VAR_018911.; VARIANT 991 991 N -> D (common polymorphism; dbSNP:rs1799944). {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:12552570, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8673091, ECO:0000269|Ref.3}. /FTId=VAR_005098.; VARIANT 1036 1036 E -> K (in BC; unknown pathological significance). {ECO:0000269|PubMed:12938098}. /FTId=VAR_020713.; VARIANT 1106 1106 S -> R (in BC; unknown pathological significance). {ECO:0000269|PubMed:12938098}. /FTId=VAR_020714.; VARIANT 1147 1147 N -> S (in dbSNP:rs1799951). {ECO:0000269|PubMed:8673091}. /FTId=VAR_005099.; VARIANT 1172 1172 S -> L (in BC; unknown pathological significance). {ECO:0000269|PubMed:15635067}. /FTId=VAR_032720.; VARIANT 1179 1179 S -> N (in BC). {ECO:0000269|PubMed:11139248}. /FTId=VAR_020715.; VARIANT 1279 1279 N -> S. {ECO:0000269|PubMed:12552570, ECO:0000269|PubMed:15172753}. /FTId=VAR_020716.; VARIANT 1286 1286 Missing. /FTId=VAR_008773.; VARIANT 1290 1290 C -> Y (in dbSNP:rs41293485). /FTId=VAR_008774.; VARIANT 1302 1302 Missing (in BC). /FTId=VAR_005100.; VARIANT 1414 1414 T -> M (in dbSNP:rs70953664). /FTId=VAR_008775.; VARIANT 1420 1420 D -> Y (in dbSNP:rs28897727). {ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:12215251, ECO:0000269|PubMed:12552570, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15635067, ECO:0000269|PubMed:26566883}. /FTId=VAR_008776.; VARIANT 1445 1445 K -> T (in BC; unknown pathological significance). {ECO:0000269|PubMed:15365993}. /FTId=VAR_020717.; VARIANT 1513 1513 D -> N. /FTId=VAR_008777.; VARIANT 1522 1522 L -> F (in one patient with BC). {ECO:0000269|PubMed:12624724}. /FTId=VAR_032721.; VARIANT 1524 1524 F -> V (in BC; unknown pathological significance). {ECO:0000269|PubMed:12938098}. /FTId=VAR_020718.; VARIANT 1529 1529 G -> R (in bladder cancer; dbSNP:rs28897728). /FTId=VAR_005101.; VARIANT 1542 1542 V -> M (in dbSNP:rs28897729). /FTId=VAR_056753.; VARIANT 1561 1561 H -> N (in dbSNP:rs2219594). {ECO:0000269|Ref.3}. /FTId=VAR_018912.; VARIANT 1580 1580 C -> Y (in BC; somatic mutation). {ECO:0000269|PubMed:11948477}. /FTId=VAR_020719.; VARIANT 1593 1593 E -> D. {ECO:0000269|PubMed:12442273}. /FTId=VAR_008778.; VARIANT 1643 1643 V -> A (in dbSNP:rs28897731). /FTId=VAR_056754.; VARIANT 1679 1679 T -> I (in BC). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020720.; VARIANT 1690 1690 K -> N (in BC). {ECO:0000269|PubMed:15172753}. /FTId=VAR_032722.; VARIANT 1730 1730 N -> Y (in BC). {ECO:0000269|PubMed:11241844}. /FTId=VAR_032723.; VARIANT 1771 1771 G -> D (in BC; unknown pathological significance; dbSNP:rs80358755). {ECO:0000269|PubMed:12552570, ECO:0000269|PubMed:15172753}. /FTId=VAR_008779.; VARIANT 1804 1804 V -> A (in BC). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020721.; VARIANT 1805 1805 N -> S (in dbSNP:rs80358765). /FTId=VAR_008780.; VARIANT 1880 1880 N -> K (polymorphism; was originally thought to be linked to breast cancer; dbSNP:rs11571657). {ECO:0000269|PubMed:11241844, ECO:0000269|Ref.3}. /FTId=VAR_005102.; VARIANT 1887 1887 T -> M (in BC). {ECO:0000269|PubMed:15172753}. /FTId=VAR_032724.; VARIANT 1901 1901 E -> K (in BC). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020722.; VARIANT 1902 1902 D -> N (in dbSNP:rs4987048). /FTId=VAR_008781.; VARIANT 1915 1915 T -> M (may be a rare polymorphism; somatic mutation; dbSNP:rs4987117). {ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:8665505, ECO:0000269|PubMed:8673091, ECO:0000269|Ref.3}. /FTId=VAR_005103.; VARIANT 1929 1929 I -> V (in BC; unknown pathological significance; dbSNP:rs79538375). {ECO:0000269|PubMed:15365993}. /FTId=VAR_020723.; VARIANT 1979 1979 S -> R (in dbSNP:rs28897737). /FTId=VAR_056755.; VARIANT 1988 1988 V -> I (in one patient with esophageal carcinoma; somatic mutation). {ECO:0000269|PubMed:11948123}. /FTId=VAR_032725.; VARIANT 2031 2031 T -> A (in BC; unknown pathological significance). {ECO:0000269|PubMed:15365993}. /FTId=VAR_020724.; VARIANT 2034 2034 R -> C (in dbSNP:rs1799954). {ECO:0000269|PubMed:12215251, ECO:0000269|PubMed:12569143, ECO:0000269|PubMed:8673091}. /FTId=VAR_005104.; VARIANT 2044 2044 G -> V (in one patient with BC; dbSNP:rs56191579). {ECO:0000269|PubMed:12624724}. /FTId=VAR_032726.; VARIANT 2072 2072 S -> C (in BC). {ECO:0000269|PubMed:12373604}. /FTId=VAR_020725.; VARIANT 2074 2074 H -> N (in dbSNP:rs34309943). /FTId=VAR_008782.; VARIANT 2089 2089 E -> D (in BC). {ECO:0000269|PubMed:9150152}. /FTId=VAR_008783.; VARIANT 2094 2094 Y -> C (in BC). {ECO:0000269|PubMed:12373604}. /FTId=VAR_020726.; VARIANT 2096 2096 P -> L (in BC). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020727.; VARIANT 2108 2108 R -> C (in dbSNP:rs55794205). {ECO:0000269|PubMed:15172753}. /FTId=VAR_032727.; VARIANT 2116 2116 H -> R (in dbSNP:rs55953736). /FTId=VAR_061563.; VARIANT 2118 2118 V -> L (in BC; unknown pathological significance). {ECO:0000269|PubMed:12442275}. /FTId=VAR_020728.; VARIANT 2128 2128 K -> N (in BC). {ECO:0000269|PubMed:12373604}. /FTId=VAR_020729.; VARIANT 2135 2135 N -> H (in BC). {ECO:0000269|PubMed:11241844}. /FTId=VAR_032728.; VARIANT 2138 2138 V -> F (in dbSNP:rs11571659). {ECO:0000269|Ref.3}. /FTId=VAR_008784.; VARIANT 2162 2162 K -> R (in dbSNP:rs11571660). {ECO:0000269|Ref.3}. /FTId=VAR_018913.; VARIANT 2222 2222 Y -> C (in BC). {ECO:0000269|PubMed:11241844}. /FTId=VAR_032729.; VARIANT 2238 2238 D -> E (in dbSNP:rs28897742). /FTId=VAR_056756.; VARIANT 2274 2274 G -> V (in BC). /FTId=VAR_005105.; VARIANT 2275 2275 E -> G (in BC; unknown pathological significance). {ECO:0000269|PubMed:15026808}. /FTId=VAR_020730.; VARIANT 2293 2293 F -> L (in BC; unknown pathological significance). {ECO:0000269|PubMed:12442275}. /FTId=VAR_020731.; VARIANT 2336 2336 R -> H (in FANCD1; affects protein splicing and expression; decreases homologous recombination-mediated DNA repair; dbSNP:rs28897743). {ECO:0000269|PubMed:16825431, ECO:0000269|PubMed:17924331, ECO:0000269|PubMed:21719596}. /FTId=VAR_032730.; VARIANT 2336 2336 R -> Q (in dbSNP:rs28897743). /FTId=VAR_056757.; VARIANT 2353 2353 G -> R (in BC; unknown pathological significance). {ECO:0000269|PubMed:15026808}. /FTId=VAR_020732.; VARIANT 2415 2415 H -> N (in BC). {ECO:0000269|PubMed:8640237}. /FTId=VAR_005106.; VARIANT 2421 2421 Q -> H (in BC). /FTId=VAR_005107.; VARIANT 2440 2440 H -> R (in dbSNP:rs4986860). {ECO:0000269|Ref.3}. /FTId=VAR_018914.; VARIANT 2447 2447 N -> D (in dbSNP:rs4986859). /FTId=VAR_056758.; VARIANT 2456 2456 Q -> E (in BC). {ECO:0000269|PubMed:15172753}. /FTId=VAR_032731.; VARIANT 2466 2466 A -> V (polymorphism; was originally thought to be linked to ovarian cancer). {ECO:0000269|PubMed:12552570, ECO:0000269|PubMed:15057823, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:8665505, ECO:0000269|Ref.3}. /FTId=VAR_008785.; VARIANT 2480 2480 L -> V (in dbSNP:rs80358965). /FTId=VAR_008786.; VARIANT 2488 2488 R -> K (in BC; unknown pathological significance). {ECO:0000269|PubMed:15026808}. /FTId=VAR_020733.; VARIANT 2490 2490 I -> T (polymorphism; no effect on homologous recombination-mediated DNA repair; no effect on interaction with SEM1; dbSNP:rs11571707). {ECO:0000269|PubMed:21719596, ECO:0000269|Ref.3}. /FTId=VAR_008787.; VARIANT 2502 2502 R -> C (in BC; unknown pathological significance). {ECO:0000269|PubMed:17924331}. /FTId=VAR_063911.; VARIANT 2502 2502 R -> H (in ovarian cancer; unknown pathological significance). {ECO:0000269|PubMed:10486320}. /FTId=VAR_008788.; VARIANT 2510 2510 L -> P (in FANCD1; hypersensitive to DNA damage; disrupts interaction with SEM1). {ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:21719596}. /FTId=VAR_032732.; VARIANT 2515 2515 T -> I (in BC; unknown pathological significance; dbSNP:rs28897744). {ECO:0000269|PubMed:10978364}. /FTId=VAR_008789.; VARIANT 2626 2626 W -> C (in FANCD1; hypersensitive to DNA damage; no effect on interaction with SEM1). {ECO:0000269|PubMed:16825431, ECO:0000269|PubMed:17924331, ECO:0000269|PubMed:21719596}. /FTId=VAR_032733.; VARIANT 2627 2627 I -> F (in BC; unknown pathological significance). {ECO:0000269|PubMed:17924331}. /FTId=VAR_063912.; VARIANT 2653 2653 L -> P (in BC; unknown pathological significance). {ECO:0000269|PubMed:17924331}. /FTId=VAR_063913.; VARIANT 2659 2659 R -> K (in BC; unknown pathological significance). {ECO:0000269|PubMed:17924331}. /FTId=VAR_063914.; VARIANT 2663 2663 E -> V (could be associated with cancer susceptibility; major splicing aberration identified with this mutant; multifactorial likelihood analysis provides evidence for pathogenicity). {ECO:0000269|PubMed:17924331, ECO:0000269|PubMed:20513136}. /FTId=VAR_063915.; VARIANT 2686 2686 L -> P (in dbSNP:rs28897746). /FTId=VAR_056759.; VARIANT 2706 2706 N -> S. {ECO:0000269|PubMed:12442273}. /FTId=VAR_020734.; VARIANT 2722 2722 T -> R (in BC). {ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:17924331}. /FTId=VAR_018661.; VARIANT 2723 2723 D -> G (could be associated with cancer susceptibility; has abrogated function consistent with pathogenicity; major splicing aberration identified with this mutant). {ECO:0000269|PubMed:17924331, ECO:0000269|PubMed:20513136}. /FTId=VAR_063916.; VARIANT 2723 2723 D -> H (in BC; unknown pathological significance; disrupts interaction with SEM1 promoting interaction with XPO1 and BRCA2 cytoplasmic localization; in heterozygous state promotes RAD51 cytoplasmic localization). {ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:24013206}. /FTId=VAR_020735.; VARIANT 2728 2728 V -> I (in BC; dbSNP:rs28897749). {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:12215251}. /FTId=VAR_020736.; VARIANT 2729 2729 K -> N (in BC; unknown pathological significance; no effect on homologous recombination-mediated DNA repair; no effect on interaction with SEM1; dbSNP:rs80359065). {ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:21719596}. /FTId=VAR_020737.; VARIANT 2748 2748 G -> D (in BC; unknown pathological significance). {ECO:0000269|PubMed:17924331}. /FTId=VAR_063917.; VARIANT 2787 2787 R -> H (in ovarian cancer; somatic mutation). {ECO:0000269|PubMed:8665505}. /FTId=VAR_008790.; VARIANT 2792 2792 L -> P (in dbSNP:rs28897751). /FTId=VAR_056760.; VARIANT 2793 2793 G -> R (in BC; unknown pathological significance). {ECO:0000269|PubMed:12442275}. /FTId=VAR_020738.; VARIANT 2835 2835 S -> P (in dbSNP:rs11571746). {ECO:0000269|Ref.3}. /FTId=VAR_018915.; VARIANT 2842 2842 R -> C (in one patient with esophageal carcinoma; somatic mutation). {ECO:0000269|PubMed:11948123}. /FTId=VAR_032734.; VARIANT 2856 2856 E -> A (in dbSNP:rs11571747). {ECO:0000269|PubMed:15026808, ECO:0000269|Ref.3}. /FTId=VAR_018916.; VARIANT 2944 2944 I -> F (in dbSNP:rs4987047). {ECO:0000269|PubMed:15635067, ECO:0000269|Ref.3}. /FTId=VAR_008791.; VARIANT 2950 2950 K -> N (in BC; unknown pathological significance; dbSNP:rs28897754). {ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15635067}. /FTId=VAR_020739.; VARIANT 2951 2951 A -> T (in dbSNP:rs11571769). {ECO:0000269|PubMed:12215251, ECO:0000269|Ref.3}. /FTId=VAR_008792.; VARIANT 2969 2969 V -> M (in dbSNP:rs59004709). /FTId=VAR_008793.; VARIANT 3013 3013 T -> I (in BC; unknown pathological significance; dbSNP:rs28897755). {ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15635067}. /FTId=VAR_020740.; VARIANT 3052 3052 R -> W (could be associated with cancer susceptibility; has abrogated function consistent with pathogenicity; multifactorial likelihood analysis provides evidence for pathogenicity). {ECO:0000269|PubMed:20513136}. /FTId=VAR_063918.; VARIANT 3063 3063 P -> S (in a patient with ovarian cancer; unknown pathological significance). {ECO:0000269|PubMed:14746861}. /FTId=VAR_020741.; VARIANT 3076 3076 G -> E. {ECO:0000269|PubMed:12569143}. /FTId=VAR_020742.; VARIANT 3095 3095 D -> E (in BC; unknown pathological significance). {ECO:0000269|PubMed:17924331, ECO:0000269|PubMed:8640235}. /FTId=VAR_005108.; VARIANT 3098 3098 Y -> H (in BC and ovarian cancer; unknown pathological significance; dbSNP:rs41293521). {ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:15026808}. /FTId=VAR_008794.; VARIANT 3101 3101 L -> R (in dbSNP:rs28897758). /FTId=VAR_056761.; VARIANT 3103 3103 I -> M (in melanoma). /FTId=VAR_005109.; VARIANT 3118 3118 M -> T (in BC). {ECO:0000269|PubMed:9609997}. /FTId=VAR_005110.; VARIANT 3124 3124 N -> I (in BC). {ECO:0000269|PubMed:11139248}. /FTId=VAR_020743.; VARIANT 3196 3196 K -> E (in BC; dbSNP:rs80359228). {ECO:0000269|PubMed:11139248}. /FTId=VAR_020744.; VARIANT 3244 3244 V -> I (in dbSNP:rs11571831). {ECO:0000269|Ref.3}. /FTId=VAR_018917.; VARIANT 3257 3257 K -> R. /FTId=VAR_008795.; VARIANT 3276 3276 R -> S. /FTId=VAR_008796.; VARIANT 3300 3300 P -> S (in one patient with esophageal carcinoma). {ECO:0000269|PubMed:11948123}. /FTId=VAR_032735.; VARIANT 3357 3357 T -> R (in BC). /FTId=VAR_005111.; VARIANT 3374 3374 T -> I (in dbSNP:rs56309455). {ECO:0000269|PubMed:12442275}. /FTId=VAR_020745.; VARIANT 3412 3412 I -> V (polymorphism; was originally thought to be associated with breast cancer; dbSNP:rs1801426). {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:14746861, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:9150152, ECO:0000269|Ref.3}. /FTId=VAR_005112.",,,,CONFLICT 758 758 S -> N (in Ref. 1; CAA64484). {ECO:0000305}.; CONFLICT 1761 1762 GY -> RI (in Ref. 1; CAA64484). {ECO:0000305}.; CONFLICT 1767 1767 K -> N (in Ref. 1; CAA64484). {ECO:0000305}.; CONFLICT 2536 2536 S -> P (in Ref. 4; CAA98995). {ECO:0000305}.; CONFLICT 3216 3216 L -> LVS (in Ref. 4; CAA97728). {ECO:0000305}.,,3,,0,,,,,,MOTIF 2682 2698 Nuclear export signal; masked by interaction with SEM1. {ECO:0000269|PubMed:24013206}.,"REGION 1 40 Interaction with PALB2.; REGION 639 1000 Interaction with NPM1. {ECO:0000269|PubMed:21084279}.; REGION 1338 1781 Interaction with POLH. {ECO:0000269|PubMed:24485656}.; REGION 1410 1595 Required for stimulation of POLH DNA polymerization activity.; REGION 2350 2545 Interaction with FANCD2.; REGION 2481 2832 Interaction with SEM1. {ECO:0000269|PubMed:10373512, ECO:0000269|PubMed:16205630}.",REPEAT 1002 1036 BRCA2 1.; REPEAT 1212 1246 BRCA2 2.; REPEAT 1421 1455 BRCA2 3.; REPEAT 1517 1551 BRCA2 4.; REPEAT 1664 1698 BRCA2 5.; REPEAT 1837 1871 BRCA2 6.; REPEAT 1971 2005 BRCA2 7.; REPEAT 2051 2085 BRCA2 8.,,,,,,,"FUNCTION: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SEM1, and is required to prevent R-loop-associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). {ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:21719596, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180}.",,,,,,,,,,,,"BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; gamma-tubulin binding [GO:0043015]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; single-stranded DNA binding [GO:0003697]; brain development [GO:0007420]; cell aging [GO:0007569]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mitotic cytokinesis [GO:0000281]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokinesis [GO:0032465]; replication fork protection [GO:0048478]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]","brain development [GO:0007420]; cell aging [GO:0007569]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mitotic cytokinesis [GO:0000281]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokinesis [GO:0032465]; replication fork protection [GO:0048478]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]",gamma-tubulin binding [GO:0043015]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; single-stranded DNA binding [GO:0003697],"BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]",GO:0000281; GO:0000722; GO:0000724; GO:0000784; GO:0000800; GO:0001556; GO:0001833; GO:0002020; GO:0003697; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006289; GO:0006302; GO:0006978; GO:0007141; GO:0007283; GO:0007420; GO:0007569; GO:0008022; GO:0008585; GO:0010165; GO:0010225; GO:0010332; GO:0010484; GO:0010485; GO:0030097; GO:0030141; GO:0032465; GO:0032991; GO:0033593; GO:0033600; GO:0042771; GO:0042802; GO:0043015; GO:0043966; GO:0043967; GO:0045893; GO:0045931; GO:0048478; GO:0051298; GO:0070200; GO:1990426,IPR015525; IPR015252; IPR036315; IPR015187; IPR015188; IPR002093; IPR012340; IPR015205; ,Itself; Q14565; Q9BXW9; Q9BXW9-2; Q9P0W2; Q86YC2; Q9NTI5; Q9Y253; Q06609; Q06609-1; P60896; P04637,"SUBUNIT: Monomer and dimer (PubMed:20729858). Interacts with RAD51; regulates RAD51 recruitment and function at sites of DNA repair (PubMed:12442171, PubMed:15800615, PubMed:18317453, PubMed:20729832, PubMed:20729859). Interacts with WDR16, USP11, DMC1, ROCK2 and NPM1 (PubMed:15314155, PubMed:15967112, PubMed:20729832, PubMed:21084279). Interacts with SEM1; the interaction masks a nuclear export signal in BRCA2 (PubMed:10373512, PubMed:16205630, PubMed:21719596, PubMed:24013206). Interacts with both nonubiquitinated and monoubiquitinated FANCD2; this complex also includes XRCC3 and phosphorylated FANCG (PubMed:15115758, PubMed:15199141, PubMed:18212739). Part of a BRCA complex containing BRCA1, BRCA2 and PALB2 (PubMed:19369211). Interacts directly with PALB2 which may serve as a scaffold for a HR complex containing PALB2, BRCA2, RAD51C, RAD51 and XRCC3 (PubMed:19369211, PubMed:24141787, PubMed:28319063, PubMed:16793542, PubMed:19609323). Interacts with BRCA1 only in the presence of PALB2 which serves as the bridging protein (PubMed:19369211). Interacts with POLH; the interaction is direct (PubMed:24485656). Interacts with the TREX-2 complex subunits PCID2 and SEM1 (PubMed:24896180, PubMed:21719596). {ECO:0000269|PubMed:10373512, ECO:0000269|PubMed:12442171, ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15314155, ECO:0000269|PubMed:15800615, ECO:0000269|PubMed:15967112, ECO:0000269|PubMed:16205630, ECO:0000269|PubMed:16793542, ECO:0000269|PubMed:18212739, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:19609323, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:21719596, ECO:0000269|PubMed:24013206, ECO:0000269|PubMed:24141787, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180, ECO:0000269|PubMed:28319063}.",8524414; 8589730; 15057823; 9140390; 10373512; 15115758; 15199141; 15314155; 15689453; 15671039; 15800615; 15967112; 16793542; 16205630; 17525332; 18212739; 18317453; 19369211; 20729859; 20729858; 20729832; 21084279; 21276791; 23186163; 24013206; 24141787; 24485656; 24896180; 28319063; 12442171; 19609323; 8665505; 8673091; 8640235; 8640236; 8640237; 9150152; 9654203; 9609997; 10486320; 10323242; 9971877; 10399947; 11062481; 10978364; 11139248; 11241844; 12145750; 12373604; 12097290; 11948123; 12215251; 12442273; 12442274; 12442275; 11948477; 12065746; 12552570; 12938098; 12624724; 12569143; 14670928; 15026808; 15172753; 14746861; 14722926; 15300854; 15365993; 15635067; 17924331; 16825431; 20513136; 21719596; 26566883,8524414; 8589730; 15057823; 9140390; 10373512; 15115758; 15199141; 15314155; 15689453; 15671039; 15800615; 15967112; 16793542; 16205630; 17525332; 18212739; 18317453; 19369211; 20729859; 20729858; 20729832; 21084279; 21276791; 23186163; 24013206; 24141787; 24485656; 24896180; 28319063; 12442171; 19609323; 8665505; 8673091; 8640235; 8640236; 8640237; 9150152; 9654203; 9609997; 10486320; 10323242; 9971877; 10399947; 11062481; 10978364; 11139248; 11241844; 12145750; 12373604; 12097290; 11948123; 12215251; 12442273; 12442274; 12442275; 11948477; 12065746; 12552570; 12938098; 12624724; 12569143; 14670928; 15026808; 15172753; 14746861; 14722926; 15300854; 15365993; 15635067; 17924331; 16825431; 20513136; 21719596; 26566883; 10029069; 10072381; 10101178; 10318934; 10438626; 10525529; 10551859; 10562567; 10652259; 10728666; 10734115; 10801132; 10809667; 10856253; 10928988; 11006276; 11044354; 11063672; 11073541; 11097234; 11130383; 11171374; 11178747; 11180449; 11181654; 11192759; 11207040; 11207041; 11221880; 11248061; 11263938; 11292842; 11377596; 11403219; 11410514; 11426450; 11433401; 11437399; 11448436; 11459987; 11466700; 11474660; 11481082; 11493753; 11504767; 11505617; 11535547; 11550168; 11556836; 11562929; 11584901; 11668223; 11698567; 11710890; 11751635; 11754111; 11786575; 11786581; 11788883; 11793480; 11802208; 11802209; 11807777; 11822793; 11832208; 11844822; 11857015; 11857383; 11857748; 11857749; 11870168; 11870509; 11873550; 11879560; 11883440; 11890937; 11896095; 11897832; 11920551; 11920621; 11927503; 11950811; 11950880; 11953874; 11964925; 11972384; 11977534; 11981002; 11983207; 12020440; 12023992; 12036913; 12039933; 12070551; 12088120; 12091911; 12100744; 12101561; 12112655; 12114473; 12125210; 12181777; 12210341; 12220452; 12228710; 12229875; 12229876; 12237285; 12237897; 12242698; 12376208; 12376518; 12385017; 12404104; 12431973; 12433008; 12440810; 12453858; 12457999; 12461697; 12464649; 12470990; 12471628; 12473589; 12474142; 12476445; 12484126; 12491828; 12496047; 12504628; 12527904; 12543786; 12556369; 12567413; 12568865; 12606939; 12611452; 12618335; 12644538; 12644778; 12655560; 12655567; 12670525; 12672886; 12673354; 12677558; 12684407; 12691152; 12698193; 12704633; 12712470; 12750298; 12756300; 12771943; 12774040; 12779088; 12798717; 12815053; 12833555; 12845657; 12879478; 12883740; 12911720; 12911837; 12912992; 12917199; 12920090; 12927042; 12937835; 12942367; 12946038; 12967657; 14507240; 14517958; 14519755; 14527420; 14551306; 14555511; 14555518; 14559878; 14572939; 14574155; 14576434; 14580253; 14580256; 14581427; 14586320; 14615451; 14636569; 14647210; 14647419; 14647438; 14651845; 14660434; 14662532; 14668548; 14673037; 14678969; 14680495; 14704203; 14709734; 14709740; 14716019; 14732925; 14735173; 14735581; 14752193; 14755459; 14761918; 14769635; 14973102; 14984481; 15015609; 15041722; 15053071; 15053073; 15059511; 15067026; 15070707; 15073127; 15082902; 15083174; 15086724; 15095307; 15104281; 15114373; 15116316; 15117986; 15131025; 15131399; 15131400; 15131403; 15138483; 15138485; 15140370; 15140371; 15144764; 15159322; 15164066; 15168169; 15170666; 15217508; 15236312; 15254695; 15265971; 15280188; 15280342; 15284715; 15304223; 15317758; 15319244; 15331870; 15345109; 15367553; 15375219; 15519522; 15545966; 15548363; 15559734; 15564800; 15571962; 15576832; 15589605; 15617999; 15665856; 15670748; 15703751; 15721786; 15726604; 15728167; 15733268; 15734731; 15734957; 15800311; 15806175; 15863145; 15880530; 15887246; 15894703; 15900600; 15916957; 15917310; 15930293; 15930334; 15936476; 15937124; 15983021; 15986445; 15994883; 15996267; 16003728; 16029503; 16030099; 16032702; 16042582; 16047333; 16049805; 16088935; 16118051; 16123081; 16137751; 16140006; 16168118; 16168123; 16168130; 16176503; 16199546; 16214912; 16234515; 16257105; 16260499; 16261400; 16261408; 16271956; 16280055; 16284991; 16322221; 16324400; 16331614; 16337601; 16369438; 16389418; 16417627; 16418514; 16419081; 16450717; 16455195; 16456781; 16484695; 16485136; 16537453; 16539696; 16541324; 16563180; 16574953; 16619214; 16621732; 16622123; 16638864; 16644204; 16648044; 16701105; 16712842; 16724247; 16724273; 16728435; 16731627; 16741161; 16760289; 16766662; 16769276; 16783967; 16792513; 16792514; 16826315; 16843109; 16845393; 16847550; 16860930; 16886281; 16905680; 16912212; 16914443; 16931905; 16944270; 16949048; 16950820; 16956909; 16998496; 16998498; 16998791; 17000754; 17010055; 17018160; 17018785; 17020472; 17021353; 17061047; 17063265; 17063270; 17080309; 17100994; 17101782; 17113724; 17114795; 17119064; 17145824; 17145825; 17148771; 17151928; 17160431; 17196508; 17210933; 17216544; 17217814; 17250666; 17257844; 17262179; 17285126; 17286961; 17289875; 17301269; 17307836; 17312021; 17324252; 17333338; 17333342; 17333343; 17333477; 17341484; 17344431; 17380889; 17386038; 17397054; 17409195; 17413421; 17416853; 17426707; 17428320; 17428325; 17445839; 17453335; 17470134; 17471561; 17474147; 17497966; 17503080; 17515903; 17515904; 17541404; 17549502; 17565157; 17582599; 17591842; 17591843; 17592676; 17603793; 17603881; 17624602; 17625123; 17625228; 17627006; 17634561; 17635951; 17636422; 17636423; 17636424; 17640379; 17645508; 17657584; 17661168; 17664283; 17673924; 17683622; 17686308; 17688236; 17700570; 17724471; 17761984; 17767707; 17850627; 17851763; 17898070; 17899372; 17917796; 17922257; 17925560; 17940634; 17945002; 17952592; 17968145; 17972172; 17972177; 17977515; 17977839; 17981954; 17996710; 17996711; 17997147; 17999359; 18026875; 18034184; 18036394; 18042939; 18043900; 18045956; 18059333; 18060494; 18086758; 18092194; 18095154; 18095987; 18097605; 18098285; 18158280; 18165636; 18167127; 18172190; 18172292; 18175183; 18175216; 18176857; 18178637; 18182994; 18200524; 18204050; 18214034; 18256600; 18256760; 18257128; 18258506; 18270339; 18279628; 18283110; 18283561; 18284688; 18285832; 18286383; 18288416; 18307534; 18312450; 18327210; 18342932; 18355772; 18363094; 18375895; 18377429; 18380995; 18393245; 18402691; 18413372; 18429825; 18430927; 18431501; 18431737; 18431743; 18434071; 18437078; 18439040; 18439106; 18439109; 18445692; 18451181; 18451254; 18463975; 18465347; 18481196; 18483851; 18489799; 18497862; 18501021; 18509731; 18513387; 18523885; 18528753; 18535008; 18543099; 18553220; 18559571; 18559594; 18563556; 18574689; 18577985; 18579371; 18593900; 18597679; 18618591; 18627636; 18632222; 18642075; 18645608; 18663943; 18676680; 18679827; 18694767; 18703817; 18710587; 18712473; 18717684; 18758995; 18765668; 18776644; 18779604; 18779615; 18783588; 18787696; 18794105; 18797466; 18807178; 18819001; 18830263; 18841560; 18842997; 18844490; 18855126; 18936947; 18940471; 18950845; 18955455; 18957201; 18990703; 18990759; 19009954; 19010876; 19011769; 19011960; 19012002; 19012493; 19016756; 19030985; 19035463; 19064572; 19064968; 19066131; 19070627; 19074197; 19082709; 19083511; 19087709; 19116388; 19124506; 19125001; 19139771; 19165595; 19170196; 19176389; 19179552; 19188187; 19189213; 19190154; 19200354; 19200971; 19214744; 19226467; 19229607; 19232099; 19237606; 19241424; 19253839; 19258476; 19258944; 19267246; 19268590; 19277124; 19288190; 19298662; 19303847; 19307946; 19329713; 19338682; 19340607; 19351817; 19353265; 19370414; 19372713; 19377795; 19383374; 19383375; 19383376; 19454451; 19473207; 19478387; 19491284; 19491894; 19494131; 19499246; 19530235; 19536092; 19540122; 19543244; 19548527; 19549808; 19549900; 19553641; 19564533; 19573080; 19578754; 19584075; 19584259; 19584272; 19597986; 19606050; 19609668; 19616529; 19617217; 19619314; 19620486; 19625176; 19626602; 19628690; 19642207; 19644020; 19649554; 19649703; 19649760; 19654294; 19656163; 19656164; 19656415; 19656774; 19661089; 19661094; 19669600; 19690177; 19692168; 19703393; 19704162; 19707196; 19709076; 19714462; 19715467; 19737859; 19745749; 19748364; 19752737; 19773279; 19780858; 19787003; 19789190; 19795125; 19798417; 19802015; 19805903; 19818997; 19841329; 19843326; 19851859; 19858402; 19861517; 19863560; 19875889; 19876733; 19877752; 19885732; 19898224; 19899408; 19902366; 19903338; 19913121; 19920816; 19921428; 19941167; 19941829; 19949853; 19956635; 19996028; 19996031; 20010525; 20020529; 20033483; 20033769; 20043088; 20059483; 20062530; 20077502; 20104584; 20130978; 20134318; 20135345; 20135348; 20151938; 20174566; 20180014; 20180971; 20195775; 20199546; 20202217; 20204502; 20206018; 20207730; 20215531; 20215541; 20216074; 20219108; 20221693; 20232139; 20234119; 20234365; 20306497; 20309627; 20337906; 20353281; 20356927; 20368571; 20373018; 20376556; 20378615; 20380699; 20383578; 20383589; 20396944; 20406939; 20411314; 20411323; 20418484; 20421506; 20422428; 20434624; 20443055; 20452659; 20453000; 20455026; 20458532; 20459916; 20472656; 20473725; 20496165; 20507642; 20512419; 20513533; 20522537; 20535403; 20537530; 20541936; 20549370; 20567915; 20570322; 20579331; 20587610; 20589654; 20606085; 20608899; 20609467; 20609468; 20610542; 20614180; 20617377; 20625126; 20625817; 20628086; 20638925; 20644561; 20644999; 20652397; 20652400; 20665887; 20676756; 20677014; 20683152; 20694749; 20713847; 20721735; 20721742; 20721747; 20721749; 20722102; 20730487; 20731661; 20733129; 20736950; 20798986; 20804917; 20807450; 20809262; 20809358; 20813000; 20842456; 20850175; 20859677; 20871615; 20871616; 20872766; 20877358; 20878484; 20878485; 20919953; 20924075; 20927582; 20950396; 20960027; 20960228; 20965415; 20972632; 20978178; 21042765; 21060860; 21063910; 21079137; 21118973; 21119070; 21119368; 21123638; 21148102; 21156238; 21161372; 21190077; 21204799; 21206239; 21221768; 21222048; 21232165; 21276604; 21278312; 21318380; 21324516; 21336636; 21356067; 21378390; 21391735; 21394826; 21399666; 21409565; 21424757; 21425892; 21427728; 21441901; 21476145; 21487248; 21514447; 21517277; 21520273; 21555554; 21557934; 21565612; 21573016; 21591024; 21593217; 21597964; 21598239; 21601571; 21614564; 21637299; 21643751; 21649643; 21653198; 21665305; 21670257; 21670699; 21708937; 21710692; 21733824; 21735045; 21750719; 21761160; 21769658; 21789034; 21798026; 21898151; 21918853; 21918854; 21934105; 21939546; 21945552; 21952622; 21958427; 21974800; 21978880; 21984204; 21987080; 21989927; 21990299; 21993507; 22009639; 22019625; 22034289; 22053997; 22072393; 22113258; 22116401; 22126563; 22133571; 22142662; 22143498; 22144499; 22158906; 22179631; 22187435; 22193042; 22193777; 22194698; 22212556; 22228431; 22252303; 22252577; 22253870; 22262156; 22274685; 22282309; 22293751; 22339411; 22366370; 22382806; 22399190; 22401979; 22406760; 22425664; 22425665; 22429596; 22430266; 22430443; 22434521; 22443199; 22447567; 22476849; 22513257; 22535016; 22569005; 22579622; 22579790; 22586318; 22593209; 22614657; 22632462; 22645136; 22645308; 22655046; 22666503; 22673632; 22678057; 22680617; 22682623; 22684231; 22710074; 22729394; 22734169; 22735704; 22736296; 22739995; 22744338; 22752604; 22753590; 22753899; 22768030; 22771033; 22788243; 22789542; 22797065; 22798144; 22809218; 22895246; 22901131; 22915752; 22923021; 22962691; 22967960; 22970155; 22972572; 22984553; 23011509; 23035815; 23050611; 23057551; 23066998; 23071527; 23082475; 23096105; 23110154; 23146383; 23146957; 23149936; 23184082; 23231788; 23232696; 23233716; 23249957; 23257159; 23262210; 23265709; 23271408; 23284877; 23299404; 23319376; 23320992; 23326384; 23364291; 23370825; 23409019; 23409121; 23411475; 23414920; 23415752; 23417715; 23420552; 23458327; 23469205; 23479189; 23483928; 23490645; 23504064; 23509288; 23528734; 23531862; 23544012; 23548269; 23562522; 23567481; 23569316; 23585894; 23615136; 23635950; 23658460; 23678008; 23683081; 23686288; 23697973; 23704879; 23704984; 23706288; 23711090; 23731732; 23747895; 23754601; 23810717; 23810788; 23846919; 23857704; 23867999; 23877192; 23881989; 23918944; 23928241; 23929434; 23935836; 23941904; 23957571; 23971979; 23975082; 23975317; 23977390; 23982256; 24065114; 24065545; 24076221; 24081797; 24081944; 24131965; 24131973; 24136669; 24140203; 24145998; 24153343; 24156927; 24162189; 24171172; 24217135; 24244370; 24259538; 24265793; 24268522; 24281364; 24285729; 24285840; 24285858; 24289229; 24289560; 24292448; 24301060; 24302565; 24306927; 24312913; 24337145; 24348212; 24371268; 24372583; 24384087; 24395671; 24442642; 24448238; 24448978; 24472143; 24473064; 24477976; 24479546; 24489760; 24489791; 24509834; 24518526; 24519767; 24529552; 24566764; 24567435; 24577588; 24598993; 24607278; 24627042; 24627786; 24672057; 24675954; 24698998; 24700448; 24728189; 24728577; 24771600; 24775809; 24814045; 24831703; 24835992; 24853100; 24880342; 24884828; 24890143; 24894343; 24902638; 24938600; 24947112; 24951607; 24996439; 25011685; 25036526; 25043256; 25047471; 25047474; 25053764; 25070656; 25082516; 25085752; 25099575; 25101567; 25111659; 25112434; 25136623; 25154392; 25154786; 25176351; 25195694; 25218637; 25243787; 25251729; 25257187; 25267367; 25282148; 25311111; 25342642; 25348513; 25348552; 25356972; 25380576; 25382762; 25395318; 25418591; 25428789; 25437005; 25445393; 25454609; 25476495; 25486196; 25503500; 25522926; 25526195; 25537514; 25581732; 25586199; 25613119; 25639900; 25659033; 25675043; 25682074; 25734415; 25735359; 25736055; 25736863; 25743105; 25749384; 25756400; 25788227; 25792249; 25803638; 25808098; 25816289; 25821000; 25824734; 25830658; 25833210; 25838448; 25849179; 25850293; 25863477; 25865228; 25868867; 25869530; 25879355; 25892146; 25919761; 25920394; 25927241; 25940717; 25948282; 25948675; 25980896; 26004055; 26006218; 26010302; 26026974; 26028024; 26047126; 26111274; 26145171; 26153499; 26181175; 26183948; 26187060; 26195121; 26219241; 26225655; 26239694; 26254840; 26272590; 26299336; 26335130; 26347108; 26378051; 26387543; 26402875; 26438354; 26439132; 26446551; 26455428; 26467043; 26467044; 26489613; 26496279; 26496610; 26496879; 26515461; 26540155; 26541979; 26543556; 26574845; 26577449; 26584049; 26586665; 26588056; 26625823; 26629528; 26638190; 26681678; 26698676; 26700119; 26724258; 26727920; 26742938; 26745875; 26748828; 26749359; 26750490; 26775038; 26780556; 26785832; 26824983; 26833046; 26833090; 26842001; 26843614; 26852015; 26857456; 26859126; 26867710; 26869327; 26888723; 26920070; 26928436; 26959114; 26961146; 26979245; 26979395; 26979459; 26986251; 26989051; 26992456; 26993268; 26997744; 27002934; 27003155; 27035098; 27037296; 27060066; 27068824; 27074266; 27083178; 27087322; 27094481; 27124784; 27129401; 27131361; 27149669; 27165220; 27167707; 27194814; 27211102; 27221885; 27225637; 27225819; 27244682; 27246457; 27249681; 27264184; 27272763; 27272846; 27283172; 27306910; 27317574; 27385001; 27393621; 27430397; 27433848; 27451331; 27463617; 27488874; 27490902; 27495310; 27511924; 27513445; 27520487; 27530658; 27532258; 27535760; 27553291; 27601588; 27603373; 27628236; 27632928; 27643881; 27656835; 27659521; 27690218; 27690720; 27692705; 27726213; 27741520; 27742670; 27755534; 27765917; 27767231; 27793035; 27794048; 27807724; 27880720; 27882536; 27893411; 27900500; 27907908; 27914478; 27928164; 27941124; 27974384; 27993796; 28039656; 28049106; 28058502; 28066861; 28067217; 28067867; 28069724; 28078281; 28079255; 28087643; 28120435; 28168276; 28176296; 28183138; 28184945; 28185119; 28199346; 28223274; 28247011; 28264872; 28283722; 28291774; 28294317; 28314837; 28339459; 28343309; 28351343; 28356425; 28375947; 28376175; 28392550; 28407998; 28410213; 28418854; 28431939; 28438622; 28448241; 28477318; 28525389; 28549976; 28551646; 28569220; 28575672; 28577564; 28577930; 28591191; 28591715; 28613254; 28617445; 28620890; 28637432; 28729482; 28739695; 28765325; 28766202; 28766224; 28790114; 28791855; 28802188; 28802254; 28814288; 28822785; 28831036; 28831696; 28862356; 28870368; 28893223; 28904335; 28961279; 28975393; 28976792; 28982360; 28985013; 29020660; 29021281; 29053959; 29086229; 29093017; 29116468; 29126396; 29126833; 29133916; 29161300; 29202330; 29242595; 29246904; 29298688; 29307397; 29338689; 29356578; 29404838; 29409476; 29433453; 29478268; 29480828; 29506471; 29514593; 29659587; 29681614; 29726012; 29735278; 29793803; 29891109; 29975922; 30014164; 30061222; 30352249; 30560944; 7587590; 8650194; 8673133; 8929543; 9008167; 9065463; 9135082; 9311981; 9398850; 9443891; 9450758; 9560268; 9660953; 9660954; 9735362; 9781043; 9826763,1996-10-01,2019-02-13,2015-11-11,212,X-ray crystallography (2),,HELIX 31 35 {ECO:0000244|PDB:3EU7}.; HELIX 1520 1522 {ECO:0000244|PDB:1N0W}.; HELIX 1536 1541 {ECO:0000244|PDB:1N0W}.,TURN 1542 1546 {ECO:0000244|PDB:1N0W}.,,,,,5 out of 5,Chain (1); Helix (3); Modified residue (10); Motif (1); Mutagenesis (3); Natural variant (160); Region (6); Repeat (8); Sequence conflict (5); Turn (1),,"TISSUE SPECIFICITY: Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.",,3D-structure;Cell cycle;Complete proteome;Cytoplasm;Cytoskeleton;DNA damage;DNA recombination;DNA repair;DNA-binding;Disease mutation;Fanconi anemia;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Tumor suppressor;Ubl conjugation,Evidence at protein level,reviewed,,,212,Function (1); Involvement in disease (5); Post-translational modification (2); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0043; KW-0131; KW-0181; KW-0206; KW-0225; KW-0227; KW-0233; KW-0234; KW-0238; KW-0539; KW-0597; KW-0621; KW-0677; KW-0832; KW-0923; KW-0963; KW-1185,,,,,"DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:16793542, ECO:0000269|PubMed:24013206, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431, ECO:0000269|PubMed:21719596}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Phosphorylated by ATM upon irradiation-induced DNA damage. Phosphorylation by CHEK1 and CHEK2 regulates interaction with RAD51. Phosphorylation at Ser-3291 by CDK1 and CDK2 is low in S phase when recombination is active, but increases as cells progress towards mitosis; this phosphorylation prevents homologous recombination-dependent repair during S phase and G2 by inhibiting RAD51 binding. {ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15800615, ECO:0000269|PubMed:18317453}.; PTM: Ubiquitinated in the absence of DNA damage; this does not lead to proteasomal degradation. In contrast, ubiquitination in response to DNA damage leads to proteasomal degradation. {ECO:0000269|PubMed:15314155}.",CHAIN 1 3418 Breast cancer type 2 susceptibility protein. /FTId=PRO_0000064984.,,,,,,MOD_RES 70 70 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 445 445 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 492 492 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 755 755 Phosphoserine. {ECO:0000244|PubMed:17525332}.; MOD_RES 1970 1970 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 2035 2035 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 2095 2095 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 3291 3291 Phosphoserine; by CDK1 and CDK2. {ECO:0000269|PubMed:15800615}.; MOD_RES 3319 3319 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 3387 3387 Phosphothreonine; by CHEK1 and CHEK2. {ECO:0000269|PubMed:18317453}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X95152;X95153;X95154;X95155;X95156;X95157;X95158;X95159;X95160;X95161;X95162;X95163;X95164;X95165;X95166;X95167;X95168;X95169;X95170;X95171;X95172;X95173;X95174;X95175;X95176;X95177;U43746;AY436640;Z74739;Z73359;
0,P53667,LIMK1_HUMAN,LIMK1 LIMK,LIMK1,LIMK,,,Homo sapiens (Human),9606,LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1),UP000005640: Chromosome 7,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MRLTLLCCTWREERMGEEGSELPVCASCGQRIYDGQYLQALNADWHADCFRCCDCSASLSHQYYEKDGQLFCKKDYWARYGESCHGCSEQITKGLVMVAGELKYHPECFICLTCGTFIGDGDTYTLVEHSKLYCGHCYYQTVVTPVIEQILPDSPGSHLPHTVTLVSIPASSHGKRGLSVSIDPPHGPPGCGTEHSHTVRVQGVDPGCMSPDVKNSIHVGDRILEINGTPIRNVPLDEIDLLIQETSRLLQLTLEHDPHDTLGHGLGPETSPLSSPAYTPSGEAGSSARQKPVLRSCSIDRSPGAGSLGSPASQRKDLGRSESLRVVCRPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGESGLPAHPEVPD,647,"72,585",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; IsoId=P53667-1; Sequence=Displayed; Name=2; IsoId=P53667-2; Sequence=VSP_003125; Name=3; IsoId=P53667-3; Sequence=VSP_003126, VSP_003127; Note=May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.; Name=4; IsoId=P53667-4; Sequence=VSP_043331; Note=No experimental confirmation available.; ",,,,,,,,,,VAR_SEQ 1 51 MRLTLLCCTWREERMGEEGSELPVCASCGQRIYDGQYLQALNADWHADCFR -> MLLASAPRRRRFLQRAK (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_043331.; VAR_SEQ 1 14 Missing (in isoform 2). {ECO:0000305}. /FTId=VSP_003125.; VAR_SEQ 294 305 LRSCSIDRSPGA -> FARTWVALSPSA (in isoform 3). {ECO:0000303|PubMed:10196227}. /FTId=VSP_003126.; VAR_SEQ 306 647 Missing (in isoform 3). {ECO:0000303|PubMed:10196227}. /FTId=VSP_003127.,"VARIANT 190 190 G -> A (in dbSNP:rs35827364). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042246.; VARIANT 247 247 S -> N (in dbSNP:rs55661242). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042247.; VARIANT 422 422 R -> Q (in dbSNP:rs55679316). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042248.; VARIANT 580 580 F -> Y (in dbSNP:rs178412). {ECO:0000269|PubMed:8689688, ECO:0000269|PubMed:8812460}. /FTId=VAR_050148.",,,,,,3,,0,,SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. {ECO:0000305}.,,,DOMAIN 25 75 LIM zinc-binding 1. {ECO:0000255|PROSITE-ProRule:PRU00125}.; DOMAIN 84 137 LIM zinc-binding 2. {ECO:0000255|PROSITE-ProRule:PRU00125}.; DOMAIN 165 258 PDZ. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 339 604 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",,,"FUNCTION: Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics. Acts downstream of several Rho family GTPase signal transduction pathways. Activated by upstream kinases including ROCK1, PAK1 and PAK4, which phosphorylate LIMK1 on a threonine residue located in its activation loop. LIMK1 subsequently phosphorylates and inactivates the actin binding/depolymerizing factors cofilin-1/CFL1, cofilin-2/CFL2 and destrin/DSTN, thereby preventing the cleavage of filamentous actin (F-actin), and stabilizing the actin cytoskeleton. In this way LIMK1 regulates several actin-dependent biological processes including cell motility, cell cycle progression, and differentiation. Phosphorylates TPPP on serine residues, thereby promoting microtubule disassembly. Stimulates axonal outgrowth and may be involved in brain development. Isoform 3 has a dominant negative effect on actin cytoskeletal changes. Required for atypical chemokine receptor ACKR2-induced phosphorylation of cofilin (CFL1). {ECO:0000269|PubMed:10196227, ECO:0000269|PubMed:10436159, ECO:0000269|PubMed:11832213, ECO:0000269|PubMed:12807904, ECO:0000269|PubMed:15660133, ECO:0000269|PubMed:16230460, ECO:0000269|PubMed:18028908, ECO:0000269|PubMed:23633677}.",,,,,,ACT_SITE 460 460 {ECO:0000250}.,BINDING 368 368 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 345 353 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; nervous system development [GO:0007399]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165],actin cytoskeleton organization [GO:0030036]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; nervous system development [GO:0007399]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165],ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634],GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006468; GO:0007165; GO:0007266; GO:0007399; GO:0016020; GO:0016607; GO:0030027; GO:0030036; GO:0031072; GO:0032233; GO:0038096; GO:0043005; GO:0045773; GO:0046872; GO:0046982; GO:0051444; GO:0051496,IPR011009; IPR001478; IPR036034; IPR000719; IPR017441; IPR001245; IPR001781; ,P29066; P29067; P23528; O95835; P50281; Q13153; Q13177; P63319; Q8WYL5,"SUBUNIT: Interacts (via LIM domain) with the cytoplasmic domain of NRG1. Interacts with NISCH. Interacts with RLIM and RNF6 (By similarity). Self-associates to form homodimers (PubMed:10196227). Interacts with HSP90AA1; this interaction promotes LIMK1 dimerization and subsequent transphosphorylation (PubMed:16641196). Interacts with CDKN1C (PubMed:14530263). Interacts with SSH1 (PubMed:15660133). Interacts with ROCK1 (PubMed:10436159, PubMed:10652353). Interacts (via LIM zinc-binding domains) with FAM89B/LRAP25 (via LRR repeat). Forms a tripartite complex with CDC42BPA, CDC42BPB and FAM89B/LRAP25 (By similarity). {ECO:0000250|UniProtKB:P53668, ECO:0000269|PubMed:10196227, ECO:0000269|PubMed:10436159, ECO:0000269|PubMed:10652353, ECO:0000269|PubMed:14530263, ECO:0000269|PubMed:15660133, ECO:0000269|PubMed:16641196}.",8183554; 8689688; 8812460; 10196227; 14702039; 12853948; 10559936; 10436159; 10652353; 11340065; 11413130; 11832213; 12807904; 14530263; 14759258; 15660133; 16230460; 16456544; 16641196; 18028908; 17188549; 18691976; 18669648; 19413330; 19369195; 22886629; 21682918; 23186163; 23633677; 17344846; ,8183554; 8689688; 8812460; 10196227; 14702039; 12853948; 10559936; 10436159; 10652353; 11340065; 11413130; 11832213; 12807904; 14530263; 14759258; 15660133; 16230460; 16456544; 16641196; 18028908; 17188549; 18691976; 18669648; 19413330; 19369195; 22886629; 21682918; 23186163; 23633677; 17344846; 11018042; 11276226; 12361576; 12642619; 12963706; 15220930; 16219803; 16837009; 17287949; 17500066; 17721511; 17853892; 17979178; 18332102; 18459146; 19424295; 21219645; 21297993; 21481795; 21923909; 22939624; 23602568; 23702034; 24695225; 25714010; 25884247; 26496610; 27153537; 7848918,1996-10-01,2019-02-13,2006-03-07,202,X-ray crystallography (5),STRAND 332 334 {ECO:0000244|PDB:3S95}.; STRAND 339 346 {ECO:0000244|PDB:3S95}.; STRAND 349 358 {ECO:0000244|PDB:3S95}.; STRAND 364 371 {ECO:0000244|PDB:3S95}.; STRAND 399 405 {ECO:0000244|PDB:3S95}.; STRAND 408 414 {ECO:0000244|PDB:3S95}.; STRAND 465 468 {ECO:0000244|PDB:3S95}.; STRAND 474 476 {ECO:0000244|PDB:3S95}.; STRAND 559 561 {ECO:0000244|PDB:3S95}.,HELIX 336 338 {ECO:0000244|PDB:3S95}.; HELIX 375 388 {ECO:0000244|PDB:3S95}.; HELIX 421 427 {ECO:0000244|PDB:3S95}.; HELIX 434 453 {ECO:0000244|PDB:3S95}.; HELIX 513 515 {ECO:0000244|PDB:3S95}.; HELIX 518 521 {ECO:0000244|PDB:3S95}.; HELIX 529 544 {ECO:0000244|PDB:3S95}.; HELIX 563 569 {ECO:0000244|PDB:3S95}.; HELIX 579 586 {ECO:0000244|PDB:3S95}.; HELIX 591 593 {ECO:0000244|PDB:3S95}.; HELIX 597 613 {ECO:0000244|PDB:3S95}.; HELIX 618 634 {ECO:0000244|PDB:3S95}.,TURN 359 361 {ECO:0000244|PDB:3S95}.; TURN 550 552 {ECO:0000244|PDB:3S95}.,,,,,5 out of 5,Active site (1); Alternative sequence (4); Beta strand (9); Binding site (1); Chain (1); Domain (4); Helix (12); Modified residue (9); Mutagenesis (8); Natural variant (4); Nucleotide binding (1); Turn (2),,"TISSUE SPECIFICITY: Highest expression in both adult and fetal nervous system. Detected ubiquitously throughout the different regions of adult brain, with highest levels in the cerebral cortex. Expressed to a lesser extent in heart and skeletal muscle.",,3D-structure;ATP-binding;Alternative splicing;Cell projection;Complete proteome;Cytoplasm;Kinase;LIM domain;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase;Ubl conjugation;Williams-Beuren syndrome;Zinc,Evidence at protein level,reviewed,,"Protein kinase superfamily, TKL Ser/Thr protein kinase family",202,Alternative products (1); Catalytic activity (2); Caution (2); Function (1); Involvement in disease (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0067; KW-0181; KW-0418; KW-0440; KW-0479; KW-0539; KW-0547; KW-0597; KW-0621; KW-0677; KW-0723; KW-0808; KW-0832; KW-0856; KW-0862; KW-0963; KW-0966; KW-1185,,,,,"DISEASE: Note=LIMK1 is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region.",,,"PTM: Autophosphorylated (By similarity). Phosphorylated on Thr-508 by ROCK1 and PAK1, resulting in activation. Phosphorylated by PAK4 which increases the ability of LIMK1 to phosphorylate cofilin. Phosphorylated at Ser-323 by MAPKAPK2 during activation of VEGFA-induced signaling, which results in activation of LIMK1 and promotion of actin reorganization, cell migration, and tubule formation of endothelial cells. Dephosphorylated and inactivated by SSH1. Phosphorylated by CDC42BP. {ECO:0000250, ECO:0000269|PubMed:10559936, ECO:0000269|PubMed:10652353, ECO:0000269|PubMed:11340065, ECO:0000269|PubMed:11413130, ECO:0000269|PubMed:15660133, ECO:0000269|PubMed:16456544, ECO:0000269|PubMed:23633677}.; PTM: Ubiquitinated. 'Lys-48'-linked polyubiquitination by RNF6 leads to proteasomal degradation through the 26S proteasome, modulating LIMK1 levels in the growth cone and its effect on axonal outgrowth. Also polyubiquitinated by RLIM (By similarity). {ECO:0000250}.",CHAIN 1 647 LIM domain kinase 1. /FTId=PRO_0000075803.,,,,,,"MOD_RES 210 210 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195}.; MOD_RES 229 229 Phosphothreonine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195}.; MOD_RES 298 298 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 302 302 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 307 307 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 310 310 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:23186163}.; MOD_RES 323 323 Phosphoserine; by MAPKAPK2. {ECO:0000269|PubMed:16456544}.; MOD_RES 337 337 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 508 508 Phosphothreonine; by ROCK1 and PAK1. {ECO:0000269|PubMed:10559936, ECO:0000269|PubMed:10652353, ECO:0000269|PubMed:15660133, ECO:0000269|PubMed:23633677}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,D26309;U62293;U62293;U63721;U63721;AF134379;AK300382;AC005057;CH471200;CH471200;CH471200;CH471200;
0,P53671,LIMK2_HUMAN,LIMK2,LIMK2,,,,Homo sapiens (Human),9606,LIM domain kinase 2 (LIMK-2) (EC 2.7.11.1),UP000005640: Chromosome 22,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSALAGEDVWRCPGCGDHIAPSQIWYRTVNETWHGSCFRCSECQDSLTNWYYEKDGKLYCPKDYWGKFGEFCHGCSLLMTGPFMVAGEFKYHPECFACMSCKVIIEDGDAYALVQHATLYCGKCHNEVVLAPMFERLSTESVQEQLPYSVTLISMPATTEGRRGFSVSVESACSNYATTVQVKEVNRMHISPNNRNAIHPGDRILEINGTPVRTLRVEEVEDAISQTSQTLQLLIEHDPVSQRLDQLRLEARLAPHMQNAGHPHALSTLDTKENLEGTLRRRSLRRSNSISKSPGPSSPKEPLLFSRDISRSESLRCSSSYSQQIFRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSMDPFPWQQKVRFAKGIASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRAPMEKATTKKRTLRKNDRKKRYTVVGNPYWMAPEMLNGKSYDETVDIFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCRLEPESRPAFSKLEDSFEALSLYLGELGIPLPAELEELDHTVSMQYGLTRDSPP,638,"72,232",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=LIMK2a; IsoId=P53671-1; Sequence=Displayed; Name=LIMK2b; IsoId=P53671-2; Sequence=VSP_012287; Name=3; IsoId=P53671-3; Sequence=VSP_012287, VSP_043332; Note=No experimental confirmation available.; ",SEQUENCE CAUTION:  Sequence=AAB54055.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; ,,,,,,,,,"VAR_SEQ 1 37 MSALAGEDVWRCPGCGDHIAPSQIWYRTVNETWHGSC -> MGSYLSVPAYFTSRDL (in isoform LIMK2b and isoform 3). {ECO:0000303|PubMed:11230166, ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:8954941}. /FTId=VSP_012287.; VAR_SEQ 592 638 PAFSKLEDSFEALSLYLGELGIPLPAELEELDHTVSMQYGLTRDSPP -> APPGAAGEGPGCADDEGPVRRQGKVTIKYDPKELRKHLNLEEWILEQLTRLYDCQEEEISELEIDVDELLDMESDDAWASRVKELLVDCYKPTEAFISGLLDKIRAMQKLSTPQKK (in isoform 3). {ECO:0000303|PubMed:15489334}. /FTId=VSP_043332.",VARIANT 35 35 G -> S (in dbSNP:rs5997917). {ECO:0000269|PubMed:17344846}. /FTId=VAR_034069.; VARIANT 45 45 D -> N (in dbSNP:rs35923988). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042249.; VARIANT 213 213 R -> C (in dbSNP:rs34930775). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042250.; VARIANT 296 296 P -> R (in dbSNP:rs34875793). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042251.; VARIANT 381 381 R -> H (in dbSNP:rs2229874). /FTId=VAR_050149.; VARIANT 418 418 R -> C (in dbSNP:rs35422808). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042252.,,,,,,1,,0,,SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. {ECO:0000305}.,,,DOMAIN 12 63 LIM zinc-binding 1. {ECO:0000255|PROSITE-ProRule:PRU00125}.; DOMAIN 72 124 LIM zinc-binding 2. {ECO:0000255|PROSITE-ProRule:PRU00125}.; DOMAIN 152 239 PDZ. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 331 608 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",,,"FUNCTION: Displays serine/threonine-specific phosphorylation of myelin basic protein and histone (MBP) in vitro. {ECO:0000269|PubMed:10436159, ECO:0000269|PubMed:11018042}.",,,,,,ACT_SITE 451 451 {ECO:0000250}.,BINDING 360 360 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 337 345 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; cornea development in camera-type eye [GO:0061303]; head development [GO:0060322]; phosphorylation [GO:0016310]; spermatogenesis [GO:0007283],actin cytoskeleton organization [GO:0030036]; cornea development in camera-type eye [GO:0061303]; head development [GO:0060322]; phosphorylation [GO:0016310]; spermatogenesis [GO:0007283],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674],cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; nucleus [GO:0005634],GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005801; GO:0007283; GO:0016310; GO:0030036; GO:0046872; GO:0046982; GO:0060322; GO:0061303,IPR011009; IPR001478; IPR036034; IPR000719; IPR017441; IPR001245; IPR001781; ,P08238,"SUBUNIT: Binds ROCK1 and MARF1 (Ref.9, PubMed:11018042, PubMed:10436159). Interacts with PARD3. Interacts with NISCH (By similarity). {ECO:0000250|UniProtKB:Q8BJ34, ECO:0000269|PubMed:10436159, ECO:0000269|PubMed:11018042, ECO:0000269|Ref.9}.",8537403; 8954941; 11230166; 15461802; 14702039; 10591208; 15489334; 10436159; 11018042; 11340065; 18691976; 18669648; 19369195; 23186163; 17344846,8537403; 8954941; 11230166; 15461802; 14702039; 10591208; 15489334; 10436159; 11018042; 11340065; 18691976; 18669648; 19369195; 23186163; 17344846; 10652353; 11171090; 11276226; 12642619; 15231748; 15647284; 15923181; 16219803; 16455074; 16505165; 16820362; 17053785; 17294230; 17721511; 18000399; 18852895; 19099536; 19369647; 20047470; 20190821; 20379614; 20711500; 21079653; 22328514; 22492986; 22883572; 22939624; 23082153; 23239465; 23585469; 23991158; 24695225; 25036637; 25344584; 25589930; 25849865; 25852190; 25981171; 26662719; 26956845; 28069000; 28818508,1996-10-01,2019-02-13,1996-10-01,192,X-ray crystallography (2); NMR spectroscopy (1),STRAND 111 113 {ECO:0000244|PDB:1X6A}.; STRAND 115 117 {ECO:0000244|PDB:1X6A}.; STRAND 119 121 {ECO:0000244|PDB:1X6A}.; STRAND 331 337 {ECO:0000244|PDB:5NXD}.; STRAND 345 350 {ECO:0000244|PDB:5NXD}.; STRAND 356 362 {ECO:0000244|PDB:5NXD}.; STRAND 391 397 {ECO:0000244|PDB:5NXD}.; STRAND 400 406 {ECO:0000244|PDB:5NXD}.; STRAND 410 412 {ECO:0000244|PDB:4TPT}.; STRAND 456 459 {ECO:0000244|PDB:5NXD}.; STRAND 465 467 {ECO:0000244|PDB:5NXD}.; STRAND 609 611 {ECO:0000244|PDB:4TPT}.,HELIX 122 129 {ECO:0000244|PDB:1X6A}.; HELIX 341 343 {ECO:0000244|PDB:5NXD}.; HELIX 367 382 {ECO:0000244|PDB:5NXD}.; HELIX 413 418 {ECO:0000244|PDB:5NXD}.; HELIX 425 444 {ECO:0000244|PDB:5NXD}.; HELIX 515 518 {ECO:0000244|PDB:5NXD}.; HELIX 527 540 {ECO:0000244|PDB:5NXD}.; HELIX 547 549 {ECO:0000244|PDB:5NXD}.; HELIX 560 567 {ECO:0000244|PDB:5NXD}.; HELIX 576 583 {ECO:0000244|PDB:5NXD}.; HELIX 588 590 {ECO:0000244|PDB:5NXD}.; HELIX 594 608 {ECO:0000244|PDB:5NXD}.; HELIX 617 629 {ECO:0000244|PDB:5NXD}.,TURN 73 75 {ECO:0000244|PDB:1X6A}.; TURN 99 101 {ECO:0000244|PDB:1X6A}.; TURN 351 353 {ECO:0000244|PDB:5NXD}.; TURN 510 512 {ECO:0000244|PDB:4TPT}.,,,,,5 out of 5,Active site (1); Alternative sequence (2); Beta strand (12); Binding site (1); Chain (1); Domain (4); Erroneous gene model prediction (1); Helix (13); Modified residue (4); Mutagenesis (2); Natural variant (6); Nucleotide binding (1); Turn (4),,"TISSUE SPECIFICITY: Highest expression in the placenta; moderate level in liver, lung, kidney, and pancreas. LIMK2a is found to be more abundant then LIMK2b in liver, colon, stomach, and spleen, while in brain, kidney, and placenta LIMK2b is the dominant form. In adult lung, both LIMK2a and LIMK2b is nearly equally observed. {ECO:0000269|PubMed:8954941}.",,3D-structure;ATP-binding;Alternative splicing;Complete proteome;Cytoplasm;Kinase;LIM domain;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase;Zinc,Evidence at protein level,reviewed,,"Protein kinase superfamily, TKL Ser/Thr protein kinase family",192,Alternative products (1); Catalytic activity (2); Caution (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (2); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0067; KW-0181; KW-0418; KW-0440; KW-0479; KW-0539; KW-0547; KW-0597; KW-0621; KW-0677; KW-0723; KW-0808; KW-0862; KW-0963; KW-1185,,,,,,,,"PTM: Phosphorylated on serine and/or threonine residues by ROCK1. {ECO:0000269|PubMed:11018042, ECO:0000269|PubMed:11340065}.",CHAIN 1 638 LIM domain kinase 2. /FTId=PRO_0000075809.,,,,,,"MOD_RES 210 210 Phosphothreonine. {ECO:0000244|PubMed:18691976}.; MOD_RES 293 293 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976}.; MOD_RES 298 298 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 505 505 Phosphothreonine; by ROCK1 and CDC42BP. {ECO:0000269|PubMed:11018042, ECO:0000269|PubMed:11340065}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,D45906;D85527;AL117466;CR456513;AK291640;AC002073;AC002073;CH471095;CH471095;CH471095;BC013051;
0,P53990,IST1_HUMAN,IST1 KIAA0174,IST1,KIAA0174,,,Homo sapiens (Human),9606,IST1 homolog (hIST1) (Putative MAPK-activating protein PM28),UP000005640: Chromosome 16,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MLGSGFKAERLRVNLRLVINRLKLLEKKKTELAQKARKEIADYLAAGKDERARIRVEHIIREDYLVEAMEILELYCDLLLARFGLIQSMKELDSGLAESVSTLIWAAPRLQSEVAELKIVADQLCAKYSKEYGKLCRTNQIGTVNDRLMHKLSVEAPPKILVERYLIEIAKNYNVPYEPDSVVMAEAPPGVETDLIDVGFTDDVKKGGPGRGGSGGFTAPVGGPDGTVPMPMPMPMPSANTPFSYPLPKGPSDFNGLPMGTYQAFPNIHPPQIPATPPSYESVDDINADKNISSAQIVGPGPKPEASAKLPSRPADNYDNFVLPELPSVPDTLPTASAGASTSASEDIDFDDLSRRFEELKKKT,364,"39,751",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=6;  Name=1; IsoId=P53990-1; Sequence=Displayed; Name=2; IsoId=P53990-2; Sequence=VSP_017118, VSP_017119; Note=No experimental confirmation available.; Name=5; IsoId=P53990-5; Sequence=VSP_047075, VSP_047076; Name=4; IsoId=P53990-4; Sequence=VSP_017118; Name=3; IsoId=P53990-3; Sequence=VSP_017118, VSP_017120; Note=No experimental confirmation available.; Name=6; IsoId=P53990-6; Sequence=VSP_055118, VSP_017118; Note=No experimental confirmation available. Gene prediction based on EST data.; ",,SEQUENCE CAUTION:  Sequence=BAA11491.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 1 148 Missing (in isoform 6). {ECO:0000305}. /FTId=VSP_055118.; VAR_SEQ 1 1 M -> MVFKLKTKEEQHSM (in isoform 5). {ECO:0000303|PubMed:14702039}. /FTId=VSP_047075.; VAR_SEQ 228 228 V -> VPM (in isoform 2, isoform 3, isoform 4 and isoform 6). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334}. /FTId=VSP_017118.; VAR_SEQ 237 237 P -> PMP (in isoform 5). {ECO:0000303|PubMed:14702039}. /FTId=VSP_047076.; VAR_SEQ 252 282 Missing (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_017119.; VAR_SEQ 283 364 VDDINADKNISSAQIVGPGPKPEASAKLPSRPADNYDNFVLPELPSVPDTLPTASAGASTSASEDIDFDDLSRRFEELKKKT -> MTLMLIRISLLHRLLVLDPSQKPLQSFLPDLQITMTTLSYQSCHLCQTHYQLHLLVPAPQHLKTLTLMIFPGGLKS (in isoform 3). {ECO:0000303|PubMed:15489334}. /FTId=VSP_017120.",,,,,,,1,,0,,SIMILARITY: Belongs to the IST1 family. {ECO:0000305}.,,,,MOTIF 321 332 Type-2 MIT-interacting motif.; MOTIF 351 361 MIT-interacting motif.,"REGION 1 168 Interaction with CHMP1A and CHMP1B.; REGION 64 279 Interaction with VPS37B. {ECO:0000269|PubMed:19129479}.; REGION 190 364 Interaction with VTA1.; REGION 348 364 Interaction with VPS4A, VTA1, MITD1 STAMBP and USP8. {ECO:0000269|PubMed:19129480}.",,,,,,,,"FUNCTION: ESCRT-III-like protein involved in specific functions of the ESCRT machinery. Is required for efficient abscission during cytokinesis, but not for HIV-1 budding. The involvement in the MVB pathway is not established. Involved in recruiting VPS4A and/or VPS4B to the midbody of dividing cells (PubMed:19129479, PubMed:19129480). During late anaphase, involved in nuclear envelope reassembly and mitotic spindle disassembly together with the ESCRT-III complex: IST1 acts by mediating the recruitment of SPAST to the nuclear membrane, leading to microtubule severing (PubMed:26040712). Regulates early endosomal tubulation together with the ESCRT-III complex by mediating the recruitment of SPAST (PubMed:23897888). {ECO:0000269|PubMed:19129479, ECO:0000269|PubMed:19129480, ECO:0000269|PubMed:23897888, ECO:0000269|PubMed:26040712}.",,,,,,,,,,,,azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; neutrophil degranulation [GO:0043312]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076],abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; neutrophil degranulation [GO:0043312]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076],cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904],azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635],GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0009838; GO:0015031; GO:0019076; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0043231; GO:0043312; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0046745; GO:0048672; GO:0051301; GO:0061640; GO:0070062; GO:0090541; GO:0090543; GO:1904903,IPR005061; ,P13798; P54253; Q7Z479; Q9Y6W3; Q7LBR1; Q9UMX0,"SUBUNIT: Interacts with CHMP1A, CHMP1B, VPS4A and VTA1. Interacts with SPAST, STAMBP, and USP8. May interact with VPS37B. May associate with the ESCRT-I complex. Interacts with MITD1, in competition with VSP4 (PubMed:23015756). Interacts with SPART (via MIT domain); leading to the recruitment of SPART to midbodies (PubMed:20719964). Interacts with SPAST (PubMed:23897888, PubMed:26040712). {ECO:0000269|PubMed:19129479, ECO:0000269|PubMed:19129480, ECO:0000269|PubMed:20719964, ECO:0000269|PubMed:23015756, ECO:0000269|PubMed:23897888, ECO:0000269|PubMed:26040712}.",8724849; 12761501; 14702039; 15616553; 15489334; 15592455; 19129480; 19129479; 20719964; 20068231; 21269460; 23015756; 22814378; 23897888; 23186163; 24275569; 26040712,8724849; 12761501; 14702039; 15616553; 15489334; 15592455; 19129480; 19129479; 20719964; 20068231; 21269460; 23015756; 22814378; 23897888; 23186163; 24275569; 26040712; 16189514; 16713569; 18951430; 19001599; 19525971; 20711500; 20849418; 21439932; 21616915; 21674799; 22623428; 23416715; 23609236; 23649269; 24403489; 24608342; 24880589; 24953135; 25416956; 25657007; 26011858; 26496610; 26634441; 28038462; 28532543; 8692836,1996-10-01,2019-02-13,1996-10-01,160,X-ray crystallography (6); Electron microscopy (2),,HELIX 8 45 {ECO:0000244|PDB:3FRR}.; HELIX 49 81 {ECO:0000244|PDB:3FRR}.; HELIX 83 87 {ECO:0000244|PDB:3FRR}.; HELIX 94 96 {ECO:0000244|PDB:3FRR}.; HELIX 97 110 {ECO:0000244|PDB:3FRR}.; HELIX 115 128 {ECO:0000244|PDB:3FRR}.; HELIX 130 137 {ECO:0000244|PDB:3FRR}.; HELIX 146 151 {ECO:0000244|PDB:3FRR}.; HELIX 159 173 {ECO:0000244|PDB:3FRR}.; HELIX 181 185 {ECO:0000244|PDB:3FRR}.; HELIX 350 360 {ECO:0000244|PDB:4WZX}.,TURN 111 113 {ECO:0000244|PDB:3FRR}.; TURN 138 141 {ECO:0000244|PDB:3FRR}.,,,,,5 out of 5,Alternative sequence (6); Chain (1); Erroneous initiation (1); Helix (11); Modified residue (2); Motif (2); Mutagenesis (5); Region (4); Turn (2),,,,3D-structure;Alternative splicing;Cell cycle;Cell division;Complete proteome;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Nucleus;Phosphoprotein;Reference proteome,Evidence at protein level,reviewed,,IST1 family,160,Alternative products (1); Caution (3); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0131; KW-0132; KW-0181; KW-0206; KW-0539; KW-0597; KW-0963; KW-0968; KW-1185,,,,,,,,,CHAIN 1 364 IST1 homolog. /FTId=PRO_0000050727.,,,,,,MOD_RES 4 4 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 43 43 Phosphotyrosine. {ECO:0000244|PubMed:15592455}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB097052;D79996;AK057258;AK293022;AK293040;BC000116;BC000430;BC004359;BC103745;
0,P0DP23,CALM1_HUMAN,CALM1 CALM CAM CAM1,CALM1,CALM CAM CAM1,,,Homo sapiens (Human),9606,Calmodulin-1,UP000005640: Chromosome 14,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK,149,"16,838",,,,,,,,,,,,,"VARIANT 54 54 N -> I (in CPVT4; increased RYR2 calcium-release channel activity; not changed calcium-dependent inactivation of L-type calcium channel; not changed protein abundance; not changed structure; not changed thermal stability both in the absence and presence of calcium; no effect on the calcium binding affinity; significantly increased binding of RYR2; increased ryanodine-sensitive calcium-release channel activity; decreased of KCNN2 calcium-activated potassium channel activity; not changed KCNN2 expression; not changed KCNN2 location at membrane; dbSNP:rs267607276). {ECO:0000269|PubMed:23040497, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696, ECO:0000269|PubMed:27516456}. /FTId=VAR_069222.; VARIANT 90 90 F -> L (in LQT14; significantly decreased of KCNN2 calcium-activated potassium channel activity; not changed KCNN2 expression; not changed KCNN2 location at membrane; dbSNP:rs730882253). {ECO:0000269|PubMed:24076290, ECO:0000269|PubMed:27165696}. /FTId=VAR_073275.; VARIANT 98 98 N -> S (in CPVT4; the mutant has significantly reduced calcium affinity compared to wild-type; calmodulin-RYR2 interaction is defective at low intracellular Ca(2+) concentrations and restored at moderate to high Ca(2+) concentrations; increased RYR2 calcium-release channel activity; decreased calcium-dependent inactivation of L-type calcium channel; not changed protein abundance; not changed structure; significantly reduced ryanodine-sensitive calcium-release channel activity; decreased of KCNN2 calcium-activated potassium channel activity; not changed KCNN2 expression; not changed KCNN2 location at membrane; dbSNP:rs398124647). {ECO:0000269|PubMed:23040497, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696, ECO:0000269|PubMed:27516456}. /FTId=VAR_078541.; VARIANT 130 130 D -> G (in LQT14; reduction in calcium affinity; not changed protein abundance; not changed structure; significantly decreased thermal stability in presence of clacium; significantly decreased RYR2 interaction; increased ryanodine-sensitive calcium-release channel activity; decreased of KCNN2 calcium-activated potassium channel activity; not changed KCNN2 expression; not changed KCNN2 location at membrane; dbSNP:rs730882252). {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:26969752, ECO:0000269|PubMed:27165696}. /FTId=VAR_078542.; VARIANT 141 141 E -> G (in LQT14; decreased calcium affinity; loss of CACNA1C calcium-dependent-inactivation; no effect on intracellular RYR2-mediated calcium release). {ECO:0000269|PubMed:26969752}. /FTId=VAR_078263.; VARIANT 142 142 F -> L (in LQT14; reduction in calcium affinity; not changed protein abundance; not changed structure; significantly decreased thermal stability in presence of calcium; no effect on RYR2 interaction; significantly reduced ryanodine-sensitive calcium-release channel activity; dbSNP:rs11551462). {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:26969752}. /FTId=VAR_073282.",,,,,,1,,0,,SIMILARITY: Belongs to the calmodulin family. {ECO:0000305}.,,,DOMAIN 8 43 EF-hand 1. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 44 79 EF-hand 2. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 81 116 EF-hand 3. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 117 149 EF-hand 4. {ECO:0000255|PROSITE-ProRule:PRU00448}.,,REGION 77 149 Necessary and sufficient for interaction with PCP4. {ECO:0000269|PubMed:27876793}.,,,,,,,,"FUNCTION: Calmodulin mediates the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding. Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases and phosphatases. Together with CCP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis (PubMed:16760425). Mediates calcium-dependent inactivation of CACNA1C (PubMed:26969752). Positively regulates calcium-activated potassium channel activity of KCNN2 (PubMed:27165696). {ECO:0000269|PubMed:16760425, ECO:0000269|PubMed:23893133, ECO:0000269|PubMed:26969752, ECO:0000269|PubMed:27165696}.",,,,,,,,,,,,"calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]; activation of adenylate cyclase activity [GO:0007190]; cofactor metabolic process [GO:0051186]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; muscle contraction [GO:0006936]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation by host of symbiont cAMP-mediated signal transduction [GO:0075206]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","activation of adenylate cyclase activity [GO:0007190]; cofactor metabolic process [GO:0051186]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; muscle contraction [GO:0006936]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation by host of symbiont cAMP-mediated signal transduction [GO:0075206]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; N-terminal myristoylation domain binding [GO:0031997]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]",calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982],GO:0000165; GO:0000922; GO:0001975; GO:0002027; GO:0002576; GO:0005088; GO:0005509; GO:0005513; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005876; GO:0005886; GO:0006936; GO:0007186; GO:0007190; GO:0007223; GO:0008179; GO:0008440; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0019855; GO:0019901; GO:0019904; GO:0021762; GO:0022400; GO:0030017; GO:0030235; GO:0030426; GO:0030672; GO:0031432; GO:0031800; GO:0031954; GO:0031966; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0038095; GO:0043209; GO:0043539; GO:0043548; GO:0043647; GO:0044325; GO:0048306; GO:0050998; GO:0050999; GO:0051000; GO:0051186; GO:0051343; GO:0051412; GO:0051592; GO:0055117; GO:0060314; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0075206; GO:0090151; GO:0097718; GO:1900242; GO:1901841; GO:1901844; GO:1902494; GO:2000300,IPR039030; IPR011992; IPR018247; IPR002048; ,,"SUBUNIT: Interacts with MYO1C, MYO5A and RRAD. Interacts with MYO10 (By similarity). Interacts with CEP97, CCP110, TTN/titin and SRY (PubMed:9804419, PubMed:12871148, PubMed:15746192, PubMed:16760425, PubMed:17719545). Interacts with USP6; the interaction is calcium dependent (PubMed:16127172). Interacts with CDK5RAP2 (PubMed:20466722). Interacts with SCN5A (PubMed:21167176). Interacts with RYR1 (PubMed:18650434). Interacts with FCHO1 (PubMed:22484487). Interacts with MIP in a 1:2 stoichiometry; the interaction with the cytoplasmic domains from two MIP subunits promotes MIP water channel closure (PubMed:23893133). Interacts with ORAI1; this may play a role in the regulation of ORAI1-mediated calcium transport (By similarity). Interacts with IQCF1 (By similarity). Interacts with SYT7 (By similarity). Interacts with CEACAM1 (via cytoplasmic domain); this interaction is in a calcium dependent manner and reduces homophilic cell adhesion through dissociation of dimer (By similarity). Interacts with RYR2; regulates RYR2 calcium-release channel activity (PubMed:27516456, PubMed:18650434, PubMed:26164367). Interacts with PCP4; regulates calmodulin calcium-binding (PubMed:27876793). Interacts with the heterotetrameric KCNQ2 and KCNQ3 channel; the interaction is calcium-independent, constitutive and participates to the proper assembly of a functional heterotetrameric M channel (PubMed:27564677). Interacts with alpha-synuclein/SNCA (PubMed:23607618). {ECO:0000250|UniProtKB:P62157, ECO:0000250|UniProtKB:P62161, ECO:0000250|UniProtKB:P62204, ECO:0000269|PubMed:12485993, ECO:0000269|PubMed:12577052, ECO:0000269|PubMed:12871148, ECO:0000269|PubMed:15719022, ECO:0000269|PubMed:15746192, ECO:0000269|PubMed:16127172, ECO:0000269|PubMed:16299511, ECO:0000269|PubMed:16760425, ECO:0000269|PubMed:17719545, ECO:0000269|PubMed:18650434, ECO:0000269|PubMed:20466722, ECO:0000269|PubMed:21167176, ECO:0000269|PubMed:22484487, ECO:0000269|PubMed:23109337, ECO:0000269|PubMed:23607618, ECO:0000269|PubMed:23893133, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27516456, ECO:0000269|PubMed:27564677, ECO:0000269|PubMed:27876793, ECO:0000269|PubMed:9804419}.; SUBUNIT: (Microbial infection) Interacts with Rubella virus protease/methyltransferase p150. {ECO:0000269|PubMed:20086014}.",6385987; 7925473; 12508121; 15489334; 7093203; 9804419; 14654843; 12871148; 16127172; 15746192; 15592455; 16760425; 17719545; 18650434; 18669648; 19413330; 19690332; 19608861; 20466722; 20086014; 21269460; 21406692; 23109337; 22223895; 22484487; 22814378; 23186163; 24275569; 24129315; 25944712; 28112733; 9927666; 11685248; 1474585; 7803388; 11807546; 12485993; 12577052; 16299511; 15719022; 21167176; 23893133; 27564677; 27876793; 23607618; 23040497; 23388215; 24076290; 26164367; 27516456; 26969752; 27165696,6385987; 7925473; 12508121; 15489334; 7093203; 9804419; 14654843; 12871148; 16127172; 15746192; 15592455; 16760425; 17719545; 18650434; 18669648; 19413330; 19690332; 19608861; 20466722; 20086014; 21269460; 21406692; 23109337; 22223895; 22484487; 22814378; 23186163; 24275569; 24129315; 25944712; 28112733; 9927666; 11685248; 1474585; 7803388; 11807546; 12485993; 12577052; 16299511; 15719022; 21167176; 23893133; 27564677; 27876793; 23607618; 23040497; 23388215; 24076290; 26164367; 27516456; 26969752; 27165696; 10075700; 10207003; 10373510; 10376602; 10376603; 10469573; 10487978; 10777564; 10781589; 10830164; 10860980; 11015619; 11030334; 11042191; 11231878; 11290418; 11879202; 11988487; 12015605; 12406570; 12482967; 12687004; 12747803; 12799359; 12825073; 12930917; 12975316; 1309946; 13115432; 1374913; 14500339; 14527397; 14622581; 14627618; 14630798; 14701808; 14765114; 14978283; 15063758; 15100408; 15131111; 15147738; 1519061; 15225611; 15262966; 15272012; 15299715; 15467163; 15476407; 15522886; 15550383; 15583004; 156362; 15713486; 15746150; 15754088; 15817490; 15916532; 16013055; 16030015; 16084495; 16138079; 16154564; 16338416; 16359877; 16525015; 16545345; 16613843; 16880514; 16920709; 17244649; 17473011; 17502104; 17569884; 17580302; 17654480; 17671360; 17687619; 17699613; 17765682; 17881003; 17884685; 17975119; 18001530; 18178620; 18184654; 18296442; 18335582; 18384083; 18452398; 18462678; 18940010; 18940602; 18989758; 19001277; 19023099; 19034380; 19080622; 19133300; 19279214; 19317469; 19342380; 193860; 19404396; 19406745; 19473981; 19584346; 19658100; 19752189; 19851316; 19855925; 19913121; 19996092; 20103772; 20198394; 20298697; 20379146; 20379614; 20388639; 20468064; 20628086; 20668654; 20738160; 20953164; 20975703; 21047202; 21102635; 21124984; 2114169; 21148297; 21299499; 21360154; 21372320; 21439835; 21555518; 21566136; 21640070; 21664913; 21730051; 21817159; 21901608; 22009783; 22009847; 22044025; 22100452; 22163646; 22295092; 22323446; 22331908; 22342729; 22437832; 22451665; 22486744; 22514276; 22518098; 22588125; 22633975; 22705208; 22711531; 22767601; 22768143; 22801425; 22803592; 22856685; 22877078; 22908850; 22944912; 2298749; 22996592; 23019329; 23109716; 23159936; 23178170; 2321095; 23235156; 23285036; 23300090; 23303910; 23315338; 23322042; 23352230; 23362265; 23437200; 23457304; 23552119; 23624269; 23632248; 23658780; 23662433; 23743201; 23755207; 23760276; 23804213; 23831686; 23838429; 23967355; 24032677; 24088894; 24419375; 24420768; 24420770; 24469830; 24495081; 24530797; 24551838; 24636949; 24713697; 24779925; 24787902; 24816216; 24907274; 24917665; 24937142; 25005783; 25036739; 25101901; 25144868; 25145833; 25232683; 25251320; 2526655; 25268113; 2536303; 25370050; 25441029; 25470139; 25703379; 2573431; 25751535; 25940090; 25956027; 26001204; 26085527; 26196381; 26391397; 26421717; 26487174; 26494044; 26529318; 26559977; 26618792; 26675311; 2667896; 26828872; 26858457; 26980593; 27009875; 27100291; 27129269; 27226555; 27325704; 27339229; 27374306; 27499441; 27516594; 27563101; 27580874; 27632770; 2764880; 27696828; 27760856; 27790916; 27798963; 27815504; 27856935; 27927985; 27933776; 27956550; 28003368; 28045382; 28092099; 28121131; 28130124; 28158429; 28174300; 28222617; 28288938; 28295264; 28335032; 28360104; 28422741; 28449373; 28462395; 28842480; 28849027; 28976808; 29214998; 29247668; 29358376; 29409956; 29429937; 29463698; 29494137; 29505720; 2953725; 29576321; 29584409; 29724949; 30116787; 30142967; 30200150; 30348784; 30474048; 3079756; 3780718; 3839510; 5461220; 6328915; 6330098; 7407067; 7479966; 7525588; 7526403; 7526779; 7545680; 7588753; 7657645; 7678445; 7702581; 7708705; 7847371; 7889407; 7929371; 8021246; 8397339; 8576111; 8615909; 8631904; 8684469; 8702940; 8756646; 8782602; 8782898; 8799126; 8809036; 8896567; 8910504; 9106655; 9173876; 9188442; 9199170; 9312192; 9368021; 9395096; 9515967; 9580552; 9625352; 9727000; 9753452,2017-05-10,2019-02-13,2017-05-10,21,X-ray crystallography (94); Model (1); NMR spectroscopy (37); Electron microscopy (10),STRAND 25 28 {ECO:0000244|PDB:6DAD}.; STRAND 61 64 {ECO:0000244|PDB:5V03}.; STRAND 97 102 {ECO:0000244|PDB:5V03}.; STRAND 113 115 {ECO:0000244|PDB:6B8P}.; STRAND 130 132 {ECO:0000244|PDB:6B8Q}.; STRAND 133 138 {ECO:0000244|PDB:5V03}.,HELIX 2 4 {ECO:0000244|PDB:5OEO}.; HELIX 7 20 {ECO:0000244|PDB:5V03}.; HELIX 30 39 {ECO:0000244|PDB:5V03}.; HELIX 46 56 {ECO:0000244|PDB:5V03}.; HELIX 66 75 {ECO:0000244|PDB:5V03}.; HELIX 76 78 {ECO:0000244|PDB:5V7X}.; HELIX 83 91 {ECO:0000244|PDB:5V03}.; HELIX 103 110 {ECO:0000244|PDB:5V03}.; HELIX 119 129 {ECO:0000244|PDB:5V03}.; HELIX 139 147 {ECO:0000244|PDB:5V03}.,,,,,,5 out of 5,Beta strand (6); Calcium binding (4); Chain (1); Cross-link (2); Domain (4); Helix (10); Initiator methionine (1); Modified residue (11); Natural variant (6); Region (1),,,"MISCELLANEOUS: This protein has four functional calcium-binding sites. {ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677}.",3D-structure;Acetylation;Calcium;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Isopeptide bond;Long QT syndrome;Metal-binding;Methylation;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation,Evidence at protein level,reviewed,,Calmodulin family,21,Function (1); Involvement in disease (2); Miscellaneous (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (2),,KW-0002; KW-0007; KW-0106; KW-0181; KW-0206; KW-0225; KW-0454; KW-0479; KW-0488; KW-0597; KW-0621; KW-0677; KW-0832; KW-0903; KW-0963; KW-1017; KW-1185,,,,,"DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 4 (CPVT4) [MIM:614916]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. CPVT4 inheritance is autosomal dominant. {ECO:0000269|PubMed:23040497, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696, ECO:0000269|PubMed:27516456}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in CALM1 are the cause of CPVT4.; DISEASE: Long QT syndrome 14 (LQT14) [MIM:616247]: A form of long QT syndrome, a heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:24076290, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:26969752, ECO:0000269|PubMed:27165696}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in CALM1 are the cause of LQT14.",,,PTM: Ubiquitination results in a strongly decreased activity. {ECO:0000250}.; PTM: Phosphorylation results in a decreased activity. {ECO:0000250}.,CHAIN 2 149 Calmodulin-1. /FTId=PRO_0000439932.,CROSSLNK 22 22 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 22 22 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate. {ECO:0000250|UniProtKB:P62157}.,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:7093203, ECO:0000269|Ref.7}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:7093203, ECO:0000269|Ref.7}.; MOD_RES 22 22 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 45 45 Phosphothreonine; by CaMK4. {ECO:0000250|UniProtKB:P0DP29}.; MOD_RES 82 82 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 95 95 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 100 100 Phosphotyrosine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 102 102 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 111 111 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 116 116 N6,N6,N6-trimethyllysine; alternate. {ECO:0000244|PubMed:24129315, ECO:0000269|PubMed:7093203}.; MOD_RES 116 116 N6-methyllysine; alternate. {ECO:0000244|PubMed:24129315}.; MOD_RES 139 139 Phosphotyrosine. {ECO:0000244|PubMed:19690332}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M27319;U12022;U11886;BT006818;AC006536;BC000454;BC008597;BC011834;
0,P0DP24,CALM2_HUMAN,CALM2 CAM2 CAMB,CALM2,CAM2 CAMB,,,Homo sapiens (Human),9606,Calmodulin-2,UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK,149,"16,838",,,,,,,,,,,,,"VARIANT 96 96 D -> V (in LQT15; reduction in calcium affinity; highly decreased calcium-dependent inactivation of L-type calcium channel; increased action potential duration; not changed protein abundance; not changed structure; increased thermal stability in absence of calcium; decreased thermal stability in presence of calcium; significantly increased RYR2 interaction; increased ryanodine-sensitive calcium-release channel activity; decreased of KCNN2 calcium-activated potassium channel activity; not changed KCNN2 expression; not changed KCNN2 location at membrane; dbSNP:rs730882254). {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696, ECO:0000269|PubMed:27516456}. /FTId=VAR_073276.; VARIANT 98 98 N -> I (in LQT15; reduction in calcium affinity; dbSNP:rs398124647). {ECO:0000269|PubMed:24917665}. /FTId=VAR_073277.; VARIANT 98 98 N -> S (in LQT15; the mutant has significantly reduced calcium affinity compared to wild-type; calmodulin-RYR2 interaction is defective at low intracellular Ca(2+) concentrations and restored at moderate to high Ca(2+) concentrations; increased RYR2 calcium-release channel activity; decreased calcium-dependent inactivation of L-type calcium channel; not changed protein abundance; not changed structure; significantly reduced ryanodine-sensitive calcium-release channel activity; decreased of KCNN2 calcium-activated potassium channel activity; not changed KCNN2 expression; not changed KCNN2 location at membrane; dbSNP:rs398124647). {ECO:0000269|PubMed:24917665, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696, ECO:0000269|PubMed:27516456}. /FTId=VAR_078543.; VARIANT 130 130 D -> G (in LQT15; reduction in calcium affinity; not changed protein abundance; not changed structure; significantly decreased thermal stability in presence of clacium; significantly decreased RYR2 interaction; increased ryanodine-sensitive calcium-release channel activity; decreased of KCNN2 calcium-activated potassium channel activity; not changed KCNN2 expression; not changed KCNN2 location at membrane; dbSNP:rs730882252). {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:26969752, ECO:0000269|PubMed:27165696}. /FTId=VAR_078544.; VARIANT 130 130 D -> V (in LQT15). {ECO:0000269|PubMed:26969752}. /FTId=VAR_078262.; VARIANT 132 132 D -> E (in LQT15; reduction in calcium affinity; dbSNP:rs398124648). {ECO:0000269|PubMed:24917665}. /FTId=VAR_073279.; VARIANT 134 134 D -> H (in LQT15; reduction in calcium affinity; dbSNP:rs398124650). {ECO:0000269|PubMed:24917665}. /FTId=VAR_073280.; VARIANT 136 136 Q -> P (in LQT15; reduction in calcium affinity; dbSNP:rs398124649). {ECO:0000269|PubMed:24917665}. /FTId=VAR_073281.",,,,CONFLICT 124 124 E -> Q (in Ref. 7; AAH08437). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the calmodulin family. {ECO:0000305}.,,,DOMAIN 8 43 EF-hand 1. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 44 79 EF-hand 2. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 81 116 EF-hand 3. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 117 149 EF-hand 4. {ECO:0000255|PROSITE-ProRule:PRU00448}.,,REGION 77 149 Necessary and sufficient for interaction with PCP4. {ECO:0000269|PubMed:27876793}.,,,,,,,,"FUNCTION: Calmodulin mediates the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding. Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases and phosphatases. Together with CCP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis (PubMed:16760425). Mediates calcium-dependent inactivation of CACNA1C (PubMed:26969752). Positively regulates calcium-activated potassium channel activity of KCNN2 (PubMed:27165696). {ECO:0000269|PubMed:16760425, ECO:0000269|PubMed:26969752, ECO:0000269|PubMed:27165696}.",,,,,,,,,,,,calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation by host of symbiont cAMP-mediated signal transduction [GO:0075206]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to calcium ion [GO:0051592]; substantia nigra development [GO:0021762],detection of calcium ion [GO:0005513]; G2/M transition of mitotic cell cycle [GO:0000086]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation by host of symbiont cAMP-mediated signal transduction [GO:0075206]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to calcium ion [GO:0051592]; substantia nigra development [GO:0021762],adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432],calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076],GO:0000086; GO:0000922; GO:0002027; GO:0005509; GO:0005513; GO:0005634; GO:0005737; GO:0005813; GO:0005876; GO:0005886; GO:0007186; GO:0008076; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0019855; GO:0019901; GO:0019904; GO:0021762; GO:0030017; GO:0031432; GO:0031954; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0043209; GO:0043388; GO:0043539; GO:0044325; GO:0051343; GO:0051592; GO:0055117; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0075206; GO:0097718; GO:1901844; GO:1902494,IPR039030; IPR011992; IPR018247; IPR002048; ,,"SUBUNIT: Interacts with MYO1C, MYO5A and RRAD. Interacts with MYO10 (By similarity). Interacts with CEP97, CCP110, TTN/titin and SRY (PubMed:9804419, PubMed:12871148, PubMed:15746192, PubMed:16760425, PubMed:17719545). Interacts with USP6; the interaction is calcium dependent (PubMed:16127172). Interacts with CDK5RAP2 (PubMed:20466722). Interacts with SCN5A (By similarity). Interacts with RYR1 (PubMed:18650434). Interacts with FCHO1 (PubMed:22484487). Interacts with MIP in a 1:2 stoichiometry; the interaction with the cytoplasmic domains from two MIP subunits promotes MIP water channel closure (By similarity). Interacts with ORAI1; this may play a role in the regulation of ORAI1-mediated calcium transport (By similarity). Interacts with IQCF1 (By similarity). Interacts with SYT7 (By similarity). Interacts with CEACAM1 (via cytoplasmic domain); this interaction is in a calcium dependent manner and reduces homophilic cell adhesion through dissociation of dimer (By similarity). Interacts with RYR2; regulates RYR2 calcium-release channel activity (PubMed:27516456, PubMed:18650434, PubMed:26164367). Interacts with PCP4; regulates calmodulin calcium-binding (PubMed:27876793). Interacts with the heterotetrameric KCNQ2 and KCNQ3 channel; the interaction is calcium-independent, constitutive and participates to the proper assembly of a functional heterotetrameric M channel (PubMed:27564677). {ECO:0000250|UniProtKB:P0DP23, ECO:0000250|UniProtKB:P62157, ECO:0000250|UniProtKB:P62161, ECO:0000250|UniProtKB:P62204, ECO:0000269|PubMed:12871148, ECO:0000269|PubMed:15746192, ECO:0000269|PubMed:16127172, ECO:0000269|PubMed:16760425, ECO:0000269|PubMed:17719545, ECO:0000269|PubMed:18650434, ECO:0000269|PubMed:20466722, ECO:0000269|PubMed:22484487, ECO:0000269|PubMed:23109337, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27516456, ECO:0000269|PubMed:27564677, ECO:0000269|PubMed:27876793, ECO:0000269|PubMed:9804419}.",2445749; 9681195; 15815621; 15489334; 7093203; 1474585; 9804419; 14654843; 12871148; 16127172; 15746192; 15592455; 16760425; 17719545; 18650434; 18669648; 19413330; 19690332; 19608861; 20466722; 21269460; 21406692; 23109337; 22223895; 22484487; 22814378; 23186163; 24275569; 24129315; 25944712; 27564677; 27876793; 23388215; 24917665; 28112733; 26164367; 27516456; 26969752; 27165696,2445749; 9681195; 15815621; 15489334; 7093203; 1474585; 9804419; 14654843; 12871148; 16127172; 15746192; 15592455; 16760425; 17719545; 18650434; 18669648; 19413330; 19690332; 19608861; 20466722; 21269460; 21406692; 23109337; 22223895; 22484487; 22814378; 23186163; 24275569; 24129315; 25944712; 27564677; 27876793; 23388215; 24917665; 28112733; 26164367; 27516456; 26969752; 27165696; 15225611; 15522886; 15583004; 15746150; 15817490; 16013055; 16030015; 16084495; 16154564; 16299511; 16359877; 16545345; 16613843; 17569884; 17580302; 17654480; 17687619; 17884685; 17975119; 18001530; 18178620; 18452398; 18940010; 18989758; 19023099; 19034380; 19080622; 19133300; 19584346; 19658100; 19855925; 19913121; 20198394; 20379146; 20379614; 20468064; 20628086; 20738160; 21047202; 21124984; 21439835; 21555518; 21640070; 21664913; 21730051; 21901608; 22009783; 22009847; 22044025; 22100452; 22163646; 22295092; 22323446; 22331908; 22342729; 22437832; 22451665; 22588125; 22633975; 22767601; 22768143; 22801425; 22856685; 22996592; 23019329; 23040497; 23159936; 23235156; 23285036; 23300090; 23322042; 23352230; 23437200; 23457304; 23552119; 23624269; 23658780; 23662433; 23743201; 23755207; 23760276; 23831686; 23838429; 23967355; 24032677; 24088894; 24419375; 24420768; 24420770; 24530797; 24551838; 24713697; 24779925; 24816216; 24907274; 25005783; 25036739; 25145833; 25251320; 25268113; 25370050; 25470139; 25703379; 25751535; 25940090; 25956027; 26001204; 26085527; 26196381; 26391397; 26421717; 26487174; 26494044; 26529318; 26559977; 26618792; 26675311; 26828872; 26858457; 26980593; 27009875; 27100291; 27129269; 27226555; 27325704; 27339229; 27374306; 27499441; 27632770; 27760856; 27790916; 27798963; 27815504; 27856935; 27927985; 27933776; 27956550; 28003368; 28092099; 28130124; 28158429; 28174300; 28222617; 28262393; 28295264; 28335032; 28360104; 28422741; 28449373; 28462395; 28575668; 28842480; 28849027; 28976808; 29162807; 29247668; 29409956; 29494137; 29505720; 29584409; 30142967; 30200150,2017-05-10,2019-01-16,2017-05-10,17,X-ray crystallography (7); Electron microscopy (1),STRAND 25 28 {ECO:0000244|PDB:5J03}.; STRAND 61 65 {ECO:0000244|PDB:5J03}.; STRAND 98 102 {ECO:0000244|PDB:5J03}.; STRAND 113 115 {ECO:0000244|PDB:5J03}.; STRAND 134 138 {ECO:0000244|PDB:5J03}.,HELIX 7 20 {ECO:0000244|PDB:5J03}.; HELIX 30 39 {ECO:0000244|PDB:5J03}.; HELIX 46 56 {ECO:0000244|PDB:5J03}.; HELIX 66 73 {ECO:0000244|PDB:5J03}.; HELIX 77 80 {ECO:0000244|PDB:5J03}.; HELIX 83 93 {ECO:0000244|PDB:5J03}.; HELIX 103 112 {ECO:0000244|PDB:5J03}.; HELIX 119 129 {ECO:0000244|PDB:5J03}.; HELIX 139 147 {ECO:0000244|PDB:5J03}.,,,,,,5 out of 5,Beta strand (5); Calcium binding (4); Chain (1); Cross-link (2); Domain (4); Helix (9); Initiator methionine (1); Modified residue (11); Natural variant (8); Region (1); Sequence conflict (1),,,MISCELLANEOUS: This protein has four functional calcium-binding sites. {ECO:0000269|PubMed:1474585}.,3D-structure;Acetylation;Calcium;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Isopeptide bond;Long QT syndrome;Metal-binding;Methylation;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation,Evidence at protein level,reviewed,,Calmodulin family,17,Function (1); Involvement in disease (1); Miscellaneous (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0106; KW-0181; KW-0206; KW-0225; KW-0454; KW-0479; KW-0488; KW-0597; KW-0621; KW-0677; KW-0832; KW-0903; KW-0963; KW-1017; KW-1185,,,,,"DISEASE: Long QT syndrome 15 (LQT15) [MIM:616249]: A form of long QT syndrome, a heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:24917665, ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:26969752, ECO:0000269|PubMed:27165696, ECO:0000269|PubMed:27516456}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in CALM2 are the cause of LQT15.",,,PTM: Ubiquitination results in a strongly decreased activity. {ECO:0000250}.; PTM: Phosphorylation results in a decreased activity. {ECO:0000250}.,CHAIN 2 149 Calmodulin-2. /FTId=PRO_0000439933.,CROSSLNK 22 22 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 22 22 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate. {ECO:0000250|UniProtKB:P62157}.,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:7093203, ECO:0000269|Ref.9}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:7093203, ECO:0000269|Ref.9}.; MOD_RES 22 22 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 45 45 Phosphothreonine; by CaMK4. {ECO:0000250|UniProtKB:P0DP30}.; MOD_RES 82 82 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 95 95 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 100 100 Phosphotyrosine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 102 102 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 111 111 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 116 116 N6,N6,N6-trimethyllysine; alternate. {ECO:0000244|PubMed:24129315, ECO:0000269|PubMed:7093203}.; MOD_RES 116 116 N6-methyllysine; alternate. {ECO:0000244|PubMed:24129315}.; MOD_RES 139 139 Phosphotyrosine. {ECO:0000244|PubMed:19690332}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M19311;D45887;U94728;U94725;U94726;BT009916;CR541990;CR542021;AC073283;BC003354;BC006464;BC008437;BC017385;BC018677;BC026065;
0,P0DP25,CALM3_HUMAN,CALM3 CALML2 CAM3 CAMC CAMIII,CALM3,CALML2 CAM3 CAMC CAMIII,,,Homo sapiens (Human),9606,Calmodulin-3,UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK,149,"16,838",,,SEQUENCE CAUTION:  Sequence=CAA36839.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; ,,,,,,,,,,VARIANT 103 103 A -> V (probable disease-associated mutation found in a patient with CPVT; decreased calcium-binding affinity; not changed binding to RYR2; increased RYR2 calcium-release channel activity; decreased calcium-dependent inactivation of L-type calcium channel; not changed action potential duration). {ECO:0000269|PubMed:27516456}. /FTId=VAR_078261.,,,,,,1,,0,,SIMILARITY: Belongs to the calmodulin family. {ECO:0000305}.,,,DOMAIN 8 43 EF-hand 1. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 44 79 EF-hand 2. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 81 116 EF-hand 3. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 117 149 EF-hand 4. {ECO:0000255|PROSITE-ProRule:PRU00448}.,,REGION 77 149 Necessary and sufficient for interaction with PCP4. {ECO:0000269|PubMed:27876793}.,,,,,,,,"FUNCTION: Calmodulin mediates the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding. Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases and phosphatases. Together with CCP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis. {ECO:0000250|UniProtKB:P0DP23, ECO:0000269|PubMed:16760425}.",,,,,,,,,,,,calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]; activation of adenylate cyclase activity [GO:0007190]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation by host of symbiont cAMP-mediated signal transduction [GO:0075206]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762],activation of adenylate cyclase activity [GO:0007190]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; G2/M transition of mitotic cell cycle [GO:0000086]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation by host of symbiont cAMP-mediated signal transduction [GO:0075206]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762],adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; N-terminal myristoylation domain binding [GO:0031997]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800],calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076],GO:0000086; GO:0000922; GO:0001975; GO:0002027; GO:0005509; GO:0005513; GO:0005634; GO:0005737; GO:0005813; GO:0005876; GO:0005886; GO:0007186; GO:0007190; GO:0008076; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0019901; GO:0019904; GO:0021762; GO:0030017; GO:0030235; GO:0030426; GO:0030672; GO:0031432; GO:0031800; GO:0031954; GO:0031966; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0043209; GO:0043388; GO:0043539; GO:0043548; GO:0044325; GO:0048306; GO:0050998; GO:0051000; GO:0051343; GO:0051412; GO:0051592; GO:0055117; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0075206; GO:0090151; GO:0097718; GO:1900242; GO:1901841; GO:1901844; GO:1902494; GO:2000300,IPR039030; IPR011992; IPR018247; IPR002048; ,Q9Z305; P29274; P49407; P32121; Q8NCR3; P27884; Q05152; Q13936; Q07652; Q9UQM7; Q13557; O43303; O15078; P40136; P53355; P00533; P25445; Q15051; Q9H0B3; O95259; O95259-2; O15554; P51787-1; A0JP07; P26645; P02686-5; Q6J8I9; Q9HD67; Q9WTI7-2; Q9QXS1-3; Q96PM5; Q14524; Q8WZ42; P63104,"SUBUNIT: Interacts with MYO1C, MYO5A and RRAD. Interacts with MYO10 (By similarity). Interacts with CEP97, CCP110, TTN/titin and SRY (PubMed:9804419, PubMed:12871148, PubMed:15746192, PubMed:16760425, PubMed:17719545). Interacts with USP6; the interaction is calcium dependent (PubMed:16127172). Interacts with CDK5RAP2 (PubMed:20466722). Interacts with SCN5A (By similarity). Interacts with RYR1 (PubMed:18650434). Interacts with FCHO1 (PubMed:22484487). Interacts with MIP in a 1:2 stoichiometry; the interaction with the cytoplasmic domains from two MIP subunits promotes MIP water channel closure (By similarity). Interacts with ORAI1; this may play a role in the regulation of ORAI1-mediated calcium transport (By similarity). Interacts with IQCF1 (By similarity). Interacts with SYT7 (By similarity). Interacts with CEACAM1 (via cytoplasmic domain); this interaction is in a calcium dependent manner and reduces homophilic cell adhesion through dissociation of dimer (By similarity). Interacts with RYR2; regulates RYR2 calcium-release channel activity (PubMed:27516456, PubMed:18650434). Interacts with PCP4; regulates calmodulin calcium-binding (PubMed:27876793). Interacts with the heterotetrameric KCNQ2 and KCNQ3 channel; the interaction is calcium-independent, constitutive and participates to the proper assembly of a functional heterotetrameric M channel (PubMed:27564677). {ECO:0000250|UniProtKB:P0DP23, ECO:0000250|UniProtKB:P62157, ECO:0000250|UniProtKB:P62161, ECO:0000250|UniProtKB:P62204, ECO:0000269|PubMed:12871148, ECO:0000269|PubMed:15746192, ECO:0000269|PubMed:16127172, ECO:0000269|PubMed:16760425, ECO:0000269|PubMed:17719545, ECO:0000269|PubMed:18650434, ECO:0000269|PubMed:20466722, ECO:0000269|PubMed:22484487, ECO:0000269|PubMed:23109337, ECO:0000269|PubMed:27516456, ECO:0000269|PubMed:27564677, ECO:0000269|PubMed:27876793, ECO:0000269|PubMed:9804419}.",3182832; 2223880; 15057824; 15489334; 7093203; 1474585; 9804419; 14654843; 12871148; 16127172; 15746192; 15592455; 16760425; 17719545; 18650434; 18669648; 19413330; 19690332; 19608861; 20466722; 21269460; 21406692; 23109337; 22223895; 22484487; 22814378; 23186163; 24275569; 24129315; 25944712; 27564677; 27876793; 28112733; 27516456,3182832; 2223880; 15057824; 15489334; 7093203; 1474585; 9804419; 14654843; 12871148; 16127172; 15746192; 15592455; 16760425; 17719545; 18650434; 18669648; 19413330; 19690332; 19608861; 20466722; 21269460; 21406692; 23109337; 22223895; 22484487; 22814378; 23186163; 24275569; 24129315; 25944712; 27564677; 27876793; 28112733; 27516456; 15225611; 15522886; 15583004; 15746150; 15817490; 16013055; 16030015; 16084495; 16154564; 16299511; 16359877; 16545345; 16613843; 17569884; 17580302; 17654480; 17687619; 17884685; 17975119; 18001530; 18178620; 18452398; 18940010; 18989758; 19023099; 19034380; 19080622; 19133300; 19584346; 19658100; 19855925; 19913121; 20198394; 20379146; 20379614; 20468064; 20628086; 20738160; 21047202; 21124984; 21439835; 21555518; 21640070; 21664913; 21730051; 21901608; 22009783; 22009847; 22044025; 22100452; 22295092; 22323446; 22331908; 22342729; 22437832; 22451665; 22588125; 22633975; 22767601; 22768143; 22801425; 22856685; 22996592; 23019329; 23040497; 23159936; 23235156; 23285036; 23300090; 23322042; 23352230; 23388215; 23437200; 23457304; 23552119; 23624269; 23658780; 23662433; 23743201; 23755207; 23760276; 23831686; 23838429; 23967355; 24032677; 24088894; 24419375; 24420768; 24420770; 24530797; 24551838; 24713697; 24779925; 24816216; 24907274; 24917665; 25005783; 25036739; 25145833; 25251320; 25268113; 25370050; 25470139; 25703379; 25751535; 25940090; 25956027; 26001204; 26085527; 26196381; 26391397; 26421717; 26487174; 26494044; 26529318; 26559977; 26618792; 26675311; 26828872; 26858457; 26969752; 27009875; 27100291; 27129269; 27165696; 27226555; 27325704; 27339229; 27374306; 27499441; 27632770; 27760856; 27790916; 27798963; 27815504; 27856935; 27927985; 27933776; 27956550; 28003368; 28092099; 28130124; 28158429; 28174300; 28222617; 28295264; 28335032; 28360104; 28422741; 28449373; 28462395; 28842480; 28849027; 28976808; 29247668; 29409956; 29494137; 29505720; 29584409; 30142967; 30200150,2017-05-10,2019-02-13,2017-05-10,20,,,,,,,,,5 out of 5,Calcium binding (4); Chain (1); Cross-link (2); Domain (4); Erroneous gene model prediction (1); Initiator methionine (1); Modified residue (11); Natural variant (1); Region (1),,,MISCELLANEOUS: This protein has four functional calcium-binding sites. {ECO:0000269|PubMed:1474585}.,Acetylation;Calcium;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Isopeptide bond;Long QT syndrome;Metal-binding;Methylation;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation,Evidence at protein level,reviewed,,Calmodulin family,20,Function (1); Involvement in disease (1); Miscellaneous (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0007; KW-0106; KW-0181; KW-0206; KW-0225; KW-0454; KW-0479; KW-0488; KW-0597; KW-0621; KW-0677; KW-0832; KW-0903; KW-0963; KW-1017; KW-1185,,,,,"DISEASE: Note=Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare condition caused by mutation in CALM3 that lead to an arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:27516456}.",,,PTM: Ubiquitination results in a strongly decreased activity. {ECO:0000250}.; PTM: Phosphorylation results in a decreased activity. {ECO:0000250}.,CHAIN 2 149 Calmodulin-3. /FTId=PRO_0000439934.,CROSSLNK 22 22 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 22 22 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate. {ECO:0000250|UniProtKB:P62157}.,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:7093203, ECO:0000269|Ref.7}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:7093203, ECO:0000269|Ref.7}.; MOD_RES 22 22 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 45 45 Phosphothreonine; by CaMK4. {ECO:0000250|UniProtKB:P0DP31}.; MOD_RES 82 82 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 95 95 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 100 100 Phosphotyrosine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 102 102 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 111 111 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 116 116 N6,N6,N6-trimethyllysine; alternate. {ECO:0000244|PubMed:24129315, ECO:0000269|PubMed:7093203}.; MOD_RES 116 116 N6-methyllysine; alternate. {ECO:0000244|PubMed:24129315}.; MOD_RES 139 139 Phosphotyrosine. {ECO:0000244|PubMed:19690332}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,J04046;X52606;X52607;X52608;BT006855;BC005137;
0,P63096,GNAI1_HUMAN,GNAI1,GNAI1,,,,Homo sapiens (Human),9606,Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein),UP000005640: Chromosome 7,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGCTLSAEDKAAVERSKMIDRNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEAGYSEEECKQYKAVVYSNTIQSIIAIIRAMGRLKIDFGDSARADDARQLFVLAGAAEEGFMTAELAGVIKRLWKDSGVQACFNRSREYQLNDSAAYYLNDLDRIAQPNYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF,354,"40,361",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P63096-1; Sequence=Displayed; Name=2; IsoId=P63096-2; Sequence=VSP_045215; ,,,,,,,,,,VAR_SEQ 1 52 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_045215.,,,,,CONFLICT 138 138 A -> G (in Ref. 3; CAB43212). {ECO:0000305}.; CONFLICT 219 219 T -> A (in Ref. 8; AAH26326). {ECO:0000305}.; CONFLICT 244 244 H -> Y (in Ref. 4; AAV38580). {ECO:0000305}.; CONFLICT 249 249 L -> M (in Ref. 4; AAV38580). {ECO:0000305}.; CONFLICT 288 288 P -> Q (in Ref. 8; AAH26326). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Signaling by an activated GPCR promotes GDP release and GTP binding. The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal. Both GDP release and GTP hydrolysis are modulated by numerous regulatory proteins (PubMed:8774883, PubMed:18434541). Signaling is mediated via effector proteins, such as adenylate cyclase. Inhibits adenylate cyclase activity, leading to decreased intracellular cAMP levels (By similarity). The inactive GDP-bound form prevents the association of RGS14 with centrosomes and is required for the translocation of RGS14 from the cytoplasm to the plasma membrane. Required for normal cytokinesis during mitosis (PubMed:17635935). Required for cortical dynein-dynactin complex recruitment during metaphase (PubMed:22327364). {ECO:0000250|UniProtKB:P10824, ECO:0000269|PubMed:17635935, ECO:0000269|PubMed:18434541, ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:8774883}.",,,,,,,"BINDING 151 151 GTP. {ECO:0000244|PDB:1KJY, ECO:0000244|PDB:2OM2, ECO:0000244|PDB:2XNS, ECO:0000244|PDB:3ONW, ECO:0000244|PDB:3QE0, ECO:0000244|PDB:3QI2, ECO:0000244|PDB:4G5Q}.; BINDING 326 326 GTP; via amide nitrogen. {ECO:0000244|PDB:1Y3A, ECO:0000244|PDB:2G83, ECO:0000244|PDB:2GTP, ECO:0000244|PDB:2IK8, ECO:0000244|PDB:2OM2, ECO:0000244|PDB:3ONW, ECO:0000244|PDB:3QE0, ECO:0000244|PDB:3QI2, ECO:0000244|PDB:3UMR, ECO:0000244|PDB:3UMS, ECO:0000244|PDB:4G5Q}.",,"METAL 47 47 Magnesium. {ECO:0000244|PDB:3QE0, ECO:0000269|PubMed:18434541, ECO:0000269|PubMed:22383884}.; METAL 181 181 Magnesium. {ECO:0000244|PDB:3QE0, ECO:0000269|PubMed:18434541, ECO:0000269|PubMed:22383884}.","NP_BIND 43 48 GTP. {ECO:0000244|PDB:1KJY, ECO:0000244|PDB:1Y3A, ECO:0000244|PDB:2G83, ECO:0000244|PDB:2GTP, ECO:0000244|PDB:2IK8, ECO:0000244|PDB:2OM2, ECO:0000244|PDB:2XNS, ECO:0000244|PDB:3ONW, ECO:0000244|PDB:3QE0, ECO:0000244|PDB:3QI2, ECO:0000244|PDB:3UMR, ECO:0000244|PDB:3UMS, ECO:0000244|PDB:4G5Q, ECO:0000269|PubMed:21115486}.; NP_BIND 175 181 GTP. {ECO:0000244|PDB:1KJY, ECO:0000244|PDB:1Y3A, ECO:0000244|PDB:2G83, ECO:0000244|PDB:2GTP, ECO:0000244|PDB:2IK8, ECO:0000244|PDB:2OM2, ECO:0000244|PDB:2XNS, ECO:0000244|PDB:3ONW, ECO:0000244|PDB:3QE0, ECO:0000244|PDB:3QI2, ECO:0000244|PDB:3UMR, ECO:0000244|PDB:3UMS, ECO:0000244|PDB:4G5Q}.; NP_BIND 200 204 GTP. {ECO:0000269|PubMed:21115486}.; NP_BIND 269 272 GTP. {ECO:0000244|PDB:1KJY, ECO:0000244|PDB:1Y3A, ECO:0000244|PDB:2G83, ECO:0000244|PDB:2GTP, ECO:0000244|PDB:2IK8, ECO:0000244|PDB:2OM2, ECO:0000244|PDB:2XNS, ECO:0000244|PDB:3ONW, ECO:0000244|PDB:3QE0, ECO:0000244|PDB:3QI2, ECO:0000244|PDB:3UMR, ECO:0000244|PDB:3UMS, ECO:0000244|PDB:4G5Q, ECO:0000269|PubMed:21115486}.",,cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to forskolin [GO:1904322]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein localization to cell cortex [GO:1904778]; protein folding [GO:0006457]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of mitotic spindle organization [GO:0060236]; response to peptide hormone [GO:0043434],adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to forskolin [GO:1904322]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein localization to cell cortex [GO:1904778]; protein folding [GO:0006457]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of mitotic spindle organization [GO:0060236]; response to peptide hormone [GO:0043434],GDP binding [GO:0019003]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287],cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886],GO:0000287; GO:0001664; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005765; GO:0005813; GO:0005834; GO:0005886; GO:0006457; GO:0007049; GO:0007186; GO:0007188; GO:0007193; GO:0019003; GO:0030496; GO:0031683; GO:0031821; GO:0043434; GO:0043949; GO:0051301; GO:0060236; GO:0070062; GO:0099738; GO:1904322; GO:1904778,IPR001408; IPR001019; IPR011025; IPR027417; ,P81274; Q9Y4H4; Q14980; Q9UGC6,"SUBUNIT: Heterotrimeric G proteins are composed of 3 units; alpha, beta and gamma. Part of a spindle orientation complex at least composed of GNAI1, GPSM2 and NUMA1 (PubMed:26766442). The alpha chain contains the guanine nucleotide binding site. Identified in complex with the beta subunit GNB1 and the gamma subunit GNG1 (PubMed:22383884). Identified in complex with the beta subunit GNB1 and the gamma subunit GNG2 (PubMed:18434541). GTP binding causes dissociation of the heterotrimer, liberating the individual subunits so that they can interact with downstream effector proteins (PubMed:22383884). Interacts (GDP-bound form) with GPSM1; this inhibits guanine nucleotide exchange and GTP binding (By similarity). Interacts (GDP-bound form) with GPSM2 (via GoLoco domains); this inhibits guanine nucleotide exchange (PubMed:22952234). Interacts with RGS10; this strongly enhances GTP hydrolysis (PubMed:8774883, PubMed:18434541). Interacts with RGS1 and RGS16; this strongly enhances GTPase activity (PubMed:18434541). Interacts with RGS4 (PubMed:18434541). Interacts with RGS12 (PubMed:18434541). Interacts (via active GTP- or inactive GDP-bound forms) with RGS14 (via RGS and GoLoco domains) (PubMed:11976690, PubMed:18434541, PubMed:21115486, PubMed:22383884). Interacts with RGS3, RGS6, RGS7, RGS8, RGS17, RGS18 and RGS20 (in vitro) (PubMed:18434541). Interacts (GDP-bound form) with RIC8A (via C-terminus) (By similarity). {ECO:0000250|UniProtKB:P10824, ECO:0000269|PubMed:11976690, ECO:0000269|PubMed:16004878, ECO:0000269|PubMed:17264214, ECO:0000269|PubMed:18434541, ECO:0000269|PubMed:21115486, ECO:0000269|PubMed:22383884, ECO:0000269|PubMed:22952234, ECO:0000269|PubMed:26766442, ECO:0000269|PubMed:8774883}.",11230166; 14702039; 12853948; 15489334; 2834384; 3110783; 15242332; 8774883; 17635935; 20213681; 21269460; 22327364; 24141704; 25255805; 26766442; 11976690; 16004878; 17603074; 17264214; 22408789; 18434541; 21115486; 22952234; 22383884,11230166; 14702039; 12853948; 15489334; 2834384; 3110783; 15242332; 8774883; 17635935; 20213681; 21269460; 22327364; 24141704; 25255805; 26766442; 11976690; 16004878; 17603074; 17264214; 22408789; 18434541; 21115486; 22952234; 22383884; 10215864; 10480595; 11118617; 11196645; 11309201; 11786497; 11815450; 11815463; 11873862; 12058044; 12297512; 12403834; 12684222; 12887316; 1322796; 13549488; 14514350; 14576516; 14581469; 14602724; 14613926; 14623889; 14625285; 14676208; 15537540; 15537656; 15572341; 15657046; 15837785; 15863506; 15889144; 15951850; 16099818; 16352729; 16371464; 16373322; 16415903; 16443778; 1645720; 1658606; 16714477; 16720719; 16775006; 16778767; 16892066; 16923326; 16981699; 17013094; 1707501; 17095603; 17215244; 17230639; 17267663; 17416965; 17502420; 17646583; 17900700; 18037379; 18083345; 18162464; 18378672; 1846707; 1849000; 18519563; 18577758; 18984596; 1898674; 19188424; 19258039; 19369247; 19494521; 19666700; 19913121; 20351284; 20360068; 20468064; 20586915; 20628086; 20679342; 20696855; 20716524; 20829352; 21388199; 21552208; 21565611; 21654736; 21880739; 21988832; 22070874; 22360420; 23086480; 23179791; 23341447; 23404499; 23416715; 23467353; 23841650; 24914133; 25078664; 25242222; 25291362; 2534964; 25416956; 25609649; 25675501; 25979337; 26258638; 26496610; 26514267; 27109834; 27298341; 27462082; 2748346; 27494760; 27498775; 27566546; 27621449; 27908592; 28145731; 28219737; 28223151; 28438833; 29259127; 29899450; 29899455; 30213947; 7556990; 7641683; 7859812; 7937899; 8015379; 8073283; 8099279; 8119955; 8208289; 8327893; 8521505; 8554519; 8662784; 8997178; 9544801; 9760042; 9865521; 9914469,1987-08-13,2019-02-13,2007-01-23,165,X-ray crystallography (15); NMR spectroscopy (2); Electron microscopy (3),STRAND 33 41 {ECO:0000244|PDB:6CRK}.; STRAND 115 117 {ECO:0000244|PDB:6CRK}.; STRAND 164 166 {ECO:0000244|PDB:2G83}.; STRAND 183 191 {ECO:0000244|PDB:6CRK}.; STRAND 194 203 {ECO:0000244|PDB:6CRK}.; STRAND 219 226 {ECO:0000244|PDB:6CRK}.; STRAND 238 241 {ECO:0000244|PDB:3UMS}.; STRAND 262 269 {ECO:0000244|PDB:6CRK}.; STRAND 319 323 {ECO:0000244|PDB:6CRK}.; STRAND 326 328 {ECO:0000244|PDB:6DDE}.,HELIX 7 31 {ECO:0000244|PDB:6CRK}.; HELIX 46 57 {ECO:0000244|PDB:6CRK}.; HELIX 63 67 {ECO:0000244|PDB:6CRK}.; HELIX 70 91 {ECO:0000244|PDB:6CRK}.; HELIX 100 110 {ECO:0000244|PDB:6CRK}.; HELIX 121 132 {ECO:0000244|PDB:6CRK}.; HELIX 134 140 {ECO:0000244|PDB:6CRK}.; HELIX 141 145 {ECO:0000244|PDB:6CRK}.; HELIX 152 156 {ECO:0000244|PDB:6CRK}.; HELIX 159 163 {ECO:0000244|PDB:6CRK}.; HELIX 171 175 {ECO:0000244|PDB:6CRK}.; HELIX 208 211 {ECO:0000244|PDB:6CRK}.; HELIX 212 215 {ECO:0000244|PDB:6CRK}.; HELIX 227 231 {ECO:0000244|PDB:6CRK}.; HELIX 242 254 {ECO:0000244|PDB:6CRK}.; HELIX 257 259 {ECO:0000244|PDB:6CRK}.; HELIX 271 277 {ECO:0000244|PDB:6CRK}.; HELIX 283 285 {ECO:0000244|PDB:6CRK}.; HELIX 296 308 {ECO:0000244|PDB:6CRK}.; HELIX 329 346 {ECO:0000244|PDB:6CRK}.; HELIX 348 350 {ECO:0000244|PDB:3UMR}.,TURN 111 114 {ECO:0000244|PDB:4G5Q}.; TURN 278 280 {ECO:0000244|PDB:6CRK}.; TURN 312 316 {ECO:0000244|PDB:6CRK}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (10); Binding site (2); Chain (1); Helix (21); Initiator methionine (1); Lipidation (2); Metal binding (2); Modified residue (3); Mutagenesis (4); Nucleotide binding (4); Sequence conflict (5); Turn (3),,,,3D-structure;ADP-ribosylation;Alternative splicing;Cell cycle;Cell division;Cell membrane;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;GTP-binding;Lipoprotein;Magnesium;Membrane;Metal-binding;Mitosis;Myristate;Nucleotide-binding;Nucleus;Palmitate;Reference proteome;Transducer;Transport,Evidence at protein level,reviewed,,"G-alpha family, G(i/o/t/z) subfamily",165,Alternative products (1); Function (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0013; KW-0025; KW-0131; KW-0132; KW-0181; KW-0206; KW-0342; KW-0449; KW-0460; KW-0472; KW-0479; KW-0498; KW-0519; KW-0539; KW-0547; KW-0564; KW-0807; KW-0813; KW-0903; KW-0963; KW-1003; KW-1185,,,,,,,,"PTM: Myristoylation at Gly-2 is required for membrane anchoring before palmitoylation. {ECO:0000250|UniProtKB:P10824}.; PTM: Palmitoylation at Cys-3 varies with membrane lipid composition. {ECO:0000250|UniProtKB:P10824}.; PTM: (Microbial infection) Deamidated at Gln-204 by Photorhabdus asymbiotica toxin PAU_02230, blocking GTP hydrolysis of heterotrimeric GNAQ or GNA11 and G-alphai (GNAI1, GNAI2 or GNAI3) proteins, thereby activating RhoA. {ECO:0000269|PubMed:24141704}.",CHAIN 2 354 Guanine nucleotide-binding protein G(i) subunit alpha-1. /FTId=PRO_0000203671.,,,,"INIT_MET 1 1 Removed. {ECO:0000269|PubMed:20213681, ECO:0000269|PubMed:25255805}.","LIPID 2 2 N-myristoyl glycine. {ECO:0000269|PubMed:20213681, ECO:0000269|PubMed:25255805}.; LIPID 3 3 S-palmitoyl cysteine. {ECO:0000250|UniProtKB:P10824}.",MOD_RES 178 178 ADP-ribosylarginine; by cholera toxin. {ECO:0000250}.; MOD_RES 204 204 Deamidated glutamine; by Photorhabdus PAU_02230. {ECO:0000269|PubMed:24141704}.; MOD_RES 351 351 ADP-ribosylcysteine; by pertussis toxin. {ECO:0000250}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF493905;AF055013;AL049933;BT019775;AK292953;AK304442;CH471091;BC026326;M20596;M20594;M20595;M17219;
0,Q02750,MP2K1_HUMAN,MAP2K1 MEK1 PRKMK1,MAP2K1,MEK1 PRKMK1,,,Homo sapiens (Human),9606,Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1),UP000005640: Chromosome 15,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPKKKPTPIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGV,393,"43,439",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; Synonyms=MKK1a; IsoId=Q02750-1; Sequence=Displayed; Name=2; Synonyms=MKK1b; IsoId=Q02750-2; Sequence=VSP_040500; ,,,,,,,,,,VAR_SEQ 147 172 Missing (in isoform 2). {ECO:0000303|PubMed:1281467}. /FTId=VSP_040500.,VARIANT 53 53 F -> S (in CFC3; dbSNP:rs121908594). {ECO:0000269|PubMed:16439621}. /FTId=VAR_035093.; VARIANT 128 128 G -> V (in CFC3; dbSNP:rs730880508). {ECO:0000269|PubMed:18042262}. /FTId=VAR_069780.; VARIANT 130 130 Y -> C (in CFC3; dbSNP:rs121908595). {ECO:0000269|PubMed:16439621}. /FTId=VAR_035094.,,,,CONFLICT 52 52 A -> R (in Ref. 3; AA sequence). {ECO:0000305}.; CONFLICT 180 180 Missing (in Ref. 3; AA sequence). {ECO:0000305}.,,2,,0,DOMAIN: The proline-rich region localized between residues 270 and 307 is important for binding to RAF1 and activation of MAP2K1/MEK1. {ECO:0000250}.,SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase subfamily. {ECO:0000305}.,,COMPBIAS 262 307 Pro-rich.,DOMAIN 68 361 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,REGION 77 78 Inhibitor binding.; REGION 144 146 Inhibitor binding.; REGION 208 212 Inhibitor binding.; REGION 270 307 RAF1-binding. {ECO:0000250}.,,,2.7.12.2,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.2; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.12.2;",,,"FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis. {ECO:0000269|PubMed:14737111, ECO:0000269|PubMed:17101779}.",,,,,,"ACT_SITE 190 190 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.","BINDING 77 77 Inhibitor; via carbonyl oxygen. {ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19161339, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:20621728, ECO:0000269|PubMed:21310613}.; BINDING 78 78 Inhibitor; via amide nitrogen and carbonyl oxygen. {ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19161339, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:20621728, ECO:0000269|PubMed:21310613}.; BINDING 97 97 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:21310613}.; BINDING 97 97 Inhibitor. {ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19161339, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:20621728, ECO:0000269|PubMed:21310613}.; BINDING 190 190 Inhibitor. {ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19161339, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:20621728, ECO:0000269|PubMed:21310613}.; BINDING 194 194 Inhibitor; via carbonyl oxygen. {ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19161339, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:20621728, ECO:0000269|PubMed:21310613}.; BINDING 208 208 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:21310613}.; BINDING 208 208 Inhibitor. {ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19161339, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:20621728, ECO:0000269|PubMed:21310613}.; BINDING 212 212 Inhibitor; via amide nitrogen. {ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19161339, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:20621728, ECO:0000269|PubMed:21310613}.",,,"NP_BIND 74 82 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:21310613}.; NP_BIND 143 146 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:21310613}.; NP_BIND 150 153 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:21310613}.; NP_BIND 192 195 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:15543157, ECO:0000269|PubMed:17880056, ECO:0000269|PubMed:18951019, ECO:0000269|PubMed:19019675, ECO:0000269|PubMed:19706763, ECO:0000269|PubMed:21310613}.",SITE 8 9 Cleavage; by anthrax lethal factor.,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; Bergmann glial cell differentiation [GO:0060020]; cell cycle arrest [GO:0007050]; cell motility [GO:0048870]; cellular senescence [GO:0090398]; cerebellar cortex formation [GO:0021697]; chemotaxis [GO:0006935]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; keratinocyte differentiation [GO:0030216]; labyrinthine layer development [GO:0060711]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; neuron differentiation [GO:0030182]; peptidyl-threonine phosphorylation [GO:0018107]; placenta blood vessel development [GO:0060674]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]","activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; Bergmann glial cell differentiation [GO:0060020]; cell cycle arrest [GO:0007050]; cell motility [GO:0048870]; cellular senescence [GO:0090398]; cerebellar cortex formation [GO:0021697]; chemotaxis [GO:0006935]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; keratinocyte differentiation [GO:0030216]; labyrinthine layer development [GO:0060711]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; neuron differentiation [GO:0030182]; peptidyl-threonine phosphorylation [GO:0018107]; placenta blood vessel development [GO:0060674]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]",ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein N-terminus binding [GO:0047485]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],GO:0000165; GO:0000187; GO:0004672; GO:0004674; GO:0004708; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006935; GO:0007050; GO:0007165; GO:0007507; GO:0008022; GO:0008285; GO:0010628; GO:0010629; GO:0018107; GO:0021697; GO:0023014; GO:0030182; GO:0030216; GO:0030878; GO:0031098; GO:0032147; GO:0032872; GO:0043539; GO:0045893; GO:0047485; GO:0048538; GO:0048679; GO:0048870; GO:0050772; GO:0060020; GO:0060324; GO:0060440; GO:0060502; GO:0060674; GO:0060711; GO:0070371; GO:0070374; GO:0071902; GO:0090170; GO:0090398; GO:0097110; GO:1903800; GO:2000641,IPR011009; IPR000719; IPR017441; IPR008271; ,Q8N9N5; Q9NR09; P15056; Q9Y297; O15519-1; P28482; P27361; Q13526; P04049; Q86Y07; Q86Y07-1; P46937,"SUBUNIT: Found in a complex with at least BRAF, HRAS, MAP2K1, MAPK3/ERK1 and RGS14. Forms a heterodimer with MAP2K2/MEK2. Forms heterodimers with KSR2 which further dimerize to form tetramers. Interacts with ARBB2, LAMTOR3, MAPK1/ERK2, MORG1 and RAF1 (By similarity). Interacts with PPARG and with isoform 1 of VRK2 (PubMed:20679487, PubMed:17101779). Interacts with Yersinia yopJ (PubMed:16728640). Interacts with SGK1 (PubMed:19447520). Interacts with BIRC6/bruce (PubMed:18329369). Interacts with KSR1 (PubMed:10409742). Interacts with KAT7; the interaction promotes KAT7 phosphorylation (By similarity). {ECO:0000250|UniProtKB:P29678, ECO:0000250|UniProtKB:P31938, ECO:0000250|UniProtKB:Q01986, ECO:0000269|PubMed:10409742, ECO:0000269|PubMed:16728640, ECO:0000269|PubMed:17101779, ECO:0000269|PubMed:18329369, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:20679487}.",1281467; 8388392; 10409742; 8131746; 9563949; 11104681; 14737111; 16129686; 16728640; 17101779; 18329369; 18691976; 19447520; 19369195; 20679487; 9779990; 15520807; 19565474; 21269460; 21779493; 24275569; 15543157; 17880056; 18951019; 19161339; 19019675; 19706763; 20621728; 21310613; 21316218; 16439621; 18042262,1281467; 8388392; 10409742; 8131746; 9563949; 11104681; 14737111; 16129686; 16728640; 17101779; 18329369; 18691976; 19447520; 19369195; 20679487; 9779990; 15520807; 19565474; 21269460; 21779493; 24275569; 15543157; 17880056; 18951019; 19161339; 19019675; 19706763; 20621728; 21310613; 21316218; 16439621; 18042262; 10037701; 10205168; 10209122; 10567369; 10712905; 10725339; 10891492; 11032810; 11042690; 11134045; 11325826; 11802164; 11802165; 11891225; 11948406; 12032872; 12063167; 12068308; 12167697; 12244094; 12370306; 12456688; 12473660; 12479806; 12522135; 12531514; 12551923; 12586835; 12609978; 12612059; 12663662; 12682854; 12689928; 12807433; 12832462; 12832465; 12839928; 12876277; 12917419; 14581471; 14636584; 14656894; 14672918; 14970219; 14993270; 15021912; 15035987; 15069060; 15118098; 15175348; 15239952; 15260967; 15284233; 15292274; 15297310; 15299019; 15466476; 15538402; 15547943; 15557124; 15572374; 15615716; 15630448; 15657353; 15657590; 15665520; 15710605; 15757891; 15888452; 15899852; 15979847; 16086581; 16093354; 16135787; 16239230; 16364920; 16508002; 16585161; 16815847; 16820947; 16861903; 16879721; 16957420; 17018604; 17038630; 17054908; 17097642; 17110930; 17178906; 17182854; 17197157; 17210721; 17255949; 17260965; 17314031; 17353931; 17366577; 17419998; 17461449; 17490600; 17496912; 17563371; 17667937; 17704260; 17721511; 17928366; 17951252; 17979178; 17981815; 18060073; 18192500; 18294816; 18390968; 18413255; 18424438; 18434598; 18533112; 18562239; 18593598; 18617556; 18632602; 18660489; 18662992; 18974108; 19001375; 19014680; 19091303; 19133693; 19153083; 19156172; 19158341; 19164283; 19197339; 19206169; 19219045; 19242111; 19261809; 19279408; 19342664; 19411838; 19453261; 19500021; 19567590; 19625741; 19681119; 19802003; 19804365; 19816936; 19835659; 19858308; 19930650; 19933846; 20007706; 20056645; 20130576; 20141835; 20172001; 20179161; 20179705; 20299489; 20302979; 20354455; 20512084; 20526349; 20610816; 20676060; 20711500; 20820846; 20858867; 20885957; 20926789; 20936779; 20956560; 21131601; 21179471; 21336309; 21383288; 21424530; 21447798; 21458501; 21621846; 21705440; 21707777; 21713404; 21779496; 21793567; 21835307; 21851590; 21965271; 22037177; 22043453; 22052387; 22119475; 22177953; 22180573; 22188669; 22197931; 22241220; 22245778; 22327936; 22357202; 22495818; 22506516; 22510884; 22546605; 22569528; 22588879; 22707717; 22745804; 22752157; 22773810; 22791812; 22805291; 22805292; 22833572; 22902540; 22935974; 22946047; 22946697; 23001481; 23157514; 23225884; 23237773; 23241949; 23352452; 23360980; 23453810; 23474388; 23524336; 23583981; 23648182; 23653349; 23680146; 23684925; 23698055; 23698777; 23727904; 23735655; 23746211; 23852369; 23923067; 23934108; 23954936; 23993095; 24011934; 24091658; 24121058; 24132923; 24135138; 24202393; 24211253; 24241536; 24255178; 24345920; 24412244; 24419498; 24445144; 24501087; 24606918; 24651010; 24681949; 24709918; 24746704; 24900486; 24909280; 24937142; 24957944; 24982505; 25155755; 25188412; 25193232; 25202140; 25204415; 25351745; 25370473; 25408231; 25416956; 25425646; 25435214; 25463315; 25534823; 25541062; 25600339; 25710724; 25713071; 25722381; 25729732; 25899310; 25907612; 25971971; 26034353; 26143635; 26155939; 26163823; 26208478; 26242183; 26324360; 26358373; 26384399; 26496610; 26544513; 26625317; 26637553; 26638075; 26825960; 26858456; 26860843; 26967560; 26980021; 27098723; 27169363; 27241017; 27496137; 27588400; 27597420; 27636997; 27693558; 27741509; 27862862; 27956260; 28178421; 28190454; 28225038; 28235676; 28423638; 28534984; 28664935; 28687621; 28688265; 29018093; 29643386; 29702094; 29729697; 30365139; 3287375; 7542586; 7565670; 7565795; 7624324; 7731720; 7854123; 7929275; 7935411; 8013650; 8019005; 8051079; 8090753; 8114697; 8157000; 8621729; 8631303; 8876196; 8952507; 9020159; 9234708; 9351825; 9553107; 9703991; 9733512; 9823899; 9858547,1993-07-01,2019-02-13,2007-01-23,210,X-ray crystallography (41),STRAND 68 76 {ECO:0000244|PDB:3EQC}.; STRAND 81 87 {ECO:0000244|PDB:3EQC}.; STRAND 93 100 {ECO:0000244|PDB:3EQC}.; STRAND 129 135 {ECO:0000244|PDB:3EQC}.; STRAND 138 143 {ECO:0000244|PDB:3EQC}.; STRAND 196 198 {ECO:0000244|PDB:3EQC}.; STRAND 204 206 {ECO:0000244|PDB:3EQC}.,HELIX 44 58 {ECO:0000244|PDB:3EQC}.; HELIX 65 67 {ECO:0000244|PDB:3EQC}.; HELIX 105 115 {ECO:0000244|PDB:3EQC}.; HELIX 116 120 {ECO:0000244|PDB:3EQC}.; HELIX 151 158 {ECO:0000244|PDB:3EQC}.; HELIX 163 184 {ECO:0000244|PDB:3EQC}.; HELIX 193 195 {ECO:0000244|PDB:3EQC}.; HELIX 213 218 {ECO:0000244|PDB:3EQC}.; HELIX 221 223 {ECO:0000244|PDB:3VVH}.; HELIX 227 229 {ECO:0000244|PDB:4AN3}.; HELIX 232 235 {ECO:0000244|PDB:3EQC}.; HELIX 242 258 {ECO:0000244|PDB:3EQC}.; HELIX 268 275 {ECO:0000244|PDB:3EQC}.; HELIX 310 319 {ECO:0000244|PDB:3EQC}.; HELIX 332 342 {ECO:0000244|PDB:3EQC}.; HELIX 352 356 {ECO:0000244|PDB:3EQC}.; HELIX 359 366 {ECO:0000244|PDB:3EQC}.; HELIX 371 379 {ECO:0000244|PDB:3EQC}.,TURN 88 90 {ECO:0000244|PDB:3EQC}.; TURN 200 202 {ECO:0000244|PDB:3DY7}.; TURN 327 329 {ECO:0000244|PDB:3EQC}.; TURN 346 348 {ECO:0000244|PDB:3EQC}.,,,,,5 out of 5,Active site (1); Alternative sequence (1); Beta strand (7); Binding site (9); Chain (1); Compositional bias (1); Domain (1); Helix (18); Modified residue (5); Mutagenesis (5); Natural variant (3); Nucleotide binding (4); Region (4); Sequence conflict (2); Site (1); Turn (4),,"TISSUE SPECIFICITY: Widely expressed, with extremely low levels in brain. {ECO:0000269|PubMed:1281467}.",,3D-structure;ATP-binding;Acetylation;Alternative splicing;Cardiomyopathy;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Ectodermal dysplasia;Kinase;Membrane;Mental retardation;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Tyrosine-protein kinase,Evidence at protein level,reviewed,,"Protein kinase superfamily, STE Ser/Thr protein kinase family, MAP kinase kinase subfamily",210,Activity regulation (1); Alternative products (1); Catalytic activity (2); Domain (1); Function (1); Involvement in disease (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0038; KW-0067; KW-0122; KW-0181; KW-0206; KW-0225; KW-0418; KW-0472; KW-0539; KW-0547; KW-0597; KW-0723; KW-0808; KW-0829; KW-0903; KW-0963; KW-0991; KW-1185,,,,,"DISEASE: Cardiofaciocutaneous syndrome 3 (CFC3) [MIM:615279]: A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. Distinctive features of CFC3 include macrostomia and horizontal shape of palpebral fissures. {ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:18042262}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Phosphorylation at Ser-218 and Ser-222 by MAP kinase kinase kinases (RAF or MEKK1) positively regulates kinase activity. Also phosphorylated at Thr-292 by MAPK1/ERK2 and at Ser-298 by PAK. MAPK1/ERK2 phosphorylation of Thr-292 occurs in response to cellular adhesion and leads to inhibition of Ser-298 phosphorylation by PAK. {ECO:0000269|PubMed:16129686, ECO:0000269|PubMed:8131746}.; PTM: Acetylation by Yersinia yopJ prevents phosphorylation and activation, thus blocking the MAPK signaling pathway. {ECO:0000269|PubMed:16728640}.",CHAIN 1 393 Dual specificity mitogen-activated protein kinase kinase 1. /FTId=PRO_0000086365.,,,,,,"MOD_RES 218 218 Phosphoserine; by RAF. {ECO:0000269|PubMed:10409742, ECO:0000269|PubMed:8131746}.; MOD_RES 222 222 Phosphoserine; by RAF. {ECO:0000269|PubMed:8131746}.; MOD_RES 286 286 Phosphothreonine. {ECO:0000244|PubMed:18691976}.; MOD_RES 292 292 Phosphothreonine; by MAPK1. {ECO:0000250|UniProtKB:Q01986}.; MOD_RES 298 298 Phosphoserine; by PAK. {ECO:0000269|PubMed:16129686}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,L05624;
0,Q12923,PTN13_HUMAN,PTPN13 PNP1 PTP1E PTPL1,PTPN13,PNP1 PTP1E PTPL1,,,Homo sapiens (Human),9606,Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1),UP000005640: Chromosome 4,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MHVSLAEALEVRGGPLQEEEIWAVLNQSAESLQELFRKVSLADPAALGFIISPWSLLLLPSGSVSFTDENISNQDLRAFTAPEVLQNQSLTSLSDVEKIHIYSLGMTLYWGADYEVPQSQPIKLGDHLNSILLGMCEDVIYARVSVRTVLDACSAHIRNSNCAPSFSYVKHLVKLVLGNLSGTDQLSCNSEQKPDRSQAIRDRLRGKGLPTGRSSTSDVLDIQKPPLSHQTFLNKGLSKSMGFLSIKDTQDENYFKDILSDNSGREDSENTFSPYQFKTSGPEKKPIPGIDVLSKKKIWASSMDLLCTADRDFSSGETATYRRCHPEAVTVRTSTTPRKKEARYSDGSIALDIFGPQKMDPIYHTRELPTSSAISSALDRIRERQKKLQVLREAMNVEEPVRRYKTYHGDVFSTSSESPSIISSESDFRQVRRSEASKRFESSSGLPGVDETLSQGQSQRPSRQYETPFEGNLINQEIMLKRQEEELMQLQAKMALRQSRLSLYPGDTIKASMLDITRDPLREIALETAMTQRKLRNFFGPEFVKMTIEPFISLDLPRSILTKKGKNEDNRRKVNIMLLNGQRLELTCDTKTICKDVFDMVVAHIGLVEHHLFALATLKDNEYFFVDPDLKLTKVAPEGWKEEPKKKTKATVNFTLFFRIKFFMDDVSLIQHTLTCHQYYLQLRKDILEERMHCDDETSLLLASLALQAEYGDYQPEVHGVSYFRMEHYLPARVMEKLDLSYIKEELPKLHNTYVGASEKETELEFLKVCQRLTEYGVHFHRVHPEKKSQTGILLGVCSKGVLVFEVHNGVRTLVLRFPWRETKKISFSKKKITLQNTSDGIKHGFQTDNSKICQYLLHLCSYQHKFQLQMRARQSNQDAQDIERASFRSLNLQAESVRGFNMGRAISTGSLASSTLNKLAVRPLSVQAEILKRLSCSELSLYQPLQNSSKEKNDKASWEEKPREMSKSYHDLSQASLYPHRKNVIVNMEPPPQTVAELVGKPSHQMSRSDAESLAGVTKLNNSKSVASLNRSPERRKHESDSSSIEDPGQAYVLGMTMHSSGNSSSQVPLKENDVLHKRWSIVSSPEREITLVNLKKDAKYGLGFQIIGGEKMGRLDLGIFISSVAPGGPADLDGCLKPGDRLISVNSVSLEGVSHHAAIEILQNAPEDVTLVISQPKEKISKVPSTPVHLTNEMKNYMKKSSYMQDSAIDSSSKDHHWSRGTLRHISENSFGPSGGLREGSLSSQDSRTESASLSQSQVNGFFASHLGDQTWQESQHGSPSPSVISKATEKETFTDSNQSKTKKPGISDVTDYSDRGDSDMDEATYSSSQDHQTPKQESSSSVNTSNKMNFKTFSSSPPKPGDIFEVELAKNDNSLGISVTGGVNTSVRHGGIYVKAVIPQGAAESDGRIHKGDRVLAVNGVSLEGATHKQAVETLRNTGQVVHLLLEKGQSPTSKEHVPVTPQCTLSDQNAQGQGPEKVKKTTQVKDYSFVTEENTFEVKLFKNSSGLGFSFSREDNLIPEQINASIVRVKKLFPGQPAAESGKIDVGDVILKVNGASLKGLSQQEVISALRGTAPEVFLLLCRPPPGVLPEIDTALLTPLQSPAQVLPNSSKDSSQPSCVEQSTSSDENEMSDKSKKQCKSPSRRDSYSDSSGSGEDDLVTAPANISNSTWSSALHQTLSNMVSQAQSHHEAPKSQEDTICTMFYYPQKIPNKPEFEDSNPSPLPPDMAPGQSYQPQSESASSSSMDKYHIHHISEPTRQENWTPLKNDLENHLEDFELEVELLITLIKSEKGSLGFTVTKGNQRIGCYVHDVIQDPAKSDGRLKPGDRLIKVNDTDVTNMTHTDAVNLLRAASKTVRLVIGRVLELPRIPMLPHLLPDITLTCNKEELGFSLCGGHDSLYQVVYISDINPRSVAAIEGNLQLLDVIHYVNGVSTQGMTLEEVNRALDMSLPSLVLKATRNDLPVVPSSKRSAVSAPKSTKGNGSYSVGSCSQPALTPNDSFSTVAGEEINEISYPKGKCSTYQIKGSPNLTLPKESYIQEDDIYDDSQEAEVIQSLLDVVDEEAQNLLNENNAAGYSCGPGTLKMNGKLSEERTEDTDCDGSPLPEYFTEATKMNGCEEYCEEKVKSESLIQKPQEKKTDDDEITWGNDELPIERTNHEDSDKDHSFLTNDELAVLPVVKVLPSGKYTGANLKSVIRVLRGLLDQGIPSKELENLQELKPLDQCLIGQTKENRRKNRYKNILPYDATRVPLGDEGGYINASFIKIPVGKEEFVYIACQGPLPTTVGDFWQMIWEQKSTVIAMMTQEVEGEKIKCQRYWPNILGKTTMVSNRLRLALVRMQQLKGFVVRAMTLEDIQTREVRHISHLNFTAWPDHDTPSQPDDLLTFISYMRHIHRSGPIITHCSAGIGRSGTLICIDVVLGLISQDLDFDISDLVRCMRLQRHGMVQTEDQYIFCYQVILYVLTRLQAEEEQKQQPQLLK,2485,"276,906",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; IsoId=Q12923-1; Sequence=Displayed; Name=2; IsoId=Q12923-2; Sequence=VSP_000496; Name=3; IsoId=Q12923-3; Sequence=VSP_000497; Name=4; IsoId=Q12923-4; Sequence=VSP_007921; Note=May be due to a competing donor splice site.; ,,,,,,,,,SEQUENCE CAUTION:  Sequence=AAH39610.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305}; ,"VAR_SEQ 884 1074 Missing (in isoform 2). {ECO:0000303|PubMed:8287977}. /FTId=VSP_000496.; VAR_SEQ 1056 1074 Missing (in isoform 3). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:7929060, ECO:0000303|PubMed:8287977}. /FTId=VSP_000497.; VAR_SEQ 1383 1383 T -> TVLFDK (in isoform 4). {ECO:0000303|PubMed:7536343, ECO:0000303|PubMed:8071359}. /FTId=VSP_007921.",VARIANT 1356 1356 F -> L (in dbSNP:rs10033029). /FTId=VAR_048359.; VARIANT 1419 1419 L -> P (in dbSNP:rs749353184). {ECO:0000269|PubMed:12436199}. /FTId=VAR_016200.; VARIANT 1522 1522 I -> M (in dbSNP:rs2230600). {ECO:0000269|PubMed:12436199}. /FTId=VAR_016201.; VARIANT 1625 1625 E -> K (in dbSNP:rs12500797). /FTId=VAR_024373.; VARIANT 1744 1744 S -> P (in dbSNP:rs17012064). /FTId=VAR_048360.; VARIANT 2081 2081 Y -> D (in dbSNP:rs989902). /FTId=VAR_024374.; VARIANT 2458 2458 I -> V (no effect on substrate affinity; dbSNP:rs34226837). {ECO:0000269|PubMed:15611135}. /FTId=VAR_048361.,,,,CONFLICT 1134 1135 LD -> FH (in Ref. 3; CAA56563). {ECO:0000305}.; CONFLICT 1216 1229 KDHHWSRGTLRHIS -> DLSRSHCHVYLAHL (in Ref. 5). {ECO:0000305}.; CONFLICT 1238 1239 GL -> A (in Ref. 5; CAA56124). {ECO:0000305}.; CONFLICT 1357 1357 S -> P (in Ref. 5; CAA56124). {ECO:0000305}.; CONFLICT 1362 1363 KP -> RS (in Ref. 5; CAA56124). {ECO:0000305}.; CONFLICT 1538 1538 P -> A (in Ref. 3; CAA56563). {ECO:0000305}.; CONFLICT 1649 1649 R -> K (in Ref. 5; CAA56124). {ECO:0000305}.; CONFLICT 1698 1714 KSQEDTICTMFYYPQKI -> RVKKIPFVPCFTILRKR (in Ref. 5; CAA56124). {ECO:0000305}.; CONFLICT 1797 1797 G -> A (in Ref. 3; CAA56563). {ECO:0000305}.; CONFLICT 1856 1857 AA -> G (in Ref. 5; CAA56124). {ECO:0000305}.; CONFLICT 2069 2069 A -> S (in Ref. 5; CAA56124). {ECO:0000305}.; CONFLICT 2206 2210 GLLDQ -> VARS (in Ref. 5; CAA56124). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the protein-tyrosine phosphatase family. Non-receptor class subfamily. {ECO:0000305}.,COILED 469 504 {ECO:0000255}.,COMPBIAS 56 59 Poly-Leu.; COMPBIAS 1742 1749 Poly-Ser.,DOMAIN 3 190 KIND. {ECO:0000255|PROSITE-ProRule:PRU00709}.; DOMAIN 572 872 FERM. {ECO:0000255|PROSITE-ProRule:PRU00084}.; DOMAIN 1093 1178 PDZ 1. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 1368 1452 PDZ 2. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 1501 1588 PDZ 3. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 1788 1868 PDZ 4. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 1882 1965 PDZ 5. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 2213 2467 Tyrosine-protein phosphatase. {ECO:0000255|PROSITE-ProRule:PRU00160}.,,REGION 2408 2414 Substrate.; REGION 2408 2414 Substrate binding. {ECO:0000250}.,,,3.1.3.48,,"CATALYTIC ACTIVITY: Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] + phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000269|PubMed:15611135, ECO:0000269|PubMed:19307596};",,,"FUNCTION: Tyrosine phosphatase which regulates negatively FAS-induced apoptosis and NGFR-mediated pro-apoptotic signaling (PubMed:15611135). May regulate phosphoinositide 3-kinase (PI3K) signaling through dephosphorylation of PIK3R2 (PubMed:23604317). {ECO:0000269|PubMed:15611135, ECO:0000269|PubMed:23604317}.",,,,,,ACT_SITE 2408 2408 Phosphocysteine intermediate. {ECO:0000305}.,BINDING 2378 2378 Substrate.; BINDING 2452 2452 Substrate. {ECO:0000250}.,,,,,cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphatidylinositol biosynthetic process [GO:0006661]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066],cellular response to cytokine stimulus [GO:0071345]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphatidylinositol biosynthetic process [GO:0006661]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066],phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725],cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],GO:0001933; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0006470; GO:0006661; GO:0014066; GO:0030027; GO:0035335; GO:0036312; GO:0043005; GO:0044297; GO:0070062; GO:0071345,IPR019749; IPR014352; IPR035963; IPR019748; IPR000299; IPR018979; IPR018980; IPR011019; IPR001478; IPR036034; IPR011993; IPR029021; IPR000242; IPR012153; IPR003595; IPR000387; IPR029071; ,P25445; Q9BUL8; Q8TEU7; Q13501,"SUBUNIT: Interacts (via the first PDZ domain) with PLEKHA1 and PLEKHA2 (PubMed:14516276). Interacts (via the second PDZ domain) with TNFRSF6 (Fas receptor) (via C-terminus) (PubMed:10704206). Interacts (via the second PDZ domain) with TRIP6 (via the third LIM domain and C-terminus) (PubMed:10826496, PubMed:10400701). Interacts (via the third PDZ domain) with NGFR (via C-terminal SVP motif) and PKN2 (via C-terminus) (PubMed:10544233, PubMed:11356191). Interacts (via the second or fourth PDZ domains) with PDLIM4 (via C-terminus only or via combined C-terminus and LIM domain, but not LIM domain only). Found in a complex with PDLIM4 and TRIP6 (By similarity). Interacts with PDLIM4; this interaction results in dephosphorylation of SRC 'Tyr-419' by this protein leading to its inactivation (PubMed:19307596). Interacts with BRD7 (By similarity). Interacts with RAPGEF6 (PubMed:12095257). Interacts with ARHGAP29 (PubMed:9305890). Interacts with PIK3R2; dephosphorylates PIK3R2 (PubMed:23604317). Interacts with FBXL2 (PubMed:23604317). Interacts (via the FERM domain) with ENTR1 (PubMed:23108400). Found in a complex with ENTR1, PTPN13 and GIT1 (PubMed:23108400). {ECO:0000250|UniProtKB:Q64512, ECO:0000269|PubMed:10400701, ECO:0000269|PubMed:10544233, ECO:0000269|PubMed:10704206, ECO:0000269|PubMed:10826496, ECO:0000269|PubMed:11356191, ECO:0000269|PubMed:12095257, ECO:0000269|PubMed:14516276, ECO:0000269|PubMed:19307596, ECO:0000269|PubMed:23108400, ECO:0000269|PubMed:23604317, ECO:0000269|PubMed:9305890}.",8071359; 8287977; 7929060; 15489334; 7536343; 10544233; 8483328; 9305890; 10400701; 10826496; 11356191; 14516276; 19413330; 19307596; 21269460; 21406692; 23186163; 23604317; 23108400; 10704206; 12095257; 15611135; 12436199,8071359; 8287977; 7929060; 15489334; 7536343; 10544233; 8483328; 9305890; 10400701; 10826496; 11356191; 14516276; 19413330; 19307596; 21269460; 21406692; 23186163; 23604317; 23108400; 10704206; 12095257; 15611135; 12436199; 10918185; 11884147; 11959286; 12101241; 12354757; 12724420; 12870871; 14596806; 14698303; 14743216; 15782144; 16306044; 16489062; 16572203; 16888780; 17240990; 17638892; 17657516; 17982484; 18038312; 18195016; 18684861; 19004008; 19240061; 19672627; 19734941; 19892796; 20039457; 20379614; 20453000; 20501847; 20620960; 20711500; 20839809; 21204784; 21235435; 21741956; 22262849; 22274591; 22279592; 22364882; 22677168; 23209399; 23519466; 23559010; 23818626; 23906871; 23950995; 24191246; 24255178; 24316673; 24338422; 24366813; 25365469; 25448478; 25494785; 25933631; 26514267; 26638075; 26801674; 26811494; 26984787; 27285768; 27544031; 28092676; 28504867; 28653805; 29415055,2000-12-01,2019-02-13,2000-12-01,207,X-ray crystallography (4); NMR spectroscopy (5),STRAND 1090 1097 {ECO:0000244|PDB:5GLJ}.; STRAND 1105 1109 {ECO:0000244|PDB:5GLJ}.; STRAND 1122 1126 {ECO:0000244|PDB:5GLJ}.; STRAND 1143 1147 {ECO:0000244|PDB:5GLJ}.; STRAND 1169 1177 {ECO:0000244|PDB:5GLJ}.; STRAND 1366 1372 {ECO:0000244|PDB:3LNY}.; STRAND 1374 1377 {ECO:0000244|PDB:1D5G}.; STRAND 1379 1384 {ECO:0000244|PDB:3LNY}.; STRAND 1385 1387 {ECO:0000244|PDB:2M0Z}.; STRAND 1388 1390 {ECO:0000244|PDB:3LNY}.; STRAND 1395 1400 {ECO:0000244|PDB:3LNY}.; STRAND 1417 1421 {ECO:0000244|PDB:3LNY}.; STRAND 1443 1450 {ECO:0000244|PDB:3LNY}.; STRAND 2188 2190 {ECO:0000244|PDB:1WCH}.; STRAND 2264 2272 {ECO:0000244|PDB:1WCH}.; STRAND 2275 2282 {ECO:0000244|PDB:1WCH}.; STRAND 2304 2307 {ECO:0000244|PDB:1WCH}.; STRAND 2311 2313 {ECO:0000244|PDB:1WCH}.; STRAND 2331 2346 {ECO:0000244|PDB:1WCH}.; STRAND 2348 2359 {ECO:0000244|PDB:1WCH}.; STRAND 2364 2373 {ECO:0000244|PDB:1WCH}.; STRAND 2404 2407 {ECO:0000244|PDB:1WCH}.; STRAND 2409 2412 {ECO:0000244|PDB:1WCH}.,HELIX 1131 1135 {ECO:0000244|PDB:5GLJ}.; HELIX 1157 1166 {ECO:0000244|PDB:5GLJ}.; HELIX 1391 1393 {ECO:0000244|PDB:3LNY}.; HELIX 1405 1409 {ECO:0000244|PDB:3LNY}.; HELIX 1431 1439 {ECO:0000244|PDB:3LNY}.; HELIX 2175 2179 {ECO:0000244|PDB:1WCH}.; HELIX 2194 2209 {ECO:0000244|PDB:1WCH}.; HELIX 2212 2220 {ECO:0000244|PDB:1WCH}.; HELIX 2231 2233 {ECO:0000244|PDB:1WCH}.; HELIX 2235 2238 {ECO:0000244|PDB:1WCH}.; HELIX 2287 2289 {ECO:0000244|PDB:1WCH}.; HELIX 2290 2299 {ECO:0000244|PDB:1WCH}.; HELIX 2385 2398 {ECO:0000244|PDB:1WCH}.; HELIX 2413 2429 {ECO:0000244|PDB:1WCH}.; HELIX 2436 2444 {ECO:0000244|PDB:1WCH}.; HELIX 2454 2475 {ECO:0000244|PDB:1WCH}.,TURN 1100 1102 {ECO:0000244|PDB:5GLJ}.; TURN 2257 2260 {ECO:0000244|PDB:1WCH}.; TURN 2360 2363 {ECO:0000244|PDB:1WCH}.,,,,,5 out of 5,Active site (1); Alternative sequence (3); Beta strand (23); Binding site (2); Chain (1); Coiled coil (1); Compositional bias (2); Domain (8); Helix (16); Modified residue (11); Mutagenesis (11); Natural variant (7); Region (2); Sequence caution (1); Sequence conflict (12); Turn (3),,"TISSUE SPECIFICITY: Present in most tissues with the exception of the liver and skeletal muscle. Most abundant in lung, kidney and fetal brain.",,3D-structure;Alternative splicing;Cell projection;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Hydrolase;Nucleus;Phosphoprotein;Polymorphism;Protein phosphatase;Reference proteome;Repeat,Evidence at protein level,reviewed,,"Protein-tyrosine phosphatase family, Non-receptor class subfamily",207,Alternative products (1); Catalytic activity (1); Caution (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0175; KW-0181; KW-0206; KW-0378; KW-0539; KW-0597; KW-0621; KW-0677; KW-0904; KW-0963; KW-0966; KW-1185,,,,,,,,,CHAIN 1 2485 Tyrosine-protein phosphatase non-receptor type 13. /FTId=PRO_0000219435.,,,,,,MOD_RES 240 240 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 301 301 Phosphoserine. {ECO:0000250|UniProtKB:Q64512}.; MOD_RES 302 302 Phosphoserine. {ECO:0000250|UniProtKB:Q64512}.; MOD_RES 890 890 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 897 897 Phosphoserine. {ECO:0000250|UniProtKB:Q64512}.; MOD_RES 908 908 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 911 911 Phosphoserine. {ECO:0000250|UniProtKB:Q64512}.; MOD_RES 914 914 Phosphoserine. {ECO:0000250|UniProtKB:Q64512}.; MOD_RES 1029 1029 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 1033 1033 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 1085 1085 Phosphoserine. {ECO:0000244|PubMed:23186163}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U12128;D21209;D21210;D21211;X80289;BC039610;BC140777;X79676;L34583;AF233323;
0,Q13131,AAPK1_HUMAN,PRKAA1 AMPK1,PRKAA1,AMPK1,,,Homo sapiens (Human),9606,5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26),UP000005640: Chromosome 5,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MRRLSSWRKMATAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTYSKMSLQLYQVDSRTYLLDFRSIDDEITEAKSGTATPQRSGSVSNYRSCQRSDSDAEAQGKSSEVSLTSSVTSLDSSPVDLTPRPGSHTIEFFEMCANLIKILAQ,559,"64,009",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q13131-1; Sequence=Displayed; Name=2; IsoId=Q13131-2; Sequence=VSP_035431; ,,SEQUENCE CAUTION:  Sequence=AAA64850.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=AAD43027.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=AAH37303.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=BAA36547.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=BAG35788.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 121 121 R -> RKSDVPGVVKTGSTKE (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_035431.,VARIANT 10 10 M -> L (in dbSNP:rs17855679). {ECO:0000269|PubMed:15489334}. /FTId=VAR_058401.; VARIANT 16 16 Q -> R (in a breast cancer sample; somatic mutation; dbSNP:rs928784854). {ECO:0000269|PubMed:16959974}. /FTId=VAR_035622.,,,,CONFLICT 5 5 S -> C (in Ref. 4; BAG35788). {ECO:0000305}.; CONFLICT 9 9 K -> S (in Ref. 5; AAD43027). {ECO:0000305}.; CONFLICT 37 37 T -> A (in Ref. 6; AAA64850). {ECO:0000305}.; CONFLICT 202 202 A -> V (in Ref. 6; AAA64850). {ECO:0000305}.; CONFLICT 208 208 I -> L (in Ref. 6; AAA64850). {ECO:0000305}.; CONFLICT 269 269 T -> S (in Ref. 3; BAA36547). {ECO:0000305}.,,4,,0,"DOMAIN: The AIS (autoinhibitory sequence) region shows some sequence similarity with the ubiquitin-associated domains and represses kinase activity. {ECO:0000269|PubMed:17088252, ECO:0000269|PubMed:9857077}.",SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. SNF1 subfamily. {ECO:0000305}.,,,DOMAIN 27 279 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,REGION 302 381 AIS.,,,2.7.11.1; 2.7.11.27; 2.7.11.31; 2.7.11.26,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:P54645}; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:P54645}; CATALYTIC ACTIVITY: Reaction=[acetyl-CoA carboxylase]-L-serine + ATP = [acetyl-CoA carboxylase]-O-phospho-L-serine + ADP + H(+); Xref=Rhea:RHEA:20333, Rhea:RHEA-COMP:13722, Rhea:RHEA-COMP:13723, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.27; Evidence={ECO:0000250|UniProtKB:P54645}; CATALYTIC ACTIVITY: Reaction=[3-hydroxy-3-methylglutaryl-coenzyme A reductase]-L-serine + ATP = [3-hydroxy-3-methylglutaryl-coenzyme A reductase]-O-phospho-L-serine + ADP + H(+); Xref=Rhea:RHEA:23172, Rhea:RHEA-COMP:13692, Rhea:RHEA-COMP:13693, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.31; Evidence={ECO:0000250|UniProtKB:P54645}; CATALYTIC ACTIVITY: Reaction=[tau protein]-L-serine + ATP = [tau protein]-O-phospho-L-serine + ADP + H(+); Xref=Rhea:RHEA:12801, Rhea:RHEA-COMP:13701, Rhea:RHEA-COMP:13702, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.26; CATALYTIC ACTIVITY: Reaction=[tau protein]-L-threonine + ATP = [tau protein]-O-phospho-L-threonine + ADP + H(+); Xref=Rhea:RHEA:53904, Rhea:RHEA-COMP:13703, Rhea:RHEA-COMP:13704, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.26;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ,,"FUNCTION: Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1/ULK1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ATG1/ULK1. In that process also activates WDR45 (PubMed:28561066). In response to nutrient limitation, phosphorylates transcription factor FOXO3 promoting FOXO3 mitochondrial import (By similarity). AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. {ECO:0000250|UniProtKB:Q5EG47, ECO:0000269|PubMed:11518699, ECO:0000269|PubMed:11554766, ECO:0000269|PubMed:12519745, ECO:0000269|PubMed:14651849, ECO:0000269|PubMed:15866171, ECO:0000269|PubMed:17486097, ECO:0000269|PubMed:17711846, ECO:0000269|PubMed:18184930, ECO:0000269|PubMed:18439900, ECO:0000269|PubMed:20074060, ECO:0000269|PubMed:20160076, ECO:0000269|PubMed:21205641, ECO:0000269|PubMed:28561066}.",,,,,,"ACT_SITE 150 150 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 56 56 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 33 41 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; activation of MAPK activity [GO:0000187]; CAMKK-AMPK signaling cascade [GO:0061762]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to ethanol [GO:0071361]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to organonitrogen compound [GO:0071417]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; cold acclimation [GO:0009631]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; macroautophagy [GO:0016236]; motor behavior [GO:0061744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of glucosylceramide biosynthetic process [GO:0046318]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; neuron cellular homeostasis [GO:0070050]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of skeletal muscle tissue development [GO:0048643]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of stress granule assembly [GO:0062028]; regulation of vesicle-mediated transport [GO:0060627]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to camptothecin [GO:1901563]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],activation of MAPK activity [GO:0000187]; CAMKK-AMPK signaling cascade [GO:0061762]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to ethanol [GO:0071361]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to organonitrogen compound [GO:0071417]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; cold acclimation [GO:0009631]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; macroautophagy [GO:0016236]; motor behavior [GO:0061744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of glucosylceramide biosynthetic process [GO:0046318]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; neuron cellular homeostasis [GO:0070050]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of skeletal muscle tissue development [GO:0048643]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of stress granule assembly [GO:0062028]; regulation of vesicle-mediated transport [GO:0060627]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to camptothecin [GO:1901563]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],[acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634],GO:0000187; GO:0001666; GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006006; GO:0006468; GO:0006633; GO:0006695; GO:0007050; GO:0007165; GO:0008022; GO:0008284; GO:0008610; GO:0009411; GO:0009631; GO:0010332; GO:0010508; GO:0010628; GO:0010629; GO:0014823; GO:0016055; GO:0016236; GO:0016324; GO:0016607; GO:0019395; GO:0030424; GO:0030425; GO:0031000; GO:0031588; GO:0031669; GO:0032007; GO:0033135; GO:0034599; GO:0035174; GO:0035556; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045542; GO:0045821; GO:0046318; GO:0046627; GO:0046872; GO:0047322; GO:0048156; GO:0048511; GO:0048643; GO:0050321; GO:0050405; GO:0050995; GO:0051291; GO:0055089; GO:0060627; GO:0061744; GO:0061762; GO:0062028; GO:0070050; GO:0070301; GO:0070507; GO:0071277; GO:0071333; GO:0071361; GO:0071380; GO:0071417; GO:0071456; GO:0097009; GO:1901563; GO:1903109; GO:1903829; GO:1903955; GO:1904428; GO:2000758,IPR032270; IPR039137; IPR028375; IPR011009; IPR000719; IPR017441; IPR008271; ,Q9NYB9; Q08117; O14503; O14627; Q13363-2; O95073; Q08379; Q6NT76; Q8IX15-3; P08238; Q9UKT9; Q8NBZ0; Q6A162; Q96JM7; Q5JR59; Q8IXK0; Q96PV4; Q9Y478; O43741; P54619; Q93062; Q8HWS3; Q9UFD9; Q9HAT0; Q9Y2D8; Q9NVV9; P14373; Q15654; Q9Y3Q8; Q5T124; Q9H9H4; Q8N1B4; P46937; O96006,"SUBUNIT: AMPK is a heterotrimer of an alpha catalytic subunit (PRKAA1 or PRKAA2), a beta (PRKAB1 or PRKAB2) and a gamma non-catalytic subunits (PRKAG1, PRKAG2 or PRKAG3). Interacts with FNIP1 and FNIP2. {ECO:0000269|PubMed:17028174, ECO:0000269|PubMed:18403135, ECO:0000269|PubMed:18663353, ECO:0000269|PubMed:21680840}.",15372022; 15489334; 14702039; 11042152; 8557660; 9857077; 11554766; 11518699; 11602624; 12519745; 14651849; 14976552; 16054095; 15980064; 15866171; 17028174; 17088252; 17711846; 17486097; 18184930; 18403135; 18220336; 18088087; 18439900; 18691976; 18663353; 18669648; 19369195; 19690332; 20074060; 20160076; 20068231; 21460634; 21269460; 21205641; 21680840; 17307971; 17712357; 23088624; 23186163; 24275569; 28561066; 16959974,15372022; 15489334; 14702039; 11042152; 8557660; 9857077; 11554766; 11518699; 11602624; 12519745; 14651849; 14976552; 16054095; 15980064; 15866171; 17028174; 17088252; 17711846; 17486097; 18184930; 18403135; 18220336; 18088087; 18439900; 18691976; 18663353; 18669648; 19369195; 19690332; 20074060; 20160076; 20068231; 21460634; 21269460; 21205641; 21680840; 17307971; 17712357; 23088624; 23186163; 24275569; 28561066; 16959974; 11018120; 12091379; 12391032; 12869384; 14511394; 14614828; 14985505; 15485651; 15579580; 16306228; 16405649; 16407220; 16466905; 16943194; 17584647; 17721511; 18195011; 18276112; 18303014; 18347656; 18359290; 18480843; 18614941; 18674809; 18692468; 18801964; 18854318; 18950855; 18996102; 19020741; 19049348; 19050283; 19138981; 19197243; 19211835; 19211918; 19376078; 19442239; 19502591; 19556893; 19723093; 19723094; 19723101; 19723105; 19728147; 19887561; 19913121; 19914239; 19923924; 19948975; 19966861; 20080969; 20103647; 20167678; 20217115; 20368287; 20368732; 20421294; 20462511; 20562859; 20564492; 20602615; 20622004; 20628086; 20682687; 20801214; 20821366; 20876741; 20921139; 21048031; 21072212; 21079763; 21088205; 21209024; 21232561; 21258367; 21416543; 21432774; 21474997; 21670147; 21678424; 21768291; 21775054; 21807092; 21819378; 21892142; 21909354; 21988832; 21994947; 22007913; 22021095; 22037551; 22212710; 22363791; 22378745; 22419736; 22434430; 22553202; 22564965; 22575644; 22607554; 22674476; 22688514; 22815988; 22833096; 22869372; 22897928; 22935535; 22939624; 22988252; 23000302; 23171948; 23221389; 23228943; 23291726; 23306156; 23324179; 23367447; 23376776; 23416715; 23417417; 23418352; 23455922; 23475945; 23506848; 23589839; 23592276; 23602568; 23623684; 23625915; 23648710; 23671028; 23677989; 23685627; 23685869; 23712032; 23716691; 23723070; 23727157; 23728343; 23778007; 23800577; 23819460; 23861218; 23878245; 23883584; 23884233; 23899558; 23904275; 23963659; 23982477; 24018441; 24055274; 24072697; 24080159; 24095280; 24104889; 24186207; 24189400; 24366874; 24395629; 24419061; 24441100; 24472739; 24491542; 24561578; 24619908; 24655923; 24700636; 24770722; 24799027; 24871657; 24874608; 24916949; 24925061; 24955726; 24988326; 25017332; 25024613; 25047736; 25122135; 25151490; 25225183; 25256353; 25330949; 25348630; 25356873; 25362209; 25367309; 25404641; 25412657; 25416956; 25425646; 25484082; 25556665; 25586669; 25595658; 25632961; 25651975; 25656579; 25659498; 25703587; 25727016; 25840010; 25846811; 25852190; 25858560; 25874865; 25902870; 25933205; 25937278; 25955819; 25980607; 26001218; 26029847; 26041108; 26058395; 26103054; 26121488; 26124005; 26129866; 26143491; 26196392; 26232429; 26236947; 26260992; 26276392; 26322680; 26330165; 26339598; 26397839; 26398719; 26427441; 26437602; 26439621; 26447757; 26456332; 26479318; 26485766; 26486079; 26496610; 26520441; 26544976; 26549816; 26638075; 26640549; 26642043; 26644014; 26648451; 26655341; 26707164; 26718214; 26755628; 26772531; 26804175; 26843621; 26952388; 26999735; 27001465; 27021965; 27041569; 27060201; 27072494; 27103439; 27121290; 27150059; 27251406; 27259535; 27304906; 27305174; 27322180; 27364911; 27416781; 27430620; 27497953; 27534430; 27568570; 27612659; 27657826; 27661114; 27687210; 27689873; 27726301; 27751856; 27797909; 27813479; 27840174; 27840318; 27864418; 27878239; 27878249; 27902686; 27914812; 27996156; 28008135; 28009297; 28052040; 28065882; 28085543; 28103582; 28186975; 28234358; 28258165; 28259820; 28298606; 28330873; 28336748; 28438603; 28440461; 28466106; 28524645; 28560405; 28600513; 28639909; 28647373; 28651973; 28665143; 28743498; 28847510; 28876465; 28919424; 28923415; 28978464; 29024810; 29039450; 29048631; 29079190; 29094484; 29115402; 29122080; 29133590; 29203239; 29222348; 29247651; 29284117; 29343420; 29413962; 29448096; 29484444; 29526819; 29540478; 29566977; 29620653; 29702405; 30104247; 30111748; 30157903; 30253744; 30270274; 30347867; 30478170; 8549768; 8779952,1998-07-15,2019-02-13,2009-07-28,207,X-ray crystallography (8),STRAND 27 35 {ECO:0000244|PDB:4RED}.; STRAND 40 49 {ECO:0000244|PDB:4RED}.; STRAND 52 59 {ECO:0000244|PDB:4RED}.; STRAND 68 70 {ECO:0000244|PDB:4RED}.; STRAND 90 95 {ECO:0000244|PDB:4RED}.; STRAND 97 105 {ECO:0000244|PDB:4RED}.; STRAND 156 158 {ECO:0000244|PDB:4RED}.; STRAND 164 167 {ECO:0000244|PDB:4RED}.; STRAND 169 171 {ECO:0000244|PDB:4RED}.; STRAND 227 229 {ECO:0000244|PDB:4RED}.,HELIX 60 66 {ECO:0000244|PDB:4RED}.; HELIX 71 77 {ECO:0000244|PDB:4RED}.; HELIX 112 118 {ECO:0000244|PDB:4RED}.; HELIX 124 144 {ECO:0000244|PDB:4RED}.; HELIX 153 155 {ECO:0000244|PDB:4RED}.; HELIX 193 196 {ECO:0000244|PDB:4RED}.; HELIX 204 220 {ECO:0000244|PDB:4RED}.; HELIX 231 233 {ECO:0000244|PDB:4RED}.; HELIX 250 259 {ECO:0000244|PDB:4RED}.; HELIX 264 266 {ECO:0000244|PDB:4RED}.; HELIX 270 274 {ECO:0000244|PDB:4RED}.; HELIX 277 280 {ECO:0000244|PDB:4RED}.; HELIX 301 310 {ECO:0000244|PDB:4RED}.; HELIX 315 323 {ECO:0000244|PDB:4RED}.; HELIX 330 340 {ECO:0000244|PDB:4RED}.; HELIX 372 374 {ECO:0000244|PDB:5EZV}.,TURN 296 298 {ECO:0000244|PDB:4RED}.; TURN 347 351 {ECO:0000244|PDB:4RED}.,,,,,5 out of 5,Active site (1); Alternative sequence (1); Beta strand (10); Binding site (1); Chain (1); Domain (1); Erroneous initiation (5); Helix (16); Modified residue (17); Mutagenesis (1); Natural variant (2); Nucleotide binding (1); Region (1); Sequence conflict (6); Turn (2),,,,3D-structure;ATP-binding;Alternative splicing;Autophagy;Biological rhythms;Cholesterol biosynthesis;Cholesterol metabolism;Chromatin regulator;Complete proteome;Cytoplasm;Fatty acid biosynthesis;Fatty acid metabolism;Kinase;Lipid biosynthesis;Lipid metabolism;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Steroid biosynthesis;Steroid metabolism;Sterol biosynthesis;Sterol metabolism;Transcription;Transcription regulation;Transferase;Ubl conjugation;Wnt signaling pathway,Evidence at protein level,reviewed,,"Protein kinase superfamily, CAMK Ser/Thr protein kinase family, SNF1 subfamily",207,Activity regulation (1); Alternative products (1); Catalytic activity (6); Cofactor (1); Domain (1); Function (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0067; KW-0072; KW-0090; KW-0152; KW-0153; KW-0156; KW-0181; KW-0275; KW-0276; KW-0418; KW-0443; KW-0444; KW-0460; KW-0479; KW-0539; KW-0547; KW-0597; KW-0621; KW-0723; KW-0752; KW-0753; KW-0756; KW-0804; KW-0805; KW-0808; KW-0832; KW-0879; KW-0963; KW-1185; KW-1207,,,,,,,,"PTM: Ubiquitinated. {ECO:0000250}.; PTM: Phosphorylated at Thr-183 by STK11/LKB1 in complex with STE20-related adapter-alpha (STRADA) pseudo kinase and CAB39. Also phosphorylated at Thr-183 by CAMKK2; triggered by a rise in intracellular calcium ions, without detectable changes in the AMP/ATP ratio. CAMKK1 can also phosphorylate Thr-183, but at a much lower level. Dephosphorylated by protein phosphatase 2A and 2C (PP2A and PP2C). Phosphorylated by ULK1 and ULK2; leading to negatively regulate AMPK activity and suggesting the existence of a regulatory feedback loop between ULK1, ULK2 and AMPK. Dephosphorylated by PPM1A and PPM1B. {ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15980064, ECO:0000269|PubMed:16054095, ECO:0000269|PubMed:21460634}.",CHAIN 1 559 5'-AMP-activated protein kinase catalytic subunit alpha-1. /FTId=PRO_0000085589.,,,,,,"MOD_RES 32 32 Phosphothreonine. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:23186163}.; MOD_RES 183 183 Phosphothreonine; by LKB1 and CaMKK2. {ECO:0000250|UniProtKB:Q5EG47}.; MOD_RES 269 269 Phosphothreonine. {ECO:0000250|UniProtKB:P54645}.; MOD_RES 355 355 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 356 356 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 360 360 Phosphoserine; by ULK1. {ECO:0000250|UniProtKB:P54645}.; MOD_RES 368 368 Phosphothreonine; by ULK1. {ECO:0000250|UniProtKB:P54645}.; MOD_RES 382 382 Phosphothreonine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 397 397 Phosphoserine. {ECO:0000250|UniProtKB:P54645}.; MOD_RES 467 467 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 486 486 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 488 488 Phosphothreonine. {ECO:0000250|UniProtKB:P54645}.; MOD_RES 490 490 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 496 496 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 508 508 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 524 524 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 527 527 Phosphoserine. {ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,BC048980;AB022017;AK312947;BC037303;AF100763;U22456;Y12856;
0,Q13188,STK3_HUMAN,STK3 KRS1 MST2,STK3,KRS1 MST2,,,Homo sapiens (Human),9606,Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)],UP000005640: Chromosome 8,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MEQPPAPKSKLKKLSEDSLTKQPEEVFDVLEKLGEGSYGSVFKAIHKESGQVVAIKQVPVESDLQEIIKEISIMQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLIEDEIATILKSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKNPEQRATATQLLQHPFIKNAKPVSILRDLITEAMEIKAKRHEEQQRELEEEEENSDEDELDSHTMVKTSVESVGTMRATSTMSEGAQTMIEHNSTMLESDLGTMVINSEDEEEEDGTMKRNATSPQVQRPSFMDYFDKQDFKNKSHENCNQNMHEPFPMSKNVFPDNWKVPQDGDFDFLKNLSLEELQMRLKALDPMMEREIEELRQRYTAKRQPILDAMDAKKRRQQNF,491,"56,301",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q13188-1; Sequence=Displayed; Name=2; IsoId=Q13188-2; Sequence=VSP_054167; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 1 8 MEQPPAPK -> MLQLMDSGITICLRNGAASVFKKKEWSTQGEENKQD (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_054167.,VARIANT 60 60 V -> L (in an ovarian clear cell carcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041122.; VARIANT 418 418 F -> C (in dbSNP:rs36047674). /FTId=VAR_051670.,,,,CONFLICT 96 98 WIV -> YLY (in Ref. 8; CAA80909). {ECO:0000305}.; CONFLICT 121 121 D -> Y (in Ref. 8; CAA80909). {ECO:0000305}.; CONFLICT 203 203 D -> G (in Ref. 8; CAA80909). {ECO:0000305}.; CONFLICT 303 303 E -> D (in Ref. 1; AAC50386). {ECO:0000305}.; CONFLICT 332 334 ESV -> GEC (in Ref. 1; AAC50386). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. STE20 subfamily. {ECO:0000305}.,COILED 287 328 {ECO:0000255}.; COILED 442 475 {ECO:0000255}.,COMPBIAS 308 314 Poly-Glu.; COMPBIAS 370 375 Poly-Glu.,DOMAIN 27 278 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.; DOMAIN 437 484 SARAH. {ECO:0000255|PROSITE-ProRule:PRU00310}.,,,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ,,"FUNCTION: Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates NKX2-1 (By similarity). Phosphorylates NEK2 and plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosome, and its ability to phosphorylate CROCC and CEP250. In conjunction with SAV1, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation. Positively regulates RAF1 activation via suppression of the inhibitory phosphorylation of RAF1 on 'Ser-259'. Phosphorylates MOBKL1A and RASSF2. Phosphorylates MOBKL1B on 'Thr-74'. Acts cooperatively with MOBKL1B to activate STK38. {ECO:0000250|UniProtKB:Q9JI10, ECO:0000269|PubMed:15688006, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:18328708, ECO:0000269|PubMed:18362890, ECO:0000269|PubMed:19525978, ECO:0000269|PubMed:20212043, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:21104395, ECO:0000269|PubMed:28087714, ECO:0000269|PubMed:8566796, ECO:0000269|PubMed:8816758}.",,,,,,ACT_SITE 146 146 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159}.,BINDING 56 56 ATP.,,,NP_BIND 33 41 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,SITE 322 323 Cleavage; by caspase-3.,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],GO:0000287; GO:0001841; GO:0003157; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007165; GO:0007417; GO:0008285; GO:0023014; GO:0031098; GO:0032092; GO:0032147; GO:0032991; GO:0035329; GO:0035556; GO:0042802; GO:0043065; GO:0043539; GO:0045600; GO:0046330; GO:0046621; GO:0046983; GO:0050821; GO:0051091; GO:0051897; GO:0060215; GO:0060706; GO:0060800; GO:0090090; GO:0097284; GO:1902043,IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; ,Itself; Q8IZU0; Q53SE7; O95166; Q9H0R8; P60520; Q99259; Q9GZQ8; Q9BXW4; Q9H8S9; Q7L9L4; P04049; Q9NS23-2; P50749; Q86WH2; Q9H2L5; Q8WWW0; Q8WWW0-1; Q9H4B6; Q14BN4; Q13043; P0C1Z6-2; Q13077,"SUBUNIT: Homodimer; mediated via the coiled-coil region. Interacts with NORE1, which inhibits autoactivation (By similarity). Interacts with and stabilizes SAV1 (PubMed:15688006, PubMed:16930133, PubMed:28087714). Interacts with RAF1, which prevents dimerization and phosphorylation. Interacts with RASSF1. Interacts (via SARAH domain) with isoform 1 of NEK2. Interacts with ESR1 only in the presence of SAV1. Interacts with PKB/AKT1. Forms a tripartite complex with MOBKL1B and STK38. Interacts with RASSF2 (via SARAH domain). Interacts with DLG5 (via PDZ domain 3) (PubMed:28087714). Interacts with LATS1; this interaction is inhibited in the presence of DLG5 (PubMed:28087714). Interacts with MARK3 in the presence of DLG5 (PubMed:28087714). {ECO:0000250|UniProtKB:Q13043, ECO:0000269|PubMed:15618521, ECO:0000269|PubMed:15688006, ECO:0000269|PubMed:16510573, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:18362890, ECO:0000269|PubMed:19525978, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20231902, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:21104395, ECO:0000269|PubMed:21199877, ECO:0000269|PubMed:28087714}.",8566796; 8816758; 14702039; 16421571; 15489334; 8274451; 11278283; 15618521; 15688006; 16510573; 16930133; 18328708; 18691976; 18362890; 18669648; 19413330; 19484742; 19369195; 19525978; 19690332; 20086174; 20212043; 21076410; 20231902; 21269460; 21199877; 21104395; 21406692; 23186163; 28087714; 17344846,8566796; 8816758; 14702039; 16421571; 15489334; 8274451; 11278283; 15618521; 15688006; 16510573; 16930133; 18328708; 18691976; 18362890; 18669648; 19413330; 19484742; 19369195; 19525978; 19690332; 20086174; 20212043; 21076410; 20231902; 21269460; 21199877; 21104395; 21406692; 23186163; 28087714; 17344846; 11964314; 12554736; 14729613; 15109305; 16892067; 17538946; 17889669; 18347058; 18640976; 19327996; 19822666; 20145135; 20360068; 20562859; 20920251; 21900206; 21944251; 21988832; 22078877; 22102242; 22195963; 22590567; 23386615; 23455922; 23904266; 23972470; 24180524; 24189400; 24255178; 24366813; 24705354; 24881775; 24992339; 25004971; 25035424; 25241761; 25367221; 25416956; 25814670; 26108669; 26496610; 26638075; 26908611; 27238285; 27535619; 27566175; 28099921; 28103766; 28152516; 28373297; 28373298; 28677804; 29063833; 29270239; 29519817,2001-02-21,2019-02-13,2004-04-26,197,X-ray crystallography (10),STRAND 27 34 {ECO:0000244|PDB:4LG4}.; STRAND 36 39 {ECO:0000244|PDB:6AO5}.; STRAND 40 46 {ECO:0000244|PDB:4LG4}.; STRAND 52 58 {ECO:0000244|PDB:4LG4}.; STRAND 85 91 {ECO:0000244|PDB:4LG4}.; STRAND 94 100 {ECO:0000244|PDB:4LG4}.; STRAND 103 106 {ECO:0000244|PDB:5DH3}.; STRAND 152 154 {ECO:0000244|PDB:4LG4}.; STRAND 160 162 {ECO:0000244|PDB:4LG4}.; STRAND 379 381 {ECO:0000244|PDB:5BRM}.,HELIX 17 20 {ECO:0000244|PDB:4LGD}.; HELIX 23 26 {ECO:0000244|PDB:4LG4}.; HELIX 64 76 {ECO:0000244|PDB:4LG4}.; HELIX 107 114 {ECO:0000244|PDB:4LG4}.; HELIX 120 139 {ECO:0000244|PDB:4LG4}.; HELIX 149 151 {ECO:0000244|PDB:4LG4}.; HELIX 170 172 {ECO:0000244|PDB:4LG4}.; HELIX 175 182 {ECO:0000244|PDB:4LG4}.; HELIX 185 187 {ECO:0000244|PDB:5DH3}.; HELIX 190 195 {ECO:0000244|PDB:4LG4}.; HELIX 201 216 {ECO:0000244|PDB:4LG4}.; HELIX 226 235 {ECO:0000244|PDB:4LG4}.; HELIX 244 246 {ECO:0000244|PDB:4LG4}.; HELIX 249 258 {ECO:0000244|PDB:4LG4}.; HELIX 263 265 {ECO:0000244|PDB:4LG4}.; HELIX 269 272 {ECO:0000244|PDB:4LG4}.; HELIX 276 279 {ECO:0000244|PDB:4LG4}.; HELIX 284 287 {ECO:0000244|PDB:4LG4}.; HELIX 288 306 {ECO:0000244|PDB:4LG4}.; HELIX 392 394 {ECO:0000244|PDB:5BRM}.; HELIX 436 440 {ECO:0000244|PDB:4L0N}.; HELIX 445 483 {ECO:0000244|PDB:4L0N}.,TURN 47 49 {ECO:0000244|PDB:4LG4}.; TURN 220 223 {ECO:0000244|PDB:4LG4}.; TURN 308 311 {ECO:0000244|PDB:6AO5}.; TURN 395 397 {ECO:0000244|PDB:5BRM}.,,,,,5 out of 5,Active site (1); Alternative sequence (1); Beta strand (10); Binding site (1); Chain (3); Coiled coil (2); Compositional bias (2); Domain (2); Helix (22); Modified residue (9); Mutagenesis (2); Natural variant (2); Nucleotide binding (1); Sequence conflict (5); Site (1); Turn (4),,"TISSUE SPECIFICITY: Expressed at high levels in adult kidney, skeletal and placenta tissues and at very low levels in adult heart, lung and brain tissues. {ECO:0000269|PubMed:8566796}.",,3D-structure;ATP-binding;Acetylation;Alternative splicing;Apoptosis;Coiled coil;Complete proteome;Cytoplasm;Direct protein sequencing;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase,Evidence at protein level,reviewed,,"Protein kinase superfamily, STE Ser/Thr protein kinase family, STE20 subfamily",197,Activity regulation (1); Alternative products (1); Catalytic activity (2); Caution (1); Cofactor (1); Function (1); Induction (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0053; KW-0067; KW-0175; KW-0181; KW-0418; KW-0460; KW-0479; KW-0539; KW-0547; KW-0597; KW-0621; KW-0723; KW-0808; KW-0903; KW-0963; KW-1185,,,,,,,,"PTM: Phosphorylation at Thr-117 and Thr-384 by PKB/AKT1, leads to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation, and increase in its binding to RAF1. {ECO:0000269|PubMed:11278283, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20231902}.; PTM: Proteolytically cleaved by caspase-3 during apoptosis. Proteolytic cleavage results in kinase activation and nuclear translocation of the truncated form (MST1/N). {ECO:0000269|PubMed:11278283}.",CHAIN 1 491 Serine/threonine-protein kinase 3. /FTId=PRO_0000086689.; CHAIN 1 322 Serine/threonine-protein kinase 3 36kDa subunit. /FTId=PRO_0000413713.; CHAIN 323 491 Serine/threonine-protein kinase 3 20kDa subunit. /FTId=PRO_0000413714.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330, ECO:0000269|Ref.7}.; MOD_RES 15 15 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 117 117 Phosphothreonine; by PKB/AKT1. {ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20231902}.; MOD_RES 180 180 Phosphothreonine; by autocatalysis. {ECO:0000250|UniProtKB:O54748, ECO:0000305}.; MOD_RES 316 316 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 336 336 Phosphothreonine. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:23186163}.; MOD_RES 384 384 Phosphothreonine; by PKB/AKT1. {ECO:0000269|PubMed:20086174}.; MOD_RES 385 385 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 444 444 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U26424;U60206;AK131363;AK291837;CH471060;BC010640;Z25422;
0,Q13464,ROCK1_HUMAN,ROCK1,ROCK1,,,,Homo sapiens (Human),9606,"Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK)",UP000005640: Chromosome 18,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS,1354,"158,175",,,,,,,,,,,,,VARIANT 108 108 S -> N (in dbSNP:rs55811609). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041055.; VARIANT 773 773 T -> S (in dbSNP:rs45562542). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041056.; VARIANT 1112 1112 T -> P (in dbSNP:rs35881519). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041057.; VARIANT 1193 1193 P -> S (in a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs1057520015). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041058.; VARIANT 1217 1217 Q -> E (in dbSNP:rs2847092). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041059.; VARIANT 1262 1262 R -> Q (in dbSNP:rs1045142). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041060.; VARIANT 1264 1264 C -> R (in dbSNP:rs2663698). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041061.,,,,CONFLICT 170 170 V -> A (in Ref. 3; AAI13115). {ECO:0000305}.; CONFLICT 197 197 R -> G (in Ref. 3; AAI13115). {ECO:0000305}.; CONFLICT 220 220 C -> R (in Ref. 3; AAI13115). {ECO:0000305}.; CONFLICT 323 325 RLG -> GTR (in Ref. 5; BAD92202). {ECO:0000305}.; CONFLICT 521 521 D -> N (in Ref. 3; AAI13115). {ECO:0000305}.; CONFLICT 965 965 K -> R (in Ref. 3; AAI13115). {ECO:0000305}.; CONFLICT 1354 1354 S -> R (in Ref. 2; ACA06069). {ECO:0000305}.,,1,,0,DOMAIN: The C-terminal auto-inhibitory domain interferes with kinase activity. RHOA binding leads to a conformation change and activation of the kinase. Truncated ROCK1 is constitutively activated.,SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. {ECO:0000305}.,COILED 422 692 {ECO:0000255}.; COILED 1011 1102 {ECO:0000255}.,COMPBIAS 636 980 Glu-rich.,DOMAIN 76 338 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.; DOMAIN 341 409 AGC-kinase C-terminal.; DOMAIN 479 556 REM-1. {ECO:0000255|PROSITE-ProRule:PRU01207}.; DOMAIN 949 1015 RhoBD. {ECO:0000255|PROSITE-ProRule:PRU01206}.; DOMAIN 1118 1317 PH. {ECO:0000255|PROSITE-ProRule:PRU00145}.,,REGION 368 727 Interaction with FHOD1. {ECO:0000269|PubMed:18694941}.; REGION 998 1010 RHOA binding.; REGION 1115 1354 Auto-inhibitory.,,ZN_FING 1228 1281 Phorbol-ester/DAG-type. {ECO:0000255|PROSITE-ProRule:PRU00226}.,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ,,"FUNCTION: Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2, MYL9/MLC2, PFN1 and PPP1R12A. Phosphorylates FHOD1 and acts synergistically with it to promote SRC-dependent non-apoptotic plasma membrane blebbing. Phosphorylates JIP3 and regulates the recruitment of JNK to JIP3 upon UVB-induced stress. Acts as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Required for centrosome positioning and centrosome-dependent exit from mitosis. Plays a role in terminal erythroid differentiation. May regulate closure of the eyelids and ventral body wall by inducing the assembly of actomyosin bundles. Promotes keratinocyte terminal differentiation. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization. {ECO:0000269|PubMed:10436159, ECO:0000269|PubMed:10652353, ECO:0000269|PubMed:11018042, ECO:0000269|PubMed:11283607, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:18573880, ECO:0000269|PubMed:18694941, ECO:0000269|PubMed:19036714, ECO:0000269|PubMed:19131646, ECO:0000269|PubMed:19181962, ECO:0000269|PubMed:19997641, ECO:0000269|PubMed:21072057, ECO:0000269|PubMed:8617235, ECO:0000269|PubMed:9722579}.",,,,,,"ACT_SITE 198 198 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 105 105 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 82 90 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,SITE 1113 1114 Cleavage; by caspase-3.,bleb [GO:0032059]; centriole [GO:0005814]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton organization [GO:0030036]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; apoptotic process [GO:0006915]; bleb assembly [GO:0032060]; cortical actin cytoskeleton organization [GO:0030866]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of amyloid-beta formation [GO:1902003]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of autophagy [GO:0010506]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],actin cytoskeleton organization [GO:0030036]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; apoptotic process [GO:0006915]; bleb assembly [GO:0032060]; cortical actin cytoskeleton organization [GO:0030866]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of amyloid-beta formation [GO:1902003]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of autophagy [GO:0010506]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],bleb [GO:0032059]; centriole [GO:0005814]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774],GO:0000139; GO:0001726; GO:0003180; GO:0003383; GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005814; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006915; GO:0006939; GO:0007159; GO:0007165; GO:0007186; GO:0007249; GO:0007266; GO:0010494; GO:0010506; GO:0010508; GO:0010613; GO:0010628; GO:0016525; GO:0017049; GO:0018105; GO:0022614; GO:0030027; GO:0030036; GO:0030155; GO:0030866; GO:0031175; GO:0032059; GO:0032060; GO:0032091; GO:0032956; GO:0034774; GO:0035509; GO:0043312; GO:0043410; GO:0043524; GO:0045616; GO:0045664; GO:0046872; GO:0048010; GO:0048013; GO:0048156; GO:0050321; GO:0050900; GO:0050901; GO:0051045; GO:0051451; GO:0051492; GO:0051893; GO:0051894; GO:0061157; GO:0070168; GO:0071559; GO:0072518; GO:0072659; GO:0097746; GO:0110061; GO:0140058; GO:1900223; GO:1900242; GO:1902003; GO:1902430; GO:1902992; GO:1903140; GO:1903347; GO:1905205; GO:1990776; GO:2000114; GO:2000145,IPR000961; IPR011009; IPR002219; IPR011993; IPR001849; IPR000719; IPR017441; IPR015008; IPR029876; IPR020684; IPR037310; IPR008271; ,Q8IYR0; Q86V42; Q7Z6J6; P25791; O15481; Q13203; Q9BUI4; P61586; Q99816,"SUBUNIT: Homodimer. Interacts with RHOB, RHOC, MYLC2B and PTEN. Interacts with ITGB1BP1 (via N-terminus and PTB domain) (By similarity). Interacts with RHOA (activated by GTP), CHORDC1, DAPK3, GEM, JIP3, RHOE, PPP1R12A, PFN1, LIMK1, LIMK2 and TSG101. Interacts with FHOD1 in a Src-dependent manner. {ECO:0000250, ECO:0000269|PubMed:10436159, ECO:0000269|PubMed:10652353, ECO:0000269|PubMed:11018042, ECO:0000269|PubMed:11283607, ECO:0000269|PubMed:11956230, ECO:0000269|PubMed:12773565, ECO:0000269|PubMed:14660612, ECO:0000269|PubMed:16249185, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:17853893, ECO:0000269|PubMed:18573880, ECO:0000269|PubMed:18694941, ECO:0000269|PubMed:19036714, ECO:0000269|PubMed:19131646, ECO:0000269|PubMed:20230755, ECO:0000269|PubMed:8617235}.",8617235; 15489334; 9722579; 10508479; 10436159; 10652353; 11018042; 11283607; 11956230; 12773565; 12778124; 17853893; 17158456; 18694941; 18691976; 18573880; 18669648; 19036714; 19181962; 19131646; 19997641; 19690332; 19608861; 20230755; 21269460; 21072057; 20803696; 21406692; 22814378; 23186163; 24275569; 14660612; 16249185; 17344846,8617235; 15489334; 9722579; 10508479; 10436159; 10652353; 11018042; 11283607; 11956230; 12773565; 12778124; 17853893; 17158456; 18694941; 18691976; 18573880; 18669648; 19036714; 19181962; 19131646; 19997641; 19690332; 19608861; 20230755; 21269460; 21072057; 20803696; 21406692; 22814378; 23186163; 24275569; 14660612; 16249185; 17344846; 11283606; 11294240; 11331307; 11751986; 11818523; 11893932; 11942626; 11992112; 12034773; 12185584; 12193698; 12749591; 12850840; 14610060; 14716844; 15044207; 15096506; 15208091; 15231748; 15494373; 15611088; 15647781; 15665056; 15699075; 15713824; 15723050; 15843433; 15855233; 15910744; 15956119; 16141422; 16219803; 16371346; 16413470; 16543245; 16687572; 16712513; 16760434; 16772336; 16784244; 16825579; 16891369; 16978606; 16983089; 17012370; 17028776; 17044646; 17138966; 17151359; 17167780; 17172270; 17174923; 17244674; 17344417; 17620599; 17651694; 17673200; 17728102; 17855350; 18079197; 18187541; 18204440; 18239683; 18331468; 18353901; 18396681; 18477564; 18495812; 18499753; 18615591; 18648664; 18668558; 18684864; 18695890; 18713748; 18852895; 18922892; 18941185; 18946488; 18948190; 18952846; 19001122; 19160018; 19167712; 19403695; 19404162; 19406912; 19420982; 19549780; 19553453; 19573309; 19590140; 19667069; 19913121; 20039424; 20053635; 20056645; 20064505; 20068229; 20070312; 20126978; 20130732; 20140017; 20223287; 20364104; 20379197; 20471253; 20558775; 20678931; 20682776; 20734064; 20801872; 20801873; 21035804; 21048031; 21051874; 21085597; 21119662; 21206971; 21265091; 21281639; 21305317; 21387396; 21417762; 21445309; 21739156; 21747168; 21840487; 21847509; 21907926; 21908715; 21986457; 21994419; 22010828; 22031287; 22041269; 22085929; 22155728; 22206673; 22232555; 22272748; 22328514; 22348083; 22363817; 22462535; 22493320; 22563075; 22584506; 22813839; 22846914; 22913419; 22921817; 22942252; 22975682; 22986902; 23066013; 23094262; 23097497; 23168335; 23188716; 23233531; 23275831; 23298303; 23328676; 23350987; 23355470; 23416715; 23479079; 23615712; 23649168; 23650620; 23665024; 23670799; 23720748; 23726972; 23732111; 23782575; 23789633; 23828571; 23872151; 23877263; 23936026; 23951055; 23975506; 24019071; 24136289; 24149105; 24168723; 24170433; 24180482; 24240172; 24296361; 24297045; 24317511; 24323043; 24324133; 24331979; 24349032; 24398981; 24457551; 24465504; 24528629; 24573110; 24587343; 24617500; 24696479; 24717605; 24801908; 24894676; 24902944; 25011614; 25169484; 25218053; 25237195; 25248678; 25266804; 25380619; 25416956; 25448675; 25529450; 25538140; 25582918; 25677806; 25723491; 25755711; 25831237; 25832437; 25912304; 25916120; 25931586; 25940707; 25987767; 26026086; 26039570; 26066055; 26081423; 26276426; 26292662; 26306811; 26335177; 26377148; 26405762; 26448639; 26458302; 26468005; 26468018; 26474697; 26481340; 26487003; 26496610; 26530325; 26562026; 26615410; 26715279; 26715733; 26818518; 26826790; 26872982; 26928204; 26970302; 27028892; 27033194; 27035227; 27108693; 27132890; 27145462; 27160703; 27173611; 27203208; 27221467; 27246255; 27251065; 27269648; 27324125; 27374095; 27378427; 27495873; 27556514; 27616626; 27758857; 27780848; 27841867; 28031255; 28035042; 28074910; 28081735; 28104444; 28117029; 28184030; 28191820; 28225294; 28317242; 28487031; 28608941; 28701359; 28709411; 28739902; 28821556; 28841710; 28848996; 28888686; 28923399; 29246448; 29324316; 29441962; 29517104; 29544562; 2966156; 29710554; 29749520; 29790629; 29804125; 29849894; 29945794; 30082069; 30114643; 30165352; 30212830; 30298816; 30384606; 3839510; 8662509; 8702756; 8816443; 9354661,2004-05-24,2019-02-13,1996-11-01,199,X-ray crystallography (27),STRAND 24 26 {ECO:0000244|PDB:5WNG}.; STRAND 76 84 {ECO:0000244|PDB:3V8S}.; STRAND 86 95 {ECO:0000244|PDB:3V8S}.; STRAND 101 108 {ECO:0000244|PDB:3V8S}.; STRAND 139 144 {ECO:0000244|PDB:3V8S}.; STRAND 146 153 {ECO:0000244|PDB:3V8S}.; STRAND 157 160 {ECO:0000244|PDB:3NDM}.; STRAND 204 206 {ECO:0000244|PDB:3V8S}.; STRAND 212 214 {ECO:0000244|PDB:3V8S}.; STRAND 227 230 {ECO:0000244|PDB:3V8S}.; STRAND 254 256 {ECO:0000244|PDB:3V8S}.; STRAND 399 402 {ECO:0000244|PDB:2ETR}.,HELIX 9 19 {ECO:0000244|PDB:3V8S}.; HELIX 27 41 {ECO:0000244|PDB:3V8S}.; HELIX 44 47 {ECO:0000244|PDB:3V8S}.; HELIX 50 69 {ECO:0000244|PDB:3V8S}.; HELIX 73 75 {ECO:0000244|PDB:3V8S}.; HELIX 109 114 {ECO:0000244|PDB:3V8S}.; HELIX 121 130 {ECO:0000244|PDB:3V8S}.; HELIX 161 167 {ECO:0000244|PDB:3V8S}.; HELIX 172 191 {ECO:0000244|PDB:3V8S}.; HELIX 201 203 {ECO:0000244|PDB:3V8S}.; HELIX 217 219 {ECO:0000244|PDB:5KKS}.; HELIX 238 240 {ECO:0000244|PDB:3V8S}.; HELIX 243 247 {ECO:0000244|PDB:3V8S}.; HELIX 258 273 {ECO:0000244|PDB:3V8S}.; HELIX 283 291 {ECO:0000244|PDB:3V8S}.; HELIX 293 296 {ECO:0000244|PDB:3V8S}.; HELIX 307 316 {ECO:0000244|PDB:3V8S}.; HELIX 320 322 {ECO:0000244|PDB:3V8S}.; HELIX 329 333 {ECO:0000244|PDB:3V8S}.; HELIX 336 338 {ECO:0000244|PDB:3V8S}.; HELIX 348 350 {ECO:0000244|PDB:3V8S}.; HELIX 365 367 {ECO:0000244|PDB:3NCZ}.; HELIX 392 394 {ECO:0000244|PDB:3V8S}.; HELIX 535 540 {ECO:0000244|PDB:3O0Z}.; HELIX 544 691 {ECO:0000244|PDB:3O0Z}.; HELIX 840 902 {ECO:0000244|PDB:4L2W}.; HELIX 947 982 {ECO:0000244|PDB:1S1C}.; HELIX 984 1011 {ECO:0000244|PDB:1S1C}.,TURN 96 98 {ECO:0000244|PDB:3V8S}.; TURN 248 252 {ECO:0000244|PDB:3V8S}.; TURN 324 327 {ECO:0000244|PDB:5WNF}.; TURN 345 347 {ECO:0000244|PDB:5WNE}.,,,,,5 out of 5,Active site (1); Beta strand (12); Binding site (1); Chain (1); Coiled coil (2); Compositional bias (1); Domain (5); Helix (28); Initiator methionine (1); Modified residue (5); Mutagenesis (1); Natural variant (7); Nucleotide binding (1); Region (3); Sequence conflict (7); Site (1); Turn (4); Zinc finger (1),,TISSUE SPECIFICITY: Detected in blood platelets. {ECO:0000269|PubMed:8617235}.,,3D-structure;ATP-binding;Acetylation;Apoptosis;Cell membrane;Cell projection;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Golgi apparatus;Kinase;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Zinc;Zinc-finger,Evidence at protein level,reviewed,,"Protein kinase superfamily, AGC Ser/Thr protein kinase family",199,Activity regulation (1); Catalytic activity (2); Cofactor (1); Domain (1); Function (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0053; KW-0067; KW-0175; KW-0181; KW-0206; KW-0333; KW-0418; KW-0460; KW-0472; KW-0479; KW-0547; KW-0597; KW-0621; KW-0723; KW-0808; KW-0862; KW-0863; KW-0903; KW-0963; KW-0966; KW-1003; KW-1185,,,,,,,,PTM: Autophosphorylated on serine and threonine residues. {ECO:0000269|PubMed:8617235}.; PTM: Cleaved by caspase-3 during apoptosis. This leads to constitutive activation of the kinase and membrane blebbing.,CHAIN 2 1354 Rho-associated protein kinase 1. /FTId=PRO_0000086619.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378, ECO:0000269|Ref.4}.",,"MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:22814378, ECO:0000269|Ref.4}.; MOD_RES 647 647 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 1105 1105 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332}.; MOD_RES 1108 1108 Phosphoserine. {ECO:0000250|UniProtKB:P70335}.; MOD_RES 1328 1328 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U43195;EF445027;BC113114;AB208965;
0,Q13487,SNPC2_HUMAN,SNAPC2 SNAP45,SNAPC2,SNAP45,,,Homo sapiens (Human),9606,snRNA-activating protein complex subunit 2 (SNAPc subunit 2) (Proximal sequence element-binding transcription factor subunit delta) (PSE-binding factor subunit delta) (PTF subunit delta) (Small nuclear RNA-activating complex polypeptide 2) (snRNA-activating protein complex 45 kDa subunit) (SNAPc 45 kDa subunit),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MKPPPRRRAAPARYLGEVTGPATWSAREKRQLVRLLQARQGQPEPDATELARELRGRSEAEIRVFLQQLKGRVAREAIQKVHPGGLQGPRRREAQPPAPIEVWTDLAEKITGPLEEALAVAFSQVLTIAATEPVTLLHSKPPKPTQARGKPLLLSAPGGQEDPAPEIPSSAPAAPSSAPRTPDPAPEKPSESSAGPSTEEDFAVDFEKIYKYLSSVSRSGRSPELSAAESAVVLDLLMSLPEELPLLPCTALVEHMTETYLRLTAPQPIPAGGSLGPAAEGDGAGSKAPEETPPATEKAEHSELKSPWQAAGICPLNPFLVPLELLGRAATPAR,334,"35,556",,,,,,,,,,,,,"VARIANT 118 118 L -> V (in dbSNP:rs475002). {ECO:0000269|PubMed:14702039, ECO:0000269|Ref.4}. /FTId=VAR_011806.",,,,,,1,,0,,,,,,,,,,,,,,,"FUNCTION: Part of the SNAPc complex required for the transcription of both RNA polymerase II and III small-nuclear RNA genes. Binds to the proximal sequence element (PSE), a non-TATA-box basal promoter element common to these 2 types of genes. Recruits TBP and BRF2 to the U6 snRNA TATA box.",,,,,,,,,,,,cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; snRNA transcription [GO:0009301]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383],snRNA transcription [GO:0009301]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383],DNA-binding transcription factor activity [GO:0003700],cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006366; GO:0006383; GO:0009301; GO:0016604; GO:0042795,IPR021281; ,,"SUBUNIT: Part of the SNAPc complex composed of 5 subunits: SNAPC1, SNAPC2, SNAPC3, SNAPC4 and SNAPC5. SNAPC2 interacts with TBP and SNAPC4. {ECO:0000269|PubMed:12621023, ECO:0000269|PubMed:9418884}.",8633057; 8524284; 14702039; 15489334; 9418884; 12621023,8633057; 8524284; 14702039; 15489334; 9418884; 12621023; 10022900; 10421633; 10473618; 11056176; 11463379; 11856838; 12370301; 12414730; 12574128; 14701755; 1619662; 16239144; 16308568; 16901896; 18079403; 18356157; 19667075; 20457598; 2125285; 21444690; 22137580; 22231121; 22252320; 22441827; 23166507; 23932780; 24097444; 24270878; 24997600; 25675981; 2944599; 7659514; 7715707; 7891697; 8253082; 8339931; 8628262; 9003788; 9188510; 9234698; 9407024; 9765293; 9832505,2000-05-30,2019-02-13,1996-11-01,146,,,,,,,,,5 out of 5,Chain (1); Natural variant (1),,,,Complete proteome;Nucleus;Polymorphism;Reference proteome;Transcription;Transcription regulation,Evidence at protein level,reviewed,,,146,Function (1); Subcellular location (1); Subunit structure (1),,KW-0181; KW-0539; KW-0621; KW-0804; KW-0805; KW-1185,,,,,,,,,CHAIN 1 334 snRNA-activating protein complex subunit 2. /FTId=PRO_0000072020.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U44898;U44755;AK314878;CH471139;CH471139;BC011868;
0,Q13554,KCC2B_HUMAN,CAMK2B CAM2 CAMK2 CAMKB,CAMK2B,CAM2 CAMK2 CAMKB,,,Homo sapiens (Human),9606,Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17),UP000005640: Chromosome 7,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MATTVTCTRFTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECLKKFNARRKLKGAILTTMLATRNFSVGRQTTAPATMSTAASGTTMGLVEQAKSLLNKKADGVKPQTNSTKNSAAATSPKGTLPPAALEPQTTVIHNPVDGIKESSDSANTTIEDEDAKAPRVPDILSSVRRGSGAPEAEGPLPCPSPAPFSPLPAPSPRISDILNSVRRGSGTPEAEGPLSAGPPPCLSPALLGPLSSPSPRISDILNSVRRGSGTPEAEGPSPVGPPPCPSPTIPGPLPTPSRKQEIIKTTEQLIEAVNNGDFEAYAKICDPGLTSFEPEALGNLVEGMDFHRFYFENLLAKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWQNVHFHCSGAPVAPLQ,666,"72,678",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=8;  Comment=The variable region of the CAMK2B protein is encoded by at least 7 exons (V1 to V7). Alternative splicing within this region gives rise to CAMK2B isoforms.; Name=4; IsoId=Q13554-1; Sequence=Displayed; Name=1; Synonyms=Beta; IsoId=Q13554-2; Sequence=VSP_004776; Name=2; Synonyms=Beta1, Beta'E; IsoId=Q13554-3; Sequence=VSP_004770, VSP_004771, VSP_004775, VSP_004776; Name=3; Synonyms=Beta2; IsoId=Q13554-4; Sequence=VSP_004770, VSP_004771, VSP_004774, VSP_004776; Name=5; Synonyms=Beta4, BetaE; IsoId=Q13554-5; Sequence=VSP_004770, VSP_004771, VSP_004776; Name=6; Synonyms=Beta6; IsoId=Q13554-6; Sequence=VSP_004773, VSP_004776, VSP_004777; Name=7; Synonyms=Beta7; IsoId=Q13554-7; Sequence=VSP_004770, VSP_004772; Name=8; IsoId=Q13554-8; Sequence=VSP_041219, VSP_004776; ",,,,,"SEQUENCE CAUTION:  Sequence=AAC99802.1; Type=Frameshift; Positions=426, 433, 511, 516; Evidence={ECO:0000305}; ",,,,,"VAR_SEQ 316 340 Missing (in isoform 8). {ECO:0000305}. /FTId=VSP_041219.; VAR_SEQ 316 316 V -> A (in isoform 2, isoform 3, isoform 5 and isoform 7). {ECO:0000303|PubMed:10819240, ECO:0000303|PubMed:10858498, ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9060999, ECO:0000303|Ref.3}. /FTId=VSP_004770.; VAR_SEQ 317 533 Missing (in isoform 7). {ECO:0000303|PubMed:10858498}. /FTId=VSP_004772.; VAR_SEQ 317 340 Missing (in isoform 2, isoform 3 and isoform 5). {ECO:0000303|PubMed:10819240, ECO:0000303|PubMed:10858498, ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9060999, ECO:0000303|Ref.3}. /FTId=VSP_004771.; VAR_SEQ 354 392 Missing (in isoform 3). {ECO:0000303|PubMed:10819240}. /FTId=VSP_004774.; VAR_SEQ 354 377 Missing (in isoform 6). {ECO:0000303|PubMed:10858498}. /FTId=VSP_004773.; VAR_SEQ 379 393 Missing (in isoform 2). {ECO:0000303|PubMed:10819240, ECO:0000303|PubMed:10858498, ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9060999}. /FTId=VSP_004775.; VAR_SEQ 410 533 Missing (in isoform 1, isoform 2, isoform 3, isoform 5, isoform 6 and isoform 8). {ECO:0000303|PubMed:10819240, ECO:0000303|PubMed:10858498, ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9060999, ECO:0000303|Ref.3}. /FTId=VSP_004776.; VAR_SEQ 559 584 Missing (in isoform 6). {ECO:0000303|PubMed:10858498}. /FTId=VSP_004777.",VARIANT 29 666 Missing (in MRD54). {ECO:0000269|PubMed:29100089}. /FTId=VAR_080588.; VARIANT 110 110 E -> K (in MRD54; decreased protein abundance; increased autophosphorylation; decreased neuronal migration). {ECO:0000269|PubMed:29100089}. /FTId=VAR_080589.; VARIANT 139 139 P -> L (in MRD54; decreased protein abundance; increased autophosphorylation; decreased neuronal migration). {ECO:0000269|PubMed:29100089}. /FTId=VAR_080590.; VARIANT 213 213 P -> L (in MRD54). {ECO:0000269|PubMed:29560374}. /FTId=VAR_081162.; VARIANT 237 237 E -> K (in MRD54; no effect on protein abundance; increased autophosphorylation; decreased neuronal migration). {ECO:0000269|PubMed:29100089}. /FTId=VAR_080591.; VARIANT 284 284 R -> S (in MRD54). {ECO:0000269|PubMed:29560374}. /FTId=VAR_081163.; VARIANT 301 301 K -> E (in MRD54; no effect on protein abundance; loss of autophosphorylation; changed function in neuronal migration). {ECO:0000269|PubMed:29100089}. /FTId=VAR_080592.; VARIANT 489 489 P -> L (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs555460132). {ECO:0000269|PubMed:17344846}. /FTId=VAR_045581.; VARIANT 510 510 E -> K (in dbSNP:rs35452727). {ECO:0000269|PubMed:17344846}. /FTId=VAR_045582.,,,,CONFLICT 68 68 L -> V (in Ref. 3; AAD03744/AAD03743). {ECO:0000305}.; CONFLICT 535 535 K -> N (in Ref. 8; AAB16863). {ECO:0000305}.,,3,,0,DOMAIN: The CAMK2 protein kinases contain a unique C-terminal subunit association domain responsible for oligomerization.,SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. CaMK subfamily. {ECO:0000305}.,,,DOMAIN 14 272 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,REGION 283 292 Autoinhibitory domain. {ECO:0000250}.; REGION 291 301 Calmodulin-binding.,,,2.7.11.17,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.17; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.17;",,,"FUNCTION: Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca(2+)/calmodulin-binding and autophosphorylation, and is involved in dendritic spine and synapse formation, neuronal plasticity and regulation of sarcoplasmic reticulum Ca(2+) transport in skeletal muscle. In neurons, plays an essential structural role in the reorganization of the actin cytoskeleton during plasticity by binding and bundling actin filaments in a kinase-independent manner. This structural function is required for correct targeting of CaMK2A, which acts downstream of NMDAR to promote dendritic spine and synapse formation and maintain synaptic plasticity which enables long-term potentiation (LTP) and hippocampus-dependent learning. In developing hippocampal neurons, promotes arborization of the dendritic tree and in mature neurons, promotes dendritic remodeling. Also regulates the migration of developing neurons (PubMed:29100089). Participates in the modulation of skeletal muscle function in response to exercise. In slow-twitch muscles, is involved in regulation of sarcoplasmic reticulum (SR) Ca(2+) transport and in fast-twitch muscle participates in the control of Ca(2+) release from the SR through phosphorylation of triadin, a ryanodine receptor-coupling factor, and phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2. {ECO:0000269|PubMed:16690701, ECO:0000269|PubMed:29100089}.",,,,,,"ACT_SITE 136 136 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 43 43 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 20 28 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; interferon-gamma-mediated signaling pathway [GO:0060333]; MAPK cascade [GO:0000165]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of neuron projection development [GO:0010976]; positive regulation of synapse maturation [GO:0090129]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of calcium ion transport [GO:0051924]; regulation of dendritic spine development [GO:0060998]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of neuron migration [GO:2001222]; regulation of skeletal muscle adaptation [GO:0014733]; regulation of synapse structural plasticity [GO:0051823]; signal transduction [GO:0007165],interferon-gamma-mediated signaling pathway [GO:0060333]; MAPK cascade [GO:0000165]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of neuron projection development [GO:0010976]; positive regulation of synapse maturation [GO:0090129]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of calcium ion transport [GO:0051924]; regulation of dendritic spine development [GO:0060998]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of neuron migration [GO:2001222]; regulation of skeletal muscle adaptation [GO:0014733]; regulation of synapse structural plasticity [GO:0051823]; signal transduction [GO:0007165],actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; Ras guanyl-nucleotide exchange factor activity [GO:0005088],cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202],GO:0000165; GO:0003779; GO:0004674; GO:0004683; GO:0005088; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0010976; GO:0014733; GO:0030054; GO:0030666; GO:0033017; GO:0042802; GO:0042803; GO:0043005; GO:0045202; GO:0046777; GO:0048169; GO:0051823; GO:0051924; GO:0060333; GO:0060998; GO:0061003; GO:0090129; GO:2001222,IPR013543; IPR039071; IPR011009; IPR032710; IPR000719; IPR017441; IPR008271; ,Itself; B3KWQ7; O00154; Q2VPB7; Q9UQM7; Q13557; Q13557-8; Q13555-5; Q8N0U1; P60412; Q3LI72; Q3SYF9; Q9UI95; Q9BUE0; Q9UBU8; Q9UBU8-2; Q9Y3B7; Q93100; Q969H6; P61225; O43251; Q93062; P62913; Q9NTN9-3; Q5W111; Q8N0Z6; A0A0C4DGF1,"SUBUNIT: CAMK2 is composed of 4 different chains: alpha (CAMK2A), beta (CAMK2B), gamma (CAMK2G), and delta (CAMK2D). The different isoforms assemble into homo- or heteromultimeric holoenzymes composed of 12 subunits with two hexameric rings stacked one on top of the other (PubMed:14722083, Ref.19). Interacts with SYNGAP1 and CAMK2N2 (By similarity). Interacts with MPDZ (PubMed:15312654). Interacts with FOXO3 (By similarity). Interacts (when in a kinase inactive state not associated with calmodulin) with ARC; leading to target ARC to inactive synapses (By similarity). {ECO:0000250|UniProtKB:P08413, ECO:0000250|UniProtKB:P28652, ECO:0000269|PubMed:14722083, ECO:0000269|PubMed:15312654, ECO:0000269|Ref.19}.",10858498; 10819240; 14702039; 12690205; 15489334; 9060999; 14722083; 15312654; 16690701; 19369195; 21529938; 15294044; 18817731; 19996366; 24275569; 17344846; 29100089; 29560374,10858498; 10819240; 14702039; 12690205; 15489334; 9060999; 14722083; 15312654; 16690701; 19369195; 21529938; 15294044; 18817731; 19996366; 24275569; 17344846; 29100089; 29560374; 10373510; 11013247; 11042361; 11290418; 11447121; 11710563; 11889801; 11972023; 12062470; 12496285; 12815021; 1309946; 14500339; 14565989; 14622581; 15322115; 15665723; 15754088; 15760475; 15792370; 16126727; 16247765; 17064357; 17353931; 17419996; 17603483; 17721511; 18184654; 18218981; 18302935; 18311135; 19058789; 19156168; 19406745; 19727074; 20379614; 21102635; 21372320; 21479273; 21566136; 21610080; 21817159; 21871176; 21884935; 21988832; 22014111; 22514276; 22592532; 22750393; 22939624; 23275563; 23303910; 23362265; 23804213; 24606918; 24937142; 25045698; 25416956; 26638075; 28130256; 29410121; 2953725; 7702581; 7929371; 8615909; 8665664; 9481670,1997-11-01,2019-02-13,2011-05-31,197,X-ray crystallography (1),STRAND 14 19 {ECO:0000244|PDB:3BHH}.; STRAND 27 33 {ECO:0000244|PDB:3BHH}.; STRAND 39 46 {ECO:0000244|PDB:3BHH}.; STRAND 76 81 {ECO:0000244|PDB:3BHH}.; STRAND 83 91 {ECO:0000244|PDB:3BHH}.; STRAND 95 97 {ECO:0000244|PDB:3BHH}.; STRAND 142 145 {ECO:0000244|PDB:3BHH}.; STRAND 153 155 {ECO:0000244|PDB:3BHH}.; STRAND 239 241 {ECO:0000244|PDB:3BHH}.,HELIX 52 67 {ECO:0000244|PDB:3BHH}.; HELIX 98 102 {ECO:0000244|PDB:3BHH}.; HELIX 110 129 {ECO:0000244|PDB:3BHH}.; HELIX 139 141 {ECO:0000244|PDB:3BHH}.; HELIX 178 180 {ECO:0000244|PDB:3BHH}.; HELIX 183 186 {ECO:0000244|PDB:3BHH}.; HELIX 194 209 {ECO:0000244|PDB:3BHH}.; HELIX 219 228 {ECO:0000244|PDB:3BHH}.; HELIX 243 252 {ECO:0000244|PDB:3BHH}.; HELIX 263 266 {ECO:0000244|PDB:3BHH}.; HELIX 270 273 {ECO:0000244|PDB:3BHH}.; HELIX 275 278 {ECO:0000244|PDB:3BHH}.; HELIX 285 298 {ECO:0000244|PDB:3BHH}.,TURN 34 36 {ECO:0000244|PDB:3BHH}.; TURN 235 238 {ECO:0000244|PDB:3BHH}.; TURN 257 259 {ECO:0000244|PDB:3BHH}.,,,,,5 out of 5,Active site (1); Alternative sequence (9); Beta strand (9); Binding site (1); Chain (1); Domain (1); Frameshift (1); Helix (13); Modified residue (9); Natural variant (9); Nucleotide binding (1); Region (2); Sequence conflict (4); Turn (3),,TISSUE SPECIFICITY: Widely expressed. Expressed in adult and fetal brain. Expression is slightly lower in fetal brain. Expressed in skeletal muscle. {ECO:0000269|PubMed:16690701}.,,3D-structure;ATP-binding;Actin-binding;Alternative splicing;Calmodulin-binding;Cell junction;Complete proteome;Cytoplasm;Cytoskeleton;Developmental protein;Differentiation;Kinase;Membrane;Mental retardation;Neurogenesis;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Sarcoplasmic reticulum;Serine/threonine-protein kinase;Synapse;Transferase,Evidence at protein level,reviewed,,"Protein kinase superfamily, CAMK Ser/Thr protein kinase family, CaMK subfamily",197,Activity regulation (1); Alternative products (1); Catalytic activity (2); Domain (1); Function (1); Induction (1); Involvement in disease (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0009; KW-0025; KW-0067; KW-0112; KW-0181; KW-0206; KW-0217; KW-0221; KW-0418; KW-0472; KW-0524; KW-0547; KW-0597; KW-0621; KW-0703; KW-0723; KW-0770; KW-0808; KW-0963; KW-0965; KW-0991; KW-1185,,,,,"DISEASE: Mental retardation, autosomal dominant 54 (MRD54) [MIM:617799]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:29100089, ECO:0000269|PubMed:29560374}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Autophosphorylation of Thr-287 following activation by Ca(2+)/calmodulin. Phosphorylation of Thr-287 locks the kinase into an activated state. {ECO:0000269|PubMed:14722083, ECO:0000269|PubMed:16690701}.",CHAIN 1 666 Calcium/calmodulin-dependent protein kinase type II subunit beta. /FTId=PRO_0000086096.,,,,,,MOD_RES 17 17 Phosphotyrosine. {ECO:0000250|UniProtKB:P28652}.; MOD_RES 287 287 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:16690701}.; MOD_RES 306 306 Phosphothreonine; by autocatalysis. {ECO:0000250}.; MOD_RES 307 307 Phosphothreonine; by autocatalysis. {ECO:0000250}.; MOD_RES 367 367 Phosphoserine. {ECO:0000250|UniProtKB:P08413}.; MOD_RES 394 394 Phosphoserine. {ECO:0000250|UniProtKB:P28652}.; MOD_RES 397 397 Phosphoserine. {ECO:0000250|UniProtKB:P08413}.; MOD_RES 400 400 Phosphothreonine. {ECO:0000250|UniProtKB:P28652}.; MOD_RES 401 401 Phosphothreonine. {ECO:0000244|PubMed:24275569}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF078803;AF081572;AF081924;AF083419;AF140350;U23460;AF112472;AF112471;AJ252236;AJ252237;AJ252238;AK290148;AK315663;CH236960;CH236960;CH236960;CH236960;CH236960;CH236960;CH236960;BC019070;U50358;
0,Q13555,KCC2G_HUMAN,CAMK2G CAMK CAMK-II CAMKG,CAMK2G,CAMK CAMK-II CAMKG,,,Homo sapiens (Human),9606,Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17),UP000005640: Chromosome 10,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKKRKSSSSVHLMPQSNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLKGRVPEGRSSRDRTAPSAGMQPQPSLCSSAMRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ,558,"62,607",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=11;  Name=1; IsoId=Q13555-1; Sequence=Displayed; Name=2; IsoId=Q13555-2; Sequence=VSP_013349; Name=3; IsoId=Q13555-3; Sequence=VSP_013350; Name=4; IsoId=Q13555-4; Sequence=VSP_004778; Name=5; IsoId=Q13555-5; Sequence=VSP_032699, VSP_032700, VSP_004778; Name=6; IsoId=Q13555-6; Sequence=VSP_032699, VSP_035456; Name=7; Synonyms=gamma F; IsoId=Q13555-7; Sequence=VSP_013350, VSP_035456; Name=8; Synonyms=gamma E; IsoId=Q13555-8; Sequence=VSP_013349, VSP_035456; Name=9; Synonyms=gamma D; IsoId=Q13555-9; Sequence=VSP_013349, VSP_036027, VSP_035456; Name=10; IsoId=Q13555-10; Sequence=VSP_013350, VSP_004778; Name=11; IsoId=Q13555-11; Sequence=VSP_059393, VSP_013349, VSP_059394; ",,SEQUENCE CAUTION:  Sequence=AAB61379.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 315 315 S -> SVGRQSSAPASPAASAAGLAGQ (in isoform 5 and isoform 6). {ECO:0000303|PubMed:15489334}. /FTId=VSP_032699.; VAR_SEQ 316 316 A -> VGRQSSAPASPAASAAGLAGQA (in isoform 11). /FTId=VSP_059393.; VAR_SEQ 331 364 Missing (in isoform 3, isoform 7 and isoform 10). {ECO:0000303|PubMed:7557101, ECO:0000303|PubMed:8449910}. /FTId=VSP_013350.; VAR_SEQ 331 341 Missing (in isoform 2, isoform 8, isoform 9 and isoform 11). {ECO:0000303|PubMed:7557101, ECO:0000303|PubMed:9060999}. /FTId=VSP_013349.; VAR_SEQ 341 363 Missing (in isoform 5). {ECO:0000303|PubMed:15489334}. /FTId=VSP_032700.; VAR_SEQ 351 364 Missing (in isoform 9). {ECO:0000303|PubMed:7557101}. /FTId=VSP_036027.; VAR_SEQ 396 426 GRVPEGRSSRDRTAPSAGMQPQPSLCSSAMR -> VR (in isoform 11). /FTId=VSP_059394.; VAR_SEQ 396 425 GRVPEGRSSRDRTAPSAGMQPQPSLCSSAM -> V (in isoform 4, isoform 5 and isoform 10). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:8449910, ECO:0000303|PubMed:9060999}. /FTId=VSP_004778.; VAR_SEQ 397 398 RV -> APLRTGNGSSV (in isoform 6, isoform 7, isoform 8 and isoform 9). {ECO:0000303|PubMed:7557101}. /FTId=VSP_035456.","VARIANT 36 36 S -> P (in dbSNP:rs17853266). {ECO:0000269|PubMed:15489334, ECO:0000269|Ref.2}. /FTId=VAR_042430.; VARIANT 292 292 R -> P (found in a patient with severe mental retardation, myopia, strabismus; unknown pathological significance; dbSNP:rs397514627). {ECO:0000269|PubMed:23033978}. /FTId=VAR_069390.",,,,CONFLICT 230 230 A -> T (in Ref. 6; AAB61379). {ECO:0000305}.,,4,,0,DOMAIN: The CAMK2 protein kinases contain a unique C-terminal subunit association domain responsible for oligomerization.,SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. CaMK subfamily. {ECO:0000305}.,,,DOMAIN 14 272 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,REGION 283 292 Autoinhibitory domain.; REGION 291 301 Calmodulin-binding. {ECO:0000250}.; REGION 294 316 Calmodulin-binding.,,,2.7.11.17,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.17; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.17;",,,"FUNCTION: Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca(2+)/calmodulin-binding and autophosphorylation, and is involved in sarcoplasmic reticulum Ca(2+) transport in skeletal muscle and may function in dendritic spine and synapse formation and neuronal plasticity. In slow-twitch muscles, is involved in regulation of sarcoplasmic reticulum (SR) Ca(2+) transport and in fast-twitch muscle participates in the control of Ca(2+) release from the SR through phosphorylation of the ryanodine receptor-coupling factor triadin. In neurons, may participate in the promotion of dendritic spine and synapse formation and maintenance of synaptic plasticity which enables long-term potentiation (LTP) and hippocampus-dependent learning. {ECO:0000269|PubMed:16690701}.",,,,,,"ACT_SITE 136 136 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 43 43 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 20 28 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; interferon-gamma-mediated signaling pathway [GO:0060333]; MAPK cascade [GO:0000165]; nervous system development [GO:0007399]; protein complex oligomerization [GO:0051259]; regulation of calcium ion transport [GO:0051924]; regulation of skeletal muscle adaptation [GO:0014733],cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; interferon-gamma-mediated signaling pathway [GO:0060333]; MAPK cascade [GO:0000165]; nervous system development [GO:0007399]; protein complex oligomerization [GO:0051259]; regulation of calcium ion transport [GO:0051924]; regulation of skeletal muscle adaptation [GO:0014733],ATP binding [GO:0005524]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; Ras guanyl-nucleotide exchange factor activity [GO:0005088],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017],GO:0000165; GO:0004674; GO:0004683; GO:0004723; GO:0005088; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007399; GO:0014733; GO:0016020; GO:0030073; GO:0030154; GO:0030666; GO:0033017; GO:0042802; GO:0042803; GO:0043005; GO:0051259; GO:0051924; GO:0060333,IPR013543; IPR039071; IPR011009; IPR032710; IPR000719; IPR017441; IPR008271; ,Itself; Q13554-3; Q13557-8; P08238,"SUBUNIT: CAMK2 is composed of 4 different chains: alpha (CAMK2A), beta (CAMK2B), gamma (CAMK2G), and delta (CAMK2D). The different isoforms assemble into homo- or heteromultimeric holoenzymes composed of 12 subunits with two hexameric rings stacked one on top of the other. {ECO:0000269|PubMed:14722083, ECO:0000269|PubMed:20668654}.",15164054; 15489334; 9240463; 12032636; 8449910; 9060999; 7557101; 14722083; 16690701; 15294044; 18691976; 18669648; 19369195; 20068231; 21269460; 23186163; 24275569; 20668654; 23033978,15164054; 15489334; 9240463; 12032636; 8449910; 9060999; 7557101; 14722083; 16690701; 15294044; 18691976; 18669648; 19369195; 20068231; 21269460; 23186163; 24275569; 20668654; 23033978; 10373510; 11013247; 11290418; 11447121; 11972023; 12062470; 12815021; 1309946; 14500339; 14565989; 14622581; 15322115; 15754088; 15760475; 16278289; 16385451; 17064357; 17603483; 17721511; 18088385; 18184654; 18218981; 18311135; 19406745; 19463016; 19615732; 19727074; 21102635; 21372320; 21566136; 21742790; 21817159; 22427672; 22456474; 22514276; 22592532; 22939624; 23289753; 23303910; 23362265; 23613689; 23764002; 23804213; 23902751; 24189400; 24725412; 24860872; 24937142; 25241761; 25852190; 26361740; 26791827; 27147617; 2953725; 7654190; 7702581; 7929371; 8615909; 8665664; 9481670; 9744891,1997-11-01,2019-02-13,2018-03-28,193,X-ray crystallography (2),STRAND 14 22 {ECO:0000244|PDB:2V7O}.; STRAND 26 33 {ECO:0000244|PDB:2V7O}.; STRAND 38 46 {ECO:0000244|PDB:2V7O}.; STRAND 76 81 {ECO:0000244|PDB:2V7O}.; STRAND 83 91 {ECO:0000244|PDB:2V7O}.; STRAND 142 145 {ECO:0000244|PDB:2V7O}.; STRAND 153 155 {ECO:0000244|PDB:2V7O}.; STRAND 453 460 {ECO:0000244|PDB:2UX0}.; STRAND 468 470 {ECO:0000244|PDB:2UX0}.; STRAND 490 501 {ECO:0000244|PDB:2UX0}.; STRAND 506 518 {ECO:0000244|PDB:2UX0}.; STRAND 524 538 {ECO:0000244|PDB:2UX0}.; STRAND 541 550 {ECO:0000244|PDB:2UX0}.,HELIX 9 13 {ECO:0000244|PDB:2V7O}.; HELIX 52 67 {ECO:0000244|PDB:2V7O}.; HELIX 98 103 {ECO:0000244|PDB:2V7O}.; HELIX 110 129 {ECO:0000244|PDB:2V7O}.; HELIX 139 141 {ECO:0000244|PDB:2V7O}.; HELIX 178 180 {ECO:0000244|PDB:2V7O}.; HELIX 183 187 {ECO:0000244|PDB:2V7O}.; HELIX 194 209 {ECO:0000244|PDB:2V7O}.; HELIX 219 227 {ECO:0000244|PDB:2V7O}.; HELIX 237 240 {ECO:0000244|PDB:2V7O}.; HELIX 243 252 {ECO:0000244|PDB:2V7O}.; HELIX 263 266 {ECO:0000244|PDB:2V7O}.; HELIX 270 273 {ECO:0000244|PDB:2V7O}.; HELIX 275 278 {ECO:0000244|PDB:2V7O}.; HELIX 285 301 {ECO:0000244|PDB:2V7O}.; HELIX 425 443 {ECO:0000244|PDB:2UX0}.; HELIX 446 452 {ECO:0000244|PDB:2UX0}.; HELIX 462 464 {ECO:0000244|PDB:2UX0}.; HELIX 471 481 {ECO:0000244|PDB:2UX0}.,TURN 34 37 {ECO:0000244|PDB:2V7O}.; TURN 257 259 {ECO:0000244|PDB:2V7O}.; TURN 482 485 {ECO:0000244|PDB:2UX0}.,,,,,5 out of 5,Active site (1); Alternative sequence (9); Beta strand (13); Binding site (1); Chain (1); Domain (1); Erroneous initiation (1); Helix (19); Modified residue (20); Natural variant (2); Nucleotide binding (1); Region (3); Sequence conflict (1); Turn (3),,TISSUE SPECIFICITY: Expressed in skeletal muscle. {ECO:0000269|PubMed:16690701}.,,3D-structure;ATP-binding;Alternative splicing;Calmodulin-binding;Complete proteome;Developmental protein;Differentiation;Kinase;Membrane;Neurogenesis;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Sarcoplasmic reticulum;Serine/threonine-protein kinase;Transferase,Evidence at protein level,reviewed,,"Protein kinase superfamily, CAMK Ser/Thr protein kinase family, CaMK subfamily",193,Activity regulation (1); Alternative products (1); Catalytic activity (2); Domain (1); Function (1); Induction (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0067; KW-0112; KW-0181; KW-0217; KW-0221; KW-0418; KW-0472; KW-0524; KW-0547; KW-0597; KW-0621; KW-0703; KW-0723; KW-0808; KW-1185,,,,,,,,"PTM: Autophosphorylation of Thr-287 following activation by Ca(2+)/calmodulin. Phosphorylation of Thr-287 locks the kinase into an activated state. {ECO:0000269|PubMed:14722083, ECO:0000269|PubMed:16690701}.",CHAIN 1 558 Calcium/calmodulin-dependent protein kinase type II subunit gamma. /FTId=PRO_0000086101.,,,,,,"MOD_RES 287 287 Phosphothreonine; by autocatalysis. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:16690701}.; MOD_RES 306 306 Phosphothreonine; by autocatalysis. {ECO:0000250}.; MOD_RES 307 307 Phosphothreonine; by autocatalysis. {ECO:0000305}.; MOD_RES 311 311 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231}.; MOD_RES 334 334 Phosphoserine. {ECO:0000250|UniProtKB:P11730}.; MOD_RES 349 349 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 352 352 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195}.; MOD_RES 419 419 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 484 484 Phosphoserine. {ECO:0000250|UniProtKB:P11730}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,CH471083;CH471083;CH471083;BC034044;U66064;AH011636;L07043;U50359;U50360;U32472;U32473;U32509;
0,Q14194,DPYL1_HUMAN,CRMP1 DPYSL1 ULIP3,CRMP1,DPYSL1 ULIP3,,,Homo sapiens (Human),9606,Dihydropyrimidinase-related protein 1 (DRP-1) (Collapsin response mediator protein 1) (CRMP-1) (Unc-33-like phosphoprotein 3) (ULIP-3),UP000005640: Chromosome 4,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSYQGKKSIPHITSDRLLIKGGRIINDDQSLYADVYLEDGLIKQIGENLIVPGGVKTIEANGRMVIPGGIDVNTYLQKPSQGMTAADDFFQGTRAALVGGTTMIIDHVVPEPGSSLLTSFEKWHEAADTKSCCDYSLHVDITSWYDGVREELEVLVQDKGVNSFQVYMAYKDVYQMSDSQLYEAFTFLKGLGAVILVHAENGDLIAQEQKRILEMGITGPEGHALSRPEELEAEAVFRAITIAGRINCPVYITKVMSKSAADIIALARKKGPLVFGEPIAASLGTDGTHYWSKNWAKAAAFVTSPPLSPDPTTPDYLTSLLACGDLQVTGSGHCPYSTAQKAVGKDNFTLIPEGVNGIEERMTVVWDKAVATGKMDENQFVAVTSTNAAKIFNLYPRKGRIAVGSDADVVIWDPDKLKTITAKSHKSAVEYNIFEGMECHGSPLVVISQGKIVFEDGNINVNKGMGRFIPRKAFPEHLYQRVKIRNKVFGLQGVSRGMYDGPVYEVPATPKYATPAPSAKSSPSKHQPPPIRNLHQSNFSLSGAQIDDNNPRRTGHRIVAPPGGRSNITSLG,572,"62,184",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q14194-1; Sequence=Displayed; Name=LCRMP-1; IsoId=Q14194-2; Sequence=VSP_042545; ,,,,,,,,,,VAR_SEQ 1 13 MSYQGKKSIPHIT -> MADRRRAWNTEDDLPVYLARPGSAAQTPRQKYGGMFAAVEGAYENKTIDFDAYSVGRRGSARTPRSAGRPDAVGLPGPGGSEDTASDVSEPSGSAVSSPGERDERPPTLRIRRPAPRDLPLGRDNGQ (in isoform LCRMP-1). {ECO:0000303|PubMed:19362386}. /FTId=VSP_042545.,VARIANT 461 461 V -> I (in dbSNP:rs34611001). /FTId=VAR_037745.,,,,CONFLICT 351 370 Missing (in Ref. 7; AAK55500). {ECO:0000305}.; CONFLICT 504 504 Y -> H (in Ref. 8; AAA93201). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the metallo-dependent hydrolases superfamily. Hydantoinase/dihydropyrimidinase family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, invasive growth and cell migration. May participate in cytokinesis. {ECO:0000269|PubMed:11562390, ECO:0000269|PubMed:19799413}.",,,,,,,,,,,,"centrosome [GO:0005813]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; axon guidance [GO:0007411]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of actin filament binding [GO:1904530]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]",axon guidance [GO:0007411]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of actin filament binding [GO:1904530]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139],"filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]",centrosome [GO:0005813]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],GO:0000226; GO:0005634; GO:0005813; GO:0005819; GO:0005829; GO:0006139; GO:0007399; GO:0007411; GO:0010977; GO:0016810; GO:0030496; GO:0031005; GO:1904530,IPR006680; IPR030624; IPR011778; IPR011059; IPR032466; ,Q9Y2T2; O15169; Q16555; Q14195-2; P42858; P08670,"SUBUNIT: Homotetramer, and heterotetramer with DPYSL2, DPYSL3, DPYSL4 or DPYSL5. Interacts with PLXNA1 (By similarity). {ECO:0000250}.",8973361; 19362386; 15815621; 15489334; 10048489; 7637782; 9375656; 11562390; 19799413,8973361; 19362386; 15815621; 15489334; 10048489; 7637782; 9375656; 11562390; 19799413; 12093729; 12372285; 12482610; 12650609; 14685275; 14996858; 15383276; 15492864; 15652488; 15676027; 16169070; 16611631; 17118363; 17607942; 17607944; 18524846; 18782567; 18847512; 19903856; 20087401; 20379614; 20506281; 21747164; 21900206; 22359051; 22363707; 22798627; 25194153; 25416956; 25526860; 25908449; 26009886; 26032958; 26249678; 26598519; 27321179; 27864146; 28630144; 29666369,1998-07-15,2019-02-13,1996-11-01,184,X-ray crystallography (1),STRAND 16 25 {ECO:0000244|PDB:4B3Z}.; STRAND 30 38 {ECO:0000244|PDB:4B3Z}.; STRAND 41 48 {ECO:0000244|PDB:4B3Z}.; STRAND 53 59 {ECO:0000244|PDB:4B3Z}.; STRAND 64 67 {ECO:0000244|PDB:4B3Z}.; STRAND 69 74 {ECO:0000244|PDB:4B3Z}.; STRAND 101 108 {ECO:0000244|PDB:4B3Z}.; STRAND 132 140 {ECO:0000244|PDB:4B3Z}.; STRAND 163 170 {ECO:0000244|PDB:4B3Z}.; STRAND 194 198 {ECO:0000244|PDB:4B3Z}.; STRAND 250 255 {ECO:0000244|PDB:4B3Z}.; STRAND 274 279 {ECO:0000244|PDB:4B3Z}.; STRAND 409 419 {ECO:0000244|PDB:4B3Z}.; STRAND 426 430 {ECO:0000244|PDB:4B3Z}.; STRAND 438 448 {ECO:0000244|PDB:4B3Z}.; STRAND 451 455 {ECO:0000244|PDB:4B3Z}.,HELIX 89 99 {ECO:0000244|PDB:4B3Z}.; HELIX 116 130 {ECO:0000244|PDB:4B3Z}.; HELIX 148 157 {ECO:0000244|PDB:4B3Z}.; HELIX 178 190 {ECO:0000244|PDB:4B3Z}.; HELIX 202 213 {ECO:0000244|PDB:4B3Z}.; HELIX 221 225 {ECO:0000244|PDB:4B3Z}.; HELIX 229 246 {ECO:0000244|PDB:4B3Z}.; HELIX 258 270 {ECO:0000244|PDB:4B3Z}.; HELIX 280 284 {ECO:0000244|PDB:4B3Z}.; HELIX 288 291 {ECO:0000244|PDB:4B3Z}.; HELIX 295 300 {ECO:0000244|PDB:4B3Z}.; HELIX 313 322 {ECO:0000244|PDB:4B3Z}.; HELIX 338 341 {ECO:0000244|PDB:4B3Z}.; HELIX 342 344 {ECO:0000244|PDB:4B3Z}.; HELIX 348 350 {ECO:0000244|PDB:4B3Z}.; HELIX 361 369 {ECO:0000244|PDB:4B3Z}.; HELIX 377 384 {ECO:0000244|PDB:4B3Z}.; HELIX 386 391 {ECO:0000244|PDB:4B3Z}.; HELIX 476 489 {ECO:0000244|PDB:4B3Z}.,TURN 171 174 {ECO:0000244|PDB:4B3Z}.; TURN 214 216 {ECO:0000244|PDB:4B3Z}.; TURN 358 360 {ECO:0000244|PDB:4B3Z}.; TURN 370 373 {ECO:0000244|PDB:4B3Z}.; TURN 395 397 {ECO:0000244|PDB:4B3Z}.; TURN 433 436 {ECO:0000244|PDB:4B3Z}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (16); Chain (1); Helix (19); Modified residue (11); Mutagenesis (1); Natural variant (1); Sequence conflict (2); Turn (6),CAUTION: Lacks most of the conserved residues that are essential for binding the metal cofactor and hence for dihydropyrimidinase activity. Its enzyme activity is therefore unsure. {ECO:0000305}.,TISSUE SPECIFICITY: Brain.,,3D-structure;Alternative splicing;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Nitration;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,"Metallo-dependent hydrolases superfamily, Hydantoinase/dihydropyrimidinase family",184,Alternative products (1); Caution (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0181; KW-0206; KW-0597; KW-0621; KW-0903; KW-0944; KW-0963; KW-1185,,,,,,,,,CHAIN 1 572 Dihydropyrimidinase-related protein 1. /FTId=PRO_0000165909.,,,,,,MOD_RES 8 8 Phosphoserine. {ECO:0000250|UniProtKB:Q62950}.; MOD_RES 101 101 Phosphothreonine; by AURKA. {ECO:0000269|PubMed:19799413}.; MOD_RES 102 102 Phosphothreonine; by AURKA. {ECO:0000269|PubMed:19799413}.; MOD_RES 316 316 Nitrated tyrosine. {ECO:0000250|UniProtKB:P97427}.; MOD_RES 504 504 Phosphotyrosine. {ECO:0000250|UniProtKB:P97427}.; MOD_RES 509 509 Phosphothreonine. {ECO:0000250|UniProtKB:P97427}.; MOD_RES 521 521 Phosphoserine. {ECO:0000250|UniProtKB:Q62950}.; MOD_RES 522 522 Phosphoserine. {ECO:0000250|UniProtKB:Q62950}.; MOD_RES 537 537 Phosphoserine. {ECO:0000250|UniProtKB:P97427}.; MOD_RES 540 540 Phosphoserine. {ECO:0000250|UniProtKB:P97427}.; MOD_RES 542 542 Phosphoserine. {ECO:0000250|UniProtKB:P97427}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,D78012;DQ206871;BT006806;AC105915;CH471131;CH471131;BC000252;BC007613;AH010780;U17278;
0,Q15139,KPCD1_HUMAN,PRKD1 PKD PKD1 PRKCM,PRKD1,PKD PKD1 PRKCM,,,Homo sapiens (Human),9606,Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu),UP000005640: Chromosome 14,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSAPPVLRPPSPLLPVAAAAAAAAAALVPGSGPGPAPFLAPVAAPVGGISFHLQIGLSREPVLLLQDSSGDYSLAHVREMACSIVDQKFPECGFYGMYDKILLFRHDPTSENILQLVKAASDIQEGDLIEVVLSASATFEDFQIRPHALFVHSYRAPAFCDHCGEMLWGLVRQGLKCEGCGLNYHKRCAFKIPNNCSGVRRRRLSNVSLTGVSTIRTSSAELSTSAPDEPLLQKSPSESFIGREKRSNSQSYIGRPIHLDKILMSKVKVPHTFVIHSYTRPTVCQYCKKLLKGLFRQGLQCKDCRFNCHKRCAPKVPNNCLGEVTINGDLLSPGAESDVVMEEGSDDNDSERNSGLMDDMEEAMVQDAEMAMAECQNDSGEMQDPDPDHEDANRTISPSTSNNIPLMRVVQSVKHTKRKSSTVMKEGWMVHYTSKDTLRKRHYWRLDSKCITLFQNDTGSRYYKEIPLSEILSLEPVKTSALIPNGANPHCFEITTANVVYYVGENVVNPSSPSPNNSVLTSGVGADVARMWEIAIQHALMPVIPKGSSVGTGTNLHRDISVSISVSNCQIQENVDISTVYQIFPDEVLGSGQFGIVYGGKHRKTGRDVAIKIIDKLRFPTKQESQLRNEVAILQNLHHPGVVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPEHITKFLITQILVALRHLHFKNIVHCDLKPENVLLASADPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIHDQIQNAAFMYPPNPWKEISHEAIDLINNLLQVKMRKRYSVDKTLSHPWLQDYQTWLDLRELECKIGERYITHESDDLRWEKYAGEQGLQYPTHLINPSASHSDTPETEETEMKALGERVSIL,912,"101,704",,,,,,,,,,,,,VARIANT 152 152 H -> Y (in a colorectal cancer sample; somatic mutation; dbSNP:rs1383618278). {ECO:0000269|PubMed:16959974}. /FTId=VAR_035468.; VARIANT 225 225 S -> P. {ECO:0000269|PubMed:17344846}. /FTId=VAR_042324.; VARIANT 299 299 L -> W (in CHDED; dbSNP:rs1057519636). {ECO:0000269|PubMed:27479907}. /FTId=VAR_078602.; VARIANT 478 478 K -> Q (in dbSNP:rs55852813). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042325.; VARIANT 585 585 P -> S (in a metastatic melanoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042326.; VARIANT 592 592 G -> R (in CHDED; dbSNP:rs1057519635). {ECO:0000269|PubMed:27479907}. /FTId=VAR_078603.; VARIANT 677 677 R -> M (in a lung bronchoalveolar carcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042327.; VARIANT 679 679 P -> L (in dbSNP:rs34588699). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042328.; VARIANT 825 825 R -> K (in dbSNP:rs11161065). /FTId=VAR_046988.; VARIANT 857 857 E -> K (in a colorectal cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_035469.; VARIANT 891 891 H -> R (in dbSNP:rs45582934). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042329.,,,,CONFLICT 135 135 A -> R (in Ref. 1; CAA53384). {ECO:0000305}.; CONFLICT 877 877 G -> R (in Ref. 1; CAA53384). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. PKD subfamily. {ECO:0000305}.,,COMPBIAS 17 26 Poly-Ala.; COMPBIAS 200 203 Poly-Arg.,DOMAIN 422 541 PH. {ECO:0000255|PROSITE-ProRule:PRU00145}.; DOMAIN 583 839 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,,ZN_FING 146 196 Phorbol-ester/DAG-type 1. {ECO:0000255|PROSITE-ProRule:PRU00226}.; ZN_FING 270 320 Phorbol-ester/DAG-type 2. {ECO:0000255|PROSITE-ProRule:PRU00226}.,2.7.11.13,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.13;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ,,"FUNCTION: Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of MAPK8/JNK1 and Ras signaling, Golgi membrane integrity and trafficking, cell survival through NF-kappa-B activation, cell migration, cell differentiation by mediating HDAC7 nuclear export, cell proliferation via MAPK1/3 (ERK1/2) signaling, and plays a role in cardiac hypertrophy, VEGFA-induced angiogenesis, genotoxic-induced apoptosis and flagellin-stimulated inflammatory response. Phosphorylates the epidermal growth factor receptor (EGFR) on dual threonine residues, which leads to the suppression of epidermal growth factor (EGF)-induced MAPK8/JNK1 activation and subsequent JUN phosphorylation. Phosphorylates RIN1, inducing RIN1 binding to 14-3-3 proteins YWHAB, YWHAE and YWHAZ and increased competition with RAF1 for binding to GTP-bound form of Ras proteins (NRAS, HRAS and KRAS). Acts downstream of the heterotrimeric G-protein beta/gamma-subunit complex to maintain the structural integrity of the Golgi membranes, and is required for protein transport along the secretory pathway. In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane. May act by activating the lipid kinase phosphatidylinositol 4-kinase beta (PI4KB) at the TGN for the local synthesis of phosphorylated inositol lipids, which induces a sequential production of DAG, phosphatidic acid (PA) and lyso-PA (LPA) that are necessary for membrane fission and generation of specific transport carriers to the cell surface. Under oxidative stress, is phosphorylated at Tyr-463 via SRC-ABL1 and contributes to cell survival by activating IKK complex and subsequent nuclear translocation and activation of NFKB1. Involved in cell migration by regulating integrin alpha-5/beta-3 recycling and promoting its recruitment in newly forming focal adhesion. In osteoblast differentiation, mediates the bone morphogenetic protein 2 (BMP2)-induced nuclear export of HDAC7, which results in the inhibition of HDAC7 transcriptional repression of RUNX2. In neurons, plays an important role in neuronal polarity by regulating the biogenesis of TGN-derived dendritic vesicles, and is involved in the maintenance of dendritic arborization and Golgi structure in hippocampal cells. May potentiate mitogenesis induced by the neuropeptide bombesin or vasopressin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression. Plays an important role in the proliferative response induced by low calcium in keratinocytes, through sustained activation of MAPK1/3 (ERK1/2) pathway. Downstream of novel PKC signaling, plays a role in cardiac hypertrophy by phosphorylating HDAC5, which in turn triggers XPO1/CRM1-dependent nuclear export of HDAC5, MEF2A transcriptional activation and induction of downstream target genes that promote myocyte hypertrophy and pathological cardiac remodeling. Mediates cardiac troponin I (TNNI3) phosphorylation at the PKA sites, which results in reduced myofilament calcium sensitivity, and accelerated crossbridge cycling kinetics. The PRKD1-HDAC5 pathway is also involved in angiogenesis by mediating VEGFA-induced specific subset of gene expression, cell migration, and tube formation. In response to VEGFA, is necessary and required for HDAC7 phosphorylation which induces HDAC7 nuclear export and endothelial cell proliferation and migration. During apoptosis induced by cytarabine and other genotoxic agents, PRKD1 is cleaved by caspase-3 at Asp-378, resulting in activation of its kinase function and increased sensitivity of cells to the cytotoxic effects of genotoxic agents. In epithelial cells, is required for transducing flagellin-stimulated inflammatory responses by binding and phosphorylating TLR5, which contributes to MAPK14/p38 activation and production of inflammatory cytokines. May play a role in inflammatory response by mediating activation of NF-kappa-B. May be involved in pain transmission by directly modulating TRPV1 receptor. Plays a role in activated KRAS-mediated stabilization of ZNF304 in colorectal cancer (CRC) cells (PubMed:24623306). Regulates nuclear translocation of transcription factor TFEB in macrophages upon live S.enterica infection (By similarity). {ECO:0000250|UniProtKB:Q62101, ECO:0000269|PubMed:10523301, ECO:0000269|PubMed:10764790, ECO:0000269|PubMed:12505989, ECO:0000269|PubMed:12637538, ECO:0000269|PubMed:15471852, ECO:0000269|PubMed:17442957, ECO:0000269|PubMed:18332134, ECO:0000269|PubMed:18509061, ECO:0000269|PubMed:19135240, ECO:0000269|PubMed:19211839, ECO:0000269|PubMed:24623306}.",,,,,,"ACT_SITE 706 706 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 612 612 ATP.,,,NP_BIND 589 597 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; negative regulation of endocytosis [GO:0045806]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of integrin-mediated signaling pathway [GO:2001044]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; negative regulation of endocytosis [GO:0045806]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of integrin-mediated signaling pathway [GO:2001044]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674],autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],GO:0000421; GO:0001525; GO:0001938; GO:0004674; GO:0004697; GO:0005524; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0006954; GO:0007030; GO:0007165; GO:0007229; GO:0007265; GO:0008283; GO:0010508; GO:0010595; GO:0010837; GO:0010976; GO:0016301; GO:0018105; GO:0018107; GO:0030148; GO:0031647; GO:0032793; GO:0033138; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0038033; GO:0042802; GO:0043123; GO:0043536; GO:0043552; GO:0045087; GO:0045669; GO:0045766; GO:0045806; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0048193; GO:0051092; GO:0060548; GO:0071447; GO:0089700; GO:1901727; GO:2001028; GO:2001044,IPR020454; IPR011009; IPR002219; IPR011993; IPR001849; IPR000719; IPR017441; IPR015727; IPR008271; ,Itself; Q07021; P12830; Q8C2B3-1; P08238; O15264; P02795,"SUBUNIT: Interacts (via N-terminus) with ADAP1/CENTA1 (PubMed:12893243). Interacts with MAPK13 (PubMed:19135240). Interacts with DAPK1 in an oxidative stress-regulated manner (PubMed:17703233). Interacts with USP28; the interaction induces phosphorylation of USP28 and activated KRAS-mediated stabilization of ZNF304 (PubMed:24623306). Interacts with AKAP13 (via C-terminal domain) (By similarity). {ECO:0000250|UniProtKB:Q62101, ECO:0000269|PubMed:12893243, ECO:0000269|PubMed:17703233, ECO:0000269|PubMed:19135240, ECO:0000269|PubMed:24623306}.",8119958; 14702039; 12508121; 10523301; 10764790; 12893243; 12505989; 12637538; 15471852; 15024053; 17703233; 17804414; 17442957; 18076381; 18332134; 18509061; 19413330; 19135240; 19211839; 11978539; 15701647; 18239146; 19369195; 19655095; 21357900; 21406692; 24623306; 16959974; 17344846; 27479907,8119958; 14702039; 12508121; 10523301; 10764790; 12893243; 12505989; 12637538; 15471852; 15024053; 17703233; 17804414; 17442957; 18076381; 18332134; 18509061; 19413330; 19135240; 19211839; 11978539; 15701647; 18239146; 19369195; 19655095; 21357900; 21406692; 24623306; 16959974; 17344846; 27479907; 10831594; 11401472; 11741879; 11903052; 11948398; 12393506; 12628923; 12646240; 12778467; 12859948; 14550308; 14607845; 14743217; 15093611; 15123666; 15226414; 15383279; 15695390; 15728188; 15755722; 16006559; 16166634; 16563698; 16891660; 17389598; 17492941; 17570131; 17591919; 17635916; 17979146; 18259765; 18337243; 18440775; 18602367; 18641342; 18692497; 18694729; 18703509; 18829454; 19011111; 19029298; 19173301; 19176759; 19243594; 19258390; 19329994; 19416469; 19458088; 19548982; 19567672; 19581308; 19767773; 19794144; 20160036; 20363754; 20444975; 20477989; 20621130; 20677014; 20857418; 20940406; 21087603; 21148796; 21189263; 21209314; 21292998; 21680539; 21726532; 21832093; 21848513; 21993564; 21996340; 22095288; 22100296; 22188925; 22217708; 22226883; 22228765; 22245102; 22260707; 22276203; 22664730; 22791710; 22855295; 22939624; 22975325; 23148218; 23178798; 23621299; 23688773; 23846685; 23926335; 23950933; 23971832; 24336522; 24606918; 24806360; 24828530; 24942367; 25000413; 25149539; 25240283; 25445362; 25713110; 25889812; 26253275; 26304723; 26338704; 26426580; 26584860; 26895471; 27013613; 27053111; 27255895; 27649783; 27662904; 28032559; 28049203; 28160554; 28360038; 29901206,1997-11-01,2019-02-13,2008-10-14,193,,,,,,,,,5 out of 5,Active site (1); Binding site (1); Chain (1); Compositional bias (2); Domain (2); Modified residue (18); Mutagenesis (9); Natural variant (11); Nucleotide binding (1); Sequence conflict (2); Zinc finger (2),,,,ATP-binding;Angiogenesis;Apoptosis;Cell membrane;Complete proteome;Cytoplasm;Differentiation;Disease mutation;Ectodermal dysplasia;Golgi apparatus;Immunity;Inflammatory response;Innate immunity;Kinase;Magnesium;Membrane;Metal-binding;Neurogenesis;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase;Zinc;Zinc-finger,Evidence at protein level,reviewed,,"Protein kinase superfamily, CAMK Ser/Thr protein kinase family, PKD subfamily",193,Activity regulation (1); Catalytic activity (2); Cofactor (1); Function (1); Induction (1); Involvement in disease (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0037; KW-0038; KW-0053; KW-0067; KW-0181; KW-0221; KW-0225; KW-0333; KW-0391; KW-0395; KW-0399; KW-0418; KW-0460; KW-0472; KW-0479; KW-0524; KW-0547; KW-0597; KW-0621; KW-0677; KW-0723; KW-0808; KW-0862; KW-0863; KW-0963; KW-1003; KW-1185,,,,,"DISEASE: Congenital heart defects and ectodermal dysplasia (CHDED) [MIM:617364]: An autosomal dominant syndrome characterized by atrial and/or ventricular septal congenital heart defects and variable features of ectodermal dysplasia, including sparse hair, dry skin, thin skin, fragile nails, premature loss of primary teeth, and small widely spaced teeth. Patients manifest developmental disabilities ranging from motor delay and delayed speech to global developmental retardation. {ECO:0000269|PubMed:27479907}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Phosphorylated at Ser-397 and Ser-401 by MAPK13 during regulation of insulin secretion in pancreatic beta cells (PubMed:19135240). Phosphorylated by DAPK1 (PubMed:17703233). Phosphorylated at Tyr-95 and by ABL at Tyr-463, which primes the kinase in response to oxidative stress, and promotes a second step activating phosphorylation at Ser-738/Ser-742 by PKRD (PubMed:12637538, PubMed:15024053, PubMed:17804414). Phosphorylated on Ser-910 upon S.enterica infection in macrophages (By similarity). {ECO:0000250|UniProtKB:Q62101, ECO:0000269|PubMed:12637538, ECO:0000269|PubMed:15024053, ECO:0000269|PubMed:17703233, ECO:0000269|PubMed:17804414, ECO:0000269|PubMed:19135240}.",CHAIN 1 912 Serine/threonine-protein kinase D1. /FTId=PRO_0000055714.,,,,,,"MOD_RES 95 95 Phosphotyrosine. {ECO:0000269|PubMed:17804414}.; MOD_RES 205 205 Phosphoserine. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:21406692}.; MOD_RES 208 208 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 219 219 Phosphoserine. {ECO:0000250|UniProtKB:Q8BZ03}.; MOD_RES 223 223 Phosphoserine. {ECO:0000250|UniProtKB:Q9BZL6}.; MOD_RES 345 345 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 397 397 Phosphoserine; by MAPK13. {ECO:0000269|PubMed:19135240}.; MOD_RES 401 401 Phosphoserine; by MAPK13. {ECO:0000269|PubMed:19135240}.; MOD_RES 432 432 Phosphotyrosine. {ECO:0000269|PubMed:12637538}.; MOD_RES 448 448 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 463 463 Phosphotyrosine; by ABL. {ECO:0000269|PubMed:12637538, ECO:0000269|PubMed:15024053}.; MOD_RES 473 473 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 502 502 Phosphotyrosine. {ECO:0000269|PubMed:12637538}.; MOD_RES 548 548 Phosphoserine. {ECO:0000250|UniProtKB:Q8K1Y2}.; MOD_RES 738 738 Phosphoserine; by PKC/PRKCD. {ECO:0000269|PubMed:15024053}.; MOD_RES 742 742 Phosphoserine; by autocatalysis and PKC/PRKCD. {ECO:0000269|PubMed:15024053}.; MOD_RES 749 749 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9BZL6}.; MOD_RES 910 910 Phosphoserine; by autocatalysis. {ECO:0000269|PubMed:17703233}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X75756;AK314170;CH471078;
0,Q16181,SEPT7_HUMAN,SEPT7 CDC10,SEPT7,CDC10,,,Homo sapiens (Human),9606,Septin-7 (CDC10 protein homolog),UP000005640: Chromosome 7,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSVSARSAAAEERSVNSSTMVAQQKNLEGYVGFANLPNQVYRKSVKRGFEFTLMVVGESGLGKSTLINSLFLTDLYSPEYPGPSHRIKKTVQVEQSKVLIKEGGVQLLLTIVDTPGFGDAVDNSNCWQPVIDYIDSKFEDYLNAESRVNRRQMPDNRVQCCLYFIAPSGHGLKPLDIEFMKRLHEKVNIIPLIAKADTLTPEECQQFKKQIMKEIQEHKIKIYEFPETDDEEENKLVKKIKDRLPLAVVGSNTIIEVNGKRVRGRQYPWGVAEVENGEHCDFTILRNMLIRTHMQDLKDVTNNVHYENYRSRKLAAVTYNGVDNNKNKGQLTKSPLAQMEEERREHVAKMKKMEMEMEQVFEMKVKEKVQKLKDSEAELQRRHEQMKKNLEAQHKELEEKRRQFEDEKANWEAQQRILEQQNSSRTLEKNKKKGKIF,437,"50,680",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q16181-1; Sequence=Displayed; Name=2; IsoId=Q16181-2; Sequence=VSP_022202; ,,SEQUENCE CAUTION:  Sequence=AAB31337.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=AAH67264.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=AAH93640.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=AAH93642.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 21 21 Missing (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_022202.,,,,,CONFLICT 271 271 V -> I (in Ref. 1; AAB31337). {ECO:0000305}.; CONFLICT 289 289 L -> K (in Ref. 1; AAB31337). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like GTPase superfamily. Septin GTPase family. {ECO:0000255|PROSITE-ProRule:PRU01056}.,COILED 332 437 {ECO:0000255}.,,DOMAIN 47 316 Septin-type G. {ECO:0000255|PROSITE-ProRule:PRU01056}.,,REGION 47 317 Interaction with SEPT12. {ECO:0000269|PubMed:25588830}.; REGION 57 64 G1 motif. {ECO:0000255|PROSITE-ProRule:PRU01056}.; REGION 113 116 G3 motif. {ECO:0000255|PROSITE-ProRule:PRU01056}.; REGION 194 197 G4 motif. {ECO:0000255|PROSITE-ProRule:PRU01056}.,,,,,,,,"FUNCTION: Filament-forming cytoskeletal GTPase. Required for normal organization of the actin cytoskeleton. Required for normal progress through mitosis. Involved in cytokinesis. Required for normal association of CENPE with the kinetochore. Plays a role in ciliogenesis and collective cell movements. Forms a filamentous structure with SEPT12, SEPT6, SEPT2 and probably SEPT4 at the sperm annulus which is required for the structural integrity and motility of the sperm tail during postmeiotic differentiation (PubMed:25588830). {ECO:0000269|PubMed:17803907, ECO:0000269|PubMed:18460473, ECO:0000305|PubMed:25588830}.",,,,,,,BINDING 90 90 GTP. {ECO:0000250}.; BINDING 116 116 GTP; via amide nitrogen. {ECO:0000250}.; BINDING 250 250 GTP; via amide nitrogen and carbonyl oxygen. {ECO:0000250}.; BINDING 265 265 GTP. {ECO:0000250}.,,,NP_BIND 57 64 GTP.; NP_BIND 195 203 GTP. {ECO:0000250}.,,axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein-containing complex scaffold activity [GO:0032947]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; protein heterooligomerization [GO:0051291]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; protein heterooligomerization [GO:0051291]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],cadherin binding [GO:0045296]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein-containing complex scaffold activity [GO:0032947]; structural molecule activity [GO:0005198],axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725],GO:0000777; GO:0001725; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005819; GO:0005829; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016476; GO:0030154; GO:0030336; GO:0030496; GO:0031105; GO:0032154; GO:0032947; GO:0042802; GO:0043065; GO:0045296; GO:0051291; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730; GO:1902857; GO:2000134,IPR030379; IPR027417; IPR016491; IPR008115; ,Itself; Q04864; B5ME97; Q9P0V9; Q8IYM1; Q14141,"SUBUNIT: Septins polymerize into heterooligomeric protein complexes that form filaments, and associate with cellular membranes, actin filaments and microtubules. GTPase activity is required for filament formation. Filaments are assembled from asymmetrical heterotrimers, composed of SEPT2, SEPT6 and SEPT7 that associate head-to-head to form a hexameric unit. Within the trimer, directly interacts with SEPT6, while interaction with SEPT2 seems indirect. In the absence of SEPT6, forms homodimers. Interacts directly with CENPE and links CENPE to septin filaments composed of SEPT2, SEPT6 and SEPT7. Interacts with SEPT5 and SEPT8 (By similarity). Interacts with SEPT9 and SEPT11. Component of a septin core octomeric complex consisting of SEPT12, SEPT7, SEPT6 and SEPT2 or SEPT4 in the order 12-7-6-2-2-6-7-12 or 12-7-6-4-4-6-7-12 and located in the sperm annulus; the SEPT12:SEPT7 association is mediated by the respective GTP-binding domains (PubMed:25588830). {ECO:0000250, ECO:0000269|PubMed:15485874, ECO:0000269|PubMed:16914550, ECO:0000269|PubMed:17637674, ECO:0000269|PubMed:18460473, ECO:0000269|PubMed:19145258, ECO:0000269|PubMed:25588830}.",8037772; 15489334; 15485874; 15915442; 16093351; 15592455; 17081983; 16914550; 17803907; 18460473; 18669648; 19413330; 19145258; 20068231; 21269460; 23186163; 24275569; 25588830; 25944712; 17637674,8037772; 15489334; 15485874; 15915442; 16093351; 15592455; 17081983; 16914550; 17803907; 18460473; 18669648; 19413330; 19145258; 20068231; 21269460; 23186163; 24275569; 25588830; 25944712; 17637674; 11584266; 16371649; 17500595; 17922164; 18543212; 19367725; 19426592; 19463016; 19916744; 20035367; 20352323; 20379614; 20385374; 20467437; 20711500; 21082023; 21509594; 21767235; 21788367; 21824007; 21851590; 22064074; 22508986; 22623428; 22956766; 23383034; 23416715; 23572511; 23902751; 24055994; 24345743; 24685401; 25380047; 26496610; 26752685; 26846171; 27006177; 27557506; 29051266; 29344665; 29568931; 29699512,1997-11-01,2019-02-13,2005-05-10,182,X-ray crystallography (3),STRAND 50 57 {ECO:0000244|PDB:3T5D}.; STRAND 71 73 {ECO:0000244|PDB:3T5D}.; STRAND 94 100 {ECO:0000244|PDB:3T5D}.; STRAND 107 113 {ECO:0000244|PDB:3T5D}.; STRAND 147 149 {ECO:0000244|PDB:3TW4}.; STRAND 160 165 {ECO:0000244|PDB:3T5D}.; STRAND 189 195 {ECO:0000244|PDB:3T5D}.; STRAND 245 247 {ECO:0000244|PDB:3T5D}.; STRAND 264 266 {ECO:0000244|PDB:3T5D}.; STRAND 271 275 {ECO:0000244|PDB:3T5D}.,HELIX 63 70 {ECO:0000244|PDB:3T5D}.; HELIX 128 146 {ECO:0000244|PDB:3T5D}.; HELIX 174 183 {ECO:0000244|PDB:3T5D}.; HELIX 196 198 {ECO:0000244|PDB:3T5D}.; HELIX 201 217 {ECO:0000244|PDB:3T5D}.; HELIX 238 242 {ECO:0000244|PDB:3T5D}.; HELIX 282 290 {ECO:0000244|PDB:3T5D}.; HELIX 294 303 {ECO:0000244|PDB:3T5D}.; HELIX 305 315 {ECO:0000244|PDB:3T5D}.,TURN 124 127 {ECO:0000244|PDB:3T5D}.; TURN 184 186 {ECO:0000244|PDB:3T5D}.; TURN 277 279 {ECO:0000244|PDB:3T5D}.; TURN 291 293 {ECO:0000244|PDB:3T5D}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (10); Binding site (4); Chain (1); Coiled coil (1); Domain (1); Erroneous initiation (4); Helix (9); Initiator methionine (1); Modified residue (8); Nucleotide binding (2); Region (4); Sequence conflict (2); Turn (4),,TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:15915442}.,MISCELLANEOUS: Coordinated expression with SEPT2 and SEPT6.,3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Cell projection;Centromere;Chromosome;Cilium;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Differentiation;Flagellum;GTP-binding;Kinetochore;Mitosis;Nucleotide-binding;Phosphoprotein;Reference proteome;Spermatogenesis,Evidence at protein level,reviewed,,"TRAFAC class TrmE-Era-EngA-EngB-Septin-like GTPase superfamily, Septin GTPase family",182,Alternative products (1); Function (1); Miscellaneous (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0131; KW-0132; KW-0137; KW-0158; KW-0175; KW-0181; KW-0206; KW-0221; KW-0282; KW-0342; KW-0498; KW-0547; KW-0597; KW-0744; KW-0963; KW-0966; KW-0969; KW-0995; KW-1185,,,,,,,,,CHAIN 2 437 Septin-7. /FTId=PRO_0000173528.,,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330}.,,"MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:19413330}.; MOD_RES 30 30 Phosphotyrosine. {ECO:0000250|UniProtKB:O55131}.; MOD_RES 77 77 Phosphoserine. {ECO:0000250|UniProtKB:O55131}.; MOD_RES 228 228 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 334 334 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 373 373 N6-acetyllysine. {ECO:0000250|UniProtKB:O55131}.; MOD_RES 424 424 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 426 426 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,S72008;BC067264;BC093640;BC093642;
0,Q1MSJ5,CSPP1_HUMAN,CSPP1 CSPP,CSPP1,CSPP,,,Homo sapiens (Human),9606,Centrosome and spindle pole-associated protein 1,UP000005640: Chromosome 8,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MLFPLQVAAVTSSVRDDPLEHCVSPRTRARSPEICKMADNLDEFIEEQKARLAEDKAELESDPPYMEMKGKLSAKLSENSKILISMAKENIPPNSQQTRGSLGIDYGLSLPLGEDYERKKHKLKEELRQDYRRYLTQGITQGKRKKNFLSTSETDPSTLGVSLPIGERLSAKERLKLERNKEYNQFLRGKEESSEKFRQVEKSTEPKSQRNKKPIGQVKPDLTSQIQTSCENSEGPRKDVLTPSEAYEELLNQRRLEEDRYRQLDDEIELRNRRIIKKANEEVGISNLKHQRFASKAGIPDRRFHRFNEDRVFDRRYHRPDQDPEVSEEMDERFRYESDFDRRLSRVYTNDRMHRNKRGNMPPMEHDGDVIEQSNIRISSAENKSAPDNETSKSANQDTCSPFAGMLFGGEDRELIQRRKEKYRLELLEQMAEQQRNKRREKDLELRVAASGAQDPEKSPDRLKQFSVAPRHFEEMIPPERPRIAFQTPLPPLSAPSVPPIPSVHPVPSQNEDLRSGLSSALGEMVSPRIAPLPPPPLLPPLATNYRTPYDDAYYFYGSRNTFDPSLAYYGSGMMGVQPAAYVSAPVTHQLAQPVVNTVGQNELKITSDQVINSGLIFEDKPKPSKQSLQSYQEALQQQIREREERRKKEREEKEEYEAKLEAEMRTYNPWGKGGGGAPLRDAKGNLITDLNRMHRQNIDAYHNPDARTYEDKRAVVSLDPNLATSNAENLEDAANKSSGHMQTQSSPFARGNVFGEPPTELQIKQQELYKNFLRFQIEEKKQREEAERERLRIAEEKEERRLAEQRARIQQEYEEEQEKKREKEEEQRLKNEEHIRLAEERQKEAERKKKEEEEKYNLQLQHYCERDNLIGEETKHMRQPSPIVPALQNKIASKLQRPPSVDSIIRSFIHESSMSRAQSPPVPARKNQLRAEEEKKNVIMELSEMRKQLRSEERRLQERLLHMDSDDEIPIRKKERNPMDIFDMARHRLQAPVRRQSPKGLDAATFQNVHDFNELKDRDSETRVDLKFMYLDPPRDHHTLEIQQQALLREQQKRLNRIKMQEGAKVDLDAIPSAKVREQRMPRDDTSDFLKNSLLESDSAFIGAYGETYPAIEDDVLPPPSQLPSARERRRNKWKGLDIDSSRPNVAPDGLSLKSISSVNVDELRVRNEERMRRLNEFHNKPINTDDESSLVDPDDIMKHIGDDGSNSVATEPWLRPGTSETLKRFMAEQLNQEQQQIPGKPGTFTWQGLSTAHG,1256,"145,522",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=3; IsoId=Q1MSJ5-3; Sequence=Displayed; Note=No experimental confirmation available. {ECO:0000305}; Name=1; Synonyms=CSPP-L; IsoId=Q1MSJ5-1; Sequence=VSP_040072; Name=2; Synonyms=CSPP, CSPP-S; IsoId=Q1MSJ5-2; Sequence=VSP_026475, VSP_026476; ",,SEQUENCE CAUTION:  Sequence=AAH22867.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 1 329 Missing (in isoform 2). {ECO:0000303|PubMed:15580290}. /FTId=VSP_026475.; VAR_SEQ 138 172 Missing (in isoform 1). {ECO:0000303|PubMed:16826565}. /FTId=VSP_040072.; VAR_SEQ 689 740 TDLNRMHRQNIDAYHNPDARTYEDKRAVVSLDPNLATSNAENLEDAANKSSG -> S (in isoform 2). {ECO:0000303|PubMed:15580290}. /FTId=VSP_026476.,VARIANT 907 907 R -> H (in dbSNP:rs16933182). {ECO:0000269|PubMed:15489334}. /FTId=VAR_033045.; VARIANT 1135 1135 W -> R (in dbSNP:rs1808140). {ECO:0000269|PubMed:15489334}. /FTId=VAR_047014.,,,,CONFLICT 855 855 E -> G (in Ref. 1; CAE47426 and 2; CAJ42307). {ECO:0000305}.; CONFLICT 860 860 Q -> E (in Ref. 5; AAH22867). {ECO:0000305}.; CONFLICT 905 905 I -> T (in Ref. 1; CAE47426 and 2; CAJ42307). {ECO:0000305}.; CONFLICT 955 955 R -> K (in Ref. 1; CAE47426 and 2; CAJ42307). {ECO:0000305}.,,4,,0,,,COILED 38 62 {ECO:0000255}.; COILED 114 135 {ECO:0000255}.; COILED 244 270 {ECO:0000255}.; COILED 417 449 {ECO:0000255}.; COILED 625 669 {ECO:0000255}.; COILED 925 964 {ECO:0000255}.,COMPBIAS 478 541 Pro-rich.; COMPBIAS 672 677 Poly-Gly.; COMPBIAS 779 855 Glu-rich.,,,,,,,,,,,FUNCTION: May play a role in cell-cycle-dependent microtubule organization. {ECO:0000269|PubMed:16826565}.,,,,,,,,,,,,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467],positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467],,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922],GO:0000922; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0032467; GO:0051781,IPR026708; ,Q08379; Q96HT8; Q6NUQ1; Q96KN7,SUBUNIT: Interacts with PLEKHG6. {ECO:0000250}.,15580290; 16826565; 16421571; 14702039; 15489334; 18669648; 19690332; 20068231; 23186163; 24360808; 24360803; 24360807,15580290; 16826565; 16421571; 14702039; 15489334; 18669648; 19690332; 20068231; 23186163; 24360808; 24360803; 24360807; 21150319; 24255178; 26638075,2007-07-10,2019-02-13,2010-11-30,108,,,,,,,,,5 out of 5,Alternative sequence (3); Chain (1); Coiled coil (6); Compositional bias (3); Erroneous initiation (1); Modified residue (6); Natural variant (2); Sequence conflict (7),,"TISSUE SPECIFICITY: Expressed in adult and fetal brain with enrichment in the cerebellum. Detected in testis. {ECO:0000269|PubMed:15580290, ECO:0000269|PubMed:24360807}.",,Alternative splicing;Ciliopathy;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Joubert syndrome;Microtubule;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,,108,Alternative products (1); Caution (1); Developmental stage (1); Function (1); Involvement in disease (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0175; KW-0181; KW-0206; KW-0493; KW-0597; KW-0621; KW-0963; KW-0979; KW-1185; KW-1186,,,,,"DISEASE: Joubert syndrome 21 (JBTS21) [MIM:615636]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly. {ECO:0000269|PubMed:24360803, ECO:0000269|PubMed:24360807, ECO:0000269|PubMed:24360808}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: Phosphorylated. Phosphorylation increases in colcemide-treated cells. {ECO:0000269|PubMed:15580290}.,CHAIN 1 1256 Centrosome and spindle pole-associated protein 1. /FTId=PRO_0000293464.,,,,,,"MOD_RES 244 244 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 459 459 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 527 527 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 901 901 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 920 920 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 966 966 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AJ583433;AM156947;BC022867;BC152993;
0,Q3KR16,PKHG6_HUMAN,PLEKHG6,PLEKHG6,,,,Homo sapiens (Human),9606,Pleckstrin homology domain-containing family G member 6 (PH domain-containing family G member 6) (Myosin-interacting guanine nucleotide exchange factor) (MyoGEF),UP000005640: Chromosome 12,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MKAFGPPHEGPLQGLVASRIETYGGRHRASAQSTAGRLYPRGYPVLDPSRRRLQQYVPFARGSGQARGLSPMRLRDPEPEKRHGGHVGAGLLHSPKLKELTKAHELEVRLHTFSMFGMPRLPPEDRRHWEIGEGGDSGLTIEKSWRELVPGHKEMSQELCHQQEALWELLTTELIYVRKLKIMTDLLAAGLLNLQRVGLLMEVSAETLFGNVPSLIRTHRSFWDEVLGPTLEETRASGQPLDPIGLQSGFLTFGQRFHPYVQYCLRVKQTMAYAREQQETNPLFHAFVQWCEKHKRSGRQMLCDLLIKPHQRITKYPLLLHAVLKRSPEARAQEALNAMIEAVESFLRHINGQVRQGEEQESLAAAAQRIGPYEVLEPPSDEVEKNLRPFSTLDLTSPMLGVASEHTRQLLLEGPVRVKEGREGKLDVYLFLFSDVLLVTKPQRKADKAKVIRPPLMLEKLVCQPLRDPNSFLLIHLTEFQCVSSALLVHCPSPTDRAQWLEKTQQAQAALQKLKAEEYVQQKRELLTLYRDQDRESPSTRPSTPSLEGSQSSAEGRTPEFSTIIPHLVVTEDTDEDAPLVPDDTSDSGYGTLIPGTPTGSRSPLSRLRQRALRRDPRLTFSTLELRDIPLRPHPPDPQAPQRRSAPELPEGILKGGSLPQEDPPTWSEEEDGASERGNVVVETLHRARLRGQLPSSPTHADSAGESPWESSGEEEEEGPLFLKAGHTSLRPMRAEDMLREIREELASQRIEGAEEPRDSRPRKLTRAQLQRMRGPHIIQLDTPLSASEV,790,"88,960",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=Q3KR16-1; Sequence=Displayed; Name=2; IsoId=Q3KR16-2; Sequence=VSP_028857; Note=No experimental confirmation available.; Name=3; IsoId=Q3KR16-3; Sequence=VSP_028856, VSP_028858; Note=No experimental confirmation available.; ",,,,,,,,,,VAR_SEQ 1 470 Missing (in isoform 3). {ECO:0000303|PubMed:15498874}. /FTId=VSP_028856.; VAR_SEQ 1 46 MKAFGPPHEGPLQGLVASRIETYGGRHRASAQSTAGRLYPRGYPVL -> MGCRLHAPGEKAAH (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_028857.; VAR_SEQ 471 508 SFLLIHLTEFQCVSSALLVHCPSPTDRAQWLEKTQQAQ -> MCPREGGRASTIHQKTEKAFGQLLCQPLGEPKIQHPLK (in isoform 3). {ECO:0000303|PubMed:15498874}. /FTId=VSP_028858.,"VARIANT 35 35 A -> T (in dbSNP:rs740842). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334}. /FTId=VAR_036710.",,,,CONFLICT 384 384 E -> G (in Ref. 5; AAI04752). {ECO:0000305}.; CONFLICT 459 459 E -> D (in Ref. 1; BAA91741). {ECO:0000305}.,,3,,0,,,,COMPBIAS 364 367 Poly-Ala.; COMPBIAS 714 718 Poly-Glu.,DOMAIN 161 353 DH. {ECO:0000255|PROSITE-ProRule:PRU00062}.; DOMAIN 409 509 PH. {ECO:0000255|PROSITE-ProRule:PRU00145}.,,,,,,,,,,"FUNCTION: Guanine nucleotide exchange factor activating the small GTPase RHOA, which, in turn, induces myosin filament formation. Also activates RHOG. Does not activate RAC1, or to a much lower extent than RHOA and RHOG. Part of a functional unit, involving PLEKHG6, MYH10 and RHOA, at the cleavage furrow to advance furrow ingression during cytokinesis. In epithelial cells, required for the formation of microvilli and membrane ruffles on the apical pole. Along with EZR, required for normal macropinocytosis. {ECO:0000269|PubMed:16721066, ECO:0000269|PubMed:17881735}.",,,,,,,,,,,,cell junction [GO:0030054]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; spindle pole [GO:0000922]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023],regulation of Rho protein signal transduction [GO:0035023],GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089],cell junction [GO:0030054]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; spindle pole [GO:0000922],GO:0000922; GO:0005089; GO:0005096; GO:0005737; GO:0005813; GO:0005902; GO:0030054; GO:0032154; GO:0035023,IPR035899; IPR000219; IPR011993; IPR001849; IPR040181; ,Q53EZ4,"SUBUNIT: Interacts with MYH10. Interacts with ELMO1 and EZR (in an open conformation). Interacts with CSPP1. {ECO:0000269|PubMed:16721066, ECO:0000269|PubMed:17881735, ECO:0000269|PubMed:19129481}.",14702039; 15498874; 16541075; 15489334; 16721066; 17881735; 19129481,14702039; 15498874; 16541075; 15489334; 16721066; 17881735; 19129481; 18694934; 19421144; 20634288; 24482237; 25336641; 25416956,2007-10-23,2019-02-13,2011-05-03,121,,,,,,,,,5 out of 5,Alternative sequence (3); Chain (1); Compositional bias (2); Domain (2); Mutagenesis (1); Natural variant (1); Sequence conflict (2),,"TISSUE SPECIFICITY: Highest expression in the placenta. Low levels in small intestine, lung, liver, kidney, thymus and heart.",,Alternative splicing;Cell projection;Complete proteome;Cytoplasm;Cytoskeleton;GTPase activation;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,,121,Alternative products (1); Caution (2); Function (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0181; KW-0206; KW-0343; KW-0621; KW-0963; KW-0966; KW-1185,,,,,,,,,CHAIN 1 790 Pleckstrin homology domain-containing family G member 6. /FTId=PRO_0000307912.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AK001527;AK095373;AF289613;BC104751;BC105961;BC109095;CH471116;
0,Q53EZ4,CEP55_HUMAN,CEP55 C10orf3 URCC6,CEP55,C10orf3 URCC6,,,Homo sapiens (Human),9606,Centrosomal protein of 55 kDa (Cep55) (Up-regulated in colon cancer 6),UP000005640: Chromosome 10,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSSRSTKDLIKSKWGSKPSNSKSETTLEKLKGEIAHLKTSVDEITSGKGKLTDKERHRLLEKIRVLEAEKEKNAYQLTEKDKEIQRLRDQLKARYSTTTLLEQLEETTREGERREQVLKALSEEKDVLKQQLSAATSRIAELESKTNTLRLSQTVAPNCFNSSINNIHEMEIQLKDALEKNQQWLVYDQQREVYVKGLLAKIFELEKKTETAAHSLPQQTKKPESEGYLQEEKQKCYNDLLASAKKDLEVERQTITQLSFELSEFRRKYEETQKEVHNLNQLLYSQRRADVQHLEDDRHKTEKIQKLREENDIARGKLEEEKKRSEELLSQVQFLYTSLLKQQEEQTRVALLEQQMQACTLDFENEKLDRQHVQHQLHVILKELRKARNQITQLESLKQLHEFAITEPLVTFQGETENREKVAASPKSPTAALNESLVECPKCNIQYPATEHRDLLVHVEYCSK,464,"54,178",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q53EZ4-1; Sequence=Displayed; Name=2; IsoId=Q53EZ4-2; Sequence=VSP_014750, VSP_014751; Note=No experimental confirmation available.; ",,SEQUENCE CAUTION:  Sequence=BAA91670.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 389 400 NQITQLESLKQL -> KNNTVGILETAS (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_014750.; VAR_SEQ 401 464 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_014751.,"VARIANT 57 57 H -> Q (polymorphism; no effect on protein localization to midbody ring; dbSNP:rs3740370). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:16406728, ECO:0000269|PubMed:28264986}. /FTId=VAR_026559.; VARIANT 86 464 Missing (in MARCH). {ECO:0000269|PubMed:28295209}. /FTId=VAR_079363.; VARIANT 99 99 T -> A (in dbSNP:rs7080916). {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21269460, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16406728, ECO:0000269|PubMed:17974005, ECO:0000269|Ref.2, ECO:0000269|Ref.4, ECO:0000269|Ref.7}. /FTId=VAR_022996.; VARIANT 236 236 C -> R (in dbSNP:rs7072484). /FTId=VAR_056791.; VARIANT 378 378 H -> L (polymorphism; no effect on protein localization to midbody ring; rescues craniofacial development when expressed in a zebrafish heterologous system; dbSNP:rs2293277). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:28264986, ECO:0000269|Ref.4, ECO:0000269|Ref.7}. /FTId=VAR_022997.; VARIANT 425 464 Missing (in MARCH; loss of protein localization to midbody ring; loss of function; fails to rescue craniofacial development when expressed in a zebrafish heterologous system). {ECO:0000269|PubMed:28264986}. /FTId=VAR_079364.",,,,CONFLICT 155 155 V -> A (in Ref. 4; BAD97215). {ECO:0000305}.; CONFLICT 204 204 E -> G (in Ref. 4; BAD97215). {ECO:0000305}.; CONFLICT 298 298 R -> G (in Ref. 5; CAE45837). {ECO:0000305}.; CONFLICT 334 334 F -> S (in Ref. 1; AAX14687 and 3; BAA91670). {ECO:0000305}.; CONFLICT 435 435 E -> G (in Ref. 1; AAX14687). {ECO:0000305}.,,3,,0,,,COILED 22 186 {ECO:0000255}.; COILED 238 337 {ECO:0000255}.; COILED 374 403 {ECO:0000255}.,,,,REGION 157 236 Interaction with TSG101.; REGION 160 214 Interaction with PDCD6IP.; REGION 355 464 Required for localization to the interphase centrosome and to the midbody during cytokinesis. {ECO:0000269|PubMed:16198290}.,,,,,,,,"FUNCTION: Plays a role in mitotic exit and cytokinesis (PubMed:16198290, PubMed:17853893). Recruits PDCD6IP and TSG101 to midbody during cytokinesis. Required for successful completion of cytokinesis (PubMed:17853893). Not required for microtubule nucleation (PubMed:16198290). Plays a role in the development of the brain and kidney (PubMed:28264986). {ECO:0000269|PubMed:16198290, ECO:0000269|PubMed:17853893, ECO:0000269|PubMed:28264986}.",,,,,,,,,,,,centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; plasma membrane [GO:0005886]; cranial skeletal system development [GO:1904888]; establishment of protein localization [GO:0045184]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; renal system development [GO:0072001],cranial skeletal system development [GO:1904888]; establishment of protein localization [GO:0045184]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; renal system development [GO:0072001],,centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; plasma membrane [GO:0005886],GO:0000281; GO:0005813; GO:0005814; GO:0005815; GO:0005886; GO:0014066; GO:0016020; GO:0030496; GO:0032154; GO:0045171; GO:0045184; GO:0061952; GO:0072001; GO:0090543; GO:1904888,IPR038926; IPR022008; ,A8K9C1; P50995; Q5T0G8; D3DTR7; O94989; Q9NX04; Q6UXH8; Q8TD31-3; O75419; Q8IYX8; Q8IYX8-2; O60941; Q8N9N8; Q86YD7; Q8TES7-6; P51116; Q0D2H9; Q96CS2; O14964; Q9BVG8; Q8NDC0; P55081; Q5JRA6-2; Q15014; Q2TAK8-2; Q8WUM4; Q9UBV8; Q13526; Q3KR16; Q6PIY2; Q96T49; Q9H3S7; Q96I25; Q9NW64; Q9P2K3; O00560; P14678-2; Q13573; Q9Y2D8; P56279; D3DUQ6; Q15561; Q8IWB6; Q92734; Q99816; A5D8V6; Q9Y3C0; Q96HA8,"SUBUNIT: Homodimer (PubMed:16406728). Interacts (phosphorylated on Ser-425 and Ser-428) with PLK1 (PubMed:16198290). Interacts with AKAP9/CG-NAP; the interaction occurs in interphase and is lost upon mitotic entry (PubMed:16198290). Interacts with PCNT/Kendrin; the interaction occurs in interphase and is lost upon mitotic entry (PubMed:16198290). Directly interacts with PDCD6IP; this interaction is required for PDCD6IP targeting to the midbody; CEP55 binds PDCD6IP in a 2:1 stoichiometry; PDCD6IP competes with TSG101 for the same binding site (PubMed:17853893, PubMed:17556548, PubMed:18641129, PubMed:18948538). Interacts with TSG101; TSG101 competes with PDCD6IP for the same binding site; interaction is required for cytokinesis but not for viral budding (PubMed:17853893, PubMed:17556548, PubMed:18948538). Interacts with MVB12A, VPS37B, VPS37C and VPS28 (PubMed:17853893). {ECO:0000269|PubMed:16198290, ECO:0000269|PubMed:16406728, ECO:0000269|PubMed:17556548, ECO:0000269|PubMed:17853893, ECO:0000269|PubMed:18641129, ECO:0000269|PubMed:18948538}.",16406728; 14702039; 17974005; 15164054; 15489334; 16198290; 17081983; 17853893; 17556548; 18691976; 18641129; 18669648; 19413330; 20068231; 21406692; 21310966; 23186163; 18948538; 19690332; 21269460; 28295209; 28264986,16406728; 14702039; 17974005; 15164054; 15489334; 16198290; 17081983; 17853893; 17556548; 18691976; 18641129; 18669648; 19413330; 20068231; 21406692; 21310966; 23186163; 18948538; 19690332; 21269460; 28295209; 28264986; 16189514; 16385451; 16790497; 17237822; 19525975; 19549727; 19609239; 19855176; 20176808; 20360068; 20400365; 21079244; 21150319; 21163940; 21516116; 22184120; 22458338; 22575643; 22591637; 22771033; 22810585; 24390615; 25178936; 25659891; 25889801; 25915844; 26392564; 26496610; 26615423; 26638075; 27127172; 28620049; 29579156; 29750778; 30277841,2005-07-19,2019-02-13,2010-05-18,143,X-ray crystallography (4),,HELIX 166 209 {ECO:0000244|PDB:3E1R}.,,,,,,5 out of 5,Alternative sequence (2); Chain (1); Coiled coil (3); Erroneous initiation (1); Helix (1); Modified residue (5); Mutagenesis (9); Natural variant (6); Region (3); Sequence conflict (6),,"TISSUE SPECIFICITY: Expressed in embryonic brain (PubMed:28264986). Expressed in fetal brain ganglionic eminence, kidney tubules and multinucleate neurons in the temporal cortex (PubMed:28264986). Expressed in adult brain, cerebellum, kidney tubules, intestine and muscles (at protein level) (PubMed:28295209, PubMed:28264986). Widely expressed, mostly in proliferative tissues. Highly expressed in testis. Intermediate levels in adult and fetal thymus, as well as in various cancer cell lines. Low levels in different parts of the digestive tract, bone marrow, lymph nodes, placenta, fetal heart and fetal spleen. Hardly detected in brain. {ECO:0000269|PubMed:16198290, ECO:0000269|PubMed:16406728, ECO:0000269|PubMed:28264986, ECO:0000269|PubMed:28295209}.",,3D-structure;Alternative splicing;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Developmental protein;Disease mutation;Mitosis;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,,143,Alternative products (1); Caution (1); Function (1); Involvement in disease (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0217; KW-0225; KW-0498; KW-0597; KW-0621; KW-0963; KW-1185,,,,,"DISEASE: Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly (MARCH) [MIM:236500]: An autosomal recessive, congenital disease characterized by severe hydranencephaly with multinucleated neurons, renal aplasia or dysplasia, and hypoplastic kidneys. Hydranencephaly is an anomaly leading to replacement of the cerebral hemispheres with a fluid-filled cyst. MARCH results in death in utero or in the perinatal period. {ECO:0000269|PubMed:28264986, ECO:0000269|PubMed:28295209}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: There is a hierachy of phosphorylation, where both Ser-425 and Ser-428 are phosphorylated at the onset of mitosis, prior to Ser-436. Phosphorylation at Ser-425 and Ser-428 is required for dissociation from the centrosome at the G2/M boundary. Phosphorylation at the 3 sites, Ser-425, Ser-428 and Ser-436, is required for protein function at the final stages of cell division to complete cytokinesis successfully. {ECO:0000269|PubMed:16198290}.",CHAIN 1 464 Centrosomal protein of 55 kDa. /FTId=PRO_0000089777.,,,,,,"MOD_RES 96 96 Phosphoserine. {ECO:0000250|UniProtKB:Q8BT07}.; MOD_RES 425 425 Phosphoserine; by CDK1 and MAPK1. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000269|PubMed:16198290}.; MOD_RES 428 428 Phosphoserine; by CDK1 and MAPK1. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:16198290}.; MOD_RES 430 430 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 436 436 Phosphoserine; by PLK1. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:16198290}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AY788918;AB091343;AK001402;AK315536;AK223495;BX640718;CH471066;CH471066;BC008947;
0,Q5JVL4,EFHC1_HUMAN,EFHC1,EFHC1,,,,Homo sapiens (Human),9606,EF-hand domain-containing protein 1 (Myoclonin-1),UP000005640: Chromosome 6,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MVSNPVHGLPFLPGTSFKDSTKTAFHRSQTLSYRNGYAIVRRPTVGIGGDRLQFNQLSQAELDELASKAPVLTYGQPKQAPPADFIPAHVAFDKKVLKFDAYFQEDVPMSTEEQYRIRQVNIYYYLEDDSMSVIEPVVENSGILQGKLIKRQRLAKNDRGDHYHWKDLNRGINITIYGKTFRVVDCDQFTQVFLESQGIELNPPEKMALDPYTELRKQPLRKYVTPSDFDQLKQFLTFDKQVLRFYAIWDDTDSMYGECRTYIIHYYLMDDTVEIREVHERNDGRDPFPLLMNRQRVPKVLVENAKNFPQCVLEISDQEVLEWYTAKDFIVGKSLTILGRTFFIYDCDPFTRRYYKEKFGITDLPRIDVSKREPPPVKQELPPYNGFGLVEDSAQNCFALIPKAPKKDVIKMLVNDNKVLRYLAVLESPIPEDKDRRFVFSYFLATDMISIFEPPVRNSGIIGGKYLGRTKVVKPYSTVDNPVYYGPSDFFIGAVIEVFGHRFIILDTDEYVLKYMESNAAQYSPEALASIQNHVRKREAPAPEAESKQTEKDPGVQELEALIDTIQKQLKDHSCKDNIREAFQIYDKEASGYVDRDMFFKICESLNVPVDDSLVKELIRMCSHGEGKINYYNFVRAFSN,640,"73,990",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=Q5JVL4-1; Sequence=Displayed; Name=2; IsoId=Q5JVL4-2; Sequence=VSP_015894, VSP_015895; Note=May be due to intron retention.; Name=3; IsoId=Q5JVL4-3; Sequence=VSP_046107; Note=No experimental confirmation available.; ",,,,,,,,,,VAR_SEQ 1 21 MVSNPVHGLPFLPGTSFKDST -> ML (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_046107.; VAR_SEQ 243 278 LRFYAIWDDTDSMYGECRTYIIHYYLMDDTVEIREV -> SDIGTTIGLLISKCDLHLLAKGLGSCIGNYFETLQL (in isoform 2). {ECO:0000303|PubMed:15258581}. /FTId=VSP_015894.; VAR_SEQ 279 640 Missing (in isoform 2). {ECO:0000303|PubMed:15258581}. /FTId=VSP_015895.,"VARIANT 77 77 P -> T (in EJM1; associated with H-221; reduces substantially the cell death effect; reduces partly the calcium influx; binds to CACNA1E; dbSNP:rs149055334). {ECO:0000269|PubMed:15258581}. /FTId=VAR_023619.; VARIANT 89 89 H -> R (in EJM1; no effect on protein expression; defective mitotic spindle organization; defective cytokinesis; dbSNP:rs543160745). {ECO:0000269|PubMed:28370826}. /FTId=VAR_079772.; VARIANT 118 118 R -> C (in EJM1; dbSNP:rs764096785). {ECO:0000269|PubMed:22727576}. /FTId=VAR_072108.; VARIANT 153 153 R -> Q (in EJM1; unknown pathological significance; dbSNP:rs745600475). {ECO:0000269|PubMed:22727576}. /FTId=VAR_072109.; VARIANT 159 159 R -> W (polymorphism; no effect on cell death; binds to CACNA1E as the wild type protein; does not affect subcellular location; dbSNP:rs3804506). {ECO:0000269|PubMed:15258581, ECO:0000269|PubMed:17159113, ECO:0000269|PubMed:22926142, ECO:0000269|PubMed:28370826}. /FTId=VAR_023620.; VARIANT 174 174 I -> V (associated with susceptibility to JAE1; dbSNP:rs137852779). {ECO:0000269|PubMed:17159113}. /FTId=VAR_043154.; VARIANT 182 182 R -> C (in EJM1; unknown pathological significance; dbSNP:rs200191497). {ECO:0000269|PubMed:22727576}. /FTId=VAR_072110.; VARIANT 182 182 R -> H (likely benign polymorphism; no effect on cell death; binds to CACNA1E; dbSNP:rs3804505). {ECO:0000269|PubMed:15258581, ECO:0000269|PubMed:17159113, ECO:0000269|PubMed:17634063, ECO:0000269|PubMed:28370826}. /FTId=VAR_023621.; VARIANT 210 210 D -> N (in EJM1; reduces substantially the cell death effect; reduces partly the calcium influx; normally binds to CACNA1E; does not affect subcellular location; results in impaired cell migration; dbSNP:rs137852777). {ECO:0000269|PubMed:15258581, ECO:0000269|PubMed:22926142}. /FTId=VAR_023622.; VARIANT 221 221 R -> C (polymorphism; dbSNP:rs139197513). {ECO:0000269|PubMed:28370826}. /FTId=VAR_079773.; VARIANT 221 221 R -> H (in EJM1; associated with T-77; reduces substantially the cell death effect; reduces partly the calcium influx; normally binds to CACNA1E; does not affect subcellular location; results in impaired cell migration; dbSNP:rs79761183). {ECO:0000269|PubMed:15258581, ECO:0000269|PubMed:22926142}. /FTId=VAR_023623.; VARIANT 229 229 F -> L (in EJM1; uncertain pathological significance; also found at homozygosity in neonatal intractable epilepsy; reduces substantially the cell death effect; reduces significantly the calcium influx; normally binds to CACNA1E; does not affect subcellular location; results in impaired cell migration; dbSNP:rs137852776). {ECO:0000269|PubMed:15258581, ECO:0000269|PubMed:17159113, ECO:0000269|PubMed:17634063, ECO:0000269|PubMed:22690745, ECO:0000269|PubMed:22926142, ECO:0000269|PubMed:28370826}. /FTId=VAR_023624.; VARIANT 253 253 D -> Y (in EJM1; reduces substantially the cell death effect; reduces partly the calcium influx; normally binds to CACNA1E; does not affect subcellular location; results in impaired cell migration; dbSNP:rs137852778). {ECO:0000269|PubMed:15258581, ECO:0000269|PubMed:22926142}. /FTId=VAR_023625.; VARIANT 259 259 C -> Y (associated with susceptibility to JAE1; dbSNP:rs137852780). {ECO:0000269|PubMed:17159113}. /FTId=VAR_043155.; VARIANT 285 285 R -> I (in dbSNP:rs17851771). {ECO:0000269|PubMed:15489334}. /FTId=VAR_026531.; VARIANT 294 294 R -> H (in dbSNP:rs1570624). {ECO:0000269|PubMed:17159113, ECO:0000269|PubMed:28370826}. /FTId=VAR_043156.; VARIANT 322 322 E -> K (in EJM1; no effect on protein expression; defective mitotic spindle organization; defective cytokinesis). {ECO:0000269|PubMed:28370826}. /FTId=VAR_079774.; VARIANT 353 353 R -> W (in EJM1; no effect on protein expression; no effect on the spindle pole localization; defective mitotic spindle organization; defective cytokinesis; dbSNP:rs527295360). {ECO:0000269|PubMed:17634063, ECO:0000269|PubMed:28370826}. /FTId=VAR_043157.; VARIANT 355 355 Y -> C (in EJM1; no effect on protein expression; defective mitotic spindle organization; defective cytokinesis; dbSNP:rs767833659). {ECO:0000269|PubMed:28370826}. /FTId=VAR_079775.; VARIANT 357 357 E -> K (in dbSNP:rs505760). /FTId=VAR_048666.; VARIANT 372 372 R -> W (in EJM1; no effect on protein expression; defective mitotic spindle organization; defective cytokinesis; dbSNP:rs371151471). {ECO:0000269|PubMed:28370826}. /FTId=VAR_079776.; VARIANT 378 378 K -> E (in EJM1; no effect on protein expression; defective mitotic spindle organization; defective cytokinesis). {ECO:0000269|PubMed:28370826}. /FTId=VAR_079777.; VARIANT 394 394 A -> S (in a sporadic case of unclassified epilepsy). {ECO:0000269|PubMed:17159113}. /FTId=VAR_043158.; VARIANT 436 436 R -> C (in EJM1; no effect on protein expression; defective mitotic spindle organization; defective cytokinesis; dbSNP:rs377286138). {ECO:0000269|PubMed:28370826}. /FTId=VAR_079778.; VARIANT 448 448 M -> T (in dbSNP:rs1266787). {ECO:0000269|PubMed:17159113, ECO:0000269|PubMed:28370826}. /FTId=VAR_043159.; VARIANT 485 485 Y -> H (in EJM1; no effect on protein expression; defective mitotic spindle organization; defective cytokinesis; dbSNP:rs779322943). {ECO:0000269|PubMed:28370826}. /FTId=VAR_079779.; VARIANT 519 519 N -> S (in EJM1; no effect on protein expression; defective mitotic spindle organization; defective cytokinesis; dbSNP:rs527539103). {ECO:0000269|PubMed:28370826}. /FTId=VAR_079780.; VARIANT 556 556 V -> L (in EJM1; no effect on protein expression; defective mitotic spindle organization; defective cytokinesis; dbSNP:rs772265107). {ECO:0000269|PubMed:28370826}. /FTId=VAR_079781.; VARIANT 619 619 I -> L (polymorphism; no effect on cell death; normally binds to CACNA1E; does not affect subcellular location; dbSNP:rs17851770). {ECO:0000269|PubMed:15258581, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:22926142, ECO:0000269|PubMed:28370826}. /FTId=VAR_023626.; VARIANT 619 619 I -> S (in EJM1; no effect on protein expression; defective mitotic spindle organization; defective cytokinesis; dbSNP:rs142458862). {ECO:0000269|PubMed:28370826}. /FTId=VAR_079782.; VARIANT 631 631 Y -> C (in EJM1; no effect on protein expression; defective mitotic spindle organization; defective cytokinesis; dbSNP:rs574948354). {ECO:0000269|PubMed:28370826}. /FTId=VAR_079783.",,,,CONFLICT 140 140 N -> D (in Ref. 2; BAG60005). {ECO:0000305}.; CONFLICT 399 399 A -> T (in Ref. 2; BAA91628). {ECO:0000305}.,,1,,0,,,,,DOMAIN 93 198 DM10 1. {ECO:0000255|PROSITE-ProRule:PRU00665}.; DOMAIN 239 359 DM10 2. {ECO:0000255|PROSITE-ProRule:PRU00665}.; DOMAIN 416 520 DM10 3. {ECO:0000255|PROSITE-ProRule:PRU00665}.; DOMAIN 574 609 EF-hand. {ECO:0000255|PROSITE-ProRule:PRU00448}.,,REGION 1 45 Required for its localization in the mitotic spindle and interaction with alpha-tubulin. {ECO:0000269|PubMed:19734894}.,,,,,,,,"FUNCTION: Microtubule-associated protein which regulates cell division and neuronal migration during cortical development. Necessary for mitotic spindle organization (PubMed:19734894, PubMed:28370826). Necessary for radial and tangential cell migration during brain development, possibly acting as a regulator of cell morphology and process formation during migration (PubMed:22926142). May enhance calcium influx through CACNA1E and stimulate programmed cell death (PubMed:15258581). {ECO:0000269|PubMed:15258581, ECO:0000269|PubMed:19734894, ECO:0000269|PubMed:22926142, ECO:0000269|PubMed:28370826}.",,,,,,,,,,,,axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; cerebral cortex cell migration [GO:0021795]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302],cerebral cortex cell migration [GO:0021795]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302],alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022],axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922],GO:0000281; GO:0000922; GO:0005509; GO:0005813; GO:0005930; GO:0007052; GO:0008022; GO:0021795; GO:0043014; GO:0043025; GO:0051302; GO:0072686,IPR010554; IPR011992; IPR002048; IPR040193; IPR006602; ,Q8IYA8; Q5JST6; Q9NRA8; Q08379; Q9NSC5; Q9UKT9; Q8WVF5; P19012; Q04864; Q04864-2; Q9UFD9; Q9NR46; E9PH57; P15884; Q8IYF3-3; Q12933; Q15654; O96006,"SUBUNIT: Interacts with the C-terminus of CACNA1E (PubMed:15258581). Interacts with alpha-tubulin (PubMed:19734894). {ECO:0000269|PubMed:15258581, ECO:0000269|PubMed:19734894}.",15258581; 14702039; 14574404; 15489334; 17159113; 17634063; 19734894; 22926142; 22690745; 22727576; 28370826,15258581; 14702039; 14574404; 15489334; 17159113; 17634063; 19734894; 22926142; 22690745; 22727576; 28370826; 14582146; 16189514; 16378686; 16824517; 16839746; 17054699; 17972043; 18505993; 18593566; 18823326; 20201926; 20379614; 22226147; 23756480; 23756481; 25416956; 25489633; 25814554; 25820252; 26496610; 27467453,2005-10-25,2019-02-13,2005-02-15,141,,,,,,,,,5 out of 5,Alternative sequence (3); Chain (1); Domain (4); Natural variant (31); Region (1); Sequence conflict (2),,TISSUE SPECIFICITY: Widely expressed. Not detected in lymphocytes. {ECO:0000269|PubMed:15258581}.,,Alternative splicing;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Epilepsy;Polymorphism;Reference proteome;Repeat,Evidence at protein level,reviewed,,,141,Alternative products (1); Caution (2); Function (1); Involvement in disease (3); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0181; KW-0206; KW-0225; KW-0621; KW-0677; KW-0887; KW-0963; KW-1185,,,,,"DISEASE: Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]: A subtype of idiopathic generalized epilepsy. Patients have afebrile seizures only, with onset in adolescence (rather than in childhood) and myoclonic jerks which usually occur after awakening and are triggered by sleep deprivation and fatigue. {ECO:0000269|PubMed:15258581, ECO:0000269|PubMed:17634063, ECO:0000269|PubMed:22690745, ECO:0000269|PubMed:22727576, ECO:0000269|PubMed:22926142, ECO:0000269|PubMed:28370826}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Juvenile absence epilepsy 1 (JAE1) [MIM:607631]: A subtype of idiopathic generalized epilepsy characterized by onset occurring around puberty, absence seizures, generalized tonic-clonic seizures (GTCS), GTCS on awakening, and myoclonic seizures. {ECO:0000269|PubMed:17159113, ECO:0000305|PubMed:17159113}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=Mutation Leu-229 may be a cause of intractable epilepsy of infancy. Affected individuals have seizures of multiple type, manifested as tonic, clonic, and myoclonic seizures in the neonatal period, and as tonic seizures activated frequently by sleep, and repeated frequent myoclonic seizures in later infancy. The seizures are unresponsive to numerous antiepileptic drugs, and infants die in the first years of life. Although heterozygosity for Leu-229 has been associated with relatively benign forms of epilepsy in adolescence, homozygosity for the same mutation has much more severe consequences. {ECO:0000269|PubMed:22690745}.",,,,CHAIN 1 640 EF-hand domain-containing protein 1. /FTId=PRO_0000073877.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AY608689;AY608690;AK001328;AK297632;BC020210;
0,Q68DK2,ZFY26_HUMAN,ZFYVE26 KIAA0321,ZFYVE26,KIAA0321,,,Homo sapiens (Human),9606,Zinc finger FYVE domain-containing protein 26 (FYVE domain-containing centrosomal protein) (FYVE-CENT) (Spastizin),UP000005640: Chromosome 14,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MNHPFGKEEAASQKQLFGFFCECLRRGEWELAQACVPQLQEGQGDIPKRVEDILQALVVCPNLLRCGQDINPQRVAWVWLLVLEKWLAREKKLLPVVFRRKLEFLLLSEDLQGDIPENILEELYETLTQGAVGHVPDGNPRRESWTPRLSSEAVSVLWDLLRQSPQPAQALLELLLEEDDGTGLCHWPLQNALVDLIRKALRALQGPDSVPPGVVDAIYGALRTLRCPAEPLGVELHLLCEELLEACRTEGSPLREERLLSCLLHKASRGLLSLYGHTYAEKVTEKPPRATASGKVSPDHLDPERAMLALFSNPNPAEAWKVAYFYCLSNNKHFLEQILVTALTLLKEEDFPNLGCLLDREFRPLSCLLVLLGWTHCQSLESAKRLLQTLHRTQGPGCDELLRDACDGLWAHLEVLEWCIQQSSNPIPKRDLLYHLHGGDSHSVLYTLHHLTNLPALREEDVLKLLQKVPAKDPQQEPDAVDAPVPEHLSQCQNLTLYQGFCAMKYAIYALCVNSHQHSQCQDCKDSLSEDLASATEPANDSLSSPGAANLFSTYLARCQQYLCSIPDSLCLELLENIFSLLLITSADLHPEPHLPEDYAEDDDIEGKSPSGLRSPSESPQHIAHPERKSERGSLGVPKTLAYTMPSHVKAEPKDSYPGPHRHSFLDLKHFTSGISGFLADEFAIGAFLRLLQEQLDEISSRSPPEKPKQESQSCSGSRDGLQSRLHRLSKVVSEAQWRHKVVTSNHRSEEQPSRRYQPATRHPSLRRGRRTRRSQADGRDRGSNPSLESTSSELSTSTSEGSLSAMSGRNELHSRLHPHPQSSLIPMMFSPPESLLASCILRGNFAEAHQVLFTFNLKSSPSSGELMFMERYQEVIQELAQVEHKIENQNSDAGSSTIRRTGSGRSTLQAIGSAAAAGMVFYSISDVTDKLLNTSGDPIPMLQEDFWISTALVEPTAPLREVLEDLSPPAMAAFDLACSQCQLWKTCKQLLETAERRLNSSLERRGRRIDHVLLNADGIRGFPVVLQQISKSLNYLLMSASQTKSESVEEKGGGPPRCSITELLQMCWPSLSEDCVASHTTLSQQLDQVLQSLREALELPEPRTPPLSSLVEQAAQKAPEAEAHPVQIQTQLLQKNLGKQTPSGSRQMDYLGTFFSYCSTLAAVLLQSLSSEPDHVEVKVGNPFVLLQQSSSQLVSHLLFERQVPPERLAALLAQENLSLSVPQVIVSCCCEPLALCSSRQSQQTSSLLTRLGTLAQLHASHCLDDLPLSTPSSPRTTENPTLERKPYSSPRDSSLPALTSSALAFLKSRSKLLATVACLGASPRLKVSKPSLSWKELRGRREVPLAAEQVARECERLLEQFPLFEAFLLAAWEPLRGSLQQGQSLAVNLCGWASLSTVLLGLHSPIALDVLSEAFEESLVARDWSRALQLTEVYGRDVDDLSSIKDAVLSCAVACDKEGWQYLFPVKDASLRSRLALQFVDRWPLESCLEILAYCISDTAVQEGLKCELQRKLAELQVYQKILGLQSPPVWCDWQTLRSCCVEDPSTVMNMILEAQEYELCEEWGCLYPIPREHLISLHQKHLLHLLERRDHDKALQLLRRIPDPTMCLEVTEQSLDQHTSLATSHFLANYLTTHFYGQLTAVRHREIQALYVGSKILLTLPEQHRASYSHLSSNPLFMLEQLLMNMKVDWATVAVQTLQQLLVGQEIGFTMDEVDSLLSRYAEKALDFPYPQREKRSDSVIHLQEIVHQAADPETLPRSPSAEFSPAAPPGISSIHSPSLRERSFPPTQPSQEFVPPATPPARHQWVPDETESICMVCCREHFTMFNRRHHCRRCGRLVCSSCSTKKMVVEGCRENPARVCDQCYSYCNKDVPEEPSEKPEALDSSKSESPPYSFVVRVPKADEVEWILDLKEEENELVRSEFYYEQAPSASLCIAILNLHRDSIACGHQLIEHCCRLSKGLTNPEVDAGLLTDIMKQLLFSAKMMFVKAGQSQDLALCDSYISKVDVLNILVAAAYRHVPSLDQILQPAAVTRLRNQLLEAEYYQLGVEVSTKTGLDTTGAWHAWGMACLKAGNLTAAREKFSRCLKPPFDLNQLNHGSRLVQDVVEYLESTVRPFVSLQDDDYFATLRELEATLRTQSLSLAVIPEGKIMNNTYYQECLFYLHNYSTNLAIISFYVRHSCLREALLHLLNKESPPEVFIEGIFQPSYKSGKLHTLENLLESIDPTLESWGKYLIAACQHLQKKNYYHILYELQQFMKDQVRAAMTCIRFFSHKAKSYTELGEKLSWLLKAKDHLKIYLQETSRSSGRKKTTFFRKKMTAADVSRHMNTLQLQMEVTRFLHRCESAGTSQITTLPLPTLFGNNHMKMDVACKVMLGGKNVEDGFGIAFRVLQDFQLDAAMTYCRAARQLVEKEKYSEIQQLLKCVSESGMAAKSDGDTILLNCLEAFKRIPPQELEGLIQAIHNDDNKVRAYLICCKLRSAYLIAVKQEHSRATALVQQVQQAAKSSGDAVVQDICAQWLLTSHPRGAHGPGSRK,2539,"284,576",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=5;  Name=1; IsoId=Q68DK2-1; Sequence=Displayed; Name=2; IsoId=Q68DK2-2; Sequence=VSP_030339; Note=No experimental confirmation available.; Name=4; IsoId=Q68DK2-4; Sequence=VSP_041049, VSP_041050; Note=No experimental confirmation available.; Name=3; IsoId=Q68DK2-3; Sequence=VSP_030338, VSP_030340, VSP_030341; Note=No experimental confirmation available.; Name=5; IsoId=Q68DK2-5; Sequence=VSP_058963, VSP_058964; ",,SEQUENCE CAUTION:  Sequence=BAG11658.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,SEQUENCE CAUTION:  Sequence=CAD97882.1; Type=Erroneous termination; Positions=1463; Note=Translated as Gln.; Evidence={ECO:0000305}; ,,,,,,,VAR_SEQ 1 1809 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_030338.; VAR_SEQ 203 223 Missing (in isoform 2). {ECO:0000303|PubMed:17974005}. /FTId=VSP_030339.; VAR_SEQ 778 791 DGRDRGSNPSLEST -> GNLKSSFPCTRQVV (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_041049.; VAR_SEQ 792 2539 Missing (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_041050.; VAR_SEQ 1810 1828 VPDETESICMVCCREHFTM -> MAISPSLLPLSSPPDGIPQ (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_030340.; VAR_SEQ 2473 2539 VRAYLICCKLRSAYLIAVKQEHSRATALVQQVQQAAKSSGDAVVQDICAQWLLTSHPRGAHGPGSRK -> IVPILAALRDRVHTEERGRSPSTLC (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_030341.; VAR_SEQ 2474 2481 RAYLICCK -> SGIVSKRW (in isoform 5). /FTId=VSP_058963.; VAR_SEQ 2482 2539 Missing (in isoform 5). /FTId=VSP_058964.,"VARIANT 429 429 K -> E (in dbSNP:rs34059852). /FTId=VAR_037987.; VARIANT 898 898 T -> S (in dbSNP:rs17192170). /FTId=VAR_037988.; VARIANT 951 951 T -> M (in dbSNP:rs35471427). /FTId=VAR_037989.; VARIANT 1071 1071 S -> N (in dbSNP:rs7156206). /FTId=VAR_037990.; VARIANT 1103 1103 P -> L (in dbSNP:rs3742885). {ECO:0000269|PubMed:17974005}. /FTId=VAR_037991.; VARIANT 1122 1122 A -> V (in dbSNP:rs3742884). /FTId=VAR_037992.; VARIANT 1164 1164 A -> E (in a breast cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_037993.; VARIANT 1457 1457 C -> Y (in dbSNP:rs2235967). {ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:9205841}. /FTId=VAR_037994.; VARIANT 1891 1891 S -> N (in dbSNP:rs3742883). {ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:9205841}. /FTId=VAR_037995.; VARIANT 1945 1945 R -> Q (in a breast cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_037996.; VARIANT 2411 2411 R -> H (in dbSNP:rs34373049). /FTId=VAR_037997.",,,,CONFLICT 243 243 L -> P (in Ref. 3; CAD97882). {ECO:0000305}.; CONFLICT 556 556 L -> P (in Ref. 1; BAG11658). {ECO:0000305}.; CONFLICT 586 586 S -> P (in Ref. 3; CAH18131). {ECO:0000305}.; CONFLICT 629 629 K -> E (in Ref. 3; CAH18131). {ECO:0000305}.; CONFLICT 946 946 D -> G (in Ref. 3; CAH18218). {ECO:0000305}.; CONFLICT 1040 1040 S -> T (in Ref. 1; BAG11658). {ECO:0000305}.; CONFLICT 1115 1115 A -> T (in Ref. 3; CAH18131). {ECO:0000305}.; CONFLICT 1320 1320 C -> S (in Ref. 3; CAH18218). {ECO:0000305}.; CONFLICT 1358 1358 R -> H (in Ref. 3; CAH18131). {ECO:0000305}.; CONFLICT 1556 1556 E -> V (in Ref. 3; CAH18131). {ECO:0000305}.; CONFLICT 1597 1597 A -> T (in Ref. 3; CAH10379). {ECO:0000305}.; CONFLICT 1615 1615 E -> K (in Ref. 3; CAH10379). {ECO:0000305}.; CONFLICT 1670 1670 S -> N (in Ref. 3; CAH18218). {ECO:0000305}.; CONFLICT 1727 1727 K -> R (in Ref. 3; CAH10379). {ECO:0000305}.; CONFLICT 1774 1774 G -> D (in Ref. 3; CAD97882). {ECO:0000305}.; CONFLICT 2246 2246 Q -> L (in Ref. 3; CAH18131). {ECO:0000305}.; CONFLICT 2288 2288 K -> R (in Ref. 3; CAD97882). {ECO:0000305}.; CONFLICT 2434 2434 M -> L (in Ref. 6; AAH33235). {ECO:0000305}.,,3,,0,DOMAIN: The FYVE-type zinc finger mediates binding to phosphatidylinositol 3-phosphate and recruitment to the midbody during cytokinesis. {ECO:0000269|PubMed:20208530}.,,COILED 868 895 {ECO:0000255}.,,,,,,ZN_FING 1812 1872 FYVE-type. {ECO:0000255|PROSITE-ProRule:PRU00091}.,,,,,,FUNCTION: Phosphatidylinositol 3-phosphate-binding protein required for the abcission step in cytokinesis: recruited to the midbody during cytokinesis and acts as a regulator of abcission. May also be required for efficient homologous recombination DNA double-strand break repair. {ECO:0000269|PubMed:20208530}.,,,,,,,,,,,,centrosome [GO:0005813]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465],double-strand break repair via homologous recombination [GO:0000724]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465],metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266],centrosome [GO:0005813]; lysosomal membrane [GO:0005765]; midbody [GO:0030496],GO:0000281; GO:0000724; GO:0005765; GO:0005813; GO:0030496; GO:0032266; GO:0032465; GO:0046872,IPR028730; IPR000306; IPR017455; IPR011011; IPR013083; ,P13196; Q9C0F1; Q08379; P07910; P19012; Q6A162; P60409; P60411; Q99750; Q8ND90; Q96PV4; O75478; P48775; Q9UBB9; Q13077; Q8N6Y0,"SUBUNIT: Interacts with AP5Z1, AP5B1, AP5S1 and SPG11. Interacts with TTC19 and KIF13A. {ECO:0000269|PubMed:20208530, ECO:0000269|PubMed:20613862}.",9205841; 14702039; 17974005; 12508121; 15489334; 18394578; 18669648; 19084844; 19805727; 20208530; 20613862; 23186163; 24275569; 16959974,9205841; 14702039; 17974005; 12508121; 15489334; 18394578; 18669648; 19084844; 19805727; 20208530; 20613862; 23186163; 24275569; 16959974; 17661097; 18332254; 19917823; 20379614; 21455500; 21516116; 21545838; 23825025; 24030950; 24284334; 24366652; 25365221; 26492578; 26496610,2008-01-15,2019-02-13,2010-05-18,128,,,,,,,,,5 out of 5,Alternative sequence (8); Chain (1); Coiled coil (1); Erroneous initiation (1); Erroneous termination (1); Modified residue (9); Mutagenesis (1); Natural variant (11); Sequence conflict (18); Zinc finger (1),,"TISSUE SPECIFICITY: Strongest expression in the adrenal gland, bone marrow, adult brain, fetal brain, lung, placenta, prostate, skeletal muscle, testis, thymus, and retina. Intermediate levels are detected in other structures, including the spinal cord. {ECO:0000269|PubMed:18394578}.",,Alternative splicing;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Hereditary spastic paraplegia;Lipid-binding;Metal-binding;Neurodegeneration;Phosphoprotein;Polymorphism;Reference proteome;Zinc;Zinc-finger,Evidence at protein level,reviewed,,,128,Alternative products (1); Caution (3); Domain (1); Function (1); Involvement in disease (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0227; KW-0234; KW-0446; KW-0479; KW-0523; KW-0597; KW-0621; KW-0862; KW-0863; KW-0890; KW-0963; KW-1185,,,,,"DISEASE: Spastic paraplegia 15, autosomal recessive (SPG15) [MIM:270700]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG15 is a complex form associated with additional neurological symptoms such as cognitive deterioration or mental retardation, axonal neuropathy, mild cerebellar signs, and, less frequently, a central hearing deficit, decreased visual acuity, or retinal degeneration. {ECO:0000269|PubMed:18394578, ECO:0000269|PubMed:19084844, ECO:0000269|PubMed:19805727}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 2539 Zinc finger FYVE domain-containing protein 26. /FTId=PRO_0000314612.,,,,,,MOD_RES 297 297 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 615 615 Phosphoserine. {ECO:0000250|UniProtKB:D4A8G9}.; MOD_RES 619 619 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 703 703 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 800 800 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1742 1742 Phosphoserine. {ECO:0000250|UniProtKB:Q5DU37}.; MOD_RES 1764 1764 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1780 1780 Phosphoserine. {ECO:0000250|UniProtKB:Q5DU37}.; MOD_RES 1782 1782 Phosphoserine. {ECO:0000250|UniProtKB:Q5DU37}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB002319;AB425197;AK304428;AK128496;BX537886;BX538025;BX648683;CR749276;CR749365;CH471061;BC008927;BC033235;
0,Q7L5Y9,MAEA_HUMAN,MAEA EMP HLC10 PIG5,MAEA,EMP,,HLC10 PIG5,Homo sapiens (Human),9606,E3 ubiquitin-protein transferase MAEA (EC 2.3.2.27) (Cell proliferation-inducing gene 5 protein) (Erythroblast macrophage protein) (Human lung cancer oncogene 10 protein) (HLC-10) (Macrophage erythroblast attacher) (P44EMLP),UP000005640: Chromosome 4,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAVQESAAQLSMTLKVQEYPTLKVPYETLNKRFRAAQKNIDRETSHVTMVVAELEKTLSGCPAVDSVVSLLDGVVEKLSVLKRKAVESIQAEDESAKLCKRRIEHLKEHSSDQPAAASVWKRKRMDRMMVEHLLRCGYYNTAVKLARQSGIEDLVNIEMFLTAKEVEESLERRETATCLAWCHDNKSRLRKMKSCLEFSLRIQEFIELIRQNKRLDAVRHARKHFSQAEGSQLDEVRQAMGMLAFPPDTHISPYKDLLDPARWRMLIQQFRYDNYRLHQLGNNSVFTLTLQAGLSAIKTPQCYKEDGSSKSPDCPVCSRSLNKLAQPLPMAHCANSRLVCKISGDVMNENNPPMMLPNGYVYGYNSLLSIRQDDKVVCPRTKEVFHFSQAEKVYIM,396,"45,287",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=5;  Name=1; IsoId=Q7L5Y9-1; Sequence=Displayed; Name=2; IsoId=Q7L5Y9-2; Sequence=VSP_024786, VSP_024790; Name=3; IsoId=Q7L5Y9-3; Sequence=VSP_024786; Name=4; IsoId=Q7L5Y9-4; Sequence=VSP_024784, VSP_024788; Note=No experimental confirmation available.; Name=5; IsoId=Q7L5Y9-5; Sequence=VSP_024785, VSP_024789; Note=May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.; ",,SEQUENCE CAUTION:  Sequence=AAO85220.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,SEQUENCE CAUTION:  Sequence=AAC67543.1; Type=Erroneous termination; Positions=397; Note=Translated as stop.; Evidence={ECO:0000305}; ,,"SEQUENCE CAUTION:  Sequence=AAC67543.1; Type=Frameshift; Positions=253, 327; Evidence={ECO:0000305}; ",,,,SEQUENCE CAUTION:  Sequence=AAC67543.1; Type=Miscellaneous discrepancy; Note=Sequence differs at N-terminus.; Evidence={ECO:0000305};  Sequence=AK128302; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305}; ,"VAR_SEQ 152 232 EDLVNIEMFLTAKEVEESLERRETATCLAWCHDNKSRLRKMKSCLEFSLRIQEFIELIRQNKRLDAVRHARKHFSQAEGSQ -> GTCKKALQPSRREPAGRGAPGHGHAGLPARHAHLPVQGPSGPCTVADADPAVPVRQLPTTPAGKQFCVHPHPAGWPLSHQD (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_024784.; VAR_SEQ 153 245 DLVNIEMFLTAKEVEESLERRETATCLAWCHDNKSRLRKMKSCLEFSLRIQEFIELIRQNKRLDAVRHARKHFSQAEGSQLDEVRQAMGMLAF -> TCKKALQPSRREPAGRGAPGHGHAGLPARHAHLPVQGPSGPCTVADADPAVPVRQLPTTPAGKQFCVHPHPAGRPLSHQDTTVLQGGRQLQEP (in isoform 5). {ECO:0000303|Ref.1}. /FTId=VSP_024785.; VAR_SEQ 153 193 Missing (in isoform 2 and isoform 3). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:9763581}. /FTId=VSP_024786.; VAR_SEQ 233 300 Missing (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_024788.; VAR_SEQ 246 396 Missing (in isoform 5). {ECO:0000303|Ref.1}. /FTId=VSP_024789.; VAR_SEQ 265 265 M -> TCTVAD (in isoform 2). {ECO:0000303|PubMed:9763581}. /FTId=VSP_024790.",VARIANT 34 34 R -> C (in dbSNP:rs34082974). /FTId=VAR_051150.,,,,CONFLICT 32 32 R -> C (in Ref. 1; AAP74806). {ECO:0000305}.; CONFLICT 56 56 K -> R (in Ref. 4; AAC67543). {ECO:0000305}.; CONFLICT 101 101 R -> L (in Ref. 4; AAC67543). {ECO:0000305}.; CONFLICT 123 123 K -> R (in Ref. 2; BAA91499). {ECO:0000305}.; CONFLICT 313 313 D -> V (in Ref. 4; AAC67543). {ECO:0000305}.; CONFLICT 327 327 P -> R (in Ref. 4; AAC67543). {ECO:0000305}.,,1,,0,"DOMAIN: The expected RING-type zinc finger domain is highly divergent and most of the expected Cys residues are not conserved (Probable). Still, the protein is required for CTLH complex E3 ubiquitin-protein transferase activity (PubMed:29911972). In addition, the conserved Cys-314 in this highly divergent region is required for ubiquitination by the yeast GID complex, suggesting a direct role in catalyzing ubiquitination (Probable). {ECO:0000269|PubMed:29911972, ECO:0000305}.",,,,DOMAIN 121 153 LisH. {ECO:0000255|PROSITE-ProRule:PRU00126}.; DOMAIN 159 216 CTLH. {ECO:0000255|PROSITE-ProRule:PRU00058}.,,REGION 1 124 Extracellular and involved in cell to cell contact. {ECO:0000269|PubMed:9763581}.,,ZN_FING 314 381 RING-Gid-type. {ECO:0000255|PROSITE-ProRule:PRU01215}.,2.3.2.27,,CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:29911972};,,,"FUNCTION: Core component of the CTLH E3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from UBE2H and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor HBP1. MAEA and RMND5A are both required for catalytic activity of the CTLH E3 ubiquitin-protein ligase complex (PubMed:29911972). MAEA is required for normal cell proliferation (PubMed:29911972). The CTLH E3 ubiquitin-protein ligase complex is not required for the degradation of enzymes involved in gluconeogenesis, such as FBP1 (PubMed:29911972). Plays a role in erythroblast enucleation during erythrocyte maturation and in the development of mature macrophages (By similarity). Mediates the attachment of erythroid cell to mature macrophages; this MAEA-mediated contact inhibits erythroid cell apoptosis (PubMed:9763581). Participates in erythroblastic island formation, which is the functional unit of definitive erythropoiesis. Associates with F-actin to regulate actin distribution in erythroblasts and macrophages (By similarity). May contribute to nuclear architecture and cells division events (Probable). {ECO:0000250|UniProtKB:Q4VC33, ECO:0000269|PubMed:29911972, ECO:0000269|PubMed:9763581, ECO:0000305|PubMed:16510120}.",,,,,,,,,,,SITE 314 314 Essential for ubiquitin ligase activity. {ECO:0000250|UniProtKB:P40492}.,actomyosin contractile ring [GO:0005826]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; GID complex [GO:0034657]; integral component of plasma membrane [GO:0005887]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; enucleate erythrocyte development [GO:0048822]; erythrocyte maturation [GO:0043249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of myeloid cell apoptotic process [GO:0033033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle [GO:0007346]; ubiquitin-dependent protein catabolic process [GO:0006511],cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; enucleate erythrocyte development [GO:0048822]; erythrocyte maturation [GO:0043249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of myeloid cell apoptotic process [GO:0033033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle [GO:0007346]; ubiquitin-dependent protein catabolic process [GO:0006511],actin binding [GO:0003779]; metal ion binding [GO:0046872]; transferase activity [GO:0016740],actomyosin contractile ring [GO:0005826]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; GID complex [GO:0034657]; integral component of plasma membrane [GO:0005887]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151],GO:0000151; GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005826; GO:0005856; GO:0005887; GO:0006511; GO:0007010; GO:0007049; GO:0007155; GO:0007346; GO:0016363; GO:0016567; GO:0016740; GO:0033033; GO:0034657; GO:0043066; GO:0043161; GO:0043249; GO:0045721; GO:0046872; GO:0048822; GO:0051301,IPR013144; IPR024964; IPR006595; IPR027714; IPR006594; ,,"SUBUNIT: Identified in the CTLH complex that contains GID4, RANBP9 and/or RANBP10, MKLN1, MAEA, RMND5A (or alternatively its paralog RMND5B), GID8, ARMC8, WDR26 and YPEL5 (PubMed:17467196, PubMed:29911972). Within this complex, MAEA, RMND5A (or alternatively its paralog RMND5B), GID8, WDR26, and RANBP9 and/or RANBP10 form the catalytic core, while GID4, MKLN1, ARMC8 and YPEL5 have ancillary roles (PubMed:29911972). Interacts with F-actin (PubMed:16510120). {ECO:0000269|PubMed:16510120, ECO:0000269|PubMed:17467196, ECO:0000269|PubMed:29911972}.",14702039; 15489334; 9763581; 16510120; 17467196; 21269460; 23186163; 24143168; 29911972,14702039; 15489334; 9763581; 16510120; 17467196; 21269460; 23186163; 24143168; 29911972; 23566571; 26496610,2007-05-01,2019-02-13,2005-07-05,122,,,,,,,,,5 out of 5,Alternative sequence (6); Chain (1); Domain (2); Erroneous initiation (1); Erroneous termination (1); Frameshift (1); Modified residue (1); Natural variant (1); Region (1); Sequence caution (2); Sequence conflict (6); Site (1); Zinc finger (1),,TISSUE SPECIFICITY: Detected at macrophage membranes (at protein level). Ubiquitous. {ECO:0000269|PubMed:9763581}.,,Actin-binding;Alternative splicing;Cell cycle;Cell division;Cell membrane;Complete proteome;Cytoplasm;Cytoskeleton;Erythrocyte maturation;Membrane;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger,Evidence at protein level,reviewed,,,122,Alternative products (1); Catalytic activity (1); Caution (2); Domain (1); Function (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0009; KW-0025; KW-0131; KW-0132; KW-0181; KW-0206; KW-0265; KW-0472; KW-0479; KW-0539; KW-0597; KW-0621; KW-0808; KW-0832; KW-0833; KW-0862; KW-0863; KW-0963; KW-1003; KW-1185,,,,,,,,PTM: Autoubiquitinated as component of the CTLH E3 ubiquitin-protein ligase complex (in vitro). {ECO:0000269|PubMed:29911972}.,CHAIN 1 396 E3 ubiquitin-protein transferase MAEA. /FTId=PRO_0000284936.,,,,,,MOD_RES 28 28 Phosphothreonine. {ECO:0000244|PubMed:23186163}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AY236486;AK001088;AK022515;AK022586;BC001225;BC006470;AF084928;AY189687;BT006957;
0,Q86YS3,RFIP4_HUMAN,RAB11FIP4 ARFO2 KIAA1821,RAB11FIP4,ARFO2 KIAA1821,,,Homo sapiens (Human),9606,Rab11 family-interacting protein 4 (FIP4-Rab11) (Rab11-FIP4) (Arfophilin-2),UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAGGAGWSGAPAALLRSVRRLREVFEVCGRDPDGFLRVERVAALGLRFGQGEEVEKLVKYLDPNDLGRINFKDFCRGVFAMKGCEELLKDVLSVESAGTLPCAPEIPDCVEQGSEVTGPTFADGELIPREPGFFPEDEEEAMTLAPPEGPQELYTDSPMESTQSLEGSVGSPAEKDGGLGGLFLPEDKSLVHTPSMTTSDLSTHSTTSLISNEEQFEDYGEGDDVDCAPSSPCPDDETRTNVYSDLGSSVSSSAGQTPRKMRHVYNSELLDVYCSQCCKKINLLNDLEARLKNLKANSPNRKISSTAFGRQLMHSSNFSSSNGSTEDLFRDSIDSCDNDITEKVSFLEKKVTELENDSLTNGDLKSKLKQENTQLVHRVHELEEMVKDQETTAEQALEEEARRHREAYGKLEREKATEVELLNARVQQLEEENTELRTTVTRLKSQTEKLDEERQRMSDRLEDTSLRLKDEMDLYKRMMDKLRQNRLEFQKEREATQELIEDLRKELEHLQMYKLDCERPGRGRSASSGLGEFNARAREVELEHEVKRLKQENYKLRDQNDDLNGQILSLSLYEAKNLFAAQTKAQSLAAEIDTASRDELMEALKEQEEINFRLRQYMDKIILAILDHNPSILEIKH,637,"71,928",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q86YS3-1; Sequence=Displayed; Name=2; IsoId=Q86YS3-2; Sequence=VSP_013724, VSP_013725; ",,,,,,,,,,VAR_SEQ 1 102 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_013724.; VAR_SEQ 103 111 APEIPDCVE -> MRTPPALGS (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_013725.,,,,,CONFLICT 417 417 T -> I (in Ref. 2; BAC05045). {ECO:0000305}.; CONFLICT 518 518 E -> G (in Ref. 2; BAC05045). {ECO:0000305}.,,1,,0,DOMAIN: The RBD-FIP domain mediates the interaction with Rab11 (RAB11A or RAB11B). {ECO:0000250}.,,COILED 280 617 {ECO:0000255}.,,DOMAIN 49 84 EF-hand. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 574 636 FIP-RBD. {ECO:0000255|PROSITE-ProRule:PRU00844}.,,"REGION 82 637 Necessary for interaction with RAB11A, subcellular location, homo- or heterooligomerization.",,,,,,,,"FUNCTION: Acts as a regulator of endocytic traffic by participating in membrane delivery. Required for the abcission step in cytokinesis, possibly by acting as an 'address tag' delivering recycling endosome membranes to the cleavage furrow during late cytokinesis. In case of infection by HCMV (human cytomegalovirus), may participate in egress of the virus out of nucleus; this function is independent of ARF6. {ECO:0000269|PubMed:12470645}.",,,,,,,,,,,,cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; endocytic recycling [GO:0032456]; neural retina development [GO:0003407]; positive regulation of G1 to G0 transition [GO:1903452]; regulation of cytokinesis [GO:0032465]; viral process [GO:0016032],endocytic recycling [GO:0032456]; neural retina development [GO:0003407]; positive regulation of G1 to G0 transition [GO:1903452]; regulation of cytokinesis [GO:0032465]; viral process [GO:0016032],ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137],cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819],GO:0003407; GO:0005509; GO:0005615; GO:0005768; GO:0005815; GO:0005819; GO:0016032; GO:0017137; GO:0030139; GO:0030306; GO:0030496; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0048471; GO:0055038; GO:1903452,IPR011992; IPR002048; IPR037245; IPR019018; ,P62331; P62491,"SUBUNIT: Homodimer. Forms a complex with Rab11 (RAB11A or RAB11B) and ARF6. Interacts with RAB11A; the interaction is direct. Forms a heterooligomeric complex with RAB11FIP2, RAB11FIP3 and RAB11FIP5. Interacts with ECPAS. {ECO:0000269|PubMed:11944901, ECO:0000269|PubMed:12470645, ECO:0000269|PubMed:15601896, ECO:0000269|PubMed:16148947, ECO:0000269|PubMed:19761540, ECO:0000269|PubMed:20682791}.; SUBUNIT: (Microbial infection) Interacts with human cytomegalovirus/HHV-5 protein gM/UL100. {ECO:0000269|PubMed:19761540}.",12470645; 14702039; 15489334; 12696059; 11347906; 17974005; 11944901; 12857874; 16148947; 15601896; 19761540; 20682791; 23186163,12470645; 14702039; 15489334; 12696059; 11347906; 17974005; 11944901; 12857874; 16148947; 15601896; 19761540; 20682791; 23186163; 16713569; 18511905; 20379614; 22522702; 25745995; 28035375; 29257314,2005-05-10,2019-02-13,2003-06-01,138,,,,,,,,,5 out of 5,Alternative sequence (2); Calcium binding (1); Chain (1); Coiled coil (1); Domain (2); Mutagenesis (1); Region (1); Sequence conflict (2),,TISSUE SPECIFICITY: Present at high level in testis (at protein level). Weakly expressed in other tissues. {ECO:0000269|PubMed:12857874}.,,Alternative splicing;Calcium;Coiled coil;Complete proteome;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Endosome;Host-virus interaction;Membrane;Metal-binding;Reference proteome;Transport,Evidence at protein level,reviewed,,,138,Alternative products (1); Domain (1); Function (1); Subcellular location (1); Subunit structure (2); Tissue specificity (1),,KW-0025; KW-0106; KW-0175; KW-0181; KW-0206; KW-0472; KW-0479; KW-0813; KW-0945; KW-0963; KW-0967; KW-0968; KW-1185,,,,,,,,,CHAIN 1 637 Rab11 family-interacting protein 4. /FTId=PRO_0000073880.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AY169244;AK097424;BC093914;BC101517;AJ314646;AB058724;AL831830;
0,Q8IXJ6,SIR2_HUMAN,SIRT2 SIR2L SIR2L2,SIRT2,SIR2L SIR2L2,,,Homo sapiens (Human),9606,NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAEPDPSHPLETQAGKVQEAQDSDSDSEGGAAGGEADMDFLRNLFSQTLSLGSQKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQSGAGVPNPSTSASPKKSPPPAKDEARTTEREKPQ,389,"43,182",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=5;  Name=1; IsoId=Q8IXJ6-1; Sequence=Displayed; Name=2; IsoId=Q8IXJ6-2; Sequence=VSP_008724; Name=3; IsoId=Q8IXJ6-3; Sequence=VSP_008726; Note=No experimental confirmation available.; Name=4; IsoId=Q8IXJ6-4; Sequence=VSP_008727, VSP_008728; Note=No experimental confirmation available.; Name=5; IsoId=Q8IXJ6-5; Sequence=VSP_055328; Note=Lacks deacetylase activity, at least toward known SIRT2 targets.; ",,SEQUENCE CAUTION:  Sequence=AAD45971.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,SEQUENCE CAUTION:  Sequence=AAF67015.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305}; ,,,,,"VAR_SEQ 1 38 MAEPDPSHPLETQAGKVQEAQDSDSDSEGGAAGGEADM -> MPLAECPSCRCLSSFRSV (in isoform 3). {ECO:0000303|Ref.5}. /FTId=VSP_008726.; VAR_SEQ 1 37 Missing (in isoform 2). {ECO:0000303|PubMed:10393250, ECO:0000303|PubMed:10931946, ECO:0000303|PubMed:12065666, ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334}. /FTId=VSP_008724.; VAR_SEQ 6 76 PSHPLETQAGKVQEAQDSDSDSEGGAAGGEADMDFLRNLFSQTLSLGSQKERLLDELTLEGVARYMQSERC -> R (in isoform 5). {ECO:0000303|PubMed:24177535}. /FTId=VSP_055328.; VAR_SEQ 266 271 VQPFAS -> GRGLAG (in isoform 4). {ECO:0000303|Ref.10}. /FTId=VSP_008727.; VAR_SEQ 272 389 Missing (in isoform 4). {ECO:0000303|Ref.10}. /FTId=VSP_008728.",,,,,CONFLICT 199 199 S -> N (in Ref. 6). {ECO:0000305}.; CONFLICT 219 219 P -> L (in Ref. 5; CAD43717). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the sirtuin family. Class I subfamily. {ECO:0000305}.,,,DOMAIN 65 340 Deacetylase sirtuin-type. {ECO:0000255|PROSITE-ProRule:PRU00236}.,MOTIF 41 51 Nuclear export signal.,REGION 116 120 Peptide inhibitor binding.; REGION 232 301 Peptide inhibitor binding.,,,3.5.1.-,,"CATALYTIC ACTIVITY: Reaction=H2O + N(6)-acetyl-L-lysyl-[protein] + NAD(+) = 2''-O-acetyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide; Xref=Rhea:RHEA:43636, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15377, ChEBI:CHEBI:17154, ChEBI:CHEBI:29969, ChEBI:CHEBI:57540, ChEBI:CHEBI:61930, ChEBI:CHEBI:83767; Evidence={ECO:0000255|PROSITE-ProRule:PRU00236, ECO:0000269|PubMed:11483616, ECO:0000269|PubMed:11812793, ECO:0000269|PubMed:16648462, ECO:0000269|PubMed:18722353, ECO:0000269|PubMed:24177535, ECO:0000269|PubMed:24389023, ECO:0000269|PubMed:24940000, ECO:0000269|PubMed:25672491};",COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:25672491};  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:25672491};,,"FUNCTION: NAD-dependent protein deacetylase, which deacetylates internal lysines on histone and alpha-tubulin as well as many other proteins such as key transcription factors (PubMed:24177535, PubMed:12620231, PubMed:16648462, PubMed:18249187, PubMed:18332217, PubMed:18995842, PubMed:20587414, PubMed:21081649, PubMed:20543840, PubMed:22014574, PubMed:21726808, PubMed:21949390, PubMed:22771473, PubMed:23468428, PubMed:23908241, PubMed:24940000, PubMed:24769394, PubMed:24681946). Participates in the modulation of multiple and diverse biological processes such as cell cycle control, genomic integrity, microtubule dynamics, cell differentiation, metabolic networks, and autophagy. Plays a major role in the control of cell cycle progression and genomic stability. Functions in the antephase checkpoint preventing precocious mitotic entry in response to microtubule stress agents, and hence allowing proper inheritance of chromosomes. Positively regulates the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase complex activity by deacetylating CDC20 and FZR1, then allowing progression through mitosis. Associates both with chromatin at transcriptional start sites (TSSs) and enhancers of active genes. Plays a role in cell cycle and chromatin compaction through epigenetic modulation of the regulation of histone H4 'Lys-20' methylation (H4K20me1) during early mitosis. Specifically deacetylates histone H4 at 'Lys-16' (H4K16ac) between the G2/M transition and metaphase enabling H4K20me1 deposition by KMT5A leading to ulterior levels of H4K20me2 and H4K20me3 deposition throughout cell cycle, and mitotic S-phase progression (PubMed:23468428). Deacetylates KMT5A modulating KMT5A chromatin localization during the mitotic stress response (PubMed:23468428). Deacetylates also histone H3 at 'Lys-57' (H3K56ac) during the mitotic G2/M transition. Upon bacterium Listeria monocytogenes infection, deacetylates 'Lys-18' of histone H3 in a receptor tyrosine kinase MET- and PI3K/Akt-dependent manner, thereby inhibiting transcriptional activity and promoting late stages of listeria infection (PubMed:23908241). During oocyte meiosis progression, may deacetylate histone H4 at 'Lys-16' (H4K16ac) and alpha-tubulin, regulating spindle assembly and chromosome alignment by influencing microtubule dynamics and kinetochore function. Deacetylates histone H4 at 'Lys-16' (H4K16ac) at the VEGFA promoter and thereby contributes to regulate expression of VEGFA, a key regulator of angiogenesis (PubMed:24940000). Deacetylates alpha-tubulin at 'Lys-40' and hence controls neuronal motility, oligodendroglial cell arbor projection processes and proliferation of non-neuronal cells. Phosphorylation at Ser-368 by a G1/S-specific cyclin E-CDK2 complex inactivates SIRT2-mediated alpha-tubulin deacetylation, negatively regulating cell adhesion, cell migration and neurite outgrowth during neuronal differentiation. Deacetylates PARD3 and participates in the regulation of Schwann cell peripheral myelination formation during early postnatal development and during postinjury remyelination. Involved in several cellular metabolic pathways. Plays a role in the regulation of blood glucose homeostasis by deacetylating and stabilizing phosphoenolpyruvate carboxykinase PCK1 activity in response to low nutrient availability. Acts as a key regulator in the pentose phosphate pathway (PPP) by deacetylating and activating the glucose-6-phosphate G6PD enzyme, and therefore, stimulates the production of cytosolic NADPH to counteract oxidative damage. Maintains energy homeostasis in response to nutrient deprivation as well as energy expenditure by inhibiting adipogenesis and promoting lipolysis. Attenuates adipocyte differentiation by deacetylating and promoting FOXO1 interaction to PPARG and subsequent repression of PPARG-dependent transcriptional activity. Plays a role in the regulation of lysosome-mediated degradation of protein aggregates by autophagy in neuronal cells. Deacetylates FOXO1 in response to oxidative stress or serum deprivation, thereby negatively regulating FOXO1-mediated autophagy (PubMed:20543840). Deacetylates a broad range of transcription factors and co-regulators regulating target gene expression. Deacetylates transcriptional factor FOXO3 stimulating the ubiquitin ligase SCF(SKP2)-mediated FOXO3 ubiquitination and degradation (By similarity). Deacetylates HIF1A and therefore promotes HIF1A degradation and inhibition of HIF1A transcriptional activity in tumor cells in response to hypoxia (PubMed:24681946). Deacetylates RELA in the cytoplasm inhibiting NF-kappaB-dependent transcription activation upon TNF-alpha stimulation. Inhibits transcriptional activation by deacetylating p53/TP53 and EP300 (PubMed:18249187). Deacetylates also EIF5A (PubMed:22771473). Functions as a negative regulator on oxidative stress-tolerance in response to anoxia-reoxygenation conditions. Plays a role as tumor suppressor (PubMed:22014574). {ECO:0000250|UniProtKB:Q8VDQ8, ECO:0000269|PubMed:12620231, ECO:0000269|PubMed:12697818, ECO:0000269|PubMed:16648462, ECO:0000269|PubMed:16909107, ECO:0000269|PubMed:17488717, ECO:0000269|PubMed:17574768, ECO:0000269|PubMed:17726514, ECO:0000269|PubMed:18249187, ECO:0000269|PubMed:18332217, ECO:0000269|PubMed:18640115, ECO:0000269|PubMed:18722353, ECO:0000269|PubMed:18995842, ECO:0000269|PubMed:19282667, ECO:0000269|PubMed:20543840, ECO:0000269|PubMed:20587414, ECO:0000269|PubMed:21081649, ECO:0000269|PubMed:21726808, ECO:0000269|PubMed:21949390, ECO:0000269|PubMed:22014574, ECO:0000269|PubMed:22771473, ECO:0000269|PubMed:22819792, ECO:0000269|PubMed:23468428, ECO:0000269|PubMed:23908241, ECO:0000269|PubMed:23932781, ECO:0000269|PubMed:24177535, ECO:0000269|PubMed:24681946, ECO:0000269|PubMed:24769394, ECO:0000269|PubMed:24940000}.; FUNCTION: Isoform 1: Deacetylates EP300, alpha-tubulin and histone H3 and H4. {ECO:0000269|PubMed:24177535}.; FUNCTION: Isoform 2: Deacetylates EP300, alpha-tubulin and histone H3 and H4. {ECO:0000269|PubMed:24177535}.; FUNCTION: Isoform 5: Lacks deacetylation activity. {ECO:0000269|PubMed:24177535}.",,,,,,ACT_SITE 187 187 Proton acceptor. {ECO:0000305}.,"BINDING 324 324 NAD; via amide nitrogen. {ECO:0000244|PDB:4RMG, ECO:0000269|PubMed:25672491}.",,"METAL 195 195 Zinc. {ECO:0000255|PROSITE-ProRule:PRU00236, ECO:0000269|PubMed:11427894, ECO:0000269|PubMed:23454361, ECO:0000269|PubMed:24389023, ECO:0000269|PubMed:25672491}.; METAL 200 200 Zinc. {ECO:0000255|PROSITE-ProRule:PRU00236, ECO:0000269|PubMed:11427894, ECO:0000269|PubMed:23454361, ECO:0000269|PubMed:24389023, ECO:0000269|PubMed:25672491}.; METAL 221 221 Zinc. {ECO:0000255|PROSITE-ProRule:PRU00236, ECO:0000269|PubMed:11427894, ECO:0000269|PubMed:23454361, ECO:0000269|PubMed:24389023, ECO:0000269|PubMed:25672491}.; METAL 224 224 Zinc. {ECO:0000255|PROSITE-ProRule:PRU00236, ECO:0000269|PubMed:11427894, ECO:0000269|PubMed:23454361, ECO:0000269|PubMed:24389023, ECO:0000269|PubMed:25672491}.","NP_BIND 85 89 NAD. {ECO:0000244|PDB:4RMG, ECO:0000269|PubMed:25672491}.; NP_BIND 95 97 NAD. {ECO:0000244|PDB:4RMG, ECO:0000269|PubMed:25672491}.; NP_BIND 167 170 NAD. {ECO:0000244|PDB:4RMG, ECO:0000269|PubMed:25672491}.; NP_BIND 262 263 NAD. {ECO:0000244|PDB:4RMG, ECO:0000269|PubMed:25672491}.; NP_BIND 286 288 NAD. {ECO:0000244|PDB:4RMG, ECO:0000269|PubMed:25672491}.",,"centriole [GO:0005814]; centrosome [GO:0005813]; chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; chromatin silencing [GO:0006342]; chromatin silencing at rDNA [GO:0000183]; chromatin silencing at telomere [GO:0006348]; gene silencing [GO:0016458]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; innate immune response [GO:0045087]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; regulation of cell cycle [GO:0051726]; regulation of exit from mitosis [GO:0007096]; regulation of myelination [GO:0031641]; regulation of phosphorylation [GO:0042325]; response to redox state [GO:0051775]; substantia nigra development [GO:0021762]; tubulin deacetylation [GO:0090042]","autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; chromatin silencing [GO:0006342]; chromatin silencing at rDNA [GO:0000183]; chromatin silencing at telomere [GO:0006348]; gene silencing [GO:0016458]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; innate immune response [GO:0045087]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; regulation of cell cycle [GO:0051726]; regulation of exit from mitosis [GO:0007096]; regulation of myelination [GO:0031641]; regulation of phosphorylation [GO:0042325]; response to redox state [GO:0051775]; substantia nigra development [GO:0021762]; tubulin deacetylation [GO:0090042]",chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270],"centriole [GO:0005814]; centrosome [GO:0005813]; chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]",GO:0000122; GO:0000183; GO:0000781; GO:0003682; GO:0004407; GO:0005634; GO:0005677; GO:0005694; GO:0005720; GO:0005730; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006342; GO:0006348; GO:0006471; GO:0006476; GO:0006914; GO:0007096; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0010801; GO:0014065; GO:0016458; GO:0016575; GO:0017136; GO:0021762; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0035035; GO:0035729; GO:0042177; GO:0042325; GO:0042826; GO:0042903; GO:0043130; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0043491; GO:0044224; GO:0044242; GO:0045087; GO:0045599; GO:0045836; GO:0045843; GO:0045892; GO:0045944; GO:0046970; GO:0048012; GO:0048471; GO:0051301; GO:0051321; GO:0051726; GO:0051775; GO:0051781; GO:0051987; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070932; GO:0070933; GO:0071219; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:1900195; GO:1900226; GO:1900425; GO:2000378; GO:2000777,IPR029035; IPR003000; IPR026591; IPR017328; IPR026590; ,O60566; O60729; Q12834; Q9UM11; P11413; Q92831; Q04206,"SUBUNIT: Interacts with CDC20, FOXO3 and FZR1. Associates with microtubules in primary cortical mature neurons (By similarity). Homotrimer. Isoform 1 and isoform 2 interact (via both phosphorylated, unphosphorylated, active or inactive forms) with HDAC6; the interaction is necessary for the complex to interact with alpha-tubulin, suggesting that these proteins belong to a large complex that deacetylates the cytoskeleton. Interacts with FOXO1; the interaction is disrupted upon serum-starvation or oxidative stress, leading to increased level of acetylated FOXO1 and induction of autophagy. Interacts with RELA; the interaction occurs in the cytoplasm and is increased in a TNF-alpha-dependent manner. Interacts with HOXA10; the interaction is direct. Interacts with YWHAB and YWHAG; the interactions occur in a AKT-dependent manner and increase SIRT2-dependent TP53 deacetylation. Interacts with MAPK1/ERK2 and MAPK3/ERK1; the interactions increase SIRT2 stability and deacetylation activity. Interacts (phosphorylated form) with KMT5A isoform 2; the interaction is direct, stimulates KMT5A-mediated methyltransferase activity on histone at 'Lys-20' (H4K20me1) and is increased in a H(2)O(2)-induced oxidative stress-dependent manner. Interacts with G6PD; the interaction is enhanced by H(2)O(2) treatment. Interacts with a G1/S-specific cyclin E-CDK2 complex. Interacts with AURKA, CDK5R1 (p35 form) and CDK5 and HIF1A. Isoform 1, isoform 2 and isoform 5 interact (via C-terminus region) with EP300 (PubMed:24177535). Interacts with the tRNA ligase SARS; recruited to the VEGFA promoter via interaction with SARS (PubMed:24940000). Interacts with BEX4; negatively regulates alpha-tubulin deacetylation by SIRT2 (PubMed:27512957). {ECO:0000250, ECO:0000250|UniProtKB:Q8VDQ8, ECO:0000269|PubMed:11427894, ECO:0000269|PubMed:12620231, ECO:0000269|PubMed:15213244, ECO:0000269|PubMed:16648462, ECO:0000269|PubMed:17726514, ECO:0000269|PubMed:18249187, ECO:0000269|PubMed:18332217, ECO:0000269|PubMed:18722353, ECO:0000269|PubMed:20543840, ECO:0000269|PubMed:21081649, ECO:0000269|PubMed:21949390, ECO:0000269|PubMed:23454361, ECO:0000269|PubMed:23468428, ECO:0000269|PubMed:23806683, ECO:0000269|PubMed:24177535, ECO:0000269|PubMed:24389023, ECO:0000269|PubMed:24681946, ECO:0000269|PubMed:24769394, ECO:0000269|PubMed:24940000, ECO:0000269|PubMed:27512957}.",10381378; 10393250; 12065666; 24177535; 10931946; 14702039; 15489334; 11226170; 11483616; 11812793; 12620231; 12697818; 12963026; 15213244; 16079181; 17081983; 16648462; 17488717; 17516032; 17574768; 16909107; 17726514; 18249187; 18722353; 18640115; 18332217; 18995842; 18669648; 19413330; 19282667; 19690332; 20587414; 21081649; 20543840; 22014574; 21791548; 21726808; 21949390; 22771473; 22819792; 22943040; 23806683; 23468428; 23186163; 23932781; 23908241; 24940000; 24769394; 24275569; 24681946; 27512957; 11427894; 23454361; 24389023; 25672491,10381378; 10393250; 12065666; 24177535; 10931946; 14702039; 15489334; 11226170; 11483616; 11812793; 12620231; 12697818; 12963026; 15213244; 16079181; 17081983; 16648462; 17488717; 17516032; 17574768; 16909107; 17726514; 18249187; 18722353; 18640115; 18332217; 18995842; 18669648; 19413330; 19282667; 19690332; 20587414; 21081649; 20543840; 22014574; 21791548; 21726808; 21949390; 22771473; 22819792; 22943040; 23806683; 23468428; 23186163; 23932781; 23908241; 24940000; 24769394; 24275569; 24681946; 27512957; 11427894; 23454361; 24389023; 25672491; 12887892; 15274642; 15328540; 16211212; 16565078; 17353931; 17708669; 18249170; 20237298; 20378838; 20562129; 21349544; 22089141; 22166219; 22302938; 22651940; 22735931; 22796962; 22857867; 22944623; 23175188; 23201684; 23217706; 23348706; 23358244; 23382805; 23416275; 23460888; 23475622; 23712749; 23723075; 23900402; 23915912; 24139700; 24161395; 24183459; 24362520; 24438005; 24446434; 24497179; 24652283; 24681949; 24792244; 24814981; 24825348; 24939540; 24996174; 25195573; 25285631; 25285640; 25341037; 25369635; 25640309; 25660418; 25666612; 25704306; 25794641; 25897714; 25915617; 25924011; 25934993; 25960087; 26001219; 26303530; 26538315; 26625292; 26638075; 26696402; 26701732; 26748890; 26808575; 26820517; 26854234; 26942878; 27036868; 27226597; 27229617; 27291931; 27311481; 27311773; 27322457; 27460777; 27503897; 27503926; 27586085; 27610633; 27783945; 27838300; 27875273; 28073696; 28103679; 28135086; 28166441; 28168426; 28240897; 28257421; 28259910; 28273448; 28287409; 28292463; 28436968; 28445509; 28461331; 28514749; 28973648; 29239724; 29262808; 29267359; 29366781; 29371109; 29545174; 29614506; 29685974; 29901178; 29908203; 29925042; 29957526; 30154464,2003-10-31,2019-02-13,2003-10-31,181,X-ray crystallography (29),STRAND 60 63 {ECO:0000244|PDB:4RMH}.; STRAND 73 75 {ECO:0000244|PDB:3ZGV}.; STRAND 79 83 {ECO:0000244|PDB:4RMH}.; STRAND 96 98 {ECO:0000244|PDB:4RMI}.; STRAND 139 142 {ECO:0000244|PDB:3ZGO}.; STRAND 161 166 {ECO:0000244|PDB:4RMH}.; STRAND 183 185 {ECO:0000244|PDB:4RMH}.; STRAND 188 196 {ECO:0000244|PDB:4RMH}.; STRAND 203 205 {ECO:0000244|PDB:4RMH}.; STRAND 227 232 {ECO:0000244|PDB:4RMH}.; STRAND 255 261 {ECO:0000244|PDB:4RMH}.; STRAND 264 266 {ECO:0000244|PDB:5Y0Z}.; STRAND 282 288 {ECO:0000244|PDB:4RMH}.; STRAND 309 311 {ECO:0000244|PDB:4RMH}.; STRAND 316 322 {ECO:0000244|PDB:4RMH}.,HELIX 35 45 {ECO:0000244|PDB:3ZGO}.; HELIX 64 71 {ECO:0000244|PDB:4RMH}.; HELIX 85 87 {ECO:0000244|PDB:4RMH}.; HELIX 89 91 {ECO:0000244|PDB:4RMH}.; HELIX 99 101 {ECO:0000244|PDB:4RMH}.; HELIX 103 105 {ECO:0000244|PDB:4X3O}.; HELIX 108 110 {ECO:0000244|PDB:4X3O}.; HELIX 115 119 {ECO:0000244|PDB:4RMH}.; HELIX 121 126 {ECO:0000244|PDB:4RMH}.; HELIX 129 138 {ECO:0000244|PDB:4RMH}.; HELIX 147 157 {ECO:0000244|PDB:4RMH}.; HELIX 172 175 {ECO:0000244|PDB:4RMH}.; HELIX 180 182 {ECO:0000244|PDB:4RMH}.; HELIX 206 215 {ECO:0000244|PDB:4RMH}.; HELIX 241 250 {ECO:0000244|PDB:4RMH}.; HELIX 269 275 {ECO:0000244|PDB:4RMH}.; HELIX 301 303 {ECO:0000244|PDB:5DY4}.; HELIX 324 334 {ECO:0000244|PDB:4RMH}.; HELIX 338 353 {ECO:0000244|PDB:4RMH}.,TURN 198 200 {ECO:0000244|PDB:4RMH}.; TURN 222 224 {ECO:0000244|PDB:4RMH}.; TURN 251 253 {ECO:0000244|PDB:4RMI}.; TURN 295 297 {ECO:0000244|PDB:4X3O}.,,,,,5 out of 5,Active site (1); Alternative sequence (5); Beta strand (15); Binding site (1); Chain (1); Domain (1); Erroneous initiation (1); Frameshift (1); Helix (19); Initiator methionine (1); Metal binding (4); Modified residue (9); Motif (1); Mutagenesis (23); Nucleotide binding (5); Region (2); Sequence conflict (2); Turn (4),,"TISSUE SPECIFICITY: Isoform 1 is expressed in heart, liver and skeletal muscle, weakly expressed in the cortex. Isoform 2 is strongly expressed in the cortex, weakly expressed in heart and liver. Weakly expressed in several malignancies including breast, liver, brain, kidney and prostate cancers compared to normal tissues. Weakly expressed in glioma cell lines compared to normal brain tissues (at protein level). Widely expressed. Highly expressed in heart, brain and skeletal muscle, while it is weakly expressed in placenta and lung. Down-regulated in many gliomas suggesting that it may act as a tumor suppressor gene in human gliomas possibly through the regulation of microtubule network. {ECO:0000269|PubMed:10381378, ECO:0000269|PubMed:10393250, ECO:0000269|PubMed:12963026, ECO:0000269|PubMed:16909107, ECO:0000269|PubMed:21791548, ECO:0000269|PubMed:22014574}.",,3D-structure;Acetylation;Alternative splicing;Autophagy;Cell cycle;Cell division;Cell membrane;Cell projection;Chromosome;Complete proteome;Cytoplasm;Cytoskeleton;Differentiation;Hydrolase;Immunity;Innate immunity;Meiosis;Membrane;Metal-binding;Microtubule;Mitosis;NAD;Neurodegeneration;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc,Evidence at protein level,reviewed,,"Sirtuin family, Class I subfamily",181,Activity regulation (1); Alternative products (1); Catalytic activity (1); Caution (3); Cofactor (1); Developmental stage (1); Function (4); Induction (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (4); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0072; KW-0131; KW-0132; KW-0158; KW-0181; KW-0206; KW-0221; KW-0378; KW-0391; KW-0399; KW-0469; KW-0472; KW-0479; KW-0493; KW-0498; KW-0520; KW-0523; KW-0524; KW-0539; KW-0597; KW-0804; KW-0805; KW-0832; KW-0862; KW-0963; KW-0966; KW-1003; KW-1185,,,,,,,,"PTM: Phosphorylated at phosphoserine and phosphothreonine. Phosphorylated at Ser-368 by a mitotic kinase CDK1/cyclin B at the G2/M transition; phosphorylation regulates the delay in cell-cycle progression. Phosphorylated at Ser-368 by a mitotic kinase G1/S-specific cyclin E/Cdk2 complex; phosphorylation inactivates SIRT2-mediated alpha-tubulin deacetylation and thereby negatively regulates cell adhesion, cell migration and neurite outgrowth during neuronal differentiation. Phosphorylated by cyclin A/Cdk2 and p35-Cdk5 complexes and to a lesser extent by the cyclin D3/Cdk4 and cyclin B/Cdk1, in vitro. Dephosphorylated at Ser-368 by CDC14A and CDC14B around early anaphase. {ECO:0000269|PubMed:12697818, ECO:0000269|PubMed:17488717, ECO:0000269|PubMed:17516032, ECO:0000269|PubMed:18332217}.; PTM: Acetylated by EP300; acetylation leads both to the decreased of SIRT2-mediated alpha-tubulin deacetylase activity and SIRT2-mediated down-regulation of TP53 transcriptional activity. {ECO:0000269|PubMed:18722353}.; PTM: Ubiquitinated. {ECO:0000269|PubMed:12697818, ECO:0000269|PubMed:17516032}.",CHAIN 2 389 NAD-dependent protein deacetylase sirtuin-2. /FTId=PRO_0000110258.,,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330}.,,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330}.; MOD_RES 23 23 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 25 25 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 27 27 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 53 53 Phosphoserine. {ECO:0000250|UniProtKB:Q5RJQ4}.; MOD_RES 100 100 Phosphoserine. {ECO:0000250|UniProtKB:Q5RJQ4}.; MOD_RES 207 207 Phosphoserine. {ECO:0000250|UniProtKB:Q5RJQ4}.; MOD_RES 368 368 Phosphoserine; by CDK2 and CDK5. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:17488717, ECO:0000269|PubMed:17516032, ECO:0000269|PubMed:18332217}.; MOD_RES 372 372 Phosphoserine. {ECO:0000269|PubMed:17516032}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF083107;AF095714;AY030277;KF032391;AJ505014;AF160214;AK290716;AK314492;CH471126;CH471126;BC003012;BC003547;AF131800;
0,Q8IYM1,SEP12_HUMAN,SEPT12,SEPT12,,,,Homo sapiens (Human),9606,Septin-12,UP000005640: Chromosome 16,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDPLRRSPSPCLSSQPSSPSTPPCEMLGPVGIEAVLDQLKIKAMKMGFEFNIMVVGQSGLGKSTMVNTLFKSKVWKSNPPGLGVPTPQTLQLHSLTHVIEEKGVKLKLTVTDTPGFGDQINNDNCWDPILGYINEQYEQYLQEEILITRQRHIPDTRVHCCVYFVPPTGHCLRPLDIEFLQRLCRTVNVVPVIARADSLTMEEREAFRRRIQQNLRTHCIDVYPQMCFDEDINDKILNSKLRDRIPFAVVGADQEHLVNGRCVLGRKTKWGIIEVENMAHCEFPLLRDLLIRSHLQDLKDITHNIHYENYRVIRLNESHLLPRGPGWVNLAPASPGQLTTPRTFKVCRGAHDDSDDEF,358,"40,748",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q8IYM1-1; Sequence=Displayed; Name=2; IsoId=Q8IYM1-2; Sequence=VSP_029918; ,,SEQUENCE CAUTION:  Sequence=AAH24017.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 125 170 Missing (in isoform 2). {ECO:0000303|PubMed:17685441, ECO:0000303|PubMed:18047794}. /FTId=VSP_029918.","VARIANT 89 89 T -> M (in SPGF10; results in significantly reduced GTP hydrolysis; disrupts interaction with SEPT7, SEPT6 and SEPT2; decreases interaction with SPAG4; dbSNP:rs199696526). {ECO:0000269|PubMed:22275165, ECO:0000269|PubMed:25588830, ECO:0000269|PubMed:25775403}. /FTId=VAR_068097.; VARIANT 197 197 D -> N (in SPGF10; results in significantly reduced GTP hydrolysis due to impaired GTP binding; disrupts interaction with SEPT7, SEPT6 and SEPT2; absence of SEPT12, SEPT7, SEPT6, SEPT2 and SEPT4 from the sperm annulus; disrupts interaction with LMNB1; dbSNP:rs371195126). {ECO:0000269|PubMed:22275165, ECO:0000269|PubMed:25588830, ECO:0000269|PubMed:25775403}. /FTId=VAR_068098.; VARIANT 213 213 Q -> R (in dbSNP:rs6500633). /FTId=VAR_057176.",,,,CONFLICT 22 22 P -> T (in Ref. 6; AAH24017). {ECO:0000305}.; CONFLICT 258 258 V -> M (in Ref. 4; BAB71681). {ECO:0000305}.; CONFLICT 280 280 H -> L (in Ref. 6; AAH24017). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like GTPase superfamily. Septin GTPase family. {ECO:0000255|PROSITE-ProRule:PRU01056}.,,,DOMAIN 46 317 Septin-type G. {ECO:0000255|PROSITE-ProRule:PRU01056}.,,REGION 46 319 Interaction with SEPT7. {ECO:0000269|PubMed:25588830}.; REGION 56 63 G1 motif. {ECO:0000255|PROSITE-ProRule:PRU01056}.; REGION 112 115 G3 motif. {ECO:0000255|PROSITE-ProRule:PRU01056}.; REGION 194 197 G4 motif. {ECO:0000255|PROSITE-ProRule:PRU01056}.; REGION 258 358 Self-association (via N-terminus) to polymerize octomeric septin 12-7-6-2/4-2/4-6-7-12 filaments.,,,,,,,,"FUNCTION: Filament-forming cytoskeletal GTPase (By similarity). Involved in spermatogenesis. Involved in the morphogenesis of sperm heads and the elongation of sperm tails probably implicating the association with alpha- and beta-tubulins (PubMed:24213608). Forms a filamentous structure with SEPT7, SEPT6, SEPT2 and probably SEPT4 at the sperm annulus which is required for the structural integrity and motility of the sperm tail during postmeiotic differentiation (PubMed:25588830). May play a role in cytokinesis (Potential). {ECO:0000250, ECO:0000269|PubMed:24213608, ECO:0000269|PubMed:25588830, ECO:0000305}.",,,,,,,BINDING 89 89 GTP. {ECO:0000250}.; BINDING 115 115 GTP; via amide nitrogen. {ECO:0000250}.; BINDING 251 251 GTP; via amide nitrogen and carbonyl oxygen. {ECO:0000250}.; BINDING 266 266 GTP. {ECO:0000250}.,,,NP_BIND 56 63 GTP. {ECO:0000250}.; NP_BIND 195 203 GTP. {ECO:0000250}.,,cleavage furrow [GO:0032154]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein-containing complex scaffold activity [GO:0032947]; cell differentiation [GO:0030154]; cytoskeleton-dependent cytokinesis [GO:0061640]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283],cell differentiation [GO:0030154]; cytoskeleton-dependent cytokinesis [GO:0061640]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283],GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein-containing complex scaffold activity [GO:0032947]; protein homodimerization activity [GO:0042803],cleavage furrow [GO:0032154]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725],GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005819; GO:0005940; GO:0007283; GO:0015630; GO:0019003; GO:0030154; GO:0030317; GO:0030496; GO:0031105; GO:0032154; GO:0032947; GO:0035091; GO:0042802; GO:0042803; GO:0048471; GO:0061640; GO:0097227,IPR030379; IPR027417; IPR016491; ,Itself; Q8WYJ6; Q15019; O43236; Q14141; Q16181; Q9NPE6,"SUBUNIT: Septins polymerize into heterooligomeric protein complexes that form filaments, and can associate with cellular membranes, actin filaments and microtubules. GTPase activity is required for filament formation (By similarity). Interacts with SEPT6 and SEPT11. Self-associates. Component of a septin core octomeric complex consisting of SEPT12, SEPT7, SEPT6 and SEPT2 or SEPT4 in the order 12-7-6-2-2-6-7-12 or 12-7-6-4-4-6-7-12 and located in the sperm annulus; the octomer polymerizes into filaments via the SEPT12 N- and C-termini; the SEPT12:SEPT7 association is mediated by the respective GTP-binding domains (PubMed:25588830). Interacts with SPAG4 and LMNB1 (PubMed:25775403). Associates with alpha- and beta-tubulins (PubMed:24213608). {ECO:0000250, ECO:0000269|PubMed:18047794, ECO:0000269|PubMed:18443421, ECO:0000269|PubMed:24213608, ECO:0000269|PubMed:25588830}.",17685441; 18047794; 14702039; 15489334; 15915442; 17967425; 18443421; 20801438; 22275165; 24213608; 25588830; 25775403,17685441; 18047794; 14702039; 15489334; 15915442; 17967425; 18443421; 20801438; 22275165; 24213608; 25588830; 25775403; 19359518; 21636737; 22116646; 22479503; 25416956; 27854341,2007-12-04,2019-02-13,2003-03-01,131,,,,,,,,,5 out of 5,Alternative sequence (1); Binding site (4); Chain (1); Domain (1); Erroneous initiation (1); Mutagenesis (1); Natural variant (3); Nucleotide binding (2); Region (5); Sequence conflict (3),,"TISSUE SPECIFICITY: Widely expressed. Expressed in lymph node. {ECO:0000269|PubMed:15915442, ECO:0000269|PubMed:17967425}.",,Alternative splicing;Cell cycle;Cell division;Cell projection;Cilium;Complete proteome;Cytoplasm;Cytoskeleton;Differentiation;Disease mutation;Flagellum;GTP-binding;Nucleotide-binding;Nucleus;Polymorphism;Reference proteome;Spermatogenesis,Evidence at protein level,reviewed,,"TRAFAC class TrmE-Era-EngA-EngB-Septin-like GTPase superfamily, Septin GTPase family",131,Alternative products (1); Developmental stage (1); Function (1); Involvement in disease (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0131; KW-0132; KW-0181; KW-0206; KW-0221; KW-0225; KW-0282; KW-0342; KW-0539; KW-0547; KW-0621; KW-0744; KW-0963; KW-0966; KW-0969; KW-1185,,,,,"DISEASE: Spermatogenic failure 10 (SPGF10) [MIM:614822]: An infertility disorder caused by spermatogenesis defects. It results in decreased sperm motility, concentration, and multiple sperm structural defects. The most prominent feature is a defective sperm annulus, a ring structure that demarcates the midpiece and the principal piece of the sperm tail. {ECO:0000269|PubMed:22275165, ECO:0000269|PubMed:25588830, ECO:0000269|PubMed:25775403}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 358 Septin-12. /FTId=PRO_0000312860.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,DQ456996;DQ517531;EF620906;AK058139;CH471112;BC024017;BC035619;
0,Q8TAP9,MPLKI_HUMAN,MPLKIP C7orf11 TTDN1,MPLKIP,C7orf11 TTDN1,,,Homo sapiens (Human),9606,M-phase-specific PLK1-interacting protein (TTD non-photosensitive 1 protein),UP000005640: Chromosome 7,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MQRQNFRPPTPPYPGPGGGGWGSGSSFRGTPGGGGPRPPSPRDGYGSPHHTPPYGPRSRPYGSSHSPRHGGSFPGGRFGSPSPGGYPGSYSRSPAGSQQQFGYSPGQQQTHPQGSPRTSTPFGSGRVREKRMSNELENYFKPSMLEDPWAGLEPVSVVDISQQYSNTQTFTGKKGRYFC,179,"19,147",,,,,,,,,,,,,VARIANT 29 29 G -> E (in a breast cancer sample; somatic mutation; dbSNP:rs565833937). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036273.; VARIANT 144 144 M -> V (in TTD4; dbSNP:rs137853117). {ECO:0000269|PubMed:15645389}. /FTId=VAR_022940.,,,,,,1,,0,,,,,,,,,,,,,,,FUNCTION: May play a role in maintenance of cell cycle integrity by regulating mitosis or cytokinesis. {ECO:0000269|PubMed:17310276}.,,,,,,,,,,,,centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301],cell cycle [GO:0007049]; cell division [GO:0051301],,centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0007049; GO:0030496; GO:0043231; GO:0051301,IPR026618; IPR028265; ,,SUBUNIT: Interacts with PLK1; phosphorylation-dependent. {ECO:0000269|PubMed:17310276}.,15489334; 11829489; 17081983; 17310276; 18691976; 18669648; 20068231; 23186163; 24129315; 15645389; 16959974,15489334; 11829489; 17081983; 17310276; 18691976; 18669648; 20068231; 23186163; 24129315; 15645389; 16959974; 16977596; 25290684; 26518168; 26880286; 29421601,2005-07-19,2019-02-13,2002-06-01,123,,,,,,,,,5 out of 5,Chain (1); Modified residue (18); Mutagenesis (3); Natural variant (2),,"TISSUE SPECIFICITY: Expressed at highest levels in liver and kidney; intermediate expression in skeletal muscle, pancreas, heart and placenta; low expression in brain and lung. Expressed in epidermis and hair follicles. {ECO:0000269|PubMed:11829489, ECO:0000269|PubMed:15645389}.",,Cell cycle;Cell division;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Methylation;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,,123,Function (1); Involvement in disease (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0131; KW-0132; KW-0181; KW-0206; KW-0225; KW-0488; KW-0498; KW-0539; KW-0597; KW-0621; KW-0963; KW-1185,,,,,"DISEASE: Trichothiodystrophy 4, non-photosensitive (TTD4) [MIM:234050]: A form of trichothiodystrophy, an autosomal recessive disease characterized by sulfur-deficient brittle hair and multisystem variable abnormalities. The spectrum of clinical features varies from mild disease with only hair involvement to severe disease with cutaneous, neurologic and profound developmental defects. Ichthyosis, intellectual and developmental disabilities, decreased fertility, abnormal characteristics at birth, ocular abnormalities, short stature, and infections are common manifestations. There are both photosensitive and non-photosensitive forms of the disorder. TTD4 patients do not manifest cutaneous photosensitivity. {ECO:0000269|PubMed:15645389}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: Phosphorylated during mitosis in the cell cycle probably by CDK1. {ECO:0000269|PubMed:17310276}.,CHAIN 1 179 M-phase-specific PLK1-interacting protein. /FTId=PRO_0000065674.,,,,,,"MOD_RES 37 37 Asymmetric dimethylarginine. {ECO:0000250|UniProtKB:Q9D011}.; MOD_RES 40 40 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 47 47 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 51 51 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 57 57 Omega-N-methylarginine. {ECO:0000244|PubMed:24129315}.; MOD_RES 59 59 Asymmetric dimethylarginine. {ECO:0000244|PubMed:24129315}.; MOD_RES 68 68 Asymmetric dimethylarginine. {ECO:0000244|PubMed:24129315}.; MOD_RES 72 72 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231}.; MOD_RES 77 77 Asymmetric dimethylarginine. {ECO:0000244|PubMed:24129315}.; MOD_RES 80 80 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 82 82 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 93 93 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000269|PubMed:17310276}.; MOD_RES 104 104 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000269|PubMed:17310276}.; MOD_RES 115 115 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 117 117 Omega-N-methylarginine. {ECO:0000244|PubMed:24129315}.; MOD_RES 120 120 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 124 124 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 133 133 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,BC026265;
0,Q8TDX7,NEK7_HUMAN,NEK7,NEK7,,,,Homo sapiens (Human),9606,Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS,302,"34,551",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q8TDX7-1; Sequence=Displayed; Name=2; IsoId=Q8TDX7-2; Sequence=VSP_041243, VSP_041244; Note=No experimental confirmation available.; ",,,,,,,,,,VAR_SEQ 67 119 IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL -> VCLLPVWERRVCALNACYFLEIIKGSESLQYMATLTNLFENLPVSHHGSFAKK (in isoform 2). {ECO:0000303|Ref.2}. /FTId=VSP_041243.; VAR_SEQ 120 302 Missing (in isoform 2). {ECO:0000303|Ref.2}. /FTId=VSP_041244.,VARIANT 35 35 R -> G (in dbSNP:rs55833332). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040924.; VARIANT 275 275 I -> M (in an ovarian serous carcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040925.,,,,,,1,,0,"DOMAIN: Displays an autoinhibited conformation: Tyr-97 side chain points into the active site, interacts with the activation loop, and blocks the alphaC helix. The autoinhibitory conformation is released upon binding with NEK9. {ECO:0000269|PubMed:19941817}.; DOMAIN: The NTE (N-terminal extension) motif is a structural component of the catalytic domain and thus contributes to activity. {ECO:0000269|PubMed:19941817}.",SIMILARITY: Belongs to the protein kinase superfamily. NEK Ser/Thr protein kinase family. NIMA subfamily. {ECO:0000305}.,,,DOMAIN 34 299 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,REGION 20 33 NTE motif.,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ,,"FUNCTION: Protein kinase which plays an important role in mitotic cell cycle progression. Required for microtubule nucleation activity of the centrosome, robust mitotic spindle formation and cytokinesis. Phosphorylates RPS6KB1. {ECO:0000269|PubMed:17101132, ECO:0000269|PubMed:17586473, ECO:0000269|PubMed:19414596}.",,,,,,"ACT_SITE 161 161 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 63 63 ATP.,,,NP_BIND 40 48 ATP.,SITE 97 97 Autoinhibitory.,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225],positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],GO:0000922; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032212; GO:0046872; GO:0051225; GO:0051973; GO:1904355,IPR011009; IPR000719; IPR017441; IPR001245; IPR008271; ,,"SUBUNIT: Monomer. Interacts with NEK9. {ECO:0000269|PubMed:19414596, ECO:0000269|PubMed:21320329}.",11701951; 16710414; 12840024; 17101132; 17586473; 19413330; 19414596; 19690332; 21320329; 17727698; 21269460; 23186163; 19941817; 17344846,11701951; 16710414; 12840024; 17101132; 17586473; 19413330; 19414596; 19690332; 21320329; 17727698; 21269460; 23186163; 19941817; 17344846; 12101123; 12589057; 17353931; 20056645; 20508983; 20562859; 20711500; 21335236; 21642957; 22100915; 23313050; 23359173; 23821772; 25280969; 25664600; 26188091; 26496610; 26522158; 26642356; 26921196; 27563009; 28216227; 28539406; 28630147,2003-10-03,2019-02-13,2002-06-01,152,X-ray crystallography (4),STRAND 34 41 {ECO:0000244|PDB:2WQM}.; STRAND 47 53 {ECO:0000244|PDB:2WQM}.; STRAND 59 65 {ECO:0000244|PDB:2WQM}.; STRAND 97 103 {ECO:0000244|PDB:2WQM}.; STRAND 106 112 {ECO:0000244|PDB:2WQM}.; STRAND 167 169 {ECO:0000244|PDB:2WQM}.; STRAND 175 177 {ECO:0000244|PDB:2WQM}.,HELIX 24 26 {ECO:0000244|PDB:2WQM}.; HELIX 31 33 {ECO:0000244|PDB:2WQM}.; HELIX 73 87 {ECO:0000244|PDB:2WQM}.; HELIX 119 128 {ECO:0000244|PDB:2WQM}.; HELIX 135 154 {ECO:0000244|PDB:2WQM}.; HELIX 164 166 {ECO:0000244|PDB:2WQM}.; HELIX 205 208 {ECO:0000244|PDB:2WQM}.; HELIX 215 231 {ECO:0000244|PDB:2WQM}.; HELIX 243 251 {ECO:0000244|PDB:2WQM}.; HELIX 265 274 {ECO:0000244|PDB:2WQM}.; HELIX 279 281 {ECO:0000244|PDB:2WQM}.; HELIX 285 299 {ECO:0000244|PDB:2WQM}.,TURN 54 56 {ECO:0000244|PDB:2WQM}.; TURN 67 70 {ECO:0000244|PDB:2WQN}.; TURN 260 262 {ECO:0000244|PDB:2WQM}.,,,,,5 out of 5,Active site (1); Alternative sequence (2); Beta strand (7); Binding site (1); Chain (1); Domain (1); Helix (12); Modified residue (3); Mutagenesis (5); Natural variant (2); Nucleotide binding (1); Region (1); Site (1); Turn (3),,"TISSUE SPECIFICITY: Highly expressed in lung, muscle, testis, brain, heart, liver, leukocyte and spleen. Lower expression in ovary, prostate and kidney. No expression seen in small intestine. {ECO:0000269|PubMed:11701951}.",,3D-structure;ATP-binding;Acetylation;Alternative splicing;Complete proteome;Cytoplasm;Cytoskeleton;Kinase;Magnesium;Metal-binding;Microtubule;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase,Evidence at protein level,reviewed,,"Protein kinase superfamily, NEK Ser/Thr protein kinase family, NIMA subfamily",152,Activity regulation (1); Alternative products (1); Catalytic activity (2); Caution (1); Cofactor (1); Domain (2); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0067; KW-0181; KW-0206; KW-0418; KW-0460; KW-0479; KW-0493; KW-0539; KW-0547; KW-0597; KW-0621; KW-0723; KW-0808; KW-0963; KW-1185,,,,,,,,PTM: Phosphorylation at Ser-195 required for its activation. {ECO:0000269|PubMed:12840024}.,CHAIN 1 302 Serine/threonine-protein kinase Nek7. /FTId=PRO_0000086430.,,,,,,MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330}.; MOD_RES 5 5 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 195 195 Phosphoserine; by NEK9. {ECO:0000269|PubMed:12840024}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB062450;CH471067;
0,Q8WUM4,PDC6I_HUMAN,PDCD6IP AIP1 ALIX KIAA1375,PDCD6IP,AIP1 ALIX KIAA1375,,,Homo sapiens (Human),9606,Programmed cell death 6-interacting protein (PDCD6-interacting protein) (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (Hp95),UP000005640: Chromosome 3,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQKKFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMVPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFARKTERDELLKDLQQSIAREPSAPSIPTPAYQSSPAGGHAPTPPTPAPRTMPPTKPQPPARPPPPVLPANRAPSATAPSPVGAGTAAPAPSQTPGSAPPPQAQGPPYPTYPGYPGYCQMPMPMGYNPYAYGQYNMPYPPVYHQSPGQAPYPGPQQPSYPFPQPPQQSYYPQQ,868,"96,023",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=Q8WUM4-1; Sequence=Displayed; Name=2; IsoId=Q8WUM4-2; Sequence=VSP_044860; Note=No experimental confirmation available.; Name=3; IsoId=Q8WUM4-3; Sequence=VSP_057190, VSP_057191; ",,SEQUENCE CAUTION:  Sequence=BAA92092.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 239 239 K -> KYFYFQ (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_044860.; VAR_SEQ 240 271 EVFPVLAAKHCIMQANAEYHQSILAKQQKKFG -> VSYCFYKHLLTLHVKYLDFFVYKKQVETYKEI (in isoform 3). {ECO:0000303|PubMed:19906316}. /FTId=VSP_057190.; VAR_SEQ 272 868 Missing (in isoform 3). {ECO:0000303|PubMed:19906316}. /FTId=VSP_057191.,"VARIANT 7 7 V -> M (in dbSNP:rs11554560). {ECO:0000269|PubMed:15489334}. /FTId=VAR_068975.; VARIANT 309 309 A -> T (in dbSNP:rs3792594). {ECO:0000269|Ref.3}. /FTId=VAR_053017.; VARIANT 378 378 V -> I (in dbSNP:rs3203777). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334}. /FTId=VAR_053018.; VARIANT 429 429 G -> S (in dbSNP:rs76608858). {ECO:0000269|PubMed:22073189}. /FTId=VAR_069765.; VARIANT 550 550 N -> S (in dbSNP:rs9813017). {ECO:0000269|PubMed:10718198, ECO:0000269|PubMed:11683497}. /FTId=VAR_053019.; VARIANT 638 638 K -> E (in dbSNP:rs3183982). /FTId=VAR_053020.; VARIANT 730 730 S -> L (in dbSNP:rs1127732). {ECO:0000269|Ref.3}. /FTId=VAR_024381.",,,,CONFLICT 580 580 M -> T (in Ref. 8; BAA92092). {ECO:0000305}.,,1,,0,,,,COMPBIAS 717 860 Pro-rich.,DOMAIN 3 392 BRO1. {ECO:0000255|PROSITE-ProRule:PRU00526}.,,"REGION 176 868 Interaction with EIAV p9.; REGION 176 503 Interaction with CHMP4A, CHMP4B and CHMP4C.; REGION 418 868 Interaction with SDCBP. {ECO:0000269|PubMed:22660413}.; REGION 503 868 Self-association.; REGION 717 720 Interaction with TSG101.; REGION 801 806 Interaction with CEP55. {ECO:0000269|PubMed:18641129}.; REGION 864 868 Essential to promote virus budding.",,,,,,,,"FUNCTION: Multifunctional protein involved in endocytosis, multivesicular body biogenesis, membrane repair, cytokinesis, apoptosis and maintenance of tight junction integrity. Class E VPS protein involved in concentration and sorting of cargo proteins of the multivesicular body (MVB) for incorporation into intralumenal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome. Binds to the phospholipid lysobisphosphatidic acid (LBPA) which is abundant in MVBs internal membranes. The MVB pathway requires the sequential function of ESCRT-O, -I,-II and -III complexes (PubMed:14739459). The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis (PubMed:17853893, PubMed:17556548). Adapter for a subset of ESCRT-III proteins, such as CHMP4, to function at distinct membranes. Required for completion of cytokinesis (PubMed:17853893, PubMed:17556548, PubMed:18641129). May play a role in the regulation of both apoptosis and cell proliferation. Regulates exosome biogenesis in concert with SDC1/4 and SDCBP (PubMed:22660413). By interacting with F-actin, PARD3 and TJP1 secures the proper assembly and positioning of actomyosin-tight junction complex at the apical sides of adjacent epithelial cells that defines a spatial membrane domain essential for the maintenance of epithelial cell polarity and barrier (By similarity). {ECO:0000250|UniProtKB:Q9WU78, ECO:0000269|PubMed:14739459, ECO:0000269|PubMed:17556548, ECO:0000269|PubMed:17853893, ECO:0000269|PubMed:18641129, ECO:0000269|PubMed:22660413}.; FUNCTION: (Microbial infection) Involved in HIV-1 virus budding. Can replace TSG101 it its role of supporting HIV-1 release; this function requires the interaction with CHMP4B. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as enveloped virus budding (HIV-1 and other lentiviruses). {ECO:0000269|PubMed:14505569, ECO:0000269|PubMed:14505570, ECO:0000269|PubMed:14519844, ECO:0000269|PubMed:17556548, ECO:0000269|PubMed:18641129}.",,,,,,,,,,,,actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],calcium-dependent protein binding [GO:0048306]; proteinase activated receptor binding [GO:0031871]; protein homodimerization activity [GO:0042803],actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815],GO:0000281; GO:0000915; GO:0001772; GO:0005815; GO:0005829; GO:0005923; GO:0005925; GO:0006915; GO:0010824; GO:0015031; GO:0016020; GO:0019058; GO:0031871; GO:0036258; GO:0039702; GO:0042470; GO:0042641; GO:0042803; GO:0045199; GO:0046755; GO:0048306; GO:0051260; GO:0061952; GO:0070062; GO:0070830; GO:0070971; GO:0090543; GO:0090559; GO:0090611; GO:1903543; GO:1903551; GO:1903553; GO:1903561,IPR025304; IPR004328; IPR038499; ,P29991; Q9Y5K6; Q53EZ4; Q9BY43; Q9H444; Q9D8B3; Q96CF2; P06241; P03347; P69730; P08631; P09022; P17931; Q90VU7; O75340,"SUBUNIT: Self-associates (PubMed:14505570, PubMed:14519844). Interacts with SH3KBP1/CIN85 (By similarity). Interacts with PDCD6 in a calcium -dependent manner (PubMed:16957052, PubMed:18256029, PubMed:18940611). Interacts with TSG101 in a calcium-dependent manner; PDCD6IP homooligomerization may be required for TSG101-binding (PubMed:14505570, PubMed:14519844, PubMed:18641129, PubMed:19520058, PubMed:17350572). Interacts with SGSM3 (PubMed:15849434). Directly interacts with CHMP4A, CHMP4B and CHMP4C (PubMed:12860994, PubMed:14505569, PubMed:14505570, PubMed:14519844, PubMed:14678797, PubMed:14583093, PubMed:17428861, PubMed:17350572, PubMed:18511562). Directly interacts with CEP55 in a 1:2 stoechiometry (PubMed:17853893, PubMed:17556548, PubMed:18641129, PubMed:18948538). The interaction with CEP55 is required for PDCD6IP targeting to the midbody (PubMed:18641129). May interact with PDGFRB (PubMed:20494825). Interacts with SH3GL1 and SH3GL2/endophilin-1 (PubMed:17350572). Forms a complex with SDCBP and SDC2 (PubMed:22660413). Found in a complex with F-actin, TJP1/ZO-1 and PARD3 (By similarity). Interacts with CD2AP (PubMed:17853893). Interacts with ARRDC1 (PubMed:21191027). {ECO:0000250|UniProtKB:Q9QZA2, ECO:0000250|UniProtKB:Q9WU78, ECO:0000269|PubMed:12860994, ECO:0000269|PubMed:14505569, ECO:0000269|PubMed:14505570, ECO:0000269|PubMed:14519844, ECO:0000269|PubMed:14583093, ECO:0000269|PubMed:14678797, ECO:0000269|PubMed:15849434, ECO:0000269|PubMed:16957052, ECO:0000269|PubMed:17350572, ECO:0000269|PubMed:17428861, ECO:0000269|PubMed:17556548, ECO:0000269|PubMed:17853893, ECO:0000269|PubMed:18256029, ECO:0000269|PubMed:18511562, ECO:0000269|PubMed:18641129, ECO:0000269|PubMed:18940611, ECO:0000269|PubMed:18948538, ECO:0000269|PubMed:19520058, ECO:0000269|PubMed:20494825, ECO:0000269|PubMed:21191027, ECO:0000269|PubMed:22660413}.; SUBUNIT: (Microbial infection) Interacts with HIV-1 p6 (PubMed:14505569, PubMed:17350572, PubMed:17277784, PubMed:18066081). Interacts with HIV-1 p9 (PubMed:18066081). {ECO:0000269|PubMed:14505569, ECO:0000269|PubMed:14519844, ECO:0000269|PubMed:17277784, ECO:0000269|PubMed:17350572, ECO:0000269|PubMed:18066081}.; SUBUNIT: (Microbial infection) Interacts with EIAV p9. {ECO:0000269|PubMed:14505569, ECO:0000269|PubMed:14519844, ECO:0000269|PubMed:17350572, ECO:0000269|PubMed:18066081}.; SUBUNIT: (Microbial infection) Interacts with Murine leukemia virus Gag polyprotein (via LYPX(n)L motif). {ECO:0000269|PubMed:15908698}.; SUBUNIT: (Microbial infection) Interacts with ebola virus protein VP40 (via YPx(n)L/I motif). {ECO:0000269|PubMed:15908698}.",11683497; 19906316; 16641997; 15489334; 14702039; 10718198; 12860994; 14505569; 14505570; 14519844; 14678797; 14583093; 14739459; 15849434; 15908698; 17081065; 16957052; 17853893; 17428861; 17556548; 18256029; 18641129; 18669648; 19413330; 19520058; 19608861; 20494825; 20068231; 21269460; 21191027; 22223895; 22660413; 23186163; 24275569; 24129315; 25944712; 25786915; 17350572; 17277784; 18066081; 18511562; 18948538; 18940611; 22073189,11683497; 19906316; 16641997; 15489334; 14702039; 10718198; 12860994; 14505569; 14505570; 14519844; 14678797; 14583093; 14739459; 15849434; 15908698; 17081065; 16957052; 17853893; 17428861; 17556548; 18256029; 18641129; 18669648; 19413330; 19520058; 19608861; 20494825; 20068231; 21269460; 21191027; 22223895; 22660413; 23186163; 24275569; 24129315; 25944712; 25786915; 17350572; 17277784; 18066081; 18511562; 18948538; 18940611; 22073189; 12421765; 12927788; 15231748; 15337774; 15473846; 15557335; 16169070; 17196169; 17353931; 19527882; 20176808; 20360068; 20467437; 20562859; 20670214; 20711500; 20936779; 20962096; 21900206; 21911577; 21988832; 22162750; 22623428; 22641034; 22762019; 23088713; 23305486; 23416715; 23602568; 23606334; 23726974; 24658140; 25416956; 26392564; 26496610; 30181294; 8051159,2003-05-23,2019-02-13,2002-03-01,180,X-ray crystallography (18),STRAND 32 34 {ECO:0000244|PDB:2OEV}.; STRAND 93 96 {ECO:0000244|PDB:5WA1}.; STRAND 98 100 {ECO:0000244|PDB:2R05}.; STRAND 110 114 {ECO:0000244|PDB:5WA1}.; STRAND 140 142 {ECO:0000244|PDB:2OEV}.; STRAND 171 173 {ECO:0000244|PDB:2OEV}.; STRAND 348 350 {ECO:0000244|PDB:3C3R}.; STRAND 408 412 {ECO:0000244|PDB:2R05}.; STRAND 591 593 {ECO:0000244|PDB:2R05}.; STRAND 802 805 {ECO:0000244|PDB:3E1R}.,HELIX 18 28 {ECO:0000244|PDB:5WA1}.; HELIX 35 54 {ECO:0000244|PDB:5WA1}.; HELIX 62 76 {ECO:0000244|PDB:5WA1}.; HELIX 116 136 {ECO:0000244|PDB:5WA1}.; HELIX 143 170 {ECO:0000244|PDB:5WA1}.; HELIX 177 179 {ECO:0000244|PDB:5WA1}.; HELIX 181 205 {ECO:0000244|PDB:5WA1}.; HELIX 210 231 {ECO:0000244|PDB:5WA1}.; HELIX 241 266 {ECO:0000244|PDB:5WA1}.; HELIX 270 290 {ECO:0000244|PDB:5WA1}.; HELIX 298 317 {ECO:0000244|PDB:5WA1}.; HELIX 326 328 {ECO:0000244|PDB:5WA1}.; HELIX 361 398 {ECO:0000244|PDB:2XS1}.; HELIX 403 406 {ECO:0000244|PDB:2XS1}.; HELIX 415 426 {ECO:0000244|PDB:2XS1}.; HELIX 430 471 {ECO:0000244|PDB:2XS1}.; HELIX 481 514 {ECO:0000244|PDB:2XS1}.; HELIX 517 523 {ECO:0000244|PDB:2XS1}.; HELIX 527 532 {ECO:0000244|PDB:2XS1}.; HELIX 541 543 {ECO:0000244|PDB:2XS1}.; HELIX 547 575 {ECO:0000244|PDB:2XS1}.; HELIX 581 590 {ECO:0000244|PDB:2XS1}.; HELIX 596 639 {ECO:0000244|PDB:2XS1}.; HELIX 644 697 {ECO:0000244|PDB:2XS1}.,TURN 77 88 {ECO:0000244|PDB:5WA1}.; TURN 104 106 {ECO:0000244|PDB:5V3R}.; TURN 292 294 {ECO:0000244|PDB:5WA1}.; TURN 354 357 {ECO:0000244|PDB:5V3R}.; TURN 399 402 {ECO:0000244|PDB:2XS1}.; TURN 427 429 {ECO:0000244|PDB:2XS1}.; TURN 473 475 {ECO:0000244|PDB:2XS1}.; TURN 810 813 {ECO:0000244|PDB:2ZNE}.,,,,,5 out of 5,Alternative sequence (3); Beta strand (10); Chain (1); Compositional bias (1); Domain (1); Erroneous initiation (1); Helix (24); Initiator methionine (1); Modified residue (8); Mutagenesis (31); Natural variant (7); Region (7); Sequence conflict (1); Turn (8),,,,3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell cycle;Cell division;Cell junction;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Host-virus interaction;Methylation;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Secreted;Tight junction;Transport,Evidence at protein level,reviewed,,,180,Alternative products (1); Caution (1); Function (2); Post-translational modification (1); Subcellular location (1); Subunit structure (5),,KW-0002; KW-0007; KW-0025; KW-0053; KW-0131; KW-0132; KW-0181; KW-0206; KW-0488; KW-0597; KW-0621; KW-0653; KW-0796; KW-0813; KW-0903; KW-0945; KW-0963; KW-0964; KW-0965; KW-1185,,,,,,,,PTM: May be phosphorylated on tyrosine residues by activated PDGFRB. {ECO:0000269|PubMed:20494825}.,CHAIN 2 868 Programmed cell death 6-interacting protein. /FTId=PRO_0000218891.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:25944712, ECO:0000269|Ref.7}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:25944712, ECO:0000269|Ref.7}.; MOD_RES 215 215 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 479 479 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 481 481 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 730 730 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 738 738 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 741 741 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 745 745 Omega-N-methylarginine. {ECO:0000244|PubMed:24129315}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF349951;GQ131806;AF151793;BT007367;BC020066;BC068454;AK002122;AB037796;
0,Q92558,WASF1_HUMAN,WASF1 KIAA0269 SCAR1 WAVE1,WASF1,KIAA0269 SCAR1 WAVE1,,,Homo sapiens (Human),9606,Wiskott-Aldrich syndrome protein family member 1 (WASP family protein member 1) (Protein WAVE-1) (Verprolin homology domain-containing protein 1),UP000005640: Chromosome 6,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPLVKRNIDPRHLCHTALPRGIKNELECVTNISLANIIRQLSSLSKYAEDIFGELFNEAHSFSFRVNSLQERVDRLSVSVTQLDPKEEELSLQDITMRKAFRSSTIQDQQLFDRKTLPIPLQETYDVCEQPPPLNILTPYRDDGKEGLKFYTNPSYFFDLWKEKMLQDTEDKRKEKRKQKQKNLDRPHEPEKVPRAPHDRRREWQKLAQGPELAEDDANLLHKHIEVANGPASHFETRPQTYVDHMDGSYSLSALPFSQMSELLTRAEERVLVRPHEPPPPPPMHGAGDAKPIPTCISSATGLIENRPQSPATGRTPVFVSPTPPPPPPPLPSALSTSSLRASMTSTPPPPVPPPPPPPATALQAPAVPPPPAPLQIAPGVLHPAPPPIAPPLVQPSPPVARAAPVCETVPVHPLPQGEVQGLPPPPPPPPLPPPGIRPSSPVTVTALAHPPSGLHPTPSTAPGPHVPLMPPSPPSQVIPASEPKRHPSTLPVISDARSVLLEAIRKGIQLRKVEEQREQEAKHERIENDVATILSRRIAVEYSDSEDDSEFDEVDWLE,559,"61,652",,,,SEQUENCE CAUTION:  Sequence=BAA13399.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,,,,,,,,1,,0,DOMAIN: Binds the Arp2/3 complex through the C-terminal region and actin through verprolin homology (VPH) domain. {ECO:0000269|PubMed:9889097}.,SIMILARITY: Belongs to the SCAR/WAVE family. {ECO:0000305}.,,COMPBIAS 278 283 Poly-Pro.; COMPBIAS 322 332 Poly-Pro.; COMPBIAS 348 359 Poly-Pro.; COMPBIAS 369 374 Poly-Pro.; COMPBIAS 424 435 Poly-Pro.,DOMAIN 497 514 WH2. {ECO:0000255|PROSITE-ProRule:PRU00406}.,,,,,,,,,,"FUNCTION: Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation. The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex (By similarity). As component of the WAVE1 complex, required for BDNF-NTRK2 endocytic trafficking and signaling from early endosomes (By similarity). {ECO:0000250|UniProtKB:Q8R5H6, ECO:0000269|PubMed:9889097}.",,,,,,,,,,,,actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dendrite cytoplasm [GO:0032839]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mitochondrial outer membrane [GO:0005741]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; SCAR complex [GO:0031209]; actin binding [GO:0003779]; protein kinase A binding [GO:0051018]; actin filament polymerization [GO:0030041]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; dendrite extension [GO:0097484]; dendritic transport of mitochondrion [GO:0098939]; lamellipodium morphogenesis [GO:0072673]; modification of postsynaptic actin cytoskeleton [GO:0098885]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; receptor-mediated endocytosis [GO:0006898],actin filament polymerization [GO:0030041]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; dendrite extension [GO:0097484]; dendritic transport of mitochondrion [GO:0098939]; lamellipodium morphogenesis [GO:0072673]; modification of postsynaptic actin cytoskeleton [GO:0098885]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; receptor-mediated endocytosis [GO:0006898],actin binding [GO:0003779]; protein kinase A binding [GO:0051018],actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; dendrite cytoplasm [GO:0032839]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mitochondrial outer membrane [GO:0005741]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; SCAR complex [GO:0031209],GO:0003779; GO:0005741; GO:0005856; GO:0005925; GO:0006898; GO:0015629; GO:0016601; GO:0030027; GO:0030041; GO:0031209; GO:0032839; GO:0032991; GO:0051018; GO:0051388; GO:0065003; GO:0072673; GO:0097484; GO:0098794; GO:0098885; GO:0098939; GO:1990416; GO:2000601,IPR028288; IPR003124; ,A0A1B0GWI1; P07737; Q15642,"SUBUNIT: Component of the WAVE1 complex composed of ABI2, CYFIP1 or CYFIP2, BRK1, NCKAP1 and WASF1/WAVE1. Within the complex, a heterodimer containing NCKAP1 and CYFIP1 interacts with a heterotrimer formed by WAVE1, ABI2 and BRK1. CYFIP2 binds to activated RAC1 which causes the complex to dissociate, releasing activated WASF1. The complex can also be activated by NCK1. Binds actin and the Arp2/3 complex. Interacts with BAIAP2. Interacts with SHANK3; the interaction mediates the association of SHANK3 with the WAVE1 complex. Interacts with ABI1 (via N-terminus). Interacts with SORBS2; this interaction greatly enhances phosphorylation by ABL1 and dephosphorylation by PTPN12 and might mediate partial to focal adhesion sites. {ECO:0000269|PubMed:11130076, ECO:0000269|PubMed:18559503, ECO:0000269|PubMed:21107423}.",9732292; 9039502; 14574404; 15489334; 9889097; 11130076; 18559503; 23186163; 21107423,9732292; 9039502; 14574404; 15489334; 9889097; 11130076; 18559503; 23186163; 21107423; 10219243; 10970852; 11231582; 11329366; 11747816; 12181570; 12429845; 12743368; 12855698; 15040784; 15280206; 15506982; 15657136; 15659634; 15670045; 16262445; 16317717; 16483316; 16702231; 16880808; 17101133; 17202194; 17251352; 17696648; 17901257; 17939402; 18287015; 18391171; 18516090; 18947485; 18995840; 19222940; 19497998; 19631450; 19731823; 19890377; 20368433; 20403076; 20426950; 21419341; 21676863; 21844371; 21946561; 22028648; 22179776; 22721732; 23273897; 23680521; 24439376; 24725412; 24819384; 25355952; 25416956; 25473116; 25609649; 25799492; 25906751; 26280122; 26288249; 26496610; 26977009; 27035872; 28473602; 9600938; 9843499,1997-11-01,2019-02-13,1997-02-01,164,X-ray crystallography (2),STRAND 512 514 {ECO:0000244|PDB:4N78}.,HELIX 26 81 {ECO:0000244|PDB:3P8C}.; HELIX 93 96 {ECO:0000244|PDB:3P8C}.; HELIX 114 116 {ECO:0000244|PDB:3P8C}.; HELIX 119 127 {ECO:0000244|PDB:3P8C}.; HELIX 134 140 {ECO:0000244|PDB:3P8C}.; HELIX 147 150 {ECO:0000244|PDB:3P8C}.; HELIX 156 181 {ECO:0000244|PDB:3P8C}.; HELIX 500 509 {ECO:0000244|PDB:4N78}.; HELIX 531 540 {ECO:0000244|PDB:4N78}.,TURN 85 87 {ECO:0000244|PDB:3P8C}.,,,,,5 out of 5,Beta strand (1); Chain (1); Compositional bias (5); Domain (1); Erroneous initiation (1); Helix (9); Modified residue (3); Turn (1),,"TISSUE SPECIFICITY: Highly expressed in brain. Lowly expressed in testis, ovary, colon, kidney, pancreas, thymus, small intestine and peripheral blood.",,3D-structure;Actin-binding;Cell junction;Complete proteome;Cytoplasm;Cytoskeleton;Methylation;Phosphoprotein;Reference proteome;Synapse,Evidence at protein level,reviewed,,SCAR/WAVE family,164,Domain (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0009; KW-0181; KW-0206; KW-0488; KW-0597; KW-0770; KW-0963; KW-0965; KW-1185,,,,,,,,PTM: Phosphorylated on tyrosine residues by ABL1 and dephosphorylated by PTPN12. {ECO:0000269|PubMed:18559503}.,CHAIN 1 559 Wiskott-Aldrich syndrome protein family member 1. /FTId=PRO_0000188992.,,,,,,MOD_RES 341 341 Asymmetric dimethylarginine; alternate. {ECO:0000250|UniProtKB:Q8R5H6}.; MOD_RES 341 341 Omega-N-methylarginine; alternate. {ECO:0000250|UniProtKB:Q8R5H6}.; MOD_RES 489 489 Phosphoserine. {ECO:0000244|PubMed:23186163}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF134303;D87459;CH471051;CH471051;CH471051;CH471051;CH471051;BC044591;
0,Q96CT7,CC124_HUMAN,CCDC124,CCDC124,,,,Homo sapiens (Human),9606,Coiled-coil domain-containing protein 124,UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPKKFQGENTKSAAARARRAEAKAAADAKKQKELEDAYWKDDDKHVMRKEQRKEEKEKRRLDQLERKKETQRLLEEEDSKLKGGKAPRVATSSKVTRAQIEDTLRRDHQLREAPDTAEKAKSHLEVPLEENVNRRVLEEGSVEARTIEDAIAVLSVAEEAADRHPERRMRAAFTAFEEAQLPRLKQENPNMRLSQLKQLLKKEWLRSPDNPMNQRAVPFNAPK,223,"25,835",,,,,,,,,,,,,VARIANT 138 138 E -> Q (in dbSNP:rs8104153). /FTId=VAR_053809.,,,,,,1,,0,,SIMILARITY: Belongs to the CCDC124 family. {ECO:0000305}.,COILED 15 82 {ECO:0000255}.,,,,,,,,,,,,FUNCTION: Required for proper progression of late cytokinetic stages. {ECO:0000269|PubMed:23894443}.,,,,,,,,,,,,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301],cell cycle [GO:0007049]; cell division [GO:0051301],RNA binding [GO:0003723],cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; plasma membrane [GO:0005886],GO:0003723; GO:0005815; GO:0005829; GO:0005886; GO:0007049; GO:0030496; GO:0051301,IPR010422; ,,SUBUNIT: Interacts with RASGEF1B. {ECO:0000269|PubMed:23894443}.,15489334; 21269460; 22814378; 23186163; 23894443,15489334; 21269460; 22814378; 23186163; 23894443; 21903422; 21911578; 23902751; 26212323; 26496610; 26638075,2006-12-12,2019-02-13,2001-12-01,126,,,,,,,,,4 out of 5,Chain (1); Coiled coil (1); Modified residue (2); Natural variant (1),,TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:23894443}.,,Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,CCDC124 family,126,Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0597; KW-0621; KW-0963; KW-1185,,,,,,,,,CHAIN 1 223 Coiled-coil domain-containing protein 124. /FTId=PRO_0000263735.,,,,,,"MOD_RES 141 141 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:23894443}.; MOD_RES 194 194 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,BC013949;
0,Q96JE9,MAP6_HUMAN,MAP6 KIAA1878,MAP6,KIAA1878,,,Homo sapiens (Human),9606,Microtubule-associated protein 6 (MAP-6) (Stable tubule-only polypeptide) (STOP),UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAWPCITRACCIARFWNQLDKADIAVPLVFTKYSEATEHPGAPPQPPPPQQQAQPALAPPSARAVAIETQPAQGELDAVARATGPAPGPTGEREPAAGPGRSGPGPGLGSGSTSGPADSVMRQDYRAWKVQRPEPSCRPRSEYQPSDAPFERETQYQKDFRAWPLPRRGDHPWIPKPVQISAASQASAPILGAPKRRPQSQERWPVQAAAEAREQEAAPGGAGGLAAGKASGADERDTRRKAGPAWIVRRAEGLGHEQTPLPAAQAQVQATGPEAGRGRAAADALNRQIREEVASAVSSSYRNEFRAWTDIKPVKPIKAKPQYKPPDDKMVHETSYSAQFKGEASKPTTADNKVIDRRRIRSLYSEPFKEPPKVEKPSVQSSKPKKTSASHKPTRKAKDKQAVSGQAAKKKSAEGPSTTKPDDKEQSKEMNNKLAEAKESLAQPVSDSSKTQGPVATEPDKDQGSVVPGLLKGQGPMVQEPLKKQGSVVPGPPKDLGPMIPLPVKDQDHTVPEPLKNESPVISAPVKDQGPSVPVPPKNQSPMVPAKVKDQGSVVPESLKDQGPRIPEPVKNQAPMVPAPVKDEGPMVSASVKDQGPMVSAPVKDQGPIVPAPVKGEGPIVPAPVKDEGPMVSAPIKDQDPMVPEHPKDESAMATAPIKNQGSMVSEPVKNQGLVVSGPVKDQDVVVPEHAKVHDSAVVAPVKNQGPVVPESVKNQDPILPVLVKDQGPTVLQPPKNQGRIVPEPLKNQVPIVPVPLKDQDPLVPVPAKDQGPAVPEPLKTQGPRDPQLPTVSPLPRVMIPTAPHTEYIESSP,813,"86,505",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; Synonyms=N-STOP, Neuronal-STOP; IsoId=Q96JE9-1; Sequence=Displayed; Name=2; Synonyms=E-STOP, Early-STOP; IsoId=Q96JE9-2; Sequence=VSP_034723; Name=3; IsoId=Q96JE9-3; Sequence=VSP_054151; Note=No experimental confirmation available.; ",,SEQUENCE CAUTION:  Sequence=AAH63860.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 1 329 Missing (in isoform 3). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334}. /FTId=VSP_054151.; VAR_SEQ 440 813 Missing (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_034723.",VARIANT 247 247 I -> M (in dbSNP:rs12225010). {ECO:0000269|PubMed:15489334}. /FTId=VAR_044542.,,,,,,2,,0,,SIMILARITY: Belongs to the STOP family. {ECO:0000305}.,,COMPBIAS 43 49 Poly-Pro.; COMPBIAS 490 804 Pro-rich.,,,REGION 118 141 Mn 1. {ECO:0000250|UniProtKB:Q63560}.; REGION 126 140 Calmodulin-binding. {ECO:0000250|UniProtKB:Q63560}.; REGION 153 176 Mn 2. {ECO:0000250|UniProtKB:Q63560}.; REGION 162 176 Calmodulin-binding. {ECO:0000250|UniProtKB:Q63560}.; REGION 189 203 Calmodulin-binding. {ECO:0000250|UniProtKB:Q63560}.; REGION 298 321 Mn 3. {ECO:0000250|UniProtKB:Q63560}.; REGION 306 320 Calmodulin-binding. {ECO:0000250|UniProtKB:Q63560}.; REGION 357 371 Calmodulin-binding. {ECO:0000250|UniProtKB:Q63560}.; REGION 384 398 Calmodulin-binding. {ECO:0000250|UniProtKB:Q63560}.,,,,,,,,"FUNCTION: Involved in microtubule stabilization in many cell types, including neuronal cells (By similarity). Specifically has microtubule cold stabilizing activity (By similarity). Involved in dendrite morphogenesis and maintenance by regulating lysosomal trafficking via its interaction with TMEM106B (PubMed:24357581). Regulates KIF5A-mediated axonal cargo transport (By similarity). Regulates axonal growth during neuron polarization (By similarity). {ECO:0000250|UniProtKB:Q63560, ECO:0000269|PubMed:24357581}.",,,,,,,,,,,,axon [GO:0030424]; cis-Golgi network [GO:0005801]; dendrite [GO:0030425]; Golgi-associated vesicle [GO:0005798]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle membrane [GO:0030658]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; cytoskeleton-dependent intracellular transport [GO:0030705]; dendrite morphogenesis [GO:0048813]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of axonogenesis [GO:0050772]; regulation of microtubule cytoskeleton organization [GO:0070507],cytoskeleton-dependent intracellular transport [GO:0030705]; dendrite morphogenesis [GO:0048813]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of axonogenesis [GO:0050772]; regulation of microtubule cytoskeleton organization [GO:0070507],calmodulin binding [GO:0005516]; microtubule binding [GO:0008017],axon [GO:0030424]; cis-Golgi network [GO:0005801]; dendrite [GO:0030425]; Golgi-associated vesicle [GO:0005798]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle membrane [GO:0030658],GO:0000226; GO:0005516; GO:0005798; GO:0005801; GO:0005874; GO:0008017; GO:0030424; GO:0030425; GO:0030658; GO:0030705; GO:0032418; GO:0048471; GO:0048813; GO:0050772; GO:0070507,IPR007882; ,,"SUBUNIT: Interacts with calmodulin (via C-terminus); the interaction is dependent on Ca(2+) (By similarity). Interacts with TMEM106B (PubMed:24357581). Interacts with ZDHHC17 (via ANK repeats) (PubMed:26198635). Interacts with ZDHHC13 (via ANK repeats) (PubMed:26198635). {ECO:0000250, ECO:0000269|PubMed:24357581, ECO:0000269|PubMed:26198635}.",14702039; 16554811; 15489334; 11347906; 14692697; 16624526; 24357581; 26198635,14702039; 16554811; 15489334; 11347906; 14692697; 16624526; 24357581; 26198635; 19165527; 20379614; 22904321; 23831686; 27541346,2008-07-22,2019-02-13,2008-07-22,118,,,,,,,,,5 out of 5,Alternative sequence (2); Chain (1); Compositional bias (2); Erroneous initiation (1); Lipidation (3); Modified residue (4); Mutagenesis (1); Natural variant (1); Region (9),,"TISSUE SPECIFICITY: Expressed in brain (at protein level). Expressed in spinal cord. Isoform 2 expression is up-regulated in the prefrontal cortex (Brodmann's area 46) of patients with schizophrenia (postmortem brain study). {ECO:0000269|PubMed:14692697, ECO:0000269|PubMed:16624526}.",,Alternative splicing;Calmodulin-binding;Cell projection;Complete proteome;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Golgi apparatus;Lipoprotein;Membrane;Microtubule;Palmitate;Phosphoprotein;Polymorphism;Reference proteome;Transport,Evidence at protein level,reviewed,,STOP family,118,Alternative products (1); Caution (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0112; KW-0181; KW-0206; KW-0333; KW-0449; KW-0472; KW-0493; KW-0564; KW-0597; KW-0621; KW-0813; KW-0963; KW-0966; KW-0968; KW-1185,,,,,,,,"PTM: Palmitoylated. Probably depalmitoylated by ABHD17A, ABHD17B and ABHD17C. During neuronal polarization, palmitoylation and depalmitoylation cycles regulate MAP6 shuttling between secretory vesicles and microtubules, and its polarized distribution in the axon. {ECO:0000250|UniProtKB:Q63560}.",CHAIN 1 813 Microtubule-associated protein 6. /FTId=PRO_0000344044.,,,,,LIPID 5 5 S-palmitoyl cysteine. {ECO:0000250|UniProtKB:Q63560}.; LIPID 10 10 S-palmitoyl cysteine. {ECO:0000250|UniProtKB:Q63560}.; LIPID 11 11 S-palmitoyl cysteine. {ECO:0000250|UniProtKB:Q63560}.,MOD_RES 102 102 Phosphoserine. {ECO:0000250|UniProtKB:Q7TSJ2}.; MOD_RES 143 143 Phosphotyrosine. {ECO:0000250|UniProtKB:Q7TSJ2}.; MOD_RES 187 187 Phosphoserine. {ECO:0000250|UniProtKB:Q63560}.; MOD_RES 812 812 Phosphoserine. {ECO:0000250|UniProtKB:Q7TSJ2}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AK123340;BC063860;BC139780;BC150254;AB058781;
0,Q96SN8,CK5P2_HUMAN,CDK5RAP2 CEP215 KIAA1633,CDK5RAP2,CEP215 KIAA1633,,,Homo sapiens (Human),9606,CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48) (Centrosome-associated protein 215),UP000005640: Chromosome 9,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MMDLVLEEDVTVPGTLSGCSGLVPSVPDDLDGINPNAGLGNGLLPNVSEETVSPTRARNMKDFENQITELKKENFNLKLRIYFLEERMQQEFHGPTEHIYKTNIELKVEVESLKRELQEREQLLIKASKAVESLAEAGGSEIQRVKEDARKKVQQVEDLLTKRILLLEKDVTAAQAELEKAFAGTETEKALRLRLESKLSEMKKMHEGDLAMALVLDEKDRLIEELKLSLKSKEALIQCLKEEKSQMACPDENVSSGELRGLCAAPREEKERETEAAQMEHQKERNSFEERIQALEEDLREKEREIATEKKNSLKRDKAIQGLTMALKSKEKKVEELNSEIEKLSAAFAKAREALQKAQTQEFQGSEDYETALSGKEALSAALRSQNLTKSTENHRLRRSIKKITQELSDLQQERERLEKDLEEAHREKSKGDCTIRDLRNEVEKLRNEVNEREKAMENRYKSLLSESNKKLHNQEQVIKHLTESTNQKDVLLQKFNEKDLEVIQQNCYLMAAEDLELRSEGLITEKCSSQQPPGSKTIFSKEKKQSSDYEELIQVLKKEQDIYTHLVKSLQESDSINNLQAELNKIFALRKQLEQDVLSYQNLRKTLEEQISEIRRREEESFSLYSDQTSYLSICLEENNRFQVEHFSQEELKKKVSDLIQLVKELYTDNQHLKKTIFDLSCMGFQGNGFPDRLASTEQTELLASKEDEDTIKIGEDDEINFLSDQHLQQSNEIMKDLSKGGCKNGYLRHTESKISDCDGAHAPGCLEEGAFINLLAPLFNEKATLLLESRPDLLKVVRELLLGQLFLTEQEVSGEHLDGKTEKTPKQKGELVHFVQTNSFSKPHDELKLSCEAQLVKAGEVPKVGLKDASVQTVATEGDLLRFKHEATREAWEEKPINTALSAEHRPENLHGVPGWQAALLSLPGITNREAKKSRLPILIKPSRSLGNMYRLPATQEVVTQLQSQILELQGELKEFKTCNKQLHQKLILAEAVMEGRPTPDKTLLNAQPPVGAAYQDSPGEQKGIKTTSSVWRDKEMDSDQQRSYEIDSEICPPDDLASLPSCKENPEDVLSPTSVATYLSSKSQPSAKVSVMGTDQSESINTSNETEYLKQKIHDLETELEGYQNFIFQLQKHSQCSEAIITVLCGTEGAQDGLSKPKNGSDGEEMTFSSLHQVRYVKHVKILGPLAPEMIDSRVLENLKQQLEEQEYKLQKEQNLNMQLFSEIHNLQNKFRDLSPPRYDSLVQSQARELSLQRQQIKDGHGICVISRQHMNTMIKAFEELLQASDVDYCVAEGFQEQLNQCAELLEKLEKLFLNGKSVGVEMNTQNELMERIEEDNLTYQHLLPESPEPSASHALSDYETSEKSFFSRDQKQDNETEKTSVMVNSFSQDLLMEHIQEIRTLRKRLEESIKTNEKLRKQLERQGSEFVQGSTSIFASGSELHSSLTSEIHFLRKQNQALNAMLIKGSRDKQKENDKLRESLSRKTVSLEHLQREYASVKEENERLQKEGSEKERHNQQLIQEVRCSGQELSRVQEEVKLRQQLLSQNDKLLQSLRVELKAYEKLDEEHRRLREASGEGWKGQDPFRDLHSLLMEIQALRLQLERSIETSSTLQSRLKEQLARGAEKAQEGALTLAVQAVSIPEVPLQPDKHDGDKYPMESDNSFDLFDSSQAVTPKSVSETPPLSGNDTDSLSCDSGSSATSTPCVSRLVTGHHLWASKNGRHVLGLIEDYEALLKQISQGQRLLAEMDIQTQEAPSSTSQELGTKGPHPAPLSKFVSSVSTAKLTLEEAYRRLKLLWRVSLPEDGQCPLHCEQIGEMKAEVTKLHKKLFEQEKKLQNTMKLLQLSKRQEKVIFDQLVVTHKILRKARGNLELRPGGAHPGTCSPSRPGS,1893,"215,038",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; IsoId=Q96SN8-1; Sequence=Displayed; Note=No experimental confirmation available.; Name=2; IsoId=Q96SN8-2; Sequence=VSP_007563; Note=No experimental confirmation available.; Name=3; IsoId=Q96SN8-3; Sequence=VSP_007564; Note=No experimental confirmation available.; Name=4; IsoId=Q96SN8-4; Sequence=VSP_007565; ,,SEQUENCE CAUTION:  Sequence=AAH04526.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=BAA91865.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=BAB13459.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};  Sequence=BAB15263.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=BAB55253.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,SEQUENCE CAUTION:  Sequence=CAD97663.1; Type=Erroneous termination; Positions=1205; Note=Translated as Gln.; Evidence={ECO:0000305}; ,,SEQUENCE CAUTION:  Sequence=CAD97828.1; Type=Frameshift; Positions=1831; Evidence={ECO:0000305}; ,,,,,"VAR_SEQ 702 733 Missing (in isoform 2). {ECO:0000303|PubMed:17974005}. /FTId=VSP_007563.; VAR_SEQ 1009 1049 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_007564.; VAR_SEQ 1576 1654 Missing (in isoform 4). {ECO:0000303|PubMed:10997877, ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:17974005}. /FTId=VSP_007565.","VARIANT 183 183 A -> P (in dbSNP:rs13287734). /FTId=VAR_056831.; VARIANT 289 289 E -> Q (in dbSNP:rs4836822). {ECO:0000269|PubMed:10997877, ECO:0000269|PubMed:17974005}. /FTId=VAR_017443.; VARIANT 1045 1045 R -> T (in dbSNP:rs3780679). /FTId=VAR_032426.; VARIANT 1330 1330 N -> I (in dbSNP:rs7875294). /FTId=VAR_059616.; VARIANT 1540 1540 V -> L (in dbSNP:rs4837768). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17974005}. /FTId=VAR_017444.; VARIANT 1607 1607 R -> S (in dbSNP:rs16909747). /FTId=VAR_056832.",,,,CONFLICT 27 27 P -> S (in Ref. 4; CAD97663). {ECO:0000305}.; CONFLICT 43 43 L -> V (in Ref. 3; AAP41926). {ECO:0000305}.; CONFLICT 292 292 I -> F (in Ref. 4; CAD97828). {ECO:0000305}.; CONFLICT 414 414 E -> K (in Ref. 4; CAD97828). {ECO:0000305}.; CONFLICT 1254 1254 S -> F (in Ref. 4; CAD97663). {ECO:0000305}.; CONFLICT 1458 1458 Q -> R (in Ref. 6; BAA91865). {ECO:0000305}.; CONFLICT 1483 1483 S -> P (in Ref. 4; CAD97663). {ECO:0000305}.; CONFLICT 1550 1550 N -> D (in Ref. 6; BAB55253). {ECO:0000305}.; CONFLICT 1838 1838 K -> R (in Ref. 6; BAA91865). {ECO:0000305}.,,5,,0,,,,,,,"REGION 58 196 Interaction with NCKAP5L. {ECO:0000269|PubMed:26485573}.; REGION 926 1208 Interaction with MAPRE1. {ECO:0000269|PubMed:19553473}.; REGION 1726 1893 Interaction with PCNT and AKAP9. {ECO:0000269|PubMed:20466722}.; REGION 1726 1768 Interaction with CDK5R1. {ECO:0000250}.; REGION 1861 1870 Required for centrosomal attachment, Golgi localization and CALM1 interaction.",,,,,,,,"FUNCTION: Potential regulator of CDK5 activity via its interaction with CDK5R1. Negative regulator of centriole disengagement (licensing) which maintains centriole engagement and cohesion. Involved in regulation of mitotic spindle orientation (By similarity). Plays a role in the spindle checkpoint activation by acting as a transcriptional regulator of both BUBR1 and MAD2 promoter. Together with EB1/MAPRE1, may promote microtubule polymerization, bundle formation, growth and dynamics at the plus ends. Regulates centrosomal maturation by recruitment of the gamma-tubulin ring complex (gamma-TuRC) onto centrosomes (PubMed:26485573). In complex with PDE4DIP isoform 13/MMG8/SMYLE, MAPRE1 and AKAP9, contributes to microtubules nucleation and extension from the centrosome to the cell periphery (PubMed:29162697). Required for the recruitment of AKAP9 to centrosomes (PubMed:29162697). Plays a role in neurogenesis (By similarity). {ECO:0000250|UniProtKB:Q8K389, ECO:0000269|PubMed:17959831, ECO:0000269|PubMed:18042621, ECO:0000269|PubMed:19282672, ECO:0000269|PubMed:19553473, ECO:0000269|PubMed:26485573, ECO:0000269|PubMed:29162697}.",,,,,,,,,,,,"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]","brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]",calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631],cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922],GO:0000086; GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0010389; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0044212; GO:0045664; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0070062; GO:0090266; GO:0097431; GO:0097711,IPR012943; ,Q76N32; Q9P209; Q38SD2-1; Q96R06,"SUBUNIT: Interacts with CDK5R1 (p35 form) (By similarity). CDK5RAP1, CDK5RAP2 and CDK5RAP3 show competitive binding to CDK5R1. May form a complex with CDK5R1 and CDK5 (By similarity). Interacts with pericentrin/PCNT; the interaction is leading to centrosomal and Golgi localization of CDK5RAP2 and PCNT (PubMed:20466722). Interacts with AKAP9; the interaction targets CDK5RAP2 and AKAP9 to Golgi apparatus (PubMed:20466722). Interacts with MAPRE1; the interaction is direct and targets CDK5RAP2 and EB1/MAPRE1 to microtubule plus ends (PubMed:19553473). Interacts with TUBG1; the interaction is leading to the centrosomal localization of CDK5RAP2 and TUBG1 (PubMed:17959831). Interacts with TUBGCP3 (PubMed:17959831). Interacts with CALM1 (PubMed:20466722). Interacts with CDC20 (PubMed:19282672). Interacts with CEP68; degradation of CEP68 in early mitosis leads to removal of CDK5RAP2 from the centrosome which promotes centriole disengagement and subsequent centriole separation (PubMed:25503564). Interacts with NCKAP5L (PubMed:26485573). Forms a pericentrosomal complex with AKAP9, MAPRE1 and PDE4DIP isoform 13/MMG8/SMYLE; within this complex, MAPRE1 binding to CDK5RAP2 may be mediated by PDE4DIP (PubMed:29162697). Interacts with LGALS3BP; this interaction may connect the pericentrosomal complex to the gamma-tubulin ring complex (gamma-TuRC) to promote microtubule assembly and acetylation (PubMed:29162697). {ECO:0000250|UniProtKB:Q9JLH5, ECO:0000269|PubMed:17959831, ECO:0000269|PubMed:19282672, ECO:0000269|PubMed:19553473, ECO:0000269|PubMed:20466722, ECO:0000269|PubMed:25503564, ECO:0000269|PubMed:26485573, ECO:0000269|PubMed:29162697}.",10997877; 17974005; 15164053; 14702039; 15489334; 10721722; 14654843; 15793586; 18042621; 17959831; 18669648; 19282672; 19553473; 19543530; 19690332; 20466722; 20068231; 21269460; 23186163; 25657325; 25503564; 26482847; 26485573; 29162697,10997877; 17974005; 15164053; 14702039; 15489334; 10721722; 14654843; 15793586; 18042621; 17959831; 18669648; 19282672; 19553473; 19543530; 19690332; 20466722; 20068231; 21269460; 23186163; 25657325; 25503564; 26482847; 26485573; 29162697; 11076968; 11956313; 12207013; 12221128; 12421765; 12852856; 13678582; 14580337; 15498487; 15705883; 16169070; 16357211; 16462731; 16631324; 16890155; 17574030; 17646400; 17719545; 18037885; 18566290; 18615013; 18694559; 19004860; 19119138; 19940019; 20080800; 20139723; 20200978; 20201926; 20230748; 20360068; 20399632; 20558667; 20711500; 21150319; 21273506; 21297427; 21346412; 21347367; 21422230; 21512315; 21548880; 21565611; 21620453; 21725307; 21792235; 21988832; 22094468; 22179047; 22653444; 22806269; 23141531; 23141541; 23253480; 23348840; 23400999; 23414517; 23455922; 23530209; 23587236; 23747070; 23769972; 23789104; 23874654; 23921553; 24053599; 24089205; 24231678; 24466316; 24469809; 24782177; 24816561; 24982133; 25047611; 25313408; 25532896; 26192437; 26197979; 26496610; 26550838; 26638075; 26987684; 28004182; 28320860; 28778786; 28883092; 29054927; 7769006; 7790358; 8838651,2003-06-16,2019-02-13,2010-05-18,167,,,,,,,,,5 out of 5,Alternative sequence (3); Chain (1); Erroneous initiation (5); Erroneous termination (1); Frameshift (1); Modified residue (7); Mutagenesis (3); Natural variant (6); Region (5); Sequence conflict (9),,"TISSUE SPECIFICITY: Widely expressed. Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:10721722}.",,Alternative splicing;Calmodulin-binding;Complete proteome;Cytoplasm;Cytoskeleton;Golgi apparatus;Mental retardation;Microtubule;Phosphoprotein;Polymorphism;Primary microcephaly;Reference proteome,Evidence at protein level,reviewed,,,167,Alternative products (1); Caution (3); Function (1); Involvement in disease (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0112; KW-0181; KW-0206; KW-0333; KW-0493; KW-0597; KW-0621; KW-0905; KW-0963; KW-0991; KW-1185,,,,,"DISEASE: Microcephaly 3, primary, autosomal recessive (MCPH3) [MIM:604804]: A disease defined as a head circumference more than 3 standard deviations below the age-related mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. Despite this marked reduction in size, the gyral pattern is relatively well preserved, with no major abnormality in cortical architecture. Affected individuals are mentally retarded. Primary microcephaly is further defined by the absence of other syndromic features or significant neurological deficits due to degenerative brain disorder. {ECO:0000269|PubMed:15793586}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: Phosphorylated in vitro by CDK5. {ECO:0000250|UniProtKB:Q9JLH5}.,CHAIN 1 1893 CDK5 regulatory subunit-associated protein 2. /FTId=PRO_0000089835.,,,,,,"MOD_RES 547 547 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1001 1001 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 1238 1238 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 1490 1490 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1663 1663 Phosphoserine. {ECO:0000250|UniProtKB:Q9JLH5}.; MOD_RES 1666 1666 Phosphoserine. {ECO:0000250|UniProtKB:Q9JLH5}.; MOD_RES 1893 1893 Phosphoserine. {ECO:0000244|PubMed:18669648}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB046853;AF448860;AL133161;BX537421;BX537759;AK001729;AK025867;AK027636;BC004526;
0,Q99569,PKP4_HUMAN,PKP4,PKP4,,,,Homo sapiens (Human),9606,Plakophilin-4 (p0071),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPAPEQASLVEEGQPQTRQEAASTGPGMEPETTATTILASVKEQELQFQRLTRELEVERQIVASQLERCRLGAESPSIASTSSTEKSFPWRSTDVPNTGVSKPRVSDAVQPNNYLIRTEPEQGTLYSPEQTSLHESEGSLGNSRSSTQMNSYSDSGYQEAGSFHNSQNVSKADNRQQHSFIGSTNNHVVRNSRAEGQTLVQPSVANRAMRRVSSVPSRAQSPSYVISTGVSPSRGSLRTSLGSGFGSPSVTDPRPLNPSAYSSTTLPAARAASPYSQRPASPTAIRRIGSVTSRQTSNPNGPTPQYQTTARVGSPLTLTDAQTRVASPSQGQVGSSSPKRSGMTAVPQHLGPSLQRTVHDMEQFGQQQYDIYERMVPPRPDSLTGLRSSYASQHSQLGQDLRSAVSPDLHITPIYEGRTYYSPVYRSPNHGTVELQGSQTALYRTGSVGIGNLQRTSSQRSTLTYQRNNYALNTTATYAEPYRPIQYRVQECNYNRLQHAVPADDGTTRSPSIDSIQKDPREFAWRDPELPEVIHMLQHQFPSVQANAAAYLQHLCFGDNKVKMEVCRLGGIKHLVDLLDHRVLEVQKNACGALRNLVFGKSTDENKIAMKNVGGIPALLRLLRKSIDAEVRELVTGVLWNLSSCDAVKMTIIRDALSTLTNTVIVPHSGWNNSSFDDDHKIKFQTSLVLRNTTGCLRNLSSAGEEARKQMRSCEGLVDSLLYVIHTCVNTSDYDSKTVENCVCTLRNLSYRLELEVPQARLLGLNELDDLLGKESPSKDSEPSCWGKKKKKKKRTPQEDQWDGVGPIPGLSKSPKGVEMLWHPSVVKPYLTLLAESSNPATLEGSAGSLQNLSAGNWKFAAYIRAAVRKEKGLPILVELLRMDNDRVVSSVATALRNMALDVRNKELIGKYAMRDLVNRLPGGNGPSVLSDETMAAICCALHEVTSKNMENAKALADSGGIEKLVNITKGRGDRSSLKVVKAAAQVLNTLWQYRDLRSIYKKDGWNQNHFITPVSTLERDRFKSHPSLSTTNQQMSPIIQSVGSTSSSPALLGIRDPRSEYDRTQPPMQYYNSQGDATHKGLYPGSSKPSPIYISSYSSPAREQNRRLQHQQLYYSQDDSNRKNFDAYRLYLQSPHSYEDPYFDDRVHFPASTDYSTQYGLKSTTNYVDFYSTKRPSYRAEQYPGSPDSWV,1192,"131,868",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; Synonyms=Long; IsoId=Q99569-1; Sequence=Displayed; Name=2; Synonyms=Short; IsoId=Q99569-2; Sequence=VSP_006737; ,,,SEQUENCE CAUTION:  Sequence=CAA57478.1; Type=Erroneous termination; Positions=1193; Note=Translated as stop.; Evidence={ECO:0000305}; ,,"SEQUENCE CAUTION:  Sequence=CAA57478.1; Type=Frameshift; Positions=334, 337, 864, 874; Evidence={ECO:0000305}; ",,,,,"VAR_SEQ 1043 1085 Missing (in isoform 2). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:8937994}. /FTId=VSP_006737.",,,,,CONFLICT 41 41 V -> M (in Ref. 3; AAH50308). {ECO:0000305}.; CONFLICT 223 223 S -> Y (in Ref. 3; AAH50308). {ECO:0000305}.; CONFLICT 235 235 G -> W (in Ref. 3; AAH50308). {ECO:0000305}.; CONFLICT 335 335 S -> V (in Ref. 1; CAA57478). {ECO:0000305}.; CONFLICT 336 336 S -> V (in Ref. 1; CAA57478). {ECO:0000305}.; CONFLICT 447 447 S -> V (in Ref. 1; CAA57478). {ECO:0000305}.; CONFLICT 448 448 V -> S (in Ref. 1; CAA57478). {ECO:0000305}.; CONFLICT 538 538 Q -> E (in Ref. 1; CAA57478). {ECO:0000305}.; CONFLICT 701 701 S -> T (in Ref. 1; CAA57478). {ECO:0000305}.; CONFLICT 766 766 N -> D (in Ref. 3; AAH50308). {ECO:0000305}.; CONFLICT 856 856 G -> S (in Ref. 1; CAA57478). {ECO:0000305}.; CONFLICT 865 865 R -> G (in Ref. 1; CAA57478). {ECO:0000305}.; CONFLICT 892 892 V -> G (in Ref. 1; CAA57478). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the beta-catenin family. {ECO:0000305}.,COILED 36 70 {ECO:0000255}.,COMPBIAS 788 794 Poly-Lys.,,,,REPEAT 415 455 ARM 1.; REPEAT 518 557 ARM 2.; REPEAT 560 599 ARM 3.; REPEAT 604 644 ARM 4.; REPEAT 660 702 ARM 5.; REPEAT 706 751 ARM 6.; REPEAT 815 855 ARM 7.; REPEAT 862 901 ARM 8.; REPEAT 950 993 ARM 9.,,,,,,,FUNCTION: Plays a role as a regulator of Rho activity during cytokinesis. May play a role in junctional plaques. {ECO:0000269|PubMed:17115030}.,,,,,,,,,,,,cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; desmosome [GO:0030057]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; cornification [GO:0070268]; keratinization [GO:0031424]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; regulation of cell adhesion [GO:0030155],cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; cornification [GO:0070268]; keratinization [GO:0031424]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; regulation of cell adhesion [GO:0030155],cadherin binding [GO:0045296],cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; desmosome [GO:0030057]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],GO:0000922; GO:0001533; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0005913; GO:0007043; GO:0007267; GO:0009898; GO:0014069; GO:0030054; GO:0030057; GO:0030155; GO:0030496; GO:0031424; GO:0032467; GO:0043547; GO:0045296; GO:0048471; GO:0051233; GO:0070268; GO:0072686; GO:0098609,IPR011989; IPR016024; IPR000225; IPR028443; IPR028435; ,Q8N5M1; Q12959; Q96RT1; Q96RT1-2; Q08379; Q9BRK4; Q14160; P36406,"SUBUNIT: Interacts with PDZD2 (By similarity). Interacts (via the C-terminus) with FRMPD2 (via the PDZ 2 domain). Interacts with RHOA; the interaction is detected at the midbody. Interacts with ECT2; the interaction is detected at the midbody. {ECO:0000250, ECO:0000269|PubMed:17115030, ECO:0000269|PubMed:19706687}.",8937994; 15815621; 15489334; 15144186; 17081983; 17115030; 18220336; 18691976; 18669648; 19413330; 19706687; 19369195; 19690332; 20068231; 21406692; 22814378; 23186163; 24275569,8937994; 15815621; 15489334; 15144186; 17081983; 17115030; 18220336; 18691976; 18669648; 19413330; 19706687; 19369195; 19690332; 20068231; 21406692; 22814378; 23186163; 24275569; 10066784; 10092585; 10411887; 10771479; 11350120; 11590230; 12047349; 12615965; 12902340; 15304078; 15797384; 16169070; 16203728; 16639001; 17264675; 17515931; 18649358; 19005682; 19165527; 19167335; 19339549; 19830446; 20379614; 21654840; 21900206; 22965878; 23139756; 23481192; 23640939; 24163434; 24255178; 25416956; 26496610; 26638075; 28808088; 28898462; 7543090; 8999895; 9395522; 9565599,2002-01-23,2019-02-13,2010-11-30,173,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (1); Erroneous termination (1); Frameshift (1); Modified residue (36); Repeat (9); Sequence conflict (13),,,,Alternative splicing;Cell adhesion;Cell junction;Cell membrane;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Membrane;Methylation;Phosphoprotein;Reference proteome;Repeat,Evidence at protein level,reviewed,,Beta-catenin family,173,Alternative products (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0025; KW-0130; KW-0175; KW-0181; KW-0206; KW-0472; KW-0488; KW-0597; KW-0677; KW-0963; KW-0965; KW-1003; KW-1185,,,,,,,,,CHAIN 1 1192 Plakophilin-4. /FTId=PRO_0000064289.,,,,,,"MOD_RES 75 75 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 84 84 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 106 106 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 132 132 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 136 136 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 139 139 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 221 221 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 231 231 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 236 236 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 254 254 Omega-N-methylarginine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 270 270 Omega-N-methylarginine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 273 273 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 281 281 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 314 314 Phosphoserine. {ECO:0000244|PubMed:15144186, ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 327 327 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 337 337 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 372 372 Phosphotyrosine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 392 392 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 403 403 Phosphoserine. {ECO:0000244|PubMed:18220336}.; MOD_RES 406 406 Phosphoserine. {ECO:0000244|PubMed:15144186, ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:23186163}.; MOD_RES 412 412 Phosphothreonine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 415 415 Phosphotyrosine. {ECO:0000244|PubMed:15144186, ECO:0000244|PubMed:19690332}.; MOD_RES 422 422 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 427 427 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 438 438 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 478 478 Phosphotyrosine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 510 510 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 512 512 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 515 515 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 776 776 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 1013 1013 Phosphothreonine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 1017 1017 Phosphothreonine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 1045 1045 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 1091 1091 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 1100 1100 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.; MOD_RES 1135 1135 Phosphoserine. {ECO:0000250|UniProtKB:Q68FH0}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X81889;BC050308;
0,Q99728,BARD1_HUMAN,BARD1,BARD1,,,,Homo sapiens (Human),9606,BRCA1-associated RING domain protein 1 (BARD-1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BARD1),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPDNRQPRNRQPRIRSGNEPRSAPAMEPDGRGAWAHSRAALDRLEKLLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIGTGCPVCYTPAWIQDLKINRQLDSMIQLCSKLRNLLHDNELSDLKEDKPRKSLFNDAGNKKNSIKMWFSPRSKKVRYVVSKASVQTQPAIKKDASAQQDSYEFVSPSPPADVSERAKKASARSGKKQKKKTLAEINQKWNLEAEKEDGEFDSKEESKQKLVSFCSQPSVISSPQINGEIDLLASGSLTESECFGSLTEVSLPLAEQIESPDTKSRNEVVTPEKVCKNYLTSKKSLPLENNGKRGHHNRLSSPISKRCRTSILSTSGDFVKQTVPSENIPLPECSSPPSCKRKVGGTSGRKNSNMSDEFISLSPGTPPSTLSSSSYRRVMSSPSAMKLLPNMAVKRNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNESSSASHCSVMNTGQRRDGPLVLIGSGLSSEQQKMLSELAVILKAKKYTEFDSTVTHVVVPGDAVQSTLKCMLGILNGCWILKFEWVKACLRRKVCEQEEKYEIPEGPRRSRLNREQLLPKLFDGCYFYLWGTFKHHPKDNLIKLVTAGGGQILSRKPKPDSDVTQTINTVAYHARPDSDQRFCTQYIIYEDLCNYHPERVRQGKVWKAPSSWFIDCVMSFELLPLDS,777,"86,648",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; Synonyms=FL; IsoId=Q99728-1; Sequence=Displayed; Name=alpha; IsoId=Q99728-2; Sequence=VSP_055876; Name=beta; IsoId=Q99728-3; Sequence=VSP_055874, VSP_055875; Name=gamma; IsoId=Q99728-4; Sequence=VSP_055877, VSP_055878; ",,,,,,,,,,VAR_SEQ 1 24 MPDNRQPRNRQPRIRSGNEPRSAP -> MVAVPGPTVAPRSTAWRSCCAARV (in isoform beta). {ECO:0000303|PubMed:18089818}. /FTId=VSP_055874.; VAR_SEQ 25 121 Missing (in isoform beta). {ECO:0000303|PubMed:18089818}. /FTId=VSP_055875.; VAR_SEQ 54 72 Missing (in isoform alpha). {ECO:0000303|PubMed:18089818}. /FTId=VSP_055876.; VAR_SEQ 122 127 DLKEDK -> GRHTFC (in isoform gamma). {ECO:0000303|PubMed:18089818}. /FTId=VSP_055877.; VAR_SEQ 128 777 Missing (in isoform gamma). {ECO:0000303|PubMed:18089818}. /FTId=VSP_055878.,VARIANT 24 24 P -> S (common polymorphism in Caucasians; less frequent in Africans; dbSNP:rs1048108). {ECO:0000269|PubMed:9425226}. /FTId=VAR_010354.; VARIANT 153 153 K -> E (in dbSNP:rs753377280). {ECO:0000269|PubMed:9425226}. /FTId=VAR_010355.; VARIANT 186 186 S -> G (in dbSNP:rs16852741). /FTId=VAR_038371.; VARIANT 241 241 S -> C (in dbSNP:rs3738885). /FTId=VAR_020109.; VARIANT 378 378 R -> S (in dbSNP:rs2229571). {ECO:0000269|PubMed:9425226}. /FTId=VAR_024611.; VARIANT 507 507 V -> M (in dbSNP:rs2070094). {ECO:0000269|PubMed:9425226}. /FTId=VAR_010356.; VARIANT 557 557 C -> S (rare polymorphism in Caucasians; dbSNP:rs28997576). {ECO:0000269|PubMed:9425226}. /FTId=VAR_010357.; VARIANT 564 564 Q -> H (in an ovarian clear cell adenocarcinoma). {ECO:0000269|PubMed:9425226}. /FTId=VAR_010358.; VARIANT 645 645 C -> R (in dbSNP:rs2228456). /FTId=VAR_038372.; VARIANT 658 658 R -> C (rare polymorphism in Caucasians; absent in Africans; dbSNP:rs3738888). {ECO:0000269|PubMed:9425226}. /FTId=VAR_010359.; VARIANT 695 695 V -> L (in a breast cancer sample; somatic mutation; dbSNP:rs111367604). {ECO:0000269|PubMed:9425226}. /FTId=VAR_010360.; VARIANT 728 728 S -> F (in dbSNP:rs13389423). /FTId=VAR_028309.; VARIANT 761 761 S -> N (in an uterine cancer sample; somatic mutation; dbSNP:rs142155101). {ECO:0000269|PubMed:9425226}. /FTId=VAR_010361.,,,,CONFLICT 85 85 V -> A (in Ref. 3; AEF57473). {ECO:0000305}.; CONFLICT 406 406 R -> Q (in Ref. 1; AAB38316 and 3; AEF57471/AEF57472). {ECO:0000305}.,,2,,0,,,,COMPBIAS 400 403 Poly-Ser.; COMPBIAS 542 545 Poly-Leu.,DOMAIN 560 653 BRCT 1. {ECO:0000255|PROSITE-ProRule:PRU00033}.; DOMAIN 667 777 BRCT 2. {ECO:0000255|PROSITE-ProRule:PRU00033}.,,REGION 26 119 Interaction with BRCA1.; REGION 554 558 Flexible linker.,REPEAT 427 459 ANK 1.; REPEAT 460 492 ANK 2.; REPEAT 493 525 ANK 3.; REPEAT 526 546 ANK 4; degenerate.,ZN_FING 50 87 RING-type. {ECO:0000255|PROSITE-ProRule:PRU00175}.,2.3.2.27,,"CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:20351172};",,,"FUNCTION: E3 ubiquitin-protein ligase. The BRCA1-BARD1 heterodimer specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Plays a central role in the control of the cell cycle in response to DNA damage. Acts by mediating ubiquitin E3 ligase activity that is required for its tumor suppressor function. Also forms a heterodimer with CSTF1/CSTF-50 to modulate mRNA processing and RNAP II stability by inhibiting pre-mRNA 3' cleavage. {ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:20351172}.",,PATHWAY: Protein modification; protein ubiquitination.,,,,,,,,,,BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein deubiquitination [GO:0016579]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of phosphorylation [GO:0042325]; tissue homeostasis [GO:0001894],cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein deubiquitination [GO:0016579]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of phosphorylation [GO:0042325]; tissue homeostasis [GO:0001894],kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842],BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],GO:0000151; GO:0000729; GO:0001894; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006303; GO:0006974; GO:0007050; GO:0016567; GO:0016579; GO:0016607; GO:0019900; GO:0031436; GO:0031441; GO:0036464; GO:0042325; GO:0042803; GO:0043065; GO:0043066; GO:0045732; GO:0046826; GO:0046872; GO:0046982; GO:0070531; GO:0085020,IPR002110; IPR020683; IPR036770; IPR033097; IPR039503; IPR001357; IPR036420; IPR001841; IPR013083; IPR017907; ,P38398; Q9P2H0; Q8NHQ1; Q12873; Q05048; P33240; O00471; Q8IZU0; Q9Y2X7; Q08379; O95251; Q6A162; O95751; O95453; O14776,"SUBUNIT: Homo- and heterodimer. Heterodimer (RING-type zinc finger) with BRCA1. Heterodimer (via ANK repeats and BRCT domains) with CSTF1/CSTF-50. Component of the BRCA1-A complex, at least composed of the BRCA1, BARD1, UIMC1/RAP80, ABRAXAS1, BRCC3/BRCC36, BABAM2 and BABAM1/NBA1. Interacts with UBXN1. {ECO:0000269|PubMed:11573085, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:17643122, ECO:0000269|PubMed:18842000, ECO:0000269|PubMed:19261749, ECO:0000269|PubMed:20351172}.",8944023; 9425226; 18089818; 15815621; 15489334; 10026184; 10477523; 12890688; 14976165; 17643122; 18669648; 19413330; 19261749; 19690332; 20351172; 23186163; 25755297; 28112733; 11573085; 17550235; 18842000; 18480049,8944023; 9425226; 18089818; 15815621; 15489334; 10026184; 10477523; 12890688; 14976165; 17643122; 18669648; 19413330; 19261749; 19690332; 20351172; 23186163; 25755297; 28112733; 11573085; 17550235; 18842000; 18480049; 10212258; 10435622; 10438626; 10550055; 10724175; 10801132; 10856253; 10859164; 10866324; 10921897; 10973490; 11006276; 11025670; 11080452; 11114888; 11139606; 11301010; 11376695; 11390642; 11459987; 11571269; 11751635; 11773071; 11779501; 11807980; 11832208; 11925436; 11927591; 11943588; 12139939; 12152085; 12154023; 12364621; 12370410; 12379650; 12431996; 12438698; 12485996; 12545175; 12578958; 12750383; 12773400; 12791985; 12832489; 12912992; 14527420; 14550946; 14560035; 14576433; 14638690; 14647430; 14716019; 14734547; 15159397; 15184379; 15189136; 15190204; 15218362; 15265711; 15342711; 15383276; 15485900; 15632137; 15665273; 15665856; 15703751; 15707391; 15782130; 15855157; 15886201; 15916957; 16061562; 16148040; 16150728; 16152612; 16153896; 16327781; 16333312; 16337601; 16360315; 16530042; 16651405; 16672066; 16768547; 16825437; 16885023; 17028982; 17114795; 17185394; 17275994; 17333333; 17399677; 17497650; 17525340; 17556008; 17575048; 17678435; 17848578; 17928296; 17962301; 17965729; 17972171; 17996710; 17996711; 18171670; 18243530; 18317453; 18443292; 18481171; 18539610; 18541667; 18676680; 18757400; 18805091; 18923075; 18950845; 18957201; 18971343; 19001859; 19064565; 19064572; 19074197; 19117993; 19124506; 19164445; 19170196; 19197335; 19202061; 19268590; 19357644; 19369211; 19412175; 19419957; 19482343; 19536092; 19584272; 19615732; 19625176; 19690564; 19692168; 19714462; 19789190; 19796682; 19887602; 19941829; 19959210; 20060929; 20077502; 20207730; 20233725; 20379136; 20379614; 20453000; 20729832; 20729858; 20729859; 20842729; 20871615; 20871616; 20965415; 21052091; 21103343; 21240188; 21263215; 21282113; 21325134; 21335604; 21344236; 21393566; 21659603; 21680713; 21693656; 21777809; 21804533; 21809034; 21815143; 21888893; 21950761; 22021381; 22024395; 22328350; 22544576; 22593209; 22635276; 22645308; 22652532; 22661229; 22661230; 22792074; 22883453; 22977173; 23056176; 23149936; 23222812; 23306437; 23333306; 23345434; 23509288; 23680151; 23686288; 23727112; 23731732; 23810717; 23966609; 24076221; 24141787; 24349422; 24371268; 24485656; 24509834; 24516540; 24667604; 24831703; 24948741; 25008968; 25113031; 25122754; 25416956; 25609649; 25634209; 25657202; 25659039; 25740706; 25994375; 26010302; 26022179; 26329992; 26415510; 26496610; 26941572; 27239795; 27477900; 27502904; 27977889; 28030839; 28161399; 28262780; 28418444; 28976962; 29367421; 29686231; 8702565; 9065463; 9528852; 9705271; 9837724; 9925639,2001-02-21,2019-02-13,2006-10-17,203,X-ray crystallography (4); NMR spectroscopy (1),STRAND 51 53 {ECO:0000244|PDB:1JM7}.; STRAND 65 67 {ECO:0000244|PDB:1JM7}.; STRAND 84 86 {ECO:0000244|PDB:1JM7}.; STRAND 571 576 {ECO:0000244|PDB:2NTE}.; STRAND 595 599 {ECO:0000244|PDB:2NTE}.; STRAND 606 613 {ECO:0000244|PDB:2NTE}.; STRAND 629 632 {ECO:0000244|PDB:2NTE}.; STRAND 676 679 {ECO:0000244|PDB:2NTE}.; STRAND 684 686 {ECO:0000244|PDB:2NTE}.; STRAND 701 705 {ECO:0000244|PDB:2NTE}.; STRAND 735 739 {ECO:0000244|PDB:2NTE}.; STRAND 750 752 {ECO:0000244|PDB:2NTE}.; STRAND 755 759 {ECO:0000244|PDB:2NTE}.,HELIX 35 46 {ECO:0000244|PDB:1JM7}.; HELIX 75 78 {ECO:0000244|PDB:1JM7}.; HELIX 99 116 {ECO:0000244|PDB:1JM7}.; HELIX 431 438 {ECO:0000244|PDB:3C5R}.; HELIX 441 449 {ECO:0000244|PDB:3C5R}.; HELIX 464 470 {ECO:0000244|PDB:3C5R}.; HELIX 474 482 {ECO:0000244|PDB:3C5R}.; HELIX 492 494 {ECO:0000244|PDB:3C5R}.; HELIX 497 503 {ECO:0000244|PDB:3C5R}.; HELIX 507 515 {ECO:0000244|PDB:3C5R}.; HELIX 530 533 {ECO:0000244|PDB:3C5R}.; HELIX 537 543 {ECO:0000244|PDB:3C5R}.; HELIX 579 591 {ECO:0000244|PDB:2NTE}.; HELIX 618 625 {ECO:0000244|PDB:2NTE}.; HELIX 634 642 {ECO:0000244|PDB:2NTE}.; HELIX 648 650 {ECO:0000244|PDB:2NTE}.; HELIX 656 665 {ECO:0000244|PDB:2NTE}.; HELIX 688 697 {ECO:0000244|PDB:2NTE}.; HELIX 709 711 {ECO:0000244|PDB:2NTE}.; HELIX 713 715 {ECO:0000244|PDB:2NTE}.; HELIX 729 731 {ECO:0000244|PDB:2NTE}.; HELIX 760 769 {ECO:0000244|PDB:2NTE}.,TURN 72 74 {ECO:0000244|PDB:1JM7}.; TURN 79 81 {ECO:0000244|PDB:1JM7}.; TURN 671 674 {ECO:0000244|PDB:2NTE}.,,,,,5 out of 5,Alternative sequence (5); Beta strand (13); Chain (1); Compositional bias (2); Cross-link (4); Domain (2); Helix (22); Modified residue (4); Natural variant (13); Region (2); Repeat (4); Sequence conflict (4); Turn (3); Zinc finger (1),CAUTION: It is uncertain whether Met-1 or Met-26 is the initiator. {ECO:0000305}.,,,3D-structure;ANK repeat;Alternative splicing;Complete proteome;DNA damage;DNA repair;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger,Evidence at protein level,reviewed,,,203,Alternative products (1); Catalytic activity (1); Caution (1); Function (1); Pathway (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0040; KW-0181; KW-0227; KW-0234; KW-0479; KW-0539; KW-0597; KW-0621; KW-0677; KW-0808; KW-0832; KW-0833; KW-0862; KW-0863; KW-1017; KW-1185,Protein modification; protein ubiquitination. ,,,,,,,PTM: Processed during apoptosis. The homodimer is more susceptible to proteolytic cleavage than the BARD1/BRCA1 heterodimer.,CHAIN 1 777 BRCA1-associated RING domain protein 1. /FTId=PRO_0000055819.,"CROSSLNK 160 160 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 170 170 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 423 423 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 548 548 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.",,,,,MOD_RES 186 186 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 299 299 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 391 391 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 394 394 Phosphothreonine. {ECO:0000244|PubMed:18669648}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U76638;AF038042;AF038034;AF038035;AF038036;AF038037;AF038038;AF038039;AF038040;AF038041;JF790280;JF790281;JF790282;AC016708;BC126426;
0,Q99816,TS101_HUMAN,TSG101,TSG101,,,,Homo sapiens (Human),9606,Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101),UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAVSESQLKKMVSKYKYRDLTVRETVNVITLYKDLKPVLDSYVFNDGSSRELMNLTGTIPVPYRGNTYNIPICLWLLDTYPYNPPICFVKPTSSMTIKTGKHVDANGKIYLPYLHEWKHPQSDLLGLIQVMIVVFGDEPPVFSRPISASYPPYQATGPPNTSYMPGMPGGISPYPSGYPPNPSGYPGCPYPPGGPYPATTSSQYPSQPPVTTVGPSRDGTISEDTIRASLISAVSDKLRWRMKEEMDRAQAELNALKRTEEDLKKGHQKLEEMVTRLDQEVAEVDKNIELLKKKDEELSSALEKMENQSENNDIDEVIIPTAPLYKQILNLYAEENAIEDTIFYLGEALRRGVIDLDVFLKHVRLLSRKQFQLRALMQKARKTAGLSDLY,390,"43,944",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Comment=Additional isoforms seem to exist. Several shorter isoforms are detected in primary breast cancers and other tumors.; Name=1; IsoId=Q99816-1; Sequence=Displayed; Name=2; IsoId=Q99816-2; Sequence=VSP_004440; Note=Detected in normal as well as cancer tissues.; ,,,,,,,,,,VAR_SEQ 15 119 Missing (in isoform 2). {ECO:0000305}. /FTId=VSP_004440.,VARIANT 167 167 M -> I (in dbSNP:rs34385327). /FTId=VAR_034572.,,,,CONFLICT 343 343 F -> L (in Ref. 3; AAH02487). {ECO:0000305}.,,2,,0,DOMAIN: The UEV domain is required for the interaction of the complex with ubiquitin. It also mediates the interaction with PTAP/PSAP motifs of HIV-1 P6 protein and human spumaretrovirus Gag protein.; DOMAIN: The coiled coil domain may interact with stathmin.; DOMAIN: The UEV domain binds ubiquitin and P-[ST]-A-P peptide motif independently.,SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family. UEV subfamily. {ECO:0000305}.,COILED 235 316 {ECO:0000255}.,,DOMAIN 2 145 UEV. {ECO:0000255|PROSITE-ProRule:PRU00652}.; DOMAIN 322 390 SB. {ECO:0000255|PROSITE-ProRule:PRU00644}.,MOTIF 320 323 PTAP motif.,REGION 158 162 Interaction with CEP55.,,,,,,,,"FUNCTION: Component of the ESCRT-I complex, a regulator of vesicular trafficking process. Binds to ubiquitinated cargo proteins and is required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies (MVBs). Mediates the association between the ESCRT-0 and ESCRT-I complex. Required for completion of cytokinesis; the function requires CEP55. May be involved in cell growth and differentiation. Acts as a negative growth regulator. Involved in the budding of many viruses through an interaction with viral proteins that contain a late-budding motif P-[ST]-A-P. This interaction is essential for viral particle budding of numerous retroviruses. Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413). It may also play a role in the extracellular release of microvesicles that differ from the exosomes (PubMed:22315426). {ECO:0000269|PubMed:11916981, ECO:0000269|PubMed:17556548, ECO:0000269|PubMed:17853893, ECO:0000269|PubMed:21070952, ECO:0000269|PubMed:21757351, ECO:0000269|PubMed:22315426, ECO:0000269|PubMed:22660413}.",,,,,,,,,,,,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]","autophagosome maturation [GO:0097352]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]",calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886],GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016197; GO:0016236; GO:0019058; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0044877; GO:0045892; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0090543; GO:0097352; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397,IPR037202; IPR017916; IPR016135; IPR008883; ,O95429; Q9Y5K6; Q53EZ4; Q9UER7; Q8IZU0; P04591; Q96CS2; O14964; Q99LI8; P46940; Q9BVG8; A1A4E9; P05783; Q15323; Q99732; Q6UWE0; O60291; Q9NR12; Q9H3S7; Q13464; Q8N0S2; Q86VP1; Q8N6Y0; Q9UK41; Q8NEZ2; Q8NEZ2-2; A5D8V6,"SUBUNIT: Component of the ESCRT-I complex (endosomal sorting complex required for transport I) which consists of TSG101, VPS28, a VPS37 protein (VPS37A to -D) and MVB12A or MVB12B in a 1:1:1:1 stoichiometry (PubMed:18005716). Interacts with VPS37A, VPS37B and VPS37C (PubMed:15218037, PubMed:15509564). Interacts with DMAP1 (PubMed:10888872). Interacts with ubiquitin (PubMed:11595185). Interacts with stathmin, GMCL and AATF (By similarity). Component of an ESCRT-I complex (endosomal sorting complex required for transport I) which consists of TSG101, VPS28, VPS37A and UBAP1 in a 1:1:1:1 stoichiometry (PubMed:21757351). Interacts with HGS; the interaction mediates the association with the ESCRT-0 complex. Interacts with GGA1 and GGA3 (PubMed:15143060, PubMed:15039775). Interacts (via UEV domain) with PDCD6IP/AIP1 (PubMed:14505570, PubMed:14519844). Interacts with VPS28, SNF8 and VPS36 (PubMed:14505570). Self-associates (PubMed:14505570, PubMed:14519844). Interacts with MVB12A; the association appears to be mediated by the TSG101-VPS37 binary subcomplex. Interacts with VPS37D. Interacts with LRSAM1. Interacts with CEP55; the interaction is required for cytokinesis but not for viral budding (PubMed:17853893). Interacts with PDCD6 (PubMed:18256029). Interacts with LITAF (PubMed:23166352). Interacts with MGRN1 (PubMed:17229889). Interacts with ARRDC1; recruits TSG101 to the plasma membrane (PubMed:21191027, PubMed:22315426). {ECO:0000250, ECO:0000250|UniProtKB:Q6IRE4, ECO:0000269|PubMed:10888872, ECO:0000269|PubMed:14505570, ECO:0000269|PubMed:15039775, ECO:0000269|PubMed:15053872, ECO:0000269|PubMed:15143060, ECO:0000269|PubMed:15218037, ECO:0000269|PubMed:15509564, ECO:0000269|PubMed:15858022, ECO:0000269|PubMed:17229889, ECO:0000269|PubMed:17556548, ECO:0000269|PubMed:17853893, ECO:0000269|PubMed:18005716, ECO:0000269|PubMed:18256029, ECO:0000269|PubMed:19520058, ECO:0000269|PubMed:19703557, ECO:0000269|PubMed:21191027, ECO:0000269|PubMed:21757351, ECO:0000269|PubMed:22315426, ECO:0000269|PubMed:23166352}.; SUBUNIT: (Microbial infection) Interacts with HIV-1 p6. {ECO:0000269|PubMed:11427703, ECO:0000269|PubMed:11595185, ECO:0000269|PubMed:12900394, ECO:0000269|PubMed:21070952, ECO:0000269|PubMed:21643473}.; SUBUNIT: (Microbial infection) Interacts with human spumavirus Gag. {ECO:0000269|PubMed:15858022}.; SUBUNIT: (Microbial infection) Interacts with HTLV-1 Gag. {ECO:0000269|PubMed:14581525}.; SUBUNIT: (Microbial infection) Interacts with Ebola virus VP40. {ECO:0000269|PubMed:12559917}.; SUBUNIT: (Microbial infection) Interacts with EIAV p9; the interaction has been shown in vitro. {ECO:0000269|PubMed:14519844}.; SUBUNIT: (Microbial infection) Interacts with Lassa virus protein Z. {ECO:0000269|PubMed:16571837}.; SUBUNIT: (Microbial infection) Interacts with hepatitis E virus protein ORF3. {ECO:0000269|PubMed:21068219}.",9019400; 9867424; 15489334; 9366528; 9242438; 9840940; 10888872; 11595185; 11427703; 11916981; 14505570; 12900394; 12559917; 14581525; 12802020; 14519844; 15256501; 15218037; 15143060; 15039775; 15509564; 15858022; 16571837; 18005716; 17853893; 17229889; 17556548; 18256029; 19413330; 19520058; 19703557; 21269460; 21757351; 21068219; 21191027; 23166352; 22660413; 22814378; 22315426; 23186163; 25944712; 12006492; 12379843; 15053872; 16552148; 21070952; 21643473,9019400; 9867424; 15489334; 9366528; 9242438; 9840940; 10888872; 11595185; 11427703; 11916981; 14505570; 12900394; 12559917; 14581525; 12802020; 14519844; 15256501; 15218037; 15143060; 15039775; 15509564; 15858022; 16571837; 18005716; 17853893; 17229889; 17556548; 18256029; 19413330; 19520058; 19703557; 21269460; 21757351; 21068219; 21191027; 23166352; 22660413; 22814378; 22315426; 23186163; 25944712; 12006492; 12379843; 15053872; 16552148; 21070952; 21643473; 11838966; 11943869; 12029088; 12388682; 12505256; 12663786; 12725919; 12743307; 12900395; 14526201; 14624836; 14761944; 14991575; 15033475; 15126635; 15452250; 15473846; 15611048; 15657031; 15908698; 16004603; 16118794; 16138902; 16189514; 16256744; 16407257; 16707569; 17014699; 17060450; 17174262; 17182691; 17321722; 17350572; 17369844; 17428861; 17446270; 17606716; 17940959; 18077552; 18367816; 18600204; 18676680; 19060904; 19170196; 19282983; 19362095; 19527882; 19549727; 19625176; 19692168; 19692479; 19787439; 20176808; 20331378; 20360068; 20372822; 20399684; 20467437; 20504928; 20711500; 21117030; 21289126; 21455631; 21706016; 21880841; 21988832; 22348143; 22675076; 22762019; 22768867; 22810585; 23217182; 23305486; 23408603; 23416715; 23933150; 24136289; 24237697; 24244542; 24522922; 25010273; 25330247; 25416956; 25510868; 25640309; 26066081; 26400331; 26457367; 26496610; 26537625; 26608825; 26729199; 26811492; 27377049; 27648839; 27764233; 29123089; 29859188; 30126636; 30343281,2000-12-01,2019-02-13,1998-08-01,211,X-ray crystallography (12); NMR spectroscopy (5),STRAND 35 42 {ECO:0000244|PDB:3OBQ}.; STRAND 51 62 {ECO:0000244|PDB:3OBQ}.; STRAND 67 75 {ECO:0000244|PDB:3OBQ}.; STRAND 86 89 {ECO:0000244|PDB:3OBQ}.; STRAND 95 97 {ECO:0000244|PDB:3OBQ}.; STRAND 100 103 {ECO:0000244|PDB:1S1Q}.; STRAND 107 109 {ECO:0000244|PDB:1KPP}.; STRAND 140 143 {ECO:0000244|PDB:3OBQ}.,HELIX 5 11 {ECO:0000244|PDB:3OBQ}.; HELIX 18 31 {ECO:0000244|PDB:3OBQ}.; HELIX 112 115 {ECO:0000244|PDB:3OBQ}.; HELIX 124 137 {ECO:0000244|PDB:3OBQ}.; HELIX 230 299 {ECO:0000244|PDB:3IV1}.,TURN 12 14 {ECO:0000244|PDB:3OBQ}.; TURN 47 49 {ECO:0000244|PDB:3P9G}.; TURN 78 82 {ECO:0000244|PDB:3OBQ}.; TURN 119 121 {ECO:0000244|PDB:3OBQ}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (8); Chain (1); Coiled coil (1); Domain (2); Helix (5); Initiator methionine (1); Modified residue (2); Motif (1); Mutagenesis (11); Natural variant (1); Region (1); Sequence conflict (1); Turn (4),,"TISSUE SPECIFICITY: Heart, brain, placenta, lung, liver, skeletal, kidney and pancreas.",,3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Endosome;Growth regulation;Host-virus interaction;Membrane;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport;Ubl conjugation,Evidence at protein level,reviewed,,"Ubiquitin-conjugating enzyme family, UEV subfamily",211,Alternative products (1); Caution (1); Domain (3); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (8); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0341; KW-0472; KW-0539; KW-0597; KW-0621; KW-0653; KW-0813; KW-0832; KW-0945; KW-0963; KW-0967; KW-1185,,,,,,,,"PTM: Monoubiquitinated at multiple sites by LRSAM1 and by MGRN1. Ubiquitination inactivates it, possibly by regulating its shuttling between an active membrane-bound protein and an inactive soluble form. Ubiquitination by MGRN1 requires the presence of UBE2D1. {ECO:0000269|PubMed:15256501, ECO:0000269|PubMed:17229889, ECO:0000269|PubMed:19703557}.",CHAIN 2 390 Tumor susceptibility gene 101 protein. /FTId=PRO_0000082606.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22814378}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22814378}.; MOD_RES 220 220 Phosphothreonine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U82130;BC002487;
0,Q99996,AKAP9_HUMAN,AKAP9 AKAP350 AKAP450 KIAA0803,AKAP9,AKAP350 AKAP450 KIAA0803,,,Homo sapiens (Human),9606,A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao),UP000005640: Chromosome 7,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MEDEERQKKLEAGKAKLAQFRQRKAQSDGQSPSKKQKKKRKTSSSKHDVSAHHDLNIDQSQCNEMYINSSQRVESTVIPESTIMRTLHSGEITSHEQGFSVELESEISTTADDCSSEVNGCSFVMRTGKPTNLLREEEFGVDDSYSEQGAQDSPTHLEMMESELAGKQHEIEELNRELEEMRVTYGTEGLQQLQEFEAAIKQRDGIITQLTANLQQARREKDETMREFLELTEQSQKLQIQFQQLQASETLRNSTHSSTAADLLQAKQQILTHQQQLEEQDHLLEDYQKKKEDFTMQISFLQEKIKVYEMEQDKKVENSNKEEIQEKETIIEELNTKIIEEEKKTLELKDKLTTADKLLGELQEQIVQKNQEIKNMKLELTNSKQKERQSSEEIKQLMGTVEELQKRNHKDSQFETDIVQRMEQETQRKLEQLRAELDEMYGQQIVQMKQELIRQHMAQMEEMKTRHKGEMENALRSYSNITVNEDQIKLMNVAINELNIKLQDTNSQKEKLKEELGLILEEKCALQRQLEDLVEELSFSREQIQRARQTIAEQESKLNEAHKSLSTVEDLKAEIVSASESRKELELKHEAEVTNYKIKLEMLEKEKNAVLDRMAESQEAELERLRTQLLFSHEEELSKLKEDLEIEHRINIEKLKDNLGIHYKQQIDGLQNEMSQKIETMQFEKDNLITKQNQLILEISKLKDLQQSLVNSKSEEMTLQINELQKEIEILRQEEKEKGTLEQEVQELQLKTELLEKQMKEKENDLQEKFAQLEAENSILKDEKKTLEDMLKIHTPVSQEERLIFLDSIKSKSKDSVWEKEIEILIEENEDLKQQCIQLNEEIEKQRNTFSFAEKNFEVNYQELQEEYACLLKVKDDLEDSKNKQELEYKSKLKALNEELHLQRINPTTVKMKSSVFDEDKTFVAETLEMGEVVEKDTTELMEKLEVTKREKLELSQRLSDLSEQLKQKHGEISFLNEEVKSLKQEKEQVSLRCRELEIIINHNRAENVQSCDTQVSSLLDGVVTMTSRGAEGSVSKVNKSFGEESKIMVEDKVSFENMTVGEESKQEQLILDHLPSVTKESSLRATQPSENDKLQKELNVLKSEQNDLRLQMEAQRICLSLVYSTHVDQVREYMENEKDKALCSLKEELIFAQEEKIKELQKIHQLELQTMKTQETGDEGKPLHLLIGKLQKAVSEECSYFLQTLCSVLGEYYTPALKCEVNAEDKENSGDYISENEDPELQDYRYEVQDFQENMHTLLNKVTEEYNKLLVLQTRLSKIWGQQTDGMKLEFGEENLPKEETEFLSIHSQMTNLEDIDVNHKSKLSSLQDLEKTKLEEQVQELESLISSLQQQLKETEQNYEAEIHCLQKRLQAVSESTVPPSLPVDSVVITESDAQRTMYPGSCVKKNIDGTIEFSGEFGVKEETNIVKLLEKQYQEQLEEEVAKVIVSMSIAFAQQTELSRISGGKENTASSKQAHAVCQQEQHYFNEMKLSQDQIGFQTFETVDVKFKEEFKPLSKELGEHGKEILLSNSDPHDIPESKDCVLTISEEMFSKDKTFIVRQSIHDEISVSSMDASRQLMLNEEQLEDMRQELVRQYQEHQQATELLRQAHMRQMERQREDQEQLQEEIKRLNRQLAQRSSIDNENLVSERERVLLEELEALKQLSLAGREKLCCELRNSSTQTQNGNENQGEVEEQTFKEKELDRKPEDVPPEILSNERYALQKANNRLLKILLEVVKTTAAVEETIGRHVLGILDRSSKSQSSASLIWRSEAEASVKSCVHEEHTRVTDESIPSYSGSDMPRNDINMWSKVTEEGTELSQRLVRSGFAGTEIDPENEELMLNISSRLQAAVEKLLEAISETSSQLEHAKVTQTELMRESFRQKQEATESLKCQEELRERLHEESRAREQLAVELSKAEGVIDGYADEKTLFERQIQEKTDIIDRLEQELLCASNRLQELEAEQQQIQEERELLSRQKEAMKAEAGPVEQQLLQETEKLMKEKLEVQCQAEKVRDDLQKQVKALEIDVEEQVSRFIELEQEKNTELMDLRQQNQALEKQLEKMRKFLDEQAIDREHERDVFQQEIQKLEQQLKVVPRFQPISEHQTREVEQLANHLKEKTDKCSELLLSKEQLQRDIQERNEEIEKLEFRVRELEQALLVSADTFQKVEDRKHFGAVEAKPELSLEVQLQAERDAIDRKEKEITNLEEQLEQFREELENKNEEVQQLHMQLEIQKKESTTRLQELEQENKLFKDDMEKLGLAIKESDAMSTQDQHVLFGKFAQIIQEKEVEIDQLNEQVTKLQQQLKITTDNKVIEEKNELIRDLETQIECLMSDQECVKRNREEEIEQLNEVIEKLQQELANIGQKTSMNAHSLSEEADSLKHQLDVVIAEKLALEQQVETANEEMTFMKNVLKETNFKMNQLTQELFSLKRERESVEKIQSIPENSVNVAIDHLSKDKPELEVVLTEDALKSLENQTYFKSFEENGKGSIINLETRLLQLESTVSAKDLELTQCYKQIKDMQEQGQFETEMLQKKIVNLQKIVEEKVAAALVSQIQLEAVQEYAKFCQDNQTISSEPERTNIQNLNQLREDELGSDISALTLRISELESQVVEMHTSLILEKEQVEIAEKNVLEKEKKLLELQKLLEGNEKKQREKEKKRSPQDVEVLKTTTELFHSNEESGFFNELEALRAESVATKAELASYKEKAEKLQEELLVKETNMTSLQKDLSQVRDHLAEAKEKLSILEKEDETEVQESKKACMFEPLPIKLSKSIASQTDGTLKISSSNQTPQILVKNAGIQINLQSECSSEEVTEIISQFTEKIEKMQELHAAEILDMESRHISETETLKREHYVAVQLLKEECGTLKAVIQCLRSKEGSSIPELAHSDAYQTREICSSDSGSDWGQGIYLTHSQGFDIASEGRGEESESATDSFPKKIKGLLRAVHNEGMQVLSLTESPYSDGEDHSIQQVSEPWLEERKAYINTISSLKDLITKMQLQREAEVYDSSQSHESFSDWRGELLLALQQVFLEERSVLLAAFRTELTALGTTDAVGLLNCLEQRIQEQGVEYQAAMECLQKADRRSLLSEIQALHAQMNGRKITLKREQESEKPSQELLEYNIQQKQSQMLEMQVELSSMKDRATELQEQLSSEKMVVAELKSELAQTKLELETTLKAQHKHLKELEAFRLEVKDKTDEVHLLNDTLASEQKKSRELQWALEKEKAKLGRSEERDKEELEDLKFSLESQKQRNLQLNLLLEQQKQLLNESQQKIESQRMLYDAQLSEEQGRNLELQVLLESEKVRIREMSSTLDRERELHAQLQSSDGTGQSRPPLPSEDLLKELQKQLEEKHSRIVELLNETEKYKLDSLQTRQQMEKDRQVHRKTLQTEQEANTEGQKKMHELQSKVEDLQRQLEEKRQQVYKLDLEGQRLQGIMQEFQKQELEREEKRESRRILYQNLNEPTTWSLTSDRTRNWVLQQKIEGETKESNYAKLIEMNGGGTGCNHELEMIRQKLQCVASKLQVLPQKASERLQFETADDEDFIWVQENIDEIILQLQKLTGQQGEEPSLVSPSTSCGSLTERLLRQNAELTGHISQLTEEKNDLRNMVMKLEEQIRWYRQTGAGRDNSSRFSLNGGANIEAIIASEKEVWNREKLTLQKSLKRAEAEVYKLKAELRNDSLLQTLSPDSEHVTLKRIYGKYLRAESFRKALIYQKKYLLLLLGGFQECEDATLALLARMGGQPAFTDLEVITNRPKGFTRFRSAVRVSIAISRMKFLVRRWHRVTGSVSININRDGFGLNQGAEKTDSFYHSSGGLELYGEPRHTTYRSRSDLDYIRSPLPFQNRYPGTPADFNPGSLACSQLQNYDPDRALTDYITRLEALQRRLGTIQSGSTTQFHAGMRR,3907,"452,987",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=6;  Name=2; IsoId=Q99996-2; Sequence=Displayed; Name=1; IsoId=Q99996-1; Sequence=VSP_059522, VSP_059526; Note=No experimental confirmation available.; Name=3; Synonyms=CG-NAP; IsoId=Q99996-3; Sequence=VSP_059525; Name=4; Synonyms=Yotiao; IsoId=Q99996-4; Sequence=VSP_059522, VSP_059523, VSP_059524; Name=5; IsoId=Q99996-5; Sequence=VSP_059522, VSP_059527; Name=6; Synonyms=AKAP350; IsoId=Q99996-6; Sequence=VSP_059522, VSP_059525, VSP_059528; ",SEQUENCE CAUTION:  Sequence=AAC60380.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; ,,,,SEQUENCE CAUTION:  Sequence=AAB86384.1; Type=Frameshift; Positions=1625; Evidence={ECO:0000305}; ,,,,,"VAR_SEQ 16 16 K -> KIEELSLAFLVRQ (in isoform 1, isoform 4, isoform 5 and isoform 6). /FTId=VSP_059522.; VAR_SEQ 1625 3900 Missing (in isoform 4). /FTId=VSP_059523.; VAR_SEQ 2163 2171 SADTFQKVE -> E (in isoform 3 and isoform 6). /FTId=VSP_059525.; VAR_SEQ 2883 2903 GSSIPELAHSDAYQTREICSS -> VFGFYNMCFSTLC (in isoform 1). /FTId=VSP_059526.; VAR_SEQ 2884 2945 Missing (in isoform 5). /FTId=VSP_059527.; VAR_SEQ 3897 3907 STTQFHAGMRR -> ALSLTTSWQHHSARPTAPLFFEILSHSLG (in isoform 6). /FTId=VSP_059528.; VAR_SEQ 3901 3907 FHAGMRR -> LAQVRVL (in isoform 4). /FTId=VSP_059524.","VARIANT 463 463 M -> I (in dbSNP:rs6964587). {ECO:0000269|PubMed:10358086}. /FTId=VAR_024249.; VARIANT 1335 1335 K -> KQ. {ECO:0000269|PubMed:10202149}. /FTId=VAR_010926.; VARIANT 1570 1570 S -> L (in LQT11; dbSNP:rs121908566). {ECO:0000269|PubMed:18093912}. /FTId=VAR_043489.; VARIANT 2409 2409 M -> I (in a colorectal cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_035785.; VARIANT 2484 2484 K -> R (in dbSNP:rs35759833). /FTId=VAR_043490.; VARIANT 2792 2792 N -> S (in dbSNP:rs6960867). /FTId=VAR_030162.; VARIANT 2979 2979 P -> S (in dbSNP:rs1063242). {ECO:0000269|PubMed:10358086, ECO:0000269|PubMed:9872452, ECO:0000269|PubMed:9915845}. /FTId=VAR_030163.; VARIANT 3297 3297 E -> Q (in a breast cancer sample; somatic mutation; dbSNP:rs756245027). {ECO:0000269|PubMed:16959974}. /FTId=VAR_035786.; VARIANT 3444 3444 Q -> R (in dbSNP:rs34956633). /FTId=VAR_043491.; VARIANT 3614 3614 M -> V (in dbSNP:rs34327395). /FTId=VAR_043492.",,,,CONFLICT 64 64 E -> Q (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 542 542 E -> G (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 626 626 R -> S (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 651 651 N -> S (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 901 901 H -> N (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 944 944 K -> N (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 968 970 QKH -> PKP (in Ref. 1; AAB86384 and 2; CAB40713). {ECO:0000305}.; CONFLICT 985 985 Q -> P (in Ref. 1; AAB86384 and 2; CAB40713). {ECO:0000305}.; CONFLICT 989 989 Q -> P (in Ref. 1; AAB86384 and 2; CAB40713). {ECO:0000305}.; CONFLICT 1008 1008 N -> D (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 1016 1016 V -> E (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 1614 1614 R -> P (in Ref. 1; AAB86384 and 2; CAB40713). {ECO:0000305}.; CONFLICT 1691 1691 N -> T (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 1695 1695 V -> G (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 1790 1791 Missing (in Ref. 7; AAD22767). {ECO:0000305}.; CONFLICT 1831 1831 A -> P (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 1944 1944 I -> V (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 2015 2015 V -> D (in Ref. 7; AAD22767). {ECO:0000305}.; CONFLICT 2145 2146 EI -> HE (in Ref. 7; AAD39719). {ECO:0000305}.; CONFLICT 2157 2157 E -> V (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 2171 2171 E -> Q (in Ref. 7; AAD39719). {ECO:0000305}.; CONFLICT 2502 2502 L -> R (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 2839 2839 I -> N (in Ref. 8; BAA34523). {ECO:0000305}.; CONFLICT 2953 2953 E -> D (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 3083 3083 Q -> H (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 3214 3214 Q -> H (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 3303 3305 ESE -> QSQ (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 3747 3747 P -> A (in Ref. 3; BAA78718). {ECO:0000305}.; CONFLICT 3829 3829 T -> S (in Ref. 3; BAA78718). {ECO:0000305}.,,4,,0,"DOMAIN: RII-binding site, predicted to form an amphipathic helix, could participate in protein-protein interactions with a complementary surface on the R-subunit dimer. {ECO:0000250|UniProtKB:Q28628}.",,COILED 152 902 {ECO:0000255}.; COILED 932 1010 {ECO:0000255}.; COILED 1088 1173 {ECO:0000255}.; COILED 1241 1268 {ECO:0000255}.; COILED 1324 1380 {ECO:0000255}.; COILED 1422 1447 {ECO:0000255}.; COILED 1573 1647 {ECO:0000255}.; COILED 1845 2443 {ECO:0000255}.; COILED 2532 2549 {ECO:0000255}.; COILED 2591 2764 {ECO:0000255}.; COILED 3061 3088 {ECO:0000255}.; COILED 3120 3466 {ECO:0000255}.; COILED 3583 3685 {ECO:0000255}.,COMPBIAS 191 280 Gln-rich.; COMPBIAS 309 998 Glu-rich.; COMPBIAS 1834 2760 Glu-rich.; COMPBIAS 3722 3726 Poly-Leu.,,,REGION 2542 2555 PKA-RII subunit binding domain.,,,,,,,,"FUNCTION: Scaffolding protein that assembles several protein kinases and phosphatases on the centrosome and Golgi apparatus. Required to maintain the integrity of the Golgi apparatus (PubMed:10202149, PubMed:15047863). Required for microtubule nucleation at the cis-side of the Golgi apparatus (PubMed:15047863, PubMed:19242490). Required for association of the centrosomes with the poles of the bipolar mitotic spindle during metaphase (PubMed:25657325). In complex with PDE4DIP isoform 13/MMG8/SMYLE, recruits CAMSAP2 to the Golgi apparatus and tethers non-centrosomal minus-end microtubules to the Golgi, an important step for polarized cell movement (PubMed:27666745, PubMed:28814570). In complex with PDE4DIP isoform 13/MMG8/SMYLE, EB1/MAPRE1 and CDK5RAP2, contributes to microtubules nucleation and extension also from the centrosome to the cell periphery (PubMed:29162697). {ECO:0000269|PubMed:10202149, ECO:0000269|PubMed:15047863, ECO:0000269|PubMed:19242490, ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:27666745, ECO:0000269|PubMed:28814570, ECO:0000269|PubMed:29162697}.; FUNCTION: Isoform 4: Associated with the N-methyl-D-aspartate receptor and is specifically found in the neuromuscular junction (NMJ) as well as in neuronal synapses, suggesting a role in the organization of postsynaptic specializations. {ECO:0000269|PubMed:9482789}.",,,,,,,,,,,,centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; DNA binding [GO:0003677]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; protein-containing complex scaffold activity [GO:0032947]; signaling receptor binding [GO:0005102]; cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165],cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165],DNA binding [GO:0003677]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein-containing complex scaffold activity [GO:0032947]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102],centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076],GO:0000086; GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007194; GO:0007268; GO:0008076; GO:0010389; GO:0015459; GO:0031116; GO:0032947; GO:0033138; GO:0034237; GO:0043025; GO:0043231; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060306; GO:0060307; GO:0071320; GO:0086091; GO:0097060; GO:0097711; GO:0098909; GO:0098962; GO:0098978; GO:0099147; GO:1901018; GO:1903358,IPR028745; IPR005539; IPR019528; ,P26769; Q9H2G9; Q6P1W5; Q08379; P52272; Q9UKT9; O60341; P43360; Q9Y5V3; Q9GZV8; Q8N6K7; Q16385; Q9NVV9; Q8N6Y0; O60763; Q9BTA9,"SUBUNIT: Interacts with the regulatory region of protein kinase N (PKN), protein phosphatase 2A (PP2A), protein phosphatase 1 (PP1) and the immature non-phosphorylated form of PKC epsilon. Interacts with CIP4 and FNBP1 (PubMed:15047863). Interacts with chloride intracellular channel proteins CLIC1, CLIC4 and CLIC5 (PubMed:12163479). CSNK1D binding promotes its centrosomal subcellular location (PubMed:12270714). Interacts with GM130/GOLGA2; leading to recruitment to the Golgi apparatus (PubMed:19242490). Interacts with KCNQ1; targets protein kinase A (PKA) catalytic and regulatory subunits and protein phosphatase 1 (PP1), to the heterodimer KCNQ1-KCNE1 (PubMed:11799244). Interacts with PDE4DIP isoform 13/MMG8/SMYLE; this interaction stabilizes both proteins (PubMed:25217626, PubMed:27666745, PubMed:28814570). In complex with PDE4DIP isoform 13, recruits CAMSAP2 to the Golgi apparatus (PubMed:27666745, PubMed:28814570). Forms a pericentrosomal complex with CDK5RAP2, EB1/MAPRE1 and PDE4DIP isoform 13; within this complex, MAPRE1 binding to CDK5RAP2 may be mediated by PDE4DIP (PubMed:29162697). Interacts with MAPRE1 and MAPRE3 (PubMed:28814570). Interacts (via C-terminus) with CAMSAP2; this interaction is much stronger in the presence of PDE4DIP isoform 13/MMG8/SMYLE (PubMed:27666745). Interacts with CAMSAP3 (PubMed:28089391). Interacts (via C-terminus) with the gamma-tubulin ring complex (gamma-TuRC), composed of gamma-tubulin, TUBGCP2, TUBGCP3, TUBGCP4, TUBGCP5 and TUBGCP6 (PubMed:27666745). {ECO:0000269|PubMed:11799244, ECO:0000269|PubMed:12163479, ECO:0000269|PubMed:12270714, ECO:0000269|PubMed:15047863, ECO:0000269|PubMed:19242490, ECO:0000269|PubMed:25217626, ECO:0000269|PubMed:27666745, ECO:0000269|PubMed:28089391, ECO:0000269|PubMed:28814570, ECO:0000269|PubMed:29162697}.",9482789; 10202149; 10358086; 12853948; 12690205; 9915845; 9872452; 12163479; 12270714; 11799244; 14654843; 15047863; 17525332; 19242490; 19690332; 21269460; 23186163; 25217626; 24275569; 25657325; 27666745; 28814570; 28089391; 29162697; 16959974; 18093912,9482789; 10202149; 10358086; 12853948; 12690205; 9915845; 9872452; 12163479; 12270714; 11799244; 14654843; 15047863; 17525332; 19242490; 19690332; 21269460; 23186163; 25217626; 24275569; 25657325; 27666745; 28814570; 28089391; 29162697; 16959974; 18093912; 10373510; 10646604; 11076968; 11956313; 12207013; 12221128; 12815021; 12852856; 13678582; 14580337; 14622581; 15498487; 15630448; 15705883; 16002409; 16357211; 16462731; 16890155; 17043677; 17353931; 17574030; 17646400; 17719545; 18037885; 18566290; 18615013; 18694559; 18974108; 19004860; 19119138; 19940019; 20230748; 20399632; 20526349; 20558667; 20711500; 21102635; 21182203; 21273506; 21347367; 21372320; 21422230; 21424530; 21516116; 21548880; 21565611; 21620453; 21725307; 21792235; 21911577; 21988832; 22094468; 22179047; 22190034; 22653444; 22745804; 23141531; 23141541; 23253480; 23303910; 23348840; 23400999; 23414517; 23455922; 23455924; 23530209; 23583981; 23602568; 23747070; 23769972; 23789104; 23921553; 24053599; 24089205; 24135138; 24231678; 24255178; 24345920; 24469809; 24591645; 24937142; 24982133; 25047611; 25204415; 25313408; 25532896; 25653285; 25907612; 7769006; 7790358; 8615909; 8665664; 8838651; 9481670,2001-06-01,2019-02-13,2018-04-25,188,,,,,,,,,5 out of 5,Alternative sequence (7); Chain (1); Coiled coil (13); Compositional bias (4); Erroneous gene model prediction (1); Frameshift (1); Modified residue (7); Natural variant (10); Region (1); Sequence conflict (34),,"TISSUE SPECIFICITY: Widely expressed (PubMed:10202149). Isoform 4: Highly expressed in skeletal muscle and in pancreas (PubMed:9482789). {ECO:0000269|PubMed:10202149, ECO:0000269|PubMed:9482789}.",,Alternative splicing;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Golgi apparatus;Long QT syndrome;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,,188,Alternative products (1); Caution (1); Domain (1); Function (2); Involvement in disease (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0175; KW-0181; KW-0206; KW-0225; KW-0333; KW-0454; KW-0597; KW-0621; KW-0963; KW-1185,,,,,"DISEASE: Long QT syndrome 11 (LQT11) [MIM:611820]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:18093912}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 3907 A-kinase anchor protein 9. /FTId=PRO_0000064534.,,,,,,"MOD_RES 153 153 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:24275569}.; MOD_RES 1327 1327 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1765 1765 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 3690 3690 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 3842 3842 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 3865 3865 Phosphoserine. {ECO:0000244|PubMed:17525332}.; MOD_RES 3897 3897 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AJ131693;AB019691;AJ010770;AF026245;AC004013;AC000066;AC000120;CH236949;CH236949;CH236949;AF083037;AF091711;AB018346;
0,Q9BRK4,LZTS2_HUMAN,LZTS2 KIAA1813 LAPSER1,LZTS2,KIAA1813 LAPSER1,,,Homo sapiens (Human),9606,Leucine zipper putative tumor suppressor 2 (hLZTS2) (Protein LAPSER1),UP000005640: Chromosome 10,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAIVQTLPVPLEPAPEAATAPQAPVMGSVSSLISGRPCPGGPAPPRHHGPPGPTFFRQQDGLLRGGYEAQEPLCPAVPPRKAVPVTSFTYINEDFRTESPPSPSSDVEDAREQRAHNAHLRGPPPKLIPVSGKLEKNMEKILIRPTAFKPVLPKPRGAPSLPSFMGPRATGLSGSQGSLTQLFGGPASSSSSSSSSSAADKPLAFSGWASGCPSGTLSDSGRNSLSSLPTYSTGGAEPTTSSPGGHLPSHGSGRGALPGPARGVPTGPSHSDSGRSSSSKSTGSLGGRVAGGLLGSGTRASPDSSSCGERSPPPPPPPPSDEALLHCVLEGKLRDREAELQQLRDSLDENEATMCQAYEERQRHWQREREALREDCAAQAQRAQRAQQLLQLQVFQLQQEKRQLQDDFAQLLQEREQLERRCATLEREQRELGPRLEETKWEVCQKSGEISLLKQQLKESQAELVQKGSELVALRVALREARATLRVSEGRARGLQEAARARELELEACSQELQRHRQEAEQLREKAGQLDAEAAGLREPPVPPATADPFLLAESDEAKVQRAAAGVGGSLRAQVERLRVELQRERRRGEEQRDSFEGERLAWQAEKEQVIRYQKQLQHNYIQMYRRNRQLEQELQQLSLELEARELADLGLAEQAPCICLEEITATEI,669,"72,759",,,,SEQUENCE CAUTION:  Sequence=BAB47442.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,,VARIANT 121 121 R -> H (in a colorectal cancer sample; somatic mutation; dbSNP:rs367898512). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036364.; VARIANT 291 291 G -> R (in a breast cancer sample; somatic mutation; dbSNP:rs1235690743). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036365.; VARIANT 299 299 R -> W (in dbSNP:rs2275381). /FTId=VAR_018277.,,,,CONFLICT 289 289 V -> L (in Ref. 4; AAH58938). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the LZTS2 family. {ECO:0000255|HAMAP-Rule:MF_03026}.,COILED 328 649 {ECO:0000255|HAMAP-Rule:MF_03026}.,COMPBIAS 188 306 Ser-rich.,,MOTIF 631 640 Nuclear export signal.,REGION 1 332 Required for centrosomal localization. {ECO:0000250}.; REGION 447 669 Sufficient for interaction with CTNNB1. {ECO:0000269|PubMed:17000760}.; REGION 450 669 Sufficient for interaction with KATNB1 and for inhibition of katanin-mediated microtubule severing. {ECO:0000250}.,,,,,,,,"FUNCTION: Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway. Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin. {ECO:0000255|HAMAP-Rule:MF_03026, ECO:0000269|PubMed:17000760, ECO:0000269|PubMed:17351128, ECO:0000269|PubMed:17950943, ECO:0000269|PubMed:18490357}.",,,,,,,,,,,,centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; midbody [GO:0030496]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; kidney development [GO:0001822]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein localization to nucleus [GO:1900181]; nuclear export [GO:0051168]; spindle midzone assembly [GO:0051255]; Wnt signaling pathway [GO:0016055],kidney development [GO:0001822]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein localization to nucleus [GO:1900181]; nuclear export [GO:0051168]; spindle midzone assembly [GO:0051255]; Wnt signaling pathway [GO:0016055],,centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; midbody [GO:0030496]; plasma membrane [GO:0005886]; vesicle [GO:0031982],GO:0000281; GO:0001822; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0008285; GO:0016055; GO:0030496; GO:0031982; GO:0051013; GO:0051168; GO:0051255; GO:0090090; GO:1900181,IPR028597; ,A8K932; P0C206; Q95HA4; Q9H6F0; Q9ULW3; Q8WTP8; Q96IX9; Q9BXS5; A7KAX9; Q9H6L4; Q8N5M1; Q8TBE0; Q9BXY8; Q13895; Q9NX04; Q9H7E9; Q9H257; Q9HC52; Q9NVL8; P24863; P51959; O75909; Q9UJX2; Q07002; Q8IVW4; Q8IYX8; Q8IYX8-2; Q8IYR0; Q9NX63; Q8N3C7; Q8NE01; Q8NE01-3; Q2TBE0; Q96GG9; Q9BY27; Q13627; Q9Y463; Q92630; Q08426; O15371; O60573; O95990-3; Q9H5Z6; Q3B820; Q5TZK3; Q9NW38; Q8TES7-6; Q96JP0; P61328; O75344; Q9BVV2; Q14331; Q96NE9; P15976-2; Q96CN9; P55040; Q8NEA9; Q9NVN8; O95872; Q9NWQ4; P62993; Q8TCT9; Q9NSB8; P17482; P10809; Q9H0B3; Q92993; Q674X7; Q9BVG8; P52292; Q14847; P06239; Q96GY3; P25800; P25791; Q8N8X9; O15481; Q9Y316; Q9UBU8; Q15014; Q6PF18; P00540; Q13330; P52298; O43639; O76041; Q9HC98; Q9Y221; Q96DC9; Q99569; Q494U1; Q8WUT1; O15160; Q6NYC8; O60828; O43741; Q8WWY3; P25786; P47897; P47897-2; P63000; O75771; Q9BTL3; Q96T37; Q96IZ5; Q9P2K3; Q9BSD3; Q13671; Q9H4P4; Q14D33; Q06455-4; Q9NUL5; Q9BWG6; Q6NXQ0; Q9H788; Q08AM8; Q05CH4; P12236; O95391; Q9BZL3; Q13573; Q8N9S9; Q9UM82; Q86W54; Q9H0A9; Q9UQ90; Q8WUK8; Q8IYB8; O43463; P03410; Q9P0N9; Q15560; Q9BT92; D3DUQ6; Q9P2Z0; Q9BT49; Q96KP6; Q14134; Q8IWZ5; Q5W5X9; P83876; Q15853; O75604; Q08E77; Q96HA8; Q06250; P24278; A0A0S2Z6H0; Q8N5A5; Q8N5A5-2; Q9BRR0; Q96NC0; Q96E35; P17024; P15622-3; Q8TAU3; Q9BUY5; Q9NWS9-2; Q9ULM2; Q7Z3I7; Q9P0T4,"SUBUNIT: Interacts with KATNB1. Also interacts with CTNNB1, gamma-tubulin and KIF23. {ECO:0000255|HAMAP-Rule:MF_03026, ECO:0000269|PubMed:17000760, ECO:0000269|PubMed:17351128}.",11347906; 15164054; 15489334; 11709705; 17974005; 17000760; 17351128; 17950943; 18490357; 21406692; 23186163; 16959974,11347906; 15164054; 15489334; 11709705; 17974005; 17000760; 17351128; 17950943; 18490357; 21406692; 23186163; 16959974; 15231748; 16189514; 16385451; 16713569; 17446270; 18985028; 20064372; 20508983; 21163940; 21516116; 21988832; 22458338; 23275340; 23602568; 23761130; 23764002; 24255178; 25416956; 26496610; 26638075; 29499699,2004-04-13,2019-02-13,2004-03-01,146,,,,,,,,,5 out of 5,Chain (1); Coiled coil (1); Compositional bias (1); Erroneous initiation (1); Modified residue (3); Motif (1); Mutagenesis (2); Natural variant (3); Region (3); Sequence conflict (1),,"TISSUE SPECIFICITY: Highly expressed in prostate and testis, and at slightly lower levels in spleen, thymus, uterus, small intestine and colon. {ECO:0000269|PubMed:11709705}.",,Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Microtubule;Mitosis;Phosphoprotein;Polymorphism;Reference proteome;Wnt signaling pathway,Evidence at protein level,reviewed,,LZTS2 family,146,Function (1); Induction (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0493; KW-0498; KW-0597; KW-0621; KW-0879; KW-0963; KW-1185,,,,,,,,,CHAIN 1 669 Leucine zipper putative tumor suppressor 2. /FTId=PRO_0000182974.,,,,,,"MOD_RES 249 249 Phosphoserine. {ECO:0000250|UniProtKB:Q91YU6}.; MOD_RES 296 296 Phosphoserine. {ECO:0000250|UniProtKB:Q91YU6}.; MOD_RES 570 570 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB058716;CH471066;CH471066;CH471066;BC006212;BC058938;AY029201;AL834338;
0,Q9BXH1,BBC3_HUMAN,BBC3 PUMA,BBC3,PUMA,,,Homo sapiens (Human),9606,Bcl-2-binding component 3 (JFY-1) (p53 up-regulated modulator of apoptosis),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MARARQEGSSPEPVEGLARDGPRPFPLGRLVPSAVSCGLCEPGLAAAPAAPTLLPAAYLCAPTAPPAVTAALGGSRWPGGPRSRPRGPRPDGPQPSLSLAEQHLESPVPSAPGALAGGPTQAAPGVRGEEEQWAREIGAQLRRMADDLNAQYERRRQEEQQRHRPSPWRVLYNLIMGLLPLPRGHRAPEMEPN,193,"20,532",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; Synonyms=PUMA alpha; IsoId=Q9BXH1-1; Sequence=Displayed; Name=2; Synonyms=PUMA beta; IsoId=Q9BXH1-2; Sequence=VSP_012238; Name=3; Synonyms=PUMA delta; IsoId=Q96PG8-1; Sequence=External; Name=4; Synonyms=PUMA gamma; IsoId=Q96PG8-2; Sequence=External; ,,,,,,,,,,VAR_SEQ 1 92 MARARQEGSSPEPVEGLARDGPRPFPLGRLVPSAVSCGLCEPGLAAAPAAPTLLPAAYLCAPTAPPAVTAALGGSRWPGGPRSRPRGPRPDG -> MKFGMGSAQACPCQVPRAASTTWVPCQICG (in isoform 2). {ECO:0000303|PubMed:11463392}. /FTId=VSP_012238.,,,,,,,1,,0,DOMAIN: The BH3 motif is intrinsically disordered. {ECO:0000269|PubMed:23340338}.,SIMILARITY: Belongs to the Bcl-2 family. {ECO:0000305}.,,,,MOTIF 137 151 BH3.,,,,,,,,,"FUNCTION: Essential mediator of p53/TP53-dependent and p53/TP53-independent apoptosis (PubMed:11463391). Functions by promoting partial unfolding of BCL2L1 and dissociation of BCL2L1 from p53/TP53. Regulates ER stress-induced neuronal apoptosis (PubMed:23340338). {ECO:0000269|PubMed:11463391, ECO:0000269|PubMed:23340338}.",,,,,,,,,,,,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; determination of adult lifespan [GO:0008340]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of growth [GO:0045926]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of thymocyte apoptotic process [GO:0070245]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of apoptotic process [GO:0042981]; release of cytochrome c from mitochondria [GO:0001836]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976],activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; determination of adult lifespan [GO:0008340]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of growth [GO:0045926]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of thymocyte apoptotic process [GO:0070245]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of apoptotic process [GO:0042981]; release of cytochrome c from mitochondria [GO:0001836]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976],,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],GO:0001836; GO:0001844; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0006919; GO:0006974; GO:0008340; GO:0032464; GO:0032471; GO:0034976; GO:0042981; GO:0043525; GO:0045926; GO:0051209; GO:0070059; GO:0070245; GO:0071456; GO:0090200; GO:0097190; GO:0097194; GO:1900740; GO:1902237; GO:1903896; GO:2001056; GO:2001244,IPR031661; ,P10415; Q07817-1; Q92843; Q07820; P97287,"SUBUNIT: Interacts with MCL1 and BCL2A1 (By similarity). Interacts (via BH3 domain) with BCL2 (PubMed:11463391). Interacts with BCL2L1/BCL-XL (PubMed:23340338). Interacts (via BH3 domain) with NOL3/ARC (via CARD domain); this interaction prevents BBC3 association with BCL2 and results in CASP8 activation (By similarity). {ECO:0000250|UniProtKB:Q80ZG6, ECO:0000250|UniProtKB:Q99ML1, ECO:0000269|PubMed:11463391, ECO:0000269|PubMed:23340338}.",11463391; 11463392; 11572983; 15489334; 21269460; 22761832; 23186163; 25944712; 23340338,11463391; 11463392; 11572983; 15489334; 21269460; 22761832; 23186163; 25944712; 23340338; 10195903; 10198631; 10807576; 11546872; 12574499; 12624108; 12963126; 14550297; 14585351; 14634023; 14684737; 14729977; 15143349; 15174051; 15547745; 15574335; 15595728; 15694340; 15731037; 15731089; 15905879; 16007132; 16091745; 16151013; 16462759; 16608847; 16697956; 16983338; 17267315; 17289999; 17360476; 17368424; 17393317; 17616685; 17698840; 17934815; 18215742; 18324703; 18354037; 18367875; 18551131; 18573879; 18579560; 18676979; 18811981; 18835564; 18941118; 19028473; 19064725; 19380879; 19421143; 19439449; 19444283; 19587239; 19638343; 19641508; 19660860; 19679565; 19737931; 19815839; 19851330; 19966853; 20206402; 20413175; 20418652; 20419447; 20421300; 20430872; 20478995; 20627101; 20723285; 20813046; 20978166; 21042732; 21044367; 21048031; 21120639; 21153863; 21159778; 21364664; 21490394; 21633093; 21699775; 21863213; 21868573; 21887277; 21997190; 22021910; 22086558; 22130069; 22178394; 22283740; 22286758; 22359675; 22394200; 22446329; 22516262; 22714709; 22763818; 22773666; 22997714; 23001513; 23220852; 23243310; 23321162; 23365256; 23475628; 23517560; 23532334; 23805223; 23873935; 23916609; 23929624; 24077289; 24127039; 24236056; 24265320; 24452416; 24625983; 24625987; 24685133; 24769730; 24824714; 24830722; 25012639; 25354317; 25356864; 25474084; 25499216; 25544752; 25585941; 25647720; 25684518; 25812964; 25831048; 25846496; 25893985; 25895606; 26030884; 26043078; 26125773; 26212789; 26397041; 26397233; 26576741; 26904937; 26917778; 27117005; 27235693; 27277529; 27339788; 27472460; 27718035; 27737950; 27780918; 27786352; 27924057; 28012060; 28128736; 28277537; 28287251; 28409774; 28423513; 28445976; 28489680; 28594323; 28692117; 28747638; 28893313; 28905491; 28921546; 29030732; 29229477; 29307600; 29533771; 29581256; 29693134; 7834748,2004-12-21,2019-02-13,2001-06-01,141,X-ray crystallography (5); NMR spectroscopy (1),,HELIX 133 150 {ECO:0000244|PDB:5UUL}.,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Helix (1); Modified residue (1); Motif (1); Mutagenesis (2),,TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:11463391}.,,3D-structure;Alternative splicing;Apoptosis;Complete proteome;Mitochondrion;Phosphoprotein;Reference proteome,Evidence at protein level,reviewed,,Bcl-2 family,141,Alternative products (1); Domain (1); Function (1); Induction (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0053; KW-0181; KW-0496; KW-0597; KW-1185,,,,,,,,,CHAIN 1 193 Bcl-2-binding component 3. /FTId=PRO_0000143083.,,,,,,MOD_RES 10 10 Phosphoserine. {ECO:0000244|PubMed:23186163}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF332558;AF354654;AF354655;U82987;CH471126;BC136481;
0,Q9BXL8,CDCA4_HUMAN,CDCA4 HEPP,CDCA4,HEPP,,,Homo sapiens (Human),9606,Cell division cycle-associated protein 4 (Hematopoietic progenitor protein),UP000005640: Chromosome 14,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MFARGLKRKCVGHEEDVEGALAGLKTVSSYSLQRQSLLDMSLVKLQLCHMLVEPNLCRSVLIANTVRQIQEEMTQDGTWRTVAPQAAERAPLDRLVSTEILCRAAWGQEGAHPAPGLGDGHTQGPVSDLCPVTSAQAPRHLQSSAWEMDGPRENRGSFHKSLDQIFETLETKNPSCMEELFSDVDSPYYDLDTVLTGMMGGARPGPCEGLEGLAPATPGPSSSCKSDLGELDHVVEILVET,241,"26,114",,,,SEQUENCE CAUTION:  Sequence=BAA91373.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,,,,,,CONFLICT 93 93 D -> N (in Ref. 2; AAH25263). {ECO:0000305}.,,1,,0,,,,,DOMAIN 30 77 SERTA. {ECO:0000255|PROSITE-ProRule:PRU00396}.,,,,,,,,,,"FUNCTION: May participate in the regulation of cell proliferation through the E2F/RB pathway. May be involved in molecular regulation of hematopoietic stem cells and progenitor cell lineage commitment and differentiation (By similarity). {ECO:0000250, ECO:0000269|PubMed:16984923}.",,,,,,,,,,,,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],,,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],GO:0005654; GO:0005829; GO:0005886,IPR009263; ,O60341; Q96LA8; O43463; Q9H5I1,,11482882; 15489334; 14702039; 16984923,11482882; 15489334; 14702039; 16984923; 18498124; 18572021; 19156129; 21516116; 23455924; 25814554; 26496610; 27492455; 29257222,2003-07-11,2019-02-13,2001-06-01,124,,,,,,,,,4 out of 5,Chain (1); Domain (1); Erroneous initiation (1); Sequence conflict (1),,"TISSUE SPECIFICITY: Highest levels of expression in the pancreas, thymus, testis, spleen, liver, placenta and leukocytes. Relatively low levels in the lung, kidney, prostate, ovary, small intestine and colon. Hardly detectable, if at all, in the brain, skeletal muscle and heart. {ECO:0000269|PubMed:16984923}.",,Complete proteome;Nucleus;Reference proteome,Evidence at protein level,reviewed,,,124,Function (1); Induction (1); Subcellular location (1); Tissue specificity (1),,KW-0181; KW-0539; KW-1185,,,,,,,,,CHAIN 1 241 Cell division cycle-associated protein 4. /FTId=PRO_0000191617.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF322239;BC011736;BC025263;AK000771;
0,Q9BZL6,KPCD2_HUMAN,PRKD2 PKD2 HSPC187,PRKD2,PKD2,,HSPC187,Homo sapiens (Human),9606,Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MATAPSYPAGLPGSPGPGSPPPPGGLELQSPPPLLPQIPAPGSGVSFHIQIGLTREFVLLPAASELAHVKQLACSIVDQKFPECGFYGLYDKILLFKHDPTSANLLQLVRSSGDIQEGDLVEVVLSASATFEDFQIRPHALTVHSYRAPAFCDHCGEMLFGLVRQGLKCDGCGLNYHKRCAFSIPNNCSGARKRRLSSTSLASGHSVRLGTSESLPCTAEELSRSTTELLPRRPPSSSSSSSASSYTGRPIELDKMLLSKVKVPHTFLIHSYTRPTVCQACKKLLKGLFRQGLQCKDCKFNCHKRCATRVPNDCLGEALINGDVPMEEATDFSEADKSALMDESEDSGVIPGSHSENALHASEEEEGEGGKAQSSLGYIPLMRVVQSVRHTTRKSSTTLREGWVVHYSNKDTLRKRHYWRLDCKCITLFQNNTTNRYYKEIPLSEILTVESAQNFSLVPPGTNPHCFEIVTANATYFVGEMPGGTPGGPSGQGAEAARGWETAIRQALMPVILQDAPSAPGHAPHRQASLSISVSNSQIQENVDIATVYQIFPDEVLGSGQFGVVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQSLRHPGIVNLECMFETPEKVFVVMEKLHGDMLEMILSSEKGRLPERLTKFLITQILVALRHLHFKNIVHCDLKPENVLLASADPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLLNQGYNRSLDMWSVGVIMYVSLSGTFPFNEDEDINDQIQNAAFMYPASPWSHISAGAIDLINNLLQVKMRKRYSVDKSLSHPWLQEYQTWLDLRELEGKMGERYITHESDDARWEQFAAEHPLPGSGLPTDRDLGGACPPQDHDMQGLAERISVL,878,"96,722",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=Q9BZL6-1; Sequence=Displayed; Name=2; IsoId=Q9BZL6-2; Sequence=VSP_057279; Note=No experimental confirmation available.; Name=3; IsoId=Q9BZL6-3; Sequence=VSP_059398; ,,,,,"SEQUENCE CAUTION:  Sequence=AAF36107.1; Type=Frameshift; Positions=604, 606, 738, 744, 755, 758, 833, 854; Evidence={ECO:0000305}; ",,,,,VAR_SEQ 1 157 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_057279.; VAR_SEQ 779 779 G -> GGAWGPPTPWA (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_059398.,VARIANT 324 324 V -> M (in dbSNP:rs45455991). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042330.; VARIANT 496 496 A -> V (in dbSNP:rs55716765). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042331.; VARIANT 604 604 S -> G (in dbSNP:rs34325043). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042332.; VARIANT 773 773 W -> R (in dbSNP:rs55933311). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042333.; VARIANT 835 835 A -> V (in dbSNP:rs314665). /FTId=VAR_061531.; VARIANT 848 848 G -> E (in a lung adenocarcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042334.; VARIANT 870 870 G -> E (in a gastric adenocarcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_042335.,,,,CONFLICT 790 790 V -> L (in Ref. 5; AAF36107). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. PKD subfamily. {ECO:0000305}.,,,DOMAIN 397 509 PH. {ECO:0000255|PROSITE-ProRule:PRU00145}.; DOMAIN 551 807 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,MOTIF 724 726 Important for ABL1-mediated Tyr-717 phosphorylation. {ECO:0000269|PubMed:28428613}.,,,ZN_FING 138 188 Phorbol-ester/DAG-type 1. {ECO:0000255|PROSITE-ProRule:PRU00226}.; ZN_FING 264 314 Phorbol-ester/DAG-type 2. {ECO:0000255|PROSITE-ProRule:PRU00226}.,2.7.11.13,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13; Evidence={ECO:0000269|PubMed:11062248, ECO:0000269|PubMed:12058027, ECO:0000269|PubMed:17962809, ECO:0000269|PubMed:28428613}; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.13; Evidence={ECO:0000269|PubMed:11062248, ECO:0000269|PubMed:12058027, ECO:0000269|PubMed:17962809, ECO:0000269|PubMed:28428613};","COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:11062248, ECO:0000269|PubMed:12058027, ECO:0000269|PubMed:28428613}; ",,"FUNCTION: Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of cell proliferation via MAPK1/3 (ERK1/2) signaling, oxidative stress-induced NF-kappa-B activation, inhibition of HDAC7 transcriptional repression, signaling downstream of T-cell antigen receptor (TCR) and cytokine production, and plays a role in Golgi membrane trafficking, angiogenesis, secretory granule release and cell adhesion (PubMed:15604256, PubMed:14743217, PubMed:17077180, PubMed:16928771, PubMed:17962809, PubMed:17951978, PubMed:18262756, PubMed:19192391, PubMed:19001381, PubMed:23503467, PubMed:28428613). May potentiate mitogenesis induced by the neuropeptide bombesin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression (By similarity). In response to oxidative stress, is phosphorylated at Tyr-438 and Tyr-717 by ABL1, which leads to the activation of PRKD2 without increasing its catalytic activity, and mediates activation of NF-kappa-B (PubMed:15604256, PubMed:28428613). In response to the activation of the gastrin receptor CCKBR, is phosphorylated at Ser-244 by CSNK1D and CSNK1E, translocates to the nucleus, phosphorylates HDAC7, leading to nuclear export of HDAC7 and inhibition of HDAC7 transcriptional repression of NR4A1/NUR77 (PubMed:17962809). Upon TCR stimulation, is activated independently of ZAP70, translocates from the cytoplasm to the nucleus and is required for interleukin-2 (IL2) promoter up-regulation (PubMed:17077180). During adaptive immune responses, is required in peripheral T-lymphocytes for the production of the effector cytokines IL2 and IFNG after TCR engagement and for optimal induction of antibody responses to antigens (By similarity). In epithelial cells stimulated with lysophosphatidic acid (LPA), is activated through a PKC-dependent pathway and mediates LPA-stimulated interleukin-8 (IL8) secretion via a NF-kappa-B-dependent pathway (PubMed:16928771). During TCR-induced T-cell activation, interacts with and is activated by the tyrosine kinase LCK, which results in the activation of the NFAT transcription factors (PubMed:19192391). In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane and in polarized cells is involved in the transport of proteins from the TGN to the basolateral membrane (PubMed:14743217). Plays an important role in endothelial cell proliferation and migration prior to angiogenesis, partly through modulation of the expression of KDR/VEGFR2 and FGFR1, two key growth factor receptors involved in angiogenesis (PubMed:19001381). In secretory pathway, is required for the release of chromogranin-A (CHGA)-containing secretory granules from the TGN (PubMed:18262756). Downstream of PRKCA, plays important roles in angiotensin-2-induced monocyte adhesion to endothelial cells (PubMed:17951978). Plays a regulatory role in angiogenesis and tumor growth by phosphorylating a downstream mediator CIB1 isoform 2, resulting in vascular endothelial growth factor A (VEGFA) secretion (PubMed:23503467). {ECO:0000250|UniProtKB:Q8BZ03, ECO:0000269|PubMed:14743217, ECO:0000269|PubMed:15604256, ECO:0000269|PubMed:16928771, ECO:0000269|PubMed:17077180, ECO:0000269|PubMed:17951978, ECO:0000269|PubMed:17962809, ECO:0000269|PubMed:18262756, ECO:0000269|PubMed:19001381, ECO:0000269|PubMed:19192391, ECO:0000269|PubMed:23503467, ECO:0000269|PubMed:28428613}.",,,,,,"ACT_SITE 674 674 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 580 580 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 557 565 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],GO:0001525; GO:0001938; GO:0002250; GO:0004672; GO:0004674; GO:0004697; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007155; GO:0008219; GO:0010595; GO:0018105; GO:0018107; GO:0030148; GO:0030949; GO:0032743; GO:0032757; GO:0032793; GO:0033138; GO:0035556; GO:0035924; GO:0038033; GO:0043536; GO:0045743; GO:0045766; GO:0045785; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0050852; GO:0050862; GO:0051091; GO:0051092; GO:0061154; GO:0070374; GO:0089700; GO:1901727; GO:1902533; GO:2000573; GO:2001028,IPR020454; IPR011009; IPR002219; IPR011993; IPR001849; IPR000719; IPR017441; IPR015727; IPR008271; ,Q8WUI4,"SUBUNIT: Interacts (via C-terminus) with LCK (PubMed:19192391). Interacts (via N-terminal AP-rich region) with CIB1 isoform 2 (PubMed:23503467). Interacts (via N-terminus and zing-finger domain 1 and 2) with PRKCD in response to oxidative stress; the interaction is independent of PRKD2 tyrosine phosphorylation (PubMed:28428613). {ECO:0000269|PubMed:19192391, ECO:0000269|PubMed:23503467, ECO:0000269|PubMed:28428613}.",11062248; 14702039; 15057824; 17974005; 11042152; 12058027; 15604256; 14743217; 17077180; 16928771; 17962809; 17951978; 18076381; 18262756; 18691976; 18669648; 19413330; 19192391; 19001381; 19369195; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 23503467; 28428613; 18836451; 17344846,11062248; 14702039; 15057824; 17974005; 11042152; 12058027; 15604256; 14743217; 17077180; 16928771; 17962809; 17951978; 18076381; 18262756; 18691976; 18669648; 19413330; 19192391; 19001381; 19369195; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 23503467; 28428613; 18836451; 17344846; 15231748; 15975900; 16899224; 17570131; 17591919; 17721511; 18758461; 19520973; 19581308; 19615732; 19913121; 20332261; 20553269; 20628086; 20731705; 20732914; 20855867; 21173164; 21736870; 21865166; 21900206; 22217708; 22734003; 22909819; 22939624; 23251465; 23393329; 23515950; 23562655; 23695357; 24336522; 24463355; 24695225; 24840177; 25218347; 25802335; 25874490; 26241492; 26253275; 26426580; 26496610; 27662904,2002-03-27,2019-02-13,2018-03-28,193,X-ray crystallography (3); NMR spectroscopy (1),STRAND 399 406 {ECO:0000244|PDB:2COA}.; STRAND 409 411 {ECO:0000244|PDB:2COA}.; STRAND 415 421 {ECO:0000244|PDB:2COA}.; STRAND 423 433 {ECO:0000244|PDB:2COA}.; STRAND 438 442 {ECO:0000244|PDB:2COA}.; STRAND 448 452 {ECO:0000244|PDB:2COA}.; STRAND 456 458 {ECO:0000244|PDB:2COA}.; STRAND 465 470 {ECO:0000244|PDB:2COA}.; STRAND 486 488 {ECO:0000244|PDB:2COA}.,HELIX 495 507 {ECO:0000244|PDB:2COA}.,TURN 443 445 {ECO:0000244|PDB:2COA}.,,,,,5 out of 5,Active site (1); Alternative sequence (2); Beta strand (9); Binding site (1); Chain (1); Domain (2); Frameshift (1); Helix (1); Modified residue (17); Motif (1); Mutagenesis (12); Natural variant (7); Nucleotide binding (1); Sequence conflict (1); Turn (1); Zinc finger (2),,TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11062248}.,,3D-structure;ATP-binding;Adaptive immunity;Alternative splicing;Angiogenesis;Cell adhesion;Cell membrane;Complete proteome;Cytoplasm;Golgi apparatus;Immunity;Kinase;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase;Zinc;Zinc-finger,Evidence at protein level,reviewed,,"Protein kinase superfamily, CAMK Ser/Thr protein kinase family, PKD subfamily",193,Activity regulation (1); Alternative products (1); Catalytic activity (2); Caution (1); Cofactor (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0037; KW-0067; KW-0130; KW-0181; KW-0333; KW-0391; KW-0418; KW-0460; KW-0472; KW-0479; KW-0539; KW-0547; KW-0597; KW-0621; KW-0677; KW-0723; KW-0808; KW-0862; KW-0863; KW-0963; KW-1003; KW-1064; KW-1185,,,,,,,,"PTM: Phosphorylation of Ser-876 correlates with the activation status of the kinase (PubMed:11062248). Ser-706 or/and Ser-710 are probably phosphorylated by PKC (PubMed:12058027, PubMed:28428613). Phosphorylation at Ser-244 by CSNK1D and CSNK1E promotes nuclear localization and substrate targeting (PubMed:17962809). Phosphorylation at Ser-244, Ser-706 and Ser-710 is required for nuclear localization (PubMed:17962809). Phosphorylated at Tyr-438 by ABL1 in response to oxidative stress (PubMed:15604256). Phosphorylated at Tyr-717 by ABL1 specifically in response to oxidative stress; requires prior phosphorylation at Ser-706 or/and Ser-710 (PubMed:28428613). {ECO:0000269|PubMed:11062248, ECO:0000269|PubMed:12058027, ECO:0000269|PubMed:15604256, ECO:0000269|PubMed:17962809, ECO:0000269|PubMed:28428613}.",CHAIN 1 878 Serine/threonine-protein kinase D2. /FTId=PRO_0000055716.,,,,,,"MOD_RES 30 30 Phosphoserine. {ECO:0000250|UniProtKB:O94806}.; MOD_RES 87 87 Phosphotyrosine. {ECO:0000250|UniProtKB:Q15139}.; MOD_RES 197 197 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 198 198 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 200 200 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 203 203 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 206 206 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:23186163}.; MOD_RES 212 212 Phosphoserine. {ECO:0000250|UniProtKB:Q8BZ03}.; MOD_RES 214 214 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:24275569}.; MOD_RES 244 244 Phosphoserine; by CSNK1D and CSNK1E. {ECO:0000269|PubMed:17962809}.; MOD_RES 407 407 Phosphotyrosine. {ECO:0000250|UniProtKB:Q15139}.; MOD_RES 438 438 Phosphotyrosine; by ABL1. {ECO:0000269|PubMed:15604256, ECO:0000305|PubMed:28428613}.; MOD_RES 518 518 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 706 706 Phosphoserine; by PKC. {ECO:0000269|PubMed:12058027, ECO:0000269|PubMed:28428613}.; MOD_RES 710 710 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:12058027, ECO:0000269|PubMed:28428613}.; MOD_RES 717 717 Phosphotyrosine; by ABL1. {ECO:0000244|PubMed:19369195, ECO:0000269|PubMed:28428613}.; MOD_RES 876 876 Phosphoserine; by autocatalysis. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000269|PubMed:11062248, ECO:0000269|PubMed:12058027}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF309082;AK074673;AK095884;AK300339;AL050147;AF151021;
0,Q9H4B4,PLK3_HUMAN,PLK3 CNK FNK PRK,PLK3,CNK FNK PRK,,,Homo sapiens (Human),9606,Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MEPAAGFLSPRPFQRAAAAPAPPAGPGPPPSALRGPELEMLAGLPTSDPGRLITDPRSGRTYLKGRLLGKGGFARCYEATDTETGSAYAVKVIPQSRVAKPHQREKILNEIELHRDLQHRHIVRFSHHFEDADNIYIFLELCSRKSLAHIWKARHTLLEPEVRYYLRQILSGLKYLHQRGILHRDLKLGNFFITENMELKVGDFGLAARLEPPEQRKKTICGTPNYVAPEVLLRQGHGPEADVWSLGCVMYTLLCGSPPFETADLKETYRCIKQVHYTLPASLSLPARQLLAAILRASPRDRPSIDQILRHDFFTKGYTPDRLPISSCVTVPDLTPPNPARSLFAKVTKSLFGRKKKSKNHAQERDEVSGLVSGLMRTSVGHQDARPEAPAASGPAPVSLVETAPEDSSPRGTLASSGDGFEEGLTVATVVESALCALRNCIAFMPPAEQNPAPLAQPEPLVWVSKWVDYSNKFGFGYQLSSRRVAVLFNDGTHMALSANRKTVHYNPTSTKHFSFSVGAVPRALQPQLGILRYFASYMEQHLMKGGDLPSVEEVEVPAPPLLLQWVKTDQALLMLFSDGTVQVNFYGDHTKLILSGWEPLLVTFVARNRSACTYLASHLRQLGCSPDLRQRLRYALRLLRDRSPA,646,"71,629",,,,SEQUENCE CAUTION:  Sequence=AAC50637.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,,VARIANT 61 61 T -> S (in dbSNP:rs17884581). {ECO:0000269|Ref.2}. /FTId=VAR_021091.; VARIANT 68 68 L -> F (in dbSNP:rs17884316). {ECO:0000269|Ref.2}. /FTId=VAR_021092.; VARIANT 283 283 L -> F (in dbSNP:rs17880471). {ECO:0000269|Ref.2}. /FTId=VAR_021093.; VARIANT 483 483 R -> C (in dbSNP:rs17884653). {ECO:0000269|Ref.2}. /FTId=VAR_021094.; VARIANT 491 491 D -> N (in dbSNP:rs17855444). {ECO:0000269|PubMed:15489334}. /FTId=VAR_062384.; VARIANT 498 498 S -> L (in dbSNP:rs17880829). {ECO:0000269|Ref.2}. /FTId=VAR_021095.; VARIANT 618 618 S -> P (in dbSNP:rs17881786). {ECO:0000269|Ref.2}. /FTId=VAR_021096.,,,,CONFLICT 16 16 A -> T (in Ref. 1; CAC10659). {ECO:0000305}.; CONFLICT 20 20 P -> T (in Ref. 1; CAC10659). {ECO:0000305}.; CONFLICT 99 99 A -> V (in Ref. 1; CAC10659). {ECO:0000305}.; CONFLICT 353 353 G -> V (in Ref. 1; CAC10659). {ECO:0000305}.; CONFLICT 419 419 D -> H (in Ref. 1; CAC10659). {ECO:0000305}.; CONFLICT 464 470 VSKWVDY -> FSEWVGF (in Ref. 1; CAC10659). {ECO:0000305}.; CONFLICT 522 522 P -> R (in Ref. 1; CAC10659). {ECO:0000305}.,,2,,0,"DOMAIN: The POLO box domains act as phosphopeptide-binding module that recognize and bind serine-[phosphothreonine/phosphoserine]-(proline/X) motifs. PLK3 recognizes and binds docking proteins that are already phosphorylated on these motifs, and then phosphorylates them (By similarity). The POLO box domains mediates localization to the centrosome. {ECO:0000250}.",SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. CDC5/Polo subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,DOMAIN 62 314 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.; DOMAIN 470 537 POLO box 1. {ECO:0000255|PROSITE-ProRule:PRU00154}.; DOMAIN 567 637 POLO box 2. {ECO:0000255|PROSITE-ProRule:PRU00154}.,,,,,2.7.11.21,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.21; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.21;",,,"FUNCTION: Serine/threonine-protein kinase involved in cell cycle regulation, response to stress and Golgi disassembly. Polo-like kinases act by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates ATF2, BCL2L1, CDC25A, CDC25C, CHEK2, HIF1A, JUN, p53/TP53, p73/TP73, PTEN, TOP2A and VRK1. Involved in cell cycle regulation: required for entry into S phase and cytokinesis. Phosphorylates BCL2L1, leading to regulate the G2 checkpoint and progression to cytokinesis during mitosis. Plays a key role in response to stress: rapidly activated upon stress stimulation, such as ionizing radiation, reactive oxygen species (ROS), hyperosmotic stress, UV irradiation and hypoxia. Involved in DNA damage response and G1/S transition checkpoint by phosphorylating CDC25A, p53/TP53 and p73/TP73. Phosphorylates p53/TP53 in response to reactive oxygen species (ROS), thereby promoting p53/TP53-mediated apoptosis. Phosphorylates CHEK2 in response to DNA damage, promoting the G2/M transition checkpoint. Phosphorylates the transcription factor p73/TP73 in response to DNA damage, leading to inhibit p73/TP73-mediated transcriptional activation and pro-apoptotic functions. Phosphorylates HIF1A and JUN is response to hypoxia. Phosphorylates ATF2 following hyperosmotic stress in corneal epithelium. Also involved in Golgi disassembly during the cell cycle: part of a MEK1/MAP2K1-dependent pathway that induces Golgi fragmentation during mitosis by mediating phosphorylation of VRK1. May participate in endomitotic cell cycle, a form of mitosis in which both karyokinesis and cytokinesis are interrupted and is a hallmark of megakaryocyte differentiation, via its interaction with CIB1. {ECO:0000269|PubMed:10557092, ECO:0000269|PubMed:11156373, ECO:0000269|PubMed:11447225, ECO:0000269|PubMed:11551930, ECO:0000269|PubMed:11971976, ECO:0000269|PubMed:12242661, ECO:0000269|PubMed:14968113, ECO:0000269|PubMed:14980500, ECO:0000269|PubMed:15021912, ECO:0000269|PubMed:16478733, ECO:0000269|PubMed:16481012, ECO:0000269|PubMed:17264206, ECO:0000269|PubMed:17804415, ECO:0000269|PubMed:18062778, ECO:0000269|PubMed:18650425, ECO:0000269|PubMed:19103756, ECO:0000269|PubMed:19490146, ECO:0000269|PubMed:20889502, ECO:0000269|PubMed:20940307, ECO:0000269|PubMed:20951827, ECO:0000269|PubMed:21098032, ECO:0000269|PubMed:21264284, ECO:0000269|PubMed:21376736, ECO:0000269|PubMed:21840391, ECO:0000269|PubMed:9353331}.",,,,,,"ACT_SITE 185 185 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 91 91 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 68 76 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle checkpoint [GO:0007093]; mitotic G1/S transition checkpoint [GO:0044819]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chaperone-mediated autophagy [GO:1904716]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to osmotic stress [GO:0006970]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]","apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle checkpoint [GO:0007093]; mitotic G1/S transition checkpoint [GO:0044819]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chaperone-mediated autophagy [GO:1904716]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to osmotic stress [GO:0006970]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]",ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674],centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GO:0000082; GO:0000086; GO:0000122; GO:0000302; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005813; GO:0006468; GO:0006915; GO:0006970; GO:0006974; GO:0006977; GO:0007093; GO:0007113; GO:0009314; GO:0030425; GO:0031122; GO:0032465; GO:0043025; GO:0043066; GO:0043491; GO:0044819; GO:0051302; GO:0090166; GO:0090316; GO:1901796; GO:1904716; GO:2000777,IPR011009; IPR033701; IPR033695; IPR000959; IPR036947; IPR000719; IPR017441; IPR008271; IPR020658; ,P14859; P04156; Q99986,"SUBUNIT: Interacts (via the POLO-box domain) with CIB1; leading to inhibit PLK3 kinase activity. Interacts with GOLGB1. {ECO:0000269|PubMed:14980500, ECO:0000269|PubMed:20473878, ECO:0000269|PubMed:20951827, ECO:0000269|PubMed:21264284}.",11039900; 16710414; 15489334; 8702627; 11746980; 12242661; 9353331; 10557092; 11156373; 11447225; 11551930; 11971976; 14980500; 14968113; 15021912; 16478733; 16481012; 17804415; 17264206; 18062778; 18650425; 19490146; 19103756; 20889502; 20940307; 20951827; 20473878; 21098032; 21840391; 21376736; 21264284; 20671765,11039900; 16710414; 15489334; 8702627; 11746980; 12242661; 9353331; 10557092; 11156373; 11447225; 11551930; 11971976; 14980500; 14968113; 15021912; 16478733; 16481012; 17804415; 17264206; 18062778; 18650425; 19490146; 19103756; 20889502; 20940307; 20951827; 20473878; 21098032; 21840391; 21376736; 21264284; 20671765; 11931760; 12548019; 15190214; 15671037; 16140933; 16189514; 16388739; 18482256; 19556223; 20508983; 22549466; 22828320; 25202016; 25267294; 25416956; 25818805; 25915845; 26352014; 26384350; 27281822; 27325299; 27344333; 27462786; 28515325,2001-04-27,2019-02-13,2004-08-16,172,X-ray crystallography (1),STRAND 62 69 {ECO:0000244|PDB:4B6L}.; STRAND 75 81 {ECO:0000244|PDB:4B6L}.; STRAND 87 94 {ECO:0000244|PDB:4B6L}.; STRAND 125 130 {ECO:0000244|PDB:4B6L}.; STRAND 132 139 {ECO:0000244|PDB:4B6L}.; STRAND 191 193 {ECO:0000244|PDB:4B6L}.; STRAND 199 201 {ECO:0000244|PDB:4B6L}.,HELIX 95 98 {ECO:0000244|PDB:4B6L}.; HELIX 101 114 {ECO:0000244|PDB:4B6L}.; HELIX 147 154 {ECO:0000244|PDB:4B6L}.; HELIX 159 178 {ECO:0000244|PDB:4B6L}.; HELIX 188 190 {ECO:0000244|PDB:4B6L}.; HELIX 229 232 {ECO:0000244|PDB:4B6L}.; HELIX 239 255 {ECO:0000244|PDB:4B6L}.; HELIX 265 273 {ECO:0000244|PDB:4B6L}.; HELIX 285 294 {ECO:0000244|PDB:4B6L}.; HELIX 299 301 {ECO:0000244|PDB:4B6L}.; HELIX 305 309 {ECO:0000244|PDB:4B6L}.; HELIX 312 315 {ECO:0000244|PDB:4B6L}.; HELIX 325 328 {ECO:0000244|PDB:4B6L}.,TURN 82 84 {ECO:0000244|PDB:4B6L}.; TURN 213 215 {ECO:0000244|PDB:4B6L}.; TURN 224 226 {ECO:0000244|PDB:4B6L}.,,,,,5 out of 5,Active site (1); Beta strand (7); Binding site (1); Chain (1); Domain (3); Erroneous initiation (1); Helix (13); Mutagenesis (4); Natural variant (7); Nucleotide binding (1); Sequence conflict (7); Turn (3),,"TISSUE SPECIFICITY: Transcripts are highly detected in placenta, lung, followed by skeletal muscle, heart, pancreas, ovaries and kidney and weakly detected in liver and brain. May have a short half-live. In cells of hematopoietic origin, strongly and exclusively detected in terminally differentiated macrophages. Transcript expression appears to be down-regulated in primary lung tumor.",,3D-structure;ATP-binding;Apoptosis;Cell cycle;Complete proteome;Cytoplasm;Cytoskeleton;DNA damage;Golgi apparatus;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase,Evidence at protein level,reviewed,,"Protein kinase superfamily, Ser/Thr protein kinase family, CDC5/Polo subfamily",172,Catalytic activity (2); Developmental stage (1); Domain (1); Function (1); Induction (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0053; KW-0067; KW-0131; KW-0181; KW-0206; KW-0227; KW-0333; KW-0418; KW-0539; KW-0547; KW-0597; KW-0621; KW-0677; KW-0723; KW-0808; KW-0963; KW-1185,,,,,,,,PTM: Phosphorylated in an ATM-dependent manner following DNA damage. Phosphorylated as cells enter mitosis and dephosphorylated as cells exit mitosis. {ECO:0000269|PubMed:12242661}.,CHAIN 1 646 Serine/threonine-protein kinase PLK3. /FTId=PRO_0000086564.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AJ293866;AY764184;CH471059;BC013899;U56998;
0,Q9H4B6,SAV1_HUMAN,SAV1 WW45,SAV1,WW45,,,Homo sapiens (Human),9606,Protein salvador homolog 1 (45 kDa WW domain protein) (hWW45),UP000005640: Chromosome 14,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MLSRKKTKNEVSKPAEVQGKYVKKETSPLLRNLMPSFIRHGPTIPRRTDICLPDSSPNAFSTSGDVVSRNQSFLRTPIQRTPHEIMRRESNRLSAPSYLARSLADVPREYGSSQSFVTEVSFAVENGDSGSRYYYSDNFFDGQRKRPLGDRAHEDYRYYEYNHDLFQRMPQNQGRHASGIGRVAATSLGNLTNHGSEDLPLPPGWSVDWTMRGRKYYIDHNTNTTHWSHPLEREGLPPGWERVESSEFGTYYVDHTNKKAQYRHPCAPSVPRYDQPPPVTYQPQQTERNQSLLVPANPYHTAEIPDWLQVYARAPVKYDHILKWELFQLADLDTYQGMLKLLFMKELEQIVKMYEAYRQALLTELENRKQRQQWYAQQHGKNF,383,"44,634",,,,,,,,,,,,,VARIANT 185 185 A -> D (in a colon cancer cell line). {ECO:0000269|PubMed:12202036}. /FTId=VAR_015880.,,,,CONFLICT 5 5 K -> Q (in Ref. 1; CAC13972). {ECO:0000305}.; CONFLICT 18 18 Q -> R (in Ref. 3; CAG33578). {ECO:0000305}.; CONFLICT 292 292 L -> F (in Ref. 2; BAB13835). {ECO:0000305}.,,2,,0,,,COILED 344 373 {ECO:0000255}.,,DOMAIN 199 232 WW 1. {ECO:0000255|PROSITE-ProRule:PRU00224}.; DOMAIN 234 267 WW 2. {ECO:0000255|PROSITE-ProRule:PRU00224}.; DOMAIN 321 368 SARAH. {ECO:0000255|PROSITE-ProRule:PRU00310}.,,,,,,,,,,"FUNCTION: Regulator of STK3/MST2 and STK4/MST1 in the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. SAV1 is required for STK3/MST2 and STK4/MST1 activation and promotes cell-cycle exit and terminal differentiation in developing epithelial tissues. Plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosomes, and its ability to phosphorylate CROCC and CEP250. In conjunction with STK3/MST2, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation. {ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:19212654, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:21104395}.",,,,,,,,,,,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein-containing complex scaffold activity [GO:0032947]; apoptotic process [GO:0006915]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; protein stabilization [GO:0050821]; regulation of stem cell population maintenance [GO:2000036]; signal transduction [GO:0007165]; ventricular septum morphogenesis [GO:0060412],apoptotic process [GO:0006915]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; protein stabilization [GO:0050821]; regulation of stem cell population maintenance [GO:2000036]; signal transduction [GO:0007165]; ventricular septum morphogenesis [GO:0060412],identical protein binding [GO:0042802]; protein-containing complex scaffold activity [GO:0032947],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],GO:0001942; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007165; GO:0030216; GO:0032947; GO:0035329; GO:0042802; GO:0043065; GO:0045600; GO:0050680; GO:0050821; GO:0051091; GO:0060044; GO:0060412; GO:0060487; GO:0060575; GO:2000036,IPR011524; IPR030030; IPR001202; IPR036020; ,Itself; O00165; Q13188; Q13043; Q13043-1,"SUBUNIT: Homodimer. Stabilized through interaction with STK3/MST2 or STK4/MST1. Interacts (via SARAH domain) with isoform 1 of NEK2. Interacts with ESR1 only in the presence of STK3/MST2. Interacts with WTIP and AJUBA. {ECO:0000269|PubMed:15688006, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:19212654, ECO:0000269|PubMed:20303269, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:21104395, ECO:0000269|PubMed:28087714}.",11027580; 14702039; 15489334; 15688006; 16930133; 18691976; 19212654; 19369195; 20303269; 21076410; 21104395; 23186163; 28087714; 12202036,11027580; 14702039; 15489334; 15688006; 16930133; 18691976; 19212654; 19369195; 20303269; 21076410; 21104395; 23186163; 28087714; 12202036; 11278283; 12969014; 15109305; 15778465; 18328708; 19950692; 20562859; 20711500; 20920251; 21489991; 21567072; 21572393; 21944251; 21988832; 22185343; 22570112; 23386615; 23455922; 23524264; 23972470; 24255178; 24366813; 25367221; 25814670; 26496610; 26638075; 27661123; 28618450; 29063833; 29519817; 8702870; 9545236,2003-07-11,2019-02-13,2003-07-11,147,X-ray crystallography (1),STRAND 316 319 {ECO:0000244|PDB:6AO5}.,HELIX 298 300 {ECO:0000244|PDB:6AO5}.; HELIX 306 313 {ECO:0000244|PDB:6AO5}.; HELIX 329 375 {ECO:0000244|PDB:6AO5}.,,,,,,5 out of 5,Beta strand (1); Chain (1); Coiled coil (1); Domain (3); Helix (3); Modified residue (3); Natural variant (1); Sequence conflict (3),,"TISSUE SPECIFICITY: Ubiquitously expressed in adult tissues with highest expression in the pancreas, aorta and interventricular septum and lowest expression in skeletal muscle. Expression was higher in fetal than in the adult heart. Expressed in various cell lines. {ECO:0000269|PubMed:19212654}.",,3D-structure;Coiled coil;Complete proteome;Cytoplasm;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat,Evidence at protein level,reviewed,,,147,Function (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0175; KW-0181; KW-0539; KW-0597; KW-0621; KW-0677; KW-0963; KW-1185,,,,,,,,PTM: Phosphorylated by STK3/MST2 and STK4/MST1. Phosphorylation is not required for SAV1 stability and may increase the number of protein binding sites on the scaffold molecule. {ECO:0000269|PubMed:16930133}.,CHAIN 1 383 Protein salvador homolog 1. /FTId=PRO_0000076060.,,,,,,MOD_RES 94 94 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 136 136 Phosphoserine. {ECO:0000250|UniProtKB:Q8VEB2}.; MOD_RES 210 210 Phosphothreonine. {ECO:0000244|PubMed:19369195}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AJ292969;AK021500;AK023071;AK290883;CR457297;CH471078;CH471078;BC020537;
0,Q9HC77,CENPJ_HUMAN,CENPJ CPAP LAP LIP1,CENPJ,CPAP LAP LIP1,,,Homo sapiens (Human),9606,Centromere protein J (CENP-J) (Centrosomal P4.1-associated protein) (LAG-3-associated protein) (LYST-interacting protein 1),UP000005640: Chromosome 13,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MFLMPTSSELNSGQNFLTQWMTNPSRAGVILNRGFPILEADKEKRAAVDISTSFPIKGTHFSDSFSFINEEDSLLEEQKLESNNPYKPQSDKSETHTAFPCIKKGPQVAACHSAPGHQEENKNDFIPDLASEFKEGAYKDPLFKKLEQLKEVQQKKQEQLKRQQLEQLQRLMEEQEKLLTMVSGQCTLPGLSLLPDDQSQKHRSPGNTTTGERATCCFPSYVYPDPTQEETYPSNILSHEQSNFCRTAHGDFVLTSKRASPNLFSEAQYQEAPVEKNNLKEENRNHPTGESILCWEKVTEQIQEANDKNLQKHDDSSEVANIEERPIKAAIGERKQTFEDYLEEQIQLEEQELKQKQLKEAEGPLPIKAKPKQPFLKRGEGLARFTNAKSKFQKGKESKLVTNQSTSEDQPLFKMDRQQLQRKTALKNKELCADNPILKKDSKARTKSGSVTLSQKPKMLKCSNRKSLSPSGLKIQTGKKCDGQFRDQIKFENKVTSNNKENVTECPKPCDTGCTGWNKTQGKDRLPLSTGPASRLAAKSPIRETMKESESSLDVSLQKKLETWEREKEKENLELDEFLFLEQAADEISFSSNSSFVLKILERDQQICKGHRMSSTPVKAVPQKTNPADPISHCNRSEDLDHTAREKESECEVAPKQLHSLSSADELREQPCKIRKAVQKSTSENQTEWNARDDEGVPNSDSSTDSEEQLDVTIKPSTEDRERGISSREDSPQVCDDKGPFKDTRTQEDKRRDVDLDLSDKDYSSDESIMESIKHKVSEPSRSSSLSLSKMDFDDERTWTDLEENLCNHDVVLGNESTYGTPQTCYPNNEIGILDKTIKRKIAPVKRGEDLSKSRRSRSPPTSELMMKFFPSLKPKPKSDSHLGNELKLNISQDQPPGDNARSQVLREKIIELETEIEKFKAENASLAKLRIERESALEKLRKEIADFEQQKAKELARIEEFKKEEMRKLQKERKVFEKYTTAARTFPDKKEREEIQTLKQQIADLREDLKRKETKWSSTHSRLRSQIQMLVRENTDLREEIKVMERFRLDAWKRAEAIESSLEVEKKDKLANTSVRFQNSQISSGTQVEKYKKNYLPMQGNPPRRSKSAPPRDLGNLDKGQAASPREPLEPLNFPDPEYKEEEEDQDIQGEISHPDGKVEKVYKNGCRVILFPNGTRKEVSADGKTITVTFFNGDVKQVMPDQRVIYYYAAAQTTHTTYPEGLEVLHFSSGQIEKHYPDGRKEITFPDQTVKNLFPDGQEESIFPDGTIVRVQRDGNKLIEFNNGQRELHTAQFKRREYPDGTVKTVYANGHQETKYRSGRIRVKDKEGNVLMDTEL,1338,"153,000",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q9HC77-1; Sequence=Displayed; Name=2; IsoId=Q9HC77-2; Sequence=VSP_056831, VSP_056832; Note=No experimental confirmation available.; ",,SEQUENCE CAUTION:  Sequence=AAH24209.3; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 1073 1086 NTSVRFQNSQISSG -> AIHLEDPSLHLLVI (in isoform 2). {ECO:0000303|PubMed:17974005}. /FTId=VSP_056831.; VAR_SEQ 1087 1338 Missing (in isoform 2). {ECO:0000303|PubMed:17974005}. /FTId=VSP_056832.,"VARIANT 21 21 M -> V (in dbSNP:rs35498994). /FTId=VAR_032427.; VARIANT 55 55 P -> A (in dbSNP:rs17081389). /FTId=VAR_032428.; VARIANT 63 63 D -> H (in dbSNP:rs7336216). /FTId=VAR_032429.; VARIANT 85 85 P -> T (in dbSNP:rs9511510). /FTId=VAR_032430.; VARIANT 151 151 E -> G (in dbSNP:rs34177811). /FTId=VAR_032431.; VARIANT 879 879 S -> A (in dbSNP:rs17402892). /FTId=VAR_032432.; VARIANT 1235 1235 E -> V (in MCPH6; reduced interaction with STIL; dbSNP:rs121434311). {ECO:0000269|PubMed:15793586, ECO:0000269|PubMed:22020124}. /FTId=VAR_032433.",,,,CONFLICT 129 129 L -> R (in Ref. 1; AAG21074). {ECO:0000305}.; CONFLICT 1142 1142 E -> R (in Ref. 7; AAG49440). {ECO:0000305}.; CONFLICT 1224 1224 L -> W (in Ref. 7; AAG49440). {ECO:0000305}.; CONFLICT 1333 1333 L -> S (in Ref. 1; AAG21074). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the TCP10 family. {ECO:0000305}.,,,,,"REGION 319 394 Alpha/beta-tubulin binding. {ECO:0000269|PubMed:19131341}.; REGION 895 1338 Interaction with STIL. {ECO:0000269|PubMed:22020124, ECO:0000269|PubMed:25385835}.",,,,,,,,"FUNCTION: Plays an important role in cell division and centrosome function by participating in centriole duplication (PubMed:17681131, PubMed:20531387). Inhibits microtubule nucleation from the centrosome. Involved in the regulation of slow processive growth of centriolar microtubules. Acts as microtubule plus-end tracking protein that stabilizes centriolar microtubules and inhibits microtubule polymerization and extension from the distal ends of centrioles (PubMed:15047868, PubMed:27219064, PubMed:27306797). Required for centriole elongation and for STIL-mediated centriole amplification (PubMed:22020124). Required for the recruitment of CEP295 to the proximal end of new-born centrioles at the centriolar microtubule wall during early S phase in a PLK4-dependent manner (PubMed:27185865). May be involved in the control of centriolar-microtubule growth by acting as a regulator of tubulin release (PubMed:27306797). {ECO:0000269|PubMed:15047868, ECO:0000269|PubMed:17681131, ECO:0000269|PubMed:20531387, ECO:0000269|PubMed:22020124, ECO:0000269|PubMed:27185865, ECO:0000269|PubMed:27219064, ECO:0000305|PubMed:27306797}.",,,,,,,,,,,,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; cell division [GO:0051301]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; microtubule polymerization [GO:0046785]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; smoothened signaling pathway [GO:0007224],cell division [GO:0051301]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; microtubule polymerization [GO:0046785]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; smoothened signaling pathway [GO:0007224],identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],GO:0000086; GO:0003714; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0005886; GO:0007020; GO:0007099; GO:0007224; GO:0008275; GO:0010389; GO:0015631; GO:0019901; GO:0019904; GO:0036064; GO:0042802; GO:0044458; GO:0046599; GO:0046785; GO:0051301; GO:0061511; GO:0097711; GO:1902857; GO:1903724; GO:1904951; GO:1905515,IPR033068; IPR009852; IPR026581; ,Itself; Q66GS9; Q96RK0; Q5VTD9; Q9NYY3; Q15468; O95271; P61981,"SUBUNIT: Forms homodimers (PubMed:27219064). Associates with microtubules plus ends; binds to beta-tublin subunits exposed on microtubule outer surface at its distal tip; also associates with microtubule lattice (PubMed:19131341, PubMed:27219064, PubMed:27306797). Associated with the gamma-tubulin complex. Interacts with the head domain of EPB41 (PubMed:11003675). Interacts with LYST (PubMed:11984006). Interacts with CEP152 (via C-terminus) (PubMed:20852615). Interacts with STIL (PubMed:22020124, PubMed:25385835). Forms a complex with STIL and SASS6 (PubMed:22020124). {ECO:0000269|PubMed:11003675, ECO:0000269|PubMed:11984006, ECO:0000269|PubMed:20852615, ECO:0000269|PubMed:22020124, ECO:0000269|PubMed:25385835, ECO:0000269|PubMed:27219064, ECO:0000269|PubMed:27306797}.",11003675; 17974005; 15057823; 15489334; 11984006; 14654843; 15047868; 17681131; 19131341; 20531387; 20522431; 20852615; 22020124; 21406692; 23186163; 25385835; 27185865; 27219064; 27306797; 15793586,11003675; 17974005; 15057823; 15489334; 11984006; 14654843; 15047868; 17681131; 19131341; 20531387; 20522431; 20852615; 22020124; 21406692; 23186163; 25385835; 27185865; 27219064; 27306797; 15793586; 11076968; 11956313; 12198240; 12207013; 12221128; 12852856; 13678582; 14580337; 15498487; 15687488; 15705883; 16316625; 16357211; 16462731; 16516142; 16631324; 16713569; 16890155; 17574030; 17646400; 17719545; 18037885; 18162190; 18566290; 18586240; 18615013; 18694559; 19004860; 19481458; 19481460; 19503075; 19889632; 19940019; 20080800; 20230748; 20399632; 20558667; 20562859; 20711500; 20936779; 21059844; 21273506; 21297427; 21347367; 21422230; 21548880; 21565611; 21620453; 21725307; 21792235; 22094468; 22100914; 22179047; 22653444; 22699936; 23141531; 23141541; 23253480; 23348840; 23369793; 23400999; 23511974; 23530209; 23747070; 23769972; 23789104; 23810536; 23921553; 24052813; 24053599; 24089205; 24231678; 24255178; 24288161; 24385583; 24469809; 24491538; 24700465; 24982133; 25047611; 25313408; 25532896; 25616662; 26496610; 26517891; 26638075; 26929011; 26997271; 29778912; 7769006; 7790358; 8838651,2005-04-26,2019-02-13,2005-04-26,148,X-ray crystallography (2),,HELIX 380 385 {ECO:0000244|PDB:5EIB}.,,,,,,5 out of 5,Alternative sequence (2); Chain (1); Erroneous initiation (1); Helix (1); Modified residue (6); Mutagenesis (12); Natural variant (7); Region (2); Sequence conflict (4),,,,3D-structure;Alternative splicing;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Dwarfism;Mental retardation;Microtubule;Phosphoprotein;Polymorphism;Primary microcephaly;Reference proteome,Evidence at protein level,reviewed,,TCP10 family,148,Alternative products (1); Caution (1); Function (1); Involvement in disease (2); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0181; KW-0206; KW-0225; KW-0242; KW-0493; KW-0597; KW-0621; KW-0905; KW-0963; KW-0991; KW-1185,,,,,"DISEASE: Microcephaly 6, primary, autosomal recessive (MCPH6) [MIM:608393]: A disease defined as a head circumference more than 3 standard deviations below the age-related mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. Despite this marked reduction in size, the gyral pattern is relatively well preserved, with no major abnormality in cortical architecture. Affected individuals are mentally retarded. Primary microcephaly is further defined by the absence of other syndromic features or significant neurological deficits due to degenerative brain disorder. {ECO:0000269|PubMed:15793586, ECO:0000269|PubMed:22020124}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Seckel syndrome 4 (SCKL4) [MIM:613676]: A rare autosomal recessive disorder characterized by proportionate dwarfism of prenatal onset associated with low birth weight, growth retardation, severe microcephaly with a bird-headed like appearance, and mental retardation. {ECO:0000269|PubMed:20522431}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: Phosphorylation at Ser-589 and Ser-595 by PLK2 is required for procentriole formation and centriole elongation. Phosphorylation by PLK2 oscillates during the cell cycle: it increases at G1/S transition and decreases during the exit from mitosis. Phosphorylation at Ser-595 is also mediated by PLK4 but is not a critical step in PLK4 function in procentriole assembly. {ECO:0000269|PubMed:20531387}.,CHAIN 1 1338 Centromere protein J. /FTId=PRO_0000089480.,,,,,,MOD_RES 260 260 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 316 316 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 540 540 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 589 589 Phosphoserine; by PLK2. {ECO:0000269|PubMed:20531387}.; MOD_RES 595 595 Phosphoserine; by PLK2 and PLK4. {ECO:0000269|PubMed:20531387}.; MOD_RES 759 759 Phosphoserine. {ECO:0000244|PubMed:21406692}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF139625;AL833182;CH471075;BC024209;BC113110;BC113662;BC113664;AJ303006;AF141337;
0,Q9NPQ8,RIC8A_HUMAN,RIC8A,RIC8A,,,,Homo sapiens (Human),9606,Synembryn-A (Protein Ric-8A),UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MEPRAVAEAVETGEEDVIMEALRSYNQEHSQSFTFDDAQQEDRKRLAELLVSVLEQGLPPSHRVIWLQSVRILSRDRNCLDPFTSRQSLQALACYADISVSEGSVPESADMDVVLESLKCLCNLVLSSPVAQMLAAEARLVVKLTERVGLYRERSFPHDVQFFDLRLLFLLTALRTDVRQQLFQELKGVRLLTDTLELTLGVTPEGNPPPTLLPSQETERAMEILKVLFNITLDSIKGEVDEEDAALYRHLGTLLRHCVMIATAGDRTEEFHGHAVNLLGNLPLKCLDVLLTLEPHGDSTEFMGVNMDVIRALLIFLEKRLHKTHRLKESVAPVLSVLTECARMHRPARKFLKAQVLPPLRDVRTRPEVGEMLRNKLVRLMTHLDTDVKRVAAEFLFVLCSESVPRFIKYTGYGNAAGLLAARGLMAGGRPEGQYSEDEDTDTDEYKEAKASINPVTGRVEEKPPNPMEGMTEEQKEHEAMKLVTMFDKLSRNRVIQPMGMSPRGHLTSLQDAMCETMEQQLSSDPDSDPD,531,"59,710",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; IsoId=Q9NPQ8-1; Sequence=Displayed; Name=2; IsoId=Q9NPQ8-2; Sequence=VSP_018507; Name=3; IsoId=Q9NPQ8-3; Sequence=VSP_018508; Name=4; IsoId=Q9NPQ8-4; Sequence=VSP_039849; ,,SEQUENCE CAUTION:  Sequence=BAB14282.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=BAB15653.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,SEQUENCE CAUTION:  Sequence=BAB14282.1; Type=Frameshift; Positions=397; Evidence={ECO:0000305};  Sequence=BAB55126.1; Type=Frameshift; Positions=48; Evidence={ECO:0000305}; ,,,,,VAR_SEQ 1 44 MEPRAVAEAVETGEEDVIMEALRSYNQEHSQSFTFDDAQQEDRK -> MMPNRRTGRWVLAQGVKGQGRVAPGRRAWWSRSSPCPQ (in isoform 2). {ECO:0000303|PubMed:17974005}. /FTId=VSP_018507.; VAR_SEQ 209 209 Missing (in isoform 4). {ECO:0000303|PubMed:15489334}. /FTId=VSP_039849.; VAR_SEQ 354 354 A -> AQGWPPP (in isoform 3). {ECO:0000303|PubMed:11230166}. /FTId=VSP_018508.,,,,,CONFLICT 48 48 E -> V (in Ref. 2; BAB55126). {ECO:0000305}.; CONFLICT 405 405 P -> L (in Ref. 4; CAD98025). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the synembryn family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Guanine nucleotide exchange factor (GEF), which can activate some, but not all, G-alpha proteins. Able to activate GNAI1, GNAO1 and GNAQ, but not GNAS by exchanging bound GDP for free GTP. Involved in regulation of microtubule pulling forces during mitotic movement of chromosomes by stimulating G(i)-alpha protein, possibly leading to release G(i)-alpha-GTP and NuMA proteins from the NuMA-GPSM2-G(i)-alpha-GDP complex (By similarity). Also acts as an activator for G(q)-alpha (GNAQ) protein by enhancing the G(q)-coupled receptor-mediated ERK activation. {ECO:0000250, ECO:0000269|PubMed:16629901}.",,,,,,,,,,,,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion involved in gastrulation [GO:0070586]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; vasculature development [GO:0001944]; visual learning [GO:0008542],adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell-cell adhesion involved in gastrulation [GO:0070586]; cell migration involved in gastrulation [GO:0042074]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; vasculature development [GO:0001944]; visual learning [GO:0008542],G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],GO:0001701; GO:0001944; GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0008542; GO:0042074; GO:0070586; GO:0071711,IPR011989; IPR016024; IPR019318; IPR008376; ,Q12805; Q7Z6G3-2; Q86Y26; Q9UI14; O00560; Q9UMX0; Q9UMX0-2,"SUBUNIT: Interacts with GDP-bound G alpha proteins GNAI1, GNAO1 and GNAQ, and with GNA13 with lower affinity. Does not interact with G-alpha proteins when they are in complex with subunits beta and gamma. Interacts (via C-terminus) with RGS14; the interaction stimulates the dissociation of the complex between RGS14 and the active GTP-bound form of GNAI1 (By similarity). {ECO:0000250}.",11230166; 14702039; 17974005; 16554811; 15489334; 17081983; 16629901; 17525332; 18691976; 18669648; 18318008; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569,11230166; 14702039; 17974005; 16554811; 15489334; 17081983; 16629901; 17525332; 18691976; 18669648; 18318008; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 16169070; 16189514; 16713569; 20479129; 20711500; 21516116; 21771786; 21880739; 21988832; 22384181; 23416715; 23665327; 24466196; 25074811; 25480567; 25519916; 26496610; 27096001,2006-05-16,2019-01-16,2010-10-05,132,,,,,,,,,5 out of 5,Alternative sequence (3); Chain (1); Erroneous initiation (2); Frameshift (2); Modified residue (7); Sequence conflict (2),,,,Alternative splicing;Cell membrane;Complete proteome;Cytoplasm;Guanine-nucleotide releasing factor;Membrane;Phosphoprotein;Reference proteome,Evidence at protein level,reviewed,,Synembryn family,132,Alternative products (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0025; KW-0181; KW-0344; KW-0472; KW-0597; KW-0963; KW-1003; KW-1185,,,,,,,,,CHAIN 1 531 Synembryn-A. /FTId=PRO_0000235890.,,,,,,"MOD_RES 436 436 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 441 441 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 443 443 Phosphothreonine. {ECO:0000250|UniProtKB:Q3TIR3}.; MOD_RES 502 502 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 523 523 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:24275569}.; MOD_RES 524 524 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:24275569}.; MOD_RES 528 528 Phosphoserine. {ECO:0000244|PubMed:18669648}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AL136935;AK022870;AK027090;AK027461;AL390088;BX538115;BC011821;BC111499;BC121807;BC121808;
0,Q9NXR1,NDE1_HUMAN,NDE1 NUDE,NDE1,NUDE,,,Homo sapiens (Human),9606,Nuclear distribution protein nudE homolog 1 (NudE),UP000005640: Chromosome 16,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MEDSGKTFSSEEEEANYWKDLAMTYKQRAENTQEELREFQEGSREYEAELETQLQQIETRNRDLLSENNRLRMELETIKEKFEVQHSEGYRQISALEDDLAQTKAIKDQLQKYIRELEQANDDLERAKRATIMSLEDFEQRLNQAIERNAFLESELDEKENLLESVQRLKDEARDLRQELAVQQKQEKPRTPMPSSVEAERTDTAVQATGSVPSTPIAHRGPSSSLNTPGSFRRGLDDSTGGTPLTPAARISALNIVGDLLRKVGALESKLASCRNLVYDQSPNRTGGPASGRSSKNRDGGERRPSSTSVPLGDKGLDTSCRWLSKSTTRSSSSC,335,"37,721",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q9NXR1-2; Sequence=Displayed; Name=2; IsoId=Q9NXR1-1; Sequence=VSP_059512; ,,,,,,,,,,VAR_SEQ 318 335 DTSCRWLSKSTTRSSSSC -> GKRLEFGKPPSHMSSSPLPSAQGVVKMLL (in isoform 2). /FTId=VSP_059512.,,,,,CONFLICT 191 191 T -> I (in Ref. 3; AAH33900). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the nudE family. {ECO:0000305}.,COILED 18 188 {ECO:0000255}.,,,,REGION 1 93 Self-association. {ECO:0000250}.; REGION 88 156 Interaction with PAFAH1B1. {ECO:0000250}.; REGION 167 290 Interaction with CENPF. {ECO:0000250}.,,,,,,,,"FUNCTION: Required for centrosome duplication and formation and function of the mitotic spindle. Essential for the development of the cerebral cortex. May regulate the production of neurons by controlling the orientation of the mitotic spindle during division of cortical neuronal progenitors of the proliferative ventricular zone of the brain. Orientation of the division plane perpendicular to the layers of the cortex gives rise to two proliferative neuronal progenitors whereas parallel orientation of the division plane yields one proliferative neuronal progenitor and a post-mitotic neuron. A premature shift towards a neuronal fate within the progenitor population may result in an overall reduction in the final number of neurons and an increase in the number of neurons in the deeper layers of the cortex. {ECO:0000269|PubMed:17600710, ECO:0000269|PubMed:21529752}.",,,,,,,,,,,,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496],cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496],identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904],centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202],GO:0000086; GO:0000132; GO:0000776; GO:0000777; GO:0001764; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0007405; GO:0008017; GO:0010389; GO:0016020; GO:0016477; GO:0019904; GO:0021987; GO:0031616; GO:0032154; GO:0042802; GO:0045202; GO:0047496; GO:0051298; GO:0051301; GO:0051303; GO:0051642; GO:0097711; GO:2000574,IPR033494; IPR006964; ,Itself; Q9GZM8; Q70YC5,"SUBUNIT: Self-associates. Interacts with CNTRL, LIS1, dynein, SLMAP and TCP1 (By similarity). Interacts with CENPF, dynactin, tubulin gamma, PAFAH1B1, PCM1 and PCNT. Interacts with ZNF365. {ECO:0000250, ECO:0000269|PubMed:16291865, ECO:0000269|PubMed:16682949, ECO:0000269|PubMed:17600710}.",14702039; 15616553; 15489334; 12556484; 16291865; 16682949; 17600710; 18220336; 18669648; 19927128; 20068231; 21529752; 21529751; 22526350; 23186163; 24275569,14702039; 15616553; 15489334; 12556484; 16291865; 16682949; 17600710; 18220336; 18669648; 19927128; 20068231; 21529752; 21529751; 22526350; 23186163; 24275569; 11076968; 11081627; 11181178; 11509732; 11804586; 11956313; 12006501; 12194817; 12207013; 12221128; 12427674; 12852856; 13678582; 14580337; 14730319; 15085137; 15339662; 15498487; 15705883; 15723797; 15737063; 15797709; 16357211; 16462731; 16541025; 16622419; 16622420; 16890155; 17030981; 17129783; 17185386; 17574030; 17646400; 17719545; 18037885; 18097444; 18178387; 18303022; 18469341; 18566290; 18615013; 18694559; 18716626; 18847512; 18983980; 19004860; 19940019; 19965387; 20048338; 20072148; 20084519; 20230748; 20360068; 20399632; 20558667; 20711500; 21273506; 21347367; 21397845; 21422230; 21548880; 21565611; 21620453; 21677187; 21725307; 21792235; 21878504; 21911489; 21987589; 22094468; 22179047; 22653444; 22843697; 22885700; 23141531; 23141541; 23253480; 23348840; 23400999; 23530209; 23704059; 23747070; 23769972; 23789104; 23921553; 24053599; 24089205; 24231678; 24469809; 24785679; 24982133; 25047611; 25313408; 25332407; 25532896; 26206584; 26350705; 26496610; 26638075; 27534551; 27553190; 27646688; 28266585; 29142105; 7769006; 7790358; 8838651,2006-06-13,2019-02-13,2018-03-28,153,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Coiled coil (1); Lipidation (1); Modified residue (9); Mutagenesis (12); Region (3); Sequence conflict (1),,"TISSUE SPECIFICITY: Expressed in the neuroepithelium throughout the developing brain, including the cerebral cortex and cerebellum. {ECO:0000269|PubMed:21529752}.",,Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Developmental protein;Differentiation;Kinetochore;Lipoprotein;Lissencephaly;Microtubule;Mitosis;Neurogenesis;Palmitate;Phosphoprotein;Reference proteome,Evidence at protein level,reviewed,,NudE family,153,Alternative products (1); Function (1); Involvement in disease (2); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0131; KW-0132; KW-0137; KW-0158; KW-0175; KW-0181; KW-0206; KW-0217; KW-0221; KW-0449; KW-0451; KW-0493; KW-0498; KW-0524; KW-0564; KW-0597; KW-0963; KW-0995; KW-1185,,,,,"DISEASE: Lissencephaly 4 (LIS4) [MIM:614019]: A neurodevelopmental disorder characterized by lissencephaly, severe brain atrophy, extreme microcephaly, and profound mental retardation. {ECO:0000269|PubMed:21529751, ECO:0000269|PubMed:21529752}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Microhydranencephaly (MHAC) [MIM:605013]: A severe neurodevelopmental disorder characterized by microcephaly, severe motor and mental retardation, spasticity, and brain malformations that include gross dilation of the ventricles with complete absence of the cerebral hemispheres or severe delay in their development. {ECO:0000269|PubMed:22526350}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: Phosphorylated in mitosis. Phosphorylated in vitro by CDC2. Phosphorylation at Thr-246 is essential for the G2/M transition (By similarity). {ECO:0000250}.,CHAIN 1 335 Nuclear distribution protein nudE homolog 1. /FTId=PRO_0000240202.,,,,,"LIPID 274 274 S-palmitoyl cysteine; by ZDHHC2, ZDHHC3 and ZDHHC7. {ECO:0000269|PubMed:19927128}.","MOD_RES 211 211 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 215 215 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 228 228 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 231 231 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 239 239 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 243 243 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 246 246 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 282 282 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 309 309 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AK000108;BC001421;BC033900;
0,Q9NZJ0,DTL_HUMAN,DTL CDT2 CDW1 DCAF2 L2DTL RAMP,DTL,CDT2 CDW1 DCAF2 L2DTL RAMP,,,Homo sapiens (Human),9606,Denticleless protein homolog (DDB1- and CUL4-associated factor 2) (Lethal(2) denticleless protein homolog) (Retinoic acid-regulated nuclear matrix-associated protein),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MLFNSVLRQPQLGVLRNGWSSQYPLQSLLTGYQCSGNDEHTSYGETGVPVPPFGCTFSSAPNMEHVLAVANEEGFVRLYNTESQSFRKKCFKEWMAHWNAVFDLAWVPGELKLVTAAGDQTAKFWDVKAGELIGTCKGHQCSLKSVAFSKFEKAVFCTGGRDGNIMVWDTRCNKKDGFYRQVNQISGAHNTSDKQTPSKPKKKQNSKGLAPSVDFQQSVTVVLFQDENTLVSAGAVDGIIKVWDLRKNYTAYRQEPIASKSFLYPGSSTRKLGYSSLILDSTGSTLFANCTDDNIYMFNMTGLKTSPVAIFNGHQNSTFYVKSSLSPDDQFLVSGSSDEAAYIWKVSTPWQPPTVLLGHSQEVTSVCWCPSDFTKIATCSDDNTLKIWRLNRGLEEKPGGDKLSTVGWASQKKKESRPGLVTVTSSQSTPAKAPRAKCNPSNSSPSSAACAPSCAGDLPLPSNTPTFSIKTSPAKARSPINRRGSVSSVSPKPPSSFKMSIRNWVTRTPSSSPPITPPASETKIMSPRKALIPVSQKSSQAEACSESRNRVKRRLDSSCLESVKQKCVKSCNCVTELDGQVENLHLDLCCLAGNQEDLSKDSLGPTKSSKIEGAGTSISEPPSPISPYASESCGTLPLPLRPCGEGSEMVGKENSSPENKNWLLAMAAKRKAENPSPRSPSSQTPNSRRQSGKKLPSPVTITPSSMRKICTYFHRKSQEDFCGPEHSTEL,730,"79,468",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q9NZJ0-1; Sequence=Displayed; Name=2; IsoId=Q9NZJ0-2; Sequence=VSP_022879, VSP_022880, VSP_022881; Note=No experimental confirmation available.; ",,SEQUENCE CAUTION:  Sequence=BAA91552.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=BAA91586.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 18 59 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_022879.; VAR_SEQ 240 253 IKVWDLRKNYTAYR -> FKSDFGFHWLYFIC (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_022880.; VAR_SEQ 254 730 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_022881.,"VARIANT 425 425 S -> N (in dbSNP:rs35137676). /FTId=VAR_062095.; VARIANT 436 436 A -> V (in dbSNP:rs3135474). {ECO:0000269|PubMed:11278750, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16861906, ECO:0000269|Ref.3, ECO:0000269|Ref.6}. /FTId=VAR_030353.; VARIANT 694 694 K -> T (in dbSNP:rs6540718). {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:11278750, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16861906, ECO:0000269|Ref.3}. /FTId=VAR_030354.",,,,CONFLICT 83 83 S -> P (in Ref. 4; BAA91355). {ECO:0000305}.; CONFLICT 356 356 L -> F (in Ref. 4; BAF85032). {ECO:0000305}.; CONFLICT 532 532 I -> T (in Ref. 4; BAA91552). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the WD repeat cdt2 family. {ECO:0000305}.,,,,MOTIF 168 171 DDB1-binding motif.; MOTIF 197 203 Nuclear localization signal. {ECO:0000255}.; MOTIF 243 246 DDB1-binding motif.,,REPEAT 47 89 WD 1.; REPEAT 96 135 WD 2.; REPEAT 138 178 WD 3.; REPEAT 214 253 WD 4.; REPEAT 267 308 WD 5.; REPEAT 313 354 WD 6.; REPEAT 358 398 WD 7.,,,,,,,"FUNCTION: Substrate-specific adapter of a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex required for cell cycle control, DNA damage response and translesion DNA synthesis. The DCX(DTL) complex, also named CRL4(CDT2) complex, mediates the polyubiquitination and subsequent degradation of CDT1, CDKN1A/p21(CIP1), FBH1, KMT5A and SDE2 (PubMed:16861906, PubMed:16949367, PubMed:16964240, PubMed:17085480, PubMed:18703516, PubMed:18794347, PubMed:18794348, PubMed:19332548, PubMed:20129063, PubMed:23478441, PubMed:23478445, PubMed:23677613, PubMed:27906959). CDT1 degradation in response to DNA damage is necessary to ensure proper cell cycle regulation of DNA replication (PubMed:16861906, PubMed:16949367, PubMed:17085480). CDKN1A/p21(CIP1) degradation during S phase or following UV irradiation is essential to control replication licensing (PubMed:18794348, PubMed:19332548). KMT5A degradation is also important for a proper regulation of mechanisms such as TGF-beta signaling, cell cycle progression, DNA repair and cell migration (PubMed:23478445). Most substrates require their interaction with PCNA for their polyubiquitination: substrates interact with PCNA via their PIP-box, and those containing the 'K+4' motif in the PIP box, recruit the DCX(DTL) complex, leading to their degradation. In undamaged proliferating cells, the DCX(DTL) complex also promotes the 'Lys-164' monoubiquitination of PCNA, thereby being involved in PCNA-dependent translesion DNA synthesis (PubMed:20129063, PubMed:23478441, PubMed:23478445, PubMed:23677613). {ECO:0000269|PubMed:16861906, ECO:0000269|PubMed:16949367, ECO:0000269|PubMed:16964240, ECO:0000269|PubMed:17085480, ECO:0000269|PubMed:18703516, ECO:0000269|PubMed:18794347, ECO:0000269|PubMed:18794348, ECO:0000269|PubMed:19332548, ECO:0000269|PubMed:20129063, ECO:0000269|PubMed:23478441, ECO:0000269|PubMed:23478445, ECO:0000269|PubMed:23677613, ECO:0000269|PubMed:27906959}.",,PATHWAY: Protein modification; protein ubiquitination.,,,,,,,,,,"centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; DNA replication [GO:0006260]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]","cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; DNA replication [GO:0006260]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]",,centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GO:0000209; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005813; GO:0005829; GO:0006260; GO:0006511; GO:0006513; GO:0006974; GO:0009411; GO:0010971; GO:0019985; GO:0031464; GO:0031465; GO:0031965; GO:0042769; GO:0043687; GO:0045732; GO:0051726; GO:0072425; GO:0080008,IPR015943; IPR001680; IPR019775; IPR017986; IPR036322; ,Q16531,"SUBUNIT: Component of the DCX(DTL) E3 ubiquitin ligase complex (also called CRL4(CDT2)), at least composed of CUL4 (CUL4A or CUL4B), DDB1, DTL/CDT2 and RBX1. Interacts with CDKN1A and CDT1. Interacts with FBXO11; SCF(FBXWO11) controls DTL stability but DCX(DTL) does not control FBXO11 stability. {ECO:0000269|PubMed:16861906, ECO:0000269|PubMed:16949367, ECO:0000269|PubMed:17041588, ECO:0000269|PubMed:17085480, ECO:0000269|PubMed:18794347, ECO:0000269|PubMed:18794348, ECO:0000269|PubMed:23478441, ECO:0000269|PubMed:23478445}.",11278750; 16861906; 14702039; 16710414; 15489334; 17106265; 17085480; 16949367; 17041588; 16964240; 18794347; 18794348; 18703516; 18669648; 19413330; 19332548; 19690332; 20129063; 20068231; 21269460; 21406692; 22223895; 22814378; 23892434; 23186163; 23478445; 23478441; 23677613; 27906959,11278750; 16861906; 14702039; 16710414; 15489334; 17106265; 17085480; 16949367; 17041588; 16964240; 18794347; 18794348; 18703516; 18669648; 19413330; 19332548; 19690332; 20129063; 20068231; 21269460; 21406692; 22223895; 22814378; 23892434; 23186163; 23478445; 23478441; 23677613; 27906959; 10597293; 11961546; 12226657; 12504025; 12504026; 12609982; 15537541; 15688063; 15799966; 15916957; 16401342; 16861890; 16943200; 17183367; 17497243; 17720710; 18093314; 18206966; 18342608; 18542055; 18649358; 18805092; 18826954; 18847512; 18851830; 18926707; 19250909; 19615732; 19617556; 19672268; 19748355; 20360068; 20433742; 20929861; 20932471; 20932472; 21220508; 21463634; 21550341; 21725088; 21778237; 21822310; 21846465; 21863050; 22287560; 22959436; 23000965; 23029527; 23201271; 23453757; 23535662; 23535663; 23555860; 23563313; 23583660; 23913683; 23995842; 24022480; 24699724; 24768535; 24962565; 25115388; 25154416; 25314029; 25349211; 25355947; 25411249; 25483071; 25483090; 25531226; 26344709; 26460955; 26472028; 26906416; 29424068,2007-02-06,2019-02-13,2010-08-10,157,,,,,,,,,5 out of 5,Alternative sequence (3); Chain (1); Erroneous initiation (2); Modified residue (16); Motif (3); Mutagenesis (16); Natural variant (3); Repeat (7); Sequence conflict (3),,"TISSUE SPECIFICITY: Expressed in placenta and testis, very low expression seen in skeletal muscle. Detected in all hematopoietic tissues examined, with highest expression in thymus and bone marrow. A low level detected in the spleen and lymph node, and barely detectable level in the peripheral leukocytes. RA treatment down-regulated the expression in NT2 cell. {ECO:0000269|PubMed:11278750, ECO:0000269|PubMed:17106265}.",,Acetylation;Alternative splicing;Chromosome;Complete proteome;Cytoplasm;Cytoskeleton;DNA damage;DNA replication;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;Ubl conjugation pathway;WD repeat,Evidence at protein level,reviewed,,WD repeat cdt2 family,157,Alternative products (1); Caution (1); Developmental stage (1); Function (1); Induction (1); Pathway (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0007; KW-0025; KW-0158; KW-0181; KW-0206; KW-0227; KW-0235; KW-0472; KW-0539; KW-0597; KW-0621; KW-0677; KW-0832; KW-0833; KW-0853; KW-0963; KW-1185,Protein modification; protein ubiquitination. ,,,,,,,"PTM: Ubiquitinated by the anaphase promoting complex/cyclosome (APC/C). Autoubiquitinated through 'Lys-48'-polyubiquitin chains in a PCNA-independent reaction, allowing proteasomal turnover. Polyubiquitinated by SCF(FBXO11) when not phosphorylated, leading to its degradation. A tight regulation of the polyubiquitination by SCF(FBXO11) is involved in the control of different processes such as TGF-beta signaling, cell cycle progression and exit. {ECO:0000269|PubMed:17106265, ECO:0000269|PubMed:23478441, ECO:0000269|PubMed:23478445}.; PTM: Phosphorylated at Thr-464 by CDK1/Cyclin-B and CDK2/Cyclin-A but not by CDK2/Cyclin-E, MAPK1 or PLK1. Phosphorylation at Thr-464 inhibits the interaction with FBXO11 and decreases upon cell cycle exit induced by TGF-beta or serum starvation. {ECO:0000269|PubMed:23478441}.",CHAIN 1 730 Denticleless protein homolog. /FTId=PRO_0000274867.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22223895}.; MOD_RES 196 196 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 410 410 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 426 426 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 464 464 Phosphothreonine; by CDK1 and CDK2. {ECO:0000269|PubMed:23478441}.; MOD_RES 485 485 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 490 490 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 495 495 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 512 512 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 516 516 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 557 557 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 676 676 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 679 679 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 684 684 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 702 702 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 717 717 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF345896;DQ641253;AF195765;AK000742;AK001206;AK001261;AK027651;AK292343;CH471100;CH471100;BC033540;BC033297;
0,Q9UBP0,SPAST_HUMAN,SPAST ADPSP FSP2 KIAA1083 SPG4,SPAST,ADPSP FSP2 KIAA1083 SPG4,,,Homo sapiens (Human),9606,Spastin (EC 5.6.1.1) (Spastic paraplegia 4 protein),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MNSPGGRGKKKGSGGASNPVPPRPPPPCLAPAPPAAGPAPPPESPHKRNLYYFSYPLFVGFALLRLVAFHLGLLFVWLCQRFSRALMAAKRSSGAAPAPASASAPAPVPGGEAERVRVFHKQAFEYISIALRIDEDEKAGQKEQAVEWYKKGIEELEKGIAVIVTGQGEQCERARRLQAKMMTNLVMAKDRLQLLEKMQPVLPFSKSQTDVYNDSTNLACRNGHLQSESGAVPKRKDPLTHTSNSLPRSKTVMKTGSAGLSGHHRAPSYSGLSMVSGVKQGSGPAPTTHKGTPKTNRTNKPSTPTTATRKKKDLKNFRNVDSNLANLIMNEIVDNGTAVKFDDIAGQDLAKQALQEIVILPSLRPELFTGLRAPARGLLLFGPPGNGKTMLAKAVAAESNATFFNISAASLTSKYVGEGEKLVRALFAVARELQPSIIFIDEVDSLLCERREGEHDASRRLKTEFLIEFDGVQSAGDDRVLVMGATNRPQELDEAVLRRFIKRVYVSLPNEETRLLLLKNLLCKQGSPLTQKELAQLARMTDGYSGSDLTALAKDAALGPIRELKPEQVKNMSASEMRNIRLSDFTESLKKIKRSVSPQTLEAYIRWNKDFGDTTV,616,"67,197",,"ALTERNATIVE PRODUCTS:  Event=Alternative promoter usage, Alternative splicing, Alternative initiation; Named isoforms=4;  Comment=Alternative promoter usage of a cryptic promoter in exon 1 can direct the synthesis of N-terminally truncated isoforms, which may also arise from alternative initiation. {ECO:0000269|PubMed:16026783, ECO:0000269|PubMed:18613979}; Name=1; Synonyms=Long, Long variant 1, 68 kDa {ECO:0000303|PubMed:19000169}, M1 {ECO:0000303|PubMed:20200447}; IsoId=Q9UBP0-1; Sequence=Displayed; Name=2; Synonyms=Long variant 2; IsoId=Q9UBP0-2; Sequence=VSP_000024; Name=3; Synonyms=Short, Short variant 1, 60 kDa {ECO:0000303|PubMed:19000169}, M87 {ECO:0000303|PubMed:20200447}; IsoId=Q9UBP0-3; Sequence=VSP_036650; Note=Produced by alternative promoter usage. May also be produced by alternative initiation at Met-87 of isoform 1. Major isoform.; Name=4; Synonyms=Short variant 2; IsoId=Q9UBP0-4; Sequence=VSP_036650, VSP_000024; Note=Produced by alternative promoter usage and alternative splicing. May also be produced by alternative initiation at Met-87 of isoform 2.; ",,,,,,,,,,"VAR_SEQ 1 86 Missing (in isoform 3 and isoform 4). {ECO:0000305}. /FTId=VSP_036650.; VAR_SEQ 197 228 Missing (in isoform 2 and isoform 4). {ECO:0000303|PubMed:10470851, ECO:0000303|PubMed:15489334}. /FTId=VSP_000024.","VARIANT 44 616 Missing (in SPG4). {ECO:0000269|PubMed:25045380}. /FTId=VAR_075827.; VARIANT 44 44 S -> L (rare polymorphism; acts as a disease modifier; patients carrying a mutated allele of spastin and L-44 on the other allele are affected by severe spastic paraplegia with an early age of onset; may decrease the activity of the alternative promoter which directs the synthesis of isoform 3 and isoform 4; dbSNP:rs121908515). {ECO:0000269|PubMed:11015453, ECO:0000269|PubMed:15248095, ECO:0000269|PubMed:15326248, ECO:0000269|PubMed:17594340, ECO:0000269|PubMed:18613979, ECO:0000269|PubMed:20214791, ECO:0000269|PubMed:20562464}. /FTId=VAR_010194.; VARIANT 45 45 P -> Q (rare polymorphism; acts as a disease modifier; patients carrying a mutated allele of spastin and Q-45 on the other allele are affected by severe spastic paraplegia with an early age of onset; dbSNP:rs121908517). {ECO:0000269|PubMed:15248095}. /FTId=VAR_027205.; VARIANT 95 95 A -> T (in SPG4; dbSNP:rs1343258361). {ECO:0000269|PubMed:22960362}. /FTId=VAR_075828.; VARIANT 97 97 P -> T (in SPG4; unknown pathological significance; dbSNP:rs372005558). {ECO:0000269|PubMed:20718791}. /FTId=VAR_067628.; VARIANT 112 616 Missing (in SPG4). {ECO:0000269|PubMed:22960362}. /FTId=VAR_075829.; VARIANT 135 616 Missing (in SPG4). {ECO:0000269|PubMed:22960362}. /FTId=VAR_075830.; VARIANT 162 162 V -> I (in SPG4; unknown pathological significance; dbSNP:rs141944844). {ECO:0000269|PubMed:20214791, ECO:0000269|PubMed:20562464}. /FTId=VAR_067563.; VARIANT 195 195 L -> V (in SPG4). {ECO:0000269|PubMed:16682546}. /FTId=VAR_026758.; VARIANT 201 201 V -> D (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20718791}. /FTId=VAR_067629.; VARIANT 229 229 S -> G (in dbSNP:rs1182763020). {ECO:0000269|PubMed:20214791}. /FTId=VAR_067630.; VARIANT 244 616 Missing (in SPG4). {ECO:0000269|PubMed:25421405}. /FTId=VAR_075831.; VARIANT 245 616 Missing (in SPG4). {ECO:0000269|PubMed:25045380}. /FTId=VAR_075832.; VARIANT 254 616 Missing (in SPG4). {ECO:0000269|PubMed:25045380}. /FTId=VAR_075833.; VARIANT 287 287 Missing (in SPG4). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067631.; VARIANT 293 293 P -> L (in SPG4; dbSNP:rs773193617). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067632.; VARIANT 309 309 R -> H (in SPG4; dbSNP:rs202152835). {ECO:0000269|PubMed:23279441}. /FTId=VAR_075834.; VARIANT 314 314 L -> S (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20718791}. /FTId=VAR_067633.; VARIANT 328 328 I -> K (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:28572275}. /FTId=VAR_079314.; VARIANT 328 328 I -> L (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067634.; VARIANT 344 344 I -> K (in SPG4; abrogates ATPase activity and promotes microtubule binding; dbSNP:rs121908513). {ECO:0000269|PubMed:12202986, ECO:0000269|PubMed:15716377}. /FTId=VAR_019448.; VARIANT 347 347 Q -> K (in SPG4; promotes microtubule binding). {ECO:0000269|PubMed:12161613, ECO:0000269|PubMed:15716377}. /FTId=VAR_027206.; VARIANT 356 356 E -> K (in SPG4; unknown pathological significance; dbSNP:rs1057519181). {ECO:0000269|PubMed:20562464}. /FTId=VAR_067564.; VARIANT 360 360 L -> V (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20718791}. /FTId=VAR_067635.; VARIANT 361 361 P -> L (in SPG4). {ECO:0000269|PubMed:15326248}. /FTId=VAR_027207.; VARIANT 362 362 S -> C (in SPG4; dbSNP:rs121908509). {ECO:0000269|PubMed:10610178, ECO:0000269|PubMed:10699187}. /FTId=VAR_010195.; VARIANT 363 363 L -> P (in SPG4). {ECO:0000269|PubMed:24824479}. /FTId=VAR_075835.; VARIANT 364 364 R -> M (in SPG4). {ECO:0000269|PubMed:21546041}. /FTId=VAR_075836.; VARIANT 364 364 R -> T (in SPG4). {ECO:0000269|PubMed:17594340}. /FTId=VAR_067636.; VARIANT 365 365 P -> S (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20562464}. /FTId=VAR_067565.; VARIANT 366 366 E -> K (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:28572275}. /FTId=VAR_079315.; VARIANT 368 368 F -> L (in SPG4). {ECO:0000269|PubMed:21546041, ECO:0000269|PubMed:28572275}. /FTId=VAR_075837.; VARIANT 368 368 F -> V (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:28572275}. /FTId=VAR_079316.; VARIANT 370 370 G -> R (in SPG4; promotes microtubule binding and the formation of thick microtubule bundles). {ECO:0000269|PubMed:10699187, ECO:0000269|PubMed:11809724}. /FTId=VAR_027208.; VARIANT 372 372 R -> G (in SPG4). {ECO:0000269|PubMed:25045380}. /FTId=VAR_075838.; VARIANT 372 372 R -> T (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:28572275}. /FTId=VAR_079317.; VARIANT 377 377 G -> E (in SPG4). {ECO:0000269|PubMed:21546041}. /FTId=VAR_075839.; VARIANT 378 378 L -> Q (in SPG4). {ECO:0000269|PubMed:14732620}. /FTId=VAR_019439.; VARIANT 378 378 L -> R (in SPG4). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067637.; VARIANT 380 380 L -> H (in SPG4). {ECO:0000269|PubMed:17594340, ECO:0000269|PubMed:20932283}. /FTId=VAR_067638.; VARIANT 381 381 F -> C (in SPG4; promotes microtubule binding and the formation of thick microtubule bundles). {ECO:0000269|PubMed:10699187, ECO:0000269|PubMed:11809724}. /FTId=VAR_027209.; VARIANT 382 382 G -> R (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20562464}. /FTId=VAR_067566.; VARIANT 386 386 N -> K (in SPG4; abrogates ATPase activity, promotes microtubule binding and the formation of thick microtubule bundles). {ECO:0000269|PubMed:10699187, ECO:0000269|PubMed:11809724, ECO:0000269|PubMed:15716377}. /FTId=VAR_027210.; VARIANT 386 386 N -> S (in SPG4; dbSNP:rs121908514). {ECO:0000269|PubMed:15210521}. /FTId=VAR_019440.; VARIANT 386 386 N -> Y (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:28572275}. /FTId=VAR_079318.; VARIANT 388 388 K -> R (in SPG4; abrogates ATPase activity, promotes microtubule binding and the formation of thick microtubule bundles and impairs traffic from the ER to Golgi). {ECO:0000269|PubMed:10699187, ECO:0000269|PubMed:11809724, ECO:0000269|PubMed:12161613, ECO:0000269|PubMed:15716377, ECO:0000269|PubMed:15891913, ECO:0000269|PubMed:16339213, ECO:0000269|PubMed:19000169}. /FTId=VAR_027211.; VARIANT 390 390 M -> T (in SPG4; unknown pathological significance; dbSNP:rs1131691977). {ECO:0000269|PubMed:28572275}. /FTId=VAR_079319.; VARIANT 390 390 M -> V (in SPG4; dbSNP:rs797044850). {ECO:0000269|PubMed:14732620}. /FTId=VAR_019441.; VARIANT 391 391 L -> P (in SPG4). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067639.; VARIANT 393 396 Missing (in SPG4). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067640.; VARIANT 399 399 S -> L (in SPG4). {ECO:0000269|PubMed:11843700, ECO:0000269|PubMed:22960362, ECO:0000269|PubMed:24824479, ECO:0000269|PubMed:25045380}. /FTId=VAR_027212.; VARIANT 404 404 Missing (in SPG4). {ECO:0000269|PubMed:12163196}. /FTId=VAR_019449.; VARIANT 406 406 I -> R (in SPG4). {ECO:0000269|PubMed:22960362}. /FTId=VAR_075840.; VARIANT 406 406 I -> V (in SPG4; dbSNP:rs587777757). {ECO:0000269|PubMed:16682546}. /FTId=VAR_026759.; VARIANT 407 407 S -> I (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20562464}. /FTId=VAR_067567.; VARIANT 407 407 S -> R (in SPG4). {ECO:0000269|PubMed:12124993}. /FTId=VAR_019450.; VARIANT 409 409 A -> T (in SPG4; dbSNP:rs1064793273). {ECO:0000269|PubMed:20932283, ECO:0000269|PubMed:22960362}. /FTId=VAR_067641.; VARIANT 410 410 S -> R (in SPG4). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067642.; VARIANT 413 413 S -> L (in SPG4). {ECO:0000269|PubMed:20550563}. /FTId=VAR_067568.; VARIANT 418 418 E -> A (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:28572275}. /FTId=VAR_079320.; VARIANT 422 422 L -> F (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20562464}. /FTId=VAR_067569.; VARIANT 423 423 V -> L (in a breast cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_035902.; VARIANT 424 424 R -> G (in SPG4). {ECO:0000269|PubMed:11015453}. /FTId=VAR_010196.; VARIANT 426 426 L -> F (in SPG4). {ECO:0000269|PubMed:20214791}. /FTId=VAR_067643.; VARIANT 426 426 L -> V (in SPG4; promotes microtubule binding and the formation of thick microtubule bundles; dbSNP:rs1060502227). {ECO:0000269|PubMed:10699187, ECO:0000269|PubMed:11809724, ECO:0000269|PubMed:11843700, ECO:0000269|PubMed:22960362}. /FTId=VAR_027213.; VARIANT 431 616 Missing (in SPG4). {ECO:0000269|PubMed:22960362}. /FTId=VAR_075841.; VARIANT 435 435 P -> L (in SPG4). {ECO:0000269|PubMed:16684598}. /FTId=VAR_027214.; VARIANT 436 436 S -> F (in SPG4). {ECO:0000269|PubMed:11087788}. /FTId=VAR_027215.; VARIANT 436 436 S -> P (in SPG4). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067644.; VARIANT 441 441 D -> G (in SPG4; dbSNP:rs121908512). {ECO:0000269|PubMed:11039577}. /FTId=VAR_027216.; VARIANT 441 441 D -> N (in SPG4). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067645.; VARIANT 441 441 D -> V (in SPG4). {ECO:0000269|PubMed:24824479}. /FTId=VAR_075842.; VARIANT 445 445 S -> N (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20562464}. /FTId=VAR_067570.; VARIANT 448 448 C -> Y (in SPG4; abrogates binding to the tail of beta-3-tubulin, abolishes microtubule severing and promotes the formation of thick microtubule bundles; dbSNP:rs121908510). {ECO:0000269|PubMed:10610178, ECO:0000269|PubMed:10699187, ECO:0000269|PubMed:11809724, ECO:0000269|PubMed:17389232}. /FTId=VAR_010197.; VARIANT 450 450 R -> S (in SPG4). {ECO:0000269|PubMed:21546041}. /FTId=VAR_075843.; VARIANT 451 451 Missing (in SPG4). {ECO:0000269|PubMed:25045380}. /FTId=VAR_075844.; VARIANT 454 454 E -> K (in SPG4). {ECO:0000269|PubMed:20550563}. /FTId=VAR_067571.; VARIANT 458 458 S -> R (in SPG4). {ECO:0000269|PubMed:25045380}. /FTId=VAR_075845.; VARIANT 459 459 R -> G (in SPG4). {ECO:0000269|PubMed:15482961}. /FTId=VAR_027217.; VARIANT 460 460 R -> C (in SPG4; dbSNP:rs878854990). {ECO:0000269|PubMed:15482961, ECO:0000269|PubMed:22960362}. /FTId=VAR_027218.; VARIANT 460 460 R -> L (in SPG4; promotes microtubule binding and the formation of thick microtubule bundles). {ECO:0000269|PubMed:10699187, ECO:0000269|PubMed:11809724}. /FTId=VAR_027219.; VARIANT 460 460 R -> S (in SPG4). {ECO:0000269|PubMed:20214791, ECO:0000269|PubMed:20562464, ECO:0000269|PubMed:20932283}. /FTId=VAR_067572.; VARIANT 461 461 L -> P (in SPG4). {ECO:0000269|PubMed:25421405}. /FTId=VAR_075846.; VARIANT 463 463 T -> A (in SPG4). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067646.; VARIANT 464 464 E -> A (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20718791}. /FTId=VAR_067647.; VARIANT 470 470 D -> V (in SPG4; dbSNP:rs121908516). {ECO:0000269|PubMed:15248095}. /FTId=VAR_027220.; VARIANT 470 470 D -> Y (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:28572275}. /FTId=VAR_079321.; VARIANT 482 482 V -> L (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20562464}. /FTId=VAR_067573.; VARIANT 485 485 A -> T (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:28572275}. /FTId=VAR_079322.; VARIANT 485 485 A -> V (in SPG4). {ECO:0000269|PubMed:12460147}. /FTId=VAR_027221.; VARIANT 489 489 P -> L (in SPG4). {ECO:0000269|PubMed:11843700}. /FTId=VAR_027222.; VARIANT 490 616 Missing (in SPG4). {ECO:0000269|PubMed:15667412}. /FTId=VAR_075847.; VARIANT 492 492 L -> F (in SPG4). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067648.; VARIANT 493 493 D -> G (in SPG4). {ECO:0000269|PubMed:16682546}. /FTId=VAR_026760.; VARIANT 498 498 R -> G (in SPG4). {ECO:0000269|PubMed:20718791, ECO:0000269|PubMed:20932283}. /FTId=VAR_067649.; VARIANT 498 498 R -> M (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:28572275}. /FTId=VAR_079323.; VARIANT 499 499 R -> C (in SPG4; abrogates ATPase activity, promotes microtubule binding and the formation of thick microtubule bundles; dbSNP:rs121908511). {ECO:0000269|PubMed:10610178, ECO:0000269|PubMed:10699187, ECO:0000269|PubMed:11309678, ECO:0000269|PubMed:11809724, ECO:0000269|PubMed:12161613, ECO:0000269|PubMed:15716377}. /FTId=VAR_010198.; VARIANT 499 499 R -> H (in SPG4; dbSNP:rs878854991). {ECO:0000269|PubMed:16682546, ECO:0000269|PubMed:25045380}. /FTId=VAR_026761.; VARIANT 503 503 R -> L (in SPG4). {ECO:0000269|PubMed:12552568}. /FTId=VAR_019442.; VARIANT 503 503 R -> RR (in SPG4). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067650.; VARIANT 503 503 R -> W (in SPG4; dbSNP:rs864622162). {ECO:0000269|PubMed:16682546, ECO:0000269|PubMed:22960362}. /FTId=VAR_026762.; VARIANT 512 512 E -> D (in SPG4). {ECO:0000269|PubMed:11985387}. /FTId=VAR_027223.; VARIANT 512 512 Missing (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20562464}. /FTId=VAR_067574.; VARIANT 514 514 R -> G (in SPG4). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067651.; VARIANT 515 515 Missing (in SPG4). {ECO:0000269|PubMed:14732620}. /FTId=VAR_019443.; VARIANT 534 534 L -> P (in SPG4). {ECO:0000269|PubMed:12939659}. /FTId=VAR_019444.; VARIANT 534 534 L -> V (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20562464}. /FTId=VAR_067575.; VARIANT 546 616 Missing (in SPG4). {ECO:0000269|PubMed:28572275}. /FTId=VAR_079324.; VARIANT 550 550 T -> I (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20718791}. /FTId=VAR_067652.; VARIANT 551 551 A -> Y (in SPG4; requires 2 nucleotide substitutions). {ECO:0000269|PubMed:12124993}. /FTId=VAR_019451.; VARIANT 555 555 D -> G (in SPG4). {ECO:0000269|PubMed:25421405}. /FTId=VAR_075848.; VARIANT 555 555 D -> N (in SPG4). {ECO:0000269|PubMed:10699187}. /FTId=VAR_027224.; VARIANT 556 556 A -> V (in SPG4; promotes microtubule binding and the formation of thick microtubule bundles). {ECO:0000269|PubMed:10699187, ECO:0000269|PubMed:11809724}. /FTId=VAR_027225.; VARIANT 559 559 G -> D (in SPG4; dbSNP:rs864622179). {ECO:0000269|PubMed:11087788, ECO:0000269|PubMed:11843700}. /FTId=VAR_027226.; VARIANT 559 559 G -> R (in SPG4; dbSNP:rs878854992). {ECO:0000269|PubMed:22960362}. /FTId=VAR_075849.; VARIANT 562 616 Missing (in SPG4). {ECO:0000269|PubMed:22960362}. /FTId=VAR_075850.; VARIANT 562 562 R -> G (in SPG4; dbSNP:rs121908518). {ECO:0000269|PubMed:11309678, ECO:0000269|PubMed:15248095}. /FTId=VAR_027227.; VARIANT 562 562 R -> P (in SPG4; unknown pathological significance). {ECO:0000269|PubMed:20562464}. /FTId=VAR_067576.; VARIANT 562 562 R -> Q (in SPG4; dbSNP:rs863224923). {ECO:0000269|PubMed:11843700}. /FTId=VAR_027228.; VARIANT 579 579 N -> H (in SPG4; unknown pathological significance; dbSNP:rs144594804). {ECO:0000269|PubMed:17594340}. /FTId=VAR_067653.; VARIANT 580 580 I -> T (in SPG4). {ECO:0000269|PubMed:20932283}. /FTId=VAR_067654.; VARIANT 581 616 Missing (in SPG4). {ECO:0000269|PubMed:25045380, ECO:0000269|PubMed:25421405}. /FTId=VAR_075851.; VARIANT 584 584 D -> H (in SPG4). {ECO:0000269|PubMed:11015453}. /FTId=VAR_010199.; VARIANT 595 595 S -> R (in SPG4). {ECO:0000269|PubMed:24824479}. /FTId=VAR_075852.; VARIANT 607 607 W -> C (in SPG4). {ECO:0000269|PubMed:16682546}. /FTId=VAR_026763.; VARIANT 614 614 T -> I (in SPG4; variant form with congenital arachnoid cysts). {ECO:0000269|PubMed:15159500}. /FTId=VAR_019445.; VARIANT 615 615 T -> I (in SPG4). {ECO:0000269|PubMed:12124993}. /FTId=VAR_019452.",,,,,,1,,0,,SIMILARITY: Belongs to the AAA ATPase family. Spastin subfamily. {ECO:0000255|HAMAP-Rule:MF_03021}.,,,DOMAIN 120 195 MIT. {ECO:0000255}.,"MOTIF 4 11 Nuclear localization signal. {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:15147984}.; MOTIF 59 67 Nuclear export signal. {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:16026783}.; MOTIF 309 312 Nuclear localization signal. {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:15147984}.","REGION 1 300 Required for interaction with RTN1. {ECO:0000269|PubMed:16602018}.; REGION 1 194 Required for midbody localization. {ECO:0000269|PubMed:18997780}.; REGION 1 80 Required for interaction with ATL1. {ECO:0000269|PubMed:16339213, ECO:0000269|PubMed:16815977}.; REGION 1 50 Required for nuclear localization. {ECO:0000269|PubMed:15147984}.; REGION 50 87 Required for interaction with SSNA1 and microtubules. {ECO:0000269|PubMed:15269182}.; REGION 112 196 Sufficient for interaction with CHMP1B. {ECO:0000269|PubMed:18997780}.; REGION 114 200 Required for interaction with microtubules. {ECO:0000269|PubMed:15269182}.; REGION 228 616 Sufficient for microtubule severing. {ECO:0000269|PubMed:15269182}.; REGION 270 328 Required for interaction with microtubules and microtubule severing. {ECO:0000269|PubMed:15269182}.; REGION 310 312 Required for interaction with microtubules. {ECO:0000269|PubMed:23272056}.",,,5.6.1.1,,"CATALYTIC ACTIVITY: Reaction=n ATP + n H(2)O + a microtubule = n ADP + n phosphate + (n+1) alpha/beta tubulin heterodimers.; EC=5.6.1.1; Evidence={ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:15716377, ECO:0000269|PubMed:16219033, ECO:0000269|PubMed:16815977, ECO:0000269|PubMed:17389232, ECO:0000269|PubMed:18410514, ECO:0000269|PubMed:22637577};",,,"FUNCTION: ATP-dependent microtubule severing protein that specifically recognizes and cuts microtubules that are polyglutamylated (PubMed:11809724, PubMed:15716377, PubMed:16219033, PubMed:17389232, PubMed:20530212, PubMed:22637577, PubMed:26875866). Preferentially recognizes and acts on microtubules decorated with short polyglutamate tails: severing activity increases as the number of glutamates per tubulin rises from one to eight, but decreases beyond this glutamylation threshold (PubMed:26875866). Severing activity is not dependent on tubulin acetylation or detyrosination (PubMed:26875866). Microtubule severing promotes reorganization of cellular microtubule arrays and the release of microtubules from the centrosome following nucleation. It is critical for the biogenesis and maintenance of complex microtubule arrays in axons, spindles and cilia. SPAST is involved in abscission step of cytokinesis and nuclear envelope reassembly during anaphase in cooperation with the ESCRT-III complex (PubMed:19000169, PubMed:21310966, PubMed:26040712). Recruited at the midbody, probably by IST1, and participates in membrane fission during abscission together with the ESCRT-III complex (PubMed:21310966). Recruited to the nuclear membrane by IST1 and mediates microtubule severing, promoting nuclear envelope sealing and mitotic spindle disassembly during late anaphase (PubMed:26040712). Required for membrane traffic from the endoplasmic reticulum (ER) to the Golgi and endosome recycling (PubMed:23897888). Recruited by IST1 to endosomes and regulates early endosomal tubulation and recycling by mediating microtubule severing (PubMed:23897888). Probably plays a role in axon growth and the formation of axonal branches (PubMed:15716377). {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:11809724, ECO:0000269|PubMed:15716377, ECO:0000269|PubMed:16219033, ECO:0000269|PubMed:17389232, ECO:0000269|PubMed:19000169, ECO:0000269|PubMed:20530212, ECO:0000269|PubMed:21310966, ECO:0000269|PubMed:22637577, ECO:0000269|PubMed:23897888, ECO:0000269|PubMed:26040712, ECO:0000269|PubMed:26875866}.; FUNCTION: Isoform 1: Involved in lipid metabolism by regulating the size and distribution of lipid droplets. {ECO:0000269|PubMed:25875445}.","BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.45 mM for ATP {ECO:0000269|PubMed:15716377, ECO:0000269|PubMed:17389232, ECO:0000269|PubMed:22637577}; Vmax=1.2 nmol/min/ug enzyme {ECO:0000269|PubMed:15716377, ECO:0000269|PubMed:17389232, ECO:0000269|PubMed:22637577}; Note=Kinetic parameters shown are for full-length enzyme. N-terminally truncated spastin (residues 228-616), which has been shown to exhibit full severing activity, shows a basal ATP turnover rate of 0.78 sec(-1) in the absence of microtubules, a KM of 0.16 mM for ATP, and the ATP turnover rate is extrapolated to 3.83 sec(-1) in the presence of microtubules. ATPase activity shows non-Michaelis-Menten kinetics in the presence of microtubules, but is close to non-cooperative behavior in their absence (PubMed:22637577). {ECO:0000269|PubMed:22637577};",,,,,,,,,"NP_BIND 382 389 ATP. {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000305|PubMed:15716377}.",,axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent cytokinesis [GO:0061640]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260],anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent cytokinesis [GO:0061640]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260],alpha-tubulin binding [GO:0043014]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877],axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819],GO:0000281; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005789; GO:0005811; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006888; GO:0007409; GO:0008017; GO:0008089; GO:0008152; GO:0008568; GO:0010458; GO:0016021; GO:0016853; GO:0016887; GO:0019896; GO:0030496; GO:0031117; GO:0031122; GO:0031410; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0044877; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0061640; GO:0070062; GO:0071782; GO:0090148; GO:1904115,IPR003593; IPR003959; IPR003960; IPR007330; IPR027417; IPR017179; IPR035106; IPR015415; ,Q8WXF7-1,"SUBUNIT: Homohexamer (PubMed:17389232, PubMed:22637577). Mostly monomeric, but assembles into hexameric structure for short periods of time. Oligomerization seems to be a prerequisite for catalytic activity (PubMed:17389232, PubMed:22637577). Binding to ATP in a cleft between two adjacent subunits stabilizes the homohexameric form (PubMed:17389232, PubMed:22637577). Binds to microtubules at least in part via the alpha-tubulin and beta-tubulin tails (PubMed:15269182, PubMed:15716377, PubMed:23272056). The hexamer adopts a ring conformation through which microtubules pass prior to being severed (PubMed:17389232, PubMed:22637577). Does not interact strongly with tubulin heterodimers (PubMed:15269182, PubMed:15716377, PubMed:23272056). Interacts (via MIT domain) with CHMP1B; the interaction is direct (PubMed:15537668, PubMed:18997780). Interacts with SSNA1 (PubMed:15269182). Interacts with ATL1 (PubMed:16339213, PubMed:16815977). Interacts with RTN1 (PubMed:16602018). Interacts with ZFYVE27 (PubMed:16826525, PubMed:23969831). Isoform 1 but not isoform 3 interacts with RTN2 (PubMed:22232211). Interacts with REEP1 (PubMed:20200447). Interacts (via MIT domain) with IST1 (PubMed:23897888, PubMed:26040712). {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:15269182, ECO:0000269|PubMed:15537668, ECO:0000269|PubMed:15716377, ECO:0000269|PubMed:16339213, ECO:0000269|PubMed:16602018, ECO:0000269|PubMed:16815977, ECO:0000269|PubMed:16826525, ECO:0000269|PubMed:17389232, ECO:0000269|PubMed:18997780, ECO:0000269|PubMed:20200447, ECO:0000269|PubMed:22232211, ECO:0000269|PubMed:22637577, ECO:0000269|PubMed:23272056, ECO:0000269|PubMed:23897888, ECO:0000269|PubMed:23969831, ECO:0000269|PubMed:26040712}.",10610178; 10470851; 15489334; 11809724; 12676568; 15147984; 15269182; 16026783; 15537668; 15716377; 16219033; 15891913; 16826525; 16339213; 16602018; 16815977; 17389232; 18613979; 18410514; 18669648; 19690332; 19000169; 20200447; 20530212; 20068231; 21406692; 21310966; 22637577; 22232211; 23272056; 23745751; 23897888; 23186163; 23969831; 24275569; 26040712; 25875445; 26875866; 18997780; 22446388; 11039577; 10699187; 11015453; 11087788; 11309678; 12460147; 11843700; 12124993; 12161613; 11985387; 12163196; 12202986; 12552568; 12939659; 14732620; 15210521; 15667412; 15248095; 15482961; 15159500; 15326248; 16682546; 16684598; 16959974; 17594340; 20214791; 20932283; 20562464; 20718791; 20550563; 21546041; 22960362; 23279441; 25421405; 25045380; 24824479; 28572275,10610178; 10470851; 15489334; 11809724; 12676568; 15147984; 15269182; 16026783; 15537668; 15716377; 16219033; 15891913; 16826525; 16339213; 16602018; 16815977; 17389232; 18613979; 18410514; 18669648; 19690332; 19000169; 20200447; 20530212; 20068231; 21406692; 21310966; 22637577; 22232211; 23272056; 23745751; 23897888; 23186163; 23969831; 24275569; 26040712; 25875445; 26875866; 18997780; 22446388; 11039577; 10699187; 11015453; 11087788; 11309678; 12460147; 11843700; 12124993; 12161613; 11985387; 12163196; 12202986; 12552568; 12939659; 14732620; 15210521; 15667412; 15248095; 15482961; 15159500; 15326248; 16682546; 16684598; 16959974; 17594340; 20214791; 20932283; 20562464; 20718791; 20550563; 21546041; 22960362; 23279441; 25421405; 25045380; 24824479; 28572275; 10980739; 11704932; 12023066; 12471215; 12490534; 12736085; 12778437; 14506940; 14681884; 15174051; 15739043; 15841487; 15858810; 15939438; 16009903; 16055926; 16240363; 16788734; 16828199; 17035675; 17098887; 17100993; 17345589; 17407089; 17420921; 17560499; 17597328; 17598600; 17690846; 17895902; 17916079; 17957230; 17971434; 18190593; 18202664; 18337300; 18401025; 18664244; 18701882; 19039240; 19084842; 19141076; 19289482; 19423133; 19620182; 19652142; 19730024; 19939411; 20154342; 20430936; 20491894; 20559269; 20665701; 20711500; 20734064; 20857310; 21757506; 21834905; 22192498; 22203332; 22573551; 22574173; 23252998; 23264559; 23400676; 23716148; 23812641; 24033003; 24123785; 24381312; 24478365; 24571573; 24659419; 24731568; 24824741; 25065914; 25390646; 25454648; 25511172; 26094131; 26208798; 26374131; 26600529; 26671083; 26932189; 27084228; 27229699; 27260292; 27334366; 28495799; 28870597; 29368828; 29710391,2001-01-11,2019-02-13,2000-05-01,184,X-ray crystallography (3),STRAND 139 141 {ECO:0000244|PDB:3EAB}.; STRAND 376 383 {ECO:0000244|PDB:3VFD}.; STRAND 402 406 {ECO:0000244|PDB:3VFD}.; STRAND 433 441 {ECO:0000244|PDB:3VFD}.; STRAND 480 487 {ECO:0000244|PDB:3VFD}.; STRAND 502 505 {ECO:0000244|PDB:3VFD}.; STRAND 573 575 {ECO:0000244|PDB:3VFD}.,HELIX 112 136 {ECO:0000244|PDB:3EAB}.; HELIX 142 144 {ECO:0000244|PDB:3EAB}.; HELIX 146 161 {ECO:0000244|PDB:3EAB}.; HELIX 169 195 {ECO:0000244|PDB:3EAB}.; HELIX 328 330 {ECO:0000244|PDB:3VFD}.; HELIX 341 343 {ECO:0000244|PDB:3VFD}.; HELIX 348 357 {ECO:0000244|PDB:3VFD}.; HELIX 359 363 {ECO:0000244|PDB:3VFD}.; HELIX 370 372 {ECO:0000244|PDB:3VFD}.; HELIX 388 398 {ECO:0000244|PDB:3VFD}.; HELIX 420 432 {ECO:0000244|PDB:3VFD}.; HELIX 443 446 {ECO:0000244|PDB:3VFD}.; HELIX 458 472 {ECO:0000244|PDB:3VFD}.; HELIX 489 491 {ECO:0000244|PDB:3VFD}.; HELIX 494 497 {ECO:0000244|PDB:3VFD}.; HELIX 511 522 {ECO:0000244|PDB:3VFD}.; HELIX 531 540 {ECO:0000244|PDB:3VFD}.; HELIX 546 556 {ECO:0000244|PDB:3VFD}.; HELIX 559 562 {ECO:0000244|PDB:3VFD}.; HELIX 582 591 {ECO:0000244|PDB:3VFD}.; HELIX 598 610 {ECO:0000244|PDB:3VFD}.,TURN 365 367 {ECO:0000244|PDB:3VFD}.; TURN 541 543 {ECO:0000244|PDB:3VFD}.,,"INTRAMEM 57 77 Helical. {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000305|PubMed:20200447}.","TOPO_DOM 1 56 Cytoplasmic. {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000305|PubMed:20200447}.; TOPO_DOM 78 616 Cytoplasmic. {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000305|PubMed:20200447}.",,5 out of 5,Alternative sequence (2); Beta strand (7); Chain (1); Domain (1); Helix (21); Intramembrane (1); Modified residue (4); Motif (3); Mutagenesis (15); Natural variant (127); Nucleotide binding (1); Region (10); Topological domain (2); Turn (2),,"TISSUE SPECIFICITY: Expressed in brain, heart, kidney, liver, lung, pancreas, placenta and skeletal muscle. The short isoforms may predominate in brain and spinal cord. {ECO:0000269|PubMed:10610178}.",,3D-structure;ATP-binding;Allosteric enzyme;Alternative initiation;Alternative promoter usage;Alternative splicing;Cell cycle;Cell division;Complete proteome;Cytoplasm;Cytoskeleton;Developmental protein;Differentiation;Disease mutation;Endoplasmic reticulum;Endosome;Hereditary spastic paraplegia;Isomerase;Lipid droplet;Membrane;Microtubule;Neurodegeneration;Neurogenesis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,"AAA ATPase family, Spastin subfamily",184,Activity regulation (1); Alternative products (1); Catalytic activity (1); Caution (2); Developmental stage (1); Function (2); Involvement in disease (1); Kinetics (1); Sequence similarities (1); Subcellular location (3); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0021; KW-0024; KW-0025; KW-0067; KW-0131; KW-0132; KW-0181; KW-0206; KW-0217; KW-0221; KW-0225; KW-0256; KW-0413; KW-0472; KW-0493; KW-0523; KW-0524; KW-0539; KW-0547; KW-0551; KW-0597; KW-0621; KW-0877; KW-0890; KW-0963; KW-0967; KW-1185,,,,,"DISEASE: Spastic paraplegia 4, autosomal dominant (SPG4) [MIM:182601]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:10610178, ECO:0000269|PubMed:10699187, ECO:0000269|PubMed:11015453, ECO:0000269|PubMed:11039577, ECO:0000269|PubMed:11087788, ECO:0000269|PubMed:11309678, ECO:0000269|PubMed:11809724, ECO:0000269|PubMed:11843700, ECO:0000269|PubMed:11985387, ECO:0000269|PubMed:12124993, ECO:0000269|PubMed:12161613, ECO:0000269|PubMed:12163196, ECO:0000269|PubMed:12202986, ECO:0000269|PubMed:12460147, ECO:0000269|PubMed:12552568, ECO:0000269|PubMed:12939659, ECO:0000269|PubMed:14732620, ECO:0000269|PubMed:15159500, ECO:0000269|PubMed:15210521, ECO:0000269|PubMed:15248095, ECO:0000269|PubMed:15326248, ECO:0000269|PubMed:15482961, ECO:0000269|PubMed:15667412, ECO:0000269|PubMed:15716377, ECO:0000269|PubMed:15891913, ECO:0000269|PubMed:16339213, ECO:0000269|PubMed:16682546, ECO:0000269|PubMed:16684598, ECO:0000269|PubMed:17389232, ECO:0000269|PubMed:17594340, ECO:0000269|PubMed:19000169, ECO:0000269|PubMed:20214791, ECO:0000269|PubMed:20550563, ECO:0000269|PubMed:20562464, ECO:0000269|PubMed:20718791, ECO:0000269|PubMed:20932283, ECO:0000269|PubMed:21546041, ECO:0000269|PubMed:22960362, ECO:0000269|PubMed:23279441, ECO:0000269|PubMed:24824479, ECO:0000269|PubMed:25045380, ECO:0000269|PubMed:25421405, ECO:0000269|PubMed:28572275}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 616 Spastin. /FTId=PRO_0000084763.,,,,,,"MOD_RES 245 245 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 268 268 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 306 306 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 597 597 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AJ246001;AJ246003;AB029006;CH471053;BC150260;
0,Q9UQB9,AURKC_HUMAN,AURKC AIE2 AIK3 AIRK3 ARK3 STK13,AURKC,AIE2 AIK3 AIRK3 ARK3 STK13,,,Homo sapiens (Human),9606,Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSSPRAVVQLGKAQPAGEELATANQTAQQPSSPAMRRLTVDDFEIGRPLGKGKFGNVYLARLKESHFIVALKVLFKSQIEKEGLEHQLRREIEIQAHLQHPNILRLYNYFHDARRVYLILEYAPRGELYKELQKSEKLDEQRTATIIEELADALTYCHDKKVIHRDIKPENLLLGFRGEVKIADFGWSVHTPSLRRKTMCGTLDYLPPEMIEGRTYDEKVDLWCIGVLCYELLVGYPPFESASHSETYRRILKVDVRFPLSMPLGARDLISRLLRYQPLERLPLAQILKHPWVQAHSRRVLPPCAQMAS,309,"35,591",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=Q9UQB9-1; Sequence=Displayed; Name=2; IsoId=Q9UQB9-2; Sequence=VSP_004872; Name=3; Synonyms=Aurora C-SV; IsoId=Q9UQB9-3; Sequence=VSP_041095; ,,,,,,,,,,"VAR_SEQ 1 34 Missing (in isoform 2). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9799611}. /FTId=VSP_004872.; VAR_SEQ 1 20 MSSPRAVVQLGKAQPAGEEL -> M (in isoform 3). {ECO:0000303|PubMed:15670791}. /FTId=VSP_041095.",VARIANT 52 52 G -> E (in a lung adenocarcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040385.; VARIANT 148 148 E -> Q (in a lung squamous cell carcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040386.; VARIANT 244 244 H -> Q (in a lung adenocarcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040387.,,,,CONFLICT 109 109 Y -> H (in Ref. 1; AAC25955). {ECO:0000305}.; CONFLICT 150 150 L -> V (in Ref. 2; AAC77369). {ECO:0000305}.; CONFLICT 193 195 SLR -> LPE (in Ref. 2; AAC77369). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. Aurora subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,DOMAIN 43 293 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,REGION 292 309 Interaction with BIRC5. {ECO:0000269|PubMed:27332895}.,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",,,"FUNCTION: Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Plays also a role in meiosis and more particularly in spermatogenesis. Has redundant cellular functions with AURKB and can rescue an AURKB knockdown. Like AURKB, AURKC phosphorylates histone H3 at 'Ser-10' and 'Ser-28'. AURKC phosphorylates the CPC complex subunits BIRC5/survivin and INCENP leading to increased AURKC activity. Phosphorylates TACC1, another protein involved in cell division, at 'Ser-228'. {ECO:0000269|PubMed:15316025, ECO:0000269|PubMed:15499654, ECO:0000269|PubMed:15670791, ECO:0000269|PubMed:15938719, ECO:0000269|PubMed:21493633, ECO:0000269|PubMed:21531210, ECO:0000269|PubMed:27332895}.",,,,,,"ACT_SITE 166 166 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 72 72 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 49 57 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,"chromosome passenger complex [GO:0032133]; condensed chromosome [GO:0000793]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; histone modification [GO:0016570]; meiotic cell cycle [GO:0051321]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; oocyte development [GO:0048599]; positive regulation of cytokinesis [GO:0032467]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]",attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; histone modification [GO:0016570]; meiotic cell cycle [GO:0051321]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; oocyte development [GO:0048599]; positive regulation of cytokinesis [GO:0032467]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283],ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712],"chromosome passenger complex [GO:0032133]; condensed chromosome [GO:0000793]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]",GO:0000780; GO:0000793; GO:0004672; GO:0004712; GO:0005524; GO:0005737; GO:0005819; GO:0005876; GO:0006468; GO:0007052; GO:0007283; GO:0008608; GO:0016570; GO:0030496; GO:0031616; GO:0032133; GO:0032465; GO:0032467; GO:0035174; GO:0048599; GO:0051233; GO:0051256; GO:0051301; GO:0051321,IPR030616; IPR030613; IPR011009; IPR000719; IPR017441; IPR008271; ,O15392; Q9NQS7,"SUBUNIT: Component of the chromosomal passenger complex (CPC) composed of at least BIRC5/survivin, CDCA8/borealin, INCENP, AURKB or AURKC; predominantly independent AURKB- and AURKC-containing complexes exist; in the complex interacts directly with BIRC5/survivin and INCENP. Interacts with TACC1. {ECO:0000269|PubMed:15316025, ECO:0000269|PubMed:15499654, ECO:0000269|PubMed:15938719, ECO:0000269|PubMed:21531210, ECO:0000269|PubMed:27332895}.",9809744; 9799611; 10066797; 15670791; 15057824; 15489334; 15499654; 15316025; 15938719; 17435757; 21531210; 21493633; 21733974; 27332895; 17344846,9809744; 9799611; 10066797; 15670791; 15057824; 15489334; 15499654; 15316025; 15938719; 17435757; 21531210; 21493633; 21733974; 27332895; 17344846; 15917996; 16258285; 17637569; 18309533; 19147683; 19649632; 19713763; 20508983; 20629650; 21353399; 21710690; 21988832; 22046298; 22888167; 22939624; 23075505; 23292864; 23581231; 23602568; 24484996; 24632603; 24947832; 25219909; 25369539; 25990457; 25994570; 26118178; 26341096; 27779748; 28369513; 28930610; 29283376; 29738175; 30077875,2003-01-17,2019-02-13,2000-05-01,179,,,,,,,,,5 out of 5,Active site (1); Alternative sequence (2); Binding site (1); Chain (1); Domain (1); Modified residue (1); Mutagenesis (3); Natural variant (3); Nucleotide binding (1); Region (1); Sequence conflict (3),,"TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in testis. Elevated expression levels were seen only in a subset of cancer cell lines such as Hep-G2, Huh-7 and HeLa. Expression is maximum at M phase. {ECO:0000269|PubMed:15670791}.",,ATP-binding;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Complete proteome;Cytoplasm;Cytoskeleton;Kinase;Meiosis;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase,Evidence at protein level,reviewed,,"Protein kinase superfamily, Ser/Thr protein kinase family, Aurora subfamily",179,Activity regulation (1); Alternative products (1); Catalytic activity (2); Function (1); Induction (1); Involvement in disease (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0067; KW-0131; KW-0132; KW-0137; KW-0158; KW-0181; KW-0206; KW-0418; KW-0469; KW-0498; KW-0539; KW-0547; KW-0597; KW-0621; KW-0723; KW-0808; KW-0963; KW-1185,,,,,"DISEASE: Spermatogenic failure 5 (SPGF5) [MIM:243060]: An infertility disorder caused by spermatogenesis defects. Semen from affected men show close to 100% morphologically abnormal multiflagellar spermatozoa with low motility, oversized irregular heads, and abnormal midpiece and acrosome. {ECO:0000269|PubMed:17435757, ECO:0000269|PubMed:21733974}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 309 Aurora kinase C. /FTId=PRO_0000085660.,,,,,,MOD_RES 198 198 Phosphothreonine; by PKA. {ECO:0000250|UniProtKB:O88445}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF054621;AF059681;AB017332;AY661554;CH471135;BC075064;
0,Q9Y230,RUVB2_HUMAN,RUVBL2 INO80J TIP48 TIP49B CGI-46,RUVBL2,INO80J TIP48 TIP49B,,CGI-46,Homo sapiens (Human),9606,RuvB-like 2 (EC 3.6.4.12) (48 kDa TATA box-binding protein-interacting protein) (48 kDa TBP-interacting protein) (51 kDa erythrocyte cytosolic protein) (ECP-51) (INO80 complex subunit J) (Repressing pontin 52) (Reptin 52) (TIP49b) (TIP60-associated protein 54-beta) (TAP54-beta),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MATVTATTKVPEIRDVTRIERIGAHSHIRGLGLDDALEPRQASQGMVGQLAARRAAGVVLEMIREGKIAGRAVLIAGQPGTGKTAIAMGMAQALGPDTPFTAIAGSEIFSLEMSKTEALTQAFRRSIGVRIKEETEIIEGEVVEIQIDRPATGTGSKVGKLTLKTTEMETIYDLGTKMIESLTKDKVQAGDVITIDKATGKISKLGRSFTRARDYDAMGSQTKFVQCPDGELQKRKEVVHTVSLHEIDVINSRTQGFLALFSGDTGEIKSEVREQINAKVAEWREEGKAEIIPGVLFIDEVHMLDIESFSFLNRALESDMAPVLIMATNRGITRIRGTSYQSPHGIPIDLLDRLLIVSTTPYSEKDTKQILRIRCEEEDVEMSEDAYTVLTRIGLETSLRYAIQLITAASLVCRKRKGTEVQVDDIKRVYSLFLDESRSTQYMKEYQDAFLFNELKGETMDTS,463,"51,157",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q9Y230-1; Sequence=Displayed; Name=2; IsoId=Q9Y230-2; Sequence=VSP_056584; Note=No experimental confirmation available.; ,,,,,SEQUENCE CAUTION:  Sequence=AAD34041.1; Type=Frameshift; Positions=401; Evidence={ECO:0000305};  Sequence=AAH08355.1; Type=Frameshift; Positions=191; Evidence={ECO:0000305}; ,,,,,VAR_SEQ 1 45 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_056584.,,,,,CONFLICT 214 214 D -> N (in Ref. 6; AAD34041). {ECO:0000305}.; CONFLICT 257 258 FL -> YV (in Ref. 5; AA sequence). {ECO:0000305}.,,3,,0,DOMAIN: The C-terminal domain is required for association with ATF2.,SIMILARITY: Belongs to the RuvB family. {ECO:0000305}.,,,,,,,,3.6.4.12,,"CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;",,,"FUNCTION: Possesses single-stranded DNA-stimulated ATPase and ATP-dependent DNA helicase (5' to 3') activity; hexamerization is thought to be critical for ATP hydrolysis and adjacent subunits in the ring-like structure contribute to the ATPase activity.; FUNCTION: Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AFZ from the nucleosome.; FUNCTION: Proposed core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair.; FUNCTION: Plays an essential role in oncogenic transformation by MYC and also modulates transcriptional activation by the LEF1/TCF1-CTNNB1 complex. May also inhibit the transcriptional activity of ATF2.; FUNCTION: Involved in the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway where it negatively regulates expression of ER stress response genes. {ECO:0000269|PubMed:25652260}.",,,,,,,,,,NP_BIND 77 84 ATP.,,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; intracellular [GO:0005622]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear euchromatin [GO:0005719]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent 5'-3' DNA helicase activity [GO:0043141]; ATP-dependent DNA helicase activity [GO:0004003]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of estrogen receptor binding [GO:0071899]; positive regulation of histone acetylation [GO:0035066]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein folding [GO:0006457]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; transcriptional activation by promoter-enhancer looping [GO:0071733],box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of estrogen receptor binding [GO:0071899]; positive regulation of histone acetylation [GO:0035066]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein folding [GO:0006457]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; transcriptional activation by promoter-enhancer looping [GO:0071733],ADP binding [GO:0043531]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; ATP-dependent 5'-3' DNA helicase activity [GO:0043141]; ATP-dependent DNA helicase activity [GO:0004003]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; intracellular [GO:0005622]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear euchromatin [GO:0005719]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812],GO:0000492; GO:0000812; GO:0000979; GO:0000980; GO:0001094; GO:0003678; GO:0003714; GO:0004003; GO:0005524; GO:0005622; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0006457; GO:0008013; GO:0016020; GO:0016363; GO:0016573; GO:0017025; GO:0031011; GO:0031490; GO:0034644; GO:0035066; GO:0035267; GO:0040008; GO:0042802; GO:0042803; GO:0043141; GO:0043531; GO:0043967; GO:0043968; GO:0045944; GO:0051082; GO:0051117; GO:0070062; GO:0071169; GO:0071339; GO:0071392; GO:0071733; GO:0071899; GO:0090090; GO:0097255; GO:1904874; GO:1990904,IPR003593; IPR027417; IPR027238; IPR037942; IPR010339; ,Itself; Q8IW40; Q9BVM2; Q8TBB1; Q9Y265; P25490,"SUBUNIT: Forms homohexameric rings (Probable). Can form a dodecamer with RUVBL1 made of two stacked hexameric rings; however, even though RUVBL1 and RUVBL2 are present in equimolar ratio, the oligomeric status of each hexamer is not known. Oligomerization may regulate binding to nucleic acids and conversely, binding to nucleic acids may affect the dodecameric assembly. Interacts with the transcriptional activation domain of MYC. Interacts With ATF2. Component of the RNA polymerase II holoenzyme complex. May also act to bridge the LEF1/TCF1-CTNNB1 complex and TBP. Component of the NuA4 histone acetyltransferase complex which contains the catalytic subunit KAT5/TIP60 and the subunits EP400, TRRAP/PAF400, BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2, ING3, actin, ACTL6A/BAF53A, MORF4L1/MRG15, MORF4L2/MRGX, MRGBP, YEATS4/GAS41, VPS72/YL1 and MEAF6. The NuA4 complex interacts with MYC and the adenovirus E1A protein. RUVBL2 interacts with EP400. Component of a NuA4-related complex which contains EP400, TRRAP/PAF400, SRCAP, BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2, actin, ACTL6A/BAF53A, VPS72 and YEATS4/GAS41. Interacts with NPAT. Component of the chromatin-remodeling INO80 complex; specifically part of a complex module associated with the helicase ATP-binding and the helicase C-terminal domain of INO80. Component of some MLL1/MLL complex, at least composed of the core components KMT2A/MLL1, ASH2L, HCFC1/HCF1, WDR5 and RBBP5, as well as the facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MGA, MYST1/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. Interacts with IGHMBP2. Interacts with TELO2. Interacts with HINT1. Component of a SWR1-like complex. Component of the R2TP complex composed at least of PIHD1, RUVBL1, RUVBL2 and RPAP3 (PubMed:20864032). Interacts with ITFG1 (PubMed:25437307). Interacts with ZMYND10 (PubMed:29601588). Interacts with WAC; WAC positively regulates MTOR activity by promoting the assembly of the TTT complex composed of TELO2, TTI1 and TTI2 and the RUVBL complex composed of RUVBL1 and RUVBL2 into the TTT-RUVBL complex which leads to the dimerization of the mTORC1 complex and its subsequent activation (PubMed:26812014). Forms a complex with APPL1 and APPL2 (PubMed:19433865). {ECO:0000269|PubMed:10428817, ECO:0000269|PubMed:10882073, ECO:0000269|PubMed:10966108, ECO:0000269|PubMed:11713276, ECO:0000269|PubMed:12963728, ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:15960975, ECO:0000269|PubMed:16014379, ECO:0000269|PubMed:16230350, ECO:0000269|PubMed:17157868, ECO:0000269|PubMed:17967892, ECO:0000269|PubMed:18026119, ECO:0000269|PubMed:19299493, ECO:0000269|PubMed:19433865, ECO:0000269|PubMed:20801936, ECO:0000269|PubMed:20864032, ECO:0000269|PubMed:21303910, ECO:0000269|PubMed:24463511, ECO:0000269|PubMed:25437307, ECO:0000269|PubMed:26812014, ECO:0000269|PubMed:29601588, ECO:0000305}.",10524211; 10428817; 10998447; 11080158; 10882073; 10810093; 11230166; 14702039; 15057824; 15489334; 12665801; 10966108; 12963728; 11713276; 14966270; 15960975; 16230350; 16014379; 17157868; 18026119; 17967892; 19413330; 19299493; 19433865; 20801936; 20864032; 21269460; 21303910; 22814378; 23186163; 25437307; 24275569; 24463511; 25652260; 25944712; 26812014; 28112733; 29601588; ,10524211; 10428817; 10998447; 11080158; 10882073; 10810093; 11230166; 14702039; 15057824; 15489334; 12665801; 10966108; 12963728; 11713276; 14966270; 15960975; 16230350; 16014379; 17157868; 18026119; 17967892; 19413330; 19299493; 19433865; 20801936; 20864032; 21269460; 21303910; 22814378; 23186163; 25437307; 24275569; 24463511; 25652260; 25944712; 26812014; 28112733; 29601588; 11074001; 12577067; 12699629; 14743216; 15161933; 15231747; 15647280; 15923622; 16157330; 16169070; 16189514; 16339074; 16601686; 16699503; 17220478; 17314511; 17342744; 17353931; 17395830; 17636026; 17657734; 17932509; 17955473; 18358808; 18457437; 18523010; 18765919; 18922472; 19167051; 19179534; 19180575; 19369355; 19403135; 19444951; 19450687; 19524533; 19620283; 19738201; 19851296; 19877184; 20085707; 20198315; 20346530; 20360068; 20371770; 20412048; 20467437; 20509972; 20553504; 20562859; 20603076; 20808282; 20888340; 21182205; 21282530; 21763315; 21911578; 21933716; 21988832; 22285491; 22341977; 22623428; 22748767; 22810585; 22923768; 23002137; 23075850; 23403462; 23878400; 23891720; 24023044; 24189400; 24255178; 24366813; 24656813; 24855944; 24990942; 25036637; 25336637; 25416956; 25428364; 25604459; 25609649; 25852190; 25875766; 25957047; 26211835; 26303906; 26496610; 26863765; 27845271; 27999200; 28561026; 28833338; 29323271; 29643506; 29662061; 30213962,2003-02-01,2019-02-13,2007-01-23,214,X-ray crystallography (3); NMR spectroscopy (1); Electron microscopy (3),STRAND 41 43 {ECO:0000244|PDB:3UK6}.; STRAND 46 48 {ECO:0000244|PDB:3UK6}.; STRAND 72 77 {ECO:0000244|PDB:6H7X}.; STRAND 100 104 {ECO:0000244|PDB:6H7X}.; STRAND 111 113 {ECO:0000244|PDB:6H7X}.; STRAND 126 145 {ECO:0000244|PDB:6H7X}.; STRAND 152 156 {ECO:0000244|PDB:2CQA}.; STRAND 161 164 {ECO:0000244|PDB:6H7X}.; STRAND 169 172 {ECO:0000244|PDB:6H7X}.; STRAND 191 194 {ECO:0000244|PDB:6H7X}.; STRAND 201 206 {ECO:0000244|PDB:2CQA}.; STRAND 232 243 {ECO:0000244|PDB:6H7X}.; STRAND 288 293 {ECO:0000244|PDB:6H7X}.; STRAND 295 300 {ECO:0000244|PDB:6H7X}.; STRAND 318 320 {ECO:0000244|PDB:6H7X}.; STRAND 323 328 {ECO:0000244|PDB:6H7X}.; STRAND 331 334 {ECO:0000244|PDB:6H7X}.; STRAND 341 343 {ECO:0000244|PDB:6H7X}.; STRAND 354 359 {ECO:0000244|PDB:6H7X}.; STRAND 419 421 {ECO:0000244|PDB:6H7X}.,HELIX 50 65 {ECO:0000244|PDB:6H7X}.; HELIX 83 94 {ECO:0000244|PDB:6H7X}.; HELIX 105 108 {ECO:0000244|PDB:6H7X}.; HELIX 115 125 {ECO:0000244|PDB:6H7X}.; HELIX 176 183 {ECO:0000244|PDB:6H7X}.; HELIX 244 251 {ECO:0000244|PDB:6H7X}.; HELIX 259 262 {ECO:0000244|PDB:6H7X}.; HELIX 270 285 {ECO:0000244|PDB:6H7X}.; HELIX 301 303 {ECO:0000244|PDB:6H7X}.; HELIX 306 315 {ECO:0000244|PDB:6H7X}.; HELIX 348 351 {ECO:0000244|PDB:6H7X}.; HELIX 364 378 {ECO:0000244|PDB:6H7X}.; HELIX 384 396 {ECO:0000244|PDB:6H7X}.; HELIX 399 415 {ECO:0000244|PDB:6H7X}.; HELIX 423 432 {ECO:0000244|PDB:6H7X}.; HELIX 436 439 {ECO:0000244|PDB:6H7X}.; HELIX 444 454 {ECO:0000244|PDB:6H7X}.,TURN 19 22 {ECO:0000244|PDB:3UK6}.; TURN 24 27 {ECO:0000244|PDB:2XSZ}.; TURN 66 70 {ECO:0000244|PDB:6H7X}.; TURN 197 200 {ECO:0000244|PDB:2CQA}.; TURN 440 443 {ECO:0000244|PDB:6H7X}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (20); Chain (1); Cross-link (3); Frameshift (2); Helix (17); Initiator methionine (1); Modified residue (2); Mutagenesis (1); Nucleotide binding (1); Sequence conflict (2); Turn (5),,TISSUE SPECIFICITY: Ubiquitously expressed. Highly expressed in testis and thymus.,,3D-structure;ATP-binding;Acetylation;Activator;Alternative splicing;Chromatin regulator;Complete proteome;Cytoplasm;DNA damage;DNA recombination;DNA repair;Direct protein sequencing;Growth regulation;Helicase;Hydrolase;Isopeptide bond;Membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation,Evidence at protein level,reviewed,,RuvB family,214,Alternative products (1); Catalytic activity (1); Caution (1); Domain (1); Function (5); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0010; KW-0025; KW-0067; KW-0156; KW-0181; KW-0227; KW-0233; KW-0234; KW-0341; KW-0347; KW-0378; KW-0472; KW-0539; KW-0547; KW-0597; KW-0804; KW-0805; KW-0832; KW-0903; KW-0963; KW-1017; KW-1185,,,,,,,,,CHAIN 2 463 RuvB-like 2. /FTId=PRO_0000165644.,CROSSLNK 9 9 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 444 444 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 456 456 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:12665801, ECO:0000269|Ref.14}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|Ref.14}.; MOD_RES 437 437 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,Y18417;AB024301;AF155138;AF124607;AF151804;AL136743;AK057498;AK074542;CR533507;CH471177;CH471177;BC000428;BC004531;BC008355;
0,Q9Y3E7,CHMP3_HUMAN,CHMP3 CGI149 NEDF VPS24 CGI-149,CHMP3,CGI149 NEDF VPS24,,CGI-149,Homo sapiens (Human),9606,Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Neuroendocrine differentiation factor) (Vacuolar protein sorting-associated protein 24) (hVps24),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGLFGKTQEKPPKELVNEWSLKIRKEMRVVDRQIRDIQREEEKVKRSVKDAAKKGQKDVCIVLAKEMIRSRKAVSKLYASKAHMNSVLMGMKNQLAVLRVAGSLQKSTEVMKAMQSLVKIPEIQATMRELSKEMMKAGIIEEMLEDTFESMDDQEEMEEEAEMEIDRILFEITAGALGKAPSKVTDALPEPEPPGAMAASEDEEEEEEALEAMQSRLATLRS,222,"25,073",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; Synonyms=Vps24alpha; IsoId=Q9Y3E7-1; Sequence=Displayed; Name=2; Synonyms=Vps24beta; IsoId=Q9Y3E7-2; Sequence=VSP_041076; Name=3; IsoId=Q9Y3E7-3; Sequence=VSP_042124; Note=No experimental confirmation available.; Name=4; IsoId=Q9Y3E7-4; Sequence=VSP_042125; Note=No experimental confirmation available.; ,,,,,,,,,,"VAR_SEQ 1 66 Missing (in isoform 2). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:17331679}. /FTId=VSP_041076.; VAR_SEQ 1 15 MGLFGKTQEKPPKEL -> MEGELYSALKEEEASESVSSTNFSGEMHFYELVEDTKDGIWLVQ (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_042124.; VAR_SEQ 74 113 Missing (in isoform 4). {ECO:0000305}. /FTId=VSP_042125.",,,,,CONFLICT 208 208 E -> D (in Ref. 1; AAF26737). {ECO:0000305}.,,3,,0,"DOMAIN: The acidic C-terminus and the basic N-termminus are thought to render the protein in a closed, soluble and inactive conformation through an autoinhibitory intramolecular interaction. The open and active conformation, which enables membrane binding and oligomerization, is achieved by interaction with other cellular binding partners, probably including other ESCRT components.",SIMILARITY: Belongs to the SNF7 family. {ECO:0000305}.,COILED 22 54 {ECO:0000255}.; COILED 141 222 {ECO:0000255}.,,,MOTIF 201 211 MIT-interacting motif.,REGION 2 113 Intramolecular interaction with C-terminus.; REGION 59 64 Important for autoinhibitory function.; REGION 151 222 Interaction with VPS4A.; REGION 151 220 Intramolecular interaction with N-terminus.; REGION 168 169 Important for autoinhibitory function.; REGION 203 207 Interaction with STAMBP.; REGION 221 222 Interaction with STAMBP.,,,,,,,,"FUNCTION: Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Selectively binds to phosphatidylinositol 3,5-bisphosphate PtdIns(3,5)P2 and PtdIns(3,4)P2 in preference to other phosphoinositides tested. Involved in late stages of cytokinesis. Plays a role in endosomal sorting/trafficking of EGF receptor. Isoform 2 prevents stress-mediated cell death and accumulation of reactive oxygen species when expressed in yeast cells. {ECO:0000269|PubMed:14505570, ECO:0000269|PubMed:15707591, ECO:0000269|PubMed:16740483, ECO:0000269|PubMed:17331679, ECO:0000269|PubMed:18076377}.",,,,,,,BINDING 216 216 STAMBP.,,,,SITE 48 48 Important for autoinhibitory function.,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803]; ubiquitin-specific protease binding [GO:1990381]; apoptotic process [GO:0006915]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of viral release from host cell [GO:1902187]; positive regulation of viral release from host cell [GO:1902188]; protein heterooligomerization [GO:0051291]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of viral process [GO:0050792]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],apoptotic process [GO:0006915]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; multivesicular body assembly [GO:0036258]; multivesicular body-lysosome fusion [GO:0061763]; multivesicular body sorting pathway [GO:0071985]; negative regulation of viral release from host cell [GO:1902187]; positive regulation of viral release from host cell [GO:1902188]; protein heterooligomerization [GO:0051291]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of viral process [GO:0050792]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803]; ubiquitin-specific protease binding [GO:1990381],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886],GO:0000815; GO:0005770; GO:0005771; GO:0005829; GO:0005886; GO:0006915; GO:0010824; GO:0015031; GO:0016197; GO:0016236; GO:0019058; GO:0031210; GO:0031410; GO:0031902; GO:0032509; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0045324; GO:0050792; GO:0051258; GO:0051291; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0097352; GO:1902187; GO:1902188; GO:1990381; GO:2000641,IPR005024; ,O43633; Q9UQN3; Q9H444; O95630,"SUBUNIT: Probable core component of the endosomal sorting required for transport complex III (ESCRT-III). ESCRT-III components are thought to multimerize to form a flat lattice on the perimeter membrane of the endosome. Several assembly forms of ESCRT-III may exist that interact and act sequentially. Forms a metastable monomer in solution; its core structure (without part of the putative autoinhibitory C-terminal acidic region) oligomerizes into a flat lattice via two different dimerization interfaces. In vitro, heteromerizes with CHMP2A (but not CHMP4) to form helical tubular structures that expose membrane-interacting sites on the outside whereas VPS4B can associate on the inside of the tubule. May interact with IGFBP7; the relevance of such interaction however remains unclear. Interacts with CHMP2A. Interacts with CHMP4A; the interaction requires the release of CHMP4A autoinhibition. Interacts with VPS4A. Interacts with STAMBP; the interaction appears to relieve the autoinhibition of CHMP3. Interacts with VTA1. {ECO:0000269|PubMed:14505570, ECO:0000269|PubMed:14519844, ECO:0000269|PubMed:16730941, ECO:0000269|PubMed:16740483, ECO:0000269|PubMed:17146056, ECO:0000269|PubMed:17261583, ECO:0000269|PubMed:17547705, ECO:0000269|PubMed:18395747, ECO:0000269|PubMed:19525971, ECO:0000269|PubMed:21543490, ECO:0000269|PubMed:21827950}.",11549700; 15707591; 16533400; 17331679; 10810093; 14702039; 15815621; 15489334; 14505570; 14519844; 15632132; 16730941; 17146056; 17261583; 17547705; 18669648; 18687924; 18076377; 18395747; 19690332; 20068231; 21269460; 21543490; 21406692; 23186163; 16740483; 19525971; 21827950,11549700; 15707591; 16533400; 17331679; 10810093; 14702039; 15815621; 15489334; 14505570; 14519844; 15632132; 16730941; 17146056; 17261583; 17547705; 18669648; 18687924; 18076377; 18395747; 19690332; 20068231; 21269460; 21543490; 21406692; 23186163; 16740483; 19525971; 21827950; 11563910; 12878588; 15075231; 15231748; 15473846; 16302002; 16371348; 16554368; 16973552; 17686835; 17711858; 18654987; 19302785; 19527882; 19615732; 20195357; 20360068; 21674799; 22762019; 23051622; 23305486; 24440309; 25416956; 25568151; 26496610,2005-08-30,2019-02-13,2007-01-23,155,X-ray crystallography (4),STRAND 120 122 {ECO:0000244|PDB:2GD5}.; STRAND 175 177 {ECO:0000244|PDB:2GD5}.,HELIX 15 53 {ECO:0000244|PDB:2GD5}.; HELIX 57 100 {ECO:0000244|PDB:2GD5}.; HELIX 109 112 {ECO:0000244|PDB:2GD5}.; HELIX 125 137 {ECO:0000244|PDB:2GD5}.; HELIX 164 167 {ECO:0000244|PDB:2GD5}.; HELIX 201 220 {ECO:0000244|PDB:2XZE}.,TURN 113 115 {ECO:0000244|PDB:2GD5}.,,,,,5 out of 5,Alternative sequence (3); Beta strand (2); Binding site (1); Chain (1); Coiled coil (2); Cross-link (1); Helix (6); Initiator methionine (1); Lipidation (1); Modified residue (1); Motif (1); Mutagenesis (16); Region (7); Sequence conflict (1); Site (1); Turn (1),,"TISSUE SPECIFICITY: Widely expressed. Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:15632132}.",MISCELLANEOUS: Its overexpression strongly inhibits HIV-1 release.,3D-structure;Alternative splicing;Apoptosis;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Endosome;Isopeptide bond;Lipoprotein;Membrane;Myristate;Phosphoprotein;Protein transport;Reference proteome;Transport;Ubl conjugation,Evidence at protein level,reviewed,,SNF7 family,155,Alternative products (1); Caution (2); Domain (1); Function (1); Miscellaneous (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0053; KW-0131; KW-0132; KW-0175; KW-0181; KW-0449; KW-0472; KW-0519; KW-0597; KW-0653; KW-0813; KW-0832; KW-0963; KW-0967; KW-1017; KW-1185,,,,,,,,,CHAIN 2 222 Charged multivesicular body protein 3. /FTId=PRO_0000211479.,CROSSLNK 179 179 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin).,,,INIT_MET 1 1 Removed. {ECO:0000255}.,LIPID 2 2 N-myristoyl glycine. {ECO:0000255}.,"MOD_RES 200 200 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF219226;AY364249;AF151907;AK290725;AK294389;AK312353;AK315835;AC015971;AC068288;CH471053;CH471053;CH471053;CH471053;BC004419;
0,Q9Y696,CLIC4_HUMAN,CLIC4,CLIC4,,,,Homo sapiens (Human),9606,Chloride intracellular channel protein 4 (Intracellular chloride ion channel protein p64H1),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MALSMPLNGLKEEDKEPLIELFVKAGSDGESIGNCPFSQRLFMILWLKGVVFSVTTVDLKRKPADLQNLAPGTHPPFITFNSEVKTDVNKIEEFLEEVLCPPKYLKLSPKHPESNTAGMDIFAKFSAYIKNSRPEANEALERGLLKTLQKLDEYLNSPLPDEIDENSMEDIKFSTRKFLDGNEMTLADCNLLPKLHIVKVVAKKYRNFDIPKEMTGIWRYLTNAYSRDEFTNTCPSDKEVEIAYSDVAKRLTK,253,"28,772",,,,,,,,,,,,,,,,,CONFLICT 14 14 D -> Y (in Ref. 2; AAD26136). {ECO:0000305}.; CONFLICT 133 134 RP -> SA (in Ref. 1; AAD38446 and 2; AAD26136). {ECO:0000305}.; CONFLICT 225 225 Y -> S (in Ref. 2; AAD26136). {ECO:0000305}.; CONFLICT 233 233 T -> A (in Ref. 2; AAD26136). {ECO:0000305}.,,4,,0,"DOMAIN: Members of this family may change from a globular, soluble state to a state where the N-terminal domain is inserted into the membrane and functions as chloride channel. A conformation change of the N-terminal domain is thought to expose hydrophobic surfaces that trigger membrane insertion. {ECO:0000269|PubMed:16581025}.",SIMILARITY: Belongs to the chloride channel CLIC family. {ECO:0000305}.,,,DOMAIN 104 244 GST C-terminal.,,REGION 2 101 Required for insertion into the membrane. {ECO:0000305}.,,,,,,,,"FUNCTION: Can insert into membranes and form poorly selective ion channels that may also transport chloride ions. Channel activity depends on the pH. Membrane insertion seems to be redox-regulated and may occur only under oxydizing conditions. Promotes cell-surface expression of HRH3. Has alternate cellular functions like a potential role in angiogenesis or in maintaining apical-basolateral membrane polarity during mitosis and cytokinesis. Could also promote endothelial cell proliferation and regulate endothelial morphogenesis (tubulogenesis). {ECO:0000269|PubMed:12163372, ECO:0000269|PubMed:14569596, ECO:0000269|PubMed:16176272, ECO:0000269|PubMed:16239224, ECO:0000269|PubMed:18302930, ECO:0000269|PubMed:19247789}.",,,,,,,,,,,,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; microvillus [GO:0005902]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; chloride transport [GO:0006821]; endothelial cell morphogenesis [GO:0001886]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; fertilization [GO:0009566]; keratinocyte differentiation [GO:0030216]; multicellular organism growth [GO:0035264]; negative regulation of cell migration [GO:0030336]; regulation of cytoskeleton organization [GO:0051493]; regulation of ion transmembrane transport [GO:0034765]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; vacuolar acidification [GO:0007035],angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; chloride transport [GO:0006821]; endothelial cell morphogenesis [GO:0001886]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; fertilization [GO:0009566]; keratinocyte differentiation [GO:0030216]; multicellular organism growth [GO:0035264]; negative regulation of cell migration [GO:0030336]; regulation of cytoskeleton organization [GO:0051493]; regulation of ion transmembrane transport [GO:0034765]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; vacuolar acidification [GO:0007035],chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244],actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; centrosome [GO:0005813]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; microvillus [GO:0005902]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],GO:0001525; GO:0001886; GO:0005244; GO:0005254; GO:0005622; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005902; GO:0005911; GO:0006821; GO:0007035; GO:0009566; GO:0009986; GO:0015629; GO:0016363; GO:0030154; GO:0030216; GO:0030336; GO:0030496; GO:0030659; GO:0034707; GO:0034765; GO:0035088; GO:0035264; GO:0045177; GO:0048471; GO:0048754; GO:0051493; GO:0061299; GO:0070062; GO:0071277,IPR002946; IPR030257; IPR010987; IPR036282; IPR040079; IPR036249; ,,"SUBUNIT: Component of a multimeric complex consisting of several cytoskeletal proteins, including actin, ezrin, alpha-actinin, gelsolin, IQGAP1 and CLIC5A. Binds directly to brain dynamin I in a complex containing actin, tubulin and 14-3-3 isoforms. Monomer. Interacts with HRH3. Interacts with AKAP9. {ECO:0000269|PubMed:10793131, ECO:0000269|PubMed:12163479, ECO:0000269|PubMed:16176272, ECO:0000269|PubMed:18302930}.",10070163; 10191309; 11230166; 15489334; 10793131; 12163372; 12163479; 14569596; 16239224; 17200346; 17636002; 18302930; 19413330; 19247789; 19608861; 21269460; 21406692; 22223895; 24275569; 25944712; 16176272; 16581025,10070163; 10191309; 11230166; 15489334; 10793131; 12163372; 12163479; 14569596; 16239224; 17200346; 17636002; 18302930; 19413330; 19247789; 19608861; 21269460; 21406692; 22223895; 24275569; 25944712; 16176272; 16581025; 16316993; 16842122; 17353931; 18028448; 19639201; 19713532; 19776349; 20374090; 20379614; 20877624; 21388519; 21988832; 22387366; 22761775; 22936677; 23380911; 23416981; 23792823; 24503901; 24503951; 24916695; 25344254; 25546839; 26496610; 28205343; 29462791; 30201851,2000-05-30,2019-02-13,2007-01-23,178,X-ray crystallography (3),STRAND 19 25 {ECO:0000244|PDB:2AHE}.; STRAND 29 32 {ECO:0000244|PDB:2AHE}.; STRAND 53 57 {ECO:0000244|PDB:2AHE}.; STRAND 77 80 {ECO:0000244|PDB:2AHE}.; STRAND 83 85 {ECO:0000244|PDB:2AHE}.; STRAND 181 183 {ECO:0000244|PDB:2AHE}.,HELIX 36 48 {ECO:0000244|PDB:2AHE}.; HELIX 64 69 {ECO:0000244|PDB:2AHE}.; HELIX 88 98 {ECO:0000244|PDB:2AHE}.; HELIX 112 115 {ECO:0000244|PDB:2AHE}.; HELIX 121 130 {ECO:0000244|PDB:2AHE}.; HELIX 134 136 {ECO:0000244|PDB:2AHE}.; HELIX 137 156 {ECO:0000244|PDB:2AHE}.; HELIX 186 206 {ECO:0000244|PDB:2AHE}.; HELIX 215 225 {ECO:0000244|PDB:2AHE}.; HELIX 228 231 {ECO:0000244|PDB:2AHE}.; HELIX 237 243 {ECO:0000244|PDB:2AHE}.,TURN 101 103 {ECO:0000244|PDB:2AHE}.; TURN 116 120 {ECO:0000244|PDB:2AHE}.; TURN 244 247 {ECO:0000244|PDB:2AHE}.,,,,TRANSMEM 37 57 Helical; Note=After insertion into the membrane. {ECO:0000255}.,5 out of 5,Beta strand (6); Chain (1); Domain (1); Helix (11); Initiator methionine (1); Modified residue (8); Region (1); Sequence conflict (5); Transmembrane (1); Turn (3),,"TISSUE SPECIFICITY: Detected in epithelial cells from colon, esophagus and kidney (at protein level). Expression is prominent in heart, kidney, placenta and skeletal muscle. {ECO:0000269|PubMed:10793131, ECO:0000269|PubMed:17200346, ECO:0000269|PubMed:17636002}.",,3D-structure;Acetylation;Cell junction;Cell membrane;Chloride;Chloride channel;Complete proteome;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Direct protein sequencing;Ion channel;Ion transport;Membrane;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport;Voltage-gated channel,Evidence at protein level,reviewed,,Chloride channel CLIC family,178,Domain (1); Function (1); Induction (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0181; KW-0206; KW-0406; KW-0407; KW-0472; KW-0496; KW-0539; KW-0597; KW-0812; KW-0813; KW-0851; KW-0868; KW-0869; KW-0903; KW-0963; KW-0965; KW-0968; KW-1003; KW-1133; KW-1185,,,,,,,,,CHAIN 2 253 Chloride intracellular channel protein 4. /FTId=PRO_0000144210.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000269|Ref.5}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000269|Ref.5}.; MOD_RES 4 4 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 24 24 N6-acetyllysine. {ECO:0000250|UniProtKB:O00299}.; MOD_RES 130 130 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 132 132 Phosphoserine. {ECO:0000250|UniProtKB:O00299}.; MOD_RES 167 167 Phosphoserine. {ECO:0000250|UniProtKB:O00299}.; MOD_RES 236 236 Phosphoserine. {ECO:0000250|UniProtKB:Q9QYB1}.; MOD_RES 244 244 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9Z1Q5}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF097330;AF109196;AL117424;BC012444;
0,P27816,MAP4_HUMAN,MAP4,MAP4,,,,Homo sapiens (Human),9606,Microtubule-associated protein 4 (MAP-4),UP000005640: Chromosome 3,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MADLSLADALTEPSPDIEGEIKRDFIATLEAEAFDDVVGETVGKTDYIPLLDVDEKTGNSESKKKPCSETSQIEDTPSSKPTLLANGGHGVEGSDTTGSPTEFLEEKMAYQEYPNSQNWPEDTNFCFQPEQVVDPIQTDPFKMYHDDDLADLVFPSSATADTSIFAGQNDPLKDSYGMSPCNTAVVPQGWSVEALNSPHSESFVSPEAVAEPPQPTAVPLELAKEIEMASEERPPAQALEIMMGLKTTDMAPSKETEMALAKDMALATKTEVALAKDMESPTKLDVTLAKDMQPSMESDMALVKDMELPTEKEVALVKDVRWPTETDVSSAKNVVLPTETEVAPAKDVTLLKETERASPIKMDLAPSKDMGPPKENKKETERASPIKMDLAPSKDMGPPKENKIVPAKDLVLLSEIEVAQANDIISSTEISSAEKVALSSETEVALARDMTLPPETNVILTKDKALPLEAEVAPVKDMAQLPETEIAPAKDVAPSTVKEVGLLKDMSPLSETEMALGKDVTPPPETEVVLIKNVCLPPEMEVALTEDQVPALKTEAPLAKDGVLTLANNVTPAKDVPPLSETEATPVPIKDMEIAQTQKGISEDSHLESLQDVGQSAAPTFMISPETVTGTGKKCSLPAEEDSVLEKLGERKPCNSQPSELSSETSGIARPEEGRPVVSGTGNDITTPPNKELPPSPEKKTKPLATTQPAKTSTSKAKTQPTSLPKQPAPTTIGGLNKKPMSLASGLVPAAPPKRPAVASARPSILPSKDVKPKPIADAKAPEKRASPSKPASAPASRSGSKSTQTVAKTTTAAAVASTGPSSRSPSTLLPKKPTAIKTEGKPAEVKKMTAKSVPADLSRPKSTSTSSMKKTTTLSGTAPAAGVVPSRVKATPMPSRPSTTPFIDKKPTSAKPSSTTPRLSRLATNTSAPDLKNVRSKVGSTENIKHQPGGGRAKVEKKTEAAATTRKPESNAVTKTAGPIASAQKQPAGKVQIVSKKVSYSHIQSKCGSKDNIKHVPGGGNVQIQNKKVDISKVSSKCGSKANIKHKPGGGDVKIESQKLNFKEKAQAKVGSLDNVGHLPAGGAVKTEGGGSEAPLCPGPPAGEEPAISEAAPEAGAPTSASGLNGHPTLSGGGDQREAQTLDSQIQETSI,1152,"121,005",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=7;  Comment=Additional isoforms seem to exist.; Name=1; IsoId=P27816-1; Sequence=Displayed; Name=2; IsoId=P27816-2; Sequence=VSP_003200; Note=May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.; Name=3; IsoId=P27816-3; Sequence=VSP_032065, VSP_032068, VSP_032072, VSP_032073, VSP_032074, VSP_032075; Name=4; IsoId=P27816-4; Sequence=VSP_032066, VSP_032067, VSP_032069, VSP_032070, VSP_032076; Name=5; IsoId=P27816-5; Sequence=VSP_032071, VSP_032077, VSP_032079; Name=6; IsoId=P27816-6; Sequence=VSP_032078; Note=No experimental confirmation available.; Name=7; IsoId=P27816-7; Sequence=VSP_043240, VSP_043241; Note=No experimental confirmation available.; ",,SEQUENCE CAUTION:  Sequence=BAD92614.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 1 151 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_032065.; VAR_SEQ 1 82 Missing (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_032066.; VAR_SEQ 83 221 LLANGGHGVEGSDTTGSPTEFLEEKMAYQEYPNSQNWPEDTNFCFQPEQVVDPIQTDPFKMYHDDDLADLVFPSSATADTSIFAGQNDPLKDSYGMSPCNTAVVPQGWSVEALNSPHSESFVSPEAVAEPPQPTAVPLE -> METTGDQGIEGMAYMDENRNITFTCPRTPSELINKSSPLEVLGSAACEKLPTPTPQVVKEGDSFPDT (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_032067.; VAR_SEQ 98 99 GS -> EA (in isoform 7). {ECO:0000303|PubMed:15489334}. /FTId=VSP_043240.; VAR_SEQ 100 1152 Missing (in isoform 7). {ECO:0000303|PubMed:15489334}. /FTId=VSP_043241.; VAR_SEQ 152 437 LVFPSSATADTSIFAGQNDPLKDSYGMSPCNTAVVPQGWSVEALNSPHSESFVSPEAVAEPPQPTAVPLELAKEIEMASEERPPAQALEIMMGLKTTDMAPSKETEMALAKDMALATKTEVALAKDMESPTKLDVTLAKDMQPSMESDMALVKDMELPTEKEVALVKDVRWPTETDVSSAKNVVLPTETEVAPAKDVTLLKETERASPIKMDLAPSKDMGPPKENKKETERASPIKMDLAPSKDMGPPKENKIVPAKDLVLLSEIEVAQANDIISSTEISSAEKVA -> MSLSDKQTASLTAAYGQLSKGKPAECRMDSPKEISQAGFEWQRTEGKLNEIGLNVSMDGQPKDGLVKNASFLEQNKLCFFEGKLDKELSIEMQDKDCQEASGHLESRYVISETCHPLEGNSVHQKTSEFHLGLIEGPDKNKTIPVQGKVAGKNGLETKSQSDLDFPGAADIPTRYVKEQETSVWNPSFHPVAQGSLGSREATPGEMENSITPGCPVIGVVNDNSEQLKCESPLLVSLAHPAPIIEHSPTTIPPITMVFTQEHLNASCHIRDHDKELEK (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_032068.; VAR_SEQ 225 271 EIEMASEERPPAQALEIMMGLKTTDMAPSKETEMALAKDMALATKTE -> NGQEIAPAQISKSLMVDNYTKDGVPGQERPKGPSAVVPSTSTGG (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_032069.; VAR_SEQ 275 666 AKDMESPTKLDVTLAKDMQPSMESDMALVKDMELPTEKEVALVKDVRWPTETDVSSAKNVVLPTETEVAPAKDVTLLKETERASPIKMDLAPSKDMGPPKENKKETERASPIKMDLAPSKDMGPPKENKIVPAKDLVLLSEIEVAQANDIISSTEISSAEKVALSSETEVALARDMTLPPETNVILTKDKALPLEAEVAPVKDMAQLPETEIAPAKDVAPSTVKEVGLLKDMSPLSETEMALGKDVTPPPETEVVLIKNVCLPPEMEVALTEDQVPALKTEAPLAKDGVLTLANNVTPAKDVPPLSETEATPVPIKDMEIAQTQKGISEDSHLESLQDVGQSAAPTFMISPETVTGTGKKCSLPAEEDSVLEKLGERKPCNSQPSELSSETS -> PITTAIETVNIHGDHSLKNKAELADSMKNEAGIDEGHVIGESESVHSGASKHSVEKVTELAKGHLLPGVPVEDQSLPGEARALEGYADRGNFPAHPVNEEKETKEGSVAVQIPDLLEDKAQKLSFCEDQNAQDRNSKGSDSLNKKVDLTLLSPKSENDKLKEISLACKITELESVSLPTPEIQSDFLHSKVEAPPSEVADTLVIMTASKGVRLPEPKDKILETPQKMTEKSESKTPGEGKKEDKSRMAEPMKGYMRPTKSRGLTPLLPKSTIQEQERHKQLKSA (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_032070.; VAR_SEQ 322 666 WPTETDVSSAKNVVLPTETEVAPAKDVTLLKETERASPIKMDLAPSKDMGPPKENKKETERASPIKMDLAPSKDMGPPKENKIVPAKDLVLLSEIEVAQANDIISSTEISSAEKVALSSETEVALARDMTLPPETNVILTKDKALPLEAEVAPVKDMAQLPETEIAPAKDVAPSTVKEVGLLKDMSPLSETEMALGKDVTPPPETEVVLIKNVCLPPEMEVALTEDQVPALKTEAPLAKDGVLTLANNVTPAKDVPPLSETEATPVPIKDMEIAQTQKGISEDSHLESLQDVGQSAAPTFMISPETVTGTGKKCSLPAEEDSVLEKLGERKPCNSQPSELSSETS -> LPEPKDKILETPQKMTEKSESKTPGEGKKEDKSRMAEPMKGYMRPTKSRGLTPLLPKSTIQEQERHKQLKSA (in isoform 5). {ECO:0000303|PubMed:17974005}. /FTId=VSP_032071.; VAR_SEQ 441 631 ETEVALARDMTLPPETNVILTKDKALPLEAEVAPVKDMAQLPETEIAPAKDVAPSTVKEVGLLKDMSPLSETEMALGKDVTPPPETEVVLIKNVCLPPEMEVALTEDQVPALKTEAPLAKDGVLTLANNVTPAKDVPPLSETEATPVPIKDMEIAQTQKGISEDSHLESLQDVGQSAAPTFMISPETVTGT -> TEEAVLNQAPQQKKAVRRALSECSHLSVPPAVNLADKYPELPAREEPSSGLLPPPSSPMPSPTPGKLGAPAMKRSMTVGEEQTASYKLSPGKLPILSTKEIPPFICEEPVAKKREELAHFSNSSSNSGKKELGTAGLYLHSKLEQIPEGSSKEKGQEDFSETRIDSCSQVCQRGEKQPGQTALA (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_032072.; VAR_SEQ 558 730 Missing (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_003200.; VAR_SEQ 635 666 CSLPAEEDSVLEKLGERKPCNSQPSELSSETS -> EIEVTATQSTPSFLFEKPPRD (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_032073.; VAR_SEQ 703 716 PLATTQPAKTSTSK -> VGARMVVIFYCHNF (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_032074.; VAR_SEQ 717 1152 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_032075.; VAR_SEQ 939 953 Missing (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_032076.; VAR_SEQ 954 1022 Missing (in isoform 5). {ECO:0000303|PubMed:17974005}. /FTId=VSP_032077.; VAR_SEQ 1088 1152 TEGGGSEAPLCPGPPAGEEPAISEAAPEAGAPTSASGLNGHPTLSGGGDQREAQTLDSQIQETSI -> IETYRLTFRANARARTDHGADIVSRPPHFPGGPNSGSRVLGPLSRAVH (in isoform 6). {ECO:0000303|Ref.4}. /FTId=VSP_032078.; VAR_SEQ 1151 1152 SI -> N (in isoform 5). {ECO:0000303|PubMed:17974005}. /FTId=VSP_032079.,"VARIANT 23 23 R -> Q (in dbSNP:rs11711953). /FTId=VAR_039566.; VARIANT 366 366 P -> L (in dbSNP:rs13097415). /FTId=VAR_039567.; VARIANT 367 367 S -> P (in dbSNP:rs13096947). /FTId=VAR_039568.; VARIANT 409 409 D -> G (in dbSNP:rs13076542). /FTId=VAR_039569.; VARIANT 427 427 S -> Y (in dbSNP:rs1060407). {ECO:0000269|PubMed:1718985}. /FTId=VAR_020361.; VARIANT 441 441 E -> Q (in dbSNP:rs2230169). /FTId=VAR_020362.; VARIANT 628 628 V -> I (in dbSNP:rs1137524). {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000269|PubMed:1718985}. /FTId=VAR_039570.; VARIANT 994 994 I -> V (in dbSNP:rs35736893). /FTId=VAR_039571.",,,,CONFLICT 160 160 A -> R (in Ref. 1; AAA59553). {ECO:0000305}.; CONFLICT 319 319 D -> G (in Ref. 10; CAH18346). {ECO:0000305}.; CONFLICT 1109 1109 I -> V (in Ref. 10; CAH18346). {ECO:0000305}.,,3,,0,,,,,,,REGION 248 545 17 X 14 AA tandem repeats.,REPEAT 248 261 1.; REPEAT 262 275 2.; REPEAT 276 289 3.; REPEAT 290 303 4.; REPEAT 304 317 5.; REPEAT 318 331 6.; REPEAT 332 345 7.; REPEAT 346 351 8; truncated.; REPEAT 352 377 26 residues 1.; REPEAT 378 403 26 residues 2.; REPEAT 408 421 9.; REPEAT 422 433 10.; REPEAT 434 447 11.; REPEAT 448 461 12.; REPEAT 462 475 13.; REPEAT 476 489 14.; REPEAT 490 503 15.; REPEAT 504 517 16.; REPEAT 532 545 17.; REPEAT 923 953 Tau/MAP 1.; REPEAT 992 1022 Tau/MAP 2.; REPEAT 1023 1053 Tau/MAP 3.; REPEAT 1054 1085 Tau/MAP 4.,,,,,,,FUNCTION: Non-neuronal microtubule-associated protein. Promotes microtubule assembly. {ECO:0000269|PubMed:10791892}.,,,,,,,,,,,,axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175],cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175],microtubule binding [GO:0008017]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198],axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],GO:0000226; GO:0003723; GO:0005198; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0007052; GO:0008017; GO:0015630; GO:0030424; GO:0031175; GO:0043005; GO:0051012; GO:0051294; GO:0051301; GO:0072686; GO:1902856,IPR001084; ,P16333,"SUBUNIT: Interacts with SEPT2; this interaction impedes tubulin-binding. Interacts with TRAF3IP1 (By similarity). {ECO:0000250|UniProtKB:P27546, ECO:0000269|PubMed:16093351}.",1718985; 7857940; 14702039; 16641997; 15489334; 1905296; 17974005; 10791892; 15144186; 14759258; 16093351; 17081983; 16964243; 17487921; 17924679; 17693683; 18088087; 18669648; 19413330; 19369195; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 25114211; 25944712; 28112733,1718985; 7857940; 14702039; 16641997; 15489334; 1905296; 17974005; 10791892; 15144186; 14759258; 16093351; 17081983; 16964243; 17487921; 17924679; 17693683; 18088087; 18669648; 19413330; 19369195; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 25114211; 25944712; 28112733; 11683421; 15216889; 16169070; 17101137; 17474147; 19367725; 19738201; 20391533; 20562859; 20711500; 21044950; 21851590; 21900206; 21988832; 22623428; 23902751; 23986595; 25232678; 25609649; 25746230; 26752685; 9398320,1992-08-01,2019-02-13,2009-11-24,190,,,,,,,,,5 out of 5,Alternative sequence (18); Chain (1); Cross-link (2); Erroneous initiation (1); Initiator methionine (1); Modified residue (45); Mutagenesis (2); Natural variant (8); Region (1); Repeat (23); Sequence conflict (3),,,,Acetylation;Alternative splicing;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Isopeptide bond;Microtubule;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation,Evidence at protein level,reviewed,,,190,Alternative products (1); Caution (3); Function (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1),,KW-0007; KW-0025; KW-0181; KW-0206; KW-0493; KW-0597; KW-0621; KW-0677; KW-0832; KW-0903; KW-0963; KW-1017; KW-1185,,,,,,,,"PTM: Phosphorylated at serine residues in K-X-G-S motifs by MAP/microtubule affinity-regulating kinase (MARK1 or MARK2), causing detachment from microtubules, and their disassembly (By similarity). Phosphorylation on Ser-787 negatively regulates MAP4 activity to promote microtubule assembly. Isoform 3 is phosphorylated on Ser-337 and Ser-338. {ECO:0000250, ECO:0000269|PubMed:10791892}.",CHAIN 2 1152 Microtubule-associated protein 4. /FTId=PRO_0000072751.,CROSSLNK 269 269 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1). {ECO:0000244|PubMed:25114211}.; CROSSLNK 838 838 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.8}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.8}.; MOD_RES 5 5 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 14 14 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 60 60 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 99 99 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 253 253 Phosphoserine. {ECO:0000250|UniProtKB:P27546}.; MOD_RES 280 280 Phosphoserine. {ECO:0000244|PubMed:17693683, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 282 282 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 354 354 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 358 358 Phosphoserine. {ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 380 380 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 384 384 Phosphoserine. {ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 440 440 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 442 442 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 507 507 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 510 510 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 521 521 Phosphothreonine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 526 526 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 571 571 Phosphothreonine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 580 580 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 585 585 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 624 624 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 636 636 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 643 643 Phosphoserine. {ECO:0000250|UniProtKB:P27546}.; MOD_RES 687 687 Phosphothreonine. {ECO:0000250|UniProtKB:P27546}.; MOD_RES 696 696 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:10791892}.; MOD_RES 713 713 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 723 723 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 787 787 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:10791892}.; MOD_RES 797 797 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 825 825 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 827 827 Phosphoserine. {ECO:0000244|PubMed:16964243}.; MOD_RES 853 853 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 928 928 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 941 941 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 942 942 Phosphothreonine. {ECO:0000244|PubMed:21406692}.; MOD_RES 1000 1000 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 1073 1073 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 1145 1145 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 1151 1151 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M64571;U19727;AK054696;AK125245;AB209377;CH471055;BC008715;BC012794;BC015149;BC051843;CR749544;
0,P68366,TBA4A_HUMAN,TUBA4A TUBA1,TUBA4A,TUBA1,,,Homo sapiens (Human),9606,Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MRECISVHVGQAGVQMGNACWELYCLEHGIQPDGQMPSDKTIGGGDDSFTTFFCETGAGKHVPRAVFVDLEPTVIDEIRNGPYRQLFHPEQLITGKEDAANNYARGHYTIGKEIIDPVLDRIRKLSDQCTGLQGFLVFHSFGGGTGSGFTSLLMERLSVDYGKKSKLEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDCAFMVDNEAIYDICRRNLDIERPTYTNLNRLISQIVSSITASLRFDGALNVDLTEFQTNLVPYPRIHFPLATYAPVISAEKAYHEQLSVAEITNACFEPANQMVKCDPRHGKYMACCLLYRGDVVPKDVNAAIAAIKTKRSIQFVDWCPTGFKVGINYQPPTVVPGGDLAKVQRAVCMLSNTTAIAEAWARLDHKFDLMYAKRAFVHWYVGEGMEEGEFSEAREDMAALEKDYEEVGIDSYEDEDEGEE,448,"49,924",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P68366-1; Sequence=Displayed; Name=2; IsoId=P68366-2; Sequence=VSP_055194; ,,,,,,,,,,VAR_SEQ 1 15 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_055194.,VARIANT 145 145 T -> P (in ALS22; dbSNP:rs730880029). {ECO:0000269|PubMed:25374358}. /FTId=VAR_072714.; VARIANT 215 215 R -> C (in ALS22; displays significantly different distribution in terms of incorporation into microtubules; dbSNP:rs730880028). {ECO:0000269|PubMed:25374358}. /FTId=VAR_072715.; VARIANT 320 320 R -> C (in ALS22; displays significantly lower levels of dimer assembly; dbSNP:rs730880025). {ECO:0000269|PubMed:25374358}. /FTId=VAR_072716.; VARIANT 320 320 R -> H (in ALS22; displays significantly lower levels of dimer assembly; dbSNP:rs730880026). {ECO:0000269|PubMed:25374358}. /FTId=VAR_072717.; VARIANT 383 383 A -> T (in ALS22; displays significantly different distribution in terms of incorporation into microtubules; destabilizes the microtubule network; dbSNP:rs368743618). {ECO:0000269|PubMed:25374358}. /FTId=VAR_072718.,,,,,,1,,0,,SIMILARITY: Belongs to the tubulin family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.",,,,,,,,,,NP_BIND 142 148 GTP. {ECO:0000255}.,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; platelet degranulation [GO:0002576]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; platelet degranulation [GO:0002576]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630],GO:0000086; GO:0000226; GO:0000278; GO:0002576; GO:0003924; GO:0005200; GO:0005525; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0005874; GO:0007017; GO:0010389; GO:0015630; GO:0019901; GO:0070062; GO:0097711,IPR002452; IPR008280; IPR000217; IPR018316; IPR037103; IPR036525; IPR023123; IPR017975; IPR003008; ,P30622,SUBUNIT: Dimer of alpha and beta chains. A typical microtubule is a hollow water-filled tube with an outer diameter of 25 nm and an inner diameter of 15 nM. Alpha-beta heterodimers associate head-to-tail to form protofilaments running lengthwise along the microtubule wall with the beta-tubulin subunit facing the microtubule plus end conferring a structural polarity. Microtubules usually have 13 protofilaments but different protofilament numbers can be found in some organisms and specialized cells. Interacts with CFAP157 (By similarity). {ECO:0000250|UniProtKB:P68368}.,3029670; 14702039; 15815621; 15489334; 14654843; 18088087; 18691976; 18669648; 19524510; 21269460; 23186163; 24906155; 24275569; 25374358; 25944712; 26875866,3029670; 14702039; 15815621; 15489334; 14654843; 18088087; 18691976; 18669648; 19524510; 21269460; 23186163; 24906155; 24275569; 25374358; 25944712; 26875866; 10036229; 10069812; 10209023; 10559986; 10562278; 10679020; 10747093; 10804209; 10903204; 11035033; 11076968; 11081627; 11285137; 11285270; 11306556; 11461920; 11483508; 11493604; 11509732; 11739780; 11956313; 12024216; 12054644; 12110184; 12149451; 12194817; 12198549; 12207013; 12221128; 12368902; 12401177; 12447383; 12577067; 12577316; 12832475; 12852856; 13678582; 14504276; 14580337; 14603322; 14630798; 14697242; 14730319; 15029241; 15033576; 15085137; 15231740; 15269286; 15272311; 15326200; 15339662; 15483056; 15489852; 15498487; 15591061; 15632110; 15705883; 15723797; 15728195; 15737063; 15878873; 15890843; 15930098; 15934946; 16039987; 16049494; 16061793; 1607388; 16097032; 16169070; 16229832; 16254602; 16257120; 16262723; 16311594; 16357211; 16362039; 16455083; 16462731; 16492809; 16493421; 16541025; 16571679; 16622419; 16622420; 16723730; 16782012; 16799092; 16890155; 16901895; 17027958; 17030981; 17084703; 17093495; 17113389; 17129783; 17139257; 17183365; 17244817; 17244818; 17274799; 17283181; 17312020; 17314511; 17360631; 17499049; 17553904; 17574030; 17620599; 17646400; 17719545; 17827179; 18037885; 18046453; 18086915; 18097444; 18180281; 18237546; 18304522; 18327258; 18331838; 18455992; 18566290; 18615013; 18664496; 18694559; 18716626; 18852297; 19000668; 19004860; 19081074; 19116309; 19147001; 19369418; 19384852; 19423573; 19450523; 19486527; 19531357; 19549984; 19564404; 19592253; 19666503; 19720863; 19758564; 19767740; 19776033; 19805633; 19823565; 19877275; 19940019; 19965387; 19996169; 20005805; 20038533; 20067783; 20136777; 20154143; 20195357; 20230748; 20395968; 20399632; 20462495; 20467437; 20519502; 20526328; 20530210; 20534429; 20546612; 20558667; 20562859; 20603001; 20668689; 20686780; 20829795; 20889716; 20956384; 21068373; 21074048; 21080425; 21150319; 21209331; 21273506; 21347367; 21397845; 21422230; 2142332; 21427764; 21525035; 21548880; 21550981; 21565611; 21620453; 21725307; 21792235; 21878504; 21936775; 21987589; 22013193; 22094468; 22118932; 22179047; 22360420; 22653444; 22810585; 22885700; 22922713; 22992454; 23141531; 23141541; 23236459; 23253480; 23348840; 23386615; 23400999; 23530209; 23747070; 23769972; 23783758; 23789104; 23839779; 23902751; 23921553; 23945166; 23990561; 24053599; 24089205; 24097348; 24189400; 24231678; 24268707; 24296415; 24339784; 24469809; 24596149; 24616010; 24806965; 24891604; 24952464; 24982133; 25047611; 25103237; 25205765; 2521221; 2522352; 25233431; 25313408; 25364732; 25443296; 25453831; 25532896; 25609649; 25852190; 25893256; 26103986; 26465396; 26496610; 26675813; 27447976; 28069311; 28478440; 30030593; 7691276; 7769006; 7790358; 7844144; 7909354; 7929562; 8096061; 8104191; 8516294; 8522608; 8602245; 8642258; 8838651; 8909537; 8991093; 9114011; 9150144; 9153422; 9265649; 9288971; 9323141; 9380700; 9427680; 9490716; 9585416; 9585417; 9630229; 9671725; 9852153,1987-08-13,2019-02-13,1987-08-13,158,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Modified residue (5); Natural variant (5); Nucleotide binding (1),,,MISCELLANEOUS: This tubulin does not have a C-terminal tyrosine.,Acetylation;Alternative splicing;Amyotrophic lateral sclerosis;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;GTP-binding;Methylation;Microtubule;Neurodegeneration;Nitration;Nucleotide-binding;Phosphoprotein;Reference proteome,Evidence at protein level,reviewed,,Tubulin family,158,Alternative products (1); Function (1); Involvement in disease (1); Miscellaneous (1); Post-translational modification (4); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0007; KW-0025; KW-0036; KW-0181; KW-0206; KW-0342; KW-0488; KW-0493; KW-0523; KW-0547; KW-0597; KW-0903; KW-0944; KW-0963; KW-1185,,,,,"DISEASE: Amyotrophic lateral sclerosis 22, with or without frontotemporal dementia (ALS22) [MIM:616208]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. Patients with ALS22 may develop frontotemporal dementia. {ECO:0000269|PubMed:25374358}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Some glutamate residues at the C-terminus are polyglutamylated, resulting in polyglutamate chains on the gamma-carboxyl group (PubMed:26875866). Polyglutamylation plays a key role in microtubule severing by spastin (SPAST). SPAST preferentially recognizes and acts on microtubules decorated with short polyglutamate tails: severing activity by SPAST increases as the number of glutamates per tubulin rises from one to eight, but decreases beyond this glutamylation threshold (PubMed:26875866). {ECO:0000269|PubMed:26875866}.; PTM: Some glutamate residues at the C-terminus are monoglycylated but not polyglycylated due to the absence of functional TTLL10 in human. Monoglycylation is mainly limited to tubulin incorporated into axonemes (cilia and flagella). Both polyglutamylation and monoglycylation can coexist on the same protein on adjacent residues, and lowering glycylation levels increases polyglutamylation, and reciprocally. The precise function of monoglycylation is still unclear (Probable). {ECO:0000305|PubMed:19524510}.; PTM: Acetylation of alpha chains at Lys-40 is located inside the microtubule lumen. This modification has been correlated with increased microtubule stability, intracellular transport and ciliary assembly. {ECO:0000269|PubMed:24906155}.; PTM: Methylation of alpha chains at Lys-40 is found in mitotic microtubules and is required for normal mitosis and cytokinesis contributing to genomic stability. {ECO:0000250|UniProtKB:P68363}.",CHAIN 1 448 Tubulin alpha-4A chain. /FTId=PRO_0000048106.,,,,,,MOD_RES 40 40 N6-acetyllysine. {ECO:0000269|PubMed:24906155}.; MOD_RES 48 48 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 83 83 Nitrated tyrosine. {ECO:0000250|UniProtKB:P68368}.; MOD_RES 432 432 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9BQE3}.; MOD_RES 439 439 Phosphoserine. {ECO:0000250|UniProtKB:Q5XIF6}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X06956;BT006731;AK054731;AK299958;AY895018;CH471063;CH471063;BC009238;
0,P81274,GPSM2_HUMAN,GPSM2 LGN,GPSM2,LGN,,,Homo sapiens (Human),9606,G-protein-signaling modulator 2 (Mosaic protein LGN),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MEENLISMREDHSFHVRYRMEASCLELALEGERLCKSGDCRAGVSFFEAAVQVGTEDLKTLSAIYSQLGNAYFYLHDYAKALEYHHHDLTLARTIGDQLGEAKASGNLGNTLKVLGNFDEAIVCCQRHLDISRELNDKVGEARALYNLGNVYHAKGKSFGCPGPQDVGEFPEEVRDALQAAVDFYEENLSLVTALGDRAAQGRAFGNLGNTHYLLGNFRDAVIAHEQRLLIAKEFGDKAAERRAYSNLGNAYIFLGEFETASEYYKKTLLLARQLKDRAVEAQSCYSLGNTYTLLQDYEKAIDYHLKHLAIAQELNDRIGEGRACWSLGNAYTALGNHDQAMHFAEKHLEISREVGDKSGELTARLNLSDLQMVLGLSYSTNNSIMSENTEIDSSLNGVRPKLGRRHSMENMELMKLTPEKVQNWNSEILAKQKPLIAKPSAKLLFVNRLKGKKYKTNSSTKVLQDASNSIDHRIPNSQRKISADTIGDEGFFDLLSRFQSNRMDDQRCCLQEKNCHTASTTTSSTPPKMMLKTSSVPVVSPNTDEFLDLLASSQSRRLDDQRASFSNLPGLRLTQNSQSVLSHLMTNDNKEADEDFFDILVKCQGSRLDDQRCAPPPATTKGPTVPDEDFFSLILRSQGKRMDEQRVLLQRDQNRDTDFGLKDFLQNNALLEFKNSGKKSADH,684,"76,662",,,,SEQUENCE CAUTION:  Sequence=AAB40385.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=AAH27732.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,,,,,,CONFLICT 400 400 R -> L (in Ref. 1; AAB40385). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the GPSM family. {ECO:0000305}.,,,DOMAIN 489 511 GoLoco 1. {ECO:0000255|PROSITE-ProRule:PRU00097}.; DOMAIN 544 566 GoLoco 2. {ECO:0000255|PROSITE-ProRule:PRU00097}.; DOMAIN 594 616 GoLoco 3. {ECO:0000255|PROSITE-ProRule:PRU00097}.; DOMAIN 628 650 GoLoco 4. {ECO:0000255|PROSITE-ProRule:PRU00097}.,,REGION 22 357 Important for interaction with NUMA1; INSC and FRMPD1. {ECO:0000250|UniProtKB:Q8VDU0}.,REPEAT 24 57 TPR 1.; REPEAT 62 95 TPR 2.; REPEAT 102 135 TPR 3.; REPEAT 142 184 TPR 4.; REPEAT 202 235 TPR 5.; REPEAT 242 275 TPR 6.; REPEAT 282 315 TPR 7.; REPEAT 322 355 TPR 8.,,,,,,,"FUNCTION: Plays an important role in mitotic spindle pole organization via its interaction with NUMA1 (PubMed:11781568, PubMed:15632202, PubMed:21816348). Required for cortical dynein-dynactin complex recruitment during metaphase (PubMed:22327364). Plays a role in metaphase spindle orientation (PubMed:22327364). Plays also an important role in asymmetric cell divisions (PubMed:21816348). Has guanine nucleotide dissociation inhibitor (GDI) activity towards G(i) alpha proteins, such as GNAI1 and GNAI3, and thereby regulates their activity (By similarity). {ECO:0000250|UniProtKB:Q8VDU0, ECO:0000269|PubMed:11781568, ECO:0000269|PubMed:15632202, ECO:0000269|PubMed:21816348, ECO:0000269|PubMed:22327364}.",,,,,,,BINDING 608 608 GDP; shared with dimeric partner. {ECO:0000250|UniProtKB:Q8VDU0}.; BINDING 613 613 GDP; shared with dimeric partner. {ECO:0000250|UniProtKB:Q8VDU0}.; BINDING 642 642 GDP; shared with dimeric partner. {ECO:0000250|UniProtKB:Q8VDU0}.; BINDING 647 647 GDP; shared with dimeric partner. {ECO:0000250|UniProtKB:Q8VDU0}.,,,,,cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236],cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236],dynein complex binding [GO:0070840]; GDP-dissociation inhibitor activity [GO:0005092]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621],cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991],GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832,IPR003109; IPR013026; IPR011990; IPR019734; ,Itself; P63096; Q14980,"SUBUNIT: Interacts with the dynein-dynactin complex; this interaction is inhibited in a PLK1-dependent manner (PubMed:22327364). Part of a spindle orientation complex at least composed of GNAI1, GPSM2 and NUMA1 (PubMed:26766442). Interacts with LLGL2 (PubMed:15632202). Interacts (via TPR repeat region) with INSC/inscuteable (PubMed:16458856, PubMed:22074847). Interacts (via TPR repeat region) with NUMA1 (via C-terminus); this interaction is direct, inhibited in a PLK1-dependent manner, prevents the binding of NUMA1 with SPAG5 and promotes spindle pole organization (PubMed:11781568, PubMed:22327364, PubMed:27462074). INSC and NUMA1 compete for the same binding site, but INSC has higher affinity and can displace NUMA1 (in vitro) (PubMed:22074847). Interacts with GNAI2 (PubMed:8973305). Interacts (via GoLoco domains) with the GDP-bound form of GNAI1 and GNAI3; has much lower affinity for the GTP-bound form. Interaction with GDP-bound GNAI3 strongly enhances the affinity for NUMA1 (By similarity). Interacts (via TPR repeat region) with FRMPD1 (PubMed:22074847). INSC and FRMPD1 compete for the same binding site, but INSC has higher affinity and can displace FRMPD1 (in vitro) (By similarity). Interacts (via TPR repeat region) with FRMPD4 (PubMed:22074847, PubMed:25664792). Identified in a complex with INSC and F2RL2/Par3 (PubMed:16458856). {ECO:0000250|UniProtKB:Q8VDU0, ECO:0000269|PubMed:11781568, ECO:0000269|PubMed:15632202, ECO:0000269|PubMed:16458856, ECO:0000269|PubMed:22074847, ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:25664792, ECO:0000269|PubMed:26766442, ECO:0000269|PubMed:27462074, ECO:0000269|PubMed:8973305}.",8973305; 16710414; 15489334; 11781568; 15632202; 16458856; 18669648; 20602914; 20068231; 21816348; 22578326; 22327364; 23186163; 26766442; 27462074; 22074847; 25664792,8973305; 16710414; 15489334; 11781568; 15632202; 16458856; 18669648; 20602914; 20068231; 21816348; 22578326; 22327364; 23186163; 26766442; 27462074; 22074847; 25664792; 11832491; 15537540; 17289029; 20056645; 20479129; 20508983; 20589935; 20933426; 21348867; 22690686; 22977735; 22987632; 23389635; 23494849; 23907121; 24165937; 2534964; 26398908; 26496610; 26662512; 26751642; 26987813; 27064331; 27180139; 2748346; 2834384; 28347229; 28712573; 29523789; 8015379,2000-05-30,2019-02-13,2010-04-20,194,X-ray crystallography (6),,HELIX 24 36 {ECO:0000244|PDB:4WND}.; HELIX 40 53 {ECO:0000244|PDB:4WND}.; HELIX 58 74 {ECO:0000244|PDB:4WND}.; HELIX 78 94 {ECO:0000244|PDB:4WND}.; HELIX 98 115 {ECO:0000244|PDB:4WND}.; HELIX 118 134 {ECO:0000244|PDB:4WND}.; HELIX 138 158 {ECO:0000244|PDB:4WND}.; HELIX 165 168 {ECO:0000244|PDB:4WNF}.; HELIX 172 194 {ECO:0000244|PDB:4WND}.; HELIX 198 215 {ECO:0000244|PDB:4WND}.; HELIX 218 234 {ECO:0000244|PDB:4WND}.; HELIX 238 254 {ECO:0000244|PDB:4WND}.; HELIX 258 272 {ECO:0000244|PDB:4WND}.; HELIX 278 294 {ECO:0000244|PDB:4WND}.; HELIX 298 314 {ECO:0000244|PDB:4WND}.; HELIX 318 334 {ECO:0000244|PDB:4WND}.; HELIX 338 354 {ECO:0000244|PDB:4WND}.; HELIX 358 376 {ECO:0000244|PDB:3SF4}.,,,,,,5 out of 5,Binding site (4); Chain (1); Domain (4); Erroneous initiation (2); Helix (18); Modified residue (9); Mutagenesis (4); Region (1); Repeat (8); Sequence conflict (1),"CAUTION: It is uncertain whether Met-1 or Met-8 is the initiator. {ECO:0000305}.; CAUTION: Mutations in GPSM2 have been identified in people with profound congenital non-syndromic deafness designated as DFNB82 (PubMed:20602914). Subsequent brain imaging of these individuals has revealed frontal polymicrogyria, abnormal corpus callosum, and gray matter heterotopia, consistent with a diagnosis of Chudley-McCullough syndrome (PubMed:22578326). {ECO:0000305|PubMed:20602914, ECO:0000305|PubMed:22578326}.",TISSUE SPECIFICITY: Ubiquitously expressed.,MISCELLANEOUS: Dysfunction of LGN is associated with the phenotype of multiple micronuclei due to chromosomal mis-segregation and defect in cell division through mis-localization of mitotic spindle regulator protein NUMA1. {ECO:0000305}.,3D-structure;Cell cycle;Cell division;Cell membrane;Complete proteome;Cytoplasm;Cytoskeleton;Deafness;Membrane;Mitosis;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;TPR repeat;Transport,Evidence at protein level,reviewed,,GPSM family,194,Caution (2); Function (1); Involvement in disease (1); Miscellaneous (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0131; KW-0132; KW-0181; KW-0206; KW-0209; KW-0472; KW-0498; KW-0547; KW-0597; KW-0677; KW-0802; KW-0813; KW-0963; KW-1003; KW-1185,,,,,"DISEASE: Chudley-McCullough syndrome (CMCS) [MIM:604213]: An autosomal recessive neurologic disorder characterized by early-onset sensorineural deafness and specific brain anomalies on MRI, including hypoplasia of the corpus callosum, enlarged cysterna magna with mild focal cerebellar dysplasia, and nodular heterotopia. Some patients have hydrocephalus. Psychomotor development is normal. {ECO:0000269|PubMed:20602914, ECO:0000269|PubMed:22578326}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 684 G-protein-signaling modulator 2. /FTId=PRO_0000106358.,,,,,,"MOD_RES 132 132 Phosphoserine; by PKG. {ECO:0000255}.; MOD_RES 352 352 Phosphoserine; by PKG. {ECO:0000255}.; MOD_RES 408 408 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 483 483 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 486 486 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 501 501 Phosphoserine; by PKC. {ECO:0000255}.; MOD_RES 541 541 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 565 565 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 607 607 Phosphoserine; by PKG. {ECO:0000255}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U54999;AB445462;CH471122;BC027732;AY136740;CR456786;
0,Q14980,NUMA1_HUMAN,NUMA1 NMP22 NUMA,NUMA1,NMP22 NUMA,,,Homo sapiens (Human),9606,Nuclear mitotic apparatus protein 1 (Nuclear matrix protein-22) (NMP-22) (Nuclear mitotic apparatus protein) (NuMA protein) (SP-H antigen),UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MTLHATRGAALLSWVNSLHVADPVEAVLQLQDCSIFIKIIDRIHGTEEGQQILKQPVSERLDFVCSFLQKNRKHPSSPECLVSAQKVLEGSELELAKMTMLLLYHSTMSSKSPRDWEQFEYKIQAELAVILKFVLDHEDGLNLNEDLENFLQKAPVPSTCSSTFPEELSPPSHQAKREIRFLELQKVASSSSGNNFLSGSPASPMGDILQTPQFQMRRLKKQLADERSNRDELELELAENRKLLTEKDAQIAMMQQRIDRLALLNEKQAASPLEPKELEELRDKNESLTMRLHETLKQCQDLKTEKSQMDRKINQLSEENGDLSFKLREFASHLQQLQDALNELTEEHSKATQEWLEKQAQLEKELSAALQDKKCLEEKNEILQGKLSQLEEHLSQLQDNPPQEKGEVLGDVLQLETLKQEAATLAANNTQLQARVEMLETERGQQEAKLLAERGHFEEEKQQLSSLITDLQSSISNLSQAKEELEQASQAHGARLTAQVASLTSELTTLNATIQQQDQELAGLKQQAKEKQAQLAQTLQQQEQASQGLRHQVEQLSSSLKQKEQQLKEVAEKQEATRQDHAQQLATAAEEREASLRERDAALKQLEALEKEKAAKLEILQQQLQVANEARDSAQTSVTQAQREKAELSRKVEELQACVETARQEQHEAQAQVAELELQLRSEQQKATEKERVAQEKDQLQEQLQALKESLKVTKGSLEEEKRRAADALEEQQRCISELKAETRSLVEQHKRERKELEEERAGRKGLEARLQQLGEAHQAETEVLRRELAEAMAAQHTAESECEQLVKEVAAWRERYEDSQQEEAQYGAMFQEQLMTLKEECEKARQELQEAKEKVAGIESHSELQISRQQNELAELHANLARALQQVQEKEVRAQKLADDLSTLQEKMAATSKEVARLETLVRKAGEQQETASRELVKEPARAGDRQPEWLEEQQGRQFCSTQAALQAMEREAEQMGNELERLRAALMESQGQQQEERGQQEREVARLTQERGRAQADLALEKAARAELEMRLQNALNEQRVEFATLQEALAHALTEKEGKDQELAKLRGLEAAQIKELEELRQTVKQLKEQLAKKEKEHASGSGAQSEAAGRTEPTGPKLEALRAEVSKLEQQCQKQQEQADSLERSLEAERASRAERDSALETLQGQLEEKAQELGHSQSALASAQRELAAFRTKVQDHSKAEDEWKAQVARGRQEAERKNSLISSLEEEVSILNRQVLEKEGESKELKRLVMAESEKSQKLEERLRLLQAETASNSARAAERSSALREEVQSLREEAEKQRVASENLRQELTSQAERAEELGQELKAWQEKFFQKEQALSTLQLEHTSTQALVSELLPAKHLCQQLQAEQAAAEKRHREELEQSKQAAGGLRAELLRAQRELGELIPLRQKVAEQERTAQQLRAEKASYAEQLSMLKKAHGLLAEENRGLGERANLGRQFLEVELDQAREKYVQELAAVRADAETRLAEVQREAQSTARELEVMTAKYEGAKVKVLEERQRFQEERQKLTAQVEQLEVFQREQTKQVEELSKKLADSDQASKVQQQKLKAVQAQGGESQQEAQRLQAQLNELQAQLSQKEQAAEHYKLQMEKAKTHYDAKKQQNQELQEQLRSLEQLQKENKELRAEAERLGHELQQAGLKTKEAEQTCRHLTAQVRSLEAQVAHADQQLRDLGKFQVATDALKSREPQAKPQLDLSIDSLDLSCEEGTPLSITSKLPRTQPDGTSVPGEPASPISQRLPPKVESLESLYFTPIPARSQAPLESSLDSLGDVFLDSGRKTRSARRRTTQIINITMTKKLDVEEPDSANSSFYSTRSAPASQASLRATSSTQSLARLGSPDYGNSALLSLPGYRPTTRSSARRSQAGVSSGAPPGRNSFYMGTCQDEPEQLDDWNRIAELQQRNRVCPPHLKTCYPLESRPSLSLGTITDEEMKTGDPQETLRRASMQPIQIAEGTGITTRQQRKRVSLEPHQGPGTPESKKATSCFPRPMTPRDRHEGRKQSTTEAQKKAAPASTKQADRRQSMAFSILNTPKKLGNSLLRRGASKKALSKASPNTRSGTRRSPRIATTTASAATAAAIGATPRAKGKAKH,2115,"238,260",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=5;  Name=1; Synonyms=Numa-1, p230; IsoId=Q14980-1; Sequence=Displayed; Name=2; IsoId=Q14980-2; Sequence=VSP_012910; Note=No experimental confirmation available.; Name=3; Synonyms=Numa-m {ECO:0000303|PubMed:7962183}, p195; IsoId=Q14980-3; Sequence=VSP_044378; Name=4; Synonyms=Numa-s {ECO:0000303|PubMed:7962183}, p194; IsoId=Q14980-4; Sequence=VSP_044379; Name=5; IsoId=Q14980-5; Sequence=VSP_054146; Note=No experimental confirmation available.; ",,,,,"SEQUENCE CAUTION:  Sequence=CAA77670.1; Type=Frameshift; Positions=1270, 1299; Evidence={ECO:0000305}; ",,,,,VAR_SEQ 414 1549 Missing (in isoform 5). {ECO:0000303|PubMed:15489334}. /FTId=VSP_054146.; VAR_SEQ 1536 1549 Missing (in isoform 2). {ECO:0000303|PubMed:1541636}. /FTId=VSP_012910.; VAR_SEQ 1725 2115 LDLSCEEGTPLSITSKLPRTQPDGTSVPGEPASPISQRLPPKVESLESLYFTPIPARSQAPLESSLDSLGDVFLDSGRKTRSARRRTTQIINITMTKKLDVEEPDSANSSFYSTRSAPASQASLRATSSTQSLARLGSPDYGNSALLSLPGYRPTTRSSARRSQAGVSSGAPPGRNSFYMGTCQDEPEQLDDWNRIAELQQRNRVCPPHLKTCYPLESRPSLSLGTITDEEMKTGDPQETLRRASMQPIQIAEGTGITTRQQRKRVSLEPHQGPGTPESKKATSCFPRPMTPRDRHEGRKQSTTEAQKKAAPASTKQADRRQSMAFSILNTPKKLGNSLLRRGASKKALSKASPNTRSGTRRSPRIATTTASAATAAAIGATPRAKGKAKH -> SQANSSQTPRDSDACPHPGLVPGPSLAPSRSWPRGPGAWTVWALSLPCLLFS (in isoform 3). {ECO:0000303|PubMed:8505359}. /FTId=VSP_044378.; VAR_SEQ 1739 2115 SKLPRTQPDGTSVPGEPASPISQRLPPKVESLESLYFTPIPARSQAPLESSLDSLGDVFLDSGRKTRSARRRTTQIINITMTKKLDVEEPDSANSSFYSTRSAPASQASLRATSSTQSLARLGSPDYGNSALLSLPGYRPTTRSSARRSQAGVSSGAPPGRNSFYMGTCQDEPEQLDDWNRIAELQQRNRVCPPHLKTCYPLESRPSLSLGTITDEEMKTGDPQETLRRASMQPIQIAEGTGITTRQQRKRVSLEPHQGPGTPESKKATSCFPRPMTPRDRHEGRKQSTTEAQKKAAPASTKQADRRQSMAFSILNTPKKLGNSLLRRGASKKALSKASPNTRSGTRRSPRIATTTASAATAAAIGATPRAKGKAKH -> RSGGSLPPYVCLWSACCLSGCILVR (in isoform 4). {ECO:0000303|PubMed:8505359}. /FTId=VSP_044379.,VARIANT 242 242 K -> R (in dbSNP:rs34239655). /FTId=VAR_031679.; VARIANT 794 794 A -> G (in dbSNP:rs3750913). /FTId=VAR_031680.; VARIANT 1153 1153 E -> D (in dbSNP:rs34311364). /FTId=VAR_031681.; VARIANT 1825 1825 V -> M (in dbSNP:rs7949430). /FTId=VAR_031682.; VARIANT 1836 1836 Y -> H (in dbSNP:rs35586429). /FTId=VAR_031683.; VARIANT 2049 2049 A -> T (in dbSNP:rs5743685). /FTId=VAR_051248.,,,,CONFLICT 772 772 Q -> L (in Ref. 2; CAA77670). {ECO:0000305}.; CONFLICT 815 816 ER -> DG (in Ref. 2; CAA77670). {ECO:0000305}.; CONFLICT 873 873 E -> K (in Ref. 2; CAA77670). {ECO:0000305}.; CONFLICT 1589 1589 L -> F (in Ref. 2; CAA77670). {ECO:0000305}.; CONFLICT 1637 1637 S -> T (in Ref. 3; Z14227/Z14228). {ECO:0000305}.; CONFLICT 1682 1682 S -> T (in Ref. 3; Z14227/Z14228). {ECO:0000305}.; CONFLICT 1798 1798 L -> Q (in Ref. 3; CAA77669). {ECO:0000305}.,,2,,0,"DOMAIN: The C-terminal tubulin-binding domain mediates direct binding to microtubules, independently of dynein-dynactin complex, and induces their bundling and stabilization (PubMed:11956313). The 4.1-binding domain is necessary for its cortical stability and spindle orientation (PubMed:24109598). {ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:24109598}.",,COILED 213 1699 {ECO:0000255}.,,,"MOTIF 1742 1748 Tankyrase-binding domain. {ECO:0000269|PubMed:12080061}.; MOTIF 1984 1989 Nuclear localization signal. {ECO:0000269|PubMed:26765568, ECO:0000269|PubMed:7962183}.","REGION 1 212 Head (Globular).; REGION 1699 1876 Membrane-binding domain 1. {ECO:0000269|PubMed:24996901}.; REGION 1700 2115 Tail (Globular).; REGION 1788 1810 4.1-binding domain. {ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24996901}.; REGION 1882 1985 Tubulin-binding domain. {ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12445386}.; REGION 1892 1926 GPSM2-binding domain. {ECO:0000269|PubMed:11781568, ECO:0000269|PubMed:12445386, ECO:0000269|PubMed:21816348, ECO:0000269|PubMed:24109598}.; REGION 1981 2060 Membrane-binding domain 2. {ECO:0000269|PubMed:24371089}.",,,,,,,,"FUNCTION: Microtubule (MT)-binding protein that plays a role in the formation and maintenance of the spindle poles and the alignement and the segregation of chromosomes during mitotic cell division (PubMed:7769006, PubMed:17172455, PubMed:19255246, PubMed:24996901, PubMed:26195665, PubMed:27462074). Functions to tether the minus ends of MTs at the spindle poles, which is critical for the establishment and maintenance of the spindle poles (PubMed:12445386, PubMed:11956313). Plays a role in the establishment of the mitotic spindle orientation during metaphase and elongation during anaphase in a dynein-dynactin-dependent manner (PubMed:23870127, PubMed:24109598, PubMed:24996901, PubMed:26765568). In metaphase, part of a ternary complex composed of GPSM2 and G(i) alpha proteins, that regulates the recruitment and anchorage of the dynein-dynactin complex in the mitotic cell cortex regions situated above the two spindle poles, and hence regulates the correct oritentation of the mitotic spindle (PubMed:23027904, PubMed:22327364, PubMed:23921553). During anaphase, mediates the recruitment and accumulation of the dynein-dynactin complex at the cell membrane of the polar cortical region through direct association with phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), and hence participates in the regulation of the spindle elongation and chromosome segregation (PubMed:22327364, PubMed:23921553, PubMed:24996901, PubMed:24371089). Binds also to other polyanionic phosphoinositides, such as phosphatidylinositol 3-phosphate (PIP), lysophosphatidic acid (LPA) and phosphatidylinositol triphosphate (PIP3), in vitro (PubMed:24996901, PubMed:24371089). Also required for proper orientation of the mitotic spindle during asymmetric cell divisions (PubMed:21816348). Plays a role in mitotic MT aster assembly (PubMed:11163243, PubMed:11229403, PubMed:12445386). Involved in anastral spindle assembly (PubMed:25657325). Positively regulates TNKS protein localization to spindle poles in mitosis (PubMed:16076287). Highly abundant component of the nuclear matrix where it may serve a non-mitotic structural role, occupies the majority of the nuclear volume (PubMed:10075938). Required for epidermal differentiation and hair follicle morphogenesis (By similarity). {ECO:0000250|UniProtKB:E9Q7G0, ECO:0000269|PubMed:11163243, ECO:0000269|PubMed:11229403, ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12445386, ECO:0000269|PubMed:16076287, ECO:0000269|PubMed:17172455, ECO:0000269|PubMed:19255246, ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23027904, ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901, ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26765568, ECO:0000269|PubMed:27462074, ECO:0000269|PubMed:7769006, ECO:0000305|PubMed:10075938, ECO:0000305|PubMed:21816348}.",,,,,,,,,,,,cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]; anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236],anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236],disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631],cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616],GO:0000132; GO:0000139; GO:0000922; GO:0001578; GO:0005198; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005876; GO:0005938; GO:0006997; GO:0007059; GO:0008017; GO:0008022; GO:0015631; GO:0016328; GO:0016363; GO:0019897; GO:0019904; GO:0030425; GO:0030513; GO:0030953; GO:0031116; GO:0031616; GO:0032388; GO:0032991; GO:0035091; GO:0035371; GO:0036449; GO:0043025; GO:0044877; GO:0045618; GO:0051010; GO:0051011; GO:0051301; GO:0051321; GO:0051798; GO:0051984; GO:0055028; GO:0055048; GO:0060236; GO:0061673; GO:0070062; GO:0070840; GO:0072686; GO:0090235; GO:0097427; GO:0097431; GO:0097575; GO:0097718; GO:0099738; GO:1902365; GO:1902846; GO:1904778; GO:1905720; GO:1905820; GO:1905832; GO:1990023,IPR026650; ,Q2TAC2; Q53SE7; P63096; P81274; Q8VDU0; P78406; Q9NYB0,"SUBUNIT: Homodimer (PubMed:10075938). Also forms multiarm oligomers by association of C-terminal tail domains, oligomers may further assemble to form a hexagonal nuclear lattice-like network (PubMed:10075938). Associates with the dynein-dynactin complex; this association promotes the transport and accumulation of NUMA1 at the mitotic spindle poles that is inhibited by the BRISC complex in a PLK1-dependent manner (PubMed:10811826, PubMed:17172455, PubMed:23027904, PubMed:22327364, PubMed:26195665). Part of a spindle orientation complex at least composed of GNAI1, GPSM2 and NUMA1 (PubMed:26766442). Interacts (via C-terminus) with microtubules (MTs); this interaction is direct and promotes both MT bundle formation and stability in a dynein-dynactin complex- and CDK1-independent manner (PubMed:12445386, PubMed:11956313, PubMed:26765568). Interacts with EPB41 and EPB41L2; these interactions are negatively regulated by CDK1 during metaphase and are important for anaphase-specific localization of NUMA1 in symmetrically dividing cells (PubMed:23870127, PubMed:24996901). Interacts (via C-terminus) with GPSM2 (via TPR repeats); this interaction is direct, prevented by competitive binding of INSC, is inhibited in a PLK1-dependent manner, blocks the association of NUMA1 with MTs and inhibits NUMA1-induced MT bundle formation, prevents the association of NUMA1 with SPAG5, induces mitotic spindle pole localization of GPSM2, both metaphase cell cortex localization of NUMA1 and mitotic spindle organization (PubMed:11781568, PubMed:12445386, PubMed:22327364, PubMed:24109598, PubMed:27462074, PubMed:21816348). Does not interact with GPSM2 during anaphase (PubMed:23870127). Interacts (via C-terminus) with the nuclear importin alpha/importin beta receptor; this interaction is inhibited by RanGTP (PubMed:11163243). Interacts (via C-terminus) with KPNB1; this interaction is inhibited by RanGTP and the BRISC complex (PubMed:11229403, PubMed:26195665). Interacts with ABRAXAS2 and the BRISC complex; these interactions regulate mitotic spindle assembly (PubMed:26195665). Interacts (via N-terminal end of the coiled-coil domain) with RAE1; this interaction promotes mitotic spindle formation (PubMed:17172455). Interacts (via C-terminus) with SPAG5 (via C-terminus); this interaction promotes the recruitment of SPAG5 to the MTs at spindle poles in a dynein-dynactin-dependent manner and regulates mitotic spindle organization and proper chromosome alignment during mitosis (PubMed:27462074). Interacts with TNKS; this interaction occurs at the onset of mitosis (PubMed:12080061, PubMed:16076287). Interacts with TNKS2 (PubMed:12080061). Interacts with tubulin (PubMed:11956313). {ECO:0000269|PubMed:10075938, ECO:0000269|PubMed:10811826, ECO:0000269|PubMed:11163243, ECO:0000269|PubMed:11229403, ECO:0000269|PubMed:11781568, ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12080061, ECO:0000269|PubMed:12445386, ECO:0000269|PubMed:16076287, ECO:0000269|PubMed:17172455, ECO:0000269|PubMed:21816348, ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23027904, ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24996901, ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26765568, ECO:0000269|PubMed:26766442, ECO:0000269|PubMed:27462074}.",1541630; 1541636; 8408288; 16554811; 15489334; 8505359; 7962183; 7769006; 9730450; 10811826; 11163243; 11781568; 11229403; 12445386; 12080061; 11956313; 16076287; 15592455; 17081983; 16964243; 17172455; 17924679; 17525332; 18220336; 19367720; 18669648; 19413330; 19255246; 19690332; 19608861; 20068230; 20068231; 20137953; 21269460; 21406692; 23027904; 22327364; 22814378; 23870127; 23921553; 23186163; 24109598; 24996901; 24275569; 24371089; 25218447; 25114211; 25772364; 26195665; 25657325; 26562023; 26766442; 26765568; 27462074; 28112733; 10075938; 21816348,1541630; 1541636; 8408288; 16554811; 15489334; 8505359; 7962183; 7769006; 9730450; 10811826; 11163243; 11781568; 11229403; 12445386; 12080061; 11956313; 16076287; 15592455; 17081983; 16964243; 17172455; 17924679; 17525332; 18220336; 19367720; 18669648; 19413330; 19255246; 19690332; 19608861; 20068230; 20068231; 20137953; 21269460; 21406692; 23027904; 22327364; 22814378; 23870127; 23921553; 23186163; 24109598; 24996901; 24275569; 24371089; 25218447; 25114211; 25772364; 26195665; 25657325; 26562023; 26766442; 26765568; 27462074; 28112733; 10075938; 21816348; 12508117; 14737102; 14968112; 15161933; 15175163; 15388855; 15537540; 15561764; 15684076; 16146802; 16263121; 17108325; 17293864; 17401638; 17609108; 18234856; 18331640; 18417561; 18847512; 19124506; 19522705; 19615282; 19759176; 19805454; 20379614; 20467816; 20479129; 20508983; 21044950; 21182205; 21255834; 21282530; 21297155; 21406448; 21865670; 21911577; 22094256; 22153077; 22157815; 22252550; 22267324; 22552228; 22619067; 22719996; 22977735; 23075850; 23097092; 23368718; 23389635; 23589328; 23707952; 23828576; 24165937; 24189400; 24309115; 24350565; 24366813; 24725408; 24976592; 25416956; 25451259; 25488052; 25665578; 25820252; 26496610; 26638075; 26832443; 27829174; 28209915; 28469279; 28748856; 28824318; 28939615; 28981686; 29185983; 29222185; 8838651,2004-07-19,2019-02-13,2007-04-17,177,X-ray crystallography (2),STRAND 1995 1997 {ECO:0000244|PDB:5GXW}.,HELIX 1920 1922 {ECO:0000244|PDB:3RO2}.,TURN 1917 1919 {ECO:0000244|PDB:3RO2}.,,,,,5 out of 5,Alternative sequence (4); Beta strand (1); Chain (1); Coiled coil (1); Cross-link (4); Frameshift (1); Glycosylation (1); Helix (1); Modified residue (49); Motif (2); Mutagenesis (9); Natural variant (6); Region (7); Sequence conflict (9); Turn (1),,,"MISCELLANEOUS: Also known as nuclear matrix protein-22/NMP-22/NMP22, an antigen used in diagnostic tests of bladder cancer. {ECO:0000269|PubMed:9730450}.",3D-structure;ADP-ribosylation;Acetylation;Alternative splicing;Cell cycle;Cell division;Cell membrane;Chromosome;Chromosome partition;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Glycoprotein;Isopeptide bond;Lipid-binding;Lipoprotein;Membrane;Microtubule;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,,177,Alternative products (1); Caution (2); Domain (1); Function (1); Miscellaneous (1); Post-translational modification (4); Subcellular location (3); Subunit structure (1),,KW-0002; KW-0007; KW-0013; KW-0025; KW-0131; KW-0132; KW-0158; KW-0159; KW-0175; KW-0181; KW-0206; KW-0325; KW-0446; KW-0449; KW-0472; KW-0493; KW-0498; KW-0539; KW-0597; KW-0621; KW-0832; KW-0963; KW-1003; KW-1017; KW-1185,,,,,,,,"PTM: Phosphorylation and dephosphorylation on Thr-2055 regulates the extent of cortical NUMA1 and the dynein-dynactin complex localization during mitotic metaphase and anaphase (PubMed:23921553). In metaphase, phosphorylation on Thr-2055 occurs in a kinase CDK1-dependent manner; this phosphorylation maintains low levels of cortical dynein-dynactin complex at metaphase, and hence proper spindle positioning (PubMed:7769006, PubMed:23921553, PubMed:24371089). In anaphase, dephosphorylated on Thr-2055 by phosphatase PPP2CA; this dephosphorylation stimulates its membrane association and with the dynein-dynactin complex its enrichment at the cell cortex, and hence robust spindle elongation (PubMed:23921553, PubMed:24371089). Probably also phosphorylated on Thr-2015 and Ser-2087 by CDK1; these phosphorylations may regulate its cell cortex recruitment during metaphase and anaphase (PubMed:23870127). Phosphorylated on Thr-1047, Ser-1769, Ser-1772, Ser-1789 and Ser-1834 by PLK1; these phosphorylations induce cortical dynein-dynactin complex dissociation from the NUMA1-GPSM2 complex and negatively regulates cortical dynein-dynactin complex localization (PubMed:22327364). {ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:7769006}.; PTM: ADP-ribosylated by TNKS at the onset of mitosis; ADP-ribosylation is not required for its localization to spindle poles (PubMed:16076287). {ECO:0000269|PubMed:16076287}.; PTM: O-glycosylated during cytokinesis at sites identical or close to phosphorylation sites, this interferes with the phosphorylation status (PubMed:20068230). {ECO:0000269|PubMed:20068230}.; PTM: Ubiquitinated with 'Lys-63'-linked polyubiquitin chains. Deubiquitination by the BRISC complex is important for the incorporation of NUMA1 into mitotic spindle poles and normal spindle pole function, probably by modulating interactions between NUMA1, dynein-dynactin complex and importin-beta. {ECO:0000269|PubMed:26195665}.",CHAIN 1 2115 Nuclear mitotic apparatus protein 1. /FTId=PRO_0000057998.,"CROSSLNK 1699 1699 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 1766 1766 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate. {ECO:0000244|PubMed:25114211}.; CROSSLNK 1766 1766 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:25114211, ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733}.; CROSSLNK 1822 1822 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.",,CARBOHYD 1844 1844 O-linked (GlcNAc) serine; alternate. {ECO:0000269|PubMed:20068230}.,,,"MOD_RES 162 162 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 163 163 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 169 169 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 203 203 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231}.; MOD_RES 211 211 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 271 271 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 379 379 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 388 388 Phosphoserine. {ECO:0000244|PubMed:17525332}.; MOD_RES 395 395 Phosphoserine. {ECO:0000244|PubMed:17525332}.; MOD_RES 820 820 Phosphoserine. {ECO:0000244|PubMed:17525332}.; MOD_RES 891 891 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 1047 1047 Phosphothreonine; by PLK1. {ECO:0000269|PubMed:22327364}.; MOD_RES 1187 1187 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 1225 1225 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 1511 1511 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 1601 1601 Phosphoserine. {ECO:0000244|PubMed:17525332}.; MOD_RES 1721 1721 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1724 1724 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1728 1728 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1757 1757 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:17525332, ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19367720, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 1760 1760 Phosphoserine. {ECO:0000244|PubMed:17525332}.; MOD_RES 1769 1769 Phosphoserine; by PLK1. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:22327364}.; MOD_RES 1772 1772 Phosphoserine; by PLK1. {ECO:0000244|PubMed:18669648, ECO:0000269|PubMed:22327364}.; MOD_RES 1774 1774 Phosphotyrosine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1776 1776 Phosphothreonine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 1788 1788 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:24275569}.; MOD_RES 1789 1789 Phosphoserine; by PLK1. {ECO:0000244|PubMed:18669648, ECO:0000269|PubMed:22327364}.; MOD_RES 1792 1792 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1800 1800 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 1804 1804 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1830 1830 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1833 1833 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1834 1834 Phosphoserine; by PLK1. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:22327364}.; MOD_RES 1836 1836 Phosphotyrosine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1840 1840 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 1844 1844 Phosphoserine; alternate. {ECO:0000244|PubMed:23186163}.; MOD_RES 1862 1862 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1887 1887 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 1969 1969 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1991 1991 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 2000 2000 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 2003 2003 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 2015 2015 Phosphothreonine; by CDK1. {ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:7769006}.; MOD_RES 2047 2047 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 2055 2055 Phosphothreonine; by CDK1. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:7769006}.; MOD_RES 2062 2062 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 2077 2077 Phosphoserine. {ECO:0000244|PubMed:17924679}.; MOD_RES 2087 2087 Phosphoserine; by CDK1. {ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:7769006}.; MOD_RES 2106 2106 Phosphothreonine; by CDK1. {ECO:0000244|PubMed:16964243, ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:7769006}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,Z11583;Z11584;CH471076;BC004165;
0,Q15058,KIF14_HUMAN,KIF14 KIAA0042,KIF14,KIAA0042,,,Homo sapiens (Human),9606,Kinesin-like protein KIF14,UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSLHSTHNRNNSGDILDIPSSQNSSSLNALTHSSRLKLHLKSDMSECENDDPLLRSAGKVRDINRTYVISASRKTADMPLTPNPVGRLALQRRTTRNKESSLLVSELEDTTEKTAETRLTLQRRAKTDSAEKWKTAEIDSVKMTLNVGGETENNGVSKESRTNVRIVNNAKNSFVASSVPLDEDPQVIEMMADKKYKETFSAPSRANENVALKYSSNRPPIASLSQTEVVRSGHLTTKPTQSKLDIKVLGTGNLYHRSIGKEIAKTSNKFGSLEKRTPTKCTTEHKLTTKCSLPQLKSPAPSILKNRMSNLQVKQRPKSSFLANKQERSAENTILPEEETVVQNTSAGKDPLKVENSQVTVAVRVRPFTKREKIEKASQVVFMSGKEITVEHPDTKQVYNFIYDVSFWSFDECHPHYASQTTVYEKLAAPLLERAFEGFNTCLFAYGQTGSGKSYTMMGFSEEPGIIPRFCEDLFSQVARKQTQEVSYHIEMSFFEVYNEKIHDLLVCKDENGQRKQPLRVREHPVYGPYVEALSMNIVSSYADIQSWLELGNKQRATAATGMNDKSSRSHSVFTLVMTQTKTEFVEGEEHDHRITSRINLIDLAGSERCSTAHTNGDRLKEGVSINKSLLTLGKVISALSEQANQRSVFIPYRESVLTWLLKESLGGNSKTAMIATISPAASNIEETLSTLRYANQARLIVNIAKVNEDMNAKLIRELKAEIAKLKAAQRNSRNIDPERYRLCRQEITSLRMKLHQQERDMAEMQRVWKEKFEQAEKRKLQETKELQKAGIMFQMDNHLPNLVNLNEDPQLSEMLLYMIKEGTTTVGKYKPNSSHDIQLSGVLIADDHCTIKNFGGTVSIIPVGEAKTYVNGKHILEITVLRHGDRVILGGDHYFRFNHPVEVQKGKRPSGRDTPISEGPKDFEFAKNELLMAQRSQLEAEIKEAQLKAKEEMMQGIQIAKEMAQQELSSQKAAYESKIKALEAELREESQRKKMQEINNQKANHKIEELEKAKQHLEQEIYVNKKRLEMETLATKQALEDHSIRHARILEALETEKQKIAKEVQILQQNRNNRDKTFTVQTTWSSMKLSMMIQEANAISSKLKTYYVFGRHDISDKSSSDTSIRVRNLKLGISTFWSLEKFESKLAAMKELYESNGSNRGEDAFCDPEDEWEPDITDAPVSSLSRRRSRSLMKNRRISGCLHDIQVHPIKNLHSSHSSGLMDKSSTIYSNSAESFLPGICKELIGSSLDFFGQSYDEERTIADSLINSFLKIYNGLFAISKAHEEQDEESQDNLFSSDRAIQSLTIQTACAFEQLVVLMKHWLSDLLPCTNIARLEDELRQEVKKLGGYLQLFLQGCCLDISSMIKEAQKNAIQIVQQAVKYVGQLAVLKGSKLHFLENGNNKAASVQEEFMDAVCDGVGLGMKILLDSGLEKAKELQHELFRQCTKNEVTKEMKTNAMGLIRSLENIFAESKIKSFRRQVQEENFEYQDFKRMVNRAPEFLKLKHCLEKAIEIIISALKGCHSDINLLQTCVESIRNLASDFYSDFSVPSTSVGSYESRVTHIVHQELESLAKSLLFCFESEESPDLLKPWETYNQNTKEEHQQSKSSGIDGSKNKGVPKRVYELHGSSPAVSSEECTPSRIQWV,1648,"186,492",,,,SEQUENCE CAUTION:  Sequence=BAA05392.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,,"VARIANT 88 1648 Missing (in MCPH20; drastically decreased expression at the mRNA level; loss of localization at the midbody during cytokinesis and consequently loss of CIT/CRIK recruitment to the midbody). {ECO:0000269|PubMed:28892560}. /FTId=VAR_080623.; VARIANT 459 459 G -> R (in MCPH20; unknown pathological significance). {ECO:0000269|PubMed:29343805}. /FTId=VAR_080624.; VARIANT 827 827 Missing (in MCPH20; unknown pathological significance). {ECO:0000269|PubMed:28892560}. /FTId=VAR_080625.; VARIANT 841 841 S -> F (in MCPH20; unknown pathological significance; dbSNP:rs139385693). {ECO:0000269|PubMed:29343805}. /FTId=VAR_080626.; VARIANT 849 849 H -> D (in MCPH20; Decreased expression at the mRNA level and loss of localization at the midbody during cytokinesis and consequently loss of CIT/CRIK recruitment to the midbody, when analyzed in primary fibroblasts from a patient who is a compound heterozygous with variant V-1221). {ECO:0000269|PubMed:28892560}. /FTId=VAR_080627.; VARIANT 1221 1221 G -> V (in MCPH20; Decreased expression at the mRNA level and loss of localization at the midbody during cytokinesis and consequently loss of CIT/CRIK recruitment to the midbody, when analyzed in primary fibroblasts from a patient who is a compound heterozygous with variant D-849). {ECO:0000269|PubMed:28892560}. /FTId=VAR_080628.; VARIANT 1633 1633 P -> A (in dbSNP:rs12120084). {ECO:0000269|PubMed:15489334}. /FTId=VAR_037777.",,,,CONFLICT 660 660 W -> C (in Ref. 4; AAH98582). {ECO:0000305}.,,1,,0,"DOMAIN: The kinesin motor domain binds to microtubules with high affinity and has a robust ATPase activity but a very slow motility. The kinesin motor domain protects microtubules from cold depolymerization. Binds to each tubulin heterodimer resulting in a microtubule complexes. Binds at the tubulin intradimer interface, at the crest of the protofilament, and orients slightly toward the next protofilament. {ECO:0000250|UniProtKB:L0N7N1}.",SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family. {ECO:0000255|PROSITE-ProRule:PRU00283}.,COILED 705 791 {ECO:0000255}.; COILED 922 1079 {ECO:0000255}.; COILED 1332 1348 {ECO:0000255}.; COILED 1468 1500 {ECO:0000255}.,,DOMAIN 358 701 Kinesin motor. {ECO:0000255|PROSITE-ProRule:PRU00283}.; DOMAIN 825 891 FHA.,,REGION 1 356 Required for PRC1-binding.; REGION 356 737 Required for microtubule-binding with high affinity. {ECO:0000250|UniProtKB:L0N7N1}.; REGION 901 1648 Required for CIT-binding.,,,,,,,,"FUNCTION: Microtubule motor protein that binds to microtubules with high affinity through each tubulin heterodimer and has an ATPase activity (By similarity). Plays a role in many processes like cell division, cytokinesis and also in cell proliferation and apoptosis (PubMed:24784001, PubMed:16648480). During cytokinesis, targets to central spindle and midbody through its interaction with PRC1 and CIT respectively (PubMed:16431929). Regulates cell growth through regulation of cell cycle progression and cytokinesis (PubMed:24854087). During cell cycle progression acts through SCF-dependent proteasomal ubiquitin-dependent protein catabolic process which controls CDKN1B degradation, resulting in positive regulation of cyclins, including CCNE1, CCND1 and CCNB1 (PubMed:24854087). During late neurogenesis, regulates the cerebellar, cerebral cortex and olfactory bulb development through regulation of apoptosis, cell proliferation and cell division (By similarity). Also is required for chromosome congression and alignment during mitotic cell cycle process (PubMed:15843429). Regulates cell spreading, focal adhesion dynamics, and cell migration through its interaction with RADIL resulting in regulation of RAP1A-mediated inside-out integrin activation by tethering RADIL on microtubules (PubMed:23209302). {ECO:0000250|UniProtKB:L0N7N1, ECO:0000269|PubMed:15843429, ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:16648480, ECO:0000269|PubMed:23209302, ECO:0000269|PubMed:24784001, ECO:0000269|PubMed:24854087}.",,,,,,,,,,NP_BIND 447 454 ATP. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,"cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446]",activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446],"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]",cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233],GO:0001558; GO:0003777; GO:0005524; GO:0005634; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007080; GO:0008017; GO:0008284; GO:0008574; GO:0010389; GO:0015631; GO:0016020; GO:0016887; GO:0019901; GO:0021685; GO:0021693; GO:0021695; GO:0021766; GO:0021772; GO:0021846; GO:0021987; GO:0030155; GO:0030165; GO:0030334; GO:0030496; GO:0031146; GO:0031641; GO:0032147; GO:0032467; GO:0032487; GO:0033624; GO:0034446; GO:0043066; GO:0043161; GO:0043523; GO:0043524; GO:0045184; GO:0051233; GO:0051301; GO:0090543; GO:1903429; GO:2000045,IPR000253; IPR027640; IPR032405; IPR019821; IPR001752; IPR036961; IPR027417; IPR008984; ,O46385,"SUBUNIT: Directly interacts with PRC1 within a complex also containing KIF4A, KIF20A and KIF23; targets to the central spindle. Directly interacts with CIT depending on the activation state of the kinase (stronger interaction with the kinase-dead form); targets to the midbody. Interacts with ARRB2; the interaction is detected in the nucleus upon OR1D2 stimulation. Interacts with AKT1; the interaction is detected in the plasma membrane upon INS stimulation and promotes AKT1 phosphorylation. Interacts with SVIL; at midbody during cytokinesis. Interacts with RADIL (via PDZ domain); recruits RADIL to the microtubule network restricting RADIL from interaction with activated RAP1A (PubMed:23209302). {ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:16820410, ECO:0000269|PubMed:20309963, ECO:0000269|PubMed:23209302, ECO:0000269|PubMed:24784001}.",7584044; 16710414; 15489334; 15843429; 17081983; 16431929; 16820410; 16648480; 18669648; 20309963; 20068231; 21269460; 23209302; 23186163; 24854087; 24784001; 24128419; 28892560; 29343805,7584044; 16710414; 15489334; 15843429; 17081983; 16431929; 16820410; 16648480; 18669648; 20309963; 20068231; 21269460; 23209302; 23186163; 24854087; 24784001; 24128419; 28892560; 29343805; 15897902; 16570270; 17099872; 17353931; 17545527; 17962437; 19123481; 19190782; 19509238; 19609547; 20306291; 20360068; 21618518; 22999822; 23414349; 23444367; 23479679; 23626713; 23716662; 24255178; 24626475; 25106407; 25348260; 26496610; 26638075; 26933822; 27128470; 27729532; 28504687; 28525372; 28630147; 28668932,2002-09-19,2019-02-13,1996-11-01,172,,,,,,,,,5 out of 5,Chain (1); Coiled coil (4); Domain (2); Erroneous initiation (1); Modified residue (7); Natural variant (7); Nucleotide binding (1); Region (3); Sequence conflict (1),,,MISCELLANEOUS: It is resistant to docetaxel anhydrous. {ECO:0000269|PubMed:24784001}.,ATP-binding;Ciliopathy;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Meckel syndrome;Microtubule;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Primary microcephaly;Reference proteome,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family",172,Domain (1); Function (1); Induction (1); Involvement in disease (2); Miscellaneous (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0067; KW-0175; KW-0181; KW-0206; KW-0225; KW-0493; KW-0505; KW-0539; KW-0547; KW-0597; KW-0621; KW-0905; KW-0963; KW-0981; KW-1185; KW-1186,,,,,"DISEASE: Meckel syndrome 12 (MKS12) [MIM:616258]: A form of Meckel syndrome, a disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly. {ECO:0000269|PubMed:24128419}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Microcephaly 20, primary, autosomal recessive (MCPH20) [MIM:617914]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age, sex and ethnically matched mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH20 features include mild to moderate intellectual disability, autistic features, poor speech. Disease severity is highly variable. {ECO:0000269|PubMed:28892560, ECO:0000269|PubMed:29343805}. Note=The disease is caused by mutations affecting the gene represented in this entry. The disease-causing variant NM_014875.2:c.263T>A, which produces a premature truncation of the protein at Leu-88 (p.Leu88Ter), may also partly result in the deletion of 372 bp of exon 2 of KIF14 by activation of a cryptic splice site. This in-frame deletion predicts a protein that lacks 124 aa (p.Gly58-Leu181del). The disease-causing mutation NM_014875.2:c.3662G>T, resulting in the missence variant p.Gly1221Val, may also induce the skipping of exon 24, resulting in a protein that misses 76 aa (p.Gly1221_ Lys1296delinsVal). {ECO:0000269|PubMed:28892560}.",,,,CHAIN 1 1648 Kinesin-like protein KIF14. /FTId=PRO_0000125449.,,,,,,"MOD_RES 12 12 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 272 272 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 277 277 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 346 346 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 915 915 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 937 937 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1292 1292 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,D26361;CH471067;BC098582;BC113742;
0,Q92974,ARHG2_HUMAN,ARHGEF2 KIAA0651 LFP40,ARHGEF2,KIAA0651 LFP40,,,Homo sapiens (Human),9606,Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSRIESLTRARIDRSRELASKTREKEKMKEAKDARYTNGHLFTTISVSGMTMCYACNKSITAKEALICPTCNVTIHNRCKDTLANCTKVKQKQQKAALLKNNTALQSVSLRSKTTIRERPSSAIYPSDSFRQSLLGSRRGRSSLSLAKSVSTTNIAGHFNDESPLGLRRILSQSTDSLNMRNRTLSVESLIDEAEVIYSELMSDFEMDEKDFAADSWSLAVDSSFLQQHKKEVMKQQDVIYELIQTELHHVRTLKIMTRLFRTGMLEELHLEPGVVQGLFPCVDELSDIHTRFLSQLLERRRQALCPGSTRNFVIHRLGDLLISQFSGPSAEQMCKTYSEFCSRHSKALKLYKELYARDKRFQQFIRKVTRPAVLKRHGVQECILLVTQRITKYPLLISRILQHSHGIEEERQDLTTALGLVKELLSNVDEGIYQLEKGARLQEIYNRMDPRAQTPVPGKGPFGREELLRRKLIHDGCLLWKTATGRFKDVLVLLMTDVLVFLQEKDQKYIFPTLDKPSVVSLQNLIVRDIANQEKGMFLISAAPPEMYEVHTASRDDRSTWIRVIQQSVRTCPSREDFPLIETEDEAYLRRIKMELQQKDRALVELLREKVGLFAEMTHFQAEEDGGSGMALPTLPRGLFRSESLESPRGERLLQDAIREVEGLKDLLVGPGVELLLTPREPALPLEPDSGGNTSPGVTANGEARTFNGSIELCRADSDSSQRDRNGNQLRSPQEEALQRLVNLYGLLHGLQAAVAQQDTLMEARFPEGPERREKLCRANSRDGEAGRAGAAPVAPEKQATELALLQRQHALLQEELRRCRRLGEERATEAGSLEARLRESEQARALLEREAEEARRQLAALGQTEPLPAEAPWARRPVDPRRRSLPAGDALYLSFNPPQPSRGTDRLDLPVTTRSVHRNFEDRERQELGSPEERLQDSSDPDTGSEEEGSSRLSPPHSPRDFTRMQDIPEETESRDGEAVASES,986,"111,543",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=Q92974-1; Sequence=Displayed; Name=2; IsoId=Q92974-2; Sequence=VSP_039458; Name=3; IsoId=Q92974-3; Sequence=VSP_039457, VSP_039458; ",,SEQUENCE CAUTION:  Sequence=AAH20567.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=BAA31626.3; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,"SEQUENCE CAUTION:  Sequence=CAA33634.1; Type=Frameshift; Positions=887, 984; Evidence={ECO:0000305}; ",,,,SEQUENCE CAUTION:  Sequence=AAC97383.1; Type=Miscellaneous discrepancy; Note=Sequence differs at a large extent from the sequence shown in the paper.; Evidence={ECO:0000305}; ,"VAR_SEQ 1 27 Missing (in isoform 3). {ECO:0000303|PubMed:17974005, ECO:0000303|PubMed:9734811}. /FTId=VSP_039457.; VAR_SEQ 194 194 Missing (in isoform 2 and isoform 3). {ECO:0000303|PubMed:11912491, ECO:0000303|PubMed:17974005, ECO:0000303|PubMed:9734811}. /FTId=VSP_039458.",,,,,CONFLICT 1 20 MSRIESLTRARIDRSRELAS -> IVGAAGHGRALSLCFDNGPLEQVPLALEETASIGMPRPQGGPLPADPRRTGHLSGTGHQGGYASRLDQDSCHPSAGPLDHSATGMLSKSVPVSGINCLLDRSDTDGNVSQSSAIDLRKRCSQLEGHSGTRVGSSLRQTFSFLSGMTGKA (in Ref. 3; BAA31626). {ECO:0000305}.; CONFLICT 631 631 M -> L (in Ref. 10; CAA33634). {ECO:0000305}.; CONFLICT 868 868 P -> Q (in Ref. 10; CAA33634). {ECO:0000305}.,,4,,0,"DOMAIN: The DH (DBL-homology) domain interacts with and promotes loading of GTP on RhoA. Promotes tyrosine phosphorylation of RIPK2.; DOMAIN: The PH domain has no affinity for phosphoinositides suggesting that it does not interact directly with membranes. {ECO:0000269|PubMed:26820534}.; DOMAIN: The phorbol-ester/DAG-type zinc-finger and the C-terminal coiled-coil domains (606-986) are both important for association with microtubules. {ECO:0000269|PubMed:11912491, ECO:0000269|PubMed:9857026}.",,COILED 587 611 {ECO:0000255}.; COILED 798 867 {ECO:0000255}.,,DOMAIN 235 432 DH. {ECO:0000255|PROSITE-ProRule:PRU00062}.; DOMAIN 472 571 PH. {ECO:0000255|PROSITE-ProRule:PRU00145}.,,REGION 131 161 Interaction with DYNLT1. {ECO:0000250|UniProtKB:Q865S3}.,,ZN_FING 39 86 Phorbol-ester/DAG-type. {ECO:0000255|PROSITE-ProRule:PRU00226}.,,,,,,"FUNCTION: Activates Rho-GTPases by promoting the exchange of GDP for GTP. May be involved in epithelial barrier permeability, cell motility and polarization, dendritic spine morphology, antigen presentation, leukemic cell differentiation, cell cycle regulation, innate immune response, and cancer. Binds Rac-GTPases, but does not seem to promote nucleotide exchange activity toward Rac-GTPases, which was uniquely reported in PubMed:9857026. May stimulate instead the cortical activity of Rac. Inactive toward CDC42, TC10, or Ras-GTPases. Forms an intracellular sensing system along with NOD1 for the detection of microbial effectors during cell invasion by pathogens. Required for RHOA and RIP2 dependent NF-kappaB signaling pathways activation upon S.flexneri cell invasion. Involved not only in sensing peptidoglycan (PGN)-derived muropeptides through NOD1 that is independent of its GEF activity, but also in the activation of NF-kappaB by Shigella effector proteins (IpgB2 and OspB) which requires its GEF activity and the activation of RhoA. Involved in innate immune signaling transduction pathway promoting cytokine IL6/interleukin-6 and TNF-alpha secretion in macrophage upon stimulation by bacterial peptidoglycans; acts as a signaling intermediate between NOD2 receptor and RIPK2 kinase. Contributes to the tyrosine phosphorylation of RIPK2 through Src tyrosine kinase leading to NF-kappaB activation by NOD2. Overexpression activates Rho-, but not Rac-GTPases, and increases paracellular permeability (By similarity). Involved in neuronal progenitor cell division and differentiation (PubMed:28453519). Involved in the migration of precerebellar neurons (By similarity). {ECO:0000250|UniProtKB:Q60875, ECO:0000250|UniProtKB:Q865S3, ECO:0000269|PubMed:19043560, ECO:0000269|PubMed:21887730, ECO:0000269|PubMed:28453519, ECO:0000269|PubMed:9857026}.",,,,,,,,,,,,"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; podosome [GO:0002102]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; vesicle [GO:0031982]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; asymmetric neuroblast division [GO:0055059]; cell morphogenesis [GO:0000902]; cellular hyperosmotic response [GO:0071474]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to tumor necrosis factor [GO:0071356]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neurogenesis [GO:0050768]; negative regulation of podosome assembly [GO:0071802]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell population proliferation [GO:0042127]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]",actin filament organization [GO:0007015]; asymmetric neuroblast division [GO:0055059]; cell morphogenesis [GO:0000902]; cellular hyperosmotic response [GO:0071474]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to tumor necrosis factor [GO:0071356]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neurogenesis [GO:0050768]; negative regulation of podosome assembly [GO:0071802]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell population proliferation [GO:0042127]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056],guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270],"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; podosome [GO:0002102]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; vesicle [GO:0031982]",GO:0000132; GO:0000902; GO:0002102; GO:0005085; GO:0005089; GO:0005737; GO:0005794; GO:0005819; GO:0005829; GO:0005856; GO:0005874; GO:0005923; GO:0005925; GO:0006886; GO:0007015; GO:0007026; GO:0007186; GO:0008017; GO:0008134; GO:0008270; GO:0017048; GO:0030676; GO:0031410; GO:0031982; GO:0032587; GO:0032755; GO:0032760; GO:0032991; GO:0035023; GO:0035556; GO:0042127; GO:0043025; GO:0043065; GO:0043198; GO:0045087; GO:0045666; GO:0045944; GO:0048365; GO:0050731; GO:0050768; GO:0051056; GO:0051092; GO:0055059; GO:0060546; GO:0071225; GO:0071356; GO:0071474; GO:0071802; GO:0098978; GO:0099092; GO:1902042; GO:1902219; GO:2001224,IPR037806; IPR035899; IPR000219; IPR002219; IPR011993; IPR001849; ,O43524; Q8N5L8; P63104,"SUBUNIT: Found in a complex composed at least of ARHGEF2, NOD2 and RIPK2. Interacts with RIPK2; the interaction mediates tyrosine phosphorylation of RIPK2 by Src kinase CSK. Interacts with RIPK1 and RIPK3. Interacts with YWHAZ/14-3-3 zeta; when phosphorylated at Ser-886. Interacts with the kinases PAK4, AURKA and MAPK1. Interacts with RHOA and RAC1. Interacts with NOD1. Interacts (via the N-terminal zinc finger) with CAPN6 (via domain II). Interacts with DYNLT1 (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q865S3}.",9857026; 11912491; 9734811; 17974005; 16710414; 15489334; 2466560; 14970201; 15827085; 17081983; 16964243; 17488622; 18211802; 18220336; 18088087; 19043560; 18669648; 18394899; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 21887730; 22814378; 23186163; 24275569; 25944712; 28453519; 26820534,9857026; 11912491; 9734811; 17974005; 16710414; 15489334; 2466560; 14970201; 15827085; 17081983; 16964243; 17488622; 18211802; 18220336; 18088087; 19043560; 18669648; 18394899; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 21887730; 22814378; 23186163; 24275569; 25944712; 28453519; 26820534; 10559246; 11756498; 12101119; 14676191; 14743216; 15161933; 15324660; 16212495; 16778209; 17314511; 17353931; 18095154; 18287519; 19261619; 19369418; 19615732; 19625450; 19667072; 19798671; 19911011; 20089843; 20467437; 20558775; 20711500; 20803552; 21212278; 21352810; 21513698; 21525035; 21851590; 22002306; 22072711; 22226472; 22226621; 22301607; 22513363; 22575643; 22593214; 22653441; 22898781; 23057787; 23416715; 23432781; 23606334; 23816534; 23902751; 24043311; 24255178; 24352660; 24525234; 24706358; 25143398; 25416956; 25609649; 25687035; 26359301; 26638075; 26759237; 26866809; 27573550; 28096473; 29089450; 7478592; 7954831; 8276860; 8810315; 8969170; 9308960,2000-05-30,2019-02-13,2008-07-22,192,X-ray crystallography (1),STRAND 454 457 {ECO:0000244|PDB:5EFX}.; STRAND 461 464 {ECO:0000244|PDB:5EFX}.; STRAND 473 482 {ECO:0000244|PDB:5EFX}.; STRAND 488 504 {ECO:0000244|PDB:5EFX}.; STRAND 509 511 {ECO:0000244|PDB:5EFX}.; STRAND 519 522 {ECO:0000244|PDB:5EFX}.; STRAND 527 530 {ECO:0000244|PDB:5EFX}.; STRAND 537 542 {ECO:0000244|PDB:5EFX}.; STRAND 547 552 {ECO:0000244|PDB:5EFX}.,HELIX 440 447 {ECO:0000244|PDB:5EFX}.; HELIX 465 469 {ECO:0000244|PDB:5EFX}.; HELIX 556 571 {ECO:0000244|PDB:5EFX}.,TURN 458 460 {ECO:0000244|PDB:5EFX}.; TURN 543 546 {ECO:0000244|PDB:5EFX}.; TURN 576 578 {ECO:0000244|PDB:5EFX}.,,,,,5 out of 5,Alternative sequence (2); Beta strand (9); Chain (1); Coiled coil (2); Domain (2); Erroneous initiation (2); Frameshift (1); Helix (3); Modified residue (31); Mutagenesis (9); Region (1); Sequence caution (1); Sequence conflict (3); Turn (3); Zinc finger (1),,,,3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Cell junction;Cell membrane;Cell projection;Coiled coil;Complete proteome;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Developmental protein;Differentiation;Golgi apparatus;Guanine-nucleotide releasing factor;Immunity;Innate immunity;Membrane;Mental retardation;Metal-binding;Microtubule;Mitosis;Neurogenesis;Phosphoprotein;Reference proteome;Tight junction;Zinc;Zinc-finger,Evidence at protein level,reviewed,,,192,Alternative products (1); Domain (3); Function (1); Induction (1); Involvement in disease (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0025; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0217; KW-0221; KW-0333; KW-0344; KW-0391; KW-0399; KW-0472; KW-0479; KW-0493; KW-0498; KW-0524; KW-0597; KW-0796; KW-0862; KW-0863; KW-0963; KW-0965; KW-0966; KW-0968; KW-0991; KW-1003; KW-1185,,,,,"DISEASE: Neurodevelopmental disorder with midbrain and hindbrain malformations (NEDMHM) [MIM:617523]: An autosomal recessive neurodevelopmental disorder characterized by intellectual disability, speech delay, mild microcephaly, midbrain-hindbrain malformations, and variable dysmorphic features. {ECO:0000269|PubMed:28453519}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Phosphorylation of Ser-886 by PAK1 induces binding to protein YWHAZ, promoting its relocation to microtubules and the inhibition of its activity. Phosphorylated by AURKA and CDK1 during mitosis, which negatively regulates its activity. Phosphorylation by MAPK1 or MAPK3 increases nucleotide exchange activity. Phosphorylation by PAK4 releases GEF-H1 from the microtubules. Phosphorylated on serine, threonine and tyrosine residues in a RIPK2-dependent manner. {ECO:0000269|PubMed:14970201, ECO:0000269|PubMed:15827085, ECO:0000269|PubMed:17488622, ECO:0000269|PubMed:18211802}.",CHAIN 1 986 Rho guanine nucleotide exchange factor 2. /FTId=PRO_0000080909.,,,,,,"MOD_RES 109 109 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 122 122 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 129 129 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 133 133 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 137 137 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 143 143 Phosphoserine; by PAK4. {ECO:0000269|PubMed:15827085}.; MOD_RES 151 151 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 163 163 Phosphoserine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 172 172 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 174 174 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 177 177 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 353 353 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 645 645 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 648 648 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 679 679 Phosphothreonine; by MAPK1 or MAPK3. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:18211802}.; MOD_RES 691 691 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 696 696 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 711 711 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 782 782 Phosphoserine. {ECO:0000250|UniProtKB:Q60875}.; MOD_RES 886 886 Phosphoserine; by PAK1 and AURKA. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:14970201, ECO:0000269|PubMed:17488622}.; MOD_RES 894 894 Phosphotyrosine. {ECO:0000244|PubMed:18669648}.; MOD_RES 896 896 Phosphoserine; by PAK4. {ECO:0000269|PubMed:15827085}.; MOD_RES 932 932 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:23186163}.; MOD_RES 940 940 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 941 941 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 945 945 Phosphothreonine. {ECO:0000244|PubMed:19690332}.; MOD_RES 947 947 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 952 952 Phosphoserine. {ECO:0000250|UniProtKB:Q60875}.; MOD_RES 953 953 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 956 956 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 960 960 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:17488622}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U72206;AF486838;AB014551;AL512715;CH471121;CH471121;CH471121;BC020567;BT007407;X15610;
0,Q9BUB5,MKNK1_HUMAN,MKNK1 MNK1,MKNK1,MNK1,,,Homo sapiens (Human),9606,MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL,465,"51,342",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1 {ECO:0000269|PubMed:11463832}; IsoId=Q9BUB5-1; Sequence=Displayed; Name=2 {ECO:0000269|PubMed:9155018}; Synonyms=MNK1a; IsoId=Q9BUB5-2; Sequence=VSP_007352; Name=3; Synonyms=MNK1b; IsoId=Q9BUB5-3; Sequence=VSP_007352, VSP_017515; ",,,,,,,,,,"VAR_SEQ 165 205 Missing (in isoform 2 and isoform 3). {ECO:0000303|PubMed:15350534, ECO:0000303|PubMed:9155018}. /FTId=VSP_007352.; VAR_SEQ 377 465 QAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL -> EQQHNGPDALRS (in isoform 3). {ECO:0000303|PubMed:15350534}. /FTId=VSP_017515.",VARIANT 49 49 K -> Q (in dbSNP:rs56351860). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040801.; VARIANT 158 158 L -> V (in dbSNP:rs56408722). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040802.; VARIANT 308 308 D -> N (in dbSNP:rs55791614). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040803.; VARIANT 446 446 R -> Q (in dbSNP:rs34881418). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040804.,,,,,,1,,0,,SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. {ECO:0000305}.,,,DOMAIN 49 374 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:11463832, ECO:0000269|PubMed:9155018}; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:11463832, ECO:0000269|PubMed:9155018};","COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:11463832, ECO:0000269|PubMed:9155018}; ",,"FUNCTION: May play a role in the response to environmental stress and cytokines. Appears to regulate translation by phosphorylating EIF4E, thus increasing the affinity of this protein for the 7-methylguanosine-containing mRNA cap. {ECO:0000269|PubMed:11463832, ECO:0000269|PubMed:15350534, ECO:0000269|PubMed:9155018, ECO:0000269|PubMed:9878069}.",,,,,,"ACT_SITE 211 211 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.","BINDING 78 78 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:11463832}.",,,NP_BIND 55 63 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417],intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417],ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006417; GO:0006468; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872,IPR011009; IPR000719; IPR017441; IPR008271; ,P28482; Q16539,"SUBUNIT: Interacts with the C-terminal regions of EIF4G1 and EIF4G2. Also binds to dephosphorylated ERK1 and ERK2, and to the p38 kinases. {ECO:0000269|PubMed:9878069}.",9155018; 11463832; 15350534; 16710414; 15489334; 9878069; 15234964; 18669648; 23186163; 17344846,9155018; 11463832; 15350534; 16710414; 15489334; 9878069; 15234964; 18669648; 23186163; 17344846; 16479008; 16917500; 17130135; 17590453; 19690147; 20927323; 20936779; 21900206; 21988832; 23047924; 23455922; 23602568; 25241761; 29497019,2003-04-30,2019-02-13,2001-06-01,177,X-ray crystallography (3),STRAND 48 57 {ECO:0000244|PDB:2HW6}.; STRAND 59 68 {ECO:0000244|PDB:2HW6}.; STRAND 74 81 {ECO:0000244|PDB:2HW6}.; STRAND 110 115 {ECO:0000244|PDB:2HW6}.; STRAND 117 125 {ECO:0000244|PDB:2HW6}.; STRAND 217 220 {ECO:0000244|PDB:2HW6}.; STRAND 227 230 {ECO:0000244|PDB:2HW6}.; STRAND 271 274 {ECO:0000244|PDB:2HW6}.; STRAND 341 343 {ECO:0000244|PDB:5WVD}.,HELIX 44 46 {ECO:0000244|PDB:2HW6}.; HELIX 87 101 {ECO:0000244|PDB:2HW6}.; HELIX 132 139 {ECO:0000244|PDB:2HW6}.; HELIX 144 163 {ECO:0000244|PDB:2HW6}.; HELIX 214 216 {ECO:0000244|PDB:2HW6}.; HELIX 277 296 {ECO:0000244|PDB:2HW6}.; HELIX 337 340 {ECO:0000244|PDB:2HW6}.; HELIX 345 354 {ECO:0000244|PDB:2HW6}.; HELIX 365 370 {ECO:0000244|PDB:2HW6}.; HELIX 439 441 {ECO:0000244|PDB:2Y9Q}.; HELIX 443 449 {ECO:0000244|PDB:2Y9Q}.,TURN 69 71 {ECO:0000244|PDB:2HW6}.; TURN 359 361 {ECO:0000244|PDB:2HW6}.; TURN 372 375 {ECO:0000244|PDB:2HW6}.,,,,,5 out of 5,Active site (1); Alternative sequence (2); Beta strand (9); Binding site (1); Chain (1); Domain (1); Helix (11); Modified residue (7); Mutagenesis (5); Natural variant (4); Nucleotide binding (1); Turn (3),,TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:15350534}.,,3D-structure;ATP-binding;Alternative splicing;Complete proteome;Cytoplasm;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Translation regulation,Evidence at protein level,reviewed,,"Protein kinase superfamily, CAMK Ser/Thr protein kinase family",177,Activity regulation (1); Alternative products (1); Catalytic activity (2); Cofactor (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (2); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0067; KW-0181; KW-0418; KW-0460; KW-0479; KW-0539; KW-0547; KW-0597; KW-0621; KW-0723; KW-0808; KW-0810; KW-0963; KW-1185,,,,,,,,"PTM: Dual phosphorylation of Thr-250 and Thr-255 activates the kinase. Phosphorylation of Thr-385 activates the kinase. MAPK3/ERK1 is one of the kinases which activate MKNK1/MNK1. Phosphorylation by PAK2 leads to a reduced phosphorylation of EIF4G1. {ECO:0000269|PubMed:11463832, ECO:0000269|PubMed:15234964, ECO:0000269|PubMed:15350534, ECO:0000269|PubMed:9155018}.",CHAIN 1 465 MAP kinase-interacting serine/threonine-protein kinase 1. /FTId=PRO_0000086334.,,,,,,"MOD_RES 39 39 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 221 221 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 226 226 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 250 250 Phosphothreonine. {ECO:0000269|PubMed:11463832}.; MOD_RES 255 255 Phosphothreonine. {ECO:0000269|PubMed:11463832}.; MOD_RES 385 385 Phosphothreonine. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:11463832}.; MOD_RES 460 460 Phosphoserine. {ECO:0000244|PubMed:18669648}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB000409;AY355461;CH471059;CH471059;CH471059;CH471059;BC002755;
0,Q9UHD8,SEPT9_HUMAN,SEPT9 KIAA0991 MSF,SEPT9,KIAA0991 MSF,,,Homo sapiens (Human),9606,Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1),UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MKKSYSGGTRTSSGRLRRLGDSSGPALKRSFEVEEVETPNSTPPRRVQTPLLRATVASSTQKFQDLGVKNSEPSARHVDSLSQRSPKASLRRVELSGPKAAEPVSRRTELSIDISSKQVENAGAIGPSRFGLKRAEVLGHKTPEPAPRRTEITIVKPQESAHRRMEPPASKVPEVPTAPATDAAPKRVEIQMPKPAEAPTAPSPAQTLENSEPAPVSQLQSRLEPKPQPPVAEATPRSQEATEAAPSCVGDMADTPRDAGLKQAPASRNEKAPVDFGYVGIDSILEQMRRKAMKQGFEFNIMVVGQSGLGKSTLINTLFKSKISRKSVQPTSEERIPKTIEIKSITHDIEEKGVRMKLTVIDTPGFGDHINNENCWQPIMKFINDQYEKYLQEEVNINRKKRIPDTRVHCCLYFIPATGHSLRPLDIEFMKRLSKVVNIVPVIAKADTLTLEERVHFKQRITADLLSNGIDVYPQKEFDEDSEDRLVNEKFREMIPFAVVGSDHEYQVNGKRILGRKTKWGTIEVENTTHCEFAYLRDLLIRTHMQNIKDITSSIHFEAYRVKRLNEGSSAMANGMEEKEPEAPEM,586,"65,401",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=8;  Comment=There are potentially 18 isoforms.; Name=1; Synonyms=Epsilon, MSF-A; IsoId=Q9UHD8-1; Sequence=Displayed; Name=2; Synonyms=Alpha; IsoId=Q9UHD8-2; Sequence=VSP_012337; Name=3; Synonyms=Beta, MSF-B; IsoId=Q9UHD8-3; Sequence=VSP_012336; Name=4; Synonyms=Delta; IsoId=Q9UHD8-4; Sequence=VSP_012335; Name=5; Synonyms=Gamma; IsoId=Q9UHD8-5; Sequence=VSP_012338; Name=7; IsoId=Q9UHD8-7; Sequence=VSP_038317; Note=No experimental confirmation available.; Name=8; IsoId=Q9UHD8-8; Sequence=VSP_038316, VSP_038318; Note=No experimental confirmation available.; Name=9; IsoId=Q9UHD8-9; Sequence=VSP_038315, VSP_038319; Note=No experimental confirmation available.; ",,,,,,,,,SEQUENCE CAUTION:  Sequence=BAB14057.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305}; ,"VAR_SEQ 1 251 Missing (in isoform 4). {ECO:0000303|PubMed:10987277, ECO:0000303|PubMed:14702039}. /FTId=VSP_012335.; VAR_SEQ 1 224 Missing (in isoform 9). {ECO:0000303|PubMed:14702039}. /FTId=VSP_038315.; VAR_SEQ 1 164 Missing (in isoform 3). {ECO:0000303|PubMed:10673329, ECO:0000303|PubMed:10987277, ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334}. /FTId=VSP_012336.; VAR_SEQ 1 112 Missing (in isoform 8). {ECO:0000303|PubMed:14702039}. /FTId=VSP_038316.; VAR_SEQ 1 25 MKKSYSGGTRTSSGRLRRLGDSSGP -> MERDRIS (in isoform 2). {ECO:0000303|PubMed:10339604, ECO:0000303|PubMed:10987277, ECO:0000303|PubMed:15489334, ECO:0000303|Ref.4, ECO:0000303|Ref.6}. /FTId=VSP_012337.; VAR_SEQ 1 25 MKKSYSGGTRTSSGRLRRLGDSSGP -> MSDPAVNAQLDGIISDFE (in isoform 5). {ECO:0000303|PubMed:10987277, ECO:0000303|PubMed:14702039}. /FTId=VSP_012338.; VAR_SEQ 7 25 Missing (in isoform 7). {ECO:0000303|PubMed:14702039}. /FTId=VSP_038317.; VAR_SEQ 113 240 DISSKQVENAGAIGPSRFGLKRAEVLGHKTPEPAPRRTEITIVKPQESAHRRMEPPASKVPEVPTAPATDAAPKRVEIQMPKPAEAPTAPSPAQTLENSEPAPVSQLQSRLEPKPQPPVAEATPRSQE -> MGSSFWEGLQVAVGLPQGCWPQGLDSGEPAEGGQLEAAPVCIVTRQSKETAGPTLGRGGWRQGSLRRGKGTSCRCRQLSPGHGPGRLTGCGECHRLPCRGLVSGFTGLRGQEEDDLAFCLATIGSDRQ (in isoform 8). {ECO:0000303|PubMed:14702039}. /FTId=VSP_038318.; VAR_SEQ 225 240 PKPQPPVAEATPRSQE -> MAGAGCTGTWSWLWGT (in isoform 9). {ECO:0000303|PubMed:14702039}. /FTId=VSP_038319.","VARIANT 76 76 R -> C (in dbSNP:rs202079794). {ECO:0000269|PubMed:10987277}. /FTId=VAR_020667.; VARIANT 106 106 R -> W (in HNA; dbSNP:rs80338761). {ECO:0000269|PubMed:16186812, ECO:0000269|PubMed:17546647, ECO:0000269|PubMed:18492087, ECO:0000269|PubMed:19451530}. /FTId=VAR_033101.; VARIANT 111 111 S -> F (in HNA; dbSNP:rs80338762). {ECO:0000269|PubMed:16186812, ECO:0000269|PubMed:17546647, ECO:0000269|PubMed:19451530}. /FTId=VAR_033102.; VARIANT 145 145 P -> L (in dbSNP:rs34587622). {ECO:0000269|PubMed:10987277, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:19451530}. /FTId=VAR_020668.; VARIANT 576 576 M -> V (in dbSNP:rs2627223). {ECO:0000269|PubMed:10231032, ECO:0000269|PubMed:10339604, ECO:0000269|PubMed:10673329, ECO:0000269|PubMed:10987277, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005, ECO:0000269|Ref.4, ECO:0000269|Ref.6, ECO:0000269|Ref.7}. /FTId=VAR_020669.",,,,CONFLICT 251 251 D -> G (in Ref. 5; BAG64494). {ECO:0000305}.; CONFLICT 487 487 V -> E (in Ref. 5; BAB14057). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like GTPase superfamily. Septin GTPase family. {ECO:0000255|PROSITE-ProRule:PRU01056}.,,,DOMAIN 295 567 Septin-type G. {ECO:0000255|PROSITE-ProRule:PRU01056}.,,REGION 305 312 G1 motif. {ECO:0000255|PROSITE-ProRule:PRU01056}.; REGION 362 365 G3 motif. {ECO:0000255|PROSITE-ProRule:PRU01056}.; REGION 444 447 G4 motif. {ECO:0000255|PROSITE-ProRule:PRU01056}.,,,,,,,,"FUNCTION: Filament-forming cytoskeletal GTPase (By similarity). May play a role in cytokinesis (Potential). May play a role in the internalization of 2 intracellular microbial pathogens, Listeria monocytogenes and Shigella flexneri. {ECO:0000250, ECO:0000305}.",,,,,,,BINDING 339 339 GTP. {ECO:0000250}.; BINDING 365 365 GTP; via amide nitrogen. {ECO:0000250}.; BINDING 501 501 GTP; via amide nitrogen and carbonyl oxygen. {ECO:0000250}.; BINDING 516 516 GTP. {ECO:0000250}.,,,NP_BIND 305 312 GTP. {ECO:0000250}.; NP_BIND 445 453 GTP. {ECO:0000250}.,,actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex scaffold activity [GO:0032947]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein heterooligomerization [GO:0051291],cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein heterooligomerization [GO:0051291],cadherin binding [GO:0045296]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein-containing complex scaffold activity [GO:0032947],actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725],GO:0001725; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005930; GO:0005940; GO:0015629; GO:0015630; GO:0031105; GO:0032947; GO:0045296; GO:0048471; GO:0051291; GO:0061640; GO:0097730; GO:1902857,IPR030379; IPR027417; IPR030645; IPR016491; ,Q16665; Q6ZU15; Q14141,"SUBUNIT: Septins polymerize into heterooligomeric protein complexes that form filaments, and associate with cellular membranes, actin filaments, and microtubules. GTPase activity is required for filament formation. Interacts with SEPT2, SEPT6, SEPT7, SEPT11 and SEPT14. Interacts with RTKN and ARHGEF18. In a mesenchymal cell line, Rho/RTKN signals cause disruption of wild-type septin filaments, but not of those containing isoform 2 variants HNA Trp-106 and Phe-111. In a mesenchymal cell line, isoform 2 variants HNA Trp-106 and Phe-111, but not wild type, form filaments with SEPT4. {ECO:0000269|PubMed:15485874, ECO:0000269|PubMed:15558029, ECO:0000269|PubMed:16007136, ECO:0000269|PubMed:17546647, ECO:0000269|PubMed:17922164, ECO:0000269|PubMed:19145258}.",10339604; 10987277; 10673329; 14702039; 15489334; 10231032; 17974005; 11593400; 15485874; 15915442; 15558029; 16007136; 17081983; 16964243; 17546647; 17922164; 18220336; 18669648; 19413330; 19145258; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 25944712; 16186812; 18492087; 19451530,10339604; 10987277; 10673329; 14702039; 15489334; 10231032; 17974005; 11593400; 15485874; 15915442; 15558029; 16007136; 17081983; 16964243; 17546647; 17922164; 18220336; 18669648; 19413330; 19145258; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 25944712; 16186812; 18492087; 19451530; 12095151; 12388755; 12626509; 15782116; 16161048; 16424018; 17353931; 18075300; 18525421; 18642054; 19018278; 19071215; 19139049; 19204161; 19251694; 19367725; 19406918; 19463016; 19738201; 19851296; 19939853; 20019224; 20029986; 20098747; 20140221; 20198315; 20407014; 20467437; 20562859; 20682395; 21059847; 21267688; 21737677; 21767235; 21831286; 22123865; 22278362; 22575643; 22956766; 22981636; 23049919; 23118862; 23416715; 23572511; 23862763; 23902751; 23988185; 23990466; 24067372; 24127542; 24344182; 24386354; 24535900; 24633736; 25293760; 25416956; 25497084; 25526039; 25640309; 25898316; 25946211; 26471083; 26496610; 26633373; 26823018; 27133379; 27417143; 27499429; 27660666; 27753040; 27999621; 28128742; 28338090; 29627389; 29970704,2004-12-21,2019-02-13,2006-04-18,178,X-ray crystallography (3),STRAND 297 305 {ECO:0000244|PDB:5CYO}.; STRAND 343 351 {ECO:0000244|PDB:5CYO}.; STRAND 354 362 {ECO:0000244|PDB:5CYO}.; STRAND 369 371 {ECO:0000244|PDB:5CYO}.; STRAND 410 415 {ECO:0000244|PDB:5CYO}.; STRAND 419 421 {ECO:0000244|PDB:5CYP}.; STRAND 437 443 {ECO:0000244|PDB:5CYO}.; STRAND 472 474 {ECO:0000244|PDB:4YQF}.; STRAND 496 498 {ECO:0000244|PDB:5CYO}.; STRAND 503 508 {ECO:0000244|PDB:5CYO}.; STRAND 511 517 {ECO:0000244|PDB:5CYO}.; STRAND 522 524 {ECO:0000244|PDB:5CYO}.,HELIX 311 322 {ECO:0000244|PDB:5CYO}.; HELIX 377 395 {ECO:0000244|PDB:5CYO}.; HELIX 424 434 {ECO:0000244|PDB:5CYO}.; HELIX 446 448 {ECO:0000244|PDB:5CYO}.; HELIX 451 467 {ECO:0000244|PDB:5CYO}.; HELIX 476 478 {ECO:0000244|PDB:5CYO}.; HELIX 482 494 {ECO:0000244|PDB:5CYO}.; HELIX 533 539 {ECO:0000244|PDB:5CYO}.; HELIX 542 554 {ECO:0000244|PDB:5CYO}.; HELIX 556 567 {ECO:0000244|PDB:5CYO}.,TURN 373 376 {ECO:0000244|PDB:5CYO}.; TURN 528 530 {ECO:0000244|PDB:5CYO}.,,,,,5 out of 5,Alternative sequence (9); Beta strand (12); Binding site (4); Chain (1); Domain (1); Helix (10); Modified residue (16); Natural variant (5); Nucleotide binding (2); Region (3); Sequence caution (1); Sequence conflict (2); Turn (2),,"TISSUE SPECIFICITY: Widely expressed. Isoforms are differentially expressed in testes, kidney, liver heart, spleen, brain, peripheral blood leukocytes, skeletal muscle and kidney. Specific isoforms appear to demonstrate tissue specificity. Isoform 5 is the most highly expressed in fetal tissue. Isoform 1 is detected in all tissues except the brain and thymus, while isoform 2, isoform 3, and isoform 4 are detected at low levels in approximately half of the fetal tissues. {ECO:0000269|PubMed:10339604, ECO:0000269|PubMed:10673329, ECO:0000269|PubMed:11593400, ECO:0000269|PubMed:15915442}.",,3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Chromosomal rearrangement;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;GTP-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,"TRAFAC class TrmE-Era-EngA-EngB-Septin-like GTPase superfamily, Septin GTPase family",178,Alternative products (1); Caution (3); Function (1); Involvement in disease (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0131; KW-0132; KW-0160; KW-0181; KW-0206; KW-0225; KW-0342; KW-0547; KW-0597; KW-0621; KW-0963; KW-1185,,,,,"DISEASE: Note=A chromosomal aberration involving SEPT9/MSF is found in therapy-related acute myeloid leukemia (t-AML). Translocation t(11;17)(q23;q25) with KMT2A/MLL1. {ECO:0000269|PubMed:10339604}.; DISEASE: Hereditary neuralgic amyotrophy (HNA) [MIM:162100]: Autosomal dominant form of recurrent focal neuropathy characterized clinically by acute, recurrent episodes of brachial plexus neuropathy with muscle weakness and atrophy preceded by severe pain in the affected arm. HNA is triggered by environmental factors such as infection or parturition. {ECO:0000269|PubMed:16186812, ECO:0000269|PubMed:17546647, ECO:0000269|PubMed:18492087, ECO:0000269|PubMed:19451530}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 586 Septin-9. /FTId=PRO_0000173535.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 22 22 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 30 30 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 38 38 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 42 42 Phosphothreonine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 49 49 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 62 62 N6-acetyllysine. {ECO:0000250|UniProtKB:Q80UG5}.; MOD_RES 82 82 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 85 85 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 89 89 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 96 96 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 142 142 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 278 278 Phosphotyrosine. {ECO:0000244|PubMed:19690332}.; MOD_RES 327 327 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 332 332 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF123052;AJ312319;AJ312320;AJ312321;AJ312322;AF189712;AF189713;AF142408;AK022493;AK290368;AK056495;AK300270;AK303449;AK304143;AK299828;AK316473;BT007215;CH471099;CH471099;CH471099;BC021192;BC054004;AB023208;AL080131;
0,P38398,BRCA1_HUMAN,BRCA1 RNF53,BRCA1,RNF53,,,Homo sapiens (Human),9606,Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1),UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDLSALRVEEVQNVINAMQKILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELLKIICAFQLDTGLEYANSYNFAKKENNSPEHLKDEVSIIQSMGYRNRAKRLLQSEPENPSLQETSLSVQLSNLGTVRTLRTKQRIQPQKTSVYIELGSDSSEDTVNKATYCSVGDQELLQITPQGTRDEISLDSAKKAACEFSETDVTNTEHHQPSNNDLNTTEKRAAERHPEKYQGSSVSNLHVEPCGTNTHASSLQHENSSLLLTKDRMNVEKAEFCNKSKQPGLARSQHNRWAGSKETCNDRRTPSTEKKVDLNADPLCERKEWNKQKLPCSENPRDTEDVPWITLNSSIQKVNEWFSRSDELLGSDDSHDGESESNAKVADVLDVLNEVDEYSGSSEKIDLLASDPHEALICKSERVHSKSVESNIEDKIFGKTYRKKASLPNLSHVTENLIIGAFVTEPQIIQERPLTNKLKRKRRPTSGLHPEDFIKKADLAVQKTPEMINQGTNQTEQNGQVMNITNSGHENKTKGDSIQNEKNPNPIESLEKESAFKTKAEPISSSISNMELELNIHNSKAPKKNRLRRKSSTRHIHALELVVSRNLSPPNCTELQIDSCSSSEEIKKKKYNQMPVRHSRNLQLMEGKEPATGAKKSNKPNEQTSKRHDSDTFPELKLTNAPGSFTKCSNTSELKEFVNPSLPREEKEEKLETVKVSNNAEDPKDLMLSGERVLQTERSVESSSISLVPGTDYGTQESISLLEVSTLGKAKTEPNKCVSQCAAFENPKGLIHGCSKDNRNDTEGFKYPLGHEVNHSRETSIEMEESELDAQYLQNTFKVSKRQSFAPFSNPGNAEEECATFSAHSGSLKKQSPKVTFECEQKEENQGKNESNIKPVQTVNITAGFPVVGQKDKPVDNAKCSIKGGSRFCLSSQFRGNETGLITPNKHGLLQNPYRIPPLFPIKSFVKTKCKKNLLEENFEEHSMSPEREMGNENIPSTVSTISRNNIRENVFKEASSSNINEVGSSTNEVGSSINEIGSSDENIQAELGRNRGPKLNAMLRLGVLQPEVYKQSLPGSNCKHPEIKKQEYEEVVQTVNTDFSPYLISDNLEQPMGSSHASQVCSETPDDLLDDGEIKEDTSFAENDIKESSAVFSKSVQKGELSRSPSPFTHTHLAQGYRRGAKKLESSEENLSSEDEELPCFQHLLFGKVNNIPSQSTRHSTVATECLSKNTEENLLSLKNSLNDCSNQVILAKASQEHHLSEETKCSASLFSSQCSELEDLTANTNTQDPFLIGSSKQMRHQSESQGVGLSDKELVSDDEERGTGLEENNQEEQSMDSNLGEAASGCESETSVSEDCSGLSSQSDILTTQQRDTMQHNLIKLQQEMAELEAVLEQHGSQPSNSYPSIISDSSALEDLRNPEQSTSEKAVLTSQKSSEYPISQNPEGLSADKFEVSADSSTSKNKEPGVERSSPSKCPSLDDRWYMHSCSGSLQNRNYPSQEELIKVVDVEEQQLEESGPHDLTETSYLPRQDLEGTPYLESGISLFSDDPESDPSEDRAPESARVGNIPSSTSALKVPQLKVAESAQSPAAAHTTDTAGYNAMEESVSREKPELTASTERVNKRMSMVVSGLTPEEFMLVYKFARKHHITLTNLITEETTHVVMKTDAEFVCERTLKYFLGIAGGKWVVSYFWVTQSIKERKMLNEHDFEVRGDVVNGRNHQGPKRARESQDRKIFRGLEICCYGPFTNMPTDQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIPHSHY,1863,"207,721",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing, Alternative initiation; Named isoforms=8;  Name=1; IsoId=P38398-1; Sequence=Displayed; Name=2; IsoId=P38398-2; Sequence=VSP_047891; Note=May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.; Name=3; Synonyms=Delta11b; IsoId=P38398-3; Sequence=VSP_035399, VSP_043797; Name=4; Synonyms=DeltaBRCA1(17aa); IsoId=P38398-4; Sequence=VSP_035396; Note=Produced by alternative initiation at Met-18 of isoform 1.; Name=5; Synonyms=Delta11, Delta772-3095; IsoId=P38398-5; Sequence=VSP_035398; Name=6; IsoId=P38398-6; Sequence=VSP_035399, VSP_043797, VSP_043798; Note=No experimental confirmation available.; Name=7; IsoId=P38398-7; Sequence=VSP_055404; Note=No experimental confirmation available. {ECO:0000305}; Name=8; IsoId=P38398-8; Sequence=VSP_057569; Note=No experimental confirmation available. The N-terminus is confirmed by several cDNAs. {ECO:0000305}; ",,SEQUENCE CAUTION:  Sequence=AAI15038.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,SEQUENCE CAUTION:  Sequence=AAI15038.1; Type=Erroneous termination; Positions=526; Note=Translated as Gln.; Evidence={ECO:0000305}; ,SEQUENCE CAUTION:  Sequence=AAB61673.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305}; ,,,POLYMORPHISM: There is evidence that the presence of the rare form of Gln-356-Arg and Leu-871-Pro polymorphisms may be associated with an increased risk for developing ovarian cancer.,,,"VAR_SEQ 1 47 Missing (in isoform 8). /FTId=VSP_057569.; VAR_SEQ 1 17 Missing (in isoform 4). {ECO:0000305}. /FTId=VSP_035396.; VAR_SEQ 64 1863 Missing (in isoform 2). {ECO:0000303|Ref.4}. /FTId=VSP_047891.; VAR_SEQ 224 1365 Missing (in isoform 5). {ECO:0000305}. /FTId=VSP_035398.; VAR_SEQ 264 1366 Missing (in isoform 3 and isoform 6). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9010228}. /FTId=VSP_035399.; VAR_SEQ 1453 1453 Missing (in isoform 3 and isoform 6). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9010228}. /FTId=VSP_043797.; VAR_SEQ 1453 1453 A -> DSHIHGQRNNSMFSKRPREHIS (in isoform 7). {ECO:0000303|PubMed:15489334}. /FTId=VSP_055404.; VAR_SEQ 1778 1863 DQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIPHSHY -> GCPPNCGCAARCLDRGQWLPCNWADV (in isoform 6). {ECO:0000303|PubMed:15489334}. /FTId=VSP_043798.","VARIANT 4 4 S -> F (in BC; unknown pathological significance; dbSNP:rs786203152). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070458.; VARIANT 10 10 E -> K (in BC and BROVCA1). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020679.; VARIANT 11 11 V -> A (found in breast-ovarian cancer patients; unknown pathological significance; dbSNP:rs80357017). /FTId=VAR_007754.; VARIANT 18 18 M -> T (in BC; unknown pathological significance; dbSNP:rs80356929). {ECO:0000269|PubMed:17924331, ECO:0000269|PubMed:23867111}. /FTId=VAR_063899.; VARIANT 21 21 I -> V (found in breast-ovarian cancer patients; unknown pathological significance; dbSNP:rs80357406). /FTId=VAR_007755.; VARIANT 22 22 L -> S (in BC; dbSNP:rs80357438). {ECO:0000269|PubMed:9609997}. /FTId=VAR_007756.; VARIANT 23 23 E -> K (in BC and BROVCA1). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020680.; VARIANT 30 30 L -> F (in a breast cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_035947.; VARIANT 45 45 K -> Q (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs769650474). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070459.; VARIANT 61 61 C -> G (in BC and ovarian cancer; no interaction with BAP1; dbSNP:rs28897672). {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14746861, ECO:0000269|PubMed:23867111, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:9528852, ECO:0000269|PubMed:9760198}. /FTId=VAR_007757.; VARIANT 64 64 C -> G (in BC; no interaction with BAP1; dbSNP:rs80357064). {ECO:0000269|PubMed:23867111, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9528852}. /FTId=VAR_007758.; VARIANT 64 64 C -> Y (in dbSNP:rs55851803). /FTId=VAR_007759.; VARIANT 67 67 D -> Y (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357102). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070460.; VARIANT 71 71 R -> K (in BC; unknown pathological significance; dbSNP:rs80356913). {ECO:0000269|PubMed:12938098}. /FTId=VAR_020681.; VARIANT 105 105 Y -> C (in dbSNP:rs28897673). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070461.; VARIANT 132 132 N -> K (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357413). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070462.; VARIANT 142 142 P -> H (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs55971303). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070463.; VARIANT 147 147 L -> F (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs748876625). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070464.; VARIANT 153 153 S -> R (in dbSNP:rs28897674). /FTId=VAR_052077.; VARIANT 165 165 L -> P (in BC; unknown pathological significance; functionally neutral in vitro). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070465.; VARIANT 170 170 R -> W (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357325). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070466.; VARIANT 186 186 S -> Y (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs55688530). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070467.; VARIANT 191 191 V -> I (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357090). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070468.; VARIANT 227 227 E -> K (in ovarian cancer; unknown pathological significance). /FTId=VAR_008759.; VARIANT 231 231 T -> M (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357001). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070469.; VARIANT 239 239 H -> R (in dbSNP:rs80357396). {ECO:0000269|PubMed:9010228, ECO:0000269|PubMed:9760198}. /FTId=VAR_007760.; VARIANT 245 245 D -> V (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80356865). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070470.; VARIANT 246 246 L -> V (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897675). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070471.; VARIANT 271 271 V -> L (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357244). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070472.; VARIANT 271 271 V -> M (in BC; dbSNP:rs80357244). {ECO:0000269|PubMed:8723683}. /FTId=VAR_007761.; VARIANT 275 275 G -> S (in dbSNP:rs8176153). {ECO:0000269|Ref.6}. /FTId=VAR_019944.; VARIANT 346 346 P -> S (in BC; unknown pathological significance; dbSNP:rs80357015). {ECO:0000269|PubMed:10323242}. /FTId=VAR_008760.; VARIANT 356 356 Q -> R (common polymorphism; dbSNP:rs1799950). {ECO:0000269|PubMed:7894493, ECO:0000269|Ref.5, ECO:0000269|Ref.6}. /FTId=VAR_007762.; VARIANT 369 369 Missing (in BC). /FTId=VAR_007763.; VARIANT 379 379 I -> M (in dbSNP:rs56128296). /FTId=VAR_007764.; VARIANT 461 461 F -> L (in BC; dbSNP:rs56046357). {ECO:0000269|PubMed:9609997}. /FTId=VAR_007765.; VARIANT 465 465 Y -> D (in BC; dbSNP:rs397508869). {ECO:0000269|PubMed:9609997}. /FTId=VAR_007766.; VARIANT 507 507 R -> I (found in breast-ovarian cancer patients; unknown pathological significance; dbSNP:rs80357224). /FTId=VAR_007767.; VARIANT 552 552 G -> V (in BC; dbSNP:rs397508893). {ECO:0000269|PubMed:9609997}. /FTId=VAR_007768.; VARIANT 656 656 N -> I. {ECO:0000269|PubMed:12442274}. /FTId=VAR_020682.; VARIANT 668 668 L -> F (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357250). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070473.; VARIANT 693 693 D -> N (rare polymorphism; dbSNP:rs4986850). {ECO:0000269|PubMed:15026808, ECO:0000269|Ref.6}. /FTId=VAR_007769.; VARIANT 695 695 D -> N (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897681). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070474.; VARIANT 723 723 N -> D (in dbSNP:rs4986845). /FTId=VAR_020110.; VARIANT 749 749 D -> Y (in BC; dbSNP:rs80357114). {ECO:0000269|PubMed:12442275}. /FTId=VAR_020683.; VARIANT 758 758 L -> F (in a breast cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_035948.; VARIANT 772 772 V -> A (rare polymorphism; dbSNP:rs80357467). {ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:9482581}. /FTId=VAR_007770.; VARIANT 778 778 G -> C (in a breast cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_035949.; VARIANT 798 798 P -> L (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs876660005). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070475.; VARIANT 810 810 N -> Y (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897682). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070476.; VARIANT 820 820 K -> E (rare polymorphism; dbSNP:rs56082113). {ECO:0000269|PubMed:9482581}. /FTId=VAR_007771.; VARIANT 826 826 T -> K (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897683). {ECO:0000269|PubMed:23867111}. /FTId=VAR_007772.; VARIANT 835 835 H -> Y (in BROVCA1; unknown pathological significance; dbSNP:rs751656678). {ECO:0000269|PubMed:12938098}. /FTId=VAR_020684.; VARIANT 841 841 R -> Q (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357337). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070477.; VARIANT 841 841 R -> W (in BROVCA1; unknown pathological significance; dbSNP:rs1800709). {ECO:0000269|PubMed:8968716, ECO:0000269|PubMed:9760198}. /FTId=VAR_007773.; VARIANT 856 856 Y -> H (in a patient with sporadic breast cancer; unknown pathological significance; dbSNP:rs80356892). {ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:23867111}. /FTId=VAR_020685.; VARIANT 866 866 R -> C (in dbSNP:rs41286300). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070478.; VARIANT 866 866 R -> Q (in BC; unknown pathological significance). {ECO:0000269|PubMed:12938098}. /FTId=VAR_020686.; VARIANT 871 871 P -> L (common polymorphism; dbSNP:rs799917). {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:15489334, ECO:0000269|Ref.6}. /FTId=VAR_007774.; VARIANT 888 888 H -> Y (in BC; unknown pathological significance; dbSNP:rs80357480). {ECO:0000269|PubMed:12938098}. /FTId=VAR_020687.; VARIANT 892 892 L -> S (in BC; dbSNP:rs397508994). {ECO:0000269|PubMed:9609997}. /FTId=VAR_007775.; VARIANT 903 1863 Missing (in FANCS). {ECO:0000269|PubMed:29133208}. /FTId=VAR_080693.; VARIANT 925 925 I -> L (in dbSNP:rs4986847). /FTId=VAR_021913.; VARIANT 960 960 G -> D (in BC; dbSNP:rs397509022). {ECO:0000269|PubMed:9609997}. /FTId=VAR_007776.; VARIANT 989 989 F -> S (in dbSNP:rs4986848). /FTId=VAR_020111.; VARIANT 1008 1008 M -> I (common polymorphism; dbSNP:rs1800704). /FTId=VAR_007777.; VARIANT 1025 1025 T -> I (in BC; dbSNP:rs397509034). {ECO:0000269|PubMed:9609997}. /FTId=VAR_007778.; VARIANT 1038 1038 E -> G (common polymorphism; dbSNP:rs16941). {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:7894493, ECO:0000269|Ref.6}. /FTId=VAR_007779.; VARIANT 1040 1040 S -> N (rare polymorphism; dbSNP:rs4986852). {ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:9482581, ECO:0000269|Ref.6}. /FTId=VAR_007780.; VARIANT 1047 1047 V -> A (in BC; dbSNP:rs397509037). {ECO:0000269|PubMed:9609997}. /FTId=VAR_007781.; VARIANT 1060 1060 E -> A (in dbSNP:rs80357184). {ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:23867111}. /FTId=VAR_020688.; VARIANT 1101 1101 S -> N (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs41293447). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070479.; VARIANT 1139 1139 S -> I (in BC; unknown pathological significance; dbSNP:rs80357228). {ECO:0000269|PubMed:12938098}. /FTId=VAR_020689.; VARIANT 1140 1140 S -> G (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs2227945). {ECO:0000269|PubMed:23867111, ECO:0000269|Ref.6}. /FTId=VAR_019945.; VARIANT 1140 1140 S -> N (in BC; unknown pathological significance; functionally neutral in vitro). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070480.; VARIANT 1150 1150 P -> S (in BC; dbSNP:rs80357272). {ECO:0000269|PubMed:8723683}. /FTId=VAR_007782.; VARIANT 1183 1183 K -> R (common polymorphism; dbSNP:rs16942). {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:7894493, ECO:0000269|Ref.6}. /FTId=VAR_007783.; VARIANT 1187 1187 S -> I (in BC and BROVCA1). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020690.; VARIANT 1200 1200 Q -> H (in BC and BROVCA1; dbSNP:rs56214134). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020691.; VARIANT 1204 1204 R -> I (in BC). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020692.; VARIANT 1207 1207 K -> N (in BC). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020693.; VARIANT 1210 1210 E -> G (in BC; unknown pathological significance; dbSNP:rs1060502347). {ECO:0000269|PubMed:12938098}. /FTId=VAR_020694.; VARIANT 1214 1214 E -> K (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80356923). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070481.; VARIANT 1217 1217 S -> Y (in BC and BROVCA1). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020695.; VARIANT 1219 1219 E -> D (found in breast-ovarian cancer patients; unknown pathological significance; dbSNP:rs80356876). /FTId=VAR_007784.; VARIANT 1226 1226 F -> L (in BROVCA1). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020696.; VARIANT 1236 1236 N -> K (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897687). {ECO:0000269|PubMed:23867111}. /FTId=VAR_052078.; VARIANT 1243 1243 R -> G (in BROVCA1). {ECO:0000269|PubMed:14722926}. /FTId=VAR_020697.; VARIANT 1250 1250 E -> K (in dbSNP:rs28897686). {ECO:0000269|PubMed:23867111}. /FTId=VAR_052079.; VARIANT 1267 1267 L -> S (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs587782190). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070482.; VARIANT 1282 1282 E -> V (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357217). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070483.; VARIANT 1297 1297 S -> P (in BC; unknown pathological significance; dbSNP:rs1450793674). {ECO:0000269|PubMed:12938098}. /FTId=VAR_020698.; VARIANT 1297 1297 Missing (in BC; unknown pathological significance; functionally neutral in vitro). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070484.; VARIANT 1301 1301 S -> R (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs273900719). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070485.; VARIANT 1346 1346 E -> K (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357407). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070486.; VARIANT 1347 1347 R -> G (in dbSNP:rs28897689). {ECO:0000269|PubMed:12215251}. /FTId=VAR_007785.; VARIANT 1378 1378 V -> I (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897690). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070487.; VARIANT 1400 1400 M -> V (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357306). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070488.; VARIANT 1406 1406 K -> N (polymorphism; dbSNP:rs1800707). /FTId=VAR_008761.; VARIANT 1407 1407 L -> P (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357492). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070489.; VARIANT 1411 1411 M -> T (in BC and ovarian cancer; unknown pathological significance; decreased interaction with PALB2; dbSNP:rs273900729). {ECO:0000269|PubMed:14746861, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:23867111}. /FTId=VAR_020699.; VARIANT 1431 1431 S -> P. /FTId=VAR_007786.; VARIANT 1443 1443 R -> G (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs41293455). {ECO:0000269|PubMed:23867111, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:9482581}. /FTId=VAR_007787.; VARIANT 1443 1443 R -> Q (in dbSNP:rs4986849). /FTId=VAR_020112.; VARIANT 1448 1448 S -> G (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357486). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070490.; VARIANT 1486 1486 S -> C (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs397507232). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070491.; VARIANT 1495 1495 R -> M (in BC; unknown pathological significance; dbSNP:rs80357389). {ECO:0000269|PubMed:17924331}. /FTId=VAR_063900.; VARIANT 1512 1512 S -> I (in dbSNP:rs1800744). {ECO:0000269|PubMed:12215251, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9760198}. /FTId=VAR_007788.; VARIANT 1534 1534 V -> M (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs55815649). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070492.; VARIANT 1561 1561 T -> I (found in breast cancer; unknown pathological significance; dbSNP:rs56158747). /FTId=VAR_007789.; VARIANT 1589 1589 R -> P (in BC; unknown pathological significance; functionally neutral in vitro). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070493.; VARIANT 1606 1606 K -> E (found in breast cancer; unknown pathological significance; dbSNP:rs80356943). /FTId=VAR_007790.; VARIANT 1613 1613 S -> G (common polymorphism; dbSNP:rs1799966). {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:9010228, ECO:0000269|Ref.6}. /FTId=VAR_007791.; VARIANT 1620 1620 T -> A (in dbSNP:rs8176219). {ECO:0000269|Ref.6}. /FTId=VAR_019946.; VARIANT 1623 1623 A -> G (could be associated with cancer susceptibility; major splicing aberration identified with this mutant; dbSNP:rs80356862). {ECO:0000269|PubMed:17924331, ECO:0000269|PubMed:20513136}. /FTId=VAR_063901.; VARIANT 1628 1628 M -> T (in some patients with sporadic breast cancer; unknown pathological significance; dbSNP:rs4986854). {ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:23867111}. /FTId=VAR_007793.; VARIANT 1628 1628 M -> V (found in breast and ovarian cancer patients; unknown pathological significance; dbSNP:rs80357465). /FTId=VAR_007792.; VARIANT 1637 1637 P -> L (rare polymorphism; dbSNP:rs80357048). {ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:9482581}. /FTId=VAR_007794.; VARIANT 1641 1641 A -> P (in ovarian cancer; unknown pathological significance; dbSNP:rs1800726). /FTId=VAR_008762.; VARIANT 1651 1651 S -> F (in BC; unknown pathological significance; dbSNP:rs80356938). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070494.; VARIANT 1651 1651 S -> P (in BC; unknown pathological significance; dbSNP:rs879254042). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070495.; VARIANT 1652 1652 M -> I (rare polymorphism; dbSNP:rs1799967). {ECO:0000269|PubMed:12215251, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:23867111, ECO:0000269|PubMed:9482581}. /FTId=VAR_007795.; VARIANT 1655 1655 S -> F (in BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357390). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070496.; VARIANT 1662 1662 F -> C (in dbSNP:rs28897695). /FTId=VAR_052080.; VARIANT 1665 1665 V -> M (in dbSNP:rs80357169). {ECO:0000269|PubMed:15026808}. /FTId=VAR_020700.; VARIANT 1685 1685 T -> A (in BC; unknown pathological significance; dbSNP:rs80356890). {ECO:0000269|PubMed:17924331}. /FTId=VAR_063902.; VARIANT 1685 1685 T -> I (could be associated with cancer susceptibility; multifactorial likelihood analysis provides evidence for pathogenicity; dbSNP:rs80357043). {ECO:0000269|PubMed:17924331, ECO:0000269|PubMed:20513136}. /FTId=VAR_063903.; VARIANT 1686 1686 H -> Q (in BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs397509218). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070497.; VARIANT 1686 1686 H -> R (in BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs730882166). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070498.; VARIANT 1688 1688 Missing (in BC; unknown pathological significance; functionally impaired in vitro). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070499.; VARIANT 1689 1689 M -> R (in BC; unknown pathological significance; dbSNP:rs80357061). {ECO:0000269|PubMed:17924331}. /FTId=VAR_063904.; VARIANT 1690 1690 K -> Q (in some patients with sporadic breast cancer; unknown pathological significance; dbSNP:rs397507239). {ECO:0000269|PubMed:15365993}. /FTId=VAR_020701.; VARIANT 1691 1691 T -> I (in BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357034). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070500.; VARIANT 1692 1692 D -> N (in ovarian cancer; unknown pathological significance; dbSNP:rs80187739). /FTId=VAR_008763.; VARIANT 1697 1697 C -> R (in ovarian cancer; dbSNP:rs80356993). {ECO:0000269|PubMed:14746861}. /FTId=VAR_020702.; VARIANT 1699 1699 R -> Q (in BC; unknown pathological significance; strongly reduces affinity for a BRIP1 phosphopeptide; functionally impaired in vitro; dbSNP:rs41293459). {ECO:0000269|PubMed:21473589, ECO:0000269|PubMed:23867111}. /FTId=VAR_070501.; VARIANT 1699 1699 R -> W (in BC, ovarian cancer and FANCS; impairs protein stability; functionally impaired in vitro; dbSNP:rs55770810). {ECO:0000269|PubMed:14746861, ECO:0000269|PubMed:17924331, ECO:0000269|PubMed:21473589, ECO:0000269|PubMed:23867111, ECO:0000269|PubMed:25472942}. /FTId=VAR_075666.; VARIANT 1706 1706 G -> A (in BC; unknown pathological significance; dbSNP:rs80356860). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070502.; VARIANT 1706 1706 G -> E (in BC; unknown pathological significance; dbSNP:rs80356860). {ECO:0000269|PubMed:17924331, ECO:0000269|PubMed:23867111}. /FTId=VAR_063905.; VARIANT 1708 1708 A -> E (in BC; abolishes ACACA binding; dbSNP:rs28897696). {ECO:0000269|PubMed:17924331, ECO:0000269|PubMed:23867111, ECO:0000269|PubMed:7939630}. /FTId=VAR_007796.; VARIANT 1713 1713 V -> G. {ECO:0000269|PubMed:15365993}. /FTId=VAR_007797.; VARIANT 1715 1715 S -> R (in BC; unknown pathological significance; dbSNP:rs80357094). {ECO:0000269|PubMed:17924331}. /FTId=VAR_063906.; VARIANT 1718 1718 W -> C (in BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357239). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070503.; VARIANT 1720 1720 T -> A (in BC; unknown pathological significance; functionally neutral in vitro; no effect on in vitro phosphorylation by ATR; dbSNP:rs56195342). {ECO:0000269|PubMed:11114888, ECO:0000269|PubMed:23867111}. /FTId=VAR_070504.; VARIANT 1735 1735 E -> K (in BC; unknown pathological significance; dbSNP:rs397509238). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070505.; VARIANT 1736 1736 V -> A (in BC and FANCS; unknown pathological significance; Decreased localization to DNA damage sites and reduced interaction with UIMC1/RAP80; dbSNP:rs45553935). {ECO:0000269|PubMed:23269703, ECO:0000269|PubMed:23867111}. /FTId=VAR_070506.; VARIANT 1738 1738 G -> R (in BC; unknown pathological significance; dbSNP:rs80356937). {ECO:0000269|PubMed:17924331}. /FTId=VAR_063907.; VARIANT 1739 1739 D -> G (in BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357227). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070507.; VARIANT 1739 1739 D -> V (in BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357227). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070508.; VARIANT 1746 1746 H -> Q (in BC; unknown pathological significance; dbSNP:rs786202389). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070509.; VARIANT 1749 1749 P -> R (in ovarian cancer; unknown pathological significance; abolishes ACACA binding and strongly reduces BRIP1 binding; dbSNP:rs80357462). {ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:11301010, ECO:0000269|PubMed:15133502}. /FTId=VAR_007798.; VARIANT 1753 1753 R -> T (in BC; unknown pathological significance; dbSNP:rs397509246). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070510.; VARIANT 1764 1764 L -> P (in BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357281). {ECO:0000269|PubMed:17924331, ECO:0000269|PubMed:23867111}. /FTId=VAR_063908.; VARIANT 1766 1766 I -> S (in BC; unknown pathological significance; dbSNP:rs80357463). {ECO:0000269|PubMed:17924331}. /FTId=VAR_063909.; VARIANT 1767 1767 C -> S (in BC; unknown pathological significance; functionally neutral in vitro). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070511.; VARIANT 1770 1770 G -> V (in BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs863224765). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070512.; VARIANT 1775 1775 M -> K (in BC; strongly reduced transcription transactivation; abolishes interaction with BRIP1 and RBBP8; dbSNP:rs41293463). {ECO:0000269|PubMed:18285836}. /FTId=VAR_063212.; VARIANT 1775 1775 M -> R (in BC; alters protein stability and abolishes ACACA and BRIP1 binding; dbSNP:rs41293463). {ECO:0000269|PubMed:11301010, ECO:0000269|PubMed:12427738, ECO:0000269|PubMed:15133502, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7939630}. /FTId=VAR_007799.; VARIANT 1776 1776 P -> S (in ovarian cancer; unknown pathological significance; dbSNP:rs1800757). /FTId=VAR_008764.; VARIANT 1780 1780 L -> P (in BC, BROVCA1 and OC; unknown pathological significance; dbSNP:rs80357474). {ECO:0000269|PubMed:28364669}. /FTId=VAR_079607.; VARIANT 1782 1782 W -> C (in BC; unknown pathological significance; functionally neutral in vitro). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070513.; VARIANT 1786 1786 L -> P (in BROVCA1; unknown pathological significance; dbSNP:rs398122697). {ECO:0000269|PubMed:12938098}. /FTId=VAR_020704.; VARIANT 1788 1788 G -> V (in BC; unknown pathological significance; dbSNP:rs80357069). {ECO:0000269|PubMed:17924331}. /FTId=VAR_063910.; VARIANT 1789 1789 A -> T (in BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357078). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070514.; VARIANT 1794 1794 E -> D (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs397509275). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070515.; VARIANT 1804 1804 V -> D (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80356920). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070516.; VARIANT 1812 1812 P -> R (in BC; unknown pathological significance; functionally neutral in vitro). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070517.; VARIANT 1812 1812 P -> S (in ovarian cancer; unknown pathological significance; dbSNP:rs1800751). /FTId=VAR_008765.; VARIANT 1837 1837 W -> R (in BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80356959). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070518.; VARIANT 1862 1862 H -> L (in BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357183). {ECO:0000269|PubMed:23867111}. /FTId=VAR_070519.",,,,CONFLICT 89 89 I -> T (in Ref. 4; AAB61673). {ECO:0000305}.; CONFLICT 148 148 Missing (in Ref. 4; AAB61673). {ECO:0000305}.; CONFLICT 253 253 A -> V (in Ref. 3; AAC00049). {ECO:0000305}.; CONFLICT 713 713 S -> P (in Ref. 8; AAI15038). {ECO:0000305}.; CONFLICT 1077 1077 G -> R (in Ref. 4; AAB61673). {ECO:0000305}.; CONFLICT 1426 1426 S -> P (in Ref. 3; AAC00049). {ECO:0000305}.; CONFLICT 1527 1527 E -> G (in Ref. 8; AAI15038). {ECO:0000305}.,,2,,0,"DOMAIN: The BRCT domains recognize and bind phosphorylated pSXXF motif on proteins. The interaction with the phosphorylated pSXXF motif of ABRAXAS1, recruits BRCA1 at DNA damage sites. {ECO:0000269|PubMed:20159462}.; DOMAIN: The RING-type zinc finger domain interacts with BAP1. {ECO:0000269|PubMed:20159462}.",,,COMPBIAS 651 654 Poly-Lys.,DOMAIN 1642 1736 BRCT 1. {ECO:0000255|PROSITE-ProRule:PRU00033}.; DOMAIN 1756 1855 BRCT 2. {ECO:0000255|PROSITE-ProRule:PRU00033}.,,REGION 1397 1424 Interaction with PALB2. {ECO:0000269|PubMed:19369211}.,,ZN_FING 24 65 RING-type. {ECO:0000255|PROSITE-ProRule:PRU00175}.,2.3.2.27,,"CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:20351172};",,,"FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.",,PATHWAY: Protein modification; protein ubiquitination.,,,,,,,,,,"BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; androgen receptor binding [GO:0050681]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to indole-3-methanol [GO:0071681]; cellular response to tumor necrosis factor [GO:0071356]; centrosome cycle [GO:0007098]; chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; fatty acid biosynthetic process [GO:0006633]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of centriole replication [GO:0046600]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of histone H4-K20 methylation [GO:0070512]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein deubiquitination [GO:0016579]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; response to estrogen [GO:0043627]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]","androgen receptor signaling pathway [GO:0030521]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to indole-3-methanol [GO:0071681]; cellular response to tumor necrosis factor [GO:0071356]; centrosome cycle [GO:0007098]; chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; fatty acid biosynthetic process [GO:0006633]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of centriole replication [GO:0046600]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of histone H4-K20 methylation [GO:0070512]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein deubiquitination [GO:0016579]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; response to estrogen [GO:0043627]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]",androgen receptor binding [GO:0050681]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151],GO:0000151; GO:0000724; GO:0000729; GO:0000800; GO:0003677; GO:0003684; GO:0003713; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005886; GO:0006260; GO:0006301; GO:0006302; GO:0006303; GO:0006349; GO:0006357; GO:0006359; GO:0006633; GO:0006915; GO:0006974; GO:0006978; GO:0007059; GO:0007098; GO:0008270; GO:0008274; GO:0008630; GO:0009048; GO:0010212; GO:0010575; GO:0010628; GO:0015631; GO:0016567; GO:0016579; GO:0019899; GO:0030521; GO:0031398; GO:0031436; GO:0031625; GO:0032991; GO:0033147; GO:0035066; GO:0035067; GO:0042127; GO:0042802; GO:0042981; GO:0043009; GO:0043627; GO:0044030; GO:0044212; GO:0044818; GO:0045717; GO:0045739; GO:0045766; GO:0045892; GO:0045893; GO:0045944; GO:0046600; GO:0050681; GO:0051571; GO:0051572; GO:0051573; GO:0051574; GO:0051865; GO:0070063; GO:0070317; GO:0070512; GO:0070531; GO:0071158; GO:0071356; GO:0071681; GO:0072425; GO:0085020; GO:1902042; GO:1990904; GO:2000378; GO:2000617; GO:2000620,IPR011364; IPR031099; IPR025994; IPR001357; IPR036420; IPR018957; IPR001841; IPR013083; IPR017907; ,Itself; Q6UWZ7; Q13085; Q92560; Q99728; P10415; Q7Z569; Q6PJG6; Q9BX63; P24385; P24864; O14757; P03372; Q92731; Q61188; Q14192; P78347; P16104; O75330; P10809; Q16666; P52292; Q14676; Q8WX92; Q86YC2; P62136; P62140; P36873; Q99708; P63165; P61956; P11388; Q12888; Q96RL1; Q96RL1-1; Q6NZY4; Q9GZX5,"SUBUNIT: Heterodimer with BARD1 (PubMed:11573085, PubMed:12890688, PubMed:14976165). Part of the BRCA1-associated genome surveillance complex (BASC), which contains BRCA1, MSH2, MSH6, MLH1, ATM, BLM, PMS2 and the MRE11-RAD50-NBN protein (MRN) complex (PubMed:10783165). This association could be a dynamic process changing throughout the cell cycle and within subnuclear domains (PubMed:10783165). Component of the BRCA1-A complex, at least composed of BRCA1, BARD1, UIMC1/RAP80, ABRAXAS1, BRCC3/BRCC36, BABAM2 and BABAM1/NBA1 (PubMed:19261746, PubMed:19261748, PubMed:19261749, PubMed:20351172). Interacts (via the BRCT domains) with ABRAXAS1 (phosphorylated form); this is important for recruitment to sites of DNA damage (PubMed:17525340, PubMed:17643121, PubMed:17643122, PubMed:24316840, PubMed:26778126, PubMed:23269703). Can form a heterotetramer with two molecules of ABRAXAS1 (phosphorylated form) (PubMed:26778126). Component of the BRCA1-RBBP8 complex (PubMed:16101277). Interacts (via the BRCT domains) with RBBP8 ('Ser-327' phosphorylated form); the interaction ubiquitinates RBBP8, regulates CHEK1 activation, and involves RBBP8 in BRCA1-dependent G2/M checkpoint control on DNA damage (PubMed:16818604, PubMed:9811458). Associates with RNA polymerase II holoenzyme (PubMed:9662397). Interacts with SMC1A, NELFB, DCLRE1C, CLSPN (PubMed:11877377, PubMed:15096610, PubMed:15456891, PubMed:11739404). Interacts with CHEK1, CHEK2, BAP1, BRCC3, AURKA, UBXN1 and PCLAF (PubMed:10724175, PubMed:11836499, PubMed:14636569, PubMed:14990569, PubMed:20351172, PubMed:21673012). Interacts (via BRCT domains) with BRIP1 (phosphorylated form) (PubMed:11301010, PubMed:15133502, PubMed:21473589). Interacts with FANCD2 (ubiquitinated form) (PubMed:11239454). Interacts with H2AFX (phosphorylated on 'Ser-140') (PubMed:12419185). Interacts (via the BRCT domains) with ACACA (phosphorylated form); the interaction prevents dephosphorylation of ACACA (PubMed:12360400, PubMed:16326698, PubMed:16698035, PubMed:18452305). Part of a BRCA complex containing BRCA1, BRCA2 and PALB2 (PubMed:19369211). Interacts directly with PALB2; the interaction is essential for its function in HRR (PubMed:19369211, PubMed:28319063). Interacts directly with BRCA2; the interaction occurs only in the presence of PALB2 which serves as the bridging protein (PubMed:19369211). Interacts (via the BRCT domains) with LMO4; the interaction represses the transcriptional activity of BRCA1 (PubMed:11751867). Interacts (via the BRCT domains) with CCAR2 (via N-terminus); the interaction represses the transcriptional activator activity of BRCA1 (PubMed:20160719). Interacts with EXD2 (PubMed:26807646). Interacts (via C-terminus) with DHX9; this interaction is direct and links BRCA1 to the RNA polymerase II holoenzyme (PubMed:9662397). {ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:10783165, ECO:0000269|PubMed:11239454, ECO:0000269|PubMed:11301010, ECO:0000269|PubMed:11573085, ECO:0000269|PubMed:11739404, ECO:0000269|PubMed:11751867, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:11877377, ECO:0000269|PubMed:12360400, ECO:0000269|PubMed:12419185, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14636569, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:15096610, ECO:0000269|PubMed:15133502, ECO:0000269|PubMed:15456891, ECO:0000269|PubMed:16101277, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16698035, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:17643121, ECO:0000269|PubMed:17643122, ECO:0000269|PubMed:18452305, ECO:0000269|PubMed:19261746, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19261749, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20159462, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:21473589, ECO:0000269|PubMed:21673012, ECO:0000269|PubMed:23269703, ECO:0000269|PubMed:24316840, ECO:0000269|PubMed:26778126, ECO:0000269|PubMed:26807646, ECO:0000269|PubMed:28319063, ECO:0000269|PubMed:9528852, ECO:0000269|PubMed:9662397, ECO:0000269|PubMed:9811458}.",7545954; 8938427; 9010228; 16625196; 15489334; 10851077; 8972225; 9662397; 9528852; 9811458; 10500182; 10783165; 11114888; 10724175; 11301010; 11739404; 11239454; 12183412; 12419185; 11877377; 11751867; 11836499; 12360400; 12890688; 12887909; 14636569; 14976165; 14990569; 15456891; 15096610; 17081983; 16818604; 16326698; 16698035; 18056443; 17643122; 17643121; 17525332; 17525340; 18762988; 18669648; 19261748; 19261749; 19261746; 19369211; 19690332; 20160719; 20351172; 20364141; 20068231; 21144835; 21673012; 21406692; 22814378; 23186163; 25218447; 25755297; 26807646; 28112733; 28319063; 11573085; 11573086; 12427738; 15609993; 15133502; 16101277; 18452305; 18285836; 20159462; 21473589; 24316840; 26778126; 8807330; 7939630; 7894491; 7894493; 8554067; 8968716; 8776600; 8723683; 9760198; 9482581; 9609997; 10486320; 10323242; 10196379; 12215251; 12442274; 12442275; 12938098; 15026808; 14746861; 14722926; 15365993; 16959974; 17924331; 20513136; 23269703; 23867111; 25472942; 28364669; 29133208,7545954; 8938427; 9010228; 16625196; 15489334; 10851077; 8972225; 9662397; 9528852; 9811458; 10500182; 10783165; 11114888; 10724175; 11301010; 11739404; 11239454; 12183412; 12419185; 11877377; 11751867; 11836499; 12360400; 12890688; 12887909; 14636569; 14976165; 14990569; 15456891; 15096610; 17081983; 16818604; 16326698; 16698035; 18056443; 17643122; 17643121; 17525332; 17525340; 18762988; 18669648; 19261748; 19261749; 19261746; 19369211; 19690332; 20160719; 20351172; 20364141; 20068231; 21144835; 21673012; 21406692; 22814378; 23186163; 25218447; 25755297; 26807646; 28112733; 28319063; 11573085; 11573086; 12427738; 15609993; 15133502; 16101277; 18452305; 18285836; 20159462; 21473589; 24316840; 26778126; 8807330; 7939630; 7894491; 7894493; 8554067; 8968716; 8776600; 8723683; 9760198; 9482581; 9609997; 10486320; 10323242; 10196379; 12215251; 12442274; 12442275; 12938098; 15026808; 14746861; 14722926; 15365993; 16959974; 17924331; 20513136; 23269703; 23867111; 25472942; 28364669; 29133208; 10050867; 10212258; 10373534; 10403822; 10435622; 10438626; 10477523; 10525529; 10542266; 10550055; 10562567; 10608806; 10684722; 10801132; 10856253; 10859164; 10866324; 10921897; 10973490; 11006276; 11025670; 11080452; 11090615; 11139606; 11163768; 11171374; 11192759; 11244506; 11263938; 11278964; 11309330; 11376695; 11390642; 11459987; 11571269; 11673449; 11751635; 11773071; 11832208; 11836613; 11950880; 12101561; 12139939; 12152085; 12354784; 12362311; 12364621; 12370410; 12379650; 12427729; 12433008; 12545175; 12578958; 12607005; 12750242; 12750383; 12773400; 12791985; 12832489; 12909625; 12912992; 12928470; 14527420; 14550570; 14560035; 14576432; 14576433; 14654789; 14680495; 14701743; 14716019; 14734547; 15059511; 15125843; 15133503; 15138485; 15140983; 15159397; 15164066; 15189136; 15190204; 15254237; 15256476; 15485900; 15519522; 15580272; 15589157; 15665856; 15674350; 15703751; 15707391; 15777502; 15916957; 15983032; 15998665; 16123081; 16148040; 16150728; 16153896; 16161633; 16260778; 16327781; 16337601; 16360315; 16452482; 16530042; 16563154; 16628214; 16638864; 16651405; 16712842; 16713569; 16885023; 17007555; 17114795; 17217814; 17312021; 17334399; 17344431; 17352427; 17428325; 17452776; 17474147; 17511879; 17541404; 17557253; 17575048; 17581638; 17585057; 17848578; 17928296; 17962301; 17965729; 17981954; 17996710; 17996711; 18001824; 18001825; 18026198; 18171670; 18256600; 18283110; 18317453; 18443292; 18523885; 18535008; 18539610; 18541667; 18543099; 18663141; 18757400; 18804494; 18805091; 18923075; 18957201; 18971343; 19001859; 19012493; 19074197; 19082709; 19124506; 19146767; 19176521; 19202061; 19268590; 19287951; 19357644; 19419957; 19428384; 19505873; 19531582; 19622773; 19683496; 19690564; 19773279; 19789190; 19809577; 19941829; 20016594; 20016603; 20062530; 20085797; 20207730; 20233725; 20516115; 20729832; 20729858; 20729859; 20871615; 20871616; 20965415; 21052091; 21118815; 21147198; 21240188; 21242970; 21263215; 21282113; 21325134; 21335604; 21338495; 21407215; 21444675; 21659603; 21680713; 21777809; 21804533; 21919919; 21988832; 22012619; 22021381; 22024395; 22193777; 22493164; 22593209; 22635276; 22645308; 22661229; 22661230; 22792074; 22884692; 22977173; 23149936; 23306437; 23333306; 23345434; 23346553; 23509288; 23624935; 23680151; 23686288; 23704879; 23727112; 23731732; 23810717; 23842040; 24013206; 24018806; 24069304; 24073851; 24076221; 24141787; 24371268; 24485656; 24492479; 24509834; 24516540; 24554720; 24662513; 24667604; 24746700; 24831703; 24845084; 25113031; 25122754; 25223785; 25429106; 25561469; 25609649; 25654734; 25659039; 25712099; 25879655; 25939603; 26745677; 26884712; 28035057; 29899443; 7587590; 8650194; 8702565; 8843195; 8929543; 8944023; 8955125; 9008167; 9065463; 9102202; 9135082; 9311981; 9398850; 9443891; 9450758; 9497340; 9660953; 9660954; 9705271; 9735362; 9826763; 9837724; 9839523; 9925639; 9926942,1994-10-01,2019-02-13,1995-02-01,245,X-ray crystallography (25); NMR spectroscopy (2); Electron microscopy (1),STRAND 25 27 {ECO:0000244|PDB:1JM7}.; STRAND 54 58 {ECO:0000244|PDB:1JM7}.; STRAND 78 80 {ECO:0000244|PDB:1JM7}.; STRAND 1651 1656 {ECO:0000244|PDB:4IGK}.; STRAND 1675 1679 {ECO:0000244|PDB:1T29}.; STRAND 1686 1689 {ECO:0000244|PDB:4IGK}.; STRAND 1695 1697 {ECO:0000244|PDB:4IGK}.; STRAND 1712 1715 {ECO:0000244|PDB:4IGK}.; STRAND 1743 1745 {ECO:0000244|PDB:1T29}.; STRAND 1765 1768 {ECO:0000244|PDB:4IGK}.; STRAND 1770 1772 {ECO:0000244|PDB:1T2V}.; STRAND 1773 1775 {ECO:0000244|PDB:4IGK}.; STRAND 1790 1794 {ECO:0000244|PDB:4IGK}.; STRAND 1801 1803 {ECO:0000244|PDB:4IGK}.; STRAND 1806 1810 {ECO:0000244|PDB:4IGK}.; STRAND 1817 1819 {ECO:0000244|PDB:1OQA}.; STRAND 1828 1830 {ECO:0000244|PDB:3PXE}.; STRAND 1832 1834 {ECO:0000244|PDB:4IGK}.,HELIX 3 5 {ECO:0000244|PDB:1JM7}.; HELIX 8 21 {ECO:0000244|PDB:1JM7}.; HELIX 46 53 {ECO:0000244|PDB:1JM7}.; HELIX 81 96 {ECO:0000244|PDB:1JM7}.; HELIX 1659 1671 {ECO:0000244|PDB:4IGK}.; HELIX 1701 1708 {ECO:0000244|PDB:4IGK}.; HELIX 1717 1725 {ECO:0000244|PDB:4IGK}.; HELIX 1731 1734 {ECO:0000244|PDB:4IGK}.; HELIX 1748 1754 {ECO:0000244|PDB:4IGK}.; HELIX 1777 1786 {ECO:0000244|PDB:4IGK}.; HELIX 1795 1797 {ECO:0000244|PDB:4IGK}.; HELIX 1812 1814 {ECO:0000244|PDB:4IGK}.; HELIX 1820 1822 {ECO:0000244|PDB:4IGK}.; HELIX 1824 1827 {ECO:0000244|PDB:4IGK}.; HELIX 1835 1844 {ECO:0000244|PDB:4IGK}.; HELIX 1851 1853 {ECO:0000244|PDB:4IGK}.,TURN 62 64 {ECO:0000244|PDB:1JM7}.; TURN 70 72 {ECO:0000244|PDB:1JM7}.; TURN 1740 1742 {ECO:0000244|PDB:4IGK}.; TURN 1755 1757 {ECO:0000244|PDB:1T29}.; TURN 1760 1763 {ECO:0000244|PDB:4IGK}.,,,,,5 out of 5,Alternative sequence (8); Beta strand (18); Chain (1); Compositional bias (1); Cross-link (13); Domain (2); Erroneous initiation (1); Erroneous termination (1); Erroneous translation (1); Helix (16); Modified residue (31); Mutagenesis (28); Natural variant (170); Region (1); Sequence conflict (8); Turn (5); Zinc finger (1),,TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.,,3D-structure;Acetylation;Activator;Alternative initiation;Alternative splicing;Cell cycle;Chromosome;Complete proteome;Cytoplasm;DNA damage;DNA recombination;DNA repair;DNA-binding;Direct protein sequencing;Disease mutation;Fanconi anemia;Fatty acid biosynthesis;Fatty acid metabolism;Isopeptide bond;Lipid biosynthesis;Lipid metabolism;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Tumor suppressor;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger,Evidence at protein level,reviewed,,,245,Activity regulation (1); Alternative products (1); Catalytic activity (1); Caution (5); Domain (2); Function (1); Involvement in disease (5); Pathway (1); Polymorphism (1); Post-translational modification (2); Subcellular location (3); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0010; KW-0024; KW-0025; KW-0043; KW-0131; KW-0158; KW-0181; KW-0225; KW-0227; KW-0233; KW-0234; KW-0238; KW-0275; KW-0276; KW-0443; KW-0444; KW-0479; KW-0539; KW-0597; KW-0621; KW-0677; KW-0804; KW-0805; KW-0808; KW-0832; KW-0833; KW-0862; KW-0863; KW-0903; KW-0923; KW-0963; KW-1017; KW-1185,Protein modification; protein ubiquitination. ,,,,"DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:11114888, ECO:0000269|PubMed:11301010, ECO:0000269|PubMed:12427738, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15133502, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:21473589, ECO:0000269|PubMed:23867111, ECO:0000269|PubMed:28364669, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3-fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:28364669, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861, ECO:0000269|PubMed:28364669}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia, complementation group S (FANCS) [MIM:617883]: A form of Fanconi anemia, a disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:23269703, ECO:0000269|PubMed:25472942, ECO:0000269|PubMed:29133208}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.",,,"PTM: Phosphorylation at Ser-308 by AURKA is required for normal cell cycle progression from G2 to mitosis. Phosphorylated in response to IR, UV, and various stimuli that cause checkpoint activation, probably by ATM or ATR. Phosphorylation at Ser-988 by CHEK2 regulates mitotic spindle assembly. {ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11114888, ECO:0000269|PubMed:12183412, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:20364141, ECO:0000269|PubMed:21144835}.; PTM: Autoubiquitinated, undergoes 'Lys-6'-linked polyubiquitination. 'Lys-6'-linked polyubiquitination does not promote degradation. {ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:20351172}.",CHAIN 1 1863 Breast cancer type 1 susceptibility protein. /FTId=PRO_0000055830.,"CROSSLNK 109 109 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 301 301 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 339 339 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 443 443 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 459 459 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:28112733}.; CROSSLNK 519 519 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 583 583 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 654 654 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447}.; CROSSLNK 734 734 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447}.; CROSSLNK 739 739 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447}.; CROSSLNK 918 918 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 987 987 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 1079 1079 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.",,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 114 114 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 308 308 Phosphoserine; by AURKA. {ECO:0000269|PubMed:14990569}.; MOD_RES 395 395 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 398 398 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 423 423 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 434 434 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 551 551 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 694 694 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 708 708 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 725 725 Phosphoserine. {ECO:0000250|UniProtKB:P48754}.; MOD_RES 753 753 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 840 840 Phosphoserine. {ECO:0000250|UniProtKB:P48754}.; MOD_RES 988 988 Phosphoserine; by CHEK2. {ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:20364141}.; MOD_RES 1009 1009 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1143 1143 Phosphoserine; by ATR; in vitro. {ECO:0000269|PubMed:11114888}.; MOD_RES 1189 1189 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1191 1191 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1211 1211 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1217 1217 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1218 1218 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692}.; MOD_RES 1280 1280 Phosphoserine; by ATR; in vitro. {ECO:0000269|PubMed:11114888}.; MOD_RES 1328 1328 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 1336 1336 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 1342 1342 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 1387 1387 Phosphoserine; by ATM and ATR. {ECO:0000269|PubMed:11114888}.; MOD_RES 1394 1394 Phosphothreonine; by ATR; in vitro. {ECO:0000269|PubMed:11114888}.; MOD_RES 1423 1423 Phosphoserine; by ATM and ATR. {ECO:0000269|PubMed:11114888}.; MOD_RES 1457 1457 Phosphoserine; by ATR; in vitro. {ECO:0000269|PubMed:11114888}.; MOD_RES 1524 1524 Phosphoserine; by ATM. {ECO:0000269|PubMed:21144835}.; MOD_RES 1542 1542 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U14680;L78833;U64805;AF005068;DQ190450;DQ190451;DQ190452;DQ190453;DQ190454;DQ190455;DQ190456;AY273801;BC072418;BC115037;
0,O00444,PLK4_HUMAN,PLK4 SAK STK18,PLK4,SAK STK18,,,Homo sapiens (Human),9606,Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak),UP000005640: Chromosome 4,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDLGTVEDSIDSGHATISTAITASSSTSISGSLFDKRRLLIGQPLPNKMTVFPKNKSSTDFSSSGDGNSFYTQWGNQETSNSGRGRVIQDAEERPHSRYLRRAYSSDRSGTSNSQSQAKTYTMERCHSAEMLSVSKRSGGGENEERYSPTDNNANIFNFFKEKTSSSSGSFERPDNNQALSNHLCPGKTPFPFADPTPQTETVQQWFGNLQINAHLRKTTEYDSISPNRDFQGHPDLQKDTSKNAWTDTKVKKNSDASDNAHSVKQQNTMKYMTALHSKPEIIQQECVFGSDPLSEQSKTRGMEPPWGYQNRTLRSITSPLVAHRLKPIRQKTKKAVVSILDSEEVCVELVKEYASQEYVKEVLQISSDGNTITIYYPNGGRGFPLADRPPSPTDNISRYSFDNLPEKYWRKYQYASRFVQLVRSKSPKITYFTRYAKCILMENSPGADFEVWFYDGVKIHKTEDFIQVIEKTGKSYTLKSESEVNSLKEEIKMYMDHANEGHRICLALESIISEEERKTRSAPFFPIIIGRKPGSTSSPKALSPPPSVDSNYPTRERASFNRMVMHSAASPTQAPILNPSMVTNEGLGLTTTASGTDISSNSLKDCLPKSAQLLKSVFVKNVGWATQLTSGAVWVQFNDGSQLVVQAGVSSISYTSPNGQTTRYGENEKLPDYIKQKLQCLSSILLMFSNPTPNFH,970,"108,972",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=O00444-1; Sequence=Displayed; Name=2; IsoId=O00444-2; Sequence=VSP_038117; Note=No experimental confirmation available.; Name=3; IsoId=O00444-3; Sequence=VSP_038116; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 1 41 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_038116.; VAR_SEQ 43 74 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_038117.,"VARIANT 86 86 Y -> C (in dbSNP:rs34156294). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041027.; VARIANT 146 146 R -> H (in dbSNP:rs35232579). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041028.; VARIANT 226 226 A -> T (in dbSNP:rs35448573). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041029.; VARIANT 232 232 S -> T (in dbSNP:rs3811740). {ECO:0000269|PubMed:11489907, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.1}. /FTId=VAR_019632.; VARIANT 317 317 P -> L (in dbSNP:rs35049837). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041030.; VARIANT 449 449 N -> D (in dbSNP:rs34906574). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041031.; VARIANT 519 519 W -> S (in dbSNP:rs56043017). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041032.; VARIANT 830 830 E -> D (in dbSNP:rs17012739). {ECO:0000269|PubMed:11489907, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:17344846, ECO:0000269|Ref.1}. /FTId=VAR_041033.",,,,CONFLICT 34 34 T -> S (in Ref. 2; BAB69958). {ECO:0000305}.; CONFLICT 58 58 Q -> K (in Ref. 1; CAA73575). {ECO:0000305}.; CONFLICT 333 333 D -> N (in Ref. 3; BAH13823). {ECO:0000305}.; CONFLICT 387 387 S -> R (in Ref. 2; BAB69958). {ECO:0000305}.; CONFLICT 692 692 F -> S (in Ref. 3; BAH13823). {ECO:0000305}.; CONFLICT 696 696 V -> L (in Ref. 2; BAB69958). {ECO:0000305}.; CONFLICT 768 768 Y -> F (in Ref. 1; CAA73575). {ECO:0000305}.; CONFLICT 842 842 A -> D (in Ref. 2; BAB69958). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. CDC5/Polo subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,DOMAIN 12 265 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.; DOMAIN 892 956 POLO box. {ECO:0000255|PROSITE-ProRule:PRU00154}.,,,,,2.7.11.21,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.21; Evidence={ECO:0000269|PubMed:16244668, ECO:0000269|PubMed:18239451, ECO:0000269|PubMed:19164942}; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.21; Evidence={ECO:0000269|PubMed:16244668, ECO:0000269|PubMed:18239451, ECO:0000269|PubMed:19164942};",,,"FUNCTION: Serine/threonine-protein kinase that plays a central role in centriole duplication. Able to trigger procentriole formation on the surface of the parental centriole cylinder, leading to the recruitment of centriole biogenesis proteins such as SASS6, CENPJ/CPAP, CCP110, CEP135 and gamma-tubulin. When overexpressed, it is able to induce centrosome amplification through the simultaneous generation of multiple procentrioles adjoining each parental centriole during S phase. Phosphorylates 'Ser-151' of FBXW5 during the G1/S transition, leading to inhibit FBXW5 ability to ubiquitinate SASS6. Its central role in centriole replication suggests a possible role in tumorigenesis, centrosome aberrations being frequently observed in tumors. Also involved in deuterosome-mediated centriole amplification in multiciliated that can generate more than 100 centrioles. Also involved in trophoblast differentiation by phosphorylating HAND1, leading to disrupt the interaction between HAND1 and MDFIC and activate HAND1. Phosphorylates CDC25C and CHEK2. Required for the recruitment of STIL to the centriole and for STIL-mediated centriole amplification (PubMed:22020124). {ECO:0000269|PubMed:16244668, ECO:0000269|PubMed:16326102, ECO:0000269|PubMed:17681131, ECO:0000269|PubMed:18239451, ECO:0000269|PubMed:19164942, ECO:0000269|PubMed:21725316, ECO:0000269|PubMed:22020124, ECO:0000269|PubMed:27796307}.",,,,,,ACT_SITE 136 136 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159}.,BINDING 41 41 ATP. {ECO:0000305}.,,,NP_BIND 18 26 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleolus [GO:0005730]; XY body [GO:0001741]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of centriole replication [GO:0046601]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; trophoblast giant cell differentiation [GO:0060707],centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of centriole replication [GO:0046601]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; trophoblast giant cell differentiation [GO:0060707],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674],centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleolus [GO:0005730]; XY body [GO:0001741],GO:0000086; GO:0001741; GO:0004674; GO:0005524; GO:0005730; GO:0005813; GO:0005814; GO:0005829; GO:0006468; GO:0007099; GO:0010389; GO:0032154; GO:0042802; GO:0046601; GO:0060707; GO:0097711; GO:0098535; GO:0098536,IPR011009; IPR033700; IPR000959; IPR033699; IPR033698; IPR033696; IPR000719; IPR017441; IPR008266; ,Itself; P36575; Q9Y297; Q9NX04; O94986; O94986-3; Q8TEP8; Q8TEP8-3; Q9H8V3; Q14241; P31947; Q15468,"SUBUNIT: Homodimer (By similarity). Interacts with CEP152 (via N-terminus). Interacts with CEP78; this interaction may be important for proper PLK4 localization to the centriole and PLK4-induced overduplication of centrioles (PubMed:27246242). {ECO:0000250|UniProtKB:Q64702, ECO:0000269|PubMed:20852615, ECO:0000269|PubMed:21059844, ECO:0000269|PubMed:27246242}.",11489907; 14702039; 15489334; 8260651; 1311287; 16326102; 16244668; 15967108; 17681131; 18239451; 18691976; 18669648; 19164942; 19454482; 19369195; 21059844; 20852615; 22020124; 21725316; 23186163; 25344692; 27246242; 17344846; 27796307,11489907; 14702039; 15489334; 8260651; 1311287; 16326102; 16244668; 15967108; 17681131; 18239451; 18691976; 18669648; 19164942; 19454482; 19369195; 21059844; 20852615; 22020124; 21725316; 23186163; 25344692; 27246242; 17344846; 27796307; 11076968; 11956313; 12207013; 12221128; 12852856; 13678582; 14580337; 15498487; 15705883; 16189514; 16357211; 16462731; 16890155; 17574030; 17646400; 17719545; 17721511; 18037885; 18566290; 18615013; 18694559; 19001868; 19004860; 19679553; 19940019; 20032307; 20230748; 20348415; 20399632; 20508983; 20516151; 20531387; 20558667; 20832753; 20923822; 21059850; 21273506; 21297952; 21347367; 21422230; 21548880; 21565611; 21609466; 21620453; 21725307; 21792235; 21900206; 21985771; 21988832; 22094468; 22179047; 22349698; 22456511; 22653444; 22829937; 23019411; 23141531; 23141541; 23249732; 23253480; 23348840; 23400999; 23530209; 23641073; 23653187; 23747070; 23769972; 23789104; 23921553; 23974100; 24053599; 24089205; 24231678; 24277814; 24389189; 24469809; 24498222; 24588599; 24797070; 24867403; 24981932; 24982133; 24997597; 25043604; 25047611; 25174401; 25313408; 25320347; 25342035; 25347426; 25416956; 25532896; 25590559; 25723005; 25795303; 25859044; 25931445; 26101219; 26188084; 26439168; 26452337; 26496610; 26638075; 26755742; 27112295; 27650967; 27872092; 27911707; 28202467; 28238495; 28562169; 28832566; 29712910; 29768346; 7769006; 7790358; 8838651,2004-08-16,2019-02-13,2007-11-13,177,X-ray crystallography (9); NMR spectroscopy (1),STRAND 12 20 {ECO:0000244|PDB:3COK}.; STRAND 22 31 {ECO:0000244|PDB:3COK}.; STRAND 37 44 {ECO:0000244|PDB:3COK}.; STRAND 75 80 {ECO:0000244|PDB:3COK}.; STRAND 82 90 {ECO:0000244|PDB:3COK}.; STRAND 104 106 {ECO:0000244|PDB:4JXF}.; STRAND 142 144 {ECO:0000244|PDB:3COK}.; STRAND 150 152 {ECO:0000244|PDB:3COK}.; STRAND 602 605 {ECO:0000244|PDB:4N9J}.; STRAND 607 613 {ECO:0000244|PDB:4N9J}.; STRAND 619 627 {ECO:0000244|PDB:4N9J}.; STRAND 630 639 {ECO:0000244|PDB:4N9J}.; STRAND 645 649 {ECO:0000244|PDB:4N9J}.; STRAND 671 674 {ECO:0000244|PDB:4N9J}.; STRAND 700 706 {ECO:0000244|PDB:4N9J}.; STRAND 708 716 {ECO:0000244|PDB:4N9J}.; STRAND 723 727 {ECO:0000244|PDB:4N9J}.; STRAND 732 735 {ECO:0000244|PDB:4N9J}.; STRAND 740 743 {ECO:0000244|PDB:4N9J}.; STRAND 749 752 {ECO:0000244|PDB:4N9J}.; STRAND 800 804 {ECO:0000244|PDB:4N9J}.; STRAND 887 893 {ECO:0000244|PDB:5LHZ}.; STRAND 897 902 {ECO:0000244|PDB:5LHZ}.; STRAND 905 911 {ECO:0000244|PDB:5LHZ}.; STRAND 916 922 {ECO:0000244|PDB:5LHZ}.; STRAND 924 929 {ECO:0000244|PDB:5LHZ}.; STRAND 935 939 {ECO:0000244|PDB:5LHZ}.,HELIX 2 5 {ECO:0000244|PDB:3COK}.; HELIX 9 11 {ECO:0000244|PDB:3COK}.; HELIX 45 50 {ECO:0000244|PDB:3COK}.; HELIX 54 64 {ECO:0000244|PDB:3COK}.; HELIX 97 102 {ECO:0000244|PDB:3COK}.; HELIX 110 129 {ECO:0000244|PDB:3COK}.; HELIX 139 141 {ECO:0000244|PDB:3COK}.; HELIX 193 206 {ECO:0000244|PDB:3COK}.; HELIX 217 225 {ECO:0000244|PDB:4JXF}.; HELIX 236 245 {ECO:0000244|PDB:3COK}.; HELIX 250 252 {ECO:0000244|PDB:3COK}.; HELIX 256 259 {ECO:0000244|PDB:3COK}.; HELIX 587 590 {ECO:0000244|PDB:4N9J}.; HELIX 651 654 {ECO:0000244|PDB:4N9J}.; HELIX 675 677 {ECO:0000244|PDB:4N9J}.; HELIX 680 682 {ECO:0000244|PDB:4N9J}.; HELIX 683 698 {ECO:0000244|PDB:4N9J}.; HELIX 755 759 {ECO:0000244|PDB:4N9J}.; HELIX 765 793 {ECO:0000244|PDB:4N9J}.; HELIX 946 961 {ECO:0000244|PDB:5LHZ}.,TURN 32 34 {ECO:0000244|PDB:3COK}.; TURN 158 161 {ECO:0000244|PDB:4JXF}.; TURN 263 265 {ECO:0000244|PDB:3COK}.; TURN 894 896 {ECO:0000244|PDB:5LHZ}.; TURN 931 933 {ECO:0000244|PDB:2N19}.,,,,,5 out of 5,Active site (1); Alternative sequence (2); Beta strand (27); Binding site (1); Chain (1); Domain (2); Helix (20); Modified residue (5); Mutagenesis (3); Natural variant (8); Nucleotide binding (1); Sequence conflict (8); Turn (5),,,,3D-structure;ATP-binding;Acetylation;Alternative splicing;Complete proteome;Cytoplasm;Cytoskeleton;Dwarfism;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation,Evidence at protein level,reviewed,,"Protein kinase superfamily, Ser/Thr protein kinase family, CDC5/Polo subfamily",177,Alternative products (1); Catalytic activity (2); Caution (2); Function (1); Induction (1); Involvement in disease (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0025; KW-0067; KW-0181; KW-0206; KW-0242; KW-0418; KW-0539; KW-0547; KW-0597; KW-0621; KW-0723; KW-0808; KW-0832; KW-0963; KW-1185,,,,,"DISEASE: Microcephaly and chorioretinopathy, autosomal recessive, 2 (MCCRP2) [MIM:616171]: A severe disorder characterized by microcephaly, delayed psychomotor development, growth retardation with dwarfism, and ocular abnormalities. {ECO:0000269|PubMed:25344692}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: Acetylation by KAT2A and KAT2B impairs kinase activity by shifting the kinase to an inactive conformation. {ECO:0000269|PubMed:27796307}.; PTM: Ubiquitinated; leading to its degradation by the proteasome. {ECO:0000250}.; PTM: Tyrosine-phosphorylated by TEC. {ECO:0000269|PubMed:11489907}.,CHAIN 1 970 Serine/threonine-protein kinase PLK4. /FTId=PRO_0000086567.,,,,,,"MOD_RES 45 45 N6-acetyllysine. {ECO:0000269|PubMed:27796307}.; MOD_RES 46 46 N6-acetyllysine. {ECO:0000269|PubMed:27796307}.; MOD_RES 401 401 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195}.; MOD_RES 665 665 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 817 817 Phosphoserine. {ECO:0000244|PubMed:19369195}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,Y13115;AB006972;AK302858;AK303399;AK314238;BC036023;
0,P49450,CENPA_HUMAN,CENPA,CENPA,,,,Homo sapiens (Human),9606,Histone H3-like centromeric protein A (Centromere autoantigen A) (Centromere protein A) (CENP-A),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGPRRRSRKPEAPRRRSPSPTPTPGPSRRGPSLGASSHQHSRRRQGWLKEIRKLQKSTHLLIRKLPFSRLAREICVKFTRGVDFNWQAQALLALQEAAEAFLVHLFEDAYLLTLHAGRVTLFPKDVQLARRIRGLEEGLG,140,"15,991",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P49450-1; Sequence=Displayed; Name=2; IsoId=P49450-2; Sequence=VSP_020430; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 71 96 Missing (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_020430.,,,,,,,1,,0,"DOMAIN: The CATD (CENPA targeting domain) region is responsible for the more compact structure of nucleosomes containing CENPA (PubMed:15282608). It is necessary and sufficient to mediate the localization into centromeres (PubMed:7962047, PubMed:15282608). {ECO:0000269|PubMed:15282608, ECO:0000269|PubMed:7962047}.",SIMILARITY: Belongs to the histone H3 family. {ECO:0000305}.,,,,,"REGION 39 54 Important for flexibility of DNA ends that protrude from nucleosomes. {ECO:0000269|PubMed:27499292}.; REGION 75 116 CATD. {ECO:0000269|PubMed:15282608, ECO:0000269|PubMed:7962047}.",,,,,,,,"FUNCTION: Histone H3-like nucleosomal protein that is specifically found in centromeric nucleosomes (PubMed:7962047, PubMed:9024683, PubMed:11756469, PubMed:14667408, PubMed:15702419, PubMed:15475964, PubMed:15282608, PubMed:17651496, PubMed:19114591, PubMed:27499292, PubMed:20739937). Replaces conventional H3 in the nucleosome core of centromeric chromatin at the inner plate of the kinetochore (PubMed:18072184). The presence of CENPA subtly modifies the nucleosome structure and the way DNA is wrapped around the nucleosome and gives rise to protruding DNA ends that are less well-ordered and rigid compared to nucleosomes containing histone H3 (PubMed:27499292, PubMed:26878239). May serve as an epigenetic mark that propagates centromere identity through replication and cell division (PubMed:15475964, PubMed:15282608, PubMed:26878239, PubMed:20739937, PubMed:21478274). Required for recruitment and assembly of kinetochore proteins, and as a consequence required for progress through mitosis, chromosome segregation and cytokinesis (PubMed:11756469, PubMed:14667408, PubMed:18072184, PubMed:23818633, PubMed:25556658, PubMed:27499292). {ECO:0000269|PubMed:11756469, ECO:0000269|PubMed:14667408, ECO:0000269|PubMed:15282608, ECO:0000269|PubMed:15475964, ECO:0000269|PubMed:15702419, ECO:0000269|PubMed:17651496, ECO:0000269|PubMed:18072184, ECO:0000269|PubMed:19114591, ECO:0000269|PubMed:21478274, ECO:0000269|PubMed:23818633, ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:26878239, ECO:0000269|PubMed:27499292, ECO:0000269|PubMed:7962047, ECO:0000269|PubMed:9024683, ECO:0000305|PubMed:20739937}.",,,,,,,,,,,,"chromosome, centromeric region [GO:0000775]; condensed chromosome inner kinetochore [GO:0000939]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; nuclear nucleosome [GO:0000788]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; CENP-A containing nucleosome assembly [GO:0034080]; establishment of mitotic spindle orientation [GO:0000132]; kinetochore assembly [GO:0051382]; mitotic cytokinesis [GO:0000281]; protein localization to chromosome, centromeric region [GO:0071459]; viral process [GO:0016032]","CENP-A containing nucleosome assembly [GO:0034080]; establishment of mitotic spindle orientation [GO:0000132]; kinetochore assembly [GO:0051382]; mitotic cytokinesis [GO:0000281]; protein localization to chromosome, centromeric region [GO:0071459]; viral process [GO:0016032]",chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982],"chromosome, centromeric region [GO:0000775]; condensed chromosome inner kinetochore [GO:0000939]; condensed nuclear chromosome, centromeric region [GO:0000780]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; nuclear nucleosome [GO:0000788]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]",GO:0000132; GO:0000281; GO:0000775; GO:0000778; GO:0000780; GO:0000786; GO:0000788; GO:0000939; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0016032; GO:0031492; GO:0031618; GO:0034080; GO:0046982; GO:0051382; GO:0071459,IPR009072; IPR007125; IPR000164; ,Q03188; P62805; Q8NCD3; Q8NCD3-1; P49736; P06748-1,"SUBUNIT: Component of centromeric nucleosomes, where DNA is wrapped around a histone octamer core (PubMed:23818633, PubMed:26878239, PubMed:20739937, PubMed:21743476). The octamer contains two molecules each of H2A, H2B, CENPA and H4 assembled in one CENPA-H4 heterotetramer and two H2A-H2B heterodimers (PubMed:23818633, PubMed:26878239, PubMed:20739937, PubMed:21743476). CENPA modulates the DNA-binding characteristics of nucleosomes so that protruding DNA ends have higher flexibility than in nucleosomes containing conventional histone H3 (PubMed:27499292, PubMed:21743476). Inhibits binding of histone H1 to nucleosomes, since histone H1 binds preferentially to rigid DNA linkers that protrude from nucleosomes (PubMed:27499292). Nucleosomes containing CENPA also contain histone H2A variants such as macroH2A H2AFY and H2A.Z/H2AFZ (Probable). The CENPA-H4 heterotetramer is more compact and structurally more rigid than corresponding H3-H4 heterotetramers (PubMed:15282608, PubMed:20739937). Can assemble into nucleosomes that contain both CENPA and histone H3.3; these nucleosomes interact with a single CENPC chain (PubMed:25408271). Heterotrimer composed of HJURP, CENPA and histone H4, where HJURP interacts with the dimer formed by CENPA and histone H4 and prevents tetramerization of CENPA and H4 (PubMed:21478274). Component of the CENPA-NAC complex, at least composed of CENPA, CENPC, CENPH, CENPM, CENPN, CENPT and CENPU (PubMed:16622419). Interacts (via CATD domain) with HJURP; the interaction is direct and is required for its localization to centromeres (PubMed:15282608, PubMed:19410544, PubMed:19410545, PubMed:23818633, PubMed:25556658). Interacts with CENPC, CENPN and CENPT; interaction is direct. Part of a centromere complex consisting of CENPA, CENPT and CENPW (PubMed:19533040). Identified in centromere complexes containing histones H2A, H2B and H4, and at least CENPA, CENPB, CENPC, CENPT, CENPN, HJURP, SUPT16H, SSRP1 and RSF1 (PubMed:27499292). Can self-associate (PubMed:9024683). The CENPA-H4 heterotetramer can bind DNA by itself (in vitro) (PubMed:20739937). Interacts with CDK1, PPP1CA and RBBP7 (PubMed:25556658). {ECO:0000269|PubMed:15282608, ECO:0000269|PubMed:16622419, ECO:0000269|PubMed:19410544, ECO:0000269|PubMed:19410545, ECO:0000269|PubMed:19412974, ECO:0000269|PubMed:19503796, ECO:0000269|PubMed:19533040, ECO:0000269|PubMed:19543270, ECO:0000269|PubMed:20739937, ECO:0000269|PubMed:21478274, ECO:0000269|PubMed:21743476, ECO:0000269|PubMed:23818633, ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:26878239, ECO:0000269|PubMed:27499292, ECO:0000269|PubMed:9024683, ECO:0000305}.; SUBUNIT: (Microbial infection) Interacts directly with herpes virus HHV-1 protein ICP0. {ECO:0000269|PubMed:11053442}.",7962047; 15815621; 15489334; 9024683; 10759786; 11053442; 11756469; 14667408; 15702419; 15475964; 15282608; 17081983; 16622419; 17651496; 18239465; 18072184; 19412974; 19114591; 18669648; 19410544; 19410545; 19533040; 19543270; 19503796; 21406692; 23186163; 23818633; 24275569; 24522885; 25556658; 27499292; 26878239; 20739937; 21478274; 21743476; 25408271; 26543159,7962047; 15815621; 15489334; 9024683; 10759786; 11053442; 11756469; 14667408; 15702419; 15475964; 15282608; 17081983; 16622419; 17651496; 18239465; 18072184; 19412974; 19114591; 18669648; 19410544; 19410545; 19533040; 19543270; 19503796; 21406692; 23186163; 23818633; 24275569; 24522885; 25556658; 27499292; 26878239; 20739937; 21478274; 21743476; 25408271; 26543159; 11081627; 11181178; 11509732; 11804586; 11884609; 12006501; 12194817; 12839935; 14730319; 15085137; 15339662; 15592459; 15723797; 15737063; 16541025; 16622420; 17030981; 17129783; 17199038; 17244537; 17339380; 17474147; 18007590; 18097444; 18716626; 19398759; 19625449; 19714251; 19717431; 19965387; 20003272; 20080577; 20160010; 20206496; 20331851; 20566683; 20630806; 20643881; 20650959; 21059934; 21068465; 21397845; 21399697; 21423629; 21768289; 21826412; 21878504; 21956590; 21987589; 22127263; 22467948; 22473132; 22542705; 22559056; 22817894; 22885700; 23184928; 23363600; 23613856; 23623556; 23644596; 23657009; 23712606; 23771058; 23890477; 24440098; 24530302; 24917673; 25036634; 25117489; 25713413; 25786215; 25795299; 25843710; 25942623; 25954010; 26496610; 26527398; 27062469; 27159521; 27270040; 27454815; 27811920; 27880912; 28017591; 28069312; 28073008; 28167779; 28266506; 28286049; 28377371; 28489565; 28596481; 28787590; 28816574; 29269420; 29280735; 29760389,1996-02-01,2019-02-13,1996-02-01,185,X-ray crystallography (6); Electron microscopy (2),STRAND 85 87 {ECO:0000244|PDB:3R45}.; STRAND 119 121 {ECO:0000244|PDB:3NQJ}.,HELIX 47 56 {ECO:0000244|PDB:3WTP}.; HELIX 64 79 {ECO:0000244|PDB:3NQJ}.; HELIX 88 115 {ECO:0000244|PDB:3NQJ}.; HELIX 123 133 {ECO:0000244|PDB:3NQJ}.,,,,,,5 out of 5,Alternative sequence (1); Beta strand (2); Chain (1); Helix (4); Initiator methionine (1); Modified residue (6); Mutagenesis (8); Region (2),,,MISCELLANEOUS: Antibodies against CENPA are present in sera from patients with autoimmune diseases that developed autoantibodies against centrosomal proteins.,3D-structure;ADP-ribosylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Complete proteome;DNA-binding;Host-virus interaction;Kinetochore;Methylation;Mitosis;Nucleosome core;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,Histone H3 family,185,Alternative products (1); Caution (1); Developmental stage (1); Domain (1); Function (1); Miscellaneous (1); Post-translational modification (4); Sequence similarities (1); Subcellular location (1); Subunit structure (2),,KW-0002; KW-0013; KW-0025; KW-0131; KW-0132; KW-0137; KW-0158; KW-0181; KW-0238; KW-0488; KW-0498; KW-0539; KW-0544; KW-0597; KW-0832; KW-0945; KW-0995; KW-1185,,,,,,,,"PTM: Ubiquitinated (Probable). Interaction with herpes virus HSV-1 ICP0 protein, leads to its degradation by the proteasome pathway. {ECO:0000269|PubMed:11053442, ECO:0000305}.; PTM: Trimethylated by NTMT1 at the N-terminal glycine after cleavage of Met-1. Methylation is low before incorporation into nucleosomes and increases with cell cycle progression, with the highest levels in mitotic nucleosomes. {ECO:0000269|PubMed:23818633}.; PTM: Phosphorylated by CDK1 at Ser-68 during early mitosis; this abolishes association with chromatin and centromeres, prevents interaction with HJURP and thereby prevents premature assembly of CENPA into centromeres (PubMed:25556658). Dephosphorylated at Ser-68 by PPP1CA during late mitosis (PubMed:25556658). Phosphorylation of Ser-7 by AURKA and AURKB during prophase is required for localization of AURKA and AURKB at inner centromere and is essential for normal cytokinesis (PubMed:11756469, PubMed:14667408, PubMed:18239465). Initial phosphorylation during prophase is mediated by AURKA and is maintained by AURKB. {ECO:0000269|PubMed:11756469, ECO:0000269|PubMed:14667408, ECO:0000269|PubMed:18239465, ECO:0000269|PubMed:25556658}.; PTM: Poly-ADP-ribosylated by PARP1. {ECO:0000250|UniProtKB:O35216}.",CHAIN 2 140 Histone H3-like centromeric protein A. /FTId=PRO_0000221373.,,,,INIT_MET 1 1 Removed. {ECO:0000269|PubMed:23818633}.,,"MOD_RES 2 2 N,N,N-trimethylglycine. {ECO:0000269|PubMed:23818633, ECO:0000269|PubMed:26543159}.; MOD_RES 7 7 Phosphoserine; by AURKA and AURKB. {ECO:0000269|PubMed:11756469, ECO:0000269|PubMed:14667408, ECO:0000269|PubMed:18239465}.; MOD_RES 17 17 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:23818633}.; MOD_RES 19 19 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:23818633}.; MOD_RES 27 27 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692}.; MOD_RES 68 68 Phosphoserine. {ECO:0000269|PubMed:25556658}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U14518;BT007246;AC011740;CH471053;CH471053;BC000881;BC002703;U82609;
0,P63165,SUMO1_HUMAN,SUMO1 SMT3C SMT3H3 UBL1 OK/SW-cl.43,SUMO1,SMT3C SMT3H3 UBL1,,OK/SW-cl.43,Homo sapiens (Human),9606,Small ubiquitin-related modifier 1 (SUMO-1) (GAP-modifying protein 1) (GMP1) (SMT3 homolog 3) (Sentrin) (Ubiquitin-homology domain protein PIC1) (Ubiquitin-like protein SMT3C) (Smt3C) (Ubiquitin-like protein UBL1),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV,101,"11,557",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P63165-1; Sequence=Displayed; Name=2; IsoId=P63165-2; Sequence=VSP_046756; Note=No experimental confirmation available. Gene prediction based on EST data.; ,,,,,,,,,,VAR_SEQ 4 28 Missing (in isoform 2). {ECO:0000305}. /FTId=VSP_046756.,,,,,CONFLICT 75 75 H -> N (in Ref. 13; AAH66306). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the ubiquitin family. SUMO subfamily. {ECO:0000305}.,,,DOMAIN 20 97 Ubiquitin-like. {ECO:0000255|PROSITE-ProRule:PRU00214}.,,,,,,,,,,"FUNCTION: Ubiquitin-like protein that can be covalently attached to proteins as a monomer or a lysine-linked polymer. Covalent attachment via an isopeptide bond to its substrates requires prior activation by the E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can be promoted by E3 ligases such as PIAS1-4, RANBP2 or CBX4. This post-translational modification on lysine residues of proteins plays a crucial role in a number of cellular processes such as nuclear transport, DNA replication and repair, mitosis and signal transduction. Involved for instance in targeting RANGAP1 to the nuclear pore complex protein RANBP2. Covalently attached to the voltage-gated potassium channel KCNB1; this modulates the gating characteristics of KCNB1 (PubMed:19223394). Polymeric SUMO1 chains are also susceptible to polyubiquitination which functions as a signal for proteasomal degradation of modified proteins. May also regulate a network of genes involved in palate development. Covalently attached to ZFHX3 (PubMed:24651376). {ECO:0000269|PubMed:18408734, ECO:0000269|PubMed:18538659, ECO:0000269|PubMed:19223394, ECO:0000269|PubMed:21965678, ECO:0000269|PubMed:24651376, ECO:0000269|PubMed:9019411, ECO:0000269|PubMed:9162015}.",,,,,,,,,,,SITE 36 36 Interaction with PIAS2.,"cytosol [GO:0005829]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear speck [GO:0016607]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; SUMO activating enzyme complex [GO:0031510]; synapse [GO:0045202]; XY body [GO:0001741]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]; protein C-terminus binding [GO:0008022]; protein tag [GO:0031386]; RNA binding [GO:0003723]; small protein activating enzyme binding [GO:0044388]; SUMO transferase activity [GO:0019789]; transcription corepressor binding [GO:0001222]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; cellular response to cadmium ion [GO:0071276]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of action potential [GO:0045759]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; PML body organization [GO:0030578]; positive regulation of calcium-transporting ATPase activity [GO:1901896]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein complex assembly [GO:0031334]; protein localization to nuclear pore [GO:0090204]; protein stabilization [GO:0050821]; protein sumoylation [GO:0016925]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein localization [GO:0032880]; roof of mouth development [GO:0060021]; viral process [GO:0016032]","cellular response to cadmium ion [GO:0071276]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of action potential [GO:0045759]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; PML body organization [GO:0030578]; positive regulation of calcium-transporting ATPase activity [GO:1901896]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein complex assembly [GO:0031334]; protein localization to nuclear pore [GO:0090204]; protein stabilization [GO:0050821]; protein sumoylation [GO:0016925]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein localization [GO:0032880]; roof of mouth development [GO:0060021]; viral process [GO:0016032]","enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]; protein C-terminus binding [GO:0008022]; protein tag [GO:0031386]; RNA binding [GO:0003723]; small protein activating enzyme binding [GO:0044388]; SUMO transferase activity [GO:0019789]; transcription corepressor binding [GO:0001222]; transcription factor binding [GO:0008134]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin protein ligase binding [GO:0031625]",cytosol [GO:0005829]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear speck [GO:0016607]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; SUMO activating enzyme complex [GO:0031510]; synapse [GO:0045202]; XY body [GO:0001741],GO:0000122; GO:0000792; GO:0001222; GO:0001650; GO:0001741; GO:0003723; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006281; GO:0006303; GO:0008022; GO:0008134; GO:0015459; GO:0016032; GO:0016604; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0030425; GO:0030578; GO:0030674; GO:0031334; GO:0031386; GO:0031510; GO:0031625; GO:0031965; GO:0032436; GO:0032880; GO:0034605; GO:0035259; GO:0043392; GO:0043433; GO:0044388; GO:0044389; GO:0045202; GO:0045759; GO:0045892; GO:0050821; GO:0060021; GO:0060334; GO:0071276; GO:0086004; GO:0090204; GO:0097165; GO:1901896; GO:1902260,IPR022617; IPR033950; IPR029071; IPR000626; ,Q59GP6; P10275; P15336; A0A0S2Z4M1; O15169; P38398; Q96B23; Q9H257; Q9UER7; Q05D60; Q9UBC3; Q86UW9; Q8WWZ3; P06730; P19419; P19419-1; A0A0S2Z3N6; Q9BPY3; Q8TES7-6; Q53SE7; O95073; O14964; Q16665; P07910; Q00613; Q9Y6K9; P10914; O00180; Q8NDC0; Q9UIS9; Q02078-1; P10242; Q00653; P06748-1; P09874; O75928; P29590; P29590-9; O75626-2; Q60636; O75475; Q9Y4B4; P46060; P10276; Q9BQY4; Q9Y3V2; O43290; Q01826; Q9P0U3; Q9HC62; P56693; P48431; P23497; G2XKQ0; Q92844; Q12800; P04637; Q12888; Q12888-1; Q9BUZ4; Q9UBT2; P63279; Q7KZS0; Q5W0Q7; Q9HCK0; Q15916; Q6PEW1; Q9UJ78,"SUBUNIT: Covalently attached to KCNB1; UBE2I increases cross-linking with KCNB1 and PIAS1 decreases cross-links with KCNB1 (PubMed:19223394). Interacts with SAE2, RANBP2, PIAS1 and PIAS2. Interacts with PRKN. Covalently attached to a number of proteins such as IKFZ1, PML, RANGAP1, HIPK2, SP100, p53, p73-alpha, MDM2, JUN, DNMT3B and TDG. Also interacts with HIF1A, HIPK2, HIPK3, CHD3, EXOSC9, RAD51 and RAD52. Interacts with USP25 (via ts SIM domain); the interaction weakly sumoylates USP25. Interacts with SIMC1, CASP8AP2, RNF111 AND SOBP (via SIM domains). Interacts with BHLHE40/DEC1. Interacts with RWDD3. Interacts with UBE2I/UBC9 and this interaction is enhanced in the presence of RWDD3. Interacts with MTA1. {ECO:0000269|PubMed:10961991, ECO:0000269|PubMed:12565818, ECO:0000269|PubMed:12924945, ECO:0000269|PubMed:15296745, ECO:0000269|PubMed:15608651, ECO:0000269|PubMed:15660128, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:16204249, ECO:0000269|PubMed:16712526, ECO:0000269|PubMed:16955485, ECO:0000269|PubMed:17099698, ECO:0000269|PubMed:17956732, ECO:0000269|PubMed:18538659, ECO:0000269|PubMed:19223394, ECO:0000269|PubMed:21829689, ECO:0000269|PubMed:21965678, ECO:0000269|PubMed:23086935}.; SUBUNIT: (Microbial infection) Interacts with Epstein-barr virus BGLF4. {ECO:0000269|PubMed:22398289}.",9119407; 8806687; 8812453; 9019411; 8978815; 8906799; 14702039; 15815621; 15489334; 9162015; 10574707; 10961991; 12383504; 12924945; 12565818; 15487983; 15608651; 17081983; 16955485; 16990542; 17956732; 18707152; 18538659; 18691976; 18408734; 19413330; 19223394; 20388717; 20068231; 21269460; 21965678; 21829689; 21406692; 22406621; 23086935; 22398289; 23186163; 24275569; 25218447; 24651376; 25772364; 25755297; 28112733; 9654451; 15296745; 15660128; 16204249; 15931224; 15959518; 15723079; 16712526; 17099698,9119407; 8806687; 8812453; 9019411; 8978815; 8906799; 14702039; 15815621; 15489334; 9162015; 10574707; 10961991; 12383504; 12924945; 12565818; 15487983; 15608651; 17081983; 16955485; 16990542; 17956732; 18707152; 18538659; 18691976; 18408734; 19413330; 19223394; 20388717; 20068231; 21269460; 21965678; 21829689; 21406692; 22406621; 23086935; 22398289; 23186163; 24275569; 25218447; 24651376; 25772364; 25755297; 28112733; 9654451; 15296745; 15660128; 16204249; 15931224; 15959518; 15723079; 16712526; 17099698; 10187858; 10550055; 10724175; 10759568; 10805787; 10862613; 10866324; 10871618; 10973490; 11025670; 11112409; 11114888; 11493912; 11604075; 11709553; 11735126; 11792325; 11889051; 11896061; 11948183; 11960997; 12032081; 12060666; 12072434; 12144530; 12149243; 12192048; 12196509; 12200128; 12297306; 12354770; 12356736; 12364621; 12419227; 12447390; 12511558; 12529333; 12552083; 12641448; 12646186; 12665592; 12697768; 12773400; 12788062; 12832072; 12855578; 12947387; 14500761; 14514699; 14527952; 14563852; 14578449; 14637113; 14752048; 14992729; 15016812; 15037602; 15082759; 15123625; 15199155; 15220454; 15229220; 15247228; 15272016; 15337742; 15355965; 15355988; 15456902; 15468306; 15494207; 15507114; 15507434; 15574327; 15592428; 15637059; 15723659; 15788563; 15823533; 15848177; 15857832; 15881673; 15882793; 15896780; 15907800; 15923626; 15931174; 15958389; 15989970; 16030353; 16055710; 16112644; 16117725; 16120648; 16122737; 16125395; 16150728; 16154161; 16169070; 16189514; 16253240; 16352666; 16415059; 16421094; 16428803; 16460827; 16464864; 16475184; 16478998; 16494873; 16501610; 16563226; 16568089; 16631117; 16651405; 16651613; 16688858; 16738331; 16763556; 16781829; 16810316; 16904644; 17000644; 17018294; 17027752; 17036045; 17060459; 17066076; 17099700; 17164289; 17283066; 17320104; 17353931; 17360386; 17466333; 17491593; 17509614; 17525340; 17553757; 17591783; 17643372; 17671677; 17693435; 17932034; 17976381; 18001824; 18001825; 18006705; 18031232; 18063693; 18077395; 18093978; 18211901; 18374648; 18394993; 18404132; 18408014; 18579533; 18592385; 18617891; 18617892; 18625722; 18628979; 18660489; 18691969; 18762900; 18836734; 18946085; 18948102; 18978678; 18983974; 19001859; 19029252; 19041634; 19057511; 19107418; 19176521; 19203578; 19203579; 19214191; 19251700; 19261749; 19287951; 19297320; 19380586; 19384898; 19407830; 19443651; 19497852; 19565496; 19596686; 19622798; 19680224; 19744555; 19779455; 19859084; 19889771; 19913121; 19917317; 19937600; 19955185; 20016594; 20016603; 20023648; 20098713; 20145208; 20164921; 20190268; 20209145; 20224576; 20351170; 20360068; 20417598; 20467437; 20501649; 20519406; 20533263; 20547755; 20584900; 20628086; 20634891; 20661221; 20663916; 20676127; 20711444; 20711500; 20738159; 20797632; 20802522; 20881090; 20932933; 21039605; 21044801; 21047957; 21057547; 21098080; 21123177; 21167178; 21189065; 21192925; 21212807; 21242980; 21252943; 21268066; 21282113; 21284855; 21293379; 21317888; 21336309; 21375726; 21474068; 21490953; 21516116; 21527745; 21545853; 21550342; 21554500; 21563299; 21641618; 21647297; 21683690; 21722636; 21811235; 21878624; 21880768; 21931855; 21957283; 21968017; 21983723; 21988832; 22022399; 22147707; 22164242; 22179609; 22194619; 22198408; 22227369; 22370726; 22373579; 22388734; 22402492; 22403398; 22457066; 22458338; 22464730; 22493095; 22508508; 22555612; 22586270; 22589545; 22612509; 22635276; 22649767; 22651256; 22661229; 22661230; 22685230; 22713753; 22731716; 22748127; 22751501; 22878415; 22905217; 22975420; 22980979; 23077236; 23078246; 23092970; 23152501; 23160374; 23229893; 23243001; 23306437; 23333306; 23350884; 23382880; 23395904; 23407422; 23414517; 23417673; 23727112; 23751493; 23871147; 23996296; 24068740; 24072711; 24174529; 24244371; 24286314; 24309115; 24344134; 24390485; 24434214; 24656128; 24667604; 24753249; 24819975; 24835590; 24942926; 24953629; 25074923; 25111678; 25114211; 25118297; 25183729; 25241153; 25378699; 25391294; 25416956; 25484073; 25497731; 25512557; 25704882; 25800734; 25867063; 26042670; 26060329; 26151477; 26212320; 26223657; 26244656; 26400283; 26403314; 26449956; 26496610; 26549688; 26563097; 26578773; 26850942; 26867680; 26993772; 27068747; 27084229; 27129204; 27195426; 27230680; 27576863; 27799292; 27935866; 28055018; 28222440; 28582471; 28770955; 29138295; 29138839; 29352251; 29382749; 29393359; 29777712; 9412458; 9452416; 9512523; 9756909; 9885291; 9920803,2004-09-27,2019-02-13,2004-09-27,176,X-ray crystallography (24); NMR spectroscopy (9),STRAND 2 6 {ECO:0000244|PDB:1A5R}.; STRAND 22 27 {ECO:0000244|PDB:4WJQ}.; STRAND 29 31 {ECO:0000244|PDB:1Z5S}.; STRAND 33 38 {ECO:0000244|PDB:4WJQ}.; STRAND 40 42 {ECO:0000244|PDB:2PE6}.; STRAND 62 66 {ECO:0000244|PDB:4WJQ}.; STRAND 69 71 {ECO:0000244|PDB:5B7A}.; STRAND 87 92 {ECO:0000244|PDB:4WJQ}.; STRAND 96 99 {ECO:0000244|PDB:2N1A}.,HELIX 45 55 {ECO:0000244|PDB:4WJQ}.; HELIX 59 61 {ECO:0000244|PDB:4WJQ}.; HELIX 77 80 {ECO:0000244|PDB:4WJQ}.,TURN 9 11 {ECO:0000244|PDB:1A5R}.; TURN 16 18 {ECO:0000244|PDB:2KQS}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (9); Chain (1); Cross-link (11); Domain (1); Helix (3); Initiator methionine (1); Modified residue (4); Mutagenesis (1); Propeptide (1); Sequence conflict (1); Site (1); Turn (2),,,,3D-structure;Acetylation;Alternative splicing;Cell membrane;Chromosomal rearrangement;Complete proteome;Cytoplasm;Host-virus interaction;Isopeptide bond;Membrane;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Ubl conjugation pathway,Evidence at protein level,reviewed,,"Ubiquitin family, SUMO subfamily",176,Alternative products (1); Caution (1); Function (1); Involvement in disease (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (2),,KW-0002; KW-0007; KW-0025; KW-0160; KW-0181; KW-0472; KW-0539; KW-0597; KW-0832; KW-0833; KW-0945; KW-0963; KW-1003; KW-1017; KW-1185,,,,,DISEASE: Non-syndromic orofacial cleft 10 (OFC10) [MIM:613705]: A birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum. {ECO:0000269|PubMed:16990542}. Note=The disease is caused by mutations affecting the gene represented in this entry. A chromosomal aberration involving SUMO1 is the cause of OFC10. Translocation t(2;8)(q33.1;q24.3). The breakpoint occurred in the SUMO1 gene and resulted in haploinsufficiency confirmed by protein assays.,,,PTM: Cleavage of precursor form by SENP1 or SENP2 is necessary for function. {ECO:0000269|PubMed:15487983}.; PTM: Polymeric SUMO1 chains undergo polyubiquitination by RNF4.,CHAIN 2 97 Small ubiquitin-related modifier 1. /FTId=PRO_0000035939.,"CROSSLNK 7 7 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate.; CROSSLNK 7 7 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733}.; CROSSLNK 16 16 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:28112733}.; CROSSLNK 17 17 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733}.; CROSSLNK 23 23 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 25 25 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1).; CROSSLNK 37 37 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 39 39 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 45 45 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 46 46 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 97 97 Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins).",,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000269|PubMed:20388717}.",,"MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000269|PubMed:20388717}.; MOD_RES 2 2 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:18707152}.; MOD_RES 9 9 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 32 32 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,PROPEP 98 101 {ECO:0000269|PubMed:15487983}. /FTId=PRO_0000035940.,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X99586;U61397;U38784;U67122;U72722;U83117;AB062294;BT006632;CR542147;CR542156;AK311840;AC079354;CH471063;CH471063;BC006462;BC053528;BC066306;
0,P67775,PP2AA_HUMAN,PPP2CA,PPP2CA,,,,Homo sapiens (Human),9606,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16) (Replication protein C) (RP-C),UP000005640: Chromosome 5,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDEKVFTKELDQWIEQLNECKQLSESQVKSLCEKAKEILTKESNVQEVRCPVTVCGDVHGQFHDLMELFRIGGKSPDTNYLFMGDYVDRGYYSVETVTLLVALKVRYRERITILRGNHESRQITQVYGFYDECLRKYGNANVWKYFTDLFDYLPLTALVDGQIFCLHGGLSPSIDTLDHIRALDRLQEVPHEGPMCDLLWSDPDDRGGWGISPRGAGYTFGQDISETFNHANGLTLVSRAHQLVMEGYNWCHDRNVVTIFSAPNYCYRCGNQAAIMELDDTLKYSFLQFDPAPRRGEPHVTRRTPDYFL,309,"35,594",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; Synonyms=PP2Acalpha1; IsoId=P67775-1; Sequence=Displayed; Name=2; Synonyms=PP2Acalpha2; IsoId=P67775-2; Sequence=VSP_044320; Note=Catalytically inactive, shows enhanced binding to IGBP1, and does not interact with the scaffolding subunit PPP2R1A.; ",,,,,,,,,,VAR_SEQ 193 246 Missing (in isoform 2). {ECO:0000305}. /FTId=VSP_044320.,VARIANT 52 52 V -> A (in dbSNP:rs11552681). /FTId=VAR_051735.,,,,,,1,,0,,SIMILARITY: Belongs to the PPP phosphatase family. PP-1 subfamily. {ECO:0000305}.,,,,,,,,3.1.3.16,,"CATALYTIC ACTIVITY: Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] + phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474, ChEBI:CHEBI:83421; EC=3.1.3.16; CATALYTIC ACTIVITY: Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] + phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474, ChEBI:CHEBI:61977; EC=3.1.3.16;",COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:17055435};  Note=Binds 2 manganese ions per subunit. {ECO:0000269|PubMed:17055435};,,"FUNCTION: PP2A is the major phosphatase for microtubule-associated proteins (MAPs). PP2A can modulate the activity of phosphorylase B kinase casein kinase 2, mitogen-stimulated S6 kinase, and MAP-2 kinase. Cooperates with SGO2 to protect centromeric cohesin from separase-mediated cleavage in oocytes specifically during meiosis I (By similarity). Can dephosphorylate SV40 large T antigen and p53/TP53. Activates RAF1 by dephosphorylating it at 'Ser-259'. {ECO:0000250, ECO:0000269|PubMed:10801873, ECO:0000269|PubMed:22613722, ECO:0000269|PubMed:9920888}.",,,,,,ACT_SITE 118 118 Proton donor. {ECO:0000250}.,,,METAL 57 57 Manganese 1. {ECO:0000269|PubMed:17055435}.; METAL 59 59 Manganese 1. {ECO:0000269|PubMed:17055435}.; METAL 85 85 Manganese 1. {ECO:0000269|PubMed:17055435}.; METAL 85 85 Manganese 2. {ECO:0000269|PubMed:17055435}.; METAL 117 117 Manganese 2. {ECO:0000269|PubMed:17055435}.; METAL 167 167 Manganese 2. {ECO:0000269|PubMed:17055435}.; METAL 241 241 Manganese 2. {ECO:0000269|PubMed:17055435}.,,,"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; synapse [GO:0045202]; GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; tau protein binding [GO:0048156]; apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; inactivation of MAPK activity [GO:0000188]; meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of microtubule binding [GO:1904528]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of growth [GO:0040008]; regulation of microtubule binding [GO:1904526]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to lead ion [GO:0010288]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]","apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; inactivation of MAPK activity [GO:0000188]; meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of microtubule binding [GO:1904528]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of growth [GO:0040008]; regulation of microtubule binding [GO:1904526]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to lead ion [GO:0010288]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]",GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; tau protein binding [GO:0048156],"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; synapse [GO:0045202]",GO:0000159; GO:0000184; GO:0000188; GO:0000775; GO:0000922; GO:0001932; GO:0004721; GO:0004722; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006275; GO:0006355; GO:0006470; GO:0006672; GO:0006915; GO:0007498; GO:0008022; GO:0008380; GO:0010033; GO:0010288; GO:0010719; GO:0015630; GO:0016020; GO:0019932; GO:0030111; GO:0030155; GO:0030308; GO:0035970; GO:0040008; GO:0042532; GO:0045121; GO:0045202; GO:0045595; GO:0046872; GO:0046982; GO:0048156; GO:0050811; GO:0051321; GO:0070062; GO:0070262; GO:0071902; GO:1904526; GO:1904528,IPR004843; IPR029052; IPR006186; ,P31749; P39687; P03129; P04020; P06730; P46695; P78318; Q61249; O14920; Q9Y6K9; Q969F8; P97346; Q9Y570; P30153; P30154; Q9Y2T4; Q15172; Q15173; Q13362; P04049; P28749; Q08999; Q04206; Q5FBB7; Q5VSL9; O43815; O75663; Q15645,"SUBUNIT: PP2A consists of a common heterodimeric core enzyme, composed of PPP2CA a 36 kDa catalytic subunit (subunit C) and PPP2R1A a 65 kDa constant regulatory subunit (PR65 or subunit A), that associates with a variety of regulatory subunits. Proteins that associate with the core dimer include three families of regulatory subunits B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56 families), the 48 kDa variable regulatory subunit, viral proteins, and cell signaling molecules. Interacts with NXN; the interaction is direct (By similarity). Interacts with KCTD20 (By similarity). Interacts with BTBD10 (By similarity). Interacts with TP53, SGO1 and SGO2. Interacts with AXIN1; the interaction dephosphorylates AXIN1. Interacts with PIM3; this interaction promotes dephosphorylation, ubiquitination and proteasomal degradation of PIM3. Interacts with RAF1. Interaction with IGBP1 protects unassembled PPP2CA from degradative ubiquitination. Interacts with GSK3B (via C2 domain). Interacts with MFHAS1; retains PPP2CA into the cytoplasm and excludes it from the nucleus (PubMed:28609714). Interacts with FAM122A (PubMed:27588481). Interacts with ADCY8; interaction is phosphatase activity-dependent; antagonizes interaction between ADCY8 and calmodulin (PubMed:16258073). {ECO:0000250, ECO:0000250|UniProtKB:P63330, ECO:0000269|PubMed:10801873, ECO:0000269|PubMed:12473674, ECO:0000269|PubMed:16258073, ECO:0000269|PubMed:16541025, ECO:0000269|PubMed:16580887, ECO:0000269|PubMed:17055435, ECO:0000269|PubMed:17245430, ECO:0000269|PubMed:17485487, ECO:0000269|PubMed:18394995, ECO:0000269|PubMed:19818709, ECO:0000269|PubMed:20080667, ECO:0000269|PubMed:20092282, ECO:0000269|PubMed:27588481, ECO:0000269|PubMed:28609714, ECO:0000269|PubMed:9647778, ECO:0000269|PubMed:9920888}.",2849764; 2837763; 1846293; 15489334; 1848668; 8206937; 9647778; 10191253; 2555176; 9920888; 10801873; 16580887; 16258073; 16541025; 12473674; 17245430; 17485487; 19818709; 20092282; 20080667; 22167190; 22613722; 27588481; 28609714; 17055435; 18394995,2849764; 2837763; 1846293; 15489334; 1848668; 8206937; 9647778; 10191253; 2555176; 9920888; 10801873; 16580887; 16258073; 16541025; 12473674; 17245430; 17485487; 19818709; 20092282; 20080667; 22167190; 22613722; 27588481; 28609714; 17055435; 18394995; 10023660; 10092233; 10196136; 10421629; 10487827; 10581160; 10600115; 10698523; 10700176; 10749138; 10799894; 10862053; 10887178; 10921899; 11003670; 11053437; 11081627; 11181178; 11238463; 11279012; 11325826; 11375957; 11494123; 11509732; 11522655; 11576548; 11591705; 11741534; 11746989; 11756411; 11804586; 11839802; 11929874; 11955436; 11976720; 11983168; 11994459; 11996003; 12000790; 12006501; 12054646; 12065642; 12067995; 12101426; 12186863; 12194817; 12370081; 12391162; 12417715; 12439748; 12474228; 12514180; 12554650; 12554878; 12593796; 12684532; 12721358; 12775720; 12815057; 12820959; 12832468; 12840032; 12859198; 12876557; 12932319; 12932339; 12963337; 1325671; 1328865; 14527413; 14527418; 14530258; 14636577; 14730319; 14742663; 15004239; 15031289; 15085137; 15142525; 15225643; 15252037; 15306667; 15327769; 15339662; 15467457; 15546618; 15564375; 15637081; 15664191; 15687260; 15711535; 15721257; 15723797; 15735151; 15737063; 15761952; 16041367; 16044149; 16085932; 16126728; 16129692; 16169070; 16189514; 16239230; 16284618; 16294014; 16306228; 16456541; 16479008; 16508002; 16551244; 16567647; 16622419; 16622420; 16753179; 16764867; 16893902; 17030981; 17053788; 17079228; 17086192; 17129783; 17143292; 17174897; 17183061; 17200115; 17255109; 17318175; 17384681; 17510365; 17529994; 17535922; 17537547; 17540176; 17569865; 17693927; 17803990; 17852432; 17893241; 17941990; 17991896; 17993263; 18097444; 18201571; 18256265; 18299321; 18311776; 18339531; 18423202; 18430997; 18477699; 18583989; 18586681; 18715871; 18716626; 18755143; 18757411; 18758438; 18782753; 18852266; 18922469; 18928587; 18949047; 18974281; 18977201; 19060897; 19060904; 19061640; 19107203; 19126401; 19131971; 19150429; 19155497; 19156129; 19237556; 19293187; 19356149; 19360341; 19405949; 19553685; 19576174; 19619488; 19690147; 19716788; 19738201; 19760609; 19859661; 19916524; 19933846; 19965387; 20023408; 20106966; 20110348; 20133759; 20195357; 20360068; 20363734; 20450893; 20558158; 20562859; 20562864; 20615878; 20636478; 20663872; 20674547; 20677014; 20711181; 20711500; 20927323; 20930030; 21072166; 21145460; 21151953; 21159657; 21164013; 21164014; 21172653; 21183070; 21183076; 21248786; 21252990; 21292165; 21346232; 21355954; 21393425; 21397845; 21454489; 21460856; 21590681; 21779496; 21791414; 21806989; 21813648; 21835928; 21878504; 21878643; 21911578; 21958460; 21959857; 21983900; 21987589; 21988832; 21996587; 22031698; 22101459; 22135143; 22192750; 22299660; 22314363; 22438566; 22443683; 22479341; 22677168; 22682247; 22685328; 22732552; 22770216; 22810585; 22885700; 22904676; 22961627; 23064762; 23085078; 23183242; 23184344; 23185379; 23234702; 23256519; 23290789; 23416715; 23434594; 23436320; 23455922; 23555304; 23579495; 23591866; 23651848; 23677989; 23720779; 23752926; 23775084; 23796501; 23892082; 23901063; 24054836; 24064353; 24100030; 24100351; 24126060; 24189400; 24269630; 24347342; 24382322; 24395787; 24462681; 24550388; 24621013; 24642616; 24696731; 24770487; 24781523; 24841198; 24958351; 24997451; 25003389; 25003662; 25015035; 25152517; 25207814; 25219467; 25253569; 25567480; 25609649; 25612003; 25645927; 25708299; 25939762; 25945834; 25956027; 26053095; 26234767; 26310906; 26378614; 26496226; 26496610; 26563471; 26575017; 26592247; 26618405; 26638075; 26876307; 27012437; 27013170; 27169767; 27306323; 27334924; 27352821; 27489114; 27517624; 27531894; 27600565; 27611305; 27612201; 27696687; 27913678; 28057023; 28144936; 29273778; 29450633; 29979448; 29996119; 30144452; 30275201; 30296597; 7592815; 7592845; 8259518; 8259519; 8392071; 8617797; 8637718; 8638126; 8757136; 8887688; 9065402; 9482734; 9556553; 9601641; 9712716; 9990852,2004-10-11,2019-02-13,2004-10-11,157,X-ray crystallography (17),STRAND 44 48 {ECO:0000244|PDB:4I5L}.; STRAND 50 55 {ECO:0000244|PDB:4I5L}.; STRAND 80 82 {ECO:0000244|PDB:4I5L}.; STRAND 87 91 {ECO:0000244|PDB:4I5L}.; STRAND 111 113 {ECO:0000244|PDB:4I5L}.; STRAND 138 140 {ECO:0000244|PDB:4I5L}.; STRAND 155 159 {ECO:0000244|PDB:4I5L}.; STRAND 163 168 {ECO:0000244|PDB:4I5L}.; STRAND 186 188 {ECO:0000244|PDB:3C5W}.; STRAND 191 193 {ECO:0000244|PDB:4I5L}.; STRAND 205 211 {ECO:0000244|PDB:4I5L}.; STRAND 215 220 {ECO:0000244|PDB:4I5L}.; STRAND 235 239 {ECO:0000244|PDB:4I5L}.; STRAND 247 251 {ECO:0000244|PDB:4I5L}.; STRAND 256 259 {ECO:0000244|PDB:4I5L}.; STRAND 273 278 {ECO:0000244|PDB:4I5L}.; STRAND 284 289 {ECO:0000244|PDB:4I5L}.,HELIX 3 18 {ECO:0000244|PDB:4I5L}.; HELIX 25 39 {ECO:0000244|PDB:4I5L}.; HELIX 62 72 {ECO:0000244|PDB:4I5L}.; HELIX 93 106 {ECO:0000244|PDB:4I5L}.; HELIX 121 127 {ECO:0000244|PDB:4I5L}.; HELIX 129 137 {ECO:0000244|PDB:4I5L}.; HELIX 141 150 {ECO:0000244|PDB:4I5L}.; HELIX 177 182 {ECO:0000244|PDB:4I5L}.; HELIX 194 200 {ECO:0000244|PDB:4I5L}.; HELIX 222 232 {ECO:0000244|PDB:4I5L}.; HELIX 265 267 {ECO:0000244|PDB:4I5L}.,TURN 75 77 {ECO:0000244|PDB:4I5L}.; TURN 108 110 {ECO:0000244|PDB:4I5L}.; TURN 160 162 {ECO:0000244|PDB:4I5L}.; TURN 252 255 {ECO:0000244|PDB:4I5L}.,,,,,5 out of 5,Active site (1); Alternative sequence (1); Beta strand (17); Chain (1); Helix (11); Metal binding (7); Modified residue (2); Mutagenesis (1); Natural variant (1); Turn (4),,,,3D-structure;Alternative splicing;Centromere;Chromosome;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Hydrolase;Manganese;Meiosis;Metal-binding;Methylation;Nucleus;Phosphoprotein;Polymorphism;Protein phosphatase;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,"PPP phosphatase family, PP-1 subfamily",157,Alternative products (1); Catalytic activity (2); Caution (1); Cofactor (1); Function (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0137; KW-0158; KW-0181; KW-0206; KW-0378; KW-0464; KW-0469; KW-0479; KW-0488; KW-0539; KW-0597; KW-0621; KW-0832; KW-0903; KW-0904; KW-0963; KW-1185,,,,,,,,"PTM: Reversibly methyl esterified on Leu-309 by leucine carboxyl methyltransferase 1 (LCMT1) and protein phosphatase methylesterase 1 (PPME1). Carboxyl methylation influences the affinity of the catalytic subunit for the different regulatory subunits, thereby modulating the PP2A holoenzyme's substrate specificity, enzyme activity and cellular localization. {ECO:0000269|PubMed:8206937}.; PTM: Phosphorylation of either threonine (by autophosphorylation-activated protein kinase) or tyrosine results in inactivation of the phosphatase. Auto-dephosphorylation has been suggested as a mechanism for reactivation.; PTM: Polyubiquitinated, leading to its degradation by the proteasome. {ECO:0000269|PubMed:27588481}.",CHAIN 1 309 Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform. /FTId=PRO_0000058839.,,,,,,MOD_RES 307 307 Phosphotyrosine. {ECO:0000250|UniProtKB:P67774}.; MOD_RES 309 309 Leucine methyl ester. {ECO:0000269|PubMed:8206937}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X12646;J03804;M60483;BC000400;BC002657;BC019275;BC031696;
0,Q99661,KIF2C_HUMAN,KIF2C KNSL6,KIF2C,KNSL6,,,Homo sapiens (Human),9606,Kinesin-like protein KIF2C (Kinesin-like protein 6) (Mitotic centromere-associated kinesin) (MCAK),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAMDSSLQARLFPGLAIKIQRSNGLIHSANVRTVNLEKSCVSVEWAEGGATKGKEIDFDDVAAINPELLQLLPLHPKDNLPLQENVTIQKQKRRSVNSKIPAPKESLRSRSTRMSTVSELRITAQENDMEVELPAAANSRKQFSVPPAPTRPSCPAVAEIPLRMVSEEMEEQVHSIRGSSSANPVNSVRRKSCLVKEVEKMKNKREEKKAQNSEMRMKRAQEYDSSFPNWEFARMIKEFRATLECHPLTMTDPIEEHRICVCVRKRPLNKQELAKKEIDVISIPSKCLLLVHEPKLKVDLTKYLENQAFCFDFAFDETASNEVVYRFTARPLVQTIFEGGKATCFAYGQTGSGKTHTMGGDLSGKAQNASKGIYAMASRDVFLLKNQPCYRKLGLEVYVTFFEIYNGKLFDLLNKKAKLRVLEDGKQQVQVVGLQEHLVNSADDVIKMIDMGSACRTSGQTFANSNSSRSHACFQIILRAKGRMHGKFSLVDLAGNERGADTSSADRQTRMEGAEINKSLLALKECIRALGQNKAHTPFRESKLTQVLRDSFIGENSRTCMIATISPGISSCEYTLNTLRYADRVKELSPHSGPSGEQLIQMETEEMEACSNGALIPGNLSKEEEELSSQMSSFNEAMTQIRELEEKAMEELKEIIQQGPDWLELSEMTEQPDYDLETFVNKAESALAQQAKHFSALRDVIKALRLAMQLEEQASRQISSKKRPQ,725,"81,313",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q99661-1; Sequence=Displayed; Name=2; Synonyms=tsMCAK; IsoId=Q99661-2; Sequence=VSP_002866; ,,,,,,,,,,VAR_SEQ 1 55 MAMDSSLQARLFPGLAIKIQRSNGLIHSANVRTVNLEKSCVSVEWAEGGATKGKE -> M (in isoform 2). {ECO:0000303|PubMed:12383881}. /FTId=VSP_002866.,"VARIANT 449 449 I -> L (in dbSNP:rs4342887). {ECO:0000269|PubMed:12383881, ECO:0000269|PubMed:9434124, ECO:0000269|Ref.5}. /FTId=VAR_049683.",,,,CONFLICT 698 698 R -> P (in Ref. 8; AAH08764). {ECO:0000305}.,,2,,0,DOMAIN: The microtubule tip localization signal (MtLS) motif; mediates interaction with MAPRE1 and targeting to the growing microtubule plus ends. {ECO:0000269|PubMed:19632184}.,SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family. MCAK/KIF2 subfamily. {ECO:0000255|PROSITE-ProRule:PRU00283}.,COILED 618 658 {ECO:0000255}.,,DOMAIN 258 588 Kinesin motor. {ECO:0000255|PROSITE-ProRule:PRU00283}.,MOTIF 98 101 Microtubule tip localization signal.; MOTIF 415 418 Nuclear localization signal. {ECO:0000255}.,REGION 2 254 Globular. {ECO:0000255}.; REGION 207 238 Negative regulator of microtubule-binding. {ECO:0000250}.,,,,,,,,"FUNCTION: In complex with KIF18B, constitutes the major microtubule plus-end depolymerizing activity in mitotic cells (PubMed:21820309). Regulates the turnover of microtubules at the kinetochore and functions in chromosome segregation during mitosis (PubMed:19060894). Plays a role in chromosome congression and is required for the lateral to end-on conversion of the chromosome-microtubule attachment (PubMed:23891108). {ECO:0000269|PubMed:19060894, ECO:0000269|PubMed:21820309, ECO:0000269|PubMed:23891108}.",,,,,,,BINDING 264 264 ATP. {ECO:0000250}.,,,NP_BIND 348 355 ATP.,,"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; centromeric DNA binding [GO:0019237]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; regulation of chromosome segregation [GO:0051983]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; regulation of chromosome segregation [GO:0051983]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",ATPase activity [GO:0016887]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]",GO:0000278; GO:0000775; GO:0000776; GO:0000777; GO:0003777; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0008017; GO:0008283; GO:0015630; GO:0016020; GO:0016887; GO:0019237; GO:0019886; GO:0030951; GO:0035371; GO:0051010; GO:0051301; GO:0051310; GO:0051315; GO:0051983,IPR027640; IPR019821; IPR001752; IPR036961; IPR027417; ,Q15691; Q5JR59,"SUBUNIT: Interacts with CENPH. Interacts with MTUS2/TIP150; the interaction is direct. Interacts with MAPRE1; the interaction is direct, regulated by phosphorylation and is probably required for targeting to growing microtubule plus ends. Interacts with KIF18B at microtubule tips; this interaction increases the affinity of both partners for microtubule plus ends and is required for robust microtubule depolymerization. Phosphorylation by AURKA or AURKB strongly reduces KIF18B-binding. {ECO:0000269|PubMed:11092768, ECO:0000269|PubMed:19543227, ECO:0000269|PubMed:19632184, ECO:0000269|PubMed:21820309, ECO:0000269|Ref.26}.",9434124; 12383881; 16710414; 15489334; 11092768; 14960279; 17485487; 17525332; 18669648; 19632184; 19543227; 19060894; 19690332; 20596523; 20068231; 21269460; 21820309; 22814378; 23891108; 23186163; ,9434124; 12383881; 16710414; 15489334; 11092768; 14960279; 17485487; 17525332; 18669648; 19632184; 19543227; 19060894; 19690332; 20596523; 20068231; 21269460; 21820309; 22814378; 23891108; 23186163; 10036229; 11081627; 11181178; 11493604; 11509732; 11739780; 11804586; 12006501; 12194817; 12198549; 12368902; 14504276; 14730319; 15029241; 15085137; 15272311; 15302853; 15304328; 15326200; 15339662; 15723797; 15737063; 15883193; 1607388; 16243029; 16262723; 16541025; 16571679; 16622419; 16622420; 16672973; 17030981; 17113389; 17129783; 17283181; 17538014; 17620599; 17653072; 17944972; 17968321; 17986458; 18046453; 18097444; 18440323; 18506187; 18663358; 18716626; 18809577; 18843200; 19001124; 19116309; 19369418; 19564404; 19758564; 19931454; 19965387; 20005805; 20136777; 20368358; 20406800; 20462495; 20467437; 20508983; 20534429; 20889715; 21165574; 21397845; 2142332; 21426902; 21471284; 21550981; 21566458; 21602793; 21666598; 21878504; 21900206; 21987589; 21988832; 22013193; 22363599; 22403406; 22492725; 22623428; 22885700; 23055517; 23098759; 23564489; 23830822; 24240690; 24255178; 24847103; 24931513; 25002494; 25002679; 2521221; 2522352; 25364732; 25504441; 25609649; 25915621; 26055718; 26148251; 26206521; 26496610; 26638075; 26733216; 26912793; 27146484; 27563815; 27733589; 27881713; 28298485; 28694425; 29244835; 7822426; 7844144; 7929562; 8602245; 8642258; 8909537,2001-01-11,2019-02-13,2002-01-23,192,X-ray crystallography (4),STRAND 250 252 {ECO:0000244|PDB:5MIO}.; STRAND 258 265 {ECO:0000244|PDB:2HEH}.; STRAND 285 296 {ECO:0000244|PDB:2HEH}.; STRAND 297 299 {ECO:0000244|PDB:4Y05}.; STRAND 302 310 {ECO:0000244|PDB:2HEH}.; STRAND 312 315 {ECO:0000244|PDB:2HEH}.; STRAND 341 348 {ECO:0000244|PDB:2HEH}.; STRAND 396 405 {ECO:0000244|PDB:2HEH}.; STRAND 408 411 {ECO:0000244|PDB:2HEH}.; STRAND 420 423 {ECO:0000244|PDB:2HEH}.; STRAND 425 427 {ECO:0000244|PDB:5MIO}.; STRAND 429 432 {ECO:0000244|PDB:2HEH}.; STRAND 437 441 {ECO:0000244|PDB:2HEH}.; STRAND 470 492 {ECO:0000244|PDB:2HEH}.; STRAND 499 502 {ECO:0000244|PDB:5MIO}.; STRAND 507 509 {ECO:0000244|PDB:4UBF}.; STRAND 557 565 {ECO:0000244|PDB:2HEH}.,HELIX 230 242 {ECO:0000244|PDB:2HEH}.; HELIX 270 274 {ECO:0000244|PDB:2HEH}.; HELIX 321 327 {ECO:0000244|PDB:2HEH}.; HELIX 330 337 {ECO:0000244|PDB:2HEH}.; HELIX 354 358 {ECO:0000244|PDB:2HEH}.; HELIX 373 385 {ECO:0000244|PDB:2HEH}.; HELIX 388 391 {ECO:0000244|PDB:2HEH}.; HELIX 442 455 {ECO:0000244|PDB:2HEH}.; HELIX 467 469 {ECO:0000244|PDB:2HEH}.; HELIX 514 531 {ECO:0000244|PDB:2HEH}.; HELIX 539 541 {ECO:0000244|PDB:2HEH}.; HELIX 543 547 {ECO:0000244|PDB:2HEH}.; HELIX 549 552 {ECO:0000244|PDB:2HEH}.; HELIX 569 571 {ECO:0000244|PDB:2HEH}.; HELIX 572 585 {ECO:0000244|PDB:2HEH}.,TURN 392 394 {ECO:0000244|PDB:2HEH}.; TURN 412 416 {ECO:0000244|PDB:2HEH}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (17); Binding site (1); Chain (1); Coiled coil (1); Domain (1); Helix (15); Initiator methionine (1); Modified residue (15); Motif (2); Mutagenesis (4); Natural variant (1); Nucleotide binding (1); Region (2); Sequence conflict (1); Turn (2),,"TISSUE SPECIFICITY: Expressed at high levels in thymus and testis, at low levels in small intestine, the mucosal lining of colon, and placenta, and at very low levels in spleen and ovary; expression is not detected in prostate, peripheral blood Leukocytes, heart, brain, lung, liver, skeletal muscle, kidney or pancreas. Isoform 2 is testis-specific. {ECO:0000269|PubMed:12383881, ECO:0000269|PubMed:9434124}.",,3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Kinetochore;Microtubule;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family, MCAK/KIF2 subfamily",192,Alternative products (1); Developmental stage (1); Domain (1); Function (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0067; KW-0131; KW-0132; KW-0137; KW-0158; KW-0159; KW-0175; KW-0181; KW-0206; KW-0493; KW-0498; KW-0539; KW-0547; KW-0597; KW-0621; KW-0832; KW-0963; KW-0995; KW-1185,,,,,,,,"PTM: Phosphorylation by AURKB, regulates association with centromeres and kinetochores and the microtubule depolymerization activity. {ECO:0000269|PubMed:14960279}.; PTM: Ubiquitinated. {ECO:0000269|PubMed:20596523}.",CHAIN 2 725 Kinesin-like protein KIF2C. /FTId=PRO_0000125418.,,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378}.,,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378}.; MOD_RES 6 6 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 22 22 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 95 95 Phosphoserine; by AURKB. {ECO:0000269|PubMed:14960279}.; MOD_RES 106 106 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 109 109 Phosphoserine. {ECO:0000250|UniProtKB:P70096}.; MOD_RES 111 111 Phosphoserine. {ECO:0000250|UniProtKB:P70096}.; MOD_RES 115 115 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 166 166 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 175 175 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 187 187 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 192 192 Phosphoserine. {ECO:0000250|UniProtKB:P70096}.; MOD_RES 519 519 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 621 621 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 633 633 Phosphoserine. {ECO:0000244|PubMed:20068231}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U63743;AY026505;BT006759;CR450302;AB264115;CH471059;BC008764;BC014924;
0,Q9P258,RCC2_HUMAN,RCC2 KIAA1470 TD60,RCC2,KIAA1470 TD60,,,Homo sapiens (Human),9606,Protein RCC2 (RCC1-like protein TD-60) (Telophase disk protein of 60 kDa),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPRKKAAAAAWEEPSSGNGTARAGPRKRGGPAGRKRERPERCSSSSGGGSSGDEDGLELDGAPGGGKRAARPATAGKAGGAAVVITEPEHTKERVKLEGSKCKGQLLIFGATNWDLIGRKEVPKQQAAYRNLGQNLWGPHRYGCLAGVRVRTVVSGSCAAHSLLITTEGKLWSWGRNEKGQLGHGDTKRVEAPRLIEGLSHEVIVSAACGRNHTLALTETGSVFAFGENKMGQLGLGNQTDAVPSPAQIMYNGQPITKMACGAEFSMIMDCKGNLYSFGCPEYGQLGHNSDGKFIARAQRIEYDCELVPRRVAIFIEKTKDGQILPVPNVVVRDVACGANHTLVLDSQKRVFSWGFGGYGRLGHAEQKDEMVPRLVKLFDFPGRGASQIYAGYTCSFAVSEVGGLFFWGATNTSRESTMYPKAVQDLCGWRIRSLACGKSSIIVAADESTISWGPSPTFGELGYGDHKPKSSTAAQEVKTLDGIFSEQVAMGYSHSLVIARDESETEKEKIKKLPEYNPRTL,522,"56,085",,,,SEQUENCE CAUTION:  Sequence=BAA95994.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,SEQUENCE CAUTION:  Sequence=CAB94882.1; Type=Frameshift; Positions=477; Evidence={ECO:0000305}; ,,,,,,,,,,CONFLICT 145 148 LAGV -> RTRG (in Ref. 4). {ECO:0000305}.,,2,,0,,,,,,,REGION 318 325 Required for interaction with RAC1. {ECO:0000269|PubMed:28869598}.,REPEAT 103 165 RCC1 1.; REPEAT 168 219 RCC1 2.; REPEAT 221 271 RCC1 3.; REPEAT 273 347 RCC1 4.; REPEAT 348 401 RCC1 5.; REPEAT 403 447 RCC1 6.; REPEAT 448 501 RCC1 7.,,,,,,,"FUNCTION: Multifunctional protein that may effect its functions by regulating the activity of small GTPases, such as RAC1 and RALA (PubMed:12919680, PubMed:25074804, PubMed:26158537, PubMed:28869598). Required for normal progress through the cell cycle, both during interphase and during mitosis (PubMed:23388455, PubMed:12919680, PubMed:26158537). Required for the presence of normal levels of MAD2L1, AURKB and BIRC5 on inner centromeres during mitosis, and for normal attachment of kinetochores to mitotic spindles (PubMed:12919680, PubMed:26158537). Required for normal organization of the microtubule cytoskeleton in interphase cells (PubMed:23388455). Functions as guanine nucleotide exchange factor (GEF) for RALA (PubMed:26158537). Interferes with the activation of RAC1 by guanine nucleotide exchange factors (PubMed:25074804). Prevents accumulation of active, GTP-bound RAC1, and suppresses RAC1-mediated reorganization of the actin cytoskeleton and formation of membrane protrusions (PubMed:25074804, PubMed:28869598). Required for normal cellular responses to contacts with the extracellular matrix of adjacent cells, and for directional cell migration in response to a fibronectin gradient (in vitro) (PubMed:25074804, PubMed:28869598). {ECO:0000269|PubMed:12919680, ECO:0000269|PubMed:23388455, ECO:0000269|PubMed:25074804, ECO:0000269|PubMed:26158537, ECO:0000269|PubMed:28869598}.",,,,,,,,,,,,"chromosome, centromeric core domain [GO:0034506]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]",activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027],guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],"chromosome, centromeric core domain [GO:0034506]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]",GO:0003723; GO:0005085; GO:0005730; GO:0005829; GO:0005874; GO:0005886; GO:0007049; GO:0007229; GO:0008017; GO:0010762; GO:0010971; GO:0019901; GO:0019904; GO:0030334; GO:0030496; GO:0031267; GO:0031901; GO:0034260; GO:0034506; GO:0045184; GO:0048041; GO:0048365; GO:0051301; GO:0051895; GO:0051987; GO:0072356; GO:0090630; GO:1900025; GO:1900027; GO:1990023,IPR009091; IPR000408; ,,"SUBUNIT: Interacts with RAC1 (PubMed:12919680, PubMed:25074804, PubMed:28869598). Interacts with nucleotide-free and with GDP and GTP-bound forms of RAC1, with a slight preference for GDP-bound RAC1 (PubMed:25074804). Binds preferentially to the nucleotide-free form of RAC1 (PubMed:12919680). Interacts with CORO1C (PubMed:25074804). Interacts with microtubules (PubMed:12919680). {ECO:0000269|PubMed:12919680, ECO:0000269|PubMed:25074804, ECO:0000269|PubMed:28869598}.",12919680; 10819331; 15489334; 17974005; 1939370; 7559776; 9914378; 12429849; 17081983; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 23388455; 23186163; 25074804; 26158537; 28869598,12919680; 10819331; 15489334; 17974005; 1939370; 7559776; 9914378; 12429849; 17081983; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 23388455; 23186163; 25074804; 26158537; 28869598; 11081627; 11181178; 11509732; 11804586; 12006501; 12194817; 12577067; 14730319; 15085137; 15339662; 15723797; 15737063; 16541025; 16622419; 16622420; 17030981; 17129783; 17353931; 18097444; 18716626; 18849993; 19367725; 19738201; 19965387; 20562859; 20873769; 21397845; 21878504; 21907836; 21987589; 22282019; 22623428; 22885700; 23442884; 25609649; 25665578; 25910952; 26496610; 26752685; 28606921; 29321004; 29913439,2005-07-19,2019-02-13,2005-07-19,163,X-ray crystallography (1),STRAND 104 111 {ECO:0000244|PDB:5GWN}.; STRAND 119 121 {ECO:0000244|PDB:5GWN}.; STRAND 135 142 {ECO:0000244|PDB:5GWN}.; STRAND 150 154 {ECO:0000244|PDB:5GWN}.; STRAND 160 166 {ECO:0000244|PDB:5GWN}.; STRAND 171 175 {ECO:0000244|PDB:5GWN}.; STRAND 184 186 {ECO:0000244|PDB:5GWN}.; STRAND 190 195 {ECO:0000244|PDB:5GWN}.; STRAND 204 209 {ECO:0000244|PDB:5GWN}.; STRAND 211 218 {ECO:0000244|PDB:5GWN}.; STRAND 223 229 {ECO:0000244|PDB:5GWN}.; STRAND 236 238 {ECO:0000244|PDB:5GWN}.; STRAND 240 248 {ECO:0000244|PDB:5GWN}.; STRAND 256 261 {ECO:0000244|PDB:5GWN}.; STRAND 263 270 {ECO:0000244|PDB:5GWN}.; STRAND 275 279 {ECO:0000244|PDB:5GWN}.; STRAND 287 289 {ECO:0000244|PDB:5GWN}.; STRAND 306 311 {ECO:0000244|PDB:5GWN}.; STRAND 316 318 {ECO:0000244|PDB:5GWN}.; STRAND 324 326 {ECO:0000244|PDB:5GWN}.; STRAND 332 337 {ECO:0000244|PDB:5GWN}.; STRAND 339 346 {ECO:0000244|PDB:5GWN}.; STRAND 351 355 {ECO:0000244|PDB:5GWN}.; STRAND 364 366 {ECO:0000244|PDB:5GWN}.; STRAND 370 375 {ECO:0000244|PDB:5GWN}.; STRAND 386 392 {ECO:0000244|PDB:5GWN}.; STRAND 395 400 {ECO:0000244|PDB:5GWN}.; STRAND 405 409 {ECO:0000244|PDB:5GWN}.; STRAND 418 423 {ECO:0000244|PDB:5GWN}.; STRAND 432 437 {ECO:0000244|PDB:5GWN}.; STRAND 442 446 {ECO:0000244|PDB:5GWN}.; STRAND 449 454 {ECO:0000244|PDB:5GWN}.; STRAND 472 477 {ECO:0000244|PDB:5GWN}.; STRAND 486 491 {ECO:0000244|PDB:5GWN}.; STRAND 493 501 {ECO:0000244|PDB:5GWN}.,HELIX 124 129 {ECO:0000244|PDB:5GWN}.; HELIX 143 145 {ECO:0000244|PDB:5GWN}.; HELIX 197 199 {ECO:0000244|PDB:5GWN}.; HELIX 282 284 {ECO:0000244|PDB:5GWN}.; HELIX 358 360 {ECO:0000244|PDB:5GWN}.; HELIX 377 380 {ECO:0000244|PDB:5GWN}.; HELIX 425 427 {ECO:0000244|PDB:5GWN}.; HELIX 479 481 {ECO:0000244|PDB:5GWN}.; HELIX 505 513 {ECO:0000244|PDB:5GWN}.,TURN 114 118 {ECO:0000244|PDB:5GWN}.; TURN 413 415 {ECO:0000244|PDB:5GWN}.,,,,,5 out of 5,Beta strand (35); Chain (1); Erroneous initiation (1); Frameshift (1); Helix (9); Modified residue (13); Mutagenesis (2); Region (1); Repeat (7); Sequence conflict (1); Turn (2),"CAUTION: Its precise role in the regulation of RAC1 activity is under debate. Was originally proposed to function as a guanine nucleotide exchange factor for RAC1, but later publications indicate it attenuates RAC1 activation by guanine nucleotide exchange factors and prevents accumulation of active, GTP-bound RAC1 (PubMed:12919680, PubMed:25074804, PubMed:28869598). Conflicting results have also been reported regarding its preferential interaction with nucleotide-free RAC1, as opposed to GPD or GTP-bound RAC1 (PubMed:12919680, PubMed:25074804). {ECO:0000269|PubMed:12919680, ECO:0000269|PubMed:25074804, ECO:0000269|PubMed:28869598}.",,,3D-structure;Acetylation;Cell cycle;Cell division;Cell membrane;Centromere;Chromosome;Complete proteome;Cytoplasm;Cytoskeleton;Guanine-nucleotide releasing factor;Membrane;Microtubule;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat,Evidence at protein level,reviewed,,,163,Caution (1); Function (1); Induction (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0131; KW-0132; KW-0137; KW-0158; KW-0181; KW-0206; KW-0344; KW-0472; KW-0493; KW-0498; KW-0539; KW-0597; KW-0677; KW-0963; KW-1003; KW-1185,,,,,,,,,CHAIN 1 522 Protein RCC2. /FTId=PRO_0000206652.,,,,,,"MOD_RES 16 16 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 20 20 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 43 43 Phosphoserine. {ECO:0000244|PubMed:17081983}.; MOD_RES 44 44 Phosphoserine. {ECO:0000244|PubMed:17081983}.; MOD_RES 45 45 Phosphoserine. {ECO:0000244|PubMed:17081983}.; MOD_RES 46 46 Phosphoserine. {ECO:0000244|PubMed:17081983}.; MOD_RES 50 50 Phosphoserine. {ECO:0000244|PubMed:17081983}.; MOD_RES 51 51 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648}.; MOD_RES 92 92 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 124 124 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8BK67}.; MOD_RES 293 293 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 342 342 Phosphothreonine. {ECO:0000244|PubMed:19690332}.; MOD_RES 377 377 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AJ421269;AB040903;BC004933;BC042141;BC053908;AL359612;
0,Q9Y266,NUDC_HUMAN,NUDC,NUDC,,,,Homo sapiens (Human),9606,Nuclear migration protein nudC (Nuclear distribution protein C homolog),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGGEQEEERFDGMLLAMAQQHEGGVQELVNTFFSFLRRKTDFFIGGEEGMAEKLITQTFSHHNQLAQKTRREKRARQEAERREKAERAARLAKEAKSETSGPQIKELTDEEAERLQLEIDQKKDAENHEAQLKNGSLDSPGKQDTEEDEEEDEKDKGKLKPNLGNGADLPNYRWTQTLSELDLAVPFCVNFRLKGKDMVVDIQRRHLRVGLKGQPAIIDGELYNEVKVEESSWLIEDGKVVTVHLEKINKMEWWSRLVSSDPEINTKKINPENSKLSDLDSETRSMVEKMMYDQRQKSMGLPTSDEQKKQEILKKFMDQHPEMDFSKAKFN,331,"38,243",,,,,,,"SEQUENCE CAUTION:  Sequence=BAA76628.1; Type=Frameshift; Positions=140, 231, 273; Evidence={ECO:0000305}; ",,,,,,,,,,CONFLICT 19 19 Q -> H (in Ref. 4; BAA76628). {ECO:0000305}.; CONFLICT 69 69 T -> N (in Ref. 6; CAB66659). {ECO:0000305}.; CONFLICT 74 74 R -> I (in Ref. 4; BAA76628). {ECO:0000305}.; CONFLICT 111 111 E -> K (in Ref. 4; BAA76628). {ECO:0000305}.; CONFLICT 114 114 R -> K (in Ref. 4; BAA76628). {ECO:0000305}.; CONFLICT 128 128 H -> P (in Ref. 4; BAA76628). {ECO:0000305}.; CONFLICT 149 149 E -> V (in Ref. 6; CAB66659). {ECO:0000305}.; CONFLICT 169 169 L -> P (in Ref. 6; CAB66659). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the nudC family. {ECO:0000305}.,COILED 60 134 {ECO:0000255}.,,DOMAIN 167 258 CS. {ECO:0000255|PROSITE-ProRule:PRU00547}.,MOTIF 68 74 Nuclear localization signal. {ECO:0000255}.,,,,,,,,,"FUNCTION: Plays a role in neurogenesis and neuronal migration (By similarity). Necessary for correct formation of mitotic spindles and chromosome separation during mitosis. Necessary for cytokinesis and cell proliferation. {ECO:0000250, ECO:0000269|PubMed:12679384, ECO:0000269|PubMed:12852857}.",,,,,,,,,,,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; developmental process [GO:0032502]; multicellular organism development [GO:0007275]; protein folding [GO:0006457],cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; developmental process [GO:0032502]; multicellular organism development [GO:0007275]; protein folding [GO:0006457],cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleoplasm [GO:0005654],GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006457; GO:0007049; GO:0007275; GO:0008283; GO:0032502; GO:0045296; GO:0051082; GO:0051301,IPR007052; IPR008978; IPR032572; IPR037898; IPR025934; ,O60884; Q9UKT8; Q8NBT0; Q8TC44; Q8WVS4,"SUBUNIT: Interacts with PAFAH1B1 (By similarity). Interacts with PLK1 (PubMed:12852857). Part of a complex containing PLK1, NUDC, dynein and dynactin (PubMed:12852857). Interacts with DCDC1 (PubMed:22159412). {ECO:0000250|UniProtKB:O35685, ECO:0000269|PubMed:12852857, ECO:0000269|PubMed:22159412}.",10210332; 10453739; 11230166; 16710414; 15489334; 12852857; 12679384; 17081983; 18669648; 19413330; 19608861; 20068231; 21269460; 22159412; 21406692; 23186163; 24275569; 25944712,10210332; 10453739; 11230166; 16710414; 15489334; 12852857; 12679384; 17081983; 18669648; 19413330; 19608861; 20068231; 21269460; 22159412; 21406692; 23186163; 24275569; 25944712; 11081627; 11181178; 11509732; 11804586; 12006501; 12194817; 14676831; 14730319; 14743216; 15085137; 15339662; 15723797; 15737063; 16088917; 16541025; 16622419; 16622420; 16860740; 17030981; 17129783; 17353931; 17658515; 18097444; 18288130; 18716626; 18847512; 19135240; 19367725; 19560457; 19615732; 19875381; 19965387; 20360068; 20467437; 20529857; 20562859; 20675372; 21044950; 21397845; 21473139; 21530541; 21878504; 21987589; 22190034; 22623428; 22885700; 23416715; 24069238; 24255178; 24366813; 25036637; 25609649; 26496610; 26638075; 26752685; 27035759; 27074040; 27959429,2005-03-29,2019-02-13,1999-11-01,169,X-ray crystallography (1),STRAND 173 176 {ECO:0000244|PDB:3QOR}.; STRAND 178 186 {ECO:0000244|PDB:3QOR}.; STRAND 198 203 {ECO:0000244|PDB:3QOR}.; STRAND 206 211 {ECO:0000244|PDB:3QOR}.; STRAND 217 224 {ECO:0000244|PDB:3QOR}.; STRAND 232 236 {ECO:0000244|PDB:3QOR}.; STRAND 240 251 {ECO:0000244|PDB:3QOR}.,HELIX 195 197 {ECO:0000244|PDB:3QOR}.; HELIX 228 230 {ECO:0000244|PDB:3QOR}.; HELIX 266 268 {ECO:0000244|PDB:3QOR}.,TURN 237 239 {ECO:0000244|PDB:3QOR}.,,,,,5 out of 5,Beta strand (7); Chain (1); Coiled coil (1); Domain (1); Frameshift (1); Helix (3); Modified residue (13); Motif (1); Mutagenesis (2); Sequence conflict (8); Turn (1),,"TISSUE SPECIFICITY: Ubiquitous. Highly expressed in fetal liver, kidney, lung and brain. Highly expressed in adult pancreas, kidney, skeletal muscle, liver, lung, placenta, prostate, brain and heart. {ECO:0000269|PubMed:10210332, ECO:0000269|PubMed:10453739}.",,3D-structure;Acetylation;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Microtubule;Mitosis;Nucleus;Phosphoprotein;Reference proteome,Evidence at protein level,reviewed,,NudC family,169,Function (1); Induction (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0493; KW-0498; KW-0539; KW-0597; KW-0963; KW-1185,,,,,,,,PTM: Reversibly phosphorylated on serine residues during the M phase of the cell cycle. Phosphorylation on Ser-274 and Ser-326 is necessary for correct formation of mitotic spindles and chromosome separation during mitosis. Phosphorylated by PLK and other kinases. {ECO:0000269|PubMed:12852857}.,CHAIN 1 331 Nuclear migration protein nudC. /FTId=PRO_0000057990.,,,,,,"MOD_RES 60 60 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 108 108 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 136 136 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 139 139 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 145 145 Phosphothreonine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 239 239 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 259 259 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 260 260 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 274 274 Phosphoserine; by PLK1. {ECO:0000269|PubMed:12852857}.; MOD_RES 277 277 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 285 285 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 298 298 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 326 326 Phosphoserine; by PLK1. {ECO:0000269|PubMed:12852857}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF130736;AF125465;AF100760;AB019408;AF086922;AL136725;BC002399;BC003132;BC006147;BC007280;BC015153;BC021139;
0,Q9Y5N6,ORC6_HUMAN,ORC6 ORC6L,ORC6,ORC6L,,,Homo sapiens (Human),9606,Origin recognition complex subunit 6,UP000005640: Chromosome 16,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGSELIGRLAPRLGLAEPDMLRKAEEYLRLSRVKCVGLSARTTETSSAVMCLDLAASWMKCPLDRAYLIKLSGLNKETYQSCLKSFECLLGLNSNIGIRDLAVQFSCIEAVNMASKILKSYESSLPQTQQVDLDLSRPLFTSAALLSACKILKLKVDKNKMVATSGVKKAIFDRLCKQLEKIGQQVDREPGDVATPPRKRKKIVVEAPAKEMEKVEEMPHKPQKDEDLTQDYEEWKRKILENAASAQKATAE,252,"28,107",,,,,,,,,,,,,VARIANT 32 32 R -> W (in dbSNP:rs3218744). /FTId=VAR_029283.; VARIANT 138 138 P -> Q (in dbSNP:rs3218745). /FTId=VAR_029284.; VARIANT 232 232 Y -> S (in MGORS3; dbSNP:rs387906969). {ECO:0000269|PubMed:21358632}. /FTId=VAR_065487.,,,,,,1,,0,,SIMILARITY: Belongs to the ORC6 family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. Does not bind histone H3 and H4 trimethylation marks H3K9me3, H3K27me3 and H4K20me3. {ECO:0000269|PubMed:22427655}.",,,,,,,,,,,,fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; DNA replication origin binding [GO:0003688]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell division [GO:0051782],DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell division [GO:0051782],DNA replication origin binding [GO:0003688],fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808],GO:0000082; GO:0000808; GO:0001650; GO:0003688; GO:0005634; GO:0005654; GO:0005664; GO:0006260; GO:0006270; GO:0016020; GO:0051782,IPR008721; IPR020529; ,P17096; Q969G2; Q9UBD5; O43929; Q96R06,"SUBUNIT: Component of ORC, a complex composed of at least 6 subunits: ORC1, ORC2, ORC3, ORC4, ORC5 and ORC6. ORC is regulated in a cell-cycle dependent manner. It is sequentially assembled at the exit from anaphase of mitosis and disassembled as cells enter S phase. Interacts with DBF4 (By similarity). {ECO:0000250}.",14702039; 15489334; 17081983; 17716973; 17525332; 18669648; 20068231; 22427655; 23186163; 28112733; 21502537; 21358632,14702039; 15489334; 17081983; 17716973; 17525332; 18669648; 20068231; 22427655; 23186163; 28112733; 21502537; 21358632; 10373557; 10436018; 10518787; 10523313; 10757793; 10882098; 11046155; 11095689; 11125146; 11323433; 11395502; 11593009; 11931757; 12045100; 12169736; 12419251; 15226314; 15232106; 15684404; 15707391; 15910003; 18234856; 19112505; 19541634; 21461783; 24137536; 25416956; 25691413; 28186598; 8266075; 9660782,2000-12-01,2019-02-13,1999-11-01,152,X-ray crystallography (1),,HELIX 98 105 {ECO:0000244|PDB:3M03}.; HELIX 108 110 {ECO:0000244|PDB:3M03}.; HELIX 111 122 {ECO:0000244|PDB:3M03}.; HELIX 127 132 {ECO:0000244|PDB:3M03}.; HELIX 138 151 {ECO:0000244|PDB:3M03}.; HELIX 158 163 {ECO:0000244|PDB:3M03}.; HELIX 169 183 {ECO:0000244|PDB:3M03}.,,,,,,5 out of 5,Chain (1); Cross-link (1); Helix (7); Modified residue (2); Mutagenesis (3); Natural variant (3),,,,3D-structure;Complete proteome;DNA replication;DNA-binding;Disease mutation;Dwarfism;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,ORC6 family,152,Function (1); Involvement in disease (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0181; KW-0225; KW-0235; KW-0238; KW-0242; KW-0539; KW-0597; KW-0621; KW-0832; KW-1017; KW-1185,,,,,"DISEASE: Meier-Gorlin syndrome 3 (MGORS3) [MIM:613803]: A syndrome characterized by bilateral microtia, aplasia/hypoplasia of the patellae, and severe intrauterine and postnatal growth retardation with short stature and poor weight gain. Additional clinical findings include anomalies of cranial sutures, microcephaly, apparently low-set and simple ears, microstomia, full lips, highly arched or cleft palate, micrognathia, genitourinary tract anomalies, and various skeletal anomalies. While almost all cases have primordial dwarfism with substantial prenatal and postnatal growth retardation, not all cases have microcephaly, and microtia and absent/hypoplastic patella are absent in some. Despite the presence of microcephaly, intellect is usually normal. {ECO:0000269|PubMed:21358632}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 252 Origin recognition complex subunit 6. /FTId=PRO_0000127097.,CROSSLNK 210 210 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,,,"MOD_RES 195 195 Phosphothreonine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 229 229 Phosphothreonine. {ECO:0000244|PubMed:17525332}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF139658;AK024019;CH471092;BC039032;BC063565;
0,P30622,CLIP1_HUMAN,CLIP1 CYLN1 RSN,CLIP1,CYLN1 RSN,,,Homo sapiens (Human),9606,CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin),UP000005640: Chromosome 12,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSMLKPSGLKAPTKILKPGSTALKTPTAVVAPVEKTISSEKASSTPSSETQEEFVDDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGSVAGVRYFQCEPLKGIFTRPSKLTRKVQAEDEANGLQTTPASRATSPLCTSTASMVSSSPSTPSNIPQKPSQPAAKEPSATPPISNLTKTASESISNLSEAGSIKKGERELKIGDRVLVGGTKAGVVRFLGETDFAKGEWCGVELDEPLGKNDGAVAGTRYFQCQPKYGLFAPVHKVTKIGFPSTTPAKAKANAVRRVMATTSASLKRSPSASSLSSMSSVASSVSSRPSRTGLLTETSSRYARKISGTTALQEALKEKQQHIEQLLAERDLERAEVAKATSHVGEIEQELALARDGHDQHVLELEAKMDQLRTMVEAADREKVELLNQLEEEKRKVEDLQFRVEEESITKGDLEQKSQISEDPENTQTKLEHARIKELEQSLLFEKTKADKLQRELEDTRVATVSEKSRIMELEKDLALRVQEVAELRRRLESNKPAGDVDMSLSLLQEISSLQEKLEVTRTDHQREITSLKEHFGAREETHQKEIKALYTATEKLSKENESLKSKLEHANKENSDVIALWKSKLETAIASHQQAMEELKVSFSKGLGTETAEFAELKTQIEKMRLDYQHEIENLQNQQDSERAAHAKEMEALRAKLMKVIKEKENSLEAIRSKLDKAEDQHLVEMEDTLNKLQEAEIKVKELEVLQAKCNEQTKVIDNFTSQLKATEEKLLDLDALRKASSEGKSEMKKLRQQLEAAEKQIKHLEIEKNAESSKASSITRELQGRELKLTNLQENLSEVSQVKETLEKELQILKEKFAEASEEAVSVQRSMQETVNKLHQKEEQFNMLSSDLEKLRENLADMEAKFREKDEREEQLIKAKEKLENDIAEIMKMSGDNSSQLTKMNDELRLKERDVEELQLKLTKANENASFLQKSIEDMTVKAEQSQQEAAKKHEEEKKELERKLSDLEKKMETSHNQCQELKARYERATSETKTKHEEILQNLQKTLLDTEDKLKGAREENSGLLQELEELRKQADKAKAAQTAEDAMQIMEQMTKEKTETLASLEDTKQTNAKLQNELDTLKENNLKNVEELNKSKELLTVENQKMEEFRKEIETLKQAAAQKSQQLSALQEENVKLAEELGRSRDEVTSHQKLEEERSVLNNQLLEMKKRESKFIKDADEEKASLQKSISITSALLTEKDAELEKLRNEVTVLRGENASAKSLHSVVQTLESDKVKLELKVKNLELQLKENKRQLSSSSGNTDTQADEDERAQESQIDFLNSVIVDLQRKNQDLKMKVEMMSEAALNGNGDDLNNYDSDDQEKQSKKKPRLFCDICDCFDLHDTEDCPTQAQMSEDPPHSTHHGSRGEERPYCEICEMFGHWATNCNDDETF,1438,"162,246",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=P30622-3; Sequence=Displayed; Name=2; Synonyms=Long; IsoId=P30622-1; Sequence=VSP_038201; Name=3; Synonyms=Short; IsoId=P30622-2; Sequence=VSP_000765; ,,,,,,,,,,"VAR_SEQ 457 502 Missing (in isoform 3). {ECO:0000303|PubMed:1356075, ECO:0000303|PubMed:15489334}. /FTId=VSP_000765.; VAR_SEQ 457 467 Missing (in isoform 2). {ECO:0000303|PubMed:1600942}. /FTId=VSP_038201.","VARIANT 162 162 S -> P (in dbSNP:rs7963597). /FTId=VAR_059206.; VARIANT 780 780 R -> W (in dbSNP:rs3741447). /FTId=VAR_048672.; VARIANT 941 941 S -> P (in dbSNP:rs17883517). {ECO:0000269|PubMed:15489334}. /FTId=VAR_048673.; VARIANT 1080 1080 D -> E (in dbSNP:rs1129167). {ECO:0000269|PubMed:1356075, ECO:0000269|PubMed:15489334}. /FTId=VAR_020398.; VARIANT 1213 1213 M -> I (in a breast cancer sample; somatic mutation; dbSNP:rs1183319975). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036446.; VARIANT 1224 1224 A -> S (in dbSNP:rs17881033). /FTId=VAR_048674.",,,,CONFLICT 193 193 S -> G (in Ref. 3; AAI14214). {ECO:0000305}.; CONFLICT 324 324 S -> P (in Ref. 3; AAI14214). {ECO:0000305}.; CONFLICT 651 651 T -> A (in Ref. 3; AAI14214). {ECO:0000305}.; CONFLICT 682 682 D -> N (in Ref. 3; AAI14214). {ECO:0000305}.; CONFLICT 766 766 L -> P (in Ref. 3; AAI14214). {ECO:0000305}.; CONFLICT 1432 1432 C -> R (in Ref. 3; AAI14214). {ECO:0000305}.,,2,,0,DOMAIN: Intramolecular interaction between the zinc finger domain and the CAP-Gly domains may inhibit interaction with tubulin. {ECO:0000269|PubMed:17563362}.,,COILED 350 1353 {ECO:0000255}.,COMPBIAS 143 204 Ser-rich.; COMPBIAS 304 331 Ser-rich.,DOMAIN 78 120 CAP-Gly 1. {ECO:0000255|PROSITE-ProRule:PRU00045}.; DOMAIN 232 274 CAP-Gly 2. {ECO:0000255|PROSITE-ProRule:PRU00045}.,,REGION 97 101 Important for tubulin binding. {ECO:0000269|PubMed:17889670}.,,"ZN_FING 1417 1434 CCHC-type. {ECO:0000269|PubMed:17563362, ECO:0000269|PubMed:17828275}.",,,,,,"FUNCTION: Binds to the plus end of microtubules and regulates the dynamics of the microtubule cytoskeleton. Promotes microtubule growth and microtubule bundling. Links cytoplasmic vesicles to microtubules and thereby plays an important role in intracellular vesicle trafficking. Plays a role macropinocytosis and endosome trafficking. {ECO:0000269|PubMed:12433698, ECO:0000269|PubMed:17563362, ECO:0000269|PubMed:17889670}.",,,,,,,,,,,,centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; ruffle [GO:0001726]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116]; protein transport into plasma membrane raft [GO:0044861],microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116]; protein transport into plasma membrane raft [GO:0044861],identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; ruffle [GO:0001726],GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005635; GO:0005768; GO:0005813; GO:0005829; GO:0005874; GO:0005881; GO:0005882; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0035371; GO:0042802; GO:0042803; GO:0044861; GO:0046872; GO:0051010,IPR036859; IPR000938; IPR032108; ,Q14203; Q15691; Q71U36; P68366,"SUBUNIT: Interacts with MTOR; phosphorylates and regulates CLIP1 (PubMed:12231510). Interacts (via CAP-Gly domains) with tubulin (PubMed:17563362, PubMed:17889670). Interacts with SLAIN2 (PubMed:21646404). Interacts (via zinc finger) with DCTN1 (PubMed:17828275, PubMed:20679239). Interacts with TUBA1B, MAPRE1 and MAPRE3 (PubMed:17563362). Binds preferentially to tyrosinated microtubules, and only marginally to detyrosinated microtubules (By similarity). {ECO:0000250|UniProtKB:Q922J3, ECO:0000269|PubMed:12231510, ECO:0000269|PubMed:17563362, ECO:0000269|PubMed:17828275, ECO:0000269|PubMed:17828277, ECO:0000269|PubMed:17889670, ECO:0000269|PubMed:20679239, ECO:0000269|PubMed:21646404}.",1600942; 1356075; 15489334; 12433698; 12231510; 17081983; 16964243; 18669648; 19413330; 19690332; 20679239; 20068231; 21269460; 23186163; 24275569; 17889670; 17828277; 17828275; 17563362; 21646404; 16959974,1600942; 1356075; 15489334; 12433698; 12231510; 17081983; 16964243; 18669648; 19413330; 19690332; 20679239; 20068231; 21269460; 23186163; 24275569; 17889670; 17828277; 17828275; 17563362; 21646404; 16959974; 11081627; 11181178; 11509732; 11804586; 11940666; 11966772; 12006501; 12110184; 12194817; 12833147; 14730319; 15085137; 15339662; 15723797; 15737063; 15862147; 16120651; 16362039; 16455083; 16541025; 16574066; 16622419; 16622420; 16772339; 17030981; 17129783; 18097444; 18237546; 18622020; 18716626; 19004523; 19020519; 19126680; 19687009; 19965387; 20195357; 20664522; 20711500; 21397845; 21749319; 21878504; 21987589; 21989536; 22014111; 22119847; 22424550; 22543185; 22885700; 23414517; 23549612; 24255178; 24451569; 24474193; 24530770; 24569606; 24777477; 25413345; 25972084; 26231764; 26504169; 26506308; 26638075; 27199431; 28039481; 29222167,1993-04-01,2019-02-13,2009-10-13,193,X-ray crystallography (6); NMR spectroscopy (3),STRAND 37 39 {ECO:0000244|PDB:2CP5}.; STRAND 63 66 {ECO:0000244|PDB:3RDV}.; STRAND 70 78 {ECO:0000244|PDB:3RDV}.; STRAND 81 85 {ECO:0000244|PDB:3RDV}.; STRAND 87 95 {ECO:0000244|PDB:3RDV}.; STRAND 97 103 {ECO:0000244|PDB:3RDV}.; STRAND 106 108 {ECO:0000244|PDB:3RDV}.; STRAND 116 119 {ECO:0000244|PDB:3RDV}.; STRAND 124 127 {ECO:0000244|PDB:2E3I}.; STRAND 193 196 {ECO:0000244|PDB:2CP6}.; STRAND 217 220 {ECO:0000244|PDB:2E3H}.; STRAND 224 233 {ECO:0000244|PDB:2E3H}.; STRAND 235 249 {ECO:0000244|PDB:2E3H}.; STRAND 252 257 {ECO:0000244|PDB:2E3H}.; STRAND 260 262 {ECO:0000244|PDB:2E3H}.; STRAND 270 274 {ECO:0000244|PDB:2E3H}.; STRAND 278 280 {ECO:0000244|PDB:2E3H}.; STRAND 295 298 {ECO:0000244|PDB:2CP6}.; STRAND 1424 1427 {ECO:0000244|PDB:2HQH}.,HELIX 121 123 {ECO:0000244|PDB:3RDV}.; HELIX 275 277 {ECO:0000244|PDB:2E3H}.; HELIX 1429 1431 {ECO:0000244|PDB:2HQH}.,TURN 67 69 {ECO:0000244|PDB:3RDV}.; TURN 113 115 {ECO:0000244|PDB:2QK0}.; TURN 221 223 {ECO:0000244|PDB:2E3H}.; TURN 267 269 {ECO:0000244|PDB:2CP6}.; TURN 1420 1423 {ECO:0000244|PDB:2HQH}.,,,,,5 out of 5,Alternative sequence (2); Beta strand (19); Chain (1); Coiled coil (1); Compositional bias (2); Domain (2); Helix (3); Modified residue (17); Mutagenesis (1); Natural variant (6); Region (1); Sequence conflict (6); Turn (5); Zinc finger (1),,"TISSUE SPECIFICITY: Detected in dendritic cells (at protein level). Highly expressed in the Reed-Sternberg cells of Hodgkin disease. {ECO:0000269|PubMed:12433698, ECO:0000269|PubMed:1600942}.",,3D-structure;Alternative splicing;Cell projection;Coiled coil;Complete proteome;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Membrane;Metal-binding;Microtubule;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transport;Zinc;Zinc-finger,Evidence at protein level,reviewed,,,193,Alternative products (1); Domain (1); Function (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0175; KW-0181; KW-0206; KW-0472; KW-0479; KW-0493; KW-0597; KW-0621; KW-0677; KW-0813; KW-0862; KW-0863; KW-0963; KW-0966; KW-0968; KW-1185,,,,,,,,"PTM: Phosphorylated. Phosphorylation induces conformational changes by increasing the affinity of the N-terminus for C-terminus, resulting in inhibition of its function thus decreasing its binding to microtubules and DCTN1. Exhibits a folded, autoinhibited conformation when phosphorylated and an open conformation when dephosphorylated with increased binding affinity to microtubules and DCTN1. Phosphorylation regulates its recruitment to tyrosinated microtubules and the recruitment of vesicular cargo to microtubules in neurons (By similarity). Phosphorylation by MTOR may positively regulate CLIP1 association with microtubules (PubMed:12231510). {ECO:0000250|UniProtKB:Q9JK25, ECO:0000269|PubMed:12231510}.",CHAIN 1 1438 CAP-Gly domain-containing linker protein 1. /FTId=PRO_0000083527.,,,,,,"MOD_RES 48 48 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 50 50 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 140 140 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 143 143 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 147 147 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 182 182 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 195 195 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 197 197 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 200 200 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 204 204 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 310 310 Phosphoserine. {ECO:0000250|UniProtKB:Q9JK25}.; MOD_RES 312 312 Phosphoserine; by PKA. {ECO:0000250|UniProtKB:Q9JK25}.; MOD_RES 315 315 Phosphoserine. {ECO:0000250|UniProtKB:Q922J3}.; MOD_RES 348 348 Phosphoserine. {ECO:0000250|UniProtKB:Q9JK25}.; MOD_RES 1236 1236 Phosphoserine. {ECO:0000250|UniProtKB:Q9JK25}.; MOD_RES 1310 1310 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1364 1364 Phosphoserine. {ECO:0000244|PubMed:20068231}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X64838;M97501;BC114213;BC117209;BC126305;
0,Q02224,CENPE_HUMAN,CENPE,CENPE,,,,Homo sapiens (Human),9606,Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin-7) (Kinesin-related protein CENPE),UP000005640: Chromosome 4,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAEEGAVAVCVRVRPLNSREESLGETAQVYWKTDNNVIYQVDGSKSFNFDRVFHGNETTKNVYEEIAAPIIDSAIQGYNGTIFAYGQTASGKTYTMMGSEDHLGVIPRAIHDIFQKIKKFPDREFLLRVSYMEIYNETITDLLCGTQKMKPLIIREDVNRNVYVADLTEEVVYTSEMALKWITKGEKSRHYGETKMNQRSSRSHTIFRMILESREKGEPSNCEGSVKVSHLNLVDLAGSERAAQTGAAGVRLKEGCNINRSLFILGQVIKKLSDGQVGGFINYRDSKLTRILQNSLGGNAKTRIICTITPVSFDETLTALQFASTAKYMKNTPYVNEVSTDEALLKRYRKEIMDLKKQLEEVSLETRAQAMEKDQLAQLLEEKDLLQKVQNEKIENLTRMLVTSSSLTLQQELKAKRKRRVTWCLGKINKMKNSNYADQFNIPTNITTKTHKLSINLLREIDESVCSESDVFSNTLDTLSEIEWNPATKLLNQENIESELNSLRADYDNLVLDYEQLRTEKEEMELKLKEKNDLDEFEALERKTKKDQEMQLIHEISNLKNLVKHAEVYNQDLENELSSKVELLREKEDQIKKLQEYIDSQKLENIKMDLSYSLESIEDPKQMKQTLFDAETVALDAKRESAFLRSENLELKEKMKELATTYKQMENDIQLYQSQLEAKKKMQVDLEKELQSAFNEITKLTSLIDGKVPKDLLCNLELEGKITDLQKELNKEVEENEALREEVILLSELKSLPSEVERLRKEIQDKSEELHIITSEKDKLFSEVVHKESRVQGLLEEIGKTKDDLATTQSNYKSTDQEFQNFKTLHMDFEQKYKMVLEENERMNQEIVNLSKEAQKFDSSLGALKTELSYKTQELQEKTREVQERLNEMEQLKEQLENRDSTLQTVEREKTLITEKLQQTLEEVKTLTQEKDDLKQLQESLQIERDQLKSDIHDTVNMNIDTQEQLRNALESLKQHQETINTLKSKISEEVSRNLHMEENTGETKDEFQQKMVGIDKKQDLEAKNTQTLTADVKDNEIIEQQRKIFSLIQEKNELQQMLESVIAEKEQLKTDLKENIEMTIENQEELRLLGDELKKQQEIVAQEKNHAIKKEGELSRTCDRLAEVEEKLKEKSQQLQEKQQQLLNVQEEMSEMQKKINEIENLKNELKNKELTLEHMETERLELAQKLNENYEEVKSITKERKVLKELQKSFETERDHLRGYIREIEATGLQTKEELKIAHIHLKEHQETIDELRRSVSEKTAQIINTQDLEKSHTKLQEEIPVLHEEQELLPNVKEVSETQETMNELELLTEQSTTKDSTTLARIEMERLRLNEKFQESQEEIKSLTKERDNLKTIKEALEVKHDQLKEHIRETLAKIQESQSKQEQSLNMKEKDNETTKIVSEMEQFKPKDSALLRIEIEMLGLSKRLQESHDEMKSVAKEKDDLQRLQEVLQSESDQLKENIKEIVAKHLETEEELKVAHCCLKEQEETINELRVNLSEKETEISTIQKQLEAINDKLQNKIQEIYEKEEQFNIKQISEVQEKVNELKQFKEHRKAKDSALQSIESKMLELTNRLQESQEEIQIMIKEKEEMKRVQEALQIERDQLKENTKEIVAKMKESQEKEYQFLKMTAVNETQEKMCEIEHLKEQFETQKLNLENIETENIRLTQILHENLEEMRSVTKERDDLRSVEETLKVERDQLKENLRETITRDLEKQEELKIVHMHLKEHQETIDKLRGIVSEKTNEISNMQKDLEHSNDALKAQDLKIQEELRIAHMHLKEQQETIDKLRGIVSEKTDKLSNMQKDLENSNAKLQEKIQELKANEHQLITLKKDVNETQKKVSEMEQLKKQIKDQSLTLSKLEIENLNLAQKLHENLEEMKSVMKERDNLRRVEETLKLERDQLKESLQETKARDLEIQQELKTARMLSKEHKETVDKLREKISEKTIQISDIQKDLDKSKDELQKKIQELQKKELQLLRVKEDVNMSHKKINEMEQLKKQFEAQNLSMQSVRMDNFQLTKKLHESLEEIRIVAKERDELRRIKESLKMERDQFIATLREMIARDRQNHQVKPEKRLLSDGQQHLTESLREKCSRIKELLKRYSEMDDHYECLNRLSLDLEKEIEFQKELSMRVKANLSLPYLQTKHIEKLFTANQRCSMEFHRIMKKLKYVLSYVTKIKEEQHESINKFEMDFIDEVEKQKELLIKIQHLQQDCDVPSRELRDLKLNQNMDLHIEEILKDFSESEFPSIKTEFQQVLSNRKEMTQFLEEWLNTRFDIEKLKNGIQKENDRICQVNNFFNNRIIAIMNESTEFEERSATISKEWEQDLKSLKEKNEKLFKNYQTLKTSLASGAQVNPTTQDNKNPHVTSRATQLTTEKIRELENSLHEAKESAMHKESKIIKMQKELEVTNDIIAKLQAKVHESNKCLEKTKETIQVLQDKVALGAKPYKEEIEDLKMKLVKIDLEKMKNAKEFEKEISATKATVEYQKEVIRLLRENLRRSQQAQDTSVISEHTDPQPSNKPLTCGGGSGIVQNTKALILKSEHIRLEKEISKLKQQNEQLIKQKNELLSNNQHLSNEVKTWKERTLKREAHKQVTCENSPKSPKVTGTASKKKQITPSQCKERNLQDPVPKESPKSCFFDSRSKSLPSPHPVRYFDNSSLGLCPEVQNAGAESVDSQPGPWHASSGKDVPECKTQ,2701,"316,415",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=Q02224-1; Sequence=Displayed; Name=2; IsoId=Q02224-2; Sequence=VSP_028822; Name=3; IsoId=Q02224-3; Sequence=VSP_028820, VSP_028821; ",,SEQUENCE CAUTION:  Sequence=BAE06078.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 549 573 Missing (in isoform 3). {ECO:0000303|Ref.2}. /FTId=VSP_028820.; VAR_SEQ 1972 2068 IQELQKKELQLLRVKEDVNMSHKKINEMEQLKKQFEAQNLSMQSVRMDNFQLTKKLHESLEEIRIVAKERDELRRIKESLKMERDQFIATLREMIAR -> Q (in isoform 3). {ECO:0000303|Ref.2}. /FTId=VSP_028821.; VAR_SEQ 2131 2166 Missing (in isoform 2). {ECO:0000303|PubMed:1406971}. /FTId=VSP_028822.,"VARIANT 933 933 D -> N (in MCPH13; results in defective mitotic spindle formation and chromosome segregation; results in delayed mitotic progression; dbSNP:rs144716013). {ECO:0000269|PubMed:24748105}. /FTId=VAR_072429.; VARIANT 1355 1355 K -> E (in MCPH13; results in defective mitotic spindle formation and chromosome segregation; results in delayed mitotic progression; dbSNP:rs141488085). {ECO:0000269|PubMed:24748105}. /FTId=VAR_072430.; VARIANT 1535 1535 F -> L (in dbSNP:rs2615542). {ECO:0000269|PubMed:1406971, ECO:0000269|PubMed:24748105}. /FTId=VAR_049689.; VARIANT 1581 1581 S -> R (in dbSNP:rs35100664). /FTId=VAR_049690.; VARIANT 1911 1911 S -> T (in dbSNP:rs1381657). /FTId=VAR_059370.; VARIANT 1925 1925 E -> D (in dbSNP:rs2306106). /FTId=VAR_049691.; VARIANT 2090 2090 T -> M (in dbSNP:rs2243682). {ECO:0000269|PubMed:1406971, ECO:0000269|PubMed:24748105}. /FTId=VAR_049692.",,,,CONFLICT 51 51 R -> H (in Ref. 5; BAF83051). {ECO:0000305}.; CONFLICT 300 300 A -> P (in Ref. 1; CAA78727). {ECO:0000305}.; CONFLICT 440 440 F -> S (in Ref. 2; BAE06078). {ECO:0000305}.; CONFLICT 566 566 A -> R (in Ref. 1; CAA78727). {ECO:0000305}.; CONFLICT 902 902 T -> P (in Ref. 1; CAA78727). {ECO:0000305}.; CONFLICT 1297 1297 E -> K (in Ref. 1; CAA78727). {ECO:0000305}.; CONFLICT 1546 1546 K -> N (in Ref. 1; CAA78727). {ECO:0000305}.; CONFLICT 1876 1876 K -> E (in Ref. 1; CAA78727). {ECO:0000305}.; CONFLICT 2008 2017 AQNLSMQSVR -> PNYLCKCE (in Ref. 1; CAA78727). {ECO:0000305}.; CONFLICT 2190 2190 S -> C (in Ref. 1; CAA78727). {ECO:0000305}.,,2,,0,"DOMAIN: The protein is composed of a N-terminal kinesin-motor domain involved in the chromosome movements, a long coil-coiled region involved in the homodimerization and an inhibitory C-tail involved in autoinhibition of the N-terminal catalytic part. {ECO:0000250}.",SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family. {ECO:0000255|PROSITE-ProRule:PRU00283}.,COILED 336 2590 {ECO:0000255}.,,DOMAIN 6 329 Kinesin motor. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,REGION 2126 2476 Kinetochore-binding domain.; REGION 2510 2698 Globular autoinhibitory domain. {ECO:0000250}.,,,,,,,,"FUNCTION: Microtubule plus-end-directed kinetochore motor which plays an important role in chromosome congression, microtubule-kinetochore conjugation and spindle assembly checkpoint activation. Drives chromosome congression (alignment of chromosomes at the spindle equator resulting in the formation of the metaphase plate) by mediating the lateral sliding of polar chromosomes along spindle microtubules towards the spindle equator and by aiding the establishment and maintenance of connections between kinetochores and spindle microtubules (PubMed:7889940, PubMed:23891108, PubMed:25395579). The transport of pole-proximal chromosomes towards the spindle equator is favored by microtubule tracks that are detyrosinated (PubMed:25908662). Acts as a processive bi-directional tracker of dynamic microtubule tips; after chromosomes have congressed, continues to play an active role at kinetochores, enhancing their links with dynamic microtubule ends (PubMed:23955301). Suppresses chromosome congression in NDC80-depleted cells and contributes positively to congression only when microtubules are stabilized (PubMed:25743205). Plays an important role in the formation of stable attachments between kinetochores and spindle microtubules (PubMed:17535814) The stabilization of kinetochore-microtubule attachment also requires CENPE-dependent localization of other proteins to the kinetochore including BUB1B, MAD1 and MAD2. Plays a role in spindle assembly checkpoint activation (SAC) via its interaction with BUB1B resulting in the activation of its kinase activity, which is important for activating SAC. Necessary for the mitotic checkpoint signal at individual kinetochores to prevent aneuploidy due to single chromosome loss (By similarity). {ECO:0000250|UniProtKB:Q6RT24, ECO:0000269|PubMed:17535814, ECO:0000269|PubMed:23891108, ECO:0000269|PubMed:23955301, ECO:0000269|PubMed:25395579, ECO:0000269|PubMed:25743205, ECO:0000269|PubMed:25908662, ECO:0000269|PubMed:7889940}.",,,,,,,,,,NP_BIND 86 93 ATP.,,"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",ATPase activity [GO:0016887]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]",GO:0000278; GO:0000775; GO:0000776; GO:0000777; GO:0000779; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007275; GO:0008017; GO:0015630; GO:0016020; GO:0016887; GO:0019886; GO:0030071; GO:0030496; GO:0043515; GO:0045860; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0099606; GO:0099607; GO:1990023,IPR027640; IPR019821; IPR001752; IPR036961; IPR027417; ,O60566; Q9Y6D9; Q9BZD4,"SUBUNIT: Monomer (PubMed:15236970). Interacts with CENPF (PubMed:9763420). Interacts with BUB1B (PubMed:9763420, PubMed:19625775). Interacts with SEPT7 (PubMed:18460473). Interacts with KIF18A (PubMed:19625775). Interacts with PRC1 (PubMed:15297875). Interacts with NUF2; this interaction determines kinetochore localization (PubMed:17535814). Interacts with SKAP; this interaction greatly favors SKAP binding to microtubules (PubMed:22110139). Interacts with TRAPPC12 (PubMed:25918224). Interacts with CTCF (PubMed:25395579). {ECO:0000269|PubMed:15236970, ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:17535814, ECO:0000269|PubMed:18460473, ECO:0000269|PubMed:19625775, ECO:0000269|PubMed:22110139, ECO:0000269|PubMed:25395579, ECO:0000269|PubMed:25918224, ECO:0000269|PubMed:9763420}.",1406971; 15815621; 14702039; 7889940; 9763420; 10852915; 15297875; 17535814; 18460473; 18374647; 18669648; 19625775; 21269460; 22110139; 23891108; 23186163; 23955301; 24748105; 26321640; 25918224; 25395579; 25743205; 25908662; 15236970,1406971; 15815621; 14702039; 7889940; 9763420; 10852915; 15297875; 17535814; 18460473; 18374647; 18669648; 19625775; 21269460; 22110139; 23891108; 23186163; 23955301; 24748105; 26321640; 25918224; 25395579; 25743205; 25908662; 15236970; 10036229; 11081627; 11181178; 11493604; 11509732; 11739780; 11804586; 12006501; 12194817; 12198549; 12368902; 12686615; 12719470; 14504276; 14730319; 15029241; 15085137; 15159587; 15181147; 15272311; 15326200; 15339662; 15592459; 15723797; 15737063; 1607388; 16144904; 16262723; 16541025; 16571679; 16622419; 16622420; 16926026; 17030981; 17093495; 17113389; 17129783; 17268814; 17283181; 17785528; 18046453; 18097444; 18342609; 18716626; 19116309; 19369418; 19389623; 19525938; 19553660; 19564404; 19723035; 19733075; 19758564; 19965387; 20005805; 20021663; 20085233; 20136777; 20237434; 20332099; 20354862; 20360068; 20462495; 20534429; 20691903; 21282530; 21397845; 2142332; 21550981; 21878504; 21987589; 22013193; 22307330; 22637578; 22801780; 22885700; 23236152; 23740391; 24920822; 24928852; 2521221; 2522352; 25364732; 25383660; 26496610; 26638075; 26933822; 27462072; 27694884; 27735937; 27835888; 28916652; 29748388; 7844144; 7929562; 8602245; 8642258; 8909537; 9744883,1993-07-01,2019-02-13,2007-10-23,193,X-ray crystallography (2),STRAND 7 13 {ECO:0000244|PDB:1T5C}.; STRAND 31 34 {ECO:0000244|PDB:1T5C}.; STRAND 37 40 {ECO:0000244|PDB:1T5C}.; STRAND 46 48 {ECO:0000244|PDB:1T5C}.; STRAND 80 87 {ECO:0000244|PDB:1T5C}.; STRAND 100 103 {ECO:0000244|PDB:1T5C}.; STRAND 123 135 {ECO:0000244|PDB:1T5C}.; STRAND 138 146 {ECO:0000244|PDB:1T5C}.; STRAND 190 197 {ECO:0000244|PDB:1T5C}.; STRAND 204 215 {ECO:0000244|PDB:1T5C}.; STRAND 226 235 {ECO:0000244|PDB:1T5C}.; STRAND 254 256 {ECO:0000244|PDB:1T5C}.; STRAND 298 308 {ECO:0000244|PDB:1T5C}.,HELIX 59 65 {ECO:0000244|PDB:1T5C}.; HELIX 68 75 {ECO:0000244|PDB:1T5C}.; HELIX 92 96 {ECO:0000244|PDB:1T5C}.; HELIX 105 116 {ECO:0000244|PDB:1T5C}.; HELIX 117 119 {ECO:0000244|PDB:1T5C}.; HELIX 175 187 {ECO:0000244|PDB:1T5C}.; HELIX 239 241 {ECO:0000244|PDB:1T5C}.; HELIX 260 274 {ECO:0000244|PDB:1T5C}.; HELIX 283 285 {ECO:0000244|PDB:1T5C}.; HELIX 287 291 {ECO:0000244|PDB:1T5C}.; HELIX 293 295 {ECO:0000244|PDB:1T5C}.; HELIX 314 326 {ECO:0000244|PDB:1T5C}.; HELIX 341 376 {ECO:0000244|PDB:5JVP}.,TURN 22 25 {ECO:0000244|PDB:1T5C}.; TURN 157 159 {ECO:0000244|PDB:1T5C}.; TURN 199 202 {ECO:0000244|PDB:1T5C}.,,,,,5 out of 5,Alternative sequence (3); Beta strand (13); Chain (1); Coiled coil (1); Domain (1); Erroneous initiation (1); Helix (13); Lipidation (1); Modified residue (7); Natural variant (7); Nucleotide binding (1); Propeptide (1); Region (2); Sequence conflict (10); Turn (3),,,,3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Developmental protein;Direct protein sequencing;Disease mutation;Kinetochore;Lipoprotein;Methylation;Microtubule;Mitosis;Motor protein;Nucleotide-binding;Phosphoprotein;Polymorphism;Prenylation;Primary microcephaly;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family",193,Alternative products (1); Domain (1); Function (1); Involvement in disease (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0067; KW-0131; KW-0132; KW-0137; KW-0158; KW-0175; KW-0181; KW-0206; KW-0217; KW-0225; KW-0449; KW-0488; KW-0493; KW-0498; KW-0505; KW-0547; KW-0597; KW-0621; KW-0636; KW-0832; KW-0903; KW-0905; KW-0963; KW-0995; KW-1185,,,,,"DISEASE: Microcephaly 13, primary, autosomal recessive (MCPH13) [MIM:616051]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age-related mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. {ECO:0000269|PubMed:24748105}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: The C-terminal inhibitory domain is phosphorylated. Phosphorylation relieves autoinhibition of the kinetochore motor (By similarity). {ECO:0000250}.; PTM: Sumoylated with SUMO2 and SUMO3. The sumoylation mediates the association to the kinetochore. {ECO:0000269|PubMed:18374647}.,CHAIN 1 2698 Centromere-associated protein E. /FTId=PRO_0000125436.,,,,,LIPID 2698 2698 S-farnesyl cysteine. {ECO:0000269|PubMed:10852915}.,MOD_RES 611 611 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 2083 2083 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 2389 2389 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 2639 2639 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 2647 2647 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 2651 2651 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 2698 2698 Cysteine methyl ester. {ECO:0000305}.,,PROPEP 2699 2701 Removed in mature form. {ECO:0000305}. /FTId=PRO_0000396742.,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,Z15005;AB209996;CH471057;AK290362;
0,Q53HL2,BOREA_HUMAN,CDCA8 PESCRG3,CDCA8,PESCRG3,,,Homo sapiens (Human),9606,Borealin (Cell division cycle-associated protein 8) (Dasra-B) (hDasra-B) (Pluripotent embryonic stem cell-related gene 3 protein),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAPRKGSSRVAKTNSLRRRKLASFLKDFDREVEIRIKQIESDRQNLLKEVDNLYNIEILRLPKALREMNWLDYFALGGNKQALEEAATADLDITEINKLTAEAIQTPLKSAKTRKVIQVDEMIVEEEEEEENERKNLQTARVKRCPPSKKRTQSIQGKGKGKRSSRANTVTPAVGRLEVSMVKPTPGLTPRFDSRVFKTPGLRTPAAGERIYNISGNGSPLADSKEIFLTVPVGGGESLRLLASDLQRHSIAQLDPEALGNIKKLSNRLAQICSSIRTHK,280,"31,323",,,,,,,"SEQUENCE CAUTION:  Sequence=BG354581; Type=Frameshift; Positions=123, 200; Evidence={ECO:0000305}; ",,,,,,VARIANT 12 12 K -> N (in dbSNP:rs17851453). {ECO:0000269|PubMed:15489334}. /FTId=VAR_027063.,,,,CONFLICT 155 155 I -> M (in Ref. 4; BAD96288). {ECO:0000305}.; CONFLICT 213 213 N -> D (in Ref. 4; BAD96269). {ECO:0000305}.,,2,,0,DOMAIN: The C-terminal region (aa 207-280) represents the dimerization motif.,SIMILARITY: Belongs to the borealin family. {ECO:0000305}.,,COMPBIAS 125 133 Poly-Glu.,,,REGION 1 140 Required for interaction with SENP3. {ECO:0000269|PubMed:18946085}.; REGION 1 88 Required for centromere localization.; REGION 1 58 Required for interaction with INCENP. {ECO:0000269|PubMed:17956729}.; REGION 10 109 Required to form a minimal CPC core complex that localizes to the central spindle and midbody and properly executes the role of the CPC during cytokinesis.; REGION 20 78 Required for interaction with INCENP and BIRC5. {ECO:0000269|PubMed:17956729}.,,,,,,,,"FUNCTION: Component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Major effector of the TTK kinase in the control of attachment-error-correction and chromosome alignment. {ECO:0000269|PubMed:15249581, ECO:0000269|PubMed:15260989, ECO:0000269|PubMed:16571674, ECO:0000269|PubMed:18243099}.",,,,,,,,,,,,"chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle midzone [GO:0051233]; cell division [GO:0051301]; chromosome organization [GO:0051276]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]",cell division [GO:0051301]; chromosome organization [GO:0051276]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070],,"chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; chromosome passenger complex [GO:0032133]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle midzone [GO:0051233]",GO:0000070; GO:0000775; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007080; GO:0010369; GO:0030496; GO:0032133; GO:0032991; GO:0045171; GO:0051233; GO:0051276; GO:0051301,IPR018851; IPR018867; ,Q96GD4; E7CU85; O15392; O15392-1; O15392-2; Q86XJ1; Q9NQS7; Q5FBB7; Q562F6,"SUBUNIT: May form homooligomers and homodimers. Component of the chromosomal passenger complex (CPC) composed of at least BIRC5/survivin, CDCA8/borealin, INCENP, AURKB or AURKC; in the complex forms a triple-helix bundle-based subcomplex with INCENP and BIRC5 (PubMed:17956729). Interacts with SENP3, UBE2I and RANBP2. Interacts (phosphorylated) with SGO1 and SGO2; the association is dependent on CDK1. {ECO:0000269|PubMed:15249581, ECO:0000269|PubMed:16239925, ECO:0000269|PubMed:16291752, ECO:0000269|PubMed:16427043, ECO:0000269|PubMed:16436504, ECO:0000269|PubMed:17956729, ECO:0000269|PubMed:18591255, ECO:0000269|PubMed:18946085, ECO:0000269|PubMed:20739936}.",12188893; 14702039; 15489334; 15260989; 15249581; 15561729; 16239925; 16427043; 16291752; 16436504; 16571674; 16547492; 18691976; 18591255; 18243099; 18669648; 19413330; 18946085; 19369195; 19690332; 20739936; 20068231; 21406692; 23186163; 28112733; 17956729; 19530738,12188893; 14702039; 15489334; 15260989; 15249581; 15561729; 16239925; 16427043; 16291752; 16436504; 16571674; 16547492; 18691976; 18591255; 18243099; 18669648; 19413330; 18946085; 19369195; 19690332; 20739936; 20068231; 21406692; 23186163; 28112733; 17956729; 19530738; 11081627; 11181178; 11509732; 11804586; 12006501; 12194817; 14730319; 15085137; 15339662; 15723797; 15737063; 16541025; 16622419; 16622420; 17030981; 17099693; 17129783; 17241471; 17483322; 17716930; 17881355; 18097444; 18311593; 18716626; 19965387; 20360068; 20562864; 20663916; 20803554; 20929775; 21051298; 21397845; 21554500; 21878504; 21987589; 21988832; 22383538; 22464730; 22724069; 22797924; 22885700; 24571573; 24917673; 25218447; 25260804; 25416956; 25854549; 26170459; 26496610; 28004745; 28025328; 30142792,2006-07-25,2019-02-13,2006-07-25,132,X-ray crystallography (3); NMR spectroscopy (1),STRAND 233 237 {ECO:0000244|PDB:2KDD}.,HELIX 16 60 {ECO:0000244|PDB:2QFA}.; HELIX 63 66 {ECO:0000244|PDB:2QFA}.; HELIX 70 75 {ECO:0000244|PDB:2QFA}.; HELIX 248 252 {ECO:0000244|PDB:2KDD}.; HELIX 256 275 {ECO:0000244|PDB:2KDD}.,TURN 243 245 {ECO:0000244|PDB:2KDD}.,,,,,5 out of 5,Beta strand (1); Chain (1); Compositional bias (1); Cross-link (1); Frameshift (1); Helix (5); Modified residue (13); Mutagenesis (23); Natural variant (1); Region (5); Sequence conflict (2); Turn (1),,,"MISCELLANEOUS: Cells lacking CDCA8 display a slight decrease in histone H3 'Ser-10' phosphorylation, suggesting that the CPC complex mediates phosphorylation of 'Ser-10' of histone H3.",3D-structure;Cell cycle;Cell division;Centromere;Chromosome;Complete proteome;Cytoplasm;Cytoskeleton;Isopeptide bond;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,Borealin family,132,Developmental stage (1); Domain (1); Function (1); Miscellaneous (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0131; KW-0132; KW-0137; KW-0158; KW-0181; KW-0206; KW-0498; KW-0539; KW-0597; KW-0621; KW-0832; KW-0963; KW-1017; KW-1185,,,,,,,,"PTM: Phosphorylated by TTK, essentially at Thr-88, Thr94, Thr-169 and Thr-230. Phosphorylation (probably by CDK1) promotes targeting of the CPC to centromeric DNA. {ECO:0000269|PubMed:15249581, ECO:0000269|PubMed:18243099, ECO:0000269|PubMed:19530738}.; PTM: Sumoylated by UBE2I and RANBP2. Desumoylated by SENP3 through the removal of SUMO2 and SUMO3. {ECO:0000269|PubMed:18946085}.",CHAIN 1 280 Borealin. /FTId=PRO_0000247075.,CROSSLNK 135 135 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,,,"MOD_RES 88 88 Phosphothreonine; by TTK. {ECO:0000269|PubMed:19530738}.; MOD_RES 94 94 Phosphothreonine; by TTK. {ECO:0000269|PubMed:19530738}.; MOD_RES 106 106 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 110 110 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 165 165 Phosphoserine; by AURKB. {ECO:0000269|PubMed:15249581}.; MOD_RES 169 169 Phosphothreonine; by TTK. {ECO:0000269|PubMed:19530738}.; MOD_RES 189 189 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 204 204 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:23186163}.; MOD_RES 219 219 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 224 224 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 230 230 Phosphothreonine; by TTK. {ECO:0000269|PubMed:19530738}.; MOD_RES 238 238 Phosphoserine. {ECO:0000269|PubMed:19530738}.; MOD_RES 244 244 Phosphoserine. {ECO:0000244|PubMed:18691976}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AY508815;AK001330;AK022104;AK022606;AK222549;AK222568;CH471059;CH471059;BC000703;BC001651;BC016944;BC008079;
0,Q96GD4,AURKB_HUMAN,AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5,AURKB,AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5,,,Homo sapiens (Human),9606,Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B),UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAQKENSYPWPYGRQTAPSGLSTLPQRVLRKEPVTPSALVLMSRSNVQPTAAPGQKVMENSSGTPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPMGAQDLISKLLRHNPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA,344,"39,311",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=5;  Name=1; IsoId=Q96GD4-1; Sequence=Displayed; Name=2; Synonyms=aurkb-sv1; IsoId=Q96GD4-2; Sequence=VSP_044385; Name=3; Synonyms=aurkb-sv2; IsoId=Q96GD4-3; Sequence=VSP_044384, VSP_044386, VSP_044387; Note=Not expressed in normal liver, high expression in metastatic liver.; Name=4; IsoId=Q96GD4-4; Sequence=VSP_047103; Name=5; IsoId=Q96GD4-5; Sequence=VSP_044384; ",,SEQUENCE CAUTION:  Sequence=AAH13300.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 1 41 Missing (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_047103.; VAR_SEQ 69 69 T -> TR (in isoform 3 and isoform 5). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:19134008}. /FTId=VSP_044384.; VAR_SEQ 86 134 GKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH -> ALLCLWPEASSVSSPSH (in isoform 2). {ECO:0000303|PubMed:19134008}. /FTId=VSP_044385.; VAR_SEQ 133 141 HHPNILRLY -> QSWRSWQML (in isoform 3). {ECO:0000303|PubMed:19134008}. /FTId=VSP_044386.; VAR_SEQ 142 344 Missing (in isoform 3). {ECO:0000303|PubMed:19134008}. /FTId=VSP_044387.","VARIANT 52 52 A -> V (in dbSNP:rs55878091). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040383.; VARIANT 100 100 H -> Q (in dbSNP:rs3027254). /FTId=VAR_027970.; VARIANT 179 179 T -> M (in dbSNP:rs55871613). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040384.; VARIANT 298 298 M -> T (in dbSNP:rs1059476). {ECO:0000269|PubMed:11471245, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16762494, ECO:0000269|PubMed:9514916, ECO:0000269|PubMed:9809983, ECO:0000269|PubMed:9858806, ECO:0000269|Ref.5, ECO:0000269|Ref.7}. /FTId=VAR_027971.",,,,CONFLICT 14 15 RQ -> DK (in Ref. 5; AAC98891). {ECO:0000305}.; CONFLICT 161 161 E -> M (in Ref. 4; AAB65786 and 5; AAC98891). {ECO:0000305}.; CONFLICT 167 169 QKS -> HKT (in Ref. 4; AAB65786). {ECO:0000305}.; CONFLICT 179 179 T -> TVRR (in Ref. 4; AAB65786). {ECO:0000305}.; CONFLICT 180 180 I -> VRAV (in Ref. 5; AAC98891). {ECO:0000305}.; CONFLICT 226 226 P -> T (in Ref. 3; BAA82709). {ECO:0000305}.; CONFLICT 249 250 MH -> ID (in Ref. 3; BAA82709). {ECO:0000305}.; CONFLICT 271 271 Missing (in Ref. 3; BAA82709). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. Aurora subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,DOMAIN 77 327 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ,,"FUNCTION: Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Involved in the bipolar attachment of spindle microtubules to kinetochores and is a key regulator for the onset of cytokinesis during mitosis. Required for central/midzone spindle assembly and cleavage furrow formation. Key component of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage: phosphorylates CHMP4C, leading to retain abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis (PubMed:22422861, PubMed:24814515). AURKB phosphorylates the CPC complex subunits BIRC5/survivin, CDCA8/borealin and INCENP. Phosphorylation of INCENP leads to increased AURKB activity. Other known AURKB substrates involved in centromeric functions and mitosis are CENPA, DES/desmin, GPAF, KIF2C, NSUN2, RACGAP1, SEPT1, VIM/vimentin, HASPIN, and histone H3. A positive feedback loop involving HASPIN and AURKB contributes to localization of CPC to centromeres. Phosphorylation of VIM controls vimentin filament segregation in cytokinetic process, whereas histone H3 is phosphorylated at 'Ser-10' and 'Ser-28' during mitosis (H3S10ph and H3S28ph, respectively). A positive feedback between HASPIN and AURKB contributes to CPC localization. AURKB is also required for kinetochore localization of BUB1 and SGO1. Phosphorylation of p53/TP53 negatively regulates its transcriptional activity. Key regulator of active promoters in resting B- and T-lymphocytes: acts by mediating phosphorylation of H3S28ph at active promoters in resting B-cells, inhibiting RNF2/RING1B-mediated ubiquitination of histone H2A and enhancing binding and activity of the USP16 deubiquitinase at transcribed genes. {ECO:0000269|PubMed:11516652, ECO:0000269|PubMed:11756469, ECO:0000269|PubMed:11784863, ECO:0000269|PubMed:11856369, ECO:0000269|PubMed:12458200, ECO:0000269|PubMed:12686604, ECO:0000269|PubMed:12689593, ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:14602875, ECO:0000269|PubMed:14610074, ECO:0000269|PubMed:14722118, ECO:0000269|PubMed:15020684, ECO:0000269|PubMed:15249581, ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:17617734, ECO:0000269|PubMed:20959462, ECO:0000269|PubMed:21658950, ECO:0000269|PubMed:22422861, ECO:0000269|PubMed:24814515}.",,,,,,"ACT_SITE 200 200 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 106 106 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 83 91 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,"chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; abscission [GO:0009838]; aging [GO:0007568]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; cleavage furrow formation [GO:0036089]; histone H3-S28 phosphorylation [GO:0043988]; histone modification [GO:0016570]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytokinesis [GO:0032467]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of chromosome segregation [GO:0051983]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; spindle organization [GO:0007051]",abscission [GO:0009838]; aging [GO:0007568]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; cleavage furrow formation [GO:0036089]; histone H3-S28 phosphorylation [GO:0043988]; histone modification [GO:0016570]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytokinesis [GO:0032467]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of chromosome segregation [GO:0051983]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; spindle organization [GO:0007051],ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674],"chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]",GO:0000122; GO:0000776; GO:0000779; GO:0000780; GO:0002903; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005876; GO:0006468; GO:0007051; GO:0007052; GO:0007094; GO:0007568; GO:0008283; GO:0008608; GO:0009838; GO:0010369; GO:0016570; GO:0019900; GO:0030496; GO:0031145; GO:0031616; GO:0032091; GO:0032133; GO:0032212; GO:0032465; GO:0032466; GO:0032467; GO:0034501; GO:0034644; GO:0035174; GO:0036089; GO:0043988; GO:0044878; GO:0046777; GO:0046872; GO:0051233; GO:0051256; GO:0051973; GO:0051983; GO:1901796; GO:1904355; GO:1990023,IPR030616; IPR028772; IPR011009; IPR000719; IPR017441; IPR008271; ,O15392; O15392-1; O15392-2; Q16543; Q53HL2; Q86XJ1; Q16695; P08238; Q9NQS7; Q9NQS7-1; Q92993; Q15691; P06748; P30153; Q8WYJ6; O75410-6; Q99986,"SUBUNIT: Component of the chromosomal passenger complex (CPC) composed of at least BIRC5/survivin, CDCA8/borealin, INCENP, AURKB or AURKC; predominantly independent AURKB- and AURKC-containing complexes exist. Associates with RACGAP1 during M phase. Interacts with CDCA1, EVI5, JTB, NDC80, PSMA3, SEPT1, SIRT2 and TACC1. Interacts with SPDYC; this interaction may be required for proper localization of active, Thr-232-phosphorylated AURKB form during prometaphase and metaphase. Interacts with p53/TP53. Interacts (via the middle kinase domain) with NOC2L (via the N- and C-terminus domains). Interacts with TTC28. Interacts with RNF2/RING1B. {ECO:0000269|PubMed:11516652, ECO:0000269|PubMed:12689593, ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:14602875, ECO:0000269|PubMed:14674694, ECO:0000269|PubMed:14722118, ECO:0000269|PubMed:15064709, ECO:0000269|PubMed:15249581, ECO:0000269|PubMed:16179162, ECO:0000269|PubMed:16764853, ECO:0000269|PubMed:17726514, ECO:0000269|PubMed:18591255, ECO:0000269|PubMed:20562864, ECO:0000269|PubMed:20605920, ECO:0000269|PubMed:20959462, ECO:0000269|PubMed:21225229, ECO:0000269|PubMed:22422861, ECO:0000269|PubMed:23036704, ECO:0000269|PubMed:27332895}.",9514916; 9809983; 9858806; 11471245; 19134008; 14702039; 16625196; 15489334; 11516652; 11756469; 11413462; 11856369; 11784863; 12689593; 12458200; 12686604; 12925766; 14674694; 14610074; 14722118; 15020684; 15249581; 14602875; 15064709; 16179162; 16103226; 16764853; 17617734; 17543862; 17726514; 18691976; 18591255; 18669648; 19995937; 19369195; 20605920; 20562864; 20068231; 20929775; 21269460; 21658950; 20959462; 21225229; 23036704; 22422861; 23186163; 24814515; 27332895; 22920039; 16762494; 17344846,,2003-01-17,2019-02-13,2011-01-11,204,X-ray crystallography (1),STRAND 77 82 {ECO:0000244|PDB:4AF3}.; STRAND 89 96 {ECO:0000244|PDB:4AF3}.; STRAND 102 109 {ECO:0000244|PDB:4AF3}.; STRAND 140 145 {ECO:0000244|PDB:4AF3}.; STRAND 147 155 {ECO:0000244|PDB:4AF3}.; STRAND 206 208 {ECO:0000244|PDB:4AF3}.; STRAND 214 216 {ECO:0000244|PDB:4AF3}.,HELIX 74 76 {ECO:0000244|PDB:4AF3}.; HELIX 110 116 {ECO:0000244|PDB:4AF3}.; HELIX 119 130 {ECO:0000244|PDB:4AF3}.; HELIX 162 169 {ECO:0000244|PDB:4AF3}.; HELIX 174 193 {ECO:0000244|PDB:4AF3}.; HELIX 203 205 {ECO:0000244|PDB:4AF3}.; HELIX 242 245 {ECO:0000244|PDB:4AF3}.; HELIX 253 268 {ECO:0000244|PDB:4AF3}.; HELIX 278 286 {ECO:0000244|PDB:4AF3}.; HELIX 298 307 {ECO:0000244|PDB:4AF3}.; HELIX 312 314 {ECO:0000244|PDB:4AF3}.; HELIX 318 322 {ECO:0000244|PDB:4AF3}.; HELIX 325 330 {ECO:0000244|PDB:4AF3}.,TURN 97 99 {ECO:0000244|PDB:4AF3}.,,,,,5 out of 5,Active site (1); Alternative sequence (5); Beta strand (7); Binding site (1); Chain (1); Domain (1); Erroneous initiation (1); Helix (13); Modified residue (5); Mutagenesis (1); Natural variant (4); Nucleotide binding (1); Sequence conflict (9); Turn (1),,"TISSUE SPECIFICITY: High level expression seen in the thymus. It is also expressed in the spleen, lung, testis, colon, placenta and fetal liver. Expressed during S and G2/M phase and expression is up-regulated in cancer cells during M phase. {ECO:0000269|PubMed:9809983, ECO:0000269|PubMed:9858806}.",,3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Complete proteome;Cytoplasm;Cytoskeleton;Kinase;Magnesium;Metal-binding;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation,Evidence at protein level,reviewed,,"Protein kinase superfamily, Ser/Thr protein kinase family, Aurora subfamily",204,Activity regulation (1); Alternative products (1); Catalytic activity (2); Caution (1); Cofactor (1); Function (1); Induction (1); Involvement in disease (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0067; KW-0131; KW-0132; KW-0137; KW-0158; KW-0181; KW-0206; KW-0418; KW-0460; KW-0479; KW-0498; KW-0539; KW-0547; KW-0597; KW-0621; KW-0723; KW-0808; KW-0832; KW-0963; KW-1185,,,,,DISEASE: Note=Disruptive regulation of expression is a possible mechanism of the perturbation of chromosomal integrity in cancer cells through its dominant-negative effect on cytokinesis.,,,"PTM: The phosphorylation of Thr-232 requires the binding to INCENP and occurs by means of an autophosphorylation mechanism. Thr-232 phosphorylation is indispensable for the AURKB kinase activity. {ECO:0000269|PubMed:14722118}.; PTM: Ubiquitinated by different BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complexes. Ubiquitinated by the BCR(KLHL9-KLHL13) E3 ubiquitin ligase complex, ubiquitination leads to removal from mitotic chromosomes and is required for cytokinesis. During anaphase, the BCR(KLHL21) E3 ubiquitin ligase complex recruits the CPC complex from chromosomes to the spindle midzone and mediates the ubiquitination of AURKB. Ubiquitination of AURKB by BCR(KLHL21) E3 ubiquitin ligase complex may not lead to its degradation by the proteasome. {ECO:0000269|PubMed:17543862, ECO:0000269|PubMed:19995937}.",CHAIN 1 344 Aurora kinase B. /FTId=PRO_0000085656.,,,,,,MOD_RES 35 35 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 62 62 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 64 64 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 227 227 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 232 232 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:14722118}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF008552;AB011450;AB011446;AF004022;AF015254;AB519677;AB519678;AB519679;BT019534;AK297976;CH471108;CH471108;CH471108;BC000442;BC009751;BC013300;BC080581;
0,Q9NQS7,INCE_HUMAN,INCENP,INCENP,,,,Homo sapiens (Human),9606,Inner centromere protein,UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGTTAPGPIHLLELCDQKLMEFLCNMDNKDLVWLEEIQEEAERMFTREFSKEPELMPKTPSQKNRRKKRRISYVQDENRDPIRRRLSRRKSRSSQLSSRRLRSKDSVEKLATVVGENGSVLRRVTRAAAAAAAATMALAAPSSPTPESPTMLTKKPEDNHTQCQLVPVVEIGISERQNAEQHVTQLMSTEPLPRTLSPTPASATAPTSQGIPTSDEESTPKKSKARILESITVSSLMATPQDPKGQGVGTGRSASKLRIAQVSPGPRDSPAFPDSPWRERVLAPILPDNFSTPTGSRTDSQSVRHSPIAPSSPSPQVLAQKYSLVAKQESVVRRASRRLAKKTAEEPAASGRIICHSYLERLLNVEVPQKVGSEQKEPPEEAEPVAAAEPEVPENNGNNSWPHNDTEIANSTPNPKPAASSPETPSAGQQEAKTDQADGPREPPQSARRKRSYKQAVSELDEEQHLEDEELQPPRSKTPSSPCPASKVVRPLRTFLHTVQRNQMLMTPTSAPRSVMKSFIKRNTPLRMDPKCSFVEKERQRLENLRRKEEAEQLRRQKVEEDKRRRLEEVKLKREERLRKVLQARERVEQMKEEKKKQIEQKFAQIDEKTEKAKEERLAEEKAKKKAAAKKMEEVEARRKQEEEARRLRWLQQEEEERRHQELLQKKKEEEQERLRKAAEAKRLAEQREQERREQERREQERREQERREQERREQERQLAEQERRREQERLQAERELQEREKALRLQKEQLQRELEEKKKKEEQQRLAERQLQEEQEKKAKEAAGASKALNVTVDVQSPACTSYQMTPQGHRAPPKINPDNYGMDLNSDDSTDDEAHPRKPIPTWARGTPLSQAIIHQYYHPPNLLELFGTILPLDLEDIFKKSKPRYHKRTSSAVWNSPPLQGARVPSSLAYSLKKH,918,"105,429",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q9NQS7-1; Sequence=Displayed; Name=2; IsoId=Q9NQS7-2; Sequence=VSP_035651; ,,,,,,,,,,VAR_SEQ 532 535 Missing (in isoform 2). {ECO:0000303|PubMed:11453556}. /FTId=VSP_035651.,"VARIANT 2 2 G -> V (in dbSNP:rs1792947). /FTId=VAR_047127.; VARIANT 100 100 R -> H (in dbSNP:rs12281503). /FTId=VAR_047128.; VARIANT 137 137 A -> V (in dbSNP:rs34441559). /FTId=VAR_047129.; VARIANT 506 506 M -> T (in dbSNP:rs2277283). /FTId=VAR_047130.; VARIANT 644 644 E -> D (in dbSNP:rs7129085). {ECO:0000269|PubMed:11453556, ECO:0000269|PubMed:15316025, ECO:0000269|PubMed:15489334}. /FTId=VAR_047131.",,,,CONFLICT 715 715 Q -> QERREQ (in Ref. 1; AAF87584). {ECO:0000305}.; CONFLICT 804 806 YQM -> SPI (in Ref. 1; AAF87584). {ECO:0000305}.; CONFLICT 812 812 R -> K (in Ref. 1; AAF87584). {ECO:0000305}.; CONFLICT 816 816 K -> Q (in Ref. 1; AAF87584). {ECO:0000305}.; CONFLICT 820 820 D -> H (in Ref. 1; AAF87584). {ECO:0000305}.; CONFLICT 861 861 H -> Q (in Ref. 1; AAF87584). {ECO:0000305}.,,3,,0,"DOMAIN: The IN box mediates interaction with AURKB and AURKC. {ECO:0000250|UniProtKB:O13024, ECO:0000269|PubMed:27332895}.; DOMAIN: The SAH (single alpha-helix) region is characterized by a high content of charged residues which are predicted to stabilize the alpha-helical structure by ionic bonds. It can refold after extension suggesting an in vivo force-dependent function. The isolated SAH domain is monomeric. {ECO:0000250|UniProtKB:P53352}.",SIMILARITY: Belongs to the INCENP family. {ECO:0000305}.,,,,MOTIF 167 171 PXVXL/I motif. {ECO:0000305|PubMed:21346195}.,REGION 124 248 Interaction with CBX5. {ECO:0000269|PubMed:21346195}.; REGION 531 765 SAH. {ECO:0000250|UniProtKB:P53352}.; REGION 822 897 Interaction with AURKC. {ECO:0000269|PubMed:27332895}.; REGION 826 900 IN box. {ECO:0000305}.,,,,,,,,"FUNCTION: Component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Acts as a scaffold regulating CPC localization and activity. The C-terminus associates with AURKB or AURKC, the N-terminus associated with BIRC5/survivin and CDCA8/borealin tethers the CPC to the inner centromere, and the microtubule binding activity within the central SAH domain directs AURKB/C toward substrates near microtubules (PubMed:15316025, PubMed:12925766, PubMed:27332895). The flexibility of the SAH domain is proposed to allow AURKB/C to follow substrates on dynamic microtubules while ensuring CPC docking to static chromatin (By similarity). Activates AURKB and AURKC (PubMed:27332895). Required for localization of CBX5 to mitotic centromeres (PubMed:21346195). Controls the kinetochore localization of BUB1 (PubMed:16760428). {ECO:0000250|UniProtKB:P53352, ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:15316025, ECO:0000269|PubMed:16760428, ECO:0000269|PubMed:21346195, ECO:0000269|PubMed:27332895}.",,,,,,,,,,,,"central element [GO:0000801]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; regulation of mitotic cytokinesis [GO:1902412]",chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; regulation of mitotic cytokinesis [GO:1902412],,"central element [GO:0000801]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]",GO:0000070; GO:0000281; GO:0000775; GO:0000776; GO:0000777; GO:0000800; GO:0000801; GO:0005634; GO:0005654; GO:0005721; GO:0005819; GO:0005829; GO:0005874; GO:0007059; GO:0010369; GO:0016604; GO:0030496; GO:0032991; GO:1902412,IPR039130; IPR022006; IPR005635; ,O14965; Q96GD4; Q9UQB9; O15392; P45973; Q53HL2,"SUBUNIT: Component of the chromosomal passenger complex (CPC) composed of at least BIRC5/survivin, CDCA8/borealin, INCENP, AURKB or AURKC; in the complex binds directly to AURKB or AURKC via the IN box, and forms a triple-helix bundle-based subcomplex with BIRC5 and CDCA8 via its N-terminus (PubMed:17956729, PubMed:27332895). The reported homodimerization is questioned as the SAH domain is shown to be monomeric (By similarity). Interacts with H2AFZ (By similarity). Interacts with CBX1 and CBX3. Interacts with tubulin beta chain. Interacts with EVI5. Interacts with CBX5; POGZ and INCENP compete for interaction with CBX5; regulates INCENP (and probably CPC) localization to centromeres in interphase and not required for proper mitotic progression or sister chromatid cohesion. Interacts with POGZ. Interacts with JTB. {ECO:0000250|UniProtKB:P53352, ECO:0000250|UniProtKB:Q9WU62, ECO:0000269|PubMed:11139336, ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:14610074, ECO:0000269|PubMed:15249581, ECO:0000269|PubMed:15316025, ECO:0000269|PubMed:16764853, ECO:0000269|PubMed:17956729, ECO:0000269|PubMed:20562864, ECO:0000269|PubMed:21225229, ECO:0000269|PubMed:21346195, ECO:0000269|PubMed:22920039, ECO:0000269|PubMed:27332895, ECO:0000269|PubMed:9864353}.",11453556; 15316025; 16554811; 15489334; 9864353; 11139336; 12925766; 14610074; 15249581; 17081983; 16764853; 16760428; 16571674; 18220336; 18691976; 18669648; 19413330; 19369195; 19690332; 20562864; 20068231; 21225229; 21346195; 21406692; 23186163; 27332895; 17956729; 22920039,11453556; 15316025; 16554811; 15489334; 9864353; 11139336; 12925766; 14610074; 15249581; 17081983; 16764853; 16760428; 16571674; 18220336; 18691976; 18669648; 19413330; 19369195; 19690332; 20562864; 20068231; 21225229; 21346195; 21406692; 23186163; 27332895; 17956729; 22920039; 11081627; 11181178; 11509732; 11804586; 12006501; 12194817; 14730319; 15085137; 15339662; 15723797; 15737063; 15796717; 15917996; 16239925; 16378098; 16541025; 16622419; 16622420; 17030981; 17099693; 17129783; 17623812; 17681274; 18097444; 18716626; 18752045; 18767990; 18946085; 19494039; 19965387; 20360068; 20372054; 20619651; 20663916; 21051298; 21397845; 21554500; 21878504; 21987589; 22024163; 22267324; 22464730; 22885700; 23562843; 23848594; 25218447; 25586992; 25609649; 26460953; 27512725,2003-04-23,2019-02-13,2008-11-04,164,X-ray crystallography (4),,HELIX 8 10 {ECO:0000244|PDB:2QFA}.; HELIX 11 28 {ECO:0000244|PDB:2QFA}.; HELIX 30 45 {ECO:0000244|PDB:2QFA}.; HELIX 844 846 {ECO:0000244|PDB:4AF3}.; HELIX 848 860 {ECO:0000244|PDB:4AF3}.; HELIX 865 869 {ECO:0000244|PDB:4AF3}.,TURN 878 880 {ECO:0000244|PDB:4AF3}.,,,,,5 out of 5,Alternative sequence (1); Chain (1); Helix (6); Modified residue (37); Motif (1); Mutagenesis (11); Natural variant (5); Region (4); Sequence conflict (6); Turn (1),CAUTION: PubMed:11139336 experiments have been carried out partly in chicken and partly in human. {ECO:0000305}.; CAUTION: Originally predicted to contain a coiled coil domain but shown to contain a stable SAH domain instead. {ECO:0000250|UniProtKB:P53352}.,,,3D-structure;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Complete proteome;Cytoplasm;Cytoskeleton;Kinetochore;Microtubule;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,INCENP family,164,Alternative products (1); Caution (2); Domain (2); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0131; KW-0132; KW-0137; KW-0158; KW-0159; KW-0181; KW-0206; KW-0493; KW-0498; KW-0539; KW-0597; KW-0621; KW-0963; KW-0995; KW-1185,,,,,,,,"PTM: Phosphorylation by AURKB or AURKC at its C-terminal part is important for AURKB or AURKC activation by INCENP. {ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:15316025, ECO:0000269|PubMed:27332895}.",CHAIN 1 918 Inner centromere protein. /FTId=PRO_0000084201.,,,,,,"MOD_RES 72 72 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 119 119 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 143 143 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 148 148 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 150 150 Phosphothreonine. {ECO:0000250|UniProtKB:Q9WU62}.; MOD_RES 195 195 Phosphothreonine. {ECO:0000269|PubMed:15316025}.; MOD_RES 197 197 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 199 199 Phosphothreonine. {ECO:0000244|PubMed:19690332}.; MOD_RES 213 213 Phosphothreonine. {ECO:0000244|PubMed:19690332}.; MOD_RES 214 214 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 219 219 Phosphothreonine. {ECO:0000250|UniProtKB:Q9WU62}.; MOD_RES 239 239 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231}.; MOD_RES 263 263 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 269 269 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 275 275 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 292 292 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 296 296 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 306 306 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 312 312 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 314 314 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 330 330 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 400 400 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 406 406 Phosphothreonine. {ECO:0000244|PubMed:18691976}.; MOD_RES 446 446 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 476 476 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 478 478 Phosphothreonine. {ECO:0000250|UniProtKB:Q9WU62}.; MOD_RES 480 480 Phosphoserine. {ECO:0000250|UniProtKB:Q9WU62}.; MOD_RES 510 510 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 514 514 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 828 828 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692}.; MOD_RES 831 831 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 832 832 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 892 892 Phosphothreonine; by AURKB and AURKC. {ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:27332895}.; MOD_RES 893 893 Phosphoserine; by AURKB and AURKC. {ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:27332895}.; MOD_RES 894 894 Phosphoserine; by AURKB and AURKC. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:27332895}.; MOD_RES 899 899 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 914 914 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF282265;AY714053;CH471076;BC098576;
0,O00291,HIP1_HUMAN,HIP1,HIP1,,,,Homo sapiens (Human),9606,Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I),UP000005640: Chromosome 7,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDRMASSMKQVPNPLPKVLSRRGVGAGLEAAERESFERTQTVSINKAINTQEVAVKEKHARTCILGTHHEKGAQTFWSVVNRLPLSSNAVLCWKFCHVFHKLLRDGHPNVLKDSLRYRNELSDMSRMWGHLSEGYGQLCSIYLKLLRTKMEYHTKNPRFPGNLQMSDRQLDEAGESDVNNFFQLTVEMFDYLECELNLFQTVFNSLDMSRSVSVTAAGQCRLAPLIQVILDCSHLYDYTVKLLFKLHSCLPADTLQGHRDRFMEQFTKLKDLFYRSSNLQYFKRLIQIPQLPENPPNFLRASALSEHISPVVVIPAEASSPDSEPVLEKDDLMDMDASQQNLFDNKFDDIFGSSFSSDPFNFNSQNGVNKDEKDHLIERLYREISGLKAQLENMKTESQRVVLQLKGHVSELEADLAEQQHLRQQAADDCEFLRAELDELRRQREDTEKAQRSLSEIERKAQANEQRYSKLKEKYSELVQNHADLLRKNAEVTKQVSMARQAQVDLEREKKELEDSLERISDQGQRKTQEQLEVLESLKQELATSQRELQVLQGSLETSAQSEANWAAEFAELEKERDSLVSGAAHREEELSALRKELQDTQLKLASTEESMCQLAKDQRKMLLVGSRKAAEQVIQDALNQLEEPPLISCAGSADHLLSTVTSISSCIEQLEKSWSQYLACPEDISGLLHSITLLAHLTSDAIAHGATTCLRAPPEPADSLTEACKQYGRETLAYLASLEEEGSLENADSTAMRNCLSKIKAIGEELLPRGLDIKQEELGDLVDKEMAATSAAIETATARIEEMLSKSRAGDTGVKLEVNERILGCCTSLMQAIQVLIVASKDLQREIVESGRGTASPKEFYAKNSRWTEGLISASKAVGWGATVMVDAADLVVQGRGKFEELMVCSHEIAASTAQLVAASKVKADKDSPNLAQLQQASRGVNQATAGVVASTISGKSQIEETDNMDFSSMTLTQIKRQEMDSQVRVLELENELQKERQKLGELRKKHYELAGVAEGWEEGTEASPPTLQEVVTEKE,1037,"116,221",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=HIP1-1; IsoId=O00291-1; Sequence=Displayed; Name=HIP1-2; IsoId=O00291-2; Sequence=Not described; Name=3; IsoId=O00291-3; Sequence=VSP_044736; Note=No experimental confirmation available.; Name=4; IsoId=O00291-4; Sequence=VSP_057400; ,,SEQUENCE CAUTION:  Sequence=AAC51257.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 1 40 MDRMASSMKQVPNPLPKVLSRRGVGAGLEAAERESFERTQ -> MMFPNPEPPPE (in isoform 4). {ECO:0000303|Ref.1}. /FTId=VSP_057400.; VAR_SEQ 803 853 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_044736.,VARIANT 263 263 M -> K (in dbSNP:rs17149023). /FTId=VAR_051032.,,,,CONFLICT 89 89 A -> P (in Ref. 5; AAC33564). {ECO:0000305}.; CONFLICT 245 251 KLHSCLP -> EFAAAST (in Ref. 8; CAA70574). {ECO:0000305}.; CONFLICT 357 357 S -> R (in Ref. 2; BAG65499). {ECO:0000305}.; CONFLICT 639 644 LNQLEE -> STRPRI (in Ref. 8; CAA70574). {ECO:0000305}.; CONFLICT 688 688 L -> F (in Ref. 5; AAL87037). {ECO:0000305}.,,5,,0,DOMAIN: The pseudo DED region (pDED) mediates the interaction with IFT57. {ECO:0000269|PubMed:11788820}.; DOMAIN: Binds F-actin via the talin-like I/LWEQ domain. {ECO:0000269|PubMed:11788820}.,SIMILARITY: Belongs to the SLA2 family. {ECO:0000305}.,COILED 368 644 {ECO:0000255}.,,DOMAIN 32 160 ENTH. {ECO:0000255|PROSITE-ProRule:PRU00243}.; DOMAIN 771 1012 I/LWEQ. {ECO:0000255|PROSITE-ProRule:PRU00292}.,,REGION 410 491 pDED.; REGION 867 924 Important for actin binding. {ECO:0000250}.,,,,,,,,"FUNCTION: Plays a role in clathrin-mediated endocytosis and trafficking (PubMed:11532990, PubMed:11577110, PubMed:11889126). Involved in regulating AMPA receptor trafficking in the central nervous system in an NMDA-dependent manner (By similarity). Regulates presynaptic nerve terminal activity (By similarity). Enhances androgen receptor (AR)-mediated transcription (PubMed:16027218). May act as a proapoptotic protein that induces cell death by acting through the intrinsic apoptosis pathway (PubMed:11007801). Binds 3-phosphoinositides (via ENTH domain) (PubMed:14732715). May act through the ENTH domain to promote cell survival by stabilizing receptor tyrosine kinases following ligand-induced endocytosis (PubMed:14732715). May play a functional role in the cell filament networks (PubMed:18790740). May be required for differentiation, proliferation, and/or survival of somatic and germline progenitors (PubMed:11007801, PubMed:12163454). {ECO:0000250|UniProtKB:Q8VD75, ECO:0000269|PubMed:11007801, ECO:0000269|PubMed:11532990, ECO:0000269|PubMed:11577110, ECO:0000269|PubMed:11889126, ECO:0000269|PubMed:12163454, ECO:0000269|PubMed:14732715, ECO:0000269|PubMed:16027218, ECO:0000269|PubMed:18790740, ECO:0000269|PubMed:9147654}.",,,,,,,,,,,,"actin cortical patch [GO:0030479]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100]",actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100],"actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]",actin cortical patch [GO:0030479]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793],GO:0005154; GO:0005200; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0006915; GO:0006919; GO:0007015; GO:0016020; GO:0030100; GO:0030136; GO:0030154; GO:0030276; GO:0030479; GO:0030665; GO:0031234; GO:0032051; GO:0032266; GO:0035091; GO:0035254; GO:0035612; GO:0035615; GO:0042803; GO:0042981; GO:0043231; GO:0043325; GO:0045742; GO:0046982; GO:0048260; GO:0048268; GO:0050821; GO:0051015; GO:0051897; GO:0061024; GO:0072583; GO:0080025; GO:0097190; GO:0098793; GO:0098794; GO:0098888; GO:0098890; GO:0098978; GO:0099637; GO:2000588,IPR011417; IPR013809; IPR008942; IPR030554; IPR032422; IPR035964; IPR002558; IPR030224; ,Q9EPV5; Q00610; Q15038; P42858; Q9CR95; Q04864,"SUBUNIT: Homodimer. Binds actin. Binds HTT (via N-terminus). This interaction is restricted to the brain. Binds to IFT57. In normal conditions, it poorly interacts with IFT57, HIP1 being strongly associated with HTT. However, in mutant HTT proteins with a long poly-Gln region, interaction between HTT and HIP1 is inhibited, promoting the interaction between HIP1 and IFT57. Interacts with CLTB (via N-terminus). Interacts (via coiled coil domain) with AR. Interacts with AP2A1, AP2A2, CLTC and HIP1R. Interacts with GRIA1, GRIN2A AND GRIN2B. {ECO:0000269|PubMed:11532990, ECO:0000269|PubMed:11788820, ECO:0000269|PubMed:11889126, ECO:0000269|PubMed:15533940, ECO:0000269|PubMed:16027218, ECO:0000269|PubMed:18790740, ECO:0000269|PubMed:9140394, ECO:0000269|PubMed:9147654}.",14702039; 12853948; 15489334; 11788820; 9140394; 9147654; 9616134; 11007801; 11063258; 11532990; 11517213; 11577110; 11889126; 12163454; 14732715; 15533940; 16027218; 18790740; 20068231; 21269460; 24275569; 25944712; 17257618; 18155047,14702039; 12853948; 15489334; 11788820; 9140394; 9147654; 9616134; 11007801; 11063258; 11532990; 11517213; 11577110; 11889126; 12163454; 14732715; 15533940; 16027218; 18790740; 20068231; 21269460; 24275569; 25944712; 17257618; 18155047; 10535736; 10542231; 10559861; 10559924; 10625686; 11082044; 11231140; 11470803; 12952949; 14622578; 14622579; 15059611; 15260957; 15318165; 15383276; 15502812; 15502813; 15581353; 15703209; 15895077; 16103228; 16169070; 16410077; 16798879; 16847693; 16979168; 17158794; 17452370; 17500595; 17609109; 17681954; 17762867; 17765681; 17978091; 18093523; 18388313; 18981233; 19092055; 19536138; 19575674; 19603039; 19626275; 20033059; 20059951; 20179344; 20428113; 20826345; 21109226; 2115402; 21278753; 21316588; 21445324; 21482805; 21613550; 21697888; 21779028; 21841790; 21900206; 21927000; 21927001; 21962517; 22099461; 22233676; 22360420; 22505844; 22623428; 22835334; 22913984; 23297414; 23416715; 23823722; 23836884; 23861397; 23891661; 24296488; 24496003; 24518094; 24581490; 24966051; 25082541; 25107275; 25241761; 25260751; 25341920; 25416956; 26042225; 26496610; 26595459; 26638075; 28452374; 29039605; 29284659; 6146630; 7877694; 8524399; 8552632; 9092476; 9100026; 9427626; 9428629; 9635431; 9736607,2001-04-27,2019-02-13,2008-09-23,193,X-ray crystallography (3),,HELIX 373 441 {ECO:0000244|PDB:3I00}.; HELIX 462 465 {ECO:0000244|PDB:2QA7}.; HELIX 482 580 {ECO:0000244|PDB:2NO2}.,TURN 459 461 {ECO:0000244|PDB:2QA7}.,,,,,5 out of 5,Alternative sequence (2); Chain (1); Coiled coil (1); Domain (2); Erroneous initiation (1); Helix (3); Modified residue (1); Mutagenesis (4); Natural variant (1); Region (2); Sequence conflict (5); Turn (1),,"TISSUE SPECIFICITY: Ubiquitously expressed with the highest level in brain. Expression is up-regulated in prostate and colon cancer. {ECO:0000269|PubMed:12163454, ECO:0000269|PubMed:9140394, ECO:0000269|PubMed:9147654}.",MISCELLANEOUS: The affinity of the huntingtin protein-HIP1 interaction is inversely correlated to the length of the polyglutamine tract added to the huntingtin protein in Huntington disease.,3D-structure;Actin-binding;Activator;Alternative splicing;Apoptosis;Chromosomal rearrangement;Coiled coil;Complete proteome;Cytoplasm;Cytoplasmic vesicle;Differentiation;Endocytosis;Membrane;Neurodegeneration;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation,Evidence at protein level,reviewed,,SLA2 family,193,Alternative products (1); Caution (1); Domain (2); Function (1); Involvement in disease (1); Miscellaneous (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0009; KW-0010; KW-0025; KW-0053; KW-0160; KW-0175; KW-0181; KW-0221; KW-0254; KW-0472; KW-0523; KW-0539; KW-0597; KW-0621; KW-0804; KW-0805; KW-0963; KW-0968; KW-1185,,,,,DISEASE: Note=A chromosomal aberration involving HIP1 is found in a form of chronic myelomonocytic leukemia (CMML). Translocation t(5;7)(q33;q11.2) with PDGFRB (PubMed:9616134). The chimeric HIP1-PDGFRB transcript results from an in-frame fusion of the two genes (PubMed:9616134). The reciprocal PDGFRB-HIP1 transcript is not expressed (PubMed:9616134). {ECO:0000269|PubMed:9616134}.,,,,CHAIN 1 1037 Huntingtin-interacting protein 1. /FTId=PRO_0000083986.,,,,,,MOD_RES 338 338 Phosphoserine. {ECO:0000244|PubMed:24275569}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,KF437291;AK304738;BC110545;AF365404;AH006397;U79734;Y09420;
0,O00562,PITM1_HUMAN,PITPNM1 DRES9 NIR2 PITPNM,PITPNM1,DRES9 NIR2 PITPNM,,,Homo sapiens (Human),9606,"Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2)",UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MLIKEYHILLPMSLDEYQVAQLYMIQKKSREESSGEGSGVEILANRPYTDGPGGSGQYTHKVYHVGSHIPGWFRALLPKAALQVEEESWNAYPYTRTRYTCPFVEKFSIEIETYYLPDGGQQPNVFNLSGAERRQRILDTIDIVRDAVAPGEYKAEEDPRLYHSVKTGRGPLSDDWARTAAQTGPLMCAYKLCKVEFRYWGMQAKIEQFIHDVGLRRVMLRAHRQAWCWQDEWTELSMADIRALEEETARMLAQRMAKCNTGSEGSEAQPPGKPSTEARSAASNTGTPDGPEAPPGPDASPDASFGKQWSSSSRSSYSSQHGGAVSPQSLSEWRMQNIARDSENSSEEEFFDAHEGFSDSEEVFPKEMTKWNSNDFIDAFASPVEAEGTPEPGAEAAKGIEDGAQAPRDSEGLDGAGELGAEACAVHALFLILHSGNILDSGPGDANSKQADVQTLSSAFEAVTRIHFPEALGHVALRLVPCPPICAAAYALVSNLSPYSHDGDSLSRSQDHIPLAALPLLATSSSRYQGAVATVIARTNQAYSAFLRSPEGAGFCGQVALIGDGVGGILGFDALCHSANAGTGSRGSSRRGSMNNELLSPEFGPVRDPLADGVEGLGRGSPEPSALPPQRIPSDMASPEPEGSQNSLQAAPATTSSWEPRRASTAFCPPAASSEAPDGPSSTARLDFKVSGFFLFGSPLGLVLALRKTVMPALEAAQMRPACEQIYNLFHAADPCASRLEPLLAPKFQAIAPLTVPRYQKFPLGDGSSLLLADTLQTHSSLFLEELEMLVPSTPTSTSGAFWKGSELATDPPAQPAAPSTTSEVVKILERWWGTKRIDYSLYCPEALTAFPTVTLPHLFHASYWESADVVAFILRQVIEKERPQLAECEEPSIYSPAFPREKWQRKRTQVKIRNVTSNHRASDTVVCEGRPQVLSGRFMYGPLDVVTLTGEKVDVYIMTQPLSGKWIHFGTEVTNSSGRLTFPVPPERALGIGVYPVRMVVRGDHTYAECCLTVVARGTEAVVFSIDGSFTASVSIMGSDPKVRAGAVDVVRHWQDSGYLIVYVTGRPDMQKHRVVAWLSQHNFPHGVVSFCDGLTHDPLRQKAMFLQSLVQEVELNIVAGYGSPKDVAVYAALGLSPSQTYIVGRAVRKLQAQCQFLSDGYVAHLGQLEAGSHSHASSGPPRAALGKSSYGVAAPVDFLRKQSQLLRSRGPSQAEREGPGTPPTTLARGKARSISLKLDSEE,1244,"134,848",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=O00562-1; Sequence=Displayed; Name=2; IsoId=O00562-2; Sequence=VSP_021157; ,,,,,,,,,,"VAR_SEQ 716 716 Missing (in isoform 2). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:15627748}. /FTId=VSP_021157.",,,,,CONFLICT 931 931 R -> P (in Ref. 2; AAK01444). {ECO:0000305}.; CONFLICT 1034 1034 S -> G (in Ref. 3; AAR06909). {ECO:0000305}.; CONFLICT 1116 1116 E -> G (in Ref. 1; CAA67224). {ECO:0000305}.; CONFLICT 1133 1133 A -> T (in Ref. 1; CAA67224). {ECO:0000305}.,,4,,0,,SIMILARITY: Belongs to the PtdIns transfer protein family. PI transfer class IIA subfamily. {ECO:0000305}.,,COMPBIAS 310 319 Poly-Ser.,DOMAIN 686 880 DDHD. {ECO:0000255|PROSITE-ProRule:PRU00378}.,,,,,,,,,,"FUNCTION: Regulates RHOA activity, and plays a role in cytoskeleton remodeling. Necessary for normal completion of cytokinesis. Plays a role in maintaining normal diacylglycerol levels in the Golgi apparatus. Binds phosphatidyl inositol phosphates (in vitro). May catalyze the transfer of phosphatidylinositol and phosphatidylcholine between membranes (By similarity). Necessary for maintaining the normal structure of the endoplasmic reticulum and the Golgi apparatus. Required for protein export from the endoplasmic reticulum and the Golgi. Binds calcium ions. {ECO:0000250, ECO:0000269|PubMed:10022914, ECO:0000269|PubMed:11909959, ECO:0000269|PubMed:15545272, ECO:0000269|PubMed:15723057}.",,,,,,,,,,,,cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transporter activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]; brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031],brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031],calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transporter activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971],cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496],GO:0005509; GO:0005737; GO:0005789; GO:0005811; GO:0005815; GO:0005829; GO:0006629; GO:0006661; GO:0007420; GO:0007602; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0016020; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0036464; GO:0044297; GO:0070300,IPR004177; IPR036412; IPR031315; IPR001666; IPR023393; ,Q12800,"SUBUNIT: Interacts with PIK4CA (By similarity). Interacts with PTK2B via its C-terminus. Interacts with RHOA. Has higher affinity for the inactive, GDP-bound form of RHOA. The CDK1-phosphorylated form interacts with PLK1. Interacts with VAPB. {ECO:0000250, ECO:0000269|PubMed:10022914, ECO:0000269|PubMed:11909959, ECO:0000269|PubMed:15125835, ECO:0000269|PubMed:15545272}.",9680295; 10022914; 15627748; 16554811; 15489334; 12225667; 11909959; 15125835; 15545272; 15723057; 23186163; 24275569,9680295; 10022914; 15627748; 16554811; 15489334; 12225667; 11909959; 15125835; 15545272; 15723057; 23186163; 24275569; 12077336; 17090528; 17377520; 20711500; 23416715; 23736259; 23897088; 24183667; 25179602; 25416956; 25887399; 26028218,2006-04-18,2019-02-13,2006-10-31,146,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Compositional bias (1); Domain (1); Modified residue (19); Mutagenesis (11); Sequence conflict (4),,TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10022914}.,,Alternative splicing;Calcium;Complete proteome;Cytoplasm;Endoplasmic reticulum;Golgi apparatus;Lipid droplet;Membrane;Metal-binding;Methylation;Phosphoprotein;Protein transport;Reference proteome;Transport,Evidence at protein level,reviewed,,"PtdIns transfer protein family, PI transfer class IIA subfamily",146,Alternative products (1); Function (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0106; KW-0181; KW-0256; KW-0333; KW-0472; KW-0479; KW-0488; KW-0551; KW-0597; KW-0653; KW-0813; KW-0963; KW-1185,,,,,,,,PTM: Phosphorylated on multiple sites by CDK1 at the onset of mitosis. Phosphorylation facilitates dissociation from the Golgi complex and is required for interaction with PLK1.; PTM: Phosphorylated on threonine residues upon treatment with oleic acid.; PTM: Phosphorylated on tyrosine residues by PTK2B.,CHAIN 1 1244 Membrane-associated phosphatidylinositol transfer protein 1. /FTId=PRO_0000232738.,,,,,,"MOD_RES 59 59 Phosphothreonine. {ECO:0000305|PubMed:12225667}.; MOD_RES 287 287 Phosphothreonine; by CDK1. {ECO:0000269|PubMed:15125835}.; MOD_RES 300 300 Phosphoserine. {ECO:0000250|UniProtKB:O35954}.; MOD_RES 304 304 Phosphoserine. {ECO:0000250|UniProtKB:O35954}.; MOD_RES 319 319 Phosphoserine. {ECO:0000250|UniProtKB:O35954}.; MOD_RES 326 326 Phosphoserine. {ECO:0000250|UniProtKB:O35954}.; MOD_RES 329 329 Phosphoserine. {ECO:0000250|UniProtKB:O35954}.; MOD_RES 342 342 Phosphoserine. {ECO:0000250|UniProtKB:Q5U2N3}.; MOD_RES 345 345 Phosphoserine. {ECO:0000250|UniProtKB:Q5U2N3}.; MOD_RES 346 346 Phosphoserine. {ECO:0000250|UniProtKB:Q5U2N3}.; MOD_RES 373 373 Phosphoserine. {ECO:0000250|UniProtKB:O35954}.; MOD_RES 382 382 Phosphoserine; by CDK1. {ECO:0000269|PubMed:15125835}.; MOD_RES 593 593 Phosphoserine. {ECO:0000250|UniProtKB:O35954}.; MOD_RES 600 600 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 621 621 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 896 896 Phosphoserine. {ECO:0000269|PubMed:15125835}.; MOD_RES 1211 1211 Omega-N-methylarginine. {ECO:0000250|UniProtKB:O35954}.; MOD_RES 1218 1218 Omega-N-methylarginine. {ECO:0000250|UniProtKB:O35954}.; MOD_RES 1237 1237 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X98654;AF334584;AY429102;CH471076;BC022230;
0,O14578,CTRO_HUMAN,CIT CRIK KIAA0949 STK21,CIT,CRIK KIAA0949 STK21,,,Homo sapiens (Human),9606,Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21),UP000005640: Chromosome 12,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MLKFKYGARNPLDAGAAEPIASRASRLNLFFQGKPPFMTQQQMSPLSREGILDALFVLFEECSQPALMKIKHVSNFVRKYSDTIAELQELQPSAKDFEVRSLVGCGHFAEVQVVREKATGDIYAMKVMKKKALLAQEQVSFFEEERNILSRSTSPWIPQLQYAFQDKNHLYLVMEYQPGGDLLSLLNRYEDQLDENLIQFYLAELILAVHSVHLMGYVHRDIKPENILVDRTGHIKLVDFGSAAKMNSNKMVNAKLPIGTPDYMAPEVLTVMNGDGKGTYGLDCDWWSVGVIAYEMIYGRSPFAEGTSARTFNNIMNFQRFLKFPDDPKVSSDFLDLIQSLLCGQKERLKFEGLCCHPFFSKIDWNNIRNSPPPFVPTLKSDDDTSNFDEPEKNSWVSSSPCQLSPSGFSGEELPFVGFSYSKALGILGRSESVVSGLDSPAKTSSMEKKLLIKSKELQDSQDKCHKMEQEMTRLHRRVSEVEAVLSQKEVELKASETQRSLLEQDLATYITECSSLKRSLEQARMEVSQEDDKALQLLHDIREQSRKLQEIKEQEYQAQVEEMRLMMNQLEEDLVSARRRSDLYESELRESRLAAEEFKRKATECQHKLLKAKDQGKPEVGEYAKLEKINAEQQLKIQELQEKLEKAVKASTEATELLQNIRQAKERAERELEKLQNREDSSEGIRKKLVEAEELEEKHREAQVSAQHLEVHLKQKEQHYEEKIKVLDNQIKKDLADKETLENMMQRHEEEAHEKGKILSEQKAMINAMDSKIRSLEQRIVELSEANKLAANSSLFTQRNMKAQEEMISELRQQKFYLETQAGKLEAQNRKLEEQLEKISHQDHSDKNRLLELETRLREVSLEHEEQKLELKRQLTELQLSLQERESQLTALQAARAALESQLRQAKTELEETTAEAEEEIQALTAHRDEIQRKFDALRNSCTVITDLEEQLNQLTEDNAELNNQNFYLSKQLDEASGANDEIVQLRSEVDHLRREITEREMQLTSQKQTMEALKTTCTMLEEQVMDLEALNDELLEKERQWEAWRSVLGDEKSQFECRVRELQRMLDTEKQSRARADQRITESRQVVELAVKEHKAEILALQQALKEQKLKAESLSDKLNDLEKKHAMLEMNARSLQQKLETERELKQRLLEEQAKLQQQMDLQKNHIFRLTQGLQEALDRADLLKTERSDLEYQLENIQVLYSHEKVKMEGTISQQTKLIDFLQAKMDQPAKKKKGLFSRRKEDPALPTQVPLQYNELKLALEKEKARCAELEEALQKTRIELRSAREEAAHRKATDHPHPSTPATARQQIAMSAIVRSPEHQPSAMSLLAPPSSRRKESSTPEEFSRRLKERMHHNIPHRFNVGLNMRATKCAVCLDTVHFGRQASKCLECQVMCHPKCSTCLPATCGLPAEYATHFTEAFCRDKMNSPGLQTKEPSSSLHLEGWMKVPRNNKRGQQGWDRKYIVLEGSKVLIYDNEAREAGQRPVEEFELCLPDGDVSIHGAVGASELANTAKADVPYILKMESHPHTTCWPGRTLYLLAPSFPDKQRWVTALESVVAGGRVSREKAEADAKLLGNSLLKLEGDDRLDMNCTLPFSDQVVLVGTEEGLYALNVLKNSLTHVPGIGAVFQIYIIKDLEKLLMIAGEERALCLVDVKKVKQSLAQSHLPAQPDISPNIFEAVKGCHLFGAGKIENGLCICAAMPSKVVILRYNENLSKYCIRKEIETSEPCSCIHFTNYSILIGTNKFYEIDMKQYTLEEFLDKNDHSLAPAVFAASSNSFPVSIVQVNSAGQREEYLLCFHEFGVFVDSYGRRSRTDDLKWSRLPLAFAYREPYLFVTHFNSLEVIEIQARSSAGTPARAYLDIPNPRYLGPAISSGAIYLASSYQDKLRVICCKGNLVKESGTEHHRGPSTSRSSPNKRGPPTYNEHITKRVASSPAPPEGPSHPREPSTPHRYREGRTELRRDKSPGRPLEREKSPGRMLSTRRERSPGRLFEDSSRGRLPAGAVRTPLSQVNKVWDQSSV,2027,"231,431",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; Synonyms=Long; IsoId=O14578-1; Sequence=Displayed; Name=2; Synonyms=Short, CRIK-SK; IsoId=O14578-2; Sequence=VSP_012434, VSP_012435; Name=3; IsoId=O14578-3; Sequence=VSP_014507, VSP_014508, VSP_014509; Note=No experimental confirmation available.; Name=4; IsoId=O14578-4; Sequence=VSP_043301; ",,SEQUENCE CAUTION:  Sequence=BAA76793.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 1 467 Missing (in isoform 3). {ECO:0000303|PubMed:10231032}. /FTId=VSP_014507.; VAR_SEQ 481 482 EV -> GG (in isoform 2). {ECO:0000303|Ref.2}. /FTId=VSP_012434.; VAR_SEQ 483 2027 Missing (in isoform 2). {ECO:0000303|Ref.2}. /FTId=VSP_012435.; VAR_SEQ 694 694 E -> EERRHSLENKVKRLETMERRENRLKDDIQTKSQQIQQMADKIL (in isoform 4). {ECO:0000303|PubMed:15983625}. /FTId=VSP_043301.; VAR_SEQ 1239 1253 Missing (in isoform 3). {ECO:0000303|PubMed:10231032}. /FTId=VSP_014508.; VAR_SEQ 1919 1919 Missing (in isoform 3). {ECO:0000303|PubMed:10231032}. /FTId=VSP_014509.,VARIANT 7 7 G -> E (in dbSNP:rs36054900). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040417.; VARIANT 9 9 R -> Q (in dbSNP:rs56193743). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040418.; VARIANT 106 106 G -> V (in MCPH17; impairs kinase activity; exhibits abnormal mitotic cytokinesis; exhibits multipolar spindles; increases the neurons apoptotic process; dbSNP:rs886037892). {ECO:0000269|PubMed:27453578}. /FTId=VAR_077442.; VARIANT 126 126 K -> Q (in MCPH17; impairs kinase activity; exhibits abnormal mitotic cytokinesis; exhibits multipolar spindles; increases the neurons apoptotic process; dbSNP:rs886037893). {ECO:0000269|PubMed:27453578}. /FTId=VAR_077443.; VARIANT 183 183 L -> F. {ECO:0000269|PubMed:17344846}. /FTId=VAR_040419.; VARIANT 230 230 D -> V (in MCPH17; impairs kinase activity; exhibits abnormal mitotic cytokinesis; exhibits multipolar spindles; increases the neurons apoptotic process; dbSNP:rs886037894). {ECO:0000269|PubMed:27453578}. /FTId=VAR_077444.,,,,CONFLICT 12 12 L -> S (in Ref. 2; AAP43922). {ECO:0000305}.; CONFLICT 56 56 F -> L (in Ref. 2; AAP43922). {ECO:0000305}.; CONFLICT 218 218 V -> L (in Ref. 2; AAP43922). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. {ECO:0000305}.,COILED 453 1297 {ECO:0000255}.,,DOMAIN 97 360 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.; DOMAIN 361 431 AGC-kinase C-terminal.; DOMAIN 1443 1563 PH. {ECO:0000255|PROSITE-ProRule:PRU00145}.; DOMAIN 1591 1881 CNH. {ECO:0000255|PROSITE-ProRule:PRU00795}.,MOTIF 1953 1958 SH3-binding. {ECO:0000255}.,REGION 1091 1302 Interaction with Rho/Rac.,,ZN_FING 1362 1411 Phorbol-ester/DAG-type. {ECO:0000255|PROSITE-ProRule:PRU00226}.,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",,,"FUNCTION: Plays a role in cytokinesis. Required for KIF14 localization to the central spindle and midbody. Putative RHO/RAC effector that binds to the GTP-bound forms of RHO and RAC1. It probably binds p21 with a tighter specificity in vivo. Displays serine/threonine protein kinase activity. Plays an important role in the regulation of cytokinesis and the development of the central nervous system. Phosphorylates MYL9/MLC2. {ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:21457715, ECO:0000269|PubMed:27453578}.",,,,,,"ACT_SITE 221 221 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 126 126 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 103 111 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cleavage furrow [GO:0032154]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; neuron apoptotic process [GO:0051402]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064],G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; neuron apoptotic process [GO:0051402]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124],cleavage furrow [GO:0032154]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634],GO:0000086; GO:0000278; GO:0000281; GO:0001889; GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0007030; GO:0008064; GO:0016020; GO:0017124; GO:0030165; GO:0030496; GO:0031985; GO:0032154; GO:0032467; GO:0035556; GO:0043025; GO:0046872; GO:0048699; GO:0051402; GO:0097110,IPR000961; IPR017405; IPR001180; IPR037708; IPR011009; IPR002219; IPR011993; IPR001849; IPR000719; IPR017441; IPR008271; ,,"SUBUNIT: Directly interacts with KIF14 depending on the activation state (stronger interaction with the kinase-dead form). Homodimer (By similarity). Interacts with TTC3. {ECO:0000250, ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:17488780}.",15983625; 10231032; 16541075; 16431929; 16236794; 17488780; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21457715; 21406692; 22814378; 23186163; 27453578; 27453579; 27503289; 27519304; 17344846,15983625; 10231032; 16541075; 16431929; 16236794; 17488780; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21457715; 21406692; 22814378; 23186163; 27453578; 27453579; 27503289; 27519304; 17344846; 12411428; 12802051; 16202622; 17534152; 19328558; 19913121; 20084519; 20369383; 20379614; 20628086; 21748597; 21849473; 22293177; 22761715; 23444367; 23716662; 25665131; 26514267; 26524911; 26586574; 27009191; 27551053; 8543060; 9792683; 9870942; 9870943,2000-05-30,2019-02-13,2005-01-04,181,,,,,,,,,5 out of 5,Active site (1); Alternative sequence (6); Binding site (1); Chain (1); Coiled coil (1); Domain (4); Erroneous initiation (1); Modified residue (10); Motif (1); Natural variant (6); Nucleotide binding (1); Region (1); Sequence conflict (3); Zinc finger (1),,,,ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Developmental protein;Differentiation;Disease mutation;Kinase;Metal-binding;Mitosis;Neurogenesis;Nucleotide-binding;Phosphoprotein;Polymorphism;Primary microcephaly;Reference proteome;SH3-binding;Serine/threonine-protein kinase;Transferase;Zinc;Zinc-finger,Evidence at protein level,reviewed,,"Protein kinase superfamily, AGC Ser/Thr protein kinase family",181,Alternative products (1); Catalytic activity (2); Caution (1); Function (1); Involvement in disease (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0007; KW-0025; KW-0067; KW-0131; KW-0132; KW-0175; KW-0181; KW-0217; KW-0221; KW-0225; KW-0418; KW-0479; KW-0498; KW-0524; KW-0547; KW-0597; KW-0621; KW-0723; KW-0729; KW-0808; KW-0862; KW-0863; KW-0905; KW-0963; KW-1185,,,,,"DISEASE: Microcephaly 17, primary, autosomal recessive (MCPH17) [MIM:617090]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age, sex and ethnically matched mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH17 is a severe form characterized by lissencephaly, enlarged ventricles, agenesis of the corpus callosum, cerebellar hypoplasia, and brainstem hypoplasia. Patients manifest delayed psychomotor development, intellectual disability, spasticity, axial hypotonia, and dysmorphic features. {ECO:0000269|PubMed:27453578, ECO:0000269|PubMed:27453579, ECO:0000269|PubMed:27503289, ECO:0000269|PubMed:27519304}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 2027 Citron Rho-interacting kinase. /FTId=PRO_0000085908.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 433 433 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 440 440 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 480 480 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 582 582 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1196 1196 Phosphotyrosine. {ECO:0000250|UniProtKB:P49025}.; MOD_RES 1721 1721 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 1940 1940 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1993 1993 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 2013 2013 Phosphothreonine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AY257469;AY209000;AY681966;AB023166;AC002563;
0,O14662,STX16_HUMAN,STX16,STX16,,,,Homo sapiens (Human),9606,Syntaxin-16 (Syn16),UP000005640: Chromosome 20,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MATRRLTDAFLLLRNNSIQNRQLLAEQVSSHITSSPLHSRSIAAELDELADDRMALVSGISLDPEAAIGVTKRPPPKWVDGVDEIQYDVGRIKQKMKELASLHDKHLNRPTLDDSSEEEHAIEITTQEITQLFHRCQRAVQALPSRARACSEQEGRLLGNVVASLAQALQELSTSFRHAQSGYLKRMKNREERSQHFFDTSVPLMDDGDDNTLYHRGFTEDQLVLVEQNTLMVEEREREIRQIVQSISDLNEIFRDLGAMIVEQGTVLDRIDYNVEQSCIKTEDGLKQLHKAEQYQKKNRKMLVILILFVIIIVLIVVLVGVKSR,325,"37,031",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=6;  Name=B; IsoId=O14662-1; Sequence=Displayed; Name=A; IsoId=O14662-2; Sequence=VSP_006348; Name=C; IsoId=O14662-3; Sequence=VSP_006349, VSP_006350, VSP_006351; Note=May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.; Name=D; IsoId=O14662-4; Sequence=VSP_006349; Name=E; IsoId=O14662-5; Sequence=VSP_043849; Name=6; IsoId=O14662-6; Sequence=VSP_045073; Note=No experimental confirmation available.; ",,,,,"SEQUENCE CAUTION:  Sequence=AAB69282.1; Type=Frameshift; Positions=142, 163, 165; Evidence={ECO:0000305};  Sequence=AAB69283.1; Type=Frameshift; Positions=142, 163, 165; Evidence={ECO:0000305};  Sequence=AAC05647.1; Type=Frameshift; Positions=142, 163, 165; Evidence={ECO:0000305}; ",,,,,"VAR_SEQ 1 53 Missing (in isoform 6). {ECO:0000303|Ref.6}. /FTId=VSP_045073.; VAR_SEQ 28 48 Missing (in isoform A). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9587053}. /FTId=VSP_006348.; VAR_SEQ 28 44 Missing (in isoform C and isoform D). {ECO:0000303|PubMed:9464276, ECO:0000303|PubMed:9587053}. /FTId=VSP_006349.; VAR_SEQ 45 48 Missing (in isoform E). {ECO:0000303|PubMed:15489334}. /FTId=VSP_043849.; VAR_SEQ 132 132 L -> A (in isoform C). {ECO:0000303|PubMed:9587053}. /FTId=VSP_006350.; VAR_SEQ 133 325 Missing (in isoform C). {ECO:0000303|PubMed:9587053}. /FTId=VSP_006351.",,,,,CONFLICT 99 99 L -> S (in Ref. 1; AAB69282/AAB69283). {ECO:0000305}.; CONFLICT 147 147 A -> E (in Ref. 1; AAC05647). {ECO:0000305}.; CONFLICT 243 243 I -> M (in Ref. 1; AAB69282/AAB69283). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the syntaxin family. {ECO:0000305}.,,,DOMAIN 230 292 t-SNARE coiled-coil homology. {ECO:0000255|PROSITE-ProRule:PRU00202}.,,,,,,,,,,FUNCTION: SNARE involved in vesicular transport from the late endosomes to the trans-Golgi network. {ECO:0000269|PubMed:18195106}.,,,,,,,,,,,,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]","Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]",SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0016021; GO:0019905; GO:0030285; GO:0031201; GO:0031985; GO:0032588; GO:0042147; GO:0043231; GO:0048278; GO:0048471; GO:0090161,IPR010989; IPR028673; IPR006012; IPR006011; IPR000727; ,P50222; Q9H115; Q12846; O95183,"SUBUNIT: Interacts with GCC2 (PubMed:18195106). Interacts with BAIAP3; this interaction is increased in the presence of calcium (PubMed:28626000). {ECO:0000269|PubMed:18195106, ECO:0000269|PubMed:28626000}.",9587053; 9464276; 11780052; 15489334; 14561710; 15800843; 18195106; 28626000,9587053; 9464276; 11780052; 15489334; 14561710; 15800843; 18195106; 28626000; 10445031; 10559959; 10637310; 11839770; 12011112; 12070132; 12377769; 15037235; 15231748; 15269279; 15654769; 15728195; 15870108; 15878329; 16885419; 16912714; 17488291; 17562788; 17684057; 18086915; 18256213; 18367545; 18946081; 19164740; 19536132; 19620288; 20685960; 20711500; 21183348; 21421921; 21436057; 21689688; 21807881; 22581368; 23091056; 23378023; 23416715; 23462996; 23839779; 25343031; 25416956; 26638075; 8221884; 8440258; 8620540; 9177194,2001-02-21,2019-02-13,2006-01-24,183,,,,,,,TOPO_DOM 1 301 Cytoplasmic. {ECO:0000255}.; TOPO_DOM 323 325 Vesicular. {ECO:0000255}.,TRANSMEM 302 322 Helical; Anchor for type IV membrane protein. {ECO:0000255}.,5 out of 5,Alternative sequence (6); Chain (1); Domain (1); Frameshift (3); Modified residue (1); Sequence conflict (5); Topological domain (2); Transmembrane (1),,TISSUE SPECIFICITY: Ubiquitous.,,Alternative splicing;Coiled coil;Complete proteome;Cytoplasm;Golgi apparatus;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport,Evidence at protein level,reviewed,,Syntaxin family,183,Alternative products (1); Caution (2); Function (1); Involvement in disease (1); Sequence similarities (1); Subcellular location (2); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0175; KW-0181; KW-0333; KW-0472; KW-0597; KW-0653; KW-0812; KW-0813; KW-0963; KW-1133; KW-1185,,,,,"DISEASE: Pseudohypoparathyroidism 1B (PHP1B) [MIM:603233]: A disorder characterized by end-organ resistance to parathyroid hormone, hypocalcemia and hyperphosphatemia. Patients affected with PHP1B lack developmental defects characteristic of Albright hereditary osteodystrophy, and typically show no other endocrine abnormalities besides resistance to PTH. {ECO:0000269|PubMed:14561710, ECO:0000269|PubMed:15800843}. Note=The gene represented in this entry is involved in disease pathogenesis. Microdeletions involving STX16 can cause loss of methylation at exon A/B of GNAS, resulting in PHP1B.",,,,CHAIN 1 325 Syntaxin-16. /FTId=PRO_0000210226.,,,,,,MOD_RES 41 41 Phosphoserine. {ECO:0000250|UniProtKB:Q8BVI5}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF008936;AF008935;AF008937;AF038897;CH471077;CH471077;CH471077;CH471077;CH471077;BC019042;BC073876;
0,O15294,OGT1_HUMAN,OGT,OGT,,,,Homo sapiens (Human),9606,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit),UP000005640: Chromosome X,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MASSVGNVADSTEPTKRMLSFQGLAELAHREYQAGDFEAAERHCMQLWRQEPDNTGVLLLLSSIHFQCRRLDRSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEAIEHYRHALRLKPDFIDGYINLAAALVAAGDMEGAVQAYVSALQYNPDLYCVRSDLGNLLKALGRLEEAKACYLKAIETQPNFAVAWSNLGCVFNAQGEIWLAIHHFEKAVTLDPNFLDAYINLGNVLKEARIFDRAVAAYLRALSLSPNHAVVHGNLACVYYEQGLIDLAIDTYRRAIELQPHFPDAYCNLANALKEKGSVAEAEDCYNTALRLCPTHADSLNNLANIKREQGNIEEAVRLYRKALEVFPEFAAAHSNLASVLQQQGKLQEALMHYKEAIRISPTFADAYSNMGNTLKEMQDVQGALQCYTRAIQINPAFADAHSNLASIHKDSGNIPEAIASYRTALKLKPDFPDAYCNLAHCLQIVCDWTDYDERMKKLVSIVADQLEKNRLPSVHPHHSMLYPLSHGFRKAIAERHGNLCLDKINVLHKPPYEHPKDLKLSDGRLRVGYVSSDFGNHPTSHLMQSIPGMHNPDKFEVFCYALSPDDGTNFRVKVMAEANHFIDLSQIPCNGKAADRIHQDGIHILVNMNGYTKGARNELFALRPAPIQAMWLGYPGTSGALFMDYIITDQETSPAEVAEQYSEKLAYMPHTFFIGDHANMFPHLKKKAVIDFKSNGHIYDNRIVLNGIDLKAFLDSLPDVKIVKMKCPDGGDNADSSNTALNMPVIPMNTIAEAVIEMINRGQIQITINGFSISNGLATTQINNKAATGEEVPRTIIVTTRSQYGLPEDAIVYCNFNQLYKIDPSTLQMWANILKRVPNSVLWLLRFPAVGEPNIQQYAQNMGLPQNRIIFSPVAPKEEHVRRGQLADVCLDTPLCNGHTTGMDVLWAGTPMVTMPGETLASRVAASQLTCLGCLELIAKNRQEYEDIAVKLGTDLEYLKKVRGKVWKQRISSPLFNTKQYTMELERLYLQMWEHYAAGNKPDHMIKPVEVTESA,1046,"116,925",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=3; Synonyms=Nucleocytoplasmic isoform, ncOGT; IsoId=O15294-1; Sequence=Displayed; Name=2; Synonyms=Mitochondrial isoform, mOGT; IsoId=O15294-2; Sequence=VSP_006553; Name=1; IsoId=O15294-3; Sequence=VSP_014164; Name=4; Synonyms=Short isoform, sOGT; IsoId=O15294-4; Sequence=VSP_040764; Note=No experimental confirmation available.; ",,,,,,,,,,"VAR_SEQ 1 381 Missing (in isoform 4). {ECO:0000303|PubMed:17974005}. /FTId=VSP_040764.; VAR_SEQ 1 176 MASSVGNVADSTEPTKRMLSFQGLAELAHREYQAGDFEAAERHCMQLWRQEPDNTGVLLLLSSIHFQCRRLDRSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEAIEHYRHALRLKPDFIDGYINLAAALVAAGDMEGAVQAYVSALQYNPDLYCVRSDLGNLLKALGRLEEA -> MLQGHFWLVREGIMISPSSPPPPNLFFFPLQIFPFPFTSFPSHLLSLTPP (in isoform 2). {ECO:0000303|PubMed:9083068}. /FTId=VSP_006553.; VAR_SEQ 13 22 Missing (in isoform 1). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005}. /FTId=VSP_014164.",VARIANT 254 254 L -> F (in MRX106; decreased protein abundance; reduced protein stability; dbSNP:rs1131692155). {ECO:0000269|PubMed:28302723}. /FTId=VAR_079254.; VARIANT 284 284 R -> P (in MRX106; decreased protein abundance; decreased enzyme activity; reduced protein stability; dbSNP:rs1114167891). {ECO:0000269|PubMed:28584052}. /FTId=VAR_079183.; VARIANT 319 319 A -> T (in MRX106; unknown pathological significance). {ECO:0000269|PubMed:26273451}. /FTId=VAR_074019.; VARIANT 538 538 L -> P (found in a renal cell carcinoma sample; somatic mutation). /FTId=VAR_064736.,,,,CONFLICT 308 308 S -> Q (in Ref. 3; CAB62528). {ECO:0000305}.; CONFLICT 663 663 L -> P (in Ref. 3; CAD97853). {ECO:0000305}.,,3,,0,DOMAIN: The TPR repeat domain is required for substrate binding and oligomerization. {ECO:0000269|PubMed:15361863}.,SIMILARITY: Belongs to the glycosyltransferase 41 family. O-GlcNAc transferase subfamily. {ECO:0000305}.,,,,MOTIF 487 503 Nuclear localization signal. {ECO:0000255}.,"REGION 991 1010 Required for phosphatidylinositol 3,4,5-triphosphate binding.",REPEAT 21 54 TPR 1.; REPEAT 89 122 TPR 2.; REPEAT 123 156 TPR 3.; REPEAT 157 190 TPR 4.; REPEAT 191 224 TPR 5.; REPEAT 225 258 TPR 6.; REPEAT 259 292 TPR 7.; REPEAT 293 326 TPR 8.; REPEAT 327 360 TPR 9.; REPEAT 361 394 TPR 10.; REPEAT 395 428 TPR 11.; REPEAT 429 462 TPR 12.; REPEAT 463 473 TPR 13; truncated.,,2.4.1.255,,"CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + UDP-N-acetyl-alpha-D-glucosamine = 3-O-(N-acetyl-beta-D-glucosaminyl)-L-seryl-[protein] + H(+) + UDP; Xref=Rhea:RHEA:48904, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12251, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:57705, ChEBI:CHEBI:58223, ChEBI:CHEBI:90838; EC=2.4.1.255; Evidence={ECO:0000269|PubMed:15361863, ECO:0000269|PubMed:21240259, ECO:0000269|PubMed:21285374, ECO:0000269|PubMed:23103939, ECO:0000305|PubMed:26678539}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + UDP-N-acetyl-alpha-D-glucosamine = 3-O-(N-acetyl-beta-D-glucosaminyl)-L-threonyl-[protein] + H(+) + UDP; Xref=Rhea:RHEA:48908, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:12252, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:57705, ChEBI:CHEBI:58223, ChEBI:CHEBI:90840; EC=2.4.1.255; Evidence={ECO:0000269|PubMed:15361863, ECO:0000269|PubMed:21240259, ECO:0000269|PubMed:21285374, ECO:0000305|PubMed:26678539};",,,"FUNCTION: Catalyzes the transfer of a single N-acetylglucosamine from UDP-GlcNAc to a serine or threonine residue in cytoplasmic and nuclear proteins resulting in their modification with a beta-linked N-acetylglucosamine (O-GlcNAc) (PubMed:26678539, PubMed:23103939, PubMed:21240259, PubMed:21285374, PubMed:15361863). Glycosylates a large and diverse number of proteins including histone H2B, AKT1, EZH2, PFKL, KMT2E/MLL5, MAPT/TAU and HCFC1. Can regulate their cellular processes via cross-talk between glycosylation and phosphorylation or by affecting proteolytic processing (PubMed:21285374). Probably by glycosylating KMT2E/MLL5, stabilizes KMT2E/MLL5 by preventing its ubiquitination (PubMed:26678539). Involved in insulin resistance in muscle and adipocyte cells via glycosylating insulin signaling components and inhibiting the 'Thr-308' phosphorylation of AKT1, enhancing IRS1 phosphorylation and attenuating insulin signaling (By similarity). Involved in glycolysis regulation by mediating glycosylation of 6-phosphofructokinase PFKL, inhibiting its activity (PubMed:22923583). Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1. Plays a key role in chromatin structure by mediating O-GlcNAcylation of 'Ser-112' of histone H2B: recruited to CpG-rich transcription start sites of active genes via its interaction with TET proteins (TET1, TET2 or TET3) (PubMed:22121020, PubMed:23353889). As part of the NSL complex indirectly involved in acetylation of nucleosomal histone H4 on several lysine residues (PubMed:20018852). O-GlcNAcylation of 'Ser-75' of EZH2 increases its stability, and facilitating the formation of H3K27me3 by the PRC2/EED-EZH2 complex (PubMed:24474760). Regulates circadian oscillation of the clock genes and glucose homeostasis in the liver. Stabilizes clock proteins ARNTL/BMAL1 and CLOCK through O-glycosylation, which prevents their ubiquitination and subsequent degradation. Promotes the CLOCK-ARNTL/BMAL1-mediated transcription of genes in the negative loop of the circadian clock such as PER1/2 and CRY1/2 (PubMed:12150998, PubMed:19451179, PubMed:20018868, PubMed:20200153, PubMed:21285374, PubMed:15361863). O-glycosylates HCFC1 and regulates its proteolytic processing and transcriptional activity (PubMed:21285374, PubMed:28584052, PubMed:28302723). Regulates mitochondrial motility in neurons by mediating glycosylation of TRAK1 (By similarity). Glycosylates HOXA1 (By similarity). {ECO:0000250|UniProtKB:P56558, ECO:0000250|UniProtKB:Q8CGY8, ECO:0000269|PubMed:12150998, ECO:0000269|PubMed:15361863, ECO:0000269|PubMed:19451179, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20018868, ECO:0000269|PubMed:20200153, ECO:0000269|PubMed:21240259, ECO:0000269|PubMed:21285374, ECO:0000269|PubMed:22121020, ECO:0000269|PubMed:22923583, ECO:0000269|PubMed:23103939, ECO:0000269|PubMed:23353889, ECO:0000269|PubMed:24474760, ECO:0000269|PubMed:26678539, ECO:0000269|PubMed:28302723, ECO:0000269|PubMed:28584052}.; FUNCTION: Isoform 2: the mitochondrial isoform (mOGT) is cytotoxic and triggers apoptosis in several cell types including INS1, an insulinoma cell line. {ECO:0000269|PubMed:20824293}.",BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.8 uM for UDP-N-acetyl-D-glucosamine {ECO:0000269|PubMed:21240259}; ,"PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:15361863, ECO:0000269|PubMed:21240259, ECO:0000269|PubMed:21285374, ECO:0000269|PubMed:23103939, ECO:0000269|PubMed:26678539}.",,,,"ACT_SITE 508 508 Proton acceptor. {ECO:0000305|PubMed:21240259, ECO:0000305|PubMed:26678539}.","BINDING 849 849 UDP. {ECO:0000244|PDB:4GYW, ECO:0000269|PubMed:23103939}.; BINDING 852 852 UDP. {ECO:0000244|PDB:4GYW, ECO:0000269|PubMed:23103939}.; BINDING 935 935 UDP. {ECO:0000244|PDB:4GYW, ECO:0000269|PubMed:23103939}.",,,"NP_BIND 906 908 UDP. {ECO:0000244|PDB:4GYW, ECO:0000269|PubMed:23103939}.; NP_BIND 911 914 UDP. {ECO:0000244|PDB:4GYW, ECO:0000269|PubMed:23103939}.; NP_BIND 930 932 UDP. {ECO:0000244|PDB:4GYW, ECO:0000269|PubMed:23103939}.",,"cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032]",apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032],"acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]",cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],GO:0000123; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016032; GO:0016262; GO:0016485; GO:0016579; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0045862; GO:0045944; GO:0046626; GO:0048015; GO:0061087; GO:0080182; GO:0097363; GO:0120162,IPR037919; IPR029489; IPR013026; IPR011990; IPR001440; IPR019734; ,P51610; P09022; O95644; A0A0S2Z5B5; Q9H1M0; Q8NDX5; P36873; P63088; P11464; Q04206; O95721; Q15750; E7EQS8; Q6N021; O43151; Q8BG87; Q9UPV9; O94763; O94763-1,"SUBUNIT: Heterotrimer; consists of one 78 kDa subunit and two 110 kDa subunits dimerized via TPR repeats 6 and 7. Component of a THAP1/THAP3-HCFC1-OGT complex (PubMed:20200153). Component of the NSL complex at least composed of MOF/KAT8, KANSL1, KANSL2, KANSL3, MCRS1, PHF20, OGT1/OGT, WDR5 and HCFC1 (PubMed:20018852). Interacts directly with HCFC1; the interaction O-glycosylates HCFC1, regulates its proteolytic processing and transcriptional activity and, in turn, stabilizes OGT in the nucleus (PubMed:12670868, PubMed:20200153, PubMed:21285374, PubMed:23353889). Interacts (via TPRs 1-6) with SIN3A; the interaction mediates transcriptional repression in parallel with histone deacetylase (PubMed:12150998). Interacts (via TPR 5-6) with TET1, TET2 and TET3 (PubMed:23353889, PubMed:23222540). Interacts (via TPR repeats 6 and 7) with ATXN10 (By similarity). Interacts with histone H2B (PubMed:22121020). Interacts with ARNTL/BMAL1. Found in a complex composed of at least SINHCAF, SIN3A, HDAC1, SAP30, RBBP4, OGT and TET1. Interacts with SINHCAF (By similarity). Component of a complex composed of KMT2E/MLL5 (isoform 3), OGT (isoform 1) and USP7; the complex stabilizes KMT2E/MLL5, preventing KMT2E/MLL5 ubiquitination and proteosomal-mediated degradation (PubMed:26678539). Isoform 1 interacts (via TRP repeats) with isoform 3 KMT2E/MLL5 (via N-terminus) (PubMed:26678539, PubMed:23629655). Isoform 1 interacts with USP7 (PubMed:26678539). Interacts with TRAK1; this interaction is not required for glycosylation of TRAK1 by this protein. Found in a complex with KIF5B, RHOT1, RHOT2 and TRAK1 (PubMed:24995978). Interacts (via TPR repeats domain) with HOXA1; the interaction takes place mainly in the nucleus (By similarity). {ECO:0000250|UniProtKB:Q8CGY8, ECO:0000269|PubMed:12150998, ECO:0000269|PubMed:12670868, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20200153, ECO:0000269|PubMed:21285374, ECO:0000269|PubMed:22121020, ECO:0000269|PubMed:23222540, ECO:0000269|PubMed:23353889, ECO:0000269|PubMed:23629655, ECO:0000269|PubMed:24995978, ECO:0000269|PubMed:26678539}.; SUBUNIT: (Microbial infection) Interacts with human T-cell leukemia virus 1/HTLV-1 protein Tax; this interaction increases Tax interacting partner CREB1 O-GlcNAcylation. {ECO:0000269|PubMed:28742148}.",9083068; 11773972; 17974005; 15489334; 12150998; 12670868; 18669648; 19413330; 19451179; 19073609; 19377461; 24336203; 20018852; 20018868; 20200153; 20824293; 21269460; 22121020; 21285374; 22814378; 22923583; 23353889; 23629655; 23186163; 23222540; 24995978; 24474760; 26678539; 28742148; 15361863; 21240259; 23103939; 26273451; 28302723; 28584052,9083068; 11773972; 17974005; 15489334; 12150998; 12670868; 18669648; 19413330; 19451179; 19073609; 19377461; 24336203; 20018852; 20018868; 20200153; 20824293; 21269460; 22121020; 21285374; 22814378; 22923583; 23353889; 23629655; 23186163; 23222540; 24995978; 24474760; 26678539; 28742148; 15361863; 21240259; 23103939; 26273451; 28302723; 28584052; 16189514; 16449650; 17000644; 17353931; 17882263; 19615732; 19932102; 20360068; 20711500; 20805357; 21295698; 21516116; 21851590; 22082911; 22575643; 23088713; 23103942; 23395175; 24256146; 24311690; 25416956; 25609649; 26237509; 26496610; 26638075; 27618188; 28659383; 29058723; 29606577; 29723473; 30285435,2000-05-30,2019-02-13,2005-06-21,211,X-ray crystallography (33),STRAND 547 549 {ECO:0000244|PDB:5NPS}.; STRAND 556 563 {ECO:0000244|PDB:5NPS}.; STRAND 565 568 {ECO:0000244|PDB:5NPS}.; STRAND 586 594 {ECO:0000244|PDB:5NPS}.; STRAND 609 614 {ECO:0000244|PDB:5NPS}.; STRAND 634 639 {ECO:0000244|PDB:5NPS}.; STRAND 641 643 {ECO:0000244|PDB:5NPS}.; STRAND 656 664 {ECO:0000244|PDB:5NPS}.; STRAND 676 679 {ECO:0000244|PDB:5NPS}.; STRAND 693 698 {ECO:0000244|PDB:5NPS}.; STRAND 719 722 {ECO:0000244|PDB:5NPS}.; STRAND 731 737 {ECO:0000244|PDB:5NPS}.; STRAND 748 750 {ECO:0000244|PDB:4GYW}.; STRAND 752 755 {ECO:0000244|PDB:5NPS}.; STRAND 773 780 {ECO:0000244|PDB:5NPS}.; STRAND 795 799 {ECO:0000244|PDB:5NPS}.; STRAND 802 806 {ECO:0000244|PDB:5NPS}.; STRAND 820 822 {ECO:0000244|PDB:4AY5}.; STRAND 825 831 {ECO:0000244|PDB:5NPS}.; STRAND 839 841 {ECO:0000244|PDB:6MA5}.; STRAND 843 845 {ECO:0000244|PDB:5NPS}.; STRAND 872 877 {ECO:0000244|PDB:5NPS}.; STRAND 900 904 {ECO:0000244|PDB:5NPS}.; STRAND 919 922 {ECO:0000244|PDB:5NPS}.; STRAND 925 927 {ECO:0000244|PDB:5NPS}.; STRAND 943 945 {ECO:0000244|PDB:5NPS}.,HELIX 27 34 {ECO:0000244|PDB:1W3B}.; HELIX 37 50 {ECO:0000244|PDB:1W3B}.; HELIX 60 67 {ECO:0000244|PDB:6EOU}.; HELIX 71 83 {ECO:0000244|PDB:6EOU}.; HELIX 89 101 {ECO:0000244|PDB:6EOU}.; HELIX 105 118 {ECO:0000244|PDB:6EOU}.; HELIX 123 135 {ECO:0000244|PDB:6EOU}.; HELIX 139 152 {ECO:0000244|PDB:6EOU}.; HELIX 157 169 {ECO:0000244|PDB:6EOU}.; HELIX 173 186 {ECO:0000244|PDB:6EOU}.; HELIX 191 203 {ECO:0000244|PDB:6EOU}.; HELIX 207 220 {ECO:0000244|PDB:6EOU}.; HELIX 225 237 {ECO:0000244|PDB:6EOU}.; HELIX 241 254 {ECO:0000244|PDB:6EOU}.; HELIX 259 271 {ECO:0000244|PDB:6EOU}.; HELIX 275 288 {ECO:0000244|PDB:6EOU}.; HELIX 293 306 {ECO:0000244|PDB:6EOU}.; HELIX 309 322 {ECO:0000244|PDB:6EOU}.; HELIX 325 340 {ECO:0000244|PDB:5NPS}.; HELIX 343 356 {ECO:0000244|PDB:5NPS}.; HELIX 361 373 {ECO:0000244|PDB:5NPS}.; HELIX 377 390 {ECO:0000244|PDB:5NPS}.; HELIX 395 407 {ECO:0000244|PDB:5NPS}.; HELIX 411 424 {ECO:0000244|PDB:5NPS}.; HELIX 429 442 {ECO:0000244|PDB:5NPS}.; HELIX 445 458 {ECO:0000244|PDB:5NPS}.; HELIX 463 475 {ECO:0000244|PDB:5NPS}.; HELIX 482 498 {ECO:0000244|PDB:5NPS}.; HELIX 510 512 {ECO:0000244|PDB:5NPS}.; HELIX 517 535 {ECO:0000244|PDB:5NPS}.; HELIX 536 538 {ECO:0000244|PDB:4GYY}.; HELIX 569 574 {ECO:0000244|PDB:5NPS}.; HELIX 577 580 {ECO:0000244|PDB:5NPS}.; HELIX 600 608 {ECO:0000244|PDB:5NPS}.; HELIX 615 617 {ECO:0000244|PDB:5NPS}.; HELIX 621 631 {ECO:0000244|PDB:5NPS}.; HELIX 649 652 {ECO:0000244|PDB:5NPS}.; HELIX 686 691 {ECO:0000244|PDB:5NPS}.; HELIX 708 711 {ECO:0000244|PDB:5NPS}.; HELIX 713 715 {ECO:0000244|PDB:5NPS}.; HELIX 741 746 {ECO:0000244|PDB:5NPS}.; HELIX 781 792 {ECO:0000244|PDB:5NPS}.; HELIX 807 809 {ECO:0000244|PDB:4GYY}.; HELIX 810 813 {ECO:0000244|PDB:5NPS}.; HELIX 815 818 {ECO:0000244|PDB:5NPS}.; HELIX 832 835 {ECO:0000244|PDB:5NPS}.; HELIX 850 852 {ECO:0000244|PDB:5NPS}.; HELIX 855 867 {ECO:0000244|PDB:5NPS}.; HELIX 880 882 {ECO:0000244|PDB:5NPS}.; HELIX 883 892 {ECO:0000244|PDB:5NPS}.; HELIX 897 899 {ECO:0000244|PDB:4GYW}.; HELIX 908 914 {ECO:0000244|PDB:5NPS}.; HELIX 915 917 {ECO:0000244|PDB:5NPS}.; HELIX 931 938 {ECO:0000244|PDB:5NPS}.; HELIX 951 953 {ECO:0000244|PDB:5NPS}.; HELIX 955 963 {ECO:0000244|PDB:5NPS}.; HELIX 966 968 {ECO:0000244|PDB:5NPS}.; HELIX 973 985 {ECO:0000244|PDB:5NPS}.; HELIX 987 1003 {ECO:0000244|PDB:5NPS}.; HELIX 1005 1007 {ECO:0000244|PDB:6MA4}.; HELIX 1009 1028 {ECO:0000244|PDB:5NPS}.,TURN 507 509 {ECO:0000244|PDB:5NPS}.; TURN 550 554 {ECO:0000244|PDB:5NPS}.; TURN 583 585 {ECO:0000244|PDB:5NPS}.; TURN 681 683 {ECO:0000244|PDB:5NPS}.,,,,,5 out of 5,Active site (1); Alternative sequence (3); Beta strand (26); Binding site (3); Chain (1); Glycosylation (2); Helix (61); Initiator methionine (1); Modified residue (5); Motif (1); Mutagenesis (5); Natural variant (4); Nucleotide binding (3); Region (1); Repeat (13); Sequence conflict (2); Turn (4),"CAUTION: Was originally thought to be part of the MLL5-L complex, at least composed of KMT2E, STK38, PPP1CA, PPP1CB, PPP1CC, HCFC1, ACTB and OGT (PubMed:19377461). However, the corresponding article has been retracted (PubMed:24336203). {ECO:0000269|PubMed:19377461, ECO:0000269|PubMed:24336203}.","TISSUE SPECIFICITY: Highly expressed in pancreas and to a lesser extent in skeletal muscle, heart, brain and placenta. Present in trace amounts in lung and liver. {ECO:0000269|PubMed:9083068}.",,3D-structure;Acetylation;Alternative splicing;Apoptosis;Biological rhythms;Cell membrane;Cell projection;Chromatin regulator;Complete proteome;Cytoplasm;Direct protein sequencing;Disease mutation;Glycoprotein;Glycosyltransferase;Host-virus interaction;Lipid-binding;Membrane;Mental retardation;Mitochondrion;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;TPR repeat;Transferase;Ubl conjugation;Ubl conjugation pathway,Evidence at protein level,reviewed,,"Glycosyltransferase 41 family, O-GlcNAc transferase subfamily",211,Activity regulation (1); Alternative products (1); Catalytic activity (2); Caution (2); Domain (1); Function (2); Induction (1); Involvement in disease (2); Kinetics (1); Pathway (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (4); Subunit structure (2); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0053; KW-0090; KW-0156; KW-0181; KW-0225; KW-0325; KW-0328; KW-0446; KW-0472; KW-0496; KW-0539; KW-0597; KW-0621; KW-0677; KW-0802; KW-0808; KW-0832; KW-0833; KW-0903; KW-0945; KW-0963; KW-0966; KW-0991; KW-1003; KW-1185,Protein modification; protein glycosylation. ,,,,"DISEASE: Note=Regulation of OGT activity and altered O-GlcNAcylations are implicated in diabetes and Alzheimer disease. O-GlcNAcylation of AKT1 affects insulin signaling and, possibly diabetes. Reduced O-GlcNAcylations and resulting increased phosphorylations of MAPT/TAU are observed in Alzheimer disease (AD) brain cerebrum.; DISEASE: Mental retardation, X-linked 106 (MRX106) [MIM:300997]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. {ECO:0000269|PubMed:26273451, ECO:0000269|PubMed:28302723, ECO:0000269|PubMed:28584052}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Ubiquitinated, leading to its proteasomal degradation. {ECO:0000269|PubMed:21285374}.; PTM: Phosphorylation on Ser-3 or Ser-4 by GSK3-beta positively regulates its activity. {ECO:0000250}.",CHAIN 2 1046 UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit. /FTId=PRO_0000191772.,,,CARBOHYD 3 3 O-linked (GlcNAc) serine; alternate. {ECO:0000250}.; CARBOHYD 4 4 O-linked (GlcNAc) serine; alternate. {ECO:0000250}.,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.5}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.5}.; MOD_RES 3 3 Phosphoserine; by GSK3-beta; alternate. {ECO:0000250|UniProtKB:Q8CGY8}.; MOD_RES 4 4 Phosphoserine; by GSK3-beta; alternate. {ECO:0000250|UniProtKB:Q8CGY8}.; MOD_RES 20 20 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 989 989 Phosphotyrosine. {ECO:0000250|UniProtKB:P56558}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U77413;AJ315767;AJ315767;AJ315767;AL050366;AL833085;BX537844;BC014434;BC038180;
0,O43765,SGTA_HUMAN,SGTA SGT SGT1,SGTA,SGT SGT1,,,Homo sapiens (Human),9606,Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) (Vpu-binding protein) (UBP),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDNKKRLAYAIIQFLHDQLRHGGLSSDAQESLEVAIQCLETAFGVTVEDSDLALPQTLPEIFEAAATGKEMPQDLRSPARTPPSEEDSAEAERLKTEGNEQMKVENFEAAVHFYGKAIELNPANAVYFCNRAAAYSKLGNYAGAVQDCERAICIDPAYSKAYGRMGLALSSLNKHVEAVAYYKKALELDPDNETYKSNLKIAELKLREAPSPTGGVGSFDIAGLLNNPGFMSMASNLMNNPQIQQLMSGMISGGNNPLGTPGTSPSQNDLASLIQAGQQFAQQMQQQNPELIEQLRSQIRSRTPSASNDDQQE,313,"34,063",,,,,,,,,,,,,,,,,,,1,,0,DOMAIN: The second tetratricopeptide repeat (TPR 2) mediates the interaction with SARS-CoV accessory protein 7a.,SIMILARITY: Belongs to the SGT family. {ECO:0000305}.,,COMPBIAS 275 287 Gln-rich.,,,,REPEAT 91 124 TPR 1.; REPEAT 125 158 TPR 2.; REPEAT 159 192 TPR 3.,,,,,,,"FUNCTION: Co-chaperone that binds misfolded and hydrophobic patches-containing client proteins in the cytosol. Mediates their targeting to the endoplasmic reticulum but also regulates their sorting to the proteasome when targeting fails (PubMed:28104892). Functions in tail-anchored/type II transmembrane proteins membrane insertion constituting with ASNA1 and the BAG6 complex a targeting module (PubMed:28104892). Functions upstream of the BAG6 complex and ASNA1, binding more rapidly the transmembrane domain of newly synthesized proteins (PubMed:28104892, PubMed:25535373). It is also involved in the regulation of the endoplasmic reticulum-associated misfolded protein catabolic process via its interaction with BAG6: collaborates with the BAG6 complex to maintain hydrophobic substrates in non-ubiquitinated states (PubMed:23129660, PubMed:25179605). Competes with RNF126 for interaction with BAG6, preventing the ubiquitination of client proteins associated with the BAG6 complex (PubMed:27193484). Binds directly to HSC70 and HSP70 and regulates their ATPase activity (PubMed:18759457). {ECO:0000269|PubMed:18759457, ECO:0000269|PubMed:23129660, ECO:0000269|PubMed:25179605, ECO:0000269|PubMed:25535373, ECO:0000269|PubMed:27193484, ECO:0000269|PubMed:28104892}.; FUNCTION: (Microbial infection) In case of infection by polyomavirus, involved in the virus endoplasmic reticulum membrane penetration and infection via interaction with DNAJB12, DNAJB14 and HSPA8/Hsc70 (PubMed:24675744). {ECO:0000269|PubMed:24675744}.",,,,,,,,,,,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of synaptic vesicle membrane [GO:0098850]; membrane [GO:0016020]; nucleus [GO:0005634]; TRC complex [GO:0072380]; BAT3 complex binding [GO:1904288]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; protein-containing complex scaffold activity [GO:0032947]; chaperone-mediated protein folding [GO:0061077]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of chaperone-mediated protein folding [GO:1903646]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032],chaperone-mediated protein folding [GO:0061077]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of chaperone-mediated protein folding [GO:1903646]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032],BAT3 complex binding [GO:1904288]; identical protein binding [GO:0042802]; protein-containing complex scaffold activity [GO:0032947]; protein self-association [GO:0043621],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of synaptic vesicle membrane [GO:0098850]; membrane [GO:0016020]; nucleus [GO:0005634]; TRC complex [GO:0072380],GO:0005634; GO:0005737; GO:0005829; GO:0006620; GO:0016020; GO:0016032; GO:0030433; GO:0032947; GO:0042802; GO:0043621; GO:0061077; GO:0071816; GO:0072380; GO:0098850; GO:1903070; GO:1903071; GO:1903646; GO:1904288; GO:2000059,IPR032374; IPR013026; IPR011990; IPR001440; IPR019734; ,Itself; A8K660; Q15848; Q8TD06; O95816; P46379; P35070; Q9BXJ1; Q9BXI9; Q8N6L0; P40259; Q8TCZ2; P55291; A0A0S2Z3K0; P08123; Q4VAQ0; P09603; P01037; P07711; A0A0S2Z3V1; Q12805; O95967; Q96DN0; Q9NVM1; Q9Y624; Q96RJ6; Q9Y680; P58549; P22466; P09681; Q14440; Q96SL4; P28799; Q02747; A0A0C4DFT7; B8Q183; P48723; P46695; Q6PIQ7; Q8N355; Q14653; Q13568; Q6GPH6; P02538; Q86UP2; Q6ISS4; O43561; P08118; Q969H8; Q8IW45; Q13232; Q5JUK9; C3PTT6; Q96AQ6; Q9UN74; P23284; P45877; Q96NZ9; Q9UL19; P04843; P31431; P05121; Q16586; Q16586-2; P03973; Q0VAQ4; Q71RC9; P08294; P10451; Q8TCT8; P10124; Q9BT88; Q9H2B2; Q07654; P02786; P01135; P01135-2; Q8WUU8; Q5JXX7; Q71RG4; O14836; O14836-2; Q5BVD1; Q9GZX9; O95881; P11441; O75631; P01282; Q9NX94; O60844,"SUBUNIT: Homodimer (PubMed:15708368). Homooligomer (By similarity). Interacts with DNAJC5 and DNAJC5B. Interacts (via TPR repeats) with HSP90AA1 (PubMed:15708368). Interacts (via Gln-rich region) with SLC2A1 (PubMed:15708368). Interacts with HSP90AB1 (PubMed:16580629). Interacts (via TPR repeats) with HSPA8/Hsc70; the interaction is direct (PubMed:24675744). Interacts with BAG6 (via ubiquitin-like domain); interaction prevents interaction between BAG6 and RNF126 (PubMed:23129660, PubMed:25179605, PubMed:27193484). Forms a multiprotein complex, at least composed of DNAJB12, DNAJB14, HSPA8/Hsc70 and SGTA; interaction with DNAJB14 and HSPA8/Hsc70 is direct (PubMed:24675744). {ECO:0000250|UniProtKB:O70593, ECO:0000269|PubMed:15708368, ECO:0000269|PubMed:16580629, ECO:0000269|PubMed:17034881, ECO:0000269|PubMed:18759457, ECO:0000269|PubMed:23129660, ECO:0000269|PubMed:24675744, ECO:0000269|PubMed:25179605, ECO:0000269|PubMed:27193484}.; SUBUNIT: (Microbial infection) Interacts with Vpu and Gag from HIV-1. {ECO:0000269|PubMed:18759457, ECO:0000269|PubMed:9573291}.; SUBUNIT: (Microbial infection) Interacts with SARS-CoV accessory protein 7a. {ECO:0000269|PubMed:16580632}.",9740675; 10567422; 9573291; 11230166; 15057824; 15489334; 15708368; 16580629; 16580632; 16964243; 17034881; 18669648; 19690332; 19608861; 20068231; 21269460; 21406692; 23129660; 23186163; 25179605; 24275569; 24675744; 25535373; 27193484; 28104892; 18759457,9740675; 10567422; 9573291; 11230166; 15057824; 15489334; 15708368; 16580629; 16580632; 16964243; 17034881; 18669648; 19690332; 19608861; 20068231; 21269460; 21406692; 23129660; 23186163; 25179605; 24275569; 24675744; 25535373; 27193484; 28104892; 18759457; 12482202; 12735788; 12815268; 14667819; 14729056; 15710426; 15972823; 16169070; 16189514; 16777091; 17353931; 17942943; 18332089; 18607086; 19367725; 19615732; 20200332; 20711500; 21516116; 21900206; 21988832; 22693264; 22733359; 23142665; 23246001; 23433514; 23740762; 23839012; 23857189; 23939810; 24195513; 24974147; 25027991; 25036637; 25415308; 25416956; 26169395; 26752685; 27103333; 27827410; 28356524,2000-05-30,2019-02-13,1998-06-01,188,X-ray crystallography (4); NMR spectroscopy (1),,HELIX 5 21 {ECO:0000244|PDB:4GOF}.; HELIX 26 43 {ECO:0000244|PDB:4GOF}.; HELIX 48 51 {ECO:0000244|PDB:4CPG}.; HELIX 58 65 {ECO:0000244|PDB:4CPG}.; HELIX 87 103 {ECO:0000244|PDB:2VYI}.; HELIX 107 120 {ECO:0000244|PDB:2VYI}.; HELIX 125 137 {ECO:0000244|PDB:2VYI}.; HELIX 141 154 {ECO:0000244|PDB:2VYI}.; HELIX 159 171 {ECO:0000244|PDB:2VYI}.; HELIX 175 188 {ECO:0000244|PDB:2VYI}.; HELIX 193 206 {ECO:0000244|PDB:2VYI}.,,,,,,5 out of 5,Chain (1); Compositional bias (1); Helix (11); Modified residue (7); Mutagenesis (1); Repeat (3),,TISSUE SPECIFICITY: Ubiquitous.,,3D-structure;Acetylation;Chaperone;Complete proteome;Cytoplasm;Direct protein sequencing;Host-virus interaction;Nucleus;Phosphoprotein;Reference proteome;Repeat;TPR repeat,Evidence at protein level,reviewed,,SGT family,188,Domain (1); Function (2); Sequence similarities (1); Subcellular location (1); Subunit structure (3); Tissue specificity (1),,KW-0002; KW-0007; KW-0143; KW-0181; KW-0539; KW-0597; KW-0677; KW-0802; KW-0903; KW-0945; KW-0963; KW-1185,,,,,,,,,CHAIN 1 313 Small glutamine-rich tetratricopeptide repeat-containing protein alpha. /FTId=PRO_0000106365.,,,,,,"MOD_RES 77 77 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 81 81 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 84 84 Phosphoserine. {ECO:0000250|UniProtKB:O70593}.; MOD_RES 137 137 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 301 301 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 303 303 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 305 305 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AJ223828;AJ133129;AF408399;AF368279;AL050156;CR533517;CR542282;AC006538;CH471139;CH471139;CH471139;BC000390;BC002989;BC005165;BC008885;
0,O75674,TM1L1_HUMAN,TOM1L1 SRCASM,TOM1L1,SRCASM,,,Homo sapiens (Human),9606,TOM1-like protein 1 (Src-activating and signaling molecule protein) (Target of Myb-like protein 1),UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAFGKSHRDPYATSVGHLIEKATFAGVQTEDWGQFMHICDIINTTQDGPKDAVKALKKRISKNYNHKEIQLTLSLIDMCVQNCGPSFQSLIVKKEFVKENLVKLLNPRYNLPLDIQNRILNFIKTWSQGFPGGVDVSEVKEVYLDLVKKGVQFPPSEAEAETARQETAQISSNPPTSVPTAPALSSVIAPKNSTVTLVPEQIGKLHSELDMVKMNVRVMSAILMENTPGSENHEDIELLQKLYKTGREMQERIMDLLVVVENEDVTVELIQVNEDLNNAILGYERFTRNQQRILEQNKNQKEATNTTSEPSAPSQDLLDLSPSPRMPRATLGELNTMNNQLSGLNFSLPSSDVTNNLKPSLHPQMNLLALENTEIPPFAQRTSQNLTSSHAYDNFLEHSNSVFLQPVSLQTIAAAPSNQSLPPLPSNHPAMTKSDLQPPNYYEVMEFDPLAPAVTTEAIYEEIDAHQHKGAQNDGD,476,"52,989",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=O75674-1; Sequence=Displayed; Name=2; IsoId=O75674-2; Sequence=VSP_056852, VSP_056853; Note=No experimental confirmation available.; Name=3; IsoId=O75674-3; Sequence=VSP_057424; Note=No experimental confirmation available.; ",,,,,,,,,,VAR_SEQ 1 77 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_057424.; VAR_SEQ 345 346 NF -> SK (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_056852.; VAR_SEQ 347 476 Missing (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_056853.,VARIANT 108 108 R -> S (in dbSNP:rs16955377). /FTId=VAR_047469.,,,,CONFLICT 48 48 G -> A (in Ref. 1; CAA08993). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the TOM1 family. {ECO:0000305}.,,,DOMAIN 22 154 VHS. {ECO:0000255|PROSITE-ProRule:PRU00218}.; DOMAIN 200 288 GAT. {ECO:0000255|PROSITE-ProRule:PRU00373}.,MOTIF 421 425 SH3-binding. {ECO:0000250}.; MOTIF 460 463 SH2-binding. {ECO:0000250}.,REGION 392 395 Interaction with GRB2. {ECO:0000250}.; REGION 442 445 Interaction with PIK3R1. {ECO:0000250}.,,,,,,,,"FUNCTION: Probable adapter protein involved in signaling pathways. Interacts with the SH2 and SH3 domains of various signaling proteins when it is phosphorylated. May promote FYN activation, possibly by disrupting intramolecular SH3-dependent interactions (By similarity). {ECO:0000250}.",,,,,,,,,,,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; lysosome [GO:0005764]; clathrin binding [GO:0030276]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130]; activation of protein kinase activity [GO:0032147]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; positive regulation of protein autophosphorylation [GO:0031954]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],activation of protein kinase activity [GO:0032147]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; positive regulation of protein autophosphorylation [GO:0031954]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],clathrin binding [GO:0030276]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; lysosome [GO:0005764],GO:0005737; GO:0005764; GO:0005768; GO:0005795; GO:0005829; GO:0006886; GO:0007165; GO:0010008; GO:0017124; GO:0019901; GO:0030276; GO:0030295; GO:0031954; GO:0032147; GO:0043130; GO:0043162; GO:0045839; GO:0070062,IPR008942; IPR004152; IPR038425; IPR014645; IPR027428; IPR002014; ,Q00610; P00533; P62993; Q9H0E2; O60784; P52735,"SUBUNIT: Interacts with FYN, GRB2 and PIK3R1 when phosphorylated. Interacts with LYN. {ECO:0000250}.",10329004; 14702039; 16625196; 15489334; 17525332; 18669648; 19413330; 19690332; 20068231; 23186163; 24275569; ,10329004; 14702039; 16625196; 15489334; 17525332; 18669648; 19413330; 19690332; 20068231; 23186163; 24275569; 15579470; 15611048; 16169070; 18367816; 18654987; 19220627; 19798056; 20150893; 20182632; 20936779; 20944134; 21900206; 21903422; 21988832; 22014111; 23023324; 26899482,2002-11-15,2019-02-13,2008-11-25,157,X-ray crystallography (1),STRAND 131 133 {ECO:0000244|PDB:3RRU}.,HELIX 10 12 {ECO:0000244|PDB:3RRU}.; HELIX 14 22 {ECO:0000244|PDB:3RRU}.; HELIX 32 44 {ECO:0000244|PDB:3RRU}.; HELIX 48 60 {ECO:0000244|PDB:3RRU}.; HELIX 66 82 {ECO:0000244|PDB:3RRU}.; HELIX 85 91 {ECO:0000244|PDB:3RRU}.; HELIX 94 97 {ECO:0000244|PDB:3RRU}.; HELIX 102 105 {ECO:0000244|PDB:3RRU}.; HELIX 107 109 {ECO:0000244|PDB:3RRU}.; HELIX 113 127 {ECO:0000244|PDB:3RRU}.; HELIX 137 148 {ECO:0000244|PDB:3RRU}.,TURN 98 101 {ECO:0000244|PDB:3RRU}.,,,,,5 out of 5,Alternative sequence (3); Beta strand (1); Chain (1); Domain (2); Helix (11); Modified residue (5); Motif (2); Natural variant (1); Region (2); Sequence conflict (1); Turn (1),,,,3D-structure;Alternative splicing;Complete proteome;Cytoplasm;Endosome;Golgi apparatus;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;SH3-binding;Transport,Evidence at protein level,reviewed,,TOM1 family,157,Alternative products (1); Caution (2); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0181; KW-0333; KW-0472; KW-0597; KW-0621; KW-0653; KW-0729; KW-0813; KW-0963; KW-0967; KW-1185,,,,,,,,PTM: Phosphorylated on tyrosines by FYN and LYN. {ECO:0000250}.,CHAIN 1 476 TOM1-like protein 1. /FTId=PRO_0000072566.,,,,,,"MOD_RES 171 171 Phosphoserine. {ECO:0000250|UniProtKB:Q923U0}.; MOD_RES 314 314 Phosphoserine. {ECO:0000244|PubMed:17525332}.; MOD_RES 321 321 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:24275569}.; MOD_RES 323 323 Phosphoserine. {ECO:0000244|PubMed:17525332, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 460 460 Phosphotyrosine. {ECO:0000250|UniProtKB:Q923U0}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AJ010071;AK315039;AK315907;AK223125;CH471109;CH471109;BC029396;
0,O95425,SVIL_HUMAN,SVIL,SVIL,,,,Homo sapiens (Human),9606,Supervillin (Archvillin) (p205/p250),UP000005640: Chromosome 10,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MKRKERIARRLEGIENDTQPILLQSCTGLVTHRLLEEDTPRYMRASDPASPHIGRSNEEEETSDSSLEKQTRSKYCTETSGVHGDSPYGSGTMDTHSLESKAERIARYKAERRRQLAEKYGLTLDPEADSEYLSRYTKSRKEPDAVEKRGGKSDKQEESSRDASSLYPGTETMGLRTCAGESKDYALHVGDGSSDPEVLLNIENQRRGQELSATRQAHDLSPAAESSSTFSFSGRDSSFTEVPRSPKHAHSSSLQQAASRSPSFGDPQLSPEARPSTGKPKHEWFLQKDSEGDTPSLINWPSRVKVREKLVKEESARNSPELASESVTQRRHQPAPVHYVSFQSEHSAFDRVPSKAAGSTRQPIRGYVQPADTGHTAKLVTPETPENASECSWVASATQNVPKPPSLTVLEGDGRDSPVLHVCESKAEEEEGEGEGEEKEEDVCFTEALEQSKKTLLALEGDGLVRSPEDPSRNEDFGKPAVSTVTLEHQKELENVAQPPQAPHQPTERTGRSEMVLYIQSEPVSQDAKPTGHNREASKKRKVRTRSLSDFTGPPQLQALKYKDPASRRELELPSSKTEGPYGEISMLDTKVSVAQLRSAFLASANACRRPELKSRVERSAEGPGLPTGVERERGSRKPRRYFSPGESRKTSERFRTQPITSAERKESDRCTSHSETPTVDDEEKVDERAKLSVAAKRLLFREMEKSFDEQNVPKRRSRNTAVEQRLRRLQDRSLTQPITTEEVVIAATEPIPASCSGGTHPVMARLPSPTVARSAVQPARLQASAHQKALAKDQTNEGKELAEQGEPDSSTLSLAEKLALFNKLSQPVSKAISTRNRIDTRQRRMNARYQTQPVTLGEVEQVQSGKLIPFSPAVNTSVSTVASTVAPMYAGDLRTKPPLDHNASATDYKFSSSIENSDSPVRSILKSQAWQPLVEGSENKGMLREYGETESKRALTGRDSGMEKYGSFEEAEASYPILNRAREGDSHKESKYAVPRRGSLERANPPITHLGDEPKEFSMAKMNAQGNLDLRDRLPFEEKVEVENVMKRKFSLRAAEFGEPTSEQTGTAAGKTIAQTTAPVSWKPQDSSEQPQEKLCKNPCAMFAAGEIKTPTGEGLLDSPSKTMSIKERLALLKKSGEEDWRNRLSRRQEGGKAPASSLHTQEAGRSLIKKRVTESRESQMTIEERKQLITVREEAWKTRGRGAANDSTQFTVAGRMVKKGLASPTAITPVASPICGKTRGTTPVSKPLEDIEARPDMQLESDLKLDRLETFLRRLNNKVGGMHETVLTVTGKSVKEVMKPDDDETFAKFYRSVDYNMPRSPVEMDEDFDVIFDPYAPKLTSSVAEHKRAVRPKRRVQASKNPLKMLAAREDLLQEYTEQRLNVAFMESKRMKVEKMSSNSNFSEVTLAGLASKENFSNVSLRSVNLTEQNSNNSAVPYKRLMLLQIKGRRHVQTRLVEPRASALNSGDCFLLLSPHCCFLWVGEFANVIEKAKASELATLIQTKRELGCRATYIQTIEEGINTHTHAAKDFWKLLGGQTSYQSAGDPKEDELYEAAIIETNCIYRLMDDKLVPDDDYWGKIPKCSLLQPKEVLVFDFGSEVYVWHGKEVTLAQRKIAFQLAKHLWNGTFDYENCDINPLDPGECNPLIPRKGQGRPDWAIFGRLTEHNETILFKEKFLDWTELKRSNEKNPGELAQHKEDPRTDVKAYDVTRMVSMPQTTAGTILDGVNVGRGYGLVEGHDRRQFEITSVSVDVWHILEFDYSRLPKQSIGQFHEGDAYVVKWKFMVSTAVGSRQKGEHSVRAAGKEKCVYFFWQGRHSTVSEKGTSALMTVELDEERGAQVQVLQGKEPPCFLQCFQGGMVVHSGRREEEEENVQSEWRLYCVRGEVPVEGNLLEVACHCSSLRSRTSMVVLNVNKALIYLWHGCKAQAHTKEVGRTAANKIKEQCPLEAGLHSSSKVTIHECDEGSEPLGFWDALGRRDRKAYDCMLQDPGSFNFAPRLFILSSSSGDFAATEFVYPARAPSVVSSMPFLQEDLYSAPQPALFLVDNHHEVYLWQGWWPIENKITGSARIRWASDRKSAMETVLQYCKGKNLKKPAPKSYLIHAGLEPLTFTNMFPSWEHREDIAEITEMDTEVSNQITLVEDVLAKLCKTIYPLADLLARPLPEGVDPLKLEIYLTDEDFEFALDMTRDEYNALPAWKQVNLKKAKGLF,2214,"247,746",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; Synonyms=Archvillin {ECO:0000303|PubMed:12711699}, p250 {ECO:0000303|PubMed:12711699}, SV2; IsoId=O95425-1; Sequence=Displayed; Name=2; Synonyms=Supervillin {ECO:0000303|PubMed:9867483}, p205 {ECO:0000303|PubMed:9867483}, SV1; IsoId=O95425-2; Sequence=VSP_012425, VSP_012426; Name=SV3; IsoId=O95425-3; Sequence=VSP_053768; Name=SV4; IsoId=O95425-4; Sequence=VSP_012426; ",,,,,,,,,,"VAR_SEQ 276 669 Missing (in isoform 2). {ECO:0000303|PubMed:9867483}. /FTId=VSP_012425.; VAR_SEQ 276 302 Missing (in isoform SV3). {ECO:0000305}. /FTId=VSP_053768.; VAR_SEQ 750 781 Missing (in isoform 2 and isoform SV4). {ECO:0000303|PubMed:23382381, ECO:0000303|PubMed:9867483}. /FTId=VSP_012426.","VARIANT 189 189 V -> A (in dbSNP:rs10160013). {ECO:0000269|PubMed:12711699, ECO:0000269|PubMed:9867483}. /FTId=VAR_020791.; VARIANT 422 422 V -> I (in dbSNP:rs1247696). {ECO:0000269|PubMed:12711699, ECO:0000269|Ref.5}. /FTId=VAR_058308.; VARIANT 1041 1041 V -> L (in dbSNP:rs7070135). /FTId=VAR_057467.; VARIANT 1235 1235 P -> A (in dbSNP:rs2368406). {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000269|PubMed:12711699, ECO:0000269|PubMed:9867483}. /FTId=VAR_020792.; VARIANT 1688 1688 S -> P (in dbSNP:rs11007612). /FTId=VAR_024691.; VARIANT 2005 2005 I -> V (in dbSNP:rs7921306). /FTId=VAR_057468.; VARIANT 2041 2041 A -> V (in dbSNP:rs17694739). /FTId=VAR_057469.",,,,,,2,,0,"DOMAIN: As opposed to other villin-type headpiece domains, supervillin HP (SVHP) doesn't bind F-actin due to the absence of a conformationally flexible region (V-loop). {ECO:0000269|PubMed:19683541}.",SIMILARITY: Belongs to the villin/gelsolin family. {ECO:0000305}.,,,DOMAIN 2151 2214 HP. {ECO:0000255|PROSITE-ProRule:PRU00595}.,,REGION 1 174 Interaction with MYLK. {ECO:0000250}.; REGION 1419 1687 Interaction with NEB. {ECO:0000269|PubMed:18639526}.,REPEAT 1441 1540 Gelsolin-like 1.; REPEAT 1560 1682 Gelsolin-like 2.; REPEAT 1752 1862 Gelsolin-like 3.; REPEAT 1881 1982 Gelsolin-like 4.; REPEAT 2015 2122 Gelsolin-like 5.,,,,,,,"FUNCTION: Isoform 1: Forms a high-affinity link between the actin cytoskeleton and the membrane. Is among the first costameric proteins to assemble during myogenesis and it contributes to myogenic membrane structure and differentiation (PubMed:12711699). Appears to be involved in myosin II assembly. May modulate myosin II regulation through MLCK during cell spreading, an initial step in cell migration. May play a role in invadopodial function (PubMed:19109420). {ECO:0000269|PubMed:12711699, ECO:0000269|PubMed:19109420}.; FUNCTION: Isoform 2: May be involved in modulation of focal adhesions. Supervillin-mediated down-regulation of focal adhesions involves binding to TRIP6. Plays a role in cytokinesis through KIF14 interaction (By similarity). {ECO:0000250|UniProtKB:O46385}.",,,,,,,,,,,,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519],cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519],actin filament binding [GO:0051015],actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102],GO:0002102; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007010; GO:0007519; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0043034; GO:0051015; GO:0071437,IPR029006; IPR007123; IPR015628; IPR007122; IPR003128; IPR036886; ,P20929,SUBUNIT: Associates with F-actin (By similarity). Interacts with NEB (By similarity). Interacts with MYH9 (By similarity). Interacts with MYLK (By similarity). Isoform 2: Interacts with TRIP6 (By similarity). Isoform 2: Interacts with DYNLT1 (By similarity). Isoform 2: Interacts with KIF14; at midbody during cytokinesis (By similarity). {ECO:0000250|UniProtKB:O46385}.,9867483; 12711699; 23382381; 15164054; 17081983; 17525332; 18639526; 18220336; 18088087; 18669648; 19109420; 19690332; 20068231; 21406692; 23186163; 24275569; 24129315; 19683541,9867483; 12711699; 23382381; 15164054; 17081983; 17525332; 18639526; 18220336; 18088087; 18669648; 19109420; 19690332; 20068231; 21406692; 23186163; 24275569; 24129315; 19683541; 11792840; 12577067; 16169070; 16385451; 17110338; 18984674; 19010793; 19047128; 20309963; 20331534; 20360068; 20379614; 21070852; 21569246; 21874239; 22550155; 23750008; 23752268; 24088567; 25605665; 25684206; 25852190; 26496610; 26638075,2005-01-04,2019-02-13,2009-07-07,168,NMR spectroscopy (2),STRAND 2169 2172 {ECO:0000244|PDB:2K6M}.; STRAND 2189 2191 {ECO:0000244|PDB:2K6M}.,HELIX 2159 2162 {ECO:0000244|PDB:2K6M}.; HELIX 2177 2179 {ECO:0000244|PDB:2K6M}.; HELIX 2182 2188 {ECO:0000244|PDB:2K6M}.; HELIX 2193 2196 {ECO:0000244|PDB:2K6M}.; HELIX 2201 2211 {ECO:0000244|PDB:2K6M}.,,,,,,5 out of 5,Alternative sequence (3); Beta strand (2); Chain (1); Domain (1); Helix (5); Modified residue (32); Mutagenesis (1); Natural variant (7); Region (2); Repeat (5),,"TISSUE SPECIFICITY: Expressed in many tissues. Most abundant in muscle, bone marrow, thyroid gland and salivary gland. Isoform 1 (archvillin) is muscle specific. {ECO:0000269|PubMed:9867483}.",,3D-structure;Actin-binding;Alternative splicing;Calcium;Cell junction;Cell membrane;Cell projection;Complete proteome;Cytoplasm;Cytoskeleton;Membrane;Methylation;Phosphoprotein;Polymorphism;Reference proteome;Repeat,Evidence at protein level,reviewed,,Villin/gelsolin family,168,Alternative products (1); Domain (1); Function (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0009; KW-0025; KW-0106; KW-0181; KW-0206; KW-0472; KW-0488; KW-0597; KW-0621; KW-0677; KW-0963; KW-0965; KW-0966; KW-1003; KW-1185,,,,,,,,,CHAIN 1 2214 Supervillin. /FTId=PRO_0000218740.,,,,,,"MOD_RES 50 50 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 221 221 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 238 238 Phosphoserine. {ECO:0000250|UniProtKB:Q8K4L3}.; MOD_RES 240 240 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 245 245 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 253 253 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 259 259 Phosphoserine. {ECO:0000250|UniProtKB:Q8K4L3}.; MOD_RES 270 270 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 319 319 Phosphoserine. {ECO:0000250|UniProtKB:Q8K4L3}.; MOD_RES 673 673 Phosphoserine. {ECO:0000250|UniProtKB:Q8K4L3}.; MOD_RES 707 707 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 769 769 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 850 850 Phosphotyrosine. {ECO:0000250|UniProtKB:Q8K4L3}.; MOD_RES 852 852 Phosphothreonine. {ECO:0000244|PubMed:17525332, ECO:0000244|PubMed:23186163}.; MOD_RES 914 914 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 920 920 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 924 924 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 968 968 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 1000 1000 Phosphoserine. {ECO:0000250|UniProtKB:Q8K4L3}.; MOD_RES 1052 1052 Phosphoserine. {ECO:0000250|UniProtKB:Q8K4L3}.; MOD_RES 1111 1111 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1120 1120 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1203 1203 Omega-N-methylarginine. {ECO:0000244|PubMed:24129315}.; MOD_RES 1225 1225 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 1230 1230 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 1234 1234 Phosphoserine. {ECO:0000250|UniProtKB:Q8K4L3}.; MOD_RES 1322 1322 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 1405 1405 Phosphoserine. {ECO:0000250|UniProtKB:Q8K4L3}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF051850;AF051851;AF109135;JX467682;CH471072;CH471072;
0,O95630,STABP_HUMAN,STAMBP AMSH,STAMBP,AMSH,,,Homo sapiens (Human),9606,STAM-binding protein (EC 3.4.19.-) (Associated molecule with the SH3 domain of STAM) (Endosome-associated ubiquitin isopeptidase),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSDHGDVSLPPEDRVRALSQLGSAVEVNEDIPPRRYFRSGVEIIRMASIYSEEGNIEHAFILYNKYITLFIEKLPKHRDYKSAVIPEKKDTVKKLKEIAFPKAEELKAELLKRYTKEYTEYNEEKKKEAEELARNMAIQQELEKEKQRVAQQKQQQLEQEQFHAFEEMIRNQELEKERLKIVQEFGKVDPGLGGPLVPDLEKPSLDVFPTLTVSSIQPSDCHTTVRPAKPPVVDRSLKPGALSNSESIPTIDGLRHVVVPGRLCPQFLQLASANTARGVETCGILCGKLMRNEFTITHVLIPKQSAGSDYCNTENEEELFLIQDQQGLITLGWIHTHPTQTAFLSSVDLHTHCSYQMMLPESVAIVCSPKFQETGFFKLTDHGLEEISSCRQKGFHPHSKDPPLFCSCSHVTVVDRAVTITDLR,424,"48,077",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=O95630-1; Sequence=Displayed; Name=2; IsoId=O95630-2; Sequence=VSP_057197; ,,,,,,,,,,VAR_SEQ 336 424 THPTQTAFLSSVDLHTHCSYQMMLPESVAIVCSPKFQETGFFKLTDHGLEEISSCRQKGFHPHSKDPPLFCSCSHVTVVDRAVTITDLR -> VETLWSLKSLHAP (in isoform 2). {ECO:0000303|PubMed:19906316}. /FTId=VSP_057197.,VARIANT 14 14 R -> P (in MICCAP). {ECO:0000269|PubMed:23542699}. /FTId=VAR_069806.; VARIANT 38 38 R -> C (in MICCAP; dbSNP:rs143739249). {ECO:0000269|PubMed:23542699}. /FTId=VAR_069807.; VARIANT 42 42 E -> G (in MICCAP; dbSNP:rs397509387). {ECO:0000269|PubMed:23542699}. /FTId=VAR_069808.; VARIANT 63 63 Y -> C (in MICCAP; dbSNP:rs781694797). {ECO:0000269|PubMed:23542699}. /FTId=VAR_069809.; VARIANT 100 100 F -> Y (in MICCAP; dbSNP:rs397514697). {ECO:0000269|PubMed:23542699}. /FTId=VAR_069810.; VARIANT 313 313 T -> I (in MICCAP; dbSNP:rs202100019). {ECO:0000269|PubMed:23542699}. /FTId=VAR_069811.,,,,,,1,,0,DOMAIN: The JAMM motif is essential for the protease activity. {ECO:0000250}.,SIMILARITY: Belongs to the peptidase M67C family. {ECO:0000305}.,,COMPBIAS 104 177 Glu-rich.,DOMAIN 257 388 MPN. {ECO:0000255|PROSITE-ProRule:PRU01182}.,MOTIF 335 348 JAMM motif. {ECO:0000255|PROSITE-ProRule:PRU01182}.,REGION 1 127 Interaction with CHMP3.; REGION 227 231 Interaction with STAM.,,,3.4.19.-,,,COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};  Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000250};,,"FUNCTION: Zinc metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains. Does not cleave 'Lys-48'-linked polyubiquitin chains (By similarity). Plays a role in signal transduction for cell growth and MYC induction mediated by IL-2 and GM-CSF. Potentiates BMP (bone morphogenetic protein) signaling by antagonizing the inhibitory action of SMAD6 and SMAD7. Has a key role in regulation of cell surface receptor-mediated endocytosis and ubiquitin-dependent sorting of receptors to lysosomes. Endosomal localization of STAMBP is required for efficient EGFR degradation but not for its internalization (By similarity). Involved in the negative regulation of PI3K-AKT-mTOR and RAS-MAP signaling pathways. {ECO:0000250, ECO:0000269|PubMed:10383417, ECO:0000269|PubMed:11483516, ECO:0000269|PubMed:15314065, ECO:0000269|PubMed:17261583, ECO:0000269|PubMed:23542699}.",,,,,,,,,METAL 335 335 Zinc 1; catalytic. {ECO:0000255|PROSITE-ProRule:PRU01182}.; METAL 337 337 Zinc 1; catalytic. {ECO:0000255|PROSITE-ProRule:PRU01182}.; METAL 348 348 Zinc 1; catalytic. {ECO:0000255|PROSITE-ProRule:PRU01182}.; METAL 350 350 Zinc 2. {ECO:0000250}.; METAL 390 390 Zinc 2. {ECO:0000250}.; METAL 396 396 Zinc 2. {ECO:0000250}.; METAL 398 398 Zinc 2. {ECO:0000250}.,,SITE 280 280 Indirect zinc-binding. {ECO:0000250}.,cleavage furrow [GO:0032154]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; protein domain specific binding [GO:0019904]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; mitotic cytokinesis [GO:0000281]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of cell population proliferation [GO:0008284]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; receptor signaling pathway via JAK-STAT [GO:0007259],mitotic cytokinesis [GO:0000281]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of cell population proliferation [GO:0008284]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; receptor signaling pathway via JAK-STAT [GO:0007259],Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; protein domain specific binding [GO:0019904]; thiol-dependent ubiquitin-specific protease activity [GO:0004843],cleavage furrow [GO:0032154]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],GO:0000281; GO:0004843; GO:0005634; GO:0005654; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0007259; GO:0008237; GO:0008284; GO:0014067; GO:0016020; GO:0016579; GO:0019904; GO:0032154; GO:0043524; GO:0046580; GO:0046872; GO:0061578; GO:0070062; GO:0070536,IPR000555; IPR037518; IPR015063; ,Q9HD42; Q7LBR1; Q9Y3E7; Q9Y3E7-1; Q9H444; Q9NZZ3; P62993; Q9Y3C5; O43541-2; Q92783; O75886,"SUBUNIT: Interacts with STAM. Interacts with SMAD6 and SMAD7. Interacts with CHMP3; the interaction appears to relieve the autoinhibition of CHMP3. Interacts with SMURF2 and RNF11; this interaction promotes ubiquitination. {ECO:0000269|PubMed:10383417, ECO:0000269|PubMed:11483516, ECO:0000269|PubMed:14755250, ECO:0000269|PubMed:15314065, ECO:0000269|PubMed:17146056, ECO:0000269|PubMed:17261583}.",10383417; 15815621; 15489334; 19906316; 11483516; 12370088; 15314065; 14755250; 17146056; 17261583; 21269460; 23186163; 23542699; 24275569,10383417; 15815621; 15489334; 19906316; 11483516; 12370088; 15314065; 14755250; 17146056; 17261583; 21269460; 23186163; 23542699; 24275569; 10982817; 12773374; 16169070; 16189514; 16520378; 16716190; 16730941; 16760479; 16854379; 17078930; 17159328; 17711858; 18395747; 18758443; 19060904; 19373254; 19615732; 19684015; 20159979; 20936779; 21448666; 21706016; 21827950; 21888914; 21988832; 22800866; 24151880; 25070368; 25416956; 25692795; 26496610; 26601948; 27725184; 28492230; 29907875,2005-07-19,2019-02-13,1999-05-01,164,X-ray crystallography (3); NMR spectroscopy (1),STRAND 257 260 {ECO:0000244|PDB:3RZV}.; STRAND 282 290 {ECO:0000244|PDB:3RZV}.; STRAND 293 301 {ECO:0000244|PDB:3RZV}.; STRAND 304 306 {ECO:0000244|PDB:3RZV}.; STRAND 311 313 {ECO:0000244|PDB:3RZV}.; STRAND 329 336 {ECO:0000244|PDB:3RZV}.; STRAND 338 340 {ECO:0000244|PDB:3RZU}.; STRAND 363 368 {ECO:0000244|PDB:3RZV}.; STRAND 373 379 {ECO:0000244|PDB:3RZV}.; STRAND 404 407 {ECO:0000244|PDB:3RZV}.; STRAND 409 414 {ECO:0000244|PDB:3RZV}.; STRAND 419 422 {ECO:0000244|PDB:3RZV}.,HELIX 11 22 {ECO:0000244|PDB:2XZE}.; HELIX 33 53 {ECO:0000244|PDB:2XZE}.; HELIX 56 71 {ECO:0000244|PDB:2XZE}.; HELIX 74 76 {ECO:0000244|PDB:2XZE}.; HELIX 88 97 {ECO:0000244|PDB:2XZE}.; HELIX 99 137 {ECO:0000244|PDB:2XZE}.; HELIX 263 276 {ECO:0000244|PDB:3RZV}.; HELIX 316 326 {ECO:0000244|PDB:3RZV}.; HELIX 346 358 {ECO:0000244|PDB:3RZV}.; HELIX 381 389 {ECO:0000244|PDB:3RZV}.,TURN 78 82 {ECO:0000244|PDB:2XZE}.; TURN 369 372 {ECO:0000244|PDB:3RZV}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (12); Chain (1); Compositional bias (1); Domain (1); Helix (10); Metal binding (7); Modified residue (5); Motif (1); Mutagenesis (1); Natural variant (6); Region (2); Site (1); Turn (2),,TISSUE SPECIFICITY: Ubiquitously expressed.,"MISCELLANEOUS: X-ray crystallography studies of STAMBPL1, another member of the peptidase M67C family, has shown that Glu-280 binds zinc indirectly via a water molecule. Nevertheless, this residue is essential for catalytic activity.",3D-structure;Alternative splicing;Complete proteome;Cytoplasm;Disease mutation;Endosome;Hydrolase;Membrane;Metal-binding;Metalloprotease;Nucleus;Phosphoprotein;Protease;Reference proteome;Ubl conjugation;Ubl conjugation pathway;Zinc,Evidence at protein level,reviewed,,Peptidase M67C family,164,Activity regulation (1); Alternative products (1); Cofactor (1); Domain (1); Function (1); Involvement in disease (1); Miscellaneous (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0181; KW-0225; KW-0378; KW-0472; KW-0479; KW-0482; KW-0539; KW-0597; KW-0645; KW-0832; KW-0833; KW-0862; KW-0963; KW-0967; KW-1185,,,,,"DISEASE: Microcephaly-capillary malformation syndrome (MICCAP) [MIM:614261]: A congenital disorder characterized by severe progressive microcephaly, early-onset refractory epilepsy, profound developmental delay, and multiple small capillary malformations spread diffusely on the body. Additional more variable features include dysmorphic facial features, distal limb abnormalities, and mild heart defects. {ECO:0000269|PubMed:23542699}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: Phosphorylated after BMP type I receptor activation. {ECO:0000269|PubMed:11483516}.; PTM: Ubiquitinated by SMURF2 in the presence of RNF11. {ECO:0000269|PubMed:14755250}.,CHAIN 1 424 STAM-binding protein. /FTId=PRO_0000194869.,,,,,,"MOD_RES 2 2 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:11483516}.; MOD_RES 48 48 Phosphoserine. {ECO:0000269|PubMed:11483516}.; MOD_RES 243 243 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:11483516}.; MOD_RES 245 245 Phosphoserine. {ECO:0000269|PubMed:11483516}.; MOD_RES 247 247 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:11483516}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U73522;AC073046;CH471053;CH471053;BC007682;BC065574;BC101467;BC101469;EU927390;
0,O95832,CLD1_HUMAN,CLDN1 CLD1 SEMP1 UNQ481/PRO944,CLDN1,CLD1 SEMP1,,UNQ481/PRO944,Homo sapiens (Human),9606,Claudin-1 (Senescence-associated epithelial membrane protein),UP000005640: Chromosome 3,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MANAGLQLLGFILAFLGWIGAIVSTALPQWRIYSYAGDNIVTAQAMYEGLWMSCVSQSTGQIQCKVFDSLLNLSSTLQATRALMVVGILLGVIAIFVATVGMKCMKCLEDDEVQKMRMAVIGGAIFLLAGLAILVATAWYGNRIVQEFYDPMTPVNARYEFGQALFTGWAAASLCLLGGALLCCSCPRKTTSYPTPRPYPKPAPSSGKDYV,211,"22,744",,,,,,,,,,,,,,,,,CONFLICT 62 62 I -> V (in Ref. 2; AAD22962). {ECO:0000305}.; CONFLICT 135 135 V -> A (in Ref. 2; AAD22962). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the claudin family. {ECO:0000305}.,,,,,"REGION 210 211 Interactions with TJP1, TJP2, TJP3 and PATJ. {ECO:0000250}.",,,,,,,,"FUNCTION: Claudins function as major constituents of the tight junction complexes that regulate the permeability of epithelia. While some claudin family members play essential roles in the formation of impermeable barriers, others mediate the permeability to ions and small molecules. Often, several claudin family members are coexpressed and interact with each other, and this determines the overall permeability. CLDN1 is required to prevent the paracellular diffusion of small molecules through tight junctions in the epidermis and is required for the normal barrier function of the skin. Required for normal water homeostasis and to prevent excessive water loss through the skin, probably via an indirect effect on the expression levels of other proteins, since CLDN1 itself seems to be dispensable for water barrier formation in keratinocyte tight junctions (PubMed:23407391). {ECO:0000269|PubMed:23407391}.; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes (PubMed:17325668, PubMed:20375010). Associates with CD81 and the CLDN1-CD81 receptor complex is essential for HCV entry into host cell (PubMed:20375010). Acts as a receptor for dengue virus (PubMed:24074594). {ECO:0000269|PubMed:17325668, ECO:0000269|PubMed:20375010, ECO:0000269|PubMed:24074594}.",,,,,,,,,,,,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; virus receptor activity [GO:0001618]; aging [GO:0007568]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell-cell junction organization [GO:0045216]; cellular response to butyrate [GO:1903545]; cellular response to interferon-gamma [GO:0071346]; cellular response to lead ion [GO:0071284]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; drug transport across blood-nerve barrier [GO:0061772]; establishment of blood-nerve barrier [GO:0008065]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of skin barrier [GO:0061436]; hyperosmotic salinity response [GO:0042538]; liver regeneration [GO:0097421]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; response to dexamethasone [GO:0071548]; response to ethanol [GO:0045471]; response to interleukin-18 [GO:0070673]; response to lipopolysaccharide [GO:0032496],aging [GO:0007568]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell-cell junction organization [GO:0045216]; cellular response to butyrate [GO:1903545]; cellular response to interferon-gamma [GO:0071346]; cellular response to lead ion [GO:0071284]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; drug transport across blood-nerve barrier [GO:0061772]; establishment of blood-nerve barrier [GO:0008065]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of skin barrier [GO:0061436]; hyperosmotic salinity response [GO:0042538]; liver regeneration [GO:0097421]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; response to dexamethasone [GO:0071548]; response to ethanol [GO:0045471]; response to interleukin-18 [GO:0070673]; response to lipopolysaccharide [GO:0032496],identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; virus receptor activity [GO:0001618],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328],GO:0001618; GO:0005198; GO:0005737; GO:0005887; GO:0005923; GO:0007568; GO:0008065; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0016338; GO:0032496; GO:0042538; GO:0042802; GO:0045216; GO:0045471; GO:0051260; GO:0051291; GO:0061436; GO:0061772; GO:0070673; GO:0070830; GO:0071284; GO:0071346; GO:0071356; GO:0071548; GO:0071560; GO:0090557; GO:0097421; GO:1903348; GO:1903545,IPR006187; IPR003548; IPR017974; IPR004031; ,P09758,"SUBUNIT: Homopolymers interact with CLDN3, but not CLDN2, homopolymers. Can form homo- and heteropolymers with other claudin family members (PubMed:23704991). Directly interacts with TJP1/ZO-1, TJP2/ZO-2 and TJP3/ZO-3. Interacts with MPDZ and PATJ (By similarity). Interacts with OCLN, CLDN4, CLDN6 and CLDN9 (PubMed:20375010). Interacts with CD81 (PubMed:20375010, PubMed:21516087). {ECO:0000250|UniProtKB:O88551, ECO:0000269|PubMed:20375010, ECO:0000269|PubMed:21516087, ECO:0000269|PubMed:23704991}.; SUBUNIT: (Microbial infection) Interacts with hepatitis c virus E1 and E2 proteins. {ECO:0000269|PubMed:17325668}.; SUBUNIT: (Microbial infection) Interacts with dengue virus small envelope protein M. {ECO:0000269|PubMed:24074594}.",9931503; 10828592; 11071387; 12975309; 15489334; 15521008; 16619213; 17325668; 20375010; 21269460; 21516087; 23407391; 24074594; 23704991,9931503; 10828592; 11071387; 12975309; 15489334; 15521008; 16619213; 17325668; 20375010; 21269460; 21516087; 23407391; 24074594; 23704991; 11889141; 11939410; 12021270; 12736707; 12909588; 15260435; 15547692; 15743508; 15820559; 15965503; 16169070; 16232121; 16253248; 17047970; 17091452; 17283368; 17359339; 17418912; 17440968; 17585317; 17611630; 17644758; 17941058; 17970035; 18095941; 18204077; 18227718; 18234789; 18337570; 18480547; 18550469; 18711353; 18756604; 18802961; 18817843; 18949385; 19052094; 19073886; 19077439; 19184060; 19297469; 19414319; 19540561; 19578981; 19661441; 19674288; 19706291; 19739116; 19776133; 19881542; 19897486; 19962368; 20379614; 20478039; 20490282; 20546350; 20651236; 20685314; 20871038; 20937153; 21233676; 21356207; 21428935; 21480761; 21489616; 21493012; 21536752; 21551950; 21569618; 21620107; 21624620; 21720707; 21757541; 21873169; 21909685; 21988832; 21997594; 22030598; 22408413; 22588068; 22641667; 22671588; 22719836; 22776839; 22897233; 22941059; 23136956; 23137868; 23160379; 23422483; 23426649; 23449973; 23498955; 23523916; 23588589; 23591077; 23721519; 23775920; 23792687; 23813140; 23844228; 23898096; 23914916; 24112161; 24141423; 24265314; 24294371; 24304426; 24305709; 24321518; 24479816; 24529330; 24535143; 24576965; 24641442; 24696415; 24815833; 24899196; 25001509; 25038829; 25046141; 25277410; 25319490; 25323998; 25342221; 25345514; 25393310; 25517868; 25544763; 25548484; 25755790; 25778318; 25798937; 25849148; 25934191; 25956626; 25964581; 25972430; 26023235; 26122225; 26157141; 26219679; 26281891; 26361141; 26436506; 26463354; 26554238; 26662145; 26820697; 26918943; 27259233; 27277258; 27581203; 27687058; 27733684; 27742576; 27766775; 27914788; 27974683; 28045912; 28055967; 28126724; 28273404; 28316062; 28342862; 28381183; 28415141; 28415153; 28415156; 28432260; 28493289; 28614291; 28617312; 28651932; 28679754; 29307823; 29524521; 9786950,2000-05-30,2019-02-13,1999-05-01,165,,,,,,,TOPO_DOM 1 7 Cytoplasmic. {ECO:0000250}.; TOPO_DOM 29 81 Extracellular. {ECO:0000255}.; TOPO_DOM 103 115 Cytoplasmic. {ECO:0000255}.; TOPO_DOM 137 163 Extracellular. {ECO:0000255}.; TOPO_DOM 185 211 Cytoplasmic. {ECO:0000250}.,TRANSMEM 8 28 Helical. {ECO:0000255}.; TRANSMEM 82 102 Helical. {ECO:0000255}.; TRANSMEM 116 136 Helical. {ECO:0000255}.; TRANSMEM 164 184 Helical. {ECO:0000255}.,5 out of 5,Chain (1); Disulfide bond (1); Mutagenesis (2); Region (1); Sequence conflict (2); Topological domain (5); Transmembrane (4),,"TISSUE SPECIFICITY: Strongly expressed in liver and kidney. Expressed in heart, brain, spleen, lung and testis. {ECO:0000269|PubMed:9931503}.",,Cell junction;Cell membrane;Complete proteome;Disulfide bond;Host cell receptor for virus entry;Host-virus interaction;Ichthyosis;Membrane;Receptor;Reference proteome;Tight junction;Transmembrane;Transmembrane helix,Evidence at protein level,reviewed,,Claudin family,165,Function (2); Involvement in disease (1); Sequence similarities (1); Subcellular location (1); Subunit structure (3); Tissue specificity (1),,KW-0181; KW-0472; KW-0675; KW-0796; KW-0812; KW-0945; KW-0965; KW-0977; KW-1003; KW-1015; KW-1133; KW-1183; KW-1185,,,,,"DISEASE: Ichthyosis-sclerosing cholangitis neonatal syndrome (NISCH) [MIM:607626]: A rare autosomal recessive complex ichthyosis syndrome characterized by scalp hypotrichosis, scarring alopecia, mild diffuse ichthyosis, sclerosing cholangitis and leukocyte vacuolization. {ECO:0000269|PubMed:15521008, ECO:0000269|PubMed:16619213}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 211 Claudin-1. /FTId=PRO_0000144729.,,DISULFID 54 64 {ECO:0000250}.,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF101051;AF115546;AF134160;AF260406;AF260403;AF260404;AF260405;AY358652;CR457138;BC012471;
0,P02545,LMNA_HUMAN,LMNA LMN1,LMNA,LMN1,,,Homo sapiens (Human),9606,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,METPSQRRATRSGAQASSTPLSPTRITRLQEKEDLQELNDRLAVYIDRVRSLETENAGLRLRITESEEVVSREVSGIKAAYEAELGDARKTLDSVAKERARLQLELSKVREEFKELKARNTKKEGDLIAAQARLKDLEALLNSKEAALSTALSEKRTLEGELHDLRGQVAKLEAALGEAKKQLQDEMLRRVDAENRLQTMKEELDFQKNIYSEELRETKRRHETRLVEIDNGKQREFESRLADALQELRAQHEDQVEQYKKELEKTYSAKLDNARQSAERNSNLVGAAHEELQQSRIRIDSLSAQLSQLQKQLAAKEAKLRDLEDSLARERDTSRRLLAEKEREMAEMRARMQQQLDEYQELLDIKLALDMEIHAYRKLLEGEEERLRLSPSPTSQRSRGRASSHSSQTQGGGSVTKKRKLESTESRSSFSQHARTSGRVAVEEVDEEGKFVRLRNKSNEDQSMGNWQIKRQNGDDPLLTYRFPPKFTLKAGQVVTIWAAGAGATHSPPTDLVWKAQNTWGCGNSLRTALINSTGEEVAMRKLVRSVTVVEDDEDEDGDDLLHHHHGSHCSSSGDPAEYNLRSRTVLCGTCGQPADKASASGSGAQVGGPISSGSSASSVTVTRSYRSVGGSGGGSFGDNLVTRSYLLGNSSPRTQSPQNCSIM,664,"74,139",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=6;  Name=A; Synonyms=Lamin A; IsoId=P02545-1; Sequence=Displayed; Name=C; Synonyms=Lamin C; IsoId=P02545-2; Sequence=VSP_002469, VSP_002470; Name=ADelta10; Synonyms=Lamin ADelta10; IsoId=P02545-3; Sequence=VSP_002468; Name=4; IsoId=P02545-4; Sequence=VSP_045977, VSP_045978, VSP_045979; Note=No experimental confirmation available. {ECO:0000305}; Name=5; IsoId=P02545-5; Sequence=VSP_053503, VSP_053504; Note=No experimental confirmation available.; Name=6; Synonyms=Progerin; IsoId=P02545-6; Sequence=VSP_053505; Note=Disease-associated isoform. Polymorphism at codon 608 results in activation of a cryptic splice donor site within exon 11, resulting in a truncated protein product that lacks the site for endoproteolytic cleavage.; ",,,,,SEQUENCE CAUTION:  Sequence=CAA27173.1; Type=Frameshift; Positions=582; Evidence={ECO:0000305}; ,,,,,"VAR_SEQ 1 99 Missing (in isoform 5). {ECO:0000305}. /FTId=VSP_053503.; VAR_SEQ 1 7 METPSQR -> MGNSEGC (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_045977.; VAR_SEQ 8 119 Missing (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_045978.; VAR_SEQ 100 119 ARLQLELSKVREEFKELKAR -> MDLEAWDPHLEPDAEAMVDG (in isoform 5). {ECO:0000305}. /FTId=VSP_053504.; VAR_SEQ 537 566 Missing (in isoform ADelta10). {ECO:0000303|PubMed:8621584}. /FTId=VSP_002468.; VAR_SEQ 567 572 GSHCSS -> VSGSRR (in isoform C). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:3453101, ECO:0000303|PubMed:3462705}. /FTId=VSP_002469.; VAR_SEQ 573 664 Missing (in isoform C). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:3453101, ECO:0000303|PubMed:3462705}. /FTId=VSP_002470.; VAR_SEQ 607 656 Missing (in isoform 6). {ECO:0000303|Ref.4}. /FTId=VSP_053505.; VAR_SEQ 664 664 M -> IQEMGMRWEVEEGRRKVSLSCLP (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_045979.","VARIANT 10 10 T -> I (in an atypical progeroid patient; diagnosed as Seip syndrome; unknown pathological significance; dbSNP:rs57077886). {ECO:0000269|PubMed:15060110}. /FTId=VAR_039745.; VARIANT 24 24 T -> S (in EDMD3). {ECO:0000269|PubMed:27234031}. /FTId=VAR_076562.; VARIANT 25 25 R -> G (in EDMD2; dbSNP:rs58327533). {ECO:0000269|PubMed:14684700}. /FTId=VAR_039746.; VARIANT 25 25 R -> P (in EDMD2; mis-localized in the nucleus; causes nuclear deformations and LMNB1 redistribution; dbSNP:rs61578124). {ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:20848652}. /FTId=VAR_039747.; VARIANT 28 28 R -> W (in FPLD2; dbSNP:rs59914820). {ECO:0000269|PubMed:12015247}. /FTId=VAR_039748.; VARIANT 32 32 Missing (in EDMD2; abnormal nuclear localization in a honeycomb expression pattern in about 11% of cultured skin fibroblasts from heterozygous patients; no effect on protein level). {ECO:0000269|PubMed:12467752, ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:15372542}. /FTId=VAR_039749.; VARIANT 33 33 E -> D (in CMT2; autosomal dominant form; dbSNP:rs57966821). {ECO:0000269|PubMed:14985400}. /FTId=VAR_039750.; VARIANT 33 33 E -> G (in EDMD2; dbSNP:rs267607614). {ECO:0000269|PubMed:14985400}. /FTId=VAR_039751.; VARIANT 35 35 L -> V (in EDMD2; dbSNP:rs56694480). {ECO:0000269|PubMed:14684700}. /FTId=VAR_039752.; VARIANT 39 39 N -> S (in MDCL and EDMD2; dbSNP:rs57983345). {ECO:0000269|PubMed:18551513, ECO:0000269|PubMed:20848652}. /FTId=VAR_063588.; VARIANT 43 43 A -> T (in EDMD2; dbSNP:rs60446065). {ECO:0000269|PubMed:11503164}. /FTId=VAR_039753.; VARIANT 45 45 Y -> C (in EDMD2; dbSNP:rs58436778). {ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:20848652}. /FTId=VAR_009971.; VARIANT 50 50 R -> P (in EDMD2 and MDCL; dbSNP:rs60695352). {ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:18551513}. /FTId=VAR_009972.; VARIANT 50 50 R -> S (in EDMD2; dbSNP:rs59931416). {ECO:0000269|PubMed:11503164}. /FTId=VAR_039754.; VARIANT 57 57 A -> P (in CMDHH; phenotype originally designated as atypical Werner syndrome; dbSNP:rs28928903). {ECO:0000269|PubMed:12927431}. /FTId=VAR_017656.; VARIANT 59 59 L -> R (in CMDHH; dbSNP:rs58922911). {ECO:0000269|PubMed:17150192, ECO:0000269|PubMed:19283854}. /FTId=VAR_064055.; VARIANT 60 60 R -> G (in CMD1A and FPLD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs28928900). {ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:12196663}. /FTId=VAR_034706.; VARIANT 62 62 R -> G (in FPLD2; dbSNP:rs56793579). {ECO:0000269|PubMed:12015247}. /FTId=VAR_039755.; VARIANT 63 63 I -> N (in EDMD2; dbSNP:rs57793737). {ECO:0000269|PubMed:12467752, ECO:0000269|PubMed:12649505, ECO:0000269|PubMed:15744034}. /FTId=VAR_039756.; VARIANT 63 63 I -> S (in EDMD2; no effect on protein level; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; dbSNP:rs57793737). {ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:15372542}. /FTId=VAR_009974.; VARIANT 65 65 E -> G (in EDMD2). {ECO:0000269|PubMed:14684700}. /FTId=VAR_039757.; VARIANT 85 85 L -> R (in CMD1A; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs28933090). {ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:11792809}. /FTId=VAR_009975.; VARIANT 89 89 R -> L (in CMD1A; dramatically aberrant localization with almost no nuclear rim staining and formation of intranuclear foci; dbSNP:rs59040894). {ECO:0000269|PubMed:12628721, ECO:0000269|PubMed:20160190}. /FTId=VAR_039758.; VARIANT 92 92 L -> F (in CMD1A; dbSNP:rs267607560). {ECO:0000269|PubMed:21846512}. /FTId=VAR_067257.; VARIANT 97 97 K -> E (in CMD1A; dbSNP:rs59065411). {ECO:0000269|PubMed:11897440}. /FTId=VAR_039759.; VARIANT 101 101 R -> P (in CMD1A; dramatically aberrant localization with almost no nuclear rim staining and formation of intranuclear foci; dbSNP:rs267607568). {ECO:0000269|PubMed:20160190}. /FTId=VAR_070174.; VARIANT 112 112 Missing (in EDMD2). {ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:14684700}. /FTId=VAR_009976.; VARIANT 125 125 G -> S (polymorphism; found in patients with atrial fibrillation; dbSNP:rs267607605). {ECO:0000269|PubMed:19427440}. /FTId=VAR_072817.; VARIANT 133 133 R -> L (in FPLD2; dbSNP:rs60864230). {ECO:0000269|PubMed:12629077}. /FTId=VAR_016913.; VARIANT 133 133 R -> P (in EDMD2; dbSNP:rs60864230). {ECO:0000269|PubMed:11503164}. /FTId=VAR_017657.; VARIANT 138 138 E -> K (in HGPS; might be associated with early and severe strokes; dbSNP:rs267607649). {ECO:0000269|PubMed:21791255}. /FTId=VAR_070175.; VARIANT 140 140 L -> P (in EDMD2; dbSNP:rs60652225). {ECO:0000269|PubMed:12649505, ECO:0000269|PubMed:15744034}. /FTId=VAR_039760.; VARIANT 140 140 L -> R (in HGPS; phenotype originally designated as atypical Werner syndrome; dbSNP:rs60652225). {ECO:0000269|PubMed:12927431}. /FTId=VAR_017658.; VARIANT 143 143 S -> F (in HGPS; dbSNP:rs58912633). {ECO:0000269|PubMed:15622532}. /FTId=VAR_034707.; VARIANT 143 143 S -> P (in CMD1A; dbSNP:rs61661343). {ECO:0000269|PubMed:15140538}. /FTId=VAR_039761.; VARIANT 145 145 E -> K (in HGPS; atypical; dbSNP:rs60310264). {ECO:0000269|PubMed:12714972}. /FTId=VAR_017659.; VARIANT 150 150 T -> P (in EDMD2; dbSNP:rs58917027). {ECO:0000269|PubMed:10908904, ECO:0000269|PubMed:20848652}. /FTId=VAR_039762.; VARIANT 161 161 E -> K (in CMD1A; dbSNP:rs28933093). {ECO:0000269|PubMed:12920062, ECO:0000269|PubMed:21846512}. /FTId=VAR_017660.; VARIANT 166 166 R -> P (in CMD1A; dramatically aberrant localization with almost no nuclear rim staining and formation of intranuclear foci; dbSNP:rs267607570). {ECO:0000269|PubMed:20160190}. /FTId=VAR_070176.; VARIANT 189 189 R -> P (in EDMD2; found also in a patient with limb-girdle muscular dystrophy; sporadic; dbSNP:rs267607643). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064962.; VARIANT 190 190 R -> Q (in EDMD2 and CMD1A; aberrant localization with decreased nuclear rim staining and increased formation of intranuclear foci; dbSNP:rs267607571). {ECO:0000269|PubMed:15744034, ECO:0000269|PubMed:20160190}. /FTId=VAR_039763.; VARIANT 190 190 R -> RR (in EDMD2). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064963.; VARIANT 190 190 R -> W (in CMD1A; dbSNP:rs59026483). {ECO:0000269|PubMed:11897440, ECO:0000269|PubMed:15219508, ECO:0000269|PubMed:16061563}. /FTId=VAR_039764.; VARIANT 192 192 D -> G (in CMD1A; dramatically increases the size of intranuclear speckles and reduces their number; this phenotype is only partially reversed by coexpression of the G-192 mutation and wild-type lamin-C; precludes insertion of lamin-C into the nuclear envelope when co-transfected with the G-192 LMNA; G-192 lamin-C expression totally disrupts the SUMO1 pattern; dbSNP:rs57045855). {ECO:0000269|PubMed:16061563}. /FTId=VAR_039765.; VARIANT 195 195 N -> K (in CMD1A; dramatically aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; distribution of endogenous LMNA, LMNB1 and LMNB2 are altered in cells expressing this mutant; causes an increased loss of endogenous EMD from the nuclear envelope; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs28933091). {ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:11792809}. /FTId=VAR_009977.; VARIANT 196 199 RLQT -> S (in EDMD2). {ECO:0000269|PubMed:11503164}. /FTId=VAR_039766.; VARIANT 203 203 E -> G (in CMD1A; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; decreased sumoylation; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; associated with increased cell death; dbSNP:rs28933092). {ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:18606848}. /FTId=VAR_009978.; VARIANT 203 203 E -> K (in CMD1A; decreased sumoylation; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; associated with increased cell death; dbSNP:rs61195471). {ECO:0000269|PubMed:11561226, ECO:0000269|PubMed:18606848, ECO:0000269|PubMed:20160190}. /FTId=VAR_039767.; VARIANT 206 206 F -> L (in EDMD2; dbSNP:rs267607629). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064964.; VARIANT 208 208 Missing (in EDMD2; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; no effect on protein level). {ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:15372542}. /FTId=VAR_034708.; VARIANT 210 210 I -> S (in CMD1A; dramatically aberrant localization with almost no nuclear rim staining and increased formation of intranuclear foci; dbSNP:rs267607572). {ECO:0000269|PubMed:20160190}. /FTId=VAR_070177.; VARIANT 215 215 L -> P (in CMD1A; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; dbSNP:rs61295588). {ECO:0000269|PubMed:12486434, ECO:0000269|PubMed:20160190}. /FTId=VAR_039768.; VARIANT 222 222 H -> P (in EDMD2; dbSNP:rs58034145). {ECO:0000269|PubMed:10939567}. /FTId=VAR_039769.; VARIANT 222 222 H -> Y (in EDMD2; dbSNP:rs28928901). {ECO:0000269|PubMed:10739764}. /FTId=VAR_009979.; VARIANT 225 225 R -> Q (in EDMD3; dbSNP:rs199474724). {ECO:0000269|PubMed:22431096}. /FTId=VAR_067697.; VARIANT 230 230 D -> N (in FPLD2; dbSNP:rs61214927). {ECO:0000269|PubMed:17250669}. /FTId=VAR_039770.; VARIANT 232 232 G -> E (in EDMD2; dbSNP:rs57207746). {ECO:0000269|PubMed:10939567}. /FTId=VAR_039771.; VARIANT 248 248 L -> P (in EDMD2; dbSNP:rs58850446). {ECO:0000269|PubMed:14684700}. /FTId=VAR_039772.; VARIANT 249 249 R -> Q (in EDMD2; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; no effect on protein level; dbSNP:rs59332535). {ECO:0000269|PubMed:10739764, ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:12032588, ECO:0000269|PubMed:12649505, ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:15744034, ECO:0000269|PubMed:20848652}. /FTId=VAR_009980.; VARIANT 249 249 R -> W (in MDCL and EDMD2; mislocalized in the nucleus; causes nuclear deformations and LMNB1 redistribution; dbSNP:rs121912496). {ECO:0000269|PubMed:18551513, ECO:0000269|PubMed:20848652}. /FTId=VAR_063589.; VARIANT 259 259 Y -> C (in EDMD2). {ECO:0000269|PubMed:27234031}. /FTId=VAR_076563.; VARIANT 260 260 K -> N (in CMDA1). {ECO:0000269|PubMed:16156025}. /FTId=VAR_039773.; VARIANT 261 261 Missing (in EDMD2). {ECO:0000269|PubMed:10908904, ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11503164}. /FTId=VAR_009981.; VARIANT 267 267 Y -> C (in EDMD2; dbSNP:rs57048196). {ECO:0000269|PubMed:14684700}. /FTId=VAR_039774.; VARIANT 268 268 S -> P (in EDMD2; dbSNP:rs267607630). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064965.; VARIANT 271 271 L -> P (in EDMD2; dbSNP:rs267607641). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064966.; VARIANT 294 294 Q -> P (in EDMD2; dbSNP:rs61616775). {ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:20848652}. /FTId=VAR_009982.; VARIANT 295 295 S -> P (in EDMD2; dbSNP:rs267607633). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064967.; VARIANT 298 298 R -> C (in CMT2B1; dbSNP:rs59885338). {ECO:0000269|PubMed:11799477}. /FTId=VAR_017661.; VARIANT 300 300 D -> G (in HGPS; atypical form with late onset; abnormal nuclear morphology with single or multple blebs, lobulation and occasional ringed or donut shaped nuclei; dbSNP:rs79907212). {ECO:0000269|PubMed:23666920}. /FTId=VAR_070178.; VARIANT 302 302 L -> P (in MDCL; dbSNP:rs267607596). {ECO:0000269|PubMed:18551513}. /FTId=VAR_063590.; VARIANT 303 303 S -> P (in EDMD2; dbSNP:rs61527854). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064968.; VARIANT 317 317 E -> K (in CMD1A; dbSNP:rs56816490). {ECO:0000269|PubMed:11897440, ECO:0000269|PubMed:21846512}. /FTId=VAR_039775.; VARIANT 318 318 A -> T (in CMD1A; no effect on nuclear morphology and lamin A localization; dbSNP:rs267607574). {ECO:0000269|PubMed:20160190}. /FTId=VAR_070179.; VARIANT 336 336 R -> Q (in EDMD2; dbSNP:rs58105277). {ECO:0000269|PubMed:10739764, ECO:0000269|PubMed:12467752}. /FTId=VAR_009983.; VARIANT 343 343 R -> Q (in EDMD2; dbSNP:rs61177390). {ECO:0000269|PubMed:12467752}. /FTId=VAR_009984.; VARIANT 349 349 R -> L (in CMD1A; dbSNP:rs58789393). {ECO:0000269|PubMed:15219508}. /FTId=VAR_039776.; VARIANT 355 355 Missing (in EDMD2). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064969.; VARIANT 358 358 E -> K (in EDMD2 and MDCL; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci when transfected in C2C12 myoblasts; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; distribution of endogenous LMNA, LMNB1 and LMNB2 are altered in cells expressing this mutant; interacts with itself and with wild-type LMNA and LMNB1; no effect on protein level; dbSNP:rs60458016). {ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:18551513, ECO:0000269|PubMed:20848652}. /FTId=VAR_009985.; VARIANT 361 361 E -> K (in EDMD2; dbSNP:rs267607634). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064970.; VARIANT 371 371 M -> K (in EDMD2; dramatically aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; distribution of endogenous LMNA, LMNB1 and LMNB2 are altered in cells expressing this mutant; causes an increased loss of endogenous EMD from the nuclear envelope; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs59653062). {ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11792809}. /FTId=VAR_009986.; VARIANT 377 377 R -> H (in EDMD2; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; no effect on protein level; dbSNP:rs61672878). {ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:12628721, ECO:0000269|PubMed:12673789, ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:15744034, ECO:0000269|PubMed:17136397}. /FTId=VAR_016205.; VARIANT 377 377 R -> L (in EDMD2; dbSNP:rs61672878). {ECO:0000269|PubMed:12032588, ECO:0000269|PubMed:12649505}. /FTId=VAR_039777.; VARIANT 380 380 L -> S (in MDCL; dbSNP:rs121912495). {ECO:0000269|PubMed:18551513}. /FTId=VAR_063591.; VARIANT 386 386 R -> K (in EDMD2; dramatically aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; distribution of endogenous LMNA, LMNB1 and LMNB2 are altered in cells expressing this mutant; causes an increased loss of endogenous EMD from the nuclear envelope; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs267607545). {ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:12649505, ECO:0000269|PubMed:20848652}. /FTId=VAR_009987.; VARIANT 388 388 R -> H (in CMD1A; no effect on nuclear morphology but restricts lamin A to the cytoplasm; dbSNP:rs267607576). {ECO:0000269|PubMed:20160190}. /FTId=VAR_070180.; VARIANT 399 399 R -> C (in FPLD2 and CMD1A; no effect on nuclear morphology and lamin A localization; dbSNP:rs58672172). {ECO:0000269|PubMed:17250669, ECO:0000269|PubMed:20160190}. /FTId=VAR_039778.; VARIANT 401 401 R -> C (in EDMD2; abnormal nuclear localization in a honeycomb expression pattern in about 22% of cultured skin fibroblasts from heterozygous patients; enhances the interaction with SYNE2; no effect on nuclear localization; no effect on protein level; dbSNP:rs61094188). {ECO:0000269|PubMed:12467752, ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:23977161}. /FTId=VAR_072818.; VARIANT 411 411 G -> D (probable disease-associated mutation found in patients with metabolic syndromes; probable lipodystrophy causing mutation; no effect on nuclear lamin A localization; no effect on the interaction with SYNE2; dbSNP:rs267607647). {ECO:0000269|PubMed:21724554, ECO:0000269|PubMed:23977161}. /FTId=VAR_072819.; VARIANT 413 413 G -> C (polymorphism; found in patients with skeletal and cardiac muscular dystrophies; no effect on nuclear lamin A localization; no effect on the interaction with SYNE2; dbSNP:rs766811975). {ECO:0000269|PubMed:23977161}. /FTId=VAR_072820.; VARIANT 415 415 V -> I (rare variant; found in patients with atrial fibrillation; unknown pathological significance; no effect on nuclear lamin A localization; enhances the interaction with SYNE2; causes nuclear deformations in heat shock experiments; dbSNP:rs267607606). {ECO:0000269|PubMed:19427440, ECO:0000269|PubMed:23977161}. /FTId=VAR_072821.; VARIANT 419 419 R -> C (polymorphism; found in patients with lipodystrophy; no effect on nuclear lamin A localization; no effect on the interaction with SYNE2; dbSNP:rs755686359). {ECO:0000269|PubMed:23977161}. /FTId=VAR_072822.; VARIANT 421 421 L -> P (disease-associated mutation found in patient with severe metabolic syndrome; probable lipodystrophy causing mutation; no effect on nuclear lamin A localization; no effect on the interaction with SYNE2; dbSNP:rs267607564). {ECO:0000269|PubMed:17711925, ECO:0000269|PubMed:23977161}. /FTId=VAR_072823.; VARIANT 427 427 R -> G (polymorphism; found in patients with skeletal and cardiac muscular dystrophies; no effect on nuclear lamin A localization; no effect on the interaction with SYNE2). {ECO:0000269|PubMed:23977161}. /FTId=VAR_072824.; VARIANT 435 435 R -> C (in CMD1A; dbSNP:rs150840924). {ECO:0000269|PubMed:14684700}. /FTId=VAR_039779.; VARIANT 439 439 R -> C (in FPLD2; increase in nuclear blebbing and formation of honeycomb-like structures in the nuclei with no accumulation of prelamin A in skin fibroblasts; causes oligomerization of the C-terminal globular domain of lamins A and C under no-reducing conditions and increases binding affinity for DNA; increases sensitivity to oxidative stress; no significant differences in stability and structure compared with the wild-type; dbSNP:rs62636506). {ECO:0000269|PubMed:19220582}. /FTId=VAR_070181.; VARIANT 446 446 D -> V (in EDMD2; dbSNP:rs58541611). {ECO:0000269|PubMed:14684700}. /FTId=VAR_039780.; VARIANT 449 449 G -> D (in EDMD2; dbSNP:rs267607637). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064971.; VARIANT 453 453 R -> P (in MDCL; dbSNP:rs267607598). {ECO:0000269|PubMed:18551513}. /FTId=VAR_063592.; VARIANT 453 453 R -> W (in EDMD2; abnormal nuclear localization; forms nuclear foci in about 8% of cultured skin fibroblasts from heterozygous patients; interacts with itself and with wild-type LMNA and LMNB1; no effect on protein level; dbSNP:rs58932704). {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:10739764, ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:20848652}. /FTId=VAR_009988.; VARIANT 454 454 L -> P (in EDMD2; dbSNP:rs267607638). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064972.; VARIANT 455 455 R -> P (in MDCL; dbSNP:rs267607597). {ECO:0000269|PubMed:18551513}. /FTId=VAR_063593.; VARIANT 456 456 N -> D (in MDCL; dbSNP:rs267607599). {ECO:0000269|PubMed:18551513}. /FTId=VAR_063594.; VARIANT 456 456 N -> I (in EDMD2; mislocalized in the nucleus; does not alter nuclear size or shape; dbSNP:rs60992550). {ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:20848652}. /FTId=VAR_039781.; VARIANT 456 456 N -> K (in EDMD2; dbSNP:rs61235244). {ECO:0000269|PubMed:10939567}. /FTId=VAR_039782.; VARIANT 461 461 D -> Y (in EDMD2; dbSNP:rs267607642). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064973.; VARIANT 465 465 G -> D (in FPLD2; dbSNP:rs61282106). {ECO:0000269|PubMed:10739751}. /FTId=VAR_009989.; VARIANT 467 467 W -> R (in EDMD2; dbSNP:rs267607639). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064974.; VARIANT 469 469 I -> T (in EDMD2; dbSNP:rs57394692). {ECO:0000269|PubMed:10739764}. /FTId=VAR_009990.; VARIANT 471 471 R -> C (in HGPS; dbSNP:rs28928902). {ECO:0000269|PubMed:12768443}. /FTId=VAR_017662.; VARIANT 471 471 R -> H (in CMD1A; no effect on nuclear morphology and lamin A localization; dbSNP:rs267607578). {ECO:0000269|PubMed:20160190}. /FTId=VAR_070182.; VARIANT 481 481 Y -> H (in EDMD2; dbSNP:rs57747780). {ECO:0000269|PubMed:11525883}. /FTId=VAR_039783.; VARIANT 482 482 R -> L (in FPLD2; abnormal nuclear localization in a honeycomb expression pattern in about 10% of cultured skin fibroblasts from heterozygous patients; no effect on protein level; dbSNP:rs11575937). {ECO:0000269|PubMed:10655060, ECO:0000269|PubMed:15372542}. /FTId=VAR_009991.; VARIANT 482 482 R -> Q (in FPLD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs11575937). {ECO:0000269|PubMed:10587585, ECO:0000269|PubMed:10739751, ECO:0000269|PubMed:11792809}. /FTId=VAR_009992.; VARIANT 482 482 R -> W (in FPLD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; decreases binding affinity for DNA; increases sensitivity to oxidative stress; dbSNP:rs57920071). {ECO:0000269|PubMed:10655060, ECO:0000269|PubMed:10739751, ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:19220582}. /FTId=VAR_009993.; VARIANT 486 486 K -> N (in FPLD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs59981161). {ECO:0000269|PubMed:11792809}. /FTId=VAR_009994.; VARIANT 488 488 T -> P (polymorphism; found in patient with atrial fibrillation; dbSNP:rs267607607). {ECO:0000269|PubMed:19427440}. /FTId=VAR_072825.; VARIANT 515 515 K -> E (in FPLD2). {ECO:0000269|PubMed:24485160}. /FTId=VAR_071968.; VARIANT 520 520 W -> S (in EDMD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs58362413). {ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11792809}. /FTId=VAR_039784.; VARIANT 523 523 G -> R (in CMD1A; dbSNP:rs201583907). {ECO:0000269|PubMed:21846512}. /FTId=VAR_067258.; VARIANT 527 527 R -> C (in HGPS; dbSNP:rs57318642). {ECO:0000269|PubMed:12768443}. /FTId=VAR_017663.; VARIANT 527 527 R -> H (in MADA; dbSNP:rs57520892). {ECO:0000269|PubMed:12075506}. /FTId=VAR_018727.; VARIANT 527 527 R -> P (in EDMD2 and FPLD2; interacts with itself and with wild-type LMNA and LMNB1; reduced binding to SUN1; abnormal nuclear localization; forms nuclear foci in about 13% of cultured skin fibroblasts from heterozygous patients; no effect on protein level; dbSNP:rs57520892). {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:10739764, ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:12196663, ECO:0000269|PubMed:12649505, ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:15744034, ECO:0000269|PubMed:19933576, ECO:0000269|PubMed:20848652}. /FTId=VAR_009995.; VARIANT 528 528 T -> K (in EDMD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs57629361). {ECO:0000269|PubMed:10739764, ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:20848652}. /FTId=VAR_009996.; VARIANT 528 528 T -> R (in EDMD2; dbSNP:rs57629361). {ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:20848652}. /FTId=VAR_039785.; VARIANT 529 529 A -> V (in MADA; dbSNP:rs60580541). {ECO:0000269|PubMed:15998779}. /FTId=VAR_034709.; VARIANT 530 530 L -> P (in EDMD2; interacts with itself and with wild-type LMNA and LMNB1; reduced binding to SUN1; no decrease in the stability compared with wild-type; dbSNP:rs60934003). {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:19933576}. /FTId=VAR_009997.; VARIANT 541 541 R -> C (in CMD1A; grossly abnormal nuclear shape with the nuclear envelope producing prominent lobules in about 10% of cultured skin fibroblasts from heterozygous patients; dbSNP:rs56984562). {ECO:0000269|PubMed:14675861, ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:19167105}. /FTId=VAR_039786.; VARIANT 541 541 R -> H (in EDMD2; dbSNP:rs61444459). {ECO:0000269|PubMed:14684700}. /FTId=VAR_039787.; VARIANT 541 541 R -> P (in EDMD2; mis-localized in the nucleus; does not alter nuclear size or shape; dbSNP:rs61444459). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064975.; VARIANT 541 541 R -> S (in EDMD2 and CMD1A; modest and non-specific nuclear membrane alterations; the phenotype is entirely reversed by coexpression of the S-541 mutation and wild-type lamin-C; dbSNP:rs56984562). {ECO:0000269|PubMed:16061563, ECO:0000269|PubMed:20848652}. /FTId=VAR_039788.; VARIANT 542 542 K -> N (in HGPS; dbSNP:rs56673169). {ECO:0000269|PubMed:15286156}. /FTId=VAR_034710.; VARIANT 573 573 S -> L (in CMD1A, FPLD2 and MADA; dbSNP:rs60890628). {ECO:0000269|PubMed:12628721, ECO:0000269|PubMed:16278265, ECO:0000269|PubMed:17250669}. /FTId=VAR_039789.; VARIANT 578 578 E -> V (in an atypical progeroid patient; diagnosed as Werner syndrome; dbSNP:rs61224243). {ECO:0000269|PubMed:15060110}. /FTId=VAR_039790.; VARIANT 582 582 R -> H (in FPLD2; dbSNP:rs57830985). {ECO:0000269|PubMed:10739751}. /FTId=VAR_009998.; VARIANT 602 602 G -> S (in EDMD2; dbSNP:rs60662302). {ECO:0000269|PubMed:20848652}. /FTId=VAR_064976.; VARIANT 608 608 G -> S (in HGPS; reduced binding to SUN1; may affect splicing by activating a cryptic splice donor site; dbSNP:rs61064130). {ECO:0000269|PubMed:12714972, ECO:0000269|PubMed:12768443, ECO:0000269|PubMed:19933576}. /FTId=VAR_017664.; VARIANT 624 624 R -> H (in EDMD2; dbSNP:rs13768). {ECO:0000269|PubMed:11503164}. /FTId=VAR_039791.; VARIANT 631 631 G -> D (probable disease-associated mutation found in a patient with metabolic syndrome; dbSNP:rs267607648). {ECO:0000269|PubMed:21724554}. /FTId=VAR_072826.; VARIANT 644 644 R -> C (in HGPS and EDMD2; partially inhibits tail cleavage; dbSNP:rs142000963). {ECO:0000269|PubMed:15060110, ECO:0000269|PubMed:20848652, ECO:0000269|PubMed:22355414}. /FTId=VAR_039792.",,,,CONFLICT 340 340 E -> K (in Ref. 5; BAG58344). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the intermediate filament family. {ECO:0000255|PROSITE-ProRule:PRU01188}.,,,DOMAIN 31 387 IF rod. {ECO:0000255|PROSITE-ProRule:PRU01188}.; DOMAIN 428 545 LTD. {ECO:0000255|PROSITE-ProRule:PRU01187}.,MOTIF 417 422 Nuclear localization signal. {ECO:0000255}.,REGION 1 130 Interaction with MLIP. {ECO:0000269|PubMed:21498514}.; REGION 1 33 Head.; REGION 34 70 Coil 1A.; REGION 71 80 Linker 1.; REGION 81 218 Coil 1B.; REGION 219 242 Linker 2.; REGION 243 383 Coil 2.; REGION 384 664 Tail.,,,,,,,,"FUNCTION: Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. Lamin A and C are present in equal amounts in the lamina of mammals. Plays an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics. Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation (PubMed:10080180, PubMed:22431096, PubMed:10814726, PubMed:11799477, PubMed:18551513). Required for osteoblastogenesis and bone formation (PubMed:12075506, PubMed:15317753, PubMed:18611980). Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone (PubMed:10587585). Required for cardiac homeostasis (PubMed:10580070, PubMed:12927431, PubMed:18611980, PubMed:23666920). {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:10587585, ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:11799477, ECO:0000269|PubMed:12075506, ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:15317753, ECO:0000269|PubMed:18551513, ECO:0000269|PubMed:18611980, ECO:0000269|PubMed:22431096, ECO:0000269|PubMed:23666920}.; FUNCTION: Prelamin-A/C can accelerate smooth muscle cell senescence. It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence.",,,,,,,,,,,SITE 266 266 Heptad change of phase.; SITE 325 325 Stutter. {ECO:0000250}.; SITE 330 330 Heptad change of phase.; SITE 646 647 Cleavage; by endoprotease.,cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; cellular protein localization [GO:0034613]; cellular response to hypoxia [GO:0071456]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; IRE1-mediated unfolded protein response [GO:0036498]; mitotic nuclear envelope reassembly [GO:0007084]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nuclear envelope organization [GO:0006998]; positive regulation of cell aging [GO:0090343]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; regulation of cell migration [GO:0030334]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; ventricular cardiac muscle cell development [GO:0055015],cellular protein localization [GO:0034613]; cellular response to hypoxia [GO:0071456]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; IRE1-mediated unfolded protein response [GO:0036498]; mitotic nuclear envelope reassembly [GO:0007084]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nuclear envelope organization [GO:0006998]; positive regulation of cell aging [GO:0090343]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; regulation of cell migration [GO:0030334]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; ventricular cardiac muscle cell development [GO:0055015],identical protein binding [GO:0042802]; structural molecule activity [GO:0005198],cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],GO:0005198; GO:0005634; GO:0005635; GO:0005638; GO:0005652; GO:0005654; GO:0005829; GO:0005882; GO:0006606; GO:0006998; GO:0007084; GO:0007517; GO:0008285; GO:0010628; GO:0016607; GO:0030334; GO:0030951; GO:0031647; GO:0031965; GO:0032204; GO:0034504; GO:0034613; GO:0036498; GO:0042802; GO:0048471; GO:0055015; GO:0071456; GO:0072201; GO:0090201; GO:0090343; GO:1900114; GO:1900180; GO:1903243; GO:2001237,IPR001664; IPR018039; IPR039008; IPR001322; IPR036415; ,P18054; Q9UII6; P16104; Q71DI3; P60409; P20700; Q03252; P10215; P10218; Q96RG2; Q9UH99; Q8N0S2; P42166; P63104; O75844,"SUBUNIT: Homodimer of lamin A and lamin C. Interacts with lamin-associated polypeptides IA, IB and TMPO-alpha, RB1 and with emerin. Interacts with SREBF1, SREBF2, SUN2 and TMEM43. Interacts with TMEM201 (By similarity). Proteolytically processed isoform A interacts with NARF. Interacts with SUN1. Prelamin-A/C interacts with EMD. Interacts with MLIP. Interacts with DMPK; may regulate nuclear envelope stability. Interacts with SUV39H1; the interaction increases stability of SUV39H1. Interacts with SYNE2. Interacts with ITSN1 isoform 2 (PubMed:29599122). {ECO:0000250, ECO:0000269|PubMed:10514485, ECO:0000269|PubMed:12475961, ECO:0000269|PubMed:19323649, ECO:0000269|PubMed:19933576, ECO:0000269|PubMed:21498514, ECO:0000269|PubMed:21949239, ECO:0000269|PubMed:23695662, ECO:0000269|PubMed:23977161, ECO:0000269|PubMed:29599122}.",3453101; 3462705; 16061563; 14702039; 16710414; 15489334; 8621584; 8175923; 9030603; 10508479; 10514485; 12475961; 12714972; 17081983; 16964243; 17924679; 18606848; 18220336; 18691976; 18669648; 19413330; 19323649; 19220582; 19608861; 20079404; 20160190; 20458013; 19933576; 20068231; 21269460; 21498514; 21406692; 22355414; 23666920; 23186163; 23695662; 21949239; 24275569; 25218447; 25114211; 25772364; 25755297; 25944712; 28112733; 29599122; 11901143; 12057196; 15476822; 10080180; 10580070; 10739751; 10739764; 10939567; 10587585; 10814726; 10655060; 10908904; 11503164; 11561226; 11792809; 11525883; 12486434; 11799477; 12075506; 12015247; 11897440; 12032588; 12196663; 12467752; 14675861; 12673789; 12628721; 12629077; 12768443; 12920062; 14684700; 12927431; 12649505; 15219508; 15140538; 15317753; 15060110; 15286156; 14985400; 15372542; 15622532; 16156025; 15998779; 15744034; 16278265; 17150192; 17250669; 17136397; 17711925; 18551513; 18611980; 19283854; 19427440; 19167105; 21846512; 21791255; 20848652; 21724554; 22431096; 23977161; 24485160; 27234031,3453101; 3462705; 16061563; 14702039; 16710414; 15489334; 8621584; 8175923; 9030603; 10508479; 10514485; 12475961; 12714972; 17081983; 16964243; 17924679; 18606848; 18220336; 18691976; 18669648; 19413330; 19323649; 19220582; 19608861; 20079404; 20160190; 20458013; 19933576; 20068231; 21269460; 21498514; 21406692; 22355414; 23666920; 23186163; 23695662; 21949239; 24275569; 25218447; 25114211; 25772364; 25755297; 25944712; 28112733; 29599122; 11901143; 12057196; 15476822; 10080180; 10580070; 10739751; 10739764; 10939567; 10587585; 10814726; 10655060; 10908904; 11503164; 11561226; 11792809; 11525883; 12486434; 11799477; 12075506; 12015247; 11897440; 12032588; 12196663; 12467752; 14675861; 12673789; 12628721; 12629077; 12768443; 12920062; 14684700; 12927431; 12649505; 15219508; 15140538; 15317753; 15060110; 15286156; 14985400; 15372542; 15622532; 16156025; 15998779; 15744034; 16278265; 17150192; 17250669; 17136397; 17711925; 18551513; 18611980; 19283854; 19427440; 19167105; 21846512; 21791255; 20848652; 21724554; 22431096; 23977161; 24485160; 27234031; 10727209; 10908652; 11243729; 11285238; 11298098; 11440372; 11792810; 11792811; 11792821; 11792822; 11973618; 12018485; 12112001; 12138353; 12145775; 12163176; 12409453; 12467734; 12493765; 12524233; 12577067; 12702809; 12729796; 12783988; 12844477; 13129702; 14597414; 14644157; 15026149; 15080529; 15140953; 15140983; 15161933; 15175163; 15205219; 15205220; 15284226; 15298354; 15342704; 15546916; 15551023; 15630448; 15636422; 15639119; 15681850; 15748902; 15798706; 15919811; 15961312; 15982412; 16079285; 16084085; 16117820; 16126733; 16129833; 16169070; 16179429; 16212417; 16218190; 16239243; 16246140; 16247757; 16248985; 16262891; 16266469; 16288872; 16289535; 16339967; 16344005; 16357800; 16371512; 16415973; 16461887; 16481476; 16495336; 16518869; 16539657; 16645051; 16697197; 16704422; 16738054; 16772334; 16823856; 16825283; 16981056; 17090536; 17097067; 17110338; 17117676; 17170708; 17227891; 17291448; 17301031; 17314511; 17327437; 17327460; 17327461; 17334235; 17342744; 17352743; 17360326; 17360355; 17428859; 17452644; 17454124; 17459035; 17469202; 17536044; 17543860; 17605093; 17612587; 17701980; 17718387; 17760566; 17848622; 17870066; 17881656; 17893350; 17935239; 17987279; 18031308; 18035086; 18041775; 18077842; 18093584; 18234856; 18308323; 18311132; 18337098; 18339564; 18348272; 18364375; 18396274; 18442054; 18442998; 18478590; 18497734; 18502446; 18524819; 18538321; 18549403; 18564364; 18604166; 18612243; 18628300; 18643848; 18646565; 18654987; 18667561; 18691775; 18714339; 18714801; 18767923; 18795223; 18805829; 18816602; 18830724; 18843043; 18848371; 18923140; 18926329; 18946024; 18950579; 18959190; 18974108; 19015316; 19022376; 19084400; 19124654; 19126678; 19141474; 19144202; 19165338; 19172989; 19201734; 19204888; 19247430; 19270485; 19318026; 19328042; 19351612; 19384091; 19401371; 19417104; 19424285; 19446900; 19490114; 19524666; 19574635; 19578796; 19589617; 19638735; 19644448; 19645629; 19672032; 19680556; 19768759; 19775189; 19841875; 19855837; 19859838; 19875404; 19875478; 19882644; 19913121; 19926845; 19938095; 19958786; 20000738; 20004208; 20041886; 20045150; 20054742; 20092787; 20127487; 20130076; 20147387; 20155465; 20307303; 20309963; 20467437; 20474083; 20485444; 20497714; 20498703; 20501691; 20526349; 20526372; 20561986; 20562859; 20580717; 20581439; 20605919; 20618440; 20625965; 20627339; 20628086; 20709679; 20711500; 20732854; 20819672; 20884875; 20886652; 20974128; 21085127; 21150319; 21151901; 21179469; 21285945; 21289091; 21311568; 21327074; 21327842; 21346069; 21350821; 21354179; 21389115; 21400569; 21406687; 21418524; 21424530; 21439080; 21462202; 21462476; 21535365; 21596650; 21599722; 21621406; 21627864; 21632249; 21655223; 21670151; 21670498; 21689390; 21818408; 21851590; 21875900; 2188730; 2188731; 21903150; 21915271; 21941106; 21945321; 21952048; 21980471; 21982404; 21988832; 21993218; 22014111; 22029807; 22057372; 22065502; 22079058; 22157815; 22186027; 22193777; 22199124; 22224630; 22231515; 22266370; 22281253; 22301279; 22326558; 22340368; 22413764; 22533413; 22549407; 22555292; 22555846; 22560296; 22623428; 22700598; 22745804; 22770216; 22773734; 22806367; 22840390; 22893709; 22986494; 23048029; 23049808; 23062543; 23064282; 23073275; 23075850; 23197810; 23243001; 23313286; 23319047; 23324461; 23328570; 23329710; 23349452; 23414517; 23427149; 23427156; 23430973; 2344612; 23450819; 23531880; 23539603; 23564641; 23582089; 23583981; 23605101; 23631840; 23658700; 23659872; 23684604; 23701190; 23702046; 23746545; 23764002; 23793583; 23811080; 23831462; 23846499; 23861385; 23870088; 23912926; 23923041; 23990565; 24001739; 24002959; 24034385; 24037902; 24040437; 24041693; 24058181; 24067370; 24080738; 24101728; 24108105; 24135138; 24189400; 24211782; 24293108; 24294364; 24315443; 24345920; 24349489; 24375749; 24523287; 24592738; 24623722; 24642510; 24656463; 24741066; 24753226; 24757177; 24780295; 24806962; 24892300; 24943589; 25005744; 25090270; 25127216; 25200614; 25204415; 25256213; 25319090; 25343322; 25416956; 25425574; 25457755; 25460776; 25482193; 25498755; 25509159; 25524705; 25535984; 25556323; 25567453; 25572245; 25609649; 25645366; 25649378; 25656816; 25753664; 25793944; 25807068; 25819867; 25829471; 25837155; 25846419; 25852190; 25873806; 25907612; 25948554; 25996284; 25996830; 26029982; 26034236; 26092935; 26122271; 26165385; 26290387; 26309016; 26312502; 26323789; 26359359; 26439802; 26447202; 26496610; 26537870; 26549451; 26573435; 26634508; 26638075; 26701887; 26724531; 26732077; 26733286; 26775134; 26876308; 26897078; 26900797; 26921507; 26922292; 26947931; 26951916; 26977629; 27034136; 27100822; 27182706; 27235420; 27265359; 27301336; 27373676; 27374873; 27405450; 27421120; 27457270; 27534416; 27552914; 27617860; 27676213; 27717888; 27736720; 27793050; 27841971; 27845687; 27884249; 27920058; 27966284; 27974701; 28056360; 28188704; 28229933; 28408391; 28422997; 28423660; 28436080; 28443701; 28455503; 28477268; 28498430; 28515154; 28679633; 28686329; 28688748; 28751304; 28754655; 28797100; 28806747; 28844980; 28854361; 28857661; 28919351; 29040816; 29108996; 29149195; 29175975; 29197877; 29237675; 29267953; 29378184; 29628476; 29665450; 29702688; 29717016; 29741282; 29770364; 29794150; 30134855; 30137533; 30190500; 7937898; 8034666; 8463284; 8655646; 8663580; 8794855; 9465049,1986-07-21,2019-02-13,1987-03-20,246,X-ray crystallography (9); NMR spectroscopy (1),STRAND 430 436 {ECO:0000244|PDB:6GHD}.; STRAND 438 445 {ECO:0000244|PDB:1IFR}.; STRAND 449 456 {ECO:0000244|PDB:1IFR}.; STRAND 458 460 {ECO:0000244|PDB:1IFR}.; STRAND 468 473 {ECO:0000244|PDB:1IFR}.; STRAND 479 482 {ECO:0000244|PDB:1IFR}.; STRAND 494 499 {ECO:0000244|PDB:1IFR}.; STRAND 511 514 {ECO:0000244|PDB:1IFR}.; STRAND 526 531 {ECO:0000244|PDB:1IFR}.; STRAND 537 543 {ECO:0000244|PDB:1IFR}.,HELIX 316 384 {ECO:0000244|PDB:1X8Y}.; HELIX 464 466 {ECO:0000244|PDB:1IVT}.; HELIX 500 502 {ECO:0000244|PDB:3GEF}.,TURN 508 510 {ECO:0000244|PDB:1IFR}.,,,,,5 out of 5,Alternative sequence (9); Beta strand (10); Chain (2); Cross-link (20); Domain (2); Frameshift (1); Helix (3); Lipidation (1); Modified residue (57); Motif (1); Mutagenesis (6); Natural variant (140); Propeptide (2); Region (8); Sequence conflict (2); Site (4); Turn (1),,"TISSUE SPECIFICITY: In the arteries, prelamin-A/C accumulation is not observed in young healthy vessels but is prevalent in medial vascular smooth muscle cells (VSMCs) from aged individuals and in atherosclerotic lesions, where it often colocalizes with senescent and degenerate VSMCs. Prelamin-A/C expression increases with age and disease. In normal aging, the accumulation of prelamin-A/C is caused in part by the down-regulation of ZMPSTE24/FACE1 in response to oxidative stress. {ECO:0000269|PubMed:20458013}.","MISCELLANEOUS: There are three types of lamins in human cells: A, B, and C.; MISCELLANEOUS: The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively.",3D-structure;Acetylation;Alternative splicing;Cardiomyopathy;Charcot-Marie-Tooth disease;Coiled coil;Complete proteome;Congenital muscular dystrophy;Direct protein sequencing;Disease mutation;Emery-Dreifuss muscular dystrophy;Intermediate filament;Isopeptide bond;Limb-girdle muscular dystrophy;Lipoprotein;Methylation;Neurodegeneration;Neuropathy;Nucleus;Phosphoprotein;Polymorphism;Prenylation;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,Intermediate filament family,246,Alternative products (1); Caution (3); Function (2); Involvement in disease (12); Miscellaneous (2); Post-translational modification (4); Sequence similarities (1); Subcellular location (2); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0122; KW-0144; KW-0175; KW-0181; KW-0225; KW-0403; KW-0449; KW-0488; KW-0523; KW-0539; KW-0597; KW-0621; KW-0622; KW-0636; KW-0832; KW-0903; KW-0912; KW-0947; KW-1017; KW-1067; KW-1185,,,,,"DISEASE: Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:10739764, ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:10908904, ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:11525883, ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:12032588, ECO:0000269|PubMed:12467752, ECO:0000269|PubMed:12649505, ECO:0000269|PubMed:12673789, ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:14985400, ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:15744034, ECO:0000269|PubMed:17136397, ECO:0000269|PubMed:19933576, ECO:0000269|PubMed:20848652, ECO:0000269|PubMed:27234031}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Emery-Dreifuss muscular dystrophy 3, autosomal recessive (EDMD3) [MIM:616516]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:22431096, ECO:0000269|PubMed:27234031}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:11561226, ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:11897440, ECO:0000269|PubMed:12486434, ECO:0000269|PubMed:12628721, ECO:0000269|PubMed:12920062, ECO:0000269|PubMed:14675861, ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:15140538, ECO:0000269|PubMed:15219508, ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:16061563, ECO:0000269|PubMed:18606848, ECO:0000269|PubMed:19167105, ECO:0000269|PubMed:20160190, ECO:0000269|PubMed:21846512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]: A disorder characterized by the loss of subcutaneous adipose tissue in the lower parts of the body (limbs, buttocks, trunk). It is accompanied by an accumulation of adipose tissue in the face and neck causing a double chin, fat neck, or cushingoid appearance. Adipose tissue may also accumulate in the axillae, back, labia majora, and intraabdominal region. Affected patients are insulin-resistant and may develop glucose intolerance and diabetes mellitus after age 20 years, hypertriglyceridemia, and low levels of high density lipoprotein cholesterol. {ECO:0000269|PubMed:10587585, ECO:0000269|PubMed:10655060, ECO:0000269|PubMed:10739751, ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:12015247, ECO:0000269|PubMed:12196663, ECO:0000269|PubMed:12629077, ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:17250669, ECO:0000269|PubMed:19220582, ECO:0000269|PubMed:24485160}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease 2B1 (CMT2B1) [MIM:605588]: A recessive axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:11799477}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]: Rare genetic disorder characterized by features reminiscent of marked premature aging. {ECO:0000269|PubMed:12714972, ECO:0000269|PubMed:12768443, ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:15060110, ECO:0000269|PubMed:15286156, ECO:0000269|PubMed:15622532, ECO:0000269|PubMed:19933576, ECO:0000269|PubMed:21791255, ECO:0000269|PubMed:22355414, ECO:0000269|PubMed:23666920}. Note=The disease is caused by mutations affecting the gene represented in this entry. HGPS is caused by the toxic accumulation of a truncated form of lamin-A/C. This mutant protein, called progerin (isoform 6), acts to deregulate mitosis and DNA damage signaling, leading to premature cell death and senescence. The mutant form is mainly generated by a silent or missense mutation at codon 608 of prelamin A that causes activation of a cryptic splice donor site, resulting in production of isoform 6 with a deletion of 50 amino acids near the C terminus. Progerin lacks the conserved ZMPSTE24/FACE1 cleavage site and therefore remains permanently farnesylated. Thus, although it can enter the nucleus and associate with the nuclear envelope, it cannot incorporate normally into the nuclear lamina (PubMed:12714972). {ECO:0000269|PubMed:12714972}.; DISEASE: Cardiomyopathy, dilated, with hypergonadotropic hypogonadism (CMDHH) [MIM:212112]: A disorder characterized by the association of genital anomalies, hypergonadotropic hypogonadism and dilated cardiomyopathy. Patients can present other variable clinical manifestations including mental retardation, skeletal anomalies, scleroderma-like skin, graying and thinning of hair, osteoporosis. Dilated cardiomyopathy is characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. {ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:17150192, ECO:0000269|PubMed:19283854}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370]: A disorder characterized by mandibular and clavicular hypoplasia, acroosteolysis, delayed closure of the cranial suture, progeroid appearance, partial alopecia, soft tissue calcinosis, joint contractures, and partial lipodystrophy with loss of subcutaneous fat from the extremities. Adipose tissue in the face, neck and trunk is normal or increased. {ECO:0000269|PubMed:12075506, ECO:0000269|PubMed:15998779, ECO:0000269|PubMed:16278265}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lethal tight skin contracture syndrome (LTSCS) [MIM:275210]: Rare disorder mainly characterized by intrauterine growth retardation, tight and rigid skin with erosions, prominent superficial vasculature and epidermal hyperkeratosis, facial features (small mouth, small pinched nose and micrognathia), sparse/absent eyelashes and eyebrows, mineralization defects of the skull, thin dysplastic clavicles, pulmonary hypoplasia, multiple joint contractures and an early neonatal lethal course. Liveborn children usually die within the first week of life. The overall prevalence of consanguineous cases suggested an autosomal recessive inheritance. {ECO:0000269|PubMed:15317753}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Heart-hand syndrome Slovenian type (HHS-Slovenian) [MIM:610140]: Heart-hand syndrome (HHS) is a clinically and genetically heterogeneous disorder characterized by the co-occurrence of a congenital cardiac disease and limb malformations. {ECO:0000269|PubMed:18611980}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]: A form of congenital muscular dystrophy. Patients present at birth, or within the first few months of life, with hypotonia, muscle weakness and often with joint contractures. {ECO:0000269|PubMed:18551513}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in LMNA may cause a late-onset cardiocutaneous progeria syndrome characterized by cutaneous manifestations of aging appearing in the third decade of life, cardiac valve calcification and dysfunction, prominent atherosclerosis, and cardiomyopathy, leading to death on average in the fourth decade. {ECO:0000269|PubMed:23666920}.",,,"PTM: Increased phosphorylation of the lamins occurs before envelope disintegration and probably plays a role in regulating lamin associations. {ECO:0000269|Ref.9}.; PTM: Proteolytic cleavage of the C-terminal of 18 residues of prelamin-A/C results in the production of lamin-A/C. The prelamin-A/C maturation pathway includes farnesylation of CAAX motif, ZMPSTE24/FACE1 mediated cleavage of the last three amino acids, methylation of the C-terminal cysteine and endoproteolytic removal of the last 15 C-terminal amino acids. Proteolytic cleavage requires prior farnesylation and methylation, and absence of these blocks cleavage. {ECO:0000269|PubMed:20458013, ECO:0000269|PubMed:8175923, ECO:0000269|PubMed:9030603}.; PTM: Sumoylation is necessary for the localization to the nuclear envelope. {ECO:0000269|PubMed:18606848}.; PTM: Farnesylation of prelamin-A/C facilitates nuclear envelope targeting.",CHAIN 1 661 Prelamin-A/C. /FTId=PRO_0000398835.; CHAIN 1 646 Lamin-A/C. /FTId=PRO_0000063810.,"CROSSLNK 32 32 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 97 97 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733}.; CROSSLNK 171 171 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 201 201 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate.; CROSSLNK 201 201 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 208 208 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:28112733}.; CROSSLNK 219 219 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 233 233 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25114211, ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 260 260 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 270 270 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 311 311 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733}.; CROSSLNK 366 366 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 378 378 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733}.; CROSSLNK 417 417 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 420 420 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733}.; CROSSLNK 450 450 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 470 470 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 486 486 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 597 597 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate. {ECO:0000244|PubMed:25114211}.; CROSSLNK 597 597 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:25114211, ECO:0000244|PubMed:28112733}.",,,,"LIPID 661 661 S-farnesyl cysteine. {ECO:0000269|PubMed:8175923, ECO:0000269|PubMed:9030603}.","MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:20068231}.; MOD_RES 3 3 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 12 12 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 18 18 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 19 19 Phosphothreonine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 22 22 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|Ref.9}.; MOD_RES 32 32 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 32 32 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 51 51 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 66 66 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 71 71 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 107 107 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 108 108 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 123 123 N6-acetyllysine. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 135 135 N6-acetyllysine. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 155 155 N6-acetyllysine. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 171 171 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 171 171 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 201 201 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 212 212 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 260 260 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 270 270 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 277 277 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:20068231}.; MOD_RES 301 301 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 307 307 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 311 311 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 390 390 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 392 392 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 395 395 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 398 398 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 403 403 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 404 404 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 407 407 Phosphoserine. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 414 414 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 429 429 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 431 431 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 450 450 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 457 457 N6-acetyllysine. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 458 458 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 463 463 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 496 496 Phosphothreonine. {ECO:0000250|UniProtKB:P48679}.; MOD_RES 505 505 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 510 510 Phosphothreonine. {ECO:0000250|UniProtKB:P48679}.; MOD_RES 533 533 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 546 546 Phosphoserine. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 548 548 Phosphothreonine. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 568 568 Phosphoserine. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 571 571 Phosphoserine. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 612 612 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 613 613 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 616 616 Phosphoserine. {ECO:0000250|UniProtKB:P48678}.; MOD_RES 619 619 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 628 628 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 632 632 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 636 636 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 652 652 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 661 661 Cysteine methyl ester. {ECO:0000269|PubMed:8175923, ECO:0000269|PubMed:9030603}.",,PROPEP 647 661 Removed in Lamin-A/C form. /FTId=PRO_0000398836.; PROPEP 662 664 Removed in Prelamin-A/C form and in Lamin-A/C form. /FTId=PRO_0000403442.,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X03444;X03445;M13451;M13452;AY847597;AY847595;AY357727;AK295390;CH471121;CH471121;BC000511;BC003162;BC014507;AF381029;
0,P05556,ITB1_HUMAN,ITGB1 FNRB MDF2 MSK12,ITGB1,FNRB MDF2 MSK12,,,Homo sapiens (Human),9606,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29),UP000005640: Chromosome 10,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MNLQPIFWIGLISSVCCVFAQTDENRCLKANAKSCGECIQAGPNCGWCTNSTFLQEGMPTSARCDDLEALKKKGCPPDDIENPRGSKDIKKNKNVTNRSKGTAEKLKPEDITQIQPQQLVLRLRSGEPQTFTLKFKRAEDYPIDLYYLMDLSYSMKDDLENVKSLGTDLMNEMRRITSDFRIGFGSFVEKTVMPYISTTPAKLRNPCTSEQNCTSPFSYKNVLSLTNKGEVFNELVGKQRISGNLDSPEGGFDAIMQVAVCGSLIGWRNVTRLLVFSTDAGFHFAGDGKLGGIVLPNDGQCHLENNMYTMSHYYDYPSIAHLVQKLSENNIQTIFAVTEEFQPVYKELKNLIPKSAVGTLSANSSNVIQLIIDAYNSLSSEVILENGKLSEGVTISYKSYCKNGVNGTGENGRKCSNISIGDEVQFEISITSNKCPKKDSDSFKIRPLGFTEEVEVILQYICECECQSEGIPESPKCHEGNGTFECGACRCNEGRVGRHCECSTDEVNSEDMDAYCRKENSSEICSNNGECVCGQCVCRKRDNTNEIYSGKFCECDNFNCDRSNGLICGGNGVCKCRVCECNPNYTGSACDCSLDTSTCEASNGQICNGRGICECGVCKCTDPKFQGQTCEMCQTCLGVCAEHKECVQCRAFNKGEKKDTCTQECSYFNITKVESRDKLPQPVQPDPVSHCKEKDVDDCWFYFTYSVNGNNEVMVHVVENPECPTGPDIIPIVAGVVAGIVLIGLALLLIWKLLMIIHDRREFAKFEKEKMNAKWDTGENPIYKSAVTTVVNPKYEGK,798,"88,415",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=5;  Name=1; Synonyms=Beta-1A; IsoId=P05556-1; Sequence=Displayed; Name=2; Synonyms=Beta-1B; IsoId=P05556-2; Sequence=VSP_002741; Name=3; Synonyms=Beta-1C; IsoId=P05556-3; Sequence=VSP_002742; Name=4; Synonyms=Beta-1C-2; IsoId=P05556-4; Sequence=VSP_002743; Name=5; Synonyms=Beta-1D; IsoId=P05556-5; Sequence=VSP_002744; ,,SEQUENCE CAUTION:  Sequence=CAD97649.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 778 798 GENPIYKSAVTTVVNPKYEGK -> VSYKTSKKQSGL (in isoform 2). {ECO:0000305}. /FTId=VSP_002741.; VAR_SEQ 778 798 GENPIYKSAVTTVVNPKYEGK -> SLSVAQPGVQWCDISSLQPLTSRFQQFSCLSLPSTWDYRVKILFIRVP (in isoform 3). {ECO:0000305}. /FTId=VSP_002742.; VAR_SEQ 778 798 GENPIYKSAVTTVVNPKYEGK -> PGVQWCDISSLQPLTSRFQQFSCLSLPSTWDYRVKILFIRVP (in isoform 4). {ECO:0000305}. /FTId=VSP_002743.; VAR_SEQ 778 798 GENPIYKSAVTTVVNPKYEGK -> QENPIYKSPINNFKNPNYGRKAGL (in isoform 5). {ECO:0000305}. /FTId=VSP_002744.,,,,,CONFLICT 112 112 T -> H (in Ref. 1; CAA30790). {ECO:0000305}.; CONFLICT 215 215 S -> T (in Ref. 1; CAA30790). {ECO:0000305}.; CONFLICT 261 265 CGSLI -> VWMLL (in Ref. 6; AAI13902). {ECO:0000305}.; CONFLICT 385 386 EN -> DG (in Ref. 6; AAI13902). {ECO:0000305}.; CONFLICT 463 463 E -> V (in Ref. 2; BAF84386). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the integrin beta chain family. {ECO:0000305}.,,,DOMAIN 140 378 VWFA.,,REGION 207 213 CX3CL1-binding. {ECO:0000269|PubMed:23125415}.; REGION 295 314 CX3CL1-binding. {ECO:0000269|PubMed:24789099}.; REGION 466 635 Cysteine-rich tandem repeats.; REGION 762 767 Signal for sorting from recycling endosomes; interaction with ACAP1.; REGION 785 792 Interaction with ITGB1BP1.,REPEAT 466 515 I.; REPEAT 516 559 II.; REPEAT 560 598 III.; REPEAT 599 635 IV.,,,,,,,"FUNCTION: Integrins alpha-1/beta-1, alpha-2/beta-1, alpha-10/beta-1 and alpha-11/beta-1 are receptors for collagen. Integrins alpha-1/beta-1 and alpha-2/beta-2 recognize the proline-hydroxylated sequence G-F-P-G-E-R in collagen. Integrins alpha-2/beta-1, alpha-3/beta-1, alpha-4/beta-1, alpha-5/beta-1, alpha-8/beta-1, alpha-10/beta-1, alpha-11/beta-1 and alpha-V/beta-1 are receptors for fibronectin. Alpha-4/beta-1 recognizes one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. Integrin alpha-5/beta-1 is a receptor for fibrinogen. Integrin alpha-1/beta-1, alpha-2/beta-1, alpha-6/beta-1 and alpha-7/beta-1 are receptors for lamimin. Integrin alpha-6/beta-1 (ITGA6:ITGB1) is present in oocytes and is involved in sperm-egg fusion (By similarity). Integrin alpha-4/beta-1 is a receptor for VCAM1. It recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha-9/beta-1 is a receptor for VCAM1, cytotactin and osteopontin. It recognizes the sequence A-E-I-D-G-I-E-L in cytotactin. Integrin alpha-3/beta-1 is a receptor for epiligrin, thrombospondin and CSPG4. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration. Integrin alpha-V/beta-1 is a receptor for vitronectin. Beta-1 integrins recognize the sequence R-G-D in a wide array of ligands. Isoform 2 interferes with isoform 1 resulting in a dominant negative effect on cell adhesion and migration (in vitro). When associated with alpha-7/beta-1 integrin, regulates cell adhesion and laminin matrix deposition. Involved in promoting endothelial cell motility and angiogenesis. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process and the formation of mineralized bone nodules. May be involved in up-regulation of the activity of kinases such as PKC via binding to KRT1. Together with KRT1 and RACK1, serves as a platform for SRC activation or inactivation. Plays a mechanistic adhesive role during telophase, required for the successful completion of cytokinesis. Integrin alpha-3/beta-1 provides a docking site for FAP (seprase) at invadopodia plasma membranes in a collagen-dependent manner and hence may participate in the adhesion, formation of invadopodia and matrix degradation processes, promoting cell invasion. ITGA4:ITGB1 binds to fractalkine (CX3CL1) and may act as its coreceptor in CX3CR1-dependent fractalkine signaling (PubMed:23125415, PubMed:24789099). ITGA4:ITGB1 and ITGA5:ITGB1 bind to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (PubMed:18635536, PubMed:25398877). ITGA5:ITGB1 acts as a receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell adhesion to FBN1 (PubMed:12807887, PubMed:17158881). ITGA5:ITGB1 is a receptor for IL1B and binding is essential for IL1B signaling (PubMed:29030430). {ECO:0000250|UniProtKB:P09055, ECO:0000269|PubMed:10455171, ECO:0000269|PubMed:12473654, ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:16256741, ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:18804435, ECO:0000269|PubMed:19064666, ECO:0000269|PubMed:21768292, ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:24789099, ECO:0000269|PubMed:25398877, ECO:0000269|PubMed:29030430, ECO:0000269|PubMed:7523423}.; FUNCTION: Isoform 5: Isoform 5 displaces isoform 1 in striated muscles. {ECO:0000250}.; FUNCTION: (Microbial infection) Integrin ITGA2:ITGB1 acts as a receptor for Human echoviruses 1 and 8. {ECO:0000269|PubMed:8411387}.; FUNCTION: (Microbial infection) Acts as a receptor for Cytomegalovirus/HHV-5. {ECO:0000269|PubMed:20660204}.; FUNCTION: (Microbial infection) Acts as a receptor for Epstein-Barr virus/HHV-4. {ECO:0000269|PubMed:17945327}.; FUNCTION: (Microbial infection) Integrin ITGA5:ITGB1 acts as a receptor for Human parvovirus B19. {ECO:0000269|PubMed:12907437}.; FUNCTION: (Microbial infection) Integrin ITGA2:ITGB1 acts as a receptor for Human rotavirus. {ECO:0000269|PubMed:12941907}.; FUNCTION: (Microbial infection) Acts as a receptor for Mammalian reovirus. {ECO:0000269|PubMed:16501085}.; FUNCTION: (Microbial infection) In case of HIV-1 infection, integrin ITGA5:ITGB1 binding to extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. {ECO:0000269|PubMed:10397733}.",,,,,,,,,METAL 152 152 Magnesium.; METAL 154 154 Calcium 1; via carbonyl oxygen.; METAL 156 156 Calcium 1.; METAL 157 157 Calcium 1.; METAL 189 189 Calcium 2.; METAL 244 244 Calcium 2.; METAL 246 246 Calcium 2.; METAL 248 248 Calcium 2; via carbonyl oxygen.; METAL 249 249 Calcium 2.; METAL 249 249 Magnesium.; METAL 362 362 Calcium 1; via carbonyl oxygen.,,,cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; integrin alpha1-beta1 complex [GO:0034665]; integrin alpha10-beta1 complex [GO:0034680]; integrin alpha11-beta1 complex [GO:0034681]; integrin alpha2-beta1 complex [GO:0034666]; integrin alpha3-beta1 complex [GO:0034667]; integrin alpha7-beta1 complex [GO:0034677]; integrin alpha8-beta1 complex [GO:0034678]; integrin complex [GO:0008305]; intercalated disc [GO:0014704]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; collagen binding involved in cell-matrix adhesion [GO:0098639]; coreceptor activity [GO:0015026]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618]; axon extension [GO:0048675]; B cell differentiation [GO:0030183]; basement membrane organization [GO:0071711]; calcium-independent cell-matrix adhesion [GO:0007161]; cardiac muscle cell differentiation [GO:0055007]; cell adhesion mediated by integrin [GO:0033627]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell projection organization [GO:0030030]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular defense response [GO:0006968]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; dendrite morphogenesis [GO:0048813]; extracellular matrix organization [GO:0030198]; formation of radial glial scaffolds [GO:0021943]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell migration [GO:0008354]; heterotypic cell-cell adhesion [GO:0034113]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; mesodermal cell differentiation [GO:0048333]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of anoikis [GO:2000811]; negative regulation of cell differentiation [GO:0045596]; negative regulation of Rho protein signal transduction [GO:0035024]; phagocytosis [GO:0006909]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of signaling receptor activity [GO:2000273]; receptor internalization [GO:0031623]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710]; regulation of immune response [GO:0050776]; sarcomere organization [GO:0045214]; visual learning [GO:0008542],axon extension [GO:0048675]; basement membrane organization [GO:0071711]; B cell differentiation [GO:0030183]; calcium-independent cell-matrix adhesion [GO:0007161]; cardiac muscle cell differentiation [GO:0055007]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion mediated by integrin [GO:0033631]; cell fate specification [GO:0001708]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell projection organization [GO:0030030]; cell-substrate adhesion [GO:0031589]; cellular defense response [GO:0006968]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; dendrite morphogenesis [GO:0048813]; extracellular matrix organization [GO:0030198]; formation of radial glial scaffolds [GO:0021943]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell migration [GO:0008354]; heterotypic cell-cell adhesion [GO:0034113]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; integrin-mediated signaling pathway [GO:0007229]; in utero embryonic development [GO:0001701]; lamellipodium assembly [GO:0030032]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; mesodermal cell differentiation [GO:0048333]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of anoikis [GO:2000811]; negative regulation of cell differentiation [GO:0045596]; negative regulation of Rho protein signal transduction [GO:0035024]; phagocytosis [GO:0006909]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of signaling receptor activity [GO:2000273]; receptor internalization [GO:0031623]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710]; regulation of immune response [GO:0050776]; sarcomere organization [GO:0045214]; visual learning [GO:0008542],actin binding [GO:0003779]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; collagen binding involved in cell-matrix adhesion [GO:0098639]; coreceptor activity [GO:0015026]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; virus receptor activity [GO:0001618],cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; integrin alpha10-beta1 complex [GO:0034680]; integrin alpha11-beta1 complex [GO:0034681]; integrin alpha1-beta1 complex [GO:0034665]; integrin alpha2-beta1 complex [GO:0034666]; integrin alpha3-beta1 complex [GO:0034667]; integrin alpha7-beta1 complex [GO:0034677]; integrin alpha8-beta1 complex [GO:0034678]; integrin complex [GO:0008305]; intercalated disc [GO:0014704]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685],GO:0000082; GO:0001618; GO:0001701; GO:0001708; GO:0001726; GO:0001968; GO:0002020; GO:0002042; GO:0003779; GO:0005178; GO:0005737; GO:0005886; GO:0005925; GO:0006909; GO:0006968; GO:0007156; GO:0007159; GO:0007160; GO:0007161; GO:0007229; GO:0008284; GO:0008305; GO:0008354; GO:0008542; GO:0009897; GO:0009986; GO:0010710; GO:0014704; GO:0015026; GO:0016020; GO:0016477; GO:0019221; GO:0021943; GO:0030027; GO:0030030; GO:0030032; GO:0030175; GO:0030183; GO:0030198; GO:0031589; GO:0031594; GO:0031623; GO:0032154; GO:0032587; GO:0033627; GO:0033631; GO:0034113; GO:0034665; GO:0034666; GO:0034667; GO:0034677; GO:0034678; GO:0034680; GO:0034681; GO:0035024; GO:0035748; GO:0042383; GO:0042470; GO:0043065; GO:0043197; GO:0043235; GO:0043236; GO:0043547; GO:0044877; GO:0045121; GO:0045214; GO:0045296; GO:0045596; GO:0045766; GO:0046872; GO:0046982; GO:0048333; GO:0048471; GO:0048675; GO:0048813; GO:0050776; GO:0050804; GO:0050839; GO:0050900; GO:0050901; GO:0051726; GO:0051897; GO:0055007; GO:0055037; GO:0070062; GO:0071404; GO:0071438; GO:0071711; GO:0097386; GO:0098639; GO:0098685; GO:0098978; GO:0099699; GO:1903078; GO:2000273; GO:2000811,IPR013111; IPR040622; IPR027071; IPR033760; IPR015812; IPR014836; IPR012896; IPR036349; IPR002369; IPR032695; IPR016201; IPR036465; ,Q9BY76; P03192; P46109; P32927; P78423; P17813; P05413; P21333; P17301; P13612; P08648; P07948; P18031; P49023; P35282; Q9Y490; P26039; Q71LX4,"SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-1 associates with either alpha-1, alpha-2, alpha-3, alpha-4, alpha-5, alpha-6, alpha-7, alpha-8, alpha-9, alpha-10, alpha-11 or alpha-V. ITGA6:ITGB1 is found in a complex with CD9; interaction takes place in oocytes and is involved in sperm-egg fusion (By similarity). Interacts with seprase FAP (seprase); the interaction occurs at the cell surface of invadopodia membrane in a collagen-dependent manner. Binds LGALS3BP and NMRK2, when associated with alpha-7, but not with alpha-5. Interacts with FGR and HCK. Interacts (via the cytoplasmic region) with RAB25 (via the hypervariable C-terminal region). Interacts with RAB21. Interacts with KRT1 in the presence of RACK1 and SRC. Interacts with JAML; integrin alpha-4/beta-1 may regulate leukocyte to endothelial cells adhesion by controlling JAML homodimerization. Interacts with FLNA, FLNB and RANBP9. Isoform 5 interacts with ACE2. Isoform 1 interacts with the C-terminal region of FLNC. Interacts with MYO10. Interacts with DAB2. Interacts with FERMT2; the interaction is inhibited in presence of ITGB1BP1. Interacts with ITGB1BP1 (via C-terminal region); the interaction is a prerequisite for focal adhesion disassembly. Interacts with TLN1; the interaction is prevented by competitive binding of ITGB1BP1. Interacts with ACAP1; required for ITGB1 recycling. Interacts with ASAP3. Isoform 5 interacts with alpha-7A and alpha-7B in adult skeletal muscle. Isoform 5 interacts with alpha-7B in cardiomyocytes of adult heart. Interacts with EMP2; the interaction may be direct or indirect and ITGB1 has an heterodimer form (By similarity). ITGA5:ITGB1 interacts with CCN3. ITGA4:ITGB1 is found in a ternary complex with CX3CR1 and CX3CL1 (PubMed:23125415). ITGA5:ITGB1 interacts with FBN1 (PubMed:12807887, PubMed:17158881). ITGA5:ITGB1 interacts with IL1B (PubMed:29030430). {ECO:0000250|UniProtKB:P09055, ECO:0000269|PubMed:10455171, ECO:0000269|PubMed:10613898, ECO:0000269|PubMed:11741838, ECO:0000269|PubMed:11807098, ECO:0000269|PubMed:11807099, ECO:0000269|PubMed:12473654, ECO:0000269|PubMed:12695522, ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:14722085, ECO:0000269|PubMed:15156152, ECO:0000269|PubMed:15181153, ECO:0000269|PubMed:15276642, ECO:0000269|PubMed:16076904, ECO:0000269|PubMed:16256741, ECO:0000269|PubMed:16754960, ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:17925226, ECO:0000269|PubMed:19064666, ECO:0000269|PubMed:21325030, ECO:0000269|PubMed:21768292, ECO:0000269|PubMed:22027826, ECO:0000269|PubMed:22451694, ECO:0000269|PubMed:22645133, ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:23317506, ECO:0000269|PubMed:29030430, ECO:0000269|PubMed:9501082}.; SUBUNIT: (Microbial infection) Integrin ITGA2:ITGB1 interacts with human echoviruses 1 and 8 capsid proteins. {ECO:0000269|PubMed:8411387}.; SUBUNIT: (Microbial infection) Interacts with human cytomegalovirus/HHV-5 envelope glycoprotein B/gB. {ECO:0000269|PubMed:20660204}.; SUBUNIT: (Microbial infection) Interacts with Epstein-Barr virus/HHV-4 gB protein. {ECO:0000269|PubMed:17945327}.; SUBUNIT: (Microbial infection) Integrin ITGA5:ITGB1 interacts with human parvovirus B19 capsid protein. {ECO:0000269|PubMed:12907437}.; SUBUNIT: (Microbial infection) Integrin ITGA2:ITGB1 interacts with human rotavirus VP4 protein. {ECO:0000269|PubMed:12941907}.; SUBUNIT: (Microbial infection) Interacts with mammalian reovirus capsid proteins. {ECO:0000269|PubMed:16501085}.; SUBUNIT: (Microbial infection) Integrin ITGA5:ITGB1 interacts with HIV-1 Tat. {ECO:0000269|PubMed:10397733}.",2958481; 14702039; 17974005; 15164054; 15489334; 7681433; 7523423; 2249781; 1551917; 7545396; 7544298; 9494094; 15276642; 8411387; 8567725; 9501082; 10397733; 10455171; 10613898; 11741838; 11919189; 11807098; 11807099; 12907437; 12473654; 12695522; 12807887; 12941907; 14722085; 15181153; 15156152; 16256741; 16076904; 16335952; 16754960; 17081065; 16501085; 17956333; 17925226; 17158881; 18804435; 18635536; 19064666; 17945327; 19159218; 19349973; 19690332; 19608861; 20660204; 21269460; 22027826; 21768292; 21325030; 23125415; 23186163; 24275569; 25114211; 25398877; 24789099; 25944712; 29030430; 22645133; 22451694; 23317506,2958481; 14702039; 17974005; 15164054; 15489334; 7681433; 7523423; 2249781; 1551917; 7545396; 7544298; 9494094; 15276642; 8411387; 8567725; 9501082; 10397733; 10455171; 10613898; 11741838; 11919189; 11807098; 11807099; 12907437; 12473654; 12695522; 12807887; 12941907; 14722085; 15181153; 15156152; 16256741; 16076904; 16335952; 16754960; 17081065; 16501085; 17956333; 17925226; 17158881; 18804435; 18635536; 19064666; 17945327; 19159218; 19349973; 19690332; 19608861; 20660204; 21269460; 22027826; 21768292; 21325030; 23125415; 23186163; 24275569; 25114211; 25398877; 24789099; 25944712; 29030430; 22645133; 22451694; 23317506; 10025398; 10209034; 10366422; 10521801; 10593924; 10604475; 10673366; 10713152; 10906324; 10982388; 11054877; 11158588; 11279249; 11313964; 11518510; 11559760; 11572855; 11857637; 11964076; 11970960; 11980922; 12070135; 12358597; 12415008; 12423238; 12456677; 12496264; 12592401; 12606711; 12617725; 12682293; 12721290; 12724312; 12879062; 14502569; 14681217; 14715956; 15225631; 15240572; 15345499; 15383545; 1542691; 15479743; 15713743; 15721307; 15721583; 1588291; 15949469; 16051604; 16099422; 16151532; 16258728; 16385451; 16405888; 16413178; 16581764; 16731529; 16754661; 16782899; 16917503; 16945929; 1697296; 17167768; 17170699; 17314405; 17377534; 17525755; 17615292; 17690686; 18177638; 18555990; 18985028; 19005162; 19115199; 19350017; 19367725; 19463016; 19502598; 19738201; 19798053; 19887187; 20033473; 20159608; 20217867; 20690820; 20705068; 20711500; 20802515; 20802519; 20926684; 21397862; 21646718; 21652699; 21806020; 21947080; 21985969; 21988832; 22106087; 22134916; 22157815; 22304920; 22413019; 22623428; 22884367; 22936677; 22940691; 23289620; 23414517; 2412224; 2420006; 24344204; 24814316; 25475857; 25694433; 2649503; 26496610; 26638075; 6643500; 7529288; 7531291; 7532190; 7541634; 7542669; 7559467; 7685013; 7693733; 7907877; 8118028; 8314844; 8344274; 8538749; 8617364; 8798654; 8910476; 9360995; 9361014; 9367446; 9396761; 9547293; 9565552; 9614184; 9645947; 9722563; 9723655; 9725916; 9858236; 9949188,1988-11-01,2019-02-13,2008-12-16,236,X-ray crystallography (9); Model (2),STRAND 45 47 {ECO:0000244|PDB:4WK0}.; STRAND 64 66 {ECO:0000244|PDB:4WK0}.; STRAND 86 91 {ECO:0000244|PDB:4WK0}.; STRAND 118 124 {ECO:0000244|PDB:4WK0}.; STRAND 129 136 {ECO:0000244|PDB:4WK0}.; STRAND 143 150 {ECO:0000244|PDB:4WK0}.; STRAND 180 187 {ECO:0000244|PDB:4WK0}.; STRAND 209 211 {ECO:0000244|PDB:4WK0}.; STRAND 218 227 {ECO:0000244|PDB:4WK0}.; STRAND 245 249 {ECO:0000244|PDB:4WK0}.; STRAND 269 280 {ECO:0000244|PDB:4WK0}.; STRAND 331 337 {ECO:0000244|PDB:4WK0}.; STRAND 352 359 {ECO:0000244|PDB:4WK0}.; STRAND 362 364 {ECO:0000244|PDB:4WK4}.; STRAND 382 386 {ECO:0000244|PDB:4WK0}.; STRAND 393 400 {ECO:0000244|PDB:4WK0}.; STRAND 406 408 {ECO:0000244|PDB:4WJK}.; STRAND 423 432 {ECO:0000244|PDB:4WK0}.; STRAND 437 439 {ECO:0000244|PDB:4WJK}.; STRAND 441 447 {ECO:0000244|PDB:4WK0}.; STRAND 454 461 {ECO:0000244|PDB:4WK0}.,HELIX 35 40 {ECO:0000244|PDB:4WK0}.; HELIX 61 63 {ECO:0000244|PDB:4WK0}.; HELIX 67 71 {ECO:0000244|PDB:4WK0}.; HELIX 108 110 {ECO:0000244|PDB:4WK0}.; HELIX 153 155 {ECO:0000244|PDB:4WK0}.; HELIX 156 161 {ECO:0000244|PDB:4WK0}.; HELIX 162 164 {ECO:0000244|PDB:4WK0}.; HELIX 165 173 {ECO:0000244|PDB:4WK0}.; HELIX 200 204 {ECO:0000244|PDB:4WK0}.; HELIX 229 236 {ECO:0000244|PDB:4WK0}.; HELIX 251 260 {ECO:0000244|PDB:4WK0}.; HELIX 262 264 {ECO:0000244|PDB:4WK0}.; HELIX 287 291 {ECO:0000244|PDB:4WK0}.; HELIX 319 328 {ECO:0000244|PDB:4WK0}.; HELIX 339 341 {ECO:0000244|PDB:4WK0}.; HELIX 342 351 {ECO:0000244|PDB:4WK0}.; HELIX 367 379 {ECO:0000244|PDB:4WK0}.; HELIX 402 404 {ECO:0000244|PDB:4WK0}.; HELIX 409 413 {ECO:0000244|PDB:4WK0}.; HELIX 752 769 {ECO:0000244|PDB:3G9W}.; HELIX 770 772 {ECO:0000244|PDB:3G9W}.,TURN 26 31 {ECO:0000244|PDB:4WK0}.; TURN 72 74 {ECO:0000244|PDB:4WK0}.; TURN 77 79 {ECO:0000244|PDB:4WK0}.; TURN 174 176 {ECO:0000244|PDB:4WK0}.; TURN 193 195 {ECO:0000244|PDB:4WK0}.; TURN 311 313 {ECO:0000244|PDB:4WK0}.,,,TOPO_DOM 21 728 Extracellular. {ECO:0000255}.; TOPO_DOM 752 798 Cytoplasmic. {ECO:0000255}.,TRANSMEM 729 751 Helical. {ECO:0000255}.,5 out of 5,Alternative sequence (4); Beta strand (21); Chain (1); Cross-link (1); Disulfide bond (28); Domain (1); Erroneous initiation (1); Glycosylation (12); Helix (21); Metal binding (11); Modified residue (5); Mutagenesis (14); Region (5); Repeat (4); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (6),,"TISSUE SPECIFICITY: Isoform 1 is widely expressed, other isoforms are generally coexpressed with a more restricted distribution. Isoform 2 is expressed in skin, liver, skeletal muscle, cardiac muscle, placenta, umbilical vein endothelial cells, neuroblastoma cells, lymphoma cells, hepatoma cells and astrocytoma cells. Isoform 3 and isoform 4 are expressed in muscle, kidney, liver, placenta, cervical epithelium, umbilical vein endothelial cells, fibroblast cells, embryonal kidney cells, platelets and several blood cell lines. Isoform 4, rather than isoform 3, is selectively expressed in peripheral T-cells. Isoform 3 is expressed in non-proliferating and differentiated prostate gland epithelial cells and in platelets, on the surface of erythroleukemia cells and in various hematopoietic cell lines. Isoform 5 is expressed specifically in striated muscle (skeletal and cardiac muscle). {ECO:0000269|PubMed:1551917, ECO:0000269|PubMed:2249781, ECO:0000269|PubMed:7544298, ECO:0000269|PubMed:7545396, ECO:0000269|PubMed:7681433, ECO:0000269|PubMed:9494094}.",,3D-structure;Acetylation;Alternative splicing;Calcium;Cell adhesion;Cell junction;Cell membrane;Cell projection;Complete proteome;Direct protein sequencing;Disulfide bond;Endosome;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Integrin;Isopeptide bond;Magnesium;Membrane;Metal-binding;Phosphoprotein;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix;Ubl conjugation,Evidence at protein level,reviewed,,Integrin beta chain family,236,Alternative products (1); Function (9); Post-translational modification (1); Sequence similarities (1); Subcellular location (2); Subunit structure (8); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0106; KW-0130; KW-0181; KW-0325; KW-0401; KW-0460; KW-0472; KW-0479; KW-0597; KW-0675; KW-0677; KW-0732; KW-0812; KW-0832; KW-0903; KW-0945; KW-0965; KW-0966; KW-0967; KW-1003; KW-1015; KW-1017; KW-1133; KW-1183; KW-1185,,,,,,,,PTM: The cysteine residues are involved in intrachain disulfide bonds. {ECO:0000250}.,CHAIN 21 798 Integrin beta-1. /FTId=PRO_0000016334.,CROSSLNK 794 794 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate. {ECO:0000244|PubMed:25114211}.,DISULFID 27 45 {ECO:0000269|PubMed:22451694}.; DISULFID 35 464 {ECO:0000269|PubMed:22451694}.; DISULFID 38 64 {ECO:0000269|PubMed:22451694}.; DISULFID 48 75 {ECO:0000269|PubMed:22451694}.; DISULFID 207 213 {ECO:0000269|PubMed:22451694}.; DISULFID 261 301 {ECO:0000269|PubMed:22451694}.; DISULFID 401 415 {ECO:0000269|PubMed:22451694}.; DISULFID 435 462 {ECO:0000269|PubMed:22451694}.; DISULFID 466 691 {ECO:0000305|PubMed:22451694}.; DISULFID 477 489 {ECO:0000250}.; DISULFID 486 525 {ECO:0000250}.; DISULFID 491 500 {ECO:0000250}.; DISULFID 502 516 {ECO:0000250}.; DISULFID 531 536 {ECO:0000250}.; DISULFID 533 568 {ECO:0000250}.; DISULFID 538 553 {ECO:0000250}.; DISULFID 555 560 {ECO:0000250}.; DISULFID 574 579 {ECO:0000250}.; DISULFID 576 607 {ECO:0000250}.; DISULFID 581 590 {ECO:0000250}.; DISULFID 592 599 {ECO:0000250}.; DISULFID 613 618 {ECO:0000250}.; DISULFID 615 661 {ECO:0000250}.; DISULFID 620 630 {ECO:0000250}.; DISULFID 633 636 {ECO:0000250}.; DISULFID 640 649 {ECO:0000250}.; DISULFID 646 723 {ECO:0000250}.; DISULFID 665 699 {ECO:0000250}.,"CARBOHYD 50 50 N-linked (GlcNAc...) asparagine. {ECO:0000255}.; CARBOHYD 94 94 N-linked (GlcNAc...) asparagine. {ECO:0000255}.; CARBOHYD 97 97 N-linked (GlcNAc...) asparagine. {ECO:0000255}.; CARBOHYD 212 212 N-linked (GlcNAc...) asparagine. {ECO:0000269|PubMed:19159218}.; CARBOHYD 269 269 N-linked (GlcNAc...) asparagine. {ECO:0000269|PubMed:22451694}.; CARBOHYD 363 363 N-linked (GlcNAc...) asparagine. {ECO:0000255}.; CARBOHYD 406 406 N-linked (GlcNAc...) asparagine. {ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19349973, ECO:0000269|PubMed:22451694}.; CARBOHYD 417 417 N-linked (GlcNAc...) asparagine. {ECO:0000255}.; CARBOHYD 481 481 N-linked (GlcNAc...) asparagine. {ECO:0000269|PubMed:19159218}.; CARBOHYD 520 520 N-linked (GlcNAc...) asparagine. {ECO:0000255}.; CARBOHYD 584 584 N-linked (GlcNAc...) asparagine. {ECO:0000255}.; CARBOHYD 669 669 N-linked (GlcNAc...) asparagine. {ECO:0000269|PubMed:19159218}.",,,MOD_RES 777 777 Phosphothreonine. {ECO:0000244|PubMed:19690332}.; MOD_RES 783 783 Phosphotyrosine. {ECO:0000244|PubMed:23186163}.; MOD_RES 785 785 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 789 789 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 794 794 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.,,,SIGNAL 1 20,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X07979;AK291697;BX537407;CH471072;CH471072;CH471072;CH471072;CH471072;CH471072;CH471072;CH471072;CH471072;CH471072;CH471072;BC020057;BC113901;U33879;U33880;U33879;U33882;U33879;U33881;U33882;U33879;M34189;M84237;M84237;U28252;
0,P05976,MYL1_HUMAN,MYL1,MYL1,,,,Homo sapiens (Human),9606,"Myosin light chain 1/3, skeletal muscle isoform (MLC1/MLC3) (MLC1F/MLC3F) (Myosin light chain alkali 1/2) (Myosin light chain A1/A2)",UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAPKKDVKKPVAAAAAAPAPAPAPAPAPAPAKPKEEKIDLSAIKIEFSKEQQDEFKEAFLLFDRTGDSKITLSQVGDVLRALGTNPTNAEVRKVLGNPSNEELNAKKIEFEQFLPMMQAISNNKDQATYEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMKEEEVEALMAGQEDSNGCINYEAFVKHIMSI,194,"21,145",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=MLC1; IsoId=P05976-1; Sequence=Displayed; Name=MLC3; IsoId=P05976-2, P06741-1; Sequence=VSP_038686; ",,,,,,,,,,"VAR_SEQ 1 53 MAPKKDVKKPVAAAAAAPAPAPAPAPAPAPAKPKEEKIDLSAIKIEFSKEQQD -> MSFSADQIA (in isoform MLC3). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:2458299, ECO:0000303|PubMed:3601661}. /FTId=VSP_038686.",,,,,CONFLICT 45 45 I -> M (in Ref. 1; CAB42646). {ECO:0000305}.,,3,,0,,,,,DOMAIN 50 85 EF-hand 1. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 127 162 EF-hand 2. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 162 194 EF-hand 3. {ECO:0000255|PROSITE-ProRule:PRU00448}.,,,,,,,,,,FUNCTION: Regulatory light chain of myosin. Does not bind calcium.,,,,,,,,,,,,cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; calcium ion binding [GO:0005509]; structural constituent of muscle [GO:0008307]; cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049],cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049],calcium ion binding [GO:0005509]; structural constituent of muscle [GO:0008307],cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017],GO:0005509; GO:0005829; GO:0005859; GO:0006936; GO:0008307; GO:0030016; GO:0030017; GO:0030049; GO:0060048,IPR011992; IPR002048; ,,SUBUNIT: Myosin is a hexamer of 2 heavy chains and 4 light chains.,3601661; 2458299; 14702039; 15489334; 2777779,3601661; 2458299; 14702039; 15489334; 2777779; 10747208; 20518849; 21731751; 22131351; 23319595; 23414517; 24725412; 26011449; 26473445; 28427997; 28618653; 29102634,1988-11-01,2019-02-13,2007-01-23,171,,,,,,,,,4 out of 5,Alternative sequence (1); Chain (1); Domain (3); Initiator methionine (2); Modified residue (6); Sequence conflict (1),,,,Acetylation;Alternative splicing;Complete proteome;Methylation;Motor protein;Muscle protein;Myosin;Phosphoprotein;Reference proteome;Repeat,Evidence at transcript level,reviewed,,,171,Alternative products (1); Function (1); Post-translational modification (1); Subunit structure (1),,KW-0007; KW-0025; KW-0181; KW-0488; KW-0505; KW-0514; KW-0518; KW-0597; KW-0677; KW-1185,,,,,,,,PTM: Isoform MLC3 is acetylated at position 2. {ECO:0000250}.,"CHAIN 2 194 Myosin light chain 1/3, skeletal muscle isoform. /FTId=PRO_0000198681.",,,,INIT_MET 1 1 Removed. {ECO:0000250|UniProtKB:P02602}.,,"MOD_RES 2 2 N,N,N-trimethylalanine. {ECO:0000250|UniProtKB:P02602}.; MOD_RES 71 71 Phosphothreonine. {ECO:0000250|UniProtKB:P02600}.; MOD_RES 73 73 Phosphoserine. {ECO:0000250|UniProtKB:P02600}.; MOD_RES 87 87 Phosphothreonine. {ECO:0000250|UniProtKB:P02600}.; MOD_RES 99 99 Phosphoserine. {ECO:0000250|UniProtKB:P02600}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X05450;X05451;M20642;M20643;CR456869;AK311942;AK311892;CH471063;CH471063;BC005318;J05026;
0,P06454,PTMA_HUMAN,PTMA TMSA,PTMA,TMSA,,,Homo sapiens (Human),9606,"Prothymosin alpha [Cleaved into: Prothymosin alpha, N-terminally processed; Thymosin alpha-1]",UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSDAAVDTSSEITTKDLKEKKEVVEEAENGRDAPANGNAENEENGEQEADNEVDEEEEEGGEEEEEEEEGDGEEEDGDEDEEAESATGKRAAEDDEDDDVDTKKQKTDEDD,111,"12,203",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P06454-1; Sequence=Displayed; Name=2; IsoId=P06454-2; Sequence=VSP_011508; ,,,,,,,,,,"VAR_SEQ 40 40 Missing (in isoform 2). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:2785990, ECO:0000303|PubMed:3466166, ECO:0000303|Ref.5}. /FTId=VSP_011508.",,,,,,,2,,0,,SIMILARITY: Belongs to the pro/parathymosin family. {ECO:0000305}.,,COMPBIAS 42 101 Asp/Glu-rich (acidic).,,,,,,,,,,,FUNCTION: Prothymosin alpha may mediate immune function by conferring resistance to certain opportunistic infections.,,,,,,,,,,,,"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; histone binding [GO:0042393]; histone exchange [GO:0043486]; transcription, DNA-templated [GO:0006351]","histone exchange [GO:0043486]; transcription, DNA-templated [GO:0006351]",activating transcription factor binding [GO:0033613]; histone binding [GO:0042393],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0033613; GO:0042393; GO:0043486,IPR004931; ,Q14145; O60356; Q9NYB0,,3467312; 3466166; 2708378; 2785990; 15489334; 7916742; 3532956; 8485135; 17081983; 18669648; 19413330; 19369195; 19690332; 19608861; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 24275569; 28112733; 22115779,3467312; 3466166; 2708378; 2785990; 15489334; 7916742; 3532956; 8485135; 17081983; 18669648; 19413330; 19369195; 19690332; 19608861; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 24275569; 28112733; 22115779; 11528108; 11727831; 12062405; 12522243; 15325071; 15556635; 15607035; 15657435; 16353248; 16628001; 16669873; 16940531; 17012289; 17046193; 17188166; 17876542; 17929838; 18240569; 18391951; 18856068; 18976813; 20121050; 20195357; 20430720; 20977946; 21044950; 21573209; 21911578; 22059741; 22110140; 22125611; 22463375; 22609059; 22810585; 23318954; 23359453; 23602568; 23695700; 23857453; 23859021; 24733561; 25197357; 25556234; 25582950; 25642593; 26348351; 26638075; 26752685; 27310139; 29106904,1988-01-01,2019-02-13,2007-01-23,181,NMR spectroscopy (2),,HELIX 3 6 {ECO:0000244|PDB:2L9I}.; HELIX 9 28 {ECO:0000244|PDB:2L9I}.,,,,,,5 out of 5,Alternative sequence (1); Chain (2); Compositional bias (1); Cross-link (1); Helix (2); Initiator methionine (1); Modified residue (13); Peptide (1),,,,3D-structure;Acetylation;Alternative splicing;Complete proteome;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,Pro/parathymosin family,181,Alternative products (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1),,KW-0002; KW-0007; KW-0025; KW-0181; KW-0539; KW-0597; KW-0832; KW-0903; KW-1017; KW-1185,,,,,,,,PTM: Covalently linked to a small RNA of about 20 nucleotides. {ECO:0000250}.,"CHAIN 1 111 Prothymosin alpha. /FTId=PRO_0000423255.; CHAIN 2 111 Prothymosin alpha, N-terminally processed. /FTId=PRO_0000299250.",CROSSLNK 103 103 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.,,,"INIT_MET 1 1 Removed; alternate. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|PubMed:22115779, ECO:0000269|PubMed:8485135}.",,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:20068231}.; MOD_RES 2 2 N-acetylserine; in Prothymosin alpha, N-terminally processed. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|PubMed:22115779, ECO:0000269|PubMed:8485135}.; MOD_RES 2 2 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:8485135}.; MOD_RES 8 8 Phosphothreonine. {ECO:0000250|UniProtKB:P01252}.; MOD_RES 9 9 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 10 10 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 13 13 Phosphothreonine. {ECO:0000250|UniProtKB:P01252}.; MOD_RES 14 14 Phosphothreonine. {ECO:0000250|UniProtKB:P01252}.; MOD_RES 15 15 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 15 15 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P26350}.; MOD_RES 102 102 Phosphothreonine. {ECO:0000244|PubMed:19690332}.; MOD_RES 103 103 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P26350}.; MOD_RES 107 107 Phosphothreonine. {ECO:0000244|PubMed:18669648}.",PEPTIDE 2 29 Thymosin alpha-1. /FTId=PRO_0000029865.,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M14630;M14483;M67480;J04797;M67480;J04797;M26708;AF348514;BC051265;BC066905;BC070480;BC071647;BC071879;S56449;
0,P07355,ANXA2_HUMAN,ANXA2 ANX2 ANX2L4 CAL1H LPC2D,ANXA2,ANX2 ANX2L4 CAL1H LPC2D,,,Homo sapiens (Human),9606,Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36),UP000005640: Chromosome 15,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSTVHEILCKLSLEGDHSTPPSAYGSVKAYTNFDAERDALNIETAIKTKGVDEVTIVNILTNRSNAQRQDIAFAYQRRTKKELASALKSALSGHLETVILGLLKTPAQYDASELKASMKGLGTDEDSLIEIICSRTNQELQEINRVYKEMYKTDLEKDIISDTSGDFRKLMVALAKGRRAEDGSVIDYELIDQDARDLYDAGVKRKGTDVPKWISIMTERSVPHLQKVFDRYKSYSPYDMLESIRKEVKGDLENAFLNLVQCIQNKPLYFADRLYDSMKGKGTRDKVLIRIMVSRSEVDMLKIRSEFKRKYGKSLYYYIQQDTKGDYQKALLYLCGGDD,339,"38,604",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P07355-1; Sequence=Displayed; Name=2; IsoId=P07355-2; Sequence=VSP_038091; ,,SEQUENCE CAUTION:  Sequence=AAH66955.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 1 1 M -> MGRQLAGCGDAGKKASFKM (in isoform 2). {ECO:0000303|PubMed:17974005}. /FTId=VSP_038091.,"VARIANT 98 98 V -> L (polymorphism; does not affect interaction with PCSK9; dbSNP:rs17845226). {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:22848640}. /FTId=VAR_012982.",,,,CONFLICT 29 29 A -> P (in Ref. 9; AA sequence). {ECO:0000305}.; CONFLICT 166 166 D -> G (in Ref. 4; CAE45704). {ECO:0000305}.; CONFLICT 293 293 V -> A (in Ref. 6; AAH23990). {ECO:0000305}.,,2,,0,DOMAIN: A pair of annexin repeats may form one binding site for calcium and phospholipid.,SIMILARITY: Belongs to the annexin family. {ECO:0000305}.,,,,,REGION 2 24 S100A10-binding site. {ECO:0000255}.,REPEAT 42 102 Annexin 1.; REPEAT 114 174 Annexin 2.; REPEAT 199 259 Annexin 3.; REPEAT 274 334 Annexin 4.,,,,,,,"FUNCTION: Calcium-regulated membrane-binding protein whose affinity for calcium is greatly enhanced by anionic phospholipids. It binds two calcium ions with high affinity. May be involved in heat-stress response. Inhibits PCSK9-enhanced LDLR degradation, probably reduces PCSK9 protein levels via a translational mechanism but also competes with LDLR for binding with PCSK9 (PubMed:18799458, PubMed:24808179, PubMed:22848640). {ECO:0000269|PubMed:18799458, ECO:0000269|PubMed:22848640, ECO:0000269|PubMed:24808179}.",,,,,,,,,,,,"azurophil granule lumen [GO:0035578]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; macropinosome [GO:0044354]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; myelin sheath adaxonal region [GO:0035749]; nucleus [GO:0005634]; PCSK9-AnxA2 complex [GO:1990667]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; sarcolemma [GO:0042383]; Schmidt-Lanterman incisure [GO:0043220]; vesicle [GO:0031982]; bone sialoprotein binding [GO:0044730]; cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; molecular function regulator [GO:0098772]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; virion binding [GO:0046790]; voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels [GO:0099511]; angiogenesis [GO:0001525]; biomineral tissue development [GO:0031214]; body fluid secretion [GO:0007589]; catabolism by host of symbiont protein [GO:0052362]; collagen fibril organization [GO:0030199]; endocardial cell differentiation [GO:0060956]; fibrinolysis [GO:0042730]; growth plate cartilage development [GO:0003417]; interleukin-12-mediated signaling pathway [GO:0035722]; membrane raft assembly [GO:0001765]; negative regulation by host of symbiont molecular function [GO:0052405]; negative regulation of development of symbiont involved in interaction with host [GO:0044147]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; neutrophil degranulation [GO:0043312]; osteoclast development [GO:0036035]; positive regulation by host of viral process [GO:0044794]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of low-density lipoprotein particle receptor binding [GO:1905597]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor recycling [GO:0001921]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vacuole organization [GO:0044090]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of viral life cycle [GO:1903902]; protein heterotetramerization [GO:0051290]; protein localization to plasma membrane [GO:0072659]; regulation of plasminogen activation [GO:0010755]; response to thyroid hormone [GO:0097066]; vesicle budding from membrane [GO:0006900]",angiogenesis [GO:0001525]; biomineral tissue development [GO:0031214]; body fluid secretion [GO:0007589]; catabolism by host of symbiont protein [GO:0052362]; collagen fibril organization [GO:0030199]; endocardial cell differentiation [GO:0060956]; fibrinolysis [GO:0042730]; growth plate cartilage development [GO:0003417]; interleukin-12-mediated signaling pathway [GO:0035722]; membrane raft assembly [GO:0001765]; negative regulation by host of symbiont molecular function [GO:0052405]; negative regulation of development of symbiont involved in interaction with host [GO:0044147]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; neutrophil degranulation [GO:0043312]; osteoclast development [GO:0036035]; positive regulation by host of viral process [GO:0044794]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of low-density lipoprotein particle receptor binding [GO:1905597]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of receptor recycling [GO:0001921]; positive regulation of vacuole organization [GO:0044090]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of viral life cycle [GO:1903902]; protein heterotetramerization [GO:0051290]; protein localization to plasma membrane [GO:0072659]; regulation of plasminogen activation [GO:0010755]; response to thyroid hormone [GO:0097066]; vesicle budding from membrane [GO:0006900],"bone sialoprotein binding [GO:0044730]; cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium channel activity [GO:0005262]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; molecular function regulator [GO:0098772]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; virion binding [GO:0046790]; voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels [GO:0099511]",azurophil granule lumen [GO:0035578]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; macropinosome [GO:0044354]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; myelin sheath adaxonal region [GO:0035749]; nucleus [GO:0005634]; PCSK9-AnxA2 complex [GO:1990667]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; sarcolemma [GO:0042383]; Schmidt-Lanterman incisure [GO:0043220]; vesicle [GO:0031982],GO:0001525; GO:0001726; GO:0001765; GO:0001786; GO:0001921; GO:0001934; GO:0002020; GO:0003417; GO:0003723; GO:0005262; GO:0005509; GO:0005544; GO:0005546; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0005737; GO:0005765; GO:0005768; GO:0005769; GO:0005811; GO:0005829; GO:0005886; GO:0005913; GO:0005938; GO:0006900; GO:0007589; GO:0008092; GO:0009986; GO:0010755; GO:0016020; GO:0016323; GO:0017137; GO:0019834; GO:0019897; GO:0030199; GO:0030496; GO:0031214; GO:0031340; GO:0031902; GO:0031982; GO:0032332; GO:0032804; GO:0035578; GO:0035722; GO:0035749; GO:0036035; GO:0042383; GO:0042470; GO:0042730; GO:0042802; GO:0043220; GO:0043312; GO:0044090; GO:0044147; GO:0044354; GO:0044548; GO:0044730; GO:0044794; GO:0045121; GO:0046790; GO:0048146; GO:0048306; GO:0048471; GO:0051290; GO:0051928; GO:0052362; GO:0052405; GO:0060956; GO:0062023; GO:0070062; GO:0072659; GO:0097066; GO:0098641; GO:0098772; GO:0099511; GO:1903902; GO:1905581; GO:1905597; GO:1905599; GO:1905602; GO:1990667,IPR001464; IPR018502; IPR018252; IPR037104; IPR002389; ,Itself; Q99IB8; P03950; P46092; P40692; P75409; P15363; Q8NBP7; Q9NUX5; P60903,"SUBUNIT: Heterotetramer containing 2 light chains of S100A10/p11 and 2 heavy chains of ANXA2/p36 (By similarity). Interacts with ATP1B1 (By similarity). Interacts with DYSF (By similarity). Interacts with COCH (PubMed:21886777). Interacts (via repeat Annexin 1) with PCSK9 (via the C-terminal domain); the interaction inhibits the degradation of LDLR (PubMed:18799458). Interacts with CEACAM1 (via the cytoplasmic domain); this interaction is regulated by phosphorylation of CEACAM1 (PubMed:14522961). Interacts with APPL2 and APPL1; targets APPL2 to endosomes and acting in parallel to RAB5A (By similarity). {ECO:0000250|UniProtKB:A2SW69, ECO:0000250|UniProtKB:P07356, ECO:0000250|UniProtKB:Q6TEQ7, ECO:0000269|PubMed:14522961, ECO:0000269|PubMed:18799458, ECO:0000269|PubMed:21886777}.; SUBUNIT: (Microbial infection) Interacts with human cytomegalovirus (HCMV). {ECO:0000269|PubMed:8117306}.",3013422; 2174397; 17974005; 16572171; 15489334; 1825830; 8110754; 8117306; 8449982; 2946940; 14522961; 14654843; 15302870; 16139798; 17081065; 18799458; 21269460; 21886777; 22848640; 23186163; 24808179; 24275569; 25114211; 25944712; 28112733; 8636985,3013422; 2174397; 17974005; 16572171; 15489334; 1825830; 8110754; 8117306; 8449982; 2946940; 14522961; 14654843; 15302870; 16139798; 17081065; 18799458; 21269460; 21886777; 22848640; 23186163; 24808179; 24275569; 25114211; 25944712; 28112733; 8636985; 11781322; 12468550; 12577067; 12629510; 12699894; 12730231; 13679511; 14504107; 14506282; 14613585; 14672933; 14991775; 14995994; 15047060; 15051937; 15064349; 15070701; 15161933; 15211578; 15226372; 15257287; 15471954; 15526283; 15567461; 15574370; 15601262; 15784727; 15788416; 15849182; 15940368; 16038020; 16100712; 16177123; 16230353; 16331566; 16493010; 16501079; 16524621; 16643892; 16709165; 16797773; 16882661; 16963080; 16984913; 16989986; 17065584; 17239928; 17353931; 17441315; 17513451; 17581860; 17620599; 17626749; 17709546; 17711622; 17721511; 17824845; 17971878; 17999956; 18008140; 18164291; 18174463; 18211896; 18262347; 18289715; 18332131; 18384219; 18389276; 18412141; 18434302; 18494762; 18502476; 18562541; 18565825; 18636554; 18712570; 18850631; 18924133; 18990701; 19016789; 19020748; 19022301; 19156129; 19176991; 19289089; 19325895; 19339807; 19367725; 19380152; 19380584; 19463016; 19549357; 19556289; 19585213; 19605586; 19642359; 19656851; 19724273; 19738201; 19764771; 19805454; 19823170; 19885616; 19913121; 19951950; 19954599; 20000738; 20015551; 20018898; 20047591; 20079732; 20093721; 20093722; 20121258; 20225235; 20229030; 20335258; 20379614; 20493868; 20540360; 20561442; 20562859; 20628086; 20702651; 20706999; 20711500; 20826156; 20847146; 20849852; 20947498; 20970165; 21033036; 21044950; 21115493; 21122411; 21132403; 21146216; 21150319; 21182205; 21193750; 21237296; 21330046; 21491466; 21565611; 21572519; 21603851; 21645192; 21809360; 21817168; 21849434; 21908427; 21918681; 21928315; 21976520; 22044461; 22141411; 22223826; 22230505; 22235123; 22301157; 22421042; 22452176; 22452352; 22493182; 22575643; 22587461; 22623428; 22645245; 22679123; 22681645; 22705595; 22792315; 22822523; 22830395; 22859294; 22879587; 22913982; 22936677; 22939813; 22940583; 22957061; 23063127; 23091277; 23091278; 23131771; 23139605; 23148505; 23174572; 23188673; 23193360; 23226323; 23275167; 23334362; 23391921; 23415230; 23416715; 23483454; 23494179; 23512564; 23522334; 23529818; 23558678; 23572070; 23637395; 23696646; 23713052; 23721211; 23757730; 23792445; 23840117; 23861394; 23902751; 23931152; 23950866; 23994525; 24019232; 24111848; 24189400; 24239898; 24366813; 24402284; 24591759; 24626613; 24668792; 24719459; 24806074; 24819400; 24884814; 2496749; 24968947; 25034653; 25139904; 25150310; 25219463; 25233429; 25284003; 25287627; 25303710; 25344575; 25347736; 25355205; 25362534; 25402728; 25416440; 25418092; 25476478; 25500542; 25519022; 25520129; 25547062; 25605255; 25609649; 25611381; 25661364; 25697644; 25712672; 25775977; 25795236; 25803884; 25816213; 25915724; 25917452; 26109000; 26189841; 26196246; 26223656; 26253946; 26272794; 26307676; 26362938; 26438086; 26465153; 26496610; 26511441; 26547929; 26632510; 26797420; 26925708; 26963384; 27008711; 27060670; 27121050; 27378781; 27385217; 27402115; 27429043; 27451994; 27468721; 27496793; 27640198; 27667176; 27697640; 27754360; 27760843; 27863502; 28178129; 28258160; 28283478; 28440436; 28450451; 28456096; 28470457; 28476852; 28501283; 28547742; 28609840; 28651352; 28652618; 28669632; 28814318; 28867585; 28963375; 28976984; 29083550; 29097873; 29187477; 29217762; 29332450; 29567212; 29749431; 29906496; 30143909; 30272362; 30355917; 7199524; 8692836; 9886297,1988-04-01,2019-02-13,2007-01-23,230,X-ray crystallography (15),STRAND 48 50 {ECO:0000244|PDB:5N7D}.; STRAND 120 122 {ECO:0000244|PDB:1W7B}.; STRAND 205 207 {ECO:0000244|PDB:2HYV}.; STRAND 279 282 {ECO:0000244|PDB:2HYV}.,HELIX 4 12 {ECO:0000244|PDB:5LPU}.; HELIX 35 47 {ECO:0000244|PDB:2HYV}.; HELIX 53 60 {ECO:0000244|PDB:2HYV}.; HELIX 65 79 {ECO:0000244|PDB:2HYV}.; HELIX 83 90 {ECO:0000244|PDB:2HYV}.; HELIX 93 103 {ECO:0000244|PDB:2HYV}.; HELIX 106 117 {ECO:0000244|PDB:2HYV}.; HELIX 125 134 {ECO:0000244|PDB:2HYV}.; HELIX 137 151 {ECO:0000244|PDB:2HYV}.; HELIX 155 161 {ECO:0000244|PDB:2HYV}.; HELIX 165 175 {ECO:0000244|PDB:2HYV}.; HELIX 188 200 {ECO:0000244|PDB:2HYV}.; HELIX 210 219 {ECO:0000244|PDB:2HYV}.; HELIX 222 232 {ECO:0000244|PDB:2HYV}.; HELIX 240 247 {ECO:0000244|PDB:2HYV}.; HELIX 250 264 {ECO:0000244|PDB:2HYV}.; HELIX 266 278 {ECO:0000244|PDB:2HYV}.; HELIX 285 295 {ECO:0000244|PDB:2HYV}.; HELIX 300 311 {ECO:0000244|PDB:2HYV}.; HELIX 315 322 {ECO:0000244|PDB:2HYV}.; HELIX 325 335 {ECO:0000244|PDB:2HYV}.,TURN 201 204 {ECO:0000244|PDB:2HYV}.; TURN 233 235 {ECO:0000244|PDB:2HYV}.; TURN 296 298 {ECO:0000244|PDB:2HYV}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (4); Chain (1); Cross-link (2); Erroneous initiation (1); Helix (21); Initiator methionine (1); Modified residue (8); Mutagenesis (7); Natural variant (1); Region (1); Repeat (4); Sequence conflict (3); Turn (3),,,MISCELLANEOUS: It may cross-link plasma membrane phospholipids with actin and the cytoskeleton and be involved with exocytosis.,3D-structure;Acetylation;Alternative splicing;Annexin;Basement membrane;Calcium;Calcium/phospholipid-binding;Complete proteome;Direct protein sequencing;Extracellular matrix;Isopeptide bond;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Repeat;Secreted;Ubl conjugation,Evidence at protein level,reviewed,,Annexin family,230,Alternative products (1); Domain (1); Function (1); Miscellaneous (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (2),,KW-0002; KW-0007; KW-0025; KW-0041; KW-0084; KW-0106; KW-0111; KW-0181; KW-0272; KW-0597; KW-0621; KW-0677; KW-0694; KW-0832; KW-0903; KW-0964; KW-1017; KW-1185,,,,,,,,"PTM: Phosphorylation of Tyr-24 enhances heat stress-induced translocation to the cell surface. {ECO:0000269|PubMed:15302870, ECO:0000269|PubMed:2946940}.; PTM: ISGylated. {ECO:0000269|PubMed:16139798}.",CHAIN 2 339 Annexin A2. /FTId=PRO_0000067470.,CROSSLNK 49 49 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate. {ECO:0000244|PubMed:25114211}.; CROSSLNK 49 49 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.,,,INIT_MET 1 1 Removed. {ECO:0000269|Ref.7}.,,MOD_RES 2 2 N-acetylserine. {ECO:0000269|Ref.7}.; MOD_RES 24 24 Phosphotyrosine; by SRC. {ECO:0000269|PubMed:15302870}.; MOD_RES 26 26 Phosphoserine; by PKC. {ECO:0000269|PubMed:2946940}.; MOD_RES 49 49 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P07356}.; MOD_RES 152 152 N6-acetyllysine. {ECO:0000250|UniProtKB:P07356}.; MOD_RES 184 184 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 199 199 Phosphotyrosine. {ECO:0000250|UniProtKB:P07356}.; MOD_RES 227 227 N6-acetyllysine. {ECO:0000250|UniProtKB:P07356}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,D00017;BT007432;BX640598;BC001388;BC009564;BC015834;BC016774;BC021114;BC023990;BC052558;BC052567;BC066955;BC068065;BC093056;
0,P08134,RHOC_HUMAN,RHOC ARH9 ARHC,RHOC,ARH9 ARHC,,,Homo sapiens (Human),9606,Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAAIRKKLVIVGDGACGKTCLLIVFSKDQFPEVYVPTVFENYIADIEVDGKQVELALWDTAGQEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLRQDEHTRRELAKMKQEPVRSEEGRDMANRISAFGYLECSAKTKEGVREVFEMATRAGLQVRKNKRRRGCPIL,193,"22,006",,,,,,,,,,,,,VARIANT 120 120 D -> H (in dbSNP:rs11538959). /FTId=VAR_051974.,,,,,,1,,0,,SIMILARITY: Belongs to the small GTPase superfamily. Rho family. {ECO:0000305}.,,,,MOTIF 34 42 Effector region. {ECO:0000255}.,,,,,,,,,"FUNCTION: Regulates a signal transduction pathway linking plasma membrane receptors to the assembly of focal adhesions and actin stress fibers. Serves as a microtubule-dependent signal that is required for the myosin contractile ring formation during cell cycle cytokinesis. Regulates apical junction formation in bronchial epithelial cells. {ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:20974804}.",,,,,,,,,,NP_BIND 12 19 GTP. {ECO:0000250}.; NP_BIND 59 63 GTP. {ECO:0000250}.; NP_BIND 117 120 GTP. {ECO:0000250}.,,"cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; G protein-coupled receptor signaling pathway [GO:0007186]; mitotic cytokinesis [GO:0000281]; positive regulation of cell migration [GO:0030335]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipase activity [GO:0060193]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; skeletal muscle satellite cell migration [GO:1902766]; wound healing, spreading of cells [GO:0044319]","actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; G protein-coupled receptor signaling pathway [GO:0007186]; mitotic cytokinesis [GO:0000281]; positive regulation of cell migration [GO:0030335]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipase activity [GO:0060193]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; skeletal muscle satellite cell migration [GO:1902766]; wound healing, spreading of cells [GO:0044319]",GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901],cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; stereocilium [GO:0032420],GO:0000281; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007015; GO:0007186; GO:0007266; GO:0008360; GO:0016477; GO:0019901; GO:0030334; GO:0030335; GO:0030950; GO:0032153; GO:0032154; GO:0032420; GO:0032464; GO:0032956; GO:0043123; GO:0043231; GO:0043297; GO:0044319; GO:0051017; GO:0051056; GO:0051496; GO:0060193; GO:0070062; GO:1902766,IPR027417; IPR005225; IPR001806; IPR003578; ,Q9Y4F9,"SUBUNIT: Interacts with RTKN (By similarity). Interacts with AKAP13 (PubMed:11546812). Interacts with DIAPH1 (PubMed:15864301). Interacts with PKN2 (PubMed:20974804). Interacts with ROCK1 and ROCK2 (PubMed:8816443). Interacts with ARHGDIA (PubMed:20400958). Interacts with RIPOR1 (PubMed:27807006). {ECO:0000250, ECO:0000250|UniProtKB:Q62159, ECO:0000269|PubMed:11546812, ECO:0000269|PubMed:15864301, ECO:0000269|PubMed:20400958, ECO:0000269|PubMed:20974804, ECO:0000269|PubMed:27807006, ECO:0000269|PubMed:8816443}.",3283705; 14702039; 16710414; 15489334; 8816443; 11546812; 16236794; 20400958; 21269460; 20974804; 24141704; 27807006; 15864301,3283705; 14702039; 16710414; 15489334; 8816443; 11546812; 16236794; 20400958; 21269460; 20974804; 24141704; 27807006; 15864301; 10360578; 10559246; 10619026; 10652353; 10655614; 10676816; 10753910; 10873388; 11018042; 11130076; 11157984; 11283606; 11294240; 11331307; 11431473; 11738596; 11804589; 11839578; 11942626; 12090470; 12101119; 12185584; 12220504; 12221096; 12423633; 12429845; 12471028; 12504591; 12730235; 12783890; 12802051; 12808121; 12939257; 12970882; 1439791; 14514689; 14555841; 14614010; 15006353; 15210733; 15260990; 15292224; 15507212; 15611088; 15642170; 15668138; 15670823; 15699075; 15821030; 15921909; 15969750; 16189514; 16202622; 16212495; 16219803; 16431929; 16439214; 16511001; 16899593; 17018591; 17151359; 17222083; 17265125; 17353931; 17497936; 17549441; 17696235; 17896152; 17897917; 18006505; 18058225; 18211678; 18218625; 18478927; 18794150; 18980974; 19016761; 19094228; 19107362; 19152186; 19157876; 19222696; 19367725; 19421144; 19462897; 19477269; 19499974; 19642867; 19701800; 19723632; 19861405; 19887681; 19911011; 19953094; 20014943; 20056178; 20101212; 20232393; 20403997; 20503409; 21079653; 21087931; 21159255; 21208644; 21242305; 21351730; 21537845; 21566117; 21575520; 21576392; 21674277; 21732343; 21757538; 21862636; 22057916; 22094460; 22190034; 22217540; 22275430; 22293682; 22304920; 22673745; 22790947; 22896661; 22911725; 22935975; 22992742; 23036489; 23145020; 23222643; 23302395; 23319595; 23382905; 23444367; 23474984; 23716662; 23764197; 23993968; 24096540; 24128008; 24312560; 24376640; 24414340; 24447566; 24457551; 24533098; 24914801; 24986540; 25123151; 25236186; 25416956; 25516960; 25622907; 25624724; 25649143; 25659578; 25677806; 25933027; 26020100; 26260613; 26615410; 26673619; 26741994; 26898345; 27108649; 27147504; 27355867; 27487132; 27494896; 27748883; 27748937; 28069441; 28146423; 2825022; 28508825; 28536953; 28818073; 28984384; 29500478; 2966156; 3839510; 7478592; 7543319; 7954831; 8276860; 8288572; 8543060; 8617235; 8662509; 8662891; 8702756; 8810315; 8969170; 9113980; 9194563; 9211904; 9308960; 9354661; 9605766; 9792683; 9857026; 9870942; 9870943; 9988689,1988-08-01,2019-02-13,1988-08-01,210,X-ray crystallography (4),STRAND 4 13 {ECO:0000244|PDB:2GCO}.; STRAND 43 48 {ECO:0000244|PDB:2GCO}.; STRAND 51 58 {ECO:0000244|PDB:2GCO}.; STRAND 78 85 {ECO:0000244|PDB:2GCO}.; STRAND 112 117 {ECO:0000244|PDB:2GCO}.; STRAND 154 158 {ECO:0000244|PDB:2GCO}.,HELIX 18 27 {ECO:0000244|PDB:2GCO}.; HELIX 64 66 {ECO:0000244|PDB:2GCO}.; HELIX 70 73 {ECO:0000244|PDB:2GCO}.; HELIX 89 97 {ECO:0000244|PDB:2GCO}.; HELIX 99 106 {ECO:0000244|PDB:2GCO}.; HELIX 119 121 {ECO:0000244|PDB:2GCO}.; HELIX 125 132 {ECO:0000244|PDB:2GCO}.; HELIX 141 150 {ECO:0000244|PDB:2GCO}.; HELIX 167 179 {ECO:0000244|PDB:2GCO}.,TURN 67 69 {ECO:0000244|PDB:2GCO}.; TURN 133 135 {ECO:0000244|PDB:2GCO}.; TURN 161 163 {ECO:0000244|PDB:2GCO}.,,,,,5 out of 5,Beta strand (6); Chain (1); Glycosylation (1); Helix (9); Lipidation (1); Modified residue (2); Motif (1); Natural variant (1); Nucleotide binding (3); Propeptide (1); Turn (3),,,,3D-structure;ADP-ribosylation;Cell membrane;Complete proteome;GTP-binding;Glycoprotein;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Polymorphism;Prenylation;Reference proteome,Evidence at protein level,reviewed,,"Small GTPase superfamily, Rho family",210,Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0013; KW-0181; KW-0325; KW-0342; KW-0449; KW-0472; KW-0488; KW-0547; KW-0621; KW-0636; KW-1003; KW-1185,,,,,,,,PTM: (Microbial infection) Glycosylated at Tyr-34 by Photorhabdus asymbiotica toxin PAU_02230. Mono-O-GlcNAcylation by PAU_02230 inhibits downstream signaling by an impaired interaction with diverse regulator and effector proteins of Rho and leads to actin disassembly. {ECO:0000269|PubMed:24141704}.,CHAIN 1 190 Rho-related GTP-binding protein RhoC. /FTId=PRO_0000042022.,,,CARBOHYD 34 34 O-linked (GlcNAc) tyrosine; by Photorhabdus PAU_02230. {ECO:0000269|PubMed:24141704}.,,LIPID 190 190 S-geranylgeranyl cysteine. {ECO:0000250|UniProtKB:P62745}.,MOD_RES 41 41 ADP-ribosylasparagine; by botulinum toxin. {ECO:0000250}.; MOD_RES 190 190 Cysteine methyl ester. {ECO:0000250|UniProtKB:P62745}.,,PROPEP 191 193 Removed in mature form. {ECO:0000250}. /FTId=PRO_0000042023.,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X06821;L25081;AF498972;CR450360;BT019448;AK094474;CH471122;BC007245;BC009177;BC052808;
0,P08670,VIME_HUMAN,VIM,VIM,,,,Homo sapiens (Human),9606,Vimentin,UP000005640: Chromosome 10,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSTRSVSSSSYRRMFGGPGTASRPSSSRSYVTTSTRTYSLGSALRPSTSRSLYASSPGGVYATRSSAVRLRSSVPGVRLLQDSVDFSLADAINTEFKNTRTNEKVELQELNDRFANYIDKVRFLEQQNKILLAELEQLKGQGKSRLGDLYEEEMRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKLQEEMLQREEAENTLQSFRQDVDNASLARLDLERKVESLQEEIAFLKKLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVRQQYESVAAKNLQEAEEWYKSKFADLSEAANRNNDALRQAKQESTEYRRQVQSLTCEVDALKGTNESLERQMREMEENFAVEAANYQDTIGRLQDEIQNMKEEMARHLREYQDLLNVKMALDIEIATYRKLLEGEESRISLPLPNFSSLNLRETNLDSLPLVDTHSKRTLLIKTVETRDGQVINETSQHHDDLE,466,"53,652",,,,,,,,,,,SEQUENCE CAUTION:  Sequence=BAB71275.1; Type=Miscellaneous discrepancy; Note=Product of a cloning artifact.; Evidence={ECO:0000305}; ,,VARIANT 151 151 E -> K (in CTRCT30; the mutation increases the proteasome activity in transfected cells; causes also a severe kinetic defect in vimentin assembly both in vitro and in vivo; dbSNP:rs121917775). {ECO:0000269|PubMed:19126778}. /FTId=VAR_070100.; VARIANT 208 208 Q -> R (in CTRCT30; unknown pathological significance; dbSNP:rs1085307141). {ECO:0000269|PubMed:28450710}. /FTId=VAR_078860.,,,,CONFLICT 42 42 S -> D (in Ref. 1; AAA61279). {ECO:0000305}.; CONFLICT 113 113 R -> P (in Ref. 12; CAA34499). {ECO:0000305}.; CONFLICT 197 197 E -> G (in Ref. 6; CAG28618). {ECO:0000305}.; CONFLICT 201 201 N -> S (in Ref. 17; AAA61281). {ECO:0000305}.; CONFLICT 265 265 L -> S (in Ref. 17; AAA61281). {ECO:0000305}.; CONFLICT 278 278 S -> I (in Ref. 17; AAA61281). {ECO:0000305}.; CONFLICT 339 339 S -> C (in Ref. 17; AAA61281). {ECO:0000305}.; CONFLICT 350 350 N -> K (in Ref. 17; AAA61281). {ECO:0000305}.; CONFLICT 442 442 L -> F (in Ref. 1; AAA61279). {ECO:0000305}.,,4,,0,DOMAIN: The central alpha-helical coiled-coil IF rod domain mediates elementary homodimerization.; DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for cysteine S-nitrosylation mediated by the iNOS-S100A8/A9 transnitrosylase complex. {ECO:0000305|PubMed:25417112}.,SIMILARITY: Belongs to the intermediate filament family. {ECO:0000255|PROSITE-ProRule:PRU01188}.,COILED 96 131 {ECO:0000269|PubMed:20176112}.; COILED 154 245 {ECO:0000269|PubMed:20176112}.; COILED 303 407 {ECO:0000269|PubMed:20176112}.,,DOMAIN 103 411 IF rod. {ECO:0000255|PROSITE-ProRule:PRU01188}.,MOTIF 326 329 [IL]-x-C-x-x-[DE] motif. {ECO:0000305|PubMed:25417112}.,REGION 2 95 Head.; REGION 96 131 Coil 1A.; REGION 132 153 Linker 1.; REGION 154 245 Coil 1B.; REGION 246 268 Linker 12.; REGION 269 407 Coil 2.; REGION 408 466 Tail.,,,,,,,,"FUNCTION: Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells. Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally. {ECO:0000269|PubMed:21746880}.; FUNCTION: Involved with LARP6 in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2. {ECO:0000269|PubMed:21746880}.",,,,,,,,,,,SITE 351 351 Stutter.,cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intermediate filament [GO:0005882]; neuron projection [GO:0043005]; nuclear matrix [GO:0016363]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212]; astrocyte development [GO:0014002]; Bergmann glial cell differentiation [GO:0060020]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cytokine-mediated signaling pathway [GO:0019221]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; muscle filament sliding [GO:0030049]; negative regulation of neuron projection development [GO:0010977]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488]; SMAD protein signal transduction [GO:0060395]; viral process [GO:0016032],astrocyte development [GO:0014002]; Bergmann glial cell differentiation [GO:0060020]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cytokine-mediated signaling pathway [GO:0019221]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; muscle filament sliding [GO:0030049]; negative regulation of neuron projection development [GO:0010977]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488]; SMAD protein signal transduction [GO:0060395]; viral process [GO:0016032],double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212],cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intermediate filament [GO:0005882]; neuron projection [GO:0043005]; nuclear matrix [GO:0016363]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904],GO:0003725; GO:0005200; GO:0005212; GO:0005737; GO:0005777; GO:0005829; GO:0005844; GO:0005856; GO:0005882; GO:0005886; GO:0005925; GO:0008022; GO:0010977; GO:0014002; GO:0016032; GO:0016363; GO:0019221; GO:0019904; GO:0030049; GO:0031252; GO:0032967; GO:0042802; GO:0043005; GO:0043488; GO:0045109; GO:0045335; GO:0045727; GO:0060020; GO:0060395; GO:0070062; GO:0070307; GO:0071222; GO:0071225; GO:0071346; GO:0097110; GO:1990254; GO:1990904,IPR001664; IPR018039; IPR039008; IPR006821; IPR027699; ,Itself; P14340; P27958; P31749; P31751; Q9H6U6; Q14457; Q14194; Q2TBE0; P17661; P14136; O95251; P35900; P05787; O76036; P07197; P48681; Q9HC29; Q96IZ0; Q16512; Q13835-2; Q96PV4; O60437; P41219; P54727; O95361; Q9BQE3; Q8N3L3; P63104,"SUBUNIT: Homopolymer assembled from elementary dimers. Interacts with LGSN and SYNM. Interacts (via rod region) with PLEC (via CH 1 domain) (By similarity). Interacts with SLC6A4 (PubMed:19270731). Interacts with STK33 (PubMed:18811945). Interacts with LARP6 (PubMed:21746880). Interacts with RAB8B (By similarity). Interacts with TOR1A; the interaction associates TOR1A with the cytoskeleton (PubMed:16361107, PubMed:18827015). Interacts with TOR1AIP1 (PubMed:16361107). Interacts with BCAS3 (PubMed:17505058). Interacts with DIAPH1 (PubMed:23325789). Identified in complexes that contain VIM, EZR, AHNAK, BFSP1, BFSP2, ANK2, PLEC, PRX and spectrin (By similarity). Interacts with EPPK1; interaction is dependent of higher-order structure of intermediate filament (PubMed:16923132). Interacts with the non-receptor tyrosine kinase SRMS; the interaction leads to phosphorylation of VIM (PubMed:29496907). Interacts with NOD2 (PubMed:27812135). Interacts (via head region) with CORO1C (By similarity). {ECO:0000250|UniProtKB:P20152, ECO:0000250|UniProtKB:P31000, ECO:0000269|PubMed:15846844, ECO:0000269|PubMed:16361107, ECO:0000269|PubMed:16923132, ECO:0000269|PubMed:17505058, ECO:0000269|PubMed:18811945, ECO:0000269|PubMed:18827015, ECO:0000269|PubMed:19270731, ECO:0000269|PubMed:20176112, ECO:0000269|PubMed:21746880, ECO:0000269|PubMed:23325789, ECO:0000269|PubMed:27812135, ECO:0000269|PubMed:29496907}.; SUBUNIT: (Microbial infection) Interacts with HCV core protein. {ECO:0000269|PubMed:15846844}.",3467175; 2251132; 14996095; 14702039; 15164054; 15489334; 2472876; 9150946; 3371665; 2323579; 9175763; 12458200; 14654843; 14762106; 15592455; 15846844; 17081983; 16923132; 16964243; 16361107; 17924679; 17505058; 18811945; 18827015; 18220336; 18691976; 18669648; 19413330; 19270731; 19690332; 19608861; 20068230; 20068231; 21269460; 21746880; 21406692; 21465480; 22905912; 22814378; 23186163; 23325789; 25417112; 24275569; 25114211; 25944712; 26694549; 27812135; 28112733; 29496907; 11243787; 11889032; 20176112; 22119849; 19126778; 28450710,3467175; 2251132; 14996095; 14702039; 15164054; 15489334; 2472876; 9150946; 3371665; 2323579; 9175763; 12458200; 14654843; 14762106; 15592455; 15846844; 17081983; 16923132; 16964243; 16361107; 17924679; 17505058; 18811945; 18827015; 18220336; 18691976; 18669648; 19413330; 19270731; 19690332; 19608861; 20068230; 20068231; 21269460; 21746880; 21406692; 21465480; 22905912; 22814378; 23186163; 23325789; 25417112; 24275569; 25114211; 25944712; 26694549; 27812135; 28112733; 29496907; 11243787; 11889032; 20176112; 22119849; 19126778; 28450710; 10469173; 10747208; 10801351; 10801826; 10852826; 11420699; 11423904; 11581269; 11744725; 11827972; 12084347; 12169273; 12194205; 12210485; 12366696; 12466525; 12483219; 12553669; 12686602; 12691412; 12727854; 12750294; 12761892; 12829607; 12906105; 14595690; 14712222; 14722118; 14743216; 15047060; 15161933; 15231822; 15255035; 15324660; 15383276; 15456890; 15556930; 15597762; 15676024; 15766329; 15777792; 15950906; 16007214; 16140754; 16169070; 16189514; 16260496; 16270034; 16298568; 16365157; 16487365; 16568083; 16678164; 16703512; 16712842; 16912072; 16944923; 16990256; 16997882; 17024653; 17031402; 17050693; 17056548; 17083913; 17266347; 17289402; 17400507; 17403663; 17427945; 17446270; 17476115; 17585878; 17601350; 17620599; 17652163; 17663720; 17703067; 17719575; 17960581; 18046501; 18056432; 18155753; 18176708; 18184460; 18219106; 18241054; 18407667; 18464297; 18632620; 18653473; 18681838; 18790770; 18847512; 18947333; 18977241; 18985028; 18985821; 19013628; 19117942; 19119138; 19136013; 19156129; 19165527; 19168853; 19252475; 19331162; 19366731; 19386766; 19397496; 19403668; 19404921; 19422834; 19447876; 19476621; 19494238; 19528485; 19584300; 19617759; 19690979; 19695088; 19696622; 19765186; 19776392; 19812368; 19888472; 19915524; 19937731; 19941857; 20104255; 20109457; 20121168; 20169076; 20171211; 2019567; 20350213; 20358301; 20422486; 20447406; 20467437; 20468064; 20471030; 20493732; 20562859; 20588206; 20602472; 20609218; 20618440; 20651380; 20701774; 20711500; 20729920; 20856200; 20975101; 21057535; 21094801; 21112954; 21182203; 21199468; 21217813; 21317457; 21327330; 21346197; 21442485; 21448168; 21491466; 21508377; 21515330; 21664858; 21699783; 21769486; 21803052; 21803859; 21900206; 21911578; 21914078; 21937440; 21969470; 21988832; 22014111; 22022619; 22038833; 22216242; 22221700; 22236966; 22251609; 22300583; 22304920; 22307379; 22340393; 22345628; 22367194; 22395512; 22407449; 22476851; 22535769; 22584948; 22623428; 22644514; 22659602; 22684479; 22693070; 22704062; 22730818; 22740688; 22759266; 22763828; 22766839; 22869704; 22879973; 22886823; 22929228; 23049725; 23056278; 23084401; 23135265; 23221510; 23224145; 23239149; 23280360; 23291835; 23292832; 23295955; 23354842; 23357686; 23412770; 23418544; 23418554; 23455323; 23482564; 23504025; 23562674; 23576498; 23614934; 23663103; 23663784; 23674515; 23677639; 23682784; 23717685; 23737341; 23751022; 23785295; 23824807; 23831462; 23873106; 23885566; 23974215; 23991044; 24001454; 24005669; 24061457; 24075276; 24139214; 24173714; 24190431; 24196446; 24282534; 24284321; 24387004; 24447545; 24474778; 24505633; 24612689; 24623428; 24642750; 24652946; 24681739; 24729088; 24737666; 24743777; 24781336; 24792370; 24843142; 24850148; 24858039; 24942637; 24954475; 24978037; 25001935; 25015719; 25028191; 25075038; 25120060; 25187410; 25189876; 25211928; 25277244; 25278713; 25282138; 25288153; 25306868; 25322343; 25329121; 25416956; 25487874; 25536665; 25548991; 25588502; 25609649; 25717187; 25736925; 25820701; 25826487; 25855378; 25902909; 25904701; 26031447; 26045832; 26109569; 26149185; 26160837; 26161965; 26168186; 26180933; 26466680; 26496610; 26499837; 26546435; 26567912; 26617803; 26638075; 26702618; 26708270; 26795465; 26819207; 26824421; 26923772; 26972711; 27038800; 27044755; 27048119; 27069130; 27072292; 27075696; 27163529; 27172790; 27304995; 27322682; 27353169; 27363026; 27423069; 27448976; 27572444; 27603133; 27604950; 27646775; 27655889; 27662907; 27694444; 27704357; 27752740; 27869227; 27888097; 27908735; 27910934; 27932314; 28027080; 28096473; 28135203; 28150354; 28225793; 28333958; 28341124; 28348116; 28373440; 28381157; 28419863; 28499703; 28566373; 28570699; 28611349; 28743511; 28744809; 28754682; 28771721; 28801345; 29022351; 29123267; 29196434; 29257346; 29317506; 29401610; 29724197; 29767267; 29905014; 29956814; 30078472; 30189187; 30408551; 30591455; 7983050; 9030781; 9168797; 9378721; 9565595; 9794428,1988-01-01,2019-02-13,2007-01-23,240,X-ray crystallography (22),STRAND 238 241 {ECO:0000244|PDB:4YPC}.,HELIX 101 135 {ECO:0000244|PDB:1GK7}.; HELIX 167 235 {ECO:0000244|PDB:4YPC}.; HELIX 266 334 {ECO:0000244|PDB:3TRT}.; HELIX 385 405 {ECO:0000244|PDB:1GK6}.,TURN 244 248 {ECO:0000244|PDB:3UF1}.,,,,,5 out of 5,Beta strand (1); Chain (1); Coiled coil (3); Cross-link (12); Domain (1); Glycosylation (3); Helix (4); Initiator methionine (1); Modified residue (56); Motif (1); Natural variant (2); Region (7); Sequence caution (1); Sequence conflict (9); Site (1); Turn (1),,"TISSUE SPECIFICITY: Highly expressed in fibroblasts, some expression in T- and B-lymphocytes, and little or no expression in Burkitt's lymphoma cell lines. Expressed in many hormone-independent mammary carcinoma cell lines. {ECO:0000269|PubMed:2472876, ECO:0000269|PubMed:3371665}.",,3D-structure;Acetylation;Cataract;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Glycoprotein;Host-virus interaction;Intermediate filament;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;S-nitrosylation;Ubl conjugation,Evidence at protein level,reviewed,,Intermediate filament family,240,Domain (2); Function (2); Induction (1); Involvement in disease (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (1); Subunit structure (2); Tissue specificity (1),,KW-0002; KW-0007; KW-0175; KW-0181; KW-0206; KW-0225; KW-0325; KW-0403; KW-0539; KW-0597; KW-0702; KW-0832; KW-0898; KW-0903; KW-0945; KW-0963; KW-1017; KW-1185,,,,,"DISEASE: Cataract 30, multiple types (CTRCT30) [MIM:116300]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. {ECO:0000269|PubMed:19126778, ECO:0000269|PubMed:26694549, ECO:0000269|PubMed:28450710}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Filament disassembly during mitosis is promoted by phosphorylation at Ser-55 as well as by nestin (By similarity). One of the most prominent phosphoproteins in various cells of mesenchymal origin. Phosphorylation is enhanced during cell division, at which time vimentin filaments are significantly reorganized. Phosphorylation by PKN1 inhibits the formation of filaments. Phosphorylated at Ser-56 by CDK5 during neutrophil secretion in the cytoplasm (PubMed:21465480). Phosphorylated by STK33 (PubMed:18811945). Phosphorylated on tyrosine residues by SRMS (PubMed:29496907). {ECO:0000250|UniProtKB:P31000, ECO:0000269|PubMed:18811945, ECO:0000269|PubMed:21465480, ECO:0000269|PubMed:29496907, ECO:0000269|Ref.14}.; PTM: O-glycosylated during cytokinesis at sites identical or close to phosphorylation sites, this interferes with the phosphorylation status. {ECO:0000269|PubMed:20068230}.; PTM: S-nitrosylation is induced by interferon-gamma and oxidatively-modified low-densitity lipoprotein (LDL(ox)) possibly implicating the iNOS-S100A8/9 transnitrosylase complex. {ECO:0000305|PubMed:25417112}.",CHAIN 2 466 Vimentin. /FTId=PRO_0000063754.,"CROSSLNK 104 104 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 120 120 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 129 129 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 139 139 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 223 223 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 262 262 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 294 294 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 313 313 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 373 373 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 439 439 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 445 445 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate. {ECO:0000244|PubMed:25114211}.; CROSSLNK 445 445 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:25114211, ECO:0000244|PubMed:28112733}.",,CARBOHYD 7 7 O-linked (GlcNAc) serine; alternate. {ECO:0000269|PubMed:20068230}.; CARBOHYD 33 33 O-linked (GlcNAc) threonine. {ECO:0000269|PubMed:20068230}.; CARBOHYD 34 34 O-linked (GlcNAc) serine; alternate. {ECO:0000269|PubMed:20068230}.,INIT_MET 1 1 Removed. {ECO:0000269|Ref.13}.,,"MOD_RES 2 2 N-acetylserine. {ECO:0000269|Ref.13}.; MOD_RES 5 5 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000269|PubMed:14762106}.; MOD_RES 7 7 Phosphoserine; by PKA and PKC; alternate. {ECO:0000269|PubMed:14762106}.; MOD_RES 8 8 Phosphoserine. {ECO:0000269|PubMed:14762106}.; MOD_RES 9 9 Phosphoserine; by PKC. {ECO:0000269|PubMed:14762106}.; MOD_RES 10 10 Phosphoserine; by PKC. {ECO:0000269|PubMed:14762106}.; MOD_RES 20 20 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 25 25 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 26 26 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 34 34 Phosphoserine; by PKC; alternate. {ECO:0000244|PubMed:18669648}.; MOD_RES 39 39 Phosphoserine; by CaMK2, PKA, PKC and ROCK2. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:14762106}.; MOD_RES 42 42 Phosphoserine; by PKC. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:14762106}.; MOD_RES 47 47 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 49 49 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 51 51 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 53 53 Phosphotyrosine. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 55 55 Phosphoserine. {ECO:0000250|UniProtKB:P31000}.; MOD_RES 56 56 Phosphoserine; by CDK5 and CDK1. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:21465480, ECO:0000269|Ref.14}.; MOD_RES 61 61 Phosphotyrosine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 66 66 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 72 72 Phosphoserine; by AURKB and ROCK2. {ECO:0000244|PubMed:18669648, ECO:0000269|PubMed:12458200, ECO:0000269|PubMed:14762106}.; MOD_RES 73 73 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:14762106}.; MOD_RES 83 83 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 87 87 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 117 117 Phosphotyrosine. {ECO:0000244|PubMed:15592455}.; MOD_RES 120 120 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 120 120 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 129 129 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 129 129 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 139 139 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 144 144 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 168 168 N6-acetyllysine. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 188 188 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 188 188 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 214 214 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 223 223 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 226 226 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 235 235 N6-acetyllysine. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 294 294 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 294 294 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 299 299 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 325 325 Phosphoserine. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 373 373 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 409 409 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 412 412 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231}.; MOD_RES 419 419 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 420 420 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:14762106}.; MOD_RES 426 426 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 430 430 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:14762106}.; MOD_RES 436 436 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 438 438 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 445 445 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 445 445 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P20152}.; MOD_RES 446 446 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 458 458 Phosphothreonine. {ECO:0000269|PubMed:14762106}.; MOD_RES 459 459 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:14762106}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M14144;X56134;AF328728;Z19554;AK056766;AK097336;AK290643;CR407690;AK222507;AK222602;EF445046;EF445046;CH471072;CH471072;BC000163;BC030573;BC066956;X16478;M18895;M18888;M18889;M18890;M18891;M18892;M18893;M18894;M25246;
0,P09493,TPM1_HUMAN,TPM1 C15orf13 TMSA,TPM1,C15orf13 TMSA,,,Homo sapiens (Human),9606,Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1),UP000005640: Chromosome 15,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDAIKKKMQMLKLDKENALDRAEQAEADKKAAEDRSKQLEDELVSLQKKLKGTEDELDKYSEALKDAQEKLELAEKKATDAEADVASLNRRIQLVEEELDRAQERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEELKTVTNNLKSLEAQAEKYSQKEDRYEEEIKVLSDKLKEAETRAEFAERSVTKLEKSIDDLEDELYAQKLKYKAISEELDHALNDMTSI,284,"32,709",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=10;  Comment=Additional isoforms seem to exist.; Name=1; Synonyms=Skeletal muscle, TPM1alpha; IsoId=P09493-1; Sequence=Displayed; Name=2; Synonyms=Smooth muscle; IsoId=P09493-2; Sequence=VSP_006576, VSP_006578, VSP_006579; Note=Incomplete sequence. {ECO:0000244|PubMed:24275569}; Name=3; Synonyms=Fibroblast, TM3; IsoId=P09493-3; Sequence=VSP_006577, VSP_006579; Name=4; IsoId=P09493-4; Sequence=VSP_006577; Name=5; IsoId=P09493-5; Sequence=VSP_017498, VSP_017499; Name=6; Synonyms=10, TPM1kappa; IsoId=P09493-6; Sequence=VSP_036064; Name=7; IsoId=P09493-7; Sequence=VSP_036064, VSP_006579; Note=No experimental confirmation available.; Name=8; IsoId=P09493-8; Sequence=VSP_047297, VSP_047298, VSP_047299, VSP_047300, VSP_006579; Note=Gene prediction based on EST data. {ECO:0000244|PubMed:19608861}; Name=9; IsoId=P09493-9; Sequence=VSP_006579; Note=Gene prediction based on EST data.; Name=10; IsoId=P09493-10; Sequence=VSP_047299, VSP_047300, VSP_047301; Note=No experimental confirmation available. {ECO:0000244|PubMed:19608861}; ",,,,,,MASS SPECTROMETRY: Mass=32875.93; Method=MALDI; Range=1-284 (P09493-3); Evidence={ECO:0000269|PubMed:11840567};,,,,"VAR_SEQ 1 80 MDAIKKKMQMLKLDKENALDRAEQAEADKKAAEDRSKQLEDELVSLQKKLKGTEDELDKYSEALKDAQEKLELAEKKATD -> MCRLRIFLRTASSEHLHERKLRET (in isoform 2). {ECO:0000303|PubMed:3138425}. /FTId=VSP_006576.; VAR_SEQ 1 80 MDAIKKKMQMLKLDKENALDRAEQAEADKKAAEDRSKQLEDELVSLQKKLKGTEDELDKYSEALKDAQEKLELAEKKATD -> MAGSSSLEAVRRKIRSLQEQADAAEERAGTLQRELDHERKLRET (in isoform 5). {ECO:0000303|PubMed:15489334}. /FTId=VSP_017498.; VAR_SEQ 41 80 DELVSLQKKLKGTEDELDKYSEALKDAQEKLELAEKKATD -> EDIAAKEKLLRVSEDERDRVLEELHKAEDSLLAAEEAAAK (in isoform 6 and isoform 7). {ECO:0000303|PubMed:15249230, ECO:0000303|PubMed:17974005}. /FTId=VSP_036064.; VAR_SEQ 41 53 DELVSLQKKLKGT -> EDIAAKEKLLRVS (in isoform 8). {ECO:0000305}. /FTId=VSP_047297.; VAR_SEQ 57 80 LDKYSEALKDAQEKLELAEKKATD -> RDRVLEELHKAEDSLLAAEEAAAK (in isoform 8). {ECO:0000305}. /FTId=VSP_047298.; VAR_SEQ 189 212 KCAELEEELKTVTNNLKSLEAQAE -> QVRQLEEQLRIMDSDLESINAAED (in isoform 2). {ECO:0000303|PubMed:3138425}. /FTId=VSP_006578.; VAR_SEQ 189 212 KCAELEEELKTVTNNLKSLEAQAE -> QVRQLEEQLRIMDQTLKALMAAED (in isoform 3 and isoform 4). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:3336357, ECO:0000303|PubMed:3336363}. /FTId=VSP_006577.; VAR_SEQ 189 192 KCAE -> QVRQ (in isoform 8 and isoform 10). {ECO:0000305}. /FTId=VSP_047299.; VAR_SEQ 196 212 ELKTVTNNLKSLEAQAE -> QLRIMDQTLKALMAAED (in isoform 8 and isoform 10). {ECO:0000305}. /FTId=VSP_047300.; VAR_SEQ 258 284 DELYAQKLKYKAISEELDHALNDMTSI -> EKVAHAKEENLSMHQMLDQTLLELNNM (in isoform 2, isoform 3, isoform 7, isoform 8 and isoform 9). {ECO:0000303|PubMed:17974005, ECO:0000303|PubMed:3138425, ECO:0000303|PubMed:3336357, ECO:0000303|PubMed:3336363}. /FTId=VSP_006579.; VAR_SEQ 259 284 ELYAQKLKYKAISEELDHALNDMTSI -> QLYQQLEQNRRLTNELKLALNED (in isoform 5). {ECO:0000303|PubMed:15489334}. /FTId=VSP_017499.; VAR_SEQ 284 284 I -> M (in isoform 10). {ECO:0000305}. /FTId=VSP_047301.","VARIANT 40 40 E -> K (in CMD1Y; dbSNP:rs104894501). {ECO:0000269|PubMed:11273725}. /FTId=VAR_043986.; VARIANT 54 54 E -> K (in CMD1Y; dbSNP:rs104894505). {ECO:0000269|PubMed:11273725}. /FTId=VAR_043987.; VARIANT 63 63 A -> V (in CMH3; dbSNP:rs199476306). {ECO:0000269|PubMed:8523464}. /FTId=VAR_013135.; VARIANT 175 175 D -> N (in CMH3; no change in homodimerization; no change in homodimer thermal stability; decreased actin binding; recessive effect in the homodimer; increased calcium-dependent regulation of myosin binding to actin filaments; dominant effect in the homodimer; dbSNP:rs104894503). {ECO:0000269|PubMed:23170982, ECO:0000269|PubMed:7898523, ECO:0000269|PubMed:8205619, ECO:0000269|PubMed:8523464, ECO:0000269|PubMed:9822100}. /FTId=VAR_007601.; VARIANT 180 180 E -> G (in CMH3; no change in homodimerization; decreased in hom odimer thermal stability; decreased in actin binding; increased calcium-dependent regulation of myosin binding to actin filaments; dominant effect in the homodimer; dbSNP:rs104894502). {ECO:0000269|PubMed:23170982, ECO:0000269|PubMed:8205619}. /FTId=VAR_007602.; VARIANT 180 180 E -> V (in CMH3; dbSNP:rs104894502). {ECO:0000269|PubMed:12974739}. /FTId=VAR_029452.; VARIANT 192 192 E -> K (in LVNC9; dbSNP:rs199476315). {ECO:0000269|PubMed:21551322}. /FTId=VAR_070121.; VARIANT 248 248 K -> E (in LVNC9; dbSNP:rs199476319). {ECO:0000269|PubMed:21551322}. /FTId=VAR_070122.",,,,CONFLICT 109 109 A -> V (in Ref. 11; CAA30930). {ECO:0000305}.; CONFLICT 203 203 N -> D (in Ref. 4; AAT68294/AAT68295). {ECO:0000305}.,,2,,0,DOMAIN: The molecule is in a coiled coil structure that is formed by 2 polypeptide chains. The sequence exhibits a prominent seven-residues periodicity.,SIMILARITY: Belongs to the tropomyosin family. {ECO:0000305}.,COILED 1 284 {ECO:0000250}.,,,,,,,,,,,,"FUNCTION: Binds to actin filaments in muscle and non-muscle cells (PubMed:23170982). Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction (PubMed:23170982). Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments.",,,,,,,,,,,,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; bleb [GO:0032059]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; muscle thin filament tropomyosin [GO:0005862]; ruffle membrane [GO:0032587]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; negative regulation of cell migration [GO:0030336]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cell adhesion [GO:0045785]; positive regulation of heart rate by epinephrine [GO:0003065]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of heart contraction [GO:0008016]; regulation of muscle contraction [GO:0006937]; ruffle organization [GO:0031529]; sarcomere organization [GO:0045214]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; wound healing [GO:0042060],actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; negative regulation of cell migration [GO:0030336]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cell adhesion [GO:0045785]; positive regulation of heart rate by epinephrine [GO:0003065]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of heart contraction [GO:0008016]; regulation of muscle contraction [GO:0006937]; ruffle organization [GO:0031529]; sarcomere organization [GO:0045214]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; wound healing [GO:0042060],actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; bleb [GO:0032059]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; muscle thin filament tropomyosin [GO:0005862]; ruffle membrane [GO:0032587]; sarcomere [GO:0030017]; stress fiber [GO:0001725],GO:0001701; GO:0001725; GO:0003065; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005862; GO:0005884; GO:0006936; GO:0006937; GO:0007010; GO:0007015; GO:0008016; GO:0008092; GO:0008307; GO:0008360; GO:0015629; GO:0030017; GO:0030049; GO:0030336; GO:0031529; GO:0032059; GO:0032587; GO:0032781; GO:0034614; GO:0042060; GO:0042802; GO:0042803; GO:0045214; GO:0045785; GO:0046982; GO:0051015; GO:0051496; GO:0055010; GO:0060048; GO:1904706; GO:1904753,IPR000533; ,Q8TAB5; Q8TC20; Q8TC20-4; Q08379; V9HW56; O14879; Q9BQD3; Q9Y6D9; Q8N0S2; P0C1Z6; P0C1Z6-2; P13805; P13805-3,"SUBUNIT: Homodimer (PubMed:23170982). Heterodimer of an alpha (TPM1, TPM3 or TPM4) and a beta (TPM2) chain (By similarity). Interacts with HRG (via the HRR domain); the interaction contributes to the antiangiogenic properties of the histidine/proline-rich region (HRR) of HRG (By similarity). Interacts (via N-terminus) with LMOD2 (via N-terminus) and TMOD1 (via N-terminus) (PubMed:26873245). {ECO:0000250, ECO:0000250|UniProtKB:P04268, ECO:0000250|UniProtKB:P04692, ECO:0000269|PubMed:23170982, ECO:0000269|PubMed:26873245}.",3548719; 3336357; 3336363; 15249230; 14702039; 17974005; 16572171; 15489334; 3138425; 8450225; 11840567; 17895359; 18669648; 19608861; 21269460; 23170982; 24275569; 26873245; 8205619; 8523464; 7898523; 9822100; 11273725; 12974739; 21551322,3548719; 3336357; 3336363; 15249230; 14702039; 17974005; 16572171; 15489334; 3138425; 8450225; 11840567; 17895359; 18669648; 19608861; 21269460; 23170982; 24275569; 26873245; 8205619; 8523464; 7898523; 9822100; 11273725; 12974739; 21551322; 10747208; 11457814; 11964245; 12065096; 12169652; 12473556; 12527301; 12577067; 12686598; 13679858; 14743216; 15000344; 15031138; 15269838; 15479242; 15695827; 15897890; 16094730; 16189514; 16260624; 17360712; 17556170; 17615292; 17932326; 18403758; 18513529; 18937355; 19035361; 19150014; 19222994; 1930128; 19509158; 19646950; 19678923; 19805454; 19820697; 19853701; 19875404; 19913121; 20031618; 20065163; 20075843; 20215591; 20359594; 20360068; 20379614; 20381070; 20465283; 20474083; 20618440; 20628086; 20965760; 21274714; 21295541; 21320446; 21376702; 21454502; 21516116; 21741356; 21817107; 21949785; 22155441; 22187526; 22304920; 22447464; 22462493; 22737252; 22740512; 22789852; 22958892; 22965424; 23147248; 23205574; 23254774; 23414517; 23420843; 23782526; 23792823; 24005378; 24036449; 24112450; 24255178; 24502978; 24585742; 24958154; 25241052; 2526655; 25408381; 25416956; 25548289; 25607779; 25609649; 25873252; 26200873; 26400351; 26496610; 26792422; 26804624; 26805581; 26960954; 27020427; 27112294; 27177193; 27402877; 27420374; 2764880; 27649540; 27878731; 27976512; 27983818; 28276320; 28359939; 28603979; 28732641; 28754317; 29024827; 29105867; 29278453; 29496559; 30390420; 3780718; 7704029; 8774330,1989-07-01,2019-02-13,1990-11-01,207,X-ray crystallography (2),,HELIX 1 28 {ECO:0000244|PDB:5KHT}.,,,,,,5 out of 5,Alternative sequence (12); Chain (1); Coiled coil (1); Helix (1); Mass spectrometry (1); Modified residue (15); Mutagenesis (3); Natural variant (8); Sequence conflict (3),,"TISSUE SPECIFICITY: Detected in primary breast cancer tissues but undetectable in normal breast tissues in Sudanese patients. Isoform 1 is expressed in adult and fetal skeletal muscle and cardiac tissues, with higher expression levels in the cardiac tissues. Isoform 10 is expressed in adult and fetal cardiac tissues, but not in skeletal muscle. {ECO:0000269|PubMed:15249230, ECO:0000269|Ref.15}.",,3D-structure;Acetylation;Actin-binding;Alternative splicing;Cardiomyopathy;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Muscle protein;Phosphoprotein;Reference proteome,Evidence at protein level,reviewed,,Tropomyosin family,207,Alternative products (1); Caution (5); Domain (1); Function (1); Involvement in disease (3); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0009; KW-0025; KW-0122; KW-0175; KW-0181; KW-0206; KW-0225; KW-0514; KW-0597; KW-0903; KW-0963; KW-1185,,,,,"DISEASE: Cardiomyopathy, familial hypertrophic 3 (CMH3) [MIM:115196]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:23170982, ECO:0000269|PubMed:7898523, ECO:0000269|PubMed:8205619, ECO:0000269|PubMed:8523464, ECO:0000269|PubMed:9822100}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1Y (CMD1Y) [MIM:611878]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11273725}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Left ventricular non-compaction 9 (LVNC9) [MIM:611878]: A form of left ventricular non-compaction, a cardiomyopathy due to myocardial morphogenesis arrest and characterized by a hypertrophic left ventricle, a severely thickened 2-layered myocardium, numerous prominent trabeculations, deep intertrabecular recesses, and poor systolic function. Clinical manifestations are variable. Some affected individuals experience no symptoms at all, others develop heart failure. In some cases, left ventricular non-compaction is associated with other congenital heart anomalies. LVNC9 is an autosomal dominant condition. {ECO:0000269|PubMed:21551322}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: Phosphorylated at Ser-283 by DAPK1 in response to oxidative stress and this phosphorylation enhances stress fiber formation in endothelial cells. {ECO:0000269|PubMed:17895359}.,CHAIN 1 284 Tropomyosin alpha-1 chain. /FTId=PRO_0000205620.,,,,,,MOD_RES 1 1 N-acetylmethionine. {ECO:0000269|PubMed:3548719}.; MOD_RES 45 45 Phosphoserine. {ECO:0000250|UniProtKB:P04692}.; MOD_RES 174 174 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 186 186 Phosphoserine. {ECO:0000250|UniProtKB:P58771}.; MOD_RES 206 206 Phosphoserine. {ECO:0000250|UniProtKB:P58771}.; MOD_RES 252 252 Phosphoserine. {ECO:0000250|UniProtKB:P58771}.; MOD_RES 261 261 Phosphotyrosine. {ECO:0000250|UniProtKB:P04692}.; MOD_RES 271 271 Phosphoserine. {ECO:0000250|UniProtKB:P58771}.; MOD_RES 283 283 Phosphoserine; by DAPK1. {ECO:0000269|PubMed:17895359}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M19267;M19713;M19714;M19715;AY640414;AY640415;AK299387;AL050179;GU324929;GU324930;GU324933;GU324935;CH471082;CH471082;CH471082;CH471082;CH471082;BC007433;BC050473;BC053545;X12369;
0,P11021,BIP_HUMAN,HSPA5 GRP78,HSPA5,GRP78,,,Homo sapiens (Human),9606,Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein),UP000005640: Chromosome 9,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MKLSLVAAMLLLLSAARAEEEDKKEDVGTVVGIDLGTTYSCVGVFKNGRVEIIANDQGNRITPSYVAFTPEGERLIGDAAKNQLTSNPENTVFDAKRLIGRTWNDPSVQQDIKFLPFKVVEKKTKPYIQVDIGGGQTKTFAPEEISAMVLTKMKETAEAYLGKKVTHAVVTVPAYFNDAQRQATKDAGTIAGLNVMRIINEPTAAAIAYGLDKREGEKNILVFDLGGGTFDVSLLTIDNGVFEVVATNGDTHLGGEDFDQRVMEHFIKLYKKKTGKDVRKDNRAVQKLRREVEKAKRALSSQHQARIEIESFYEGEDFSETLTRAKFEELNMDLFRSTMKPVQKVLEDSDLKKSDIDEIVLVGGSTRIPKIQQLVKEFFNGKEPSRGINPDEAVAYGAAVQAGVLSGDQDTGDLVLLDVCPLTLGIETVGGVMTKLIPRNTVVPTKKSQIFSTASDNQPTVTIKVYEGERPLTKDNHLLGTFDLTGIPPAPRGVPQIEVTFEIDVNGILRVTAEDKGTGNKNKITITNDQNRLTPEEIERMVNDAEKFAEEDKKLKERIDTRNELESYAYSLKNQIGDKEKLGGKLSSEDKETMEKAVEEKIEWLESHQDADIEDFKAKKKELEEIVQPIISKLYGSAGPPPTGEEDTAEKDEL,654,"72,333",,,,,,,,,,,,,VARIANT 543 543 N -> H (in dbSNP:rs35356639). {ECO:0000269|Ref.5}. /FTId=VAR_025815.,,,,CONFLICT 297 297 Missing (in Ref. 1; AAA52614 and 2; CAA61201). {ECO:0000305}.; CONFLICT 418 418 D -> H (in Ref. 1; AAA52614 and 2; CAA61201). {ECO:0000305}.; CONFLICT 439 439 R -> S (in Ref. 1; AAA52614 and 2; CAA61201). {ECO:0000305}.; CONFLICT 447 447 K -> N (in Ref. 1; AAA52614 and 2; CAA61201). {ECO:0000305}.,,2,,0,"DOMAIN: The interdomain linker regulates the chaperone activity by mediating the formation of homooligomers. Homooligomers are formed by engagement of the interdomain linker of one HSPA5/BiP molecule as a typical substrate of an adjacent HSPA5/BiP molecule. HSPA5/BiP oligomerization inactivates participating HSPA5/BiP protomers. HSPA5/BiP oligomers probably act as reservoirs to store HSPA5/BiP molecules when they are not needed by the cell. When the levels of unfolded proteins rise, cells can rapidly break up these oligomers to make active monomers. {ECO:0000250|UniProtKB:G3I8R9}.",SIMILARITY: Belongs to the heat shock protein 70 family. {ECO:0000305}.,,,,MOTIF 651 654 Prevents secretion from ER. {ECO:0000255}.,REGION 125 280 Nucleotide-binding (NBD). {ECO:0000303|PubMed:28286085}.; REGION 409 419 Interdomain linker. {ECO:0000250|UniProtKB:G3I8R9}.; REGION 420 500 Substrate-binding (SBD). {ECO:0000303|PubMed:28286085}.,,,3.6.4.10,,"CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.10; Evidence={ECO:0000269|PubMed:26655470};",,,"FUNCTION: Endoplasmic reticulum chaperone that plays a key role in protein folding and quality control in the endoplasmic reticulum lumen (PubMed:2294010, PubMed:23769672, PubMed:23990668, PubMed:28332555). Involved in the correct folding of proteins and degradation of misfolded proteins via its interaction with DNAJC10/ERdj5, probably to facilitate the release of DNAJC10/ERdj5 from its substrate (By similarity). Acts as a key repressor of the ERN1/IRE1-mediated unfolded protein response (UPR) (PubMed:1550958, PubMed:19538957). In the unstressed endoplasmic reticulum, recruited by DNAJB9/ERdj4 to the luminal region of ERN1/IRE1, leading to disrupt the dimerization of ERN1/IRE1, thereby inactivating ERN1/IRE1 (By similarity). Accumulation of misfolded protein in the endoplasmic reticulum causes release of HSPA5/BiP from ERN1/IRE1, allowing homodimerization and subsequent activation of ERN1/IRE1 (By similarity). Plays an auxiliary role in post-translational transport of small presecretory proteins across endoplasmic reticulum (ER). May function as an allosteric modulator for SEC61 channel-forming translocon complex, likely cooperating with SEC62 to enable the productive insertion of these precursors into SEC61 channel. Appears to specifically regulate translocation of precursors having inhibitory residues in their mature region that weaken channel gating. {ECO:0000250|UniProtKB:G3I8R9, ECO:0000250|UniProtKB:P20029, ECO:0000269|PubMed:1550958, ECO:0000269|PubMed:19538957, ECO:0000269|PubMed:2294010, ECO:0000269|PubMed:23769672, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:28332555, ECO:0000269|PubMed:29719251}.",,,,,,,BINDING 96 96 ATP. {ECO:0000269|PubMed:21526763}.,,,NP_BIND 36 39 ATP. {ECO:0000269|PubMed:21526763}.; NP_BIND 227 229 ATP. {ECO:0000269|PubMed:21526763}.; NP_BIND 293 300 ATP. {ECO:0000269|PubMed:21526763}.; NP_BIND 364 367 ATP. {ECO:0000269|PubMed:21526763}.,,"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; ATF6-mediated unfolded protein response [GO:0036500]; cellular response to antibiotic [GO:0071236]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to unfolded protein [GO:0034620]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; IRE1-mediated unfolded protein response [GO:0036498]; luteolysis [GO:0001554]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein homodimerization activity [GO:0090074]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; protein folding in endoplasmic reticulum [GO:0034975]; protein refolding [GO:0042026]; regulation of ATF6-mediated unfolded protein response [GO:1903891]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of PERK-mediated unfolded protein response [GO:1903897]; regulation of protein folding in endoplasmic reticulum [GO:0060904]; response to cocaine [GO:0042220]; response to methamphetamine hydrochloride [GO:1904313]; response to unfolded protein [GO:0006986]; stress response to metal ion [GO:0097501]; substantia nigra development [GO:0021762]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433]",ATF6-mediated unfolded protein response [GO:0036500]; cellular response to antibiotic [GO:0071236]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to unfolded protein [GO:0034620]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; IRE1-mediated unfolded protein response [GO:0036498]; luteolysis [GO:0001554]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein homodimerization activity [GO:0090074]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; protein folding in endoplasmic reticulum [GO:0034975]; protein refolding [GO:0042026]; regulation of ATF6-mediated unfolded protein response [GO:1903891]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of PERK-mediated unfolded protein response [GO:1903897]; regulation of protein folding in endoplasmic reticulum [GO:0060904]; response to cocaine [GO:0042220]; response to methamphetamine hydrochloride [GO:1904313]; response to unfolded protein [GO:0006986]; stress response to metal ion [GO:0097501]; substantia nigra development [GO:0021762]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433],"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]",cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790],GO:0001554; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005793; GO:0005829; GO:0005886; GO:0005925; GO:0006983; GO:0006986; GO:0009986; GO:0010976; GO:0016020; GO:0016887; GO:0019899; GO:0019904; GO:0021589; GO:0021680; GO:0021762; GO:0030176; GO:0030182; GO:0030335; GO:0030433; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031398; GO:0031625; GO:0032991; GO:0034605; GO:0034620; GO:0034663; GO:0034975; GO:0035437; GO:0035690; GO:0036498; GO:0036499; GO:0036500; GO:0042026; GO:0042149; GO:0042220; GO:0042470; GO:0042623; GO:0043022; GO:0043066; GO:0043231; GO:0044183; GO:0045296; GO:0051082; GO:0051085; GO:0051087; GO:0051402; GO:0051787; GO:0060904; GO:0070062; GO:0071236; GO:0071277; GO:0071287; GO:0071320; GO:0071353; GO:0071480; GO:0090074; GO:0097501; GO:1901998; GO:1903891; GO:1903894; GO:1903895; GO:1903897; GO:1904313; GO:1990090; GO:1990440,IPR018181; IPR029048; IPR029047; IPR013126; ,Q6T424; P31749; P18850; Q6E0U4; Q9UBS4; Q91YW3; Q9NZJ5; O75460; O75460-1; P14625; Q9Y4L1; Q96IZ0; Q62627; Q15084; P04049; P61619,"SUBUNIT: Monomer and homooligomer; homooligomerization via the interdomain linker inactivates the chaperone activity and acts as a storage of HSPA5/BiP molecules (By similarity). Interacts with DNAJC1 (via J domain) (By similarity). Component of an EIF2 complex at least composed of CELF1/CUGBP1, CALR, CALR3, EIF2S1, EIF2S2, HSP90B1 and HSPA5 (By similarity). Part of a large chaperone multiprotein complex comprising DNAJB11, HSP90B1, HSPA5, HYOU, PDIA2, PDIA4, PDIA6, PPIB, SDF2L1, UGT1A1 and very small amounts of ERP29, but not, or at very low levels, CALR nor CANX (By similarity). Interacts with TMEM132A and TRIM21 (PubMed:12699405). May form a complex with ERLEC1, OS9, SEL1L and SYVN1 (PubMed:18264092,PubMed:18502753). Interacts with DNAJC10 (PubMed:12411443, PubMed:23769672). Interacts with DNAJB9/ERdj4; leading to recruit HSPA5/BiP to ERN1/IRE1 (By similarity). Interacts with ERN1/IRE1; interaction takes place following interaction with DNAJB9/ERdj4 and leads to inactivate ERN1/IRE1 (By similarity). Interacts with MX1 (By similarity). Interacts with METTL23 (PubMed:23349634). Interacts with CEMIP; the interaction induces calcium leakage from the endoplasmic reticulum and cell migration (PubMed:23990668). Interacts with PCSK4 form; the interaction takes place in the endoplasmic reticulum (PubMed:21080038). Interacts with CIPC (PubMed:26657846). Interacts with CCDC88B (via C-terminus); the interaction opposes ERN1-mediated JNK activation, protecting against apoptosis (PubMed:21289099). Interacts with INPP5K; necessary for INPP5K localization at the endoplasmic reticulum (PubMed:26940976). Interacts with MANF; the interaction is direct (PubMed:22637475). Interacts with LOXL2; leading to activate the ERN1/IRE1-XBP1 pathway of the unfolded protein response (PubMed:28332555). {ECO:0000250|UniProtKB:G3I8R9, ECO:0000250|UniProtKB:P20029, ECO:0000269|PubMed:12411443, ECO:0000269|PubMed:12699405, ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:18502753, ECO:0000269|PubMed:21080038, ECO:0000269|PubMed:21289099, ECO:0000269|PubMed:22637475, ECO:0000269|PubMed:23349634, ECO:0000269|PubMed:23769672, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:26657846, ECO:0000269|PubMed:26940976, ECO:0000269|PubMed:28332555}.",2840249; 15164053; 15489334; 1480470; 11160188; 9150946; 2294010; 9150948; 1550958; 20068231; 21269460; 21289099; 23349634; 12475965; 12699405; 12411443; 12643545; 17081065; 18502753; 18264092; 19538957; 21080038; 22637475; 22905912; 23921388; 23990668; 23769672; 24275569; 24129315; 25218447; 25114211; 25601083; 25755297; 25944712; 26657846; 26940976; 28286085; 28112733; 28332555; 29719251; 29497057; 20072699; 21526763; 26655470,2840249; 15164053; 15489334; 1480470; 11160188; 9150946; 2294010; 9150948; 1550958; 20068231; 21269460; 21289099; 23349634; 12475965; 12699405; 12411443; 12643545; 17081065; 18502753; 18264092; 19538957; 21080038; 22637475; 22905912; 23921388; 23990668; 23769672; 24275569; 24129315; 25218447; 25114211; 25601083; 25755297; 25944712; 26657846; 26940976; 28286085; 28112733; 28332555; 29719251; 29497057; 20072699; 21526763; 26655470; 10064069; 10777614; 10954706; 11160214; 11514579; 11719466; 11752154; 11821395; 11897784; 11907036; 12076252; 12097557; 12110171; 12480769; 12516782; 12552023; 12577067; 12621026; 12665508; 12713871; 12840015; 12853476; 12974469; 14681859; 14743216; 14973138; 15077298; 15161933; 15324660; 15514946; 15525676; 15618547; 15657067; 15657421; 15664986; 15778089; 15802566; 15817150; 1586970; 15899857; 15949590; 16097032; 16168956; 16169070; 16182273; 16282978; 16306228; 16329989; 16400691; 16428306; 16472112; 16497268; 16543232; 16567808; 16731524; 16880273; 16912156; 16912197; 16973740; 17002502; 17062670; 17110338; 17139257; 17174955; 17184779; 17215244; 17220478; 17431395; 1754405; 17601350; 17620599; 17640713; 17670764; 17728248; 17805346; 17848573; 17906960; 17931354; 17932454; 17936241; 17942541; 17956313; 17979178; 17991893; 18022401; 18064632; 18083346; 18192872; 18278507; 18331622; 18343577; 18403493; 18411300; 18457437; 18482745; 18550409; 18556570; 18654987; 18708056; 18708359; 18720263; 18757373; 18776923; 18781276; 18790759; 18840615; 18842681; 18850735; 18923428; 18923430; 18977241; 19014922; 19017364; 19097122; 19103594; 19107326; 19128512; 19135240; 19151922; 19156129; 19164805; 19165527; 19167051; 19188365; 19196713; 19212831; 19228285; 19236758; 19296942; 19309398; 19343720; 19386345; 19411306; 19421146; 19470730; 19482905; 19486527; 19533686; 19546472; 19616278; 19626590; 19632185; 19671925; 19674193; 19713465; 19718440; 19722195; 19738201; 19741001; 19765186; 19776128; 19805454; 19823030; 19838160; 19838163; 19842229; 19845896; 19950238; 20017148; 20072656; 20082722; 20085233; 20145413; 20176102; 20204278; 20208072; 20213805; 20335166; 20360535; 20467437; 20473863; 20484513; 20492754; 20497865; 20506407; 20525207; 20562859; 20605795; 20618438; 20651985; 20664690; 20672702; 20720212; 20735358; 20739513; 20869947; 20936779; 20979610; 21056970; 21112319; 21137052; 21156321; 21182205; 21189163; 21199322; 21221131; 21343306; 21374734; 21382870; 21389343; 21418596; 21445305; 21467168; 21472681; 21479362; 21503958; 21565611; 21597391; 21622563; 21642380; 21673190; 21779363; 21800051; 21840908; 21890413; 21911578; 21940774; 21947079; 21947694; 21988832; 22004425; 22028648; 22038833; 22076227; 22146569; 22157815; 22215138; 22297694; 22306319; 22425662; 22430489; 22446326; 22460328; 22472071; 22495374; 22527697; 22528773; 22541429; 22543280; 22546345; 22581315; 22613557; 22623428; 22627132; 22689054; 22735594; 22751133; 22752300; 22796945; 22801219; 22810585; 22851173; 22855534; 22889453; 22912664; 22945507; 22996014; 23056589; 23085757; 23089287; 23123197; 23161089; 23200913; 23220234; 23280503; 23322163; 23363602; 23378021; 23386615; 23402331; 23416888; 23428538; 23456958; 23457489; 23470966; 23485528; 23544152; 23575540; 23578665; 23721263; 23759331; 23760505; 23818965; 23823123; 23922175; 24002052; 24048331; 24080088; 24113381; 24126384; 24189400; 24244613; 24314144; 24383061; 2450918; 24512104; 24516643; 24526410; 24587347; 24602846; 24749068; 24756776; 24766948; 24781973; 24795528; 24810055; 24821775; 24829380; 24853418; 24882382; 24924946; 24977433; 24982359; 25017472; 25059665; 25194164; 25212833; 25216103; 25218495; 25227822; 25239945; 25270224; 25277244; 25277658; 25292337; 25301734; 25333575; 25336069; 25338653; 25360516; 25403445; 25431258; 25480418; 25516752; 25519021; 25546329; 25588955; 25605012; 25609649; 25618598; 25669168; 25673690; 25691589; 25692299; 25748049; 25750184; 25778936; 25798051; 25823022; 25921171; 25934251; 25958313; 25973748; 25976624; 26005757; 26025442; 26045166; 26064972; 26075355; 26085089; 26119938; 26147472; 26202523; 26327128; 26472187; 26496610; 26504039; 26514267; 26530532; 26593250; 26614265; 26618558; 26638075; 26740554; 26752685; 26939701; 26952514; 27002159; 27004760; 27012209; 27016417; 27034162; 27129228; 27129294; 27130664; 27144892; 27185209; 27254284; 27391061; 27502501; 27566407; 27573888; 27634156; 27698188; 27713511; 27771165; 27779201; 27791469; 27814589; 27815359; 27822448; 27845899; 27881906; 27918543; 27986562; 28038712; 28038917; 28052026; 28054532; 28102850; 28110670; 28157699; 28176394; 28177155; 28186997; 28202509; 28236071; 28245171; 28258248; 28320302; 28389416; 28393217; 28394345; 28407787; 28423613; 28457968; 28464871; 28550415; 28586043; 28601093; 28618969; 28639913; 28645527; 28679661; 28720068; 28739722; 28854502; 28870813; 28947141; 28949004; 28951310; 29024602; 29048640; 29066620; 29073630; 29084938; 29178343; 29185956; 29198525; 29226519; 29251598; 29276183; 29292760; 29323121; 29368272; 29410209; 29445274; 29458176; 29481792; 29593095; 29650944; 29654145; 29665387; 29749510; 29932125; 30015969; 30407281; 6457647; 7585962; 7642652; 7876241; 8509403; 8721986; 9305631; 9605141; 9873016; 9920933,1989-07-01,2019-02-13,2001-07-11,221,X-ray crystallography (16),STRAND 31 34 {ECO:0000244|PDB:5F0X}.; STRAND 37 45 {ECO:0000244|PDB:5F0X}.; STRAND 47 52 {ECO:0000244|PDB:5F0X}.; STRAND 60 63 {ECO:0000244|PDB:5F0X}.; STRAND 66 68 {ECO:0000244|PDB:5F0X}.; STRAND 74 76 {ECO:0000244|PDB:5F0X}.; STRAND 91 93 {ECO:0000244|PDB:6ASY}.; STRAND 116 122 {ECO:0000244|PDB:5F0X}.; STRAND 125 131 {ECO:0000244|PDB:5F0X}.; STRAND 137 140 {ECO:0000244|PDB:5F0X}.; STRAND 167 172 {ECO:0000244|PDB:5F0X}.; STRAND 194 200 {ECO:0000244|PDB:5F0X}.; STRAND 215 225 {ECO:0000244|PDB:5F0X}.; STRAND 230 238 {ECO:0000244|PDB:5F0X}.; STRAND 241 250 {ECO:0000244|PDB:5F0X}.; STRAND 302 313 {ECO:0000244|PDB:5F0X}.; STRAND 316 323 {ECO:0000244|PDB:5F0X}.; STRAND 358 363 {ECO:0000244|PDB:5F0X}.; STRAND 415 419 {ECO:0000244|PDB:6ASY}.; STRAND 424 428 {ECO:0000244|PDB:6ASY}.; STRAND 433 437 {ECO:0000244|PDB:6ASY}.; STRAND 442 451 {ECO:0000244|PDB:6ASY}.; STRAND 461 468 {ECO:0000244|PDB:6ASY}.; STRAND 476 484 {ECO:0000244|PDB:6ASY}.; STRAND 491 493 {ECO:0000244|PDB:6ASY}.; STRAND 497 503 {ECO:0000244|PDB:6ASY}.; STRAND 509 515 {ECO:0000244|PDB:6ASY}.; STRAND 521 526 {ECO:0000244|PDB:5E85}.,HELIX 78 82 {ECO:0000244|PDB:5F0X}.; HELIX 84 86 {ECO:0000244|PDB:6ASY}.; HELIX 88 90 {ECO:0000244|PDB:5F0X}.; HELIX 95 97 {ECO:0000244|PDB:5F0X}.; HELIX 106 114 {ECO:0000244|PDB:5F0X}.; HELIX 142 161 {ECO:0000244|PDB:5F0X}.; HELIX 178 190 {ECO:0000244|PDB:5F0X}.; HELIX 201 208 {ECO:0000244|PDB:5F0X}.; HELIX 255 274 {ECO:0000244|PDB:5F0X}.; HELIX 278 280 {ECO:0000244|PDB:5F0X}.; HELIX 282 298 {ECO:0000244|PDB:5F0X}.; HELIX 324 337 {ECO:0000244|PDB:5F0X}.; HELIX 339 348 {ECO:0000244|PDB:5F0X}.; HELIX 353 355 {ECO:0000244|PDB:5F0X}.; HELIX 364 367 {ECO:0000244|PDB:5F0X}.; HELIX 369 378 {ECO:0000244|PDB:5F0X}.; HELIX 393 405 {ECO:0000244|PDB:5F0X}.; HELIX 473 475 {ECO:0000244|PDB:6ASY}.; HELIX 535 576 {ECO:0000244|PDB:6ASY}.; HELIX 582 585 {ECO:0000244|PDB:6ASY}.; HELIX 588 607 {ECO:0000244|PDB:6ASY}.; HELIX 613 631 {ECO:0000244|PDB:6ASY}.,TURN 98 100 {ECO:0000244|PDB:5F0X}.; TURN 209 212 {ECO:0000244|PDB:5F0X}.; TURN 299 301 {ECO:0000244|PDB:5F0X}.; TURN 379 381 {ECO:0000244|PDB:5F0X}.; TURN 390 392 {ECO:0000244|PDB:5F0X}.; TURN 429 431 {ECO:0000244|PDB:5E85}.; TURN 516 518 {ECO:0000244|PDB:6ASY}.; TURN 528 531 {ECO:0000244|PDB:5E85}.; TURN 579 581 {ECO:0000244|PDB:6ASY}.,,,,,5 out of 5,Beta strand (28); Binding site (1); Chain (1); Cross-link (2); Helix (22); Modified residue (17); Motif (1); Mutagenesis (2); Natural variant (1); Nucleotide binding (4); Region (3); Sequence conflict (8); Signal peptide (1); Turn (9),"CAUTION: AMPylation was initially reported to take place at Ser-365 and Thr-366 in vitro, and promote activation of HSPA5/BiP (PubMed:25601083). However, it was later shown that AMPylation takes place at Thr-518 and leads to inactivation of HSPA5/BiP. {ECO:0000250|UniProtKB:G3I8R9, ECO:0000269|PubMed:25601083}.",,,3D-structure;ATP-binding;Acetylation;Chaperone;Complete proteome;Cytoplasm;Direct protein sequencing;Endoplasmic reticulum;Hydrolase;Isopeptide bond;Methylation;Nitration;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Signal;Ubl conjugation,Evidence at protein level,reviewed,,Heat shock protein 70 family,221,Activity regulation (1); Catalytic activity (1); Caution (1); Domain (1); Function (1); Induction (1); Involvement in disease (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0067; KW-0143; KW-0181; KW-0256; KW-0378; KW-0488; KW-0547; KW-0597; KW-0621; KW-0732; KW-0832; KW-0903; KW-0944; KW-0963; KW-1017; KW-1185,,,,,DISEASE: Note=Autoantigen in rheumatoid arthritis. {ECO:0000269|PubMed:11160188}.,,,"PTM: AMPylated by FICD (PubMed:25601083). In unstressed cells, AMPylation at Thr-518 by FICD inactivates the chaperome activity: AMPylated form is locked in a relatively inert state and only weakly stimulated by J domain-containing proteins (By similarity). In response to endoplasmic reticulum stress, de-AMPylation by the same protein, FICD, restores the chaperone activity (By similarity). {ECO:0000250|UniProtKB:G3I8R9, ECO:0000269|PubMed:25601083}.",CHAIN 19 654 Endoplasmic reticulum chaperone BiP. /FTId=PRO_0000013566.,"CROSSLNK 352 352 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25114211, ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 353 353 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate. {ECO:0000244|PubMed:25114211}.",,,,,"MOD_RES 86 86 Phosphoserine. {ECO:0000250|UniProtKB:P06761}.; MOD_RES 125 125 N6-acetyllysine. {ECO:0000250|UniProtKB:P20029}.; MOD_RES 160 160 Nitrated tyrosine. {ECO:0000250|UniProtKB:P20029}.; MOD_RES 213 213 N6-acetyllysine. {ECO:0000250|UniProtKB:P20029}.; MOD_RES 271 271 N6-acetyllysine. {ECO:0000250|UniProtKB:P0DMV8}.; MOD_RES 326 326 N6-acetyllysine. {ECO:0000250|UniProtKB:P20029}.; MOD_RES 353 353 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P20029}.; MOD_RES 447 447 N6-succinyllysine. {ECO:0000250|UniProtKB:P20029}.; MOD_RES 492 492 Omega-N-methylarginine. {ECO:0000250|UniProtKB:P0DMV8}.; MOD_RES 518 518 O-AMP-threonine; alternate. {ECO:0000250|UniProtKB:G3I8R9}.; MOD_RES 518 518 Phosphothreonine; alternate. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 585 585 N6,N6,N6-trimethyllysine; by METTL21A; in vitro. {ECO:0000244|PubMed:24129315, ECO:0000269|PubMed:23349634, ECO:0000269|PubMed:23921388}.; MOD_RES 585 585 N6,N6-dimethyllysine; alternate. {ECO:0000244|PubMed:24129315}.; MOD_RES 585 585 N6-methyllysine; alternate. {ECO:0000244|PubMed:24129315}.; MOD_RES 591 591 N6-methyllysine. {ECO:0000244|PubMed:24129315}.; MOD_RES 643 643 Phosphothreonine. {ECO:0000250|UniProtKB:P20029}.; MOD_RES 648 648 Phosphothreonine. {ECO:0000250|UniProtKB:P20029}.",,,"SIGNAL 1 18 {ECO:0000269|PubMed:2294010, ECO:0000269|PubMed:9150948}.",,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M19645;X87949;AJ271729;AF216292;DQ385847;CH471090;BC020235;X59969;AF188611;
0,P11166,GTR1_HUMAN,SLC2A1 GLUT1,SLC2A1,GLUT1,,,Homo sapiens (Human),9606,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)",UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV,492,"54,084",,,,,,,,,,,,,"VARIANT 34 34 N -> I (in GLUT1DS2; dbSNP:rs80359812). {ECO:0000269|PubMed:14605501}. /FTId=VAR_054755.; VARIANT 34 34 N -> S (in GLUT1DS1; 55% of wild-type glucose uptake activity). {ECO:0000269|PubMed:15622525}. /FTId=VAR_054756.; VARIANT 34 34 N -> Y (in GLUT1DS1). {ECO:0000269|PubMed:20129935}. /FTId=VAR_065206.; VARIANT 51 51 R -> H (in EIG12; unknown pathological significance; dbSNP:rs201815571). {ECO:0000269|PubMed:23280796}. /FTId=VAR_076226.; VARIANT 60 60 T -> M (in EIG12; unknown pathological significance; decreased glucose transport; dbSNP:rs142986731). {ECO:0000269|PubMed:23280796}. /FTId=VAR_076227.; VARIANT 66 66 S -> F (in GLUT1DS1; dbSNP:rs80359813). {ECO:0000269|PubMed:10980529}. /FTId=VAR_013283.; VARIANT 77 77 M -> T (in EIG12; decreased glucose transport; dbSNP:rs1187210267). {ECO:0000269|PubMed:23280796}. /FTId=VAR_076228.; VARIANT 91 91 G -> D (in GLUT1DS1; significantly decreases the transport of 3-O-methyl-D-glucose; dbSNP:rs80359814). {ECO:0000269|PubMed:11136715, ECO:0000269|PubMed:20574033}. /FTId=VAR_013182.; VARIANT 92 92 R -> W (in GLUT1DS2; dbSNP:rs202060209). {ECO:0000269|PubMed:19630075}. /FTId=VAR_069077.; VARIANT 93 93 R -> W (in GLUT1DS2; dbSNP:rs267607061). {ECO:0000269|PubMed:20129935}. /FTId=VAR_065207.; VARIANT 95 95 S -> I (in GLUT1DS2; dbSNP:rs267607060). {ECO:0000269|PubMed:20574033}. /FTId=VAR_065208.; VARIANT 96 96 M -> V (in GLUT1DS1; dbSNP:rs753161833). {ECO:0000269|PubMed:20129935}. /FTId=VAR_065209.; VARIANT 126 126 R -> C (in GLUT1DS1, GLUT1DS2 and DYT9; reduced transporter activity; dbSNP:rs80359818). {ECO:0000269|PubMed:12325075, ECO:0000269|PubMed:19798636, ECO:0000269|PubMed:21832227}. /FTId=VAR_054757.; VARIANT 126 126 R -> H (in GLUT1DS1; significantly decreases the transport of 3-O-methyl-D-glucose and dehydroascorbic acid; 57% of wild-type glucose uptake activity; dbSNP:rs80359816). {ECO:0000269|PubMed:11603379, ECO:0000269|PubMed:12325075, ECO:0000269|PubMed:15622525, ECO:0000269|PubMed:20574033}. /FTId=VAR_013183.; VARIANT 126 126 R -> L (in GLUT1DS1; compound heterozygote with V-256; dbSNP:rs80359816). {ECO:0000269|PubMed:10980529}. /FTId=VAR_013184.; VARIANT 130 130 G -> S (in GLUT1DS1; 75% of wild-type glucose uptake activity; dbSNP:rs80359819). {ECO:0000269|PubMed:15622525, ECO:0000269|PubMed:20129935}. /FTId=VAR_054758.; VARIANT 146 146 E -> K (in GLUT1DS1; dbSNP:rs80359820). {ECO:0000269|PubMed:10980529, ECO:0000269|PubMed:12325075}. /FTId=VAR_013284.; VARIANT 149 149 P -> A (in EIG12; unknown pathological significance). {ECO:0000269|PubMed:23280796}. /FTId=VAR_076229.; VARIANT 153 153 R -> C (in GLUT1DS1; 44% of wild-type glucose uptake activity). {ECO:0000269|PubMed:12325075, ECO:0000269|PubMed:15622525}. /FTId=VAR_054759.; VARIANT 153 153 R -> H (in GLUT1DS2; dbSNP:rs794727642). {ECO:0000269|PubMed:20129935}. /FTId=VAR_065210.; VARIANT 155 155 A -> V (in GLUT1DS1). {ECO:0000269|PubMed:20129935}. /FTId=VAR_065211.; VARIANT 165 165 V -> I (in GLUT1DS2; dbSNP:rs1057520545). {ECO:0000269|PubMed:20621801}. /FTId=VAR_065212.; VARIANT 169 169 Missing (in GLUT1DS1; 48% of wild-type glucose uptake activity). {ECO:0000269|PubMed:15622525}. /FTId=VAR_054760.; VARIANT 212 212 R -> C (in GLUT1DS1 and DYT9; dbSNP:rs387907312). {ECO:0000269|PubMed:20129935, ECO:0000269|PubMed:21832227}. /FTId=VAR_065213.; VARIANT 212 212 R -> H (in GLUT1DS1; dbSNP:rs886039517). {ECO:0000269|PubMed:20129935}. /FTId=VAR_065214.; VARIANT 218 218 R -> S (in EIG12; decreased glucose transport). {ECO:0000269|PubMed:23280796}. /FTId=VAR_076230.; VARIANT 223 223 R -> P (in EIG12; mild phenotype; reduced transporter activity; dbSNP:rs397514564). {ECO:0000269|PubMed:19798636, ECO:0000269|PubMed:20574033}. /FTId=VAR_065215.; VARIANT 223 223 R -> Q (in EIG12; unknown pathological significance; no effect on glucose transport; dbSNP:rs397514564). {ECO:0000269|PubMed:23280796}. /FTId=VAR_076231.; VARIANT 223 223 R -> W (in GLUT1DS1; dbSNP:rs796053248). {ECO:0000269|PubMed:20129935}. /FTId=VAR_065216.; VARIANT 232 232 R -> C (in EIG12; the mutant protein is expressed at the cell surface but has mildly decreased glucose uptake (70%) compared to wild-type; dbSNP:rs387907313). {ECO:0000269|PubMed:22282645}. /FTId=VAR_069078.; VARIANT 243 243 E -> V (in EIG12; decreased glucose transport). {ECO:0000269|PubMed:23280796}. /FTId=VAR_076232.; VARIANT 256 256 K -> E (in GLUT1DS1; compound heterozygote with L-126; dbSNP:rs121909738). {ECO:0000269|PubMed:10980529}. /FTId=VAR_013185.; VARIANT 275 275 A -> T (in GLUT1DS2; the mutation decreases glucose transport but does not affect cation permeability; dbSNP:rs121909740). {ECO:0000269|PubMed:18451999}. /FTId=VAR_054761.; VARIANT 282 285 Missing (in GLUT1DS2; accompanied by hemolytic anemia and altered erythrocyte ion concentrations; the mutation decreases glucose transport and causes a cation leak that alteres intracellular concentrations of sodium potassium and calcium). {ECO:0000269|PubMed:18451999}. /FTId=VAR_054762.; VARIANT 286 286 G -> D (in SDCHCN; no effect on protein abundance; no effect on localization to the plasma membrane; loss of D-glucose transporter activity; increased cation leakage; dbSNP:rs864309514). {ECO:0000269|PubMed:21791420, ECO:0000269|PubMed:22492876}. /FTId=VAR_076233.; VARIANT 292 292 Y -> YY (in GLUT1DS1). {ECO:0000269|PubMed:19901175}. /FTId=VAR_069079.; VARIANT 294 294 S -> P (in GLUT1DS2). {ECO:0000269|PubMed:20830593}. /FTId=VAR_065784.; VARIANT 295 295 T -> M (in GLUT1DS1; 75% of wild-type glucose uptake activity; dbSNP:rs80359823). {ECO:0000269|PubMed:15622525, ECO:0000269|PubMed:20129935}. /FTId=VAR_054763.; VARIANT 303 303 V -> L (found in a patient with GLUT1 deficiency syndrome; dbSNP:rs1205631854). {ECO:0000269|PubMed:20129935}. /FTId=VAR_065217.; VARIANT 310 310 T -> I (in GLUT1DS1; dbSNP:rs80359824). {ECO:0000269|PubMed:10227690}. /FTId=VAR_013285.; VARIANT 314 314 G -> S (in GLUT1DS2; the mutation decreases glucose transport but does not affect cation permeability; dbSNP:rs121909739). {ECO:0000269|PubMed:18451999, ECO:0000269|PubMed:20574033}. /FTId=VAR_054764.; VARIANT 317 317 N -> T (in GLUT1DS2). {ECO:0000269|PubMed:21204808}. /FTId=VAR_065218.; VARIANT 324 324 S -> L (in GLUT1DS2; mild phenotype; reduced transporter activity; dbSNP:rs796053253). {ECO:0000269|PubMed:19798636, ECO:0000269|PubMed:20574033}. /FTId=VAR_065219.; VARIANT 329 329 E -> Q (in GLUT1DS1; stabilizes the inward-open conformation). {ECO:0000269|PubMed:20129935}. /FTId=VAR_065220.; VARIANT 333 333 R -> Q (in GLUT1DS1 and GLUT1DS2). {ECO:0000269|PubMed:19630075, ECO:0000269|PubMed:20129935}. /FTId=VAR_065221.; VARIANT 333 333 R -> W (in GLUT1DS1; 43% of wild-type glucose uptake activity; dbSNP:rs80359825). {ECO:0000269|PubMed:10980529, ECO:0000269|PubMed:12325075, ECO:0000269|PubMed:15622525}. /FTId=VAR_013286.; VARIANT 382 382 G -> D (in GLUT1DS1). {ECO:0000269|PubMed:20129935}. /FTId=VAR_065222.; VARIANT 405 405 A -> D (in GLUT1DS1). {ECO:0000269|PubMed:20129935}. /FTId=VAR_065223.; VARIANT 411 411 N -> S (in EIG12; decreased glucose transport; dbSNP:rs398123069). {ECO:0000269|PubMed:23280796}. /FTId=VAR_076234.; VARIANT 435 435 Missing (in SDCHCN; no effect on protein abundance; no effect on localization to the plasma membrane; loss of D-glucose transporter activity; increased cation leakage). {ECO:0000269|PubMed:21791420, ECO:0000269|PubMed:22492876}. /FTId=VAR_076235.; VARIANT 458 458 R -> W (in EIG12; decreased glucose transport; dbSNP:rs13306758). {ECO:0000269|PubMed:23280796}. /FTId=VAR_076236.; VARIANT 468 468 R -> W (in GLUT1DS1; dbSNP:rs267607059). {ECO:0000269|PubMed:20221955}. /FTId=VAR_069080.; VARIANT 485 485 P -> L (in GLUT1DS1). {ECO:0000269|PubMed:20129935}. /FTId=VAR_065224.",,,,CONFLICT 25 26 Missing (in Ref. 2; BAF85480). {ECO:0000305}.; CONFLICT 95 95 S -> L (in Ref. 2; BAF85480). {ECO:0000305}.; CONFLICT 152 152 L -> F (in Ref. 1; AAA52571). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. Glucose transporter subfamily. {ECO:0000305}.,,,,,REGION 282 288 Monosaccharide binding.,,,,,,,,"FUNCTION: Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses. {ECO:0000269|PubMed:18245775, ECO:0000269|PubMed:19449892}.",,,,,,,BINDING 317 317 Monosaccharide.; BINDING 388 388 Monosaccharide.,,,,SITE 411 411 Not glycosylated. {ECO:0000269|PubMed:3839598}.,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; female pronucleus [GO:0001939]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; lactose biosynthetic process [GO:0005989]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion [GO:0050796]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016],cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glucose transmembrane transport [GO:1904659]; lactose biosynthetic process [GO:0005989]; L-ascorbic acid metabolic process [GO:0019852]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion [GO:0050796]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016],dehydroascorbic acid transmembrane transporter activity [GO:0033300]; D-glucose transmembrane transporter activity [GO:0055056]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; female pronucleus [GO:0001939]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018],GO:0000139; GO:0001666; GO:0001939; GO:0005355; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0005989; GO:0007565; GO:0010827; GO:0014704; GO:0016020; GO:0016323; GO:0016324; GO:0019852; GO:0019900; GO:0021987; GO:0030018; GO:0030496; GO:0030864; GO:0032868; GO:0033300; GO:0042149; GO:0042383; GO:0042470; GO:0042802; GO:0042910; GO:0043621; GO:0050796; GO:0055056; GO:0065003; GO:0070062; GO:0071260; GO:0071474; GO:0072562; GO:1904016; GO:1904659,IPR002439; IPR020846; IPR005828; IPR036259; IPR003663; IPR005829; ,Itself; O43889-2,"SUBUNIT: Interacts with GIPC (via PDZ domain) (By similarity). Found in a complex with ADD2, DMTN and SLC2A1. Interacts (via C-terminus cytoplasmic region) with DMTN isoform 2 (PubMed:18347014). Interacts with SNX27; the interaction is required when endocytosed to prevent degradation in lysosomes and promote recycling to the plasma membrane (PubMed:23563491). Interacts with STOM (PubMed:23219802). Interacts with SGTA (via Gln-rich region) (By similarity). {ECO:0000250|UniProtKB:P11167, ECO:0000269|PubMed:18347014, ECO:0000269|PubMed:23219802, ECO:0000269|PubMed:23563491}.",3839598; 14702039; 15489334; 2834252; 17081065; 18245775; 18347014; 18691976; 19449892; 19349973; 20068231; 21269460; 21406692; 22814378; 23219802; 23186163; 23563491; 24275569; 24847886; 10227690; 10980529; 11603379; 11136715; 12325075; 14605501; 15622525; 18451999; 19798636; 19901175; 19630075; 20221955; 20129935; 21204808; 20621801; 20574033; 21791420; 20830593; 21832227; 23280796; 22492876; 22282645,3839598; 14702039; 15489334; 2834252; 17081065; 18245775; 18347014; 18691976; 19449892; 19349973; 20068231; 21269460; 21406692; 22814378; 23219802; 23186163; 23563491; 24275569; 24847886; 10227690; 10980529; 11603379; 11136715; 12325075; 14605501; 15622525; 18451999; 19798636; 19901175; 19630075; 20221955; 20129935; 21204808; 20621801; 20574033; 21791420; 20830593; 21832227; 23280796; 22492876; 22282645; 10759149; 10862609; 11168944; 11231353; 11425315; 11477169; 11681785; 11747430; 11780755; 11836704; 11920478; 11953883; 11991658; 12064911; 12086959; 12112827; 12122099; 12133004; 12145475; 12379105; 12379106; 12393496; 12583599; 12752470; 12849991; 12942120; 12969152; 1429721; 14622599; 14674124; 14757434; 14991538; 15073187; 15086844; 15147968; 15331928; 15454279; 15502921; 15682272; 15709778; 15745834; 15767416; 15778389; 15823019; 15847702; 15902306; 15924676; 15955807; 15967114; 16125330; 16126902; 16136514; 16142350; 16147855; 16169070; 16172126; 16195374; 16220828; 16310037; 16407180; 16443776; 16519917; 16681687; 16681688; 16800634; 16842248; 17020877; 17064664; 17071132; 17080242; 17167225; 17192790; 17294670; 17380317; 17387384; 17404017; 17442736; 17451637; 17452775; 17504522; 17554865; 17591274; 17635959; 17727838; 17854396; 17991316; 18097583; 18172662; 18177733; 18191496; 18212354; 18227718; 18246802; 18271924; 18290322; 18311082; 18324916; 18343752; 18351386; 18387950; 18401196; 18410529; 18422279; 18577546; 18613291; 18614966; 18676680; 18695903; 18726700; 18764953; 18821326; 18948400; 18953257; 18973239; 18981181; 18987250; 18990414; 19016655; 19020718; 19020742; 19085834; 19142800; 19152396; 19166280; 19170196; 19173807; 19234439; 19286567; 19289587; 19303158; 19304421; 19347605; 19366592; 19386788; 19420105; 19434538; 19463016; 19465749; 19490621; 19533082; 19533890; 19536037; 19554504; 19569052; 19587357; 19619276; 19625176; 19648108; 19648882; 19655166; 19681047; 19692168; 19709351; 19738201; 19819644; 19822956; 19883765; 19948975; 19955252; 20030103; 20063428; 20079187; 20113375; 20375117; 20382060; 20395120; 20424473; 20428049; 20512538; 20526721; 20527231; 20540786; 20569445; 20607826; 20630673; 20679470; 20687207; 20703861; 20730618; 20803547; 20846124; 20854211; 20937822; 20947823; 20965718; 21029693; 21033220; 21075472; 21109935; 21135204; 21194153; 21206329; 21270293; 21273616; 21281236; 21294792; 21295279; 21306648; 21317389; 21321933; 21332301; 21384913; 21395180; 21411785; 21438910; 21442770; 21445818; 21475039; 21521642; 21528061; 21546213; 21555602; 21697701; 21707071; 21786248; 21808860; 21838819; 21870331; 21899256; 21911578; 21920790; 21938742; 21962875; 21987722; 22011817; 22029179; 22069254; 22072148; 22153830; 22157815; 22199327; 22200795; 22221271; 22228332; 22234467; 22253523; 22263435; 22270867; 22282454; 22304920; 22308487; 22363641; 22376167; 22398711; 22437877; 22470192; 22475893; 22483234; 22509097; 22623428; 22663547; 22704013; 22707195; 22795339; 22800355; 22812641; 22813791; 22814174; 22829208; 22835601; 22843905; 22847606; 22888973; 22899793; 22901702; 22961556; 22971162; 23002041; 23030583; 23076555; 23098453; 23106342; 23108021; 23187830; 23227892; 23306390; 23359198; 23427181; 23453806; 23480298; 23483445; 23615963; 23617290; 23661345; 23674658; 23720776; 23740044; 23744486; 23861325; 23889809; 23935399; 24146103; 24164300; 24242681; 24343741; 24368212; 24467213; 24502553; 24552568; 24699711; 24726496; 24745019; 24817962; 24824030; 24824604; 24932809; 24934577; 24980293; 25022942; 25056472; 25101238; 25120770; 25121413; 25125078; 25132463; 25157747; 25187207; 25193692; 25227787; 25306890; 25307508; 25321477; 25347093; 25367121; 25376377; 25412955; 25433755; 25492937; 25502934; 25532859; 25594612; 25596248; 25701507; 25766729; 25811313; 25837797; 25838393; 25852190; 25863229; 25912843; 25914049; 25919356; 25963717; 25982116; 26023239; 26050557; 26088884; 26092229; 26183839; 26193257; 26193382; 26238658; 26293674; 26337659; 26358256; 26407611; 26496610; 26508030; 26513490; 26537434; 26539827; 26573871; 26598494; 26692443; 26746193; 26873505; 26899926; 26919485; 27020375; 27039889; 27067254; 27078104; 27265003; 27334434; 27351131; 27353463; 27357903; 27404888; 27440994; 27456707; 27476171; 27511728; 27644880; 27725288; 27792451; 27829222; 27842912; 27858715; 27884659; 27909246; 27918085; 27931517; 27981520; 27989750; 27998284; 28000878; 28028797; 28036362; 28053105; 28058711; 28086215; 28124377; 28178665; 28180987; 28222430; 28260073; 28347233; 28355545; 28381136; 28412205; 28419191; 28419980; 28429188; 28440026; 28443597; 28488541; 28498467; 28498810; 28524154; 28542798; 28545938; 28556183; 28589878; 28617850; 28623979; 28646353; 28731193; 28759035; 28803777; 28803837; 28852964; 28884839; 28892135; 28892790; 28945223; 29066623; 29164572; 29205188; 29223885; 29374351; 29374742; 29481555; 29629851; 29684818; 29797802; 29978611; 30028251; 30062472; 30353771; 30508885; 30591458; 7589840; 7593639; 7929812; 8027028; 8457197; 8987985; 9228080; 9751501,1989-07-01,2019-02-13,2006-10-03,226,X-ray crystallography (4); Model (1),,HELIX 11 30 {ECO:0000244|PDB:5EQG}.; HELIX 37 52 {ECO:0000244|PDB:5EQG}.; HELIX 58 90 {ECO:0000244|PDB:5EQG}.; HELIX 92 98 {ECO:0000244|PDB:5EQG}.; HELIX 100 111 {ECO:0000244|PDB:5EQG}.; HELIX 119 145 {ECO:0000244|PDB:5EQG}.; HELIX 153 156 {ECO:0000244|PDB:5EQG}.; HELIX 159 174 {ECO:0000244|PDB:5EQG}.; HELIX 186 191 {ECO:0000244|PDB:5EQG}.; HELIX 194 203 {ECO:0000244|PDB:5EQG}.; HELIX 204 206 {ECO:0000244|PDB:5EQG}.; HELIX 211 215 {ECO:0000244|PDB:5EQG}.; HELIX 221 232 {ECO:0000244|PDB:5EQG}.; HELIX 238 253 {ECO:0000244|PDB:5EQG}.; HELIX 259 264 {ECO:0000244|PDB:5EQG}.; HELIX 269 283 {ECO:0000244|PDB:5EQG}.; HELIX 288 301 {ECO:0000244|PDB:5EQG}.; HELIX 306 328 {ECO:0000244|PDB:5EQG}.; HELIX 333 356 {ECO:0000244|PDB:5EQG}.; HELIX 364 379 {ECO:0000244|PDB:5EQG}.; HELIX 386 394 {ECO:0000244|PDB:5EQG}.; HELIX 400 429 {ECO:0000244|PDB:5EQG}.; HELIX 430 432 {ECO:0000244|PDB:5EQG}.; HELIX 433 451 {ECO:0000244|PDB:5EQG}.,TURN 112 117 {ECO:0000244|PDB:5EQG}.; TURN 150 152 {ECO:0000244|PDB:5EQG}.; TURN 177 180 {ECO:0000244|PDB:5EQG}.; TURN 183 185 {ECO:0000244|PDB:5EQG}.; TURN 216 218 {ECO:0000244|PDB:5EQG}.; TURN 266 268 {ECO:0000244|PDB:5EQG}.; TURN 284 286 {ECO:0000244|PDB:5EQG}.; TURN 357 360 {ECO:0000244|PDB:5EQG}.; TURN 380 385 {ECO:0000244|PDB:5EQG}.; TURN 397 399 {ECO:0000244|PDB:5EQG}.,,,TOPO_DOM 1 11 Cytoplasmic. {ECO:0000269|PubMed:24847886}.; TOPO_DOM 34 66 Extracellular. {ECO:0000269|PubMed:24847886}.; TOPO_DOM 88 90 Cytoplasmic. {ECO:0000269|PubMed:24847886}.; TOPO_DOM 113 120 Extracellular. {ECO:0000269|PubMed:24847886}.; TOPO_DOM 145 155 Cytoplasmic. {ECO:0000269|PubMed:24847886}.; TOPO_DOM 177 185 Extracellular. {ECO:0000269|PubMed:24847886}.; TOPO_DOM 207 271 Cytoplasmic. {ECO:0000269|PubMed:24847886}.; TOPO_DOM 294 306 Extracellular. {ECO:0000269|PubMed:24847886}.; TOPO_DOM 329 334 Cytoplasmic. {ECO:0000269|PubMed:24847886}.; TOPO_DOM 356 365 Extracellular. {ECO:0000269|PubMed:24847886}.; TOPO_DOM 389 401 Cytoplasmic. {ECO:0000269|PubMed:24847886}.; TOPO_DOM 423 429 Extracellular. {ECO:0000269|PubMed:24847886}.; TOPO_DOM 451 492 Cytoplasmic. {ECO:0000269|PubMed:24847886}.,TRANSMEM 12 33 Helical; Name=1.; TRANSMEM 67 87 Helical; Name=2.; TRANSMEM 91 112 Helical; Name=3.; TRANSMEM 121 144 Helical; Name=4.; TRANSMEM 156 176 Helical; Name=5.; TRANSMEM 186 206 Helical; Name=6.; TRANSMEM 272 293 Helical; Name=7.; TRANSMEM 307 328 Helical; Name=8.; TRANSMEM 335 355 Helical; Name=9.; TRANSMEM 366 388 Helical; Name=10.; TRANSMEM 402 422 Helical; Name=11.; TRANSMEM 430 450 Helical; Name=12.,5 out of 5,Binding site (2); Chain (1); Glycosylation (1); Helix (24); Modified residue (4); Mutagenesis (5); Natural variant (53); Region (1); Sequence conflict (3); Site (1); Topological domain (13); Transmembrane (12); Turn (10),,TISSUE SPECIFICITY: Detected in erythrocytes (at protein level). Expressed at variable levels in many human tissues. {ECO:0000269|PubMed:23219802}.,,3D-structure;Acetylation;Cataract;Cell membrane;Complete proteome;Direct protein sequencing;Disease mutation;Dystonia;Epilepsy;Glycoprotein;Hereditary hemolytic anemia;Membrane;Mental retardation;Phosphoprotein;Reference proteome;Sugar transport;Transmembrane;Transmembrane helix;Transport,Evidence at protein level,reviewed,,"Major facilitator superfamily, Sugar transporter (TC 2.A.1.1) family, Glucose transporter subfamily",226,Function (1); Involvement in disease (5); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0181; KW-0225; KW-0325; KW-0360; KW-0472; KW-0597; KW-0762; KW-0812; KW-0813; KW-0887; KW-0898; KW-0903; KW-0991; KW-1003; KW-1023; KW-1133; KW-1185,,,,,"DISEASE: GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]: A neurologic disorder showing wide phenotypic variability. The most severe 'classic' phenotype comprises infantile-onset epileptic encephalopathy associated with delayed development, acquired microcephaly, motor incoordination, and spasticity. Onset of seizures, usually characterized by apneic episodes, staring spells, and episodic eye movements, occurs within the first 4 months of life. Other paroxysmal findings include intermittent ataxia, confusion, lethargy, sleep disturbance, and headache. Varying degrees of cognitive impairment can occur, ranging from learning disabilities to severe mental retardation. {ECO:0000269|PubMed:10227690, ECO:0000269|PubMed:10980529, ECO:0000269|PubMed:11136715, ECO:0000269|PubMed:11603379, ECO:0000269|PubMed:12325075, ECO:0000269|PubMed:15622525, ECO:0000269|PubMed:19901175, ECO:0000269|PubMed:20129935, ECO:0000269|PubMed:20221955, ECO:0000269|PubMed:20574033, ECO:0000269|PubMed:24847886}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]: A clinically variable disorder characterized primarily by onset in childhood of paroxysmal exercise-induced dyskinesia. The dyskinesia involves transient abnormal involuntary movements, such as dystonia and choreoathetosis, induced by exercise or exertion, and affecting the exercised limbs. Some patients may also have epilepsy, most commonly childhood absence epilepsy. Mild mental retardation may also occur. In some patients involuntary exertion-induced dystonic, choreoathetotic, and ballistic movements may be associated with macrocytic hemolytic anemia. {ECO:0000269|PubMed:14605501, ECO:0000269|PubMed:18451999, ECO:0000269|PubMed:19630075, ECO:0000269|PubMed:19798636, ECO:0000269|PubMed:20129935, ECO:0000269|PubMed:20574033, ECO:0000269|PubMed:20621801, ECO:0000269|PubMed:20830593, ECO:0000269|PubMed:21204808}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epilepsy, idiopathic generalized 12 (EIG12) [MIM:614847]: A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Seizure types include juvenile myoclonic seizures, absence seizures, and generalized tonic-clonic seizures. In some EIG12 patients seizures may remit with age. {ECO:0000269|PubMed:19798636, ECO:0000269|PubMed:22282645, ECO:0000269|PubMed:23280796}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Dystonia 9 (DYT9) [MIM:601042]: An autosomal dominant neurologic disorder characterized by childhood onset of paroxysmal choreoathetosis and progressive spastic paraplegia. Most patients show some degree of cognitive impairment. Other variable features may include seizures, migraine headaches, and ataxia. {ECO:0000269|PubMed:21832227}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Stomatin-deficient cryohydrocytosis with neurologic defects (SDCHCN) [MIM:608885]: A rare form of stomatocytosis characterized by episodic hemolytic anemia, cold-induced red cells cation leak, erratic hyperkalemia, neonatal hyperbilirubinemia, hepatosplenomegaly, cataracts, seizures, mental retardation, and movement disorder. {ECO:0000269|PubMed:21791420, ECO:0000269|PubMed:22492876}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,"CHAIN 1 492 Solute carrier family 2, facilitated glucose transporter member 1. /FTId=PRO_0000050338.",,,"CARBOHYD 45 45 N-linked (GlcNAc...) asparagine. {ECO:0000269|PubMed:19349973, ECO:0000269|PubMed:3839598}.",,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 465 465 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 478 478 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 490 490 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,K03195;AK292791;AK312403;CH471059;BC118590;M20653;AF070544;AY034633;
0,P11233,RALA_HUMAN,RALA RAL,RALA,RAL,,,Homo sapiens (Human),9606,Ras-related protein Ral-A,UP000005640: Chromosome 7,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAANKPKGQNSLALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTAGQEDYAAIRDNYFRSGEGFLCVFSITEMESFAATADFREQILRVKEDENVPFLLVGNKSDLEDKRQVSVEEAKNRAEQWNVNYVETSAKTRANVDKVFFDLMREIRARKMEDSKEKNGKKKRKSLAKRIRERCCIL,206,"23,567",,,,,,,,,,,,,,,,,CONFLICT 1 2 MA -> MVDYL (in Ref. 2; AAA36542 and 3; AAM12624). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the small GTPase superfamily. Ras family. {ECO:0000305}.,,,,MOTIF 43 51 Effector region.,,,,,,,,,"FUNCTION: Multifunctional GTPase involved in a variety of cellular processes including gene expression, cell migration, cell proliferation, oncogenic transformation and membrane trafficking. Accomplishes its multiple functions by interacting with distinct downstream effectors. Acts as a GTP sensor for GTP-dependent exocytosis of dense core vesicles. The RALA-exocyst complex regulates integrin-dependent membrane raft exocytosis and growth signaling (PubMed:20005108). Key regulator of LPAR1 signaling and competes with GRK2 for binding to LPAR1 thus affecting the signaling properties of the receptor. Required for anchorage-independent proliferation of transformed cells (PubMed:19306925). During mitosis, supports the stabilization and elongation of the intracellular bridge between dividing cells. Cooperates with EXOC2 to recruit other components of the exocyst to the early midbody (PubMed:18756269). {ECO:0000269|PubMed:18756269, ECO:0000269|PubMed:19306925, ECO:0000269|PubMed:20005108}.",,,,,,,,,,"NP_BIND 24 29 GTP. {ECO:0000269|PubMed:15809419, ECO:0000269|PubMed:16177825}.; NP_BIND 40 46 GTP. {ECO:0000269|PubMed:15809419, ECO:0000269|PubMed:16177825}.; NP_BIND 127 130 GTP. {ECO:0000269|PubMed:15809419, ECO:0000269|PubMed:16177825}.",,cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton reorganization [GO:0031532]; cell cycle [GO:0007049]; cell division [GO:0051301]; chemotaxis [GO:0006935]; exocytosis [GO:0006887]; interleukin-12-mediated signaling pathway [GO:0035722]; membrane organization [GO:0061024]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of filopodium assembly [GO:0051491]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165],actin cytoskeleton reorganization [GO:0031532]; cell cycle [GO:0007049]; cell division [GO:0051301]; chemotaxis [GO:0006935]; exocytosis [GO:0006887]; interleukin-12-mediated signaling pathway [GO:0035722]; membrane organization [GO:0061024]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of filopodium assembly [GO:0051491]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165],ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625],cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886],GO:0001843; GO:0003924; GO:0005525; GO:0005886; GO:0005925; GO:0006887; GO:0006935; GO:0007049; GO:0007165; GO:0007265; GO:0009986; GO:0017022; GO:0017157; GO:0019003; GO:0030659; GO:0031532; GO:0031625; GO:0031755; GO:0032154; GO:0035722; GO:0051117; GO:0051301; GO:0051491; GO:0051665; GO:0061024; GO:0070062; GO:0090543,IPR027417; IPR028412; IPR005225; IPR001806; IPR020849; ,O54921; P30154; Q15311,"SUBUNIT: Interacts (via effector domain) with RALBP1 (PubMed:7673236). Interacts with EXOC2/Sec5 and EXOC8/Exo84; binding to EXOC2 and EXOC8 is mutually exclusive (PubMed:14525976, PubMed:18756269, PubMed:15920473). Interacts with Clostridium exoenzyme C3 (PubMed:16177825, PubMed:15809419). Interacts with RALGPS1 (PubMed:10747847). Interacts with LPAR1 and LPAR2. Interacts with GRK2 in response to LPAR1 activation. RALA and GRK2 binding to LPAR1 is mutually exclusive (PubMed:19306925). Interacts with CDC42 (By similarity). {ECO:0000250|UniProtKB:P63322, ECO:0000269|PubMed:10747847, ECO:0000269|PubMed:14525976, ECO:0000269|PubMed:15809419, ECO:0000269|PubMed:15920473, ECO:0000269|PubMed:16177825, ECO:0000269|PubMed:18756269, ECO:0000269|PubMed:19306925, ECO:0000269|PubMed:7673236}.",2662142; 2550440; 12690205; 12853948; 15489334; 1903399; 7673236; 10747847; 14525976; 16213214; 17875936; 18756269; 19306925; 20005108; 21269460; 25944712; 15920473; 16177825; 15809419,2662142; 2550440; 12690205; 12853948; 15489334; 1903399; 7673236; 10747847; 14525976; 16213214; 17875936; 18756269; 19306925; 20005108; 21269460; 25944712; 15920473; 16177825; 15809419; 10022860; 10675331; 12034722; 12687004; 12839989; 12856001; 15130921; 15231748; 15550383; 15817490; 15950903; 16038020; 16525015; 16964283; 17174914; 17237388; 17524504; 17540176; 17606711; 17709381; 17765682; 18948269; 19222999; 19414599; 19463016; 19802010; 19822090; 19901077; 20018811; 20379614; 20579884; 2108160; 21148297; 21170262; 21241894; 21242975; 21282111; 21346190; 21441953; 21634118; 21645515; 21810610; 21822277; 22013078; 22330069; 22442671; 22580611; 22700969; 22761837; 22790202; 23416715; 23770673; 23830877; 24063364; 24222664; 24725430; 25210032; 25241761; 25277244; 26158537; 26205497; 26216878; 26477566; 26496610; 27188791; 27269287; 27286458; 27510034; 27566179; 27741517; 29208460; 29532894; 7972015; 8094051; 8664345,1989-07-01,2019-02-13,1989-07-01,202,X-ray crystallography (6),STRAND 14 20 {ECO:0000244|PDB:2A9K}.; STRAND 49 57 {ECO:0000244|PDB:2A9K}.; STRAND 60 68 {ECO:0000244|PDB:2A9K}.; STRAND 87 94 {ECO:0000244|PDB:2A9K}.; STRAND 122 127 {ECO:0000244|PDB:2A9K}.; STRAND 152 155 {ECO:0000244|PDB:2A9K}.,HELIX 27 36 {ECO:0000244|PDB:2A9K}.; HELIX 76 85 {ECO:0000244|PDB:2A9K}.; HELIX 98 115 {ECO:0000244|PDB:2A9K}.; HELIX 129 134 {ECO:0000244|PDB:2A9K}.; HELIX 139 148 {ECO:0000244|PDB:2A9K}.; HELIX 164 180 {ECO:0000244|PDB:2A9K}.,TURN 158 160 {ECO:0000244|PDB:2A9K}.,,,,,5 out of 5,Beta strand (6); Chain (1); Helix (6); Lipidation (1); Modified residue (1); Motif (1); Mutagenesis (17); Nucleotide binding (3); Propeptide (1); Sequence conflict (2); Turn (1),,,,3D-structure;Cell cycle;Cell division;Cell membrane;Complete proteome;Exocytosis;GTP-binding;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Prenylation;Reference proteome,Evidence at protein level,reviewed,,"Small GTPase superfamily, Ras family",202,Activity regulation (1); Function (1); Induction (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0131; KW-0132; KW-0181; KW-0268; KW-0342; KW-0449; KW-0472; KW-0488; KW-0547; KW-0636; KW-1003; KW-1185,,,,,,,,"PTM: Prenylation is essential for membrane localization. The geranylgeranylated form and the farnesylated mutant do not undergo alternative prenylation in response to geranylgeranyltransferase I inhibitors (GGTIs) and farnesyltransferase I inhibitors (FTIs). {ECO:0000269|PubMed:17875936, ECO:0000269|PubMed:1903399}.",CHAIN 1 203 Ras-related protein Ral-A. /FTId=PRO_0000082693.,,,,,"LIPID 203 203 S-geranylgeranyl cysteine. {ECO:0000269|PubMed:17875936, ECO:0000269|PubMed:1903399}.",MOD_RES 203 203 Cysteine methyl ester. {ECO:0000250}.,,PROPEP 204 206 Removed in mature form. {ECO:0000250}. /FTId=PRO_0000281344.,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X15014;M29893;AF493910;CH236951;CH471073;BC039858;
0,P14625,ENPL_HUMAN,HSP90B1 GRP94 TRA1,HSP90B1,GRP94 TRA1,,,Homo sapiens (Human),9606,Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog),UP000005640: Chromosome 12,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MRALWVLGLCCVLLTFGSVRADDEVDVDGTVEEDLGKSREGSRTDDEVVQREEEAIQLDGLNASQIRELREKSEKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASDALDKIRLISLTDENALSGNEELTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGTSEFLNKMTEAQEDGQSTSELIGQFGVGFYSAFLVADKVIVTSKHNNDTQHIWESDSNEFSVIADPRGNTLGRGTTITLVLKEEASDYLELDTIKNLVKKYSQFINFPIYVWSSKTETVEEPMEEEEAAKEEKEESDDEAAVEEEEEEKKPKTKKVEKTVWDWELMNDIKPIWQRPSKEVEEDEYKAFYKSFSKESDDPMAYIHFTAEGEVTFKSILFVPTSAPRGLFDEYGSKKSDYIKLYVRRVFITDDFHDMMPKYLNFVKGVVDSDDLPLNVSRETLQQHKLLKVIRKKLVRKTLDMIKKIADDKYNDTFWKEFGTNIKLGVIEDHSNRTRLAKLLRFQSSHHPTDITSLDQYVERMKEKQDKIYFMAGSSRKEAESSPFVERLLKKGYEVIYLTEPVDEYCIQALPEFDGKRFQNVAKEGVKFDESEKTKESREAVEKEFEPLLNWMKDKALKDKIEKAVVSQRLTESPCALVASQYGWSGNMERIMKAQAYQTGKDISTNYYASQKKTFEINPRHPLIRDMLRRIKEDEDDKTVLDLAVVLFETATLRSGYLLPDTKAYGDRIERMLRLSLNIDPDAKVEEEPEEEPEETAEDTTEDTEQDEDEEMDVGTDEEEETAKESTAEKDEL,803,"92,469",,,,,,,,,,,,,,,,,CONFLICT 188 188 T -> S (in Ref. 4; AAK74072). {ECO:0000305}.; CONFLICT 419 419 T -> P (in Ref. 4; AAK74072). {ECO:0000305}.; CONFLICT 803 803 L -> F (in Ref. 4; AAK74072). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the heat shock protein 90 family. {ECO:0000305}.,,,,MOTIF 800 803 Prevents secretion from ER.,,,,,,,,,"FUNCTION: Molecular chaperone that functions in the processing and transport of secreted proteins. When associated with CNPY3, required for proper folding of Toll-like receptors (By similarity). Functions in endoplasmic reticulum associated degradation (ERAD). Has ATPase activity. {ECO:0000250, ECO:0000269|PubMed:18264092}.",,,,,,,BINDING 107 107 ATP. {ECO:0000250}.; BINDING 149 149 ATP. {ECO:0000250}.; BINDING 162 162 ATP. {ECO:0000250}.; BINDING 168 168 ATP. {ECO:0000250}.; BINDING 199 199 ATP; via amide nitrogen. {ECO:0000250}.; BINDING 448 448 ATP. {ECO:0000250}.,,,,,"collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; actin rod assembly [GO:0031247]; ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cellular response to ATP [GO:0071318]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of apoptotic process [GO:0043066]; post-translational protein modification [GO:0043687]; protein folding in endoplasmic reticulum [GO:0034975]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to endoplasmic reticulum stress [GO:0034976]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; sequestering of calcium ion [GO:0051208]; toll-like receptor signaling pathway [GO:0002224]; ubiquitin-dependent ERAD pathway [GO:0030433]","actin rod assembly [GO:0031247]; ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cellular response to ATP [GO:0071318]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of apoptotic process [GO:0043066]; post-translational protein modification [GO:0043687]; protein folding in endoplasmic reticulum [GO:0034975]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to endoplasmic reticulum stress [GO:0034976]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; sequestering of calcium ion [GO:0051208]; toll-like receptor signaling pathway [GO:0002224]; ubiquitin-dependent ERAD pathway [GO:0030433]",ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082],collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],GO:0001666; GO:0002224; GO:0003723; GO:0005509; GO:0005524; GO:0005576; GO:0005634; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0005925; GO:0006898; GO:0015031; GO:0016020; GO:0019221; GO:0019903; GO:0030433; GO:0030496; GO:0030970; GO:0031247; GO:0032991; GO:0034663; GO:0034975; GO:0034976; GO:0036500; GO:0042470; GO:0043066; GO:0043666; GO:0043687; GO:0044267; GO:0048471; GO:0050750; GO:0051082; GO:0051208; GO:0062023; GO:0070062; GO:0071318; GO:0071682,IPR003594; IPR036890; IPR019805; IPR037196; IPR001404; IPR020575; IPR020568; ,P04626; Q00597; P11021,"SUBUNIT: Homodimer; disulfide-linked. Component of an EIF2 complex at least composed of CELF1/CUGBP1, CALR, CALR3, EIF2S1, EIF2S2, HSP90B1 and HSPA5 (By similarity). Part of a large chaperone multiprotein complex comprising DNAJB11, HSP90B1, HSPA5, HYOU, PDIA2, PDIA4, PDIA6, PPIB, SDF2L1, UGT1A1 and very small amounts of ERP29, but not, or at very low levels, CALR nor CANX. Interacts with AIMP1; regulates its retention in the endoplasmic reticulum. Interacts with OS9. Interacts with CNPY3. This interaction is disrupted in the presence of ATP (By similarity). Interacts with TLR4 and TLR9, but not with TLR3. Interacts with MZB1 in a calcium-dependent manner (By similarity). Interacts with METTL23. {ECO:0000250, ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:20865800, ECO:0000269|PubMed:23349634}.",2377606; 15489334; 2546060; 12665801; 12475965; 12643545; 12754519; 18669648; 20865800; 17081065; 16263699; 18264092; 19159218; 20068231; 21269460; 21406692; 23186163; 23349634; 24275569; 26091039; 25944712,2377606; 15489334; 2546060; 12665801; 12475965; 12643545; 12754519; 18669648; 20865800; 17081065; 16263699; 18264092; 19159218; 20068231; 21269460; 21406692; 23186163; 23349634; 24275569; 26091039; 25944712; 10686426; 10722588; 11278437; 11557039; 11907036; 11958450; 12488451; 12654781; 12763022; 1339697; 14500642; 14609958; 14743216; 15107540; 15192333; 15257553; 15620698; 15637761; 15728573; 15962384; 16015374; 16288044; 16497268; 16630554; 16754684; 16926412; 17082602; 17275357; 17347446; 17431395; 17545519; 17612505; 17709607; 17726464; 17805476; 18155754; 18178560; 18273841; 18331622; 18340425; 18411291; 18482745; 18509083; 1852209; 18554719; 18662321; 18941243; 19135240; 19212831; 19227971; 19343720; 19578160; 19615732; 19724918; 19752220; 19805454; 19875450; 19895174; 19911804; 19913121; 19965672; 20000738; 20029029; 20176102; 20195357; 20217867; 20232284; 20237496; 20300187; 20351288; 20352117; 20360967; 20467437; 20562859; 20599762; 20628086; 20704820; 20711500; 20721957; 20839070; 20849212; 20888598; 20936779; 21208614; 21343306; 21637029; 21642380; 21708117; 21774995; 21782039; 21900206; 21988832; 21992474; 21998592; 22028648; 22190034; 22223641; 22245095; 22270544; 22304920; 22363530; 2251254; 22532561; 22554506; 22653265; 22665516; 22672426; 22724016; 22777994; 22810585; 22938940; 23035116; 23109341; 2318890; 23208072; 23266770; 23606334; 23755898; 23823123; 23829397; 24146856; 24189400; 24332488; 24511009; 24743777; 24899641; 25027323; 25470779; 25609649; 25637791; 25798051; 25803899; 25852190; 25880332; 25973087; 26108996; 26115722; 26167512; 26235316; 26318431; 26339394; 26464709; 26493996; 26496610; 26497551; 26638075; 26718209; 26719248; 26752685; 26872972; 26910913; 26945068; 26982636; 27183126; 27580824; 27599983; 27662661; 28000571; 28347227; 28706421; 29328381; 29368272; 29447283; 29852388; 3467373; 6088540; 6255257; 7607209; 8127896; 8344253; 8429030; 8751442; 8784195; 9148899; 9225214; 9465098; 9511720; 9548586; 9596688,1990-04-01,2019-02-13,1990-04-01,223,X-ray crystallography (1),STRAND 134 139 {ECO:0000244|PDB:4NH9}.; STRAND 144 149 {ECO:0000244|PDB:4NH9}.; STRAND 206 214 {ECO:0000244|PDB:4NH9}.; STRAND 221 225 {ECO:0000244|PDB:4NH9}.; STRAND 230 234 {ECO:0000244|PDB:4NH9}.; STRAND 241 251 {ECO:0000244|PDB:4NH9}.; STRAND 279 284 {ECO:0000244|PDB:4NH9}.; STRAND 331 335 {ECO:0000244|PDB:4NH9}.,HELIX 80 92 {ECO:0000244|PDB:4NH9}.; HELIX 99 118 {ECO:0000244|PDB:4NH9}.; HELIX 156 160 {ECO:0000244|PDB:4NH9}.; HELIX 175 184 {ECO:0000244|PDB:4NH9}.; HELIX 189 194 {ECO:0000244|PDB:4NH9}.; HELIX 198 204 {ECO:0000244|PDB:4NH9}.; HELIX 256 259 {ECO:0000244|PDB:4NH9}.; HELIX 261 271 {ECO:0000244|PDB:4NH9}.,TURN 119 121 {ECO:0000244|PDB:4NH9}.; TURN 123 128 {ECO:0000244|PDB:4NH9}.; TURN 140 143 {ECO:0000244|PDB:4NH9}.,,,,,5 out of 5,Beta strand (8); Binding site (6); Chain (1); Disulfide bond (1); Glycosylation (6); Helix (8); Modified residue (9); Motif (1); Sequence conflict (3); Signal peptide (1); Turn (3),,,,3D-structure;ATP-binding;Acetylation;Calcium;Chaperone;Complete proteome;Direct protein sequencing;Disulfide bond;Endoplasmic reticulum;Glycoprotein;Nucleotide-binding;Phosphoprotein;Reference proteome;Signal,Evidence at protein level,reviewed,,Heat shock protein 90 family,223,Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0067; KW-0106; KW-0143; KW-0181; KW-0256; KW-0325; KW-0547; KW-0597; KW-0732; KW-0903; KW-1015; KW-1185,,,,,,,,,CHAIN 22 803 Endoplasmin. /FTId=PRO_0000013598.,,DISULFID 138 138 Interchain. {ECO:0000250}.,"CARBOHYD 62 62 N-linked (GlcNAc...) asparagine. {ECO:0000269|PubMed:19159218}.; CARBOHYD 107 107 N-linked (GlcNAc...) asparagine. {ECO:0000269|PubMed:16263699, ECO:0000269|PubMed:19159218}.; CARBOHYD 217 217 N-linked (GlcNAc...) asparagine. {ECO:0000269|PubMed:12754519, ECO:0000269|PubMed:19159218}.; CARBOHYD 445 445 N-linked (GlcNAc...) asparagine. {ECO:0000269|PubMed:12754519, ECO:0000269|PubMed:19159218}.; CARBOHYD 481 481 N-linked (GlcNAc...) asparagine. {ECO:0000255}.; CARBOHYD 502 502 N-linked (GlcNAc...) asparagine. {ECO:0000255}.",,,"MOD_RES 64 64 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 172 172 Phosphoserine. {ECO:0000250|UniProtKB:Q66HD0}.; MOD_RES 306 306 Phosphoserine; by FAM20C. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:26091039}.; MOD_RES 403 403 Phosphoserine. {ECO:0000250|UniProtKB:Q66HD0}.; MOD_RES 404 404 N6-succinyllysine. {ECO:0000250|UniProtKB:P08113}.; MOD_RES 447 447 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 479 479 N6-acetyllysine. {ECO:0000250|UniProtKB:P08113}.; MOD_RES 633 633 N6-succinyllysine. {ECO:0000250|UniProtKB:P08113}.; MOD_RES 786 786 Phosphothreonine. {ECO:0000244|PubMed:24275569}.",,,"SIGNAL 1 21 {ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:12665801}.",,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X15187;M33716;BC066656;M26596;AY040226;
0,P17661,DESM_HUMAN,DES,DES,,,,Homo sapiens (Human),9606,Desmin,UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSQAYSSSQRVSSYRRTFGGAPGFPLGSPLSSPVFPRAGFGSKGSSSSVTSRVYQVSRTSGGAGGLGSLRASRLGTTRTPSSYGAGELLDFSLADAVNQEFLTTRTNEKVELQELNDRFANYIEKVRFLEQQNAALAAEVNRLKGREPTRVAELYEEELRELRRQVEVLTNQRARVDVERDNLLDDLQRLKAKLQEEIQLKEEAENNLAAFRADVDAATLARIDLERRIESLNEEIAFLKKVHEEEIRELQAQLQEQQVQVEMDMSKPDLTAALRDIRAQYETIAAKNISEAEEWYKSKVSDLTQAANKNNDALRQAKQEMMEYRHQIQSYTCEIDALKGTNDSLMRQMRELEDRFASEASGYQDNIARLEEEIRHLKDEMARHLREYQDLLNVKMALDVEIATYRKLLEGEESRINLPIQTYSALNFRETSPEQRGSEVHTKKTVMIKTIETRDGEVVSEATQQQHEVL,470,"53,536",,,,,,,,,,,,,"VARIANT 2 2 S -> I (in MFM1; dbSNP:rs58999456). {ECO:0000269|PubMed:14711882}. /FTId=VAR_042448.; VARIANT 7 7 S -> F (in MFM1; dbSNP:rs903985237). {ECO:0000269|PubMed:22106715}. /FTId=VAR_067207.; VARIANT 13 13 S -> F (in MFM1; some patients manifest a severe cardiac phenotype with right ventricular predominance; dbSNP:rs62636495). {ECO:0000269|PubMed:18061454, ECO:0000269|PubMed:19879535}. /FTId=VAR_067208.; VARIANT 16 16 R -> C (in MFM1; dbSNP:rs60798368). {ECO:0000269|PubMed:16376610}. /FTId=VAR_079048.; VARIANT 46 46 S -> F (in MFM1; exhibits significantly delayed filament assembly kinetics when bound to NEB; enhanced binding affinity towards NEB; dbSNP:rs60794845). {ECO:0000269|PubMed:14711882, ECO:0000269|PubMed:23615443}. /FTId=VAR_042449.; VARIANT 46 46 S -> Y (in MFM1; dbSNP:rs60794845). {ECO:0000269|PubMed:14711882}. /FTId=VAR_042450.; VARIANT 116 116 N -> S (in MFM1; the clinical picture is dominated by arrhythmogenic right ventricular cardiomyopathy and terminal heart failure; results in impaired filaments formation; dbSNP:rs267607499). {ECO:0000269|PubMed:20829228}. /FTId=VAR_069191.; VARIANT 120 120 A -> D (in CMD1I; results in impaired filaments formation, does not localize at intercalated disks). {ECO:0000269|PubMed:24200904}. /FTId=VAR_075228.; VARIANT 136 136 L -> P (in CMD1I; results in impaired filaments formation, does not localize at intercalated disks; dbSNP:rs397516695). {ECO:0000269|PubMed:26724190}. /FTId=VAR_075229.; VARIANT 173 179 Missing (in MFM1; severe form). {ECO:0000269|PubMed:9736733}. /FTId=VAR_009188.; VARIANT 213 213 A -> V (rare polymorphism; may play a role in cardiomyopathies and distal myopathies if combined with other DES mutations or mutations in other genes; does not affect the formation of a normal complete filamentous network; dbSNP:rs41272699). {ECO:0000269|PubMed:14648196, ECO:0000269|PubMed:16865695, ECO:0000269|PubMed:21842594, ECO:0000269|PubMed:23168288}. /FTId=VAR_042451.; VARIANT 240 240 Missing (in MFM1; the mutant cannot form de novo desmin intermediate filaments causing disruption of the endogenous intermediate filament network and formation of pathologic aggregates). {ECO:0000269|PubMed:12620971}. /FTId=VAR_070101.; VARIANT 241 241 K -> E (found in a patient with severe arrhythmogenic right ventricular cardiomyopathy also carrying a pathogenic frameshift mutation in PKP2; dbSNP:rs201945924). {ECO:0000269|PubMed:23168288}. /FTId=VAR_069192.; VARIANT 245 245 E -> D (in MFM1; exhibits significantly delayed filament assembly kinetics when bound to NEB and NEBL; enhanced binding affinity towards NEB and NEBL; dbSNP:rs267607486). {ECO:0000269|PubMed:23615443}. /FTId=VAR_042452.; VARIANT 326 326 H -> R (rare polymorphism; does not result in impaired filaments formation). {ECO:0000269|PubMed:24200904}. /FTId=VAR_075230.; VARIANT 337 337 A -> P (in MFM1; mild adult-onset; unable to form a functional filamentous network; dbSNP:rs59962885). {ECO:0000269|PubMed:10717012, ECO:0000269|PubMed:9697706}. /FTId=VAR_007900.; VARIANT 338 338 L -> R (in MFM1; results in the formation of a filamentous network disrupted by multiple breaks and clumps or large aggregates; dbSNP:rs57496341). {ECO:0000269|PubMed:16865695}. /FTId=VAR_067209.; VARIANT 342 342 N -> D (in MFM1; unable to form a filamentous network; abolishes binding to MTM1; dbSNP:rs267607482). {ECO:0000269|PubMed:10717012, ECO:0000269|PubMed:14648196, ECO:0000269|PubMed:21135508}. /FTId=VAR_042453.; VARIANT 345 345 L -> P (in MFM1; distal onset; incapable of forming filamentous networks; dbSNP:rs57639980). {ECO:0000269|PubMed:10545598}. /FTId=VAR_009189.; VARIANT 350 350 R -> P (in Kaeser syndrome and MFM1; incapable of de novo formation of a desmin intermediate filaments network; exerts a dominant negative effect on the ordered lateral arrangement of desmin subunits; may produce structural changes; forms subsarcolemmal aggregates; dbSNP:rs57965306). {ECO:0000269|PubMed:15800015, ECO:0000269|PubMed:17439987, ECO:0000269|PubMed:25394388}. /FTId=VAR_042454.; VARIANT 355 355 R -> P (in MFM1; dbSNP:rs61368398). {ECO:0000269|PubMed:16009553}. /FTId=VAR_042455.; VARIANT 357 357 A -> P (in MFM1; unable to polymerize and form an intracellular filamentous network; abolishes binding to MTM1; dbSNP:rs58898021). {ECO:0000269|PubMed:12766977, ECO:0000269|PubMed:14648196, ECO:0000269|PubMed:21135508}. /FTId=VAR_042456.; VARIANT 359 361 Missing (in MFM1). {ECO:0000269|PubMed:14648196}. /FTId=VAR_018769.; VARIANT 360 360 A -> P (in MFM1; heterozygous with I-393 gives a severe childhood-onset; unable to form a functional filamentous network in the presence of I-393; abolishes binding to MTM1; dbSNP:rs121913000). {ECO:0000269|PubMed:10717012, ECO:0000269|PubMed:16865695, ECO:0000269|PubMed:21135508, ECO:0000269|PubMed:9697706}. /FTId=VAR_007901.; VARIANT 366 366 Missing (in MFM1). {ECO:0000269|PubMed:14648196}. /FTId=VAR_018770.; VARIANT 370 370 L -> P (in MFM1; unable to polymerize and form an intracellular filamentous network; does not affect binding to MTM1; dbSNP:rs59308628). {ECO:0000269|PubMed:12766977, ECO:0000269|PubMed:14648196, ECO:0000269|PubMed:21135508}. /FTId=VAR_042457.; VARIANT 385 385 L -> P (in MFM1; dbSNP:rs57955682). {ECO:0000269|PubMed:11061256}. /FTId=VAR_018771.; VARIANT 389 389 Q -> P (in MFM1; dbSNP:rs121913004). {ECO:0000269|PubMed:11668632}. /FTId=VAR_018772.; VARIANT 393 393 N -> I (in MFM1; heterozygous with P-360 gives a severe childhood-onset; filamentous network is not affected however several spots indicate focal disorganization; dbSNP:rs121913001). {ECO:0000269|PubMed:10717012, ECO:0000269|PubMed:16865695, ECO:0000269|PubMed:9697706}. /FTId=VAR_007902.; VARIANT 399 399 D -> Y (in MFM1; results in the formation of a filamentous network disrupted by multiple breaks and clumps or large aggregates; dbSNP:rs61130669). {ECO:0000269|PubMed:16865695}. /FTId=VAR_067210.; VARIANT 401 401 E -> K (in MFM1; results in the formation of a filamentous network disrupted by multiple breaks and clumps or large aggregates; dbSNP:rs57694264). {ECO:0000269|PubMed:16865695}. /FTId=VAR_067211.; VARIANT 406 406 R -> W (in MFM1; unable to form a filamentous network; dbSNP:rs121913003). {ECO:0000269|PubMed:10717012, ECO:0000269|PubMed:10905661, ECO:0000269|PubMed:16376610}. /FTId=VAR_042458.; VARIANT 419 419 P -> S (in MFM1; found in a family with myofibrillar myopathy and arrhythmogenic right ventricular cardiomyopathy; dbSNP:rs62635763). {ECO:0000269|PubMed:22395865}. /FTId=VAR_069074.; VARIANT 442 442 T -> I (in MFM1; reveals a severe disturbance of filament-formation competence and filament-filament interactions; dbSNP:rs121913005). {ECO:0000269|PubMed:17221859}. /FTId=VAR_042459.; VARIANT 449 449 K -> M (in MFM1). /FTId=VAR_042460.; VARIANT 449 449 K -> T (in MFM1; dbSNP:rs267607485). {ECO:0000269|PubMed:14711882}. /FTId=VAR_042461.; VARIANT 451 451 I -> M (in CMD1I and MFM1; reveals a severe disturbance of filament-formation competence and filament-filament interactions; reduced interaction with CRYAB; dbSNP:rs121913002). {ECO:0000269|PubMed:10430757, ECO:0000269|PubMed:10717012, ECO:0000269|PubMed:17221859, ECO:0000269|PubMed:28470624}. /FTId=VAR_018773.; VARIANT 453 453 T -> I (in MFM1; exhibits significantly delayed filament assembly kinetics when bound to NEB and NEBL; enhanced binding affinity towards NEB and NEBL; dbSNP:rs267607488). {ECO:0000269|PubMed:16376610, ECO:0000269|PubMed:23615443}. /FTId=VAR_079049.; VARIANT 454 454 R -> W (in MFM1; reveals a severe disturbance of filament-formation competence and filament-filament interactions; increased interaction with CRYAB; dbSNP:rs267607490). {ECO:0000269|PubMed:17221859, ECO:0000269|PubMed:22106715, ECO:0000269|PubMed:28470624}. /FTId=VAR_042462.; VARIANT 460 460 S -> I (in MFM1; reveals a severe disturbance of filament-formation competence and filament-filament interactions; dbSNP:rs267607491). {ECO:0000269|PubMed:17221859}. /FTId=VAR_042463.",,,,"CONFLICT 23 25 GFP -> VFS (in Ref. 1 and 2; AAA99221). {ECO:0000305}.; CONFLICT 39 39 G -> P (in Ref. 1 and 2; AAA99221). {ECO:0000305}.; CONFLICT 119 123 FANYI -> SPIYM (in Ref. 1 and 2; AAA99221). {ECO:0000305}.; CONFLICT 134 134 Missing (in Ref. 1, 2; AAA99221 and 3; AAC50680). {ECO:0000305}.",,3,,0,,SIMILARITY: Belongs to the intermediate filament family. {ECO:0000255|PROSITE-ProRule:PRU01188}.,,,DOMAIN 108 416 IF rod. {ECO:0000255|PROSITE-ProRule:PRU01188}.,,REGION 1 108 Head.; REGION 109 141 Coil 1A.; REGION 142 151 Linker 1.; REGION 152 252 Coil 1B.; REGION 253 268 Linker 12.; REGION 268 415 Interaction with NEB. {ECO:0000269|PubMed:23615443}.; REGION 269 287 Coil 2A.; REGION 288 295 Linker 2.; REGION 296 412 Coil 2B.; REGION 413 470 Tail.; REGION 438 453 Interaction with CRYAB. {ECO:0000269|PubMed:28470624}.,,,,,,,,"FUNCTION: Muscle-specific type III intermediate filament essential for proper muscular structure and function. Plays a crucial role in maintaining the structure of sarcomeres, inter-connecting the Z-disks and forming the myofibrils, linking them not only to the sarcolemmal cytoskeleton, but also to the nucleus and mitochondria, thus providing strength for the muscle fiber during activity (PubMed:25358400). In adult striated muscle they form a fibrous network connecting myofibrils to each other and to the plasma membrane from the periphery of the Z-line structures (PubMed:24200904, PubMed:25394388, PubMed:26724190). May act as a sarcomeric microtubule-anchoring protein: specifically associates with detyrosinated tubulin-alpha chains, leading to buckled microtubules and mechanical resistance to contraction. Contributes to the transcriptional regulation of the NKX2-5 gene in cardiac progenitor cells during a short period of cardiomyogenesis and in cardiac side population stem cells in the adult. Plays a role in maintaining an optimal conformation of nebulette (NEB) on heart muscle sarcomeres to bind and recruit cardiac alpha-actin (By similarity). {ECO:0000250|UniProtKB:P31001, ECO:0000269|PubMed:24200904, ECO:0000269|PubMed:25394388, ECO:0000269|PubMed:26724190, ECO:0000303|PubMed:25358400}.",,,,,,,,,,,,cardiac myofibril [GO:0097512]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; cytoskeleton organization [GO:0007010]; intermediate filament organization [GO:0045109]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; regulation of heart contraction [GO:0008016],cytoskeleton organization [GO:0007010]; intermediate filament organization [GO:0045109]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; regulation of heart contraction [GO:0008016],cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200],cardiac myofibril [GO:0097512]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; sarcolemma [GO:0042383]; Z disc [GO:0030018],GO:0005200; GO:0005634; GO:0005829; GO:0005882; GO:0005916; GO:0006936; GO:0007010; GO:0008016; GO:0008092; GO:0014704; GO:0030018; GO:0030049; GO:0031594; GO:0042383; GO:0042802; GO:0045109; GO:0045111; GO:0070062; GO:0097512,IPR027698; IPR001664; IPR018039; IPR039008; IPR006821; ,Itself; O43812; Q9UBX2; Q6RFH8; O75923; Q08426; P14136; P40692; Q13496; P07196; Q6NYC8; P41219; Q7KZS0; P08670,"SUBUNIT: Homopolymer (PubMed:21135508). Interacts with DST (By similarity). Interacts with MTM1 (PubMed:21135508). Interacts with EPPK1; interaction is dependent of higher-order structure of intermediate filament (PubMed:16923132). Interacts with CRYAB (PubMed:28470624). Interacts with NEB (via nebulin repeats 160-164) (PubMed:23615443). Interacts (via rod region) with NEBL (via nebulin repeats 1-5) (PubMed:27733623). {ECO:0000250|UniProtKB:P31001, ECO:0000269|PubMed:16923132, ECO:0000269|PubMed:21135508, ECO:0000269|PubMed:23615443, ECO:0000269|PubMed:27733623, ECO:0000269|PubMed:28470624}.",2673923; 2007603; 8792816; 9697706; 10430757; 11668632; 14648196; 15489334; 10545598; 9875213; 12686604; 16923132; 19413330; 21135508; 14724127; 15495235; 23687351; 24275569; 25358400; 27565725; 9736733; 10905661; 11061256; 10717012; 12620971; 12766977; 14711882; 15800015; 16009553; 16376610; 16865695; 17439987; 17221859; 18061454; 19879535; 20829228; 21842594; 22106715; 22395865; 23168288; 24200904; 23615443; 25394388; 26724190; 27733623; 28470624,2673923; 2007603; 8792816; 9697706; 10430757; 11668632; 14648196; 15489334; 10545598; 9875213; 12686604; 16923132; 19413330; 21135508; 14724127; 15495235; 23687351; 24275569; 25358400; 27565725; 9736733; 10905661; 11061256; 10717012; 12620971; 12766977; 14711882; 15800015; 16009553; 16376610; 16865695; 17439987; 17221859; 18061454; 19879535; 20829228; 21842594; 22106715; 22395865; 23168288; 24200904; 23615443; 25394388; 26724190; 27733623; 28470624; 10747208; 11581269; 12064939; 12477713; 12609507; 15468102; 15759133; 16439510; 16545539; 16761416; 17188893; 17325244; 17353931; 17381546; 17418574; 17436150; 17626518; 17720647; 17872945; 17924085; 18157088; 18691435; 18985028; 19005210; 19165527; 19460759; 19473514; 19763525; 19913121; 20031618; 20133133; 20171226; 20423733; 20448486; 20474083; 20618440; 20628086; 20654101; 20696008; 20706999; 20718792; 21083940; 21262226; 21768101; 21784990; 21982405; 22085644; 22096479; 22304920; 22349865; 22386993; 22395512; 22403400; 22484823; 22575643; 22775584; 22908310; 23036309; 23051780; 23075894; 23414517; 23713052; 24441330; 25277244; 25416956; 25541946; 25575565; 25609649; 25680090; 25732530; 26431784; 26947931; 27304995; 27393313; 28171858; 28427417; 28793217; 29167554; 29196434; 30096250,1990-08-01,2019-02-13,2007-01-23,203,,,,,,,,,5 out of 5,Chain (1); Domain (1); Modified residue (21); Mutagenesis (2); Natural variant (40); Region (11); Sequence conflict (9),,,,ADP-ribosylation;Cardiomyopathy;Cell membrane;Coiled coil;Complete proteome;Cytoplasm;Desmin-related myopathy;Disease mutation;Intermediate filament;Limb-girdle muscular dystrophy;Membrane;Methylation;Muscle protein;Myofibrillar myopathy;Nucleus;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,Intermediate filament family,203,Function (1); Involvement in disease (3); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0013; KW-0122; KW-0175; KW-0181; KW-0225; KW-0403; KW-0472; KW-0488; KW-0514; KW-0539; KW-0597; KW-0621; KW-0911; KW-0947; KW-0963; KW-1003; KW-1060; KW-1185,,,,,"DISEASE: Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]: A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM1 is characterized by skeletal muscle weakness associated with cardiac conduction blocks, arrhythmias, restrictive heart failure, and accumulation of desmin-reactive deposits in cardiac and skeletal muscle cells. {ECO:0000269|PubMed:10545598, ECO:0000269|PubMed:10717012, ECO:0000269|PubMed:10905661, ECO:0000269|PubMed:11061256, ECO:0000269|PubMed:11668632, ECO:0000269|PubMed:12620971, ECO:0000269|PubMed:12766977, ECO:0000269|PubMed:14648196, ECO:0000269|PubMed:14711882, ECO:0000269|PubMed:14724127, ECO:0000269|PubMed:15495235, ECO:0000269|PubMed:15800015, ECO:0000269|PubMed:16009553, ECO:0000269|PubMed:16376610, ECO:0000269|PubMed:16865695, ECO:0000269|PubMed:17221859, ECO:0000269|PubMed:18061454, ECO:0000269|PubMed:19879535, ECO:0000269|PubMed:20829228, ECO:0000269|PubMed:22106715, ECO:0000269|PubMed:22395865, ECO:0000269|PubMed:23615443, ECO:0000269|PubMed:23687351, ECO:0000269|PubMed:25394388, ECO:0000269|PubMed:27733623, ECO:0000269|PubMed:28470624, ECO:0000269|PubMed:9697706, ECO:0000269|PubMed:9736733}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in the DES gene are associated with a variable clinical phenotype which encompasses isolated myopathies, pure cardiac phenotypes (including dilated cardiomyopathy, restrictive cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy), cardiac conduction disease, and combinations of these disorders. If both cardiologic and neurologic features occur, they can manifest in any order, as cardiologic features can precede, occur simultaneously with, or follow manifestation of generalized neuromuscular disease (PubMed:19879535). {ECO:0000269|PubMed:19879535}.; DISEASE: Cardiomyopathy, dilated 1I (CMD1I) [MIM:604765]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:10430757, ECO:0000269|PubMed:24200904, ECO:0000269|PubMed:26724190}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurogenic scapuloperoneal syndrome Kaeser type (Kaeser syndrome) [MIM:181400]: Autosomal dominant disorder with a peculiar scapuloperoneal distribution of weakness and atrophy. A large clinical variability is observed ranging from scapuloperoneal, limb grindle and distal phenotypes with variable cardiac or respiratory involvement. Facial weakness, dysphagia and gynaecomastia are frequent additional symptoms. Affected men seemingly bear a higher risk of sudden, cardiac death as compared to affected women. Histological and immunohistochemical examination of muscle biopsy specimens reveal a wide spectrum of findings ranging from near normal or unspecific pathology to typical, myofibrillar changes with accumulation of desmin. {ECO:0000269|PubMed:17439987, ECO:0000269|PubMed:25394388}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: ADP-ribosylation prevents ability to form intermediate filaments. {ECO:0000250|UniProtKB:P48675}.; PTM: Phosphorylation at Ser-7, Ser-28 and Ser-32 by CDK1, phosphorylation at Ser-60 by AURKB and phosphorylation at Thr-76 by ROCK1 contribute to efficient separation of desmin intermediate filaments during mitosis. {ECO:0000250|UniProtKB:P31001}.",CHAIN 1 470 Desmin. /FTId=PRO_0000063771.,,,,,,"MOD_RES 7 7 Phosphoserine; by CDK1. {ECO:0000250|UniProtKB:P31001}.; MOD_RES 12 12 Phosphoserine; by AURKB. {ECO:0000269|PubMed:12686604}.; MOD_RES 16 16 Omega-N-methylarginine. {ECO:0000250|UniProtKB:P31001}.; MOD_RES 17 17 Phosphothreonine; by AURKB and ROCK1. {ECO:0000269|PubMed:12686604, ECO:0000269|PubMed:9875213}.; MOD_RES 28 28 Phosphoserine; by CDK1. {ECO:0000244|PubMed:24275569}.; MOD_RES 31 31 Phosphoserine. {ECO:0000250|UniProtKB:P31001}.; MOD_RES 32 32 Phosphoserine; by CDK1. {ECO:0000269|PubMed:27565725}.; MOD_RES 37 37 Asymmetric dimethylarginine; alternate. {ECO:0000250|UniProtKB:P31001}.; MOD_RES 37 37 Omega-N-methylarginine; alternate. {ECO:0000250|UniProtKB:P31001}.; MOD_RES 45 45 Phosphoserine. {ECO:0000250|UniProtKB:P48675}.; MOD_RES 58 58 ADP-ribosylarginine. {ECO:0000250|UniProtKB:P48675}.; MOD_RES 60 60 Phosphoserine; by AURKB. {ECO:0000269|PubMed:12686604}.; MOD_RES 68 68 Phosphoserine. {ECO:0000250|UniProtKB:P31001}.; MOD_RES 70 70 Omega-N-methylarginine. {ECO:0000250|UniProtKB:P31001}.; MOD_RES 76 76 Phosphothreonine; by ROCK1. {ECO:0000269|PubMed:9875213}.; MOD_RES 77 77 Phosphothreonine; by ROCK1. {ECO:0000269|PubMed:9875213}.; MOD_RES 81 81 Phosphoserine. {ECO:0000250|UniProtKB:P48675}.; MOD_RES 290 290 Phosphoserine. {ECO:0000250|UniProtKB:P48675}.; MOD_RES 358 358 Phosphoserine. {ECO:0000250|UniProtKB:P48675}.; MOD_RES 361 361 Phosphoserine. {ECO:0000250|UniProtKB:P48675}.; MOD_RES 424 424 Phosphoserine. {ECO:0000250|UniProtKB:P31001}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M63391;U59167;AF055081;AF055082;AF055083;AF137053;AF486807;AF487828;AF521879;AF527578;AY083345;AY114212;AY125465;BC032116;AJ132926;
0,P20700,LMNB1_HUMAN,LMNB1 LMN2 LMNB,LMNB1,LMN2 LMNB,,,Homo sapiens (Human),9606,Lamin-B1,UP000005640: Chromosome 5,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MATATPVPPRMGSRAGGPTTPLSPTRLSRLQEKEELRELNDRLAVYIDKVRSLETENSALQLQVTEREEVRGRELTGLKALYETELADARRALDDTARERAKLQIELGKCKAEHDQLLLNYAKKESDLNGAQIKLREYEAALNSKDAALATALGDKKSLEGDLEDLKDQIAQLEASLAAAKKQLADETLLKVDLENRCQSLTEDLEFRKSMYEEEINETRRKHETRLVEVDSGRQIEYEYKLAQALHEMREQHDAQVRLYKEELEQTYHAKLENARLSSEMNTSTVNSAREELMESRMRIESLSSQLSNLQKESRACLERIQELEDLLAKEKDNSRRMLTDKEREMAEIRDQMQQQLNDYEQLLDVKLALDMEISAYRKLLEGEEERLKLSPSPSSRVTVSRASSSRSVRTTRGKRKRVDVEESEASSSVSISHSASATGNVCIEEIDVDGKFIRLKNTSEQDQPMGGWEMIRKIGDTSVSYKYTSRYVLKAGQTVTIWAANAGVTASPPTDLIWKNQNSWGTGEDVKVILKNSQGEEVAQRSTVFKTTIPEEEEEEEEAAGVVVEEELFHQQGTPRASNRSCAIM,586,"66,408",,,,,,,,,,,,,VARIANT 436 436 A -> V (found in a family with amyotrophic lateral sclerosis carrying a probable causative mutation in MATR3; unknown pathological significance; dbSNP:rs1380634377). {ECO:0000269|PubMed:24686783}. /FTId=VAR_071077.; VARIANT 501 501 A -> V (in dbSNP:rs36105360). /FTId=VAR_031646.,,,,CONFLICT 382 382 E -> Q (in Ref. 5; AAH12295). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the intermediate filament family. {ECO:0000255|PROSITE-ProRule:PRU01188}.,,COMPBIAS 552 559 Glu-rich (highly acidic; could be involved in chromatin binding).,DOMAIN 32 388 IF rod. {ECO:0000255|PROSITE-ProRule:PRU01188}.; DOMAIN 430 546 LTD. {ECO:0000255|PROSITE-ProRule:PRU01187}.,MOTIF 415 420 Nuclear localization signal. {ECO:0000255}.,REGION 2 34 Head.; REGION 35 69 Coil 1A.; REGION 70 81 Linker 1.; REGION 82 215 Coil 1B.; REGION 216 243 Linker 2.; REGION 244 386 Coil 2.; REGION 387 586 Tail.,,,,,,,,"FUNCTION: Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin.",,,,,,,,,,,,lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural molecule activity [GO:0005198]; interleukin-12-mediated signaling pathway [GO:0035722],interleukin-12-mediated signaling pathway [GO:0035722],phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural molecule activity [GO:0005198],lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GO:0005198; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005654; GO:0016020; GO:0016363; GO:0031965; GO:0035722; GO:0043274; GO:1990837,IPR001664; IPR018039; IPR039008; IPR001322; IPR036415; ,P52294; P02545; P02545-1; Q03252; Q9GZQ8; Q8WWB5; Q05322,"SUBUNIT: Homodimer. Interacts with lamin-associated polypeptides IA, IB and 2. Interacts with SPAG4 and SEPT12. {ECO:0000269|PubMed:22265972, ECO:0000269|PubMed:25775403}.",2325650; 7557986; 14702039; 15489334; 2684976; 14654843; 17081983; 16964243; 16951681; 18691976; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 22223895; 23186163; 24275569; 24129315; 25218447; 25114211; 25755297; 25775403; 28112733; 22265972; 24686783,2325650; 7557986; 14702039; 15489334; 2684976; 14654843; 17081983; 16964243; 16951681; 18691976; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 22223895; 23186163; 24275569; 24129315; 25218447; 25114211; 25755297; 25775403; 28112733; 22265972; 24686783; 10908652; 11285238; 11792822; 12493765; 12898336; 14504265; 14968112; 15161933; 15284226; 15546916; 15621527; 15655109; 15681850; 16038020; 16079285; 16283426; 16339967; 16365157; 16371512; 16410549; 16495336; 16543417; 16704422; 16901784; 17158953; 17170708; 17242198; 17242207; 17353931; 17446270; 17452644; 17543860; 18234856; 18334554; 18524819; 18628300; 18985028; 19001169; 19141474; 19151023; 19198602; 19348623; 19383719; 19522540; 19765186; 19961535; 20004208; 20085707; 20360068; 20711500; 20816241; 21225301; 21389115; 21418524; 21516116; 2188730; 2188731; 21909802; 21988832; 22246186; 22496421; 22623428; 22770216; 22986494; 23075850; 23261988; 23439683; 2344612; 23475125; 23531880; 23649844; 23681646; 23733478; 23764002; 23857605; 23873483; 23934658; 23964094; 24293108; 24297448; 24732130; 24858279; 25477337; 25535332; 25609649; 25637521; 25701871; 25733566; 25852190; 26053668; 26311780; 26496610; 26876308; 27503760; 27760841; 27926867; 28229933; 28844980; 28939839; 29115590; 29753763; 7937898; 8034666; 8463284; 8794855; 8978814; 9465049,1991-02-01,2019-02-13,2007-01-23,201,X-ray crystallography (4); NMR spectroscopy (1),STRAND 432 447 {ECO:0000244|PDB:3UMN}.; STRAND 451 458 {ECO:0000244|PDB:3UMN}.; STRAND 460 462 {ECO:0000244|PDB:3UMN}.; STRAND 470 475 {ECO:0000244|PDB:3UMN}.; STRAND 478 483 {ECO:0000244|PDB:3UMN}.; STRAND 495 500 {ECO:0000244|PDB:3UMN}.; STRAND 512 515 {ECO:0000244|PDB:3UMN}.; STRAND 523 525 {ECO:0000244|PDB:3UMN}.; STRAND 527 532 {ECO:0000244|PDB:3UMN}.; STRAND 538 546 {ECO:0000244|PDB:3UMN}.,HELIX 315 381 {ECO:0000244|PDB:3TYY}.,TURN 509 511 {ECO:0000244|PDB:3UMN}.,,,,,5 out of 5,Beta strand (10); Chain (1); Compositional bias (1); Cross-link (12); Disulfide bond (1); Domain (2); Helix (1); Initiator methionine (1); Lipidation (1); Modified residue (25); Motif (1); Natural variant (2); Propeptide (1); Region (7); Sequence conflict (1); Turn (1),,,"MISCELLANEOUS: The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively.",3D-structure;Acetylation;Chromosomal rearrangement;Coiled coil;Complete proteome;Direct protein sequencing;Disulfide bond;Intermediate filament;Isopeptide bond;Leukodystrophy;Lipoprotein;Membrane;Methylation;Nucleus;Phosphoprotein;Polymorphism;Prenylation;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,Intermediate filament family,201,Function (1); Involvement in disease (1); Miscellaneous (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0160; KW-0175; KW-0181; KW-0403; KW-0449; KW-0472; KW-0488; KW-0539; KW-0597; KW-0621; KW-0636; KW-0832; KW-0903; KW-1015; KW-1017; KW-1026; KW-1185,,,,,"DISEASE: Leukodystrophy, demyelinating, autosomal dominant, adult-onset (ADLD) [MIM:169500]: A slowly progressive and fatal demyelinating leukodystrophy, presenting in the fourth or fifth decade of life. Clinically characterized by early autonomic abnormalities, pyramidal and cerebellar dysfunction, and symmetric demyelination of the CNS. It differs from multiple sclerosis and other demyelinating disorders in that neuropathology shows preservation of oligodendroglia in the presence of subtotal demyelination and lack of astrogliosis. {ECO:0000269|PubMed:16951681}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: B-type lamins undergo a series of modifications, such as farnesylation and phosphorylation. Increased phosphorylation of the lamins occurs before envelope disintegration and probably plays a role in regulating lamin associations.",CHAIN 2 583 Lamin-B1. /FTId=PRO_0000063816.,"CROSSLNK 102 102 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:28112733}.; CROSSLNK 123 123 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 145 145 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 157 157 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 181 181 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 241 241 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25114211, ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 261 261 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 271 271 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 312 312 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 330 330 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:28112733}.; CROSSLNK 532 532 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 547 547 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.",DISULFID 317 317 Interchain. {ECO:0000269|PubMed:22265972}.,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:22223895, ECO:0000269|Ref.6}.",LIPID 583 583 S-farnesyl cysteine. {ECO:0000269|PubMed:2684976}.,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:22223895, ECO:0000269|Ref.6}.; MOD_RES 3 3 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 5 5 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 14 14 Omega-N-methylarginine. {ECO:0000244|PubMed:24129315}.; MOD_RES 20 20 Phosphothreonine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 23 23 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 25 25 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 28 28 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 111 111 N6-acetyllysine. {ECO:0000250|UniProtKB:P14733}.; MOD_RES 126 126 Phosphoserine. {ECO:0000250|UniProtKB:P70615}.; MOD_RES 157 157 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 158 158 Phosphoserine. {ECO:0000250|UniProtKB:P70615}.; MOD_RES 200 200 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 210 210 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 232 232 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 271 271 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 278 278 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 302 302 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 330 330 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P14733}.; MOD_RES 375 375 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 413 413 Omega-N-methylarginine. {ECO:0000250|UniProtKB:P21619}.; MOD_RES 483 483 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 534 534 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 575 575 Phosphothreonine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 583 583 Cysteine methyl ester. {ECO:0000305}.",,PROPEP 584 586 Removed in mature form. {ECO:0000305}. /FTId=PRO_0000393945.,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M34458;L37747;L37737;L37738;L37739;L37740;L37741;L37742;L37743;L37744;L37745;L37746;AK312603;CH471086;BC012295;BC103723;
0,P23528,COF1_HUMAN,CFL1 CFL,CFL1,CFL,,,Homo sapiens (Human),9606,"Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)",UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MASGVAVSDGVIKVFNDMKVRKSSTPEEVKKRKKAVLFCLSEDKKNIILEEGKEILVGDVGQTVDDPYATFVKMLPDKDCRYALYDATYETKESKKEDLVFIFWAPESAPLKSKMIYASSKDAIKKKLTGIKHELQANCYEEVKDRCTLAEKLGGSAVISLEGKPL,166,"18,502",,,,,,,,,,,,,,,,,,,3,,0,,SIMILARITY: Belongs to the actin-binding proteins ADF family. {ECO:0000305}.,,,DOMAIN 4 153 ADF-H. {ECO:0000255|PROSITE-ProRule:PRU00599}.,MOTIF 30 34 Nuclear localization signal. {ECO:0000255}.,,,,,,,,,"FUNCTION: Binds to F-actin and exhibits pH-sensitive F-actin depolymerizing activity. Regulates actin cytoskeleton dynamics. Important for normal progress through mitosis and normal cytokinesis. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required for the up-regulation of atypical chemokine receptor ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation (PubMed:11812157, PubMed:15580268, PubMed:21834987, PubMed:23633677). Required for neural tube morphogenesis and neural crest cell migration (By similarity). {ECO:0000250|UniProtKB:P18760, ECO:0000269|PubMed:11812157, ECO:0000269|PubMed:15580268, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:23633677}.",,,,,,,,,,,,cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; cytoskeleton organization [GO:0007010]; establishment of cell polarity [GO:0030010]; interleukin-12-mediated signaling pathway [GO:0035722]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation by host of viral process [GO:0044794]; positive regulation of actin filament depolymerization [GO:0030836]; protein phosphorylation [GO:0006468]; regulation of cell morphogenesis [GO:0022604]; regulation of dendritic spine morphogenesis [GO:0061001]; response to amino acid [GO:0043200]; response to virus [GO:0009615]; Rho protein signal transduction [GO:0007266],actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; cytoskeleton organization [GO:0007010]; establishment of cell polarity [GO:0030010]; interleukin-12-mediated signaling pathway [GO:0035722]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation by host of viral process [GO:0044794]; positive regulation of actin filament depolymerization [GO:0030836]; protein phosphorylation [GO:0006468]; regulation of cell morphogenesis [GO:0022604]; regulation of dendritic spine morphogenesis [GO:0061001]; response to amino acid [GO:0043200]; response to virus [GO:0009615]; Rho protein signal transduction [GO:0007266],actin filament binding [GO:0051015]; signaling receptor binding [GO:0005102],cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; vesicle [GO:0031982],GO:0000281; GO:0001755; GO:0001842; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005911; GO:0005925; GO:0006468; GO:0007010; GO:0007266; GO:0009615; GO:0016020; GO:0016363; GO:0022604; GO:0030010; GO:0030027; GO:0030036; GO:0030042; GO:0030043; GO:0030836; GO:0030864; GO:0031258; GO:0031982; GO:0032587; GO:0035722; GO:0043066; GO:0043200; GO:0044794; GO:0051015; GO:0061001; GO:0070062,IPR002108; IPR029006; IPR017904; IPR027234; ,P60709; P63261; P54253; Q549N0; P57058; P53667; P0DOE7; Q13393; O14939; Q1KLZ0; Q8WYL5; P63104,SUBUNIT: Can bind G- and F-actin in a 1:1 ratio of cofilin to actin. It is a major component of intranuclear and cytoplasmic actin rods. {ECO:0000250|UniProtKB:P10668}.,2263493; 7552146; 8800436; 14702039; 15489334; 12665801; 8037689; 11812157; 12837278; 14654843; 15592455; 15580268; 17081983; 16548883; 18669648; 19413330; 19369195; 19690332; 19608861; 20068231; 21834987; 21269460; 21406692; 22223895; 22814378; 23186163; 23633677; 24275569; 25944712; 28112733; 14627701,2263493; 7552146; 8800436; 14702039; 15489334; 12665801; 8037689; 11812157; 12837278; 14654843; 15592455; 15580268; 17081983; 16548883; 18669648; 19413330; 19369195; 19690332; 19608861; 20068231; 21834987; 21269460; 21406692; 22223895; 22814378; 23186163; 23633677; 24275569; 25944712; 28112733; 14627701; 10436159; 10613909; 10644754; 11093160; 11171090; 11276226; 11294912; 11418599; 11571311; 11784854; 12361576; 12451591; 12577067; 12642619; 12655149; 12791392; 12904289; 14630798; 14634665; 14636893; 14645219; 15159416; 15161933; 15213453; 15485906; 15584898; 15598710; 15647284; 15660133; 15671020; 15719172; 15816841; 15846844; 15866889; 15901596; 16038020; 16061204; 16169070; 16189514; 16230460; 16301112; 16456544; 16505165; 16713569; 16803871; 17088134; 17130184; 17196218; 17352815; 17353931; 17470633; 17500066; 17583572; 17620599; 17853892; 17954607; 18070928; 18079118; 18096821; 18309290; 18442045; 18459146; 18716285; 18771940; 18775311; 18809681; 18937355; 18987670; 19000834; 19029335; 19110265; 19223396; 19329994; 19339277; 19367725; 19403692; 19424295; 19463016; 19483084; 19546591; 19556892; 19562668; 19567672; 19654210; 19683683; 19721896; 19734890; 19738201; 19802004; 19805454; 19997845; 20000738; 20029029; 20095995; 20133759; 20381070; 20471030; 20472933; 20558337; 20562859; 20564088; 20610540; 20646534; 20676060; 20711500; 20729910; 20819441; 20825680; 20838616; 20873970; 21044950; 21045147; 21150319; 21163940; 21179570; 21221513; 21237490; 21469165; 21516116; 21525957; 21571222; 21647301; 21723825; 21735353; 21875597; 21894436; 21900206; 21911578; 21923909; 22019611; 22158895; 22212282; 22216116; 22270398; 22304920; 22345165; 22450169; 22550395; 22575643; 22593798; 22623428; 22623727; 22623803; 22689060; 22742733; 22790341; 22810585; 22855535; 22869619; 22970259; 23022583; 23060131; 23112838; 23153585; 23170111; 23227181; 23320827; 23338717; 23362981; 23395798; 23416715; 23505076; 23702034; 23737525; 23831569; 23897816; 23911787; 23934191; 23951242; 23999301; 24003227; 24018823; 24023293; 24106833; 24254706; 24284899; 24418541; 24425731; 24454796; 24478456; 24486488; 24505128; 24631019; 24658140; 24664099; 24795566; 24813767; 24840177; 25056928; 25096578; 25179631; 25416956; 25468977; 25486435; 25529407; 25549357; 25556234; 25568344; 25597880; 25609649; 25635941; 25640309; 25642645; 25684665; 25714964; 25781955; 25784483; 25864508; 25995115; 25998423; 26056138; 26058485; 26085344; 26169356; 26268695; 26269174; 26271467; 26324884; 26344167; 26450610; 26496610; 26558842; 26639431; 26857814; 26878213; 26880202; 26918678; 26934847; 26956845; 26967395; 26996939; 27003257; 27035282; 27052944; 27153537; 27402302; 27462783; 27573465; 27595610; 27626171; 27665963; 27748441; 27768223; 28161904; 28216224; 28365778; 28388575; 28440035; 28446539; 28679472; 28826686; 29347944; 29396473; 30463566; 9113405; 9655398; 9864364,1991-11-01,2019-02-13,2007-01-23,216,X-ray crystallography (3); NMR spectroscopy (2); Electron microscopy (1),STRAND 33 40 {ECO:0000244|PDB:5L6W}.; STRAND 44 56 {ECO:0000244|PDB:5L6W}.; STRAND 77 79 {ECO:0000244|PDB:4BEX}.; STRAND 81 90 {ECO:0000244|PDB:5L6W}.; STRAND 95 104 {ECO:0000244|PDB:5L6W}.; STRAND 134 139 {ECO:0000244|PDB:5L6W}.; STRAND 160 165 {ECO:0000244|PDB:5L6W}.,HELIX 9 19 {ECO:0000244|PDB:5L6W}.; HELIX 26 31 {ECO:0000244|PDB:5L6W}.; HELIX 57 59 {ECO:0000244|PDB:5L6W}.; HELIX 67 74 {ECO:0000244|PDB:5L6W}.; HELIX 111 127 {ECO:0000244|PDB:5L6W}.; HELIX 140 144 {ECO:0000244|PDB:5L6W}.; HELIX 147 154 {ECO:0000244|PDB:5L6W}.; HELIX 155 157 {ECO:0000244|PDB:4BEX}.,TURN 61 63 {ECO:0000244|PDB:5L6W}.,,,,,5 out of 5,Beta strand (7); Chain (1); Cross-link (1); Domain (1); Helix (8); Initiator methionine (1); Modified residue (11); Motif (1); Turn (1),,TISSUE SPECIFICITY: Widely distributed in various tissues.,,3D-structure;Acetylation;Actin-binding;Cell membrane;Cell projection;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Isopeptide bond;Membrane;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,Actin-binding proteins ADF family,216,Function (1); Induction (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0009; KW-0181; KW-0206; KW-0472; KW-0539; KW-0597; KW-0832; KW-0903; KW-0963; KW-0966; KW-1003; KW-1017; KW-1185,,,,,,,,"PTM: Inactivated by phosphorylation on Ser-3. Phosphorylated on Ser-3 in resting cells (By similarity). Dephosphorylated by PDXP/chronophin; this restores its activity in promoting actin filament depolymerization. The phosphorylation of Ser-24 may prevent recognition of the nuclear localization signal (By similarity). Phosphorylated via a ARRB1-RAC1-LIMK1-PAK1 cascade upon active ligand stimulation of atypical chemokine receptor ACKR2. {ECO:0000250|UniProtKB:P45695, ECO:0000269|PubMed:12837278, ECO:0000269|PubMed:23633677}.",CHAIN 2 166 Cofilin-1. /FTId=PRO_0000214898.,CROSSLNK 132 132 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:12665801, ECO:0000269|Ref.9}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|Ref.9}.; MOD_RES 3 3 Phosphoserine; by NRK. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:12837278}.; MOD_RES 8 8 Phosphoserine. {ECO:0000250|UniProtKB:P18760}.; MOD_RES 13 13 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 25 25 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 41 41 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 68 68 Phosphotyrosine. {ECO:0000244|PubMed:19690332}.; MOD_RES 73 73 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 140 140 Phosphotyrosine. {ECO:0000244|PubMed:15592455}.; MOD_RES 144 144 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 156 156 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,D00682;U21909;X95404;BT006846;AK097690;CH471076;BC011005;BC012265;BC012318;BC018256;
0,P24844,MYL9_HUMAN,MYL9 MLC2 MRLC1 MYRL2,MYL9,MLC2 MRLC1 MYRL2,,,Homo sapiens (Human),9606,"Myosin regulatory light polypeptide 9 (20 kDa myosin light chain) (LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1)",UP000005640: Chromosome 20,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSSKRAKAKTTKKRPQRATSNVFAMFDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASLGKNPTDEYLEGMMSEAPGPINFTMFLTMFGEKLNGTDPEDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFNYVEFTRILKHGAKDKDD,172,"19,827",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P24844-1; Sequence=Displayed; Name=2; IsoId=P24844-2; Sequence=VSP_042834; ,,,,,,,,,,"VAR_SEQ 62 115 Missing (in isoform 2). {ECO:0000303|PubMed:15489334, ECO:0000303|Ref.2}. /FTId=VSP_042834.",,,,,CONFLICT 10 10 T -> A (in Ref. 1; AAA59852). {ECO:0000305}.; CONFLICT 81 81 I -> Y (in Ref. 1; AAA59852). {ECO:0000305}.; CONFLICT 114 114 A -> S (in Ref. 1; AAA59852). {ECO:0000305}.; CONFLICT 125 125 E -> K (in Ref. 1; AAA59852). {ECO:0000305}.; CONFLICT 148 148 I -> V (in Ref. 1; AAA59852). {ECO:0000305}.; CONFLICT 171 171 D -> H (in Ref. 1; AAA59852). {ECO:0000305}.,,4,,0,,,,,DOMAIN 29 64 EF-hand 1. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 98 133 EF-hand 2. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 134 169 EF-hand 3. {ECO:0000255|PROSITE-ProRule:PRU00448}.,,,,,,,,,,"FUNCTION: Myosin regulatory subunit that plays an important role in regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. Implicated in cytokinesis, receptor capping, and cell locomotion. {ECO:0000269|PubMed:11942626, ECO:0000269|PubMed:2526655}.",,,,,,,,,,,,cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of muscle contraction [GO:0006937],muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of muscle contraction [GO:0006937],calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of muscle [GO:0008307],cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; stress fiber [GO:0001725]; Z disc [GO:0030018],GO:0001725; GO:0005509; GO:0005829; GO:0005859; GO:0006936; GO:0006937; GO:0008307; GO:0030018; GO:0032036; GO:0045652; GO:0070527,IPR011992; IPR018247; IPR002048; ,,SUBUNIT: Myosin is a hexamer of 2 heavy chains and 4 light chains: interacts with myosin heavy chain MYO19. {ECO:0000250|UniProtKB:Q9CQ19}.,2526655; 11942626; 11780052; 15489334; 18854160; 21072057; 21457715; 21408167,2526655; 11942626; 11780052; 15489334; 18854160; 21072057; 21457715; 21408167; 10047984; 10639334; 11331307; 11457814; 12081505; 12185584; 12802051; 16076902; 16169070; 17151359; 18480596; 18835557; 1930128; 19724058; 20711500; 20876458; 21251247; 23538510; 24084383; 24189459; 24338276; 24510904; 25179839; 25277244; 25609649; 26169356; 27104745; 2764880; 28388691; 2966156; 2995373; 3079756; 3780718; 3839510; 8662509; 8702756; 9354661,1992-03-01,2019-02-13,2007-01-23,174,,,,,,,,,5 out of 5,Alternative sequence (1); Calcium binding (1); Chain (1); Domain (3); Initiator methionine (1); Modified residue (3); Sequence conflict (6),,"TISSUE SPECIFICITY: Smooth muscle tissues and in some, but not all, nonmuscle cells. {ECO:0000269|PubMed:2526655}.",MISCELLANEOUS: This chain binds calcium.,Acetylation;Alternative splicing;Calcium;Complete proteome;Metal-binding;Motor protein;Muscle protein;Myosin;Phosphoprotein;Reference proteome;Repeat,Evidence at protein level,reviewed,,,174,Alternative products (1); Function (1); Miscellaneous (1); Post-translational modification (1); Subunit structure (1); Tissue specificity (1),,KW-0007; KW-0025; KW-0106; KW-0181; KW-0479; KW-0505; KW-0514; KW-0518; KW-0597; KW-0677; KW-1185,,,,,,,,"PTM: Phosphorylation increases the actin-activated myosin ATPase activity and thereby regulates the contractile activity. It is required to generate the driving force in the migration of the cells but not necessary for localization of myosin-2 at the leading edge. {ECO:0000269|PubMed:11942626, ECO:0000269|PubMed:21457715}.",CHAIN 2 172 Myosin regulatory light polypeptide 9. /FTId=PRO_0000198735.,,,,INIT_MET 1 1 Removed. {ECO:0000250|UniProtKB:P29269}.,,"MOD_RES 2 2 N-acetylserine. {ECO:0000250|UniProtKB:P29269}.; MOD_RES 19 19 Phosphothreonine; by MLCK, CIT and ROCK2. {ECO:0000269|PubMed:11942626, ECO:0000269|PubMed:21457715}.; MOD_RES 20 20 Phosphoserine; by CDC42BP, CIT, MLCK, PAK1, ROCK1, ROCK2, DAPK1, DAPK2 and ZIPK/DAPK3. {ECO:0000269|PubMed:11942626, ECO:0000269|PubMed:18854160, ECO:0000269|PubMed:21072057, ECO:0000269|PubMed:21408167, ECO:0000269|PubMed:21457715}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,J02854;AF176043;D82057;CH471077;CH471077;CH471077;CH471077;CH471077;BC002648;
0,P30291,WEE1_HUMAN,WEE1,WEE1,,,,Homo sapiens (Human),9606,Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase),UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSFLSRQQPPPPRRAGAACTLRQKLIFSPCSDCEEEEEEEEEEGSGHSTGEDSAFQEPDSPLPPARSPTEPGPERRRSPGPAPGSPGELEEDLLLPGACPGADEAGGGAEGDSWEEEGFGSSSPVKSPAAPYFLGSSFSPVRCGGPGDASPRGCGARRAGEGRRSPRPDHPGTPPHKTFRKLRLFDTPHTPKSLLSKARGIDSSSVKLRGSSLFMDTEKSGKREFDVRQTPQVNINPFTPDSLLLHSSGQCRRRKRTYWNDSCGEDMEASDYELEDETRPAKRITITESNMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRKSAEQLRIELNAEKFKNSLLQKELKKAQMAKAAAEERALFTDRMATRSTTQSNRTSRLIGKKMNRSVSLTIY,646,"71,597",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P30291-1; Sequence=Displayed; Name=2; IsoId=P30291-2; Sequence=VSP_044959; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 1 214 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_044959.,VARIANT 210 210 G -> C (in dbSNP:rs34412975). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041302.; VARIANT 472 472 S -> I (in dbSNP:rs56411856). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041303.,,,,CONFLICT 65 65 A -> E (in Ref. 6; CAA43979). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. WEE1 subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,COMPBIAS 9 12 Poly-Pro.; COMPBIAS 34 43 Poly-Glu.,DOMAIN 299 569 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,,,2.7.10.2,,"CATALYTIC ACTIVITY: Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-[protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2; Evidence={ECO:0000255|PROSITE-ProRule:PRU10027};",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420;  Note=Binds 2 magnesium ions per subunit.;,,"FUNCTION: Acts as a negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed CDK1 before the onset of mitosis by mediating phosphorylation of CDK1 on 'Tyr-15'. Specifically phosphorylates and inactivates cyclin B1-complexed CDK1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-CDK1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric CDK1 does not occur. Its activity increases during S and G2 phases and decreases at M phase when it is hyperphosphorylated. A correlated decrease in protein level occurs at M/G1 phase, probably due to its degradation.",,,,,,"ACT_SITE 426 426 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027}.",BINDING 328 328 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,METAL 431 431 Magnesium; via carbonyl oxygen. {ECO:0000269|PubMed:15837193}.; METAL 463 463 Magnesium; via carbonyl oxygen. {ECO:0000269|PubMed:15837193}.,NP_BIND 305 313 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812],cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812],ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GO:0000086; GO:0000226; GO:0000287; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0007093; GO:0016301; GO:0030010; GO:0048812; GO:0051301; GO:2000134,IPR011009; IPR000719; IPR017441; IPR008271; IPR017164; ,Q9Y297; Q9UKB1; P63104,,7743995; 11528126; 14702039; 16554811; 1840647; 8428596; 15150265; 15070733; 18220336; 18691976; 19690332; 20026642; 20068231; 22692537; 23186163; 15837193; 17344846,7743995; 11528126; 14702039; 16554811; 1840647; 8428596; 15150265; 15070733; 18220336; 18691976; 19690332; 20026642; 20068231; 22692537; 23186163; 15837193; 17344846; 10775038; 11585773; 12525641; 12601350; 12669309; 1384126; 1396589; 14534529; 14760118; 15037762; 15161933; 15175024; 15324660; 15583029; 15735666; 15778465; 15964826; 16085715; 16533053; 17353931; 17431037; 17620599; 17687495; 17721511; 17764157; 17869387; 18191399; 1836978; 18385244; 18560763; 18820127; 18950845; 19126550; 19821025; 19858290; 19903823; 19913121; 20038582; 20360068; 20372791; 20508983; 20628086; 20832752; 21358821; 21529352; 21859861; 22112940; 22289989; 22641220; 22719872; 22730174; 22847610; 22907750; 22935698; 22942255; 23051732; 23416158; 23531080; 23538902; 23767999; 24053672; 24336073; 24377575; 24381593; 24424027; 24536047; 24626094; 24661910; 24817118; 24927813; 25093290; 25241761; 25283841; 25428911; 25500533; 25649652; 25659151; 25732734; 25744022; 25852190; 26025928; 26054341; 26431163; 26496610; 26598692; 26602815; 26645158; 26738845; 26890070; 27027998; 27072241; 27077811; 27220319; 27363019; 27558135; 28030798; 28122647; 28178688; 28294307; 28792760; 28898169; 29019284; 29343688; 29605721; 30488993; 9016762; 9034337,1993-04-01,2019-02-13,1996-02-01,200,X-ray crystallography (20),STRAND 299 308 {ECO:0000244|PDB:1X8B}.; STRAND 311 318 {ECO:0000244|PDB:1X8B}.; STRAND 324 331 {ECO:0000244|PDB:1X8B}.; STRAND 335 337 {ECO:0000244|PDB:5VD5}.; STRAND 362 368 {ECO:0000244|PDB:1X8B}.; STRAND 371 377 {ECO:0000244|PDB:1X8B}.; STRAND 432 435 {ECO:0000244|PDB:1X8B}.; STRAND 458 461 {ECO:0000244|PDB:1X8B}.; STRAND 468 472 {ECO:0000244|PDB:5VD8}.; STRAND 518 520 {ECO:0000244|PDB:1X8B}.,HELIX 294 298 {ECO:0000244|PDB:1X8B}.; HELIX 338 352 {ECO:0000244|PDB:1X8B}.; HELIX 384 394 {ECO:0000244|PDB:1X8B}.; HELIX 400 419 {ECO:0000244|PDB:1X8B}.; HELIX 429 431 {ECO:0000244|PDB:1X8B}.; HELIX 464 466 {ECO:0000244|PDB:5V5Y}.; HELIX 480 482 {ECO:0000244|PDB:1X8B}.; HELIX 485 488 {ECO:0000244|PDB:1X8B}.; HELIX 495 510 {ECO:0000244|PDB:1X8B}.; HELIX 521 527 {ECO:0000244|PDB:1X8B}.; HELIX 540 549 {ECO:0000244|PDB:1X8B}.; HELIX 554 556 {ECO:0000244|PDB:1X8B}.; HELIX 560 564 {ECO:0000244|PDB:1X8B}.,TURN 319 321 {ECO:0000244|PDB:1X8B}.; TURN 567 569 {ECO:0000244|PDB:5VD8}.,,,,,5 out of 5,Active site (1); Alternative sequence (1); Beta strand (10); Binding site (1); Chain (1); Compositional bias (2); Domain (1); Helix (13); Metal binding (2); Modified residue (16); Mutagenesis (5); Natural variant (2); Nucleotide binding (1); Sequence conflict (1); Turn (2),,,,3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Complete proteome;Kinase;Magnesium;Metal-binding;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Tyrosine-protein kinase;Ubl conjugation,Evidence at protein level,reviewed,,"Protein kinase superfamily, Ser/Thr protein kinase family, WEE1 subfamily",200,Activity regulation (1); Alternative products (1); Catalytic activity (1); Caution (1); Cofactor (1); Function (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (1),,KW-0002; KW-0025; KW-0067; KW-0131; KW-0132; KW-0181; KW-0418; KW-0460; KW-0479; KW-0498; KW-0539; KW-0547; KW-0597; KW-0621; KW-0808; KW-0829; KW-0832; KW-1185,,,,,,,,"PTM: Phosphorylated during M and G1 phases. Also autophosphorylated. Phosphorylation at Ser-642 by BRSK1 and BRSK2 in post-mitotic neurons, leads to down-regulate WEE1 activity in polarized neurons. Phosphorylated at Ser-53 and Ser-123 by PLK1 and CDK1, respectively, generating an signal for degradation that can be recognized by the SCF(BTRC) complex, leading to its ubiquitination and degradation at the onset of G2/M phase. {ECO:0000269|PubMed:15070733, ECO:0000269|PubMed:15150265, ECO:0000269|PubMed:20026642, ECO:0000269|PubMed:22692537}.; PTM: Dephosphorylated at Thr-239 by CTDP1.; PTM: Ubiquitinated and degraded at the onset of G2/M phase. {ECO:0000269|PubMed:15070733}.",CHAIN 1 646 Wee1-like protein kinase. /FTId=PRO_0000086810.,,,,,,"MOD_RES 53 53 Phosphoserine; by PLK1. {ECO:0000269|PubMed:15070733}.; MOD_RES 78 78 Phosphoserine. {ECO:0000250|UniProtKB:Q63802}.; MOD_RES 85 85 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 123 123 Phosphoserine; by CDK1. {ECO:0000269|PubMed:15070733}.; MOD_RES 127 127 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 137 137 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 139 139 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 150 150 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 165 165 Phosphoserine. {ECO:0000250|UniProtKB:P47810}.; MOD_RES 187 187 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 190 190 Phosphothreonine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:23186163}.; MOD_RES 239 239 Phosphothreonine. {ECO:0000269|PubMed:22692537}.; MOD_RES 270 270 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 307 307 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 312 312 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:23186163}.; MOD_RES 642 642 Phosphoserine; by BRSK1 and BRSK2. {ECO:0000269|PubMed:15150265, ECO:0000269|PubMed:20026642}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U10564;AJ277546;AK122837;CH471064;CH471064;CH471064;X62048;
0,P31150,GDIA_HUMAN,GDI1 GDIL OPHN2 RABGDIA XAP4,GDI1,GDIL OPHN2 RABGDIA XAP4,,,Homo sapiens (Human),9606,Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (Oligophrenin-2) (Protein XAP-4),UP000005640: Chromosome X,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDEEYDVIVLGTGLTECILSGIMSVNGKKVLHMDRNPYYGGESSSITPLEELYKRFQLLEGPPESMGRGRDWNVDLIPKFLMANGQLVKMLLYTEVTRYLDFKVVEGSFVYKGGKIYKVPSTETEALASNLMGMFEKRRFRKFLVFVANFDENDPKTFEGVDPQTTSMRDVYRKFDLGQDVIDFTGHALALYRTDDYLDQPCLETVNRIKLYSESLARYGKSPYLYPLYGLGELPQGFARLSAIYGGTYMLNKPVDDIIMENGKVVGVKSEGEVARCKQLICDPSYIPDRVRKAGQVIRIICILSHPIKNTNDANSCQIIIPQNQVNRKSDIYVCMISYAHNVAAQGKYIAIASTTVETTDPEKEVEPALELLEPIDQKFVAISDLYEPIDDGCESQVFCSCSYDATTHFETTCNDIKDIYKRMAGTAFDFENMKRKQNDVFGEAEQ,447,"50,583",,,,,,,,,,,,,VARIANT 92 92 L -> P (in MRX41; causes reduced binding and recycling of RAB3A; dbSNP:rs121434607). {ECO:0000269|PubMed:9620768}. /FTId=VAR_008130.; VARIANT 423 423 R -> P (in MRX41; dbSNP:rs121434609). {ECO:0000269|PubMed:9668174}. /FTId=VAR_008131.,,,,CONFLICT 34 34 D -> G (in Ref. 2; BAA08078). {ECO:0000305}.; CONFLICT 36 36 N -> K (in Ref. 2; BAA08078). {ECO:0000305}.; CONFLICT 149 151 NFD -> GTY (in Ref. 2; BAA08078). {ECO:0000305}.; CONFLICT 347 347 G -> V (in Ref. 13; AAC15851). {ECO:0000305}.; CONFLICT 409 409 H -> Q (in Ref. 13; AAC15851). {ECO:0000305}.; CONFLICT 416 416 D -> G (in Ref. 13; AAC15851). {ECO:0000305}.; CONFLICT 442 442 F -> S (in Ref. 2; BAA08078). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the Rab GDI family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Regulates the GDP/GTP exchange reaction of most Rab proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them. Promotes the dissociation of GDP-bound Rab proteins from the membrane and inhibits their activation. Promotes the dissociation of RAB1A, RAB3A, RAB5A and RAB10 from membranes. {ECO:0000269|PubMed:23815289}.",,,,,,,,,,,,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165],negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165],GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991],GO:0005092; GO:0005093; GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0007165; GO:0015031; GO:0017137; GO:0030424; GO:0030496; GO:0032482; GO:0032991; GO:0043025; GO:0043209; GO:0045773; GO:0050771; GO:0051056; GO:0051592; GO:0090315,IPR036188; IPR018203; IPR000806; ,Q8TBB1; P61027; P62820; P20338,"SUBUNIT: Interacts with RHOH. Interacts with RAB1A, RAB3A, RAB5A and RAB10. {ECO:0000269|PubMed:11809807, ECO:0000269|PubMed:19570034, ECO:0000269|PubMed:23815289}.",7849400; 7585614; 8733135; 12777533; 15772651; 15489334; 1286667; 7543319; 11809807; 19570034; 21269460; 23815289; 24275569; 9620768; 9668174,7849400; 7585614; 8733135; 12777533; 15772651; 15489334; 1286667; 7543319; 11809807; 19570034; 21269460; 23815289; 24275569; 9620768; 9668174; 10655614; 10676816; 10818110; 10990452; 11038176; 11179213; 11516400; 11689439; 11703925; 11746448; 11784320; 11917121; 12058051; 12221131; 12244319; 12364329; 12427552; 12471028; 12475894; 12684051; 12944476; 12972505; 1439791; 15096524; 15138286; 1516130; 15161933; 15247254; 15292224; 15388334; 15528189; 15561770; 15647276; 15692570; 15878329; 15914536; 15921909; 15958533; 16207721; 16373702; 16410077; 16525024; 16525121; 16571673; 16596196; 16641372; 16713569; 16754960; 16880209; 16950109; 17043139; 17132146; 17189207; 17208202; 17239822; 17287728; 17353931; 17488286; 17562788; 17574030; 17646400; 17671165; 17678623; 18076383; 18094055; 18255255; 18354496; 18367545; 1845915; 18477474; 18487148; 18559336; 18585354; 18664496; 18701652; 18779367; 18804435; 1900457; 19109890; 19345684; 19367725; 19403694; 19490898; 19620288; 19656848; 19725050; 19729655; 19745841; 19942850; 19996123; 20008558; 20154091; 20159109; 20159556; 20305638; 20308558; 20381070; 20404108; 20434987; 20562859; 20592283; 20711500; 20797862; 20851765; 20937701; 21041651; 2115402; 21183348; 21187289; 21216617; 21273506; 21330364; 21421921; 21445324; 21458671; 21532587; 21554507; 21565611; 21586568; 21683469; 21706022; 21718402; 21736009; 21776405; 21900206; 21951725; 22002931; 22013193; 22065758; 22072793; 22171327; 22365832; 22433857; 22511774; 22581368; 22595670; 22622570; 22648168; 22653444; 22705394; 22762500; 22908308; 22983554; 23084991; 23091056; 23140504; 23176487; 23176493; 23220125; 23239882; 23247405; 23263280; 23333653; 23351085; 23357852; 23378591; 23420520; 23444368; 23478338; 23645161; 23678941; 23684622; 23713133; 23839779; 24296415; 24644286; 24694596; 24719330; 24891604; 24917561; 24967941; 25074980; 25341920; 25343031; 25346144; 25416956; 25472813; 25609649; 25648148; 25694352; 25713415; 25925668; 26177209; 26245486; 26434594; 26496610; 26538022; 26925400; 26936971; 27041585; 27044746; 27103185; 27246931; 27329675; 7688123; 7911226; 8144603; 8408203; 8522602; 8863739; 9020086; 9020161; 9030515; 9113980; 9136770; 9194563; 9323142; 9590177; 9733780,1993-07-01,2019-02-13,1996-10-01,194,,,,,,,,,5 out of 5,Chain (1); Natural variant (2); Sequence conflict (7),,TISSUE SPECIFICITY: Brain; predominant in neural and sensory tissues. {ECO:0000269|PubMed:7543319}.,,Complete proteome;Cytoplasm;Direct protein sequencing;Disease mutation;GTPase activation;Golgi apparatus;Mental retardation;Reference proteome,Evidence at protein level,reviewed,,Rab GDI family,194,Function (1); Involvement in disease (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0181; KW-0225; KW-0333; KW-0343; KW-0903; KW-0963; KW-0991; KW-1185,,,,,"DISEASE: Mental retardation, X-linked 41 (MRX41) [MIM:300849]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. {ECO:0000269|PubMed:9620768, ECO:0000269|PubMed:9668174}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 447 Rab GDP dissociation inhibitor alpha. /FTId=PRO_0000056671.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X79353;X79354;X79355;X79356;X79357;X79358;X79359;X79360;X79364;X79361;X79362;X79363;D45021;L44140;AF400433;AB101741;AB101742;AB101743;AB101744;AB101745;AB101746;AB101747;AB101748;AB101749;AB101750;AB101751;AB101752;AB101753;AB101754;AB101755;AB101756;AB101757;AB101758;AB101759;AB101760;AB101771;AB101772;AB101773;AB101774;AB101775;AB101776;AB101777;AB101778;AB101779;AB101780;AB101781;AB101782;AB101783;AB101784;AB101785;AB101786;AB101787;AB101788;AB101789;AB101790;AB101801;AB101802;AB101803;AB101804;AB101805;AB101806;AB101807;AB101808;AB101809;AB101810;AB101811;AB101812;AB101813;AB101814;AB101815;AB101816;AB101817;AB101818;AB101819;AB101820;AB101831;AB101832;AB101833;AB101834;AB101835;AB101836;AB101837;AB101838;AB101839;AB101840;AB101841;AB101842;AB101843;AB101844;AB101845;AB101846;AB101847;AB101848;AB101849;AB101850;AB102647;CR542258;CR542276;BT019884;CH471172;BC000317;BC012201;U14623;L05086;
0,P32856,STX2_HUMAN,STX2 EPIM STX2A STX2B STX2C,STX2,EPIM STX2A STX2B STX2C,,,Homo sapiens (Human),9606,Syntaxin-2 (Epimorphin),UP000005640: Chromosome 12,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MRDRLPDLTACRKNDDGDTVVVVEKDHFMDDFFHQVEEIRNSIDKITQYVEEVKKNHSIILSAPNPEGKIKEELEDLNKEIKKTANKIRAKLKAIEQSFDQDESGNRTSVDLRIRRTQHSVLSRKFVEAMAEYNEAQTLFRERSKGRIQRQLEITGRTTTDDELEEMLESGKPSIFTSDIISDSQITRQALNEIESRHKDIMKLETSIRELHEMFMDMAMFVETQGEMINNIERNVMNATDYVEHAKEETKKAIKYQSKARRKKWIIIAVSVVLVAIIALIIGLSVGK,288,"33,341",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Comment=Additional isoforms seem to exist.; Name=3; IsoId=P32856-1; Sequence=Displayed; Name=1; IsoId=P32856-2; Sequence=VSP_006334; Name=2; IsoId=P32856-3; Sequence=VSP_006335; ,,,,,SEQUENCE CAUTION:  Sequence=BAA03436.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305}; ,,,,,"VAR_SEQ 263 288 KKWIIIAVSVVLVAIIALIIGLSVGK -> QQHCHSNHIPRAIYP (in isoform 2). {ECO:0000303|PubMed:8466509}. /FTId=VSP_006335.; VAR_SEQ 264 288 KWIIIAVSVVLVAIIALIIGLSVGK -> LMFIIICVIVLLVILGIILATTLS (in isoform 1). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:8466509}. /FTId=VSP_006334.",VARIANT 42 42 S -> T (in dbSNP:rs17564). /FTId=VAR_014850.; VARIANT 54 54 K -> R (in dbSNP:rs7301926). /FTId=VAR_057259.,,,,CONFLICT 89 89 R -> A (in Ref. 1; BAA03436). {ECO:0000305}.; CONFLICT 276 276 A -> V (in Ref. 1; BAA03436). {ECO:0000305}.; CONFLICT 288 288 K -> I (in Ref. 1; BAA03436). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the syntaxin family. {ECO:0000305}.,COILED 35 101 {ECO:0000255}.,,DOMAIN 191 253 t-SNARE coiled-coil homology. {ECO:0000255|PROSITE-ProRule:PRU00202}.,,,,,,,,,,FUNCTION: Essential for epithelial morphogenesis. May mediate Ca(2+)-regulation of exocytosis acrosomal reaction in sperm.,,,,,,,,,,,,basolateral plasma membrane [GO:0016323]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; calcium-dependent protein binding [GO:0048306]; protein dimerization activity [GO:0046983]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; acrosome reaction [GO:0007340]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; ectoderm development [GO:0007398]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; protein complex oligomerization [GO:0051259]; response to hydroperoxide [GO:0033194]; signal transduction [GO:0007165]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],acrosome reaction [GO:0007340]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; ectoderm development [GO:0007398]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; protein complex oligomerization [GO:0051259]; response to hydroperoxide [GO:0033194]; signal transduction [GO:0007165]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],calcium-dependent protein binding [GO:0048306]; protein dimerization activity [GO:0046983]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],basolateral plasma membrane [GO:0016323]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021],GO:0000149; GO:0005484; GO:0005615; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0007165; GO:0007340; GO:0007398; GO:0008021; GO:0009887; GO:0012505; GO:0016021; GO:0016323; GO:0030027; GO:0030154; GO:0031201; GO:0031629; GO:0033194; GO:0042734; GO:0043231; GO:0046983; GO:0048278; GO:0048306; GO:0048787; GO:0051259; GO:1903575,IPR010989; IPR028671; IPR006012; IPR006011; IPR000727; ,Q9Y5P4-2; Q9H115,SUBUNIT: Interacts with SYT6 and SYT8; the interaction is Ca(2+)-dependent. {ECO:0000250}.,8466509; 16541075; 15489334,8466509; 16541075; 15489334; 12198139; 15651999; 17485553; 18273050; 19129200; 21156930; 22045676; 22792389; 23219092; 24039787; 24373201; 24578379; 27362846; 28209294; 29767240,1993-10-01,2019-02-13,2010-03-23,175,,,,,,,TOPO_DOM 1 264 Cytoplasmic. {ECO:0000255}.,TRANSMEM 265 288 Helical; Anchor for type IV membrane protein. {ECO:0000255}.,5 out of 5,Alternative sequence (2); Chain (1); Coiled coil (1); Domain (1); Frameshift (1); Natural variant (2); Sequence conflict (3); Topological domain (1); Transmembrane (1),,,,Alternative splicing;Coiled coil;Complete proteome;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix,Evidence at protein level,reviewed,,Syntaxin family,175,Alternative products (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0025; KW-0175; KW-0181; KW-0472; KW-0621; KW-0812; KW-1133; KW-1185,,,,,,,,,CHAIN 1 288 Syntaxin-2. /FTId=PRO_0000210196.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,D14582;BC047496;
0,P37198,NUP62_HUMAN,NUP62,NUP62,,,,Homo sapiens (Human),9606,Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSGFNFGGTGAPTGGFTFGTAKTATTTPATGFSFSTSGTGGFNFGAPFQPATSTPSTGLFSLATQTPATQTTGFTFGTATLASGGTGFSLGIGASKLNLSNTAATPAMANPSGFGLGSSNLTNAISSTVTSSQGTAPTGFVFGPSTTSVAPATTSGGFSFTGGSTAQPSGFNIGSAGNSAQPTAPATLPFTPATPAATTAGATQPAAPTPTATITSTGPSLFASIATAPTSSATTGLSLCTPVTTAGAPTAGTQGFSLKAPGAASGTSTTTSTAATATATTTSSSSTTGFALNLKPLAPAGIPSNTAAAVTAPPGPGAAAGAAASSAMTYAQLESLINKWSLELEDQERHFLQQATQVNAWDRTLIENGEKITSLHREVEKVKLDQKRLDQELDFILSQQKELEDLLSPLEELVKEQSGTIYLQHADEEREKTYKLAENIDAQLKRMAQDLKDIIEHLNTSGAPADTSDPLQQICKILNAHMDSLQWIDQNSALLQRKVEEVTKVCEGRRKEQERSFRITFD,522,"53,255",,,,,,,,,,,,,"VARIANT 139 139 G -> S (in dbSNP:rs3745489). /FTId=VAR_028064.; VARIANT 233 233 A -> S (in dbSNP:rs2290772). /FTId=VAR_013467.; VARIANT 283 283 S -> T (in dbSNP:rs1062798). {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:1915414}. /FTId=VAR_028065.; VARIANT 391 391 Q -> P (in SNDI; dbSNP:rs121917865). {ECO:0000269|PubMed:16786527}. /FTId=VAR_034904.",,,,CONFLICT 418 419 SG -> RA (in Ref. 1; CAA41411). {ECO:0000305}.; CONFLICT 431 431 E -> Q (in Ref. 1; CAA41411). {ECO:0000305}.; CONFLICT 507 507 E -> V (in Ref. 1; CAA41411). {ECO:0000305}.,,3,,0,DOMAIN: Contains FG repeats.,SIMILARITY: Belongs to the nucleoporin NSP1/NUP62 family. {ECO:0000305}.,COILED 328 458 {ECO:0000255}.,COMPBIAS 9 288 Thr-rich.; COMPBIAS 176 331 Ala-rich.,,,REGION 6 143 5 X 2 AA repeats of F-G.; REGION 328 458 Required for centrosome localization. {ECO:0000269|PubMed:24107630}.,REPEAT 6 7 1.; REPEAT 44 45 2.; REPEAT 76 77 3.; REPEAT 114 115 4.; REPEAT 142 143 5.,,,,,,,"FUNCTION: Essential component of the nuclear pore complex (PubMed:1915414). The N-terminal is probably involved in nucleocytoplasmic transport (PubMed:1915414). The C-terminal is involved in protein-protein interaction probably via coiled-coil formation, promotes its association with centrosomes and may function in anchorage of p62 to the pore complex (PubMed:1915414, PubMed:24107630). Plays a role in mitotic cell cycle progression by regulating centrosome segregation, centriole maturation and spindle orientation (PubMed:24107630). It might be involved in protein recruitment to the centrosome after nuclear breakdown (PubMed:24107630). {ECO:0000269|PubMed:1915414, ECO:0000269|PubMed:24107630}.",,,,,,,,,,,,"annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; phospholipid binding [GO:0005543]; PTB domain binding [GO:0051425]; receptor signaling complex scaffold activity [GO:0030159]; SH2 domain binding [GO:0042169]; structural constituent of nuclear pore [GO:0017056]; thyroid hormone receptor binding [GO:0046966]; ubiquitin binding [GO:0043130]; cell aging [GO:0007569]; cell death [GO:0008219]; cell surface receptor signaling pathway [GO:0007166]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; hormone-mediated signaling pathway [GO:0009755]; mitotic centrosome separation [GO:0007100]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of centriole replication [GO:0046601]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of transcription, DNA-templated [GO:0045893]; protein heterotrimerization [GO:0070208]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; regulation of Ras protein signal transduction [GO:0046578]; regulation of signal transduction [GO:0009966]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]","cell aging [GO:0007569]; cell death [GO:0008219]; cell surface receptor signaling pathway [GO:0007166]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; hormone-mediated signaling pathway [GO:0009755]; mitotic centrosome separation [GO:0007100]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of centriole replication [GO:0046601]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of transcription, DNA-templated [GO:0045893]; protein heterotrimerization [GO:0070208]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; regulation of Ras protein signal transduction [GO:0046578]; regulation of signal transduction [GO:0009966]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]",chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; phospholipid binding [GO:0005543]; PTB domain binding [GO:0051425]; receptor signaling complex scaffold activity [GO:0030159]; SH2 domain binding [GO:0042169]; structural constituent of nuclear pore [GO:0017056]; thyroid hormone receptor binding [GO:0046966]; ubiquitin binding [GO:0043130],annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922],GO:0000922; GO:0003682; GO:0005543; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0005813; GO:0006351; GO:0006406; GO:0006606; GO:0007080; GO:0007098; GO:0007100; GO:0007166; GO:0007283; GO:0007569; GO:0008219; GO:0008285; GO:0009755; GO:0009966; GO:0016032; GO:0017056; GO:0019894; GO:0030159; GO:0030544; GO:0031965; GO:0042059; GO:0042169; GO:0042306; GO:0043066; GO:0043069; GO:0043123; GO:0043130; GO:0043407; GO:0044613; GO:0045742; GO:0045840; GO:0045893; GO:0046578; GO:0046580; GO:0046601; GO:0046966; GO:0051425; GO:0051879; GO:0060236; GO:0070208; GO:0072686; GO:0090543; GO:0098534; GO:1903438; GO:1904781; GO:1990904,IPR026010; IPR007758; IPR033072; ,Q9H614; Q9NYB9; Q13444; Q8TD06; O15265; Q12934; Q9UL45; Q8TAB5; Q6ZUS5; Q8IYE0-2; Q8NCX0; Q494R4; Q8TD31-3; Q71F23; Q8IYX8-2; Q9UGL9; O60941; P05413; Q96CS2; A0A0S2Z4Q4; Q03933; Q03933-2; Q8IY31; Q70UQ0; Q9H1K1; Q7Z3B3; Q9BVG8; Q5THT1; P52292; P04264; P35900; P25791; Q7Z3B4; Q9BVL2; P61970; Q9UBU9; O43482; E5LBS6; Q96BD5; Q13526; Q969G3; O75971; A1L4H1; P51687; Q9NVV9; P40222; P10238; Q9Y3C0; Q96QU8-2,"SUBUNIT: Component of the p62 complex, a complex at least composed of NUP62, NUP54, and NUP58 (By similarity). Interacts with NUTF2 (By similarity). Interacts with HIKESHI (PubMed:22541429). Interacts with OSBPL8 (PubMed:21698267). Interacts with CAPG (PubMed:18266911). Interacts with SAS6 and TUBG1 at the centrosome (PubMed:24107630). {ECO:0000250|UniProtKB:P17955, ECO:0000269|PubMed:18266911, ECO:0000269|PubMed:21698267, ECO:0000269|PubMed:22541429, ECO:0000269|PubMed:24107630}.; SUBUNIT: (Microbial infection) Interacts with Epstein-barr virus BGLF4; this interaction allows BGLF4 nuclear entry. {ECO:0000269|PubMed:22623767}.",1915414; 17974005; 14702039; 15057824; 15489334; 14654843; 18266911; 19413330; 19690332; 20068231; 21269460; 21698267; 22541429; 22623767; 22223895; 24107630; 23186163; 24275569; 16786527,1915414; 17974005; 14702039; 15057824; 15489334; 14654843; 18266911; 19413330; 19690332; 20068231; 21269460; 21698267; 22541429; 22623767; 22223895; 24107630; 23186163; 24275569; 16786527; 10228171; 10323864; 10531003; 10574707; 10601273; 10668806; 10920397; 11014198; 11124902; 11231581; 11256625; 11259411; 11259602; 11289803; 11333016; 11451485; 11579093; 11739738; 11756420; 11792325; 11836381; 11932251; 12003494; 12032081; 12093754; 12138183; 12163599; 12228227; 12589057; 14667819; 15082759; 15120988; 15175327; 1531330; 15574331; 15608651; 15643423; 15702989; 16169070; 16189514; 16314397; 16608852; 16688858; 16730000; 16933365; 17081640; 17132145; 17224653; 17317185; 17376915; 17599067; 17698605; 17960595; 18394993; 18423201; 18596238; 18691969; 18842624; 18946085; 18985028; 19144712; 19167051; 19494120; 19615732; 19828735; 1985200; 20129943; 2017161; 2017166; 20622012; 20630994; 20663916; 20711500; 20953181; 20974803; 21078624; 21098080; 21335236; 21516116; 21554500; 21988832; 22064859; 22308026; 22334672; 22458338; 22464730; 22558357; 22732409; 22944664; 23075850; 23150874; 23477864; 23582887; 23777819; 23794287; 23804756; 23882114; 24074597; 24315095; 24388755; 24418548; 24596094; 24739174; 24782567; 25114211; 25218447; 25410863; 25416956; 26496610; 26552607; 27081072; 27298184; 29217659; 7559393; 7958838; 8113738; 9092824; 9214382; 9405152; 9412458; 9452416; 9512417; 9618489; 9660920; 9660949; 9756909; 9837918; 9885291,1994-10-01,2019-02-13,2007-03-20,200,Model (1); Electron microscopy (2),,,,,,,,5 out of 5,Chain (1); Coiled coil (1); Compositional bias (2); Disulfide bond (2); Glycosylation (2); Initiator methionine (1); Modified residue (3); Natural variant (4); Region (2); Repeat (5); Sequence conflict (3),,,,3D-structure;Acetylation;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Disulfide bond;Glycoprotein;Host-virus interaction;Nuclear pore complex;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Repeat;Translocation;Transport;mRNA transport,Evidence at protein level,reviewed,,Nucleoporin NSP1/NUP62 family,200,Domain (1); Function (1); Involvement in disease (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (2),,KW-0002; KW-0007; KW-0175; KW-0181; KW-0206; KW-0225; KW-0325; KW-0509; KW-0539; KW-0597; KW-0621; KW-0653; KW-0677; KW-0811; KW-0813; KW-0906; KW-0945; KW-0963; KW-1015; KW-1185,,,,,"DISEASE: Infantile striatonigral degeneration (SNDI) [MIM:271930]: Neurological disorder characterized by symmetrical degeneration of the caudate nucleus, putamen, and occasionally the globus pallidus, with little involvement of the rest of the brain. The clinical features include developmental regression, choreoathetosis, dystonia, spasticity, dysphagia, failure to thrive, nystagmus, optic atrophy, and mental retardation. {ECO:0000269|PubMed:16786527}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: O-glycosylated. Contains about 10 N-acetylglucosamine side chain sites predicted for the entire protein, among which only one in the C-terminal. {ECO:0000305}.; PTM: The inner channel of the NPC has a different redox environment from the cytoplasm and allows the formation of interchain disulfide bonds between some nucleoporins, the significant increase of these linkages upon oxidative stress reduces the permeability of the NPC. {ECO:0000250}.",CHAIN 2 522 Nuclear pore glycoprotein p62. /FTId=PRO_0000204880.,,DISULFID 475 475 Interchain (with NUP155). {ECO:0000250}.; DISULFID 506 506 Interchain (with NUP155). {ECO:0000250}.,CARBOHYD 373 373 O-linked (GlcNAc) threonine. {ECO:0000250}.; CARBOHYD 468 468 O-linked (GlcNAc) serine. {ECO:0000250}.,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895}.",,"MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895}.; MOD_RES 408 408 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 418 418 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X58521;AL162061;AK125857;CR541721;CH471177;BC003663;BC014842;BC050717;BC095410;BC101104;BC101105;BC101106;BC101107;
0,P40818,UBP8_HUMAN,USP8 KIAA0055 UBPY,USP8,KIAA0055 UBPY,,,Homo sapiens (Human),9606,Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8),UP000005640: Chromosome 15,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPAVASVPKELYLSSSLKDLNKKTEVKPEKISTKSYVHSALKIFKTAEECRLDRDEERAYVLYMKYVTVYNLIKKRPDFKQQQDYFHSILGPGNIKKAVEEAERLSESLKLRYEEAEVRKKLEEKDRQEEAQRLQQKRQETGREDGGTLAKGSLENVLDSKDKTQKSNGEKNEKCETKEKGAITAKELYTMMTDKNISLIIMDARRMQDYQDSCILHSLSVPEEAISPGVTASWIEAHLPDDSKDTWKKRGNVEYVVLLDWFSSAKDLQIGTTLRSLKDALFKWESKTVLRNEPLVLEGGYENWLLCYPQYTTNAKVTPPPRRQNEEVSISLDFTYPSLEESIPSKPAAQTPPASIEVDENIELISGQNERMGPLNISTPVEPVAASKSDVSPIIQPVPSIKNVPQIDRTKKPAVKLPEEHRIKSESTNHEQQSPQSGKVIPDRSTKPVVFSPTLMLTDEEKARIHAETALLMEKNKQEKELRERQQEEQKEKLRKEEQEQKAKKKQEAEENEITEKQQKAKEEMEKKESEQAKKEDKETSAKRGKEITGVKRQSKSEHETSDAKKSVEDRGKRCPTPEIQKKSTGDVPHTSVTGDSGSGKPFKIKGQPESGILRTGTFREDTDDTERNKAQREPLTRARSEEMGRIVPGLPSGWAKFLDPITGTFRYYHSPTNTVHMYPPEMAPSSAPPSTPPTHKAKPQIPAERDREPSKLKRSYSSPDITQAIQEEEKRKPTVTPTVNRENKPTCYPKAEISRLSASQIRNLNPVFGGSGPALTGLRNLGNTCYMNSILQCLCNAPHLADYFNRNCYQDDINRSNLLGHKGEVAEEFGIIMKALWTGQYRYISPKDFKITIGKINDQFAGYSQQDSQELLLFLMDGLHEDLNKADNRKRYKEENNDHLDDFKAAEHAWQKHKQLNESIIVALFQGQFKSTVQCLTCHKKSRTFEAFMYLSLPLASTSKCTLQDCLRLFSKEEKLTDNNRFYCSHCRARRDSLKKIEIWKLPPVLLVHLKRFSYDGRWKQKLQTSVDFPLENLDLSQYVIGPKNNLKKYNLFSVSNHYGGLDGGHYTAYCKNAARQRWFKFDDHEVSDISVSSVKSSAAYILFYTSLGPRVTDVAT,1118,"127,523",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P40818-1; Sequence=Displayed; Name=2; IsoId=P40818-2; Sequence=VSP_054594, VSP_054595; Note=No experimental confirmation available.; ",,,,,,,,,SEQUENCE CAUTION:  Sequence=AAH38801.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};  Sequence=AAH51345.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305}; ,VAR_SEQ 35 111 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_054594.; VAR_SEQ 601 629 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_054595.,VARIANT 310 310 Q -> K (found in a patient with spastic paraplegia; unknown pathological significance; dbSNP:rs587777201). {ECO:0000269|PubMed:24482476}. /FTId=VAR_077850.; VARIANT 443 443 D -> G (in dbSNP:rs3743044). /FTId=VAR_017796.; VARIANT 718 723 Missing (in PITA4; somatic mutation; unknown pathological significance). {ECO:0000269|PubMed:28505279}. /FTId=VAR_079717.; VARIANT 718 718 S -> C (in PITA4; somatic mutation; unknown pathological significance; dbSNP:rs672601308). {ECO:0000269|PubMed:28505279}. /FTId=VAR_079718.; VARIANT 718 718 S -> P (in PITA4; somatic mutation; unknown pathological significance; localizes to nucleus instead of cytoplasm; dbSNP:rs672601307). {ECO:0000269|PubMed:28505279}. /FTId=VAR_079719.; VARIANT 718 718 Missing (in PITA4; somatic mutation; unknown pathological significance). {ECO:0000269|PubMed:28505279}. /FTId=VAR_079720.; VARIANT 720 720 P -> R (in PITA4; somatic mutation; unknown pathological significance; dbSNP:rs672601311). {ECO:0000269|PubMed:28505279}. /FTId=VAR_079721.; VARIANT 739 739 T -> A (in dbSNP:rs11638390). /FTId=VAR_051525.; VARIANT 827 827 A -> G (in dbSNP:rs1056577). /FTId=VAR_017797.,,,,CONFLICT 526 526 E -> G (in Ref. 3; CAD97662). {ECO:0000305}.; CONFLICT 717 717 Y -> H (in Ref. 3; CAD97662). {ECO:0000305}.; CONFLICT 945 945 T -> A (in Ref. 3; CAD97662). {ECO:0000305}.,,1,,0,"DOMAIN: The MIT domain is required for endosomal localization, CHMP1B-binding, maintenance of ESCRT-0 stability and EGFR degradation. {ECO:0000269|PubMed:17711858}.; DOMAIN: The rhodanese domain is sufficient for RNF41-binding. {ECO:0000250}.",SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.,,,DOMAIN 33 116 MIT.; DOMAIN 195 313 Rhodanese. {ECO:0000255|PROSITE-ProRule:PRU00173}.; DOMAIN 777 1109 USP.,MOTIF 405 413 SH3-binding. {ECO:0000250}.,,,,3.4.19.12,,"CATALYTIC ACTIVITY: Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).; EC=3.4.19.12; Evidence={ECO:0000269|PubMed:9628861};",,,"FUNCTION: Hydrolase that can remove conjugated ubiquitin from proteins and therefore plays an important regulatory role at the level of protein turnover by preventing degradation. Converts both 'Lys-48' an 'Lys-63'-linked ubiquitin chains. Catalytic activity is enhanced in the M phase. Involved in cell proliferation. Required to enter into S phase in response to serum stimulation. May regulate T-cell anergy mediated by RNF128 via the formation of a complex containing RNF128 and OTUB1. Probably regulates the stability of STAM2 and RASGRF1. Regulates endosomal ubiquitin dynamics, cargo sorting, membrane traffic at early endosomes, and maintenance of ESCRT-0 stability. The level of protein ubiquitination on endosomes is essential for maintaining the morphology of the organelle. Deubiquitinates EPS15 and controles tyrosine kinase stability. Removes conjugated ubiquitin from EGFR thus regulating EGFR degradation and downstream MAPK signaling. Involved in acrosome biogenesis through interaction with the spermatid ESCRT-0 complex and microtubules. Deubiquitinates BIRC6/bruce and KIF23/MKLP1. Deubiquitinates BACE1 which inhibits BACE1 lysosomal degradation and modulates BACE-medaited APP cleavage and amyloid-beta formation (PubMed:27302062). {ECO:0000269|PubMed:16520378, ECO:0000269|PubMed:17711858, ECO:0000269|PubMed:18329369, ECO:0000269|PubMed:27302062, ECO:0000269|PubMed:9628861}.",,,,,,"ACT_SITE 786 786 Nucleophile. {ECO:0000255|PROSITE-ProRule:PRU10092, ECO:0000255|PROSITE-ProRule:PRU10093}.; ACT_SITE 1067 1067 Proton acceptor. {ECO:0000255|PROSITE-ProRule:PRU10092, ECO:0000255|PROSITE-ProRule:PRU10093}.",,,,,,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cell population proliferation [GO:0008283]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]","cell population proliferation [GO:0008283]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]",cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],GO:0000281; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0008283; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0045296; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1990090,IPR038765; IPR001394; IPR001763; IPR036873; IPR015063; IPR018200; IPR028889; ,Q9HD42; Q7LBR1; Q96CF2; Q99814; Q16665; Q14596,"SUBUNIT: Forms a ternary complex with RNF128 and OTUB1. Interacts (via C-terminal UCH catalytic domain) with OTUB1 isoform 1. Interacts with STAM2 (via SH3 domain). Interacts with DNAJB3, EGFR, EPS15, RASGRF1, RNF41, YWHAE, YWHAG and YWHAZ (By similarity). Interacts with NBR1, RASGRF1, RNF41 and IST1. Associates with the ESCRT-0 complex and with microtubules (By similarity). Interacts with BIRC6/bruce and KIF23/MKLP1. {ECO:0000250, ECO:0000269|PubMed:17035239, ECO:0000269|PubMed:17711858, ECO:0000269|PubMed:18329369, ECO:0000269|PubMed:19129480, ECO:0000269|PubMed:19427866}.",7584044; 14702039; 17974005; 16572171; 15489334; 9628861; 16520378; 16964243; 17711858; 18329369; 18669648; 19413330; 19427866; 19129480; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 27302062; 17035239; 24482476; 28505279,7584044; 14702039; 17974005; 16572171; 15489334; 9628861; 16520378; 16964243; 17711858; 18329369; 18669648; 19413330; 19427866; 19129480; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 27302062; 17035239; 24482476; 28505279; 10982817; 12176364; 12773374; 14661020; 15161933; 15324660; 15778465; 17210635; 17353931; 17979178; 19302785; 19615732; 20495530; 21415856; 23287719; 23416715; 24255178; 24378640; 24828152; 25260751; 25675982; 26496610; 29473952,1995-02-01,2019-02-13,1995-02-01,205,X-ray crystallography (5); NMR spectroscopy (1),STRAND 181 183 {ECO:0000244|PDB:1WHB}.; STRAND 195 197 {ECO:0000244|PDB:1WHB}.; STRAND 199 203 {ECO:0000244|PDB:2GWF}.; STRAND 219 221 {ECO:0000244|PDB:1WHB}.; STRAND 253 259 {ECO:0000244|PDB:2GWF}.; STRAND 295 297 {ECO:0000244|PDB:2GWF}.; STRAND 782 784 {ECO:0000244|PDB:2GFO}.; STRAND 842 845 {ECO:0000244|PDB:2GFO}.; STRAND 862 865 {ECO:0000244|PDB:2GFO}.; STRAND 928 936 {ECO:0000244|PDB:2GFO}.; STRAND 942 954 {ECO:0000244|PDB:2GFO}.; STRAND 959 963 {ECO:0000244|PDB:2GFO}.; STRAND 975 977 {ECO:0000244|PDB:2GFO}.; STRAND 983 985 {ECO:0000244|PDB:2GFO}.; STRAND 990 992 {ECO:0000244|PDB:2GFO}.; STRAND 994 1002 {ECO:0000244|PDB:2GFO}.; STRAND 1005 1011 {ECO:0000244|PDB:2GFO}.; STRAND 1014 1016 {ECO:0000244|PDB:2GFO}.; STRAND 1018 1023 {ECO:0000244|PDB:2GFO}.; STRAND 1027 1029 {ECO:0000244|PDB:2GFO}.; STRAND 1051 1061 {ECO:0000244|PDB:2GFO}.; STRAND 1067 1074 {ECO:0000244|PDB:2GFO}.; STRAND 1079 1084 {ECO:0000244|PDB:2GFO}.; STRAND 1087 1090 {ECO:0000244|PDB:2GFO}.; STRAND 1101 1107 {ECO:0000244|PDB:2GFO}.,HELIX 17 21 {ECO:0000244|PDB:2A9U}.; HELIX 22 24 {ECO:0000244|PDB:2A9U}.; HELIX 28 30 {ECO:0000244|PDB:2A9U}.; HELIX 33 52 {ECO:0000244|PDB:2A9U}.; HELIX 56 73 {ECO:0000244|PDB:2A9U}.; HELIX 77 81 {ECO:0000244|PDB:2A9U}.; HELIX 83 90 {ECO:0000244|PDB:2A9U}.; HELIX 92 138 {ECO:0000244|PDB:2A9U}.; HELIX 185 193 {ECO:0000244|PDB:2GWF}.; HELIX 207 212 {ECO:0000244|PDB:2GWF}.; HELIX 223 225 {ECO:0000244|PDB:2GWF}.; HELIX 232 237 {ECO:0000244|PDB:2GWF}.; HELIX 241 248 {ECO:0000244|PDB:2GWF}.; HELIX 265 267 {ECO:0000244|PDB:2GWF}.; HELIX 273 282 {ECO:0000244|PDB:2GWF}.; HELIX 300 307 {ECO:0000244|PDB:2GWF}.; HELIX 309 311 {ECO:0000244|PDB:2GWF}.; HELIX 763 765 {ECO:0000244|PDB:2GFO}.; HELIX 786 796 {ECO:0000244|PDB:2GFO}.; HELIX 799 806 {ECO:0000244|PDB:2GFO}.; HELIX 810 813 {ECO:0000244|PDB:2GFO}.; HELIX 825 839 {ECO:0000244|PDB:2GFO}.; HELIX 848 857 {ECO:0000244|PDB:2GFO}.; HELIX 859 861 {ECO:0000244|PDB:2GFO}.; HELIX 869 884 {ECO:0000244|PDB:2GFO}.; HELIX 903 917 {ECO:0000244|PDB:2GFO}.; HELIX 921 926 {ECO:0000244|PDB:2GFO}.; HELIX 964 971 {ECO:0000244|PDB:2GFO}.; HELIX 979 981 {ECO:0000244|PDB:3N3K}.; HELIX 1038 1040 {ECO:0000244|PDB:2GFO}.; HELIX 1093 1095 {ECO:0000244|PDB:2GFO}.,TURN 249 252 {ECO:0000244|PDB:2GWF}.; TURN 807 809 {ECO:0000244|PDB:2GFO}.; TURN 937 939 {ECO:0000244|PDB:2GFO}.; TURN 986 989 {ECO:0000244|PDB:2GFO}.; TURN 1063 1065 {ECO:0000244|PDB:2GFO}.; TURN 1075 1078 {ECO:0000244|PDB:2GFO}.,,,,,5 out of 5,Active site (2); Alternative sequence (2); Beta strand (25); Chain (1); Domain (3); Helix (31); Modified residue (8); Motif (1); Mutagenesis (1); Natural variant (9); Sequence caution (2); Sequence conflict (3); Turn (6),,,,3D-structure;Alternative splicing;Cell cycle;Cell membrane;Complete proteome;Cushing syndrome;Cytoplasm;Disease mutation;Endosome;Hydrolase;Membrane;Nucleus;Phosphoprotein;Polymorphism;Protease;Reference proteome;SH3-binding;Thiol protease;Ubl conjugation;Ubl conjugation pathway,Evidence at protein level,reviewed,,Peptidase C19 family,205,Alternative products (1); Catalytic activity (1); Caution (1); Domain (2); Function (1); Induction (1); Involvement in disease (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0131; KW-0181; KW-0225; KW-0378; KW-0472; KW-0539; KW-0597; KW-0621; KW-0645; KW-0729; KW-0788; KW-0832; KW-0833; KW-0963; KW-0967; KW-1003; KW-1062; KW-1185,,,,,"DISEASE: Pituitary adenoma 4, ACTH-secreting (PITA4) [MIM:219090]: A form of pituitary adenoma, a neoplasm of the pituitary gland and one of the most common neuroendocrine tumors. Pituitary adenomas are clinically classified as functional and non-functional tumors, and manifest with a variety of features, including local invasion of surrounding structures and excessive hormone secretion. Functional pituitary adenomas are further classified by the type of hormone they secrete. PITA4 results in excessive production of adrenocorticotropic hormone. This leads to hypersecretion of cortisol by the adrenal glands and ACTH-dependent Cushing syndrome. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269|PubMed:28505279}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Phosphorylation of Ser-718 is essential for interaction with YWHAE and for cytosol localization. Undergoes dephosphorylation at Ser-718 in the M phase. Tyrosine-phosphorylated in its N-terminal half in an EGFR-dependent manner. {ECO:0000250}.; PTM: Ubiquitinated. Inactive form is mostly monoubiquitinated, but polyubiquitination happens too. Ubiquitination is increased in EGF-stimulated cells. Ubiquitination of active form is undetectable, suggesting a possibility that USP8 deubiquitinates itself, thereby regulating its own function (By similarity). {ECO:0000250}.",CHAIN 1 1118 Ubiquitin carboxyl-terminal hydrolase 8. /FTId=PRO_0000080627.,,,,,,"MOD_RES 160 160 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 392 392 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 400 400 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 452 452 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 577 577 Phosphothreonine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 718 718 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 719 719 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 945 945 Phosphothreonine. {ECO:0000250|UniProtKB:Q80U87}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,D29956;AK296480;BX537420;BC038801;BC051345;BC110590;
0,P46108,CRK_HUMAN,CRK,CRK,,,,Homo sapiens (Human),9606,Adapter molecule crk (Proto-oncogene c-Crk) (p38),UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAGNFDSEERSSWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPGDYVLSVSENSRVSHYIINSSGPRPPVPPSPAQPPPGVSPSRLRIGDQEFDSLPALLEFYKIHYLDTTTLIEPVSRSRQGSGVILRQEEAEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAEDSEGKRGMIPVPYVEKYRPASASVSALIGGNQEGSHPQPLGGPEPGPYAQPSVNTPLPNLQNGPIYARVIQKRVPNAYDKTALALEVGELVKVTKINVSGQWEGECNGKRGHFPFTHVRLLDQQNPDEDFS,304,"33,831",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=Crk-II; IsoId=P46108-1; Sequence=Displayed; Name=Crk-I; IsoId=P46108-2; Sequence=VSP_041153, VSP_041154; ",,,,,,,,,,"VAR_SEQ 204 204 N -> R (in isoform Crk-I). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334}. /FTId=VSP_041153.; VAR_SEQ 205 304 Missing (in isoform Crk-I). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334}. /FTId=VSP_041154.",,,,,CONFLICT 109 109 L -> W (in Ref. 1; BAA01505 and 2; AAB28213). {ECO:0000305}.; CONFLICT 215 215 G -> P (in Ref. 1; BAA01505 and 2; AAB28213). {ECO:0000305}.; CONFLICT 278 278 E -> G (in Ref. 1; BAA01505 and 2; AAB28213). {ECO:0000305}.,,2,,0,DOMAIN: The C-terminal SH3 domain function as a negative modulator for transformation and the N-terminal SH3 domain appears to function as a positive regulator for transformation. {ECO:0000250}.; DOMAIN: The SH2 domain mediates interaction with tyrosine phosphorylated proteins. Mediates interaction with SHB.,SIMILARITY: Belongs to the CRK family. {ECO:0000305}.,,,DOMAIN 13 118 SH2. {ECO:0000255|PROSITE-ProRule:PRU00191}.; DOMAIN 132 192 SH3 1. {ECO:0000255|PROSITE-ProRule:PRU00192}.; DOMAIN 235 296 SH3 2. {ECO:0000255|PROSITE-ProRule:PRU00192}.,,,,,,,,,,"FUNCTION: Isoform Crk-II: Regulates cell adhesion, spreading and migration. Mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4. May regulate the EFNA5-EPHA3 signaling. {ECO:0000269|PubMed:11870224, ECO:0000269|PubMed:1630456, ECO:0000269|PubMed:17515907, ECO:0000269|PubMed:19004829}.",,,,,,,,,,,SITE 237 237 Proline switch. {ECO:0000250}.,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; insulin-like growth factor receptor binding [GO:0005159]; phosphotyrosine residue binding [GO:0001784]; protein phosphorylated amino acid binding [GO:0045309]; protein self-association [GO:0043621]; protein tyrosine kinase binding [GO:1990782]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; activation of GTPase activity [GO:0090630]; activation of MAPKK activity [GO:0000186]; cell chemotaxis [GO:0060326]; cellular response to endothelin [GO:1990859]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nitric oxide [GO:0071732]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; cytokine-mediated signaling pathway [GO:0019221]; dendrite development [GO:0016358]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; negative regulation of cell motility [GO:2000146]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of wound healing [GO:0061045]; neuron migration [GO:0001764]; positive regulation of cell growth [GO:0030307]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; reelin-mediated signaling pathway [GO:0038026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of GTPase activity [GO:0043087]; regulation of protein binding [GO:0043393]; regulation of Rac protein signal transduction [GO:0035020]; regulation of signal transduction [GO:0009966]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholecystokinin [GO:0061847]; response to hepatocyte growth factor [GO:0035728]; response to hydrogen peroxide [GO:0042542]; response to yeast [GO:0001878]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],activation of GTPase activity [GO:0090630]; activation of MAPKK activity [GO:0000186]; cell chemotaxis [GO:0060326]; cellular response to endothelin [GO:1990859]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nitric oxide [GO:0071732]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; cytokine-mediated signaling pathway [GO:0019221]; dendrite development [GO:0016358]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; negative regulation of cell motility [GO:2000146]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of wound healing [GO:0061045]; neuron migration [GO:0001764]; positive regulation of cell growth [GO:0030307]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; reelin-mediated signaling pathway [GO:0038026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of GTPase activity [GO:0043087]; regulation of protein binding [GO:0043393]; regulation of Rac protein signal transduction [GO:0035020]; regulation of signal transduction [GO:0009966]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholecystokinin [GO:0061847]; response to hepatocyte growth factor [GO:0035728]; response to hydrogen peroxide [GO:0042542]; response to yeast [GO:0001878]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; insulin-like growth factor receptor binding [GO:0005159]; phosphotyrosine residue binding [GO:0001784]; protein phosphorylated amino acid binding [GO:0045309]; protein self-association [GO:0043621]; protein tyrosine kinase binding [GO:1990782]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; SH3/SH2 adaptor activity [GO:0005070]; SH3 domain binding [GO:0017124],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],GO:0000186; GO:0001764; GO:0001784; GO:0001878; GO:0005070; GO:0005159; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006629; GO:0008092; GO:0008360; GO:0009966; GO:0014911; GO:0015629; GO:0016358; GO:0017124; GO:0019221; GO:0021766; GO:0021987; GO:0030010; GO:0030307; GO:0032956; GO:0032991; GO:0033628; GO:0035020; GO:0035685; GO:0035728; GO:0038026; GO:0038096; GO:0042169; GO:0042542; GO:0043087; GO:0043393; GO:0043621; GO:0045121; GO:0045309; GO:0045953; GO:0046875; GO:0048010; GO:0048013; GO:0050773; GO:0060326; GO:0061045; GO:0061847; GO:0070062; GO:0071560; GO:0071732; GO:0090630; GO:0097110; GO:0098749; GO:1900026; GO:1990090; GO:1990314; GO:1990782; GO:1990859; GO:2000146; GO:2000404,IPR035458; IPR035457; IPR000980; IPR036860; IPR036028; IPR001452; ,P00519; P42684; Q96Q35-2; O15085; Q9ULH1; Q8TDY4; Q96DX5; P54253; P56945; Q6P1W5; P22681; Q13191; Q7L190; P00533; P41970; P21860; P11362; P21333; Q14315; P36888; Q13480; O14654; P35968; P10721; Q92918; Q9Y4K4; P45983; P20774; O40931; P16234; P27986; Q92569; Q8ND30; P62937; P62333; Q05397; P29074; Q13905; Q8TB24; Q8IYX7; Q9UPX8; P29353; O60493; Q07889; Q07890; Q9NYB0; Q05BL1; Q70EK8,"SUBUNIT: Interacts with ABL1, C3G, DOCK3, DOCK5, MAP4K1, MAPK8 and SOS via its first SH3 domain. Interacts (via SH2 domain) with BCAR1, CBL, CBLB, PXN, IRS4 and GAB1 upon stimulus-induced tyrosine phosphorylation. Interacts (via SH2 domain) with several tyrosine-phosphorylated growth factor receptors such as EGFR and INSR. Interacts with FLT1 (tyrosine-phosphorylated). Interacts with DOCK1 and DOCK4. Interacts with SHB. Interacts with PEAK1. Interacts with FASLG. Isoform Crk-II interacts with KIT. Interacts with EPHA3; upon activation of EPHA3 by the ligand EFNA5 and EPHA3 tyrosine kinase activity-dependent. Interacts with EPHA3 (phosphorylated); mediates EFNA5-EPHA3 signaling through RHOA GTPase activation. Interacts with FLT4 (tyrosine-phosphorylated). Isoform Crk-II (via SH2 domain) interacts with PDGFRA (tyrosine phosphorylated) and PDGFRB (tyrosine phosphorylated). Part of a collagen stimulated complex involved in cell migration composed of CDC42, CRK, TNK2 and p130cas/BCAR1. Interacts (via SH2 domain) with the 'Tyr-9' phosphorylated form of PDPK1. Interacts with CBLC. Found in a complex with ABL1, ABL2, CRK and UNC119; leading to the inhibition of CRK phosphorylation by ABL kinases. {ECO:0000269|PubMed:10362357, ECO:0000269|PubMed:10733900, ECO:0000269|PubMed:10964504, ECO:0000269|PubMed:11870224, ECO:0000269|PubMed:12384576, ECO:0000269|PubMed:12628187, ECO:0000269|PubMed:12878163, ECO:0000269|PubMed:16076871, ECO:0000269|PubMed:17038317, ECO:0000269|PubMed:18024423, ECO:0000269|PubMed:19381274, ECO:0000269|PubMed:19807924, ECO:0000269|PubMed:20534451, ECO:0000269|PubMed:8657152, ECO:0000269|PubMed:8662907, ECO:0000269|PubMed:9614078}.",1630456; 8378094; 14702039; 16625196; 15489334; 8657152; 8662907; 9614078; 10362357; 10733900; 10964504; 11870224; 12628187; 12878163; 16076871; 16129412; 15592455; 17038317; 18024423; 18669648; 19807924; 19004829; 19381274; 20534451; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 24275569; 12384576; 17515907,1630456; 8378094; 14702039; 16625196; 15489334; 8657152; 8662907; 9614078; 10362357; 10733900; 10964504; 11870224; 12628187; 12878163; 16076871; 16129412; 15592455; 17038317; 18024423; 18669648; 19807924; 19004829; 19381274; 20534451; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 24275569; 12384576; 17515907; 10464310; 10508235; 10618718; 10660596; 10704446; 10753869; 10777559; 10871282; 11146548; 11316748; 11406630; 11839772; 11911970; 12006644; 12134158; 12138161; 12198159; 12475948; 12640026; 12738793; 12799422; 12807879; 12955086; 12970743; 14657239; 15051508; 15167895; 15263018; 15308668; 15326184; 15522217; 15572663; 15581361; 15700267; 15831672; 15834156; 15886098; 16158059; 16189514; 16267043; 16273093; 16275761; 16284401; 16339550; 16440329; 16581250; 16628223; 16713569; 16849525; 16982329; 17308335; 17353931; 17399949; 17428306; 17474147; 17764157; 17786281; 17848169; 17875741; 17936057; 18070987; 18155796; 18165234; 18602365; 18660489; 18725541; 18768933; 19001122; 19146815; 19351132; 19380743; 19447967; 19522292; 19737974; 19760510; 20088952; 20237902; 20598684; 20729917; 21044950; 21319228; 21339045; 21602891; 21664574; 21988832; 22012249; 22074159; 22144090; 22321011; 22327338; 22383989; 22464172; 22569336; 22848689; 23275563; 23397142; 23666597; 23853584; 24210993; 24356912; 24499776; 24518591; 24571054; 24658140; 24675776; 24702481; 24728074; 24969300; 25225668; 25241761; 25284755; 25381819; 25416956; 25506591; 25814554; 25816892; 25860930; 25956913; 26250463; 26456136; 26473374; 26496610; 26638075; 26656091; 26792730; 27027347; 27332121; 27633569; 28368102; 28465009; 28553779; 28790195; 28974561; 29171987; 29590589; 7537265; 7561682; 8194526; 8524328; 8621483; 8626543; 8649859; 8702917; 9472046; 9546424; 9560161; 9642287; 9739761; 9788432; 9819391,1995-11-01,2019-02-13,2007-07-24,203,X-ray crystallography (2); NMR spectroscopy (8),STRAND 7 13 {ECO:0000244|PDB:2DVJ}.; STRAND 14 16 {ECO:0000244|PDB:2EYY}.; STRAND 30 33 {ECO:0000244|PDB:2DVJ}.; STRAND 34 39 {ECO:0000244|PDB:1JU5}.; STRAND 41 43 {ECO:0000244|PDB:1JU5}.; STRAND 46 52 {ECO:0000244|PDB:1JU5}.; STRAND 54 56 {ECO:0000244|PDB:2DVJ}.; STRAND 57 63 {ECO:0000244|PDB:1JU5}.; STRAND 66 69 {ECO:0000244|PDB:1JU5}.; STRAND 70 77 {ECO:0000244|PDB:2DVJ}.; STRAND 87 89 {ECO:0000244|PDB:1JU5}.; STRAND 92 96 {ECO:0000244|PDB:1JU5}.; STRAND 109 112 {ECO:0000244|PDB:1JU5}.; STRAND 116 118 {ECO:0000244|PDB:1JU5}.; STRAND 120 123 {ECO:0000244|PDB:2EYV}.; STRAND 135 141 {ECO:0000244|PDB:5UL6}.; STRAND 146 150 {ECO:0000244|PDB:2DVJ}.; STRAND 158 163 {ECO:0000244|PDB:5UL6}.; STRAND 165 173 {ECO:0000244|PDB:5UL6}.; STRAND 179 183 {ECO:0000244|PDB:5UL6}.; STRAND 187 190 {ECO:0000244|PDB:5UL6}.; STRAND 208 210 {ECO:0000244|PDB:2DVJ}.; STRAND 224 227 {ECO:0000244|PDB:2EYZ}.; STRAND 229 231 {ECO:0000244|PDB:2EYZ}.; STRAND 239 242 {ECO:0000244|PDB:2EYX}.; STRAND 253 255 {ECO:0000244|PDB:2EYX}.; STRAND 260 269 {ECO:0000244|PDB:2EYX}.; STRAND 273 279 {ECO:0000244|PDB:2EYX}.; STRAND 282 287 {ECO:0000244|PDB:2EYX}.,HELIX 20 27 {ECO:0000244|PDB:1JU5}.; HELIX 97 106 {ECO:0000244|PDB:1JU5}.; HELIX 126 128 {ECO:0000244|PDB:2EYY}.; HELIX 184 186 {ECO:0000244|PDB:5UL6}.; HELIX 288 290 {ECO:0000244|PDB:2EYX}.,TURN 78 80 {ECO:0000244|PDB:2DVJ}.,,,,,5 out of 5,Alternative sequence (2); Beta strand (29); Chain (1); Domain (3); Helix (5); Initiator methionine (1); Modified residue (10); Mutagenesis (2); Sequence conflict (6); Site (1); Turn (1),,,,3D-structure;Acetylation;Alternative splicing;Cell membrane;Complete proteome;Cytoplasm;Membrane;Phosphoprotein;Proto-oncogene;Reference proteome;Repeat;SH2 domain;SH3 domain,Evidence at protein level,reviewed,,CRK family,203,Alternative products (1); Domain (2); Function (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0025; KW-0181; KW-0472; KW-0597; KW-0656; KW-0677; KW-0727; KW-0728; KW-0963; KW-1003; KW-1185,,,,,,,,"PTM: Phosphorylation of Crk-II (40 kDa) gives rise to a 42 kDa form. Isoform Crk-II is phosphorylated by KIT.; PTM: Phosphorylated on Tyr-221 upon cell adhesion. Results in the negative regulation of the association with SH2- and SH3-binding partners, possibly by the formation of an intramolecular interaction of phosphorylated Tyr-221 with the SH2 domain. This leads finally to the down-regulation of the Crk signaling pathway. {ECO:0000269|PubMed:17515907}.; PTM: Proline isomerization at Pro-237 by PPIA acts as a switch between two conformations: an autoinhibitory conformation in the cis form, where the tandem SH3 domains interact intramolecularly, and an activated conformation in the trans form. {ECO:0000250}.",CHAIN 2 304 Adapter molecule crk. /FTId=PRO_0000079351.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.; MOD_RES 40 40 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 41 41 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 74 74 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 83 83 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 108 108 Phosphotyrosine. {ECO:0000244|PubMed:23186163}.; MOD_RES 125 125 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 221 221 Phosphotyrosine; by ABL1. {ECO:0000269|PubMed:17515907}.; MOD_RES 239 239 Phosphotyrosine. {ECO:0000244|PubMed:15592455}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,D10656;S65701;BT007277;EU332838;AK291060;CH471108;CH471108;CH471108;BC001718;BC008506;BC009837;
0,P46940,IQGA1_HUMAN,IQGAP1 KIAA0051,IQGAP1,KIAA0051,,,Homo sapiens (Human),9606,Ras GTPase-activating-like protein IQGAP1 (p195),UP000005640: Chromosome 15,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSAADEVDGLGVARPHYGSVLDNERLTAEEMDERRRQNVAYEYLCHLEEAKRWMEACLGEDLPPTTELEEGLRNGVYLAKLGNFFSPKVVSLKKIYDREQTRYKATGLHFRHTDNVIQWLNAMDEIGLPKIFYPETTDIYDRKNMPRCIYCIHALSLYLFKLGLAPQIQDLYGKVDFTEEEINNMKTELEKYGIQMPAFSKIGGILANELSVDEAALHAAVIAINEAIDRRIPADTFAALKNPNAMLVNLEEPLASTYQDILYQAKQDKMTNAKNRTENSERERDVYEELLTQAEIQGNINKVNTFSALANIDLALEQGDALALFRALQSPALGLRGLQQQNSDWYLKQLLSDKQQKRQSGQTDPLQKEELQSGVDAANSAAQQYQRRLAAVALINAAIQKGVAEKTVLELMNPEAQLPQVYPFAADLYQKELATLQRQSPEHNLTHPELSVAVEMLSSVALINRALESGDVNTVWKQLSSSVTGLTNIEEENCQRYLDELMKLKAQAHAENNEFITWNDIQACVDHVNLVVQEEHERILAIGLINEALDEGDAQKTLQALQIPAAKLEGVLAEVAQHYQDTLIRAKREKAQEIQDESAVLWLDEIQGGIWQSNKDTQEAQKFALGIFAINEAVESGDVGKTLSALRSPDVGLYGVIPECGETYHSDLAEAKKKKLAVGDNNSKWVKHWVKGGYYYYHNLETQEGGWDEPPNFVQNSMQLSREEIQSSISGVTAAYNREQLWLANEGLITRLQARCRGYLVRQEFRSRMNFLKKQIPAITCIQSQWRGYKQKKAYQDRLAYLRSHKDEVVKIQSLARMHQARKRYRDRLQYFRDHINDIIKIQAFIRANKARDDYKTLINAEDPPMVVVRKFVHLLDQSDQDFQEELDLMKMREEVITLIRSNQQLENDLNLMDIKIGLLVKNKITLQDVVSHSKKLTKKNKEQLSDMMMINKQKGGLKALSKEKREKLEAYQHLFYLLQTNPTYLAKLIFQMPQNKSTKFMDSVIFTLYNYASNQREEYLLLRLFKTALQEEIKSKVDQIQEIVTGNPTVIKMVVSFNRGARGQNALRQILAPVVKEIMDDKSLNIKTDPVDIYKSWVNQMESQTGEASKLPYDVTPEQALAHEEVKTRLDSSIRNMRAVTDKFLSAIVSSVDKIPYGMRFIAKVLKDSLHEKFPDAGEDELLKIIGNLLYYRYMNPAIVAPDAFDIIDLSAGGQLTTDQRRNLGSIAKMLQHAASNKMFLGDNAHLSIINEYLSQSYQKFRRFFQTACDVPELQDKFNVDEYSDLVTLTKPVIYISIGEIINTHTLLLDHQDAIAPEHNDPIHELLDDLGEVPTIESLIGESSGNLNDPNKEALAKTEVSLTLTNKFDVPGDENAEMDARTILLNTKRLIVDVIRFQPGETLTEILETPATSEQEAEHQRAMQRRAIRDAKTPDKMKKSKSVKEDSNLTLQEKKEKIQTGLKKLTELGTVDPKNKYQELINDIARDIRNQRRYRQRRKAELVKLQQTYAALNSKATFYGEQVDYYKSYIKTCLDNLASKGKVSKKPREMKGKKSKKISLKYTAARLHEKGVLLEIEDLQVNQFKNVIFEISPTEEVGDFEVKAKFMGVQMETFMLHYQDLLQLQYEGVAVMKLFDRAKVNVNLLIFLLNKKFYGK,1657,"189,252",,,,SEQUENCE CAUTION:  Sequence=BAA06123.2; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,,VARIANT 256 256 S -> A (in dbSNP:rs12324924). /FTId=VAR_049134.,,,,,,1,,0,"DOMAIN: Regions C1 and C2 can either interact with nucleotide-free CDC42, or interact together, depending on the phosphorylation state of Ser-1443. When Ser-1443 is not phosphorylated, C1 and C2 interact, which prevents binding of nucleotide-free CDC42 and promotes binding of GTP-bound CDC42. Phosphorylation of Ser-1443 prevents interaction between C1 and C2, which opens the structure of the C-terminus and allows binding and sequestration of nucleotide-free CDC42 on both C1 and C2. {ECO:0000269|PubMed:15355962}.",,,,DOMAIN 44 159 Calponin-homology (CH). {ECO:0000255|PROSITE-ProRule:PRU00044}.; DOMAIN 679 712 WW. {ECO:0000255|PROSITE-ProRule:PRU00224}.; DOMAIN 745 774 IQ 1. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 775 804 IQ 2. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 805 834 IQ 3. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 835 864 IQ 4. {ECO:0000255|PROSITE-ProRule:PRU00116}.; DOMAIN 1004 1237 Ras-GAP. {ECO:0000255|PROSITE-ProRule:PRU00167}.,,REGION 956 1274 C1.; REGION 1276 1657 C2.,,,,,,,,"FUNCTION: Plays a crucial role in regulating the dynamics and assembly of the actin cytoskeleton. Binds to activated CDC42 but does not stimulate its GTPase activity. It associates with calmodulin. Could serve as an assembly scaffold for the organization of a multimolecular complex that would interface incoming signals to the reorganization of the actin cytoskeleton at the plasma membrane. May promote neurite outgrowth (PubMed:15695813). May play a possible role in cell cycle regulation by contributing to cell cycle progression after DNA replication arrest (PubMed:20883816). {ECO:0000269|PubMed:15695813, ECO:0000269|PubMed:20883816}.",,,,,,,,,,,,"actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; mitogen-activated protein kinase binding [GO:0051019]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; protein-containing complex scaffold activity [GO:0032947]; Rac GTPase binding [GO:0048365]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]",cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032],"cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; mitogen-activated protein kinase binding [GO:0051019]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein-containing complex binding [GO:0044877]; protein-containing complex scaffold activity [GO:0032947]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; Rac GTPase binding [GO:0048365]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]",actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057],GO:0001726; GO:0001817; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0016032; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0031234; GO:0031267; GO:0032947; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043312; GO:0043406; GO:0043539; GO:0044548; GO:0044877; GO:0045121; GO:0045296; GO:0045860; GO:0048008; GO:0048365; GO:0051019; GO:0051894; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1900006; GO:1900086; GO:1903829; GO:1904754; GO:1990138; GO:1990776,IPR001715; IPR036872; IPR000048; IPR027417; IPR000593; IPR023152; IPR001936; IPR008936; IPR001202; ,O43707; P56945; P15056; Q9Y5K6; P60953; P35222; O08808; P00533; P04626; Q96QZ7; O60500; Q9NP85; O60331-4; O00592; P63000; Q05823; Q99816,"SUBUNIT: Interacts with CDC42; the interaction is demonstrated with IQGAP1 in GTP-bound and in nucleotide-free state (PubMed:15355962). Interacts with RAC1 (PubMed:15355962). Does not interact with RHOA. Interacts with TSG101 (PubMed:17853893). Interacts with PAK6 (PubMed:18642328). Interacts with TMEM14B; this interaction increases IQGAP1 phosphorylation and induces its nuclear translocation (PubMed:29033352). {ECO:0000269|PubMed:15355962, ECO:0000269|PubMed:17853893, ECO:0000269|PubMed:18642328, ECO:0000269|PubMed:29033352}.; SUBUNIT: (Microbial infection) Interacts with ebolavirus vp40. {ECO:0000269|PubMed:23637409}.",8051149; 7584044; 15489334; 15355962; 15695813; 8670801; 17081983; 17853893; 18669648; 18642328; 20068231; 21269460; 20883816; 22223895; 22814378; 23186163; 23637409; 24275569; 25944712; 29033352; ,8051149; 7584044; 15489334; 15355962; 15695813; 8670801; 17081983; 17853893; 18669648; 18642328; 20068231; 21269460; 20883816; 22223895; 22814378; 23186163; 23637409; 24275569; 25944712; 29033352; 10209122; 10409742; 10473551; 10611248; 10725339; 10891492; 11181538; 11734550; 11809768; 11948177; 12068308; 12110184; 12180908; 12377780; 12446675; 12473660; 12577067; 12745076; 12832465; 12900413; 12938160; 14636584; 14699063; 14743216; 14970219; 15035987; 15121898; 15161933; 15217908; 15252131; 15331416; 15520807; 15521075; 15543157; 15569269; 15630448; 15634346; 15994232; 16105843; 16135787; 16179592; 16190873; 16245300; 16364920; 16380380; 16387427; 16622255; 16879721; 17050673; 17085436; 17244649; 17255093; 17306374; 17353931; 17496912; 17517894; 17544257; 17563371; 17620407; 17693642; 17981797; 18237546; 18541705; 18562239; 18567582; 18575779; 18587628; 18809683; 18974108; 19036171; 19073898; 19079338; 19091303; 19119138; 19134119; 19135240; 19155310; 19156129; 19219045; 19242111; 19279408; 19321438; 19366706; 19367725; 19454477; 19463016; 19486527; 19615732; 19737400; 19738201; 19805454; 19856315; 19933846; 20017185; 20075861; 20127691; 20130576; 20141835; 20179705; 20360068; 20467437; 20526349; 20530982; 20562859; 20644981; 20711500; 20858867; 20875083; 20959410; 20977743; 21177863; 21182205; 21295032; 21299499; 21349850; 21376238; 21424530; 21525035; 21537845; 21621326; 21640080; 21681737; 21724847; 21730051; 21750196; 21779496; 21876773; 21885850; 21983832; 22080369; 22177953; 22182509; 22328503; 22483753; 22510884; 22519731; 22569528; 22573807; 22623428; 22634185; 22662192; 22745804; 22793650; 22863774; 22944912; 22964981; 22992742; 23071436; 23145020; 23352452; 23386615; 23405264; 23416715; 23454766; 23577172; 23583981; 23602568; 23603816; 23650620; 23788642; 23807500; 23902751; 23982733; 24101133; 24103286; 24121058; 24135138; 24189400; 24196961; 24202393; 24278215; 24345920; 24352566; 24397597; 24462863; 24488174; 24550401; 24639526; 24651010; 24747073; 24800852; 24937142; 24947010; 24957944; 24998570; 25022754; 25044025; 25175832; 25204415; 25222038; 25229330; 25400725; 25435214; 25436461; 25554515; 25609649; 25652011; 25675045; 25722290; 25733387; 25907612; 25924234; 25928398; 26046126; 26051604; 26078295; 26195666; 26242911; 26252773; 26398880; 26473364; 26496610; 26554303; 26638075; 26845769; 26934121; 27080863; 27100492; 27104745; 27377965; 27440047; 27458251; 27470543; 27488117; 27524202; 27798963; 27815503; 28035419; 28098764; 28259970; 28279977; 28396345; 28618949; 28708206; 28739799; 28864474; 28970065; 28987385; 29125886; 29779034; 29846864; 30015941; 3287375; 7565670; 7565795; 7731720; 7929275; 7935411; 8051079; 8157000; 8702968; 8756646; 8798539; 9020159; 9199170; 9368021; 9405718; 9694656; 9858547,1995-11-01,2019-02-13,1995-11-01,201,X-ray crystallography (3); NMR spectroscopy (2),STRAND 1039 1042 {ECO:0000244|PDB:3FAY}.; STRAND 1282 1284 {ECO:0000244|PDB:3FAY}.; STRAND 1290 1292 {ECO:0000244|PDB:3FAY}.; STRAND 1561 1564 {ECO:0000244|PDB:1X0H}.; STRAND 1572 1577 {ECO:0000244|PDB:1X0H}.; STRAND 1589 1593 {ECO:0000244|PDB:1X0H}.; STRAND 1596 1599 {ECO:0000244|PDB:1X0H}.; STRAND 1601 1608 {ECO:0000244|PDB:1X0H}.; STRAND 1615 1617 {ECO:0000244|PDB:1X0H}.; STRAND 1632 1635 {ECO:0000244|PDB:1X0H}.; STRAND 1639 1642 {ECO:0000244|PDB:1X0H}.,HELIX 31 58 {ECO:0000244|PDB:5L0O}.; HELIX 65 67 {ECO:0000244|PDB:5L0O}.; HELIX 70 72 {ECO:0000244|PDB:5L0O}.; HELIX 76 85 {ECO:0000244|PDB:5L0O}.; HELIX 92 94 {ECO:0000244|PDB:5L0O}.; HELIX 101 105 {ECO:0000244|PDB:5L0O}.; HELIX 110 112 {ECO:0000244|PDB:5L0O}.; HELIX 113 125 {ECO:0000244|PDB:5L0O}.; HELIX 130 132 {ECO:0000244|PDB:5L0O}.; HELIX 136 140 {ECO:0000244|PDB:5L0O}.; HELIX 145 161 {ECO:0000244|PDB:5L0O}.; HELIX 179 190 {ECO:0000244|PDB:5L0O}.; HELIX 199 201 {ECO:0000244|PDB:2RR8}.; HELIX 962 981 {ECO:0000244|PDB:3FAY}.; HELIX 984 991 {ECO:0000244|PDB:3FAY}.; HELIX 1000 1009 {ECO:0000244|PDB:3FAY}.; HELIX 1016 1037 {ECO:0000244|PDB:3FAY}.; HELIX 1043 1046 {ECO:0000244|PDB:3FAY}.; HELIX 1050 1058 {ECO:0000244|PDB:3FAY}.; HELIX 1062 1081 {ECO:0000244|PDB:3FAY}.; HELIX 1091 1106 {ECO:0000244|PDB:3FAY}.; HELIX 1118 1121 {ECO:0000244|PDB:3FAY}.; HELIX 1125 1150 {ECO:0000244|PDB:3FAY}.; HELIX 1151 1155 {ECO:0000244|PDB:3FAY}.; HELIX 1158 1174 {ECO:0000244|PDB:3FAY}.; HELIX 1180 1191 {ECO:0000244|PDB:3FAY}.; HELIX 1192 1196 {ECO:0000244|PDB:3FAY}.; HELIX 1197 1201 {ECO:0000244|PDB:3FAY}.; HELIX 1219 1236 {ECO:0000244|PDB:3FAY}.; HELIX 1246 1248 {ECO:0000244|PDB:3FAY}.; HELIX 1249 1270 {ECO:0000244|PDB:3FAY}.; HELIX 1275 1278 {ECO:0000244|PDB:3FAY}.; HELIX 1299 1311 {ECO:0000244|PDB:3FAY}.; HELIX 1313 1316 {ECO:0000244|PDB:3FAY}.; HELIX 1323 1331 {ECO:0000244|PDB:3FAY}.; HELIX 1565 1571 {ECO:0000244|PDB:1X0H}.; HELIX 1583 1587 {ECO:0000244|PDB:1X0H}.; HELIX 1619 1628 {ECO:0000244|PDB:1X0H}.; HELIX 1643 1652 {ECO:0000244|PDB:1X0H}.,TURN 87 89 {ECO:0000244|PDB:5L0O}.; TURN 96 99 {ECO:0000244|PDB:5L0O}.; TURN 172 174 {ECO:0000244|PDB:5L0O}.; TURN 206 208 {ECO:0000244|PDB:2RR8}.; TURN 1010 1013 {ECO:0000244|PDB:3FAY}.; TURN 1203 1207 {ECO:0000244|PDB:3FAY}.; TURN 1285 1287 {ECO:0000244|PDB:3FAY}.; TURN 1636 1638 {ECO:0000244|PDB:1X0H}.,,,,,5 out of 5,Beta strand (11); Chain (1); Domain (7); Erroneous initiation (1); Helix (39); Initiator methionine (1); Modified residue (6); Mutagenesis (4); Natural variant (1); Region (2); Turn (8),,"TISSUE SPECIFICITY: Expressed in the placenta, lung, and kidney. A lower level expression is seen in the heart, liver, skeletal muscle and pancreas.",,3D-structure;Acetylation;Calmodulin-binding;Cell membrane;Complete proteome;Cytoplasm;Direct protein sequencing;Host-virus interaction;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat,Evidence at protein level,reviewed,,,201,Developmental stage (1); Domain (1); Function (1); Post-translational modification (1); Subcellular location (1); Subunit structure (2); Tissue specificity (1),,KW-0002; KW-0007; KW-0112; KW-0181; KW-0472; KW-0539; KW-0597; KW-0621; KW-0677; KW-0903; KW-0945; KW-0963; KW-1003; KW-1185,,,,,,,,"PTM: Phosphorylation of Ser-1443 by PKC/PRKCE prevents interaction between C1 and C2, allowing binding of nucleotide-free CDC42. Ser-1443 phosphorylation enhances the ability to promote neurite outgrowth. {ECO:0000269|PubMed:15355962, ECO:0000269|PubMed:15695813}.",CHAIN 2 1657 Ras GTPase-activating-like protein IQGAP1. /FTId=PRO_0000056648.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|Ref.5}.",,"MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|Ref.5}.; MOD_RES 2 2 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 172 172 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9JKF1}.; MOD_RES 330 330 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1441 1441 Phosphoserine; by PKC. {ECO:0000305|PubMed:15695813}.; MOD_RES 1443 1443 Phosphoserine; by PKC/PRKCE. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:15355962, ECO:0000269|PubMed:15695813}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,L33075;D29640;CH471101;BC151834;
0,P50402,EMD_HUMAN,EMD EDMD STA,EMD,EDMD STA,,,Homo sapiens (Human),9606,Emerin,UP000005640: Chromosome X,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDNYADLSDTELTTLLRRYNIPHGPVVGSTRRLYEKKIFEYETQRRRLSPPSSSAASSYSFSDLNSTRGDADMYDLPKKEDALLYQSKGYNDDYYEESYFTTRTYGEPESAGPSRAVRQSVTSFPDADAFHHQVHDDDLLSSSEEECKDRERPMYGRDSAYQSITHYRPVSASRSSLDLSYYPTSSSTSFMSSSSSSSSWLTRRAIRPENRAPGAGLGQDRQVPLWGQLLLFLVFVIVLFFIYHFMQAEEGNPF,254,"28,994",,,,,,,,,,,,,"VARIANT 54 54 S -> F (in EDMD1; no loss of binding to F-actin, enhanced rate of actin polymerization and loss of binding to BCLAF1). {ECO:0000269|PubMed:15009215, ECO:0000269|PubMed:15328537}. /FTId=VAR_005198.; VARIANT 133 133 Q -> H (in EDMD1; loss of binding to F-actin). {ECO:0000269|PubMed:11587540, ECO:0000269|PubMed:15328537}. /FTId=VAR_016016.; VARIANT 149 149 D -> H (in dbSNP:rs2070818). /FTId=VAR_038433.; VARIANT 183 183 P -> H (in EDMD1; no loss of binding to F-actin and enhanced rate of actin polymerization; dbSNP:rs104894805). {ECO:0000269|PubMed:10323252, ECO:0000269|PubMed:15328537}. /FTId=VAR_005199.; VARIANT 183 183 P -> T (in EDMD1; dbSNP:rs104894806). {ECO:0000269|PubMed:10323252}. /FTId=VAR_005200.",,,,,,1,,0,,,,COMPBIAS 192 199 Poly-Ser.,DOMAIN 1 45 LEM. {ECO:0000255|PROSITE-ProRule:PRU00313}.,,REGION 46 222 Interaction with F-actin. {ECO:0000305}.; REGION 168 186 Interaction with CTNNB1. {ECO:0000269|PubMed:16858403}.,,,,,,,,"FUNCTION: Stabilizes and promotes the formation of a nuclear actin cortical network. Stimulates actin polymerization in vitro by binding and stabilizing the pointed end of growing filaments. Inhibits beta-catenin activity by preventing its accumulation in the nucleus. Acts by influencing the nuclear accumulation of beta-catenin through a CRM1-dependent export pathway. Links centrosomes to the nuclear envelope via a microtubule association. EMD and BAF are cooperative cofactors of HIV-1 infection. Association of EMD with the viral DNA requires the presence of BAF and viral integrase. The association of viral DNA with chromatin requires the presence of BAF and EMD. Required for proper localization of non-farnesylated prelamin-A/C. {ECO:0000269|PubMed:15328537, ECO:0000269|PubMed:16680152, ECO:0000269|PubMed:16858403, ECO:0000269|PubMed:17785515, ECO:0000269|PubMed:19323649}.",,,,,,,,,,,,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; actin binding [GO:0003779]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; cellular response to growth factor stimulus [GO:0071363]; mitotic nuclear envelope reassembly [GO:0007084]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of protein export from nucleus [GO:0046827]; regulation of canonical Wnt signaling pathway [GO:0060828]; skeletal muscle cell differentiation [GO:0035914],cellular response to growth factor stimulus [GO:0071363]; mitotic nuclear envelope reassembly [GO:0007084]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of protein export from nucleus [GO:0046827]; regulation of canonical Wnt signaling pathway [GO:0060828]; skeletal muscle cell differentiation [GO:0035914],actin binding [GO:0003779]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; spindle [GO:0005819],GO:0003779; GO:0005635; GO:0005637; GO:0005640; GO:0005654; GO:0005737; GO:0005783; GO:0005819; GO:0005874; GO:0006936; GO:0007084; GO:0007517; GO:0016020; GO:0016021; GO:0031965; GO:0035914; GO:0045296; GO:0046827; GO:0048147; GO:0048487; GO:0060828; GO:0071363; GO:0090090,IPR035004; IPR011015; IPR003887; IPR034989; ,Q9ULW3; P68135; P60709; Q8WTP8; O75531; Q9NYF8; Q8N7W2-2; Q13895; Q8NEC5; Q8N6L0; Q8NHQ1; O43889-2; P35222; Q5JST6; Q969F0; Q9P127; Q8N8X9; P50222; Q9P286; Q99962; Q12846; Q9D666; Q9UH99; Q8NF91-11; Q8NF91-3; Q8WXH0-3; Q5SNT2-2; Q9Y228; Q8IWZ5; O95292; Q9NTW7; P49910; Q53Z40; Q9UNY5,"SUBUNIT: Interacts with lamins A and C, BANF1, GMCL, BCLAF1 and YTHDC1/YT521. Interacts with TMEM43; the interaction retains emerin in the nuclear inner membrane. Interacts with SUN1 and SUN2 (By similarity). Interacts with ACTB, SPTAN1, F-actin, CTNNB1 and beta-tubulin. Interacts with TMEM201. {ECO:0000250, ECO:0000269|PubMed:11792822, ECO:0000269|PubMed:12493765, ECO:0000269|PubMed:12755701, ECO:0000269|PubMed:15009215, ECO:0000269|PubMed:15328537, ECO:0000269|PubMed:16858403, ECO:0000269|PubMed:16972941, ECO:0000269|PubMed:17785515, ECO:0000269|PubMed:19323649, ECO:0000269|PubMed:21610090}.",7894480; 8733135; 8655156; 8595407; 15772651; 15489334; 12665801; 9673989; 9472006; 11792822; 12755701; 12493765; 15144186; 15009215; 15328537; 15592455; 17081983; 16858403; 16972941; 16680152; 17785515; 18220336; 18691976; 18669648; 19413330; 19323649; 19167377; 19369195; 19690332; 20068231; 21269460; 21610090; 21406692; 22223895; 22814378; 23186163; 24275569; 25944712; 11470279; 11435115; 10323252; 11587540,7894480; 8733135; 8655156; 8595407; 15772651; 15489334; 12665801; 9673989; 9472006; 11792822; 12755701; 12493765; 15144186; 15009215; 15328537; 15592455; 17081983; 16858403; 16972941; 16680152; 17785515; 18220336; 18691976; 18669648; 19413330; 19323649; 19167377; 19369195; 19690332; 20068231; 21269460; 21610090; 21406692; 22223895; 22814378; 23186163; 24275569; 25944712; 11470279; 11435115; 10323252; 11587540; 10908652; 11285238; 11792821; 11973618; 12163176; 12783988; 15109603; 15140983; 15546916; 15681850; 16169070; 16189514; 16204256; 16246140; 16283426; 16339967; 16371512; 16481476; 16495336; 16704422; 16761279; 16823856; 16997877; 17067998; 17097067; 17110338; 17117676; 17170708; 17355960; 17462627; 17536044; 17652388; 17932509; 18266676; 18400857; 18628300; 18646565; 19022376; 19126678; 19167051; 19302538; 19727227; 19738201; 19759537; 19759913; 19789182; 19913121; 19933576; 20054742; 20360068; 20474083; 20562859; 20628086; 21182205; 21278420; 21486941; 21565611; 21697856; 21900206; 21907836; 21911578; 22480903; 22593156; 22623428; 22770216; 22986494; 23075850; 23623980; 23873439; 24014020; 24819607; 24950247; 24997722; 25052089; 25416956; 25502304; 25665578; 25852190; 26496610; 26514267; 26638075; 27865926; 27960036; 28238874; 28290476; 29510091; 30137533; 30188764; 7937898; 8034666; 8463284; 9465049,1996-10-01,2019-02-13,1996-10-01,205,X-ray crystallography (1); NMR spectroscopy (3),,HELIX 9 18 {ECO:0000244|PDB:6GHD}.; HELIX 31 43 {ECO:0000244|PDB:6GHD}.,TURN 3 6 {ECO:0000244|PDB:6GHD}.; TURN 28 30 {ECO:0000244|PDB:6GHD}.,,,,TRANSMEM 223 243 Helical. {ECO:0000255}.,5 out of 5,Chain (1); Compositional bias (1); Domain (1); Helix (2); Modified residue (15); Mutagenesis (4); Natural variant (5); Region (2); Transmembrane (1); Turn (2),,"TISSUE SPECIFICITY: Skeletal muscle, heart, colon, testis, ovary and pancreas.",,3D-structure;Acetylation;Actin-binding;Cardiomyopathy;Complete proteome;Direct protein sequencing;Disease mutation;Emery-Dreifuss muscular dystrophy;Membrane;Microtubule;Nucleus;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix,Evidence at protein level,reviewed,,,205,Function (1); Involvement in disease (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0009; KW-0122; KW-0181; KW-0225; KW-0472; KW-0493; KW-0539; KW-0597; KW-0812; KW-0903; KW-1067; KW-1133; KW-1185,,,,,"DISEASE: Emery-Dreifuss muscular dystrophy 1, X-linked (EDMD1) [MIM:310300]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:10323252, ECO:0000269|PubMed:11587540, ECO:0000269|PubMed:15009215, ECO:0000269|PubMed:15328537}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Found in four different phosphorylated forms, three of which appear to be associated with the cell cycle. {ECO:0000269|PubMed:16972941, ECO:0000269|PubMed:9472006}.",CHAIN 1 254 Emerin. /FTId=PRO_0000206140.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|Ref.11}.; MOD_RES 8 8 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 29 29 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 49 49 Phosphoserine; by PKA. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:16972941}.; MOD_RES 54 54 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 60 60 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 87 87 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 98 98 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 141 141 Phosphoserine. {ECO:0000250|UniProtKB:Q63190}.; MOD_RES 142 142 Phosphoserine. {ECO:0000250|UniProtKB:Q63190}.; MOD_RES 143 143 Phosphoserine. {ECO:0000250|UniProtKB:Q63190}.; MOD_RES 161 161 Phosphotyrosine. {ECO:0000250|UniProtKB:O08579}.; MOD_RES 171 171 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 173 173 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 175 175 Phosphoserine. {ECO:0000250|UniProtKB:O08579}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X82434;L44140;D64111;X86810;BT007401;CR536536;CH471172;BC000738;
0,P51178,PLCD1_HUMAN,PLCD1,PLCD1,,,,Homo sapiens (Human),9606,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-1) (Phospholipase C-III) (PLC-III) (Phospholipase C-delta-1) (PLC-delta-1)",UP000005640: Chromosome 3,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDSGRDFLTLHGLQDDEDLQALLKGSQLLKVKSSSWRRERFYKLQEDCKTIWQESRKVMRTPESQLFSIEDIQEVRMGHRTEGLEKFARDVPEDRCFSIVFKDQRNTLDLIAPSPADAQHWVLGLHKIIHHSGSMDQRQKLQHWIHSCLRKADKNKDNKMSFKELQNFLKELNIQVDDSYARKIFRECDHSQTDSLEDEEIEAFYKMLTQRVEIDRTFAEAAGSGETLSVDQLVTFLQHQQREEAAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSADGSAFSLAHRRVYQDMGQPLSHYLVSSSHNTYLLEDQLAGPSSTEAYIRALCKGCRCLELDCWDGPNQEPIIYHGYTFTSKILFCDVLRAIRDYAFKASPYPVILSLENHCTLEQQRVMARHLHAILGPMLLNRPLDGVTNSLPSPEQLKGKILLKGKKLGGLLPPGGEGGPEATVVSDEDEAAEMEDEAVRSRVQHKPKEDKLRLAQELSDMVIYCKSVHFGGFSSPGTPGQAFYEMASFSENRALRLLQESGNGFVRHNVGHLSRIYPAGWRTDSSNYSPVEMWNGGCQIVALNFQTPGPEMDVYQGRFQDNGACGYVLKPAFLRDPNGTFNPRALAQGPWWARKRLNIRVISGQQLPKVNKNKNSIVDPKVTVEIHGVSRDVASRQTAVITNNGFNPWWDTEFAFEVVVPDLALIRFLVEDYDASSKNDFIGQSTIPLNSLKQGYRHVHLMSKNGDQHPSATLFVKISLQD,756,"85,665",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P51178-1; Sequence=Displayed; Name=2; IsoId=P51178-2; Sequence=VSP_042919; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 1 11 MDSGRDFLTLH -> MQCLGIRSRSRSRELYLQERSLKVAALNGRRL (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_042919.,VARIANT 209 209 T -> R (in NDNC3). {ECO:0000269|PubMed:21665001}. /FTId=VAR_066399.; VARIANT 257 257 R -> H (in dbSNP:rs933135). /FTId=VAR_046560.; VARIANT 574 574 I -> T (in NDNC3). {ECO:0000269|PubMed:21665001}. /FTId=VAR_066400.,,,,CONFLICT 224 224 S -> P (in Ref. 1; AAA73567). {ECO:0000305}.; CONFLICT 264 264 A -> T (in Ref. 1; AAA73567). {ECO:0000305}.; CONFLICT 591 591 G -> D (in Ref. 1; AAA73567). {ECO:0000305}.,,2,,0,,,,,DOMAIN 21 130 PH. {ECO:0000255|PROSITE-ProRule:PRU00145}.; DOMAIN 140 175 EF-hand 1. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 176 211 EF-hand 2. {ECO:0000255|PROSITE-ProRule:PRU00448}.; DOMAIN 296 440 PI-PLC X-box. {ECO:0000255|PROSITE-ProRule:PRU00270}.; DOMAIN 492 609 PI-PLC Y-box. {ECO:0000255|PROSITE-ProRule:PRU00271}.; DOMAIN 616 720 C2. {ECO:0000255|PROSITE-ProRule:PRU00041}.,,REGION 30 57 Substrate binding. {ECO:0000250}.,,,3.1.4.11,,"CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + H2O = 1D-myo-inositol 1,4,5-trisphosphate + a 1,2-diacyl-sn-glycerol + H(+); Xref=Rhea:RHEA:33179, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:58456, ChEBI:CHEBI:203600; EC=3.1.4.11;",COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};  Note=Binds 3 Ca(2+) ions per subunit. Two of the Ca(2+) ions are bound to the C2 domain. {ECO:0000250};,,"FUNCTION: The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. Essential for trophoblast and placental development.",,,,,,ACT_SITE 311 311 {ECO:0000255|PROSITE-ProRule:PRU00270}.; ACT_SITE 356 356 {ECO:0000255|PROSITE-ProRule:PRU00270}.,BINDING 438 438 Substrate. {ECO:0000250}.; BINDING 440 440 Substrate. {ECO:0000250}.; BINDING 522 522 Substrate. {ECO:0000250}.; BINDING 549 549 Substrate. {ECO:0000250}.,,METAL 312 312 Calcium 1; catalytic. {ECO:0000250}.; METAL 341 341 Calcium 1; catalytic. {ECO:0000250}.; METAL 343 343 Calcium 1; catalytic. {ECO:0000250}.; METAL 390 390 Calcium 1; catalytic. {ECO:0000250}.; METAL 651 651 Calcium 2; via carbonyl oxygen. {ECO:0000250}.; METAL 653 653 Calcium 2. {ECO:0000250}.; METAL 677 677 Calcium 2. {ECO:0000250}.; METAL 706 706 Calcium 3. {ECO:0000250}.; METAL 707 707 Calcium 3; via carbonyl oxygen. {ECO:0000250}.; METAL 708 708 Calcium 3. {ECO:0000250}.,,,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTPase activating protein binding [GO:0032794]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; angiogenesis [GO:0001525]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; regulation of cell population proliferation [GO:0042127]",angiogenesis [GO:0001525]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; regulation of cell population proliferation [GO:0042127],"calcium ion binding [GO:0005509]; GTPase activating protein binding [GO:0032794]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol phospholipase C activity [GO:0004435]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],GO:0001525; GO:0004435; GO:0005509; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0006644; GO:0016042; GO:0032794; GO:0032959; GO:0035556; GO:0042127; GO:0043647; GO:0060716; GO:0070062,IPR000008; IPR035892; IPR011992; IPR018247; IPR002048; IPR011993; IPR001849; IPR001192; IPR028391; IPR017946; IPR015359; IPR000909; IPR001711; ,,,7890667; 14702039; 16641997; 15489334; 23186163; 24275569; 21665001,7890667; 14702039; 16641997; 15489334; 23186163; 24275569; 21665001; 10518533; 11022047; 11022048; 11960991; 12761218; 14550290; 15037625; 15509571; 15702972; 15809301; 15817490; 16107206; 16115628; 16240320; 17041247; 18006814; 18434237; 19086053; 19179337; 19344632; 19448674; 19578796; 19913121; 20018811; 20056178; 20398908; 20530480; 20628086; 20657189; 21909432; 22078044; 22265909; 22458588; 22576628; 23388389; 23416715; 23948486; 23982733; 24903829; 25477137; 2550068; 25655282; 25995263; 26755577; 28112359; 28375666; 2841328; 28423710; 28430185; 28528980; 29122566; 9360711,1996-10-01,2019-02-13,2008-09-23,194,,,,,,,,,5 out of 5,Active site (2); Alternative sequence (1); Binding site (4); Calcium binding (2); Chain (1); Domain (6); Glycosylation (2); Metal binding (10); Modified residue (2); Natural variant (3); Region (1); Sequence conflict (3),,,,Alternative splicing;Calcium;Complete proteome;Disease mutation;Glycoprotein;Hydrolase;Lipid degradation;Lipid metabolism;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transducer,Evidence at protein level,reviewed,,,194,Alternative products (1); Catalytic activity (1); Caution (1); Cofactor (1); Function (1); Involvement in disease (1),,KW-0025; KW-0106; KW-0181; KW-0225; KW-0325; KW-0378; KW-0442; KW-0443; KW-0479; KW-0597; KW-0621; KW-0677; KW-0807; KW-1185,,,,,"DISEASE: Nail disorder, non-syndromic congenital, 3 (NDNC3) [MIM:151600]: A nail disorder characterized by a white appearance of the nail plate (true leukonychia), the nail bed (pseudoleukonychia), or neither (apparent leukonychia). Leukonychia may involve all of the nail (leukonychia totalis) or only part of the nail (leukonychia partialis), or can appear as one or more transverse bands (leukonychia striata) or white spots (leukonychia punctata). {ECO:0000269|PubMed:21665001}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,"CHAIN 1 756 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1. /FTId=PRO_0000088504.",,,CARBOHYD 191 191 O-linked (GlcNAc) serine. {ECO:0000250}.; CARBOHYD 193 193 O-linked (GlcNAc) threonine. {ECO:0000250}.,,,"MOD_RES 457 457 Phosphothreonine. {ECO:0000250|UniProtKB:Q8R3B1}.; MOD_RES 460 460 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U09117;AK090774;CH471055;BC050382;
0,P51812,KS6A3_HUMAN,RPS6KA3 ISPK1 MAPKAPK1B RSK2,RPS6KA3,ISPK1 MAPKAPK1B RSK2,,,Homo sapiens (Human),9606,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),UP000005640: Chromosome X,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPLAQLADPWQKMAVESPSDSAENGQQIMDEPMGEEEINPQTEEVSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDPEFTAKTPKDSPGIPPSANAHQLFRGFSFVAITSDDESQAMQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRGIKKITSTAL,740,"83,736",,,,SEQUENCE CAUTION:  Sequence=BAD92170.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,,"VARIANT 38 38 I -> S (in dbSNP:rs56218010). {ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9837815}. /FTId=VAR_006188.; VARIANT 75 75 G -> V (in CLS; dbSNP:rs122454124). {ECO:0000269|PubMed:8955270}. /FTId=VAR_006189.; VARIANT 82 82 V -> F (in CLS; dbSNP:rs122454126). {ECO:0000269|PubMed:9837815}. /FTId=VAR_006190.; VARIANT 114 114 R -> W (in CLS; dbSNP:rs122454127). {ECO:0000269|PubMed:10094187}. /FTId=VAR_006191.; VARIANT 115 115 T -> S (in MRX19; dbSNP:rs387906703). {ECO:0000269|PubMed:17100996}. /FTId=VAR_065892.; VARIANT 127 127 H -> Q (in CLS). {ECO:0000269|PubMed:9837815}. /FTId=VAR_006192.; VARIANT 152 152 Missing (in MRX19). {ECO:0000269|PubMed:17100996}. /FTId=VAR_065893.; VARIANT 154 154 D -> Y (in CLS). {ECO:0000269|PubMed:9837815}. /FTId=VAR_006193.; VARIANT 189 189 I -> K (in CLS; dbSNP:rs122454130). {ECO:0000269|PubMed:10528858}. /FTId=VAR_065894.; VARIANT 202 202 Missing (in MRX19). {ECO:0000269|PubMed:17100996}. /FTId=VAR_065895.; VARIANT 225 225 A -> V (in CLS; dbSNP:rs879027948). {ECO:0000269|PubMed:9837815}. /FTId=VAR_006194.; VARIANT 227 227 S -> A (in CLS; dbSNP:rs122454125). {ECO:0000269|PubMed:8955270}. /FTId=VAR_006195.; VARIANT 268 268 F -> S (in CLS; dbSNP:rs122454131). {ECO:0000269|PubMed:14986828}. /FTId=VAR_065896.; VARIANT 383 383 R -> W (in MRX19; kinase activity is decreased but not abolished; dbSNP:rs122454129). {ECO:0000269|PubMed:10319851}. /FTId=VAR_065897.; VARIANT 416 416 I -> V (in a breast cancer sample; somatic mutation; dbSNP:rs148050184). {ECO:0000269|PubMed:16959974}. /FTId=VAR_035627.; VARIANT 431 431 G -> D (in CLS). {ECO:0000269|PubMed:9837815}. /FTId=VAR_006196.; VARIANT 477 477 Missing (in CLS). {ECO:0000269|PubMed:15214012}. /FTId=VAR_065898.; VARIANT 483 483 Y -> C (in a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1271090915). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040629.; VARIANT 608 608 L -> F (in a glioblastoma multiforme sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040630.; VARIANT 723 723 R -> C (in dbSNP:rs35026425). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040631.; VARIANT 729 729 R -> Q (in CLS; dbSNP:rs28935171). {ECO:0000269|PubMed:10094187}. /FTId=VAR_006197.",,,,CONFLICT 89 89 S -> L (in Ref. 5; AAH96303). {ECO:0000305}.; CONFLICT 410 410 Missing (in Ref. 3; BAD92170). {ECO:0000305}.; CONFLICT 424 424 V -> L (in Ref. 6; AAC82495). {ECO:0000305}.; CONFLICT 480 480 K -> N (in Ref. 6; AAC82495). {ECO:0000305}.; CONFLICT 494 494 Missing (in Ref. 6; AAC82495). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. S6 kinase subfamily. {ECO:0000305}.,,,DOMAIN 68 327 Protein kinase 1. {ECO:0000255|PROSITE-ProRule:PRU00159}.; DOMAIN 328 397 AGC-kinase C-terminal.; DOMAIN 422 679 Protein kinase 2. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:17213202}; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; ,,"FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3. Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1. Phosphorylates SOS1 at 'Ser-1134' and 'Ser-1161' that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). {ECO:0000250|UniProtKB:P18654, ECO:0000269|PubMed:10436156, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:8250835, ECO:0000269|PubMed:9770464}.",BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.56 uM for NFATC4 {ECO:0000269|PubMed:17213202}; Vmax=11.5 umol/min/ug enzyme toward ATP {ECO:0000269|PubMed:17213202}; ,,,,,ACT_SITE 193 193 Proton acceptor. {ECO:0000250}.; ACT_SITE 539 539 Proton acceptor. {ECO:0000250}.,BINDING 100 100 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.; BINDING 451 451 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 74 82 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.; NP_BIND 428 436 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224],cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224],ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711],cytosol [GO:0005829]; nucleoplasm [GO:0005654],GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0004711; GO:0005524; GO:0005654; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0018105; GO:0019901; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944,IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR008271; ,P28482,"SUBUNIT: Forms a complex with either MAPK1/ERK2 or MAPK3/ERK1 in quiescent cells. Transiently dissociates following mitogenic stimulation (By similarity). Interacts with NFATC4, ETV1/ER81 and FGFR1. {ECO:0000250, ECO:0000269|PubMed:17213202}.",7813820; 14702039; 15772651; 15489334; 8141249; 12777533; 8250835; 9770464; 10436156; 16213824; 16223362; 16964243; 17213202; 17360704; 18722121; 18508509; 18691976; 18813292; 18669648; 19369195; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 26158630; 8955270; 9837815; 10094187; 10528858; 10319851; 14986828; 15214012; 17100996; 16959974; 17344846,7813820; 14702039; 15772651; 15489334; 8141249; 12777533; 8250835; 9770464; 10436156; 16213824; 16223362; 16964243; 17213202; 17360704; 18722121; 18508509; 18691976; 18813292; 18669648; 19369195; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 26158630; 8955270; 9837815; 10094187; 10528858; 10319851; 14986828; 15214012; 17100996; 16959974; 17344846; 10094392; 10480933; 10856237; 10980595; 11160957; 11564891; 11896450; 11992250; 12054624; 12393804; 12562765; 12792428; 12796492; 12832467; 14678837; 14973203; 15833840; 16626623; 16691578; 16879200; 17225856; 17318637; 17353931; 17512525; 17721511; 17785199; 17785202; 17938253; 18156174; 18775331; 19129453; 19150432; 19223461; 19435896; 19453261; 19716794; 20234090; 20351173; 20383198; 20385620; 20819778; 20832753; 21061166; 21501342; 21619683; 21900206; 21930553; 21988832; 22031759; 22466421; 22685297; 22918890; 22939624; 23041051; 23118220; 23329845; 23416715; 23455922; 23540679; 23541530; 23602568; 23606334; 23608533; 24085294; 24086335; 24141780; 24189400; 24284076; 24311527; 24416220; 24534486; 24554780; 24606918; 24719417; 25002506; 25014166; 25044551; 25241761; 25624005; 25855080; 25889895; 26270416; 26297997; 26354035; 26496610; 26625210; 26977024; 27041561; 27082640; 27476168; 27491410; 27829215; 28013489; 28314444; 28409880; 28582508; 28733463; 29133416; 29279389; 30126195; 8663493,1996-10-01,2019-02-13,1996-10-01,199,X-ray crystallography (10),STRAND 68 76 {ECO:0000244|PDB:4NW6}.; STRAND 78 87 {ECO:0000244|PDB:4NW6}.; STRAND 96 104 {ECO:0000244|PDB:4NW6}.; STRAND 133 139 {ECO:0000244|PDB:4NW6}.; STRAND 142 148 {ECO:0000244|PDB:4NW6}.; STRAND 152 154 {ECO:0000244|PDB:5D9K}.; STRAND 189 192 {ECO:0000244|PDB:5D9L}.; STRAND 199 201 {ECO:0000244|PDB:4NW6}.; STRAND 203 205 {ECO:0000244|PDB:4NUS}.; STRAND 207 209 {ECO:0000244|PDB:4NW6}.; STRAND 214 216 {ECO:0000244|PDB:5D9L}.; STRAND 409 411 {ECO:0000244|PDB:4JG7}.; STRAND 422 430 {ECO:0000244|PDB:4D9T}.; STRAND 432 441 {ECO:0000244|PDB:4D9T}.; STRAND 446 454 {ECO:0000244|PDB:4D9T}.; STRAND 479 484 {ECO:0000244|PDB:4D9T}.; STRAND 486 494 {ECO:0000244|PDB:4D9T}.; STRAND 545 551 {ECO:0000244|PDB:4D9T}.; STRAND 557 559 {ECO:0000244|PDB:4D9T}.; STRAND 571 573 {ECO:0000244|PDB:4JG8}.; STRAND 646 648 {ECO:0000244|PDB:4JG6}.,HELIX 50 54 {ECO:0000244|PDB:5D9L}.; HELIX 65 67 {ECO:0000244|PDB:4NW6}.; HELIX 109 124 {ECO:0000244|PDB:4NW6}.; HELIX 155 162 {ECO:0000244|PDB:4NW6}.; HELIX 167 186 {ECO:0000244|PDB:4NW6}.; HELIX 196 198 {ECO:0000244|PDB:4NW6}.; HELIX 217 223 {ECO:0000244|PDB:4NUS}.; HELIX 232 234 {ECO:0000244|PDB:4NW6}.; HELIX 237 240 {ECO:0000244|PDB:4NW6}.; HELIX 249 263 {ECO:0000244|PDB:4NW6}.; HELIX 273 282 {ECO:0000244|PDB:4NW6}.; HELIX 293 302 {ECO:0000244|PDB:4NW6}.; HELIX 307 309 {ECO:0000244|PDB:4NW6}.; HELIX 319 322 {ECO:0000244|PDB:4NW6}.; HELIX 325 327 {ECO:0000244|PDB:4NW6}.; HELIX 332 336 {ECO:0000244|PDB:4NW6}.; HELIX 351 353 {ECO:0000244|PDB:5D9L}.; HELIX 412 414 {ECO:0000244|PDB:4D9U}.; HELIX 461 470 {ECO:0000244|PDB:4D9T}.; HELIX 501 506 {ECO:0000244|PDB:4D9T}.; HELIX 513 532 {ECO:0000244|PDB:4D9T}.; HELIX 542 544 {ECO:0000244|PDB:4D9T}.; HELIX 554 556 {ECO:0000244|PDB:4D9T}.; HELIX 587 613 {ECO:0000244|PDB:4D9T}.; HELIX 626 635 {ECO:0000244|PDB:4D9T}.; HELIX 643 645 {ECO:0000244|PDB:4D9U}.; HELIX 650 659 {ECO:0000244|PDB:4D9T}.; HELIX 670 673 {ECO:0000244|PDB:4D9T}.; HELIX 677 680 {ECO:0000244|PDB:4D9T}.; HELIX 682 684 {ECO:0000244|PDB:4D9T}.; HELIX 696 710 {ECO:0000244|PDB:4D9T}.; HELIX 711 713 {ECO:0000244|PDB:4JG8}.,TURN 91 94 {ECO:0000244|PDB:4NW6}.; TURN 105 107 {ECO:0000244|PDB:4NW6}.; TURN 224 226 {ECO:0000244|PDB:4NUS}.; TURN 315 318 {ECO:0000244|PDB:4NW6}.; TURN 419 421 {ECO:0000244|PDB:4D9T}.; TURN 442 445 {ECO:0000244|PDB:4D9T}.; TURN 455 457 {ECO:0000244|PDB:4D9T}.; TURN 664 666 {ECO:0000244|PDB:4D9T}.,,,,,5 out of 5,Active site (2); Beta strand (21); Binding site (2); Chain (1); Domain (3); Erroneous initiation (1); Helix (32); Modified residue (9); Natural variant (21); Nucleotide binding (2); Sequence conflict (5); Turn (8),,"TISSUE SPECIFICITY: Expressed in many tissues, highest levels in skeletal muscle.",,3D-structure;ATP-binding;Cell cycle;Complete proteome;Cytoplasm;Disease mutation;Kinase;Magnesium;Mental retardation;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Stress response;Transferase,Evidence at protein level,reviewed,,"Protein kinase superfamily, AGC Ser/Thr protein kinase family, S6 kinase subfamily",199,Activity regulation (1); Catalytic activity (2); Cofactor (1); Function (1); Involvement in disease (2); Kinetics (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0067; KW-0131; KW-0181; KW-0225; KW-0346; KW-0418; KW-0460; KW-0479; KW-0539; KW-0547; KW-0597; KW-0621; KW-0677; KW-0723; KW-0808; KW-0963; KW-0991; KW-1185,,,,,"DISEASE: Coffin-Lowry syndrome (CLS) [MIM:303600]: A X-linked mental retardation associated with facial and digital dysmorphisms, progressive skeletal malformations, growth retardation, hearing deficit and paroxysmal movement disorders. {ECO:0000269|PubMed:10094187, ECO:0000269|PubMed:10528858, ECO:0000269|PubMed:14986828, ECO:0000269|PubMed:15214012, ECO:0000269|PubMed:8955270, ECO:0000269|PubMed:9837815}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mental retardation, X-linked 19 (MRX19) [MIM:300844]: A non-syndromic form of mild to moderate mental retardation. Mental retardation is characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. In contrast to syndromic or specific X-linked mental retardation which also present with associated physical, neurological and/or psychiatric manifestations, intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation. {ECO:0000269|PubMed:10319851, ECO:0000269|PubMed:17100996}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Activated by phosphorylation at Ser-227 by PDPK1. Autophosphorylated on Ser-386, as part of the activation process. May be phosphorylated at Thr-365 and Ser-369 by MAPK1/ERK2 and MAPK3/ERK1. Can also be activated via phosphorylation at Ser-386 by MAPKAPK2.; PTM: N-terminal myristoylation results in an activated kinase in the absence of added growth factors.",CHAIN 1 740 Ribosomal protein S6 kinase alpha-3. /FTId=PRO_0000086203.,,,,,,"MOD_RES 227 227 Phosphoserine; by PDPK1. {ECO:0000250|UniProtKB:P18654, ECO:0000305}.; MOD_RES 365 365 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 369 369 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 375 375 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195}.; MOD_RES 386 386 Phosphoserine; by autocatalysis and MAPKAPK2. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:24275569}.; MOD_RES 415 415 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 529 529 Phosphotyrosine; by FGFR3. {ECO:0000250|UniProtKB:P18654}.; MOD_RES 556 556 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 715 715 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U08316;AK313932;AB208933;BC096301;BC096302;BC096303;L07599;AB102662;
0,P55072,TERA_HUMAN,VCP,VCP,,,,Homo sapiens (Human),9606,Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP),UP000005640: Chromosome 9,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MASGADSKGDDLSTAILKQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDTCSDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRKGDIFLVRGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGEPIKREDEEESLNEVGYDDIGGCRKQLAQIKEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTHGEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETIDAEVMNSLAVTMDDFRWALSQSNPSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQSRGFGSFRFPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLYG,806,"89,322",,,,,,,,,,,,,"VARIANT 95 95 R -> G (in IBMPFD1; cultured cells expressing the mutant protein show a marked general increase in the level of ubiquitin-conjugated proteins and impaired protein degradation through the endoplasmic reticulum-associated degradation (ERAD) pathway; shows strongly reduced affinity for ADP and increased affinity for ATP; abolishes enhancement of K-315 methylation by ASPSCR1; decreased interaction with CAV1 and UBXN6; dbSNP:rs121909332). {ECO:0000269|PubMed:15034582, ECO:0000269|PubMed:16321991, ECO:0000269|PubMed:20512113, ECO:0000269|PubMed:21822278}. /FTId=VAR_033016.; VARIANT 97 97 G -> E (in CMT2Y; increased ATPase activity; dbSNP:rs864309502). {ECO:0000269|PubMed:25878907}. /FTId=VAR_076464.; VARIANT 126 126 I -> F (in IBMPFD1; unknown pathological significance). {ECO:0000269|PubMed:27209344}. /FTId=VAR_076465.; VARIANT 155 155 R -> C (in IBMPFD1; also in one patient without evidence of Paget disease of the bone; dbSNP:rs121909330). {ECO:0000269|PubMed:15034582, ECO:0000269|PubMed:15732117}. /FTId=VAR_033017.; VARIANT 155 155 R -> H (in ALS14 and IBMPFD1; ALS14 patients do not manifest frontotemporal dementia; properly assembles into a hexameric structure; cultured cells expressing the mutant protein show a marked general increase in the level of ubiquitin-conjugated proteins and impaired protein degradation through the endoplasmic reticulum-associated degradation (ERAD) pathway; shows strongly reduced affinity for ADP and increased affinity for ATP; shows normal ATPase activity according to PubMed:16321991 while according to PubMed:25878907 and PubMed:25125609 shows increased ATPase activity; no defect in ubiquitin-dependent protein degradation by the proteasome; impaired autophagic function; defective maturation of ubiquitin-containing autophagosomes; decreased interaction with CAV1 and UBXN6; decreased endosome to lysosome transport via multivesicular body sorting pathway of CAV1; decreases the arsenite-induced stress granules (SGs) clearance process; dbSNP:rs121909329). {ECO:0000269|PubMed:15034582, ECO:0000269|PubMed:16321991, ECO:0000269|PubMed:20104022, ECO:0000269|PubMed:20512113, ECO:0000269|PubMed:21145000, ECO:0000269|PubMed:21822278, ECO:0000269|PubMed:23349634, ECO:0000269|PubMed:25125609, ECO:0000269|PubMed:25878907, ECO:0000269|PubMed:27753622, ECO:0000269|PubMed:29804830}. /FTId=VAR_033018.; VARIANT 155 155 R -> L (in IBMPFD1). {ECO:0000269|PubMed:20335036}. /FTId=VAR_078910.; VARIANT 155 155 R -> P (in IBMPFD1; dbSNP:rs121909329). {ECO:0000269|PubMed:15034582}. /FTId=VAR_033019.; VARIANT 155 155 R -> S (in IBMPFD1; impaired autophagic function). {ECO:0000269|PubMed:20104022}. /FTId=VAR_076466.; VARIANT 159 159 R -> G (in ALS14; dbSNP:rs387906789). {ECO:0000269|PubMed:21145000, ECO:0000269|PubMed:23349634}. /FTId=VAR_065910.; VARIANT 159 159 R -> H (in IBMPFD1; without frontotemporal dementia; abolishes enhancement of K-315 methylation by ASPSCR1; dbSNP:rs121909335). {ECO:0000269|PubMed:16247064}. /FTId=VAR_033020.; VARIANT 185 185 E -> K (in CMT2Y; normal ATPase activity; impaired autophagic function; dbSNP:rs864309501). {ECO:0000269|PubMed:25125609}. /FTId=VAR_076467.; VARIANT 191 191 R -> Q (in ALS14 and IBMPFD1; abolishes enhancement of K-315 methylation by ASPSCR1; dbSNP:rs121909334). {ECO:0000269|PubMed:15034582, ECO:0000269|PubMed:21145000, ECO:0000269|PubMed:23349634}. /FTId=VAR_033021.; VARIANT 198 198 L -> W (in IBMPFD1; increased ATPase activity; impaired autophagic function). {ECO:0000269|PubMed:17935506, ECO:0000269|PubMed:20335036, ECO:0000269|PubMed:25878907, ECO:0000269|PubMed:27753622}. /FTId=VAR_076468.; VARIANT 232 232 A -> E (in IBMPFD1; increased ATPase activity; no defect in ubiquitin-dependent protein degradation by the proteasome; impaired autophagic function; defect in maturation of ubiquitin-containing autophagosomes; decreased interaction with CAV1 and UBXN6; dbSNP:rs121909331). {ECO:0000269|PubMed:15034582, ECO:0000269|PubMed:20104022, ECO:0000269|PubMed:21822278, ECO:0000269|PubMed:25125609, ECO:0000269|PubMed:25878907, ECO:0000269|PubMed:27753622}. /FTId=VAR_033022.; VARIANT 387 387 N -> H (in IBMPFD1; unknown pathological significance). {ECO:0000269|PubMed:17935506}. /FTId=VAR_078911.; VARIANT 592 592 D -> N (in ALS14; ALS14 patients do not show frontotemporal dementia; dbSNP:rs387906790). {ECO:0000269|PubMed:21145000}. /FTId=VAR_065911.",,,,CONFLICT 169 169 D -> H (in Ref. 6; AAI21795). {ECO:0000305}.; CONFLICT 312 312 K -> I (in Ref. 3; BAG35235). {ECO:0000305}.,,4,,0,DOMAIN: The PIM (PUB-interaction motif) motif mediates interaction with the PUB domain of RNF31. {ECO:0000269|PubMed:24726327}.,SIMILARITY: Belongs to the AAA ATPase family. {ECO:0000305}.,,,,MOTIF 802 806 PIM motif. {ECO:0000269|PubMed:24726327}.,REGION 797 806 Interaction with UBXN6. {ECO:0000269|PubMed:18656546}.,,,3.6.4.6,,"CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.6; Evidence={ECO:0000269|PubMed:26471729};",,,"FUNCTION: Necessary for the fragmentation of Golgi stacks during mitosis and for their reassembly after mitosis. Involved in the formation of the transitional endoplasmic reticulum (tER). The transfer of membranes from the endoplasmic reticulum to the Golgi apparatus occurs via 50-70 nm transition vesicles which derive from part-rough, part-smooth transitional elements of the endoplasmic reticulum (tER). Vesicle budding from the tER is an ATP-dependent process. The ternary complex containing UFD1, VCP and NPLOC4 binds ubiquitinated proteins and is necessary for the export of misfolded proteins from the ER to the cytoplasm, where they are degraded by the proteasome. The NPLOC4-UFD1-VCP complex regulates spindle disassembly at the end of mitosis and is necessary for the formation of a closed nuclear envelope. Regulates E3 ubiquitin-protein ligase activity of RNF19A. Component of the VCP/p97-AMFR/gp78 complex that participates in the final step of the sterol-mediated ubiquitination and endoplasmic reticulum-associated degradation (ERAD) of HMGCR. Involved in endoplasmic reticulum stress-induced pre-emptive quality control, a mechanism that selectively attenuates the translocation of newly synthesized proteins into the endoplasmic reticulum and reroutes them to the cytosol for proteasomal degradation (PubMed:26565908). Plays a role in the regulation of stress granules (SGs) clearance process upon arsenite-induced response (PubMed:29804830). Also involved in DNA damage response: recruited to double-strand breaks (DSBs) sites in a RNF8- and RNF168-dependent manner and promotes the recruitment of TP53BP1 at DNA damage sites (PubMed:22020440, PubMed:22120668). Recruited to stalled replication forks by SPRTN: may act by mediating extraction of DNA polymerase eta (POLH) to prevent excessive translesion DNA synthesis and limit the incidence of mutations induced by DNA damage (PubMed:23042607, PubMed:23042605). Required for cytoplasmic retrotranslocation of stressed/damaged mitochondrial outer-membrane proteins and their subsequent proteasomal degradation (PubMed:16186510, PubMed:21118995). Essential for the maturation of ubiquitin-containing autophagosomes and the clearance of ubiquitinated protein by autophagy (PubMed:20104022, PubMed:27753622). Acts as a negative regulator of type I interferon production by interacting with DDX58/RIG-I: interaction takes place when DDX58/RIG-I is ubiquitinated via 'Lys-63'-linked ubiquitin on its CARD domains, leading to recruit RNF125 and promote ubiquitination and degradation of DDX58/RIG-I (PubMed:26471729). May play a role in the ubiquitin-dependent sorting of membrane proteins to lysosomes where they undergo degradation (PubMed:21822278). May more particularly play a role in caveolins sorting in cells (PubMed:21822278, PubMed:23335559). By controlling the steady-state expression of the IGF1R receptor, indirectly regulates the insulin-like growth factor receptor signaling pathway (PubMed:26692333). {ECO:0000269|PubMed:15456787, ECO:0000269|PubMed:16168377, ECO:0000269|PubMed:16186510, ECO:0000269|PubMed:20104022, ECO:0000269|PubMed:21118995, ECO:0000269|PubMed:21822278, ECO:0000269|PubMed:22020440, ECO:0000269|PubMed:22120668, ECO:0000269|PubMed:22607976, ECO:0000269|PubMed:23042605, ECO:0000269|PubMed:23042607, ECO:0000269|PubMed:23335559, ECO:0000269|PubMed:26471729, ECO:0000269|PubMed:26565908, ECO:0000269|PubMed:26692333, ECO:0000269|PubMed:27753622, ECO:0000269|PubMed:29804830}.",,,,,,,BINDING 348 348 ATP 1. {ECO:0000269|PubMed:20512113}.; BINDING 384 384 ATP 1. {ECO:0000269|PubMed:20512113}.,,,NP_BIND 247 253 ATP 1. {ECO:0000269|PubMed:20512113}.; NP_BIND 521 526 ATP 2. {ECO:0000250|UniProtKB:Q01853}.,,"ATPase complex [GO:1904949]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; VCP-NSFL1C complex [GO:1990730]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; BAT3 complex binding [GO:1904288]; deubiquitinase activator activity [GO:0035800]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; lipid binding [GO:0008289]; MHC class I protein binding [GO:0042288]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-specific protease binding [GO:1990381]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aggresome assembly [GO:0070842]; ATP metabolic process [GO:0046034]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; error-free translesion synthesis [GO:0070987]; establishment of protein localization [GO:0045184]; flavin adenine dinucleotide catabolic process [GO:0072389]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; NADH metabolic process [GO:0006734]; neutrophil degranulation [GO:0043312]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Lys63-specific deubiquitinase activity [GO:1903007]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of synapse organization [GO:0050807]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral genome replication [GO:0019079]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aggresome assembly [GO:0070842]; ATP metabolic process [GO:0046034]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; establishment of protein localization [GO:0045184]; flavin adenine dinucleotide catabolic process [GO:0072389]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; NADH metabolic process [GO:0006734]; neutrophil degranulation [GO:0043312]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Lys63-specific deubiquitinase activity [GO:1903007]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of synapse organization [GO:0050807]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral genome replication [GO:0019079]",ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; BAT3 complex binding [GO:1904288]; deubiquitinase activator activity [GO:0035800]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; lipid binding [GO:0008289]; MHC class I protein binding [GO:0042288]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381],ATPase complex [GO:1904949]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; VCP-NSFL1C complex [GO:1990730],GO:0000502; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005811; GO:0005829; GO:0006281; GO:0006302; GO:0006457; GO:0006734; GO:0006888; GO:0006914; GO:0006919; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0010918; GO:0016236; GO:0016567; GO:0016579; GO:0016887; GO:0018279; GO:0019079; GO:0019903; GO:0019904; GO:0019985; GO:0030433; GO:0030968; GO:0030970; GO:0031334; GO:0031593; GO:0031625; GO:0032436; GO:0032510; GO:0032991; GO:0034098; GO:0034214; GO:0034605; GO:0034774; GO:0035578; GO:0035617; GO:0035800; GO:0035861; GO:0036435; GO:0036503; GO:0036513; GO:0042288; GO:0042802; GO:0042981; GO:0043161; GO:0043231; GO:0043312; GO:0043531; GO:0044389; GO:0045184; GO:0045732; GO:0046034; GO:0048471; GO:0050807; GO:0051228; GO:0051260; GO:0055085; GO:0061857; GO:0070062; GO:0070842; GO:0070987; GO:0071712; GO:0072389; GO:0090263; GO:0097352; GO:0098978; GO:1903006; GO:1903007; GO:1903715; GO:1903843; GO:1903862; GO:1904288; GO:1904813; GO:1904949; GO:1990381; GO:1990730; GO:2001171,IPR003593; IPR005938; IPR009010; IPR003959; IPR003960; IPR004201; IPR029067; IPR003338; IPR027417; IPR015415; ,Itself; Q9UKV5; Q9BZE9; P54252-1; O96017; Q9WTX6; Q13619; Q9UNN5-1; Q96CS3; O94868; P62993; Q9UNZ2; P62136; P07602-1; P26045; B1AQ61; Q96LJ8; Q5T124-6; P68543; Q14CS0; Q92575; Q9BZV1; O94888; O00124; Q92890; P63104,"SUBUNIT: Homohexamer. Forms a ring-shaped particle of 12.5 nm diameter, that displays 6-fold radial symmetry. Part of a ternary complex containing STX5A, NSFL1C and VCP. NSFL1C forms a homotrimer that binds to one end of a VCP homohexamer. The complex binds to membranes enriched in phosphatidylethanolamine-containing lipids and promotes Golgi membrane fusion. Binds to a heterodimer of NPLOC4 and UFD1, binding to this heterodimer inhibits Golgi-membrane fusion (PubMed:26471729). Interaction with VCIP135 leads to dissociation of the complex via ATP hydrolysis by VCP. Part of a ternary complex containing NPLOC4, UFD1 and VCP. Interacts with NSFL1C-like protein p37; the complex has membrane fusion activity and is required for Golgi and endoplasmic reticulum biogenesis. Interacts with SELENOS and SYVN1, as well as with DERL1, DERL2 and DERL3; which probably transfer misfolded proteins from the ER to VCP. Interacts with SVIP. Component of a complex required to couple retrotranslocation, ubiquitination and deglycosylation composed of NGLY1, SAKS1, AMFR, VCP and RAD23B. Directly interacts with UBXN4 and RNF19A. Interacts with CASR. Interacts with UBE4B and YOD1. Interacts with clathrin. Interacts with RNF103. Interacts with TRIM13 and TRIM21. Component of a VCP/p97-AMFR/gp78 complex that participates in the final step of the endoplasmic reticulum-associated degradation (ERAD) of HMGCR. Interacts directly with AMFR/gp78 (via its VIM). Interacts with RHBDD1 (via C-terminal domain). Interacts with SPRTN; leading to recruitment to stalled replication forks (PubMed:23042607, PubMed:23042605). Interacts with WASHC5. Interacts with UBOX5. Interacts (via N-terminus) with UBXN7, UBXN8, and probably several other UBX domain-containing proteins (via UBX domains); the interactions are mutually exclusive with VIM-dependent interactions such as those with AMFR and SELENOS. Forms a complex with UBQLN1 and UBXN4. Interacts (via the PIM motif) with RNF31 (via the PUB domain) (PubMed:24726327). Interacts with DDX58/RIG-I and RNF125; interaction takes place when DDX58/RIG-I is ubiquitinated via 'Lys-63'-linked ubiquitin on its CARD domains, leading to recruit RNF125 and promote ubiquitination and degradation of DDX58/RIG-I (PubMed:26471729). Interacts with BAG6 (PubMed:21636303). Interacts with UBXN10 (PubMed:26389662). Interacts with UBXN6; the interaction with UBXN6 is direct and competitive with UFD1 (PubMed:19174149, PubMed:19275885). Forms a ternary complex with CAV1 and UBXN6 (PubMed:21822278, PubMed:18656546, PubMed:19174149). Interacts with PLAA, UBXN6 and YOD1; may form a complex involved in macroautophagy (PubMed:27753622). Interacts with ANKZF1 (PubMed:28302725). Interacts with ubiquitin-binding protein FAF1 (PubMed:26842564). Interacts with ZFAND2B (via VIM motif); the interaction is direct (PubMed:24160817, PubMed:26337389). Interacts with ZFAND1 (via its ubiquitin-like region); this interaction occurs in an arsenite-dependent manner (PubMed:29804830). {ECO:0000250|UniProtKB:P46462, ECO:0000250|UniProtKB:Q01853, ECO:0000269|PubMed:15215856, ECO:0000269|PubMed:15362974, ECO:0000269|PubMed:15456787, ECO:0000269|PubMed:16168377, ECO:0000269|PubMed:16186509, ECO:0000269|PubMed:16186510, ECO:0000269|PubMed:16289116, ECO:0000269|PubMed:16449189, ECO:0000269|PubMed:16513638, ECO:0000269|PubMed:16968747, ECO:0000269|PubMed:17314412, ECO:0000269|PubMed:18022694, ECO:0000269|PubMed:18656546, ECO:0000269|PubMed:18675248, ECO:0000269|PubMed:19174149, ECO:0000269|PubMed:19275885, ECO:0000269|PubMed:19818707, ECO:0000269|PubMed:19822669, ECO:0000269|PubMed:19887378, ECO:0000269|PubMed:20512113, ECO:0000269|PubMed:20833645, ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:21822278, ECO:0000269|PubMed:21914798, ECO:0000269|PubMed:21949850, ECO:0000269|PubMed:22120668, ECO:0000269|PubMed:22537386, ECO:0000269|PubMed:22795130, ECO:0000269|PubMed:22902628, ECO:0000269|PubMed:23042605, ECO:0000269|PubMed:23042607, ECO:0000269|PubMed:24160817, ECO:0000269|PubMed:24726327, ECO:0000269|PubMed:26337389, ECO:0000269|PubMed:26389662, ECO:0000269|PubMed:26471729, ECO:0000269|PubMed:26842564, ECO:0000269|PubMed:27753622, ECO:0000269|PubMed:28302725, ECO:0000269|PubMed:29804830, ECO:0000269|PubMed:8413590}.",10931946; 14702039; 15164053; 15489334; 12665801; 8413590; 23349634; 15362974; 15456787; 15215856; 16139798; 16289116; 16168377; 16186510; 16186509; 16513638; 16449189; 16968747; 17314412; 17525332; 18675248; 18656546; 18691976; 18022694; 19413330; 19174149; 19275885; 19822669; 19818707; 19369195; 19690332; 20833645; 20068231; 21269460; 21118995; 21636303; 21822278; 22020440; 22120668; 21949850; 21406692; 22537386; 22795130; 22902628; 22607976; 22223895; 22948820; 23042607; 23042605; 23335559; 23186163; 24160817; 24275569; 24726327; 26565908; 26471729; 26337389; 26389662; 25944712; 26842564; 26692333; 28302725; 28112733; 20512113; 19887378; 21914798; 15034582; 15732117; 16247064; 16321991; 17935506; 20104022; 29804830; 20335036; 21145000; 25125609; 25878907; 27209344; 27753622,10931946; 14702039; 15164053; 15489334; 12665801; 8413590; 23349634; 15362974; 15456787; 15215856; 16139798; 16289116; 16168377; 16186510; 16186509; 16513638; 16449189; 16968747; 17314412; 17525332; 18675248; 18656546; 18691976; 18022694; 19413330; 19174149; 19275885; 19822669; 19818707; 19369195; 19690332; 20833645; 20068231; 21269460; 21118995; 21636303; 21822278; 22020440; 22120668; 21949850; 21406692; 22537386; 22795130; 22902628; 22607976; 22223895; 22948820; 23042607; 23042605; 23335559; 23186163; 24160817; 24275569; 24726327; 26565908; 26471729; 26337389; 26389662; 25944712; 26842564; 26692333; 28302725; 28112733; 20512113; 19887378; 21914798; 15034582; 15732117; 16247064; 16321991; 17935506; 20104022; 29804830; 20335036; 21145000; 25125609; 25878907; 27209344; 27753622; 10364224; 10915768; 11146634; 11740563; 11812794; 11927012; 12351637; 12560433; 12944474; 14743216; 14760088; 15037256; 15161933; 15215855; 15358861; 15452376; 15611333; 15752563; 15883021; 15932873; 16027165; 16055502; 16097032; 16118227; 16140914; 16234241; 16275660; 16306228; 16386250; 16461343; 16525503; 16551632; 16621797; 16783167; 16807242; 16868077; 16901789; 16914519; 16966435; 17110338; 17200190; 17220478; 17272822; 17346713; 17353931; 17457594; 17478428; 17493577; 17618707; 17620599; 17622780; 17626287; 17763460; 17785525; 17872946; 17889967; 17907600; 17948026; 18048502; 18077418; 18166610; 18199748; 18264092; 18279508; 18341608; 18502753; 18544453; 18550891; 18654987; 18706391; 18711132; 18716059; 18775313; 19002207; 19164805; 19208399; 19286132; 19356220; 19364651; 19506019; 19615732; 19704082; 19805454; 19828315; 19913121; 1998343; 20008565; 20057067; 20085233; 20097236; 20100830; 20116073; 20126661; 20195357; 20410307; 20414249; 20427671; 20508983; 20628086; 20702414; 20711500; 20876349; 20935584; 20938780; 21135095; 21152665; 21173115; 21249466; 21320982; 21343306; 21357747; 21387114; 21501964; 21556036; 21645854; 21684747; 21733848; 21739474; 21741246; 21781992; 21900206; 21909394; 21911578; 21918864; 21920633; 21959292; 21981919; 21983102; 21984748; 21988832; 22040362; 22078486; 22102026; 22105171; 22137929; 22190034; 22196955; 22207755; 22210628; 22216170; 22270372; 22298039; 22321369; 22349865; 22355145; 22360420; 22379090; 22466964; 22572540; 22579784; 22593156; 22623428; 22686199; 22699758; 22789697; 22810585; 22870330; 22900631; 22970133; 23000505; 23102936; 23140793; 23152587; 23190606; 23250913; 23293021; 23297223; 23333620; 23383273; 23393163; 23412975; 23414517; 23457492; 23498974; 23500464; 23533167; 23606334; 23650620; 23652004; 23722536; 23782134; 23791177; 23844095; 23867461; 24019521; 24019527; 24025715; 24085347; 24089527; 24100225; 24129571; 24152492; 24163436; 24189400; 24196352; 24196964; 24215292; 24248593; 24377547; 24417208; 24448410; 24502978; 24598262; 24610782; 24685677; 24700463; 2475911; 24768535; 24807418; 24811749; 24820123; 24855649; 24885147; 25030448; 25034784; 25078495; 25118285; 25146396; 25447673; 25457024; 25463965; 25492614; 25526666; 25566966; 25609649; 25618255; 25694454; 2570460; 25775548; 25814554; 25874486; 25970786; 26107514; 26168958; 26210183; 26311884; 26320413; 26463207; 26463447; 26475856; 26496610; 26504085; 26511028; 26549226; 26555175; 26611529; 26712278; 26712280; 26720340; 26797118; 26818443; 26822609; 26826127; 27226613; 27344168; 27407164; 27561680; 27594680; 27623077; 27653958; 27684549; 27714797; 27716483; 27762274; 27913212; 28036256; 28115426; 28274878; 28320958; 28360103; 28494016; 28512218; 28551275; 28564594; 28692196; 28819009; 28878026; 28939772; 28970065; 29238611; 7523390; 7529176; 7553863; 7553864; 8625414; 8692836,1996-10-01,2019-02-13,2007-01-23,209,X-ray crystallography (29); Electron microscopy (5),STRAND 25 29 {ECO:0000244|PDB:5B6C}.; STRAND 38 41 {ECO:0000244|PDB:5B6C}.; STRAND 53 55 {ECO:0000244|PDB:5FTN}.; STRAND 56 60 {ECO:0000244|PDB:5B6C}.; STRAND 66 73 {ECO:0000244|PDB:5B6C}.; STRAND 75 77 {ECO:0000244|PDB:3HU1}.; STRAND 81 83 {ECO:0000244|PDB:5B6C}.; STRAND 93 95 {ECO:0000244|PDB:5FTN}.; STRAND 99 104 {ECO:0000244|PDB:5B6C}.; STRAND 112 119 {ECO:0000244|PDB:5B6C}.; STRAND 126 128 {ECO:0000244|PDB:5IFS}.; STRAND 144 147 {ECO:0000244|PDB:5B6C}.; STRAND 151 154 {ECO:0000244|PDB:5B6C}.; STRAND 157 159 {ECO:0000244|PDB:4KDI}.; STRAND 161 176 {ECO:0000244|PDB:5B6C}.; STRAND 181 183 {ECO:0000244|PDB:5B6C}.; STRAND 198 200 {ECO:0000244|PDB:5FTJ}.; STRAND 240 244 {ECO:0000244|PDB:4KO8}.; STRAND 246 250 {ECO:0000244|PDB:4KLN}.; STRAND 263 270 {ECO:0000244|PDB:4KO8}.; STRAND 298 305 {ECO:0000244|PDB:4KO8}.; STRAND 313 315 {ECO:0000244|PDB:5FTK}.; STRAND 341 348 {ECO:0000244|PDB:4KO8}.; STRAND 365 368 {ECO:0000244|PDB:4KO8}.; STRAND 388 390 {ECO:0000244|PDB:5DYG}.; STRAND 432 436 {ECO:0000244|PDB:3HU1}.; STRAND 458 461 {ECO:0000244|PDB:4KO8}.; STRAND 513 517 {ECO:0000244|PDB:5FTJ}.; STRAND 538 542 {ECO:0000244|PDB:5FTJ}.; STRAND 571 578 {ECO:0000244|PDB:5FTJ}.; STRAND 588 590 {ECO:0000244|PDB:5FTJ}.; STRAND 613 624 {ECO:0000244|PDB:5FTJ}.; STRAND 626 629 {ECO:0000244|PDB:5FTJ}.; STRAND 635 639 {ECO:0000244|PDB:5FTK}.; STRAND 641 644 {ECO:0000244|PDB:5FTJ}.; STRAND 662 664 {ECO:0000244|PDB:5C1B}.; STRAND 722 724 {ECO:0000244|PDB:5IFW}.,HELIX 22 24 {ECO:0000244|PDB:5IFW}.; HELIX 43 48 {ECO:0000244|PDB:5B6C}.; HELIX 62 64 {ECO:0000244|PDB:3QQ8}.; HELIX 86 92 {ECO:0000244|PDB:5B6C}.; HELIX 120 123 {ECO:0000244|PDB:5B6C}.; HELIX 130 133 {ECO:0000244|PDB:5B6C}.; HELIX 135 139 {ECO:0000244|PDB:5B6C}.; HELIX 191 193 {ECO:0000244|PDB:4KDL}.; HELIX 203 205 {ECO:0000244|PDB:4KO8}.; HELIX 210 219 {ECO:0000244|PDB:4KO8}.; HELIX 221 225 {ECO:0000244|PDB:4KO8}.; HELIX 227 233 {ECO:0000244|PDB:4KO8}.; HELIX 251 261 {ECO:0000244|PDB:4KO8}.; HELIX 271 275 {ECO:0000244|PDB:4KO8}.; HELIX 281 295 {ECO:0000244|PDB:4KO8}.; HELIX 306 308 {ECO:0000244|PDB:4KO8}.; HELIX 319 333 {ECO:0000244|PDB:4KO8}.; HELIX 335 337 {ECO:0000244|PDB:5DYG}.; HELIX 350 352 {ECO:0000244|PDB:4KO8}.; HELIX 355 358 {ECO:0000244|PDB:4KO8}.; HELIX 374 385 {ECO:0000244|PDB:4KO8}.; HELIX 396 401 {ECO:0000244|PDB:4KO8}.; HELIX 408 424 {ECO:0000244|PDB:4KO8}.; HELIX 439 444 {ECO:0000244|PDB:4KO8}.; HELIX 449 457 {ECO:0000244|PDB:4KO8}.; HELIX 476 478 {ECO:0000244|PDB:5FTK}.; HELIX 483 498 {ECO:0000244|PDB:5FTJ}.; HELIX 500 505 {ECO:0000244|PDB:5FTJ}.; HELIX 524 534 {ECO:0000244|PDB:5FTJ}.; HELIX 544 552 {ECO:0000244|PDB:5FTJ}.; HELIX 559 568 {ECO:0000244|PDB:5FTJ}.; HELIX 581 586 {ECO:0000244|PDB:5FTJ}.; HELIX 599 609 {ECO:0000244|PDB:5FTJ}.; HELIX 631 634 {ECO:0000244|PDB:5FTJ}.; HELIX 650 661 {ECO:0000244|PDB:5FTJ}.; HELIX 672 678 {ECO:0000244|PDB:5FTJ}.; HELIX 684 706 {ECO:0000244|PDB:5FTJ}.; HELIX 735 741 {ECO:0000244|PDB:5FTJ}.; HELIX 749 762 {ECO:0000244|PDB:5FTJ}.; HELIX 763 765 {ECO:0000244|PDB:5FTM}.,TURN 15 17 {ECO:0000244|PDB:4KLN}.; TURN 140 142 {ECO:0000244|PDB:5B6C}.; TURN 360 362 {ECO:0000244|PDB:5FTL}.; TURN 403 405 {ECO:0000244|PDB:5FTJ}.; TURN 425 429 {ECO:0000244|PDB:4KO8}.; TURN 462 468 {ECO:0000244|PDB:4KO8}.,,,,,5 out of 5,Beta strand (37); Binding site (2); Chain (1); Cross-link (2); Helix (40); Initiator methionine (1); Modified residue (18); Motif (1); Mutagenesis (17); Natural variant (16); Nucleotide binding (2); Region (1); Sequence conflict (2); Turn (6),"CAUTION: It is unclear how it participates in the recruitment of TP53BP1 at DNA damage sites. According to a first report, participates in the recruitment of TP53BP1 by promoting ubiquitination and removal of L3MBTL1 from DNA damage sites (PubMed:22120668). According to a second report, it acts by removing 'Lys-48'-linked ubiquitination from sites of DNA damage (PubMed:22020440). {ECO:0000305|PubMed:22020440, ECO:0000305|PubMed:22120668}.",,,3D-structure;ATP-binding;Acetylation;Amyotrophic lateral sclerosis;Autophagy;Charcot-Marie-Tooth disease;Complete proteome;Cytoplasm;DNA damage;DNA repair;Direct protein sequencing;Disease mutation;Endoplasmic reticulum;Hydrolase;Isopeptide bond;Lipid-binding;Methylation;Neurodegeneration;Neuropathy;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transport;Ubl conjugation;Ubl conjugation pathway,Evidence at protein level,reviewed,,AAA ATPase family,209,Catalytic activity (1); Caution (1); Domain (1); Function (1); Involvement in disease (3); Post-translational modification (3); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0036; KW-0067; KW-0072; KW-0144; KW-0181; KW-0225; KW-0227; KW-0234; KW-0256; KW-0378; KW-0446; KW-0488; KW-0523; KW-0539; KW-0547; KW-0597; KW-0622; KW-0813; KW-0832; KW-0833; KW-0903; KW-0963; KW-1017; KW-1185,,,,,"DISEASE: Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (IBMPFD1) [MIM:167320]: An autosomal dominant disease characterized by disabling muscle weakness clinically resembling to limb girdle muscular dystrophy, osteolytic bone lesions consistent with Paget disease, and premature frontotemporal dementia. Clinical features show incomplete penetrance. {ECO:0000269|PubMed:15034582, ECO:0000269|PubMed:15732117, ECO:0000269|PubMed:16247064, ECO:0000269|PubMed:16321991, ECO:0000269|PubMed:17935506, ECO:0000269|PubMed:20104022, ECO:0000269|PubMed:20335036, ECO:0000269|PubMed:20512113, ECO:0000269|PubMed:21822278, ECO:0000269|PubMed:23349634, ECO:0000269|PubMed:25125609, ECO:0000269|PubMed:25878907, ECO:0000269|PubMed:27209344, ECO:0000269|PubMed:27753622, ECO:0000269|PubMed:29804830}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia (ALS14) [MIM:613954]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. Patients with ALS14 may develop frontotemporal dementia. {ECO:0000269|PubMed:21145000, ECO:0000269|PubMed:23349634}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease 2Y (CMT2Y) [MIM:616687]: An autosomal dominant, axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:25125609, ECO:0000269|PubMed:25878907}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Phosphorylated by tyrosine kinases in response to T-cell antigen receptor activation. Phosphorylated in mitotic cells. {ECO:0000250|UniProtKB:P46462}.; PTM: ISGylated. {ECO:0000269|PubMed:16139798}.; PTM: Methylation at Lys-315 catalyzed by VCPKMT is increased in the presence of ASPSCR1. Lys-315 methylation may decrease ATPase activity. {ECO:0000269|PubMed:22948820, ECO:0000269|PubMed:23349634}.",CHAIN 2 806 Transitional endoplasmic reticulum ATPase. /FTId=PRO_0000084572.,CROSSLNK 8 8 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 18 18 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:12665801, ECO:0000269|Ref.8}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:25944712, ECO:0000269|Ref.8}.; MOD_RES 3 3 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 7 7 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 13 13 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 37 37 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 315 315 N6,N6,N6-trimethyllysine; by VCPKMT. {ECO:0000269|PubMed:22948820, ECO:0000269|PubMed:23349634}.; MOD_RES 436 436 Phosphothreonine. {ECO:0000244|PubMed:18691976}.; MOD_RES 462 462 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 502 502 N6-acetyllysine. {ECO:0000250|UniProtKB:Q01853}.; MOD_RES 505 505 N6-acetyllysine. {ECO:0000250|UniProtKB:Q01853}.; MOD_RES 668 668 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q01853}.; MOD_RES 668 668 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q01853}.; MOD_RES 702 702 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 754 754 N6-acetyllysine. {ECO:0000250|UniProtKB:Q01853}.; MOD_RES 770 770 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 775 775 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 787 787 Phosphoserine. {ECO:0000244|PubMed:18691976}.; MOD_RES 805 805 Phosphotyrosine. {ECO:0000250|UniProtKB:Q01853}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AC004472;AF100752;AK312310;CH471071;BC110913;BC121794;Z70768;
0,P60981,DEST_HUMAN,DSTN ACTDP DSN,DSTN,ACTDP DSN,,,Homo sapiens (Human),9606,Destrin (Actin-depolymerizing factor) (ADF),UP000005640: Chromosome 20,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MASGVQVADEVCRIFYDMKVRKCSTPEEIKKRKKAVIFCLSADKKCIIVEEGKEILVGDVGVTITDPFKHFVGMLPEKDCRYALYDASFETKESRKEELMFFLWAPELAPLKSKMIYASSKDAIKKKFQGIKHECQANGPEDLNRACIAEKLGGSLIVAFEGCPV,165,"18,506",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P60981-1; Sequence=Displayed; Name=2; IsoId=P60981-2; Sequence=VSP_043069; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 1 17 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_043069.,VARIANT 139 139 G -> E (in a colorectal cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036459.,,,,,,3,,0,,SIMILARITY: Belongs to the actin-binding proteins ADF family. {ECO:0000305}.,,,DOMAIN 4 153 ADF-H. {ECO:0000255|PROSITE-ProRule:PRU00599}.,MOTIF 30 34 Nuclear localization signal. {ECO:0000255}.,,,,,,,,,FUNCTION: Actin-depolymerizing protein. Severs actin filaments (F-actin) and binds to actin monomers (G-actin). Acts in a pH-independent manner. {ECO:0000269|PubMed:11812157}.,,,,,,,,,,,,actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; positive regulation of actin filament depolymerization [GO:0030836],actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; positive regulation of actin filament depolymerization [GO:0030836],actin filament binding [GO:0051015],actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062],GO:0008154; GO:0015629; GO:0030042; GO:0030043; GO:0030836; GO:0030864; GO:0051014; GO:0051015; GO:0070062,IPR002108; IPR029006; IPR017904; IPR029924; ,P60709; P63261; Q549N0; Q1KLZ0; Q86VP1,,8399167; 14702039; 11780052; 15489334; 12665801; 11812157; 17081983; 16815975; 19413330; 19369195; 19608861; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 25944712; 16959974,8399167; 14702039; 11780052; 15489334; 12665801; 11812157; 17081983; 16815975; 19413330; 19369195; 19608861; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 25944712; 16959974; 11171090; 14627701; 15231748; 15660133; 15816841; 16189514; 17196218; 17353931; 17583572; 19367725; 19463016; 20835250; 20873970; 21571222; 22898637; 23153585; 25416956; 25609649; 26496610; 26996939; 7615564,2004-04-26,2019-02-13,2007-01-23,150,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Domain (1); Initiator methionine (1); Modified residue (3); Motif (1); Natural variant (1),,TISSUE SPECIFICITY: Widely distributed in various tissues.,,Acetylation;Actin-binding;Alternative splicing;Complete proteome;Direct protein sequencing;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,Actin-binding proteins ADF family,150,Alternative products (1); Caution (1); Function (1); Post-translational modification (1); Sequence similarities (1); Tissue specificity (1),,KW-0007; KW-0009; KW-0025; KW-0181; KW-0597; KW-0621; KW-0832; KW-0903; KW-1185,,,,,,,,PTM: ISGylated. {ECO:0000305|PubMed:16815975}.,CHAIN 2 165 Destrin. /FTId=PRO_0000214918.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:12665801}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:12665801}.; MOD_RES 3 3 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 19 19 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,S65738;CR457042;AK302338;AK312645;CH471133;CH471133;CH471133;BC009477;
0,P61158,ARP3_HUMAN,ACTR3 ARP3,ACTR3,ARP3,,,Homo sapiens (Human),9606,Actin-related protein 3 (Actin-like protein 3),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAGRLPACVVDCGTGYTKLGYAGNTEPQFIIPSCIAIKESAKVGDQAQRRVMKGVDDLDFFIGDEAIEKPTYATKWPIRHGIVEDWDLMERFMEQVIFKYLRAEPEDHYFLLTEPPLNTPENREYTAEIMFESFNVPGLYIAVQAVLALAASWTSRQVGERTLTGTVIDSGDGVTHVIPVAEGYVIGSCIKHIPIAGRDITYFIQQLLRDREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSKWIKQYTGINAISKKEFSIDVGYERFLGPEIFFHPEFANPDFTQPISEVVDEVIQNCPIDVRRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELSGGRLKPKPIDVQVITHHMQRYAVWFGGSMLASTPEFYQVCHTKKDYEEIGPSICRHNPVFGVMS,418,"47,371",,,,,,,,,,,,,,,,,,,3,,0,,SIMILARITY: Belongs to the actin family. ARP3 subfamily. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: ATP-binding component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) (PubMed:9000076). The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility (PubMed:9000076). Seems to contact the pointed end of the daughter actin filament (PubMed:9000076). In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA (PubMed:17220302, PubMed:29925947). The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) (PubMed:29925947). Plays a role in ciliogenesis (PubMed:20393563). {ECO:0000269|PubMed:17220302, ECO:0000269|PubMed:20393563, ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:9000076}.",,,,,,,,,,,,actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cilium assembly [GO:0060271]; ephrin receptor signaling pathway [GO:0048013]; establishment or maintenance of cell polarity [GO:0007163]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; membrane organization [GO:0061024]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spindle localization [GO:0051653],actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cilium assembly [GO:0060271]; ephrin receptor signaling pathway [GO:0048013]; establishment or maintenance of cell polarity [GO:0007163]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; membrane organization [GO:0061024]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spindle localization [GO:0051653],actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200],actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],GO:0003779; GO:0005200; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0005903; GO:0005911; GO:0005925; GO:0007163; GO:0008356; GO:0015629; GO:0016020; GO:0016344; GO:0030027; GO:0033206; GO:0034314; GO:0035861; GO:0038096; GO:0045944; GO:0048013; GO:0051653; GO:0060271; GO:0061024; GO:0070062; GO:0070358; GO:0071346,IPR004000; IPR020902; IPR015623; ,P17535,"SUBUNIT: Component of the Arp2/3 complex composed of ACTR2/ARP2, ACTR3/ARP3, ARPC1B/p41-ARC, ARPC2/p34-ARC, ARPC3/p21-ARC, ARPC4/p20-ARC and ARPC5/p16-ARC (PubMed:9000076, PubMed:9230079, PubMed:11741539). Interacts with WHDC1 (PubMed:18614018). Interacts weakly with MEFV (PubMed:19109554). {ECO:0000269|PubMed:11741539, ECO:0000269|PubMed:18614018, ECO:0000269|PubMed:19109554, ECO:0000269|PubMed:9000076, ECO:0000269|PubMed:9230079}.",9230079; 14702039; 15815621; 15489334; 9000076; 11741539; 15592455; 17220302; 18614018; 19413330; 16767080; 19109554; 19608861; 20393563; 21269460; 24275569; 25944712; 29925947,9230079; 14702039; 15815621; 15489334; 9000076; 11741539; 15592455; 17220302; 18614018; 19413330; 16767080; 19109554; 19608861; 20393563; 21269460; 24275569; 25944712; 29925947; 10219243; 10535736; 10542231; 10559861; 10559924; 10625686; 11082044; 11231140; 11231575; 11231582; 11329366; 11470803; 11517213; 11532990; 11577110; 11747816; 11854399; 11889126; 12036877; 12055636; 12105426; 12200375; 12429845; 12464680; 12577067; 12672817; 12743368; 12769847; 12791263; 12952949; 14622578; 14622579; 15040784; 15242766; 15260957; 15279900; 15318165; 15385624; 15469433; 15502812; 15502813; 15703209; 15741236; 15895077; 16004967; 16103228; 16253999; 16262445; 16403731; 16410077; 16798879; 16880808; 17085436; 17092940; 17158794; 17251352; 17353931; 17501982; 17524364; 17576929; 17609109; 17681954; 17765681; 17978091; 18093523; 18388313; 18391171; 18516090; 18790740; 18981233; 19092055; 19262673; 19286135; 19536138; 19575674; 19603039; 19738201; 19913427; 20033059; 20059951; 20195357; 20360068; 20404198; 20428113; 20711500; 20826345; 21108927; 2115402; 21182203; 21182205; 21278753; 21316588; 21445324; 21482805; 21613550; 21676863; 21779028; 21841790; 21927000; 21927001; 21962517; 22099461; 22100162; 22233676; 22505844; 22623428; 23051739; 23297414; 23320827; 23823722; 23861397; 23891661; 24344184; 24469447; 24581490; 24872192; 24966051; 25107275; 25264243; 25341920; 25665578; 26028144; 26042225; 26370503; 26496610; 26638075; 26655834; 26848712; 26991540; 26997484; 27052944; 27181356; 27559607; 28170369; 29636431; 30049513; 6146630; 7877694; 8524399; 8552632; 9092476; 9100026; 9427626; 9428629; 9600938; 9635431; 9736607; 9885284,2004-05-10,2019-02-13,2007-01-23,157,,,,,,,,,5 out of 5,Chain (1); Initiator methionine (1); Modified residue (5),,,,ATP-binding;Acetylation;Actin-binding;Cell projection;Cilium biogenesis/degradation;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Nucleotide-binding;Nucleus;Reference proteome,Evidence at protein level,reviewed,,"Actin family, ARP3 subfamily",157,Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0007; KW-0009; KW-0067; KW-0181; KW-0206; KW-0539; KW-0547; KW-0903; KW-0963; KW-0966; KW-0970; KW-1185,,,,,,,,,CHAIN 2 418 Actin-related protein 3. /FTId=PRO_0000089079.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000269|Ref.8}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000269|Ref.8}.; MOD_RES 240 240 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 244 244 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 251 251 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 254 254 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF006083;AF127773;AK312659;AC110769;CH471103;BC044590;
0,P61160,ARP2_HUMAN,ACTR2 ARP2,ACTR2,ARP2,,,Homo sapiens (Human),9606,Actin-related protein 2 (Actin-like protein 2),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDSQGRKVVVCDNGTGFVKCGYAGSNFPEHIFPALVGRPIIRSTTKVGNIEIKDLMVGDEASELRSMLEVNYPMENGIVRNWDDMKHLWDYTFGPEKLNIDTRNCKILLTEPPMNPTKNREKIVEVMFETYQFSGVYVAIQAVLTLYAQGLLTGVVVDSGDGVTHICPVYEGFSLPHLTRRLDIAGRDITRYLIKLLLLRGYAFNHSADFETVRMIKEKLCYVGYNIEQEQKLALETTVLVESYTLPDGRIIKVGGERFEAPEALFQPHLINVEGVGVAELLFNTIQAADIDTRSEFYKHIVLSGGSTMYPGLPSRLERELKQLYLERVLKGDVEKLSKFKIRIEDPPRRKHMVFLGGAVLADIMKDKDNFWMTRQEYQEKGVRVLEKLGVTVR,394,"44,761",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P61160-1; Sequence=Displayed; Name=2; IsoId=P61160-2; Sequence=VSP_046178; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 53 53 K -> KNNKKM (in isoform 2). {ECO:0000303|PubMed:17974005}. /FTId=VSP_046178.,,,,,CONFLICT 67 67 M -> T (in Ref. 6; AAH14546). {ECO:0000305}.; CONFLICT 172 172 G -> S (in Ref. 6; AAH14546). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the actin family. ARP2 subfamily. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: ATP-binding component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) (PubMed:9000076). The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility (PubMed:9000076). Seems to contact the pointed end of the daughter actin filament (PubMed:9000076). In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA (PubMed:17220302, PubMed:29925947). The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) (PubMed:29925947). {ECO:0000269|PubMed:17220302, ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:9000076}.",,,,,,,,,,NP_BIND 160 162 ATP. {ECO:0000250|UniProtKB:A7MB62}.; NP_BIND 214 218 ATP. {ECO:0000250|UniProtKB:A7MB62}.; NP_BIND 305 310 ATP. {ECO:0000250|UniProtKB:A7MB62}.,,actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; podosome core [GO:0061825]; postsynaptic density [GO:0014069]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; associative learning [GO:0008306]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cellular response to trichostatin A [GO:0035984]; cilium assembly [GO:0060271]; cytosolic transport [GO:0016482]; ephrin receptor signaling pathway [GO:0048013]; establishment or maintenance of cell polarity [GO:0007163]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; membrane organization [GO:0061024]; neutrophil degranulation [GO:0043312]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; spindle localization [GO:0051653],Arp2/3 complex-mediated actin nucleation [GO:0034314]; associative learning [GO:0008306]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cellular response to trichostatin A [GO:0035984]; cilium assembly [GO:0060271]; cytosolic transport [GO:0016482]; ephrin receptor signaling pathway [GO:0048013]; establishment or maintenance of cell polarity [GO:0007163]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; membrane organization [GO:0061024]; neutrophil degranulation [GO:0043312]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; spindle localization [GO:0051653],actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200],actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; podosome core [GO:0061825]; postsynaptic density [GO:0014069]; site of double-strand break [GO:0035861],GO:0003779; GO:0005200; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0005925; GO:0007163; GO:0008306; GO:0008356; GO:0014069; GO:0015629; GO:0016020; GO:0016344; GO:0016482; GO:0030027; GO:0030478; GO:0033206; GO:0034314; GO:0035578; GO:0035861; GO:0035902; GO:0035984; GO:0038096; GO:0043312; GO:0045471; GO:0045944; GO:0048013; GO:0051653; GO:0060271; GO:0061003; GO:0061024; GO:0061825; GO:0070062; GO:0071346; GO:0071437; GO:1904813; GO:1905168,IPR004000; IPR020902; IPR027306; ,,"SUBUNIT: Component of the Arp2/3 complex composed of ACTR2/ARP2, ACTR3/ARP3, ARPC1B/p41-ARC, ARPC2/p34-ARC, ARPC3/p21-ARC, ARPC4/p20-ARC and ARPC5/p16-ARC. {ECO:0000269|PubMed:11741539, ECO:0000269|PubMed:9000076}.",9230079; 14702039; 17974005; 15815621; 15489334; 9000076; 11741539; 17220302; 19608861; 21269460; 24275569; 25944712; 29925947,9230079; 14702039; 17974005; 15815621; 15489334; 9000076; 11741539; 17220302; 19608861; 21269460; 24275569; 25944712; 29925947; 10219243; 10535736; 10542231; 10559861; 10559924; 10625686; 11082044; 11231140; 11231582; 11329366; 11470803; 11517213; 11532990; 11577110; 11747816; 11854399; 11889126; 12036877; 12055636; 12105426; 12200375; 12429845; 12464680; 12577067; 12672817; 12743368; 12769847; 12791263; 12952949; 14622578; 14622579; 15040784; 15242766; 15260957; 15318165; 15385624; 15469433; 15502812; 15502813; 15703209; 15741236; 15834156; 15895077; 16004967; 16103228; 16253999; 16262445; 16403731; 16410077; 16638851; 16798879; 16880808; 17085436; 17092940; 17158794; 17251352; 17353931; 17459058; 17501982; 17609109; 17681954; 17765681; 17978091; 18093523; 18388313; 18391171; 18516090; 18720401; 18725535; 18790740; 18981233; 19092055; 19262673; 19286135; 19536138; 19575674; 19603039; 19913427; 20033059; 20059951; 20404198; 20428113; 20467437; 20826345; 2115402; 21182205; 21278753; 21316588; 21445324; 21482805; 21613550; 21676863; 21779028; 21841790; 21927000; 21927001; 21962517; 21988832; 22099461; 22100162; 22125478; 22233676; 22505844; 22623428; 23051739; 23212915; 23297414; 23650620; 23823722; 23861397; 23891661; 24344184; 24469447; 24581490; 24872192; 24918434; 24966051; 25107275; 25264243; 25341920; 25601402; 26028144; 26042225; 26370503; 26496610; 26638075; 26655834; 26848712; 26991540; 26997484; 27052944; 27181356; 27559607; 27872092; 27926942; 28599093; 29636431; 6146630; 7877694; 8524399; 8552632; 8692836; 9092476; 9100026; 9427626; 9428629; 9600938; 9635431; 9736607; 9885284,2004-05-10,2019-02-13,2004-05-10,151,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Modified residue (3); Nucleotide binding (3); Sequence conflict (2),,,,ATP-binding;Acetylation;Actin-binding;Alternative splicing;Cell projection;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Nucleotide-binding;Nucleus;Reference proteome,Evidence at protein level,reviewed,,"Actin family, ARP2 subfamily",151,Alternative products (1); Caution (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0007; KW-0009; KW-0025; KW-0067; KW-0181; KW-0206; KW-0539; KW-0547; KW-0903; KW-0963; KW-0966; KW-1185,,,,,,,,,CHAIN 1 394 Actin-related protein 2. /FTId=PRO_0000089067.,,,,,,MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:25944712}.; MOD_RES 299 299 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 322 322 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF006082;AK315205;CH471053;CH471053;CH471053;CH471053;BC014546;
0,P61586,RHOA_HUMAN,RHOA ARH12 ARHA RHO12,RHOA,ARH12 ARHA RHO12,,,Homo sapiens (Human),9606,Transforming protein RhoA (Rho cDNA clone 12) (h12),UP000005640: Chromosome 3,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAAIRKKLVIVGDGACGKTCLLIVFSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLRNDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQARRGKKKSGCLVL,193,"21,768",,,,,,,,,,,,,,,,,CONFLICT 23 23 I -> T (in Ref. 5; BAD96276). {ECO:0000305}.,,1,,0,DOMAIN: The basic-rich region is essential for yopT recognition and cleavage.,SIMILARITY: Belongs to the small GTPase superfamily. Rho family. {ECO:0000305}.,,COMPBIAS 182 187 Arg/Lys-rich (basic).,,MOTIF 34 42 Effector region. {ECO:0000255}.,,,,,,,COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:12777804}; ,,"FUNCTION: Regulates a signal transduction pathway linking plasma membrane receptors to the assembly of focal adhesions and actin stress fibers. Involved in a microtubule-dependent signal that is required for the myosin contractile ring formation during cell cycle cytokinesis. Plays an essential role in cleavage furrow formation. Required for the apical junction formation of keratinocyte cell-cell adhesion. Stimulates PKN2 kinase activity. May be an activator of PLCE1. Activated by ARHGEF2, which promotes the exchange of GDP for GTP. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. The MEMO1-RHOA-DIAPH1 signaling pathway plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. It controls the localization of APC and CLASP2 to the cell membrane, via the regulation of GSK3B activity. In turn, membrane-bound APC allows the localization of the MACF1 to the cell membrane, which is required for microtubule capture and stabilization. Regulates a signal transduction pathway linking plasma membrane receptors to the assembly of focal adhesions and actin stress fibers. Involved in a microtubule-dependent signal that is required for the myosin contractile ring formation during cell cycle cytokinesis. Plays an essential role in cleavage furrow formation. Required for the apical junction formation of keratinocyte cell-cell adhesion. May be an activator of PLCE1. Activated by ARHGEF2, which promotes the exchange of GDP for GTP. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. The MEMO1-RHOA-DIAPH1 signaling pathway plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. It controls the localization of APC and CLASP2 to the cell membrane, via the regulation of GSK3B activity. In turn, membrane-bound APC allows the localization of the MACF1 to the cell membrane, which is required for microtubule capture and stabilization (By similarity). Regulates KCNA2 potassium channel activity by reducing its location at the cell surface in response to CHRM1 activation; promotes KCNA2 endocytosis (PubMed:9635436, PubMed:19403695). {ECO:0000250, ECO:0000269|PubMed:12900402, ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20937854, ECO:0000269|PubMed:20974804, ECO:0000269|PubMed:8910519, ECO:0000269|PubMed:9121475, ECO:0000269|PubMed:9635436}.; FUNCTION: (Microbial infection) Serves as a target for the yopT cysteine peptidase from Yersinia pestis, vector of the plague. {ECO:0000269|PubMed:12062101, ECO:0000269|PubMed:12538863}.; FUNCTION: (Microbial infection) Serves as a target for the yopT cysteine peptidase from Yersinia pseudotuberculosis, which causes gastrointestinal disorders. {ECO:0000269|PubMed:12062101, ECO:0000269|PubMed:12538863}.",,,,,,,,,,"NP_BIND 12 19 GTP. {ECO:0000269|PubMed:10748207, ECO:0000269|PubMed:12777804}.; NP_BIND 59 63 GTP. {ECO:0000250}.; NP_BIND 117 120 GTP. {ECO:0000269|PubMed:10748207, ECO:0000269|PubMed:12777804}.",SITE 189 190 Cleavage; by yopT.,"apical junction complex [GO:0043296]; axon [GO:0030424]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]; vesicle [GO:0031982]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; alpha-beta T cell lineage commitment [GO:0002363]; androgen receptor signaling pathway [GO:0030521]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; apical junction assembly [GO:0043297]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; beta selection [GO:0043366]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to chemokine [GO:1990869]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex cell migration [GO:0021795]; cleavage furrow formation [GO:0036089]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; ephrin receptor signaling pathway [GO:0048013]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain radial glial cell differentiation [GO:0021861]; G protein-coupled receptor signaling pathway [GO:0007186]; GTP metabolic process [GO:0046039]; mitotic cleavage furrow formation [GO:1903673]; mitotic spindle assembly [GO:0090307]; negative chemotaxis [GO:0050919]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell size [GO:0045792]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection morphogenesis [GO:0048812]; neutrophil degranulation [GO:0043312]; odontogenesis [GO:0042476]; ossification involved in bone maturation [GO:0043931]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell growth [GO:0030307]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokinesis [GO:0032467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipase activity [GO:0060193]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell migration [GO:2000406]; positive regulation of translation [GO:0045727]; positive regulation of vascular smooth muscle contraction [GO:1904695]; protein deubiquitination [GO:0016579]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium ion transport [GO:0051924]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of osteoblast proliferation [GO:0033688]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]; skeletal muscle satellite cell migration [GO:1902766]; skeletal muscle tissue development [GO:0007519]; stress fiber assembly [GO:0043149]; stress-activated protein kinase signaling cascade [GO:0031098]; substantia nigra development [GO:0021762]; trabecula morphogenesis [GO:0061383]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of cells [GO:0044319]","actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; alpha-beta T cell lineage commitment [GO:0002363]; androgen receptor signaling pathway [GO:0030521]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; apical junction assembly [GO:0043297]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; beta selection [GO:0043366]; cell junction assembly [GO:0034329]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular response to chemokine [GO:1990869]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex cell migration [GO:0021795]; cleavage furrow formation [GO:0036089]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; ephrin receptor signaling pathway [GO:0048013]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain radial glial cell differentiation [GO:0021861]; G protein-coupled receptor signaling pathway [GO:0007186]; GTP metabolic process [GO:0046039]; mitotic cleavage furrow formation [GO:1903673]; mitotic spindle assembly [GO:0090307]; negative chemotaxis [GO:0050919]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell size [GO:0045792]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection morphogenesis [GO:0048812]; neutrophil degranulation [GO:0043312]; odontogenesis [GO:0042476]; ossification involved in bone maturation [GO:0043931]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell growth [GO:0030307]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokinesis [GO:0032467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipase activity [GO:0060193]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell migration [GO:2000406]; positive regulation of translation [GO:0045727]; positive regulation of vascular smooth muscle contraction [GO:1904695]; protein deubiquitination [GO:0016579]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium ion transport [GO:0051924]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of osteoblast proliferation [GO:0033688]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]; skeletal muscle satellite cell migration [GO:1902766]; skeletal muscle tissue development [GO:0007519]; stress-activated protein kinase signaling cascade [GO:0031098]; stress fiber assembly [GO:0043149]; substantia nigra development [GO:0021762]; trabecula morphogenesis [GO:0061383]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of cells [GO:0044319]",GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022],apical junction complex [GO:0043296]; axon [GO:0030424]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]; vesicle [GO:0031982],GO:0001666; GO:0001998; GO:0002363; GO:0003100; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005768; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0006357; GO:0007015; GO:0007160; GO:0007179; GO:0007186; GO:0007266; GO:0007519; GO:0008360; GO:0009612; GO:0009749; GO:0010812; GO:0016032; GO:0016477; GO:0016579; GO:0017022; GO:0019003; GO:0019901; GO:0019904; GO:0021762; GO:0021795; GO:0021861; GO:0030027; GO:0030036; GO:0030054; GO:0030307; GO:0030334; GO:0030424; GO:0030496; GO:0030521; GO:0030667; GO:0030838; GO:0030950; GO:0031098; GO:0031234; GO:0031532; GO:0031982; GO:0032153; GO:0032154; GO:0032467; GO:0032587; GO:0032956; GO:0033144; GO:0033688; GO:0034329; GO:0035385; GO:0036089; GO:0038027; GO:0042476; GO:0043123; GO:0043124; GO:0043149; GO:0043197; GO:0043200; GO:0043231; GO:0043280; GO:0043296; GO:0043297; GO:0043312; GO:0043366; GO:0043524; GO:0043525; GO:0043542; GO:0043931; GO:0044319; GO:0045198; GO:0045471; GO:0045666; GO:0045727; GO:0045792; GO:0046039; GO:0046638; GO:0048010; GO:0048013; GO:0048015; GO:0048812; GO:0050771; GO:0050772; GO:0050773; GO:0050919; GO:0051017; GO:0051022; GO:0051056; GO:0051384; GO:0051496; GO:0051893; GO:0051924; GO:0060071; GO:0060193; GO:0061383; GO:0070062; GO:0070507; GO:0071222; GO:0071345; GO:0071803; GO:0071902; GO:0071944; GO:0090051; GO:0090307; GO:0090324; GO:0097498; GO:0098794; GO:0098978; GO:0101003; GO:1901224; GO:1902766; GO:1903427; GO:1903673; GO:1904695; GO:1904996; GO:1905274; GO:1990869; GO:2000145; GO:2000177; GO:2000406,IPR027417; IPR005225; IPR001806; IPR003578; ,Q15109; Q07960; P52565; O15085; Q9NZN5; Q8IW93; P46527; Q9Y4D1; O60610; O08808; Q9UKT9; Q6PDM6; P19338; Q9Z0S9; Q9Y4F9; Q13464; Q9BST9; Q8C6B2; Q15796; Q9HCE7-2; A0A0F6B1Q8; Q9FD10; Q15654,"SUBUNIT: Interacts with ARHGEF28 (By similarity). Interacts (via GTP-bound form) with RIPOR1 (via N-terminus); this interaction links RHOA to STK24 and STK26 kinases (PubMed:27807006). Interacts with RIPOR2 (via active GTP- or inactive GDP-bound forms) isoform 1 and isoform 2; these interactions are direct, block the loading of GTP to RHOA and decrease upon chemokine CCL19 stimulation in primary T lymphocytes (PubMed:25588844). Binds PRKCL1, ROCK1 and ROCK2. Interacts with ARHGEF2, ARHGEF3, NET1 and RTKN. Interacts with PLCE1 and AKAP13. Interacts with DIAPH1 (PubMed:23325789). Interacts (in the constitutively activated, GTP-bound form) with DGKQ. Interacts with RACK1; enhances RHOA activation. Interacts with PKP4; the interaction is detected at the midbody. Interacts (GTP-bound form preferentially) with PKN2; the interaction stimulates autophosphorylation and phosphorylation of PKN2. Interacts with ARHGDIA; this interaction inactivates and stabilizes RHOA. Interacts with ARHGDIB. Interacts (GTP-bound form) with KCNA2 (via cytoplasmic N-terminal domain) (PubMed:9635436). {ECO:0000250|UniProtKB:Q9QUI0, ECO:0000269|PubMed:10066731, ECO:0000269|PubMed:10388627, ECO:0000269|PubMed:10748207, ECO:0000269|PubMed:10940294, ECO:0000269|PubMed:11696353, ECO:0000269|PubMed:12006984, ECO:0000269|PubMed:12062101, ECO:0000269|PubMed:12221096, ECO:0000269|PubMed:12538863, ECO:0000269|PubMed:12777804, ECO:0000269|PubMed:12900402, ECO:0000269|PubMed:17115030, ECO:0000269|PubMed:19403695, ECO:0000269|PubMed:20400958, ECO:0000269|PubMed:20499158, ECO:0000269|PubMed:20974804, ECO:0000269|PubMed:23325789, ECO:0000269|PubMed:25588844, ECO:0000269|PubMed:27807006, ECO:0000269|PubMed:8617235, ECO:0000269|PubMed:8641286, ECO:0000269|PubMed:9121475, ECO:0000269|PubMed:9857026, ECO:0000305|PubMed:9635436}.; SUBUNIT: (Microbial infection) Interacts with human respiratory syncytial virus (HRSV) protein F; this interaction facilitates virus-induced syncytium formation. {ECO:0000269|PubMed:10438814}.",3822842; 7835413; 17974005; 16641997; 15489334; 8039707; 1328215; 1556108; 8617235; 8641286; 8910519; 9121475; 9635436; 9857026; 10066731; 10438814; 10940294; 11162591; 11696353; 12221096; 12062101; 12900402; 12538863; 16103226; 16236794; 17115030; 19934221; 19403695; 19362538; 19782033; 19039103; 19948726; 20400958; 20937854; 21269460; 21565175; 20499158; 20974804; 23325789; 24141704; 25588844; 25944712; 27807006; 9302995; 9545299; 10388627; 10748207; 11927263; 12006984; 12777804,3822842; 7835413; 17974005; 16641997; 15489334; 8039707; 1328215; 1556108; 8617235; 8641286; 8910519; 9121475; 9635436; 9857026; 10066731; 10438814; 10940294; 11162591; 11696353; 12221096; 12062101; 12900402; 12538863; 16103226; 16236794; 17115030; 19934221; 19403695; 19362538; 19782033; 19039103; 19948726; 20400958; 20937854; 21269460; 21565175; 20499158; 20974804; 23325789; 24141704; 25588844; 25944712; 27807006; 9302995; 9545299; 10388627; 10748207; 11927263; 12006984; 12777804; 10360578; 10489445; 10559246; 10591629; 10619026; 10648409; 10652353; 10655614; 10676816; 10753910; 10769020; 10873388; 10877843; 10913441; 11018042; 11058585; 11130076; 11157984; 11179879; 11207612; 11283606; 11294240; 11331307; 11335720; 11431473; 11447115; 11689693; 11738596; 11741970; 11779461; 11788600; 11803464; 11804589; 11818523; 11822867; 11830597; 11839765; 11889037; 11907271; 11933159; 11942626; 12016230; 12071848; 12101119; 12115629; 12119292; 12134165; 12154081; 12169092; 12185584; 12220504; 12221077; 12244193; 12397214; 12401808; 12423633; 12429845; 12429848; 12445208; 12471028; 12504591; 12524425; 12534282; 12579323; 12584113; 12593858; 12692008; 12692556; 12719789; 12730235; 12732141; 12783890; 12802051; 12805219; 12808121; 12847276; 12879077; 12939257; 12953056; 12972426; 12972601; 1383236; 1439791; 14506264; 14514689; 14581471; 14605490; 14612927; 14644158; 14657501; 14660612; 14661020; 14966521; 15003991; 15009099; 15016733; 15068789; 15096506; 15102021; 15128850; 15155793; 15156151; 15208091; 15210733; 15210811; 15260990; 15292224; 15298851; 15308673; 15322077; 15326221; 15331592; 15364580; 15448013; 15475352; 15475381; 15501440; 15530360; 15535843; 15545284; 15557193; 15572519; 15574779; 15579505; 15598682; 15611088; 15640525; 15642170; 15643515; 15644318; 15668138; 15670823; 15699075; 15710384; 15755723; 15761148; 15793569; 15809302; 15817453; 15821030; 15843433; 15848799; 15866170; 15890975; 15901767; 15921909; 15925904; 15963982; 16061799; 16112081; 16118207; 16188938; 16189514; 16202622; 16212495; 16219803; 16246900; 16247472; 16257181; 16308318; 16352658; 16394104; 16402387; 16424340; 16427251; 16431929; 16481321; 16496227; 16513651; 16537448; 16540523; 16622418; 16632465; 16644720; 16645187; 16652149; 16681996; 16684954; 16760434; 16773203; 16776827; 16864657; 16904289; 16969490; 16978776; 16979770; 16996686; 17007568; 17018591; 17018860; 17077126; 17086988; 17130286; 17151359; 17178865; 17190792; 17197445; 17222083; 17245604; 17273773; 17284169; 17300916; 17301291; 17301947; 17310253; 17332506; 17353931; 17360533; 17446864; 17488622; 17492768; 17493936; 17502338; 17507466; 17517067; 17562701; 17597401; 17635521; 17636025; 17658517; 17673200; 17702745; 17719543; 17825823; 17855350; 17896152; 17914970; 17947237; 17947676; 17951409; 17976533; 18001770; 18005700; 18005701; 18006505; 18078809; 18079197; 18096806; 18162551; 18172303; 18182571; 18198190; 18218625; 18256687; 18287089; 18287519; 18292502; 18300342; 18314880; 18316594; 18334926; 18356691; 18420945; 18434237; 18445682; 18458160; 18477564; 18495213; 18509267; 18509476; 18511940; 18524772; 18541705; 18567581; 18575772; 18589439; 18628484; 18651974; 18653556; 18660502; 18687805; 18688040; 18694745; 18713748; 18721871; 18751372; 18757369; 18757503; 18781093; 18824598; 18827818; 18829495; 18829532; 18835241; 18844232; 18851832; 18922893; 18923426; 18923442; 18929667; 18937283; 18953413; 18955552; 18983771; 18996344; 18996642; 19015318; 19038009; 19049388; 19103606; 19147496; 19147561; 19151751; 19152186; 19173301; 19234490; 19265130; 19293150; 19306108; 19318350; 19365405; 19372585; 19391109; 19421144; 19443661; 19470470; 19477269; 19487339; 19499974; 19506078; 19509057; 19527220; 19533666; 19550117; 19553453; 19573309; 19586902; 19602845; 19620060; 19620624; 19625450; 19635823; 19642867; 19644046; 19651782; 19654316; 19682162; 19723632; 19726670; 19737918; 19752040; 19762715; 19772916; 19773279; 19776349; 19787194; 19798549; 19826000; 19857574; 19887681; 19911011; 19912238; 19913121; 19944695; 19956681; 19996094; 20006706; 20030946; 20041165; 20056178; 20061625; 20068229; 20130732; 20195357; 20220547; 20223287; 20236512; 20300064; 20307617; 20348106; 20360068; 20363740; 20376724; 20383141; 20399237; 20403997; 20416077; 20429915; 20430886; 20442409; 20473500; 20503409; 20507639; 20547485; 20553488; 20554761; 20558775; 20591975; 20628086; 20628200; 20655307; 20696764; 20697357; 20711218; 20711500; 20733052; 20801873; 20803696; 20805359; 20808760; 20811682; 20814828; 20828398; 20859068; 20877624; 20886658; 20937815; 20945370; 20971525; 21029865; 21071443; 21079737; 21087931; 21112276; 21130456; 21145500; 21161732; 21186079; 21208644; 21209619; 21242305; 21257924; 21258369; 21265091; 21266463; 21273559; 21281639; 21303778; 21304528; 21351730; 21390328; 21439370; 21445309; 21451048; 21454543; 21454546; 21475975; 21518791; 21534245; 21566117; 21572420; 21574962; 21575498; 21576392; 21600098; 21628952; 21643014; 21667311; 21698469; 21708152; 21750647; 21756816; 21757538; 21779788; 21816819; 21858203; 21878647; 21898412; 21907186; 21917148; 21983114; 21988832; 22001926; 22009749; 22041269; 22049212; 22070920; 22072711; 22087025; 22092654; 22114142; 22120672; 22124327; 22161021; 22226472; 22226621; 22241857; 22251897; 22275376; 22328514; 22361510; 22363817; 22404908; 22456196; 22495072; 22500016; 22504159; 22575513; 22583359; 22584506; 22593208; 22621765; 22628549; 22645245; 22655072; 22673622; 22673745; 22699054; 22705156; 22740689; 22750095; 22774404; 22820501; 22847784; 22854067; 22893699; 22949615; 22963825; 22984590; 22992742; 23012358; 23042265; 23057787; 23066013; 23070684; 23079622; 23166513; 23176180; 23195957; 23243284; 23255405; 23283961; 23295150; 23307872; 23322732; 23324271; 23352230; 23361851; 23416715; 23420497; 23444367; 23469924; 23474751; 23488932; 23493395; 23500462; 23512987; 23521319; 23525486; 23536606; 23570668; 23613866; 23615712; 23620398; 23644655; 23648482; 23649168; 23650620; 23658012; 23669310; 23716662; 23720748; 23726972; 23774217; 23828571; 23834289; 23842948; 23895422; 23900609; 23940119; 24040310; 24043311; 24056963; 24086303; 24096540; 24098519; 24100445; 24114199; 24128008; 24178298; 24191200; 24200678; 24220306; 24225494; 24240172; 24241683; 24280143; 24287595; 24297045; 24316235; 24318513; 24324133; 24331979; 24333506; 24337944; 24356540; 24371121; 24413734; 24413737; 24421399; 24447566; 24525234; 24549567; 24551161; 24582560; 24584070; 24615351; 24642103; 24646293; 24786457; 24816255; 24835590; 24840563; 24902944; 24915967; 24917553; 24949629; 24980435; 24984542; 24995336; 25022753; 25025568; 25043657; 25101858; 25107911; 25120748; 25172658; 25173885; 25184334; 25186459; 25241761; 25261370; 25279428; 25288732; 25343250; 25359885; 25365944; 25413277; 25416956; 25434638; 25445891; 25454559; 25486363; 25490770; 25499974; 25529450; 25582918; 25612650; 25631751; 25673874; 25712672; 25734240; 25743845; 25802147; 25823974; 25832437; 25866182; 25869366; 25872785; 25883194; 25903128; 25909223; 25916117; 25940707; 25959226; 25962701; 25963656; 26066055; 26067270; 26100637; 26142737; 26159734; 26190758; 26193369; 26251521; 26261596; 26336927; 26350504; 26358398; 26368311; 26409448; 26458995; 26470595; 26474844; 26482039; 26483365; 26487003; 26496610; 26512756; 26529257; 26574607; 26574844; 26615410; 26616858; 26631033; 26638075; 26648547; 26649141; 26695096; 26719334; 26741994; 26751560; 26752649; 26774166; 26816343; 26829051; 26830684; 26892468; 26900962; 26928204; 26976596; 27041563; 27070728; 27084452; 27090015; 27097314; 27126939; 27138333; 27147504; 27153759; 27175941; 27195967; 27216196; 27250838; 27270401; 27279564; 27288754; 27311713; 27333992; 27355867; 27363609; 27369867; 27378427; 27424208; 27481945; 27495873; 27505894; 27517626; 27626171; 27650961; 27693615; 27713154; 27756879; 27795403; 27802291; 27806312; 27812894; 27863394; 27909884; 27913679; 27923225; 27927130; 27939884; 28004812; 28089989; 28096473; 28104444; 28146427; 28184030; 28222172; 2825022; 28284839; 28329735; 28411215; 28498638; 28499918; 28508825; 28509344; 28522256; 28536953; 28558721; 28608226; 28608941; 28624843; 28630045; 28656284; 28691928; 28695771; 28712859; 28779705; 28843271; 28888686; 28945625; 28990085; 29089377; 29114068; 29121972; 29196061; 29206819; 29207169; 29247652; 29279389; 29432180; 29500478; 29547847; 2966156; 29695506; 29749520; 29786744; 29849894; 29876405; 29949791; 30190425; 3839510; 7478592; 7543319; 7744773; 7787244; 7954816; 7954831; 8276860; 8288572; 8543060; 8571126; 8599934; 8645157; 8662509; 8662891; 8702756; 8769096; 8810315; 8816443; 8912005; 8969170; 8990121; 9113980; 9194563; 9195882; 9214622; 9233797; 9308960; 9338791; 9354661; 9407060; 9490638; 9605766; 9748241; 9792683; 9822636; 9870942; 9870943; 9988689,1988-01-01,2019-02-13,1988-01-01,183,X-ray crystallography (42),STRAND 4 13 {ECO:0000244|PDB:5C4M}.; STRAND 43 47 {ECO:0000244|PDB:5C4M}.; STRAND 52 58 {ECO:0000244|PDB:5C4M}.; STRAND 78 85 {ECO:0000244|PDB:5C4M}.; STRAND 107 109 {ECO:0000244|PDB:5FR2}.; STRAND 112 117 {ECO:0000244|PDB:5C4M}.; STRAND 154 158 {ECO:0000244|PDB:5C4M}.; STRAND 185 187 {ECO:0000244|PDB:5ZHX}.; STRAND 190 193 {ECO:0000244|PDB:5FR1}.,HELIX 14 16 {ECO:0000244|PDB:4XH9}.; HELIX 18 27 {ECO:0000244|PDB:5C4M}.; HELIX 63 69 {ECO:0000244|PDB:5C4M}.; HELIX 70 73 {ECO:0000244|PDB:5C4M}.; HELIX 89 97 {ECO:0000244|PDB:5C4M}.; HELIX 99 106 {ECO:0000244|PDB:5C4M}.; HELIX 119 121 {ECO:0000244|PDB:5C4M}.; HELIX 125 132 {ECO:0000244|PDB:5C4M}.; HELIX 141 151 {ECO:0000244|PDB:5C4M}.; HELIX 167 179 {ECO:0000244|PDB:5C4M}.,TURN 133 135 {ECO:0000244|PDB:5C4M}.; TURN 161 163 {ECO:0000244|PDB:5C4M}.; TURN 182 184 {ECO:0000244|PDB:5ZHX}.,,,,,5 out of 5,Beta strand (9); Chain (1); Compositional bias (1); Glycosylation (1); Helix (10); Lipidation (1); Modified residue (5); Motif (1); Mutagenesis (5); Nucleotide binding (3); Propeptide (1); Sequence conflict (1); Site (1); Turn (3),,,,3D-structure;ADP-ribosylation;Cell cycle;Cell division;Cell membrane;Cell projection;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;GTP-binding;Glycoprotein;Host-virus interaction;Lipoprotein;Magnesium;Membrane;Methylation;Nucleotide-binding;Phosphoprotein;Prenylation;Proto-oncogene;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,"Small GTPase superfamily, Rho family",183,Activity regulation (1); Cofactor (1); Domain (1); Function (3); Post-translational modification (6); Sequence similarities (1); Subcellular location (1); Subunit structure (2),,KW-0002; KW-0013; KW-0131; KW-0132; KW-0181; KW-0206; KW-0325; KW-0342; KW-0449; KW-0460; KW-0472; KW-0488; KW-0547; KW-0597; KW-0636; KW-0656; KW-0832; KW-0903; KW-0945; KW-0963; KW-0966; KW-1003; KW-1185,,,,,,,,"PTM: (Microbial infection) Substrate for botulinum ADP-ribosyltransferase. {ECO:0000269|PubMed:1328215}.; PTM: (Microbial infection) Cleaved by yopT protease when the cell is infected by some Yersinia pathogens. This removes the lipid attachment, and leads to its displacement from plasma membrane and to subsequent cytoskeleton cleavage. {ECO:0000269|PubMed:12062101, ECO:0000269|PubMed:12538863}.; PTM: (Microbial infection) AMPylation at Tyr-34 and Thr-37 are mediated by bacterial enzymes in case of infection by H.somnus and V.parahaemolyticus, respectively. AMPylation occurs in the effector region and leads to inactivation of the GTPase activity by preventing the interaction with downstream effectors, thereby inhibiting actin assembly in infected cells. It is unclear whether some human enzyme mediates AMPylation; FICD has such ability in vitro but additional experiments remain to be done to confirm results in vivo. {ECO:0000269|PubMed:19039103, ECO:0000269|PubMed:19362538}.; PTM: (Microbial infection) Glycosylated at Tyr-34 by Photorhabdus asymbiotica toxin PAU_02230. Mono-O-GlcNAcylation by PAU_02230 inhibits downstream signaling by an impaired interaction with diverse regulator and effector proteins of Rho and leads to actin disassembly. {ECO:0000269|PubMed:24141704}.; PTM: Phosphorylation by PRKG1 at Ser-188 inactivates RHOA signaling (PubMed:11162591). Phosphorylation by SLK at Ser-188 in response to AGTR2 activation (By similarity). {ECO:0000250|UniProtKB:P61589, ECO:0000269|PubMed:11162591}.; PTM: Ubiquitinated by the BCR(KCTD13) and BCR(TNFAIP1) E3 ubiquitin ligase complexes, leading to its degradation by the proteasome, thereby regulating the actin cytoskeleton and synaptic transmission in neurons. {ECO:0000269|PubMed:19782033}.",CHAIN 1 190 Transforming protein RhoA. /FTId=PRO_0000030411.,,,CARBOHYD 34 34 O-linked (GlcNAc) tyrosine; by Photorhabdus PAU_02230; alternate. {ECO:0000269|PubMed:24141704}.,,LIPID 190 190 S-geranylgeranyl cysteine. {ECO:0000250|UniProtKB:P62745}.,MOD_RES 34 34 O-AMP-tyrosine; by Haemophilus IbpA; alternate. {ECO:0000269|PubMed:19362538}.; MOD_RES 37 37 O-AMP-threonine; by Vibrio VopS. {ECO:0000269|PubMed:19039103}.; MOD_RES 41 41 ADP-ribosylasparagine; by botulinum toxin. {ECO:0000305|PubMed:1328215}.; MOD_RES 188 188 Phosphoserine; by PKG/PRKG1. {ECO:0000269|PubMed:11162591}.; MOD_RES 190 190 Cysteine methyl ester. {ECO:0000250|UniProtKB:P62745}.,,PROPEP 191 193 Removed in mature form. /FTId=PRO_0000030412.,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X05026;L25080;AF498970;BT019870;AK222556;BX647063;BC001360;BC005976;L09159;M83094;
0,P62330,ARF6_HUMAN,ARF6,ARF6,,,,Homo sapiens (Human),9606,ADP-ribosylation factor 6,UP000005640: Chromosome 14,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGKVLSKIFGNKEMRILMLGLDAAGKTTILYKLKLGQSVTTIPTVGFNVETVTYKNVKFNVWDVGGQDKIRPLWRHYYTGTQGLIFVVDCADRDRIDEARQELHRIINDREMRDAIILIFANKQDLPDAMKPHEIQEKLGLTRIRDRNWYVQPSCATSGDGLYEGLTWLTSNYKS,175,"20,082",,,,,,,,,,,,,,,,,,,2,,0,,SIMILARITY: Belongs to the small GTPase superfamily. Arf family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: GTP-binding protein involved in protein trafficking that regulates endocytic recycling and cytoskeleton remodeling (PubMed:11266366, PubMed:21170023, PubMed:16737952, PubMed:7589240, PubMed:18400762). Required for normal completion of mitotic cytokinesis (By similarity). Plays a role in the reorganization of the actin cytoskeleton and the formation of stress fibers (By similarity). Involved in the regulation of dendritic spine development, contributing to the regulation of dendritic branching and filopodia extension (PubMed:14978216). Plays an important role in membrane trafficking, during junctional remodeling and epithelial polarization. Regulates surface levels of adherens junction proteins such as CDH1 (By similarity). Required for NTRK1 sorting to the recycling pathway from early endosomes (By similarity). {ECO:0000250|UniProtKB:P62331, ECO:0000250|UniProtKB:P62332, ECO:0000269|PubMed:11266366, ECO:0000269|PubMed:14978216, ECO:0000269|PubMed:16099990, ECO:0000269|PubMed:16737952, ECO:0000269|PubMed:18400762, ECO:0000269|PubMed:21170023, ECO:0000269|PubMed:7589240}.; FUNCTION: (Microbial infection) Functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. {ECO:0000269|PubMed:16099990}.",,,,,,,,,,"NP_BIND 23 28 GTP. {ECO:0000269|PubMed:16099990, ECO:0000269|PubMed:19644450, ECO:0000269|PubMed:21170023, ECO:0000269|PubMed:22939626, ECO:0000269|PubMed:23940353}.; NP_BIND 41 44 GTP. {ECO:0000269|PubMed:16099990, ECO:0000269|PubMed:19644450, ECO:0000269|PubMed:21170023, ECO:0000269|PubMed:22939626, ECO:0000269|PubMed:23940353}.; NP_BIND 63 67 GTP. {ECO:0000269|PubMed:16099990, ECO:0000269|PubMed:19644450, ECO:0000269|PubMed:21170023, ECO:0000269|PubMed:22939626, ECO:0000269|PubMed:23940353}.; NP_BIND 122 125 GTP. {ECO:0000269|PubMed:16099990, ECO:0000269|PubMed:19644450, ECO:0000269|PubMed:21170023, ECO:0000269|PubMed:22939626, ECO:0000269|PubMed:23940353}.; NP_BIND 155 156 GTP. {ECO:0000269|PubMed:16099990, ECO:0000269|PubMed:19644450, ECO:0000269|PubMed:21170023, ECO:0000269|PubMed:22939626, ECO:0000269|PubMed:23940353}.",,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; myeloid cell apoptotic process [GO:0033028]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of presynapse assembly [GO:1905606]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192],cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; myeloid cell apoptotic process [GO:0033028]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of presynapse assembly [GO:1905606]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996],cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726],GO:0001726; GO:0001889; GO:0003924; GO:0005525; GO:0005737; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006886; GO:0007049; GO:0007155; GO:0016020; GO:0016192; GO:0030139; GO:0030838; GO:0030866; GO:0031527; GO:0031901; GO:0031996; GO:0032154; GO:0032456; GO:0033028; GO:0034394; GO:0035020; GO:0036010; GO:0047485; GO:0048261; GO:0048488; GO:0051301; GO:0051489; GO:0051549; GO:0055038; GO:0060998; GO:0070062; GO:0090162; GO:0090543; GO:0097178; GO:0097284; GO:0098793; GO:0098978; GO:0099562; GO:1903078; GO:1903393; GO:1905606; GO:1990090; GO:2000009; GO:2000171,IPR027417; IPR005225; IPR006689; ,P53365; P21283; Q02241; O60271,"SUBUNIT: Interacts (when activated) with GGA1, GGA2 and GGA3; the interaction is required for proper subcellular location of GGA1, GGA2 and GGA3 (PubMed:11950392). Interacts with PIP5K1C (PubMed:12847086). Interacts with USP6 (via Rab-GAP TBC domain) (PubMed:15509780). Interacts with RAB11FIP3 and RAB11FIP4 (PubMed:16148947, PubMed:17030804, PubMed:17628206). Interacts with HERC1 (PubMed:15642342). Interacts with ARHGAP21 (PubMed:15793564). Interacts with ASAP3; the interaction is stabilized by calcium ions (PubMed:16737952, PubMed:20510928). Interacts with NCS1/FREQ at the plasma membrane (PubMed:17555535). Interacts with TBC1D24 (PubMed:20727515). Interacts with ECPAS (PubMed:20682791). Interacts with MICALL1 (PubMed:21951725). Interacts with SPAG9 homodimers, forming heterotetramers (PubMed:19644450). Interacts with CYTH3 (PubMed:23940353). Interacts with ASAP2 (By similarity). Interacts with UACA (By similarity). Interacts with KIF23, forming heterodimers and heterotetramers (By similarity). Interacts with C9orf72 (By similarity). {ECO:0000250|UniProtKB:P62331, ECO:0000250|UniProtKB:P62332, ECO:0000269|PubMed:11950392, ECO:0000269|PubMed:12847086, ECO:0000269|PubMed:15509780, ECO:0000269|PubMed:15642342, ECO:0000269|PubMed:15793564, ECO:0000269|PubMed:16148947, ECO:0000269|PubMed:16737952, ECO:0000269|PubMed:17030804, ECO:0000269|PubMed:17555535, ECO:0000269|PubMed:17628206, ECO:0000269|PubMed:19644450, ECO:0000269|PubMed:20510928, ECO:0000269|PubMed:20682791, ECO:0000269|PubMed:20727515, ECO:0000269|PubMed:21951725, ECO:0000269|PubMed:23940353}.; SUBUNIT: (Microbial infection) Interacts with the V.cholerae enterotoxin subunit A1; this causes a conformation change so that the toxin can bind NAD and catalyze the ADP-ribosylation of Gs alpha. {ECO:0000269|PubMed:16099990}.; SUBUNIT: (Microbial infection) Interacts with EspG from enteropathogenic E.coli. {ECO:0000269|PubMed:21170023, ECO:0000269|PubMed:22939626}.; SUBUNIT: (Microbial infection) Identified in a complex with RAB1A and EspG from enteropathogenic E.coli. {ECO:0000269|PubMed:22939626}.",1993656; 14659046; 9653160; 14702039; 15489334; 7589240; 11062263; 11950392; 12847086; 15509780; 14978216; 16148947; 15642342; 15793564; 16737952; 17030804; 17398095; 17628206; 17555535; 18400762; 20727515; 19948740; 20682791; 21269460; 21951725; 23603394; 24275569; 25255805; 25944712; 10881192; 11266366; 16099990; 16839550; 19644450; 20510928; 21170023; 22939626; 23940353,1993656; 14659046; 9653160; 14702039; 15489334; 7589240; 11062263; 11950392; 12847086; 15509780; 14978216; 16148947; 15642342; 15793564; 16737952; 17030804; 17398095; 17628206; 17555535; 18400762; 20727515; 19948740; 20682791; 21269460; 21951725; 23603394; 24275569; 25255805; 25944712; 10881192; 11266366; 16099990; 16839550; 19644450; 20510928; 21170023; 22939626; 23940353; 11516654; 11867621; 11877457; 11877461; 12016212; 12032069; 12213833; 12447393; 12526811; 12799371; 12902467; 14555962; 14581451; 14607973; 14617351; 14625293; 14675422; 15087504; 15210957; 15231847; 15590645; 15802264; 15817676; 15897187; 15916959; 16213822; 16415858; 16461286; 16484220; 16527809; 16545942; 16669702; 16707488; 16880396; 16903783; 17077126; 17157409; 17353931; 17461797; 17623778; 17640372; 17719203; 17762867; 18000860; 18084281; 18094045; 18326492; 1847920; 18597672; 18814847; 19033387; 19155310; 19211056; 19264606; 19276089; 19287005; 19327867; 19359423; 19365558; 19463016; 19642173; 19666113; 19738201; 19855388; 20018626; 20029029; 20089652; 20211604; 20385769; 20462959; 20525696; 20601426; 20709080; 20711500; 20713492; 20848231; 20945365; 21148312; 21346189; 21438025; 21439824; 21458045; 21499258; 21634118; 21664574; 21779028; 21790911; 21795701; 21858086; 22053287; 22085542; 22188517; 22219378; 22226746; 22522702; 22523074; 22580824; 22659138; 22666423; 22701712; 22781129; 22815487; 22863004; 22907437; 22916275; 22931251; 22962618; 23095975; 23264734; 23295182; 23416715; 23462101; 23555901; 23621612; 23752192; 23950892; 24085844; 24130457; 24139303; 24392021; 24407288; 24581425; 24637612; 24835390; 24902879; 24916416; 25114232; 25253741; 25296758; 25326380; 25713146; 25736891; 25773595; 25779663; 25799492; 26170135; 26372645; 26379158; 26403691; 26503427; 26884337; 27031991; 27044754; 27044891; 27061682; 27265506; 27269287; 27698019; 27754741; 27871329; 28025100; 28495929; 28584192; 28780751; 28870903; 29119258; 29237817; 29276036; 29388044; 29992963; 9312003,2004-07-05,2019-02-13,2007-01-23,169,X-ray crystallography (12); NMR spectroscopy (2); Electron microscopy (2),STRAND 13 19 {ECO:0000244|PDB:2A5D}.; STRAND 39 44 {ECO:0000244|PDB:1E0S}.; STRAND 45 54 {ECO:0000244|PDB:2A5D}.; STRAND 57 64 {ECO:0000244|PDB:2A5D}.; STRAND 83 89 {ECO:0000244|PDB:2A5D}.; STRAND 116 122 {ECO:0000244|PDB:2A5D}.; STRAND 125 128 {ECO:0000244|PDB:3LVQ}.; STRAND 149 153 {ECO:0000244|PDB:2A5D}.,HELIX 3 9 {ECO:0000244|PDB:1E0S}.; HELIX 26 35 {ECO:0000244|PDB:2A5D}.; HELIX 65 67 {ECO:0000244|PDB:3N5C}.; HELIX 68 77 {ECO:0000244|PDB:2A5D}.; HELIX 93 95 {ECO:0000244|PDB:2A5D}.; HELIX 96 107 {ECO:0000244|PDB:2A5D}.; HELIX 110 112 {ECO:0000244|PDB:2A5D}.; HELIX 132 138 {ECO:0000244|PDB:2A5D}.; HELIX 141 143 {ECO:0000244|PDB:2A5D}.; HELIX 162 172 {ECO:0000244|PDB:2A5D}.,TURN 78 80 {ECO:0000244|PDB:1E0S}.; TURN 156 159 {ECO:0000244|PDB:2A5D}.,,,,,5 out of 5,Beta strand (8); Chain (1); Helix (10); Initiator methionine (1); Lipidation (1); Mutagenesis (3); Nucleotide binding (5); Turn (2),,"TISSUE SPECIFICITY: Ubiquitous, with higher levels in heart, substantia nigra, and kidney. {ECO:0000269|PubMed:14659046}.",,3D-structure;Cell cycle;Cell division;Cell membrane;Cell projection;Complete proteome;Cytoplasm;Differentiation;Endosome;GTP-binding;Golgi apparatus;Lipoprotein;Membrane;Myristate;Neurogenesis;Nucleotide-binding;Protein transport;Reference proteome;Transport,Evidence at protein level,reviewed,,"Small GTPase superfamily, Arf family",169,Activity regulation (1); Function (2); Sequence similarities (1); Subcellular location (1); Subunit structure (4); Tissue specificity (1),,KW-0002; KW-0131; KW-0132; KW-0181; KW-0221; KW-0333; KW-0342; KW-0449; KW-0472; KW-0519; KW-0524; KW-0547; KW-0653; KW-0813; KW-0963; KW-0966; KW-0967; KW-1003; KW-1185,,,,,,,,,CHAIN 2 175 ADP-ribosylation factor 6. /FTId=PRO_0000207400.,,,,INIT_MET 1 1 Removed. {ECO:0000269|PubMed:25255805}.,"LIPID 2 2 N-myristoyl glycine. {ECO:0000269|PubMed:25255805, ECO:0000269|PubMed:7589240}.",,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M57763;AY296206;AF047432;AF493885;AK313790;CR541964;CH471078;BC008918;
0,P62491,RB11A_HUMAN,RAB11A RAB11,RAB11A,RAB11,,,Homo sapiens (Human),9606,Ras-related protein Rab-11A (Rab-11) (YL8),UP000005640: Chromosome 15,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGTRDDEYDYLFKVVLIGDSGVGKSNLLSRFTRNEFNLESKSTIGVEFATRSIQVDGKTIKAQIWDTAGQERYRAITSAYYRGAVGALLVYDIAKHLTYENVERWLKELRDHADSNIVIMLVGNKSDLRHLRAVPTDEARAFAEKNGLSFIETSALDSTNVEAAFQTILTEIYRIVSQKQMSDRRENDMSPSNNVVPIHVPPTTENKPKVQCCQNI,216,"24,394",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=P62491-1; Sequence=Displayed; Name=2; IsoId=P62491-2; Sequence=VSP_046755; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 147 216 GLSFIETSALDSTNVEAAFQTILTEIYRIVSQKQMSDRRENDMSPSNNVVPIHVPPTTENKPKVQCCQNI -> EANVRQTRK (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_046755.,,,,,,,3,,0,,SIMILARITY: Belongs to the small GTPase superfamily. Rab family. {ECO:0000305}.,,,,MOTIF 40 48 Effector region. {ECO:0000250}.,,,,,,,,,"FUNCTION: The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different set of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. That Rab regulates endocytic recycling. Acts as a major regulator of membrane delivery during cytokinesis. Together with MYO5B and RAB8A participates in epithelial cell polarization. Together with RAB3IP, RAB8A, the exocyst complex, PARD3, PRKCI, ANXA2, CDC42 and DNMBP promotes transcytosis of PODXL to the apical membrane initiation sites (AMIS), apical surface formation and lumenogenesis. Together with MYO5B participates in CFTR trafficking to the plasma membrane and TF (Transferrin) recycling in nonpolarized cells. Required in a complex with MYO5B and RAB11FIP2 for the transport of NPC1L1 to the plasma membrane. Participates in the sorting and basolateral transport of CDH1 from the Golgi apparatus to the plasma membrane. Regulates the recycling of FCGRT (receptor of Fc region of monomeric Ig G) to basolateral membranes. May also play a role in melanosome transport and release from melanocytes. {ECO:0000269|PubMed:15601896, ECO:0000269|PubMed:15689490, ECO:0000269|PubMed:17462998, ECO:0000269|PubMed:19542231, ECO:0000269|PubMed:20890297, ECO:0000269|PubMed:21282656}.",,,,,,,,,,"NP_BIND 18 26 GTP. {ECO:0000244|PDB:2D7C, ECO:0000244|PDB:2GZD, ECO:0000244|PDB:2GZH, ECO:0000244|PDB:2HV8, ECO:0000244|PDB:5EZ5, ECO:0000269|PubMed:16905101, ECO:0000269|PubMed:17007872, ECO:0000269|PubMed:17030804}.; NP_BIND 37 43 GTP. {ECO:0000244|PDB:2D7C, ECO:0000244|PDB:2GZD, ECO:0000244|PDB:2GZH, ECO:0000244|PDB:2HV8, ECO:0000244|PDB:5EZ5}.; NP_BIND 66 70 GTP. {ECO:0000244|PDB:1OIW, ECO:0000244|PDB:4D0L, ECO:0000244|PDB:4D0M, ECO:0000244|PDB:5C46, ECO:0000244|PDB:5FBL, ECO:0000269|PubMed:16905101, ECO:0000269|PubMed:17007872, ECO:0000269|PubMed:17030804}.; NP_BIND 124 127 GTP. {ECO:0000244|PDB:2D7C, ECO:0000244|PDB:2GZD, ECO:0000244|PDB:2GZH, ECO:0000244|PDB:2HV8, ECO:0000244|PDB:5EZ5, ECO:0000269|PubMed:16905101, ECO:0000269|PubMed:17007872, ECO:0000269|PubMed:17030804}.; NP_BIND 154 156 GTP. {ECO:0000244|PDB:2D7C, ECO:0000244|PDB:2GZD, ECO:0000244|PDB:2GZH, ECO:0000244|PDB:2HV8, ECO:0000244|PDB:5EZ5, ECO:0000269|PubMed:16905101, ECO:0000269|PubMed:17007872, ECO:0000269|PubMed:17030804}.",,"axon [GO:0030424]; cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; syntaxin binding [GO:0019905]; amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of protein localization to membrane [GO:0090150]; establishment of protein localization to organelle [GO:0072594]; establishment of vesicle localization [GO:0051650]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; plasma membrane to endosome transport [GO:0048227]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein localization to plasma membrane [GO:1903078]; post-translational protein modification [GO:0043687]; protein localization to plasma membrane [GO:0072659]; Rab protein signal transduction [GO:0032482]; regulation of cytokinesis [GO:0032465]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of multivesicular body size [GO:0010796]; regulation of protein transport [GO:0051223]; regulation of vesicle-mediated transport [GO:0060627]; renal water homeostasis [GO:0003091]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]","amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of protein localization to membrane [GO:0090150]; establishment of protein localization to organelle [GO:0072594]; establishment of vesicle localization [GO:0051650]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; plasma membrane to endosome transport [GO:0048227]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein localization to plasma membrane [GO:1903078]; post-translational protein modification [GO:0043687]; protein localization to plasma membrane [GO:0072659]; Rab protein signal transduction [GO:0032482]; regulation of cytokinesis [GO:0032465]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of multivesicular body size [GO:0010796]; regulation of protein transport [GO:0051223]; regulation of vesicle-mediated transport [GO:0060627]; renal water homeostasis [GO:0003091]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]",GTPase activity [GO:0003924]; GTP binding [GO:0005525]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; syntaxin binding [GO:0019905],axon [GO:0030424]; cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; vesicle [GO:0031982],GO:0000922; GO:0003091; GO:0003924; GO:0005525; GO:0005768; GO:0005771; GO:0005794; GO:0005802; GO:0005815; GO:0005829; GO:0006886; GO:0006887; GO:0007080; GO:0008017; GO:0010634; GO:0010796; GO:0010971; GO:0016192; GO:0019905; GO:0030133; GO:0030424; GO:0030659; GO:0030953; GO:0031175; GO:0031410; GO:0031489; GO:0031982; GO:0032154; GO:0032402; GO:0032465; GO:0032482; GO:0032991; GO:0036258; GO:0043231; GO:0043687; GO:0045335; GO:0045773; GO:0048169; GO:0048227; GO:0048471; GO:0051223; GO:0051650; GO:0055037; GO:0055038; GO:0060627; GO:0070062; GO:0072594; GO:0072659; GO:0090150; GO:0090307; GO:0097711; GO:0098685; GO:0098837; GO:0098887; GO:0098978; GO:0099003; GO:0150093; GO:1903078; GO:1990182,IPR027417; IPR005225; IPR001806; ,Q7LBR1; O60447; Q9UBF8-2; Q7L804; O75154-1; Q86YS3-1; Q9BXF6; Q96QF0-2; P46937; Q5T4F4,"SUBUNIT: Interacts with RIP11 and STXBP6. Interacts with SGSM1, SGSM2 and SGSM3 (By similarity). Interacts with EXOC6 in a GTP-dependent manner (By similarity). Interacts with RAB11FIP1, RAB11FIP2, RAB11FIP3 (via its C-terminus) and RAB11FIP4. Interacts with EVI5; EVI5 and RAB11FIP3 may be mutually exclusive and compete for binding RAB11A. Interacts with VIPAS39. Interacts with MYO5B. Found in a complex with MYO5B and CFTR. Interacts with NPC1L1. Interacts (GDP-bound form) with ZFYVE27 (PubMed:21976701, PubMed:17082457). Interacts with BIRC6/bruce. May interact with TBC1D14. Interacts with UNC119; in a cell cycle-dependent manner. GDP-bound and nucleotide-free forms interact with SH3BP5 (PubMed:26506309, PubMed:30217979). Interacts (GDP-bound form) with KIF5A in a ZFYVE27-dependent manner (PubMed:21976701). Interacts (GDP-bound form) with RELCH (By similarity). Found in a complex composed of RELCH, OSBP1 and RAB11A (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:P62492, ECO:0000269|PubMed:11495908, ECO:0000269|PubMed:11786538, ECO:0000269|PubMed:12470645, ECO:0000269|PubMed:15173169, ECO:0000269|PubMed:15181150, ECO:0000269|PubMed:15280022, ECO:0000269|PubMed:15601896, ECO:0000269|PubMed:15837192, ECO:0000269|PubMed:16034420, ECO:0000269|PubMed:16148947, ECO:0000269|PubMed:16905101, ECO:0000269|PubMed:17007872, ECO:0000269|PubMed:17030804, ECO:0000269|PubMed:17082457, ECO:0000269|PubMed:17229837, ECO:0000269|PubMed:17462998, ECO:0000269|PubMed:18329369, ECO:0000269|PubMed:19542231, ECO:0000269|PubMed:20190753, ECO:0000269|PubMed:21282656, ECO:0000269|PubMed:21976701, ECO:0000269|PubMed:22613832, ECO:0000269|PubMed:23535298, ECO:0000269|PubMed:26506309, ECO:0000269|PubMed:30217979}.",1704119; 9662449; 14702039; 16572171; 15489334; 11495908; 12470645; 11786538; 11994279; 15280022; 15173169; 15304524; 15181150; 16148947; 15601896; 15689490; 17082457; 17462998; 17229837; 18329369; 19542231; 20890297; 20190753; 21269460; 21976701; 21282656; 21255211; 22613832; 23535298; 24023390; 26506309; 25944712; 29514919; 16034420; 15837192; 17007872; 17030804; 16905101; 30217979,1704119; 9662449; 14702039; 16572171; 15489334; 11495908; 12470645; 11786538; 11994279; 15280022; 15173169; 15304524; 15181150; 16148947; 15601896; 15689490; 17082457; 17462998; 17229837; 18329369; 19542231; 20890297; 20190753; 21269460; 21976701; 21282656; 21255211; 22613832; 23535298; 24023390; 26506309; 25944712; 29514919; 16034420; 15837192; 17007872; 17030804; 16905101; 30217979; 11076974; 11141079; 11389151; 11675392; 12194985; 12221131; 12687004; 14699104; 15158452; 15188492; 15190120; 15550383; 16120822; 16126723; 16155582; 16189514; 16214890; 16431365; 16473307; 1648736; 16525015; 16730941; 16890161; 16962593; 17043677; 17114793; 17156409; 17157409; 17353931; 17411337; 17426287; 17476295; 17538027; 17540176; 17574030; 17628206; 17646400; 17765682; 17854769; 18511905; 18532927; 18550774; 18685082; 18701709; 18801063; 18843107; 19017632; 19081074; 19153612; 19193894; 19297529; 19367725; 19454479; 19463016; 19603039; 19641023; 19752198; 19797056; 19996123; 20026645; 20083215; 20308558; 20357086; 20399632; 20711500; 20727405; 20877624; 20933442; 21273506; 21307188; 21525351; 21550243; 21565611; 21586748; 21911578; 21988832; 22188018; 22303009; 22304920; 22420621; 22420646; 22433857; 22537031; 22593156; 22653444; 22685325; 22981775; 22983554; 23176490; 23253480; 23283983; 23351793; 23454239; 23567335; 23621612; 23640058; 23733193; 24056041; 24163434; 24190883; 24248336; 24296415; 24302731; 24413175; 24591568; 24876499; 24892806; 24962317; 25092884; 25117932; 25299335; 25341920; 25446083; 25556234; 25673875; 25814554; 26041286; 26258637; 26378159; 26399276; 26496610; 26635365; 26637356; 26663395; 26756197; 26879265; 26885694; 26941330; 27154205; 27623148; 27696383; 27875067; 28724771; 28739266; 28922401; 28939769; 29123131; 7957092; 7991565; 8164745; 8349690; 8375503; 8513495; 8631982; 8662963; 8683474; 8836150; 9227644,2004-07-19,2019-02-13,2007-01-23,177,X-ray crystallography (27),STRAND 9 18 {ECO:0000244|PDB:1OIX}.; STRAND 34 38 {ECO:0000244|PDB:6DJL}.; STRAND 45 55 {ECO:0000244|PDB:1OIX}.; STRAND 58 67 {ECO:0000244|PDB:1OIX}.; STRAND 72 74 {ECO:0000244|PDB:1OIX}.; STRAND 86 92 {ECO:0000244|PDB:1OIX}.; STRAND 118 124 {ECO:0000244|PDB:1OIX}.; STRAND 149 152 {ECO:0000244|PDB:1OIX}.,HELIX 20 22 {ECO:0000244|PDB:6DJL}.; HELIX 24 33 {ECO:0000244|PDB:1OIX}.; HELIX 78 81 {ECO:0000244|PDB:1OIX}.; HELIX 96 100 {ECO:0000244|PDB:1OIX}.; HELIX 102 112 {ECO:0000244|PDB:1OIX}.; HELIX 126 131 {ECO:0000244|PDB:1OIX}.; HELIX 136 145 {ECO:0000244|PDB:1OIX}.; HELIX 161 172 {ECO:0000244|PDB:1OIX}.,TURN 41 44 {ECO:0000244|PDB:6DJL}.; TURN 155 157 {ECO:0000244|PDB:1OIX}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (8); Chain (1); Helix (8); Initiator methionine (1); Lipidation (2); Modified residue (2); Motif (1); Mutagenesis (14); Nucleotide binding (5); Propeptide (1); Turn (2),,,,3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell membrane;Complete proteome;Cytoplasmic vesicle;Direct protein sequencing;Endosome;GTP-binding;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Prenylation;Protein transport;Reference proteome;Transport,Evidence at protein level,reviewed,,"Small GTPase superfamily, Rab family",177,Alternative products (1); Caution (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0025; KW-0131; KW-0181; KW-0342; KW-0449; KW-0472; KW-0488; KW-0547; KW-0636; KW-0653; KW-0813; KW-0903; KW-0967; KW-0968; KW-1003; KW-1185,,,,,,,,,CHAIN 2 213 Ras-related protein Rab-11A. /FTId=PRO_0000121151.,,,,INIT_MET 1 1 Removed. {ECO:0000269|Ref.11}.,LIPID 212 212 S-geranylgeranyl cysteine. {ECO:0000269|PubMed:24023390}.; LIPID 213 213 S-geranylgeranyl cysteine. {ECO:0000269|PubMed:24023390}.,MOD_RES 2 2 N-acetylglycine. {ECO:0000269|Ref.11}.; MOD_RES 213 213 Cysteine methyl ester. {ECO:0000255}.,,PROPEP 214 216 Removed in mature form. {ECO:0000255}. /FTId=PRO_0000370807.,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X53143;X56740;AF000231;AF498946;CR407669;CR536493;BT020151;BT020154;AK300008;AK311770;CH471082;BC013348;
0,P62745,RHOB_HUMAN,RHOB ARH6 ARHB,RHOB,ARH6 ARHB,,,Homo sapiens (Human),9606,Rho-related GTP-binding protein RhoB (Rho cDNA clone 6) (h6),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAAIRKKLVVVGDGACGKTCLLIVFSKDEFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQEDYDRLRPLSYPDTDVILMCFSVDSPDSLENIPEKWVPEVKHFCPNVPIILVANKKDLRSDEHVRTELARMKQEPVRTDDGRAMAVRIQAYDYLECSAKTKEGVREVFETATRAALQKRYGSQNGCINCCKVL,196,"22,123",,,,,,,,,,,,,,,,,,,1,,0,,SIMILARITY: Belongs to the small GTPase superfamily. Rho family. {ECO:0000305}.,,,,MOTIF 34 42 Effector region. {ECO:0000255}.,,,,,,,,,"FUNCTION: Mediates apoptosis in neoplastically transformed cells after DNA damage. Not essential for development but affects cell adhesion and growth factor signaling in transformed cells. Plays a negative role in tumorigenesis as deletion causes tumor formation. Involved in intracellular protein trafficking of a number of proteins. Targets PKN1 to endosomes and is involved in trafficking of the EGF receptor from late endosomes to lysosomes. Also required for stability and nuclear trafficking of AKT1/AKT which promotes endothelial cell survival during vascular development. Serves as a microtubule-dependent signal that is required for the myosin contractile ring formation during cell cycle cytokinesis. Required for genotoxic stress-induced cell death in breast cancer cells. {ECO:0000269|PubMed:10508588, ECO:0000269|PubMed:15226397, ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:21373644, ECO:0000269|PubMed:9478917}.",,,,,,,,,,NP_BIND 12 19 GTP. {ECO:0000250}.; NP_BIND 59 63 GTP. {ECO:0000250}.; NP_BIND 117 120 GTP. {ECO:0000250}.,,cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; endosome to lysosome transport [GO:0008333]; endothelial tube morphogenesis [GO:0061154]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; endosome to lysosome transport [GO:0008333]; endothelial tube morphogenesis [GO:0061154]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901],cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; plasma membrane [GO:0005886],GO:0000281; GO:0001525; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006886; GO:0006915; GO:0007015; GO:0007155; GO:0007186; GO:0007266; GO:0008333; GO:0008360; GO:0010008; GO:0010595; GO:0016477; GO:0019003; GO:0019901; GO:0030154; GO:0030334; GO:0030336; GO:0030950; GO:0031902; GO:0032153; GO:0032154; GO:0032956; GO:0043065; GO:0043231; GO:0045766; GO:0045786; GO:0051017; GO:0051056; GO:0061154; GO:0070062; GO:0070301; GO:0071479,IPR027417; IPR005225; IPR001806; IPR003578; ,Q9HCE7-2; Q13829,"SUBUNIT: Binds ROCK1 and ROCK2 (By similarity). Also binds PKN1/PRK1 (PubMed:9478917). Interacts with ARGGEF3 (PubMed:12221096). Interacts with RTKN (By similarity). Interacts with AKAP13 (PubMed:11546812). Interacts with RIPOR1 (PubMed:27807006). {ECO:0000250|UniProtKB:P62746, ECO:0000250|UniProtKB:P62747, ECO:0000269|PubMed:11546812, ECO:0000269|PubMed:12221096, ECO:0000269|PubMed:27807006, ECO:0000269|PubMed:9478917}.",3283705; 14702039; 15815621; 15489334; 3888408; 9478917; 10508588; 15226397; 7537292; 1400319; 7713879; 11546812; 12221096; 16236794; 21269460; 21373644; 24141704; 27807006,3283705; 14702039; 15815621; 15489334; 3888408; 9478917; 10508588; 15226397; 7537292; 1400319; 7713879; 11546812; 12221096; 16236794; 21269460; 21373644; 24141704; 27807006; 10360578; 10559246; 10619026; 10652353; 10655614; 10676816; 10753910; 10873388; 10913192; 11018042; 11130076; 11157984; 11283606; 11294240; 11331307; 11353846; 11431473; 11738596; 11741970; 11788600; 11804589; 11905808; 11942626; 12101119; 12185584; 12220504; 12423633; 12429845; 12471028; 12473120; 12504591; 12730235; 12783890; 12802051; 12878865; 12939257; 13679859; 1439791; 14514689; 14647415; 14722096; 15102679; 15210733; 15260990; 15292224; 15451670; 15574879; 15611088; 15642170; 15699075; 15713677; 15767687; 15821030; 15921909; 15944396; 16202622; 16212495; 16219803; 16278215; 16431929; 16642435; 17046241; 17054945; 17096327; 17151359; 17198702; 17222083; 17304710; 17405813; 18006505; 18047684; 18056259; 18212741; 18218625; 18464290; 18471322; 18524772; 18589439; 18590726; 18694745; 19208833; 19463016; 19477269; 19637314; 19723632; 19782069; 19889053; 19911011; 19995557; 19997872; 20237151; 20460403; 20473933; 20717930; 20810568; 21347332; 21351730; 21565167; 22092654; 22227305; 22366462; 22539766; 22673745; 22724071; 22896740; 22992742; 23135917; 23339407; 23420497; 23444367; 23488932; 23583411; 23716662; 23792460; 24086429; 24128008; 24223801; 24321314; 24636898; 24984542; 25207810; 25216671; 25249323; 25320360; 25454559; 25486363; 25540389; 25630770; 26148238; 26496610; 26741994; 26759237; 27121468; 27138256; 27147504; 27210746; 27324125; 27384222; 27503856; 27832197; 28212429; 2825022; 29233918; 29474434; 29500478; 29660302; 2966156; 30297842; 3839510; 7478592; 7543319; 7954831; 8276860; 8288572; 8543060; 8617235; 8662509; 8662891; 8702756; 8810315; 8816443; 8969170; 8990121; 9113980; 9194563; 9308960; 9354661; 9605766; 9792683; 9857026; 9870942; 9870943; 9988689,1986-07-21,2019-02-13,1988-08-01,168,X-ray crystallography (1),STRAND 4 12 {ECO:0000244|PDB:2FV8}.; STRAND 41 48 {ECO:0000244|PDB:2FV8}.; STRAND 51 59 {ECO:0000244|PDB:2FV8}.; STRAND 79 85 {ECO:0000244|PDB:2FV8}.; STRAND 112 117 {ECO:0000244|PDB:2FV8}.; STRAND 154 158 {ECO:0000244|PDB:2FV8}.,HELIX 18 27 {ECO:0000244|PDB:2FV8}.; HELIX 70 73 {ECO:0000244|PDB:2FV8}.; HELIX 89 97 {ECO:0000244|PDB:2FV8}.; HELIX 99 106 {ECO:0000244|PDB:2FV8}.; HELIX 119 123 {ECO:0000244|PDB:2FV8}.; HELIX 125 133 {ECO:0000244|PDB:2FV8}.; HELIX 141 150 {ECO:0000244|PDB:2FV8}.; HELIX 167 179 {ECO:0000244|PDB:2FV8}.,TURN 67 69 {ECO:0000244|PDB:2FV8}.; TURN 161 163 {ECO:0000244|PDB:2FV8}.,,,,,5 out of 5,Beta strand (6); Chain (1); Glycosylation (1); Helix (8); Lipidation (4); Modified residue (3); Motif (1); Mutagenesis (6); Nucleotide binding (3); Propeptide (1); Turn (2),,,"MISCELLANEOUS: RHOB is one of the targets of farnesyltransferase inhibitors which are currently under investigation as cancer therapeutics. These elevate the levels of geranylgeranylated RHOB and cause mislocalization, leading to apoptosis and antineoplastic effects.",3D-structure;ADP-ribosylation;Angiogenesis;Apoptosis;Cell adhesion;Cell membrane;Complete proteome;Developmental protein;Differentiation;Direct protein sequencing;Endosome;GTP-binding;Glycoprotein;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Nucleus;Palmitate;Phosphoprotein;Prenylation;Protein transport;Reference proteome;Transport;Tumor suppressor,Evidence at protein level,reviewed,,"Small GTPase superfamily, Rho family",168,Function (1); Induction (1); Miscellaneous (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0013; KW-0037; KW-0043; KW-0053; KW-0130; KW-0181; KW-0217; KW-0221; KW-0325; KW-0342; KW-0449; KW-0472; KW-0488; KW-0539; KW-0547; KW-0564; KW-0597; KW-0636; KW-0653; KW-0813; KW-0903; KW-0967; KW-1003; KW-1185,,,,,,,,"PTM: Prenylation specifies the subcellular location of RHOB. The farnesylated form is localized to the plasma membrane while the geranylgeranylated form is localized to the endosome. {ECO:0000269|PubMed:1400319, ECO:0000269|PubMed:7713879}.; PTM: (Microbial infection) Glycosylated at Tyr-34 by Photorhabdus asymbiotica toxin PAU_02230. Mono-O-GlcNAcylation by PAU_02230 inhibits downstream signaling by an impaired interaction with diverse regulator and effector proteins of Rho and leads to actin disassembly. {ECO:0000269|PubMed:24141704}.",CHAIN 1 193 Rho-related GTP-binding protein RhoB. /FTId=PRO_0000030417.,,,CARBOHYD 34 34 O-linked (GlcNAc) tyrosine; by Photorhabdus PAU_02230. {ECO:0000269|PubMed:24141704}.,,"LIPID 189 189 S-palmitoyl cysteine. {ECO:0000269|PubMed:1400319}.; LIPID 192 192 S-palmitoyl cysteine. {ECO:0000269|PubMed:1400319}.; LIPID 193 193 S-farnesyl cysteine; in plasma membrane form. {ECO:0000269|PubMed:1400319, ECO:0000269|PubMed:7713879}.; LIPID 193 193 S-geranylgeranyl cysteine; in endosomal form. {ECO:0000269|PubMed:1400319, ECO:0000269|PubMed:7713879}.",MOD_RES 41 41 ADP-ribosylasparagine; by botulinum toxin. {ECO:0000250}.; MOD_RES 154 154 Phosphotyrosine. {ECO:0000250|UniProtKB:P62746}.; MOD_RES 193 193 Cysteine methyl ester. {ECO:0000269|PubMed:1400319}.,,PROPEP 194 196 Removed in mature form. /FTId=PRO_0000030418.,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X06820;AF498971;CR542272;AK124398;AK312487;BT019546;BT019547;AC023137;CH471053;CH471053;BC066954;M12174;BK001232;BK001671;
0,P63244,RACK1_HUMAN,RACK1 GNB2L1 HLC7 PIG21,RACK1,GNB2L1,,HLC7 PIG21,Homo sapiens (Human),9606,"Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]",UP000005640: Chromosome 5,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MTEQMTLRGTLKGHNGWVTQIATTPQFPDMILSASRDKTIIMWKLTRDETNYGIPQRALRGHSHFVSDVVISSDGQFALSGSWDGTLRLWDLTTGTTTRRFVGHTKDVLSVAFSSDNRQIVSGSRDKTIKLWNTLGVCKYTVQDESHSEWVSCVRFSPNSSNPIIVSCGWDKLVKVWNLANCKLKTNHIGHTGYLNTVTVSPDGSLCASGGKDGQAMLWDLNEGKHLYTLDGGDIINALCFSPNRYWLCAATGPSIKIWDLEGKIIVDELKQEVISTSSKAEPPQCTSLAWSADGQTLFAGYTDNLVRVWQVTIGTR,317,"35,077",,,,SEQUENCE CAUTION:  Sequence=AAO21313.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,SEQUENCE CAUTION:  Sequence=AAR24619.1; Type=Frameshift; Positions=94; Evidence={ECO:0000305}; ,,,,,,,,,,CONFLICT 70 111 Missing (in Ref. 4; BAG53102). {ECO:0000305}.; CONFLICT 94 94 T -> TRK (in Ref. 3; AAR24619). {ECO:0000305}.; CONFLICT 221 221 L -> F (in Ref. 6; BAD96208). {ECO:0000305}.,,3,,0,DOMAIN: The 7 WD repeats mediate protein-protein interactions with binding partners. {ECO:0000269|PubMed:15140893}.,SIMILARITY: Belongs to the WD repeat G protein beta family. Ribosomal protein RACK1 subfamily. {ECO:0000305}.,,,,,,REPEAT 13 44 WD 1.; REPEAT 61 91 WD 2.; REPEAT 103 133 WD 3.; REPEAT 146 178 WD 4.; REPEAT 190 220 WD 5.; REPEAT 231 260 WD 6.; REPEAT 281 311 WD 7.,,,,,,,"FUNCTION: Scaffolding protein involved in the recruitment, assembly and/or regulation of a variety of signaling molecules. Interacts with a wide variety of proteins and plays a role in many cellular processes. Component of the 40S ribosomal subunit involved in translational repression (PubMed:23636399). Involved in the initiation of the ribosome quality control (RQC), a pathway that takes place when a ribosome has stalled during translation, by promoting ubiquitination of a subset of 40S ribosomal subunits (PubMed:28132843). Binds to and stabilizes activated protein kinase C (PKC), increasing PKC-mediated phosphorylation. May recruit activated PKC to the ribosome, leading to phosphorylation of EIF6. Inhibits the activity of SRC kinases including SRC, LCK and YES1. Inhibits cell growth by prolonging the G0/G1 phase of the cell cycle. Enhances phosphorylation of BMAL1 by PRKCA and inhibits transcriptional activity of the BMAL1-CLOCK heterodimer. Facilitates ligand-independent nuclear translocation of AR following PKC activation, represses AR transactivation activity and is required for phosphorylation of AR by SRC. Modulates IGF1R-dependent integrin signaling and promotes cell spreading and contact with the extracellular matrix. Involved in PKC-dependent translocation of ADAM12 to the cell membrane. Promotes the ubiquitination and proteasome-mediated degradation of proteins such as CLEC1B and HIF1A. Required for VANGL2 membrane localization, inhibits Wnt signaling, and regulates cellular polarization and oriented cell division during gastrulation. Required for PTK2/FAK1 phosphorylation and dephosphorylation. Regulates internalization of the muscarinic receptor CHRM2. Promotes apoptosis by increasing oligomerization of BAX and disrupting the interaction of BAX with the anti-apoptotic factor BCL2L. Inhibits TRPM6 channel activity. Regulates cell surface expression of some GPCRs such as TBXA2R. Plays a role in regulation of FLT1-mediated cell migration. Involved in the transport of ABCB4 from the Golgi to the apical bile canalicular membrane (PubMed:19674157). Promotes migration of breast carcinoma cells by binding to and activating RHOA (PubMed:20499158). {ECO:0000269|PubMed:11884618, ECO:0000269|PubMed:12589061, ECO:0000269|PubMed:12958311, ECO:0000269|PubMed:17108144, ECO:0000269|PubMed:17244529, ECO:0000269|PubMed:17956333, ECO:0000269|PubMed:18088317, ECO:0000269|PubMed:18258429, ECO:0000269|PubMed:18621736, ECO:0000269|PubMed:19423701, ECO:0000269|PubMed:19674157, ECO:0000269|PubMed:19785988, ECO:0000269|PubMed:20499158, ECO:0000269|PubMed:20541605, ECO:0000269|PubMed:20573744, ECO:0000269|PubMed:20976005, ECO:0000269|PubMed:21212275, ECO:0000269|PubMed:21347310, ECO:0000269|PubMed:23636399, ECO:0000269|PubMed:28132843, ECO:0000269|PubMed:9584165}.; FUNCTION: (Microbial infection) Binds to Y.pseudotuberculosis yopK which leads to inhibition of phagocytosis and survival of bacteria following infection of host cells. {ECO:0000269|PubMed:21347310}.; FUNCTION: (Microbial infection) Enhances phosphorylation of HIV-1 Nef by PKCs. {ECO:0000269|PubMed:11312657}.; FUNCTION: (Microbial infection) In case of poxvirus infection, remodels the ribosomes so that they become optimal for the viral mRNAs (containing poly-A leaders) translation but not for host mRNAs. {ECO:0000269|PubMed:28636603}.; FUNCTION: (Microbial infection) Contributes to the cap-independent internal ribosome entry site (IRES)-mediated translation by some RNA viruses. {ECO:0000269|PubMed:25416947}.",,,,,,,,,,,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; IRE1-RACK1-PP2A complex [GO:1990630]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935]; cadherin binding [GO:0045296]; cyclin binding [GO:0030332]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; enzyme binding [GO:0019899]; ion channel inhibitor activity [GO:0008200]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase inhibitor activity [GO:0030292]; protein-containing complex scaffold activity [GO:0032947]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell cycle [GO:0007049]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]; viral process [GO:0016032],activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell cycle [GO:0007049]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]; viral process [GO:0016032],cadherin binding [GO:0045296]; cyclin binding [GO:0030332]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; enzyme binding [GO:0019899]; ion channel inhibitor activity [GO:0008200]; protein-containing complex scaffold activity [GO:0032947]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; IRE1-RACK1-PP2A complex [GO:1990630]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935],GO:0001891; GO:0001934; GO:0003723; GO:0005080; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006919; GO:0007049; GO:0007369; GO:0008200; GO:0008656; GO:0010629; GO:0010803; GO:0015935; GO:0016032; GO:0016567; GO:0017148; GO:0019899; GO:0019903; GO:0022627; GO:0030178; GO:0030292; GO:0030308; GO:0030332; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0032436; GO:0032464; GO:0032880; GO:0032947; GO:0033137; GO:0035591; GO:0042169; GO:0042803; GO:0042998; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043473; GO:0043547; GO:0045296; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051343; GO:0051726; GO:0051898; GO:0051901; GO:0070062; GO:0071333; GO:0071363; GO:0072344; GO:1900102; GO:1903208; GO:1990630; GO:2000114; GO:2000304; GO:2000543; GO:2001244,IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; IPR036322; ,P22303; P35609; Q9UKV8; O43521; O54918-1; P03206; P63167; O75530; P48551; Q0VD86; Q92615; Q9Y561; P07948; Q9NWQ8; Q99497; O75928; Q08752; P40337,"SUBUNIT: Monomer; also forms homodimers and homooligomers (PubMed:20529362, PubMed:15140893). Interacts with CPNE3 (PubMed:20010870). May interact with ABCB4 (PubMed:19674157). Component of the small (40S) ribosomal subunit (By similarity). Interacts with the 80S ribosome (PubMed:23636399). Binds SLC9A3R1. Forms a ternary complex with TRIM63 and PRKCE. Interacts with HABP4, KRT1 and OTUB1. Interacts with SRC (via SH2 domain); the interaction is enhanced by tyrosine phosphorylation of RACK1. Recruited in a circadian manner into a nuclear complex which also includes BMAL1 and PRKCA. Interacts with AR. Interacts with IGF1R but not with INSR. Interacts with ADAM12. Interacts with CLEC1B (via N-terminal region) and with HIF1A; the interaction promotes their degradation. Interacts with RHOA; this enhances RHOA activation and promotes cell migration. Interacts with CHRM2; the interaction regulates CHRM2 internalization. Interacts with TRPM6 (via kinase domain). Interacts with PTK2/FAK1; required for PTK2/FAK1 phosphorylation and dephosphorylation. Interacts with FLT1. Interacts with TBXA2R isoform 2. Interacts with HRAS. Interacts with LARP4B. Interacts with LARP4 (PubMed:21098120). Interacts with PKD2L1. {ECO:0000250, ECO:0000269|PubMed:11279199, ECO:0000269|PubMed:11884618, ECO:0000269|PubMed:11956211, ECO:0000269|PubMed:12958311, ECO:0000269|PubMed:14500341, ECO:0000269|PubMed:14699138, ECO:0000269|PubMed:15596539, ECO:0000269|PubMed:17108144, ECO:0000269|PubMed:17244529, ECO:0000269|PubMed:17956333, ECO:0000269|PubMed:18088317, ECO:0000269|PubMed:18258429, ECO:0000269|PubMed:18621736, ECO:0000269|PubMed:18954305, ECO:0000269|PubMed:19423701, ECO:0000269|PubMed:19674157, ECO:0000269|PubMed:19785988, ECO:0000269|PubMed:20010870, ECO:0000269|PubMed:20499158, ECO:0000269|PubMed:20529362, ECO:0000269|PubMed:20541605, ECO:0000269|PubMed:20573744, ECO:0000269|PubMed:20976005, ECO:0000269|PubMed:21098120, ECO:0000269|PubMed:21212275, ECO:0000269|PubMed:22174419, ECO:0000269|PubMed:23636399, ECO:0000269|PubMed:9584165}.; SUBUNIT: (Microbial infection) Interacts with Y.pseudotuberculosis yopK. {ECO:0000269|PubMed:21347310}.; SUBUNIT: (Microbial infection) Interacts with Y.pseudotuberculosis yopK. Interacts with a number of viral proteins including Epstein-Barr virus BZLF1 and HIV-1 Nef; interaction with Nef increases Nef phosphorylation by PKC. {ECO:0000269|PubMed:10849009, ECO:0000269|PubMed:11312657}.",2499885; 14702039; 15489334; 9584165; 10849009; 11279199; 11312657; 11956211; 11884618; 12400005; 14500341; 12958311; 12589061; 14654843; 15140893; 15596539; 14699138; 15592455; 17108144; 17956333; 17244529; 18258429; 18621736; 18088317; 19413330; 19785988; 18954305; 19674157; 19423701; 19608861; 20541605; 20010870; 20976005; 20573744; 21269460; 20499158; 21212275; 21098120; 21347310; 21406692; 22174419; 22223895; 22814378; 23186163; 24524803; 25416947; 24275569; 25944712; 28132843; 28161490; 28636603; 20529362; 22869111; 23636399,2499885; 14702039; 15489334; 9584165; 10849009; 11279199; 11312657; 11956211; 11884618; 12400005; 14500341; 12958311; 12589061; 14654843; 15140893; 15596539; 14699138; 15592455; 17108144; 17956333; 17244529; 18258429; 18621736; 18088317; 19413330; 19785988; 18954305; 19674157; 19423701; 19608861; 20541605; 20010870; 20976005; 20573744; 21269460; 20499158; 21212275; 21098120; 21347310; 21406692; 22174419; 22223895; 22814378; 23186163; 24524803; 25416947; 24275569; 25944712; 28132843; 28161490; 28636603; 20529362; 22869111; 23636399; 11046044; 11824616; 11934885; 11964397; 12391233; 12809483; 12960323; 14559993; 14654845; 14743216; 14963031; 14966116; 14978742; 15047060; 15202772; 15240704; 15252133; 15254245; 15467455; 15548575; 15577927; 15611085; 16061178; 16169070; 16189514; 16212959; 16382134; 16449650; 16603398; 16689683; 16702786; 16705158; 16849317; 16920332; 16997272; 17072338; 17110338; 17166942; 17201176; 17269730; 17361105; 17409124; 17515463; 17574549; 17718421; 17875644; 17875659; 17900862; 17936896; 17965024; 18057008; 18194455; 18420585; 18442364; 18557705; 18567578; 18596232; 18624398; 18755685; 19000751; 19010305; 19251694; 19367725; 19451233; 19767770; 19805454; 19892429; 19946739; 19966859; 20020495; 20080539; 20099848; 20103773; 20360068; 20410295; 20689807; 20697360; 20711500; 20819076; 20858845; 20871634; 20874815; 20875397; 21146485; 21182203; 21282530; 21376236; 21525958; 21685945; 21756811; 21848913; 21860413; 21900206; 21935400; 21988832; 22007921; 22069327; 22207523; 22210188; 22240482; 22246531; 22262830; 22289149; 22314363; 22334666; 22365833; 22378065; 22522808; 22523568; 22538239; 22592183; 22623428; 22653060; 22810585; 22903704; 23173782; 23414517; 23416715; 23608534; 23636454; 23651062; 23663784; 23866081; 23893384; 23905995; 23912224; 24000012; 24005669; 24008630; 24189400; 24323043; 24436055; 24481459; 24504450; 24591271; 24681954; 24725412; 24947010; 25048599; 25065497; 25428880; 25489024; 25583988; 25609649; 25650116; 25665578; 25686824; 25694432; 25779661; 25901680; 25901709; 25957688; 26038599; 26155016; 26199092; 26257302; 26268370; 26496610; 26514267; 26549445; 26604301; 26718491; 26863570; 26893362; 27129200; 27170279; 27279145; 27325703; 27453417; 27498047; 27505161; 27530427; 27530921; 27600565; 27644318; 27665925; 27752045; 27754360; 28069443; 28158562; 28192162; 28267599; 28336233; 28396991; 28412309; 28418088; 28465488; 28518135; 28723557; 28732596; 28760343; 28797110; 29039466; 29048616; 29143818; 29401259; 29470995; 29875412,2004-10-11,2019-02-13,2007-01-23,157,X-ray crystallography (2); Electron microscopy (15),STRAND 4 11 {ECO:0000244|PDB:4AOW}.; STRAND 18 23 {ECO:0000244|PDB:4AOW}.; STRAND 30 35 {ECO:0000244|PDB:4AOW}.; STRAND 40 45 {ECO:0000244|PDB:4AOW}.; STRAND 48 50 {ECO:0000244|PDB:4AOW}.; STRAND 52 59 {ECO:0000244|PDB:4AOW}.; STRAND 66 71 {ECO:0000244|PDB:4AOW}.; STRAND 75 82 {ECO:0000244|PDB:4AOW}.; STRAND 85 91 {ECO:0000244|PDB:4AOW}.; STRAND 96 102 {ECO:0000244|PDB:4AOW}.; STRAND 108 113 {ECO:0000244|PDB:4AOW}.; STRAND 120 124 {ECO:0000244|PDB:4AOW}.; STRAND 129 132 {ECO:0000244|PDB:4AOW}.; STRAND 138 142 {ECO:0000244|PDB:4AOW}.; STRAND 144 146 {ECO:0000244|PDB:4AOW}.; STRAND 151 156 {ECO:0000244|PDB:4AOW}.; STRAND 160 162 {ECO:0000244|PDB:4AOW}.; STRAND 164 169 {ECO:0000244|PDB:4AOW}.; STRAND 174 178 {ECO:0000244|PDB:4AOW}.; STRAND 183 188 {ECO:0000244|PDB:4AOW}.; STRAND 195 200 {ECO:0000244|PDB:4AOW}.; STRAND 204 211 {ECO:0000244|PDB:4AOW}.; STRAND 215 220 {ECO:0000244|PDB:4AOW}.; STRAND 225 231 {ECO:0000244|PDB:4AOW}.; STRAND 236 241 {ECO:0000244|PDB:4AOW}.; STRAND 243 252 {ECO:0000244|PDB:4AOW}.; STRAND 255 260 {ECO:0000244|PDB:4AOW}.; STRAND 265 270 {ECO:0000244|PDB:4AOW}.; STRAND 286 291 {ECO:0000244|PDB:4AOW}.; STRAND 295 302 {ECO:0000244|PDB:4AOW}.; STRAND 307 313 {ECO:0000244|PDB:4AOW}.,,TURN 92 95 {ECO:0000244|PDB:4AOW}.; TURN 179 182 {ECO:0000244|PDB:4AOW}.; TURN 221 224 {ECO:0000244|PDB:4AOW}.; TURN 261 264 {ECO:0000244|PDB:4AOW}.,,,,,5 out of 5,Beta strand (31); Chain (2); Erroneous initiation (1); Frameshift (1); Initiator methionine (1); Modified residue (14); Mutagenesis (13); Repeat (7); Sequence conflict (3); Turn (4),,"TISSUE SPECIFICITY: In the liver, expressed at higher levels in activated hepatic stellate cells than in hepatocytes or Kupffer cells. Up-regulated in hepatocellular carcinomas and in the adjacent non-tumor liver tissue. {ECO:0000269|PubMed:18621736}.",,3D-structure;Acetylation;Apoptosis;Biological rhythms;Cell cycle;Cell membrane;Cell projection;Complete proteome;Cytoplasm;Developmental protein;Direct protein sequencing;Gastrulation;Growth regulation;Host-virus interaction;Membrane;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribonucleoprotein;Ribosomal protein;Translation regulation;WD repeat,Evidence at protein level,reviewed,,"WD repeat G protein beta family, Ribosomal protein RACK1 subfamily",157,Domain (1); Function (5); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (3); Tissue specificity (1),,KW-0002; KW-0007; KW-0053; KW-0090; KW-0131; KW-0181; KW-0217; KW-0306; KW-0341; KW-0472; KW-0539; KW-0597; KW-0677; KW-0687; KW-0689; KW-0810; KW-0853; KW-0903; KW-0945; KW-0963; KW-0966; KW-1003; KW-1185,,,,,,,,"PTM: Phosphorylated on Tyr-228 and/or Tyr-246 by SRC. This is required for binding to SRC. {ECO:0000269|PubMed:11279199, ECO:0000269|PubMed:12400005, ECO:0000269|PubMed:19423701}.; PTM: (Microbial infection) Phosphorylated by vaccinia virus B1 kinase on serine and threonine residues; this phosphorylation remodels the ribosome properties, favoring the viral mRNA translation. {ECO:0000269|PubMed:28636603}.","CHAIN 1 317 Receptor of activated protein C kinase 1. /FTId=PRO_0000424480.; CHAIN 2 317 Receptor of activated protein C kinase 1, N-terminally processed. /FTId=PRO_0000127731.",,,,"INIT_MET 1 1 Removed; alternate. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.9}.",,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 2 2 N-acetylthreonine; in Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.9}.; MOD_RES 6 6 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 10 10 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 52 52 Phosphotyrosine; by ABL1. {ECO:0000305|PubMed:19423701}.; MOD_RES 96 96 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 130 130 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 183 183 N6-acetyllysine. {ECO:0000250|UniProtKB:P68040}.; MOD_RES 228 228 Phosphotyrosine. {ECO:0000269|PubMed:11279199}.; MOD_RES 276 276 Phosphoserine; by viral VacV B1 kinase. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:28636603}.; MOD_RES 277 277 Phosphothreonine; by viral VacV B1 kinase. {ECO:0000269|PubMed:28636603}.; MOD_RES 278 278 Phosphoserine; by viral VacV B1 kinase. {ECO:0000269|PubMed:28636603}.; MOD_RES 279 279 Phosphoserine; by viral VacV B1 kinase. {ECO:0000269|PubMed:28636603}.; MOD_RES 316 316 Phosphothreonine. {ECO:0000250|UniProtKB:P68040}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M24194;AY159316;AY336089;AK095666;CR456978;CR541909;AK222488;CH471165;CH471165;BC000214;BC000366;BC010119;BC014256;BC014788;BC017287;BC019093;BC019362;BC021993;BC032006;
0,Q02952,AKA12_HUMAN,AKAP12 AKAP250,AKAP12,AKAP250,,,Homo sapiens (Human),9606,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),UP000005640: Chromosome 6,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGAGSSTEQRSPEQPPEGSSTPAEPEPSGGGPSAEAAPDTTADPAIAASDPATKLLQKNGQLSTINGVAEQDELSLQEGDLNGQKGALNGQGALNSQEEEEVIVTEVGQRDSEDVSKRDSDKEMATKSAVVHDITDDGQEETPEIIEQIPSSESNLEELTQPTESQANDIGFKKVFKFVGFKFTVKKDKTEKPDTVQLLTVKKDEGEGAAGAGDHKDPSLGAGEAASKESEPKQSTEKPEETLKREQSHAEISPPAESGQAVEECKEEGEEKQEKEPSKSAESPTSPVTSETGSTFKKFFTQGWAGWRKKTSFRKPKEDEVEASEKKKEQEPEKVDTEEDGKAEVASEKLTASEQAHPQEPAESAHEPRLSAEYEKVELPSEEQVSGSQGPSEEKPAPLATEVFDEKIEVHQEEVVAEVHVSTVEERTEEQKTEVEETAGSVPAEELVEMDAEPQEAEPAKELVKLKETCVSGEDPTQGADLSPDEKVLSKPPEGVVSEVEMLSSQERMKVQGSPLKKLFTSTGLKKLSGKKQKGKRGGGDEESGEHTQVPADSPDSQEEQKGESSASSPEEPEEITCLEKGLAEVQQDGEAEEGATSDGEKKREGVTPWASFKKMVTPKKRVRRPSESDKEDELDKVKSATLSSTESTASEMQEEMKGSVEEPKPEEPKRKVDTSVSWEALICVGSSKKRARRGSSSDEEGGPKAMGGDHQKADEAGKDKETGTDGILAGSQEHDPGQGSSSPEQAGSPTEGEGVSTWESFKRLVTPRKKSKSKLEEKSEDSIAGSGVEHSTPDTEPGKEESWVSIKKFIPGRRKKRPDGKQEQAPVEDAGPTGANEDDSDVPAVVPLSEYDAVEREKMEAQQAQKSAEQPEQKAATEVSKELSESQVHMMAAAVADGTRAATIIEERSPSWISASVTEPLEQVEAEAALLTEEVLEREVIAEEEPPTVTEPLPENREARGDTVVSEAELTPEAVTAAETAGPLGAEEGTEASAAEETTEMVSAVSQLTDSPDTTEEATPVQEVEGGVPDIEEQERRTQEVLQAVAEKVKEESQLPGTGGPEDVLQPVQRAEAERPEEQAEASGLKKETDVVLKVDAQEAKTEPFTQGKVVGQTTPESFEKAPQVTESIESSELVTTCQAETLAGVKSQEMVMEQAIPPDSVETPTDSETDGSTPVADFDAPGTTQKDEIVEIHEENEVASGTQSGGTEAEAVPAQKERPPAPSSFVFQEETKEQSKMEDTLEHTDKEVSVETVSILSKTEGTQEADQYADEKTKDVPFFEGLEGSIDTGITVSREKVTEVALKGEGTEEAECKKDDALELQSHAKSPPSPVEREMVVQVEREKTEAEPTHVNEEKLEHETAVTVSEEVSKQLLQTVNVPIIDGAKEVSSLEGSPPPCLGQEEAVCTKIQVQSSEASFTLTAAAEEEKVLGETANILETGETLEPAGAHLVLEEKSSEKNEDFAAHPGEDAVPTGPDCQAKSTPVIVSATTKKGLSSDLEGEKTTSLKWKSDEVDEQVACQEVKVSVAIEDLEPENGILELETKSSKLVQNIIQTAVDQFVRTEETATEMLTSELQTQAHVIKADSQDAGQETEKEGEEPQASAQDETPITSAKEESESTAVGQAHSDISKDMSEASEKTMTVEVEGSTVNDQQLEEVVLPSEEEGGGAGTKSVPEDDGHALLAERIEKSLVEPKEDEKGDDVDDPENQNSALADTDASGGLTKESPDTNGPKQKEKEDAQEVELQEGKVHSESDKAITPQAQEELQKQERESAKSELTES,1782,"191,482",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; Synonyms=Alpha; IsoId=Q02952-1; Sequence=Displayed; Name=2; Synonyms=Beta; IsoId=Q02952-2; Sequence=VSP_004110, VSP_004111; Name=3; Synonyms=Gamma; IsoId=Q02952-3; Sequence=VSP_028133, VSP_028134; ",,SEQUENCE CAUTION:  Sequence=BAE06085.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 1 105 Missing (in isoform 3). {ECO:0000303|PubMed:17974005}. /FTId=VSP_028133.; VAR_SEQ 1 98 Missing (in isoform 2). {ECO:0000303|PubMed:9604001}. /FTId=VSP_004110.; VAR_SEQ 99 106 EEEVIVTE -> MLGTITIT (in isoform 2). {ECO:0000303|PubMed:9604001}. /FTId=VSP_004111.; VAR_SEQ 106 106 E -> M (in isoform 3). {ECO:0000303|PubMed:17974005}. /FTId=VSP_028134.,"VARIANT 117 117 K -> E (in dbSNP:rs10872670). {ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:9000000, ECO:0000269|Ref.3, ECO:0000269|Ref.6}. /FTId=VAR_035115.; VARIANT 216 216 K -> Q (in dbSNP:rs3734799). {ECO:0000269|PubMed:17974005, ECO:0000269|PubMed:9000000, ECO:0000269|Ref.3, ECO:0000269|Ref.6}. /FTId=VAR_035116.; VARIANT 240 240 E -> K (in a colorectal cancer sample; somatic mutation; dbSNP:rs552053449). {ECO:0000269|PubMed:16959974}. /FTId=VAR_035780.; VARIANT 920 920 E -> G (in dbSNP:rs13212161). {ECO:0000269|PubMed:17974005}. /FTId=VAR_035117.; VARIANT 987 987 A -> S (in dbSNP:rs1042069). {ECO:0000269|PubMed:9000000}. /FTId=VAR_056731.; VARIANT 1096 1096 V -> I (in dbSNP:rs3734797). /FTId=VAR_035118.; VARIANT 1296 1296 R -> L (in dbSNP:rs9478198). /FTId=VAR_035119.; VARIANT 1355 1355 E -> K (in dbSNP:rs12201388). {ECO:0000269|PubMed:17974005}. /FTId=VAR_035120.; VARIANT 1600 1600 E -> D (in dbSNP:rs3823310). {ECO:0000269|Ref.3}. /FTId=VAR_035121.; VARIANT 1689 1689 E -> D (in dbSNP:rs3734795). /FTId=VAR_035122.",,,,"CONFLICT 142 145 TPEI -> NRN (in Ref. 1; AAC51366). {ECO:0000305}.; CONFLICT 423 423 T -> I (in Ref. 3; BAE06085). {ECO:0000305}.; CONFLICT 449 449 E -> G (in Ref. 1; AAC51366). {ECO:0000305}.; CONFLICT 695 695 G -> R (in Ref. 1; AAC51366). {ECO:0000305}.; CONFLICT 868 868 S -> G (in Ref. 1; AAC51366). {ECO:0000305}.; CONFLICT 946 946 E -> G (in Ref. 4; CAH18338). {ECO:0000305}.; CONFLICT 1182 1182 A -> T (in Ref. 4; CAH18338). {ECO:0000305}.; CONFLICT 1531 1531 E -> EE (in Ref. 4; CAH18338, 3; BAE06085, 6; AAB58938 and 7; AAA35931). {ECO:0000305}.; CONFLICT 1582 1582 V -> M (in Ref. 4; CAH18338 and 7; AAA35931). {ECO:0000305}.; CONFLICT 1602 1602 Q -> L (in Ref. 2; BAA19927). {ECO:0000305}.",,4,,0,DOMAIN: Polybasic regions located between residues 266 and 557 are involved in binding PKC.,,,COMPBIAS 98 101 Poly-Glu.,DOMAIN 604 634 AKAP 1.; DOMAIN 753 783 AKAP 2.; DOMAIN 798 828 AKAP 3.,,REGION 266 557 Involved in PKC-binding. {ECO:0000305}.; REGION 1541 1554 RII-binding. {ECO:0000305}.,,,,,,,,FUNCTION: Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) and protein kinase C (PKC).,,,,,,,,,,,,cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase binding [GO:0008179]; protein kinase A binding [GO:0051018]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of protein kinase A signaling [GO:0010739]; protein targeting [GO:0006605]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein kinase C signaling [GO:0090036],adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of protein kinase A signaling [GO:0010739]; protein targeting [GO:0006605]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein kinase C signaling [GO:0090036],adenylate cyclase binding [GO:0008179]; protein kinase A binding [GO:0051018],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685],GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0006605; GO:0007186; GO:0007193; GO:0008179; GO:0010738; GO:0010739; GO:0050804; GO:0051018; GO:0090036; GO:0098685,IPR028540; IPR001573; IPR018459; ,P00533,SUBUNIT: Binds to dimeric RII-alpha regulatory subunit of PKC.,9000000; 9604001; 17974005; 14574404; 1522245; 15496411; 17081983; 17525332; 19413330; 19369195; 20213681; 21269460; 21406692; 23186163; 24275569; 25255805; 25114211; 25807930; 16959974,9000000; 9604001; 17974005; 14574404; 1522245; 15496411; 17081983; 17525332; 19413330; 19369195; 20213681; 21269460; 21406692; 23186163; 24275569; 25255805; 25114211; 25807930; 16959974; 12857743; 14657015; 15258566; 15590635; 15923193; 16642035; 16762919; 17081159; 17200117; 17442483; 17442832; 17577780; 18199717; 18397319; 18554502; 18579430; 18950703; 19210988; 19724895; 19851296; 20018890; 20029029; 20195357; 20198315; 20360068; 20364105; 20711500; 20979053; 21115911; 21310466; 21461577; 21900206; 21903576; 21918680; 22584896; 22710722; 23063527; 23414517; 23543478; 23838009; 24042196; 24065476; 24870731; 24986638; 25188285; 25229625; 25356636; 25637608; 25748058; 25792458; 26406118; 26428665; 26638075; 26645718; 26646106; 27683220; 28698137; 29391485; 29484387; 30385176,1994-02-01,2019-02-13,2011-01-11,173,,,,,,,,,5 out of 5,Alternative sequence (4); Chain (1); Compositional bias (1); Cross-link (1); Domain (3); Erroneous initiation (1); Initiator methionine (1); Lipidation (1); Modified residue (43); Natural variant (10); Region (2); Sequence conflict (14),,"TISSUE SPECIFICITY: Expressed in endothelial cells, cultured fibroblasts and osteosarcoma, but not in platelets, leukocytes, monocytic cell lines or peripherical blood cells.",MISCELLANEOUS: Antibodies against the C-terminal of gravin can be produced by patients with myasthenia gravis (MG).,Alternative splicing;Complete proteome;Cytoplasm;Cytoskeleton;Isopeptide bond;Lipoprotein;Membrane;Myristate;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation,Evidence at protein level,reviewed,,,173,Alternative products (1); Domain (1); Function (1); Induction (1); Miscellaneous (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0181; KW-0206; KW-0449; KW-0472; KW-0519; KW-0597; KW-0621; KW-0677; KW-0832; KW-0963; KW-1017; KW-1185,,,,,,,,,CHAIN 2 1782 A-kinase anchor protein 12. /FTId=PRO_0000064519.,CROSSLNK 1051 1051 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1). {ECO:0000244|PubMed:25114211}.,,,"INIT_MET 1 1 Removed. {ECO:0000269|PubMed:25255805, ECO:0000269|PubMed:25807930}.","LIPID 2 2 N-myristoyl glycine. {ECO:0000269|PubMed:20213681, ECO:0000269|PubMed:25255805, ECO:0000269|PubMed:25807930}.","MOD_RES 11 11 Phosphoserine. {ECO:0000250|UniProtKB:Q5QD51}.; MOD_RES 19 19 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 28 28 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 75 75 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 96 96 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 154 154 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 219 219 Phosphoserine. {ECO:0000244|PubMed:17081983}.; MOD_RES 248 248 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 258 258 Phosphoserine. {ECO:0000250|UniProtKB:Q5QD51}.; MOD_RES 280 280 Phosphoserine. {ECO:0000250|UniProtKB:Q5QD51}.; MOD_RES 283 283 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 286 286 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 347 347 Phosphoserine. {ECO:0000250|UniProtKB:Q5QD51}.; MOD_RES 371 371 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 374 374 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 381 381 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 392 392 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 483 483 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 505 505 Phosphoserine. {ECO:0000244|PubMed:17525332}.; MOD_RES 554 554 Phosphoserine. {ECO:0000250|UniProtKB:Q5QD51}.; MOD_RES 557 557 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 598 598 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 612 612 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 627 627 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 629 629 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 642 642 Phosphothreonine. {ECO:0000250|UniProtKB:Q5QD51}.; MOD_RES 644 644 Phosphoserine. {ECO:0000250|UniProtKB:Q5QD51}.; MOD_RES 645 645 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 648 648 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 651 651 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 696 696 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 697 697 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 698 698 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 749 749 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 761 761 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 787 787 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 806 806 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 1328 1328 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1331 1331 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 1391 1391 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.; MOD_RES 1395 1395 Phosphoserine. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:24275569}.; MOD_RES 1587 1587 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 1727 1727 Phosphoserine. {ECO:0000250|UniProtKB:Q9WTQ5}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U81607;AB003476;AB210003;CR749527;AF001504;M96322;
0,Q03252,LMNB2_HUMAN,LMNB2 LMN2,LMNB2,LMN2,,,Homo sapiens (Human),9606,Lamin-B2,UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSPPSPGRRREQRRPRAAATMATPLPGRAGGPATPLSPTRLSRLQEKEELRELNDRLAHYIDRVRALELENDRLLLKISEKEEVTTREVSGIKALYESELADARRVLDETARERARLQIEIGKLRAELDEVNKSAKKREGELTVAQGRVKDLESLFHRSEVELAAALSDKRGLESDVAELRAQLAKAEDGHAVAKKQLEKETLMRVDLENRCQSLQEELDFRKSVFEEEVRETRRRHERRLVEVDSSRQQEYDFKMAQALEELRSQHDEQVRLYKLELEQTYQAKLDSAKLSSDQNDKAASAAREELKEARMRLESLSYQLSGLQKQASAAEDRIRELEEAMAGERDKFRKMLDAKEQEMTEMRDVMQQQLAEYQELLDVKLALDMEINAYRKLLEGEEERLKLSPSPSSRVTVSRATSSSSGSLSATGRLGRSKRKRLEVEEPLGSGPSVLGTGTGGSGGFHLAQQASASGSVSIEEIDLEGKFVQLKNNSDKDQSLGNWRIKRQVLEGEEIAYKFTPKYILRAGQMVTVWAAGAGVAHSPPSTLVWKGQSSWGTGESFRTVLVNADGEEVAMRTVKKSSVMRENENGEEEEEEAEFGEEDLFHQQGDPRTTSRGCYVM,620,"69,948",,,,SEQUENCE CAUTION:  Sequence=AAH06551.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,,"VARIANT 157 157 H -> Y (in EPM9; disrupts fibrillar formation; dbSNP:rs797045143). {ECO:0000269|PubMed:25954030}. /FTId=VAR_074170.; VARIANT 235 235 R -> Q (polymorphism; may be a risk factor for partial aquired lipodystrophy; dbSNP:rs121912497). {ECO:0000269|PubMed:16826530, ECO:0000269|PubMed:27535533}. /FTId=VAR_031063.; VARIANT 236 236 R -> W (in a colorectal cancer sample; somatic mutation; dbSNP:rs774297966). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036370.; VARIANT 252 252 Y -> H (in APLD). {ECO:0000269|PubMed:22768673}. /FTId=VAR_074171.; VARIANT 427 427 A -> T (in APLD; dbSNP:rs57521499). {ECO:0000269|PubMed:16826530}. /FTId=VAR_031064.",,,,CONFLICT 401 401 R -> S (in Ref. 5; AAA80979). {ECO:0000305}.; CONFLICT 439 475 LEVEEPLGSGPSVLGTGTGGSGGFHLAQQASASGSVS -> WRWRSPWQRPKRPGHGHGWQRWLPPGPAGLGLGQRH (in Ref. 5; AAA80979). {ECO:0000305}.,,4,,0,,SIMILARITY: Belongs to the intermediate filament family. {ECO:0000255|PROSITE-ProRule:PRU01188}.,,COMPBIAS 590 602 Asp/Glu-rich (highly acidic; could be involved in chromatin binding).,DOMAIN 46 402 IF rod. {ECO:0000255|PROSITE-ProRule:PRU01188}.; DOMAIN 462 579 LTD. {ECO:0000255|PROSITE-ProRule:PRU01187}.,MOTIF 435 440 Nuclear localization signal. {ECO:0000255}.,REGION 1 48 Head.; REGION 49 83 Coil 1A.; REGION 84 95 Linker 1.; REGION 96 229 Coil 1B.; REGION 230 256 Linker 2.; REGION 257 400 Coil 2.; REGION 401 620 Tail.,,,,,,,,"FUNCTION: Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin.",,,,,,,,,,,,lamin filament [GO:0005638]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; structural molecule activity [GO:0005198],,structural molecule activity [GO:0005198],lamin filament [GO:0005638]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965],GO:0005198; GO:0005637; GO:0005638; GO:0031965,IPR001664; IPR018039; IPR039008; IPR001322; IPR036415; ,P02545; P20700; Q4G0R1,SUBUNIT: Interacts with TMEM43. {ECO:0000250}.,15057824; 15489334; 1630457; 17081983; 18220336; 19367720; 18691976; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 23186163; 24275569; 25755297; 25944712; 28112733; 16826530; 16959974; 22768673; 25954030; 27535533,15057824; 15489334; 1630457; 17081983; 18220336; 19367720; 18691976; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 23186163; 24275569; 25755297; 25944712; 28112733; 16826530; 16959974; 22768673; 25954030; 27535533; 12902329; 12912926; 15024083; 15284226; 15611042; 16543417; 17070523; 17290216; 18847512; 19165527; 19913121; 20004208; 20309963; 20628086; 20711500; 21400569; 23075850; 23475125; 23531880; 23764002; 25477337; 25609649; 26237509; 26496610; 26921073,1994-06-01,2019-02-13,2015-11-11,194,X-ray crystallography (1); NMR spectroscopy (1),STRAND 473 479 {ECO:0000244|PDB:2LLL}.; STRAND 484 490 {ECO:0000244|PDB:2LLL}.; STRAND 492 494 {ECO:0000244|PDB:2LLL}.; STRAND 502 507 {ECO:0000244|PDB:2LLL}.; STRAND 512 516 {ECO:0000244|PDB:2LLL}.; STRAND 528 533 {ECO:0000244|PDB:2LLL}.; STRAND 545 548 {ECO:0000244|PDB:2LLL}.; STRAND 552 555 {ECO:0000244|PDB:2LLL}.; STRAND 558 565 {ECO:0000244|PDB:2LLL}.; STRAND 571 580 {ECO:0000244|PDB:2LLL}.,HELIX 534 536 {ECO:0000244|PDB:2LLL}.,TURN 542 544 {ECO:0000244|PDB:2LLL}.,,,,,5 out of 5,Beta strand (10); Chain (1); Compositional bias (1); Cross-link (5); Domain (2); Erroneous initiation (1); Helix (1); Lipidation (1); Modified residue (12); Motif (1); Natural variant (5); Propeptide (1); Region (7); Sequence conflict (2); Turn (1),,,"MISCELLANEOUS: The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively.",3D-structure;Acetylation;Coiled coil;Complete proteome;Direct protein sequencing;Disease mutation;Epilepsy;Intermediate filament;Isopeptide bond;Lipoprotein;Membrane;Methylation;Nucleus;Phosphoprotein;Polymorphism;Prenylation;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,Intermediate filament family,194,Function (1); Involvement in disease (2); Miscellaneous (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0175; KW-0181; KW-0225; KW-0403; KW-0449; KW-0472; KW-0488; KW-0539; KW-0597; KW-0621; KW-0636; KW-0832; KW-0887; KW-0903; KW-1017; KW-1185,,,,,"DISEASE: Partial acquired lipodystrophy (APLD) [MIM:608709]: A rare childhood disease characterized by loss of subcutaneous fat from the face and trunk. Fat deposition on the pelvic girdle and lower limbs is normal or excessive. Most frequently, onset between 5 and 15 years of age. Most affected subjects are females and some show no other abnormality, but many develop glomerulonephritis, diabetes mellitus, hyperlipidemia, and complement deficiency. Mental retardation in some cases. APLD is a sporadic disorder of unknown etiology. {ECO:0000269|PubMed:16826530, ECO:0000269|PubMed:22768673}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epilepsy, progressive myoclonic 9 (EPM9) [MIM:616540]: An autosomal recessive form of progressive myoclonic epilepsy, a rare disease initially responsive to antiepileptic drugs which over time becomes refractory and can be associated with cognitive decline. EPM9 features include myoclonus, tonic-clonic seizures, ataxia, and psychomotor development. {ECO:0000269|PubMed:25954030}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",,,"PTM: B-type lamins undergo a series of modifications, such as farnesylation and phosphorylation. Increased phosphorylation of the lamins occurs before envelope disintegration and probably plays a role in regulating lamin associations.",CHAIN 1 617 Lamin-B2. /FTId=PRO_0000063820.,"CROSSLNK 77 77 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 81 81 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate. {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 195 195 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 255 255 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 489 489 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.",,,,LIPID 617 617 S-farnesyl cysteine. {ECO:0000250}.,"MOD_RES 23 23 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 34 34 Phosphothreonine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 37 37 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 81 81 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 316 316 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 420 420 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 422 422 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692}.; MOD_RES 424 424 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692}.; MOD_RES 426 426 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692}.; MOD_RES 433 433 Omega-N-methylarginine. {ECO:0000250|UniProtKB:P21619}.; MOD_RES 497 497 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 617 617 Cysteine methyl ester. {ECO:0000250}.",,PROPEP 618 620 Removed in mature form. {ECO:0000250}. /FTId=PRO_0000403470.,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,BT007441;AC005624;BC006551;M94362;M94363;
0,Q07157,ZO1_HUMAN,TJP1 ZO1,TJP1,ZO1,,,Homo sapiens (Human),9606,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),UP000005640: Chromosome 15,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSARAAAAKSTAMEETAIWEQHTVTLHRAPGFGFGIAISGGRDNPHFQSGETSIVISDVLKGGPAEGQLQENDRVAMVNGVSMDNVEHAFAVQQLRKSGKNAKITIRRKKKVQIPVSRPDPEPVSDNEEDSYDEEIHDPRSGRSGVVNRRSEKIWPRDRSASRERSLSPRSDRRSVASSQPAKPTKVTLVKSRKNEEYGLRLASHIFVKEISQDSLAARDGNIQEGDVVLKINGTVTENMSLTDAKTLIERSKGKLKMVVQRDERATLLNVPDLSDSIHSANASERDDISEIQSLASDHSGRSHDRPPRRSRSRSPDQRSEPSDHSRHSPQQPSNGSLRSRDEERISKPGAVSTPVKHADDHTPKTVEEVTVERNEKQTPSLPEPKPVYAQVGQPDVDLPVSPSDGVLPNSTHEDGILRPSMKLVKFRKGDSVGLRLAGGNDVGIFVAGVLEDSPAAKEGLEEGDQILRVNNVDFTNIIREEAVLFLLDLPKGEEVTILAQKKKDVYRRIVESDVGDSFYIRTHFEYEKESPYGLSFNKGEVFRVVDTLYNGKLGSWLAIRIGKNHKEVERGIIPNKNRAEQLASVQYTLPKTAGGDRADFWRFRGLRSSKRNLRKSREDLSAQPVQTKFPAYERVVLREAGFLRPVTIFGPIADVAREKLAREEPDIYQIAKSEPRDAGTDQRSSGIIRLHTIKQIIDQDKHALLDVTPNAVDRLNYAQWYPIVVFLNPDSKQGVKTMRMRLCPESRKSARKLYERSHKLRKNNHHLFTTTINLNSMNDGWYGALKEAIQQQQNQLVWVSEGKADGATSDDLDLHDDRLSYLSAPGSEYSMYSTDSRHTSDYEDTDTEGGAYTDQELDETLNDEVGTPPESAITRSSEPVREDSSGMHHENQTYPPYSPQAQPQPIHRIDSPGFKPASQQKAEASSPVPYLSPETNPASSTSAVNHNVNLTNVRLEEPTPAPSTSYSPQADSLRTPSTEAAHIMLRDQEPSLSSHVDPTKVYRKDPYPEEMMRQNHVLKQPAVSHPGHRPDKEPNLTYEPQLPYVEKQASRDLEQPTYRYESSSYTDQFSRNYEHRLRYEDRVPMYEEQWSYYDDKQPYPSRPPFDNQHSQDLDSRQHPEESSERGYFPRFEEPAPLSYDSRPRYEQAPRASALRHEEQPAPGYDTHGRLRPEAQPHPSAGPKPAESKQYFEQYSRSYEQVPPQGFTSRAGHFEPLHGAAAVPPLIPSSQHKPEALPSNTKPLPPPPTQTEEEEDPAMKPQSVLTRVKMFENKRSASLETKKDVNDTGSFKPPEVASKPSGAPIIGPKPTSQNQFSEHDKTLYRIPEPQKPQLKPPEDIVRSNHYDPEEDEEYYRKQLSYFDRRSFENKPPAHIAASHLSEPAKPAHSQNQSNFSSYSSKGKPPEADGVDRSFGEKRYEPIQATPPPPPLPSQYAQPSQPVTSASLHIHSKGAHGEGNSVSLDFQNSLVSKPDPPPSQNKPATFRPPNREDTAQAAFYPQKSFPDKAPVNGTEQTQKTVTPAYNRFTPKPYTSSARPFERKFESPKFNHNLLPSETAHKPDLSSKTPTSPKTLVKSHSLAQPPEFDSGVETFSIHAEKPKYQINNISTVPKAIPVSPSAVEEDEDEDGHTVVATARGIFNSNGGVLSSIETGVSIIIPQGAIPEGVEQEIYFKVCRDNSILPPLDKEKGETLLSPLVMCGPHGLKFLKPVELRLPHCDPKTWQNKCLPGDPNYLVGANCVSVLIDHF,1748,"195,459",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=Long; IsoId=Q07157-1; Sequence=Displayed; Name=Short; IsoId=Q07157-2; Sequence=VSP_003148; ,,SEQUENCE CAUTION:  Sequence=AAA02891.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 922 1001 Missing (in isoform Short). {ECO:0000305}. /FTId=VSP_003148.,"VARIANT 471 471 N -> S (in dbSNP:rs2229517). {ECO:0000269|Ref.3}. /FTId=VAR_025153.; VARIANT 790 790 I -> V (in dbSNP:rs2229515). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:8395056, ECO:0000269|Ref.3}. /FTId=VAR_025154.; VARIANT 930 930 P -> L (in dbSNP:rs45529137). {ECO:0000269|Ref.3}. /FTId=VAR_025155.; VARIANT 1110 1110 H -> R (in dbSNP:rs45567033). {ECO:0000269|Ref.3}. /FTId=VAR_025156.; VARIANT 1347 1347 D -> A (in dbSNP:rs2291166). {ECO:0000269|Ref.3}. /FTId=VAR_025157.; VARIANT 1605 1605 N -> S (in dbSNP:rs45578638). {ECO:0000269|Ref.3}. /FTId=VAR_025158.",,,,CONFLICT 394 417 QPDVDLPVSPSDGVLPNSTHEDGI -> NQMWIYLSVHLMVSYLIQLMKMGF (in Ref. 1; AAA02891). {ECO:0000305}.; CONFLICT 545 545 V -> A (in Ref. 1; AAA02891). {ECO:0000305}.; CONFLICT 688 688 I -> Y (in Ref. 1; AAA02891). {ECO:0000305}.; CONFLICT 762 762 R -> A (in Ref. 1; AAA02891). {ECO:0000305}.,,3,,0,"DOMAIN: The 244-aa domain between residues 633 and 876 is the primary occludin (OCLN)-binding site and is required for stable association with the tight junction (PubMed:9792688). {ECO:0000269|PubMed:9792688}.; DOMAIN: The C-terminal region (residues 1151-1372) is an actin-binding region (ABR) that interacts directly with F-actin and plays an important role in the localization of TJP1 at junctions (PubMed:9792688, PubMed:12354695, PubMed:20930113). The ABR is also required for the localization to puncta at the free edge of cells before initiation of cell-cell contact (PubMed:12354695). The ABR is also necessary for TJP1 recruitment to podosomes (PubMed:20930113). {ECO:0000269|PubMed:12354695, ECO:0000269|PubMed:20930113, ECO:0000269|PubMed:9792688}.; DOMAIN: The second PDZ domain (PDZ2) mediates homodimerization and heterodimerization with TJP2 and TJP3 (PubMed:9792688, PubMed:17928286). {ECO:0000269|PubMed:17928286, ECO:0000269|PubMed:9792688}.",SIMILARITY: Belongs to the MAGUK family. {ECO:0000305}.,,COMPBIAS 1243 1248 Poly-Pro.; COMPBIAS 1426 1432 Poly-Pro.,DOMAIN 23 110 PDZ 1. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 186 264 PDZ 2. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 421 502 PDZ 3. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 516 584 SH3. {ECO:0000255|PROSITE-ProRule:PRU00192}.; DOMAIN 598 779 Guanylate kinase-like. {ECO:0000255|PROSITE-ProRule:PRU00100}.; DOMAIN 1634 1748 ZU5. {ECO:0000255|PROSITE-ProRule:PRU00485}.,,REGION 633 876 Occludin (OCLN)-binding region. {ECO:0000269|PubMed:9792688}.; REGION 1151 1371 Actin-binding region (ABR). {ECO:0000269|PubMed:12354695}.,,,,,,,,"FUNCTION: TJP1, TJP2, and TJP3 are closely related scaffolding proteins that link tight junction (TJ) transmembrane proteins such as claudins, junctional adhesion molecules, and occludin to the actin cytoskeleton (PubMed:7798316, PubMed:9792688). The tight junction acts to limit movement of substances through the paracellular space and as a boundary between the compositionally distinct apical and basolateral plasma membrane domains of epithelial and endothelial cells. Necessary for lumenogenesis, and particularly efficient epithelial polarization and barrier formation (By similarity). Plays a role in the regulation of cell migration by targeting CDC42BPB to the leading edge of migrating cells (PubMed:21240187). Plays an important role in podosome formation and associated function, thus regulating cell adhesion and matrix remodeling (PubMed:20930113). With TJP2 and TJP3, participates to the junctional retention and stability of the transcription factor DBPA, but is not involved in its shuttling to the nucleus (By similarity). {ECO:0000250|UniProtKB:O97758, ECO:0000269|PubMed:20930113, ECO:0000269|PubMed:21240187}.",,,,,,,,,,,,apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; podosome [GO:0002102]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cell-cell junction assembly [GO:0007043]; cell-cell signaling involved in cell-cell junction organization [GO:1901350]; establishment of endothelial intestinal barrier [GO:0090557]; hippo signaling [GO:0035329]; regulation of bicellular tight junction assembly [GO:2000810],cell-cell junction assembly [GO:0007043]; cell-cell signaling involved in cell-cell junction organization [GO:1901350]; establishment of endothelial intestinal barrier [GO:0090557]; hippo signaling [GO:0035329]; regulation of bicellular tight junction assembly [GO:2000810],cadherin binding [GO:0045296]; calmodulin binding [GO:0005516],apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; podosome [GO:0002102],GO:0002102; GO:0005516; GO:0005737; GO:0005829; GO:0005886; GO:0005913; GO:0005921; GO:0005923; GO:0007043; GO:0016323; GO:0030054; GO:0035329; GO:0042995; GO:0043296; GO:0045177; GO:0045296; GO:0090557; GO:1901350; GO:2000810,IPR008145; IPR008144; IPR027417; IPR001478; IPR036034; IPR036028; IPR001452; IPR005417; IPR005418; IPR035597; IPR000906; ,O43707; P17302; Q8N144; Q96J84; Q9EPK5,"SUBUNIT: Homodimer (PubMed:17928286). Forms heterodimers (via the PDZ2 domain) with TJP2 and TJP3 (PubMed:9792688, PubMed:17928286, PubMed:16737969). Interacts with OCLN, CALM, claudins, CGN/cingulin, CXADR, GJA12, GJD3 and UBN1 (PubMed:7798316, PubMed:11734628, PubMed:12023291, PubMed:12154091, PubMed:15183511, PubMed:18823282, PubMed:20200156). Interacts (via ZU5 domain) with CDC42BPB and MYZAP (PubMed:20093627, PubMed:21240187). Interacts (via PDZ domain) with GJA1 (PubMed:18636092). Interacts (via PDZ domains) with ANKRD2 (PubMed:22016770). Interacts with BVES (via the C-terminus cytoplasmic tail) (By similarity). Interacts with HSPA4 and KIRREL1 (By similarity). Interacts with DLL1 (By similarity). Interacts with USP53 (via the C-terminal region) (By similarity). Interacts (via ABR region) with F-actin (PubMed:9792688, PubMed:12354695, PubMed:20930113). {ECO:0000250|UniProtKB:O97758, ECO:0000250|UniProtKB:P39447, ECO:0000269|PubMed:11734628, ECO:0000269|PubMed:12023291, ECO:0000269|PubMed:12154091, ECO:0000269|PubMed:12354695, ECO:0000269|PubMed:15183511, ECO:0000269|PubMed:16737969, ECO:0000269|PubMed:17928286, ECO:0000269|PubMed:18636092, ECO:0000269|PubMed:18823282, ECO:0000269|PubMed:20093627, ECO:0000269|PubMed:20200156, ECO:0000269|PubMed:20930113, ECO:0000269|PubMed:21240187, ECO:0000269|PubMed:22016770, ECO:0000269|PubMed:9792688}.",8395056; 14702039; 16572171; 15489334; 7798316; 7542259; 9792688; 11734628; 12354695; 12023291; 12154091; 15183511; 17081983; 18220336; 18669648; 19413330; 18823282; 19332538; 20093627; 20068231; 21269460; 20930113; 22016770; 21406692; 23186163; 24275569; 28169360; 16737969; 17928286; 18636092; 20200156; 21240187; 21387411,8395056; 14702039; 16572171; 15489334; 7798316; 7542259; 9792688; 11734628; 12354695; 12023291; 12154091; 15183511; 17081983; 18220336; 18669648; 19413330; 18823282; 19332538; 20093627; 20068231; 21269460; 20930113; 22016770; 21406692; 23186163; 24275569; 28169360; 16737969; 17928286; 18636092; 20200156; 21240187; 21387411; 10748157; 11124251; 11313345; 11557048; 12064592; 12169098; 12506110; 12577316; 12708492; 12725331; 12881224; 15054114; 15456900; 15500294; 15540229; 15622522; 15855653; 16140936; 16737968; 16891661; 16909128; 16944923; 17039425; 17110338; 17118974; 17217619; 17243118; 17259442; 17509776; 17541973; 17717529; 17724469; 17760848; 17962811; 18162065; 18315903; 18386163; 18418437; 18474622; 18562690; 18649178; 18662404; 18802961; 18922801; 19017651; 19017653; 19071123; 19184677; 19199833; 19567915; 19615732; 19639579; 19661441; 19784548; 19840438; 19885549; 19885626; 19954602; 20150971; 20200207; 20360068; 20562859; 20576493; 20651236; 20711500; 20723289; 20808826; 20850437; 21129259; 21342646; 21411628; 21454477; 21486949; 21536752; 21732359; 21764691; 21785870; 21832836; 21857898; 21872657; 21965684; 22030391; 22064657; 22219277; 22245583; 22262837; 22334078; 22546605; 22671591; 22673509; 22711802; 22808170; 22898551; 22931549; 23151788; 23220562; 23241943; 23416715; 23428392; 23553632; 23670122; 23750010; 23820955; 23835672; 23856837; 23902751; 23967087; 24255178; 24318462; 24327615; 24338688; 24368520; 24657059; 24927439; 25107366; 25158098; 25184792; 25201524; 25248927; 25435485; 25452107; 25683991; 25753039; 25892136; 25953589; 26023235; 26259745; 26293574; 26306999; 26638075; 26645068; 26657896; 26846344; 27109589; 27132469; 27216347; 27436828; 27580405; 27802160; 28153728; 28257821; 28332063; 28428082; 28553432; 28867253; 28906292; 29115525; 29136627; 29199076; 29252987; 29428726; 29776350; 30061227; 9707407,1994-10-01,2019-02-13,2006-01-24,211,X-ray crystallography (15); NMR spectroscopy (3),STRAND 19 27 {ECO:0000244|PDB:2H2B}.; STRAND 36 40 {ECO:0000244|PDB:2H2B}.; STRAND 54 59 {ECO:0000244|PDB:2H2B}.; STRAND 74 78 {ECO:0000244|PDB:2H2B}.; STRAND 100 110 {ECO:0000244|PDB:2H2B}.; STRAND 186 190 {ECO:0000244|PDB:2RCZ}.; STRAND 194 196 {ECO:0000244|PDB:2JWE}.; STRAND 200 211 {ECO:0000244|PDB:2RCZ}.; STRAND 228 232 {ECO:0000244|PDB:2RCZ}.; STRAND 255 261 {ECO:0000244|PDB:2RCZ}.; STRAND 422 428 {ECO:0000244|PDB:4Q2Q}.; STRAND 435 439 {ECO:0000244|PDB:4Q2Q}.; STRAND 441 443 {ECO:0000244|PDB:4Q2Q}.; STRAND 445 450 {ECO:0000244|PDB:4Q2Q}.; STRAND 452 454 {ECO:0000244|PDB:3SHW}.; STRAND 466 470 {ECO:0000244|PDB:4Q2Q}.; STRAND 495 501 {ECO:0000244|PDB:4Q2Q}.; STRAND 519 523 {ECO:0000244|PDB:3TSZ}.; STRAND 542 549 {ECO:0000244|PDB:3TSZ}.; STRAND 553 562 {ECO:0000244|PDB:3TSZ}.; STRAND 568 575 {ECO:0000244|PDB:3TSZ}.; STRAND 632 640 {ECO:0000244|PDB:3TSZ}.; STRAND 647 651 {ECO:0000244|PDB:3TSZ}.; STRAND 669 671 {ECO:0000244|PDB:3TSZ}.; STRAND 679 681 {ECO:0000244|PDB:3TSZ}.; STRAND 703 706 {ECO:0000244|PDB:3TSZ}.; STRAND 724 729 {ECO:0000244|PDB:3TSZ}.; STRAND 770 774 {ECO:0000244|PDB:3TSZ}.; STRAND 796 801 {ECO:0000244|PDB:3TSZ}.; STRAND 1633 1640 {ECO:0000244|PDB:2KXR}.; STRAND 1645 1648 {ECO:0000244|PDB:2KXR}.; STRAND 1655 1658 {ECO:0000244|PDB:2KXR}.; STRAND 1669 1677 {ECO:0000244|PDB:2KXR}.; STRAND 1679 1681 {ECO:0000244|PDB:2KXR}.; STRAND 1701 1703 {ECO:0000244|PDB:2KXR}.; STRAND 1706 1715 {ECO:0000244|PDB:2KXR}.; STRAND 1738 1747 {ECO:0000244|PDB:2KXR}.,HELIX 88 96 {ECO:0000244|PDB:2H2B}.; HELIX 216 220 {ECO:0000244|PDB:2RCZ}.; HELIX 242 250 {ECO:0000244|PDB:2RCZ}.; HELIX 455 458 {ECO:0000244|PDB:4Q2Q}.; HELIX 480 489 {ECO:0000244|PDB:4Q2Q}.; HELIX 504 510 {ECO:0000244|PDB:3TSV}.; HELIX 550 552 {ECO:0000244|PDB:3TSZ}.; HELIX 564 566 {ECO:0000244|PDB:3TSZ}.; HELIX 577 584 {ECO:0000244|PDB:3TSZ}.; HELIX 654 664 {ECO:0000244|PDB:3TSZ}.; HELIX 691 698 {ECO:0000244|PDB:3TSZ}.; HELIX 710 718 {ECO:0000244|PDB:3TSZ}.; HELIX 733 743 {ECO:0000244|PDB:3TSZ}.; HELIX 751 765 {ECO:0000244|PDB:3TSZ}.; HELIX 766 768 {ECO:0000244|PDB:3TSZ}.; HELIX 781 795 {ECO:0000244|PDB:3TSZ}.; HELIX 1720 1723 {ECO:0000244|PDB:2KXS}.; HELIX 1732 1734 {ECO:0000244|PDB:2KXR}.,TURN 30 32 {ECO:0000244|PDB:2H2B}.; TURN 47 49 {ECO:0000244|PDB:2H2B}.; TURN 64 68 {ECO:0000244|PDB:4YYX}.; TURN 191 193 {ECO:0000244|PDB:2JWE}.; TURN 251 254 {ECO:0000244|PDB:3CYY}.; TURN 666 668 {ECO:0000244|PDB:3TSZ}.; TURN 699 701 {ECO:0000244|PDB:3TSZ}.; TURN 1650 1652 {ECO:0000244|PDB:2KXR}.; TURN 1687 1689 {ECO:0000244|PDB:2KXR}.; TURN 1735 1737 {ECO:0000244|PDB:2KXR}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (37); Chain (1); Compositional bias (2); Domain (6); Erroneous initiation (1); Helix (18); Modified residue (50); Mutagenesis (4); Natural variant (6); Region (2); Sequence conflict (4); Turn (10),,TISSUE SPECIFICITY: The alpha-containing isoform is found in most epithelial cell junctions. The short isoform is found both in endothelial cells and the highly specialized epithelial junctions of renal glomeruli and Sertoli cells of the seminiferous tubules.,,3D-structure;Alternative splicing;Calmodulin-binding;Cell junction;Cell membrane;Cell projection;Complete proteome;Gap junction;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH3 domain;Tight junction,Evidence at protein level,reviewed,,MAGUK family,211,Alternative products (1); Domain (3); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0112; KW-0181; KW-0303; KW-0472; KW-0597; KW-0621; KW-0677; KW-0728; KW-0796; KW-0965; KW-0966; KW-1003; KW-1185,,,,,,,,"PTM: Phosphorylated at tyrosine redidues in response to epidermal growth factor (EGF) (PubMed:19332538, PubMed:7542259). This response is dependent on an intact actin microfilament system (PubMed:7542259). Dephosphorylated by PTPRJ (PubMed:19332538). {ECO:0000269|PubMed:19332538, ECO:0000269|PubMed:7542259}.",CHAIN 1 1748 Tight junction protein ZO-1. /FTId=PRO_0000094540.,,,,,,"MOD_RES 125 125 Phosphoserine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 132 132 Phosphotyrosine. {ECO:0000250|UniProtKB:A0A0G2K2P5}.; MOD_RES 175 175 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 178 178 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 179 179 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 185 185 Phosphothreonine. {ECO:0000244|PubMed:21406692}.; MOD_RES 212 212 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 241 241 Phosphoserine. {ECO:0000250|UniProtKB:P39447}.; MOD_RES 267 267 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 275 275 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 277 277 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:24275569}.; MOD_RES 280 280 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 284 284 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 290 290 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 294 294 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 297 297 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 300 300 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 323 323 Phosphoserine. {ECO:0000250|UniProtKB:P39447}.; MOD_RES 329 329 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 334 334 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 337 337 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 353 353 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 354 354 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 617 617 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 622 622 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 809 809 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 810 810 Phosphoserine. {ECO:0000250|UniProtKB:P39447}.; MOD_RES 821 821 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 822 822 Phosphotyrosine. {ECO:0000250|UniProtKB:P39447}.; MOD_RES 824 824 Phosphoserine. {ECO:0000250|UniProtKB:P39447}.; MOD_RES 828 828 Phosphoserine. {ECO:0000250|UniProtKB:A0A0G2K2P5}.; MOD_RES 837 837 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 846 846 Phosphothreonine. {ECO:0000250|UniProtKB:A0A0G2K2P5}.; MOD_RES 848 848 Phosphothreonine. {ECO:0000250|UniProtKB:P39447}.; MOD_RES 854 854 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 861 861 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 868 868 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 912 912 Phosphoserine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 968 968 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 1071 1071 Phosphoserine. {ECO:0000250|UniProtKB:P39447}.; MOD_RES 1111 1111 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1139 1139 Phosphoserine. {ECO:0000250|UniProtKB:P39447}.; MOD_RES 1140 1140 Phosphotyrosine. {ECO:0000250|UniProtKB:P39447}.; MOD_RES 1165 1165 Phosphotyrosine. {ECO:0000250|UniProtKB:P39447}.; MOD_RES 1354 1354 Phosphotyrosine. {ECO:0000250|UniProtKB:P39447}.; MOD_RES 1366 1366 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 1413 1413 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1545 1545 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1617 1617 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,L14837;AK304758;DQ015919;BC111712;
0,Q08379,GOGA2_HUMAN,GOLGA2,GOLGA2,,,,Homo sapiens (Human),9606,Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95),UP000005640: Chromosome 9,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MWPQPRLPPRPAMSEETRQSKLAAAKKKLREYQQRNSPGVPTGAKKKKKIKNGSNPETTTSGGCHSPEDTPKDNAATLQPSDDTVLPGGVPSPGASLTSMAASQNHDADNVPNLMDETKTFSSTESLRQLSQQLNGLVCESATCVNGEGPASSANLKDLESRYQQLAVALDSSYVTNKQLNITIEKLKQQNQEITDQLEEEKKECHQKQGALREQLQVHIQTIGILVSEKAELQTALAHTQHAARQKEGESEDLASRLQYSRRRVGELERALSAVSTQQKKADRYNKELTKERDALRLELYKNTQSNEDLKQEKSELEEKLRVLVTEKAGMQLNLEELQKKLEMTELLLQQFSSRCEAPDANQQLQQAMEERAQLEAHLGQVMESVRQLQMERDKYAENLKGESAMWRQRMQQMSEQVHTLREEKECSMSRVQELETSLAELRNQMAEPPPPEPPAGPSEVEQQLQAEAEHLRKELEGLAGQLQAQVQDNEGLSRLNREQEERLLELERAAELWGEQAEARRQILETMQNDRTTISRALSQNRELKEQLAELQSGFVKLTNENMEITSALQSEQHVKRELGKKLGELQEKLSELKETVELKSQEAQSLQQQRDQYLGHLQQYVAAYQQLTSEKEVLHNQLLLQTQLVDQLQQQEAQGKAVAEMARQELQETQERLEAATQQNQQLRAQLSLMAHPGEGDGLDREEEEDEEEEEEEAVAVPQPMPSIPEDLESREAMVAFFNSAVASAEEEQARLRGQLKEQRVRCRRLAHLLASAQKEPEAAAPAPGTGGDSVCGETHRALQGAMEKLQSRFMELMQEKADLKERVEELEHRCIQLSGETDTIGEYIALYQSQRAVLKERHREKEEYISRLAQDKEEMKVKLLELQELVLRLVGDRNEWHGRFLAAAQNPADEPTSGAPAPQELGAANQQGDLCEVSLAGSVEPAQGEAREGSPRDNPTAQQIMQLLREMQNPRERPGLGSNPCIPFFYRADENDEVKITVI,1002,"113,086",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q08379-1; Sequence=Displayed; Name=2; IsoId=Q08379-2; Sequence=VSP_007727; ,SEQUENCE CAUTION:  Sequence=EAW87762.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; ,SEQUENCE CAUTION:  Sequence=AAH69268.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,SEQUENCE CAUTION:  Sequence=AAP35912.1; Type=Miscellaneous discrepancy; Note=Sequence differs from that shown after position 826 due to an internal deletion.; Evidence={ECO:0000305}; ,VAR_SEQ 1 382 Missing (in isoform 2). {ECO:0000303|PubMed:8315394}. /FTId=VSP_007727.,VARIANT 902 902 R -> G (in dbSNP:rs2240961). /FTId=VAR_033974.,,,,CONFLICT 709 709 Missing (in Ref. 6; AAP35912). {ECO:0000305}.; CONFLICT 762 762 R -> S (in Ref. 6; AAP35912). {ECO:0000305}.,,3,,0,"DOMAIN: Extended rod-like protein with long coiled-coil domains. {ECO:0000250|UniProtKB:Q62839}.; DOMAIN: The nuclear localization signal (cNLS) mediates interaction with importin-alpha, recruiting importin-alpha to the Golgi membrane and liberating TPX2. {ECO:0000269|PubMed:26165940}.",SIMILARITY: Belongs to the GOLGA2 family. {ECO:0000305}.,COILED 16 892 {ECO:0000255}.,COMPBIAS 46 51 Poly-Lys.; COMPBIAS 449 455 Poly-Pro.; COMPBIAS 704 715 Poly-Glu.,,MOTIF 26 49 Nuclear localization signal. {ECO:0000269|PubMed:26165940}.,REGION 1 84 Interaction with p115/USO1. {ECO:0000250|UniProtKB:Q62839}.; REGION 992 1002 Interaction with GORASP1/GRASP65. {ECO:0000250|UniProtKB:Q62839}.,,,,,,,,"FUNCTION: Peripheral membrane component of the cis-Golgi stack that acts as a membrane skeleton that maintains the structure of the Golgi apparatus, and as a vesicle thether that facilitates vesicle fusion to the Golgi membrane (Probable) (PubMed:16489344). Required for normal protein transport from the endoplasmic reticulum to the Golgi apparatus and the cell membrane (By similarity). Together with p115/USO1 and STX5, involved in vesicle tethering and fusion at the cis-Golgi membrane to maintain the stacked and inter-connected structure of the Golgi apparatus. Plays a central role in mitotic Golgi disassembly: phosphorylation at Ser-37 by CDK1 at the onset of mitosis inhibits the interaction with p115/USO1, preventing tethering of COPI vesicles and thereby inhibiting transport through the Golgi apparatus during mitosis (By similarity). Also plays a key role in spindle pole assembly and centrosome organization (PubMed:26165940). Promotes the mitotic spindle pole assembly by activating the spindle assembly factor TPX2 to nucleate microtubules around the Golgi and capture them to couple mitotic membranes to the spindle: upon phosphorylation at the onset of mitosis, GOLGA2 interacts with importin-alpha via the nuclear localization signal region, leading to recruit importin-alpha to the Golgi membranes and liberate the spindle assembly factor TPX2 from importin-alpha. TPX2 then activates AURKA kinase and stimulates local microtubule nucleation. Upon filament assembly, nascent microtubules are further captured by GOLGA2, thus linking Golgi membranes to the spindle (PubMed:19242490, PubMed:26165940). Regulates the meiotic spindle pole assembly, probably via the same mechanism (By similarity). Also regulates the centrosome organization (PubMed:18045989, PubMed:19109421). Also required for the Golgi ribbon formation and glycosylation of membrane and secretory proteins (PubMed:16489344, PubMed:17314401). {ECO:0000250|UniProtKB:Q62839, ECO:0000250|UniProtKB:Q921M4, ECO:0000269|PubMed:16489344, ECO:0000269|PubMed:17314401, ECO:0000269|PubMed:18045989, ECO:0000269|PubMed:19109421, ECO:0000269|PubMed:19242490, ECO:0000269|PubMed:26165940, ECO:0000305|PubMed:26363069}.",,,,,,,,,,,,cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306],asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306],cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905],cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922],GO:0000137; GO:0000139; GO:0000922; GO:0005794; GO:0005801; GO:0005874; GO:0006486; GO:0006888; GO:0007020; GO:0007030; GO:0007098; GO:0008017; GO:0008356; GO:0010507; GO:0015031; GO:0019901; GO:0019905; GO:0030134; GO:0032091; GO:0032580; GO:0033116; GO:0042802; GO:0045296; GO:0048208; GO:0051225; GO:0051289; GO:0060050; GO:0061676; GO:0072686; GO:0090161; GO:0090166; GO:0090306; GO:0090307; GO:1904668,IPR024858; ,Itself; A8K2R3; P29991; Q9WMX2; O75689; Q08117; Q08117-2; Q9UHB7; Q9UHB7-2; Q99996; Q96Q83; Q9Y2J4-4; Q96IX9; Q0P5N6; P40617; O15145; Q8NEY4-2; Q6PJ05; Q8N5Z9; O75348; O15169; Q8TBE0; A0AVN2; Q99728; O75934; P41182; A8KA13; Q13895; Q8NA57; Q9NX04; Q53TS8; Q9HC52; Q8IX12; Q8IYE0-2; Q8NCX0; Q96LX7; Q9NVL8; Q6NSX1; Q9NVE4; Q8TD31-3; P24863; P51946; Q86Y33; Q99459; Q6P1J9; Q07002; Q8IVW4; Q6IPU0; Q8IYX8; Q8IYX8-2; Q9Y6H1; Q9NX63; Q96RK0; Q9BW66; P31146; Q1MSJ5-1; Q93034; Q6BCY4; Q9UER7; Q9UJW0; O43602; P26196; Q05D60; Q15398; Q08495; Q86UW9; Q5JVL4; A0A0S2Z3U4; O75821; Q9NQT4; Q9BQ89; Q9H5Z6; Q8IXS8; Q3B820; Q6P9G8; Q96PV7-2; Q9NSI2; Q32MH5; Q9Y247; Q86YD7; Q8TES7-6; Q96D16; Q9NVF7; Q6UN15; A4D1I3; Q9BVV2; P23769; Q8WXI9; Q96CN9; P55040; P14136; Q8IVS8; P63218; Q9H8Y8; O95872; Q92917; Q14687; A4D1E9; Q96CS2; Q643R0; P56524; A0A0S2Z4Q4; O14964; P17482; Q96KN8-3; Q96M11; Q8IY31; Q9BW83; Q15735; Q9H1K1; P27987; Q63ZY3; Q7Z3B3; Q92993; Q5T5P2-6; Q9BVG8; P04264; P05783; P02538; P04259; P48668; Q14847; Q6PJG3; Q96JN0; Q13094; Q96BZ8; P17931; Q6NVH9; A0A0S2Z5S9; Q7Z4I7-5; O14910; Q96FE5; P25800; P25791; Q8TAP4-4; P61968; Q6IAQ1; Q96S90; Q9Y586; P61326; Q96A72; O95983; Q7L590-2; P33993; P55081; Q9UJV3-2; Q9BU76; P51948; Q9UBU8; Q15014; Q6PF18; P00540; Q8IXL7; Q499L9; Q6P444; Q9P2K5-2; P19878; Q9GZM8; O76041; I6L9F6; P07196; Q9Y5B8; P29474; O43809; Q9NPJ8; Q96F82; Q9BYG5; Q86TB9; O75928; Q7Z2X4; O00459; Q9BSJ6; Q13526; P78337; Q16512; Q99569; Q8WUT1; Q96T49; Q6NYC8; O60828; Q13131; O43741; Q8WWY3; P25786; P25789; P61019; Q8WUD1; Q14964; Q96DA2; Q96I25; Q14498-3; Q96IZ5; Q9P2K3; P57771; Q9BSD3; Q8N443; Q96K30; Q8IUD6; Q63HN8-6; A0A0S2Z4G9; Q9UHP6; Q7L4I2-2; Q14D33; A0A0S2Z4M5; P28702-3; Q9UPU9; Q9UHR5; Q9UPN6; O95171; Q9BWG6; Q96T21; P59797; Q6NXQ0; Q9H788; Q9H788-2; Q08AM8; Q92529; O95391; Q969G3; P49901; Q5SQN1; Q96H20; P14678-2; P08579; Q5TAL4; Q13573; Q9UM82; Q8NHS9; Q96FJ0; O00506; Q9P289; Q5T7P8-2; Q9NU19; Q32MN6; Q15560; Q8N8B7; D2IYK5; Q9Y242; P56279; D3DUQ6; Q15561; A0A0S2Z5Z9; Q8N6V9; Q01664; Q9BT49; P09493; P09493-10; P09493-5; Q9BUZ4; Q14134; Q8IWZ5; Q8IV54; Q9Y5U2; Q96PN8; Q5W5X9; Q96NG3; Q8N5M4; P40222; P63279; Q5VVX9; Q15386; O75604; Q08E77; Q5TAP6; Q548N1; Q9UK41; A5D8V6; Q9Y3C0; Q96HA8; Q9BW85; Q05516; Q8IUH5; G3V1X1; Q6ZN57; Q68DK2-5; A0A0S2Z6H0; Q8N5A5; Q8N5A5-2; Q96NC0; Q15973; P15622-3; Q86VK4; Q96IQ9; Q8TAU3; Q96MN9; Q7Z3I7; Q9P0T4; Q96SQ5; A0A0S2Z5X4; A0A0S2Z6P0; Q6NX45,"SUBUNIT: Homodimer, may assemble into homohexamers (PubMed:26363069). Homotetramer; forms a parallel homotetramer with a flexible rod-like structure that can give rise to I- and Y-shaped conformations (By similarity). Interacts with GORASP1/GRASP65 (PubMed:16489344, PubMed:18045989, PubMed:26363069). The homooligomer forms a complex with GORASP1 with a 1:1 stoichiometry (By similarity). Interacts with RAB1B that has been activated by GTP-binding (PubMed:11306556). Interacts with p115/USO1; interaction with p115/USO1 inhibits interaction with STX5 and/or RAB1B. Interacts with STX5 (By similarity). Interacts with ZFPL1 (PubMed:18323775). Interacts with AKAP450/AKAP9; leading to recruit AKAP450/AKAP9 to the cis-Golgi (PubMed:19242490). {ECO:0000250|UniProtKB:Q62839, ECO:0000269|PubMed:11306556, ECO:0000269|PubMed:16489344, ECO:0000269|PubMed:18045989, ECO:0000269|PubMed:18323775, ECO:0000269|PubMed:19242490, ECO:0000269|PubMed:26363069}.",8315394; 15164053; 15489334; 11306556; 11781572; 15003503; 16964243; 16489344; 17314401; 18323775; 18045989; 18691976; 18669648; 19242490; 19109421; 20421892; 20068231; 21269460; 23186163; 24275569; 26165940; 25944712; 26363069,8315394; 15164053; 15489334; 11306556; 11781572; 15003503; 16964243; 16489344; 17314401; 18323775; 18045989; 18691976; 18669648; 19242490; 19109421; 20421892; 20068231; 21269460; 23186163; 24275569; 26165940; 25944712; 26363069; 10679020; 10747087; 10903204; 10931861; 11035033; 11238451; 11285137; 11447294; 11739401; 11927603; 12270925; 12388752; 12839990; 14742712; 15037601; 15678101; 15728195; 15796781; 15878873; 16169070; 16189514; 16303754; 16624868; 16723730; 16880273; 17038314; 17196169; 17274799; 17431395; 17627283; 18086915; 18167358; 18201567; 18480410; 18985028; 1902553; 19164740; 19758564; 20064372; 20083603; 20086247; 20197635; 20214750; 20936779; 20937827; 21078624; 21169990; 21182205; 21516116; 21532587; 21900206; 21911577; 21988832; 22013193; 22228731; 22593156; 22726585; 22735382; 22805525; 22810585; 22841714; 23378591; 23455922; 23602568; 23698585; 23839779; 24119662; 24136289; 24189400; 24386440; 24705354; 24806965; 24814574; 25406594; 25416956; 25609649; 25787021; 25892554; 26314804; 26496610; 26617790; 26687599; 26742501; 28782625; 7691276; 7737117; 8663406; 9094723; 9150144; 9307973; 9382863; 9490716; 9647643; 9753325,1997-11-01,2019-02-13,2010-04-20,179,X-ray crystallography (1),,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (3); Erroneous gene model prediction (1); Erroneous initiation (1); Modified residue (11); Motif (1); Mutagenesis (7); Natural variant (1); Region (2); Sequence caution (1); Sequence conflict (2),,,,3D-structure;Alternative splicing;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Golgi apparatus;Membrane;Methylation;Microtubule;Mitosis;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport,Evidence at protein level,reviewed,,GOLGA2 family,179,Alternative products (1); Domain (2); Function (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0333; KW-0472; KW-0488; KW-0493; KW-0498; KW-0597; KW-0621; KW-0653; KW-0813; KW-0963; KW-1185,,,,,,,,"PTM: Cleaved by caspases at the onset of apoptosis. {ECO:0000269|PubMed:15003503}.; PTM: Methylation by PRMT5 is required for Golgi ribbon formation. While dimethylation at Arg-30 and Arg-35 are confirmed in vivo, it is unclear whether Arg-18 is methylated in vivo. {ECO:0000269|PubMed:20421892}.; PTM: Phosphorylated at Ser-37 by CDK1 at the onset of mitosis, inhibiting the interaction with p115/USO1 and triggering Golgi disassembly (PubMed:20421892, PubMed:26165940). Phosphorylated at Ser-37 in prophase as the Golgi complex starts to break down, and remains phosphorylated during further breakdown and partitioning of the Golgi fragments in metaphase and anaphase. In telophase, GM130 is dephosphorylated by PP2A as the Golgi fragments start to reassemble (By similarity). {ECO:0000250|UniProtKB:Q62839, ECO:0000269|PubMed:20421892, ECO:0000269|PubMed:26165940}.",CHAIN 1 1002 Golgin subfamily A member 2. /FTId=PRO_0000190054.,,,,,,"MOD_RES 18 18 Omega-N-methylated arginine. {ECO:0000305|PubMed:20421892}.; MOD_RES 30 30 Dimethylated arginine. {ECO:0000269|PubMed:20421892}.; MOD_RES 35 35 Dimethylated arginine. {ECO:0000269|PubMed:20421892}.; MOD_RES 37 37 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000269|PubMed:20421892}.; MOD_RES 66 66 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 273 273 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 438 438 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 690 690 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 937 937 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 953 953 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 981 981 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,L06147;CH471090;BC014188;BC069268;AF248953;BT007248;
0,Q08945,SSRP1_HUMAN,SSRP1 FACT80,SSRP1,FACT80,,,Homo sapiens (Human),9606,FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit) (FACT 80 kDa subunit) (FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (hSSRP1) (T160),UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAETLEFNDVYQEVKGSMNDGRLRLSRQGIIFKNSKTGKVDNIQAGELTEGIWRRVALGHGLKLLTKNGHVYKYDGFRESEFEKLSDFFKTHYRLELMEKDLCVKGWNWGTVKFGGQLLSFDIGDQPVFEIPLSNVSQCTTGKNEVTLEFHQNDDAEVSLMEVRFYVPPTQEDGVDPVEAFAQNVLSKADVIQATGDAICIFRELQCLTPRGRYDIRIYPTFLHLHGKTFDYKIPYTTVLRLFLLPHKDQRQMFFVISLDPPIKQGQTRYHFLILLFSKDEDISLTLNMNEEEVEKRFEGRLTKNMSGSLYEMVSRVMKALVNRKITVPGNFQGHSGAQCITCSYKASSGLLYPLERGFIYVHKPPVHIRFDEISFVNFARGTTTTRSFDFEIETKQGTQYTFSSIEREEYGKLFDFVNAKKLNIKNRGLKEGMNPSYDEYADSDEDQHDAYLERMKEEGKIREENANDSSDDSGEETDESFNPGEEEEDVAEEFDSNASASSSSNEGDSDRDEKKRKQLKKAKMAKDRKSRKKPVEVKKGKDPNAPKRPMSAYMLWLNASREKIKSDHPGISITDLSKKAGEIWKGMSKEKKEEWDRKAEDARRDYEKAMKEYEGGRGESSKRDKSKKKKKVKVKMEKKSTPSRGSSSKSSSRQLSESFKSKEFVSSDESSSGENKSKKKRRRSEDSEEEELASTPPSSEDSASGSDE,709,"81,075",,,,,,,,,,,SEQUENCE CAUTION:  Sequence=AAH91486.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305}; ,,VARIANT 225 225 L -> V (in dbSNP:rs768436). /FTId=VAR_052495.; VARIANT 458 458 E -> Q (in dbSNP:rs11540304). /FTId=VAR_052496.,,,,,,1,,0,DOMAIN: The HMG box DNA-binding domain mediates DNA-binding. It has both affinity and specificity for DNA damaged globally with cisplatin. {ECO:0000269|PubMed:11344167}.,SIMILARITY: Belongs to the SSRP1 family. {ECO:0000305}.,,COMPBIAS 439 496 Asp/Glu-rich (acidic).; COMPBIAS 497 511 Ser-rich.; COMPBIAS 512 534 Arg/Lys-rich (basic).; COMPBIAS 623 640 Arg/Lys-rich (basic).; COMPBIAS 641 709 Ser-rich.,,,,,,,,,,,"FUNCTION: Component of the FACT complex, a general chromatin factor that acts to reorganize nucleosomes. The FACT complex is involved in multiple processes that require DNA as a template such as mRNA elongation, DNA replication and DNA repair. During transcription elongation the FACT complex acts as a histone chaperone that both destabilizes and restores nucleosomal structure. It facilitates the passage of RNA polymerase II and transcription by promoting the dissociation of one histone H2A-H2B dimer from the nucleosome, then subsequently promotes the reestablishment of the nucleosome following the passage of RNA polymerase II. The FACT complex is probably also involved in phosphorylation of 'Ser-392' of p53/TP53 via its association with CK2 (casein kinase II). Binds specifically to double-stranded DNA and at low levels to DNA modified by the antitumor agent cisplatin. May potentiate cisplatin-induced cell death by blocking replication and repair of modified DNA. Also acts as a transcriptional coactivator for p63/TP63. {ECO:0000269|PubMed:10912001, ECO:0000269|PubMed:11239457, ECO:0000269|PubMed:12374749, ECO:0000269|PubMed:12934006, ECO:0000269|PubMed:16713563, ECO:0000269|PubMed:9489704, ECO:0000269|PubMed:9566881, ECO:0000269|PubMed:9836642}.",,,,,,,,DNA_BIND 547 615 HMG box. {ECO:0000255|PROSITE-ProRule:PRU00267}.,,,SITE 450 451 Cleavage; by caspase-3 and/or caspase-7.,"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]",DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]",chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],GO:0000981; GO:0003677; GO:0003682; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006281; GO:0006366; GO:0006368; GO:1901796,IPR013719; IPR009071; IPR036910; IPR011993; IPR035417; IPR000969; IPR024954; IPR038167; ,P68400; P33991; Q14566; Q9Y5B9,"SUBUNIT: Interacts with MYOG (via C-terminal region) (By similarity). Component of the FACT complex, a stable heterodimer of SSRP1 and SUPT16H (PubMed:10421373). Also component of a CK2-SPT16-SSRP1 complex which forms following UV irradiation, composed of SSRP1, SUPT16H, CSNK2A1, CSNK2A2 and CSNK2B (PubMed:11239457, PubMed:12393879). Binds to histone H3-H4 tetramers, but not to intact nucleosomes. Identified in a centromere complex containing histones H2A, H2B and H4, and at least CENPA, CENPB, CENPC, CENPT, CENPN, HJURP, SUPT16H, SSRP1 and RSF1 (PubMed:27499292). Interacts with isoform gamma of TP63 (PubMed:12374749). Interacts with FYTTD1/UIF (PubMed:19836239). Interacts with SRF (By similarity). Interacts with NEK9 (PubMed:14660563). {ECO:0000250|UniProtKB:Q04931, ECO:0000250|UniProtKB:Q08943, ECO:0000269|PubMed:10421373, ECO:0000269|PubMed:11239457, ECO:0000269|PubMed:12374749, ECO:0000269|PubMed:12393879, ECO:0000269|PubMed:14660563, ECO:0000269|PubMed:19836239, ECO:0000269|PubMed:27499292}.; SUBUNIT: (Microbial infection) Interacts with Herpes simplex virus 1 (HHV-1) protein ICP22; this interaction relocalizes the FACT complex to viral genomes in infected cells. {ECO:0000269|PubMed:28611249}.",1372440; 15489334; 9489704; 9566881; 9836642; 10421373; 10912001; 11344167; 11239457; 12374749; 12393879; 11824977; 12934006; 14660563; 15561718; 15659405; 16713563; 17081983; 16498457; 18220336; 18669648; 18318008; 19413330; 19836239; 19690332; 19608861; 20068231; 21269460; 21406692; 22002106; 22223895; 22814378; 23186163; 24275569; 27499292; 28611249; 28112733,1372440; 15489334; 9489704; 9566881; 9836642; 10421373; 10912001; 11344167; 11239457; 12374749; 12393879; 11824977; 12934006; 14660563; 15561718; 15659405; 16713563; 17081983; 16498457; 18220336; 18669648; 18318008; 19413330; 19836239; 19690332; 19608861; 20068231; 21269460; 21406692; 22002106; 22223895; 22814378; 23186163; 24275569; 27499292; 28611249; 28112733; 11313498; 11313499; 11859374; 12676794; 14559993; 15034300; 15047060; 15231747; 15489290; 16169070; 16730941; 16902406; 17209051; 17234882; 17353931; 17672918; 18274552; 19214185; 19367725; 19463016; 19625449; 19639603; 19710137; 19738201; 19759537; 19952111; 19995907; 20195357; 20562859; 20603019; 21113133; 21232560; 21252943; 21454601; 21679440; 21723284; 21907836; 21969370; 22012619; 22113938; 22575643; 22623428; 22940245; 22988298; 23325844; 23538671; 23610384; 23839038; 23902751; 24357716; 24554720; 24662513; 25000480; 25028470; 25429106; 25561469; 25609649; 25712099; 25852190; 26496610; 26638075; 26659056; 26687053; 26755331; 26842758; 26966247; 27146025; 27216501; 27370399; 27467129; 27525970; 28423528; 29048646; 29514976; 29764934; 8370526,1995-02-01,2019-02-13,1995-02-01,199,X-ray crystallography (3); NMR spectroscopy (1),STRAND 3 14 {ECO:0000244|PDB:5UMR}.; STRAND 17 34 {ECO:0000244|PDB:5UMR}.; STRAND 40 44 {ECO:0000244|PDB:5UMR}.; STRAND 48 55 {ECO:0000244|PDB:5UMR}.; STRAND 57 66 {ECO:0000244|PDB:5UMR}.; STRAND 71 77 {ECO:0000244|PDB:5UMR}.; STRAND 198 209 {ECO:0000244|PDB:5UMS}.; STRAND 212 218 {ECO:0000244|PDB:5UMS}.; STRAND 220 229 {ECO:0000244|PDB:5UMS}.; STRAND 231 235 {ECO:0000244|PDB:5UMS}.; STRAND 239 246 {ECO:0000244|PDB:5UMS}.; STRAND 250 265 {ECO:0000244|PDB:5UMS}.; STRAND 268 278 {ECO:0000244|PDB:5UMS}.; STRAND 282 286 {ECO:0000244|PDB:5UMS}.; STRAND 304 309 {ECO:0000244|PDB:5UMS}.; STRAND 322 324 {ECO:0000244|PDB:5UMS}.; STRAND 335 337 {ECO:0000244|PDB:5UMS}.; STRAND 339 345 {ECO:0000244|PDB:5UMS}.; STRAND 348 354 {ECO:0000244|PDB:5UMS}.; STRAND 356 365 {ECO:0000244|PDB:5UMS}.; STRAND 367 370 {ECO:0000244|PDB:5UMS}.; STRAND 374 381 {ECO:0000244|PDB:5UMS}.; STRAND 383 385 {ECO:0000244|PDB:5UMS}.; STRAND 388 395 {ECO:0000244|PDB:5UMS}.; STRAND 400 407 {ECO:0000244|PDB:5UMS}.,HELIX 45 47 {ECO:0000244|PDB:5UMR}.; HELIX 79 81 {ECO:0000244|PDB:5UMR}.; HELIX 82 92 {ECO:0000244|PDB:5UMR}.; HELIX 236 238 {ECO:0000244|PDB:5UMS}.; HELIX 291 298 {ECO:0000244|PDB:5UMS}.; HELIX 310 321 {ECO:0000244|PDB:5UMS}.; HELIX 371 373 {ECO:0000244|PDB:5UMS}.; HELIX 408 410 {ECO:0000244|PDB:5UMS}.; HELIX 411 420 {ECO:0000244|PDB:5UMS}.; HELIX 552 568 {ECO:0000244|PDB:5VWE}.; HELIX 574 587 {ECO:0000244|PDB:5VWE}.; HELIX 590 614 {ECO:0000244|PDB:5VWE}.,TURN 35 37 {ECO:0000244|PDB:5UMR}.,,,,,5 out of 5,Beta strand (25); Chain (1); Compositional bias (5); Cross-link (3); DNA binding (1); Helix (12); Initiator methionine (1); Modified residue (19); Mutagenesis (4); Natural variant (2); Sequence caution (1); Site (1); Turn (1),,,"MISCELLANEOUS: Autoantibodies against SSRP1 are present in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.",3D-structure;Acetylation;Chromosome;Complete proteome;DNA damage;DNA repair;DNA replication;DNA-binding;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation,Evidence at protein level,reviewed,,SSRP1 family,199,Domain (1); Function (1); Miscellaneous (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (1); Subunit structure (2),,KW-0002; KW-0007; KW-0158; KW-0181; KW-0227; KW-0234; KW-0235; KW-0238; KW-0539; KW-0597; KW-0621; KW-0804; KW-0805; KW-0832; KW-0903; KW-1017; KW-1185,,,,,,,,"PTM: Phosphorylated by CK2 following UV but not gamma irradiation. Phosphorylation inhibits its DNA-binding activity. {ECO:0000269|PubMed:12393879, ECO:0000269|PubMed:15659405}.; PTM: Ubiquitinated. Polyubiquitinated following caspase cleavage resulting in degradation of the N-terminal ubiquitinated part of the cleaved protein. {ECO:0000269|PubMed:16498457}.; PTM: Sumoylated. {ECO:0000269|PubMed:15561718}.",CHAIN 2 709 FACT complex subunit SSRP1. /FTId=PRO_0000048606.,CROSSLNK 90 90 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 296 296 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 364 364 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.3}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.3}.; MOD_RES 170 170 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 233 233 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 413 413 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 437 437 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 441 441 Phosphotyrosine. {ECO:0000250|UniProtKB:Q08943}.; MOD_RES 444 444 Phosphoserine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 452 452 Phosphotyrosine. {ECO:0000250|UniProtKB:Q08943}.; MOD_RES 471 471 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 510 510 Phosphoserine; by CK2. {ECO:0000305|PubMed:15659405}.; MOD_RES 542 542 N6-acetyllysine. {ECO:0000250|UniProtKB:Q08943}.; MOD_RES 657 657 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000269|PubMed:15659405}.; MOD_RES 659 659 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 667 667 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 668 668 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692}.; MOD_RES 671 671 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692}.; MOD_RES 672 672 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 673 673 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 688 688 Phosphoserine; by CK2. {ECO:0000305|PubMed:15659405}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,M86737;BC005116;BC091486;
0,Q12959,DLG1_HUMAN,DLG1,DLG1,,,,Homo sapiens (Human),9606,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97) (hDlg),UP000005640: Chromosome 3,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPVRKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVINIFQSNLFQALIDIQEFYEVTLLDNPKCIDRSKPSEPIQPVNTWEISSLPSSTVTSETLPSSLSPSVEKYRYQDEDTPPQEHISPQITNEVIGPELVHVSEKNLSEIENVHGFVSHSHISPIKPTEAVLPSPPTVPVIPVLPVPAENTVILPTIPQANPPPVLVNTDSLETPTYVNGTDADYEYEEITLERGNSGLGFSIAGGTDNPHIGDDSSIFITKIITGGAAAQDGRLRVNDCILRVNEVDVRDVTHSKAVEALKEAGSIVRLYVKRRKPVSEKIMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEGGAAHKDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSDFVYLKVAKPTSMYMNDGYAPPDITNSSSQPVDNHVSPSSFLGQTPASPARYSPVSKAVLGDDEITREPRKVVLHRGSTGLGFNIVGGEDGEGIFISFILAGGPADLSGELRKGDRIISVNSVDLRAASHEQAAAALKNAGQAVTIVAQYRPEEYSRFEAKIHDLREQMMNSSISSGSGSLRTSQKRSLYVRALFDYDKTKDSGLPSQGLNFKFGDILHVINASDDEWWQARQVTPDGESDEVGVIPSKRRVEKKERARLKTVKFNSKTRDKGEIPDDMGSKGLKHVTSNASDSESSYRGQEEYVLSYEPVNQQEVNYTRPVIILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSREQMEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNAIKRLQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEHFTAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL,904,"100,455",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=9;  Name=1; IsoId=Q12959-1; Sequence=Displayed; Name=2; IsoId=Q12959-2; Sequence=VSP_003150; Name=3; IsoId=Q12959-3; Sequence=VSP_012862; Name=4; IsoId=Q12959-4; Sequence=VSP_012862, VSP_003150; Name=5; IsoId=Q12959-5; Sequence=VSP_012862, VSP_012863; Name=6; IsoId=Q12959-6; Sequence=VSP_012864; Name=7; IsoId=Q12959-7; Sequence=VSP_012865; Name=8; IsoId=Q12959-8; Sequence=VSP_045896, VSP_045897; Note=No experimental confirmation available.; Name=9; IsoId=Q12959-9; Sequence=VSP_045896, VSP_045897, VSP_012865, VSP_045898; Note=No experimental confirmation available.; ",,,,,,,,,,"VAR_SEQ 1 77 MPVRKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVINIFQSNLFQALIDIQEFYEVTLLDNPKCIDRSKPSEPIQ -> MNYIFGNNTLLYSRGSRGGNTSSSHGSAGPKQKHWAKKGSSDELQAEPEPSRWQQIVAFFTRRHSFIDCISVATSST (in isoform 8 and isoform 9). {ECO:0000303|PubMed:14702039}. /FTId=VSP_045896.; VAR_SEQ 78 193 Missing (in isoform 8 and isoform 9). {ECO:0000303|PubMed:14702039}. /FTId=VSP_045897.; VAR_SEQ 162 194 Missing (in isoform 3, isoform 4 and isoform 5). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:7937897}. /FTId=VSP_012862.; VAR_SEQ 195 212 Missing (in isoform 5). {ECO:0000305}. /FTId=VSP_012863.; VAR_SEQ 669 680 EIPDDMGSKGLK -> QSFNDKRKKNLFSRKFPFYKNKDQSEQETSDADQ (in isoform 2 and isoform 4). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:7937897}. /FTId=VSP_003150.; VAR_SEQ 681 693 Missing (in isoform 6). {ECO:0000305}. /FTId=VSP_012864.; VAR_SEQ 693 693 Y -> YLILITDEYGCSKG (in isoform 7 and isoform 9). {ECO:0000303|PubMed:14702039}. /FTId=VSP_012865.; VAR_SEQ 694 694 Missing (in isoform 9). {ECO:0000303|PubMed:14702039}. /FTId=VSP_045898.","VARIANT 140 140 K -> R (in dbSNP:rs1802668). /FTId=VAR_054334.; VARIANT 278 278 R -> Q (in dbSNP:rs1134986). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:7937897}. /FTId=VAR_054335.; VARIANT 899 899 P -> L (in dbSNP:rs34492126). /FTId=VAR_054336.",,,,CONFLICT 237 237 S -> N (in Ref. 2; BAG57902). {ECO:0000305}.; CONFLICT 801 801 E -> G (in Ref. 1; AAA50598/AAA50599). {ECO:0000305}.,,2,,0,DOMAIN: The alternatively spliced domain I3 corresponding to amino acids (636-669) of isoform 4 is an EPB41 binding site mediating association to membranes in polarized and non-polarized cells.; DOMAIN: The PDZ domains may also mediate association to membranes by binding to EPB41 and ADGRA2 together with the L27 domain that binds CASK and DLG2.; DOMAIN: The L27 domain may regulate DLG1 self-association. The N-terminal alternatively spliced region is capable of binding several SH3 domains and also moderates the level of protein oligomerization.,SIMILARITY: Belongs to the MAGUK family. {ECO:0000305}.,,,DOMAIN 4 64 L27. {ECO:0000255|PROSITE-ProRule:PRU00365}.; DOMAIN 224 310 PDZ 1. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 319 405 PDZ 2. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 466 546 PDZ 3. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 581 651 SH3. {ECO:0000255|PROSITE-ProRule:PRU00192}.; DOMAIN 714 889 Guanylate kinase-like. {ECO:0000255|PROSITE-ProRule:PRU00100}.,,REGION 162 212 Interaction with SH3 domains.,,,,,,,,"FUNCTION: Essential multidomain scaffolding protein required for normal development (By similarity). Recruits channels, receptors and signaling molecules to discrete plasma membrane domains in polarized cells. May play a role in adherens junction assembly, signal transduction, cell proliferation, synaptogenesis and lymphocyte activation. Regulates the excitability of cardiac myocytes by modulating the functional expression of Kv4 channels. Functional regulator of Kv1.5 channel. {ECO:0000250, ECO:0000269|PubMed:10656683, ECO:0000269|PubMed:12445884, ECO:0000269|PubMed:14699157, ECO:0000269|PubMed:15263016, ECO:0000269|PubMed:19213956, ECO:0000269|PubMed:20605917}.",,,,,,,,,,,,apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex scaffold activity [GO:0032947]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; structural constituent of postsynaptic density [GO:0098919]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cellular protein-containing complex localization [GO:0034629]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; MAPK cascade [GO:0000165]; membrane raft organization [GO:0031579]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110]; T cell cytokine production [GO:0002369]; viral process [GO:0016032],actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cellular protein-containing complex localization [GO:0034629]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; MAPK cascade [GO:0000165]; membrane raft organization [GO:0031579]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110]; T cell cytokine production [GO:0002369]; viral process [GO:0016032],cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein-containing complex scaffold activity [GO:0032947]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; structural constituent of postsynaptic density [GO:0098919],apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383],GO:0000122; GO:0000165; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0002369; GO:0004385; GO:0004721; GO:0005088; GO:0005604; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005911; GO:0005923; GO:0007015; GO:0007093; GO:0007163; GO:0007268; GO:0008022; GO:0008092; GO:0008284; GO:0008360; GO:0009898; GO:0014704; GO:0015459; GO:0016032; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0019902; GO:0030054; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031434; GO:0031579; GO:0031594; GO:0031641; GO:0032147; GO:0032947; GO:0033268; GO:0034629; GO:0035255; GO:0035748; GO:0042110; GO:0042130; GO:0042383; GO:0042391; GO:0042982; GO:0043005; GO:0043113; GO:0043219; GO:0043268; GO:0043622; GO:0044325; GO:0045121; GO:0045197; GO:0045296; GO:0045930; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0070062; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097120; GO:0098609; GO:0098839; GO:0098911; GO:0098919; GO:0098978; GO:0099645; GO:1902305; GO:1903078; GO:1903286; GO:1903753; GO:1903760; GO:1903764,IPR016313; IPR019590; IPR008145; IPR008144; IPR020590; IPR015143; IPR004172; IPR036892; IPR027417; IPR001478; IPR019583; IPR036034; IPR036028; IPR001452; ,P78536; Q96PE1; Q8IWK6-3; Q9NQ90; A1A5B4; Q5VV41; Q9Y297; Q86XJ0; P15813; P34998; Q9UQB3; Q9NS75; P31016; O57125; P03126; P06427; P06463; P17386; P21735; P24835; P27228; P36799; P50804; P54667; O60447; P0C2L3; Q14CM0; Q13224; Q14957; P33402; Q9P2D3; Q9NQT8; O60333-3; P36507; P53778; Q7Z628; Q99569; P85299; Q15311; Q9ICL1; O15427; Q9C0D5; P09708; Q9ULK5,"SUBUNIT: Homotetramer (Probable). Interacts (via guanylate kinase-like domain) with DLGAP1, DLGAP2, DLGAP3, DLGAP4 and MAP1A (By similarity). Interacts (via guanylate kinase-like domain) with KIF13B (PubMed:10859302). May interact with HTR2A (By similarity). Interacts (via PDZ domains) with GRIA1 (By similarity). Interacts (via PDZ domains) with GRIN2A (By similarity). Interacts (via PDZ domains) with KCND2 and KCND3 (PubMed:19213956). Interacts (via PDZ domains) with KCNA1, KCNA2, KCNA3 and KCNA4 (PubMed:7477295). Interacts (via PDZ domains) with ADGRA3 (PubMed:15021905). Interacts with KCNF1 (PubMed:12445884). Interacts with CAMK2 (By similarity). Interacts with cytoskeleton-associated protein EPB41 (PubMed:7937897, PubMed:8922391). Interacts with cytoskeleton-associated protein EZR (By similarity). Found in a complex with KCNA5 and CAV3 (By similarity). Found in a complex with APC and CTNNB1 (PubMed:8638125, PubMed:10656683). Interacts with CDH1 through binding to PIK3R1 (PubMed:14699157). Forms multiprotein complexes with CASK, LIN7A, LIN7B, LIN7C, APBA1, and KCNJ12 (By similarity). Interacts with TOPK (PubMed:10779557). Forms a tripartite complex composed of DLG1, MPP7 and LIN7 (LIN7A or LIN7C) (PubMed:17237226, PubMed:17332497, PubMed:20702775). May interact with TJAP1 (PubMed:11602598). Interacts with PTEN (By similarity). Interacts with FRMPD4 (via C-terminus) (PubMed:19118189). Interacts with LRFN1, LRFN2 and LRFN4 (PubMed:16630835). Interacts with SFPQ (PubMed:20605917). Interacts (via PDZ domains) with ADGRA2 (via PDZ-binding motif) (PubMed:15021905, PubMed:25558062). {ECO:0000250|UniProtKB:Q62696, ECO:0000250|UniProtKB:Q811D0, ECO:0000269|PubMed:10656683, ECO:0000269|PubMed:10779557, ECO:0000269|PubMed:10859302, ECO:0000269|PubMed:12445884, ECO:0000269|PubMed:14699157, ECO:0000269|PubMed:15021905, ECO:0000269|PubMed:16630835, ECO:0000269|PubMed:17237226, ECO:0000269|PubMed:17332497, ECO:0000269|PubMed:19118189, ECO:0000269|PubMed:19213956, ECO:0000269|PubMed:20605917, ECO:0000269|PubMed:20702775, ECO:0000269|PubMed:25558062, ECO:0000269|PubMed:7477295, ECO:0000269|PubMed:7937897, ECO:0000269|PubMed:8638125, ECO:0000269|PubMed:8922391, ECO:0000305}.; SUBUNIT: (Microbial infection) Interacts with HTLV-1 protein Tax. {ECO:0000269|PubMed:10557085}.; SUBUNIT: (Microbial infection) Interacts with human papillomavirus 18/HPV-18 protein E6. {ECO:0000269|PubMed:9192623}.",7937897; 14702039; 17974005; 16641997; 15489334; 7477295; 8922391; 8638125; 9192623; 10557085; 10859302; 10656683; 10779557; 11602598; 12445884; 11723125; 12807908; 14699157; 15263016; 15021905; 12766944; 17081983; 16630835; 17237226; 17332497; 19118189; 18220336; 18669648; 19213956; 19690332; 20605917; 20068231; 21269460; 23186163; 24275569; 25558062; 25944712; 8757139; 20702775,7937897; 14702039; 17974005; 16641997; 15489334; 7477295; 8922391; 8638125; 9192623; 10557085; 10859302; 10656683; 10779557; 11602598; 12445884; 11723125; 12807908; 14699157; 15263016; 15021905; 12766944; 17081983; 16630835; 17237226; 17332497; 19118189; 18220336; 18669648; 19213956; 19690332; 20605917; 20068231; 21269460; 23186163; 24275569; 25558062; 25944712; 8757139; 20702775; 11274188; 11807220; 12067714; 12081647; 12097473; 12419826; 12444549; 12668732; 12902344; 12970345; 14743216; 15221964; 15286176; 15485825; 15507623; 15669058; 15729360; 15992371; 16103886; 16228013; 16466689; 16495444; 16619250; 16636290; 16882004; 17069616; 17156128; 17172448; 17574238; 17696365; 17713926; 17980554; 18245566; 18311135; 18461433; 18665322; 18725271; 18760273; 18930083; 19017653; 19066288; 19086053; 19307009; 19342380; 19555689; 19586902; 19615732; 20201926; 20356847; 20379614; 20398908; 20551903; 20643107; 20691406; 20980075; 21041448; 21113079; 21164104; 21489588; 21525870; 21595829; 21615688; 21850710; 21858148; 22027822; 22185284; 22225629; 22272285; 22307621; 22377151; 22378744; 22383878; 22434720; 22657348; 22682247; 22792261; 23185531; 23185543; 23532850; 23576434; 23624197; 23638119; 23864692; 24324269; 24366813; 24503895; 24788832; 24937328; 24989932; 25098293; 25241761; 25253337; 25268382; 25429624; 25499266; 25720117; 25852190; 26440542; 26638075; 26653181; 27026592; 27240320; 27760079; 28040505; 28195572; 28244171; 28652577; 28990294; 29168728; 29263038; 8782898; 9341123; 9625352,1997-11-01,2019-02-13,2009-02-10,217,X-ray crystallography (8); NMR spectroscopy (2),STRAND 24 26 {ECO:0000244|PDB:3LRA}.; STRAND 221 228 {ECO:0000244|PDB:3RL7}.; STRAND 233 239 {ECO:0000244|PDB:3RL7}.; STRAND 254 258 {ECO:0000244|PDB:3RL7}.; STRAND 275 279 {ECO:0000244|PDB:3RL7}.; STRAND 301 309 {ECO:0000244|PDB:3RL7}.; STRAND 317 323 {ECO:0000244|PDB:2X7Z}.; STRAND 331 337 {ECO:0000244|PDB:2X7Z}.; STRAND 348 353 {ECO:0000244|PDB:2X7Z}.; STRAND 370 374 {ECO:0000244|PDB:2X7Z}.; STRAND 377 382 {ECO:0000244|PDB:2OQS}.; STRAND 396 403 {ECO:0000244|PDB:2X7Z}.; STRAND 465 470 {ECO:0000244|PDB:1PDR}.; STRAND 472 474 {ECO:0000244|PDB:1PDR}.; STRAND 477 482 {ECO:0000244|PDB:1PDR}.; STRAND 484 487 {ECO:0000244|PDB:1PDR}.; STRAND 489 494 {ECO:0000244|PDB:1PDR}.; STRAND 510 515 {ECO:0000244|PDB:1PDR}.; STRAND 537 545 {ECO:0000244|PDB:1PDR}.; STRAND 717 721 {ECO:0000244|PDB:3W9Y}.; STRAND 778 784 {ECO:0000244|PDB:3W9Y}.; STRAND 787 792 {ECO:0000244|PDB:3W9Y}.; STRAND 805 808 {ECO:0000244|PDB:3W9Y}.; STRAND 826 830 {ECO:0000244|PDB:3W9Y}.; STRAND 869 872 {ECO:0000244|PDB:3W9Y}.,HELIX 5 20 {ECO:0000244|PDB:3LRA}.; HELIX 30 42 {ECO:0000244|PDB:3LRA}.; HELIX 44 55 {ECO:0000244|PDB:3LRA}.; HELIX 64 66 {ECO:0000244|PDB:3LRA}.; HELIX 263 267 {ECO:0000244|PDB:3RL7}.; HELIX 289 298 {ECO:0000244|PDB:3RL7}.; HELIX 358 362 {ECO:0000244|PDB:2X7Z}.; HELIX 384 392 {ECO:0000244|PDB:2X7Z}.; HELIX 499 503 {ECO:0000244|PDB:1PDR}.; HELIX 525 533 {ECO:0000244|PDB:1PDR}.; HELIX 547 554 {ECO:0000244|PDB:1PDR}.; HELIX 724 734 {ECO:0000244|PDB:3W9Y}.; HELIX 766 774 {ECO:0000244|PDB:3W9Y}.; HELIX 793 800 {ECO:0000244|PDB:3W9Y}.; HELIX 813 820 {ECO:0000244|PDB:3W9Y}.; HELIX 855 864 {ECO:0000244|PDB:3W9Y}.; HELIX 865 867 {ECO:0000244|PDB:3W9Y}.; HELIX 877 892 {ECO:0000244|PDB:3W9Y}.; HELIX 900 902 {ECO:0000244|PDB:3W9Y}.,TURN 60 62 {ECO:0000244|PDB:3LRA}.; TURN 736 738 {ECO:0000244|PDB:3W9Y}.; TURN 756 758 {ECO:0000244|PDB:3W9Y}.; TURN 801 803 {ECO:0000244|PDB:3W9Y}.,,,,,5 out of 5,Alternative sequence (8); Beta strand (25); Chain (1); Domain (6); Helix (19); Modified residue (17); Mutagenesis (1); Natural variant (3); Region (1); Sequence conflict (4); Turn (4),,"TISSUE SPECIFICITY: Abundantly expressed in atrial myocardium (at protein level). Expressed in lung fibroblasts, cervical epithelial and B-cells (at protein level). Widely expressed, with isoforms displaying different expression profiles. {ECO:0000269|PubMed:12445884, ECO:0000269|PubMed:19213956, ECO:0000269|PubMed:7937897}.",,3D-structure;Alternative splicing;Cell junction;Cell membrane;Complete proteome;Cytoplasm;Endoplasmic reticulum;Host-virus interaction;Membrane;Phosphoprotein;Polymorphism;Postsynaptic cell membrane;Reference proteome;Repeat;SH3 domain;Synapse,Evidence at protein level,reviewed,,MAGUK family,217,Alternative products (1); Caution (2); Domain (3); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (3); Tissue specificity (1),,KW-0002; KW-0025; KW-0181; KW-0256; KW-0472; KW-0597; KW-0621; KW-0628; KW-0677; KW-0728; KW-0770; KW-0945; KW-0963; KW-0965; KW-1003; KW-1185,,,,,,,,PTM: Phosphorylated by MAPK12. Phosphorylation of Ser-232 regulates association with GRIN2A (By similarity). {ECO:0000250}.,CHAIN 1 904 Disks large homolog 1. /FTId=PRO_0000094548.,,,,,,"MOD_RES 115 115 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 122 122 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 138 138 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 158 158 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 232 232 Phosphoserine. {ECO:0000250|UniProtKB:Q62696}.; MOD_RES 399 399 Phosphotyrosine. {ECO:0000250|UniProtKB:Q811D0}.; MOD_RES 568 568 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 573 573 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 575 575 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 579 579 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 598 598 Phosphoserine. {ECO:0000250|UniProtKB:Q811D0}.; MOD_RES 619 619 Phosphoserine. {ECO:0000244|PubMed:18220336}.; MOD_RES 684 684 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 687 687 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 834 834 Phosphoserine. {ECO:0000250|UniProtKB:Q62696}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U13896;U13897;AK294772;AK294855;EF553524;CH471191;CH471191;CH471191;CH471191;BC140841;BC144651;
0,Q13017,RHG05_HUMAN,ARHGAP5 RHOGAP5,ARHGAP5,RHOGAP5,,,Homo sapiens (Human),9606,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),UP000005640: Chromosome 14,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MMAKNKEPRPPSYTISIVGLSGTEKDKGNCGVGKSCLCNRFVRSKADEYYPEHTSVLSTIDFGGRVVNNDHFLYWGDIIQNSEDGVECKIHVIEQTEFIDDQTFLPHRSTNLQPYIKRAAASKLQSAEKLMYICTDQLGLEQDFEQKQMPEGKLNVDGFLLCIDVSQGCNRKFDDQLKFVNNLFVQLSKSKKPVIIAATKCDECVDHYLREVQAFASNKKNLLVVETSARFNVNIETCFTALVQMLDKTRSKPKIIPYLDAYKTQRQLVVTATDKFEKLVQTVRDYHATWKTVSNKLKNHPDYEEYINLEGTRKARNTFSKHIEQLKQEHIRKRREEYINTLPRAFNTLLPNLEEIEHLNWSEALKLMEKRADFQLCFVVLEKTPWDETDHIDKINDRRIPFDLLSTLEAEKVYQNHVQHLISEKRRVEMKEKFKKTLEKIQFISPGQPWEEVMCFVMEDEAYKYITEADSKEVYGRHQREIVEKAKEEFQEMLFEHSELFYDLDLNATPSSDKMSEIHTVLSEEPRYKALQKLAPDRESLLLKHIGFVYHPTKETCLSGQNCTDIKVEQLLASSLLQLDHGRLRLYHDSTNIDKVNLFILGKDGLAQELANEIRTQSTDDEYALDGKIYELDLRPVDAKSPYFLSQLWTAAFKPHGCFCVFNSIESLSFIGEFIGKIRTEASQIRKDKYMANLPFTLILANQRDSISKNLPILRHQGQQLANKLQCPFVDVPAGTYPRKFNETQIKQALRGVLESVKHNLDVVSPIPANKDLSEADLRIVMCAMCGDPFSVDLILSPFLDSHSCSAAQAGQNNSLMLDKIIGEKRRRIQITILSYHSSIGVRKDELVHGYILVYSAKRKASMGMLRAFLSEVQDTIPVQLVAVTDSQADFFENEAIKELMTEGEHIATEITAKFTALYSLSQYHRQTEVFTLFFSDVLEKKNMIENSYLSDNTRESTHQSEDVFLPSPRDCFPYNNYPDSDDDTEAPPPYSPIGDDVQLLPTPSDRSRYRLDLEGNEYPIHSTPNCHDHERNHKVPPPIKPKPVVPKTNVKKLDPNLLKTIEAGIGKNPRKQTSRVPLAHPEDMDPSDNYAEPIDTIFKQKGYSDEIYVVPDDSQNRIKIRNSFVNNTQGDEENGFSDRTSKSHGERRPSKYKYKSKTLFSKAKSYYRRTHSDASDDEAFTTSKTKRKGRHRGSEEDPLLSPVETWKGGIDNPAITSDQELDDKKMKKKTHKVKEDKKQKKKTKNFNPPTRRNWESNYFGMPLQDLVTAEKPIPLFVEKCVEFIEDTGLCTEGLYRVSGNKTDQDNIQKQFDQDHNINLVSMEVTVNAVAGALKAFFADLPDPLIPYSLHPELLEAAKIPDKTERLHALKEIVKKFHPVNYDVFRYVITHLNRVSQQHKINLMTADNLSICFWPTLMRPDFENREFLSTTKIHQSVVETFIQQCQFFFYNGEIVETTNIVAPPPPSNPGQLVEPMVPLQLPPPLQPQLIQPQLQTDPLGII,1502,"172,460",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; IsoId=Q13017-1; Sequence=Displayed; Name=2; IsoId=Q13017-2; Sequence=VSP_034166; Note=No experimental confirmation available.; Name=3; IsoId=Q13017-3; Sequence=VSP_034164, VSP_034167; Note=No experimental confirmation available.; Name=4; IsoId=Q13017-4; Sequence=VSP_034165; Note=No experimental confirmation available.; ",,,,,SEQUENCE CAUTION:  Sequence=AAA95963.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305}; ,,,,SEQUENCE CAUTION:  Sequence=AAH32723.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305}; ,VAR_SEQ 1 1265 Missing (in isoform 3). {ECO:0000303|PubMed:15489334}. /FTId=VSP_034164.; VAR_SEQ 1 1261 Missing (in isoform 4). {ECO:0000303|PubMed:15489334}. /FTId=VSP_034165.; VAR_SEQ 1240 1240 Missing (in isoform 2). {ECO:0000303|Ref.5}. /FTId=VSP_034166.; VAR_SEQ 1266 1288 DLVTAEKPIPLFVEKCVEFIEDT -> MSLPPPPPGPLPLRRRRRRPTLL (in isoform 3). {ECO:0000303|PubMed:15489334}. /FTId=VSP_034167.,VARIANT 17 17 I -> V (in dbSNP:rs17386818). /FTId=VAR_043980.,,,,CONFLICT 80 80 Q -> R (in Ref. 3; AAH50059). {ECO:0000305}.; CONFLICT 409 409 E -> G (in Ref. 4; BAF85655). {ECO:0000305}.; CONFLICT 541 541 L -> F (in Ref. 5; BAD92988). {ECO:0000305}.; CONFLICT 620 620 D -> G (in Ref. 4; BAF85655). {ECO:0000305}.; CONFLICT 1383 1383 D -> G (in Ref. 3; AAH50059). {ECO:0000305}.,,2,,0,DOMAIN: The pG1 pseudoGTPase domain does not bind GTP. {ECO:0000269|PubMed:28894085}.,,,COMPBIAS 1225 1245 Lys-rich.,DOMAIN 267 325 FF 1.; DOMAIN 366 420 FF 2.; DOMAIN 427 481 FF 3.; DOMAIN 482 548 FF 4.; DOMAIN 590 763 pG1 pseudoGTPase. {ECO:0000255|PROSITE-ProRule:PRU01199}.; DOMAIN 779 944 pG2 pseudoGTPase. {ECO:0000255|PROSITE-ProRule:PRU01200}.; DOMAIN 1262 1449 Rho-GAP. {ECO:0000255|PROSITE-ProRule:PRU00172}.,,,,,,,,,,FUNCTION: GTPase-activating protein for Rho family members (PubMed:8537347). {ECO:0000269|PubMed:8537347}.,,,,,,,,,,,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; SH2 domain binding [GO:0042169]; cell adhesion [GO:0007155]; mammary gland development [GO:0030879]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],cell adhesion [GO:0007155]; mammary gland development [GO:0030879]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; SH2 domain binding [GO:0042169],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0007155; GO:0007266; GO:0030879; GO:0042169; GO:0051056,IPR002713; IPR036517; IPR027417; IPR039007; IPR008936; IPR032835; IPR000198; IPR039006; IPR001806; ,P61588,SUBUNIT: May interact with RASA1/p120GAP. {ECO:0000305|PubMed:8537347}.,8537347; 15489334; 14702039; 16777052; 18691976; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 28894085,8537347; 15489334; 14702039; 16777052; 18691976; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 28894085; 10713673; 11431473; 11804589; 12705864; 14610059; 15231748; 16469769; 17222083; 18829532; 18996642; 19822667; 23474761; 23552690; 23622247; 23653363; 24316134; 25961434; 27231093; 28100790; 2825022; 8288572; 9605766,2003-02-28,2019-02-13,2008-06-10,171,X-ray crystallography (1); NMR spectroscopy (2),STRAND 595 601 {ECO:0000244|PDB:5U4V}.; STRAND 622 625 {ECO:0000244|PDB:5U4V}.; STRAND 628 637 {ECO:0000244|PDB:5U4V}.; STRAND 656 664 {ECO:0000244|PDB:5U4V}.; STRAND 696 701 {ECO:0000244|PDB:5U4V}.; STRAND 729 732 {ECO:0000244|PDB:5U4V}.; STRAND 1258 1262 {ECO:0000244|PDB:2EE4}.; STRAND 1341 1343 {ECO:0000244|PDB:2EE4}.; STRAND 1425 1427 {ECO:0000244|PDB:2EE5}.,HELIX 606 615 {ECO:0000244|PDB:5U4V}.; HELIX 665 683 {ECO:0000244|PDB:5U4V}.; HELIX 711 725 {ECO:0000244|PDB:5U4V}.; HELIX 743 760 {ECO:0000244|PDB:5U4V}.; HELIX 1264 1267 {ECO:0000244|PDB:2EE4}.; HELIX 1276 1287 {ECO:0000244|PDB:2EE4}.; HELIX 1302 1314 {ECO:0000244|PDB:2EE4}.; HELIX 1320 1323 {ECO:0000244|PDB:2EE4}.; HELIX 1327 1340 {ECO:0000244|PDB:2EE4}.; HELIX 1351 1358 {ECO:0000244|PDB:2EE4}.; HELIX 1363 1373 {ECO:0000244|PDB:2EE4}.; HELIX 1381 1397 {ECO:0000244|PDB:2EE4}.; HELIX 1399 1402 {ECO:0000244|PDB:2EE4}.; HELIX 1406 1417 {ECO:0000244|PDB:2EE4}.; HELIX 1434 1443 {ECO:0000244|PDB:2EE4}.; HELIX 1445 1448 {ECO:0000244|PDB:2EE4}.,TURN 1293 1297 {ECO:0000244|PDB:2EE4}.; TURN 1348 1350 {ECO:0000244|PDB:2EE4}.; TURN 1374 1376 {ECO:0000244|PDB:2EE4}.,,,,,5 out of 5,Alternative sequence (4); Beta strand (9); Chain (1); Compositional bias (1); Domain (7); Frameshift (1); Helix (16); Modified residue (11); Natural variant (1); Sequence caution (1); Sequence conflict (5); Turn (3),,TISSUE SPECIFICITY: Detected in skin fibroblasts (at protein level) (PubMed:8537347). {ECO:0000269|PubMed:8537347}.,,3D-structure;Alternative splicing;Cell membrane;Complete proteome;Cytoplasm;GTPase activation;Membrane;Nitration;Phosphoprotein;Polymorphism;Reference proteome;Repeat,Evidence at protein level,reviewed,,,171,Alternative products (1); Caution (3); Domain (1); Function (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0181; KW-0343; KW-0472; KW-0597; KW-0621; KW-0677; KW-0944; KW-0963; KW-1003; KW-1185,,,,,,,,,CHAIN 1 1502 Rho GTPase-activating protein 5. /FTId=PRO_0000056702.,,,,,,"MOD_RES 550 550 Nitrated tyrosine. {ECO:0000244|PubMed:16777052}.; MOD_RES 590 590 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 765 765 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 951 951 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 968 968 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 1115 1115 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1173 1173 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 1176 1176 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 1195 1195 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 1202 1202 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1218 1218 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U17032;CH471078;CH471078;CH471078;CH471078;BC032723;BC050059;BC075799;BC129928;BC129929;AK292966;AB209751;
0,Q13490,BIRC2_HUMAN,BIRC2 API1 MIHB RNF48,BIRC2,API1 MIHB RNF48,,,Homo sapiens (Human),9606,Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2),UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MHKTASQRLFPGPSYQNIKSIMEDSTILSDWTNSNKQKMKYDFSCELYRMSTYSTFPAGVPVSERSLARAGFYYTGVNDKVKCFCCGLMLDNWKLGDSPIQKHKQLYPSCSFIQNLVSASLGSTSKNTSPMRNSFAHSLSPTLEHSSLFSGSYSSLSPNPLNSRAVEDISSSRTNPYSYAMSTEEARFLTYHMWPLTFLSPSELARAGFYYIGPGDRVACFACGGKLSNWEPKDDAMSEHRRHFPNCPFLENSLETLRFSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRYPHLLEQLLSTSDTTGEENADPPIIHFGPGESSSEDAVMMNTPVVKSALEMGFNRDLVKQTVQSKILTTGENYKTVNDIVSALLNAEDEKREEEKEKQAEEMASDDLSLIRKNRMALFQQLTCVLPILDNLLKANVINKQEHDIIKQKTQIPLQARELIDTILVKGNAAANIFKNCLKEIDSTLYKNLFVDKNMKYIPTEDVSGLSLEEQLRRLQEERTCKVCMDKEVSVVFIPCGHLVVCQECAPSLRKCPICRGIIKGTVRTFLS,618,"69,900",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q13490-1; Sequence=Displayed; Name=2; IsoId=Q13490-2; Sequence=VSP_045314; ,,,,,,,,,,VAR_SEQ 1 49 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_045314.,VARIANT 453 453 M -> I (in dbSNP:rs34749508). /FTId=VAR_049535.; VARIANT 453 453 M -> V (in dbSNP:rs370745983). {ECO:0000269|Ref.4}. /FTId=VAR_025016.; VARIANT 506 506 A -> V (in dbSNP:rs34510872). {ECO:0000269|Ref.4}. /FTId=VAR_025017.; VARIANT 549 549 P -> S (in dbSNP:rs35494784). {ECO:0000269|Ref.4}. /FTId=VAR_025018.,,,,CONFLICT 157 157 S -> P (in Ref. 2; AAC50372). {ECO:0000305}.; CONFLICT 308 308 C -> G (in Ref. 2; AAC50372). {ECO:0000305}.; CONFLICT 414 414 Q -> L (in Ref. 2; AAC50372). {ECO:0000305}.; CONFLICT 514 514 L -> W (in Ref. 2; AAC50372). {ECO:0000305}.,,2,,0,DOMAIN: The BIR domains mediate nuclear localization. {ECO:0000269|PubMed:21549626}.; DOMAIN: The CARD domain is necessary to stabilize the protein and inhibit the activation of E3 ubiquitin-protein ligase activity of BIRC2/c-IAP1 by preventing RING domain dimerization and E2 ubiquitin donor binding and activation. {ECO:0000269|PubMed:21549626}.,SIMILARITY: Belongs to the IAP family. {ECO:0000305}.,,,DOMAIN 453 543 CARD. {ECO:0000255|PROSITE-ProRule:PRU00046}.,,,REPEAT 46 113 BIR 1.; REPEAT 184 250 BIR 2.; REPEAT 269 336 BIR 3.,ZN_FING 571 606 RING-type. {ECO:0000255|PROSITE-ProRule:PRU00175}.,2.3.2.27,,"CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:18082613, ECO:0000269|PubMed:21145488, ECO:0000269|PubMed:21931591, ECO:0000269|PubMed:23453969};",,,"FUNCTION: Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling, and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin-protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-canonical NF-kappa-B signaling. The target proteins for its E3 ubiquitin-protein ligase activity include: RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, TRAF2, DIABLO/SMAC, MAP3K14/NIK, MAP3K5/ASK1, IKBKG/NEMO, IKBKE and MXD1/MAD1. Can also function as an E3 ubiquitin-protein ligase of the NEDD8 conjugation pathway, targeting effector caspases for neddylation and inactivation. Acts as an important regulator of innate immune signaling via regulation of Toll-like receptors (TLRs), Nodlike receptors (NLRs) and RIG-I like receptors (RLRs), collectively referred to as pattern recognition receptors (PRRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase-independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8. Can stimulate the transcriptional activity of E2F1. Plays a role in the modulation of the cell cycle. {ECO:0000269|PubMed:15665297, ECO:0000269|PubMed:18082613, ECO:0000269|PubMed:21145488, ECO:0000269|PubMed:21653699, ECO:0000269|PubMed:21931591, ECO:0000269|PubMed:23453969}.",,,,,,,,,METAL 306 306 Zinc.; METAL 309 309 Zinc.; METAL 326 326 Zinc.; METAL 333 333 Zinc.,,,CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; XY body [GO:0001741]; chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; NIK/NF-kappaB signaling [GO:0038061]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein heterooligomerization [GO:0051291]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209],cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; NIK/NF-kappaB signaling [GO:0038061]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein heterooligomerization [GO:0051291]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209],chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; XY body [GO:0001741],GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0010803; GO:0016579; GO:0016740; GO:0033209; GO:0034121; GO:0035631; GO:0038061; GO:0039535; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043161; GO:0045088; GO:0045121; GO:0045471; GO:0045595; GO:0047485; GO:0050727; GO:0051087; GO:0051291; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0070424; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:1990001; GO:2000116; GO:2000377,IPR001370; IPR001315; IPR011029; IPR001841; ,Itself; Q96CA5; Q9Y3E2; P55210; P55211; Q9NR28; Q96CJ1; Q9NQT4; Q96CN9; P14136; P08949; P08949-2; Q96FW1; Q8N3J5; P63000; Q13546; O43353; Q9Y572; P57078; Q9NP84; Q13077; Q12933; Q9BZW7; Q96HA8,"SUBUNIT: Interacts with DIABLO/SMAC and with PRSS25; these interactions inhibit apoptotic suppressor activity. Interacts with CASP9. Interacts (via BIR domains) with TRAF2; the interaction is required for IKBKE ubiquitination. Interacts with E2F1, RIPK1, RIPK2, RIPK3, RIPK4, BIRC5/survivin and USP19. Interacts with HSP90AB1 (PubMed:25486457). Interacts with UBXN1 (PubMed:25681446). {ECO:0000269|PubMed:15665297, ECO:0000269|PubMed:19153467, ECO:0000269|PubMed:21653699, ECO:0000269|PubMed:21849505, ECO:0000269|PubMed:21931591, ECO:0000269|PubMed:25486457, ECO:0000269|PubMed:25681446}.",8548810; 8552191; 8643514; 14702039; 16554811; 15489334; 15665297; 18082613; 18414036; 18669648; 19690332; 20888210; 21145488; 20651737; 21447281; 21653699; 21849505; 21931591; 22095281; 23453969; 25486457; 25681446; 10404221; 19153467; 21549626,8548810; 8552191; 8643514; 14702039; 16554811; 15489334; 15665297; 18082613; 18414036; 18669648; 19690332; 20888210; 21145488; 20651737; 21447281; 21653699; 21849505; 21931591; 22095281; 23453969; 25486457; 25681446; 10404221; 19153467; 21549626; 10797013; 10929712; 11084335; 11106668; 11583623; 11604410; 12167698; 12208731; 12209092; 12218061; 12243753; 12374738; 12388702; 12525502; 12529173; 12571250; 12603340; 12651874; 12851723; 12887920; 12888921; 14708638; 14960576; 14960583; 15064760; 15084608; 15183896; 15187025; 15258597; 15318034; 15359644; 15501771; 15585864; 15644327; 15824857; 15911110; 16080516; 16180223; 16189514; 16260783; 16282325; 16339151; 16510124; 16603398; 16775178; 16929535; 16953224; 16983704; 17220297; 17626072; 17822677; 17993464; 18022362; 18022363; 18079694; 18178551; 18230607; 18239673; 18434593; 18566024; 18570872; 18621506; 18621737; 18635759; 18676680; 18775313; 18827186; 18846111; 18931663; 18997792; 18997794; 19029953; 19154529; 19170196; 19223549; 19336370; 19373254; 19397698; 19416853; 19426221; 19524512; 19567200; 19690564; 19720604; 19815541; 19893574; 19910467; 19913121; 20005846; 20078866; 20097753; 20185725; 20304918; 20385093; 20447407; 20458734; 20562859; 20628086; 20667824; 20711500; 20932475; 20951133; 20954235; 21048031; 21113135; 21331077; 21393245; 21414315; 21516116; 21525013; 21737330; 21795072; 21817100; 21822306; 21903422; 21988832; 22021857; 22117219; 22128162; 22179575; 22274400; 22297296; 22403404; 22413863; 22434933; 22435550; 22493164; 22591684; 22733500; 22815481; 22817896; 22848449; 22927431; 23109427; 23166698; 23250032; 23269702; 23275033; 23298277; 23313255; 23524849; 23605047; 23815148; 23928071; 24008361; 24083782; 24093940; 24098568; 24169315; 24194568; 24246475; 24276241; 24298274; 24371121; 24382102; 24422988; 24425875; 24559922; 24577083; 24633224; 24704827; 24841289; 24975362; 25046208; 25079338; 25113061; 25152365; 25241761; 25273171; 25383668; 25416956; 25469840; 25549803; 25635055; 25669656; 25911380; 26011589; 26168135; 26314849; 26666816; 26733177; 27014915; 27070702; 27197231; 27608596; 27637083; 27693792; 28492317; 28515292; 28542143; 28871172; 29021293; 30055105; 30181285; 30523153; 7544915; 7639698; 8663299; 8702708; 8943045; 9122217; 9718306; 9852070,1997-11-01,2019-02-13,1997-11-01,200,X-ray crystallography (18); NMR spectroscopy (2),STRAND 72 74 {ECO:0000244|PDB:3M1D}.; STRAND 81 83 {ECO:0000244|PDB:3M1D}.; STRAND 279 282 {ECO:0000244|PDB:1QBH}.; STRAND 283 285 {ECO:0000244|PDB:4HY4}.; STRAND 295 297 {ECO:0000244|PDB:4HY4}.; STRAND 304 306 {ECO:0000244|PDB:4HY4}.; STRAND 312 314 {ECO:0000244|PDB:3D9T}.; STRAND 485 487 {ECO:0000244|PDB:2L9M}.; STRAND 575 578 {ECO:0000244|PDB:3T6P}.; STRAND 581 584 {ECO:0000244|PDB:3T6P}.; STRAND 589 591 {ECO:0000244|PDB:3T6P}.; STRAND 611 614 {ECO:0000244|PDB:3T6P}.,HELIX 43 51 {ECO:0000244|PDB:3M1D}.; HELIX 52 55 {ECO:0000244|PDB:3M1D}.; HELIX 64 69 {ECO:0000244|PDB:3M1D}.; HELIX 99 106 {ECO:0000244|PDB:3M1D}.; HELIX 111 117 {ECO:0000244|PDB:3M1D}.; HELIX 264 266 {ECO:0000244|PDB:4HY4}.; HELIX 269 274 {ECO:0000244|PDB:4HY4}.; HELIX 287 292 {ECO:0000244|PDB:4HY4}.; HELIX 322 329 {ECO:0000244|PDB:4HY4}.; HELIX 334 340 {ECO:0000244|PDB:4HY4}.; HELIX 342 348 {ECO:0000244|PDB:4HY4}.; HELIX 355 361 {ECO:0000244|PDB:5M6N}.; HELIX 389 391 {ECO:0000244|PDB:3T6P}.; HELIX 394 401 {ECO:0000244|PDB:3T6P}.; HELIX 406 420 {ECO:0000244|PDB:3T6P}.; HELIX 427 450 {ECO:0000244|PDB:3T6P}.; HELIX 456 463 {ECO:0000244|PDB:3T6P}.; HELIX 465 471 {ECO:0000244|PDB:3T6P}.; HELIX 476 484 {ECO:0000244|PDB:3T6P}.; HELIX 490 497 {ECO:0000244|PDB:3T6P}.; HELIX 502 516 {ECO:0000244|PDB:3T6P}.; HELIX 518 531 {ECO:0000244|PDB:3T6P}.; HELIX 533 540 {ECO:0000244|PDB:3T6P}.; HELIX 553 555 {ECO:0000244|PDB:3T6P}.; HELIX 558 566 {ECO:0000244|PDB:3T6P}.; HELIX 596 598 {ECO:0000244|PDB:3T6P}.,TURN 84 86 {ECO:0000244|PDB:3M1D}.; TURN 275 278 {ECO:0000244|PDB:4HY4}.; TURN 307 309 {ECO:0000244|PDB:4HY4}.; TURN 451 453 {ECO:0000244|PDB:2L9M}.; TURN 572 574 {ECO:0000244|PDB:3T6P}.; TURN 593 595 {ECO:0000244|PDB:3T6P}.; TURN 603 605 {ECO:0000244|PDB:3T6P}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (12); Chain (1); Domain (1); Helix (26); Metal binding (4); Natural variant (4); Repeat (3); Sequence conflict (4); Turn (7); Zinc finger (1),,"TISSUE SPECIFICITY: Present in many fetal and adult tissues. Mainly expressed in adult skeletal muscle, thymus, testis, ovary, and pancreas, low or absent in brain and peripheral blood leukocytes.",,3D-structure;Activator;Alternative splicing;Apoptosis;Complete proteome;Cytoplasm;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger,Evidence at protein level,reviewed,,IAP family,200,Activity regulation (1); Alternative products (1); Catalytic activity (1); Domain (2); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0010; KW-0025; KW-0053; KW-0181; KW-0479; KW-0539; KW-0621; KW-0677; KW-0804; KW-0805; KW-0808; KW-0832; KW-0833; KW-0862; KW-0863; KW-0963; KW-1185,,,,,,,,PTM: Auto-ubiquitinated and degraded by the proteasome in apoptotic cells.,CHAIN 1 618 Baculoviral IAP repeat-containing protein 2. /FTId=PRO_0000122347.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,L49431;U45879;U37547;AK303197;DQ068066;BC016174;BC028578;
0,Q13618,CUL3_HUMAN,CUL3 KIAA0617,CUL3,KIAA0617,,,Homo sapiens (Human),9606,Cullin-3 (CUL-3),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSNLSKGTGSRKDTKMRIRAFPMTMDEKYVNSIWDLLKNAIQEIQRKNNSGLSFEELYRNAYTMVLHKHGEKLYTGLREVVTEHLINKVREDVLNSLNNNFLQTLNQAWNDHQTAMVMIRDILMYMDRVYVQQNNVENVYNLGLIIFRDQVVRYGCIRDHLRQTLLDMIARERKGEVVDRGAIRNACQMLMILGLEGRSVYEEDFEAPFLEMSAEFFQMESQKFLAENSASVYIKKVEARINEEIERVMHCLDKSTEEPIVKVVERELISKHMKTIVEMENSGLVHMLKNGKTEDLGCMYKLFSRVPNGLKTMCECMSSYLREQGKALVSEEGEGKNPVDYIQGLLDLKSRFDRFLLESFNNDRLFKQTIAGDFEYFLNLNSRSPEYLSLFIDDKLKKGVKGLTEQEVETILDKAMVLFRFMQEKDVFERYYKQHLARRLLTNKSVSDDSEKNMISKLKTECGCQFTSKLEGMFRDMSISNTTMDEFRQHLQATGVSLGGVDLTVRVLTTGYWPTQSATPKCNIPPAPRHAFEIFRRFYLAKHSGRQLTLQHHMGSADLNATFYGPVKKEDGSEVGVGGAQVTGSNTRKHILQVSTFQMTILMLFNNREKYTFEEIQQETDIPERELVRALQSLACGKPTQRVLTKEPKSKEIENGHIFTVNDQFTSKLHRVKIQTVAAKQGESDPERKETRQKVDDDRKHEIEAAIVRIMKSRKKMQHNVLVAEVTQQLKARFLPSPVVIKKRIEGLIEREYLARTPEDRKVYTYVA,768,"88,930",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; Synonyms=Cul-3 Long; IsoId=Q13618-1; Sequence=Displayed; Name=2; IsoId=Q13618-2; Sequence=VSP_008824; Name=3; Synonyms=Cul-3 Short; IsoId=Q13618-3; Sequence=VSP_008825; ,,SEQUENCE CAUTION:  Sequence=BAA31592.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,"SEQUENCE CAUTION:  Sequence=AAC28621.1; Type=Frameshift; Positions=452; Evidence={ECO:0000305};  Sequence=AAC36682.1; Type=Frameshift; Positions=159, 179; Evidence={ECO:0000305}; ",,,,,VAR_SEQ 1 24 Missing (in isoform 2). {ECO:0000303|Ref.4}. /FTId=VSP_008824.; VAR_SEQ 23 88 Missing (in isoform 3). {ECO:0000305}. /FTId=VSP_008825.,VARIANT 13 13 D -> H (in dbSNP:rs2969802). /FTId=VAR_017194.; VARIANT 184 184 R -> S (in dbSNP:rs17480168). /FTId=VAR_048839.; VARIANT 413 413 D -> G (in PHA2E; dbSNP:rs199469656). {ECO:0000269|PubMed:22266938}. /FTId=VAR_067532.; VARIANT 459 459 K -> R (in PHA2E; dbSNP:rs199469658). {ECO:0000269|PubMed:22266938}. /FTId=VAR_067533.; VARIANT 567 567 V -> I (in dbSNP:rs3738952). /FTId=VAR_017195.; VARIANT 719 719 H -> R (found in a patient with autism spectrum disorder; unknown pathological significance; dbSNP:rs763087632). {ECO:0000269|PubMed:25969726}. /FTId=VAR_078688.,,,,CONFLICT 13 13 D -> G (in Ref. 3; AAC36682). {ECO:0000305}.; CONFLICT 397 397 K -> T (in Ref. 4; AAQ01660). {ECO:0000305}.; CONFLICT 481 481 N -> T (in Ref. 4; AAQ01660). {ECO:0000305}.; CONFLICT 609 609 E -> G (in Ref. 8; AAH31844). {ECO:0000305}.; CONFLICT 666 666 T -> I (in Ref. 4; AAQ01660). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the cullin family. {ECO:0000255|PROSITE-ProRule:PRU00330}.,,,,,,,,,,,,,"FUNCTION: Core component of multiple cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. BCR complexes and ARIH1 collaborate in tandem to mediate ubiquitination of target proteins (PubMed:27565346). As a scaffold protein may contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. The E3 ubiquitin-protein ligase activity of the complex is dependent on the neddylation of the cullin subunit and is inhibited by the association of the deneddylated cullin subunit with TIP120A/CAND1. The functional specificity of the BCR complex depends on the BTB domain-containing protein as the substrate recognition component. BCR(KLHL42) is involved in ubiquitination of KATNA1. BCR(SPOP) is involved in ubiquitination of BMI1/PCGF4, BRMS1, H2AFY and DAXX, GLI2 and GLI3. Can also form a cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex containing homodimeric SPOPL or the heterodimer formed by SPOP and SPOPL; these complexes have lower ubiquitin ligase activity. BCR(KLHL9-KLHL13) controls the dynamic behavior of AURKB on mitotic chromosomes and thereby coordinates faithful mitotic progression and completion of cytokinesis. BCR(KLHL12) is involved in ER-Golgi transport by regulating the size of COPII coats, thereby playing a key role in collagen export, which is required for embryonic stem (ES) cells division: BCR(KLHL12) acts by mediating monoubiquitination of SEC31 (SEC31A or SEC31B) (PubMed:22358839, PubMed:27716508). BCR(KLHL3) acts as a regulator of ion transport in the distal nephron; by mediating ubiquitination of WNK4 (PubMed:23387299, PubMed:23453970, PubMed:23576762). The BCR(KLHL20) E3 ubiquitin ligase complex is involved in interferon response and anterograde Golgi to endosome transport: it mediates both ubiquitination leading to degradation and 'Lys-33'-linked ubiquitination (PubMed:20389280, PubMed:21840486, PubMed:21670212, PubMed:24768539). The BCR(KLHL21) E3 ubiquitin ligase complex regulates localization of the chromosomal passenger complex (CPC) from chromosomes to the spindle midzone in anaphase and mediates the ubiquitination of AURKB (PubMed:19995937). The BCR(KLHL22) ubiquitin ligase complex mediates monoubiquitination of PLK1, leading to PLK1 dissociation from phosphoreceptor proteins and subsequent removal from kinetochores, allowing silencing of the spindle assembly checkpoint (SAC) and chromosome segregation (PubMed:23455478). The BCR(KLHL22) ubiquitin ligase complex is also responsible for the amino acid-stimulated 'Lys-48' polyubiquitination and proteasomal degradation of DEPDC5. Through the degradation of DEPDC5, releases the GATOR1 complex-mediated inhibition of the TORC1 pathway (PubMed:29769719). The BCR(KLHL25) ubiquitin ligase complex is involved in translational homeostasis by mediating ubiquitination and subsequent degradation of hypophosphorylated EIF4EBP1 (4E-BP1) (PubMed:22578813). The BCR(KBTBD8) complex acts by mediating monoubiquitination of NOLC1 and TCOF1, leading to remodel the translational program of differentiating cells in favor of neural crest specification (PubMed:26399832). Involved in ubiquitination of cyclin E and of cyclin D1 (in vitro) thus involved in regulation of G1/S transition. Involved in the ubiquitination of KEAP1, ENC1 and KLHL41. In concert with ATF2 and RBX1, promotes degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM. The BCR(KCTD17) E3 ubiquitin ligase complex mediates ubiquitination and degradation of TCHP, a down-regulator of cilium assembly, thereby inducing ciliogenesis (PubMed:25270598). The BCR(KLHL24) E3 ubiquitin ligase complex mediates ubiquitination of KRT14, controls KRT14 levels during keratinocytes differentiation, and is essential for skin integrity (PubMed:27798626). {ECO:0000269|PubMed:10500095, ECO:0000269|PubMed:11311237, ECO:0000269|PubMed:15897469, ECO:0000269|PubMed:15983046, ECO:0000269|PubMed:16524876, ECO:0000269|PubMed:17543862, ECO:0000269|PubMed:18397884, ECO:0000269|PubMed:19261606, ECO:0000269|PubMed:19995937, ECO:0000269|PubMed:20389280, ECO:0000269|PubMed:21670212, ECO:0000269|PubMed:21840486, ECO:0000269|PubMed:22085717, ECO:0000269|PubMed:22358839, ECO:0000269|PubMed:22578813, ECO:0000269|PubMed:22632832, ECO:0000269|PubMed:23387299, ECO:0000269|PubMed:23453970, ECO:0000269|PubMed:23455478, ECO:0000269|PubMed:23576762, ECO:0000269|PubMed:24768539, ECO:0000269|PubMed:25270598, ECO:0000269|PubMed:26399832, ECO:0000269|PubMed:27565346, ECO:0000269|PubMed:27716508, ECO:0000269|PubMed:27798626, ECO:0000269|PubMed:29769719}.",,PATHWAY: Protein modification; protein ubiquitination.,,,,,,,,,,Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polar microtubule [GO:0005827]; SCF ubiquitin ligase complex [GO:0019005]; sperm flagellum [GO:0036126]; cyclin binding [GO:0030332]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway [GO:0097193]; liver morphogenesis [GO:0072576]; MAPK cascade [GO:0000165]; mitotic metaphase plate congression [GO:0007080]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway [GO:0097193]; liver morphogenesis [GO:0072576]; MAPK cascade [GO:0000165]; mitotic metaphase plate congression [GO:0007080]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],cyclin binding [GO:0030332]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625],Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polar microtubule [GO:0005827]; SCF ubiquitin ligase complex [GO:0019005]; sperm flagellum [GO:0036126],GO:0000082; GO:0000122; GO:0000139; GO:0000165; GO:0000209; GO:0001831; GO:0005112; GO:0005654; GO:0005737; GO:0005827; GO:0005829; GO:0006511; GO:0006513; GO:0006888; GO:0007050; GO:0007080; GO:0007229; GO:0007369; GO:0008284; GO:0016020; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0019005; GO:0030030; GO:0030332; GO:0031145; GO:0031146; GO:0031208; GO:0031398; GO:0031461; GO:0031463; GO:0031625; GO:0031648; GO:0032467; GO:0035024; GO:0036126; GO:0040016; GO:0042803; GO:0043149; GO:0043161; GO:0043687; GO:0044346; GO:0045842; GO:0046982; GO:0048208; GO:0070062; GO:0071630; GO:0072576; GO:0090090; GO:0097193,IPR016157; IPR016158; IPR036317; IPR001373; IPR019559; IPR016159; IPR036388; IPR036390; ,Q969K4; Q86VP6; Q14790; O60826; Q8IWE4; Q53SE7; P08238; Q8WZ19; Q8NC69; Q7L273; Q53G59; O95198; Q9Y2M5; Q8N4I8; Q9UH77; Q8IXQ5; Q8TBC3; O43791; Q13829; P50591; O94888; Q9H898,"SUBUNIT: Forms neddylation-dependent homodimers. Component of multiple BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complexes formed of CUL3, RBX1 and a variable BTB domain-containing protein acting as both, adapter to cullin and substrate recognition subunit. The BCR complex may be active as a heterodimeric complex, in which NEDD8, covalently attached to one CUL3 molecule, binds to the C-terminus of a second CUL3 molecule. Interacts with RBX1, RNF7, CYCE and TIP120A/CAND1 (PubMed:10500095, PubMed:10230407, PubMed:12609982). Part of the BCR(SPOP) containing SPOP, and of BCR containing homodimeric SPOPL or the heterodimer formed by SPOP and SPOPL. Part of the probable BCR(KLHL9-KLHL13) complex with BTB domain proteins KLHL9 and KLHL13. Part of the BCR(KLHL41) complex containing KLHL41. Component of the BCR(KLHL12) E3 ubiquitin ligase complex, at least composed of CUL3 and KLHL12 and RBX1. Component of the BCR(KLHL3) E3 ubiquitin ligase complex, at least composed of CUL3 and KLHL3 and RBX1 (Probable). Part of the BCR(ENC1) complex containing ENC1. Part of a complex consisting of BMI1/PCGF4, CUL3 and SPOP. Part of a complex consisting of BRMS1, CUL3 and SPOP. Component of the BCR(KLHL21) E3 ubiquitin ligase complex, at least composed of CUL3, KLHL21 and RBX1. Component of the BCR(KLHL22) E3 ubiquitin ligase complex, at least composed of CUL3, KLHL22 and RBX1. Component of the BCR(KLHL25) E3 ubiquitin ligase complex, at least composed of CUL3, KLHL25 and RBX1. Part of a complex consisting of H2AFY, CUL3 and SPOP. Component of the BCR(KLHL42) E3 ubiquitin ligase complex, at least composed of CUL3 and KLHL42. Interacts with KLHL42 (via the BTB domain). Interacts with KATNA1; the interaction is enhanced by KLHL42. Component of the BCR(KBTBD8) E3 ubiquitin ligase complex, at least composed of CUL3, KBTBD8 and RBX1 (PubMed:26399832). Interacts with KCTD5, KLHL9, KLHL11, KLHL13, GAN, ZBTB16, KLHL3, KLHL15, KLHL20, KLHL36, GMCL2, BTBD1. Part of a complex that contains CUL3, RBX1 and GAN. Interacts (via BTB domain) with KLHL17; the interaction regulates surface GRIK2 expression. Interacts with KCTD7. Part of the BCR(GAN) complex containing GAN. Part of the BCR(KEAP1) complex containing KEAP1. Interacts with KLHL10 (By similarity). Interacts with KAT5 and ATF2. Interacts with DCUN1D3. Interacts with KCTD17 in the BCR(KCTD17) E3 ubiquitin ligase complex, at least composed of CUL3, KCTD17 and RBX1 (PubMed:25270598). Interacts (when neddylated) with ARIH1; leading to activate the E3 ligase activity of ARIH1 (PubMed:24076655, PubMed:27565346). Interacts with COPS9 isoform 2 (PubMed:23776465). Interacts with PPP2R5B; this interaction is indirect and mediated through KLHL15-binding and leads to PPP2R5B proteasomal degradation (PubMed:23135275). Interacts with RBBP8/CtIP; this interaction is indirect and mediated through KLHL15-binding and leads to RBBP8 proteasomal degradation (PubMed:27561354). Interacts with KLHL24 in the BCR(KLHL24) E3 ubiquitin ligase complex, composed of CUL3, RBX1 and KLHL24 (PubMed:27798626). Interacts with RHOBTB2 (PubMed:29276004). {ECO:0000250, ECO:0000269|PubMed:10230407, ECO:0000269|PubMed:10500095, ECO:0000269|PubMed:12609982, ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:15897469, ECO:0000269|PubMed:15983046, ECO:0000269|PubMed:16524876, ECO:0000269|PubMed:17543862, ECO:0000269|PubMed:18397884, ECO:0000269|PubMed:18573101, ECO:0000269|PubMed:19261606, ECO:0000269|PubMed:19995937, ECO:0000269|PubMed:20389280, ECO:0000269|PubMed:21670212, ECO:0000269|PubMed:21840486, ECO:0000269|PubMed:22085717, ECO:0000269|PubMed:22358839, ECO:0000269|PubMed:22578813, ECO:0000269|PubMed:22632832, ECO:0000269|PubMed:22748208, ECO:0000269|PubMed:23135275, ECO:0000269|PubMed:23349464, ECO:0000269|PubMed:23387299, ECO:0000269|PubMed:23453970, ECO:0000269|PubMed:23455478, ECO:0000269|PubMed:23573258, ECO:0000269|PubMed:23576762, ECO:0000269|PubMed:23776465, ECO:0000269|PubMed:24076655, ECO:0000269|PubMed:24768539, ECO:0000269|PubMed:25270598, ECO:0000269|PubMed:25349211, ECO:0000269|PubMed:26399832, ECO:0000269|PubMed:27561354, ECO:0000269|PubMed:27565346, ECO:0000269|PubMed:27798626, ECO:0000269|PubMed:29276004, ECO:0000305}.",9733711; 9734811; 9663463; 14702039; 15815621; 15489334; 8681378; 10500095; 11311237; 10597293; 10230407; 12609982; 14528312; 15983046; 15897469; 16524876; 17543862; 17254749; 17192413; 18573101; 18397884; 19261606; 19995937; 20389280; 21269460; 22085717; 21840486; 21670212; 22748208; 23135275; 22578813; 22358839; 22814378; 23387299; 23453970; 24076655; 23186163; 23455478; 23776465; 23576762; 25349211; 24768539; 25270598; 26399832; 27716508; 27565346; 27561354; 27798626; 28395323; 29276004; 29769719; 22632832; 23573258; 23349464; 22266938; 25969726,9733711; 9734811; 9663463; 14702039; 15815621; 15489334; 8681378; 10500095; 11311237; 10597293; 10230407; 12609982; 14528312; 15983046; 15897469; 16524876; 17543862; 17254749; 17192413; 18573101; 18397884; 19261606; 19995937; 20389280; 21269460; 22085717; 21840486; 21670212; 22748208; 23135275; 22578813; 22358839; 22814378; 23387299; 23453970; 24076655; 23186163; 23455478; 23776465; 23576762; 25349211; 24768539; 25270598; 26399832; 27716508; 27565346; 27561354; 27798626; 28395323; 29276004; 29769719; 22632832; 23573258; 23349464; 22266938; 25969726; 11961546; 12504025; 12504026; 12600938; 12646216; 15115751; 15198976; 15282312; 15537541; 15601839; 15688063; 15799966; 16401342; 16547521; 16651542; 16740475; 16943200; 16954532; 17183367; 17497243; 18075312; 18093314; 18218622; 18221766; 18251510; 18274552; 18303015; 18757741; 18775313; 18805092; 18850735; 18851830; 18926707; 19028597; 19037258; 19367725; 19427028; 19463016; 19489725; 19489739; 19573811; 19615732; 19684112; 19748355; 19768582; 19782033; 19805454; 19818708; 19852954; 19874575; 19955409; 20014402; 20154143; 20360068; 20360384; 20452971; 20463177; 20487519; 20562859; 20800603; 20956384; 21463634; 21577200; 21778237; 21828050; 21863050; 21878643; 21988832; 22147914; 22219362; 22542517; 22810585; 22939624; 22959436; 23308193; 23365135; 23453757; 23454126; 23535662; 23535663; 23563313; 23583660; 23661552; 23665031; 23689903; 23838290; 23902721; 23955340; 23962426; 24024173; 24067371; 24072710; 24266877; 24518042; 24608665; 25011449; 25114896; 25250572; 25355947; 25416956; 25684205; 25848797; 26021998; 26100637; 26188516; 26219975; 26334369; 26514267; 26544623; 26632597; 26687681; 27008177; 27477274; 27664236; 28115426; 28429677; 28499918; 28593901; 28804198; 28860350; 28981750; 29249570; 29306329; 29550478; 9874371,1997-11-01,2019-02-13,2001-01-24,194,X-ray crystallography (5); NMR spectroscopy (2),STRAND 195 198 {ECO:0000244|PDB:4EOZ}.,HELIX 26 45 {ECO:0000244|PDB:4EOZ}.; HELIX 49 51 {ECO:0000244|PDB:4EOZ}.; HELIX 54 66 {ECO:0000244|PDB:4EOZ}.; HELIX 70 87 {ECO:0000244|PDB:4EOZ}.; HELIX 89 94 {ECO:0000244|PDB:4EOZ}.; HELIX 101 122 {ECO:0000244|PDB:4EOZ}.; HELIX 124 129 {ECO:0000244|PDB:4EOZ}.; HELIX 132 134 {ECO:0000244|PDB:4EOZ}.; HELIX 139 150 {ECO:0000244|PDB:4EOZ}.; HELIX 155 173 {ECO:0000244|PDB:4EOZ}.; HELIX 180 192 {ECO:0000244|PDB:4EOZ}.; HELIX 199 204 {ECO:0000244|PDB:4EOZ}.; HELIX 206 227 {ECO:0000244|PDB:4EOZ}.; HELIX 230 251 {ECO:0000244|PDB:4EOZ}.; HELIX 254 256 {ECO:0000244|PDB:4EOZ}.; HELIX 257 268 {ECO:0000244|PDB:4EOZ}.; HELIX 273 277 {ECO:0000244|PDB:4EOZ}.; HELIX 284 287 {ECO:0000244|PDB:4EOZ}.; HELIX 293 303 {ECO:0000244|PDB:4EOZ}.; HELIX 309 323 {ECO:0000244|PDB:4EOZ}.; HELIX 339 358 {ECO:0000244|PDB:4AP2}.; HELIX 364 380 {ECO:0000244|PDB:4AP2}.,TURN 95 98 {ECO:0000244|PDB:4EOZ}.; TURN 151 153 {ECO:0000244|PDB:4EOZ}.; TURN 269 272 {ECO:0000244|PDB:4EOZ}.; TURN 280 282 {ECO:0000244|PDB:4EOZ}.; TURN 288 291 {ECO:0000244|PDB:4EOZ}.,,,,,5 out of 5,Alternative sequence (2); Beta strand (1); Chain (1); Cross-link (1); Erroneous initiation (1); Frameshift (2); Helix (22); Initiator methionine (1); Modified residue (2); Natural variant (6); Sequence conflict (5); Turn (5),,"TISSUE SPECIFICITY: Brain, spermatozoa, and testis (at protein level). Widely expressed. {ECO:0000269|PubMed:28395323}.",,3D-structure;Acetylation;Alternative splicing;Cell projection;Cilium;Cilium biogenesis/degradation;Complete proteome;Cytoplasm;Disease mutation;ER-Golgi transport;Flagellum;Golgi apparatus;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transport;Ubl conjugation;Ubl conjugation pathway,Evidence at protein level,reviewed,,Cullin family,194,Alternative products (1); Function (1); Involvement in disease (1); Pathway (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0181; KW-0225; KW-0282; KW-0333; KW-0539; KW-0597; KW-0621; KW-0813; KW-0832; KW-0833; KW-0931; KW-0963; KW-0966; KW-0969; KW-0970; KW-1017; KW-1185,Protein modification; protein ubiquitination. ,,,,"DISEASE: Pseudohypoaldosteronism 2E (PHA2E) [MIM:614496]: An autosomal dominant disorder characterized by severe hypertension, hyperkalemia, hyperchloremia, hyperchloremic metabolic acidosis, and correction of physiologic abnormalities by thiazide diuretics. {ECO:0000269|PubMed:22266938}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Neddylated. Attachment of NEDD8 is required for the E3 ubiquitin-protein ligase activity of the BCR complex. Deneddylated via its interaction with the COP9 signalosome (CSN) complex. {ECO:0000269|PubMed:10500095, ECO:0000269|PubMed:10597293, ECO:0000269|PubMed:24076655, ECO:0000269|PubMed:27565346}.",CHAIN 2 768 Cullin-3. /FTId=PRO_0000119793.,CROSSLNK 712 712 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8). {ECO:0000250|UniProtKB:Q13616}.,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378}.,,MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:22814378}.; MOD_RES 585 585 Phosphoserine. {ECO:0000244|PubMed:23186163}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF064087;AB014517;AF062537;AY337761;AK291151;CH471063;BC031844;BC039598;BC092409;U58089;AF052147;
0,Q14118,DAG1_HUMAN,DAG1,DAG1,,,,Homo sapiens (Human),9606,Dystroglycan (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)],UP000005640: Chromosome 3,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MRMSVGLSLLLPLSGRTFLLLLSVVMAQSHWPSEPSEAVRDWENQLEASMHSVLSDLHEAVPTVVGIPDGTAVVGRSFRVTIPTDLIASSGDIIKVSAAGKEALPSWLHWDSQSHTLEGLPLDTDKGVHYISVSATRLGANGSHIPQTSSVFSIEVYPEDHSELQSVRTASPDPGEVVSSACAADEPVTVLTVILDADLTKMTPKQRIDLLHRMRSFSEVELHNMKLVPVVNNRLFDMSAFMAGPGNAKKVVENGALLSWKLGCSLNQNSVPDIHGVEAPAREGAMSAQLGYPVVGWHIANKKPPLPKRVRRQIHATPTPVTAIGPPTTAIQEPPSRIVPTPTSPAIAPPTETMAPPVRDPVPGKPTVTIRTRGAIIQTPTLGPIQPTRVSEAGTTVPGQIRPTMTIPGYVEPTAVATPPTTTTKKPRVSTPKPATPSTDSTTTTTRRPTKKPRTPRPVPRVTTKVSITRLETASPPTRIRTTTSGVPRGGEPNQRPELKNHIDRVDAWVGTYFEVKIPSDTFYDHEDTTTDKLKLTLKLREQQLVGEKSWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDKGGLSAVDAFEIHVHRRPQGDRAPARFKAKFVGDPALVLNDIHKKIALVKKLAFAFGDRNCSTITLQNITRGSIVVEWTNNTLPLEPCPKEQIAGLSRRIAEDDGKPRPAFSNALEPDFKATSITVTGSGSCRHLQFIPVVPPRRVPSEAPPTEVPDRDPEKSSEDDVYLHTVIPAVVVAAILLIAGIIAMICYRKKRKGKLTLEDQATFIKKGVPIIFADELDDSKPPPSSSMPLILQEEKAPLPPPEYPNQSVPETTPLNQDTMGEYTPLRDEDPNAPPYQPPPPFTAPMEGKGSRPKNMTPYRSPPPYVPP,895,"97,441",,,,,,,,,,,,,"VARIANT 14 14 S -> W (in dbSNP:rs2131107). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:8268918, ECO:0000269|Ref.4}. /FTId=VAR_024335.; VARIANT 74 74 V -> I (in MDDGC9; no effect on dystroglycan expression; impairs alpha-dystroglycan glycosylation; dbSNP:rs189360006). {ECO:0000269|PubMed:25503980}. /FTId=VAR_075809.; VARIANT 111 111 D -> N (in MDDGC9; does not affect dystroglycan expression; impairs alpha-dystroglycan glycosylation; dbSNP:rs117209107). {ECO:0000269|PubMed:25503980}. /FTId=VAR_075810.; VARIANT 192 192 T -> M (in MDDGC9; results in impaired interaction with LARGE1 and incomplete DAG1 glycosylation; dbSNP:rs193922955). {ECO:0000269|PubMed:21388311}. /FTId=VAR_065266.; VARIANT 669 669 C -> F (in MDDGA9; dbSNP:rs797045023). {ECO:0000269|PubMed:24052401}. /FTId=VAR_075811.",,,,CONFLICT 163 163 E -> D (in Ref. 1; AAA81779). {ECO:0000305}.; CONFLICT 248 248 A -> P (in Ref. 1; AAA81779). {ECO:0000305}.; CONFLICT 319 319 T -> A (in Ref. 2; BAF84381). {ECO:0000305}.; CONFLICT 871 871 A -> V (in Ref. 1; AAA81779). {ECO:0000305}.,,2,,0,,,,COMPBIAS 317 484 Thr-rich.; COMPBIAS 809 895 Pro-rich.,DOMAIN 603 712 Peptidase S72.,MOTIF 776 782 Nuclear localization signal. {ECO:0000269|PubMed:20512930}.; MOTIF 889 892 PPXY motif.,REGION 30 408 Required for laminin recognition.; REGION 169 200 O-glycosylated at one site.; REGION 316 485 Mucin-like domain.; REGION 463 485 O-glycosylated at seven sites with GalNAc.; REGION 819 895 Required for interaction with CAV3. {ECO:0000269|PubMed:10988290}.; REGION 880 895 Required for binding DMD and UTRN.,,,,,,,,"FUNCTION: The dystroglycan complex is involved in a number of processes including laminin and basement membrane assembly, sarcolemmal stability, cell survival, peripheral nerve myelination, nodal structure, cell migration, and epithelial polarization.; FUNCTION: Alpha-dystroglycan is an extracellular peripheral glycoprotein that acts as a receptor for both extracellular matrix proteins containing laminin-G domains. Receptor for laminin-2 (LAMA2) and agrin in peripheral nerve Schwann cells.; FUNCTION: Beta-dystroglycan is a transmembrane protein that plays important roles in connecting the extracellular matrix to the cytoskeleton. Acts as a cell adhesion receptor in both muscle and non-muscle tissues. Receptor for both DMD and UTRN and, through these interactions, scaffolds axin to the cytoskeleton. Also functions in cell adhesion-mediated signaling and implicated in cell polarity.; FUNCTION: (Microbial infection) Alpha-dystroglycan acts as a receptor for lassa virus and lymphocytic choriomeningitis virus glycoprotein and class C new-world arenaviruses (PubMed:16254364, PubMed:19324387, PubMed:17360738). Alpha-dystroglycan acts as a Schwann cell receptor for Mycobacterium leprae, the causative organism of leprosy, but only in the presence of the G-domain of LAMA2 (PubMed:9851927). {ECO:0000269|PubMed:16254364, ECO:0000269|PubMed:17360738, ECO:0000269|PubMed:19324387, ECO:0000269|PubMed:9851927}.",,,,,,,,,,,SITE 653 654 Cleavage; by autolysis. {ECO:0000269|PubMed:17905726}.; SITE 715 716 Cleavage; by MMP9. {ECO:0000269|PubMed:19946898}.,basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; collagen-containing extracellular matrix [GO:0062023]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; virus receptor activity [GO:0001618]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; extracellular matrix organization [GO:0030198]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; modulation by virus of host morphology or physiology [GO:0019048]; morphogenesis of an epithelial sheet [GO:0002011]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of embryonic cell shape [GO:0016476]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; skeletal muscle tissue regeneration [GO:0043403],aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; extracellular matrix organization [GO:0030198]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; modulation by virus of host morphology or physiology [GO:0019048]; morphogenesis of an epithelial sheet [GO:0002011]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of embryonic cell shape [GO:0016476]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; skeletal muscle tissue regeneration [GO:0043403],actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; virus receptor activity [GO:0001618],basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; collagen-containing extracellular matrix [GO:0062023]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383],GO:0001618; GO:0001954; GO:0002011; GO:0002162; GO:0003779; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005654; GO:0005737; GO:0005788; GO:0005796; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005925; GO:0006509; GO:0007016; GO:0007568; GO:0008307; GO:0009897; GO:0010470; GO:0010717; GO:0014894; GO:0015631; GO:0016010; GO:0016011; GO:0016021; GO:0016323; GO:0016340; GO:0016476; GO:0017166; GO:0019048; GO:0021682; GO:0022011; GO:0030027; GO:0030175; GO:0030198; GO:0030336; GO:0031103; GO:0031643; GO:0033268; GO:0034399; GO:0034453; GO:0042169; GO:0042383; GO:0043034; GO:0043237; GO:0043403; GO:0043409; GO:0043434; GO:0044853; GO:0045211; GO:0045860; GO:0048714; GO:0050807; GO:0051393; GO:0051898; GO:0060055; GO:0060441; GO:0060445; GO:0062023; GO:0070062; GO:0070938; GO:0071260; GO:0071397; GO:0071679; GO:0071711; GO:0098696; GO:0098942; GO:0098978; GO:0098982; GO:0099524; GO:1904261,IPR027468; IPR006644; IPR015919; IPR008465; IPR013783; IPR030398; ,Q3T1J5; P16333,"SUBUNIT: Monomer. Heterodimer of alpha- and beta-dystroglycan subunits which are the central components of the dystrophin-glycoprotein complex. This complex then can form a dystrophin-associated glycoprotein complex (DGC) which is composed of three subcomplexes: a cytoplasmic complex comprised of DMD (or UTRN), DTNA and a number of syntrophins, such as SNTB1, SNTB2, SNTG1 and SNTG2, the transmembrane dystroglycan complex, and the sarcoglycan-sarcospan complex. Interacts (via the N-terminal of alphaDAG1) with LARGE1; the interaction enhances laminin binding (By similarity). Interacts with SGCD. Interacts with AGR2 and AGR3. Interacts (betaDAG1) with DMD; the interaction is inhibited by phosphorylation on the PPXY motif. Interacts (betaDAG1, via its PPXY motif) with UTRN (via its WWW and ZZ domains); the interaction is inhibited by phosphorylation on the PPXY motif. Interacts (betaDAG1, via its phosphorylated PPXY motif) with the SH2 domain-containing proteins, FYN, CSK, NCK and SHC. Interacts (betaDAG1) with CAV3 (via a central WW-like domain); the interaction disrupts the binding of DMD. BetaDAG1 directly interacts with ANK3, but not with ANK2; this interaction does not interfere with DMD-binding and is required for retention at costameres (By similarity). Identified in a dystroglycan complex that contains at least PRX, DRP2, UTRN, DMD and DAG1 (By similarity). Interacts with POMGNT1 (PubMed:27493216). {ECO:0000250|UniProtKB:Q28685, ECO:0000250|UniProtKB:Q62165, ECO:0000269|PubMed:10767429, ECO:0000269|PubMed:10769203, ECO:0000269|PubMed:10988290, ECO:0000269|PubMed:11495720, ECO:0000269|PubMed:11724572, ECO:0000269|PubMed:12592373, ECO:0000269|PubMed:27493216, ECO:0000269|PubMed:7592992}.; SUBUNIT: (Microbial infection) Interacts with lassa virus and lymphocytic choriomeningitis virus glycoprotein (PubMed:16254364, PubMed:19324387). {ECO:0000269|PubMed:16254364, ECO:0000269|PubMed:19324387}.; SUBUNIT: (Microbial infection) Interacts with surface molecules of mycobacterium leprae. {ECO:0000269|PubMed:9851927}.",8268918; 14702039; 16641997; 15489334; 7592992; 9851927; 10767429; 10988290; 10769203; 11724572; 11495720; 12140558; 12795607; 12592373; 15175026; 16254364; 17212656; 17360738; 17905726; 18764929; 19946898; 19838169; 19324387; 20507882; 20512930; 20044576; 21269460; 21388311; 21987822; 23186163; 23234360; 24052401; 24256719; 24275569; 25503980; 25934851; 10932245; 27493216; 28781947,8268918; 14702039; 16641997; 15489334; 7592992; 9851927; 10767429; 10988290; 10769203; 11724572; 11495720; 12140558; 12795607; 12592373; 15175026; 16254364; 17212656; 17360738; 17905726; 18764929; 19946898; 19838169; 19324387; 20507882; 20512930; 20044576; 21269460; 21388311; 21987822; 23186163; 23234360; 24052401; 24256719; 24275569; 25503980; 25934851; 10932245; 27493216; 28781947; 10022829; 10903901; 11423118; 11470830; 11709191; 12369018; 12386278; 12588800; 12598319; 12920582; 14699049; 14724282; 15175275; 15894594; 16466646; 16575202; 17005282; 17012237; 17196572; 17474147; 17516554; 17640712; 17878207; 18087214; 18456664; 18691338; 18939472; 18983465; 19109891; 19138766; 19244252; 19299310; 19587235; 19913121; 20307617; 20338590; 20350218; 20625412; 20626751; 20628086; 20711500; 20736308; 21203384; 21255062; 21347376; 21741360; 21931648; 22106087; 22138543; 22172424; 22307776; 22405130; 22801424; 22958903; 22964035; 23217742; 23223448; 23329833; 23453667; 23929950; 23940118; 23951345; 24041696; 24077328; 24361964; 24792180; 24925318; 24970085; 25082828; 25139094; 26077903; 26848865; 27130732; 27194101; 27733679; 27788222; 27854211; 28591567; 29635000; 7925941; 8043271; 8349731; 8625852,1997-11-01,2019-02-13,2009-05-05,185,X-ray crystallography (3); NMR spectroscopy (1),STRAND 70 73 {ECO:0000244|PDB:5LLK}.; STRAND 78 81 {ECO:0000244|PDB:5LLK}.; STRAND 93 98 {ECO:0000244|PDB:5LLK}.; STRAND 101 103 {ECO:0000244|PDB:5LLK}.; STRAND 108 111 {ECO:0000244|PDB:5LLK}.; STRAND 116 119 {ECO:0000244|PDB:5LLK}.; STRAND 127 138 {ECO:0000244|PDB:5LLK}.; STRAND 144 157 {ECO:0000244|PDB:5LLK}.; STRAND 188 196 {ECO:0000244|PDB:5LLK}.; STRAND 225 229 {ECO:0000244|PDB:5LLK}.; STRAND 241 245 {ECO:0000244|PDB:5LLK}.; STRAND 256 265 {ECO:0000244|PDB:5LLK}.; STRAND 294 302 {ECO:0000244|PDB:5LLK}.,HELIX 84 87 {ECO:0000244|PDB:5LLK}.; HELIX 123 125 {ECO:0000244|PDB:5LLK}.; HELIX 159 161 {ECO:0000244|PDB:5LLK}.; HELIX 199 201 {ECO:0000244|PDB:5LLK}.; HELIX 204 218 {ECO:0000244|PDB:5LLK}.; HELIX 222 224 {ECO:0000244|PDB:5LLK}.; HELIX 275 283 {ECO:0000244|PDB:5LLK}.; HELIX 285 290 {ECO:0000244|PDB:5LLK}.,TURN 112 115 {ECO:0000244|PDB:5LLK}.; TURN 268 270 {ECO:0000244|PDB:5LLK}.,,,TOPO_DOM 654 749 Extracellular. {ECO:0000255}.; TOPO_DOM 776 895 Cytoplasmic. {ECO:0000255}.,TRANSMEM 750 775 Helical. {ECO:0000255}.,5 out of 5,Beta strand (13); Chain (2); Compositional bias (2); Disulfide bond (2); Domain (1); Glycosylation (14); Helix (8); Modified residue (2); Motif (2); Mutagenesis (17); Natural variant (5); Region (6); Sequence conflict (4); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (2),,"TISSUE SPECIFICITY: Expressed in a variety of fetal and adult tissues. In epidermal tissue, located to the basement membrane. Also expressed in keratinocytes and fibroblasts. {ECO:0000269|PubMed:15175026, ECO:0000269|PubMed:8268918}.",,3D-structure;Autocatalytic cleavage;Cell junction;Cell membrane;Complete proteome;Congenital muscular dystrophy;Cytoplasm;Cytoskeleton;Disease mutation;Disulfide bond;Dystroglycanopathy;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Limb-girdle muscular dystrophy;Lissencephaly;Membrane;Nucleus;Phosphoprotein;Polymorphism;Postsynaptic cell membrane;Receptor;Reference proteome;Secreted;Signal;Synapse;Transmembrane;Transmembrane helix,Evidence at protein level,reviewed,,,185,Function (4); Involvement in disease (2); Post-translational modification (4); Subcellular location (2); Subunit structure (3); Tissue specificity (1),,KW-0002; KW-0068; KW-0181; KW-0206; KW-0225; KW-0325; KW-0451; KW-0472; KW-0539; KW-0597; KW-0621; KW-0628; KW-0675; KW-0732; KW-0770; KW-0812; KW-0912; KW-0945; KW-0947; KW-0963; KW-0964; KW-0965; KW-1003; KW-1015; KW-1133; KW-1183; KW-1185; KW-1215,,,,,"DISEASE: Muscular dystrophy-dystroglycanopathy limb-girdle C9 (MDDGC9) [MIM:613818]: An autosomal recessive muscular dystrophy showing onset in early childhood, and associated with mental retardation without structural brain anomalies. {ECO:0000269|PubMed:21388311, ECO:0000269|PubMed:25503980}. Note=The disease is caused by mutations affecting the gene represented in this entry. MDDGC7 is caused by DAG1 mutations that interfere with normal post-translational processing, resulting in defective DAG1 glycosylation and impaired interactions with extracellular-matrix components. Other muscular dystrophy-dystroglycanopathies are caused by defects in enzymes involved in protein O-glycosylation.; DISEASE: Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A9 (MDDGA9) [MIM:616538]: An autosomal recessive disorder characterized by congenital muscular dystrophy associated with cobblestone lissencephaly and other brain anomalies, eye malformations, profound mental retardation, and death usually in the first years of life. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease. {ECO:0000269|PubMed:24052401, ECO:0000269|PubMed:25934851}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: O-glycosylated. POMGNT1 catalyzes the initial addition of N-acetylglucosamine, giving rise to the GlcNAc(beta1-2)Man(alpha1-)O-Ser/Thr moiety and thus providing the necessary basis for the addition of further carbohydrate moieties (PubMed:27493216). Alpha-dystroglycan is heavily O-glycosylated comprising of up to two thirds of its mass and the carbohydrate composition differs depending on tissue type. Mucin-type O-glycosylation is important for ligand binding activity. O-mannosylation of alpha-DAG1 is found in high abundance in both brain and muscle where the most abundant glycan is Sia-alpha-2-3-Gal-beta-1-4-Glc-NAc-beta-1-2-Man. In muscle, glycosylation on Thr-317, Thr-319 and Thr-379 by a phosphorylated O-mannosyl glycan with the structure 2-(N-acetylamido)-2-deoxygalactosyl-beta-1,3-2-(N-acetylamido)-2-deoxyglucosyl-beta-1,4-6-phosphomannose is mediated by like-acetylglucosaminyltransferase (LARGE1) protein and is required for laminin binding (PubMed:20044576, PubMed:21987822, PubMed:24256719). O-mannosylation is also required for binding lymphocytic choriomeningitis virus, Old World Lassa fever virus, and clade C New World arenaviruses. The O-glycosyl hexose on Thr-367, Thr-369, Thr-372, Thr-381 and Thr-388 is probably mannose. O-glycosylated in the N-terminal region with a core 1 or possibly core 8 glycan. {ECO:0000269|PubMed:12140558, ECO:0000269|PubMed:16254364, ECO:0000269|PubMed:17360738, ECO:0000269|PubMed:17905726, ECO:0000269|PubMed:19838169, ECO:0000269|PubMed:20044576, ECO:0000269|PubMed:20507882, ECO:0000269|PubMed:21987822, ECO:0000269|PubMed:23234360, ECO:0000269|PubMed:24256719, ECO:0000269|PubMed:27493216}.; PTM: The beta subunit is N-glycosylated. {ECO:0000255}.; PTM: Autolytic cleavage produces the alpha and beta subunits. In cutaneous cells, as well as in certain pathological conditions, shedding of beta-dystroglcan can occur releasing a peptide of about 30 kDa. {ECO:0000269|PubMed:15175026, ECO:0000269|PubMed:17905726, ECO:0000269|PubMed:18764929, ECO:0000269|PubMed:19946898}.; PTM: SRC-mediated phosphorylation of the PPXY motif of the beta subunit recruits SH2 domain-containing proteins, but inhibits binding to WWW domain-containing proteins, DMD and UTRN. This phosphorylation also inhibits nuclear entry.",CHAIN 30 653 Alpha-dystroglycan. /FTId=PRO_0000021065.; CHAIN 654 895 Beta-dystroglycan. /FTId=PRO_0000021066.,,"DISULFID 182 264 {ECO:0000244|PDB:5LLK, ECO:0000269|PubMed:28781947}.; DISULFID 669 713 {ECO:0000269|PubMed:17212656}.","CARBOHYD 63 63 O-linked (GalNAc...) threonine. {ECO:0000269|PubMed:23234360}.; CARBOHYD 141 141 N-linked (GlcNAc...) asparagine. {ECO:0000255}.; CARBOHYD 317 317 O-linked (Man6P...) threonine. {ECO:0000269|PubMed:21987822, ECO:0000269|PubMed:24256719}.; CARBOHYD 319 319 O-linked (Man6P...) threonine. {ECO:0000269|PubMed:21987822, ECO:0000269|PubMed:24256719}.; CARBOHYD 367 367 O-linked (Hex...) threonine. {ECO:0000269|PubMed:20507882}.; CARBOHYD 369 369 O-linked (Hex...) threonine. {ECO:0000269|PubMed:20507882}.; CARBOHYD 372 372 O-linked (Hex...) threonine. {ECO:0000269|PubMed:20507882}.; CARBOHYD 379 379 O-linked (Man6P...) threonine. {ECO:0000269|PubMed:20044576}.; CARBOHYD 381 381 O-linked (Hex...) threonine. {ECO:0000269|PubMed:20044576}.; CARBOHYD 388 388 O-linked (Hex...) threonine. {ECO:0000269|PubMed:20044576}.; CARBOHYD 455 455 O-linked (GalNAc...) threonine. {ECO:0000269|PubMed:20507882}.; CARBOHYD 641 641 N-linked (GlcNAc...) asparagine. {ECO:0000255}.; CARBOHYD 649 649 N-linked (GlcNAc...) asparagine. {ECO:0000255}.; CARBOHYD 661 661 N-linked (GlcNAc...) asparagine. {ECO:0000255}.",,,"MOD_RES 790 790 Phosphothreonine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 892 892 Phosphotyrosine; by SRC. {ECO:0000269|PubMed:11495720, ECO:0000269|PubMed:12795607, ECO:0000269|PubMed:20512930}.",,,SIGNAL 1 29 {ECO:0000255}.,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,L19711;AK291692;CH471055;BC012740;BC014616;
0,Q14145,KEAP1_HUMAN,KEAP1 INRF2 KIAA0132 KLHL19,KEAP1,INRF2 KIAA0132 KLHL19,,,Homo sapiens (Human),9606,Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MQPDPRPSGAGACCRFLPLQSQCPEGAGDAVMYASTECKAEVTPSQHGNRTFSYTLEDHTKQAFGIMNELRLSQQLCDVTLQVKYQDAPAAQFMAHKVVLASSSPVFKAMFTNGLREQGMEVVSIEGIHPKVMERLIEFAYTASISMGEKCVLHVMNGAVMYQIDSVVRACSDFLVQQLDPSNAIGIANFAEQIGCVELHQRAREYIYMHFGEVAKQEEFFNLSHCQLVTLISRDDLNVRCESEVFHACINWVKYDCEQRRFYVQALLRAVRCHSLTPNFLQMQLQKCEILQSDSRCKDYLVKIFEELTLHKPTQVMPCRAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVTMEPCRKQIDQQNCTC,624,"69,666",,,,SEQUENCE CAUTION:  Sequence=BAA09481.3; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,,VARIANT 23 23 C -> Y (in a breast cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036084.; VARIANT 167 167 V -> F (in a lung adenocarcinoma patient). {ECO:0000269|PubMed:17020408}. /FTId=VAR_032102.; VARIANT 236 236 D -> H (in a NSCLC cell line). {ECO:0000269|PubMed:17020408}. /FTId=VAR_032103.; VARIANT 284 284 Q -> L (in a lung adenocarcinoma patient). {ECO:0000269|PubMed:17020408}. /FTId=VAR_032104.; VARIANT 333 333 G -> C (in a NSCLC cell line; strongly reduces interaction with NFE2L2 and reduces repression of NFE2L2-dependent gene expression). {ECO:0000269|PubMed:17020408}. /FTId=VAR_032105.; VARIANT 349 349 D -> N (in dbSNP:rs1048289). {ECO:0000269|PubMed:8590280}. /FTId=VAR_032106.; VARIANT 350 350 G -> S (in a NSCLC cell line; dbSNP:rs777308626). {ECO:0000269|PubMed:17020408}. /FTId=VAR_032107.; VARIANT 364 364 G -> C (in a lung adenocarcinoma cell line; also in NSCLC cell lines; may be a polymorphism; strongly reduces interaction with NFE2L2 and reduces repression of NFE2L2-dependent gene expression; dbSNP:rs1397945617). {ECO:0000269|PubMed:16507366}. /FTId=VAR_032108.; VARIANT 430 430 G -> C (in a lung adenocarcinoma patient; somatic mutation; strongly reduces interaction with NFE2L2 and reduces repression of NFE2L2-dependent gene expression). {ECO:0000269|PubMed:16507366}. /FTId=VAR_032109.; VARIANT 522 522 A -> V (in a breast cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036085.,,,,CONFLICT 504 504 N -> S (in Ref. 4; BAG51647). {ECO:0000305}.,,2,,0,"DOMAIN: The Kelch repeats mediate interaction with NF2L2/NRF2, BPTF and PGAM5. {ECO:0000269|PubMed:17046835}.",,,,DOMAIN 77 149 BTB. {ECO:0000255|PROSITE-ProRule:PRU00037}.; DOMAIN 184 286 BACK.,MOTIF 301 310 Nuclear export signal.,,REPEAT 327 372 Kelch 1.; REPEAT 373 423 Kelch 2.; REPEAT 424 470 Kelch 3.; REPEAT 471 517 Kelch 4.; REPEAT 518 564 Kelch 5.; REPEAT 565 611 Kelch 6.,,,,,,,"FUNCTION: Acts as a substrate adapter protein for the E3 ubiquitin ligase complex formed by CUL3 and RBX1 and targets NFE2L2/NRF2 for ubiquitination and degradation by the proteasome, thus resulting in the suppression of its transcriptional activity and the repression of antioxidant response element-mediated detoxifying enzyme gene expression. Retains NFE2L2/NRF2 and may also retain BPTF in the cytosol. Targets PGAM5 for ubiquitination and degradation by the proteasome. {ECO:0000269|PubMed:14585973, ECO:0000269|PubMed:15379550, ECO:0000269|PubMed:15572695, ECO:0000269|PubMed:15983046, ECO:0000269|PubMed:17046835}.",,PATHWAY: Protein modification; protein ubiquitination.,,,,,,,,,,actin filament [GO:0005884]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; disordered domain specific binding [GO:0097718]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; cellular response to interleukin-4 [GO:0071353]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of epidermal cell differentiation [GO:0045604]; viral process [GO:0016032],cellular response to interleukin-4 [GO:0071353]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of epidermal cell differentiation [GO:0045604]; viral process [GO:0016032],disordered domain specific binding [GO:0097718]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134],actin filament [GO:0005884]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleoplasm [GO:0005654],GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005815; GO:0005829; GO:0005884; GO:0008134; GO:0010499; GO:0016032; GO:0016567; GO:0016579; GO:0030496; GO:0031463; GO:0032436; GO:0042803; GO:0042994; GO:0043433; GO:0043687; GO:0045604; GO:0071353; GO:0097718,IPR011705; IPR017096; IPR000210; IPR030563; IPR015915; IPR006652; IPR011333; ,Q5JTC6; P45381; A9UGY9; Q9NPC3; Q9NY33; P62495; Q6P1L5; Q14440; A0A0C4DFT7; B8Q183; O14920; O88351; P15314; Q8N4I8; P62310; Q13257; O60336; Q16236; Q9NZJ9; Q8N573-5; Q86YC2; P54619; P06454-2; Q6P9E2; Q04206; P58004; Q13501; Q64337; P54274; Q9Y3Q8; Q9BRX9; I3L3J2,"SUBUNIT: Homodimer. Forms a ternary complex with NFE2L2 and PGAM5. Interacts with the N-terminal regulatory domain of NFE2L2/NRF2. Interacts with BPTF and PTMA. Interacts with CUL3. Part of a complex that contains KEAP1, CUL3 and RBX1. Interacts with NFE2L1 and MAP1LC3B. Interacts indirectly with ENC1. Interacts with SESN1 and SESN2 (PubMed:23274085). Interacts with HSP90AA1 and HSP90AB1 (PubMed:26517842). {ECO:0000269|PubMed:15379550, ECO:0000269|PubMed:15572695, ECO:0000269|PubMed:15657435, ECO:0000269|PubMed:15983046, ECO:0000269|PubMed:16687406, ECO:0000269|PubMed:16888629, ECO:0000269|PubMed:17046835, ECO:0000269|PubMed:18387606, ECO:0000269|PubMed:19424503, ECO:0000269|PubMed:23274085, ECO:0000269|PubMed:24089205, ECO:0000269|PubMed:26517842}.; SUBUNIT: (Microbial infection) Interacts with ebolavirus protein VP24; this interaction activates transcription factor NRF2 by blocking its interaction with KEAP1. {ECO:0000269|PubMed:24630991}.",8590280; 14702039; 15057824; 15489334; 14585973; 15379550; 15572695; 15983046; 15657435; 16687406; 17046835; 18387606; 19424503; 21269460; 23274085; 24089205; 26517842; 24630991; 15583386; 16204884; 16888629; 16507366; 17020408; 16959974,8590280; 14702039; 15057824; 15489334; 14585973; 15379550; 15572695; 15983046; 15657435; 16687406; 17046835; 18387606; 19424503; 21269460; 23274085; 24089205; 26517842; 24630991; 15583386; 16204884; 16888629; 16507366; 17020408; 16959974; 10444327; 11921171; 11961546; 12145307; 12504025; 12504026; 12609982; 12646216; 12947090; 15231748; 15282312; 15475350; 15537541; 15601839; 15688063; 15799966; 15917255; 16000310; 16006525; 16137655; 16189514; 16401342; 16508120; 16943200; 16954532; 17145701; 17183367; 17259171; 17497243; 17603223; 17636022; 17822677; 17925401; 17980616; 18062931; 18093314; 18240569; 18251510; 18316592; 18434303; 18476723; 18555005; 18692501; 18757741; 18805092; 18829555; 18851830; 18926707; 19028597; 19321346; 19424632; 19489725; 19489739; 19520915; 19596235; 19608619; 19615732; 19671143; 19706542; 19748355; 19818716; 19874575; 19967722; 20061377; 20064547; 20124447; 20173742; 20196834; 20213688; 20378532; 20421418; 20452972; 20495340; 20534738; 20562859; 20600852; 20711500; 20801881; 21044950; 21173573; 21248763; 21251164; 21357422; 21463634; 21506927; 21516116; 21610322; 21676886; 21693047; 21778237; 21795997; 21863050; 21875324; 21897267; 21900206; 21903422; 21926171; 21988832; 22089114; 22125611; 22215675; 22279539; 22348534; 22448038; 22609006; 22683333; 22684020; 22810585; 22872865; 22943825; 22959436; 23045278; 23047008; 23052169; 23056183; 23061798; 23066931; 23075683; 23117207; 23188707; 23242280; 23249627; 23318954; 23390006; 23453757; 23454126; 23455180; 23535662; 23535663; 23563313; 23583660; 23645672; 23647822; 23674500; 23722832; 23724128; 23727018; 23766854; 23824739; 23938463; 23986495; 24102512; 24127568; 24224011; 24323028; 24386210; 24504667; 24746615; 24763052; 24769730; 24896564; 25036637; 25114896; 25236737; 25269472; 25355947; 25358602; 25416956; 25447793; 25449014; 25498967; 25505069; 25528168; 25531322; 25582950; 25589623; 25612817; 25674242; 25739673; 25841332; 25878335; 25879528; 25926686; 25939382; 26078391; 26149655; 26191276; 26195781; 26205490; 26219975; 26233704; 26301506; 26350055; 26363505; 26453926; 26496610; 26527616; 26551700; 26551704; 26551706; 26602019; 26632597; 26638075; 26657794; 26698668; 26773127; 26857210; 26878775; 26904936; 26987716; 26989875; 27029077; 27086966; 27170270; 27212020; 27323010; 27474998; 27497688; 27497696; 27573160; 27601007; 27621311; 27650414; 27663261; 27663899; 27769838; 27799074; 27806574; 27840932; 28061435; 28061437; 28115426; 28128368; 28129239; 28159763; 28202604; 28237856; 28315327; 28333129; 28453520; 28533375; 28583303; 28617433; 28621229; 28663241; 28684421; 28757910; 28760781; 28839075; 28842501; 28967920; 29033244; 29053012; 29306329; 29407955; 29474635; 29499228; 29569716; 29590092; 29675925; 29717933; 29743966; 29927029; 30071261; 30397576,2001-04-27,2019-02-13,2007-05-01,198,X-ray crystallography (35),STRAND 79 83 {ECO:0000244|PDB:5GIT}.; STRAND 86 88 {ECO:0000244|PDB:5DAD}.; STRAND 91 95 {ECO:0000244|PDB:5GIT}.; STRAND 121 125 {ECO:0000244|PDB:5GIT}.; STRAND 327 331 {ECO:0000244|PDB:1ZGK}.; STRAND 334 338 {ECO:0000244|PDB:1ZGK}.; STRAND 342 345 {ECO:0000244|PDB:1ZGK}.; STRAND 352 354 {ECO:0000244|PDB:1ZGK}.; STRAND 362 364 {ECO:0000244|PDB:2FLU}.; STRAND 366 370 {ECO:0000244|PDB:1ZGK}.; STRAND 373 377 {ECO:0000244|PDB:1ZGK}.; STRAND 380 383 {ECO:0000244|PDB:1ZGK}.; STRAND 386 389 {ECO:0000244|PDB:1ZGK}.; STRAND 393 396 {ECO:0000244|PDB:1ZGK}.; STRAND 403 405 {ECO:0000244|PDB:1ZGK}.; STRAND 417 421 {ECO:0000244|PDB:1ZGK}.; STRAND 424 428 {ECO:0000244|PDB:1ZGK}.; STRAND 440 444 {ECO:0000244|PDB:1ZGK}.; STRAND 449 452 {ECO:0000244|PDB:1ZGK}.; STRAND 464 468 {ECO:0000244|PDB:1ZGK}.; STRAND 471 475 {ECO:0000244|PDB:1ZGK}.; STRAND 480 483 {ECO:0000244|PDB:4L7C}.; STRAND 487 491 {ECO:0000244|PDB:1ZGK}.; STRAND 496 499 {ECO:0000244|PDB:1ZGK}.; STRAND 511 515 {ECO:0000244|PDB:1ZGK}.; STRAND 518 522 {ECO:0000244|PDB:1ZGK}.; STRAND 527 530 {ECO:0000244|PDB:1ZGK}.; STRAND 534 538 {ECO:0000244|PDB:1ZGK}.; STRAND 543 547 {ECO:0000244|PDB:1ZGK}.; STRAND 558 562 {ECO:0000244|PDB:1ZGK}.; STRAND 565 569 {ECO:0000244|PDB:1ZGK}.; STRAND 574 577 {ECO:0000244|PDB:5F72}.; STRAND 580 585 {ECO:0000244|PDB:1ZGK}.; STRAND 590 596 {ECO:0000244|PDB:1ZGK}.; STRAND 605 609 {ECO:0000244|PDB:1ZGK}.,HELIX 59 72 {ECO:0000244|PDB:5GIT}.; HELIX 97 103 {ECO:0000244|PDB:5GIT}.; HELIX 105 111 {ECO:0000244|PDB:5GIT}.; HELIX 130 142 {ECO:0000244|PDB:5GIT}.; HELIX 149 151 {ECO:0000244|PDB:5GIT}.; HELIX 152 161 {ECO:0000244|PDB:5GIT}.; HELIX 165 177 {ECO:0000244|PDB:5GIT}.; HELIX 184 194 {ECO:0000244|PDB:5NLB}.; HELIX 199 202 {ECO:0000244|PDB:5NLB}.,TURN 181 183 {ECO:0000244|PDB:5NLB}.; TURN 347 349 {ECO:0000244|PDB:1ZGK}.; TURN 398 400 {ECO:0000244|PDB:1ZGK}.; TURN 445 448 {ECO:0000244|PDB:1ZGK}.; TURN 492 495 {ECO:0000244|PDB:1ZGK}.; TURN 539 542 {ECO:0000244|PDB:1ZGK}.; TURN 586 589 {ECO:0000244|PDB:1ZGK}.,,,,,5 out of 5,Beta strand (35); Chain (1); Domain (2); Erroneous initiation (1); Helix (9); Motif (1); Mutagenesis (16); Natural variant (10); Repeat (6); Sequence conflict (1); Turn (7),,"TISSUE SPECIFICITY: Broadly expressed, with highest levels in skeletal muscle. {ECO:0000269|PubMed:15379550}.",,3D-structure;Complete proteome;Cytoplasm;Host-virus interaction;Kelch repeat;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Ubl conjugation pathway,Evidence at protein level,reviewed,,,198,Activity regulation (1); Domain (1); Function (1); Pathway (1); Post-translational modification (1); Subcellular location (1); Subunit structure (2); Tissue specificity (1),,KW-0002; KW-0181; KW-0539; KW-0621; KW-0677; KW-0804; KW-0805; KW-0832; KW-0833; KW-0880; KW-0945; KW-0963; KW-1185,Protein modification; protein ubiquitination. ,,,,,,,"PTM: Ubiquitinated by the E3 ubiquitin ligase complex formed by CUL3 and RBX1 and is subject to proteasomal-independent degradation. Quinone-induced oxidative stress, but not sulforaphane, increases its ubiquitination. Ubiquitination and subsequent degradation is most pronounced following prolonged exposure of cells to oxidative stress, particularly in glutathione-deficient cells that are highly susceptible to oxidative stress. {ECO:0000269|PubMed:15572695, ECO:0000269|PubMed:15983046}.",CHAIN 1 624 Kelch-like ECH-associated protein 1. /FTId=PRO_0000119093.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF361892;AF361888;AF361889;AF361890;AF361891;AF361886;D50922;AK056204;BC002417;BC002930;BC015945;BC021957;
0,Q15311,RBP1_HUMAN,RALBP1 RLIP1 RLIP76,RALBP1,RLIP1 RLIP76,,,Homo sapiens (Human),9606,RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (Ral-interacting protein 1),UP000005640: Chromosome 18,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MTECFLPPTSSPSEHRRVEHGSGLTRTPSSEEISPTKFPGLYRTGEPSPPHDILHEPPDVVSDDEKDHGKKKGKFKKKEKRTEGYAAFQEDSSGDEAESPSKMKRSKGIHVFKKPSFSKKKEKDFKIKEKPKEEKHKEEKHKEEKHKEKKSKDLTAADVVKQWKEKKKKKKPIQEPEVPQIDVPNLKPIFGIPLADAVERTMMYDGIRLPAVFRECIDYVEKYGMKCEGIYRVSGIKSKVDELKAAYDREESTNLEDYEPNTVASLLKQYLRDLPENLLTKELMPRFEEACGRTTETEKVQEFQRLLKELPECNYLLISWLIVHMDHVIAKELETKMNIQNISIVLSPTVQISNRVLYVFFTHVQELFGNVVLKQVMKPLRWSNMATMPTLPETQAGIKEEIRRQEFLLNCLHRDLQGGIKDLSKEERLWEVQRILTALKRKLREAKRQECETKIAQEIASLSKEDVSKEEMNENEEVINILLAQENEILTEQEELLAMEQFLRRQIASEKEEIERLRAEIAEIQSRQQHGRSETEEYSSESESESEDEEELQIILEDLQRQNEELEIKNNHLNQAIHEEREAIIELRVQLRLLQMQRAKAEQQAQEDEEPEWRGGAVQPPRDGVLEPKAAKEQPKAGKEPAKPSPSRDRKETSI,655,"76,063",,,,,,,,,,,,,VARIANT 617 617 A -> V (in dbSNP:rs35867116). /FTId=VAR_049147.,,,,,,3,,0,,,,COMPBIAS 164 171 Poly-Lys.,DOMAIN 192 380 Rho-GAP. {ECO:0000255|PROSITE-ProRule:PRU00172}.,,REGION 403 499 Interaction with RalA.,,,,,,,,"FUNCTION: Can activate specifically hydrolysis of GTP bound to RAC1 and CDC42, but not RALA. Mediates ATP-dependent transport of S-(2,4-dinitrophenyl)-glutathione (DNP-SG) and doxorubicin (DOX) and is the major ATP-dependent transporter of glutathione conjugates of electrophiles (GS-E) and DOX in erythrocytes. Can catalyze transport of glutathione conjugates and xenobiotics, and may contribute to the multidrug resistance phenomenon. Serves as a scaffold protein that brings together proteins forming an endocytotic complex during interphase and also with CDK1 to switch off endocytosis, One of its substrates would be EPN1/Epsin. {ECO:0000269|PubMed:11437348, ECO:0000269|PubMed:12775724, ECO:0000269|PubMed:7673236}.",,,,,,,,,,,,"cytosol [GO:0005829]; membrane [GO:0016020]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; drug transmembrane transporter activity [GO:0015238]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; transmembrane transporter activity [GO:0022857]; chemotaxis [GO:0006935]; doxorubicin transport [GO:1900753]; drug transmembrane transport [GO:0006855]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; transmembrane transport [GO:0055085]",chemotaxis [GO:0006935]; doxorubicin transport [GO:1900753]; drug transmembrane transport [GO:0006855]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; transmembrane transport [GO:0055085],"ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; drug transmembrane transporter activity [GO:0015238]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; transmembrane transporter activity [GO:0022857]",cytosol [GO:0005829]; membrane [GO:0016020],GO:0005096; GO:0005829; GO:0006855; GO:0006897; GO:0006935; GO:0007165; GO:0007264; GO:0015238; GO:0016020; GO:0017160; GO:0022857; GO:0042626; GO:0043087; GO:0043547; GO:0048365; GO:0051056; GO:0055085; GO:1900753,IPR039767; IPR008936; IPR000198; ,Q9H6F0; Q9Y2J4-4; Q8TAB5; Q16204; P78556; Q86XR8; Q12959; Q13227; Q63ZY3; O60437; P11233; Q14160; Q969G3; Q86VP1; Q05BL0; P0C1Z6-2; Q15025; P43897; P40337-3; Q96C28,"SUBUNIT: Interacts with the GTP-bound form of RALA, RALB, CDC42 and RAC1. Interacts with REPS1 and REPS2 and this does not affect the Ral-binding activity. Interacts with DAB2IP. Interacts with catalytically active CCNB1 and CDK1 during mitosis. Interacts with EPN1, NUMB and TFAP2A during interphase and mitosis. {ECO:0000269|PubMed:12775724, ECO:0000269|PubMed:15310755, ECO:0000269|PubMed:20696399, ECO:0000269|PubMed:7673236, ECO:0000269|PubMed:9422736}.",7673236; 10924126; 15489334; 9422736; 12775724; 11437348; 15310755; 17081983; 18220336; 18088087; 18669648; 19413330; 19369195; 19690332; 21269460; 21406692; 23186163; 24275569; 20696399,7673236; 10924126; 15489334; 9422736; 12775724; 11437348; 15310755; 17081983; 18220336; 18088087; 18669648; 19413330; 19369195; 19690332; 21269460; 21406692; 23186163; 24275569; 20696399; 10910768; 11431473; 11732624; 11804589; 12433796; 12527936; 12632060; 12632061; 15707977; 16087181; 16188027; 16189514; 16890208; 17047155; 17222083; 17703191; 17706599; 17982077; 17993611; 18086001; 18239685; 18474607; 18628450; 19073149; 19375851; 19417134; 19626587; 20183533; 21516116; 21671802; 21822277; 22331470; 22549157; 23211419; 23276796; 23414517; 23419874; 23576547; 24207123; 24450627; 24839008; 25213293; 25241761; 25416956; 25814554; 25993541; 26067553; 26125275; 26406496; 26496610; 26975227; 27473470; 27572296; 27657824; 27748916; 2825022; 28537681; 8288572; 9605766; 9753634,2003-08-15,2019-02-13,2007-01-23,171,NMR spectroscopy (3),STRAND 184 187 {ECO:0000244|PDB:2MBG}.; STRAND 384 386 {ECO:0000244|PDB:2MBG}.,HELIX 194 200 {ECO:0000244|PDB:2MBG}.; HELIX 211 222 {ECO:0000244|PDB:2MBG}.; HELIX 237 248 {ECO:0000244|PDB:2MBG}.; HELIX 255 257 {ECO:0000244|PDB:2MBG}.; HELIX 260 273 {ECO:0000244|PDB:2MBG}.; HELIX 280 291 {ECO:0000244|PDB:2MBG}.; HELIX 296 309 {ECO:0000244|PDB:2MBG}.; HELIX 312 334 {ECO:0000244|PDB:2MBG}.; HELIX 339 350 {ECO:0000244|PDB:2MBG}.; HELIX 354 367 {ECO:0000244|PDB:2MBG}.; HELIX 395 414 {ECO:0000244|PDB:2KWH}.; HELIX 424 444 {ECO:0000244|PDB:2KWH}.,TURN 223 225 {ECO:0000244|PDB:2MBG}.; TURN 228 232 {ECO:0000244|PDB:2MBG}.; TURN 417 419 {ECO:0000244|PDB:2MBG}.,,,,,5 out of 5,Beta strand (2); Chain (1); Compositional bias (1); Domain (1); Helix (12); Initiator methionine (1); Modified residue (12); Natural variant (1); Region (1); Turn (3),,TISSUE SPECIFICITY: Expressed ubiquitously but at low levels. Shows a strong expression in the erythrocytes. {ECO:0000269|PubMed:11437348}.,,3D-structure;Acetylation;Complete proteome;Direct protein sequencing;GTPase activation;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transport,Evidence at protein level,reviewed,,,171,Function (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0181; KW-0343; KW-0472; KW-0597; KW-0621; KW-0813; KW-0903; KW-1185,,,,,,,,,CHAIN 2 655 RalA-binding protein 1. /FTId=PRO_0000056733.,,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000269|PubMed:10924126}.",,"MOD_RES 2 2 N-acetylthreonine. {ECO:0000244|PubMed:19413330}.; MOD_RES 29 29 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 30 30 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 34 34 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 44 44 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 48 48 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 62 62 Phosphoserine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 92 92 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 93 93 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 461 461 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 463 463 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 645 645 Phosphoserine. {ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,L42542;CH471113;CH471113;CH471113;CH471113;BC013126;
0,Q15349,KS6A2_HUMAN,RPS6KA2 MAPKAPK1C RSK3,RPS6KA2,MAPKAPK1C RSK3,,,Homo sapiens (Human),9606,Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3),UP000005640: Chromosome 6,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDLSMKKFAVRRFFSVYLRRKSRSKSSSLSRLEEEGVVKEIDISHHVKEGFEKADPSQFELLKVLGQGSYGKVFLVRKVKGSDAGQLYAMKVLKKATLKVRDRVRSKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKITDFGLSKEAIDHDKRAYSFCGTIEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMALILKAKLGMPQFLSGEAQSLLRALFKRNPCNRLGAGIDGVEEIKRHPFFVTIDWNTLYRKEIKPPFKPAVGRPEDTFHFDPEFTARTPTDSPGVPPSANAHHLFRGFSFVASSLIQEPSQQDLHKVPVHPIVQQLHGNNIHFTDGYEIKEDIGVGSYSVCKRCVHKATDTEYAVKIIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKFVYLVMELMRGGELLDRILRQRYFSEREASDVLCTITKTMDYLHSQGVVHRDLKPSNILYRDESGSPESIRVCDFGFAKQLRAGNGLLMTPCYTANFVAPEVLKRQGYDAACDIWSLGILLYTMLAGFTPFANGPDDTPEEILARIGSGKYALSGGNWDSISDAAKDVVSKMLHVDPHQRLTAMQVLKHPWVVNREYLSPNQLSRQDVHLVKGAMAATYFALNRTPQAPRLEPVLSSNLAQRRGMKRLTSTRL,733,"83,239",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=Q15349-1; Sequence=Displayed; Name=2; IsoId=Q15349-2; Sequence=VSP_017732; Note=No experimental confirmation available.; Name=3; IsoId=Q15349-3; Sequence=VSP_041836; ,,SEQUENCE CAUTION:  Sequence=AAC82496.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};  Sequence=BAD92353.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,SEQUENCE CAUTION:  Sequence=BAG53121.1; Type=Frameshift; Positions=527; Evidence={ECO:0000305}; ,,,,,VAR_SEQ 1 32 MDLSMKKFAVRRFFSVYLRRKSRSKSSSLSRL -> MPIAQLLELWKKIEVEPMEIETTEEDLNLDVGPATEDTAEEGKSDSAACKTKVAGSV (in isoform 2). {ECO:0000303|Ref.2}. /FTId=VSP_017732.; VAR_SEQ 1 32 MDLSMKKFAVRRFFSVYLRRKSRSKSSSLSRL -> MPIAQLLELWKKIEVEPMEIETTEEDLNLDVEPTTEDTAE (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_041836.,VARIANT 311 311 E -> K (in a metastatic melanoma sample; somatic mutation; dbSNP:rs267600891). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040627.; VARIANT 732 732 R -> Q (in a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs376029388). {ECO:0000269|PubMed:17344846}. /FTId=VAR_040628.,,,,CONFLICT 256 256 S -> A (in Ref. 6; AAC82496). {ECO:0000305}.; CONFLICT 269 269 A -> S (in Ref. 6; AAC82496). {ECO:0000305}.; CONFLICT 339 339 V -> L (in Ref. 1; CAA59427 and 6; AAC82496). {ECO:0000305}.; CONFLICT 447 447 D -> G (in Ref. 6; AAC82496). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. S6 kinase subfamily. {ECO:0000305}.,,,DOMAIN 59 318 Protein kinase 1. {ECO:0000255|PROSITE-ProRule:PRU00159}.; DOMAIN 319 388 AGC-kinase C-terminal.; DOMAIN 415 672 Protein kinase 2. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ,,"FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of transcription factors, regulates translation, and mediates cellular proliferation, survival, and differentiation. May function as tumor suppressor in epithelial ovarian cancer cells. {ECO:0000269|PubMed:16878154, ECO:0000269|PubMed:7623830}.",,,,,,ACT_SITE 184 184 Proton acceptor. {ECO:0000250}.; ACT_SITE 532 532 Proton acceptor. {ECO:0000250}.,BINDING 91 91 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.; BINDING 444 444 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 65 73 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.; NP_BIND 421 429 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165],intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165],ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008285; GO:0016301; GO:0035556; GO:0043065; GO:0045786,IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR008271; ,P15056; P28482; P27361; Q02156; Q14160; Q9Y566,"SUBUNIT: Forms a complex with either MAPK1/ERK2 or MAPK3/ERK1 in quiescent cells. Transiently dissociates following mitogenic stimulation (By similarity). Interacts with FBXO5; cooperate to induce the metaphase arrest of early blastomeres; increases and stabilizes interaction of FBXO5 with CDC20 (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q9WUT3}.",7623830; 14702039; 14574404; 15489334; 8141249; 10480933; 16878154; 18691976; 18813292; 19369195; 17344846,7623830; 14702039; 14574404; 15489334; 8141249; 10480933; 16878154; 18691976; 18813292; 19369195; 17344846; 11160957; 12016217; 12393804; 12832467; 14646589; 15112576; 15995633; 16621805; 16626623; 16810323; 16895915; 17721511; 20351173; 20379614; 21035469; 21527514; 21988832; 22939624; 23455922; 23564320; 23602568; 23606334; 23635776; 23727904; 24403857; 24606918; 25241761; 25852190; 26977024; 29144123; 7642538; 8663493; 9770464,1998-12-15,2019-02-13,2006-03-21,193,,,,,,,,,5 out of 5,Active site (2); Alternative sequence (2); Binding site (2); Chain (1); Domain (3); Erroneous initiation (2); Frameshift (1); Modified residue (2); Natural variant (2); Nucleotide binding (2); Sequence conflict (7),,"TISSUE SPECIFICITY: Widely expressed with higher expression in lung, skeletal muscle, brain, uterus, ovary, thyroid and prostate. {ECO:0000269|PubMed:16878154, ECO:0000269|PubMed:7623830}.",,ATP-binding;Alternative splicing;Complete proteome;Cytoplasm;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase;Tumor suppressor,Evidence at protein level,reviewed,,"Protein kinase superfamily, AGC Ser/Thr protein kinase family, S6 kinase subfamily",193,Activity regulation (1); Alternative products (1); Catalytic activity (2); Caution (1); Cofactor (1); Function (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0043; KW-0067; KW-0181; KW-0418; KW-0460; KW-0479; KW-0539; KW-0547; KW-0597; KW-0621; KW-0677; KW-0723; KW-0808; KW-0963; KW-1185,,,,,,,,"PTM: Activated by phosphorylation at Ser-218 by PDPK1. Autophosphorylated on Ser-377, as part of the activation process. May be phosphorylated at Thr-356 and Ser-360 by MAPK1/ERK2 and MAPK3/ERK1 (By similarity). {ECO:0000250}.; PTM: N-terminal myristoylation results in an activated kinase in the absence of added growth factors. {ECO:0000250}.",CHAIN 1 733 Ribosomal protein S6 kinase alpha-2. /FTId=PRO_0000086201.,,,,,,MOD_RES 218 218 Phosphoserine; by PDPK1. {ECO:0000269|PubMed:10480933}.; MOD_RES 377 377 Phosphoserine. {ECO:0000244|PubMed:19369195}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X85106;AB209116;AK095751;AL022069;Z98049;Z98049;AL022069;BC002363;L07598;
0,Q15418,KS6A1_HUMAN,RPS6KA1 MAPKAPK1A RSK1,RPS6KA1,MAPKAPK1A RSK1,,,Homo sapiens (Human),9606,Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPLAQLKEPWPLMELVPLDPENGQTSGEEAGLQPSKDEGVLKEISITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKPPFKPAVAQPDDTFYFDTEFTSRTPKDSPGIPPSAGAHQLFRGFSFVATGLMEDDGKPRAPQAPLHSVVQQLHGKNLVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALNSSKPTPQLKPIESSILAQRRVRKLPSTTL,735,"82,723",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; IsoId=Q15418-1; Sequence=Displayed; Name=2; IsoId=Q15418-2; Sequence=VSP_041380; Name=3; IsoId=Q15418-3; Sequence=VSP_041580; Note=No experimental confirmation available.; Name=4 {ECO:0000305}; IsoId=Q15418-4; Sequence=VSP_057469; ,,,,,,,,,,VAR_SEQ 1 92 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_041580.; VAR_SEQ 1 36 MPLAQLKEPWPLMELVPLDPENGQTSGEEAGLQPSK -> MEQDPKPPRLRLWALIPWLPRKQRPRISQTSLPVPGPGSGPQRDS (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_041380.; VAR_SEQ 1 35 MPLAQLKEPWPLMELVPLDPENGQTSGEEAGLQPS -> MQTPADFPRVERDLVPCPR (in isoform 4). /FTId=VSP_057469.,"VARIANT 335 335 K -> T (in dbSNP:rs2229712). {ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8141249}. /FTId=VAR_021864.",,,,CONFLICT 609 609 A -> T (in Ref. 2; BAF85411). {ECO:0000305}.; CONFLICT 619 619 S -> G (in Ref. 2; BAF85411). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. S6 kinase subfamily. {ECO:0000305}.,,,DOMAIN 62 321 Protein kinase 1. {ECO:0000255|PROSITE-ProRule:PRU00159}.; DOMAIN 322 391 AGC-kinase C-terminal.; DOMAIN 418 675 Protein kinase 2. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ,,"FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1, which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the pre-initiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Mediates induction of hepatocyte prolifration by TGFA through phosphorylation of CEBPB (By similarity). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). {ECO:0000250|UniProtKB:P18653, ECO:0000250|UniProtKB:Q63531, ECO:0000269|PubMed:10679322, ECO:0000269|PubMed:11684016, ECO:0000269|PubMed:12213813, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:15342917, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:16763566, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:9430688}.",,,,,,ACT_SITE 187 187 Proton acceptor. {ECO:0000250}.; ACT_SITE 535 535 Proton acceptor. {ECO:0000250}.,BINDING 94 94 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.; BINDING 447 447 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 68 76 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.; NP_BIND 424 432 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165],cell cycle [GO:0007049]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165],ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0007049; GO:0007165; GO:0016301; GO:0030307; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944; GO:0072574; GO:2000491,IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR008271; ,O43823; P46527; P08238; P28482; Q14160; P50552,"SUBUNIT: Forms a complex with either MAPK1/ERK2 or MAPK3/ERK1 in quiescent cells. Transiently dissociates following mitogenic stimulation. Interacts with ETV1/ER81 and FGFR1. {ECO:0000269|PubMed:12213813, ECO:0000269|PubMed:12832467, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:15342917, ECO:0000269|PubMed:17965187}.",8141249; 14702039; 16710414; 15489334; 9687510; 9430688; 10679322; 11684016; 12213813; 12832467; 15117958; 15342917; 16213824; 16223362; 16763566; 16964243; 17360704; 18722121; 18508509; 18691976; 18813292; 18669648; 19369195; 20068231; 21269460; 21406692; 23186163; 24275569; 26158630; 17965187; 17344846,8141249; 14702039; 16710414; 15489334; 9687510; 9430688; 10679322; 11684016; 12213813; 12832467; 15117958; 15342917; 16213824; 16223362; 16763566; 16964243; 17360704; 18722121; 18508509; 18691976; 18813292; 18669648; 19369195; 20068231; 21269460; 21406692; 23186163; 24275569; 26158630; 17965187; 17344846; 10480933; 11160957; 11500364; 11861786; 11914378; 12019261; 12036856; 12080086; 12138104; 12393804; 12618428; 15112576; 15615708; 15647351; 15905173; 16282323; 16458888; 16626623; 16738324; 17512525; 17634259; 17721511; 18084084; 18450423; 18950845; 19150432; 19171933; 19332537; 19371592; 19470470; 19675165; 19716794; 19804365; 19808666; 20048145; 20304964; 20351173; 20628086; 20832753; 20849292; 20957203; 21035469; 21044953; 21075852; 21273600; 21423205; 21501342; 21832046; 21900206; 22006917; 22031759; 22050627; 22130794; 22216126; 22246185; 22249268; 22357623; 22427657; 22674792; 22683790; 22865467; 22939624; 23047924; 23401857; 23416715; 23455922; 23519423; 23606334; 24036112; 24189400; 24269382; 24269383; 24277696; 24332215; 24627490; 25320298; 25513777; 25579842; 25689261; 25730857; 25889895; 26527685; 26580203; 26625210; 26638075; 26862730; 26977024; 27236820; 27591897; 27613090; 27786305; 28167505; 28559278; 28740606; 29083550; 29109170; 29483509; 8663493; 9770464,1998-12-15,2019-02-13,2002-04-16,204,X-ray crystallography (17),STRAND 62 71 {ECO:0000244|PDB:2Z7Q}.; STRAND 74 81 {ECO:0000244|PDB:2Z7Q}.; STRAND 83 86 {ECO:0000244|PDB:2Z7Q}.; STRAND 90 96 {ECO:0000244|PDB:2Z7Q}.; STRAND 127 133 {ECO:0000244|PDB:2Z7Q}.; STRAND 136 141 {ECO:0000244|PDB:2Z7Q}.; STRAND 193 195 {ECO:0000244|PDB:2Z7Q}.; STRAND 197 199 {ECO:0000244|PDB:2Z7Q}.; STRAND 201 203 {ECO:0000244|PDB:2Z7Q}.; STRAND 307 310 {ECO:0000244|PDB:2Z7Q}.; STRAND 418 427 {ECO:0000244|PDB:4NIF}.; STRAND 430 437 {ECO:0000244|PDB:4NIF}.; STRAND 442 450 {ECO:0000244|PDB:4NIF}.; STRAND 475 480 {ECO:0000244|PDB:4NIF}.; STRAND 482 490 {ECO:0000244|PDB:4NIF}.; STRAND 503 505 {ECO:0000244|PDB:3RNY}.; STRAND 541 547 {ECO:0000244|PDB:4NIF}.; STRAND 553 555 {ECO:0000244|PDB:4NIF}.; STRAND 733 735 {ECO:0000244|PDB:5N7D}.,HELIX 59 61 {ECO:0000244|PDB:2Z7Q}.; HELIX 149 156 {ECO:0000244|PDB:2Z7Q}.; HELIX 161 180 {ECO:0000244|PDB:2Z7Q}.; HELIX 190 192 {ECO:0000244|PDB:2Z7Q}.; HELIX 226 228 {ECO:0000244|PDB:2Z7Q}.; HELIX 231 234 {ECO:0000244|PDB:2Z7Q}.; HELIX 241 257 {ECO:0000244|PDB:2Z7Q}.; HELIX 267 276 {ECO:0000244|PDB:2Z7Q}.; HELIX 287 296 {ECO:0000244|PDB:2Z7Q}.; HELIX 312 316 {ECO:0000244|PDB:2Z7Q}.; HELIX 319 321 {ECO:0000244|PDB:2Z7Q}.; HELIX 326 330 {ECO:0000244|PDB:2Z7Q}.; HELIX 457 466 {ECO:0000244|PDB:4NIF}.; HELIX 497 501 {ECO:0000244|PDB:4NIF}.; HELIX 509 528 {ECO:0000244|PDB:4NIF}.; HELIX 538 540 {ECO:0000244|PDB:4NIF}.; HELIX 550 552 {ECO:0000244|PDB:4NIF}.; HELIX 583 609 {ECO:0000244|PDB:4NIF}.; HELIX 622 631 {ECO:0000244|PDB:4NIF}.; HELIX 639 642 {ECO:0000244|PDB:4NIF}.; HELIX 646 655 {ECO:0000244|PDB:4NIF}.; HELIX 660 662 {ECO:0000244|PDB:4NIF}.; HELIX 666 671 {ECO:0000244|PDB:4NIF}.; HELIX 673 676 {ECO:0000244|PDB:4NIF}.; HELIX 678 680 {ECO:0000244|PDB:4NIF}.; HELIX 691 706 {ECO:0000244|PDB:4NIF}.; HELIX 717 719 {ECO:0000244|PDB:5V62}.; HELIX 721 725 {ECO:0000244|PDB:5V62}.,TURN 301 303 {ECO:0000244|PDB:2Z7Q}.; TURN 438 441 {ECO:0000244|PDB:4NIF}.; TURN 451 453 {ECO:0000244|PDB:4NIF}.; TURN 574 576 {ECO:0000244|PDB:2WNT}.,,,,,5 out of 5,Active site (2); Alternative sequence (3); Beta strand (19); Binding site (2); Chain (1); Domain (3); Helix (28); Modified residue (9); Natural variant (1); Nucleotide binding (2); Sequence conflict (2); Turn (4),,,,3D-structure;ATP-binding;Alternative splicing;Cell cycle;Complete proteome;Cytoplasm;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Stress response;Transferase,Evidence at protein level,reviewed,,"Protein kinase superfamily, AGC Ser/Thr protein kinase family, S6 kinase subfamily",204,Activity regulation (1); Alternative products (1); Catalytic activity (2); Caution (1); Cofactor (1); Function (1); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0067; KW-0131; KW-0181; KW-0346; KW-0418; KW-0460; KW-0479; KW-0539; KW-0547; KW-0597; KW-0621; KW-0677; KW-0723; KW-0808; KW-0963; KW-1185,,,,,,,,"PTM: Activated by phosphorylation at Ser-221 by PDPK1. Autophosphorylated on Ser-380, as part of the activation process. May be phosphorylated at Thr-359 and Ser-363 by MAPK1/ERK2 and MAPK3/ERK1. {ECO:0000269|PubMed:9430688}.; PTM: N-terminal myristoylation results in an activated kinase in the absence of added growth factors.",CHAIN 1 735 Ribosomal protein S6 kinase alpha-1. /FTId=PRO_0000086198.,,,,,,"MOD_RES 54 54 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 221 221 Phosphoserine; by PDPK1. {ECO:0000305|PubMed:9430688}.; MOD_RES 307 307 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 359 359 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:9430688}.; MOD_RES 363 363 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:9430688}.; MOD_RES 369 369 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:23186163}.; MOD_RES 380 380 Phosphoserine; by autocatalysis. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:9430688}.; MOD_RES 573 573 Phosphothreonine. {ECO:0000269|PubMed:9430688}.; MOD_RES 732 732 Phosphoserine. {ECO:0000269|PubMed:9430688}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,L07597;AK292722;AK299007;AK315730;AL109743;CH471059;BC014966;
0,Q16625,OCLN_HUMAN,OCLN,OCLN,,,,Homo sapiens (Human),9606,Occludin,UP000005640: Chromosome 5,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSSRPLESPPPYRPDEFKPNHYAPSNDIYGGEMHVRPMLSQPAYSFYPEDEILHFYKWTSPPGVIRILSMLIIVMCIAIFACVASTLAWDRGYGTSLLGGSVGYPYGGSGFGSYGSGYGYGYGYGYGYGGYTDPRAAKGFMLAMAAFCFIAALVIFVTSVIRSEMSRTRRYYLSVIIVSAILGIMVFIATIVYIMGVNPTAQSSGSLYGSQIYALCNQFYTPAATGLYVDQYLYHYCVVDPQEAIAIVLGFMIIVAFALIIFFAVKTRRKMDRYDKSNILWDKEHIYDEQPPNVEEWVKNVSAGTQDVPSPPSDYVERVDSPMAYSSNGKVNDKRFYPESSYKSTPVPEVVQELPLTSPVDDFRQPRYSSGGNFETPSKRAPAKGRAGRSKRTEQDHYETDYTTGGESCDELEEDWIREYPPITSDQQRQLYKRNFDTGLQEYKSLQSELDEINKELSRLDKELDDYREESEEYMAAADEYNRLKQVKGSADYKSKKNHCKQLKSKLSHIKKMVGDYDRQKT,522,"59,144",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=7;  Name=1; Synonyms=WT-OCLN, TM4(+); IsoId=Q16625-1; Sequence=Displayed; Name=2; Synonyms=OCLN-ex4del, TM4(-); IsoId=Q16625-2; Sequence=VSP_043877; Name=3; Synonyms=OCLN-ex7ext; IsoId=Q16625-3; Sequence=VSP_043879; Name=4; Synonyms=OCLN-ex3del, OCLN-ex3pdel; IsoId=Q16625-4; Sequence=VSP_043872; Name=5; Synonyms=OCLN-ex3-4del; IsoId=Q16625-5; Sequence=VSP_043872, VSP_043878; Name=6; Synonyms=OCLN-ex3p-9pdel; IsoId=Q16625-6; Sequence=VSP_043873, VSP_043875, VSP_043876; Name=7; Synonyms=OCLN-ex3p-7pdel; IsoId=Q16625-7; Sequence=VSP_043874, VSP_043876; ",,,,,,,,,,VAR_SEQ 1 251 Missing (in isoform 4 and isoform 5). {ECO:0000303|PubMed:20463075}. /FTId=VSP_043872.; VAR_SEQ 50 69 DEILHFYKWTSPPGVIRILS -> ESLQAVKEQIVTHQEDGWRL (in isoform 6). {ECO:0000303|PubMed:20463075}. /FTId=VSP_043873.; VAR_SEQ 52 70 ILHFYKWTSPPGVIRILSM -> MTIEKKVKSTWLLLMNTID (in isoform 7). {ECO:0000303|PubMed:20463075}. /FTId=VSP_043874.; VAR_SEQ 70 70 Missing (in isoform 6). {ECO:0000303|PubMed:20463075}. /FTId=VSP_043875.; VAR_SEQ 71 522 Missing (in isoform 6 and isoform 7). {ECO:0000303|PubMed:20463075}. /FTId=VSP_043876.; VAR_SEQ 244 297 Missing (in isoform 2). {ECO:0000305}. /FTId=VSP_043877.; VAR_SEQ 252 322 Missing (in isoform 5). {ECO:0000303|PubMed:20463075}. /FTId=VSP_043878.; VAR_SEQ 476 522 AAADEYNRLKQVKGSADYKSKKNHCKQLKSKLSHIKKMVGDYDRQKT -> VNST (in isoform 3). {ECO:0000303|PubMed:20463075}. /FTId=VSP_043879.,VARIANT 219 219 F -> S (in PTORCH1; dbSNP:rs267606926). {ECO:0000269|PubMed:20727516}. /FTId=VAR_064910.,,,,CONFLICT 233 233 L -> S (in Ref. 7; AAH29886). {ECO:0000305}.,,1,,0,"DOMAIN: The C-terminal is cytoplasmic and is important for interaction with ZO-1. Sufficient for the tight junction localization. Involved in the regulation of the permeability barrier function of the tight junction (By similarity). The first extracellular loop participates in an adhesive interaction. {ECO:0000250, ECO:0000269|PubMed:9175707}.",SIMILARITY: Belongs to the ELL/occludin family. {ECO:0000305}.,COILED 426 489 {ECO:0000255}.,COMPBIAS 92 131 Gly/Tyr-rich.,DOMAIN 60 269 MARVEL. {ECO:0000255|PROSITE-ProRule:PRU00581}.,,,,,,,,,,FUNCTION: May play a role in the formation and regulation of the tight junction (TJ) paracellular permeability barrier. It is able to induce adhesion when expressed in cells lacking tight junctions. {ECO:0000269|PubMed:19114660}.,,,,,,,,,,,,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; protein domain specific binding [GO:0019904]; bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; cellular response to tumor necrosis factor [GO:0071356]; protein-containing complex assembly [GO:0065003]; regulation of bicellular tight junction assembly [GO:2000810]; response to interleukin-18 [GO:0070673],bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; cellular response to tumor necrosis factor [GO:0071356]; protein-containing complex assembly [GO:0065003]; regulation of bicellular tight junction assembly [GO:2000810]; response to interleukin-18 [GO:0070673],protein domain specific binding [GO:0019904],apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886],GO:0005886; GO:0005911; GO:0005923; GO:0016021; GO:0016324; GO:0016327; GO:0016328; GO:0019904; GO:0030054; GO:0030139; GO:0031410; GO:0045216; GO:0065003; GO:0070673; GO:0070830; GO:0071356; GO:2000810,IPR031176; IPR008253; IPR036259; IPR002958; IPR010844; ,Q9BXN2; P49674; O15162; P24723; Q8N205,"SUBUNIT: Interacts with TJP1/ZO1 (PubMed:19017651). Interacts with VAPA (PubMed:10523508). Interacts with CLDN1, CLDN6, CLDN9, CLDN11, CLDN12 and CLDN17 (PubMed:20375010). {ECO:0000269|PubMed:10523508, ECO:0000269|PubMed:19017651, ECO:0000269|PubMed:20375010}.",8601611; 9175707; 20463075; 19054851; 15372022; 15489334; 10523508; 12118072; 17525332; 18318008; 19017651; 19332538; 19114660; 20375010; 21406692; 24275569; 19125584; 20727516; 23923978,8601611; 9175707; 20463075; 19054851; 15372022; 15489334; 10523508; 12118072; 17525332; 18318008; 19017651; 19332538; 19114660; 20375010; 21406692; 24275569; 19125584; 20727516; 23923978; 12169098; 12184633; 12419305; 12667324; 12668723; 14991532; 15054114; 15069537; 15472219; 15500294; 15622522; 15659655; 15806147; 16081103; 16134968; 16207910; 16616143; 16924233; 16959951; 17038551; 17243118; 17283368; 17359339; 17635647; 17855770; 17962811; 18005733; 18276783; 18386163; 18397460; 18474622; 18489585; 18550469; 18560860; 18662404; 18782596; 18802961; 19052094; 19073886; 19174516; 19182773; 19184677; 19437620; 19478092; 19515778; 19538290; 19661441; 19756380; 20003786; 20028514; 20152177; 20164257; 20504882; 20663912; 20822789; 20844048; 20878095; 20937238; 21415414; 21536752; 21545357; 21551950; 21632765; 21806988; 21821450; 21857898; 21956164; 22135309; 22197032; 22438576; 22516225; 22671587; 22711802; 22761434; 22927233; 23155001; 23220562; 23390516; 23428392; 23555257; 23758859; 23792687; 23793442; 23924897; 24081143; 24318462; 24739782; 24862212; 25201524; 25241761; 25248927; 25302477; 25416956; 25452107; 25972430; 26080028; 26090670; 26561856; 26571379; 26638075; 26662145; 26689621; 26731262; 26731658; 26863122; 26887345; 26977027; 27151944; 27185880; 27423695; 27563375; 27580405; 27616439; 27790907; 28153728; 28179633; 28184927; 28332063; 28534944; 28642978; 29136627; 29252987; 29516973; 29750300,1998-12-15,2019-02-13,1996-11-01,173,X-ray crystallography (3),,HELIX 426 466 {ECO:0000244|PDB:1XAW}.; HELIX 472 488 {ECO:0000244|PDB:1XAW}.; HELIX 491 520 {ECO:0000244|PDB:1XAW}.,TURN 417 419 {ECO:0000244|PDB:1XAW}.,,,TOPO_DOM 1 66 Cytoplasmic. {ECO:0000255}.; TOPO_DOM 90 135 Extracellular. {ECO:0000269|PubMed:9175707}.; TOPO_DOM 161 170 Cytoplasmic. {ECO:0000255}.; TOPO_DOM 196 243 Extracellular. {ECO:0000255}.; TOPO_DOM 266 522 Cytoplasmic. {ECO:0000255}.,TRANSMEM 67 89 Helical. {ECO:0000255}.; TRANSMEM 136 160 Helical. {ECO:0000255}.; TRANSMEM 171 195 Helical. {ECO:0000255}.; TRANSMEM 244 265 Helical. {ECO:0000255}.,5 out of 5,Alternative sequence (8); Chain (1); Coiled coil (1); Compositional bias (1); Disulfide bond (1); Domain (1); Helix (3); Modified residue (14); Mutagenesis (7); Natural variant (1); Sequence conflict (1); Topological domain (5); Transmembrane (4); Turn (1),,TISSUE SPECIFICITY: Localized at tight junctions of both epithelial and endothelial cells. Highly expressed in kidney. Not detected in testis.,,3D-structure;Alternative splicing;Cell junction;Cell membrane;Coiled coil;Complete proteome;Disease mutation;Disulfide bond;Membrane;Phosphoprotein;Reference proteome;Tight junction;Transmembrane;Transmembrane helix,Evidence at protein level,reviewed,,ELL/occludin family,173,Alternative products (1); Domain (1); Function (1); Involvement in disease (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0175; KW-0181; KW-0225; KW-0472; KW-0597; KW-0796; KW-0812; KW-0965; KW-1003; KW-1015; KW-1133; KW-1185,,,,,"DISEASE: Pseudo-TORCH syndrome 1 (PTORCH1) [MIM:251290]: An autosomal recessive neurologic disorder with characteristic clinical and neuroradiologic features that mimic intrauterine TORCH infection in the absence of evidence of infection. Affected individuals have congenital microcephaly, intracranial calcifications, and severe developmental delay. {ECO:0000269|PubMed:20727516}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Dephosphorylated by PTPRJ. The tyrosine phosphorylation on Tyr-398 and Tyr-402 reduces its ability to interact with TJP1. Phosphorylation at Ser-490 also attenuates the interaction with TJP1. {ECO:0000269|PubMed:19017651, ECO:0000269|PubMed:19114660, ECO:0000269|PubMed:19125584, ECO:0000269|PubMed:19332538}.",CHAIN 1 522 Occludin. /FTId=PRO_0000146739.,,DISULFID 216 237 {ECO:0000269|PubMed:23923978}.,,,,"MOD_RES 302 302 Phosphoserine. {ECO:0000250|UniProtKB:Q61146}.; MOD_RES 305 305 Phosphothreonine. {ECO:0000250|UniProtKB:Q61146}.; MOD_RES 313 313 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 321 321 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 340 340 Phosphoserine. {ECO:0000250|UniProtKB:Q61146}.; MOD_RES 368 368 Phosphotyrosine. {ECO:0000244|PubMed:24275569}.; MOD_RES 369 369 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 370 370 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 398 398 Phosphotyrosine. {ECO:0000269|PubMed:19017651}.; MOD_RES 402 402 Phosphotyrosine. {ECO:0000269|PubMed:19017651}.; MOD_RES 403 403 Phosphothreonine; by PKC/PRKCH. {ECO:0000269|PubMed:19114660}.; MOD_RES 404 404 Phosphothreonine; by PKC/PRKCH. {ECO:0000269|PubMed:19114660}.; MOD_RES 408 408 Phosphoserine. {ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:24275569}.; MOD_RES 490 490 Phosphoserine. {ECO:0000269|PubMed:19125584}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U49184;U53823;FJ786083;FJ786084;AF400630;AF400623;AF400624;AF400625;AF400626;AF400627;AF400628;AF400629;GQ225096;GQ225097;GQ225098;GQ402517;AB451306;AB451437;BC029886;BK001650;
0,Q7LBR1,CHM1B_HUMAN,CHMP1B C18orf2,CHMP1B,C18orf2,,,Homo sapiens (Human),9606,Charged multivesicular body protein 1b (CHMP1.5) (Chromatin-modifying protein 1b) (CHMP1b) (Vacuolar protein sorting-associated protein 46-2) (Vps46-2) (hVps46-2),UP000005640: Chromosome 18,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSNMEKHLFNLKFAAKELSRSAKKCDKEEKAEKAKIKKAIQKGNMEVARIHAENAIRQKNQAVNFLRMSARVDAVAARVQTAVTMGKVTKSMAGVVKSMDATLKTMNLEKISALMDKFEHQFETLDVQTQQMEDTMSSTTTLTTPQNQVDMLLQEMADEAGLDLNMELPQGQTGSVGTSVASAEQDELSQRLARLRDQV,199,"22,109",,,,SEQUENCE CAUTION:  Sequence=AAG01449.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,,,,,,,,1,,0,,SIMILARITY: Belongs to the SNF7 family. {ECO:0000305}.,COILED 26 48 {ECO:0000255}.; COILED 178 199 {ECO:0000255}.,,,MOTIF 186 196 MIT-interacting motif.,"REGION 132 156 Interaction with IST1.; REGION 174 199 Interaction with SPAST. {ECO:0000269|PubMed:15537668}.; REGION 180 199 Interaction with VTA1.; REGION 180 196 Interaction with VPS4A, MITD1 and STAMBP. {ECO:0000269|PubMed:19129480}.; REGION 183 199 Interaction with VPS4B.",,,,,,,,"FUNCTION: Probable peripherally associated component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Involved in cytokinesis. Involved in recruiting VPS4A and/or VPS4B and SPAST to the midbody of dividing cells. Involved in HIV-1 p6- and p9-dependent virus release. {ECO:0000269|PubMed:14519844, ECO:0000269|PubMed:19129479}.",,,,,,,,,,,,cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; viral budding via host ESCRT complex [GO:0039702],cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; viral budding via host ESCRT complex [GO:0039702],identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904],cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; nucleus [GO:0005634],GO:0000815; GO:0005634; GO:0005771; GO:0005829; GO:0006997; GO:0007080; GO:0010008; GO:0010824; GO:0015031; GO:0019904; GO:0030117; GO:0030496; GO:0031902; GO:0032509; GO:0036258; GO:0039702; GO:0042802; GO:0045184; GO:0045324; GO:0051301; GO:0061952; GO:0070062; GO:1901673; GO:1904903,IPR005024; ,Itself; P53990-4; P62491; O75643; O95630; P40818; Q9UN37,"SUBUNIT: Probable peripherally associated component of the endosomal sorting required for transport complex III (ESCRT-III). ESCRT-III components are thought to multimerize to form a flat lattice on the perimeter membrane of the endosome. Several assembly forms of ESCRT-III may exist that interact and act sequentially. Interacts with CHMP1A. Interacts with VTA1; the interaction probably involves the open conformation of CHMP1B. Interacts with CHMP2A. Interacts with VPS4A; the interaction is direct. Interacts with VPS4B; the interaction is direct. Interacts with SPAST (via MIT domain); the interaction is direct. Interacts with IST1. Interacts with MITD1. Interacts with STAMBP. {ECO:0000269|PubMed:14505570, ECO:0000269|PubMed:14519844, ECO:0000269|PubMed:15537668, ECO:0000269|PubMed:16174732, ECO:0000269|PubMed:16730941, ECO:0000269|PubMed:17928862, ECO:0000269|PubMed:18385515, ECO:0000269|PubMed:18997780, ECO:0000269|PubMed:19129479, ECO:0000269|PubMed:19129480, ECO:0000269|PubMed:21543490}.",11474171; 11559747; 15489334; 14505570; 14519844; 15537668; 16174732; 16730941; 17928862; 18385515; 19129480; 19129479; 21269460; 21543490; 24275569; 18997780,11474171; 11559747; 15489334; 14505570; 14519844; 15537668; 16174732; 16730941; 17928862; 18385515; 19129480; 19129479; 21269460; 21543490; 24275569; 18997780; 16094257; 17711858; 19302785; 19328558; 20064372; 20711500; 21616915; 21674799; 21988832; 23416715; 25416956; 25637630; 26496610; 26634441,2005-08-30,2019-02-13,2004-07-05,120,X-ray crystallography (3); Electron microscopy (2),,HELIX 151 159 {ECO:0000244|PDB:3EAB}.; HELIX 187 196 {ECO:0000244|PDB:4TXR}.,,,,,,5 out of 5,Chain (1); Coiled coil (2); Erroneous initiation (1); Helix (2); Motif (1); Mutagenesis (9); Region (5),,"TISSUE SPECIFICITY: Widely expressed. Expressed in pancreas, kidney, skeletal muscle, liver, lung, placenta and brain. {ECO:0000269|PubMed:11474171}.",,3D-structure;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Endosome;Membrane;Protein transport;Reference proteome;Transport,Evidence at protein level,reviewed,,SNF7 family,120,Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0131; KW-0132; KW-0175; KW-0181; KW-0472; KW-0653; KW-0813; KW-0963; KW-0967; KW-1185,,,,,,,,,CHAIN 1 199 Charged multivesicular body protein 1b. /FTId=PRO_0000211454.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF306520;AF281064;BC065933;BC012733;
0,Q8IWB6,TEX14_HUMAN,TEX14 SGK307,TEX14,SGK307,,,Homo sapiens (Human),9606,Inactive serine/threonine-protein kinase TEX14 (Protein kinase-like protein SgK307) (Sugen kinase 307) (Testis-expressed sequence 14) (Testis-expressed sequence 14 protein),UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSRAVRLPVPCPVQLGTLRNDSLEAQLHEYVKQGNYVKVKKILKKGIYVDAVNSLGQTALFVAALLGLRKFVDVLVDYGSDPNHRCFDGSTPVHAAAFSGNQWILSKLLDAGGDLRLHDERGQNPKTWALTAGKERSTQIVEFMQRCASHMQAIIQGFSYDLLKKIDSPQRLVYSPSWCGGLVQGNPNGSPNRLLKAGVISAQNIYSFGFGKAMPWFQFYLTGATQMAYLGSLPVIGEKEVIQADDEPTFSFFSGPYMVMTNLVWNGSRVTVKELNLPTHPHCSRLRLADLLIAEQEHSSKLRHPYLLQLMAVCLSQDLEKTRLVYERITIGTLFSVLHERRSQFPVLHMEVIVHLLLQISDALRYLHFQGFIHRSLSSYAVHIISPGEARLTNLEYMLESEDRGVQRDLTRVPLPTQLYNWAAPEVILQKAATVKSDIYSFSMIMQEILTDDIPWKGLDGSVVKKAVVSGNYLEADVRLPKPYYDIVKSGIHVKQKDRTMNLQDIRYILKNDLKDFTGAQRTQPTESPRVQRYGLHPDVNVYLGLTSEHPRETPDMEIIELKEMGSQPHSPRVHSLFTEGTLDPQAPDPCLMARETQNQDAPCPAPFMAEEASSPSTGQPSLCSFEINEIYSGCLILEDDIEEPPGAASSLEADGPNQVDELKSMEEELDKMEREACCFGSEDESSSKAETEYSFDDWDWQNGSLSSLSLPESTREAKSNLNNMSTTEEYLISKCVLDLKIMQTIMHENDDRLRNIEQILDEVEMKQKEQEERMSLWATSREFTNAYKLPLAVGPPSLNYIPPVLQLSGGQKPDTSGNYPTLPRFPRMLPTLCDPGKQNTDEQFQCTQGAKDSLETSRIQNTSSQGRPRESTAQAKATQFNSALFTLSSHRQGPSASPSCHWDSTRMSVEPVSSEIYNAESRNKDDGKVHLKWKMEVKEMAKKAATGQLTVPPWHPQSSLTLESEAENEPDALLQPPIRSPENTDWQRVIEYHRENDEPRGNGKFDKTGNNDCDSDQHGRQPRLGSFTSIRHPSPRQKEQPEHSEAFQASSDTLVAVEKSYSHQSMQSTCSPESSEDITDEFLTPDGEYFYSSTAQENLALETSSPIEEDFEGIQGAFAQPQVSGEEKFQMRKILGKNAEILPRSQFQPVRSTEDEQEETSKESPKELKEKDISLTDIQDLSSISYEPDSSFKEASCKTPKINHAPTSVSTPLSPGSVSSAASQYKDCLESITFQVKTEFASCWNSQEFIQTLSDDFISVRERAKKLDSLLTSSETPPSRLTGLKRLSSFIGAGSPSLVKACDSSPPHATQRRSLPKVEAFSQHHIDELPPPSQELLDDIELLKQQQGSSTVLHENTASDGGGTANDQRHLEEQETDSKKEDSSMLLSKETEDLGEDTERAHSTLDEDLERWLQPPEESVELQDLPKGSERETNIKDQKVGEEKRKREDSITPERRKSEGVLGTSEEDELKSCFWKRLGWSESSRIIVLDQSDLSD,1497,"167,901",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=Q8IWB6-1; Sequence=Displayed; Name=2; IsoId=Q8IWB6-2; Sequence=VSP_019868; Name=3; IsoId=Q8IWB6-3; Sequence=VSP_019868, VSP_019869; ",,SEQUENCE CAUTION:  Sequence=AAK31980.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 213 218 Missing (in isoform 2 and isoform 3). {ECO:0000303|PubMed:11279525, ECO:0000303|PubMed:17974005}. /FTId=VSP_019868.; VAR_SEQ 1064 1103 Missing (in isoform 3). {ECO:0000303|PubMed:11279525, ECO:0000303|PubMed:17974005}. /FTId=VSP_019869.",VARIANT 88 88 D -> G (in dbSNP:rs56292204). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041388.; VARIANT 321 321 K -> E (in a gastric adenocarcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041389.; VARIANT 443 443 S -> C. {ECO:0000269|PubMed:17344846}. /FTId=VAR_041390.; VARIANT 559 559 I -> M. {ECO:0000269|PubMed:17344846}. /FTId=VAR_041391.,,,,CONFLICT 1326 1326 H -> R (in Ref. 4; AAK31980). {ECO:0000305}.; CONFLICT 1387 1387 L -> P (in Ref. 1; CAD38856). {ECO:0000305}.,,2,,0,DOMAIN: The protein kinase domain is predicted to be catalytically inactive.; DOMAIN: The GPPX3Y motif mediates interaction with CEP55.,SIMILARITY: Belongs to the protein kinase superfamily. {ECO:0000305}.,,,DOMAIN 227 518 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,MOTIF 795 801 GPPX3Y.; MOTIF 852 860 D-box.,,REPEAT 27 54 ANK 1.; REPEAT 55 84 ANK 2.; REPEAT 88 117 ANK 3.,,,,,,,"FUNCTION: Required both for the formation of intercellular bridges during meiosis and for kinetochore-microtubule attachment during mitosis. Intercellular bridges are evolutionarily conserved structures that connect differentiating germ cells and are required for spermatogenesis and male fertility. Acts by promoting the conversion of midbodies into intercellular bridges via its interaction with CEP55: interaction with CEP55 inhibits the interaction between CEP55 and PDCD6IP/ALIX and TSG101, blocking cell abscission and leading to transform midbodies into intercellular bridges. Also plays a role during mitosis: recruited to kinetochores by PLK1 during early mitosis and regulates the maturation of the outer kinetochores and microtubule attachment. Has no protein kinase activity in vitro (By similarity). {ECO:0000250}.",,,,,,,BINDING 273 273 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,,NP_BIND 233 241 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.,,cell [GO:0005623]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091],attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901],cell [GO:0005623]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496],GO:0000776; GO:0000777; GO:0004672; GO:0005524; GO:0005623; GO:0005737; GO:0007094; GO:0007140; GO:0008608; GO:0019901; GO:0030496; GO:0032091; GO:0032466; GO:0043063; GO:0045171; GO:0051301; GO:0051306; GO:0070062; GO:1990830,IPR002110; IPR020683; IPR036770; IPR011009; IPR000719; IPR001245; IPR039339; ,Q53EZ4; P61968,SUBUNIT: Interacts with KIF23 and RBM44. Interacts with CEP55; inhibiting interaction between CEP55 and PDCD6IP/ALIX and TSG101 (By similarity). {ECO:0000250}.,17974005; 16625196; 15489334; 11279525; 12711554; 20176808; 22405274; 28206990; 17344846,17974005; 16625196; 15489334; 11279525; 12711554; 20176808; 22405274; 28206990; 17344846; 12471243; 20056645; 20378615; 26392564,2006-07-25,2019-02-13,2006-07-25,148,X-ray crystallography (2),STRAND 797 800 {ECO:0000244|PDB:3WUT}.,,,,,,,5 out of 5,Alternative sequence (2); Beta strand (1); Binding site (1); Chain (1); Domain (1); Erroneous initiation (1); Modified residue (8); Motif (2); Mutagenesis (2); Natural variant (4); Nucleotide binding (1); Repeat (3); Sequence conflict (2),CAUTION: Ser-376 is present instead of the conserved Asp which is expected to be an active site residue. {ECO:0000305}.,"TISSUE SPECIFICITY: Expression restricted to testis. {ECO:0000269|PubMed:11279525, ECO:0000269|PubMed:28206990}.",,3D-structure;ANK repeat;ATP-binding;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Complete proteome;Cytoplasm;Kinetochore;Mitosis;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat,Evidence at protein level,reviewed,,Protein kinase superfamily,148,Alternative products (1); Caution (1); Domain (2); Function (1); Involvement in disease (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0040; KW-0067; KW-0131; KW-0132; KW-0137; KW-0158; KW-0181; KW-0498; KW-0547; KW-0597; KW-0621; KW-0677; KW-0963; KW-0995; KW-1185,,,,,DISEASE: Spermatogenic failure 23 (SPGF23) [MIM:617707]: An infertility disorder caused by spermatogenesis defects that result in non-obstructive azoospermia. {ECO:0000269|PubMed:28206990}. Note=The disease is caused by mutations affecting the gene represented in this entry.,,,"PTM: Phosphorylated on Thr residues by CDK1 during early phases of mitosis, promoting the interaction with PLK1 and recruitment to kinetochores. Phosphorylated on Ser-437 by PLK1 during late prometaphase promotes the rapid depletion from kinetochores and its subsequent degradation by the APC/C complex. {ECO:0000269|PubMed:22405274}.",CHAIN 1 1497 Inactive serine/threonine-protein kinase TEX14. /FTId=PRO_0000246995.,,,,,,MOD_RES 175 175 Phosphoserine. {ECO:0000250|UniProtKB:F1M5M3}.; MOD_RES 437 437 Phosphoserine; by PLK1. {ECO:0000250|UniProtKB:Q7M6U3}.; MOD_RES 567 567 Phosphoserine. {ECO:0000250|UniProtKB:F1M5M3}.; MOD_RES 665 665 Phosphoserine. {ECO:0000250|UniProtKB:F1M5M3}.; MOD_RES 1106 1106 Phosphoserine. {ECO:0000250|UniProtKB:Q7M6U3}.; MOD_RES 1404 1404 Phosphoserine. {ECO:0000250|UniProtKB:Q7M6U3}.; MOD_RES 1459 1459 Phosphoserine. {ECO:0000250|UniProtKB:Q7M6U3}.; MOD_RES 1496 1496 Phosphoserine. {ECO:0000250|UniProtKB:Q7M6U3}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AL834143;BC040526;AF285601;BK000998;
0,Q8N3E9,PLCD3_HUMAN,PLCD3 KIAA1964,PLCD3,KIAA1964,,,Homo sapiens (Human),9606,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3)",UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MLCGRWRRCRRPPEEPPVAAQVAAQVAAPVALPSPPTPSDGGTKRPGLRALKKMGLTEDEDVRAMLRGSRLRKIRSRTWHKERLYRLQEDGLSVWFQRRIPRAPSQHIFFVQHIEAVREGHQSEGLRRFGGAFAPARCLTIAFKGRRKNLDLAAPTAEEAQRWVRGLTKLRARLDAMSQRERLDHWIHSYLHRADSNQDSKMSFKEIKSLLRMVNVDMNDMYAYLLFKECDHSNNDRLEGAEIEEFLRRLLKRPELEEIFHQYSGEDRVLSAPELLEFLEDQGEEGATLARAQQLIQTYELNETAKQHELMTLDGFMMYLLSPEGAALDNTHTCVFQDMNQPLAHYFISSSHNTYLTDSQIGGPSSTEAYVRAFAQGCRCVELDCWEGPGGEPVIYHGHTLTSKILFRDVVQAVRDHAFTLSPYPVILSLENHCGLEQQAAMARHLCTILGDMLVTQALDSPNPEELPSPEQLKGRVLVKGKKLPAARSEDGRALSDREEEEEDDEEEEEEVEAAAQRRLAKQISPELSALAVYCHATRLRTLHPAPNAPQPCQVSSLSERKAKKLIREAGNSFVRHNARQLTRVYPLGLRMNSANYSPQEMWNSGCQLVALNFQTPGYEMDLNAGRFLVNGQCGYVLKPACLRQPDSTFDPEYPGPPRTTLSIQVLTAQQLPKLNAEKPHSIVDPLVRIEIHGVPADCARQETDYVLNNGFNPRWGQTLQFQLRAPELALVRFVVEDYDATSPNDFVGQFTLPLSSLKQGYRHIHLLSKDGASLSPATLFIQIRIQRS,789,"89,258",,,,,,,,,,,,,VARIANT 652 652 P -> L (in dbSNP:rs734921). /FTId=VAR_035316.,,,,CONFLICT 207 207 I -> T (in Ref. 3; CAD39054). {ECO:0000305}.,,3,,0,DOMAIN: The C2 domain is a Ca(2+)-dependent membrane-targeting module.; DOMAIN: The PH domain mediates interaction with the surface membrane by binding to PIP2.,,,,DOMAIN 63 172 PH.; DOMAIN 182 217 EF-hand 1.; DOMAIN 218 253 EF-hand 2.; DOMAIN 250 285 EF-hand 3.; DOMAIN 337 482 PI-PLC X-box. {ECO:0000255|PROSITE-ProRule:PRU00270}.; DOMAIN 528 644 PI-PLC Y-box. {ECO:0000255|PROSITE-ProRule:PRU00271}.; DOMAIN 647 752 C2. {ECO:0000255|PROSITE-ProRule:PRU00041}.,,REGION 73 101 Substrate binding. {ECO:0000250}.,,,3.1.4.11,,"CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + H2O = 1D-myo-inositol 1,4,5-trisphosphate + a 1,2-diacyl-sn-glycerol + H(+); Xref=Rhea:RHEA:33179, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:58456, ChEBI:CHEBI:203600; EC=3.1.4.11; Evidence={ECO:0000269|PubMed:10336610};",COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000305|PubMed:9799116};  Note=Binds 3 Ca(2+) ions per subunit. Two of the Ca(2+) ions are bound to the C2 domain. {ECO:0000305|PubMed:9799116};,,"FUNCTION: Hydrolyzes the phosphatidylinositol 4,5-bisphosphate (PIP2) to generate 2 second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG mediates the activation of protein kinase C (PKC), while IP3 releases Ca(2+) from intracellular stores. Essential for trophoblast and placental development. May participate in cytokinesis by hydrolyzing PIP2 at the cleavage furrow.",BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=105.3 uM for PIP2 {ECO:0000269|PubMed:10336610}; Vmax=28.5 umol/min/mg enzyme {ECO:0000269|PubMed:10336610}; ,,,,,ACT_SITE 352 352 {ECO:0000255|PROSITE-ProRule:PRU00270}.; ACT_SITE 397 397 {ECO:0000255|PROSITE-ProRule:PRU00270}.,BINDING 480 480 Substrate. {ECO:0000250}.; BINDING 482 482 Substrate. {ECO:0000250}.; BINDING 557 557 Substrate. {ECO:0000250}.; BINDING 584 584 Substrate. {ECO:0000250}.,,METAL 353 353 Calcium 1; catalytic. {ECO:0000250}.; METAL 382 382 Calcium 1; catalytic. {ECO:0000250}.; METAL 384 384 Calcium 1; catalytic. {ECO:0000250}.; METAL 431 431 Calcium 1; catalytic. {ECO:0000250}.; METAL 683 683 Calcium 2; via carbonyl oxygen. {ECO:0000250}.; METAL 685 685 Calcium 2. {ECO:0000250}.; METAL 709 709 Calcium 2. {ECO:0000250}.; METAL 738 738 Calcium 3. {ECO:0000250}.; METAL 739 739 Calcium 3; via carbonyl oxygen. {ECO:0000250}.; METAL 740 740 Calcium 3. {ECO:0000250}.,,,cleavage furrow [GO:0032154]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; angiogenesis [GO:0001525]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; regulation of cell population proliferation [GO:0042127],angiogenesis [GO:0001525]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; regulation of cell population proliferation [GO:0042127],metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435],cleavage furrow [GO:0032154]; cytosol [GO:0005829]; plasma membrane [GO:0005886],GO:0001525; GO:0004435; GO:0005829; GO:0005886; GO:0016042; GO:0032154; GO:0032959; GO:0035556; GO:0042127; GO:0043647; GO:0046872; GO:0060716,IPR000008; IPR035892; IPR011992; IPR018247; IPR011993; IPR001849; IPR001192; IPR028406; IPR039504; IPR017946; IPR000909; IPR001711; ,,,14702039; 15489334; 17974005; 11853319; 9360711; 9056492; 9799116; 10702670; 10336610; 11500033; 11706040; 15505048; 17041247; 18669648; 20068231; 23186163,14702039; 15489334; 17974005; 11853319; 9360711; 9056492; 9799116; 10702670; 10336610; 11500033; 11706040; 15505048; 17041247; 18669648; 20068231; 23186163; 11022047; 11022048; 15231748; 15702972; 16107206; 19179337; 19329342; 19344632; 19367725; 19430483; 19913121; 20056178; 20628086; 20852445; 22723964; 23902751; 23948486; 2550068; 26496610; 2841328; 29115528; 7890667,2007-10-02,2019-02-13,2007-10-02,161,,,,,,,,,5 out of 5,Active site (2); Binding site (4); Calcium binding (2); Chain (1); Domain (7); Metal binding (10); Modified residue (3); Natural variant (1); Region (1); Sequence conflict (1),,TISSUE SPECIFICITY: Present in corneal epithelial cells (at protein level). {ECO:0000269|PubMed:15505048}.,,Calcium;Complete proteome;Cytoplasm;Hydrolase;Lipid degradation;Lipid metabolism;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transducer,Evidence at protein level,reviewed,,,161,Activity regulation (1); Catalytic activity (1); Cofactor (1); Domain (2); Function (1); Induction (1); Kinetics (1); Subcellular location (1); Tissue specificity (1),,KW-0106; KW-0181; KW-0378; KW-0442; KW-0443; KW-0472; KW-0479; KW-0597; KW-0621; KW-0677; KW-0807; KW-0963; KW-1185,,,,,,,,,"CHAIN 1 789 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3. /FTId=PRO_0000306821.",,,,,,"MOD_RES 105 105 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 496 496 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 573 573 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AK074240;BC010668;BC072384;AL834392;AB075844;
0,Q8NBX0,SCPDL_HUMAN,SCCPDH CGI-49,SCCPDH,,,CGI-49,Homo sapiens (Human),9606,Saccharopine dehydrogenase-like oxidoreductase (EC 1.-.-.-),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MATEQRPFHLVVFGASGFTGQFVTEEVAREQVDPERSSRLPWAVAGRSREKLQRVLEKAALKLGRPTLSSEVGIIICDIANPASLDEMAKQATVVLNCVGPYRFYGEPVIKACIENGASCIDISGEPQFLELMQLKYHEKAADKGVYIIGSSGFDSIPADLGVIYTRNKMNGTLTAVESFLTIHSGPEGLSIHDGTWKSAIYGFGDQSNLRKLRNVSNLKPVPLIGPKLKRRWPISYCRELKGYSIPFMGSDVSVVRRTQRYLYENLEESPVQYAAYVTVGGITSVIKLMFAGLFFLFFVRFGIGRQLLIKFPWFFSFGYFSKQGPTQKQIDAASFTLTFFGQGYSQGTGTDKNKPNIKICTQVKGPEAGYVATPIAMVQAAMTLLSDASHLPKAGGVFTPGAAFSKTKLIDRLNKHGIEFSVISSSEV,429,"47,151",,,,,,,,,,,,,VARIANT 418 418 G -> R (in dbSNP:rs7779). /FTId=VAR_034486.,,,,CONFLICT 37 43 SSRLPWA -> TQPALG (in Ref. 1; AAD34044). {ECO:0000305}.; CONFLICT 187 187 P -> H (in Ref. 4; AAH26185). {ECO:0000305}.; CONFLICT 347 347 Q -> R (in Ref. 4; AAH26185). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the saccharopine dehydrogenase family. {ECO:0000305}.,,,,,,,,1.-.-.-,,,,,,,,,,,,,,,,,extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; oxidoreductase activity [GO:0016491]; glycolipid biosynthetic process [GO:0009247]; platelet degranulation [GO:0002576],glycolipid biosynthetic process [GO:0009247]; platelet degranulation [GO:0002576],oxidoreductase activity [GO:0016491],extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093],GO:0002576; GO:0005576; GO:0005634; GO:0005739; GO:0005811; GO:0005886; GO:0009247; GO:0016020; GO:0016491; GO:0030496; GO:0031093,IPR036291; IPR005097; ,,,10810093; 14702039; 16710414; 15489334; 21269460; 23186163; 24275569; 25944712,10810093; 14702039; 16710414; 15489334; 21269460; 23186163; 24275569; 25944712; 19463016; 20877624; 22593156; 23606334; 23640497; 6457647; 8467233,2005-08-30,2019-02-13,2002-10-01,129,,,,,,,,,4 out of 5,Chain (1); Initiator methionine (1); Modified residue (2); Natural variant (1); Sequence conflict (3),,,,Acetylation;Complete proteome;Direct protein sequencing;Oxidoreductase;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,Saccharopine dehydrogenase family,129,Sequence similarities (1),,KW-0007; KW-0181; KW-0560; KW-0597; KW-0621; KW-0903; KW-1185,,,,,,,,,CHAIN 2 429 Saccharopine dehydrogenase-like oxidoreductase. /FTId=PRO_0000212840.,,,,INIT_MET 1 1 Removed. {ECO:0000269|Ref.5}.,,MOD_RES 2 2 N-acetylalanine. {ECO:0000269|Ref.5}.; MOD_RES 217 217 Phosphoserine. {ECO:0000244|PubMed:23186163}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF151807;AK075178;BC026185;
0,Q8NF91,SYNE1_HUMAN,SYNE1 C6orf98 KIAA0796 KIAA1262 KIAA1756 MYNE1,SYNE1,C6orf98 KIAA0796 KIAA1262 KIAA1756 MYNE1,,,Homo sapiens (Human),9606,Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1),UP000005640: Chromosome 6,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MATSRGASRCPRDIANVMQRLQDEQEIVQKRTFTKWINSHLAKRKPPMVVDDLFEDMKDGVKLLALLEVLSGQKLPCEQGRRMKRIHAVANIGTALKFLEGRKIKLVNINSTDIADGRPSIVLGLMWTIILYFQIEELTSNLPQLQSLSSSASSVDSIVSSETPSPPSKRKVTTKIQGNAKKALLKWVQYTAGKQTGIEVKDFGKSWRSGVAFHSVIHAIRPELVDLETVKGRSNRENLEDAFTIAETELGIPRLLDPEDVDVDKPDEKSIMTYVAQFLKHYPDIHNASTDGQEDDEILPGFPSFANSVQNFKREDRVIFKEMKVWIEQFERDLTRAQMVESNLQDKYQSFKHFRVQYEMKRKQIEHLIQPLHRDGKLSLDQALVKQSWDRVTSRLFDWHIQLDKSLPAPLGTIGAWLYRAEVALREEITVQQVHEETANTIQRKLEQHKDLLQNTDAHKRAFHEIYRTRSVNGIPVPPDQLEDMAERFHFVSSTSELHLMKMEFLELKYRLLSLLVLAESKLKSWIIKYGRRESVEQLLQNYVSFIENSKFFEQYEVTYQILKQTAEMYVKADGSVEEAENVMKFMNETTAQWRNLSVEVRSVRSMLEEVISNWDRYGNTVASLQAWLEDAEKMLNQSENAKKDFFRNLPHWIQQHTAMNDAGNFLIETCDEMVSRDLKQQLLLLNGRWRELFMEVKQYAQADEMDRMKKEYTDCVVTLSAFATEAHKKLSEPLEVSFMNVKLLIQDLEDIEQRVPVMDAQYKIITKTAHLITKESPQEEGKEMFATMSKLKEQLTKVKECYSPLLYESQQLLIPLEELEKQMTSFYDSLGKINEIITVLEREAQSSALFKQKHQELLACQENCKKTLTLIEKGSQSVQKFVTLSNVLKHFDQTRLQRQIADIHVAFQSMVKKTGDWKKHVETNSRLMKKFEESRAELEKVLRIAQEGLEEKGDPEELLRRHTEFFSQLDQRVLNAFLKACDELTDILPEQEQQGLQEAVRKLHKQWKDLQGEAPYHLLHLKIDVEKNRFLASVEECRTELDRETKLMPQEGSEKIIKEHRVFFSDKGPHHLCEKRLQLIEELCVKLPVRDPVRDTPGTCHVTLKELRAAIDSTYRKLMEDPDKWKDYTSRFSEFSSWISTNETQLKGIKGEAIDTANHGEVKRAVEEIRNGVTKRGETLSWLKSRLKVLTEVSSENEAQKQGDELAKLSSSFKALVTLLSEVEKMLSNFGDCVQYKEIVKNSLEELISGSKEVQEQAEKILDTENLFEAQQLLLHHQQKTKRISAKKRDVQQQIAQAQQGEGGLPDRGHEELRKLESTLDGLERSRERQERRIQVTLRKWERFETNKETVVRYLFQTGSSHERFLSFSSLESLSSELEQTKEFSKRTESIAVQAENLVKEASEIPLGPQNKQLLQQQAKSIKEQVKKLEDTLEEDIKTMEMVKTKWDHFGSNFETLSVWITEKEKELNALETSSSAMDMQISQIKVTIQEIESKLSSIVGLEEEAQSFAQFVTTGESARIKAKLTQIRRYGEELREHAQCLEGTILGHLSQQQKFEENLRKIQQSVSEFEDKLAVPIKICSSATETYKVLQEHMDLCQALESLSSAITAFSASARKVVNRDSCVQEAAALQQQYEDILRRAKERQTALENLLAHWQRLEKELSSFLTWLERGEAKASSPEMDISADRVKVEGELQLIQALQNEVVSQASFYSKLLQLKESLFSVASKDDVKMMKLHLEQLDERWRDLPQIINKRINFLQSVVAEHQQFDELLLSFSVWIKLFLSELQTTSEISIMDHQVALTRHKDHAAEVESKKGELQSLQGHLAKLGSLGRAEDLHLLQGKAEDCFQLFEEASQVVERRQLALSHLAEFLQSHASLSGILRQLRQTVEATNSMNKNESDLIEKDLNDALQNAKALESAAVSLDGILSKAQYHLKIGSSEQRTSCRATADQLCGEVERIQNLLGTKQSEADALAVLKKAFQDQKEELLKSIEDIEERTDKERLKEPTRQALQQRLRVFNQLEDELNSHEHELCWLKDKAKQIAQKDVAFAPEVDREINRLEVTWDDTKRLIHENQGQCCGLIDLMREYQNLKSAVSKVLENASSVIVTRTTIKDQEDLKWAFSKHETAKNKMNYKQKDLDNFTSKGKHLLSELKKIHSSDFSLVKTDMESTVDKWLDVSEKLEENMDRLRVSLSIWDDVLSTRDEIEGWSNNCVPQMAENISNLDNHLRAEELLKEFESEVKNKALRLEELHSKVNDLKELTKNLETPPDLQFIEADLMQKLEHAKEITEVAKGTLKDFTAQSTQVEKFINDITTWFTKVEESLMNCAQNETCEALKKVKDIQKELQSQQSNISSTQENLNSLCRKYHSAELESLGRAMTGLIKKHEAVSQLCSKTQASLQESLEKHFSESMQEFQEWFLGAKAAAKESSDRTGDSKVLEAKLHDLQNILDSVSDGQSKLDAVTQEGQTLYAHLSKQIVSSIQEQITKANEEFQAFLKQCLKDKQALQDCASELGSFEDQHRKLNLWIHEMEERFNTENLGESKQHIPEKKNEVHKVEMFLGELLAARESLDKLSQRGQLLSEEGHGAGQEGRLCSQLLTSHQNLLRMTKEKLRSCQVALQEHEALEEALQSMWFWVKAIQDRLACAESTLGSKDTLEKRLSQIQDILLMKGEGEVKLNMAIGKGEQALRSSNKEGQRVIQTQLETLKEVWADIMSSSVHAQSTLESVISQWNDYVERKNQLEQWMESVDQKIEHPLQPQPGLKEKFVLLDHLQSILSEAEDHTRALHRLIAKSRELYEKTEDESFKDTAQEELKTQFNDIMTVAKEKMRKVEEIVKDHLMYLDAVHEFTDWLHSAKEELHRWSDMSGDSSATQKKLSKIKELIDSREIGASRLSRVESLAPEVKQNTTASGCELMHTEMQALRADWKQWEDSVFQTQSCLENLVSQMALSEQEFSGQVAQLEQALEQFSALLKTWAQQLTLLEGKNTDEEIVECWHKGQEILDALQKAEPRTEDLKSQLNELCRFSRDLSTYSGKVSGLIKEYNCLCLQASKGCQNKEQILQQRFRKAFRDFQQWLVNAKITTAKCFDIPQNISEVSTSLQKIQEFLSESENGQHKLNMMLSKGELLSTLLTKEKAKGIQAKVTAAKEDWKNFHSNLHQKESALENLKIQMKDFEVSAEPIQDWLSKTEKMVHESSNRLYDLPAKRREQQKLQSVLEEIHCYEPQLNRLKEKAQQLWEGQAASKSFRHRVSQLSSQYLALSNLTKEKVSRLDRIVAEHNQFSLGIKELQDWMTDAIHMLDSYCHPTSDKSVLDSRTLKLEALLSVKQEKEIQMKMIVTRGESVLQNTSPEGIPTIQQQLQSVKDMWASLLSAGIRCKSQLEGALSKWTSYQDGVRQFSGWMDSMEANLNESERQHAELRDKTTMLGKAKLLNEEVLSYSSLLETIEVKGAGMTEHYVTQLELQDLQERYRAIQERAKEAVTKSEKLVRLHQEYQRDLKAFEVWLGQEQEKLDQYSVLEGDAHTHETTLRDLQELQVHCAEGQALLNSVLHTREDVIPSGIPQAEDRALESLRQDWQAYQHRLSETRTQFNNVVNKLRLMEQKFQQVDEWLKTAEEKVSPRTRRQSNRATKEIQLHQMKKWHEEVTAYRDEVEEVGARAQEILDESHVNSRMGCQATQLTSRYQALLLQVLEQIKFLEEEIQSLEESESSLSSYSDWYGSTHKNFKNVATKIDKVDTVMMGKKLKTLEVLLKDMEKGHSLLKSAREKGERAVKYLEEGEAERLRKEIHDHMEQLKELTSTVRKEHMTLEKGLHLAKEFSDKCKALTQWIAEYQEILHVPEEPKMELYEKKAQLSKYKSLQQTVLSHEPSVKSVREKGEALLELVQDVTLKDKIDQLQSDYQDLCSIGKEHVFSLEAKVKDHEDYNSELQEVEKWLLQMSGRLVAPDLLETSSLETITQQLAHHKAMMEEIAGFEDRLNNLQMKGDTLIGQCADHLQAKLKQNVHAHLQGTKDSYSAICSTAQRMYQSLEHELQKHVSRQDTLQQCQAWLSAVQPDLEPSPQPPLSRAEAIKQVKHFRALQEQARTYLDLLCSMCDLSNASVKTTAKDIQQTEQTIEQKLVQAQNLTQGWEEIKHLKSELWIYLQDADQQLQNMKRRHSELELNIAQNMVSQVKDFVKKLQSKQASVNTIIEKVNKLTKKEESPEHKEINHLNDQWLDLCRQSNNLCLQREEDLQRTRDYHDCMNVVEVFLEKFTTEWDNLARSDAESTAVHLEALKKLALALQERKYAIEDLKDQKQKMIEHLNLDDKELVKEQTSHLEQRWFQLEDLIKRKIQVSVTNLEELNVVQSRFQELMEWAEEQQPNIAEALKQSPPPDMAQNLLMDHLAICSELEAKQMLLKSLIKDADRVMADLGLNERQVIQKALSDAQSHVNCLSDLVGQRRKYLNKALSEKTQFLMAVFQATSQIQQHERKIMFREHICLLPDDVSKQVKTCKSAQASLKTYQNEVTGLWAQGRELMKEVTEQEKSEVLGKLQELQSVYDSVLQKCSHRLQELEKNLVSRKHFKEDFDKACHWLKQADIVTFPEINLMNESSELHTQLAKYQNILEQSPEYENLLLTLQRTGQTILPSLNEVDHSYLSEKLNALPRQFNVIVALAKDKFYKVQEAILARKEYASLIELTTQSLSELEAQFLRMSKVPTDLAVEEALSLQDGCRAILDEVAGLGEAVDELNQKKEGFRSTGQPWQPDKMLHLVTLYHRLKRQTEQRVSLLEDTTSAYQEHEKMCQQLERQLKSVKEEQSKVNEETLPAEEKLKMYHSLAGSLQDSGIVLKRVTIHLEDLAPHLDPLAYEKARHQIQSWQGELKLLTSAIGETVTECESRMVQSIDFQTEMSRSLDWLRRVKAELSGPVYLDLNLQDIQEEIRKIQIHQEEVQSSLRIMNALSHKEKEKFTKAKELISADLEHSLAELSELDGDIQEALRTRQATLTEIYSQCQRYYQVFQAANDWLEDAQELLQLAGNGLDVESAEENLKSHMEFFSTEDQFHSNLEELHSLVATLDPLIKPTGKEDLEQKVASLELRSQRMSRDSGAQVDLLQRCTAQWHDYQKAREEVIELMNDTEKKLSEFSLLKTSSSHEAEEKLSEHKALVSVVNSFHEKIVALEEKASQLEKTGNDASKATLSRSMTTVWQRWTRLRAVAQDQEKILEDAVDEWTGFNNKVKKATEMIDQLQDKLPGSSAEKASKAELLTLLEYHDTFVLELEQQQSALGMLRQQTLSMLQDGAAPTPGEEPPLMQEITAMQDRCLNMQEKVKTNGKLVKQELKDREMVETQINSVKCWVQETKEYLGNPTIEIDAQLEELQILLTEATNHRQNIEKMAEEQKEKYLGLYTILPSELSLQLAEVALDLKIRDQIQDKIKEVEQSKATSQELSRQIQKLAKDLTTILTKLKAKTDNVVQAKTDQKVLGEELDGCNSKLMELDAAVQKFLEQNGQLGKPLAKKIGKLTELHQQTIRQAENRLSKLNQAASHLEEYNEMLELILKWIEKAKVLAHGTIAWNSASQLREQYILHQTLLEESKEIDSELEAMTEKLQYLTSVYCTEKMSQQVAELGRETEELRQMIKIRLQNLQDAAKDMKKFEAELKKLQAALEQAQATLTSPEVGRLSLKEQLSHRQHLLSEMESLKPKVQAVQLCQSALRIPEDVVASLPLCHAALRLQEEASRLQHTAIQQCNIMQEAVVQYEQYEQEMKHLQQLIEGAHREIEDKPVATSNIQELQAQISRHEELAQKIKGYQEQIASLNSKCKMLTMKAKHATMLLTVTEVEGLAEGTEDLDGELLPTPSAHPSVVMMTAGRCHTLLSPVTEESGEEGTNSEISSPPACRSPSPVANTDASVNQDIAYYQALSAERLQTDAAKIHPSTSASQEFYEPGLEPSATAKLGDLQRSWETLKNVISEKQRTLYEALERQQKYQDSLQSISTKMEAIELKLSESPEPGRSPESQMAEHQALMDEILMLQDEINELQSSLAEELVSESCEADPAEQLALQSTLTVLAERMSTIRMKASGKRQLLEEKLNDQLEEQRQEQALQRYRCEADELDSWLLSTKATLDTALSPPKEPMDMEAQLMDCQNMLVEIEQKVVALSELSVHNENLLLEGKAHTKDEAEQLAGKLRRLKGSLLELQRALHDKQLNMQGTAQEKEESDVDLTATQSPGVQEWLAQARTTWTQQRQSSLQQQKELEQELAEQKSLLRSVASRGEEILIQHSAAETSGDAGEKPDVLSQELGMEGEKSSAEDQMRMKWESLHQEFSTKQKLLQNVLEQEQEQVLYSRPNRLLSGVPLYKGDVPTQDKSAVTSLLDGLNQAFEEVSSQSGGAKRQSIHLEQKLYDGVSATSTWLDDVEERLFVATALLPEETETCLFNQEILAKDIKEMSEEMDKNKNLFSQAFPENGDNRDVIEDTLGCLLGRLSLLDSVVNQRCHQMKERLQQILNFQNDLKVLFTSLADNKYIILQKLANVFEQPVAEQIEAIQQAEDGLKEFDAGIIELKRRGDKLQVEQPSMQELSKLQDMYDELMMIIGSRRSGLNQNLTLKSQYERALQDLADLLETGQEKMAGDQKIIVSSKEEIQQLLDKHKEYFQGLESHMILTETLFRKIISFAVQKETQFHTELMAQASAVLKRAHKRGVELEYILETWSHLDEDQQELSRQLEVVESSIPSVGLVEENEDRLIDRITLYQHLKSSLNEYQPKLYQVLDDGKRLLISISCSDLESQLNQLGECWLSNTNKMSKELHRLETILKHWTRYQSESADLIHWLQSAKDRLEFWTQQSVTVPQELEMVRDHLNAFLEFSKEVDAQSSLKSSVLSTGNQLLRLKKVDTATLRSELSRIDSQWTDLLTNIPAVQEKLHQLQMDKLPSRHAISEVMSWISLMENVIQKDEDNIKNSIGYKAIHEYLQKYKGFKIDINCKQLTVDFVNQSVLQISSQDVESKRSDKTDFAEQLGAMNKSWQILQGLVTEKIQLLEGLLESWSEYENNVQCLKTWFETQEKRLKQQHRIGDQASVQNALKDCQDLEDLIKAKEKEVEKIEQNGLALIQNKKEDVSSIVMSTLRELGQTWANLDHMVGQLKILLKSVLDQWSSHKVAFDKINSYLMEARYSLSRFRLLTGSLEAVQVQVDNLQNLQDDLEKQERSLQKFGSITNQLLKECHPPVTETLTNTLKEVNMRWNNLLEEIAEQLQSSKALLQLWQRYKDYSKQCASTVQQQEDRTNELLKAATNKDIADDEVATWIQDCNDLLKGLGTVKDSLFFLHELGEQLKQQVDASAASAIQSDQLSLSQHLCALEQALCKQQTSLQAGVLDYETFAKSLEALEAWIVEAEEILQGQDPSHSSDLSTIQERMEELKGQMLKFSSMAPDLDRLNELGYRLPLNDKEIKRMQNLNRHWSLISSQTTERFSKLQSFLLQHQTFLEKCETWMEFLVQTEQKLAVEISGNYQHLLEQQRAHELFQAEMFSRQQILHSIIIDGQRLLEQGQVDDRDEFNLKLTLLSNQWQGVIRRAQQRRGIIDSQIRQWQRYREMAEKLRKWLVEVSYLPMSGLGSVPIPLQQARTLFDEVQFKEKVFLRQQGSYILTVEAGKQLLLSADSGAEAALQAELAEIQEKWKSASMRLEEQKKKLAFLLKDWEKCEKGIADSLEKLRTFKKKLSQSLPDHHEELHAEQMRCKELENAVGSWTDDLTQLSLLKDTLSAYISADDISILNERVELLQRQWEELCHQLSLRRQQIGERLNEWAVFSEKNKELCEWLTQMESKVSQNGDILIEEMIEKLKKDYQEEIAIAQENKIQLQQMGERLAKASHESKASEIEYKLGKVNDRWQHLLDLIAARVKKLKETLVAVQQLDKNMSSLRTWLAHIESELAKPIVYDSCNSEEIQRKLNEQQELQRDIEKHSTGVASVLNLCEVLLHDCDACATDAECDSIQQATRNLDRRWRNICAMSMERRLKIEETWRLWQKFLDDYSRFEDWLKSSERTAAFPSSSGVIYTVAKEELKKFEAFQRQVHECLTQLELINKQYRRLARENRTDSACSLKQMVHEGNQRWDNLQKRVTSILRRLKHFIGQREEFETARDSILVWLTEMDLQLTNIEHFSECDVQAKIKQLKAFQQEISLNHNKIEQIIAQGEQLIEKSEPLDAAIIEEELDELRRYCQEVFGRVERYHKKLIRLPLPDDEHDLSDRELELEDSAALSDLHWHDRSADSLLSPQPSSNLSLSLAQPLRSERSGRDTPASVDSIPLEWDHDYDLSRDLESAMSRALPSEDEEGQDDKDFYLRGAVGLSGDHSALESQIRQLGKALDDSRFQIQQTENIIRSKTPTGPELDTSYKGYMKLLGECSSSIDSVKRLEHKLKEEEESLPGFVNLHSTETQTAGVIDRWELLQAQALSKELRMKQNLQKWQQFNSDLNSIWAWLGDTEEELEQLQRLELSTDIQTIELQIKKLKELQKAVDHRKAIILSINLCSPEFTQADSKESRDLQDRLSQMNGRWDRVCSLLEEWRGLLQDALMQCQGFHEMSHGLLLMLENIDRRKNEIVPIDSNLDAEILQDHHKQLMQIKHELLESQLRVASLQDMSCQLLVNAEGTDCLEAKEKVHVIGNRLKLLLKEVSRHIKELEKLLDVSSSQQDLSSWSSADELDTSGSVSPTSGRSTPNRQKTPRGKCSLSQPGPSVSSPHSRSTKGGSDSSLSEPGPGRSGRGFLFRVLRAALPLQLLLLLLIGLACLVPMSEEDYSCALSNNFARSFHPMLRYTNGPPPL,8797,"1,011,086",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=12;  Name=1; Synonyms=Nesprin-1 Giant, Enaptin; IsoId=Q8NF91-1; Sequence=Displayed; Name=2; Synonyms=Beta; IsoId=Q8NF91-2; Sequence=VSP_007130; Name=3; Synonyms=Alpha; IsoId=Q8NF91-3; Sequence=VSP_007132, VSP_007144; Name=4; IsoId=Q8NF91-4; Sequence=VSP_007134, VSP_007139, VSP_007140, VSP_007144; Name=5; IsoId=Q8NF91-5; Sequence=VSP_007135, VSP_007136; Note=No experimental confirmation available.; Name=6; IsoId=Q8NF91-6; Sequence=VSP_007137, VSP_007138; Note=No experimental confirmation available.; Name=7; IsoId=Q8NF91-7; Sequence=VSP_007141, VSP_007142; Note=No experimental confirmation available.; Name=8; Synonyms=Beta 2; IsoId=Q8NF91-8; Sequence=VSP_007131; Name=9; Synonyms=Alpha 2; IsoId=Q8NF91-9; Sequence=VSP_007133, VSP_007143, VSP_007144; Name=10; Synonyms=drop1; IsoId=Q8NF91-10; Sequence=VSP_057478, VSP_057479, VSP_057480; Note=Lost in uterus, cervix, kidney, lung, thyroid and pancreas carcinomas, already at early tumor stages. {ECO:0000269|PubMed:18709643}; Name=11; Synonyms=myne-1, 131kDa; IsoId=Q8NF91-11; Sequence=VSP_057476; Note=Muscle-specific.; Name=GSRP-56; Synonyms=56kDa; IsoId=Q8NF91-12; Sequence=VSP_057477, VSP_057481, VSP_057482; Note=Interacts with TRPV2. {ECO:0000269|PubMed:16875688}; ",,SEQUENCE CAUTION:  Sequence=AAC02992.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=AAH39121.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};  Sequence=BAC04284.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=CAD28486.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,SEQUENCE CAUTION:  Sequence=AAM95335.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin.; Evidence={ECO:0000305};  Sequence=BAB71097.1; Type=Miscellaneous discrepancy; Note=Chimeric cDNA.; Evidence={ECO:0000305}; ,"VAR_SEQ 1 7843 Missing (in isoform 9). {ECO:0000303|Ref.6}. /FTId=VSP_007133.; VAR_SEQ 1 7838 Missing (in isoform 3). {ECO:0000303|PubMed:11792814}. /FTId=VSP_007132.; VAR_SEQ 1 7658 Missing (in isoform 11). {ECO:0000303|PubMed:11801724}. /FTId=VSP_057476.; VAR_SEQ 1 5585 Missing (in isoform 8). {ECO:0000303|Ref.6}. /FTId=VSP_007131.; VAR_SEQ 1 5476 Missing (in isoform 2). {ECO:0000303|PubMed:11792814}. /FTId=VSP_007130.; VAR_SEQ 1 2918 Missing (in isoform GSRP-56). {ECO:0000303|PubMed:15489334}. /FTId=VSP_057477.; VAR_SEQ 103 103 K -> KSMHRGSP (in isoform 4). {ECO:0000303|PubMed:15093733}. /FTId=VSP_007134.; VAR_SEQ 297 313 Missing (in isoform 10). {ECO:0000303|PubMed:18709643}. /FTId=VSP_057478.; VAR_SEQ 1437 1443 DIKTMEM -> EYVIDKS (in isoform 5). {ECO:0000303|PubMed:11214970}. /FTId=VSP_007135.; VAR_SEQ 1444 8797 Missing (in isoform 5). {ECO:0000303|PubMed:11214970}. /FTId=VSP_007136.; VAR_SEQ 1702 1725 LQNEVVSQASFYSKLLQLKESLFS -> SSRKCEEGKNKMLFVTVTLFKIIK (in isoform 6). {ECO:0000303|PubMed:17974005}. /FTId=VSP_007137.; VAR_SEQ 1726 8797 Missing (in isoform 6). {ECO:0000303|PubMed:17974005}. /FTId=VSP_007138.; VAR_SEQ 3049 3049 C -> W (in isoform 10). {ECO:0000303|PubMed:18709643}. /FTId=VSP_057479.; VAR_SEQ 3050 8797 Missing (in isoform 10). {ECO:0000303|PubMed:18709643}. /FTId=VSP_057480.; VAR_SEQ 3325 3394 ALLSVKQEKEIQMKMIVTRGESVLQNTSPEGIPTIQQQLQSVKDMWASLLSAGIRCKSQLEGALSKWTSY -> VCIFTQKYLQPTEFVFLKISRLHPPGVMMSHSLHDKSQMLCECNAVCLGCTCQRIPESSDPGCFPKNKIK (in isoform GSRP-56). {ECO:0000303|PubMed:15489334}. /FTId=VSP_057481.; VAR_SEQ 3395 8797 Missing (in isoform GSRP-56). {ECO:0000303|PubMed:15489334}. /FTId=VSP_057482.; VAR_SEQ 3620 3641 Missing (in isoform 4). {ECO:0000303|PubMed:15093733}. /FTId=VSP_007139.; VAR_SEQ 3912 3967 Missing (in isoform 4). {ECO:0000303|PubMed:15093733}. /FTId=VSP_007140.; VAR_SEQ 5571 5580 TLLEESKEID -> VTLGKIIFKK (in isoform 7). {ECO:0000303|PubMed:10574462}. /FTId=VSP_007141.; VAR_SEQ 5581 8797 Missing (in isoform 7). {ECO:0000303|PubMed:10574462}. /FTId=VSP_007142.; VAR_SEQ 7844 7874 AKASHESKASEIEYKLGKVNDRWQHLLDLIA -> MVVAEDLSALRMAEDGCVDADLPDCNCDVTR (in isoform 9). {ECO:0000303|Ref.6}. /FTId=VSP_007143.; VAR_SEQ 8325 8325 S -> SDVMIPESPEAYVKLTENAIKNTS (in isoform 3, isoform 4 and isoform 9). {ECO:0000303|PubMed:11792814, ECO:0000303|PubMed:15093733, ECO:0000303|Ref.6}. /FTId=VSP_007144.","VARIANT 655 655 Q -> R (found in a patient with mild intellectual disability, spastic paraplegia, axon neuropathy and leukoencephalopathy; unknown pathological significance; dbSNP:rs9397509). {ECO:0000269|PubMed:24123876}. /FTId=VAR_056211.; VARIANT 885 885 L -> V (in dbSNP:rs17082709). /FTId=VAR_056212.; VARIANT 1035 1035 V -> A (in dbSNP:rs214976). /FTId=VAR_056213.; VARIANT 1062 1062 R -> S. {ECO:0000269|PubMed:25787250}. /FTId=VAR_074190.; VARIANT 2030 2030 S -> G (in dbSNP:rs35763277). /FTId=VAR_056214.; VARIANT 2795 2795 A -> V (in dbSNP:rs214950). /FTId=VAR_056215.; VARIANT 3088 3088 A -> T (found in a patient with mild intellectual disability, spastic paraplegia, axon neuropathy and leukoencephalopathy; unknown pathological significance; dbSNP:rs398123005). {ECO:0000269|PubMed:24123876}. /FTId=VAR_070561.; VARIANT 3671 3671 V -> M (in a colorectal cancer sample; somatic mutation; dbSNP:rs567753957). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036250.; VARIANT 3874 3874 K -> T (in dbSNP:rs13210127). /FTId=VAR_056216.; VARIANT 3892 3892 L -> S (found in a patient with mild intellectual disability, spastic paraplegia, axon neuropathy and leukoencephalopathy; unknown pathological significance; dbSNP:rs180727534). {ECO:0000269|PubMed:24123876}. /FTId=VAR_070562.; VARIANT 3954 3954 S -> T (in dbSNP:rs7775119). /FTId=VAR_056217.; VARIANT 4060 4060 E -> D (in dbSNP:rs4645434). /FTId=VAR_056218.; VARIANT 4121 4121 K -> N (in dbSNP:rs28385621). /FTId=VAR_056219.; VARIANT 4121 4121 K -> R (in dbSNP:rs9479297). /FTId=VAR_056220.; VARIANT 4203 4203 E -> K (in dbSNP:rs2130262). /FTId=VAR_056221.; VARIANT 4210 4210 E -> D (in a colorectal cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036251.; VARIANT 4223 4223 R -> H (in a colorectal cancer sample; somatic mutation; dbSNP:rs140492158). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036252.; VARIANT 4546 4546 V -> I (in dbSNP:rs4870093). /FTId=VAR_056222.; VARIANT 4596 4596 S -> T (in dbSNP:rs6911096). {ECO:0000269|PubMed:10574462, ECO:0000269|PubMed:12408964}. /FTId=VAR_056223.; VARIANT 4944 4944 L -> M (in dbSNP:rs2306916). /FTId=VAR_056224.; VARIANT 5015 5015 L -> M (in dbSNP:rs2306916). {ECO:0000269|PubMed:10574462, ECO:0000269|PubMed:12408964}. /FTId=VAR_056225.; VARIANT 5377 5377 M -> L (in dbSNP:rs35987150). /FTId=VAR_056226.; VARIANT 5426 5426 T -> M (in dbSNP:rs2306914). /FTId=VAR_056227.; VARIANT 5507 5507 L -> R (in a colorectal cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036253.; VARIANT 6566 6566 M -> I (in dbSNP:rs35654757). /FTId=VAR_056228.; VARIANT 6664 6664 T -> I (in dbSNP:rs35079654). /FTId=VAR_056229.; VARIANT 6951 6951 Q -> H (in dbSNP:rs3945783). /FTId=VAR_056230.; VARIANT 7302 7302 F -> V (in dbSNP:rs2147377). {ECO:0000269|PubMed:11792814, ECO:0000269|PubMed:12408964, ECO:0000269|PubMed:9872452, ECO:0000269|Ref.6}. /FTId=VAR_056231.; VARIANT 7506 7506 S -> G (in dbSNP:rs35763277). /FTId=VAR_056232.; VARIANT 8095 8095 R -> H (in EDMD4; dbSNP:rs119103246). {ECO:0000269|PubMed:17761684}. /FTId=VAR_062974.; VARIANT 8161 8161 N -> H (in dbSNP:rs36215251). /FTId=VAR_056233.; VARIANT 8168 8168 A -> S (in dbSNP:rs17082236). /FTId=VAR_056234.; VARIANT 8323 8323 G -> A (in dbSNP:rs2252755). {ECO:0000269|PubMed:11792814, ECO:0000269|PubMed:11801724, ECO:0000269|PubMed:12408964, ECO:0000269|PubMed:9872452, ECO:0000269|Ref.6}. /FTId=VAR_015548.; VARIANT 8387 8387 V -> L (in EDMD4; dbSNP:rs119103247). {ECO:0000269|PubMed:17761684}. /FTId=VAR_062975.; VARIANT 8461 8461 E -> K (in EDMD4; dbSNP:rs119103248). {ECO:0000269|PubMed:17761684}. /FTId=VAR_062976.; VARIANT 8468 8468 R -> H (in a colorectal cancer sample; somatic mutation; dbSNP:rs143049227). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036254.; VARIANT 8687 8687 T -> I (in dbSNP:rs35591210). /FTId=VAR_056235.; VARIANT 8741 8741 L -> M (in dbSNP:rs2295190). /FTId=VAR_056236.",,,,"CONFLICT 98 98 F -> L (in Ref. 2; AAN60442). {ECO:0000305}.; CONFLICT 494 494 S -> P (in Ref. 9; AAM95335). {ECO:0000305}.; CONFLICT 1440 1440 T -> P (in Ref. 12; CAD28486). {ECO:0000305}.; CONFLICT 3096 3096 N -> D (in Ref. 10; BAB71097). {ECO:0000305}.; CONFLICT 5526 5526 A -> T (in Ref. 1; AAL33798). {ECO:0000305}.; CONFLICT 5564 5564 E -> K (in Ref. 1; AAL33798). {ECO:0000305}.; CONFLICT 5735 5735 E -> A (in Ref. 5; AAN03486). {ECO:0000305}.; CONFLICT 6549 6549 K -> E (in Ref. 1; AAL33798, 2; AAN60442 and 6; AAO27774). {ECO:0000305}.; CONFLICT 6626 6626 L -> P (in Ref. 1; AAL33798, 2; AAN60442 and 6; AAO27774). {ECO:0000305}.; CONFLICT 6645 6645 E -> V (in Ref. 1; AAL33798, 2; AAN60442 and 6; AAO27774). {ECO:0000305}.; CONFLICT 6923 6923 I -> T (in Ref. 1; AAL33798, 2; AAN60442 and 6; AAO27774). {ECO:0000305}.; CONFLICT 6929 6929 V -> A (in Ref. 1; AAL33798, 2; AAN60442 and 6; AAO27774). {ECO:0000305}.; CONFLICT 7075 7075 E -> D (in Ref. 1; AAL33798, 2; AAN60442 and 6; AAO27774). {ECO:0000305}.; CONFLICT 7091 7091 N -> T (in Ref. 1; AAL33798, 2; AAN60442 and 6; AAO27774). {ECO:0000305}.",,4,,0,"DOMAIN: The KASH domain, which contains a transmembrane domain, mediates the nuclear envelope targeting and is involved in the binding to SUN1 and SUN2 through recognition of their SUN domains. {ECO:0000269|PubMed:18396275}.",SIMILARITY: Belongs to the nesprin family. {ECO:0000305}.,COILED 314 8666 {ECO:0000255}.,COMPBIAS 8663 8729 Ser-rich.,DOMAIN 27 134 Calponin-homology (CH) 1. {ECO:0000255|PROSITE-ProRule:PRU00044}.; DOMAIN 178 283 Calponin-homology (CH) 2. {ECO:0000255|PROSITE-ProRule:PRU00044}.; DOMAIN 8738 8797 KASH. {ECO:0000255|PROSITE-ProRule:PRU00385}.,,REGION 1 289 Actin-binding.,REPEAT 314 397 Spectrin 1.; REPEAT 398 502 Spectrin 2.; REPEAT 503 609 Spectrin 3.; REPEAT 610 703 Spectrin 4.; REPEAT 704 815 Spectrin 5.; REPEAT 816 923 Spectrin 6.; REPEAT 924 1024 Spectrin 7.; REPEAT 1025 1122 Spectrin 8.; REPEAT 1123 1246 Spectrin 9.; REPEAT 1247 1335 Spectrin 10.; REPEAT 1336 1444 Spectrin 11.; REPEAT 1445 1550 Spectrin 12.; REPEAT 1551 1653 Spectrin 13.; REPEAT 1654 1763 Spectrin 14.; REPEAT 1764 1879 Spectrin 15.; REPEAT 1880 1976 Spectrin 16.; REPEAT 1977 2081 Spectrin 17.; REPEAT 2082 2195 Spectrin 18.; REPEAT 2196 2303 Spectrin 19.; REPEAT 2304 2401 Spectrin 20.; REPEAT 2402 2513 Spectrin 21.; REPEAT 2514 2619 Spectrin 22.; REPEAT 2620 2731 Spectrin 23.; REPEAT 2732 2838 Spectrin 24.; REPEAT 2839 2962 Spectrin 25.; REPEAT 2963 3062 Spectrin 26.; REPEAT 3063 3171 Spectrin 27.; REPEAT 3172 3275 Spectrin 28.; REPEAT 3276 3387 Spectrin 29.; REPEAT 3388 3490 Spectrin 30.; REPEAT 3491 3593 Spectrin 31.; REPEAT 3594 3720 Spectrin 32.; REPEAT 3721 3814 Spectrin 33.; REPEAT 3815 3920 Spectrin 34.; REPEAT 3921 4028 Spectrin 35.; REPEAT 4029 4139 Spectrin 36.; REPEAT 4140 4235 Spectrin 37.; REPEAT 4236 4339 Spectrin 38.; REPEAT 4340 4451 Spectrin 39.; REPEAT 4452 4560 Spectrin 40.; REPEAT 4561 4669 Spectrin 41.; REPEAT 4670 4776 Spectrin 42.; REPEAT 4777 4882 Spectrin 43.; REPEAT 4883 4991 Spectrin 44.; REPEAT 4992 5099 Spectrin 45.; REPEAT 5100 5209 Spectrin 46.; REPEAT 5210 5318 Spectrin 47.; REPEAT 5319 5424 Spectrin 48.; REPEAT 5425 5522 Spectrin 49.; REPEAT 5523 5630 Spectrin 50.; REPEAT 5631 5736 Spectrin 51.; REPEAT 5737 5842 Spectrin 52.; REPEAT 5962 6071 Spectrin 53.; REPEAT 6072 6178 Spectrin 54.; REPEAT 6374 6485 Spectrin 55.; REPEAT 6486 6581 Spectrin 56.; REPEAT 6582 6691 Spectrin 57.; REPEAT 6692 6795 Spectrin 58.; REPEAT 6796 6902 Spectrin 59.; REPEAT 6903 7020 Spectrin 60.; REPEAT 7021 7128 Spectrin 61.; REPEAT 7129 7237 Spectrin 62.; REPEAT 7238 7350 Spectrin 63.; REPEAT 7351 7454 Spectrin 64.; REPEAT 7455 7558 Spectrin 65.; REPEAT 7559 7671 Spectrin 66.; REPEAT 7672 7783 Spectrin 67.; REPEAT 7784 7883 Spectrin 68.; REPEAT 7884 7997 Spectrin 69.; REPEAT 7998 8106 Spectrin 70.; REPEAT 8107 8216 Spectrin 71.; REPEAT 8329 8438 Spectrin 72.; REPEAT 8439 8548 Spectrin 73.; REPEAT 8549 8666 Spectrin 74.,,,,,,,"FUNCTION: Multi-isomeric modular protein which forms a linking network between organelles and the actin cytoskeleton to maintain the subcellular spatial organization. As a component of the LINC (LInker of Nucleoskeleton and Cytoskeleton) complex involved in the connection between the nuclear lamina and the cytoskeleton. The nucleocytoplasmic interactions established by the LINC complex play an important role in the transmission of mechanical forces across the nuclear envelope and in nuclear movement and positioning. May be involved in nucleus-centrosome attachment and nuclear migration in neural progenitors implicating LINC complex association with SUN1/2 and probably association with cytoplasmic dynein-dynactin motor complexes; SYNE1 and SYNE2 may act redundantly. Required for centrosome migration to the apical cell surface during early ciliogenesis. May be involved in nuclear remodeling during sperm head formation in spermatogenenis; a probable SUN3:SYNE1/KASH1 LINC complex may tether spermatid nuclei to posterior cytoskeletal structures such as the manchette. {ECO:0000250|UniProtKB:Q6ZWR6, ECO:0000269|PubMed:11792814, ECO:0000269|PubMed:18396275}.",,,,,,,,,,,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017],GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090286; GO:0090292,IPR001589; IPR001715; IPR036872; IPR012315; IPR018159; IPR002017; IPR030265; ,Q9NRI5; P50402; O94901; Q9UH99,"SUBUNIT: Core component of LINC complexes which are composed of inner nuclear membrane SUN domain-containing proteins coupled to outer nuclear membrane KASH domain-containing nesprins. SUN and KASH domain-containing proteins seem to bind each other promiscuously; however, differentially expression of LINC complex constituents can give rise to specific assemblies. At least SUN1/2-containing core LINC complexes are proposed to be hexameric composed of three protomers of each KASH and SUN domain-containing protein. The SUN2:SYNE1/KASH1 LINC complex is a heterohexamer; the homotrimeric cloverleave-like conformation of the SUN domain is a prerequisite for LINC complex formation in which three separate SYNE1/KASH1 peptides bind at the interface of adjacent SUN domains. Self-associates. Interacts with SYNE3. Interacts with SPAG4/SUN4. May interact with MUSK. Interacts with F-actin via its N-terminal domain. Interacts with EMD and LMNA in vitro. {ECO:0000250|UniProtKB:Q6ZWR6, ECO:0000269|PubMed:12163176, ECO:0000269|PubMed:18396275, ECO:0000269|PubMed:22518138}.",11792814; 12408964; 11801724; 18709643; 15093733; 15489334; 14574404; 12808039; 14702039; 11214970; 17974005; 10574462; 9872452; 12168954; 12163176; 17081983; 16875688; 17159980; 18396275; 19690332; 22518138; 23671687; 24275569; 22632968; 16959974; 17761684; 24123876; 25787250,11792814; 12408964; 11801724; 18709643; 15093733; 15489334; 14574404; 12808039; 14702039; 11214970; 17974005; 10574462; 9872452; 12168954; 12163176; 17081983; 16875688; 17159980; 18396275; 19690332; 22518138; 23671687; 24275569; 22632968; 16959974; 17761684; 24123876; 25787250; 12812986; 16079285; 17452644; 17543860; 17903302; 17932509; 18985028; 19805454; 20056644; 20201924; 20360068; 20711500; 20936779; 21150319; 21911577; 22810585; 23414517; 23902751; 8794855,2003-04-11,2019-02-13,2012-11-28,179,X-ray crystallography (1),STRAND 8783 8785 {ECO:0000244|PDB:4DXR}.; STRAND 8787 8793 {ECO:0000244|PDB:4DXR}.,HELIX 8780 8782 {ECO:0000244|PDB:4DXR}.,,,,TOPO_DOM 1 8746 Cytoplasmic. {ECO:0000255|PROSITE-ProRule:PRU00385}.; TOPO_DOM 8768 8797 Perinuclear space. {ECO:0000255|PROSITE-ProRule:PRU00385}.,TRANSMEM 8747 8767 Helical; Anchor for type IV membrane protein. {ECO:0000255|PROSITE-ProRule:PRU00385}.,5 out of 5,Alternative sequence (22); Beta strand (2); Chain (1); Coiled coil (1); Compositional bias (1); Disulfide bond (2); Domain (3); Erroneous initiation (4); Helix (1); Modified residue (9); Mutagenesis (1); Natural variant (38); Region (1); Repeat (74); Sequence caution (2); Sequence conflict (28); Topological domain (2); Transmembrane (1),,"TISSUE SPECIFICITY: Expressed in HeLa, A431, A172 and HaCaT cells (at protein level). Widely expressed. Highly expressed in skeletal and smooth muscles, heart, spleen, peripheral blood leukocytes, pancreas, cerebellum, stomach, kidney and placenta. Isoform GSRP-56 is predominantly expressed in heart and skeletal muscle (at protein level). {ECO:0000269|PubMed:11792814, ECO:0000269|PubMed:11801724, ECO:0000269|PubMed:15093733, ECO:0000269|PubMed:16875688, ECO:0000269|PubMed:22518138}.",,3D-structure;Actin-binding;Alternative splicing;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Differentiation;Disease mutation;Disulfide bond;Emery-Dreifuss muscular dystrophy;Golgi apparatus;Membrane;Neurodegeneration;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Spermatogenesis;Transmembrane;Transmembrane helix,Evidence at protein level,reviewed,,Nesprin family,179,Alternative products (1); Caution (6); Domain (1); Function (1); Involvement in disease (2); Post-translational modification (1); Sequence similarities (1); Subcellular location (2); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0009; KW-0025; KW-0175; KW-0181; KW-0206; KW-0221; KW-0225; KW-0333; KW-0472; KW-0523; KW-0539; KW-0597; KW-0621; KW-0677; KW-0744; KW-0812; KW-0963; KW-1015; KW-1067; KW-1133; KW-1185,,,,,"DISEASE: Spinocerebellar ataxia, autosomal recessive, 8 (SCAR8) [MIM:610743]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR8 is an autosomal recessive form. {ECO:0000269|PubMed:17159980}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Emery-Dreifuss muscular dystrophy 4, autosomal dominant (EDMD4) [MIM:612998]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:17761684}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,PTM: The disulfid bond with SUN1 or SUN2 is required for stability of the respective LINC complex under tensile forces. {ECO:0000250|UniProtKB:Q8WXH0}.,CHAIN 1 8797 Nesprin-1. /FTId=PRO_0000163591.,,DISULFID 8774 8774 Interchain (C-563 in SUN2); alternate. {ECO:0000250|UniProtKB:Q8WXH0}.; DISULFID 8774 8774 Interchain (with C-657 in SUN1); alternate. {ECO:0000250|UniProtKB:Q8WXH0}.,,,,"MOD_RES 732 732 Phosphoserine. {ECO:0000250|UniProtKB:Q6ZWR6}.; MOD_RES 2270 2270 Phosphothreonine. {ECO:0000250|UniProtKB:Q6ZWR6}.; MOD_RES 5657 5657 Phosphoserine. {ECO:0000250|UniProtKB:Q6ZWR6}.; MOD_RES 8223 8223 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:24275569}.; MOD_RES 8274 8274 Phosphothreonine. {ECO:0000244|PubMed:17081983}.; MOD_RES 8277 8277 Phosphoserine. {ECO:0000244|PubMed:17081983}.; MOD_RES 8280 8280 Phosphoserine. {ECO:0000244|PubMed:17081983}.; MOD_RES 8305 8305 Phosphoserine. {ECO:0000250|UniProtKB:Q6ZWR6}.; MOD_RES 8360 8360 Phosphothreonine. {ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AY061755;AY061756;AY184203;AY184206;AF535142;AF444779;FM162565;AF495910;BC039121;AY135172;AY183142;AK056122;AK094094;AB051543;AL713682;AB033088;AB018339;AF043290;
0,Q8WYJ6,SEPT1_HUMAN,SEPT1 DIFF6 PNUTL3,SEPT1,DIFF6 PNUTL3,,,Homo sapiens (Human),9606,Septin-1 (LARP) (Peanut-like protein 3) (Serologically defined breast cancer antigen NY-BR-24),UP000005640: Unplaced,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDKEYVGFAALPNQLHRKSVKKGFDFTLMVAGESGLGKSTLINSLFLTNLYEDRQVPEASARLTQTLAIERRGVEIEEGGVKVKLTLVDTPGFGDSVDCSDCWLPVVKFIEEQFEQYLRDESGLNRKNIQDSRVHCCLYFISPFGRGLRPLDVAFLRAVHEKVNIIPVIGKADALMPQETQALKQKIRDQLKEEEIHIYQFPECDSDEDEDFKRQDAEMKESIPFAVVGSCEVVRDGGNRPVRGRRYSWGTVEVENPHHCDFLNLRRMLVQTHLQDLKEVTHDLLYEGYRARCLQSLARPGARDRASRSKLSRQSATEIPLPMLPLADTEKLIREKDEELRRMQEMLEKMQAQMQQSQAQGEQSDAL,367,"41,971",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q8WYJ6-1; Sequence=Displayed; Name=2; IsoId=Q8WYJ6-2; Sequence=VSP_038269, VSP_038270; Note=No experimental confirmation available.; ",,SEQUENCE CAUTION:  Sequence=AAK61491.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 148 167 LRPLDVAFLRAVHEKVNIIP -> SGGGILGAGAFREGWGVSAP (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_038269.; VAR_SEQ 168 367 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_038270.,VARIANT 80 80 G -> V (in dbSNP:rs34518080). /FTId=VAR_051934.,,,,CONFLICT 60 60 S -> G (in Ref. 1; AAL40393). {ECO:0000305}.; CONFLICT 148 150 LRP -> SR (in Ref. 1; AAL40393). {ECO:0000305}.; CONFLICT 240 241 RP -> GL (in Ref. 1; AAL40393). {ECO:0000305}.; CONFLICT 324 324 L -> P (in Ref. 1; AAL40393). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like GTPase superfamily. Septin GTPase family. {ECO:0000255|PROSITE-ProRule:PRU01056}.,,,DOMAIN 22 296 Septin-type G. {ECO:0000255|PROSITE-ProRule:PRU01056}.,,REGION 32 39 G1 motif. {ECO:0000255|PROSITE-ProRule:PRU01056}.; REGION 89 92 G3 motif. {ECO:0000255|PROSITE-ProRule:PRU01056}.; REGION 170 173 G4 motif. {ECO:0000255|PROSITE-ProRule:PRU01056}.,,,,,,,,"FUNCTION: Filament-forming cytoskeletal GTPase (By similarity). May play a role in cytokinesis (Potential). {ECO:0000250, ECO:0000305}.",,,,,,,BINDING 66 66 GTP. {ECO:0000250}.; BINDING 92 92 GTP; via amide nitrogen. {ECO:0000250}.; BINDING 229 229 GTP; via amide nitrogen and carbonyl oxygen. {ECO:0000250}.; BINDING 245 245 GTP. {ECO:0000250}.,,,NP_BIND 32 39 GTP. {ECO:0000250}.; NP_BIND 171 179 GTP. {ECO:0000250}.,,microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein-containing complex scaffold activity [GO:0032947]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157],cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein-containing complex scaffold activity [GO:0032947],microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021],GO:0003924; GO:0005525; GO:0005815; GO:0005940; GO:0008021; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032947; GO:0042802; GO:0061640,IPR030379; IPR027417; IPR016491; ,Itself; Q4VCS5-2; Q96GD4; Q9NVA2; Q8IYM1; Q99719; Q14141; A0A0S2Z5W9; Q8IYF3,"SUBUNIT: Septins polymerize into heterooligomeric protein complexes that form filaments, and can associate with cellular membranes, actin filaments and microtubules. GTPase activity is required for filament formation (By similarity). Interacts with AURKB. {ECO:0000250, ECO:0000269|PubMed:16179162}.",14702039; 15489334; 17974005; 12747765; 16179162; 15915442; 19799413; 19690332; 21269460; 24275569,14702039; 15489334; 17974005; 12747765; 16179162; 15915442; 19799413; 19690332; 21269460; 24275569; 16189514; 17912427; 17922164; 20064372; 21988832; 23087102; 25416956,2002-04-16,2019-02-13,2002-04-16,152,,,,,,,,,5 out of 5,Alternative sequence (2); Binding site (4); Chain (1); Domain (1); Erroneous initiation (1); Modified residue (5); Mutagenesis (6); Natural variant (1); Nucleotide binding (2); Region (3); Sequence conflict (4),,TISSUE SPECIFICITY: Expressed at high levels in lymphoid and hematopoietic tissues. {ECO:0000269|PubMed:15915442}.,,Alternative splicing;Cell cycle;Cell division;Complete proteome;Cytoplasm;Cytoskeleton;GTP-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,"TRAFAC class TrmE-Era-EngA-EngB-Septin-like GTPase superfamily, Septin GTPase family",152,Alternative products (1); Caution (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0131; KW-0132; KW-0181; KW-0206; KW-0342; KW-0547; KW-0597; KW-0621; KW-0963; KW-1185,,,,,,,,,CHAIN 1 367 Septin-1. /FTId=PRO_0000173513.,,,,,,"MOD_RES 206 206 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 248 248 Phosphoserine; by AURKB. {ECO:0000244|PubMed:19690332, ECO:0000269|PubMed:16179162}.; MOD_RES 251 251 Phosphothreonine. {ECO:0000250|UniProtKB:P42209}.; MOD_RES 307 307 Phosphoserine; by AURKB. {ECO:0000269|PubMed:16179162}.; MOD_RES 315 315 Phosphoserine; by AURKB. {ECO:0000244|PubMed:19690332, ECO:0000269|PubMed:16179162}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF085235;AY034176;AK301045;BC012161;AL833004;AF308288;
0,Q8WYL5,SSH1_HUMAN,SSH1 KIAA1298 SSH1L,SSH1,KIAA1298 SSH1L,,,Homo sapiens (Human),9606,Protein phosphatase Slingshot homolog 1 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 1) (SSH-1L) (hSSH-1L),UP000005640: Chromosome 12,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MALVTLQRSPTPSAASSSASNSELEAGSEEDRKLNLSLSESFFMVKGAALFLQQGSSPQGQRSLQHPHKHAGDLPQHLQVMINLLRCEDRIKLAVRLESAWADRVRYMVVVYSSGRQDTEENILLGVDFSSKESKSCTIGMVLRLWSDTKIHLDGDGGFSVSTAGRMHIFKPVSVQAMWSALQVLHKACEVARRHNYFPGGVALIWATYYESCISSEQSCINEWNAMQDLESTRPDSPALFVDKPTEGERTERLIKAKLRSIMMSQDLENVTSKEIRNELEKQMNCNLKELKEFIDNEMLLILGQMDKPSLIFDHLYLGSEWNASNLEELQGSGVDYILNVTREIDNFFPGLFAYHNIRVYDEETTDLLAHWNEAYHFINKAKRNHSKCLVHCKMGVSRSASTVIAYAMKEFGWPLEKAYNYVKQKRSITRPNAGFMRQLSEYEGILDASKQRHNKLWRQQTDSSLQQPVDDPAGPGDFLPETPDGTPESQLPFLDDAAQPGLGPPLPCCFRRLSDPLLPSPEDETGSLVHLEDPEREALLEEAAPPAEVHRPARQPQQGSGLCEKDVKKKLEFGSPKGRSGSLLQVEETEREEGLGAGRWGQLPTQLDQNLLNSENLNNNSKRSCPNGMEDDAIFGILNKVKPSYKSCADCMYPTASGAPEASRERCEDPNAPAICTQPAFLPHITSSPVAHLASRSRVPEKPASGPTEPPPFLPPAGSRRADTSGPGAGAALEPPASLLEPSRETPKVLPKSLLLKNSHCDKNPPSTEVVIKEESSPKKDMKPAKDLRLLFSNESEKPTTNSYLMQHQESIIQLQKAGLVRKHTKELERLKSVPADPAPPSRDGPASRLEASIPEESQDPAALHELGPLVMPSQAGSDEKSEAAPASLEGGSLKSPPPFFYRLDHTSSFSKDFLKTICYTPTSSSMSSNLTRSSSSDSIHSVRGKPGLVKQRTQEIETRLRLAGLTVSSPLKRSHSLAKLGSLTFSTEDLSSEADPSTVADSQDTTLSESSFLHEPQGTPRDPAATSKPSGKPAPENLKSPSWMSKS,1049,"115,511",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=5;  Name=1; Synonyms=L; IsoId=Q8WYL5-1; Sequence=Displayed; Name=2; Synonyms=S; IsoId=Q8WYL5-2; Sequence=VSP_016318, VSP_016319; Note=May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.; Name=3; Synonyms=B; IsoId=Q8WYL5-3; Sequence=VSP_016312, VSP_016314, VSP_016315, VSP_016316; Note=Due to intron retention. No experimental confirmation available.; Name=4; IsoId=Q8WYL5-4; Sequence=VSP_016311, VSP_016317; Name=5; IsoId=Q8WYL5-5; Sequence=VSP_016313, VSP_016318, VSP_016319; Note=No experimental confirmation available.; ",,SEQUENCE CAUTION:  Sequence=BAA92536.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 1 312 Missing (in isoform 4). {ECO:0000303|PubMed:10718198}. /FTId=VSP_016311.; VAR_SEQ 1 73 Missing (in isoform 3). {ECO:0000303|PubMed:11832213}. /FTId=VSP_016312.; VAR_SEQ 1 37 MALVTLQRSPTPSAASSSASNSELEAGSEEDRKLNLS -> MARARRAVVGSVRDVSTAATNLFYFTDFCIFLQPTHCFCCPEVSSSNY (in isoform 5). {ECO:0000303|PubMed:14702039}. /FTId=VSP_016313.; VAR_SEQ 74 93 LPQHLQVMINLLRCEDRIKL -> MGGRHHLQRQVSESMSALFQ (in isoform 3). {ECO:0000303|PubMed:11832213}. /FTId=VSP_016314.; VAR_SEQ 135 157 Missing (in isoform 3). {ECO:0000303|PubMed:11832213}. /FTId=VSP_016315.; VAR_SEQ 245 1049 Missing (in isoform 3). {ECO:0000303|PubMed:11832213}. /FTId=VSP_016316.; VAR_SEQ 313 334 FDHLYLGSEWNASNLEELQGSG -> MRCYLSWDRWTSPPLSSIIFIS (in isoform 4). {ECO:0000303|PubMed:10718198}. /FTId=VSP_016317.; VAR_SEQ 632 692 DDAIFGILNKVKPSYKSCADCMYPTASGAPEASRERCEDPNAPAICTQPAFLPHITSSPVA -> VGRARPAGWHTPSLPSHSNWPTSASVVGTTGTRHHTQLIFFYCLLWAPSSHLQGPEGSFTG (in isoform 2 and isoform 5). {ECO:0000303|PubMed:11832213, ECO:0000303|PubMed:14702039}. /FTId=VSP_016318.; VAR_SEQ 693 1049 Missing (in isoform 2 and isoform 5). {ECO:0000303|PubMed:11832213, ECO:0000303|PubMed:14702039}. /FTId=VSP_016319.",,,,,CONFLICT 2 2 A -> V (in Ref. 4; AAH62341). {ECO:0000305}.; CONFLICT 230 230 L -> P (in Ref. 1; BAB84116). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the protein-tyrosine phosphatase family. {ECO:0000305}.,,,DOMAIN 308 448 Tyrosine-protein phosphatase.,,REGION 897 1049 Interaction with YWHAG. {ECO:0000269|PubMed:15159416}.,,,3.1.3.16; 3.1.3.48,,"CATALYTIC ACTIVITY: Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] + phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU10044}; CATALYTIC ACTIVITY: Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] + phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474, ChEBI:CHEBI:83421; EC=3.1.3.16; CATALYTIC ACTIVITY: Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] + phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474, ChEBI:CHEBI:61977; EC=3.1.3.16;",,,"FUNCTION: Protein phosphatase which regulates actin filament dynamics. Dephosphorylates and activates the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Inhibitory phosphorylation of cofilin is mediated by LIMK1, which may also be dephosphorylated and inactivated by this protein. {ECO:0000269|PubMed:11832213, ECO:0000269|PubMed:12684437, ECO:0000269|PubMed:12807904, ECO:0000269|PubMed:14531860, ECO:0000269|PubMed:14645219, ECO:0000269|PubMed:15056216, ECO:0000269|PubMed:15159416, ECO:0000269|PubMed:15660133, ECO:0000269|PubMed:15671020, ECO:0000269|PubMed:16230460}.",,,,,,ACT_SITE 393 393 Phosphocysteine intermediate. {ECO:0000305}.,,,,,,cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; midbody [GO:0030496]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902]; cellular response to ATP [GO:0071318]; excitatory chemical synaptic transmission [GO:0098976]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron death [GO:1901216]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein dephosphorylation [GO:0006470]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cellular protein metabolic process [GO:0032268]; regulation of lamellipodium assembly [GO:0010591],actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902]; cellular response to ATP [GO:0071318]; excitatory chemical synaptic transmission [GO:0098976]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron death [GO:1901216]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein dephosphorylation [GO:0006470]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cellular protein metabolic process [GO:0032268]; regulation of lamellipodium assembly [GO:0010591],actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; midbody [GO:0030496]; plasma membrane [GO:0005886],GO:0000902; GO:0003779; GO:0004721; GO:0004725; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006470; GO:0008064; GO:0008138; GO:0010591; GO:0030027; GO:0030036; GO:0030426; GO:0030496; GO:0031915; GO:0032154; GO:0032268; GO:0050770; GO:0071318; GO:0098976; GO:1901216; GO:1904719; GO:1904754; GO:2000463,IPR014876; IPR000340; IPR024950; IPR029021; IPR027233; IPR016130; IPR000387; IPR020422; ,P23528; Q9BR76; P53667; P31946; P27348,"SUBUNIT: Interacts with actin and this stimulates phosphatase activity. Also interacts with LIMK1 and with the 14-3-3 proteins YWHAB, YWHAG, YWHAQ, and YWHAZ. Interaction with 14-3-3 proteins inhibits phosphatase activity and also blocks recruitment to lamellipodia and stimulation by actin. {ECO:0000269|PubMed:11832213, ECO:0000269|PubMed:14531860, ECO:0000269|PubMed:15159416, ECO:0000269|PubMed:15660133}.",11832213; 10718198; 14702039; 15489334; 14531860; 12807904; 12684437; 15056216; 14645219; 15159416; 15660133; 15671020; 16230460; 18669648; 19413330; 20068231; 23186163; 24275569,11832213; 10718198; 14702039; 15489334; 14531860; 12807904; 12684437; 15056216; 14645219; 15159416; 15660133; 15671020; 16230460; 18669648; 19413330; 20068231; 23186163; 24275569; 15459975; 16513117; 17350576; 17848544; 18096821; 18809681; 19329994; 19339277; 19371722; 19567672; 20477815; 21289500; 21525957; 21690039; 21888893; 22282498; 23247370; 23834120; 24039253; 24418541; 24670325; 24840177; 25100728; 25684665; 26496610; 27865840,2005-11-22,2019-02-13,2005-11-22,153,,,,,,,,,5 out of 5,Active site (1); Alternative sequence (9); Chain (1); Domain (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (7); Mutagenesis (4); Region (1); Sequence conflict (2),,,MISCELLANEOUS: Tyrosine phosphatase activity has not been demonstrated for this protein to date.,Acetylation;Actin-binding;Alternative splicing;Cell projection;Complete proteome;Cytoplasm;Cytoskeleton;Hydrolase;Phosphoprotein;Protein phosphatase;Reference proteome,Evidence at protein level,reviewed,,Protein-tyrosine phosphatase family,153,Alternative products (1); Catalytic activity (3); Caution (3); Function (1); Miscellaneous (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0007; KW-0009; KW-0025; KW-0181; KW-0206; KW-0378; KW-0597; KW-0904; KW-0963; KW-0966; KW-1185,,,,,,,,"PTM: Phosphorylated. Inhibitory phosphorylation by PAK4 promotes binding to YWHAZ. Phosphorylation at Ser-978 is decreased by stimuli which promote actin reorganization and lamellipodia formation. Can be dephosphorylated and activated by PPP3CA/calcineurin A. Phosphorylation decreases immediately prior to telophase. {ECO:0000269|PubMed:12807904, ECO:0000269|PubMed:15159416, ECO:0000269|PubMed:15660133, ECO:0000269|PubMed:15671020}.",CHAIN 2 1049 Protein phosphatase Slingshot homolog 1. /FTId=PRO_0000094841.,,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330}.,,MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330}.; MOD_RES 37 37 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 57 57 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 515 515 Phosphoserine. {ECO:0000250|UniProtKB:Q76I79}.; MOD_RES 576 576 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 897 897 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 978 978 Phosphoserine. {ECO:0000269|PubMed:15159416}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB072355;AB072356;AB072357;AB037719;AK095421;BC062341;
0,Q99829,CPNE1_HUMAN,CPNE1 CPN1,CPNE1,CPN1,,,Homo sapiens (Human),9606,Copine-1 (Chromobindin 17) (Copine I),UP000005640: Chromosome 20,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAHCVTLVQLSISCDHLIDKDIGSKSDPLCVLLQDVGGGSWAELGRTERVRNCSSPEFSKTLQLEYRFETVQKLRFGIYDIDNKTPELRDDDFLGGAECSLGQIVSSQVLTLPLMLKPGKPAGRGTITVSAQELKDNRVVTMEVEARNLDKKDFLGKSDPFLEFFRQGDGKWHLVYRSEVIKNNLNPTWKRFSVPVQHFCGGNPSTPIQVQCSDYDSDGSHDLIGTFHTSLAQLQAVPAEFECIHPEKQQKKKSYKNSGTIRVKICRVETEYSFLDYVMGGCQINFTVGVDFTGSNGDPSSPDSLHYLSPTGVNEYLMALWSVGSVVQDYDSDKLFPAFGFGAQVPPDWQVSHEFALNFNPSNPYCAGIQGIVDAYRQALPQVRLYGPTNFAPIINHVARFAAQAAHQGTASQYFMLLLLTDGAVTDVEATREAVVRASNLPMSVIIVGVGGADFEAMEQLDADGGPLHTRSGQAAARDIVQFVPYRRFQNAPREALAQTVLAEVPTQLVSYFRAQGWAPLKPLPPSAKDPAQAPQA,537,"59,059",,,,,,,,,,,,,VARIANT 211 211 Q -> R (in dbSNP:rs6579255). /FTId=VAR_024423.; VARIANT 347 347 P -> R (in dbSNP:rs12481228). /FTId=VAR_048846.; VARIANT 535 535 P -> L (in dbSNP:rs11543239). /FTId=VAR_048847.,,,,CONFLICT 332 339 SDKLFPAF -> NSARAARV (in Ref. 6; AAG49297). {ECO:0000305}.; CONFLICT 367 367 A -> V (in Ref. 2; CAG33071). {ECO:0000305}.,,1,,0,DOMAIN: C2 domains are necessary for calcium-dependent cell membrane association. C2 domains are necessary for neuronal progenitor cell differentiation in a calcium-independent manner (PubMed:25450385). {ECO:0000269|PubMed:25450385}.,SIMILARITY: Belongs to the copine family. {ECO:0000305}.,,,DOMAIN 1 98 C2 1. {ECO:0000255|PROSITE-ProRule:PRU00041}.; DOMAIN 144 228 C2 2. {ECO:0000255|PROSITE-ProRule:PRU00041}.; DOMAIN 285 505 VWFA. {ECO:0000255|PROSITE-ProRule:PRU00219}.,,,,,,,,,,"FUNCTION: Calcium-dependent phospholipid-binding protein that plays a role in calcium-mediated intracellular processes (PubMed:14674885). Involved in the TNF-alpha receptor signaling pathway in a calcium-dependent manner (PubMed:14674885). Exhibits calcium-dependent phospholipid binding properties (PubMed:9430674, PubMed:19539605). Plays a role in neuronal progenitor cell differentiation; induces neurite outgrowth via a AKT-dependent signaling cascade and calcium-independent manner (PubMed:23263657, PubMed:25450385). May recruit target proteins to the cell membrane in a calcium-dependent manner (PubMed:12522145). May function in membrane trafficking (PubMed:9430674). Involved in TNF-alpha-induced NF-kappa-B transcriptional repression by inducing endoprotease processing of the transcription factor NF-kappa-B p65/RELA subunit (PubMed:18212740). Also induces endoprotease processing of NF-kappa-B p50/NFKB1, p52/NFKB2, RELB and REL (PubMed:18212740). {ECO:0000269|PubMed:12522145, ECO:0000269|PubMed:14674885, ECO:0000269|PubMed:18212740, ECO:0000269|PubMed:19539605, ECO:0000269|PubMed:23263657, ECO:0000269|PubMed:25450385, ECO:0000269|PubMed:9430674}.",,,,,,,,,,,,azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; vesicle-mediated transport [GO:0016192],cellular response to calcium ion [GO:0071277]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; vesicle-mediated transport [GO:0016192],calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; transporter activity [GO:0005215],azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],GO:0001786; GO:0004175; GO:0005215; GO:0005509; GO:0005544; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0006629; GO:0010629; GO:0016020; GO:0016192; GO:0031965; GO:0035577; GO:0042803; GO:0043122; GO:0043312; GO:0043392; GO:0045666; GO:0046474; GO:0051059; GO:0051897; GO:0070062; GO:0071277; GO:1901223; GO:1903265; GO:1990138,IPR000008; IPR035892; IPR037768; IPR010734; IPR002035; IPR036465; ,,"SUBUNIT: Homodimer; homodimerizes via its C2 domains (PubMed:18212740). Interacts with p65/RELA (via N-terminus); this interaction induces proteolytic cleavage of p65/RELA subunit and inhibition of NF-kappa-B transcriptional activity (PubMed:18212740). Interacts (via VWFA domain) with ACTB, CCDC22, MYCBP2, PPP5C, RDX and UBE2O (PubMed:12522145). {ECO:0000269|PubMed:12522145, ECO:0000269|PubMed:18212740}.",9430674; 11780052; 15489334; 12522145; 12949241; 14674885; 18212740; 19539605; 19608861; 21087455; 21269460; 23263657; 25450385,9430674; 11780052; 15489334; 12522145; 12949241; 14674885; 18212740; 19539605; 19608861; 21087455; 21269460; 23263657; 25450385; 12440769; 15161933; 17620599; 19367725; 19615732; 19738201; 21988832; 23416715; 8692836,2000-12-01,2019-02-13,1997-05-01,164,,,,,,,,,5 out of 5,Chain (1); Domain (3); Modified residue (1); Mutagenesis (4); Natural variant (3); Sequence conflict (2),,TISSUE SPECIFICITY: Expressed in neutrophils (at protein level) (PubMed:12949241). Widely expressed. Expressed in the brain. Expressed in neutrophil precursors from bone marrow and peripheral blood (PubMed:12949241). {ECO:0000269|PubMed:12949241}.,,Acetylation;Cell membrane;Complete proteome;Cytoplasm;Differentiation;Membrane;Nucleus;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation,Evidence at protein level,reviewed,,Copine family,164,Domain (1); Function (1); Induction (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0007; KW-0181; KW-0221; KW-0472; KW-0539; KW-0621; KW-0677; KW-0678; KW-0804; KW-0805; KW-0963; KW-1003; KW-1185,,,,,,,,,CHAIN 1 537 Copine-1. /FTId=PRO_0000144834.,,,,,,MOD_RES 171 171 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U83246;CR456790;CH471077;CH471077;CH471077;CH471077;CH471077;CH471077;CH471077;CH471077;CH471077;CH471077;CH471077;CH471077;BC001142;AF314092;
0,Q99961,SH3G1_HUMAN,SH3GL1 CNSA1 SH3D2B,SH3GL1,CNSA1 SH3D2B,,,Homo sapiens (Human),9606,Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein) (EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1),UP000005640: Chromosome 19,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSVAGLKKQFYKASQLVSEKVGGAEGTKLDDDFKEMEKKVDVTSKAVTEVLARTIEYLQPNPASRAKLTMLNTVSKIRGQVKNPGYPQSEGLLGECMIRHGKELGGESNFGDALLDAGESMKRLAEVKDSLDIEVKQNFIDPLQNLCEKDLKEIQHHLKKLEGRRLDFDYKKKRQGKIPDEELRQALEKFEESKEVAETSMHNLLETDIEQVSQLSALVDAQLDYHRQAVQILDELAEKLKRRMREASSRPKREYKPKPREPFDLGEPEQSNGGFPCTTAPKIAASSSFRSSDKPIRTPSRSMPPLDQPSCKALYDFEPENDGELGFHEGDVITLTNQIDENWYEGMLDGQSGFFPLSYVEVLVPLPQ,368,"41,490",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=Q99961-1; Sequence=Displayed; Name=2; IsoId=Q99961-2; Sequence=VSP_045837; Note=No experimental confirmation available.; Name=3; IsoId=Q99961-3; Sequence=VSP_047037; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 63 110 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_045837.; VAR_SEQ 80 143 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_047037.,,,,,CONFLICT 316 316 D -> G (in Ref. 5; BAG61213). {ECO:0000305}.,,1,,0,"DOMAIN: An N-terminal amphipathic helix, the BAR domain and a second amphipathic helix inserted into helix 1 of the BAR domain (N-BAR domain) induce membrane curvature and bind curved membranes. {ECO:0000250}.",SIMILARITY: Belongs to the endophilin family. {ECO:0000305}.,COILED 145 250 {ECO:0000255}.,,DOMAIN 18 249 BAR. {ECO:0000255|PROSITE-ProRule:PRU00361}.; DOMAIN 306 365 SH3. {ECO:0000255|PROSITE-ProRule:PRU00192}.,,REGION 1 21 Membrane-binding amphipathic helix. {ECO:0000250}.; REGION 60 87 Required for dimerization upon membrane association. {ECO:0000250}.; REGION 218 254 Interaction with ARC. {ECO:0000250}.,,,,,,,,FUNCTION: Implicated in endocytosis. May recruit other proteins to membranes with high curvature (By similarity). {ECO:0000250}.,,,,,,,,,,,SITE 15 16 Breakpoint for translocation to form KMT2A/MLL1-EEN oncogene.,"cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; podosome [GO:0002102]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; beta-1 adrenergic receptor binding [GO:0031697]; cadherin binding [GO:0045296]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; lipid binding [GO:0008289]; phosphatase binding [GO:0019902]; protein C-terminus binding [GO:0008022]; SH3 domain binding [GO:0017124]; central nervous system development [GO:0007417]; modulation of excitatory postsynaptic potential [GO:0098815]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191]",central nervous system development [GO:0007417]; modulation of excitatory postsynaptic potential [GO:0098815]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191],beta-1 adrenergic receptor binding [GO:0031697]; cadherin binding [GO:0045296]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; lipid binding [GO:0008289]; phosphatase binding [GO:0019902]; protein C-terminus binding [GO:0008022]; SH3 domain binding [GO:0017124],"cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; podosome [GO:0002102]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]",GO:0002102; GO:0005737; GO:0005829; GO:0007165; GO:0007417; GO:0008022; GO:0008289; GO:0016191; GO:0017124; GO:0019902; GO:0030054; GO:0031697; GO:0031901; GO:0042802; GO:0042995; GO:0044325; GO:0045296; GO:0051020; GO:0098685; GO:0098686; GO:0098793; GO:0098815; GO:0098978; GO:0099092; GO:1900244,IPR027267; IPR004148; IPR028501; IPR035824; IPR036028; IPR001452; ,Itself; Q7L190; Q92917; Q9H788; Q99962; Q99963,"SUBUNIT: Interacts with ARC (By similarity). Interacts with SYNJ1 and DNM1. Interacts with PDCD6IP. Interacts with BIN2. {ECO:0000250, ECO:0000269|PubMed:10542231, ECO:0000269|PubMed:17350572, ECO:0000269|PubMed:23285027}.",9169142; 9122235; 14702039; 15057824; 15489334; 10542231; 17350572; 18088087; 18669648; 19413330; 20068231; 21269460; 21406692; 23285027; 23186163; 24275569,9169142; 9122235; 14702039; 15057824; 15489334; 10542231; 17350572; 18088087; 18669648; 19413330; 20068231; 21269460; 21406692; 23285027; 23186163; 24275569; 10535736; 10559861; 10559924; 10567358; 10625686; 10652316; 10764144; 10766823; 10953014; 11082044; 11231140; 11239472; 11470803; 11517213; 11532990; 11577110; 11889126; 11894095; 11894096; 11919637; 11988742; 12057195; 12072436; 12218189; 12551915; 12686592; 12717448; 12952949; 14551139; 14622578; 14622579; 14985334; 15077184; 15214844; 15252009; 15260957; 15318165; 15465819; 15502812; 15502813; 15649145; 15701692; 15703209; 15828871; 15895077; 15944398; 15962011; 16054026; 16103228; 16113677; 16115810; 16169070; 16189514; 16215232; 16326391; 16410077; 16516836; 16606361; 16798879; 16903783; 17018281; 17065230; 17158794; 17512409; 17540576; 17609109; 17681954; 17765681; 17978091; 18093523; 18388313; 18790740; 18981233; 19054389; 19060904; 19092055; 19109251; 19296720; 19458185; 19536138; 19575674; 19603039; 19696796; 19696798; 19814798; 20033059; 20059951; 20231386; 20428113; 20448150; 20562859; 20627007; 20711500; 20826345; 20946875; 2115402; 21187331; 21278753; 21316588; 21445324; 21482805; 21516116; 21613550; 21779028; 21841790; 21900206; 21927000; 21927001; 21962517; 21988832; 22099461; 22183150; 22233676; 22357968; 22360420; 22505844; 22750032; 22942912; 22998870; 23050879; 23297414; 23536704; 23823722; 23861397; 23891661; 23970061; 24186068; 24384571; 24581490; 24704450; 24746795; 24789820; 24828152; 24966051; 25107275; 25263444; 25341920; 25517096; 25784716; 25819436; 26042225; 26752685; 27220321; 27741419; 28702842; 28974266; 29113429; 6146630; 7877694; 8524399; 8552632; 9092476; 9100026; 9427626; 9428629; 9635431; 9723620; 9736607,2000-12-01,2019-02-13,1997-05-01,193,,,,,,,,,5 out of 5,Alternative sequence (2); Chain (1); Coiled coil (1); Domain (2); Modified residue (4); Region (3); Sequence conflict (1); Site (1),,"TISSUE SPECIFICITY: Ubiquitous. Higher expression in pancreas, placenta, prostate, testis and uterus.",,Alternative splicing;Cell junction;Cell projection;Chromosomal rearrangement;Coiled coil;Complete proteome;Cytoplasm;Endocytosis;Endosome;Lipid-binding;Membrane;Phosphoprotein;Proto-oncogene;Reference proteome;SH3 domain,Evidence at protein level,reviewed,,Endophilin family,193,Alternative products (1); Caution (2); Domain (1); Function (1); Involvement in disease (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0160; KW-0175; KW-0181; KW-0254; KW-0446; KW-0472; KW-0597; KW-0656; KW-0728; KW-0963; KW-0965; KW-0966; KW-0967; KW-1185,,,,,"DISEASE: Note=In some cases of acute leukemia, a translocation results in the formation of a KMT2A/MLL1-EEN fusion gene. {ECO:0000269|PubMed:9122235}.",,,,CHAIN 1 368 Endophilin-A2. /FTId=PRO_0000146744.,,,,,,"MOD_RES 288 288 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 292 292 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 298 298 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 315 315 Phosphotyrosine. {ECO:0000250|UniProtKB:Q62419}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X99656;U65999;AF190465;AK299166;BC001270;
0,Q9BV40,VAMP8_HUMAN,VAMP8,VAMP8,,,,Homo sapiens (Human),9606,Vesicle-associated membrane protein 8 (VAMP-8) (Endobrevin) (EDB),UP000005640: Chromosome 2,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MEEASEGGGNDRVRNLQSEVEGVKNIMTQNVERILARGENLEHLRNKTEDLEATSEHFKTTSQKVARKFWWKNVKMIVLICVIVFIIILFIVLFATGAFS,100,"11,438",,,,,,,,,,,,,,,,,CONFLICT 12 12 R -> L (in Ref. 1; AAC08434). {ECO:0000305}.; CONFLICT 81 81 C -> R (in Ref. 3; CAG33276). {ECO:0000305}.,,1,,0,,SIMILARITY: Belongs to the synaptobrevin family. {ECO:0000305}.,,,DOMAIN 12 72 v-SNARE coiled-coil homology. {ECO:0000255|PROSITE-ProRule:PRU00290}.,,,,,,,,,,"FUNCTION: SNAREs, soluble N-ethylmaleimide-sensitive factor-attachment protein receptors, are essential proteins for fusion of cellular membranes. SNAREs localized on opposing membranes assemble to form a trans-SNARE complex, an extended, parallel four alpha-helical bundle that drives membrane fusion. VAMP8 is a SNARE involved in autophagy through the direct control of autophagosome membrane fusion with the lysososome membrane via its interaction with the STX17-SNAP29 binary t-SNARE complex (PubMed:23217709, PubMed:25686604). Also required for dense-granule secretion in platelets (PubMed:12130530). Plays also a role in regulated enzyme secretion in pancreatic acinar cells (By similarity). Involved in the abscission of the midbody during cell division, which leads to completely separate daughter cells (By similarity). Involved in the homotypic fusion of early and late endosomes (By similarity). {ECO:0000250|UniProtKB:Q9WUF4, ECO:0000269|PubMed:12130530, ECO:0000269|PubMed:23217709, ECO:0000269|PubMed:25686604}.",,,,,,,,,,,SITE 33 33 Interaction with STX8. {ECO:0000250|UniProtKB:Q9WUF4}.,"azurophil granule membrane [GO:0035577]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mucin granule [GO:0098594]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; membrane organization [GO:0061024]; mucus secretion [GO:0070254]; negative regulation of secretion by cell [GO:1903531]; neutrophil degranulation [GO:0043312]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031]; regulation of protein localization to plasma membrane [GO:1903076]; viral entry into host cell [GO:0046718]","antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; membrane organization [GO:0061024]; mucus secretion [GO:0070254]; negative regulation of secretion by cell [GO:1903531]; neutrophil degranulation [GO:0043312]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031]; regulation of protein localization to plasma membrane [GO:1903076]; viral entry into host cell [GO:0046718]",chloride channel inhibitor activity [GO:0019869],azurophil granule membrane [GO:0035577]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mucin granule [GO:0098594]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982],GO:0002479; GO:0005737; GO:0005765; GO:0005769; GO:0005829; GO:0005886; GO:0015031; GO:0016020; GO:0016021; GO:0016240; GO:0019869; GO:0030665; GO:0030667; GO:0030670; GO:0031201; GO:0031901; GO:0031902; GO:0031982; GO:0035577; GO:0035579; GO:0043312; GO:0046718; GO:0048471; GO:0055037; GO:0055038; GO:0061024; GO:0070062; GO:0070254; GO:0070821; GO:0097352; GO:0098594; GO:1903076; GO:1903531; GO:1903595,IPR001388; IPR016444; ,O95721; P56962,"SUBUNIT: Forms a SNARE complex composed of VAMP8, SNAP29 and STX17 involved in fusion of autophagosome with lysosome (PubMed:25686604). Found in a number of SNARE complexes with NAPA, SNAP23, SNAP25, STX1A, STX4, STX7, STX8 and VTI1B (PubMed:12130530). Interacts with PICALM (By similarity). SNARE complex formation and binding by PICALM are mutually exclusive processes for VAMP8 (By similarity). Interacts with SBF2/MTMR13 (PubMed:25648148). Interacts with RAB21 (in GTP-bound form) in response to starvation; the interaction probably regulates VAMP8 endolysosomal trafficking (PubMed:25648148). {ECO:0000250|UniProtKB:O70404, ECO:0000269|PubMed:12130530, ECO:0000269|PubMed:25648148, ECO:0000269|PubMed:25686604}.",9614193; 15815621; 15489334; 12130530; 19413330; 21269460; 23217709; 23186163; 25648148; 25944712; 25686604,9614193; 15815621; 15489334; 12130530; 19413330; 21269460; 23217709; 23186163; 25648148; 25944712; 25686604; 10394364; 10436022; 10535736; 10542231; 10559861; 10559924; 10625686; 10766823; 11082044; 11231140; 11239472; 11470803; 11517213; 11532990; 11577110; 11604418; 11694590; 11889126; 11994746; 12057195; 12952949; 14622578; 14622579; 15252009; 15260957; 15318165; 15502812; 15502813; 15649145; 15703209; 15895077; 16103228; 16110299; 16155256; 16169070; 16195891; 16215232; 16326391; 16410077; 16516836; 16690874; 16798879; 16903783; 16984405; 17018281; 17116749; 17158794; 17512409; 17540576; 17609109; 17681954; 17765681; 17975119; 17978091; 17979178; 18073581; 18093523; 18253931; 18388313; 18570918; 18692471; 18790740; 18973100; 18981233; 19023099; 19092055; 19282863; 19296720; 19374688; 19458185; 19536138; 19557002; 19575674; 19603039; 19696796; 19738360; 19752551; 19913121; 19943878; 20033059; 20059951; 20089838; 20231386; 20428113; 20448150; 20533276; 20628086; 20706999; 20826345; 20877624; 20946875; 2115402; 21187331; 21278753; 21316588; 21445324; 21482805; 21486954; 21613550; 21674799; 21779028; 21841790; 21927000; 21927001; 21962517; 21988832; 22099461; 22118466; 22144578; 22192511; 22233676; 22505844; 22623428; 23297414; 23416715; 23536704; 23650620; 23823722; 23861397; 23891661; 24186068; 24494924; 24550300; 24581490; 24789820; 24966051; 25083866; 25107275; 25209430; 25341920; 26042225; 26124288; 26191281; 26359495; 26496610; 26638075; 6146630; 7877694; 8374173; 8524399; 8552632; 8670264; 8692836; 9092476; 9100026; 9427626; 9428629; 9635431; 9727496; 9736607,2004-11-23,2019-02-13,2001-06-01,155,X-ray crystallography (1),,HELIX 12 72 {ECO:0000244|PDB:4WY4}.,,,,TOPO_DOM 1 75 Cytoplasmic. {ECO:0000255}.; TOPO_DOM 97 100 Vesicular. {ECO:0000255}.,TRANSMEM 76 96 Helical; Anchor for type IV membrane protein. {ECO:0000255}.,5 out of 5,Chain (1); Domain (1); Helix (1); Modified residue (7); Sequence conflict (2); Site (1); Topological domain (2); Transmembrane (1),,TISSUE SPECIFICITY: Platelets. {ECO:0000269|PubMed:12130530}.,,3D-structure;Acetylation;Autophagy;Cell membrane;Coiled coil;Complete proteome;Direct protein sequencing;Endosome;Lysosome;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport,Evidence at protein level,reviewed,,Synaptobrevin family,155,Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0072; KW-0175; KW-0181; KW-0458; KW-0472; KW-0597; KW-0653; KW-0812; KW-0813; KW-0903; KW-0967; KW-1003; KW-1133; KW-1185,,,,,,,,,CHAIN 1 100 Vesicle-associated membrane protein 8. /FTId=PRO_0000206736.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:25944712}.; MOD_RES 5 5 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 18 18 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 28 28 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 48 48 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 54 54 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 55 55 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF053233;BT006700;CR456995;AC016753;BC001634;
0,Q9H3U1,UN45A_HUMAN,UNC45A SMAP1,UNC45A,SMAP1,,,Homo sapiens (Human),9606,Protein unc-45 homolog A (Unc-45A) (GCUNC-45) (Smooth muscle cell-associated protein 1) (SMAP-1),UP000005640: Chromosome 15,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MTVSGPGTPEPRPATPGASSVEQLRKEGNELFKCGDYGGALAAYTQALGLDATPQDQAVLHRNRAACHLKLEDYDKAETEASKAIEKDGGDVKALYRRSQALEKLGRLDQAVLDLQRCVSLEPKNKVFQEALRNIGGQIQEKVRYMSSTDAKVEQMFQILLDPEEKGTEKKQKASQNLVVLAREDAGAEKIFRSNGVQLLQRLLDMGETDLMLAALRTLVGICSEHQSRTVATLSILGTRRVVSILGVESQAVSLAACHLLQVMFDALKEGVKKGFRGKEGAIIVDPARELKVLISNLLDLLTEVGVSGQGRDNALTLLIKAVPRKSLKDPNNSLTLWVIDQGLKKILEVGGSLQDPPGELAVTANSRMSASILLSKLFDDLKCDAERENFHRLCENYIKSWFEGQGLAGKLRAIQTVSCLLQGPCDAGNRALELSGVMESVIALCASEQEEEQLVAVEALIHAAGKAKRASFITANGVSLLKDLYKCSEKDSIRIRALVGLCKLGSAGGTDFSMKQFAEGSTLKLAKQCRKWLCNDQIDAGTRRWAVEGLAYLTFDADVKEEFVEDAAALKALFQLSRLEERSVLFAVASALVNCTNSYDYEEPDPKMVELAKYAKQHVPEQHPKDKPSFVRARVKKLLAAGVVSAMVCMVKTESPVLTSSCRELLSRVFLALVEEVEDRGTVVAQGGGRALIPLALEGTDVGQTKAAQALAKLTITSNPEMTFPGERIYEVVRPLVSLLHLNCSGLQNFEALMALTNLAGISERLRQKILKEKAVPMIEGYMFEEHEMIRRAATECMCNLAMSKEVQDLFEAQGNDRLKLLVLYSGEDDELLQRAAAGGLAMLTSMRPTLCSRIPQVTTHWLEILQALLLSSNQELQHRGAVVVLNMVEASREIASTLMESEMMEILSVLAKGDHSPVTRAAAACLDKAVEYGLIQPNQDGE,944,"103,077",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; Synonyms=2, SMAP-1b; IsoId=Q9H3U1-1; Sequence=Displayed; Name=2; Synonyms=3; IsoId=Q9H3U1-2; Sequence=VSP_020585; Name=3; IsoId=Q9H3U1-3; Sequence=VSP_020584; ",,,,,,,,,,"VAR_SEQ 1 722 Missing (in isoform 3). {ECO:0000303|Ref.2}. /FTId=VSP_020584.; VAR_SEQ 1 17 MTVSGPGTPEPRPATPG -> MT (in isoform 2). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334, ECO:0000303|Ref.1, ECO:0000303|Ref.2}. /FTId=VSP_020585.",VARIANT 796 796 T -> M (in dbSNP:rs8041035). /FTId=VAR_052629.,,,,CONFLICT 921 921 T -> R (in Ref. 2; CAB93429). {ECO:0000305}.,,1,,0,,,,,,,,REPEAT 21 54 TPR 1.; REPEAT 58 91 TPR 2.; REPEAT 92 125 TPR 3.,,,,,,,"FUNCTION: Acts as co-chaperone for HSP90. Prevents the stimulation of HSP90AB1 ATPase activity by AHSA1. Positive factor in promoting PGR function in the cell. May be necessary for proper folding of myosin (Potential). Necessary for normal cell proliferation. Necessary for normal myotube formation and myosin accumulation during muscle cell development. May play a role in erythropoiesis in stroma cells in the spleen (By similarity). {ECO:0000250, ECO:0000269|PubMed:12119110, ECO:0000269|PubMed:16478993, ECO:0000305}.",,,,,,,,,,,,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; muscle organ development [GO:0007517],cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; muscle organ development [GO:0007517],cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471],GO:0005794; GO:0005829; GO:0007517; GO:0016607; GO:0030154; GO:0045296; GO:0048471; GO:0051879; GO:0061077,IPR011989; IPR016024; IPR013026; IPR011990; IPR019734; IPR024660; ,Q8NA82; P61244; P61244-2; P50222; Q9UJV3-2,"SUBUNIT: Interacts with PGR isoforms A and B as well as with NR3C1 in the absence of ligand, and with HSP90AB1. Binding to HSP90AB1 involves 2 UNC45A monomers per HSP90AB1 dimer. {ECO:0000269|PubMed:16478993}.",14702039; 15489334; 12119110; 18691976; 19413330; 19608861; 20068231; 21269460; 23186163; 24275569; 25944712; 16478993,14702039; 15489334; 12119110; 18691976; 19413330; 19608861; 20068231; 21269460; 23186163; 24275569; 25944712; 16478993; 15231748; 17353931; 19367725; 19615732; 19875381; 20467437; 20562859; 21182205; 22190034; 22575643; 22593156; 23455922; 25036637; 25416956; 26638075,2006-09-19,2019-02-13,2001-03-01,167,NMR spectroscopy (1),,HELIX 21 32 {ECO:0000244|PDB:2DBA}.; HELIX 37 48 {ECO:0000244|PDB:2DBA}.; HELIX 54 70 {ECO:0000244|PDB:2DBA}.; HELIX 74 87 {ECO:0000244|PDB:2DBA}.; HELIX 92 105 {ECO:0000244|PDB:2DBA}.; HELIX 108 121 {ECO:0000244|PDB:2DBA}.; HELIX 126 135 {ECO:0000244|PDB:2DBA}.,TURN 33 35 {ECO:0000244|PDB:2DBA}.,,,,,5 out of 5,Alternative sequence (2); Chain (1); Helix (7); Modified residue (3); Mutagenesis (4); Natural variant (1); Repeat (3); Sequence conflict (1); Turn (1),,"TISSUE SPECIFICITY: Detected in peripheral blood leukocytes, bone marrow, adrenal gland, trachea, spinal cord, thyroid, lymph node and stomach. {ECO:0000269|PubMed:12119110}.",,3D-structure;Acetylation;Alternative splicing;Chaperone;Complete proteome;Cytoplasm;Developmental protein;Differentiation;Myogenesis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;TPR repeat,Evidence at protein level,reviewed,,,167,Alternative products (1); Function (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0143; KW-0181; KW-0217; KW-0221; KW-0517; KW-0539; KW-0597; KW-0621; KW-0677; KW-0802; KW-0963; KW-1185,,,,,,,,,CHAIN 1 944 Protein unc-45 homolog A. /FTId=PRO_0000249888.,,,,,,"MOD_RES 15 15 Phosphothreonine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231}.; MOD_RES 70 70 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 483 483 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB014729;AB014736;AL357537;AL357538;AK291622;AK125721;CH471101;BC006214;BC010995;BC037992;BC045635;
0,Q9H4B7,TBB1_HUMAN,TUBB1,TUBB1,,,,Homo sapiens (Human),9606,Tubulin beta-1 chain,UP000005640: Chromosome 20,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MREIVHIQIGQCGNQIGAKFWEMIGEEHGIDLAGSDRGASALQLERISVYYNEAYGRKYVPRAVLVDLEPGTMDSIRSSKLGALFQPDSFVHGNSGAGNNWAKGHYTEGAELIENVLEVVRHESESCDCLQGFQIVHSLGGGTGSGMGTLLMNKIREEYPDRIMNSFSVMPSPKVSDTVVEPYNAVLSIHQLIENADACFCIDNEALYDICFRTLKLTTPTYGDLNHLVSLTMSGITTSLRFPGQLNADLRKLAVNMVPFPRLHFFMPGFAPLTAQGSQQYRALSVAELTQQMFDARNTMAACDLRRGRYLTVACIFRGKMSTKEVDQQLLSVQTRNSSCFVEWIPNNVKVAVCDIPPRGLSMAATFIGNNTAIQEIFNRVSEHFSAMFKRKAFVHWYTSEGMDINEFGEAENNIHDLVSEYQQFQDAKAVLEEDEEVTEEAEMEPEDKGH,451,"50,327",,,,,,,,,,,,,"VARIANT 43 43 Q -> H (in dbSNP:rs415064). /FTId=VAR_034542.; VARIANT 43 43 Q -> P (in dbSNP:rs463312). {ECO:0000269|PubMed:15956286, ECO:0000269|PubMed:18849486}. /FTId=VAR_034543.; VARIANT 274 274 T -> M (in dbSNP:rs35565630). /FTId=VAR_052671.; VARIANT 307 307 R -> H (in dbSNP:rs6070697). {ECO:0000269|PubMed:18849486}. /FTId=VAR_052672.; VARIANT 318 318 R -> W (in MAD-TUBB1; dbSNP:rs121918555). {ECO:0000269|PubMed:18849486}. /FTId=VAR_063411.",,,,,,1,,0,,SIMILARITY: Belongs to the tubulin family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain (By similarity). {ECO:0000250}.",,,,,,,,,,NP_BIND 140 146 GTP. {ECO:0000255}.,,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225],microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874],GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0051225; GO:0070062,IPR013838; IPR002453; IPR008280; IPR000217; IPR018316; IPR037103; IPR036525; IPR023123; IPR017975; IPR003008; ,,SUBUNIT: Dimer of alpha and beta chains. A typical microtubule is a hollow water-filled tube with an outer diameter of 25 nm and an inner diameter of 15 nM. Alpha-beta heterodimers associate head-to-tail to form protofilaments running lengthwise along the microtubule wall with the beta-tubulin subunit facing the microtubule plus end conferring a structural polarity. Microtubules usually have 13 protofilaments but different protofilament numbers can be found in some organisms and specialized cells. Interacts with RANBP10. {ECO:0000269|PubMed:18347012}.,11780052; 15489334; 12665801; 16371510; 18347012; 19524510; 20191564; 26875866; 15956286; 18849486,11780052; 15489334; 12665801; 16371510; 18347012; 19524510; 20191564; 26875866; 15956286; 18849486; 10036229; 10069812; 10209023; 10559986; 10562278; 10679020; 10747093; 10804209; 10831612; 10903204; 11035033; 11081627; 11285137; 11285270; 11306556; 11461920; 11483508; 11493604; 11509732; 11739780; 11956313; 12024216; 12110184; 12149451; 12194817; 12198549; 12368902; 12401177; 12447383; 12577316; 12832475; 12840015; 14504276; 14603322; 14730319; 15029241; 15033576; 15085137; 15161933; 1520276; 15231740; 15269286; 15272311; 15315966; 15326200; 15339662; 15483056; 15489852; 15591061; 15632110; 15723797; 15728195; 15737063; 15878873; 15890843; 15930098; 16049494; 16061793; 1607388; 16229832; 16254602; 16262723; 16311594; 16492809; 16493421; 16541025; 16571679; 16616141; 16622419; 16622420; 16723730; 16782012; 16810318; 16901895; 17027958; 17030981; 17084703; 17113389; 17129783; 17139257; 17244817; 17244818; 17274799; 17283181; 17312020; 17360631; 17373842; 17488662; 17499049; 17553904; 17574030; 17827179; 17993481; 18046453; 18086915; 18097444; 18180281; 18237546; 18304522; 18327258; 18331838; 18455992; 18664496; 18716626; 18852297; 19000668; 19081074; 19116309; 19132255; 19147001; 19369418; 19384852; 19388931; 19450523; 19486527; 19531357; 19549984; 19564404; 19592253; 19666503; 19720863; 19758564; 19767740; 19776033; 19805454; 19805633; 19823565; 19877275; 19965387; 19996169; 19996274; 20005805; 20038533; 20067783; 20136777; 20154143; 20395968; 20462495; 20467437; 20519502; 20526328; 20530210; 20532885; 20534429; 20562859; 20603001; 20740604; 20829795; 20889716; 20956384; 21068373; 21074048; 21209331; 21384078; 21397845; 2142332; 21427764; 21550981; 21878504; 21936775; 21987589; 22013193; 22118932; 22360420; 22805305; 22885700; 22922713; 22992454; 23236459; 23358242; 23386615; 23606334; 23783758; 23823123; 23839779; 23945166; 23990561; 24097348; 24275654; 24296415; 24339784; 24344610; 24596149; 24616010; 24806965; 24891604; 24894670; 24906155; 24952464; 25036637; 25103237; 25205765; 2521221; 2522352; 25233431; 25364732; 25443296; 25453831; 25468068; 25529050; 25609649; 25957412; 26540125; 26743950; 29044293; 7452228; 7691276; 7844144; 7909354; 7929562; 8096061; 8104191; 8516294; 8522608; 8602245; 8642258; 8909537; 8991093; 9114011; 9150144; 9153422; 9265649; 9288971; 9323141; 9380700; 9427680; 9490716; 9585416; 9585417; 9630229; 9671725; 9852153,2005-02-01,2019-02-13,2001-03-01,154,,,,,,,,,5 out of 5,Chain (1); Modified residue (2); Natural variant (5); Nucleotide binding (1),,"TISSUE SPECIFICITY: Hematopoietic cell-specific. Major isotype in leukocytes, where it represents 50% of all beta-tubulins. {ECO:0000269|PubMed:20191564}.",,Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;GTP-binding;Isopeptide bond;Microtubule;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,Tubulin family,154,Function (1); Involvement in disease (1); Post-translational modification (3); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0181; KW-0206; KW-0225; KW-0342; KW-0493; KW-0547; KW-0597; KW-0621; KW-0903; KW-0963; KW-1017; KW-1185,,,,,"DISEASE: Macrothrombocytopenia, autosomal dominant, TUBB1-related (MAD-TUBB1) [MIM:613112]: A congenital blood disorder characterized by increased platelet size and decreased number of circulating platelets. {ECO:0000269|PubMed:18849486}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Some glutamate residues at the C-terminus are polyglutamylated, resulting in polyglutamate chains on the gamma-carboxyl group (PubMed:26875866). Polyglutamylation plays a key role in microtubule severing by spastin (SPAST). SPAST preferentially recognizes and acts on microtubules decorated with short polyglutamate tails: severing activity by SPAST increases as the number of glutamates per tubulin rises from one to eight, but decreases beyond this glutamylation threshold (PubMed:26875866). {ECO:0000269|PubMed:26875866}.; PTM: Some glutamate residues at the C-terminus are monoglycylated but not polyglycylated due to the absence of functional TTLL10 in human. Monoglycylation is mainly limited to tubulin incorporated into axonemes (cilia and flagella). Both polyglutamylation and monoglycylation can coexist on the same protein on adjacent residues, and lowering glycylation levels increases polyglutamylation, and reciprocally. The precise function of monoglycylation is still unclear (Probable). {ECO:0000305|PubMed:19524510}.; PTM: Phosphorylated on Ser-172 by CDK1 during the cell cycle, from metaphase to telophase, but not in interphase. This phosphorylation inhibits tubulin incorporation into microtubules. {ECO:0000269|PubMed:16371510}.",CHAIN 1 451 Tubulin beta-1 chain. /FTId=PRO_0000048242.,,,,,,MOD_RES 172 172 Phosphoserine; by CDK1. {ECO:0000269|PubMed:16371510}.; MOD_RES 440 440 5-glutamyl polyglutamate. {ECO:0000250|UniProtKB:Q2T9S0}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AJ292757;BC033679;
0,Q9H8V3,ECT2_HUMAN,ECT2,ECT2,,,,Homo sapiens (Human),9606,Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene),UP000005640: Chromosome 3,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAENSVLTSTTGRTSLADSSIFDSKVTEISKENLLIGSTSYVEEEMPQIETRVILVQEAGKQEELIKALKTIKIMEVPVIKIKESCPGKSDEKLIKSVINMDIKVGFVKMESVEEFEGLDSPEFENVFVVTDFQDSVFNDLYKADCRVIGPPVVLNCSQKGEPLPFSCRPLYCTSMMNLVLCFTGFRKKEELVRLVTLVHHMGGVIRKDFNSKVTHLVANCTQGEKFRVAVSLGTPIMKPEWIYKAWERRNEQDFYAAVDDFRNEFKVPPFQDCILSFLGFSDEEKTNMEEMTEMQGGKYLPLGDERCTHLVVEENIVKDLPFEPSKKLYVVKQEWFWGSIQMDARAGETMYLYEKANTPELKKSVSMLSLNTPNSNRKRRRLKETLAQLSRETDVSPFPPRKRPSAEHSLSIGSLLDISNTPESSINYGDTPKSCTKSSKSSTPVPSKQSARWQVAKELYQTESNYVNILATIIQLFQVPLEEEGQRGGPILAPEEIKTIFGSIPDIFDVHTKIKDDLEDLIVNWDESKSIGDIFLKYSKDLVKTYPPFVNFFEMSKETIIKCEKQKPRFHAFLKINQAKPECGRQSLVELLIRPVQRLPSVALLLNDLKKHTADENPDKSTLEKAIGSLKEVMTHINEDKRKTEAQKQIFDVVYEVDGCPANLLSSHRSLVQRVETISLGEHPCDRGEQVTLFLFNDCLEIARKRHKVIGTFRSPHGQTRPPASLKHIHLMPLSQIKKVLDIRETEDCHNAFALLVRPPTEQANVLLSFQMTSDELPKENWLKMLCRHVANTICKADAENLIYTADPESFEVNTKDMDSTLSRASRAIKKTSKKVTRAFSFSKTPKRALRRALMTSHGSVEGRSPSSNDKHVMSRLSSTSSLAGIPSPSLVSLPSFFERRSHTLSRSTTHLI,914,"103,505",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1; IsoId=Q9H8V3-1; Sequence=Displayed; Name=2; IsoId=Q9H8V3-2; Sequence=VSP_041976, VSP_041977; Name=3; IsoId=Q9H8V3-3; Sequence=VSP_041978; Note=May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. No experimental confirmation available.; Name=4; IsoId=Q9H8V3-4; Sequence=VSP_041977; ",,SEQUENCE CAUTION:  Sequence=BAA91624.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 44 44 Missing (in isoform 2). {ECO:0000303|PubMed:10579713, ECO:0000303|PubMed:14587037, ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334}. /FTId=VSP_041976.; VAR_SEQ 71 101 Missing (in isoform 2 and isoform 4). {ECO:0000303|PubMed:10579713, ECO:0000303|PubMed:14587037, ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334}. /FTId=VSP_041977.; VAR_SEQ 886 914 GIPSPSLVSLPSFFERRSHTLSRSTTHLI -> ITHSVSTSNVIGFTKHVYVQRLNSTGGRSQYSWFQSVRHSAFRASFSEILEGNTDFSNFKKVLSKSSLTFVKN (in isoform 3). {ECO:0000303|PubMed:17974005}. /FTId=VSP_041978.",VARIANT 15 15 S -> T (in dbSNP:rs34703432). /FTId=VAR_047064.; VARIANT 833 833 T -> P (in a breast cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_035975.,,,,CONFLICT 66 66 I -> T (in Ref. 5; BAB14498). {ECO:0000305}.; CONFLICT 276 276 L -> F (in Ref. 5; BAB14498). {ECO:0000305}.; CONFLICT 393 393 E -> D (in Ref. 5; BAB14498). {ECO:0000305}.,,4,,0,"DOMAIN: The BRCT domain 1 and 2 are required for the intramolecular interaction, but not for the intermolecular oligomerization. The BRCT domains negatively inhibit its GEF activity in interphase cells. The same BRCT domains may act as a positive regulatory motif for the completion of cytokinesis after the breakdown of nuclear membrane during mitosis.",,,,DOMAIN 171 260 BRCT 1. {ECO:0000255|PROSITE-ProRule:PRU00033}.; DOMAIN 266 354 BRCT 2. {ECO:0000255|PROSITE-ProRule:PRU00033}.; DOMAIN 452 641 DH. {ECO:0000255|PROSITE-ProRule:PRU00062}.; DOMAIN 675 794 PH.,MOTIF 378 382 Nuclear localization signal.; MOTIF 401 405 Nuclear localization signal.,,,,,,,,,"FUNCTION: Guanine nucleotide exchange factor (GEF) that catalyzes the exchange of GDP for GTP. Promotes guanine nucleotide exchange on the Rho family members of small GTPases, like RHOA, RHOC, RAC1 and CDC42. Required for signal transduction pathways involved in the regulation of cytokinesis. Component of the centralspindlin complex that serves as a microtubule-dependent and Rho-mediated signaling required for the myosin contractile ring formation during the cell cycle cytokinesis. Regulates the translocation of RHOA from the central spindle to the equatorial region. Plays a role in the control of mitotic spindle assembly; regulates the activation of CDC42 in metaphase for the process of spindle fibers attachment to kinetochores before chromosome congression. Involved in the regulation of epithelial cell polarity; participates in the formation of epithelial tight junctions in a polarity complex PARD3-PARD6-protein kinase PRKCQ-dependent manner. Plays a role in the regulation of neurite outgrowth. Inhibits phenobarbital (PB)-induced NR1I3 nuclear translocation. Stimulates the activity of RAC1 through its association with the oncogenic PARD6A-PRKCI complex in cancer cells, thereby acting to coordinately drive tumor cell proliferation and invasion. Also stimulates genotoxic stress-induced RHOB activity in breast cancer cells leading to their cell death. {ECO:0000269|PubMed:10579713, ECO:0000269|PubMed:14645260, ECO:0000269|PubMed:15254234, ECO:0000269|PubMed:15545273, ECO:0000269|PubMed:15642749, ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:16170345, ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:16495035, ECO:0000269|PubMed:19129481, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:19617897, ECO:0000269|PubMed:21189248, ECO:0000269|PubMed:21373644}.",,,,,,,,,,,,"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]","activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]",GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; Rho guanyl-nucleotide exchange factor activity [GO:0005089],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634],GO:0000281; GO:0000902; GO:0005085; GO:0005089; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005911; GO:0005923; GO:0007186; GO:0015031; GO:0030496; GO:0032147; GO:0032154; GO:0032467; GO:0035023; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431,IPR001357; IPR036420; IPR035899; IPR000219; IPR026817; IPR001331; IPR011993; ,P12830; P35221; Q02241; P16333; O00444; Q9H0H5,"SUBUNIT: Interacts with NR1I3 (By similarity). Homodimer. Homooligomer. Found in the centralspindlin complex. Interacts (Thr-359 phosphorylated form) with PARD6A; the interaction is observed in cancer cells. Interacts (Thr-359 phosphorylated form) with PRKCI; the interaction is observed in cancer cells. Interacts with PKP4; the interaction is observed at the midbody. Interacts with RACGAP1; the interaction is direct, occurs in a microtubule-dependent manner, is inhibited in metaphase by phosphorylation of ECT2 on Thr-373 and is stimulated in early anaphase by dephosphorylation of ECT2 probably on Thr-373 through CDK1 activity. Interacts with PLK1; the interaction is stimulated upon its phosphorylation on Thr-444. Associates with RACGAP1 at anaphase and during cytokinesis. Interacts with KIF23, PARD3, PARD6A, PARD6B and PRKCQ. {ECO:0000250, ECO:0000269|PubMed:15254234, ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:16129829, ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:16247472, ECO:0000269|PubMed:17115030, ECO:0000269|PubMed:18511905, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:19468302, ECO:0000269|PubMed:19617897}.",10579713; 14587037; 17115030; 14702039; 16641997; 15489334; 17974005; 14645260; 15254234; 15545273; 15642749; 16103226; 16129829; 16495035; 16236794; 16170345; 16247472; 18511905; 18220336; 18669648; 19129481; 19617897; 19468300; 19468302; 19690332; 20068231; 21189248; 21373644; 21406692; 22814378; 23186163; 28112733; 16959974,10579713; 14587037; 17115030; 14702039; 16641997; 15489334; 17974005; 14645260; 15254234; 15545273; 15642749; 16103226; 16129829; 16495035; 16236794; 16170345; 16247472; 18511905; 18220336; 18669648; 19129481; 19617897; 19468300; 19468302; 19690332; 20068231; 21189248; 21373644; 21406692; 22814378; 23186163; 28112733; 16959974; 10559246; 11756498; 12101119; 16118207; 16212495; 16352658; 16778203; 16803869; 16862181; 17353931; 17474147; 17488623; 17688947; 17942602; 18201571; 18642445; 18842503; 19008376; 19015243; 19118053; 20360068; 20467437; 20734064; 21124766; 21474972; 21886810; 22172673; 22514687; 22552385; 22683310; 22898780; 23414517; 23601845; 23851435; 24198276; 24484057; 24784921; 25068414; 25237947; 25486481; 25486482; 25609649; 25617497; 25674238; 26211594; 26496610; 26638075; 26993610; 27106762; 27231202; 27926870; 28012134; 28110998; 28362321; 28654632; 28794404; 29051317; 29088286; 7478592; 7954831; 8276860; 8810315; 8969170; 9308960; 9857026,2001-09-26,2019-02-13,2011-11-16,159,X-ray crystallography (2),STRAND 51 56 {ECO:0000244|PDB:4N40}.; STRAND 107 112 {ECO:0000244|PDB:4N40}.; STRAND 124 129 {ECO:0000244|PDB:4N40}.; STRAND 147 149 {ECO:0000244|PDB:4N40}.; STRAND 183 185 {ECO:0000244|PDB:4N40}.; STRAND 218 220 {ECO:0000244|PDB:4N40}.; STRAND 278 280 {ECO:0000244|PDB:3L46}.; STRAND 309 313 {ECO:0000244|PDB:3L46}.; STRAND 318 320 {ECO:0000244|PDB:3L46}.; STRAND 330 333 {ECO:0000244|PDB:3L46}.,HELIX 57 59 {ECO:0000244|PDB:4N40}.; HELIX 63 70 {ECO:0000244|PDB:4N40}.; HELIX 115 119 {ECO:0000244|PDB:4N40}.; HELIX 136 143 {ECO:0000244|PDB:4N40}.; HELIX 151 159 {ECO:0000244|PDB:4N40}.; HELIX 189 200 {ECO:0000244|PDB:4N40}.; HELIX 225 233 {ECO:0000244|PDB:4N40}.; HELIX 241 247 {ECO:0000244|PDB:4N40}.; HELIX 260 266 {ECO:0000244|PDB:4N40}.; HELIX 283 295 {ECO:0000244|PDB:3L46}.; HELIX 334 343 {ECO:0000244|PDB:3L46}.; HELIX 349 351 {ECO:0000244|PDB:3L46}.,TURN 175 178 {ECO:0000244|PDB:4N40}.; TURN 201 203 {ECO:0000244|PDB:4N40}.; TURN 248 251 {ECO:0000244|PDB:4N40}.; TURN 270 273 {ECO:0000244|PDB:3L46}.; TURN 315 317 {ECO:0000244|PDB:3L46}.,,,,,5 out of 5,Alternative sequence (3); Beta strand (10); Chain (1); Cross-link (1); Domain (4); Erroneous initiation (1); Helix (12); Initiator methionine (1); Modified residue (12); Motif (2); Mutagenesis (12); Natural variant (2); Sequence conflict (3); Turn (5),,"TISSUE SPECIFICITY: Expressed in lung epithelial cells (at protein level). Expressed in squamous cell carcinoma, primary non-small cell lung cancer tumors and lung adenocarcinoma. {ECO:0000269|PubMed:19617897}.",,3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Cell junction;Complete proteome;Cytoplasm;Cytoskeleton;Differentiation;Guanine-nucleotide releasing factor;Isopeptide bond;Neurogenesis;Nucleus;Oncogene;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Repeat;Tight junction;Transport;Ubl conjugation,Evidence at protein level,reviewed,,,159,Alternative products (1); Caution (1); Domain (1); Function (1); Induction (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0131; KW-0132; KW-0181; KW-0206; KW-0221; KW-0344; KW-0524; KW-0539; KW-0553; KW-0597; KW-0621; KW-0653; KW-0677; KW-0796; KW-0813; KW-0832; KW-0963; KW-0965; KW-1017; KW-1185,,,,,,,,"PTM: Phosphorylated by PLK1 in vitro. Hyperphosphorylated during the G2 phase of the cell cycle. Phosphorylation at Thr-373 occurs during the G2/M phase, relieves its auto-inhibition status and stimulates its GEF activity. Phosphorylation at Thr-444 in G2/M phase is required for subsequent binding with PLK1 and Rho exchange activation. Dephosphorylated at the time of cytokinesis. Phosphorylation at Thr-359 is required for its transformation activity in cancer cells. {ECO:0000269|PubMed:10579713, ECO:0000269|PubMed:16170345, ECO:0000269|PubMed:16247472, ECO:0000269|PubMed:21189248}.",CHAIN 2 914 Protein ECT2. /FTId=PRO_0000080938.,CROSSLNK 611 611 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378}.,,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378}.; MOD_RES 359 359 Phosphothreonine; by PKC/PRKCI. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:21189248}.; MOD_RES 367 367 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 370 370 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 373 373 Phosphothreonine; by CDK1. {ECO:0000244|PubMed:18669648, ECO:0000269|PubMed:16170345}.; MOD_RES 376 376 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 444 444 Phosphothreonine; by CDK1. {ECO:0000269|PubMed:16247472}.; MOD_RES 716 716 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 842 842 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 846 846 Phosphothreonine; by CDK1. {ECO:0000244|PubMed:18669648}.; MOD_RES 861 861 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 866 866 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AY376439;DQ847274;AK001323;AK023267;AK314581;BC112086;AL137710;
0,Q9HCD5,NCOA5_HUMAN,NCOA5 KIAA1637,NCOA5,KIAA1637,,,Homo sapiens (Human),9606,Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA),UP000005640: Chromosome 20,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MNTAPSRPSPTRRDPYGFGDSRDSRRDRSPIRGSPRREPRDGRNGRDARDSRDIRDPRDLRDHRHSRDLRDHRDSRSVRDVRDVRDLRDFRDLRDSRDFRDQRDPMYDRYRDMRDSRDPMYRREGSYDRYLRMDDYCRRKDDSYFDRYRDSFDGRGPPGPESQSRAKERLKREERRREELYRQYFEEIQRRFDAERPVDCSVIVVNKQTKDYAESVGRKVRDLGMVVDLIFLNTEVSLSQALEDVSRGGSPFAIVITQQHQIHRSCTVNIMFGTPQEHRNMPQADAMVLVARNYERYKNECREKEREEIARQAAKMADEAILQERERGGPEEGVRGGHPPAIQSLINLLADNRYLTAEETDKIINYLRERKERLMRSSTDSLPGPISRQPLGATSGASLKTQPSSQPLQSGQVLPSATPTPSAPPTSQQELQAKILSLFNSGTVTANSSSASPSVAAGNTPNQNFSTAANSQPQQRSQASGNQPPSILGQGGSAQNMGPRPGAPSQGLFGQPSSRLAPASNMTSQRPVSSTGINFDNPSVQKALDTLIQSGPALSHLVSQTTAQMGQPQAPMGSYQRHY,579,"65,536",,,,SEQUENCE CAUTION:  Sequence=AAG36793.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,,VARIANT 326 326 E -> G (in dbSNP:rs11549557). /FTId=VAR_053530.,,,,,,2,,0,DOMAIN: Contains one Leu-Xaa-Xaa-Leu-Leu (LxxLL) motif that is essential for the association with nuclear receptors.,,,COMPBIAS 7 150 Arg/Asp-rich (mixed charge).,,MOTIF 345 349 LXXLL motif.,REGION 1 158 Transcription repression.; REGION 458 579 Transcription activation.,,,,,,,,"FUNCTION: Nuclear receptor coregulator that can have both coactivator and corepressor functions. Interacts with nuclear receptors for steroids (ESR1 and ESR2) independently of the steroid binding domain (AF-2) of the ESR receptors, and with the orphan nuclear receptor NR1D2. Involved in the coactivation of nuclear steroid receptors (ER) as well as the corepression of MYC in response to 17-beta-estradiol (E2). {ECO:0000269|PubMed:15073177}.",,,,,,,,,,,,actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627],glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627],chromatin binding [GO:0003682]; RNA binding [GO:0003723],actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleus [GO:0005634],GO:0003682; GO:0003723; GO:0005615; GO:0005634; GO:0015629; GO:0042593; GO:0046627,IPR036621,Q60674,"SUBUNIT: Binds HTATIP2/TIP30. Interacts with YLPM1. Forms a complex with ILF2, ILF3, YLPM1, KHDRBS1, RBMX and PPP1CA. {ECO:0000269|PubMed:11113208, ECO:0000269|PubMed:15073177, ECO:0000269|PubMed:17890166}.",11113208; 15073177; 11780052; 15489334; 10997877; 12168954; 17081983; 17890166; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; ,11113208; 15073177; 11780052; 15489334; 10997877; 12168954; 17081983; 17890166; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 20562859; 20650312; 20711500; 21516116; 21645569; 21900206; 24332041; 25416054; 25665578; 26496610; 26638075; 27847318; 29626478,2003-02-12,2019-02-13,2003-02-12,147,X-ray crystallography (3); NMR spectroscopy (1),STRAND 200 207 {ECO:0000244|PDB:1V95}.; STRAND 227 231 {ECO:0000244|PDB:1V95}.; STRAND 251 256 {ECO:0000244|PDB:1V95}.; STRAND 265 270 {ECO:0000244|PDB:1V95}.; STRAND 272 274 {ECO:0000244|PDB:1V95}.; STRAND 277 282 {ECO:0000244|PDB:1V95}.; STRAND 304 306 {ECO:0000244|PDB:1V95}.,HELIX 208 210 {ECO:0000244|PDB:1V95}.; HELIX 211 221 {ECO:0000244|PDB:1V95}.; HELIX 238 248 {ECO:0000244|PDB:1V95}.; HELIX 258 263 {ECO:0000244|PDB:1V95}.; HELIX 283 302 {ECO:0000244|PDB:1V95}.; HELIX 345 350 {ECO:0000244|PDB:2J7Y}.,TURN 222 224 {ECO:0000244|PDB:1V95}.,,,,,5 out of 5,Beta strand (7); Chain (1); Compositional bias (1); Erroneous initiation (1); Helix (6); Modified residue (16); Motif (1); Mutagenesis (2); Natural variant (1); Region (2); Turn (1),,TISSUE SPECIFICITY: Widely expressed.,,3D-structure;Acetylation;Activator;Complete proteome;Direct protein sequencing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation,Evidence at protein level,reviewed,,,147,Domain (1); Function (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0010; KW-0181; KW-0539; KW-0597; KW-0621; KW-0678; KW-0804; KW-0805; KW-0903; KW-1185,,,,,,,,,CHAIN 1 579 Nuclear receptor coactivator 5. /FTId=PRO_0000094411.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 3 3 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 9 9 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 21 21 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 24 24 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 29 29 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 34 34 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 96 96 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 116 116 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 126 126 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 143 143 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 151 151 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:23186163}.; MOD_RES 274 274 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 378 378 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 379 379 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 381 381 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF230533;AF470686;CH471077;CH471077;BC140836;BC151133;AB046857;
0,Q9NQ66,PLCB1_HUMAN,PLCB1 KIAA0581,PLCB1,KIAA0581,,,Homo sapiens (Human),9606,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I) (PLC-I) (Phospholipase C-beta-1) (PLC-beta-1)",UP000005640: Chromosome 20,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAGAQPGVHALQLKPVCVSDSLKKGTKFVKWDDDSTIVTPIILRTDPQGFFFYWTDQNKETELLDLSLVKDARCGRHAKAPKDPKLRELLDVGNIGRLEQRMITVVYGPDLVNISHLNLVAFQEEVAKEWTNEVFSLATNLLAQNMSRDAFLEKAYTKLKLQVTPEGRIPLKNIYRLFSADRKRVETALEACSLPSSRNDSIPQEDFTPEVYRVFLNNLCPRPEIDNIFSEFGAKSKPYLTVDQMMDFINLKQRDPRLNEILYPPLKQEQVQVLIEKYEPNNSLARKGQISVDGFMRYLSGEENGVVSPEKLDLNEDMSQPLSHYFINSSHNTYLTAGQLAGNSSVEMYRQVLLSGCRCVELDCWKGRTAEEEPVITHGFTMTTEISFKEVIEAIAECAFKTSPFPILLSFENHVDSPKQQAKMAEYCRLIFGDALLMEPLEKYPLESGVPLPSPMDLMYKILVKNKKKSHKSSEGSGKKKLSEQASNTYSDSSSMFEPSSPGAGEADTESDDDDDDDDCKKSSMDEGTAGSEAMATEEMSNLVNYIQPVKFESFEISKKRNKSFEMSSFVETKGLEQLTKSPVEFVEYNKMQLSRIYPKGTRVDSSNYMPQLFWNAGCQMVALNFQTMDLAMQINMGMYEYNGKSGYRLKPEFMRRPDKHFDPFTEGIVDGIVANTLSVKIISGQFLSDKKVGTYVEVDMFGLPVDTRRKAFKTKTSQGNAVNPVWEEEPIVFKKVVLPTLACLRIAVYEEGGKFIGHRILPVQAIRPGYHYICLRNERNQPLTLPAVFVYIEVKDYVPDTYADVIEALSNPIRYVNLMEQRAKQLAALTLEDEEEVKKEADPGETPSEAPSEARTTPAENGVNHTTTLTPKPPSQALHSQPAPGSVKAPAKTEDLIQSVLTEVEAQTIEELKQQKSFVKLQKKHYKEMKDLVKRHHKKTTDLIKEHTTKYNEIQNDYLRRRAALEKSAKKDSKKKSEPSSPDHGSSTIEQDLAALDAEMTQKLIDLKDKQQQQLLNLRQEQYYSEKYQKREHIKLLIQKLTDVAEECQNNQLKKLKEICEKEKKELKKKMDKKRQEKITEAKSKDKSQMEEEKTEMIRSYIQEVVQYIKRLEEAQSKRQEKLVEKHKEIRQQILDEKPKLQVELEQEYQDKFKRLPLEILEFVQEAMKGKISEDSNHGSAPLSLSSDPGKVNHKTPSSEELGGDIPGKEFDTPL,1216,"138,567",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=A; IsoId=Q9NQ66-1; Sequence=Displayed; Name=B; IsoId=Q9NQ66-2; Sequence=VSP_004718; ,,SEQUENCE CAUTION:  Sequence=BAA25507.3; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};  Sequence=BAB14641.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 1142 1216 LQVELEQEYQDKFKRLPLEILEFVQEAMKGKISEDSNHGSAPLSLSSDPGKVNHKTPSSEELGGDIPGKEFDTPL -> GEGSSSFLSETCHEDPSVSPNFTPPNPQALKW (in isoform B). {ECO:0000303|PubMed:11118617, ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005}. /FTId=VSP_004718.",VARIANT 854 854 E -> K (in dbSNP:rs2076413). /FTId=VAR_050541.; VARIANT 907 907 A -> P (in a breast cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036547.,,,,CONFLICT 1 34 MAGAQPGVHALQLKPVCVSDSLKKGTKFVKWDDD -> MGSLQGIATKILIRILSDALIRKETDLKS (in Ref. 2; AAF86613). {ECO:0000305}.; CONFLICT 189 189 L -> M (in Ref. 2; AAF86613). {ECO:0000305}.; CONFLICT 203 203 P -> L (in Ref. 2; AAF86613). {ECO:0000305}.; CONFLICT 216 216 L -> F (in Ref. 2; AAF86613). {ECO:0000305}.; CONFLICT 221 221 P -> L (in Ref. 2; AAF86613). {ECO:0000305}.; CONFLICT 266 266 L -> P (in Ref. 2; AAF86613). {ECO:0000305}.; CONFLICT 309 309 P -> T (in Ref. 2; AAF86613). {ECO:0000305}.; CONFLICT 320 320 Q -> R (in Ref. 2; AAF86613). {ECO:0000305}.; CONFLICT 352 352 V -> A (in Ref. 2; AAF86613). {ECO:0000305}.; CONFLICT 366 366 K -> R (in Ref. 2; AAF86613). {ECO:0000305}.; CONFLICT 393 393 E -> K (in Ref. 2; AAF86613). {ECO:0000305}.; CONFLICT 983 983 P -> S (in Ref. 1; CAB98143). {ECO:0000305}.,,1,,0,,,,,DOMAIN 316 467 PI-PLC X-box. {ECO:0000255|PROSITE-ProRule:PRU00270}.; DOMAIN 540 656 PI-PLC Y-box. {ECO:0000255|PROSITE-ProRule:PRU00271}.; DOMAIN 663 761 C2. {ECO:0000255|PROSITE-ProRule:PRU00041}.,,,,,3.1.4.11,,"CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + H2O = 1D-myo-inositol 1,4,5-trisphosphate + a 1,2-diacyl-sn-glycerol + H(+); Xref=Rhea:RHEA:33179, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:58456, ChEBI:CHEBI:203600; EC=3.1.4.11;",COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; ,,"FUNCTION: The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes.",,,,,,ACT_SITE 331 331 {ECO:0000255|PROSITE-ProRule:PRU00270}.; ACT_SITE 378 378 {ECO:0000255|PROSITE-ProRule:PRU00270}.,,,,,,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase C activity [GO:0004629]; protein homodimerization activity [GO:0042803]; activation of meiosis involved in egg activation [GO:0060466]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; negative regulation of monocyte extravasation [GO:2000438]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of CD24 biosynthetic process [GO:2000560]; positive regulation of developmental growth [GO:0048639]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; release of sequestered calcium ion into cytosol [GO:0051209]; signal transduction [GO:0007165]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","activation of meiosis involved in egg activation [GO:0060466]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-1-mediated signaling pathway [GO:0070498]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; negative regulation of monocyte extravasation [GO:2000438]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of CD24 biosynthetic process [GO:2000560]; positive regulation of developmental growth [GO:0048639]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; release of sequestered calcium ion into cytosol [GO:0051209]; signal transduction [GO:0007165]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; lamin binding [GO:0005521]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein homodimerization activity [GO:0042803]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794],GO:0000086; GO:0000790; GO:0004435; GO:0004629; GO:0005096; GO:0005509; GO:0005516; GO:0005521; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0007165; GO:0007186; GO:0007213; GO:0007215; GO:0007223; GO:0007613; GO:0008277; GO:0016042; GO:0016607; GO:0019899; GO:0021987; GO:0031965; GO:0032735; GO:0032959; GO:0035722; GO:0035723; GO:0040019; GO:0042803; GO:0043647; GO:0045444; GO:0045663; GO:0045892; GO:0045893; GO:0046330; GO:0046488; GO:0048009; GO:0048015; GO:0048639; GO:0051209; GO:0060466; GO:0070062; GO:0070498; GO:0080154; GO:0098794; GO:0098978; GO:0098982; GO:0099170; GO:0099178; GO:1900087; GO:2000344; GO:2000438; GO:2000560,IPR000008; IPR035892; IPR011992; IPR001192; IPR016280; IPR028400; IPR014815; IPR009535; IPR037862; IPR017946; IPR015359; IPR000909; IPR001711; ,Q8TAP6; Q13363-2; P56545; P56545-3; Q12800,SUBUNIT: Interacts with DGKQ. {ECO:0000269|PubMed:12799190}.,11118617; 10760467; 9628581; 12168954; 11780052; 15489334; 17974005; 14702039; 12799190; 20833646; 16959974,11118617; 10760467; 9628581; 12168954; 11780052; 15489334; 17974005; 14702039; 12799190; 20833646; 16959974; 10393909; 11015615; 11287604; 11588141; 11753430; 12213492; 12821674; 1322796; 1333955; 15085153; 15579586; 15611108; 15790568; 16136505; 16182515; 1644792; 16754659; 16860758; 17041247; 1707501; 17335878; 17363325; 17393430; 17620288; 17900700; 18203956; 1846707; 18515384; 18617639; 18649358; 18692062; 18957514; 19114693; 19240061; 19361438; 19491339; 19519170; 19729020; 19734545; 20007474; 20056178; 20125193; 20171262; 20379614; 20936779; 21091263; 21338571; 21663700; 22076473; 22286107; 22459146; 22507702; 22690784; 22889834; 23006664; 23058275; 23555755; 23656785; 23659438; 23793622; 23916604; 24035496; 24076015; 24296032; 24315024; 24338081; 24475116; 24684524; 25160985; 25192965; 25416956; 25977289; 26434682; 26525203; 26614510; 26620550; 26639088; 26746047; 28106288; 2841328; 7859812; 8407970; 8454637; 8530101; 9931014,2001-01-11,2019-02-13,2000-10-01,192,,,,,,,,,5 out of 5,Active site (2); Alternative sequence (1); Chain (1); Domain (3); Erroneous initiation (2); Modified residue (10); Natural variant (2); Sequence conflict (12),,,"MISCELLANEOUS: The receptor-mediated activation of PLC-beta-1 is mediated by two G-protein alpha subunits, alpha-Q and alpha-11.",Alternative splicing;Calcium;Complete proteome;Cytoplasm;Epilepsy;Hydrolase;Lipid degradation;Lipid metabolism;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transducer,Evidence at protein level,reviewed,,,192,Alternative products (1); Catalytic activity (1); Cofactor (1); Function (1); Involvement in disease (1); Miscellaneous (1); Subcellular location (1); Subunit structure (1),,KW-0025; KW-0106; KW-0181; KW-0378; KW-0442; KW-0443; KW-0472; KW-0539; KW-0597; KW-0621; KW-0807; KW-0887; KW-0963; KW-1185,,,,,"DISEASE: Epileptic encephalopathy, early infantile, 12 (EIEE12) [MIM:613722]: A form of epilepsy characterized by frequent tonic seizures or spasms beginning in infancy with a specific EEG finding of suppression-burst patterns, characterized by high-voltage bursts alternating with almost flat suppression phases. Patients may progress to West syndrome, which is characterized by tonic spasms with clustering, arrest of psychomotor development, and hypsarrhythmia on EEG. {ECO:0000269|PubMed:20833646}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,"CHAIN 1 1216 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1. /FTId=PRO_0000088486.",,,,,,MOD_RES 236 236 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z1B3}.; MOD_RES 417 417 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z1B3}.; MOD_RES 509 509 Phosphothreonine. {ECO:0000250|UniProtKB:Q9Z1B3}.; MOD_RES 511 511 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z1B3}.; MOD_RES 582 582 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z1B3}.; MOD_RES 887 887 Phosphoserine; by PKC. {ECO:0000250|UniProtKB:P10894}.; MOD_RES 978 978 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z1B3}.; MOD_RES 987 987 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z1B3}.; MOD_RES 1199 1199 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z1B3}.; MOD_RES 1200 1200 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z1B3}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AJ278313;AJ278314;AY004175;AB011153;CH471133;CH471133;CH471133;CH471133;BC069420;BC117231;AL137267;AK023689;
0,Q9NQC7,CYLD_HUMAN,CYLD CYLD1 KIAA0849 HSPC057,CYLD,CYLD1 KIAA0849,,HSPC057,Homo sapiens (Human),9606,Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD),UP000005640: Chromosome 16,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSSGLWSQEKVTSPYWEERIFYLLLQECSVTDKQTQKLLKVPKGSIGQYIQDRSVGHSRIPSAKGKKNQIGLKILEQPHAVLFVDEKDVVEINEKFTELLLAITNCEERFSLFKNRNRLSKGLQIDVGCPVKVQLRSGEEKFPGVVRFRGPLLAERTVSGIFFGVELLEEGRGQGFTDGVYQGKQLFQCDEDCGVFVALDKLELIEDDDTALESDYAGPGDTMQVELPPLEINSRVSLKVGETIESGTVIFCDVLPGKESLGYFVGVDMDNPIGNWDGRFDGVQLCSFACVESTILLHINDIIPALSESVTQERRPPKLAFMSRGVGDKGSSSHNKPKATGSTSDPGNRNRSELFYTLNGSSVDSQPQSKSKNTWYIDEVAEDPAKSLTEISTDFDRSSPPLQPPPVNSLTTENRFHSLPFSLTKMPNTNGSIGHSPLSLSAQSVMEELNTAPVQESPPLAMPPGNSHGLEVGSLAEVKENPPFYGVIRWIGQPPGLNEVLAGLELEDECAGCTDGTFRGTRYFTCALKKALFVKLKSCRPDSRFASLQPVSNQIERCNSLAFGGYLSEVVEENTPPKMEKEGLEIMIGKKKGIQGHYNSCYLDSTLFCLFAFSSVLDTVLLRPKEKNDVEYYSETQELLRTEIVNPLRIYGYVCATKIMKLRKILEKVEAASGFTSEEKDPEEFLNILFHHILRVEPLLKIRSAGQKVQDCYFYQIFMEKNEKVGVPTIQQLLEWSFINSNLKFAEAPSCLIIQMPRFGKDFKLFKKIFPSLELNITDLLEDTPRQCRICGGLAMYECRECYDDPDISAGKIKQFCKTCNTQVHLHPKRLNHKYNPVSLPKDLPDWDWRHGCIPCQNMELFAVLCIETSHYVAFVKYGKDDSAWLFFDSMADRDGGQNGFNIPQVTPCPEVGEYLKMSLEDLHSLDSRRIQGCARRLLCDAYMCMYQSPTMSLYK,956,"107,316",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q9NQC7-1; Sequence=Displayed; Name=2; IsoId=Q9NQC7-2; Sequence=VSP_011277; ,,SEQUENCE CAUTION:  Sequence=BAA74872.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,"SEQUENCE CAUTION:  Sequence=AAF29029.1; Type=Frameshift; Positions=776, 808, 932; Evidence={ECO:0000305}; ",,,,,"VAR_SEQ 305 307 Missing (in isoform 2). {ECO:0000303|PubMed:10048485, ECO:0000303|PubMed:15489334}. /FTId=VSP_011277.",VARIANT 747 747 E -> G (in MFT1 and BRSS; dbSNP:rs121908389). {ECO:0000269|PubMed:14632188}. /FTId=VAR_045967.,,,,,,1,,0,,SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.,,,DOMAIN 153 198 CAP-Gly 1. {ECO:0000255|PROSITE-ProRule:PRU00045}.; DOMAIN 253 286 CAP-Gly 2. {ECO:0000255|PROSITE-ProRule:PRU00045}.; DOMAIN 492 535 CAP-Gly 3. {ECO:0000255|PROSITE-ProRule:PRU00045}.; DOMAIN 592 950 USP.,,"REGION 106 593 Interaction with TRIP. {ECO:0000269|PubMed:14676304}.; REGION 394 469 Interaction with TRAF2.; REGION 470 554 Interaction with IKBKG/NEMO. {ECO:0000269|PubMed:15341735}.; REGION 781 833 B-box. {ECO:0000269|PubMed:18313383, ECO:0000269|PubMed:27591049}.",,,3.4.19.12,,"CATALYTIC ACTIVITY: Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).; EC=3.4.19.12; Evidence={ECO:0000269|PubMed:18313383, ECO:0000269|PubMed:27458237, ECO:0000269|PubMed:27591049};",,,"FUNCTION: Deubiquitinase that specifically cleaves 'Lys-63'- and linear 'Met-1'-linked polyubiquitin chains and is involved in NF-kappa-B activation and TNF-alpha-induced necroptosis (PubMed:18636086, PubMed:26670046, PubMed:27458237, PubMed:26997266, PubMed:27591049, PubMed:29291351, PubMed:18313383). Plays an important role in the regulation of pathways leading to NF-kappa-B activation (PubMed:12917689, PubMed:12917691). Contributes to the regulation of cell survival, proliferation and differentiation via its effects on NF-kappa-B activation (PubMed:12917690). Negative regulator of Wnt signaling (PubMed:20227366). Inhibits HDAC6 and thereby promotes acetylation of alpha-tubulin and stabilization of microtubules (PubMed:19893491). Plays a role in the regulation of microtubule dynamics, and thereby contributes to the regulation of cell proliferation, cell polarization, cell migration, and angiogenesis (PubMed:18222923, PubMed:20194890). Required for normal cell cycle progress and normal cytokinesis (PubMed:17495026, PubMed:19893491). Inhibits nuclear translocation of NF-kappa-B (PubMed:18636086). Plays a role in the regulation of inflammation and the innate immune response, via its effects on NF-kappa-B activation (PubMed:18636086). Dispensable for the maturation of intrathymic natural killer cells, but required for the continued survival of immature natural killer cells (By similarity). Negatively regulates TNFRSF11A signaling and osteoclastogenesis (By similarity). Involved in the regulation of ciliogenesis, allowing ciliary basal bodies to migrate and dock to the plasma membrane; this process does not depend on NF-kappa-B activation (By similarity). Ability to remove linear ('Met-1'-linked) polyubiquitin chains regulates innate immunity and TNF-alpha-induced necroptosis: recruited to the LUBAC complex via interaction with SPATA2 and restricts linear polyubiquitin formation on target proteins (PubMed:26997266, PubMed:26670046, PubMed:27458237, PubMed:27591049). Regulates innate immunity by restricting linear polyubiquitin formation on RIPK2 in response to NOD2 stimulation (PubMed:26997266). Involved in TNF-alpha-induced necroptosis by removing linear ('Met-1'-linked) polyubiquitin chains from RIPK1, thereby regulating the kinase activity of RIPK1 (By similarity). Removes 'Lys-63' linked polyubiquitin chain of MAP3K7, which inhibits phosphorylation and blocks downstream activation of the JNK-p38 kinase cascades (PubMed:29291351). {ECO:0000250|UniProtKB:Q80TQ2, ECO:0000269|PubMed:12917689, ECO:0000269|PubMed:12917690, ECO:0000269|PubMed:12917691, ECO:0000269|PubMed:17495026, ECO:0000269|PubMed:18222923, ECO:0000269|PubMed:18313383, ECO:0000269|PubMed:18636086, ECO:0000269|PubMed:19893491, ECO:0000269|PubMed:20194890, ECO:0000269|PubMed:20227366, ECO:0000269|PubMed:26670046, ECO:0000269|PubMed:26997266, ECO:0000269|PubMed:27458237, ECO:0000269|PubMed:27591049, ECO:0000269|PubMed:29291351}.",,,,,,"ACT_SITE 601 601 Nucleophile. {ECO:0000255|PROSITE-ProRule:PRU10092, ECO:0000269|PubMed:18313383}.; ACT_SITE 871 871 Proton acceptor. {ECO:0000305|PubMed:18313383}.",,,METAL 788 788 Zinc 1.; METAL 791 791 Zinc 1.; METAL 799 799 Zinc 2.; METAL 802 802 Zinc 2.; METAL 817 817 Zinc 1.; METAL 820 820 Zinc 1.; METAL 825 825 Zinc 2.; METAL 833 833 Zinc 2.,,,"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell cycle [GO:0007049]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]","CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell cycle [GO:0007049]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]",Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819],GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006511; GO:0007049; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0019901; GO:0031234; GO:0032088; GO:0032480; GO:0036064; GO:0036459; GO:0043369; GO:0043393; GO:0045087; GO:0045577; GO:0045582; GO:0046329; GO:0048471; GO:0048872; GO:0050727; GO:0050862; GO:0060544; GO:0061578; GO:0070064; GO:0070266; GO:0070423; GO:0070507; GO:0070536; GO:0090090; GO:0097542; GO:1901026; GO:1901223; GO:1902017; GO:1903753; GO:1903829; GO:1990108; GO:1990380; GO:2001238; GO:2001242,IPR036859; IPR000938; IPR038765; IPR001394; IPR018200; IPR028889; ,O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36,"SUBUNIT: Interacts (via CAP-Gly domain) with IKBKG/NEMO (via proline-rich C-terminal region) (PubMed:12917689, PubMed:12917690, PubMed:12917691, PubMed:15341735). Interacts with TRAF2 and TRIP (PubMed:12917691, PubMed:14676304). Interacts with PLK1, DVL1, DVL3, MAVS, TBK1, IKKE and DDX58 (PubMed:17495026, PubMed:18636086, PubMed:20227366). Interacts (via CAP-Gly domain) with microtubules (PubMed:19893491). Interacts with HDAC6 and BCL3 (PubMed:19893491). Interacts with MAP3K7 (By similarity). Identified in a complex with TRAF6 and SQSTM1 (By similarity). Interacts with CEP350 (PubMed:25134987). Interacts with RNF31; the interaction is indirect and is mediated via SPATA2 (PubMed:26997266). Interacts with SPATA2 (via the PUB domain); the interaction is direct and recruits CYLD to the LUBAC complex, thereby regulating TNF-alpha-induced necroptosis (PubMed:27307491, PubMed:27458237, PubMed:27545878, PubMed:27591049). {ECO:0000250|UniProtKB:Q80TQ2, ECO:0000269|PubMed:12917689, ECO:0000269|PubMed:12917690, ECO:0000269|PubMed:12917691, ECO:0000269|PubMed:14676304, ECO:0000269|PubMed:15341735, ECO:0000269|PubMed:17495026, ECO:0000269|PubMed:18636086, ECO:0000269|PubMed:19893491, ECO:0000269|PubMed:20227366, ECO:0000269|PubMed:25134987, ECO:0000269|PubMed:26997266, ECO:0000269|PubMed:27307491, ECO:0000269|PubMed:27458237, ECO:0000269|PubMed:27545878, ECO:0000269|PubMed:27591049}.",10835629; 10048485; 12168954; 15489334; 11042152; 12917689; 12917690; 12917691; 14676304; 15870263; 17495026; 18636086; 18222923; 18669648; 20194890; 19893491; 20227366; 23186163; 24275569; 25134987; 12190880; 12950348; 16307661; 15854031; 16922728; 26670046; 27307491; 27458237; 27545878; 26997266; 27591049; 29291351; 15341735; 18313383; 14632188,10835629; 10048485; 12168954; 15489334; 11042152; 12917689; 12917690; 12917691; 14676304; 15870263; 17495026; 18636086; 18222923; 18669648; 20194890; 19893491; 20227366; 23186163; 24275569; 25134987; 12190880; 12950348; 16307661; 15854031; 16922728; 26670046; 27307491; 27458237; 27545878; 26997266; 27591049; 29291351; 15341735; 18313383; 14632188; 12887920; 15024746; 15226292; 15289313; 15496400; 15620648; 16135788; 16230348; 16260783; 16500080; 16603398; 16627981; 16713561; 16774947; 16953224; 17606441; 17608805; 17609426; 17662085; 17851586; 17875891; 17925880; 17981138; 18178551; 18234730; 18242958; 18245814; 18332137; 18363762; 18467330; 18497946; 18977328; 19076795; 19373254; 19462465; 19481526; 19615732; 19800320; 19807742; 19910467; 19911186; 19913121; 19917957; 19951577; 20151946; 20347313; 20414373; 20502185; 20593489; 20628086; 20711500; 20797623; 20832754; 20838385; 20854080; 20972631; 21389835; 21408173; 21420166; 21478324; 21498625; 21552290; 21577203; 21605102; 21718647; 21900959; 21931648; 21988832; 22017589; 22037414; 22049921; 22057290; 22077640; 22157808; 22179575; 22297296; 22362744; 22435550; 22469839; 22491319; 22689134; 22848449; 22895009; 23002441; 23171463; 23300340; 23313255; 23404581; 23567228; 23575688; 23584127; 23641715; 23694822; 23725390; 23754495; 23832602; 23861985; 23879700; 24092863; 24098568; 24104553; 24247569; 24255178; 24261740; 24398777; 24461064; 24469800; 24552808; 24577083; 24614225; 24867235; 24961988; 25117167; 25130432; 25234269; 25329885; 25347032; 25389768; 25501176; 25565632; 25641919; 25751345; 25782638; 25824771; 25923723; 25935309; 26056944; 26271973; 26329847; 26370355; 26638075; 26711782; 26717101; 26719415; 26861065; 27189061; 27357419; 27391066; 27448305; 27570065; 27681433; 27738385; 28184924; 28295222; 28534976; 28566736; 28572092; 28629782; 28840581; 28901464; 29054757; 29166644; 29286108; 29808164; 29974194; 30542706,2004-08-16,2019-02-13,2000-10-01,173,X-ray crystallography (1); NMR spectroscopy (3),STRAND 130 134 {ECO:0000244|PDB:1WHL}.; STRAND 136 139 {ECO:0000244|PDB:1WHL}.; STRAND 141 149 {ECO:0000244|PDB:1WHL}.; STRAND 154 157 {ECO:0000244|PDB:1WHL}.; STRAND 163 167 {ECO:0000244|PDB:1WHL}.; STRAND 169 171 {ECO:0000244|PDB:1WHL}.; STRAND 194 197 {ECO:0000244|PDB:1WHL}.; STRAND 202 204 {ECO:0000244|PDB:1WHL}.; STRAND 235 240 {ECO:0000244|PDB:1WHM}.; STRAND 243 253 {ECO:0000244|PDB:1WHM}.; STRAND 264 272 {ECO:0000244|PDB:1WHM}.; STRAND 278 280 {ECO:0000244|PDB:1WHM}.; STRAND 283 285 {ECO:0000244|PDB:1WHM}.; STRAND 293 298 {ECO:0000244|PDB:1WHM}.; STRAND 302 304 {ECO:0000244|PDB:1WHM}.; STRAND 466 468 {ECO:0000244|PDB:1IXD}.; STRAND 474 478 {ECO:0000244|PDB:1IXD}.; STRAND 480 482 {ECO:0000244|PDB:1IXD}.; STRAND 486 492 {ECO:0000244|PDB:1IXD}.; STRAND 495 497 {ECO:0000244|PDB:1IXD}.; STRAND 501 508 {ECO:0000244|PDB:1IXD}.; STRAND 514 518 {ECO:0000244|PDB:1IXD}.; STRAND 531 535 {ECO:0000244|PDB:1IXD}.; STRAND 539 541 {ECO:0000244|PDB:1IXD}.; STRAND 588 591 {ECO:0000244|PDB:2VHF}.; STRAND 612 614 {ECO:0000244|PDB:2VHF}.; STRAND 652 654 {ECO:0000244|PDB:2VHF}.; STRAND 699 704 {ECO:0000244|PDB:2VHF}.; STRAND 710 713 {ECO:0000244|PDB:2VHF}.; STRAND 743 747 {ECO:0000244|PDB:2VHF}.; STRAND 750 755 {ECO:0000244|PDB:2VHF}.; STRAND 760 764 {ECO:0000244|PDB:2VHF}.; STRAND 773 775 {ECO:0000244|PDB:2VHF}.; STRAND 781 784 {ECO:0000244|PDB:2VHF}.; STRAND 859 868 {ECO:0000244|PDB:2VHF}.; STRAND 871 877 {ECO:0000244|PDB:2VHF}.; STRAND 879 881 {ECO:0000244|PDB:2VHF}.; STRAND 885 889 {ECO:0000244|PDB:2VHF}.; STRAND 905 908 {ECO:0000244|PDB:2VHF}.; STRAND 944 948 {ECO:0000244|PDB:2VHF}.,HELIX 199 201 {ECO:0000244|PDB:1WHL}.; HELIX 299 301 {ECO:0000244|PDB:1WHM}.; HELIX 536 538 {ECO:0000244|PDB:1IXD}.; HELIX 584 586 {ECO:0000244|PDB:2VHF}.; HELIX 601 611 {ECO:0000244|PDB:2VHF}.; HELIX 615 617 {ECO:0000244|PDB:2VHF}.; HELIX 618 622 {ECO:0000244|PDB:2VHF}.; HELIX 633 642 {ECO:0000244|PDB:2VHF}.; HELIX 645 650 {ECO:0000244|PDB:2VHF}.; HELIX 656 669 {ECO:0000244|PDB:2VHF}.; HELIX 682 690 {ECO:0000244|PDB:2VHF}.; HELIX 730 741 {ECO:0000244|PDB:2VHF}.; HELIX 778 780 {ECO:0000244|PDB:2VHF}.; HELIX 800 802 {ECO:0000244|PDB:2VHF}.; HELIX 818 824 {ECO:0000244|PDB:2VHF}.; HELIX 828 830 {ECO:0000244|PDB:2VHF}.; HELIX 844 846 {ECO:0000244|PDB:2VHF}.; HELIX 911 914 {ECO:0000244|PDB:2VHF}.; HELIX 920 925 {ECO:0000244|PDB:2VHF}.; HELIX 928 930 {ECO:0000244|PDB:2VHF}.; HELIX 935 940 {ECO:0000244|PDB:2VHF}.; HELIX 950 952 {ECO:0000244|PDB:2VHF}.,TURN 191 193 {ECO:0000244|PDB:1WHL}.; TURN 259 261 {ECO:0000244|PDB:1WHM}.; TURN 463 465 {ECO:0000244|PDB:1IXD}.; TURN 691 694 {ECO:0000244|PDB:2VHF}.; TURN 789 791 {ECO:0000244|PDB:2VHF}.; TURN 806 811 {ECO:0000244|PDB:2VHF}.,,,,,5 out of 5,Active site (2); Alternative sequence (1); Beta strand (40); Chain (1); Domain (4); Erroneous initiation (1); Frameshift (1); Helix (22); Metal binding (8); Modified residue (3); Mutagenesis (18); Natural variant (1); Region (4); Turn (6),,"TISSUE SPECIFICITY: Detected in fetal brain, testis, and skeletal muscle, and at a lower level in adult brain, leukocytes, liver, heart, kidney, spleen, ovary and lung. Isoform 2 is found in all tissues except kidney. {ECO:0000269|PubMed:10835629, ECO:0000269|PubMed:29291351}.",,3D-structure;Alternative splicing;Cell cycle;Cell membrane;Cell projection;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Hydrolase;Immunity;Innate immunity;Membrane;Metal-binding;Microtubule;Phosphoprotein;Protease;Reference proteome;Repeat;Thiol protease;Tumor suppressor;Ubl conjugation;Ubl conjugation pathway;Wnt signaling pathway;Zinc,Evidence at protein level,reviewed,,Peptidase C19 family,173,Activity regulation (1); Alternative products (1); Catalytic activity (1); Function (1); Involvement in disease (3); Post-translational modification (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0043; KW-0131; KW-0181; KW-0206; KW-0225; KW-0378; KW-0391; KW-0399; KW-0472; KW-0479; KW-0493; KW-0597; KW-0645; KW-0677; KW-0788; KW-0832; KW-0833; KW-0862; KW-0879; KW-0963; KW-0966; KW-1003; KW-1185,,,,,"DISEASE: Cylindromatosis, familial (FCYL) [MIM:132700]: A disorder characterized by multiple skin tumors that develop from skin appendages, such as hair follicles and sweat glands. Affected individuals typically develop large numbers of tumors called cylindromas that arise predominantly in hairy parts of the body with approximately 90% on the head and neck. In severely affected individuals, cylindromas may combine into a confluent mass which may ulcerate or become infected (turban tumor syndrome). Individuals with familial cylindromatosis occasionally develop other types of tumors including spiradenomas that begin in sweat glands, and trichoepitheliomas arising from hair follicles. {ECO:0000269|PubMed:12190880, ECO:0000269|PubMed:16922728}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiple familial trichoepithelioma 1 (MFT1) [MIM:601606]: Autosomal dominant dermatosis characterized by the presence of many skin tumors predominantly on the face. Since histologic examination shows dermal aggregates of basaloid cells with connection to or differentiation toward hair follicles, this disorder has been thought to represent a benign hamartoma of the pilosebaceous apparatus. Trichoepitheliomas can degenerate into basal cell carcinoma. {ECO:0000269|PubMed:14632188, ECO:0000269|PubMed:16307661, ECO:0000269|PubMed:16922728}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brooke-Spiegler syndrome (BRSS) [MIM:605041]: An autosomal dominant disorder characterized by the appearance of multiple skin appendage tumors such as cylindroma, trichoepithelioma, and spiradenoma. These tumors are typically located in the head and neck region, appear in early adulthood, and gradually increase in size and number throughout life. {ECO:0000269|PubMed:12190880, ECO:0000269|PubMed:12950348, ECO:0000269|PubMed:14632188, ECO:0000269|PubMed:15854031}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Ubiquitinated. Polyubiquitinated in hepatocytes treated with palmitic acid. Ubiquitination is mediated by E3 ligase TRIM47 and leads to proteasomal degradation. {ECO:0000269|PubMed:29291351}.; PTM: Phosphorylated on several serine residues by IKKA and/or IKKB in response to immune stimuli. Phosphorylation requires IKBKG. Phosphorylation abolishes TRAF2 deubiquitination, interferes with the activation of Jun kinases, and strongly reduces CD40-dependent gene activation by NF-kappa-B. {ECO:0000269|PubMed:15870263}.",CHAIN 1 956 Ubiquitin carboxyl-terminal hydrolase CYLD. /FTId=PRO_0000080698.,,,,,,"MOD_RES 387 387 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 418 418 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:15870263}.; MOD_RES 422 422 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AJ250014;AB020656;BC012342;AF161542;
0,Q9NQT8,KI13B_HUMAN,KIF13B GAKIN KIAA0639,KIF13B,GAKIN KIAA0639,,,Homo sapiens (Human),9606,Kinesin-like protein KIF13B (Kinesin-like protein GAKIN),UP000005640: Chromosome 8,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGDSKVKVAVRIRPMNRRETDLHTKCVVDVDANKVILNPVNTNLSKGDARGQPKVFAYDHCFWSMDESVKEKYAGQDIVFKCLGENILQNAFDGYNACIFAYGQTGSGKSYTMMGTADQPGLIPRLCSGLFERTQKEENEEQSFKVEVSYMEIYNEKVRDLLDPKGSRQTLKVREHSVLGPYVDGLSKLAVTSYKDIESLMSEGNKSRTVAATNMNEESSRSHAVFKITLTHTLYDVKSGTSGEKVGKLSLVDLAGSERATKTGAAGDRLKEGSNINKSLTTLGLVISALADQSAGKNKNKFVPYRDSVLTWLLKDSLGGNSKTAMVATVSPAADNYDETLSTLRYADRAKHIVNHAVVNEDPNARIIRDLREEVEKLREQLTKAEAMKSPELKDRLEESEKLIQEMTVTWEEKLRKTEEIAQERQKQLESLGISLQSSGIKVGDDKCFLVNLNADPALNELLVYYLKEHTLIGSANSQDIQLCGMGILPEHCIIDITSEGQVMLTPQKNTRTFVNGSSVSSPIQLHHGDRILWGNNHFFRLNLPKKKKKAEREDEDQDPSMKNENSSEQLDVDGDSSSEVSSEVNFNYEYAQMEVTMKALGSNDPMQSILNSLEQQHEEEKRSALERQRLMYEHELEQLRRRLSPEKQNCRSMDRFSFHSPSAQQRLRQWAEEREATLNNSLMRLREQIVKANLLVREANYIAEELDKRTEYKVTLQIPASSLDANRKRGSLLSEPAIQVRRKGKGKQIWSLEKLDNRLLDMRDLYQEWKECEEDNPVIRSYFKRADPFYDEQENHSLIGVANVFLESLFYDVKLQYAVPIINQKGEVAGRLHVEVMRLSGDVGERIAGGDEVAEVSFEKETQENKLVCMVKILQATGLPQHLSHFVFCKYSFWDQQEPVIVAPEVDTSSSSVSKEPHCMVVFDHCNEFSVNITEDFIEHLSEGALAIEVYGHKINDPRKNPALWDLGIIQAKTRSLRDRWSEVTRKLEFWVQILEQNENGEYCPVEVISAKDVPTGGIFQLRQGQSRRVQVEVKSVQESGTLPLMEECILSVGIGCVKVRPLRAPRTHETFHEEEEDMDSYQDRDLERLRRKWLNALTKRQEYLDQQLQKLVSKRDKTEDDADREAQLLEMRLTLTEERNAVMVPSAGSGIPGAPAEWTPVPGMETHIPVIFLDLNADDFSSQDNLDDPEAGGWDATLTGEEEEEFFELQIVKQHDGEVKAEASWDSAVHGCPQLSRGTPVDERLFLIVRVTVQLSHPADMQLVLRKRICVNVHGRQGFAQSLLKKMSHRSSIPGCGVTFEIVSNIPEDAQGVEEREALARMAANVENPASADSEAYIEKYLRSVLAVENLLTLDRLRQEVAVKEQLTGKGKLSRRSISSPNVNRLSGSRQDLIPSYSLGSNKGRWESQQDVSQTTVSRGIAPAPALSVSPQNNHSPDPGLSNLAASYLNPVKSFVPQMPKLLKSLFPVRDEKRGKRPSPLAHQPVPRIMVQSASPDIRVTRMEEAQPEMGPDVLVQTMGAPALKICDKPAKVPSPPPVIAVTAVTPAPEAQDGPPSPLSEASSGYFSHSVSTATLSDALGPGLDAAAPPGSMPTAPEAEPEAPISHPPPPTAVPAEEPPGPQQLVSPGRERPDLEAPAPGSPFRVRRVRASELRSFSRMLAGDPGCSPGAEGNAPAPGAGGQALASDSEEADEVPEWLREGEFVTVGAHKTGVVRYVGPADFQEGTWVGVELDLPSGKNDGSIGGKQYFRCNPGYGLLVRPSRVRRATGPVRRRSTGLRLGAPEARRSATLSGSATNLASLTAALAKADRSHKNPENRKSWAS,1826,"202,789",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q9NQT8-1; Sequence=Displayed; Name=2; IsoId=Q9NQT8-2; Sequence=VSP_056360, VSP_056361; Note=No experimental confirmation available.; ",,SEQUENCE CAUTION:  Sequence=BAA31614.3; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 1 1460 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_056360.; VAR_SEQ 1487 1507 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_056361.,VARIANT 1471 1471 V -> I (in dbSNP:rs17526980). /FTId=VAR_055982.,,,,CONFLICT 55 55 V -> C (in Ref. 1; AAF81263). {ECO:0000305}.; CONFLICT 191 191 V -> A (in Ref. 1; AAF81263). {ECO:0000305}.; CONFLICT 226 226 F -> L (in Ref. 1; AAF81263). {ECO:0000305}.; CONFLICT 237 237 V -> A (in Ref. 1; AAF81263). {ECO:0000305}.; CONFLICT 278 278 K -> E (in Ref. 1; AAF81263). {ECO:0000305}.; CONFLICT 356 356 H -> N (in Ref. 1; AAF81263). {ECO:0000305}.; CONFLICT 797 797 H -> L (in Ref. 1; AAF81263). {ECO:0000305}.; CONFLICT 858 858 S -> P (in Ref. 1; AAF81263). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family. {ECO:0000255|PROSITE-ProRule:PRU00283}.,COILED 364 439 {ECO:0000255}.; COILED 607 710 {ECO:0000255}.; COILED 752 772 {ECO:0000255}.; COILED 1096 1143 {ECO:0000255}.,,DOMAIN 5 353 Kinesin motor. {ECO:0000255|PROSITE-ProRule:PRU00283}.; DOMAIN 471 535 FHA.; DOMAIN 1721 1763 CAP-Gly. {ECO:0000255|PROSITE-ProRule:PRU00045}.,,,,,,,,,,FUNCTION: Involved in reorganization of the cortical cytoskeleton. Regulates axon formation by promoting the formation of extra axons. May be functionally important for the intracellular trafficking of MAGUKs and associated protein complexes. {ECO:0000269|PubMed:20194617}.,,,,,,,,,,NP_BIND 103 110 ATP. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microvillus [GO:0005902]; paranode region of axon [GO:0033270]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110],microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110],14-3-3 protein binding [GO:0071889]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microvillus [GO:0005902]; paranode region of axon [GO:0033270],GO:0003777; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0005902; GO:0006605; GO:0007018; GO:0007165; GO:0008017; GO:0016887; GO:0019901; GO:0030424; GO:0033270; GO:0042110; GO:0050770; GO:0071889,IPR036859; IPR000938; IPR000253; IPR036978; IPR022164; IPR027640; IPR022140; IPR032405; IPR019821; IPR001752; IPR036961; IPR027417; IPR008984; ,O75689; Q12959-2,"SUBUNIT: Binds to DLG1 and DLG4. Interacts (when phosphorylated at Ser-1381 and Ser-1410) with 14-3-3. {ECO:0000269|PubMed:10859302, ECO:0000269|PubMed:20194617}.",10859302; 9734811; 14702039; 16421571; 17974005; 18088087; 18669648; 19690332; 20194617; 20068231; 21269460; 23186163; 24275569; ,10859302; 9734811; 14702039; 16421571; 17974005; 18088087; 18669648; 19690332; 20194617; 20068231; 21269460; 23186163; 24275569; 11493604; 11739780; 12368902; 14504276; 15029241; 15272311; 15326200; 1607388; 16147992; 16262723; 16571679; 16864656; 17113389; 17696365; 19116309; 19369418; 19615732; 19758564; 20005805; 20136777; 20201926; 20379614; 20462495; 20534429; 20711500; 21057110; 2142332; 21550981; 22013193; 23077056; 25128562; 2521221; 2522352; 25364732; 26077951; 26496610; 27642159; 28134340; 7844144; 7929562; 8602245,2002-09-19,2019-02-13,2013-06-26,168,X-ray crystallography (3); NMR spectroscopy (1),STRAND 6 12 {ECO:0000244|PDB:3GBJ}.; STRAND 28 31 {ECO:0000244|PDB:3GBJ}.; STRAND 34 37 {ECO:0000244|PDB:3GBJ}.; STRAND 54 57 {ECO:0000244|PDB:3GBJ}.; STRAND 59 63 {ECO:0000244|PDB:3GBJ}.; STRAND 97 103 {ECO:0000244|PDB:3GBJ}.; STRAND 117 120 {ECO:0000244|PDB:3GBJ}.; STRAND 142 154 {ECO:0000244|PDB:3GBJ}.; STRAND 157 160 {ECO:0000244|PDB:3GBJ}.; STRAND 189 191 {ECO:0000244|PDB:3GBJ}.; STRAND 222 235 {ECO:0000244|PDB:3GBJ}.; STRAND 241 253 {ECO:0000244|PDB:3GBJ}.; STRAND 323 330 {ECO:0000244|PDB:3GBJ}.; STRAND 449 452 {ECO:0000244|PDB:3FM8}.; STRAND 464 466 {ECO:0000244|PDB:3FM8}.; STRAND 469 476 {ECO:0000244|PDB:3FM8}.; STRAND 480 482 {ECO:0000244|PDB:3FM8}.; STRAND 493 497 {ECO:0000244|PDB:3FM8}.; STRAND 503 507 {ECO:0000244|PDB:3FM8}.; STRAND 513 515 {ECO:0000244|PDB:3FM8}.; STRAND 524 526 {ECO:0000244|PDB:3FM8}.; STRAND 531 534 {ECO:0000244|PDB:3FM8}.; STRAND 538 543 {ECO:0000244|PDB:3FM8}.; STRAND 1706 1708 {ECO:0000244|PDB:2COW}.; STRAND 1710 1712 {ECO:0000244|PDB:2COW}.; STRAND 1714 1721 {ECO:0000244|PDB:2COW}.; STRAND 1724 1728 {ECO:0000244|PDB:2COW}.; STRAND 1730 1734 {ECO:0000244|PDB:2COW}.; STRAND 1736 1738 {ECO:0000244|PDB:2COW}.; STRAND 1743 1746 {ECO:0000244|PDB:2COW}.; STRAND 1760 1762 {ECO:0000244|PDB:2COW}.,HELIX 17 22 {ECO:0000244|PDB:3GBJ}.; HELIX 76 92 {ECO:0000244|PDB:3GBJ}.; HELIX 109 113 {ECO:0000244|PDB:3GBJ}.; HELIX 122 137 {ECO:0000244|PDB:3GBJ}.; HELIX 194 206 {ECO:0000244|PDB:3GBJ}.; HELIX 272 292 {ECO:0000244|PDB:3GBJ}.; HELIX 305 307 {ECO:0000244|PDB:3GBJ}.; HELIX 309 313 {ECO:0000244|PDB:3GBJ}.; HELIX 315 318 {ECO:0000244|PDB:3GBJ}.; HELIX 334 336 {ECO:0000244|PDB:3GBJ}.; HELIX 337 350 {ECO:0000244|PDB:3GBJ}.; HELIX 1764 1766 {ECO:0000244|PDB:2COW}.,TURN 70 72 {ECO:0000244|PDB:3GBJ}.; TURN 457 460 {ECO:0000244|PDB:3MDB}.; TURN 535 537 {ECO:0000244|PDB:3FM8}.,,,,,5 out of 5,Alternative sequence (2); Beta strand (31); Chain (1); Coiled coil (4); Domain (3); Erroneous initiation (1); Helix (12); Modified residue (13); Mutagenesis (2); Natural variant (1); Nucleotide binding (1); Sequence conflict (8); Turn (3),,TISSUE SPECIFICITY: Ubiquitous.,,3D-structure;ATP-binding;Alternative splicing;Cell projection;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Microtubule;Motor protein;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family",168,Alternative products (1); Caution (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0067; KW-0175; KW-0181; KW-0206; KW-0493; KW-0505; KW-0547; KW-0597; KW-0621; KW-0963; KW-0966; KW-1185,,,,,,,,"PTM: Phosphorylated at Ser-1381 and Ser-1410 by MARK2, promoting interaction with 14-3-3 and inhibiting microtubule-dependent accumulation and formation of axons. {ECO:0000269|PubMed:20194617}.",CHAIN 1 1826 Kinesin-like protein KIF13B. /FTId=PRO_0000125448.,,,,,,"MOD_RES 661 661 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1379 1379 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1381 1381 Phosphoserine; by MARK2. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:20194617}.; MOD_RES 1382 1382 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1391 1391 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1410 1410 Phosphoserine; by MARK2. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:20194617}.; MOD_RES 1432 1432 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1438 1438 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1537 1537 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1545 1545 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1559 1559 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1644 1644 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:23186163}.; MOD_RES 1797 1797 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF279865;AB014539;AK294837;AL583912;
0,Q9NQW6,ANLN_HUMAN,ANLN,ANLN,,,,Homo sapiens (Human),9606,Anillin,UP000005640: Chromosome 7,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDPFTEKLLERTRARRENLQRKMAERPTAAPRSMTHAKRARQPLSEASNQQPLSGGEEKSCTKPSPSKKRCSDNTEVEVSNLENKQPVESTSAKSCSPSPVSPQVQPQAADTISDSVAVPASLLGMRRGLNSRLEATAASSVKTRMQKLAEQRRRWDNDDMTDDIPESSLFSPMPSEEKAASPPRPLLSNASATPVGRRGRLANLAATICSWEDDVNHSFAKQNSVQEQPGTACLSKFSSASGASARINSSSVKQEATFCSQRDGDASLNKALSSSADDASLVNASISSSVKATSPVKSTTSITDAKSCEGQNPELLPKTPISPLKTGVSKPIVKSTLSQTVPSKGELSREICLQSQSKDKSTTPGGTGIKPFLERFGERCQEHSKESPARSTPHRTPIITPNTKAIQERLFKQDTSSSTTHLAQQLKQERQKELACLRGRFDKGNIWSAEKGGNSKSKQLETKQETHCQSTPLKKHQGVSKTQSLPVTEKVTENQIPAKNSSTEPKGFTECEMTKSSPLKITLFLEEDKSLKVTSDPKVEQKIEVIREIEMSVDDDDINSSKVINDLFSDVLEEGELDMEKSQEEMDQALAESSEEQEDALNISSMSLLAPLAQTVGVVSPESLVSTPRLELKDTSRSDESPKPGKFQRTRVPRAESGDSLGSEDRDLLYSIDAYRSQRFKETERPSIKQVIVRKEDVTSKLDEKNNAFPCQVNIKQKMQELNNEINMQQTVIYQASQALNCCVDEEHGKGSLEEAEAERLLLIATGKRTLLIDELNKLKNEGPQRKNKASPQSEFMPSKGSVTLSEIRLPLKADFVCSTVQKPDAANYYYLIILKAGAENMVATPLASTSNSLNGDALTFTTTFTLQDVSNDFEINIEVYSLVQKKDPSGLDKKKKTSKSKAITPKRLLTSITTKSNIHSSVMASPGGLSAVRTSNFALVGSYTLSLSSVGNTKFVLDKVPFLSSLEGHIYLKIKCQVNSSVEERGFLTIFEDVSGFGAWHRRWCVLSGNCISYWTYPDDEKRKNPIGRINLANCTSRQIEPANREFCARRNTFELITVRPQREDDRETLVSQCRDTLCVTKNWLSADTKEERDLWMQKLNQVLVDIRLWQPDACYKPIGKP,1124,"124,199",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q9NQW6-1; Sequence=Displayed; Name=2; IsoId=Q9NQW6-2; Sequence=VSP_017617; ,,SEQUENCE CAUTION:  Sequence=AAH34692.1; Type=Erroneous initiation; Evidence={ECO:0000305};  Sequence=BAA91710.1; Type=Erroneous initiation; Evidence={ECO:0000305};  Sequence=BAA91711.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 508 544 Missing (in isoform 2). {ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334}. /FTId=VSP_017617.","VARIANT 65 65 S -> W (in dbSNP:rs3735400). /FTId=VAR_025661.; VARIANT 185 185 R -> K (in dbSNP:rs197367). {ECO:0000244|PubMed:16964243, ECO:0000269|PubMed:10931866}. /FTId=VAR_025662.; VARIANT 431 431 R -> C (in FSGS8; results in decreased interaction with CD2AP; dbSNP:rs587777741). {ECO:0000269|PubMed:24676636}. /FTId=VAR_072418.; VARIANT 618 618 G -> C (in FSGS8). {ECO:0000269|PubMed:24676636}. /FTId=VAR_072419.",,,,CONFLICT 53 53 L -> F (in Ref. 1; AAF75796). {ECO:0000305}.; CONFLICT 62 62 T -> S (in Ref. 1; AAF75796). {ECO:0000305}.; CONFLICT 294 294 T -> TS (in Ref. 1 and 3). {ECO:0000305}.; CONFLICT 410 410 R -> K (in Ref. 2; AAH70066). {ECO:0000305}.; CONFLICT 625 625 L -> S (in Ref. 4; BAA91711). {ECO:0000305}.; CONFLICT 1035 1035 A -> V (in Ref. 3; CAI56788). {ECO:0000305}.,,2,,0,,,COILED 569 604 {ECO:0000255}.,,DOMAIN 983 1107 PH. {ECO:0000255|PROSITE-ProRule:PRU00145}.,,REGION 1 230 Nuclear localization.; REGION 1 155 Interaction with CD2AP. {ECO:0000269|PubMed:15800069}.; REGION 1 45 Required for ubiquitination.; REGION 231 676 Interaction with F-actin.; REGION 730 1124 Localization to the cleavage furrow.,,,,,,,,"FUNCTION: Required for cytokinesis (PubMed:16040610). Essential for the structural integrity of the cleavage furrow and for completion of cleavage furrow ingression. Plays a role in bleb assembly during metaphase and anaphase of mitosis (PubMed:23870127). May play a significant role in podocyte cell migration (PubMed:24676636). {ECO:0000269|PubMed:10931866, ECO:0000269|PubMed:12479805, ECO:0000269|PubMed:15496454, ECO:0000269|PubMed:16040610, ECO:0000269|PubMed:16357138, ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:24676636}.",,,,,,,,,,,,actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex region [GO:0099738]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; GTP-Rho binding [GO:0017049]; actomyosin contractile ring assembly [GO:0000915]; cortical cytoskeleton organization [GO:0030865]; glomerular visceral epithelial cell migration [GO:0090521]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; protein localization to mitotic actomyosin contractile ring [GO:1904498]; regulation of exit from mitosis [GO:0007096]; septin ring assembly [GO:0000921]; septin ring organization [GO:0031106],actomyosin contractile ring assembly [GO:0000915]; cortical cytoskeleton organization [GO:0030865]; glomerular visceral epithelial cell migration [GO:0090521]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; protein localization to mitotic actomyosin contractile ring [GO:1904498]; regulation of exit from mitosis [GO:0007096]; septin ring assembly [GO:0000921]; septin ring organization [GO:0031106],actin binding [GO:0003779]; cadherin binding [GO:0045296]; GTP-Rho binding [GO:0017049],actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex region [GO:0099738]; midbody [GO:0030496]; nucleoplasm [GO:0005654],GO:0000281; GO:0000915; GO:0000921; GO:0002244; GO:0003779; GO:0005654; GO:0005826; GO:0007096; GO:0015629; GO:0017049; GO:0030496; GO:0030865; GO:0031106; GO:0032059; GO:0045296; GO:0090521; GO:0099738; GO:1904172; GO:1904498,IPR012966; IPR031970; IPR011993; IPR037840; IPR001849; ,Q8NA82,"SUBUNIT: Interacts with F-actin (PubMed:10931866). Interacts with CD2AP (PubMed:15800069). May interact with RHOA (PubMed:16357138). Interacts with FZR1/CDH1 during mitotic exit (PubMed:16040610). {ECO:0000269|PubMed:10931866, ECO:0000269|PubMed:15800069, ECO:0000269|PubMed:16040610, ECO:0000269|PubMed:16357138}.",10931866; 15489334; 17974005; 14702039; 12479805; 12637748; 16357138; 16203764; 16040610; 15496454; 15616196; 15800069; 16129829; 16964243; 17924679; 18220336; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 22814378; 23870127; 23186163; 24676636; 25114211,10931866; 15489334; 17974005; 14702039; 12479805; 12637748; 16357138; 16203764; 16040610; 15496454; 15616196; 15800069; 16129829; 16964243; 17924679; 18220336; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 22814378; 23870127; 23186163; 24676636; 25114211; 18158243; 19995712; 20360068; 20467437; 21109967; 21150319; 21849473; 22514687; 23547718; 24088567; 24809965; 24994938; 25223638; 25359885; 25809162; 25814554; 25959226; 26135313; 26319989; 26486082; 26496610; 26638075; 27062703; 27863473; 28081137; 28600503; 28931593,2006-03-21,2019-02-13,2006-03-21,144,X-ray crystallography (3),STRAND 802 813 {ECO:0000244|PDB:4XOI}.; STRAND 827 845 {ECO:0000244|PDB:4XOI}.; STRAND 854 856 {ECO:0000244|PDB:4XOI}.; STRAND 859 861 {ECO:0000244|PDB:4XOI}.; STRAND 866 871 {ECO:0000244|PDB:4XOI}.; STRAND 877 887 {ECO:0000244|PDB:4XOI}.; STRAND 940 947 {ECO:0000244|PDB:4XOI}.; STRAND 956 958 {ECO:0000244|PDB:4XOI}.; STRAND 970 979 {ECO:0000244|PDB:4XOI}.; STRAND 986 996 {ECO:0000244|PDB:2Y7B}.; STRAND 999 1010 {ECO:0000244|PDB:2Y7B}.; STRAND 1013 1019 {ECO:0000244|PDB:2Y7B}.; STRAND 1029 1033 {ECO:0000244|PDB:2Y7B}.; STRAND 1039 1041 {ECO:0000244|PDB:2Y7B}.; STRAND 1055 1063 {ECO:0000244|PDB:2Y7B}.; STRAND 1072 1077 {ECO:0000244|PDB:2Y7B}.; STRAND 1080 1088 {ECO:0000244|PDB:2Y7B}.,HELIX 716 742 {ECO:0000244|PDB:4XOI}.; HELIX 747 749 {ECO:0000244|PDB:4XOI}.; HELIX 754 781 {ECO:0000244|PDB:4XOI}.; HELIX 815 823 {ECO:0000244|PDB:4XOI}.; HELIX 949 951 {ECO:0000244|PDB:4XOI}.; HELIX 1020 1023 {ECO:0000244|PDB:2Y7B}.; HELIX 1034 1036 {ECO:0000244|PDB:2Y7B}.; HELIX 1092 1110 {ECO:0000244|PDB:2Y7B}.,TURN 750 752 {ECO:0000244|PDB:4XOI}.; TURN 851 853 {ECO:0000244|PDB:4XOI}.; TURN 1047 1049 {ECO:0000244|PDB:2Y7B}.,,,,,5 out of 5,Alternative sequence (1); Beta strand (17); Chain (1); Coiled coil (1); Cross-link (1); Domain (1); Erroneous initiation (3); Helix (8); Modified residue (35); Mutagenesis (3); Natural variant (4); Region (5); Sequence conflict (7); Turn (3),,"TISSUE SPECIFICITY: Ubiquitously expressed. Present at highest levels in the brain, at high levels in the placenta and testis, at intermediate levels in the intestine, ovary, skeletal muscle and thymus and at lower levels in heart, kidney, liver, lung, pancreas, prostate and spleen. In the kidney, it is widely expressed in tubules, but sparsely expressed in the glomerulus (PubMed:24676636). Expression is significantly increased in renal biopsy specimens from idiopathic FSGS (PubMed:24676636). Overexpressed in many tumor types including breast, colorectal, endometrial, hepatic, kidney, lung, ovarian and pancreatic tumors. {ECO:0000269|PubMed:16203764, ECO:0000269|PubMed:24676636}.",,3D-structure;Acetylation;Actin-binding;Alternative splicing;Cell cycle;Cell division;Cell projection;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Disease mutation;Isopeptide bond;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,,144,Alternative products (1); Developmental stage (1); Function (1); Involvement in disease (1); Post-translational modification (2); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0009; KW-0025; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0225; KW-0498; KW-0539; KW-0597; KW-0621; KW-0832; KW-0963; KW-0966; KW-1017; KW-1185,,,,,"DISEASE: Focal segmental glomerulosclerosis 8 (FSGS8) [MIM:616032]: A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. {ECO:0000269|PubMed:24676636}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Phosphorylated during mitosis. {ECO:0000269|PubMed:15800069, ECO:0000269|PubMed:16357138}.; PTM: Ubiquitinated, and this requires FZR1/CDH1. {ECO:0000269|PubMed:16040610}.",CHAIN 1 1124 Anillin. /FTId=PRO_0000227965.,CROSSLNK 254 254 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1). {ECO:0000244|PubMed:25114211}.,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 54 54 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 72 72 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 97 97 Phosphoserine. {ECO:0000250|UniProtKB:Q8K298}.; MOD_RES 102 102 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 172 172 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 182 182 Phosphoserine. {ECO:0000244|PubMed:16964243}.; MOD_RES 194 194 Phosphothreonine. {ECO:0000244|PubMed:16964243}.; MOD_RES 225 225 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 252 252 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 261 261 Phosphoserine. {ECO:0000250|UniProtKB:Q8K298}.; MOD_RES 320 320 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 323 323 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 339 339 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 364 364 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 371 371 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 397 397 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 401 401 Phosphothreonine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 417 417 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 419 419 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 449 449 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 485 485 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 518 518 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 553 553 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 561 561 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 637 637 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 642 642 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 658 658 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 661 661 Phosphoserine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 664 664 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 671 671 Phosphotyrosine. {ECO:0000250|UniProtKB:Q8K298}.; MOD_RES 678 678 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 688 688 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 792 792 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 927 927 Phosphoserine. {ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF273437;BC034692;BC070066;CR936650;AK001468;AK001472;AK023208;
0,Q9P2Y5,UVRAG_HUMAN,UVRAG,UVRAG,,,,Homo sapiens (Human),9606,UV radiation resistance-associated gene protein (p63),UP000005640: Chromosome 11,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSASASVGGPVPQPPPGPAAALPPGSAARALHVELPSQQRRLRHLRNIAARNIVNRNGHQLLDTYFTLHLCSTEKIYKEFYRSEVIKNSLNPTWRSLDFGIMPDRLDTSVSCFVVKIWGGKENIYQLLIEWKVCLDGLKYLGQQIHARNQNEIIFGLNDGYYGAPFEHKGYSNAQKTILLQVDQNCVRNSYDVFSLLRLHRAQCAIKQTQVTVQKIGKEIEEKLRLTSTSNELKKKSECLQLKILVLQNELERQKKALGREVALLHKQQIALQDKGSAFSAEHLKLQLQKESLNELRKECTAKRELFLKTNAQLTIRCRQLLSELSYIYPIDLNEHKDYFVCGVKLPNSEDFQAKDDGSIAVALGYTAHLVSMISFFLQVPLRYPIIHKGSRSTIKDNINDKLTEKEREFPLYPKGGEKLQFDYGVYLLNKNIAQLRYQHGLGTPDLRQTLPNLKNFMEHGLMVRCDRHHTSSAIPVPKRQSSIFGGADVGFSGGIPSPDKGHRKRASSENERLQYKTPPPSYNSALAQPVTTVPSMGETERKITSLSSSLDTSLDFSKENKKKGEDLVGSLNGGHANVHPSQEQGEALSGHRATVNGTLLPSEQAGSASVQLPGEFHPVSEAELCCTVEQAEEIIGLEATGFASGDQLEAFNCIPVDSAVAVECDEQVLGEFEEFSRRIYALNENVSSFRRPRRSSDK,699,"78,151",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q9P2Y5-1; Sequence=Displayed; Name=2; IsoId=Q9P2Y5-2; Sequence=VSP_056176; Note=No experimental confirmation available.; ,SEQUENCE CAUTION:  Sequence=CAA67507.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; ,,,,,,,,,VAR_SEQ 1 372 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_056176.,VARIANT 10 10 P -> H (in dbSNP:rs7118567). /FTId=VAR_059737.,,,,,,1,,0,,,COILED 224 305 {ECO:0000255}.,,DOMAIN 44 128 C2.,,"REGION 200 269 Sufficient for interaction with STX7; VTI1B AND STX8. {ECO:0000269|PubMed:24550300}.; REGION 270 442 Sufficient for interaction with VPS16, required for interaction with CEP63. {ECO:0000269|PubMed:18552835, ECO:0000269|PubMed:22542840}.; REGION 443 699 Required for interaction with PRKDC, XRCC6 and XRCC5. {ECO:0000269|PubMed:22542840}.",,,,,,,,"FUNCTION: Versatile protein that is involved in regulation of different cellular pathways implicated in membrane trafficking. Involved in regulation of the COPI-dependent retrograde transport from Golgi and the endoplasmic reticulum by associating with the NRZ complex; the function is dependent on its binding to phosphatidylinositol 3-phosphate (PtdIns(3)P) (PubMed:24056303). During autophagy acts as regulatory subunit of the alternative PI3K complex II (PI3KC3-C2) that mediates formation of phosphatidylinositol 3-phosphate and is believed to be involved in maturation of autophagosomes and endocytosis. Activates lipid kinase activity of PIK3C3. Involved in the regulation of degradative endocytic trafficking and cytokinesis, and in regulation of ATG9A transport from the Golgi to the autophagosome; the functions seems to implicate its association with PI3KC3-C2 (PubMed:16799551, PubMed:20643123, PubMed:24056303). Involved in maturation of autophagosomes and degradative endocytic trafficking independently of BECN1 but depending on its association with a class C Vps complex (possibly the HOPS complex); the association is also proposed to promote autophagosome recruitment and activation of Rab7 and endosome-endosome fusion events (PubMed:18552835). Enhances class C Vps complex (possibly HOPS complex) association with a SNARE complex and promotes fusogenic SNARE complex formation during late endocytic membrane fusion (PubMed:24550300). In case of negative-strand RNA virus infection is required for efficient virus entry, promotes endocytic transport of virions and is implicated in a VAMP8-specific fusogenic SNARE complex assembly (PubMed:24550300). {ECO:0000269|PubMed:18552835, ECO:0000269|PubMed:20643123, ECO:0000269|PubMed:24056303, ECO:0000305}.; FUNCTION: Involved in maintaining chromosomal stability. Promotes DNA double-strand break (DSB) repair by association with DNA-dependent protein kinase complex DNA-PK and activating it in non-homologous end joining (NHEJ) (PubMed:22542840). Required for centrosome stability and proper chromosome segregation (PubMed:22542840). {ECO:0000269|PubMed:22542840}.",,,,,,,,,,,,"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; protein-containing complex [GO:0032991]; SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; multivesicular body sorting pathway [GO:0071985]; positive regulation of autophagosome maturation [GO:1901098]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of protein serine/threonine kinase activity [GO:0071900]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; viral entry into host cell [GO:0046718]","autophagy [GO:0006914]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; multivesicular body sorting pathway [GO:0071985]; positive regulation of autophagosome maturation [GO:1901098]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of protein serine/threonine kinase activity [GO:0071900]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; viral entry into host cell [GO:0046718]",SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; protein-containing complex [GO:0032991]",GO:0000149; GO:0000775; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005783; GO:0005813; GO:0006281; GO:0006890; GO:0006914; GO:0007051; GO:0007059; GO:0007098; GO:0017124; GO:0030496; GO:0032465; GO:0032801; GO:0032991; GO:0035493; GO:0045335; GO:0046718; GO:0051684; GO:0071900; GO:0071985; GO:0097680; GO:1901098,IPR000008; IPR035892; IPR018791; ,Q07812; Q14457; Q8NEB9; Q6NUQ1; Q92622; Q9Y371; Q9QUM4; Q96AX1,"SUBUNIT: Component of the PI3K (PI3KC3/PI3K-III/class III phosphatidylinositol 3-kinase) complex II (PI3KC3-C2) in which the core composed of the catalytic subunit PIK3C3, the regulatory subunit PIK3R4 and BECN1 is associated with UVRAG; in the complex interacts directly with BECN1. PI3KC3-C2 can associate with further regulatory subunits such as RUBCN and probably SH3GLB1/Bif-1 (PubMed:16799551, PubMed:18843052, PubMed:19050071, PubMed:19270696, PubMed:20643123, PubMed:23878393, PubMed:24056303). Interacts with SH3GLB1; UVRAG bridges the interaction to BECN1 indicative for an association with the PI3K complex PI3KC3-C2 (PubMed:17891140). Interacts with RINT1. Associates with the NRZ complex under basal conditions and dissociates from it under autophagy conditions to associate with the PI3K complex; these complex associations seem to be mutually exclusive (PubMed:24056303). Interacts with VPS16; VPS11; VPS18; VPS33 (VPS33A or VPS33B) and VPS39; indicative for an association with a class C Vps tethering complex (possibly the HOPS complex) (PubMed:18552835, PubMed:25533187). Interacts with RAB7A; RAB7A competes with UVRAG for RUBCN binding (PubMed:25533187, PubMed:20974968). Interacts with STX7, VTI1B, STX8 (PubMed:24550300). Interacts with PRKDC, XRCC6 and XRCC5; indicative for an association with the DNA-dependent protein kinase complex DNA-PK. Interacts with CEP63 (PubMed:22542840). Directly interacts with FEZ1 and SCOC; the interaction with SCOC is reduced by amino acid starvation, but the complex is stabilized in the presence of FEZ1 (PubMed:22354037). Interacts with BECN1P1/BECN2 (PubMed:23954414). Interracts with SLAMF1( PubMed:22493499). {ECO:0000269|PubMed:16799551, ECO:0000269|PubMed:17891140, ECO:0000269|PubMed:18552835, ECO:0000269|PubMed:18843052, ECO:0000269|PubMed:19050071, ECO:0000269|PubMed:19270696, ECO:0000269|PubMed:20643123, ECO:0000269|PubMed:20974968, ECO:0000269|PubMed:22354037, ECO:0000269|PubMed:22493499, ECO:0000269|PubMed:22542840, ECO:0000269|PubMed:23878393, ECO:0000269|PubMed:23954414, ECO:0000269|PubMed:24056303, ECO:0000269|PubMed:24550300, ECO:0000269|PubMed:25533187}.",9169138; 10798355; 14702039; 16554811; 16799551; 17891140; 18843052; 18691976; 18552835; 18669648; 19050071; 19369195; 19270696; 19690332; 20643123; 20974968; 20068231; 22542840; 22354037; 22493499; 23954414; 23186163; 23878393; 24056303; 24275569; 24550300; 25533187,9169138; 10798355; 14702039; 16554811; 16799551; 17891140; 18843052; 18691976; 18552835; 18669648; 19050071; 19369195; 19270696; 19690332; 20643123; 20974968; 20068231; 22542840; 22354037; 22493499; 23954414; 23186163; 23878393; 24056303; 24275569; 24550300; 25533187; 17106237; 18495205; 18641390; 20163458; 20379614; 20562859; 20724836; 21062745; 21597469; 21606679; 22081109; 22314358; 23200933; 24034250; 24349490; 24554770; 24785657; 24849286; 24882360; 24956373; 25490155; 25568151; 25807108; 26139536; 26234763; 26496610; 26717041; 27203177; 28982601; 29277783; 29710477; 29866835; 30061422,2002-01-23,2019-02-13,2000-10-01,147,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Coiled coil (1); Domain (1); Erroneous gene model prediction (1); Modified residue (10); Mutagenesis (1); Natural variant (1); Region (3),,"TISSUE SPECIFICITY: Highly expressed in brain, lung, kidney and liver. {ECO:0000269|PubMed:10798355}.",,Alternative splicing;Centromere;Chromosome;Coiled coil;Complete proteome;DNA damage;DNA repair;Endoplasmic reticulum;Endosome;Lysosome;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,,147,Alternative products (1); Caution (1); Function (2); Involvement in disease (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0137; KW-0158; KW-0175; KW-0181; KW-0227; KW-0234; KW-0256; KW-0458; KW-0597; KW-0621; KW-0967; KW-1185,,,,,DISEASE: Note=A chromosomal aberration involving UVRAG has been observed in a patient with heterotaxy (left-right axis malformation). Inversion Inv(11)(q13.5;q25). {ECO:0000269|PubMed:10798355}.,,,"PTM: Phosphorylated at Ser-498 by MTOR under basal conditions; increases the interaction with RUBCN implicated in inhibitory effect of RUBCN on PI3KC3 and decreases interaction with RAB7,A and VPS16 and VPS39 (indicative for a class C Vps complex, possibly the HOPS complex) (PubMed:25533187). {ECO:0000269|PubMed:25533187}.",CHAIN 1 699 UV radiation resistance-associated gene protein. /FTId=PRO_0000065750.,,,,,,"MOD_RES 493 493 Phosphoserine. {ECO:0000269|PubMed:25533187}.; MOD_RES 498 498 Phosphoserine; by MTOR. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:25533187}.; MOD_RES 508 508 Phosphoserine. {ECO:0000269|PubMed:25533187}.; MOD_RES 518 518 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 522 522 Phosphoserine. {ECO:0000269|PubMed:25533187}.; MOD_RES 549 549 Phosphoserine. {ECO:0000269|PubMed:25533187}.; MOD_RES 550 550 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:25533187}.; MOD_RES 571 571 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 582 582 Phosphoserine. {ECO:0000269|PubMed:25533187}.; MOD_RES 689 689 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X99050;AB012958;AK095352;AK296871;AK316133;
0,Q9UDY2,ZO2_HUMAN,TJP2 X104 ZO2,TJP2,X104 ZO2,,,Homo sapiens (Human),9606,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),UP000005640: Chromosome 9,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MPVRGDRGFPPRRELSGWLRAPGMEELIWEQYTVTLQKDSKRGFGIAVSGGRDNPHFENGETSIVISDVLPGGPADGLLQENDRVVMVNGTPMEDVLHSFAVQQLRKSGKVAAIVVKRPRKVQVAALQASPPLDQDDRAFEVMDEFDGRSFRSGYSERSRLNSHGGRSRSWEDSPERGRPHERARSRERDLSRDRSRGRSLERGLDQDHARTRDRSRGRSLERGLDHDFGPSRDRDRDRSRGRSIDQDYERAYHRAYDPDYERAYSPEYRRGARHDARSRGPRSRSREHPHSRSPSPEPRGRPGPIGVLLMKSRANEEYGLRLGSQIFVKEMTRTGLATKDGNLHEGDIILKINGTVTENMSLTDARKLIEKSRGKLQLVVLRDSQQTLINIPSLNDSDSEIEDISEIESNRSFSPEERRHQYSDYDYHSSSEKLKERPSSREDTPSRLSRMGATPTPFKSTGDIAGTVVPETNKEPRYQEDPPAPQPKAAPRTFLRPSPEDEAIYGPNTKMVRFKKGDSVGLRLAGGNDVGIFVAGIQEGTSAEQEGLQEGDQILKVNTQDFRGLVREDAVLYLLEIPKGEMVTILAQSRADVYRDILACGRGDSFFIRSHFECEKETPQSLAFTRGEVFRVVDTLYDGKLGNWLAVRIGNELEKGLIPNKSRAEQMASVQNAQRDNAGDRADFWRMRGQRSGVKKNLRKSREDLTAVVSVSTKFPAYERVLLREAGFKRPVVLFGPIADIAMEKLANELPDWFQTAKTEPKDAGSEKSTGVVRLNTVRQIIEQDKHALLDVTPKAVDLLNYTQWFPIVIFFNPDSRQGVKTMRQRLNPTSNKSSRKLFDQANKLKKTCAHLFTATINLNSANDSWFGSLKDTIQHQQGEAVWVSEGKMEGMDDDPEDRMSYLTAMGADYLSCDSRLISDFEDTDGEGGAYTDNELDEPAEEPLVSSITRSSEPVQHEESIRKPSPEPRAQMRRAASSDQLRDNSPPPAFKPEPPKAKTQNKEESYDFSKSYEYKSNPSAVAGNETPGASTKGYPPPVAAKPTFGRSILKPSTPIPPQEGEEVGESSEEQDNAPKSVLGKVKIFEKMDHKARLQRMQELQEAQNARIEIAQKHPDIYAVPIKTHKPDPGTPQHTSSRPPEPQKAPSRPYQDTRGSYGSDAEEEEYRQQLSEHSKRGYYGQSARYRDTEL,1190,"133,958",,"ALTERNATIVE PRODUCTS:  Event=Alternative promoter usage, Alternative splicing; Named isoforms=7;  Name=A1; IsoId=Q9UDY2-1; Sequence=Displayed; Note=Produced by alternative promoter usage.; Name=A2; IsoId=Q9UDY2-2; Sequence=VSP_003149; Note=Produced by alternative splicing of isoform A1.; Name=A3; IsoId=Q9UDY2-5; Sequence=VSP_007835, VSP_007836; Note=Produced by alternative splicing of isoform A1.; Name=C1; IsoId=Q9UDY2-3; Sequence=VSP_006953; Note=Produced by alternative promoter usage.; Name=C2; IsoId=Q9UDY2-4; Sequence=VSP_006953, VSP_003149; Note=Produced by alternative splicing of isoform C1.; Name=6; IsoId=Q9UDY2-6; Sequence=VSP_046115, VSP_046116; Note=No experimental confirmation available.; Name=7; IsoId=Q9UDY2-7; Sequence=VSP_046114; Note=No experimental confirmation available.; ",,,,,"SEQUENCE CAUTION:  Sequence=AAA61300.1; Type=Frameshift; Positions=1086, 1092, 1095; Evidence={ECO:0000305}; ",,,,,VAR_SEQ 1 23 Missing (in isoform C1 and isoform C2). {ECO:0000305}. /FTId=VSP_006953.; VAR_SEQ 1 20 MPVRGDRGFPPRRELSGWLR -> MKTAQALHRMWIQAVKKLRRWKGRVSPSASSPLVFPNLSSWEGEGSKTILT (in isoform 7). {ECO:0000303|PubMed:14702039}. /FTId=VSP_046114.; VAR_SEQ 1 19 MPVRGDRGFPPRRELSGWL -> MKTAQALHRMWIQAVKKLRRWKG (in isoform 6). {ECO:0000303|PubMed:14702039}. /FTId=VSP_046115.; VAR_SEQ 961 1107 Missing (in isoform A2 and isoform C2). {ECO:0000305}. /FTId=VSP_003149.; VAR_SEQ 961 997 Missing (in isoform 6). {ECO:0000303|PubMed:14702039}. /FTId=VSP_046116.; VAR_SEQ 961 993 SIRKPSPEPRAQMRRAASSDQLRDNSPPPAFKP -> VRRGRPRAGTGEPGVFLALSWTAVCSGCCGRHS (in isoform A3). {ECO:0000303|Ref.3}. /FTId=VSP_007835.; VAR_SEQ 994 1190 Missing (in isoform A3). {ECO:0000303|Ref.3}. /FTId=VSP_007836.,"VARIANT 48 48 V -> A (in FHCA; dbSNP:rs121918299). {ECO:0000269|PubMed:12704386}. /FTId=VAR_016004.; VARIANT 482 482 D -> E (in dbSNP:rs2309428). {ECO:0000244|PubMed:21269460, ECO:0000269|PubMed:11018256, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:7951235, ECO:0000269|Ref.3}. /FTId=VAR_030798.; VARIANT 668 668 M -> I (in dbSNP:rs34774441). {ECO:0000269|PubMed:14702039}. /FTId=VAR_046675.; VARIANT 711 711 S -> P (in dbSNP:rs35797487). /FTId=VAR_046676.; VARIANT 822 822 K -> N (in dbSNP:rs1049624). {ECO:0000269|PubMed:7951235}. /FTId=VAR_046677.; VARIANT 829 829 N -> D (in dbSNP:rs1049625). {ECO:0000269|PubMed:7951235}. /FTId=VAR_046678.",,,,CONFLICT 411 411 N -> T (in Ref. 1; AAA61300 and 3; AAM28524). {ECO:0000305}.; CONFLICT 718 718 A -> V (in Ref. 4; BAH13722). {ECO:0000305}.; CONFLICT 782 782 I -> V (in Ref. 1; AAA61300 and 3; AAM28524). {ECO:0000305}.; CONFLICT 808 808 P -> S (in Ref. 1; AAA61300). {ECO:0000305}.; CONFLICT 812 814 FFN -> SFT (in Ref. 1; AAA61300). {ECO:0000305}.; CONFLICT 834 834 K -> N (in Ref. 1; AAA61300). {ECO:0000305}.; CONFLICT 842 842 Q -> H (in Ref. 1; AAA61300). {ECO:0000305}.; CONFLICT 996 996 P -> S (in Ref. 1; AAA61300). {ECO:0000305}.; CONFLICT 1093 1093 R -> G (in Ref. 1; AAA61300). {ECO:0000305}.; CONFLICT 1110 1110 I -> L (in Ref. 4; BAH13722). {ECO:0000305}.; CONFLICT 1136 1136 S -> N (in Ref. 9; AAB41794). {ECO:0000305}.; CONFLICT 1155 1158 GSYG -> RSFC (in Ref. 9; AAB41794). {ECO:0000305}.; CONFLICT 1165 1167 EYR -> IRS (in Ref. 9; AAB41794). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the MAGUK family. {ECO:0000305}.,,COMPBIAS 1162 1165 Poly-Glu.,DOMAIN 33 120 PDZ 1. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 307 385 PDZ 2. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 509 590 PDZ 3. {ECO:0000255|PROSITE-ProRule:PRU00143}.; DOMAIN 604 669 SH3. {ECO:0000255|PROSITE-ProRule:PRU00192}.; DOMAIN 678 876 Guanylate kinase-like. {ECO:0000255|PROSITE-ProRule:PRU00100}.,,REGION 1188 1190 Interaction with SCRIB. {ECO:0000269|PubMed:15975580}.,,,,,,,,FUNCTION: Plays a role in tight junctions and adherens junctions.,,,,,,,,,,,,"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; guanylate kinase activity [GO:0004385]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; establishment of endothelial intestinal barrier [GO:0090557]; hippo signaling [GO:0035329]; intestinal absorption [GO:0050892]; regulation of membrane permeability [GO:0090559]",establishment of endothelial intestinal barrier [GO:0090557]; hippo signaling [GO:0035329]; intestinal absorption [GO:0050892]; regulation of membrane permeability [GO:0090559],"cadherin binding [GO:0045296]; guanylate kinase activity [GO:0004385]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]",adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],GO:0004385; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0019904; GO:0030054; GO:0030674; GO:0035329; GO:0045296; GO:0050892; GO:0090557; GO:0090559,IPR008145; IPR008144; IPR027417; IPR001478; IPR036034; IPR036028; IPR001452; IPR005417; IPR005419; IPR035598; ,Q14847,"SUBUNIT: Homodimer, and heterodimer with ZO1. Interacts with occludin, SAFB and UBN1. Interaction with SAFB occurs in the nucleus. Interacts with SCRIB. Interacts with USP53 (via the C-terminal region) (By similarity). {ECO:0000250|UniProtKB:Q9Z0U1, ECO:0000269|PubMed:15975580, ECO:0000269|PubMed:17897942, ECO:0000269|PubMed:18823282}.",7951235; 11018256; 14702039; 15164053; 15489334; 10360833; 10495427; 15975580; 17081983; 18088087; 18669648; 18318008; 19413330; 18823282; 19690332; 20068231; 21406692; 23186163; 24275569; 24614073; 17897942; 12704386; 21269460,7951235; 11018256; 14702039; 15164053; 15489334; 10360833; 10495427; 15975580; 17081983; 18088087; 18669648; 18318008; 19413330; 18823282; 19690332; 20068231; 21406692; 23186163; 24275569; 24614073; 17897942; 12704386; 21269460; 15054114; 15324660; 15494376; 15778465; 17353931; 19071123; 19342771; 19615732; 20195357; 20562859; 20850437; 20868367; 22094256; 22665060; 23416715; 23602568; 23902751; 24255178; 25277244; 26496610; 26638075,2001-04-27,2019-02-13,2011-01-11,203,X-ray crystallography (1); NMR spectroscopy (1),STRAND 306 311 {ECO:0000244|PDB:3E17}.; STRAND 315 317 {ECO:0000244|PDB:2OSG}.; STRAND 321 332 {ECO:0000244|PDB:3E17}.; STRAND 349 353 {ECO:0000244|PDB:3E17}.; STRAND 376 381 {ECO:0000244|PDB:3E17}.,HELIX 337 341 {ECO:0000244|PDB:3E17}.; HELIX 363 372 {ECO:0000244|PDB:3E17}.,TURN 373 375 {ECO:0000244|PDB:3E17}.,,,,,5 out of 5,Alternative sequence (7); Beta strand (5); Chain (1); Compositional bias (1); Domain (5); Frameshift (1); Helix (2); Modified residue (41); Natural variant (6); Region (1); Sequence conflict (15); Turn (1),,"TISSUE SPECIFICITY: This protein is found in epithelial cell junctions. Isoform A1 is abundant in the heart and brain. Detected in brain and skeletal muscle. It is present almost exclusively in normal tissues. Isoform C1 is expressed at high level in the kidney, pancreas, heart and placenta. Not detected in brain and skeletal muscle. Found in normal as well as in most neoplastic tissues. {ECO:0000269|PubMed:11018256}.",,3D-structure;Alternative promoter usage;Alternative splicing;Cell junction;Cell membrane;Complete proteome;Disease mutation;Intrahepatic cholestasis;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH3 domain;Tight junction,Evidence at protein level,reviewed,,MAGUK family,203,Alternative products (1); Caution (7); Function (1); Involvement in disease (2); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0181; KW-0225; KW-0472; KW-0539; KW-0597; KW-0621; KW-0677; KW-0728; KW-0796; KW-0877; KW-0965; KW-0988; KW-1003; KW-1185,,,,,"DISEASE: Familial hypercholanemia (FHCA) [MIM:607748]: A disorder characterized by elevated serum bile acid concentrations, itching, and fat malabsorption. {ECO:0000269|PubMed:12704386}. Note=The disease may be caused by mutations affecting distinct genetic loci, including the gene represented in this entry.; DISEASE: Cholestasis, progressive familial intrahepatic, 4 (PFIC4) [MIM:615878]: A disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease before adulthood. {ECO:0000269|PubMed:24614073}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 1190 Tight junction protein ZO-2. /FTId=PRO_0000094543.,,,,,,"MOD_RES 16 16 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 130 130 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 150 150 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 153 153 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 163 163 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z0U1}.; MOD_RES 168 168 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 170 170 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 174 174 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 200 200 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 220 220 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 232 232 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 244 244 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 266 266 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 325 325 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 398 398 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z0U1}.; MOD_RES 400 400 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 406 406 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 415 415 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 424 424 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 430 430 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 431 431 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 455 455 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 499 499 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 574 574 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9Z0U1}.; MOD_RES 702 702 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:24275569}.; MOD_RES 902 902 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z0U1}.; MOD_RES 905 905 Phosphothreonine. {ECO:0000250|UniProtKB:Q9Z0U1}.; MOD_RES 913 913 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 920 920 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 925 925 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 933 933 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 966 966 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 978 978 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 986 986 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 1006 1006 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z0U1}.; MOD_RES 1067 1067 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 1068 1068 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692}.; MOD_RES 1118 1118 Phosphotyrosine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1131 1131 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1147 1147 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 1159 1159 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,L27476;AF177533;AF043195;AF043196;AF043197;AF177518;AF177519;AF177520;AF177521;AF177522;AF177523;AF177524;AF177525;AF177526;AF177527;AF177528;AF177529;AF177530;AF177531;AF177532;AF177533;AF043196;AF043197;AF177518;AF177519;AF177520;AF177521;AF177522;AF177523;AF177524;AF177525;AF177526;AF177527;AF177528;AF177529;AF177530;AF177531;AF177532;AF177533;AF043195;AF043196;AF043197;AF177518;AF177519;AF177520;AF177521;AF177522;AF177523;AF177524;AF177525;AF177526;AF177527;AF177528;AF177529;AF177532;AF177533;AF043196;AF043197;AF177518;AF177519;AF177520;AF177521;AF177522;AF177523;AF177524;AF177525;AF177526;AF177527;AF177528;AF177529;AF177532;AF489824;AK295034;AK302483;BC027592;AF083892;AF083893;U84581;
0,Q9UFW8,CGBP1_HUMAN,CGGBP1 CGGBP,CGGBP1,CGGBP,,,Homo sapiens (Human),9606,CGG triplet repeat-binding protein 1 (CGG-binding protein 1) (20 kDa CGG-binding protein) (p20-CGGBP DNA-binding protein),UP000005640: Chromosome 3,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MERFVVTAPPARNRSKTALYVTPLDRVTEFGGELHEDGGKLFCTSCNVVLNHVRKSAISDHLKSKTHTKRKAEFEEQNVRKKQRPLTASLQCNSTAQTEKVSVIQDFVKMCLEANIPLEKADHPAVRAFLSRHVKNGGSIPKSDQLRRAYLPDGYENENQLLNSQDC,167,"18,820",,,,,,,SEQUENCE CAUTION:  Sequence=CAB55894.1; Type=Frameshift; Positions=149; Evidence={ECO:0000305}; ,,,,,,,,,,CONFLICT 165 165 Q -> R (in Ref. 2; CAB55894). {ECO:0000305}.,,2,,0,,,,,,MOTIF 80 84 Nuclear localization signal. {ECO:0000255}.,,,,,,,,,FUNCTION: Binds to nonmethylated 5'-d(CGG)(n)-3' trinucleotide repeats in the FMR1 promoter. May play a role in regulating FMR1 promoter. {ECO:0000269|PubMed:9201980}.,,,,,,,,,,,,"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]",negative regulation of transcription by RNA polymerase II [GO:0000122],"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]",nucleoplasm [GO:0005654]; nucleus [GO:0005634],GO:0000122; GO:0000977; GO:0001227; GO:0003690; GO:0005634; GO:0005654; GO:0042802,IPR033375; ,Itself; Q86V42; O76003; Q04864; O00560; Q05086-3,,9201980; 14667814; 17974005; 15489334; 17525332; 20068231; 21269460,9201980; 14667814; 17974005; 15489334; 17525332; 20068231; 21269460; 10692448; 16169070; 19728537; 20141036; 21516116; 21733196; 22810585; 23902751; 24196442; 24491049; 25416956; 25483050; 25609649; 25981527; 26306647; 26482656; 26496610,2006-10-17,2019-02-13,2006-10-17,131,,,,,,,,,5 out of 5,Chain (1); Frameshift (1); Modified residue (2); Motif (1); Sequence conflict (1),,"TISSUE SPECIFICITY: Ubiquitous. Highly expressed in placenta, thymus, lymph nodes, cerebellum and cerebral cortex. Low expression in other regions of the brain. {ECO:0000269|PubMed:14667814}.",MISCELLANEOUS: Binding is severely inhibited by complete or partial cytosine-specific DNA methylation of the binding motif.,Complete proteome;DNA-binding;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation,Evidence at protein level,reviewed,,,131,Developmental stage (1); Function (1); Miscellaneous (1); Subcellular location (1); Tissue specificity (1),,KW-0181; KW-0238; KW-0539; KW-0597; KW-0804; KW-0805; KW-0903; KW-1185,,,,,,,,,CHAIN 1 167 CGG triplet repeat-binding protein 1. /FTId=PRO_0000252415.,,,,,,"MOD_RES 56 56 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 164 164 Phosphoserine. {ECO:0000244|PubMed:17525332, ECO:0000244|PubMed:20068231}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AJ000258;AF094481;CR456854;AL117392;AM393707;CH471110;CH471110;BC052980;
0,Q9UHB6,LIMA1_HUMAN,LIMA1 EPLIN SREBP3 PP624,LIMA1,EPLIN SREBP3,,PP624,Homo sapiens (Human),9606,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),UP000005640: Chromosome 12,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MESSPFNRRQWTSLSLRVTAKELSLVNKNKSSAIVEIFSKYQKAAEETNMEKKRSNTENLSQHFRKGTLTVLKKKWENPGLGAESHTDSLRNSSTEIRHRADHPPAEVTSHAASGAKADQEEQIHPRSRLRSPPEALVQGRYPHIKDGEDLKDHSTESKKMENCLGESRHEVEKSEISENTDASGKIEKYNVPLNRLKMMFEKGEPTQTKILRAQSRSASGRKISENSYSLDDLEIGPGQLSSSTFDSEKNESRRNLELPRLSETSIKDRMAKYQAAVSKQSSSTNYTNELKASGGEIKIHKMEQKENVPPGPEVCITHQEGEKISANENSLAVRSTPAEDDSRDSQVKSEVQQPVHPKPLSPDSRASSLSESSPPKAMKKFQAPARETCVECQKTVYPMERLLANQQVFHISCFRCSYCNNKLSLGTYASLHGRIYCKPHFNQLFKSKGNYDEGFGHRPHKDLWASKNENEEILERPAQLANARETPHSPGVEDAPIAKVGVLAASMEAKASSQQEKEDKPAETKKLRIAWPPPTELGSSGSALEEGIKMSKPKWPPEDEISKPEVPEDVDLDLKKLRRSSSLKERSRPFTVAASFQSTSVKSPKTVSPPIRKGWSMSEQSEESVGGRVAERKQVENAKASKKNGNVGKTTWQNKESKGETGKRSKEGHSLEMENENLVENGADSDEDDNSFLKQQSPQEPKSLNWSSFVDNTFAEEFTTQNQKSQDVELWEGEVVKELSVEEQIKRNRYYDEDEDEE,759,"85,226",,"ALTERNATIVE PRODUCTS:  Event=Alternative promoter usage, Alternative splicing; Named isoforms=5;  Name=Beta; IsoId=Q9UHB6-1; Sequence=Displayed; Note=Produced by alternative promoter usage.; Name=Alpha; IsoId=Q9UHB6-2; Sequence=VSP_003116; Note=Produced by alternative promoter usage. {ECO:0000244|PubMed:22814378}; Name=3; IsoId=Q9UHB6-3; Sequence=VSP_003117; Note=Produced by alternative splicing of isoform Beta.; Name=4; IsoId=Q9UHB6-4; Sequence=VSP_040136; Note=Produced by alternative splicing. {ECO:0000244|PubMed:20068231}; Name=5; IsoId=Q9UHB6-5; Sequence=VSP_003116, VSP_040136; Note=No experimental confirmation available. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:22814378}; ",,SEQUENCE CAUTION:  Sequence=BAD92749.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,"SEQUENCE CAUTION:  Sequence=AAG17267.1; Type=Frameshift; Positions=365, 662; Evidence={ECO:0000305};  Sequence=BAA91120.1; Type=Frameshift; Positions=697; Evidence={ECO:0000305}; ",,POLYMORPHISM: Genetic variations in LIMA1 influence low density lipoprotein cholesterol (LDL-C) variability and contribute to the low density lipoprotein cholesterol level quantitative trait locus 8 (LDLCQ8) [MIM:618079]. {ECO:0000269|PubMed:29880681}.,,,"VAR_SEQ 1 302 Missing (in isoform 3). {ECO:0000303|PubMed:10931946, ECO:0000303|PubMed:14702039}. /FTId=VSP_003117.; VAR_SEQ 1 160 Missing (in isoform Alpha and isoform 5). {ECO:0000303|PubMed:10618726, ECO:0000303|PubMed:14702039}. /FTId=VSP_003116.; VAR_SEQ 344 344 R -> PG (in isoform 4 and isoform 5). {ECO:0000303|PubMed:10931946, ECO:0000303|Ref.5}. /FTId=VSP_040136.",VARIANT 25 25 L -> I (polymorphism; associated with lower plasma levels of low-density lipoprotein cholesterol; reduces protein stability; dbSNP:rs140372565). {ECO:0000269|PubMed:29880681}. /FTId=VAR_080864.,,,,CONFLICT 381 381 Missing (in Ref. 4; BAA90914 and 7; AAH01247). {ECO:0000305}.; CONFLICT 415 415 F -> L (in Ref. 8; AAG17267). {ECO:0000305}.; CONFLICT 463 463 D -> G (in Ref. 4; BAA90914). {ECO:0000305}.; CONFLICT 491 491 P -> Q (in Ref. 2; AAF67491). {ECO:0000305}.; CONFLICT 520 521 DK -> NR (in Ref. 2; AAF67491). {ECO:0000305}.,,1,,0,"DOMAIN: Contains at least 2 actin-binding domains, one on each side of the LIM domain. Both domains bind actin monomers and filaments. The C-terminal domain binds filaments more efficiently than the N-terminus. {ECO:0000269|PubMed:12566430}.",,,,DOMAIN 388 448 LIM zinc-binding. {ECO:0000255|PROSITE-ProRule:PRU00125}.,MOTIF 164 166 Required for interaction with NPC1L1. {ECO:0000250|UniProtKB:Q9ERG0}.,REGION 493 513 Required for interaction with MYO5B. {ECO:0000250|UniProtKB:Q9ERG0}.,,,,,,,,"FUNCTION: Actin-binding protein involved in actin cytoskeleton regulation and dynamics. Increases the number and size of actin stress fibers and inhibits membrane ruffling. Inhibits actin filament depolymerization. Bundles actin filaments, delays filament nucleation and reduces formation of branched filaments (PubMed:12566430). Plays a role in cholesterol homeostasis. Influences plasma cholesterol levels through regulation of intestinal cholesterol absorption. May act as a scaffold protein by regulating NPC1L1 transportation, an essential protein for cholesterol absorption, to the plasma membrane by recruiting MYO5B to NPC1L1, and thus facilitates cholesterol uptake (By similarity). {ECO:0000250|UniProtKB:Q9ERG0, ECO:0000269|PubMed:12566430}.",,,,,,,,,,,,actin cytoskeleton [GO:0015629]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; ruffle organization [GO:0031529],actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; ruffle organization [GO:0031529],actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872],actin cytoskeleton [GO:0015629]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725],GO:0001725; GO:0001726; GO:0003785; GO:0005829; GO:0005886; GO:0005925; GO:0008203; GO:0015629; GO:0016477; GO:0030299; GO:0030835; GO:0031526; GO:0031529; GO:0032154; GO:0042632; GO:0045296; GO:0046872; GO:0051015; GO:0051017,IPR028740; IPR001781; ,P12830; P35221; O46385,"SUBUNIT: Interacts with NPCL1; bridges NPC1L1 with MYO5B (PubMed:29880681). Interacts with MYO5B; bridges NPC1L1 with MYO5B (PubMed:29880681). Interacts with PXN; this complex stabilizes actin dynamics (PubMed:24694988). Interacts with F-actin and G-actin (PubMed:12566430). {ECO:0000269|PubMed:12566430, ECO:0000269|PubMed:24694988, ECO:0000269|PubMed:29880681}.",10618726; 10931946; 11230166; 14702039; 15489334; 15498874; 11256614; 10806352; 12566430; 17081983; 17924679; 18088087; 18691976; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 24694988; 29880681; ,10618726; 10931946; 11230166; 14702039; 15489334; 15498874; 11256614; 10806352; 12566430; 17081983; 17924679; 18088087; 18691976; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 24694988; 29880681; 12577067; 15161933; 17110338; 17620599; 17979178; 18093941; 18796137; 19221476; 20309963; 20711500; 20848180; 21182203; 21625216; 22194609; 22493360; 22555292; 23188829; 23764002; 24135282; 24189400; 24255178; 26350886; 26496610; 27035883; 28465438,2002-03-05,2019-02-13,2000-05-01,183,NMR spectroscopy (1),STRAND 384 387 {ECO:0000244|PDB:2D8Y}.; STRAND 401 404 {ECO:0000244|PDB:2D8Y}.; STRAND 406 411 {ECO:0000244|PDB:2D8Y}.; STRAND 432 434 {ECO:0000244|PDB:2D8Y}.,HELIX 439 445 {ECO:0000244|PDB:2D8Y}.,TURN 391 393 {ECO:0000244|PDB:2D8Y}.; TURN 412 414 {ECO:0000244|PDB:2D8Y}.; TURN 418 420 {ECO:0000244|PDB:2D8Y}.; TURN 426 428 {ECO:0000244|PDB:2D8Y}.,,,,,5 out of 5,Alternative sequence (3); Beta strand (4); Chain (1); Domain (1); Erroneous initiation (1); Frameshift (2); Helix (1); Modified residue (31); Motif (1); Natural variant (1); Region (1); Sequence conflict (6); Turn (4),,"TISSUE SPECIFICITY: Highly expressed in placenta, kidney, pancreas, prostate, ovary, spleen and heart. Also detected in lung, liver, brain, skeletal muscle, thymus, testis and intestine. Not detected in leukocytes. Isoform Beta expressed generally at very low levels. Isoform Alpha abundant in epithelial cells from mammary gland, prostate and in normal oral keratinocytes. Low levels in aortic endothelial cells and dermal fibroblasts. Not detectable in myocardium. {ECO:0000269|PubMed:24694988}.",,3D-structure;Acetylation;Actin-binding;Alternative promoter usage;Alternative splicing;Cell junction;Cell membrane;Cholesterol metabolism;Complete proteome;Cytoplasm;Cytoskeleton;LIM domain;Lipid metabolism;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Steroid metabolism;Sterol metabolism;Zinc,Evidence at protein level,reviewed,,,183,Alternative products (1); Caution (5); Domain (1); Function (1); Induction (1); Polymorphism (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0009; KW-0025; KW-0153; KW-0181; KW-0206; KW-0440; KW-0443; KW-0472; KW-0479; KW-0597; KW-0621; KW-0753; KW-0862; KW-0877; KW-0963; KW-0965; KW-1003; KW-1185; KW-1207,,,,,,,,PTM: Phosphorylation of the C-terminal region by MAPK1/MAPK3 reduces its association with F-actin and contributes to actin filament reorganization and enhances cell motility. {ECO:0000250|UniProtKB:Q9ERG0}.,CHAIN 1 759 LIM domain and actin-binding protein 1. /FTId=PRO_0000075730.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:20068231}.; MOD_RES 4 4 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 15 15 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 55 55 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 132 132 Phosphoserine. {ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 225 225 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 229 229 Phosphotyrosine. {ECO:0000244|PubMed:18669648}.; MOD_RES 230 230 Phosphoserine. {ECO:0000250|UniProtKB:Q9ERG0}.; MOD_RES 242 242 Phosphoserine. {ECO:0000250|UniProtKB:Q9ERG0}.; MOD_RES 263 263 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 343 343 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 350 350 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 362 362 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 365 365 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 369 369 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 374 374 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 439 439 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9ERG0}.; MOD_RES 490 490 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 601 601 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 604 604 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 609 609 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 617 617 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 686 686 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 692 692 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231}.; MOD_RES 698 698 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692}.; MOD_RES 726 726 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 741 741 Phosphoserine. {ECO:0000250|UniProtKB:Q9ERG0}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF198454;AF198455;AF157325;AL136911;AK000372;AK000335;AK023649;AK000057;AK314447;AB209512;CH471111;BC001247;BC010664;BC110815;BC136763;AF218025;
0,Q9UIF7,MUTYH_HUMAN,MUTYH MYH,MUTYH,MYH,,,Homo sapiens (Human),9606,Adenine DNA glycosylase (EC 3.2.2.31) (MutY homolog) (hMYH),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MTPLVSRLSRLWAIMRKPRAAVGSGHRKQAASQEGRQKHAKNNSQAKPSACDGMIAECPGAPAGLARQPEEVVLQASVSSYHLFRDVAEVTAFRGSLLSWYDQEKRDLPWRRRAEDEMDLDRRAYAVWVSEVMLQQTQVATVINYYTGWMQKWPTLQDLASASLEEVNQLWAGLGYYSRGRRLQEGARKVVEELGGHMPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIGADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQCPVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWDQTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAGLWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIKLTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQQPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ,546,"60,069",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=6;  Name=Alpha-1; IsoId=Q9UIF7-1; Sequence=Displayed; Name=Alpha-2; IsoId=Q9UIF7-2; Sequence=VSP_010549; Name=Alpha-3; IsoId=Q9UIF7-3; Sequence=VSP_010550; Name=Beta-1; IsoId=Q9UIF7-4; Sequence=VSP_010548; Name=Gamma-2; IsoId=Q9UIF7-5; Sequence=VSP_010548, VSP_010549; Name=Gamma-3; IsoId=Q9UIF7-6; Sequence=VSP_010548, VSP_010550; ",,SEQUENCE CAUTION:  Sequence=BAA89339.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};  Sequence=BAA89345.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,SEQUENCE CAUTION:  Sequence=BAA89339.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};  Sequence=BAA89345.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305}; ,"VAR_SEQ 1 14 Missing (in isoform Beta-1, isoform Gamma-2 and isoform Gamma-3). {ECO:0000303|PubMed:10684930}. /FTId=VSP_010548.; VAR_SEQ 53 63 Missing (in isoform Alpha-3 and isoform Gamma-3). {ECO:0000303|PubMed:10684930, ECO:0000303|PubMed:15489334}. /FTId=VSP_010550.; VAR_SEQ 53 62 Missing (in isoform Alpha-2 and isoform Gamma-2). {ECO:0000303|PubMed:10684930}. /FTId=VSP_010549.","VARIANT 18 18 P -> L (in FAP2; also found in multiple polyposis, colorectal and lung cancer cases; unknown pathological significance; decreased function in DNA repair; dbSNP:rs79777494). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077640.; VARIANT 22 22 V -> M (polymorphism; does not affect function in DNA repair; dbSNP:rs3219484). {ECO:0000269|PubMed:12606733, ECO:0000269|PubMed:16134147, ECO:0000269|PubMed:16287072, ECO:0000269|PubMed:16941501, ECO:0000269|PubMed:25820570, ECO:0000269|Ref.4}. /FTId=VAR_018872.; VARIANT 25 25 G -> D (polymorphism; does not affect function in DNA repair; dbSNP:rs75321043). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077641.; VARIANT 72 72 V -> E (polymorphism; does not affect DNA glycosylase activity). {ECO:0000269|PubMed:20848659}. /FTId=VAR_077642.; VARIANT 100 100 W -> R (found in sporadic hepatocellular carcinoma; unknown pathological significance; loss of function in DNA repair; dbSNP:rs1140507). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077643.; VARIANT 102 102 D -> N (found in multiple polyposis and sporadic colorectal cancer cases; unknown pathological significance; does not affect DNA glycosylase activity; does not affect function in DNA repair; dbSNP:rs587780746). {ECO:0000269|PubMed:25820570, ECO:0000269|PubMed:26694661}. /FTId=VAR_077644.; VARIANT 121 121 D -> G (polymorphism; does not affect DNA glycosylase activity; does not affect function in DNA repair). {ECO:0000269|PubMed:26694661}. /FTId=VAR_077645.; VARIANT 125 125 Y -> H (in FAP2; decreased function in DNA repair). {ECO:0000269|PubMed:15366000, ECO:0000269|PubMed:25820570}. /FTId=VAR_026045.; VARIANT 128 128 W -> R (in FAP2; loss of function in DNA repair; dbSNP:rs730881832). {ECO:0000269|PubMed:12853198, ECO:0000269|PubMed:25820570}. /FTId=VAR_026046.; VARIANT 148 148 G -> GIW (in FAP2; reduced DNA glycosylase activity; decreased DNA binding; loss of function in DNA repair). {ECO:0000269|PubMed:16287072, ECO:0000269|PubMed:19953527, ECO:0000269|PubMed:20418187}. /FTId=VAR_064938.; VARIANT 154 154 P -> L (in FAP2; decreased function in DNA repair; dbSNP:rs777184451). {ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:25820570}. /FTId=VAR_077646.; VARIANT 176 176 Y -> C (in FAP2; loss of DNA glycosylase activity; decreased DNA binding; loss of function in DNA repair; dbSNP:rs34612342). {ECO:0000269|PubMed:11818965, ECO:0000269|PubMed:12606733, ECO:0000269|PubMed:12853198, ECO:0000269|PubMed:16134147, ECO:0000269|PubMed:16287072, ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:16941501, ECO:0000269|PubMed:18091433, ECO:0000269|PubMed:19953527, ECO:0000269|PubMed:20418187, ECO:0000269|PubMed:20848659, ECO:0000269|PubMed:25820570}. /FTId=VAR_018873.; VARIANT 177 177 Y -> S (in FAP2). {ECO:0000269|PubMed:16941501}. /FTId=VAR_077647.; VARIANT 179 179 R -> C (in FAP2; also found in multiple polyposis and colorectal cancer cases; loss of function in DNA repair; dbSNP:rs747993448). {ECO:0000269|PubMed:18091433, ECO:0000269|PubMed:25820570}. /FTId=VAR_064939.; VARIANT 179 179 R -> H (in FAP2; loss of DNA glycosylase activity; loss of function in DNA repair; dbSNP:rs143353451). {ECO:0000269|PubMed:15366000, ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:20848659, ECO:0000269|PubMed:25820570}. /FTId=VAR_026047.; VARIANT 182 182 R -> Q (in FAP2; loss of function in DNA repair; dbSNP:rs533899702). {ECO:0000269|PubMed:16287072, ECO:0000269|PubMed:25820570}. /FTId=VAR_077648.; VARIANT 182 182 R -> W (in FAP2; loss of DNA glycosylase activity; loss of DNA binding; loss of function in DNA repair; dbSNP:rs750592289). {ECO:0000269|PubMed:18091433, ECO:0000269|PubMed:19953527, ECO:0000269|PubMed:20418187}. /FTId=VAR_064940.; VARIANT 186 186 G -> E (in FAP2; decreased function in DNA repair; dbSNP:rs754155145). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077649.; VARIANT 213 213 G -> E (in FAP2; dbSNP:rs768553551). {ECO:0000269|PubMed:18515411}. /FTId=VAR_077650.; VARIANT 220 220 I -> V (in FAP2; also found in multiple polyposis case; unknown pathological significance; reduced DNA glycosylase activity; no effect on function in DNA repair; dbSNP:rs200872702). {ECO:0000269|PubMed:16287072, ECO:0000269|PubMed:20848659, ECO:0000269|PubMed:25820570}. /FTId=VAR_077651.; VARIANT 224 224 A -> V (functional polymorphism; decreased function in DNA repair; dbSNP:rs11545695). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077652.; VARIANT 231 231 V -> M (probable disease-associated mutation found in a case of familial colorectal cancer; no significant effect on DNA glycosylase activity; slightly decreased function in DNA repair; dbSNP:rs200165598). {ECO:0000269|PubMed:25820570, ECO:0000269|PubMed:26694661}. /FTId=VAR_077653.; VARIANT 235 235 N -> S (in FAP2; loss of DNA glycosylase activity; loss of function in DNA repair; dbSNP:rs1057517765). {ECO:0000269|PubMed:18515411, ECO:0000269|PubMed:26694661}. /FTId=VAR_077654.; VARIANT 238 238 R -> W (in FAP2; also found in a case of sporadic colorectal cancer; unknown pathological significance; decreased function in DNA repair; dbSNP:rs34126013). {ECO:0000269|PubMed:15366000, ECO:0000269|PubMed:25820570}. /FTId=VAR_026048.; VARIANT 242 242 R -> C (probable disease-associated mutation found in multiple polyposis cases; decreased function in DNA repair; dbSNP:rs200495564). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077655.; VARIANT 242 242 R -> H (in FAP2; loss of function in DNA repair; dbSNP:rs140342925). {ECO:0000269|PubMed:16134147, ECO:0000269|PubMed:16287072, ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:25820570}. /FTId=VAR_077656.; VARIANT 243 243 V -> F (polymorphism; does not affect function; dbSNP:rs587780749). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077657.; VARIANT 244 244 R -> G (functional polymorphism; reduced DNA glycosylase activity; decreased function in DNA repair; dbSNP:rs587782885). {ECO:0000269|PubMed:26694661}. /FTId=VAR_077658.; VARIANT 271 271 R -> W (in FAP2; loss of function in DNA repair; dbSNP:rs769237459). {ECO:0000269|PubMed:16134147, ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:25820570}. /FTId=VAR_077659.; VARIANT 280 280 M -> V (in FAP2; reduced DNA glycosylase activity; dbSNP:rs876659676). {ECO:0000269|PubMed:16941501, ECO:0000269|PubMed:20848659}. /FTId=VAR_077660.; VARIANT 283 283 G -> E (in FAP2; also found in a patient with multiple polyps; unknown pathological significance; does not affect function in DNA repair; dbSNP:rs730881833). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077661.; VARIANT 287 287 C -> W (found in a case of sporadic lung cancer; unknown pathological significance; loss of function in DNA repair). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077662.; VARIANT 292 292 P -> L (in FAP2; also found in multiple polyposis cases; loss of function in DNA repair; dbSNP:rs374950566). {ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:16941501, ECO:0000269|PubMed:25820570}. /FTId=VAR_077663.; VARIANT 306 306 R -> C (in FAP2; also found in multiple polyposis cases; unknown pathological significance; does not affect DNA glycosylase activity; slightly decreased function in DNA repair; dbSNP:rs138089183). {ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:20848659, ECO:0000269|PubMed:25820570}. /FTId=VAR_077664.; VARIANT 319 319 S -> N (polymorphism; does not affect DNA glycosylase activity; does not affect function in DNA repair; dbSNP:rs587781810). {ECO:0000269|PubMed:26694661}. /FTId=VAR_077665.; VARIANT 335 335 Q -> H (polymorphism; does not affect function in DNA repair; dbSNP:rs3219489). {ECO:0000269|PubMed:12606733, ECO:0000269|PubMed:16134147, ECO:0000269|PubMed:16287072, ECO:0000269|PubMed:16941501, ECO:0000269|PubMed:25820570, ECO:0000269|Ref.4}. /FTId=VAR_018874.; VARIANT 335 335 Q -> R (found in a family with non-polyposis colorectal cancer-like syndrome; unknown pathological significance; does not affect function in DNA repair; dbSNP:rs199742231). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077666.; VARIANT 370 370 A -> V (polymorphism; does not affect DNA glycosylase activity; dbSNP:rs35352891). {ECO:0000269|PubMed:20848659}. /FTId=VAR_048262.; VARIANT 377 377 P -> T (in FAP2; decreased function in DNA repair). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077667.; VARIANT 385 385 L -> P (in FAP2; also found in multiple polyposis cases; loss of DNA glycosylase activity; loss of function in DNA repair; dbSNP:rs1060501335). {ECO:0000269|PubMed:16134147, ECO:0000269|PubMed:16941501, ECO:0000269|PubMed:20848659, ECO:0000269|PubMed:25820570}. /FTId=VAR_077668.; VARIANT 393 393 G -> D (in FAP2; reduced DNA glycosylase activity; decreased DNA binding; decreased function in DNA repair; dbSNP:rs36053993). {ECO:0000269|PubMed:11818965, ECO:0000269|PubMed:12606733, ECO:0000269|PubMed:12853198, ECO:0000269|PubMed:16134147, ECO:0000269|PubMed:16287072, ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:16941501, ECO:0000269|PubMed:18091433, ECO:0000269|PubMed:19953527, ECO:0000269|PubMed:20418187, ECO:0000269|PubMed:20848659, ECO:0000269|PubMed:25820570}. /FTId=VAR_018875.; VARIANT 402 402 P -> L (in FAP2; also found in multiple polyposis and colorectal cancer cases; loss of DNA glycosylase activity; loss of function in DNA repair; dbSNP:rs529008617). {ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:20848659, ECO:0000269|PubMed:25820570}. /FTId=VAR_077669.; VARIANT 402 402 P -> S (in GASC; sporadic; decreased function in DNA repair; dbSNP:rs121908382). {ECO:0000269|PubMed:15273732, ECO:0000269|PubMed:25820570}. /FTId=VAR_026049.; VARIANT 411 411 Q -> R (in GASC; sporadic; unknown pathological significance; does not affect function in DNA repair; dbSNP:rs121908383). {ECO:0000269|PubMed:15273732, ECO:0000269|PubMed:25820570}. /FTId=VAR_026050.; VARIANT 417 417 L -> M (in FAP2; also found in patient with multiple polyps and in a family with non-polyposis colorectal cancer-like syndrome; unknown pathological significance; does not affect function in DNA repair; dbSNP:rs144079536). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077670.; VARIANT 423 423 R -> C (in FAP2; unknown pathological significance; does not affect function in DNA repair; dbSNP:rs150792276). {ECO:0000269|PubMed:16134147, ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:25820570}. /FTId=VAR_077671.; VARIANT 434 434 R -> P (found in sporadic colorectal cancer cases; unknown pathological significance; decreased function in DNA repair). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077672.; VARIANT 434 434 R -> Q (polymorphism; does not affect function in DNA repair; dbSNP:rs587782120). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077673.; VARIANT 470 470 A -> D (in FAP2; loss of function in DNA repair; dbSNP:rs200844166). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077674.; VARIANT 470 470 A -> T (found in patient with multiple polyposis; unknown pathological significance; does not affect function in DNA repair; dbSNP:rs192816572). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077675.; VARIANT 474 474 T -> M (in FAP2; unknown pathological significance; dbSNP:rs767747402). {ECO:0000269|PubMed:18515411}. /FTId=VAR_077676.; VARIANT 477 477 Missing (in FAP2; also found in a case of sporadic colorectal cancer; loss of DNA glycosylase activity; loss of DNA binding; loss of function in DNA repair). {ECO:0000269|PubMed:16134147, ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:19953527, ECO:0000269|PubMed:20418187, ECO:0000269|PubMed:20848659, ECO:0000269|PubMed:25820570}. /FTId=VAR_064941.; VARIANT 486 486 A -> T (in FAP2; decreased function in DNA repair; dbSNP:rs587782263). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077677.; VARIANT 490 490 V -> F (in FAP2; found also in sporadic colorectal cancer cases; unknown pathological significance; decreased function in DNA repair; dbSNP:rs587782228). {ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:25820570}. /FTId=VAR_077678.; VARIANT 500 500 G -> E (functional polymorphism; decreased function in DNA repair; dbSNP:rs3219494). {ECO:0000269|PubMed:25820570, ECO:0000269|Ref.4}. /FTId=VAR_018876.; VARIANT 512 512 S -> F (polymorphism; does not affect DNA glycosylase activity; does not affect function in DNA repair; dbSNP:rs140118273). {ECO:0000269|PubMed:12606733, ECO:0000269|PubMed:16941501, ECO:0000269|PubMed:20848659, ECO:0000269|PubMed:25820570}. /FTId=VAR_026051.; VARIANT 513 513 P -> L (polymorphism; does not affect function in DNA repair; dbSNP:rs587778542). {ECO:0000269|PubMed:25820570}. /FTId=VAR_077679.; VARIANT 520 520 R -> H (polymorphism; does not affect DNA glycosylase activity; does not affect function in DNA repair; dbSNP:rs374655042). {ECO:0000269|PubMed:26694661}. /FTId=VAR_077680.; VARIANT 526 526 L -> M (polymorphism; does not affect function in DNA repair; dbSNP:rs3219496). {ECO:0000269|PubMed:25820570, ECO:0000269|Ref.4}. /FTId=VAR_018877.; VARIANT 531 531 R -> Q (polymorphism; does not affect function in DNA repair; dbSNP:rs3219497). {ECO:0000269|PubMed:25820570, ECO:0000269|Ref.4}. /FTId=VAR_018878.; VARIANT 536 536 T -> A (polymorphism; does not affect DNA glycosylase activity; does not affect function in DNA repair; dbSNP:rs151196169). {ECO:0000269|PubMed:26694661}. /FTId=VAR_077681.",,,,,,1,,0,,SIMILARITY: Belongs to the Nth/MutY family. {ECO:0000305}.,,,DOMAIN 364 495 Nudix hydrolase. {ECO:0000255|PROSITE-ProRule:PRU00794}.,MOTIF 404 426 Nudix box.,,,,3.2.2.31,,"CATALYTIC ACTIVITY: Reaction=Hydrolyzes free adenine bases from 7,8-dihydro-8-oxoguanine:adenine mismatched double-stranded DNA, leaving an apurinic site.; EC=3.2.2.31; Evidence={ECO:0000269|PubMed:20418187};","COFACTOR: Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883; Evidence={ECO:0000250};  Note=Binds 1 [4Fe-4S] cluster. The cluster does not appear to play a role in catalysis, but is probably involved in the proper positioning of the enzyme along the DNA strand. {ECO:0000250};",,"FUNCTION: Involved in oxidative DNA damage repair. Initiates repair of A*oxoG to C*G by removing the inappropriately paired adenine base from the DNA backbone. Possesses both adenine and 2-OH-A DNA glycosylase activities. {ECO:0000269|PubMed:10684930, ECO:0000269|PubMed:20418187, ECO:0000269|PubMed:20848659, ECO:0000269|PubMed:25820570, ECO:0000269|PubMed:26694661}.",,,,,,ACT_SITE 131 131 Proton donor/acceptor. {ECO:0000250|UniProtKB:P83847}.,,,METAL 287 287 Iron-sulfur (4Fe-4S). {ECO:0000250}.; METAL 294 294 Iron-sulfur (4Fe-4S). {ECO:0000250}.; METAL 297 297 Iron-sulfur (4Fe-4S). {ECO:0000250}.; METAL 303 303 Iron-sulfur (4Fe-4S). {ECO:0000250}.,,SITE 233 233 Transition state stabilizer. {ECO:0000250|UniProtKB:P83847}.,"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]",base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298],"4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]",mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GO:0000701; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006298; GO:0019104; GO:0032357; GO:0032407; GO:0034039; GO:0035485; GO:0045007; GO:0046872; GO:0051539,IPR011257; IPR004036; IPR003651; IPR004035; IPR003265; IPR000445; IPR023170; IPR029119; IPR015797; IPR000086; ,Q6RW13,,8682794; 10684930; 20843780; 16710414; 15489334; 11818965; 12853198; 12606733; 15366000; 15273732; 16134147; 16941501; 16287072; 16557584; 18091433; 18515411; 20418187; 19953527; 20848659; 25820570; 26694661,8682794; 10684930; 20843780; 16710414; 15489334; 11818965; 12853198; 12606733; 15366000; 15273732; 16134147; 16941501; 16287072; 16557584; 18091433; 18515411; 20418187; 19953527; 20848659; 25820570; 26694661; 11160897; 11433026; 11801590; 11805113; 12056405; 12393807; 12707038; 12807753; 12966098; 14991577; 14999774; 15034862; 15188161; 15236166; 15290654; 15449173; 15450125; 15523092; 15635083; 15673720; 15761860; 15890374; 15931596; 15943555; 16134146; 16169070; 16292541; 16408224; 16492928; 16521226; 16600130; 16609022; 16645203; 16773329; 16774938; 16804517; 16831587; 16890597; 16938257; 17031395; 17039270; 17081686; 17203305; 17207658; 17219200; 17219385; 17220334; 17417778; 17489848; 17505512; 17674103; 17703316; 17920897; 17931073; 17949294; 17956577; 18022921; 18027849; 18155253; 18172263; 18186383; 18271935; 18294051; 18298557; 18301448; 18383848; 18422726; 18454351; 18495334; 18503156; 18506705; 18534194; 18564191; 18612690; 18776649; 18811933; 18823566; 18848840; 18980800; 19000687; 19029194; 19032956; 19161591; 19245865; 19279422; 19300419; 19338676; 19394335; 19399402; 19443904; 19527492; 19531215; 19593690; 19620482; 19672709; 19685280; 19692168; 19732775; 19793053; 19820168; 19836313; 19902366; 19932167; 20110747; 20149637; 20150366; 20191381; 20226869; 20364408; 20453000; 20522537; 20570909; 20571908; 20574454; 20618354; 20625837; 20628285; 20640893; 20663686; 20687945; 20724227; 20725929; 20816984; 20877624; 20924072; 20924129; 20939750; 21044966; 21061173; 21063410; 21112374; 21171015; 21279954; 21287799; 21355073; 21424714; 21443744; 21615992; 21777424; 21826668; 21846783; 21901162; 21952991; 21962078; 22103048; 22126480; 22266422; 22297469; 22371070; 22469480; 22469746; 22473953; 22641385; 22780951; 22809968; 22851115; 22865608; 22926731; 22976915; 23007840; 23108399; 23322991; 23361220; 23396182; 23499241; 23561487; 23605219; 23618615; 23805267; 23936466; 24039736; 24209961; 24315136; 24377541; 24377542; 24412244; 24420788; 24444654; 24470512; 24518836; 24569162; 24620956; 24799981; 24953332; 25127721; 25822476; 25829257; 25916209; 25998844; 26056087; 26074017; 26202870; 26273655; 26377631; 26446593; 26511139; 26684191; 26902849; 26980051; 27194394; 27253753; 27631816; 27829682; 27870730; 27999205; 28087410; 28127763; 28173856; 28340109; 28575236; 28634180; 28891849; 29149600; 29257843; 29330641,2004-06-07,2019-02-13,2000-05-01,180,X-ray crystallography (1); NMR spectroscopy (1),STRAND 289 291 {ECO:0000244|PDB:3N5N}.; STRAND 358 360 {ECO:0000244|PDB:1X51}.; STRAND 366 377 {ECO:0000244|PDB:1X51}.; STRAND 379 388 {ECO:0000244|PDB:1X51}.; STRAND 403 405 {ECO:0000244|PDB:1X51}.; STRAND 447 456 {ECO:0000244|PDB:1X51}.; STRAND 470 474 {ECO:0000244|PDB:1X51}.,HELIX 87 104 {ECO:0000244|PDB:3N5N}.; HELIX 109 116 {ECO:0000244|PDB:3N5N}.; HELIX 120 135 {ECO:0000244|PDB:3N5N}.; HELIX 139 152 {ECO:0000244|PDB:3N5N}.; HELIX 156 160 {ECO:0000244|PDB:3N5N}.; HELIX 164 171 {ECO:0000244|PDB:3N5N}.; HELIX 177 193 {ECO:0000244|PDB:3N5N}.; HELIX 202 208 {ECO:0000244|PDB:3N5N}.; HELIX 214 224 {ECO:0000244|PDB:3N5N}.; HELIX 234 243 {ECO:0000244|PDB:3N5N}.; HELIX 253 266 {ECO:0000244|PDB:3N5N}.; HELIX 272 285 {ECO:0000244|PDB:3N5N}.; HELIX 300 302 {ECO:0000244|PDB:3N5N}.; HELIX 304 316 {ECO:0000244|PDB:3N5N}.; HELIX 330 332 {ECO:0000244|PDB:3N5N}.; HELIX 410 424 {ECO:0000244|PDB:1X51}.; HELIX 475 480 {ECO:0000244|PDB:1X51}.; HELIX 485 495 {ECO:0000244|PDB:1X51}.,,,,,,5 out of 5,Active site (1); Alternative sequence (3); Beta strand (7); Chain (1); Domain (1); Erroneous initiation (2); Helix (18); Metal binding (4); Motif (1); Mutagenesis (1); Natural variant (61); Sequence caution (2); Site (1),,,,3D-structure;4Fe-4S;Alternative splicing;Complete proteome;DNA damage;DNA repair;Disease mutation;Glycosidase;Hydrolase;Iron;Iron-sulfur;Metal-binding;Mitochondrion;Nucleus;Polymorphism;Reference proteome;Tumor suppressor,Evidence at protein level,reviewed,,Nth/MutY family,180,Alternative products (1); Catalytic activity (1); Cofactor (1); Function (1); Involvement in disease (2); Sequence similarities (1); Subcellular location (1),,KW-0002; KW-0004; KW-0025; KW-0043; KW-0181; KW-0225; KW-0227; KW-0234; KW-0326; KW-0378; KW-0408; KW-0411; KW-0479; KW-0496; KW-0539; KW-0621; KW-1185,,,,,"DISEASE: Familial adenomatous polyposis 2 (FAP2) [MIM:608456]: A condition characterized by the development of multiple colorectal adenomatous polyps, benign neoplasms derived from glandular epithelium. Some affected individuals may develop colorectal carcinoma. {ECO:0000269|PubMed:11818965, ECO:0000269|PubMed:12606733, ECO:0000269|PubMed:12853198, ECO:0000269|PubMed:15366000, ECO:0000269|PubMed:16134147, ECO:0000269|PubMed:16287072, ECO:0000269|PubMed:16557584, ECO:0000269|PubMed:16941501, ECO:0000269|PubMed:18091433, ECO:0000269|PubMed:18515411, ECO:0000269|PubMed:19953527, ECO:0000269|PubMed:20418187, ECO:0000269|PubMed:20848659, ECO:0000269|PubMed:25820570, ECO:0000269|PubMed:26694661}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. {ECO:0000269|PubMed:15273732, ECO:0000269|PubMed:25820570}. Note=The gene represented in this entry may be involved in disease pathogenesis. Somatic mutations contribute to the development of a sub-set of sporadic gastric cancers in carriers of Helicobacter pylori (PubMed:15273732). {ECO:0000269|PubMed:15273732}.",,,,CHAIN 1 546 Adenine DNA glycosylase. /FTId=PRO_0000102239.,,,,,,,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U63329;AB032920;AB032921;AB032922;AB032923;AB032924;AB032925;AB032926;AB032927;AB032928;AB032929;HQ205466;HQ205468;HQ205469;HQ205470;HQ205472;HQ205473;HQ205474;HQ205475;HQ205476;HQ205477;HQ205479;HQ205480;HQ205481;HQ205482;HQ205483;HQ205484;HQ205485;HQ205486;HQ205487;HQ205488;HQ205489;HQ205490;HQ205491;HQ205492;HQ205493;HQ205494;HQ205495;HQ205496;HQ205497;HQ205498;HQ205499;HQ205500;HQ205501;HQ205502;HQ205503;HQ205505;AF527839;CH471059;CH471059;CH471059;BC003178;
0,Q9UKX2,MYH2_HUMAN,MYH2 MYHSA2,MYH2,MYHSA2,,,Homo sapiens (Human),9606,"Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain IIa) (MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2)",UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSSDSELAVFGEAAPFLRKSERERIEAQNRPFDAKTSVFVAEPKESFVKGTIQSREGGKVTVKTEGGATLTVKDDQVFPMNPPKYDKIEDMAMMTHLHEPAVLYNLKERYAAWMIYTYSGLFCVTVNPYKWLPVYKPEVVTAYRGKKRQEAPPHIFSISDNAYQFMLTDRENQSILITGESGAGKTVNTKRVIQYFATIAVTGEKKKEEITSGKIQGTLEDQIISANPLLEAFGNAKTVRNDNSSRFGKFIRIHFGTTGKLASADIETYLLEKSRVVFQLKAERSYHIFYQITSNKKPELIEMLLITTNPYDYPFVSQGEISVASIDDQEELMATDSAIDILGFTNEEKVSIYKLTGAVMHYGNLKFKQKQREEQAEPDGTEVADKAAYLQSLNSADLLKALCYPRVKVGNEYVTKGQTVEQVSNAVGALAKAVYEKMFLWMVARINQQLDTKQPRQYFIGVLDIAGFEIFDFNSLEQLCINFTNEKLQQFFNHHMFVLEQEEYKKEGIEWTFIDFGMDLAACIELIEKPMGIFSILEEECMFPKATDTSFKNKLYDQHLGKSANFQKPKVVKGKAEAHFALIHYAGVVDYNITGWLEKNKDPLNETVVGLYQKSAMKTLAQLFSGAQTAEGEGAGGGAKKGGKKKGSSFQTVSALFRENLNKLMTNLRSTHPHFVRCIIPNETKTPGAMEHELVLHQLRCNGVLEGIRICRKGFPSRILYADFKQRYKVLNASAIPEGQFIDSKKASEKLLASIDIDHTQYKFGHTKVFFKAGLLGLLEEMRDDKLAQLITRTQARCRGFLARVEYQRMVERREAIFCIQYNIRSFMNVKHWPWMKLFFKIKPLLKSAETEKEMATMKEEFQKIKDELAKSEAKRKELEEKMVTLLKEKNDLQLQVQAEAEGLADAEERCDQLIKTKIQLEAKIKEVTERAEDEEEINAELTAKKRKLEDECSELKKDIDDLELTLAKVEKEKHATENKVKNLTEEMAGLDETIAKLTKEKKALQEAHQQTLDDLQAEEDKVNTLTKAKIKLEQQVDDLEGSLEQEKKLRMDLERAKRKLEGDLKLAQESIMDIENEKQQLDEKLKKKEFEISNLQSKIEDEQALGIQLQKKIKELQARIEELEEEIEAERASRAKAEKQRSDLSRELEEISERLEEAGGATSAQIEMNKKREAEFQKMRRDLEEATLQHEATAATLRKKHADSVAELGEQIDNLQRVKQKLEKEKSEMKMEIDDLASNVETVSKAKGNLEKMCRTLEDQLSELKSKEEEQQRLINDLTAQRGRLQTESGEFSRQLDEKEALVSQLSRGKQAFTQQIEELKRQLEEEIKAKNALAHALQSSRHDCDLLREQYEEEQESKAELQRALSKANTEVAQWRTKYETDAIQRTEELEEAKKKLAQRLQAAEEHVEAVNAKCASLEKTKQRLQNEVEDLMLDVERTNAACAALDKKQRNFDKILAEWKQKCEETHAELEASQKEARSLGTELFKIKNAYEESLDQLETLKRENKNLQQEISDLTEQIAEGGKRIHELEKIKKQVEQEKCELQAALEEAEASLEHEEGKILRIQLELNQVKSEVDRKIAEKDEEIDQLKRNHIRIVESMQSTLDAEIRSRNDAIRLKKKMEGDLNEMEIQLNHANRMAAEALRNYRNTQGILKDTQIHLDDALRSQEDLKEQLAMVERRANLLQAEIEELRATLEQTERSRKIAEQELLDASERVQLLHTQNTSLINTKKKLETDISQMQGEMEDILQEARNAEEKAKKAITDAAMMAEELKKEQDTSAHLERMKKNMEQTVKDLQLRLDEAEQLALKGGKKQIQKLEARVRELEGEVESEQKRNAEAVKGLRKHERRVKELTYQTEEDRKNILRLQDLVDKLQAKVKSYKRQAEEAEEQSNTNLAKFRKLQHELEEAEERADIAESQVNKLRVKSREVHTKVISEE,1941,"223,044",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q9UKX2-1; Sequence=Displayed; Name=2; IsoId=Q9UKX2-2; Sequence=VSP_056291; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 659 1891 Missing (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_056291.,VARIANT 706 706 E -> K (in MYPOP; dbSNP:rs121434589). {ECO:0000269|PubMed:11114175}. /FTId=VAR_032630.; VARIANT 970 970 V -> I (in one patient with familial myopathy; unknown pathological significance; dbSNP:rs143872329). {ECO:0000269|PubMed:15741996}. /FTId=VAR_032631.; VARIANT 1061 1061 L -> V (in dbSNP:rs142586585). {ECO:0000269|PubMed:15741996}. /FTId=VAR_032632.; VARIANT 1927 1927 R -> Q (in dbSNP:rs34161789). /FTId=VAR_032633.,,,,CONFLICT 150 150 E -> G (in Ref. 2; CAD91136). {ECO:0000305}.; CONFLICT 1844 1844 K -> R (in Ref. 6; CAA83687). {ECO:0000305}.,,1,,0,"DOMAIN: The rodlike tail sequence is highly repetitive, showing cycles of a 28-residue repeat pattern composed of 4 heptapeptides, characteristic for alpha-helical coiled coils.; DOMAIN: Limited proteolysis of myosin heavy chain produces 1 light meromyosin (LMM) and 1 heavy meromyosin (HMM). HMM can be further cleaved into 2 globular subfragments (S1) and 1 rod-shaped subfragment (S2). {ECO:0000305}.",SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Myosin family. {ECO:0000305}.,COILED 845 1941 {ECO:0000255}.,,DOMAIN 33 82 Myosin N-terminal SH3-like. {ECO:0000255|PROSITE-ProRule:PRU01190}.; DOMAIN 86 784 Myosin motor. {ECO:0000255|PROSITE-ProRule:PRU00782}.; DOMAIN 787 816 IQ. {ECO:0000255|PROSITE-ProRule:PRU00116}.,,REGION 661 683 Actin-binding. {ECO:0000250}.; REGION 763 777 Actin-binding. {ECO:0000250}.,,,,,,,,FUNCTION: Muscle contraction. Required for cytoskeleton organization (By similarity). {ECO:0000250}.,,,,,,,,,,NP_BIND 179 186 ATP. {ECO:0000255}.,,cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049],Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146],cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017],GO:0000146; GO:0005516; GO:0005524; GO:0005829; GO:0005859; GO:0006936; GO:0030016; GO:0030017; GO:0030049; GO:0032982; GO:0032991; GO:0038096; GO:0051015,IPR000048; IPR036961; IPR001609; IPR027401; IPR004009; IPR008989; IPR002928; IPR027417; ,,"SUBUNIT: Muscle myosin is a hexameric protein that consists of 2 heavy chain subunits (MHC), 2 alkali light chain subunits (MLC) and 2 regulatory light chain subunits (MLC-2). Interacts with GCSAM. {ECO:0000269|PubMed:17823310}.",10388558; 17974005; 16625196; 15489334; 7545970; 7751403; 17823310; 11114175; 15741996,10388558; 17974005; 16625196; 15489334; 7545970; 7751403; 17823310; 11114175; 15741996; 11108967; 11854399; 11889243; 12235157; 12687004; 15496418; 15550383; 16525015; 17005402; 17353931; 17765682; 18495866; 19615732; 20357587; 20418530; 20562859; 20618440; 21102503; 21470888; 22337492; 22349865; 22575643; 22960022; 23190566; 23361003; 23388406; 24193343; 24781731; 25567808; 26059207; 27160899; 28053086; 28729039; 9885284,2001-04-27,2019-02-13,2000-05-01,181,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Coiled coil (1); Domain (3); Modified residue (37); Natural variant (4); Nucleotide binding (1); Region (2); Sequence conflict (2),CAUTION: Represents a conventional myosin. This protein should not be confused with the unconventional myosin-2 (MYO2). {ECO:0000305}.,,,ATP-binding;Actin-binding;Alternative splicing;Calmodulin-binding;Coiled coil;Complete proteome;Cytoplasm;Disease mutation;Methylation;Motor protein;Muscle protein;Myosin;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Thick filament,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Myosin family",181,Alternative products (1); Caution (2); Domain (2); Function (1); Involvement in disease (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0009; KW-0025; KW-0067; KW-0112; KW-0175; KW-0181; KW-0225; KW-0488; KW-0505; KW-0514; KW-0518; KW-0547; KW-0597; KW-0621; KW-0787; KW-0963; KW-1185,,,,,"DISEASE: Myopathy, proximal, and ophthalmoplegia (MYPOP) [MIM:605637]: A muscular disorder characterized by mild-to-moderate muscle weakness, ophthalmoplegia, and contractures at birth in some patients. Muscle biopsies from patients show predominance of type 1 fibers and small or absent type 2A fibers. The disease is non-progressive or it progresses very slowly. Inheritance is autosomal dominant or recessive. {ECO:0000269|PubMed:11114175}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 1941 Myosin-2. /FTId=PRO_0000123393.,,,,,,"MOD_RES 64 64 Phosphothreonine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 69 69 Phosphothreonine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 130 130 N6,N6,N6-trimethyllysine. {ECO:0000255}.; MOD_RES 389 389 Phosphotyrosine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 392 392 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 419 419 Phosphothreonine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 625 625 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 759 759 Pros-methylhistidine. {ECO:0000250|UniProtKB:Q28641}.; MOD_RES 1094 1094 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1098 1098 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1164 1164 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1239 1239 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1243 1243 Phosphothreonine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1245 1245 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1257 1257 Phosphothreonine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1263 1263 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1288 1288 Phosphothreonine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1290 1290 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1294 1294 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1305 1305 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1308 1308 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1469 1469 Phosphothreonine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1476 1476 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1494 1494 Phosphotyrosine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1497 1497 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1503 1503 Phosphothreonine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1516 1516 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1519 1519 Phosphothreonine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1556 1556 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1576 1576 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1602 1602 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1605 1605 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1716 1716 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1728 1728 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1732 1732 Phosphothreonine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1738 1738 Phosphothreonine. {ECO:0000250|UniProtKB:Q29RW1}.; MOD_RES 1741 1741 Phosphoserine. {ECO:0000250|UniProtKB:Q29RW1}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF111784;BX510904;BC093082;BC126409;S73840;Z32858;
0,Q9ULW0,TPX2_HUMAN,TPX2 C20orf1 C20orf2 DIL2 HCA519,TPX2,C20orf1 C20orf2 DIL2 HCA519,,,Homo sapiens (Human),9606,Targeting protein for Xklp2 (Differentially expressed in cancerous and non-cancerous lung cells 2) (DIL-2) (Hepatocellular carcinoma-associated antigen 519) (Hepatocellular carcinoma-associated antigen 90) (Protein fls353) (Restricted expression proliferation-associated protein 100) (p100),UP000005640: Chromosome 20,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSQVKSSYSYDAPSDFINFSSLDDEGDTQNIDSWFEEKANLENKLLGKNGTGGLFQGKTPLRKANLQQAIVTPLKPVDNTYYKEAEKENLVEQSIPSNACSSLEVEAAISRKTPAQPQRRSLRLSAQKDLEQKEKHHVKMKAKRCATPVIIDEILPSKKMKVSNNKKKPEEEGSAHQDTAEKNASSPEKAKGRHTVPCMPPAKQKFLKSTEEQELEKSMKMQQEVVEMRKKNEEFKKLALAGIGQPVKKSVSQVTKSVDFHFRTDERIKQHPKNQEEYKEVNFTSELRKHPSSPARVTKGCTIVKPFNLSQGKKRTFDETVSTYVPLAQQVEDFHKRTPNRYHLRSKKDDINLLPSKSSVTKICRDPQTPVLQTKHRARAVTCKSTAELEAEELEKLQQYKFKARELDPRILEGGPILPKKPPVKPPTEPIGFDLEIEKRIQERESKKKTEDEHFEFHSRPCPTKILEDVVGVPEKKVLPITVPKSPAFALKNRIRMPTKEDEEEDEPVVIKAQPVPHYGVPFKPQIPEARTVEICPFSFDSRDKERQLQKEKKIKELQKGEVPKFKALPLPHFDTINLPEKKVKNVTQIEPFCLETDRRGALKAQTWKHQLEEELRQQKEAACFKARPNTVISQEPFVPKKEKKSVAEGLSGSLVQEPFQLATEKRAKERQELEKRMAEVEAQKAQQLEEARLQEEEQKKEELARLRRELVHKANPIRKYQGLEIKSSDQPLTVPVSPKFSTRFHC,747,"85,653",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=Q9ULW0-1; Sequence=Displayed; Name=2; Synonyms=HCA90; IsoId=Q9ULW0-2; Sequence=VSP_057355; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 351 351 I -> IKTGSCSVTQAGVQWRDHGSLQCPTPGLKQSSCLSLP (in isoform 2). {ECO:0000303|PubMed:12097419}. /FTId=VSP_057355.,VARIANT 464 464 T -> N (in a colorectal cancer sample; somatic mutation). {ECO:0000269|PubMed:16959974}. /FTId=VAR_036269.,,,,CONFLICT 182 182 K -> N (in Ref. 3; BAA76931). {ECO:0000305}.; CONFLICT 273 273 K -> E (in Ref. 1; BAA85893). {ECO:0000305}.,,2,,0,,SIMILARITY: Belongs to the TPX2 family. {ECO:0000305}.,,,,,,,,,,,,,"FUNCTION: Spindle assembly factor required for normal assembly of mitotic spindles. Required for normal assembly of microtubules during apoptosis. Required for chromatin and/or kinetochore dependent microtubule nucleation. Mediates AURKA localization to spindle microtubules (PubMed:18663142, PubMed:19208764). Activates AURKA by promoting its autophosphorylation at 'Thr-288' and protects this residue against dephosphorylation (PubMed:18663142, PubMed:19208764). TPX2 is inactivated upon binding to importin-alpha (PubMed:26165940). At the onset of mitosis, GOLGA2 interacts with importin-alpha, liberating TPX2 from importin-alpha, allowing TPX2 to activates AURKA kinase and stimulates local microtubule nucleation (PubMed:26165940). {ECO:0000269|PubMed:18663142, ECO:0000269|PubMed:19208764, ECO:0000269|PubMed:26165940}.",,,,,,,,,,,,axon hillock [GO:0043203]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; importin-alpha family protein binding [GO:0061676]; protein kinase binding [GO:0019901]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; regulation of signal transduction by p53 class mediator [GO:1901796],activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; regulation of signal transduction by p53 class mediator [GO:1901796],ATP binding [GO:0005524]; GTP binding [GO:0005525]; importin-alpha family protein binding [GO:0061676]; protein kinase binding [GO:0019901],axon hillock [GO:0043203]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922],GO:0000278; GO:0000922; GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005815; GO:0005819; GO:0005829; GO:0005874; GO:0006915; GO:0008283; GO:0010389; GO:0015630; GO:0019901; GO:0032147; GO:0043203; GO:0045171; GO:0051301; GO:0060236; GO:0061676; GO:0072686; GO:0090307; GO:1901796,IPR015128; IPR027329; IPR027330; IPR009675; ,O14965; P62993; O75330; P16333; P27986,"SUBUNIT: Interacts with AURKA (PubMed:14580337, PubMed:18662907, PubMed:18663142). Interacts with importin-alpha; leading to inactivate TPX2 (PubMed:26165940). Interacts with HNRNPU; this interaction recruits HNRNPU to spindle microtubules (MTs) (PubMed:21242313, PubMed:25986610). {ECO:0000269|PubMed:14580337, ECO:0000269|PubMed:18662907, ECO:0000269|PubMed:18663142, ECO:0000269|PubMed:21242313, ECO:0000269|PubMed:25986610, ECO:0000269|PubMed:26165940}.",10512675; 10393424; 12097419; 11780052; 15489334; 17974005; 10871281; 9207457; 17081983; 16964243; 17924679; 18663142; 18691976; 18669648; 19413330; 19208764; 19369195; 19608861; 20068231; 21242313; 21406692; 23186163; 25218447; 26165940; 25986610; 28112733; 14580337; 18662907; 16959974,10512675; 10393424; 12097419; 11780052; 15489334; 17974005; 10871281; 9207457; 17081983; 16964243; 17924679; 18663142; 18691976; 18669648; 19413330; 19208764; 19369195; 19608861; 20068231; 21242313; 21406692; 23186163; 25218447; 26165940; 25986610; 28112733; 14580337; 18662907; 16959974; 12177045; 12389033; 12477396; 12612055; 14702041; 15498487; 15705883; 16287863; 16489064; 17474147; 17705509; 17716627; 18234856; 18847512; 19121998; 19148505; 19424574; 19648931; 19773279; 19801554; 20360068; 20467437; 20508983; 20599806; 20708655; 21099343; 21147853; 21187329; 21347367; 21988832; 22094256; 22094468; 22207630; 22307108; 22560880; 22761906; 23045526; 23328114; 23357462; 23416715; 23444224; 23725757; 23752268; 23873098; 23963785; 24341487; 24488334; 24556998; 24625450; 24718984; 24867643; 24875404; 25239289; 25302620; 25365214; 25532896; 25609649; 25632068; 25688093; 25830658; 25914189; 26018074; 26240182; 26257190; 26279431; 26414402; 26496610; 26624896; 27314162; 27775325; 28069036; 28108243; 28636807; 28799673; 28869599; 29120325; 29865033; 30257313; 30257343; 30412141,2001-02-21,2019-02-13,2001-02-21,180,X-ray crystallography (5); Electron microscopy (1),,HELIX 30 32 {ECO:0000244|PDB:5LXM}.; HELIX 33 41 {ECO:0000244|PDB:5LXM}.; HELIX 327 336 {ECO:0000244|PDB:6BJC}.,TURN 19 21 {ECO:0000244|PDB:5LXM}.,,,,,5 out of 5,Alternative sequence (1); Chain (1); Cross-link (4); Helix (3); Modified residue (18); Natural variant (1); Sequence conflict (2); Turn (1),,TISSUE SPECIFICITY: Expressed in lung carcinoma cell lines but not in normal lung tissues.,,3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell cycle;Cell division;Complete proteome;Cytoplasm;Cytoskeleton;Isopeptide bond;Microtubule;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,TPX2 family,180,Alternative products (1); Caution (1); Developmental stage (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0025; KW-0053; KW-0131; KW-0132; KW-0181; KW-0206; KW-0493; KW-0498; KW-0539; KW-0597; KW-0621; KW-0832; KW-0963; KW-1017; KW-1185,,,,,,,,,CHAIN 1 747 Targeting protein for Xklp2. /FTId=PRO_0000065581.,"CROSSLNK 477 477 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 500 500 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 641 641 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:28112733}.; CROSSLNK 740 740 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.",,,,,"MOD_RES 59 59 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 72 72 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 121 121 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 125 125 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 128 128 N6-acetyllysine. {ECO:0000250|UniProtKB:A2APB8}.; MOD_RES 147 147 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 257 257 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 292 292 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 293 293 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 305 305 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 310 310 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 338 338 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 359 359 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 369 369 Phosphothreonine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:23186163}.; MOD_RES 375 375 N6-acetyllysine. {ECO:0000250|UniProtKB:A2APB8}.; MOD_RES 486 486 Phosphoserine. {ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 499 499 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 738 738 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB027467;AF098158;AB024704;AF146731;AF287265;CH471077;CH471077;BC004136;BC020207;AL117534;AF244547;
0,Q9UM54,MYO6_HUMAN,MYO6 KIAA0389,MYO6,KIAA0389,,,Homo sapiens (Human),9606,Unconventional myosin-VI (Unconventional myosin-6),UP000005640: Chromosome 6,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MEDGKPVWAPHPTDGFQMGNIVDIGPDSLTIEPLNQKGKTFLALINQVFPAEEDSKKDVEDNCSLMYLNEATLLHNIKVRYSKDRIYTYVANILIAVNPYFDIPKIYSSEAIKSYQGKSLGTRPPHVFAIADKAFRDMKVLKMSQSIIVSGESGAGKTENTKFVLRYLTESYGTGQDIDDRIVEANPLLEAFGNAKTVRNNNSSRFGKFVEIHFNEKSSVVGGFVSHYLLEKSRICVQGKEERNYHIFYRLCAGASEDIREKLHLSSPDNFRYLNRGCTRYFANKETDKQILQNRKSPEYLKAGSMKDPLLDDHGDFIRMCTAMKKIGLDDEEKLDLFRVVAGVLHLGNIDFEEAGSTSGGCNLKNKSAQSLEYCAELLGLDQDDLRVSLTTRVMLTTAGGTKGTVIKVPLKVEQANNARDALAKTVYSHLFDHVVNRVNQCFPFETSSYFIGVLDIAGFEYFEHNSFEQFCINYCNEKLQQFFNERILKEEQELYQKEGLGVNEVHYVDNQDCIDLIEAKLVGILDILDEENRLPQPSDQHFTSAVHQKHKDHFRLTIPRKSKLAVHRNIRDDEGFIIRHFAGAVCYETTQFVEKNNDALHMSLESLICESRDKFIRELFESSTNNNKDTKQKAGKLSFISVGNKFKTQLNLLLDKLRSTGASFIRCIKPNLKMTSHHFEGAQILSQLQCSGMVSVLDLMQGGYPSRASFHELYNMYKKYMPDKLARLDPRLFCKALFKALGLNENDYKFGLTKVFFRPGKFAEFDQIMKSDPDHLAELVKRVNHWLTCSRWKKVQWCSLSVIKLKNKIKYRAEACIKMQKTIRMWLCKRRHKPRIDGLVKVGTLKKRLDKFNEVVSVLKDGKPEMNKQIKNLEISIDTLMAKIKSTMMTQEQIQKEYDALVKSSEELLSALQKKKQQEEEAERLRRIQEEMEKERKRREEDEKRRRKEEEERRMKLEMEAKRKQEEEERKKREDDEKRIQAEVEAQLARQKEEESQQQAVLEQERRDRELALRIAQSEAELISDEAQADLALRRSLDSYPVSKNDGTRPKMTPEQMAKEMSEFLSRGPAVLATKAAAGTKKYDLSKWKYAELRDTINTSCDIELLAACREEFHRRLKVYHAWKSKNKKRNTETEQRAPKSVTDYDFAPFLNNSPQQNPAAQIPARQREIEMNRQQRFFRIPFIRPADQYKDPQSKKKGWWYAHFDGPWIARQMELHPDKPPILLVAGKDDMEMCELNLEETGLTRKRGAEILPRQFEEIWERCGGIQYLQNAIESRQARPTYATAMLQSLLK,1294,"149,691",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=6;  Name=3; IsoId=Q9UM54-3; Sequence=Displayed; Name=1; IsoId=Q9UM54-1; Sequence=VSP_022332; Name=2; IsoId=Q9UM54-2; Sequence=VSP_007985; Name=4; IsoId=Q9UM54-4; Sequence=VSP_022333; Name=5; IsoId=Q9UM54-5; Sequence=VSP_007985, VSP_022333; Name=6; IsoId=Q9UM54-6; Sequence=VSP_042208; ",,SEQUENCE CAUTION:  Sequence=BAA20843.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 1037 1068 Missing (in isoform 2 and isoform 5). {ECO:0000303|PubMed:9259267}. /FTId=VSP_007985.; VAR_SEQ 1037 1045 Missing (in isoform 1). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9205841}. /FTId=VSP_022332.; VAR_SEQ 1147 1156 DFAPFLNNSP -> A (in isoform 6). {ECO:0000303|PubMed:16344560}. /FTId=VSP_042208.; VAR_SEQ 1147 1155 Missing (in isoform 4 and isoform 5). {ECO:0000305}. /FTId=VSP_022333.",VARIANT 216 216 E -> V (in DFNB37; dbSNP:rs121912559). {ECO:0000269|PubMed:12687499}. /FTId=VAR_016209.; VARIANT 246 246 H -> R (in DFNHCM; dbSNP:rs121912560). {ECO:0000269|PubMed:15060111}. /FTId=VAR_029988.; VARIANT 442 442 C -> Y (in DFNA22). {ECO:0000269|PubMed:11468689}. /FTId=VAR_012110.,,,,CONFLICT 1156 1156 P -> A (in Ref. 5; CAI42826). {ECO:0000305}.,,4,,0,"DOMAIN: Divided into three regions: a N-terminal motor (head) domain, followed by a neck domain consisting of a calmodulin-binding linker domain and a single IQ motif, and a C-terminal tail region with a three-helix bundle region, a SAH domain and a unique globular domain required for interaction with other proteins such as cargo-binding. {ECO:0000305}.; DOMAIN: The SAH (single alpha-helix) region is characterized by a high content of charged residues which are predicted to stabilize the alpha-helical structure by ionic bonds. Its contribution to the mechanism confering the myosin movement on actin filaments is debated. {ECO:0000305|PubMed:25122759}.",SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Myosin family. {ECO:0000305}.,,COMPBIAS 920 1027 Glu-rich.,DOMAIN 2 53 Myosin N-terminal SH3-like. {ECO:0000255|PROSITE-ProRule:PRU01190}.; DOMAIN 57 771 Myosin motor. {ECO:0000255|PROSITE-ProRule:PRU00782}.; DOMAIN 814 834 IQ.,,REGION 273 317 Responsible for slow ATPase activity. {ECO:0000250}.; REGION 665 672 Actin-binding. {ECO:0000255}.; REGION 782 810 Required for binding calmodulin. {ECO:0000250}.; REGION 835 916 Three-helix bundle.; REGION 917 984 SAH. {ECO:0000305|PubMed:25122759}.; REGION 1116 1118 Interaction with OPTN.,,,,,,,,"FUNCTION: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Myosin 6 is a reverse-direction motor protein that moves towards the minus-end of actin filaments. Has slow rate of actin-activated ADP release due to weak ATP binding. Functions in a variety of intracellular processes such as vesicular membrane trafficking and cell migration. Required for the structural integrity of the Golgi apparatus via the p53-dependent pro-survival pathway. Appears to be involved in a very early step of clathrin-mediated endocytosis in polarized epithelial cells. May act as a regulator of F-actin dynamics. May play a role in transporting DAB2 from the plasma membrane to specific cellular targets. Required for structural integrity of inner ear hair cells (By similarity). {ECO:0000250, ECO:0000269|PubMed:10519557, ECO:0000269|PubMed:11447109, ECO:0000269|PubMed:16507995, ECO:0000269|PubMed:16949370}.",,,,,,,,,,NP_BIND 151 158 ATP. {ECO:0000255}.,,"actin filament [GO:0005884]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; minus-end directed microfilament motor activity [GO:0060001]; motor activity [GO:0003774]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; response to drug [GO:0042493]; sensory perception of sound [GO:0007605]","actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; response to drug [GO:0042493]; sensory perception of sound [GO:0007605]",actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; minus-end directed microfilament motor activity [GO:0060001]; motor activity [GO:0003774],"actin filament [GO:0005884]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]",GO:0001726; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005794; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005905; GO:0005938; GO:0006886; GO:0006897; GO:0007605; GO:0016020; GO:0016461; GO:0016591; GO:0030048; GO:0030139; GO:0030330; GO:0030665; GO:0031410; GO:0031941; GO:0031965; GO:0032587; GO:0042493; GO:0042802; GO:0043531; GO:0045177; GO:0045944; GO:0048471; GO:0051015; GO:0051046; GO:0060001; GO:0070062,IPR036961; IPR032412; IPR001609; IPR004009; IPR008989; IPR036114; IPR027417; ,P98082; P98078; Q9Z0G0,"SUBUNIT: Homodimer; dimerization seems to implicate the unfolding of the three-helix bundle region creating an additional calmodulin binding site, and cargo binding (By similarity). Binding to calmodulin through a unique insert, not found in other myosins, located in the neck region between the motor domain and the IQ domain appears to contribute to the directionality reversal. This interaction occurs only if the C-terminal lobe of calmodulin is occupied by calcium. Interaction with F-actin/ACTN1 occurs only at the apical brush border domain of the proximal tubule cells (By similarity). Interacts with DAB2. In vitro, the C-terminal globular tail binds a C-terminal region of DAB2. Interacts with CFTR. Forms a complex with CFTR and DAB2 in the apical membrane of epithelial cells. Interacts with OPTN (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q29122}.",9259267; 9205841; 14574404; 15489334; 16344560; 10519557; 11447109; 11967127; 15247260; 15044955; 16949370; 16507995; 18511944; 21269460; 23186163; 25122759; 24275569; 11468689; 12687499; 15060111,9259267; 9205841; 14574404; 15489334; 16344560; 10519557; 11447109; 11967127; 15247260; 15044955; 16949370; 16507995; 18511944; 21269460; 23186163; 25122759; 24275569; 11468689; 12687499; 15060111; 12577067; 14743216; 15123708; 15146066; 15231748; 16169070; 16499958; 17071605; 17108328; 17187061; 17353931; 17635994; 17683200; 18029400; 18212818; 18311135; 18348273; 18429820; 18543251; 19367725; 19615732; 19855435; 19893302; 19913121; 20201926; 20353999; 20379614; 20576604; 20604900; 20850010; 20936779; 21148290; 21182205; 21278381; 21735821; 22157815; 22171985; 22321127; 22323290; 22884421; 22992744; 23007415; 23023224; 23340379; 23416715; 23635807; 24028494; 24105371; 24928903; 25080041; 25125183; 25227905; 25609649; 25643992; 25703929; 25859013; 25999546; 26263762; 26324058; 26407123; 26950368; 26971995; 27018747; 27044563; 27374232; 27431378; 27474411; 27515005; 27561828; 28143933; 28348208; 29022908; 29044474; 29187741; 29217166; 29224747,2001-04-27,2019-02-13,2007-01-09,193,NMR spectroscopy (5),STRAND 1077 1079 {ECO:0000244|PDB:2N12}.,HELIX 999 1022 {ECO:0000244|PDB:2N11}.; HELIX 1026 1036 {ECO:0000244|PDB:2N11}.; HELIX 1038 1040 {ECO:0000244|PDB:2N11}.; HELIX 1055 1066 {ECO:0000244|PDB:2N11}.; HELIX 1091 1100 {ECO:0000244|PDB:2N0Z}.; HELIX 1106 1119 {ECO:0000244|PDB:2N0Z}.,,,,,,5 out of 5,Alternative sequence (4); Beta strand (1); Chain (1); Compositional bias (1); Domain (3); Erroneous initiation (1); Helix (6); Modified residue (5); Natural variant (3); Nucleotide binding (1); Region (6); Sequence conflict (1),CAUTION: Represents an unconventional myosin. This protein should not be confused with the conventional myosin-6 (MYH6). {ECO:0000305}.; CAUTION: Originally predicted to contain a coiled coil domain but generally accepted to contain a stable SAH domain instead. {ECO:0000305}.,"TISSUE SPECIFICITY: Expressed in most tissues examined including heart, brain, placenta, pancreas, spleen, thymus, prostate, testis, ovary, small intestine and colon. Highest levels in brain, pancreas, testis and small intestine. Also expressed in fetal brain and cochlea. Isoform 1 and isoform 2, containing the small insert, and isoform 4, containing neither insert, are expressed in unpolarized epithelial cells. {ECO:0000269|PubMed:9259267}.",,3D-structure;ATP-binding;Actin-binding;Alternative splicing;Calmodulin-binding;Cardiomyopathy;Cell membrane;Cell projection;Coated pit;Complete proteome;Cytoplasm;Cytoplasmic vesicle;Deafness;Disease mutation;Endocytosis;Golgi apparatus;Hearing;Membrane;Motor protein;Myosin;Non-syndromic deafness;Nucleotide-binding;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Transport,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Myosin family",193,Alternative products (1); Caution (2); Domain (2); Function (1); Involvement in disease (3); Post-translational modification (1); Sequence similarities (1); Subcellular location (3); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0009; KW-0025; KW-0067; KW-0112; KW-0122; KW-0168; KW-0181; KW-0209; KW-0225; KW-0254; KW-0333; KW-0472; KW-0505; KW-0518; KW-0539; KW-0547; KW-0597; KW-0653; KW-0813; KW-0963; KW-0966; KW-0968; KW-1003; KW-1009; KW-1010; KW-1185,,,,,"DISEASE: Deafness, autosomal dominant, 22 (DFNA22) [MIM:606346]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA22 is progressive and postlingual, with onset during childhood. By the age of approximately 50 years, affected individuals invariably have profound sensorineural deafness. {ECO:0000269|PubMed:11468689}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 37 (DFNB37) [MIM:607821]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:12687499}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy (DFNHCM) [MIM:606346]: An autosomal dominant sensorineural deafness associated with hypertrophic cardiomyopathy. {ECO:0000269|PubMed:15060111}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Phosphorylation in the motor domain, induced by EGF, results in translocation of MYO6 from the cell surface to membrane ruffles and affects F-actin dynamics. Phosphorylated in vitro by p21-activated kinase (PAK) (By similarity). {ECO:0000250}.",CHAIN 1 1294 Unconventional myosin-VI. /FTId=PRO_0000123464.,,,,,,"MOD_RES 267 267 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 405 405 Phosphothreonine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 604 604 Phosphoserine. {ECO:0000250|UniProtKB:Q64331}.; MOD_RES 1025 1025 Phosphoserine. {ECO:0000250|UniProtKB:Q64331}.; MOD_RES 1155 1155 Phosphoserine. {ECO:0000250|UniProtKB:Q64331}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U90236;AF229111;AF229082;AF229083;AF229084;AF229085;AF229086;AF229087;AF229088;AF229089;AF229090;AF229091;AF229092;AF229093;AF229094;AF229095;AF229096;AF229097;AF229098;AF229099;AF229100;AF229101;AF229102;AF229103;AF229104;AF229105;AF229106;AF229107;AF229108;AF229109;AF229110;AL109897;AL136093;AL109897;AL136093;AL109897;AL136093;AL136093;AL109897;AL136093;AL109897;AL136093;AL109897;AB002387;CH471051;CH471051;BC146764;
0,Q9UN37,VPS4A_HUMAN,VPS4A VPS4,VPS4A,VPS4,,,Homo sapiens (Human),9606,Vacuolar protein sorting-associated protein 4A (EC 3.6.4.6) (Protein SKD2) (VPS4-1) (hVPS4),UP000005640: Chromosome 16,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MTTSTLQKAIDLVTKATEEDKAKNYEEALRLYQHAVEYFLHAIKYEAHSDKAKESIRAKCVQYLDRAEKLKDYLRSKEKHGKKPVKENQSEGKGSDSDSEGDNPEKKKLQEQLMGAVVMEKPNIRWNDVAGLEGAKEALKEAVILPIKFPHLFTGKRTPWRGILLFGPPGTGKSYLAKAVATEANNSTFFSVSSSDLMSKWLGESEKLVKNLFELARQHKPSIIFIDEVDSLCGSRNENESEAARRIKTEFLVQMQGVGNNNDGTLVLGATNIPWVLDSAIRRRFEKRIYIPLPEEAARAQMFRLHLGSTPHNLTDANIHELARKTEGYSGADISIIVRDSLMQPVRKVQSATHFKKVCGPSRTNPSMMIDDLLTPCSPGDPGAMEMTWMDVPGDKLLEPVVCMSDMLRSLATTRPTVNADDLLKVKKFSEDFGQES,437,"48,898",,,,,,,"SEQUENCE CAUTION:  Sequence=AAL75948.1; Type=Frameshift; Positions=123, 133, 157, 163; Evidence={ECO:0000305}; ",,,,,,VARIANT 193 193 Missing (probable disease-associated mutation found in a patient with severe intellecutal disabillity and microcephaly). {ECO:0000269|PubMed:25356899}. /FTId=VAR_078655.,,,,CONFLICT 79 79 K -> E (in Ref. 3; AAL75948 and 5; AAF17203). {ECO:0000305}.; CONFLICT 185 185 N -> T (in Ref. 3; AAL75948). {ECO:0000305}.; CONFLICT 284 284 R -> K (in Ref. 8; AAD42971). {ECO:0000305}.,,1,,0,"DOMAIN: The MIT domain serves as an adapter for ESCRT-III proteins. It forms an asymmetric three-helix bundle that binds amphipathic MIM (MIT interacting motif) helices along the groove between MIT helices 2 and 3 present in a subset of ESCRT-III proteins thus establishing the canonical MIM-MIT interaction. In an extended conformation along the groove between helices 1 and 3, also binds to a type-2 MIT interacting motif (MIM2). {ECO:0000250|UniProtKB:O75351}.",SIMILARITY: Belongs to the AAA ATPase family. {ECO:0000255}.,,,DOMAIN 2 80 MIT.,,REGION 1 84 Interaction with CHMP1B.,,,3.6.4.6,,"CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.6;",,,"FUNCTION: Involved in late steps of the endosomal multivesicular bodies (MVB) pathway. Recognizes membrane-associated ESCRT-III assemblies and catalyzes their disassembly, possibly in combination with membrane fission. Redistributes the ESCRT-III components to the cytoplasm for further rounds of MVB sorting. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. In conjunction with the ESCRT machinery also appears to function in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and enveloped virus budding (HIV-1 and other lentiviruses). Involved in cytokinesis: retained at the midbody by ZFYVE19/ANCHR and CHMP4C until abscission checkpoint signaling is terminated at late cytokinesis. It is then released following dephosphorylation of CHMP4C, leading to abscission (PubMed:24814515). VPS4A/B are required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413). {ECO:0000269|PubMed:11563910, ECO:0000269|PubMed:11595185, ECO:0000269|PubMed:15075231, ECO:0000269|PubMed:22660413, ECO:0000269|PubMed:24814515}.",,,,,,,,,,NP_BIND 167 174 ATP. {ECO:0000305}.,,"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]",abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192]; vesicle uncoating [GO:0072319]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076],"ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774],GO:0000916; GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005774; GO:0005813; GO:0005829; GO:0005886; GO:0006622; GO:0006900; GO:0006997; GO:0006998; GO:0007033; GO:0007080; GO:0008022; GO:0009838; GO:0010008; GO:0016192; GO:0016197; GO:0016236; GO:0016887; GO:0019058; GO:0019076; GO:0019904; GO:0030496; GO:0031468; GO:0031902; GO:0032367; GO:0032466; GO:0032880; GO:0034058; GO:0036258; GO:0039702; GO:0042623; GO:0043162; GO:0044877; GO:0044878; GO:0048471; GO:0051301; GO:0061640; GO:0061738; GO:0061952; GO:0070062; GO:0072319; GO:0090543; GO:0090611; GO:1902188; GO:1903076; GO:1903543; GO:1903774; GO:1903902; GO:1904896; GO:1904903,IPR003593; IPR003959; IPR003960; IPR007330; IPR036181; IPR027417; IPR015415; ,Q9HD42; Q9HD42-1; Q7LBR1; O43633; Q96K21-1,"SUBUNIT: Proposed to be monomeric or homodimeric in nucleotide-free form and to oligomerize upon binding to ATP to form two stacked hexameric or heptameric rings with a central pore through which ESCRT-III substrates are translocated in an ATP-dependent manner (By similarity). Interacts with CHMP1A, CHMP1B, CHMP2A, CHMP2B, CHMP3, CHMP4A, CHMP4B, CHMP4C and CHMP6. Interacts with VPS4B; the interaction suggests a heteromeric assembly with VPS4B. Interacts with SPAST. Interacts with IST1. Interacts with ZFYVE19/ANCHR; leading to retain it at midbody. {ECO:0000250, ECO:0000269|PubMed:11559748, ECO:0000269|PubMed:11563910, ECO:0000269|PubMed:14505570, ECO:0000269|PubMed:14519844, ECO:0000269|PubMed:16174732, ECO:0000269|PubMed:17928862, ECO:0000269|PubMed:18606141, ECO:0000269|PubMed:18997780, ECO:0000269|PubMed:19129479, ECO:0000269|PubMed:19129480, ECO:0000269|PubMed:21543490, ECO:0000269|PubMed:24814515}.",11563910; 12594041; 10931946; 14702039; 15489334; 10637304; 11595185; 11559748; 14505570; 14519844; 15075231; 16193069; 17853893; 18997780; 19129480; 19129479; 19608861; 21269460; 21543490; 22660413; 24814515; 16174732; 17928862; 18606141; 25356899,11563910; 12594041; 10931946; 14702039; 15489334; 10637304; 11595185; 11559748; 14505570; 14519844; 15075231; 16193069; 17853893; 18997780; 19129480; 19129479; 19608861; 21269460; 21543490; 22660413; 24814515; 16174732; 17928862; 18606141; 25356899; 11937716; 12860994; 15473846; 15632132; 16730941; 16841193; 17110338; 17553870; 17601348; 17913808; 18621683; 19524996; 19527882; 19615732; 19640981; 19828764; 20195357; 20339000; 20616062; 20621136; 20805225; 21394086; 22216284; 22231449; 22762019; 23009658; 23305486; 23416715; 24725412; 25033200; 25164817; 25503676; 26496610; 26551458; 27001827; 28349933; 28604678,2005-04-12,2019-02-13,2000-05-01,174,NMR spectroscopy (3),,HELIX 5 21 {ECO:0000244|PDB:1YXR}.; HELIX 25 45 {ECO:0000244|PDB:1YXR}.; HELIX 50 76 {ECO:0000244|PDB:1YXR}.,,,,,,5 out of 5,Chain (1); Domain (1); Frameshift (1); Helix (3); Modified residue (3); Mutagenesis (11); Natural variant (1); Nucleotide binding (1); Region (1); Sequence conflict (4),,"TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:10637304, ECO:0000269|PubMed:11563910}.",,3D-structure;ATP-binding;Acetylation;Cell cycle;Cell division;Complete proteome;Disease mutation;Endosome;Hydrolase;Membrane;Nucleotide-binding;Phosphoprotein;Protein transport;Reference proteome;Transport,Evidence at protein level,reviewed,,AAA ATPase family,174,Catalytic activity (1); Domain (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0067; KW-0131; KW-0132; KW-0181; KW-0225; KW-0378; KW-0472; KW-0547; KW-0597; KW-0653; KW-0813; KW-0967; KW-1185,,,,,,,,,CHAIN 1 437 Vacuolar protein sorting-associated protein 4A. /FTId=PRO_0000084765.,,,,,,MOD_RES 8 8 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 95 95 Phosphoserine. {ECO:0000250|UniProtKB:Q793F9}.; MOD_RES 97 97 Phosphoserine. {ECO:0000250|UniProtKB:Q793F9}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF255952;AF282903;AF132747;AF159063;AF112215;AK315026;CH471092;BC047932;AF155740;
0,Q9UPT5,EXOC7_HUMAN,EXOC7 EXO70 KIAA1067,EXOC7,EXO70 KIAA1067,,,Homo sapiens (Human),9606,Exocyst complex component 7 (Exocyst complex component Exo70),UP000005640: Chromosome 17,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MIPPQEASARRREIEDKLKQEEETLSFIRDSLEKSDQLTKNMVSILSSFESRLMKLENSIIPVHKQTENLQRLQENVEKTLSCLDHVISYYHVASDTEKIIREGPTGRLEEYLGSMAKIQKAVEYFQDNSPDSPELNKVKLLFERGKEALESEFRSLMTRHSKVVSPVLILDLISGDDDLEAQEDVTLEHLPESVLQDVIRISRWLVEYGRNQDFMNVYYQIRSSQLDRSIKGLKEHFHKSSSSSGVPYSPAIPNKRKDTPTKKPVKRPGTIRKAQNLLKQYSQHGLDGKKGGSNLIPLEGLLPCTPRGGLPGPWINAACVCAADISPGHEHDFRVKHLSEALNDKHGPLAGRDDMLDVETDAYIHCVSAFVKLAQSEYQLLADIIPEHHQKKTFDSLIQDALDGLMLEGENIVSAARKAIVRHDFSTVLTVFPILRHLKQTKPEFDQVLQGTAASTKNKLPGLITSMETIGAKALEDFADNIKNDPDKEYNMPKDGTVHELTSNAILFLQQLLDFQETAGAMLASQETSSSATSYSSEFSKRLLSTYICKVLGNLQLNLLSKSKVYEDPALSAIFLHNNYNYILKSLEKSELIQLVAVTQKTAERSYREHIEQQIQTYQRSWLKVTDYIAEKNLPVFQPGVKLRDKERQIIKERFKGFNDGLEELCKIQKAWAIPDTEQRDRIRQAQKTIVKETYGAFLQKFGSVPFTKNPEKYIKYGVEQVGDMIDRLFDTSA,735,"83,382",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=6;  Name=3; IsoId=Q9UPT5-3; Sequence=Displayed; Note=No experimental confirmation available.; Name=1; IsoId=Q9UPT5-1; Sequence=VSP_008878; Name=2; IsoId=Q9UPT5-2; Sequence=VSP_001483; Name=4; IsoId=Q9UPT5-4; Sequence=VSP_008876, VSP_008877; Note=May be due to intron retention. No experimental confirmation available.; Name=5; IsoId=Q9UPT5-5; Sequence=VSP_041098; Name=6; IsoId=Q9UPT5-6; Sequence=VSP_041099; ",,SEQUENCE CAUTION:  Sequence=BAA83019.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};  Sequence=BAB14095.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,,,,,,,"VAR_SEQ 269 327 Missing (in isoform 5). {ECO:0000303|Ref.1}. /FTId=VSP_041098.; VAR_SEQ 271 352 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_001483.; VAR_SEQ 271 283 TIRKAQNLLKQYS -> EPPSWPISATARG (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_008876.; VAR_SEQ 284 735 Missing (in isoform 4). {ECO:0000303|PubMed:14702039}. /FTId=VSP_008877.; VAR_SEQ 301 328 Missing (in isoform 6). {ECO:0000303|Ref.1}. /FTId=VSP_041099.; VAR_SEQ 302 352 Missing (in isoform 1). {ECO:0000303|PubMed:10470851, ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005}. /FTId=VSP_008878.",,,,,CONFLICT 234 234 L -> Q (in Ref. 3; BAB14694). {ECO:0000305}.; CONFLICT 362 362 D -> N (in Ref. 3; BAB14694). {ECO:0000305}.; CONFLICT 459 459 N -> I (in Ref. 6; AAH18466). {ECO:0000305}.; CONFLICT 646 646 D -> G (in Ref. 3; BAB14694). {ECO:0000305}.,,3,,0,DOMAIN: The N-terminus is involved in SEC8 and ARHQ binding. {ECO:0000250}.; DOMAIN: The C-terminus is required for translocation to the plasma membrane. {ECO:0000250}.,SIMILARITY: Belongs to the EXO70 family. {ECO:0000305}.,COILED 5 42 {ECO:0000255}.; COILED 63 85 {ECO:0000255}.,,,,,,,,,,,,"FUNCTION: Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane. In adipocytes, plays a crucial role in targeting SLC2A4 vesicle to the plasma membrane in response to insulin, perhaps directing the vesicle to the precise site of fusion (By similarity). {ECO:0000250}.",,,,,,,,,,,,centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of macroautophagy [GO:0016241],exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of macroautophagy [GO:0016241],,centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886],GO:0000145; GO:0005815; GO:0005829; GO:0005886; GO:0006887; GO:0015031; GO:0016020; GO:0016241; GO:0032584; GO:0034451; GO:0090543; GO:2000535,IPR016159; IPR004140; ,Q9WMX2; Q9Y6D5; O14964; Q8IY31; Q969G3; A1L4H1,"SUBUNIT: The exocyst complex is composed of EXOC1, EXOC2, EXOC3, EXOC4, EXOC5, EXOC6, EXOC7 and EXOC8. Interacts with ARHQ in a GTP-dependent manner. Interacts with RAB11FIP3 (By similarity). {ECO:0000250}.",10470851; 14702039; 17974005; 16625196; 15489334; 16213214; 16148947; 19413330; 21269460; 23186163,10470851; 14702039; 17974005; 16625196; 15489334; 16213214; 16148947; 19413330; 21269460; 23186163; 11493706; 12687004; 15158452; 15550383; 15705715; 15878854; 16155582; 16169070; 16189514; 16525015; 16714477; 17043677; 17765682; 18000879; 19297529; 19454479; 20467437; 20579884; 20711500; 21241894; 21550243; 21565611; 22049025; 22420621; 22433857; 22595671; 22983554; 23300727; 23351793; 23416715; 23567335; 23948253; 24296415; 24331928; 25416956; 25594178; 26514725; 26848864; 27025610; 28698570,2002-12-06,2019-02-13,2003-11-14,174,,,,,,,,,5 out of 5,Alternative sequence (6); Chain (1); Coiled coil (2); Erroneous initiation (2); Modified residue (1); Sequence conflict (4),,,,Alternative splicing;Cell membrane;Coiled coil;Complete proteome;Cytoplasm;Exocytosis;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transport,Evidence at protein level,reviewed,,EXO70 family,174,Alternative products (1); Caution (2); Domain (2); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0025; KW-0175; KW-0181; KW-0268; KW-0472; KW-0597; KW-0653; KW-0813; KW-0963; KW-1003; KW-1185,,,,,,,,,CHAIN 1 735 Exocyst complex component 7. /FTId=PRO_0000118960.,,,,,,MOD_RES 133 133 Phosphoserine. {ECO:0000250|UniProtKB:O54922}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,FJ457119;FJ457120;AB028990;AK022397;AK022552;AK023832;AL834324;BC011045;BC018466;
0,Q9Y371,SHLB1_HUMAN,SH3GLB1 KIAA0491 CGI-61,SH3GLB1,KIAA0491,,CGI-61,Homo sapiens (Human),9606,Endophilin-B1 (Bax-interacting factor 1) (Bif-1) (SH3 domain-containing GRB2-like protein B1),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MNIMDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAECTKIWTEKIMKQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQYMIDAGTEFGPGTAYGNALIKCGETQKRIGTADRELIQTSALNFLTPLRNFIEGDYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNSSEQELRITQSEFDRQAEITRLLLEGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNNNQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLKECSGSRKARVLYDYDAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLELLN,365,"40,796",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Comment=Additional isoforms seem to exist.; Name=1; IsoId=Q9Y371-1; Sequence=Displayed; Name=2; IsoId=Q9Y371-2; Sequence=VSP_009276; Name=3; IsoId=Q9Y371-3; Sequence=VSP_044895; Note=No experimental confirmation available.; ,,SEQUENCE CAUTION:  Sequence=AAF81225.1; Type=Erroneous initiation; Evidence={ECO:0000305};  Sequence=BAD88797.1; Type=Erroneous initiation; Evidence={ECO:0000305}; ,,,,,,,,VAR_SEQ 1 100 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_044895.; VAR_SEQ 190 190 S -> SQLNSARLEGDNIMIWAEEVTK (in isoform 2). {ECO:0000303|PubMed:12456676}. /FTId=VSP_009276.,,,,,,,1,,0,"DOMAIN: An N-terminal amphipathic helix, the BAR domain and a second amphipathic helix inserted into helix 1 of the BAR domain (N-BAR domain) induce membrane curvature and bind curved membranes. {ECO:0000269|PubMed:11604418}.; DOMAIN: The SH3 domain is required and sufficient for the interaction with UVRAG. {ECO:0000269|PubMed:17891140}.",SIMILARITY: Belongs to the endophilin family. {ECO:0000305}.,COILED 155 195 {ECO:0000255}.,,DOMAIN 27 261 BAR. {ECO:0000255|PROSITE-ProRule:PRU00361}.; DOMAIN 305 365 SH3. {ECO:0000255|PROSITE-ProRule:PRU00192}.,,REGION 1 37 Required for membrane binding. {ECO:0000269|PubMed:21068542}.; REGION 1 30 Membrane-binding amphipathic helix.,,,,,,,,"FUNCTION: May be required for normal outer mitochondrial membrane dynamics (PubMed:15452144). Required for coatomer-mediated retrograde transport in certain cells (By similarity). May recruit other proteins to membranes with high curvature. May promote membrane fusion (PubMed:11604418). Involved in activation of caspase-dependent apoptosis by promoting BAX/BAK1 activation (PubMed:16227588). Isoform 1 acts proapoptotic in fibroblasts (By similarity). Involved in caspase-independent apoptosis during nutrition starvation and involved in the regulation of autophagy. Activates lipid kinase activity of PIK3C3 during autophagy probably by associating with the PI3K complex II (PI3KC3-C2) (PubMed:17891140). Associated with PI3KC3-C2 during autophagy may regulate the trafficking of ATG9A from the Golgi complex to the peripheral cytoplasm for the formation of autophagosomes by inducing Golgi membrane tubulation and fragmentation (PubMed:21068542). Involved in regulation of degradative endocytic trafficking and cytokinesis, probably in the context of PI3KC3-C2 (PubMed:20643123). Isoform 2 acts antiapoptotic in neuronal cells; involved in maintenance of mitochondrial morphology and promotes neuronal viability (By similarity). {ECO:0000250|UniProtKB:Q9JK48, ECO:0000269|PubMed:11604418, ECO:0000269|PubMed:15452144, ECO:0000269|PubMed:17891140, ECO:0000269|PubMed:20643123, ECO:0000269|PubMed:21068542}.",,,,,,,,,,,,autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; membrane fission [GO:0090148]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein complex oligomerization [GO:0051259]; protein localization to vacuolar membrane [GO:1903778]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647],apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; membrane fission [GO:0090148]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein complex oligomerization [GO:0051259]; protein localization to vacuolar membrane [GO:1903778]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647],cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803],autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741],GO:0000139; GO:0000421; GO:0005737; GO:0005741; GO:0005829; GO:0006914; GO:0006915; GO:0008289; GO:0010508; GO:0016241; GO:0030496; GO:0031410; GO:0031647; GO:0032461; GO:0032465; GO:0032801; GO:0034198; GO:0042149; GO:0042802; GO:0042803; GO:0045296; GO:0048102; GO:0051259; GO:0090148; GO:1903527; GO:1903778; GO:1903955; GO:2000786,IPR027267; IPR004148; IPR036028; IPR001452; IPR028503; IPR035695; ,Itself; Q07812; Q96DZ9; Q8NI60; Q8IVP5; P24522; P25786; Q9NR46; Q9UBB9; Q6FGS1; Q9P2Y5; Q9H609,"SUBUNIT: Homodimer, and heterodimer with SH3GLB2 (PubMed:11161816). Binds BAX; induction of apoptosis augments BAX binding (PubMed:11161816, PubMed:11259440). Binds DNM1, HTT, AMPH, BIN1 and ARFGAP1 (By similarity). Interacts with UVRAG; UVRAG bridges the interaction to BECN1 indicative for an association with the PI3K complex II (PI3KC3-C2) (PubMed:17891140, PubMed:20643123). {ECO:0000250|UniProtKB:Q9JK48, ECO:0000269|PubMed:11161816, ECO:0000269|PubMed:11259440, ECO:0000269|PubMed:17891140}.",11161816; 11259440; 12456676; 9455484; 10810093; 14702039; 16710414; 15489334; 11604418; 15452144; 16227588; 17891140; 20643123; 21068542; 21269460; 21499257; 22814378; 25944712,11161816; 11259440; 12456676; 9455484; 10810093; 14702039; 16710414; 15489334; 11604418; 15452144; 16227588; 17891140; 20643123; 21068542; 21269460; 21499257; 22814378; 25944712; 16374509; 16763557; 16916719; 17446270; 18474606; 18752120; 18824435; 18833585; 19074440; 19125733; 19132989; 19805544; 20159967; 20562859; 20711500; 21283040; 21988832; 22785202; 23414517; 23416715; 23429496; 24056303; 25416956; 25619828; 25981964; 26496610; 26638075; 27112121; 27508440; 27609472,2004-01-16,2019-02-13,1999-11-01,171,,,,,,,,,5 out of 5,Alternative sequence (2); Chain (1); Coiled coil (1); Domain (2); Erroneous initiation (2); Modified residue (2); Mutagenesis (3); Region (2),"CAUTION: It is uncertain whether Met-1 or Met-4 is the initiator. {ECO:0000305}.; CAUTION: Was originally thought to have lysophosphatidic acid acyltransferase activity, but by homology with SH3GL2/endophilin A1 is unlikely to have this activity. {ECO:0000305|PubMed:12456676}.","TISSUE SPECIFICITY: Highly expressed in heart, skeletal muscle, kidney and placenta. Detected at lower levels in brain, colon, thymus, spleen, liver, small intestine, lung and peripheral blood leukocytes. {ECO:0000269|PubMed:11161816, ECO:0000269|PubMed:11259440}.",MISCELLANEOUS: HeLa cells lacking SH3GLB1 show dissociation of outer and inner mitochondrial membrane as well as abnormal mitochondrial morphology. Cells overexpressing SH3GLB1 lacking an N-terminal amphipathic helix show a similar phenotype.; MISCELLANEOUS: SH3GLB1 binds liposomes and induces formation of tubules from liposomes. SH3GLB1 lacking the N-terminal amphipathic helix fails to induce liposome tubulation.,Acetylation;Alternative splicing;Apoptosis;Autophagy;Coiled coil;Complete proteome;Cytoplasm;Cytoplasmic vesicle;Golgi apparatus;Lipid-binding;Membrane;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Reference proteome;SH3 domain,Evidence at protein level,reviewed,,Endophilin family,171,Alternative products (1); Caution (3); Domain (2); Function (1); Miscellaneous (2); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0007; KW-0025; KW-0053; KW-0072; KW-0175; KW-0181; KW-0333; KW-0446; KW-0472; KW-0496; KW-0597; KW-0728; KW-0963; KW-0968; KW-1000; KW-1185,,,,,,,,PTM: Phosphorylated at Thr-145 by CDK5; this phosphorylation is required for autophagy induction in starved neurons and facilitates homodimerization. {ECO:0000269|PubMed:21499257}.,CHAIN 1 365 Endophilin-B1. /FTId=PRO_0000146753.,,,,,,MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 145 145 Phosphothreonine; by CDK5. {ECO:0000269|PubMed:21499257}.,,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF257318;AF350371;AF263293;AB007960;AF151819;AK001954;AK303710;BC007455;
0,Q9Y490,TLN1_HUMAN,TLN1 KIAA1027 TLN,TLN1,KIAA1027 TLN,,,Homo sapiens (Human),9606,Talin-1,UP000005640: Chromosome 9,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MVALSLKISIGNVVKTMQFEPSTMVYDACRIIRERIPEAPAGPPSDFGLFLSDDDPKKGIWLEAGKALDYYMLRNGDTMEYRKKQRPLKIRMLDGTVKTIMVDDSKTVTDMLMTICARIGITNHDEYSLVRELMEEKKEEITGTLRKDKTLLRDEKKMEKLKQKLHTDDELNWLDHGRTLREQGVEEHETLLLRRKFFYSDQNVDSRDPVQLNLLYVQARDDILNGSHPVSFDKACEFAGFQCQIQFGPHNEQKHKAGFLDLKDFLPKEYVKQKGERKIFQAHKNCGQMSEIEAKVRYVKLARSLKTYGVSFFLVKEKMKGKNKLVPRLLGITKECVMRVDEKTKEVIQEWNLTNIKRWAASPKSFTLDFGDYQDGYYSVQTTEGEQIAQLIAGYIDIILKKKKSKDHFGLEGDEESTMLEDSVSPKKSTVLQQQYNRVGKVEHGSVALPAIMRSGASGPENFQVGSMPPAQQQITSGQMHRGHMPPLTSAQQALTGTINSSMQAVQAAQATLDDFDTLPPLGQDAASKAWRKNKMDESKHEIHSQVDAITAGTASVVNLTAGDPAETDYTAVGCAVTTISSNLTEMSRGVKLLAALLEDEGGSGRPLLQAAKGLAGAVSELLRSAQPASAEPRQNLLQAAGNVGQASGELLQQIGESDTDPHFQDALMQLAKAVASAAAALVLKAKSVAQRTEDSGLQTQVIAAATQCALSTSQLVACTKVVAPTISSPVCQEQLVEAGRLVAKAVEGCVSASQAATEDGQLLRGVGAAATAVTQALNELLQHVKAHATGAGPAGRYDQATDTILTVTENIFSSMGDAGEMVRQARILAQATSDLVNAIKADAEGESDLENSRKLLSAAKILADATAKMVEAAKGAAAHPDSEEQQQRLREAAEGLRMATNAAAQNAIKKKLVQRLEHAAKQAAASATQTIAAAQHAASTPKASAGPQPLLVQSCKAVAEQIPLLVQGVRGSQAQPDSPSAQLALIAASQSFLQPGGKMVAAAKASVPTIQDQASAMQLSQCAKNLGTALAELRTAAQKAQEACGPLEMDSALSVVQNLEKDLQEVKAAARDGKLKPLPGETMEKCTQDLGNSTKAVSSAIAQLLGEVAQGNENYAGIAARDVAGGLRSLAQAARGVAALTSDPAVQAIVLDTASDVLDKASSLIEEAKKAAGHPGDPESQQRLAQVAKAVTQALNRCVSCLPGQRDVDNALRAVGDASKRLLSDSLPPSTGTFQEAQSRLNEAAAGLNQAATELVQASRGTPQDLARASGRFGQDFSTFLEAGVEMAGQAPSQEDRAQVVSNLKGISMSSSKLLLAAKALSTDPAAPNLKSQLAAAARAVTDSINQLITMCTQQAPGQKECDNALRELETVRELLENPVQPINDMSYFGCLDSVMENSKVLGEAMTGISQNAKNGNLPEFGDAISTASKALCGFTEAAAQAAYLVGVSDPNSQAGQQGLVEPTQFARANQAIQMACQSLGEPGCTQAQVLSAATIVAKHTSALCNSCRLASARTTNPTAKRQFVQSAKEVANSTANLVKTIKALDGAFTEENRAQCRAATAPLLEAVDNLSAFASNPEFSSIPAQISPEGRAAMEPIVISAKTMLESAGGLIQTARALAVNPRDPPSWSVLAGHSRTVSDSIKKLITSMRDKAPGQLECETAIAALNSCLRDLDQASLAAVSQQLAPREGISQEALHTQMLTAVQEISHLIEPLANAARAEASQLGHKVSQMAQYFEPLTLAAVGAASKTLSHPQQMALLDQTKTLAESALQLLYTAKEAGGNPKQAAHTQEALEEAVQMMTEAVEDLTTTLNEAASAAGVVGGMVDSITQAINQLDEGPMGEPEGSFVDYQTTMVRTAKAIAVTVQEMVTKSNTSPEELGPLANQLTSDYGRLASEAKPAAVAAENEEIGSHIKHRVQELGHGCAALVTKAGALQCSPSDAYTKKELIECARRVSEKVSHVLAALQAGNRGTQACITAASAVSGIIADLDTTIMFATAGTLNREGTETFADHREGILKTAKVLVEDTKVLVQNAAGSQEKLAQAAQSSVATITRLADVVKLGAASLGAEDPETQVVLINAVKDVAKALGDLISATKAAAGKVGDDPAVWQLKNSAKVMVTNVTSLLKTVKAVEDEATKGTRALEATTEHIRQELAVFCSPEPPAKTSTPEDFIRMTKGITMATAKAVAAGNSCRQEDVIATANLSRRAIADMLRACKEAAYHPEVAPDVRLRALHYGRECANGYLELLDHVLLTLQKPSPELKQQLTGHSKRVAGSVTELIQAAEAMKGTEWVDPEDPTVIAENELLGAAAAIEAAAKKLEQLKPRAKPKEADESLNFEEQILEAAKSIAAATSALVKAASAAQRELVAQGKVGAIPANALDDGQWSQGLISAARMVAAATNNLCEAANAAVQGHASQEKLISSAKQVAASTAQLLVACKVKADQDSEAMKRLQAAGNAVKRASDNLVKAAQKAAAFEEQENETVVVKEKMVGGIAQIIAAQEEMLRKERELEEARKKLAQIRQQQYKFLPSELRDEH,2541,"269,767",,,,SEQUENCE CAUTION:  Sequence=BAA82979.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,,,,,,,VARIANT 1227 1227 S -> L (in dbSNP:rs2295795). {ECO:0000269|Ref.1}. /FTId=VAR_023751.; VARIANT 1919 1919 R -> W (in dbSNP:rs17854239). {ECO:0000269|PubMed:15489334}. /FTId=VAR_023752.; VARIANT 1984 1984 A -> T (in dbSNP:rs35642290). /FTId=VAR_055538.,,,,CONFLICT 824 824 R -> G (in Ref. 1; AAD13152 and 2; AAF23322). {ECO:0000305}.; CONFLICT 1549 1549 A -> P (in Ref. 1; AAD13152 and 2; AAF23322). {ECO:0000305}.; CONFLICT 1604 1604 K -> Q (in Ref. 1; AAD13152 and 2; AAF23322). {ECO:0000305}.; CONFLICT 1701 1701 Q -> E (in Ref. 1; AAD13152 and 2; AAF23322). {ECO:0000305}.; CONFLICT 1718 1718 N -> H (in Ref. 1; AAD13152 and 2; AAF23322). {ECO:0000305}.; CONFLICT 1966 1966 A -> R (in Ref. 1; AAD13152). {ECO:0000305}.; CONFLICT 2256 2256 Missing (in Ref. 2; AAF27330). {ECO:0000305}.,,3,,0,,,,,DOMAIN 86 403 FERM. {ECO:0000255|PROSITE-ProRule:PRU00084}.; DOMAIN 2293 2533 I/LWEQ. {ECO:0000255|PROSITE-ProRule:PRU00292}.,,REGION 280 435 Interaction with LAYN. {ECO:0000250|UniProtKB:P54939}.; REGION 1327 1948 Interaction with SYNM. {ECO:0000269|PubMed:18342854}.; REGION 1359 1659 Interaction with VCL and F-actin. {ECO:0000250|UniProtKB:P26039}.,,,,,,,,"FUNCTION: Probably involved in connections of major cytoskeletal structures to the plasma membrane. High molecular weight cytoskeletal protein concentrated at regions of cell-substratum contact and, in lymphocytes, at cell-cell contacts (By similarity). {ECO:0000250}.",,,,,,,,,,,,cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032],cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032],actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166],cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; ruffle [GO:0001726]; ruffle membrane [GO:0032587],GO:0001726; GO:0001786; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005925; GO:0006936; GO:0007016; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0036498; GO:0045296; GO:0051015; GO:0070062; GO:0070527,IPR036723; IPR019749; IPR014352; IPR035963; IPR019748; IPR019747; IPR000299; IPR032425; IPR018979; IPR035964; IPR002558; IPR011993; IPR037438; IPR015224; IPR036476; IPR029071; IPR015009; ,P00533; P04626; P05556; P05106,"SUBUNIT: Binds with high affinity to VCL and with low affinity to integrins (PubMed:15070891). Interacts with APBB1IP; this inhibits VCL binding. Interacts with PTK2/FAK1 (By similarity). Interacts with PIP5K1C and NRAP (PubMed:10320340, PubMed:12422220). Interacts with LAYN (By similarity). Interacts with SYNM (PubMed:18342854). Interacts with ITGB1; the interaction is prevented by competitive binding of ITGB1BP1 (PubMed:21768292, PubMed:12473654). {ECO:0000250|UniProtKB:P26039, ECO:0000250|UniProtKB:P54939, ECO:0000269|PubMed:10320340, ECO:0000269|PubMed:12422220, ECO:0000269|PubMed:12473654, ECO:0000269|PubMed:15070891, ECO:0000269|PubMed:18342854, ECO:0000269|PubMed:21768292, ECO:0000269|PubMed:25121749}.; SUBUNIT: (Microbial infection) Interacts with human cytomegalovirus protein UL135. {ECO:0000269|PubMed:25121749}.",10610730; 10470851; 12168954; 15164053; 15489334; 10320340; 12422220; 12473654; 17081983; 18342854; 18088087; 18669648; 19690332; 19608861; 20068231; 21269460; 21768292; 21406692; 23186163; 25121749; 24275569; 25944712; 15070891,10610730; 10470851; 12168954; 15164053; 15489334; 10320340; 12422220; 12473654; 17081983; 18342854; 18088087; 18669648; 19690332; 19608861; 20068231; 21269460; 21768292; 21406692; 23186163; 25121749; 24275569; 25944712; 15070891; 10209122; 10409742; 10446041; 10725339; 10777559; 10891492; 10934324; 10964917; 11279249; 11457814; 11476890; 11940607; 12005431; 12068308; 12473660; 12585966; 12640026; 12832465; 14581461; 14630798; 14636584; 14754902; 14970219; 15031296; 15035987; 15157149; 15161933; 15520807; 15543157; 15581353; 15630448; 15728584; 15983060; 16005629; 16040750; 16115959; 16135787; 16273093; 16286926; 16364920; 16407302; 16539657; 16546176; 16581250; 16879721; 16919435; 16930978; 17218263; 1722201; 17430904; 17496912; 17563371; 17591693; 17591777; 17597073; 17624957; 17722883; 18056416; 18156175; 18434644; 18562239; 18974108; 19091303; 19148538; 19219045; 19242111; 19279408; 1930128; 19363486; 19367725; 19437340; 19463016; 19703396; 19738201; 19903453; 19933846; 19952892; 20130576; 20141835; 20160039; 20179705; 20467437; 20488542; 20526349; 20665668; 20858867; 20947017; 21291860; 21424530; 21454358; 21720550; 21763488; 21779496; 21846996; 21911599; 22045736; 22075696; 22177953; 22270917; 22334306; 22471464; 22510884; 22569528; 22623428; 22648415; 22745804; 22964303; 23022222; 23204516; 23266827; 23352452; 23414517; 23416715; 23479679; 23583981; 23722670; 23886189; 24121058; 24135138; 24136115; 24202393; 24345920; 24446374; 24452080; 24452377; 24651010; 24677266; 24761880; 24793790; 24937142; 24957944; 25142525; 25204415; 25233425; 2526655; 25435214; 25520155; 25907612; 25925041; 26000342; 26283369; 26336988; 26419705; 26496610; 26514267; 26752685; 26822056; 27169142; 27207789; 27410476; 27442684; 27644664; 2764880; 27775586; 27816808; 28099903; 28284333; 28375585; 28637452; 28945706; 29936723; 3287375; 3780718; 7513017; 7565670; 7565795; 7731720; 7929275; 7935411; 7997267; 8051079; 8157000; 8621540; 8631894; 8649368; 8755247; 9020159; 9351824; 9566877; 9858547,2000-12-01,2019-02-13,2005-11-08,197,X-ray crystallography (2); NMR spectroscopy (1),STRAND 311 313 {ECO:0000244|PDB:2MWN}.; STRAND 316 318 {ECO:0000244|PDB:2MWN}.; STRAND 320 327 {ECO:0000244|PDB:2MWN}.; STRAND 329 333 {ECO:0000244|PDB:2MWN}.; STRAND 336 340 {ECO:0000244|PDB:2MWN}.; STRAND 363 369 {ECO:0000244|PDB:2MWN}.; STRAND 377 381 {ECO:0000244|PDB:2MWN}.,HELIX 385 399 {ECO:0000244|PDB:2MWN}.; HELIX 608 625 {ECO:0000244|PDB:1SYQ}.; HELIX 2079 2098 {ECO:0000244|PDB:4DJ9}.,TURN 342 344 {ECO:0000244|PDB:2MWN}.,,,,,5 out of 5,Beta strand (7); Chain (1); Domain (2); Erroneous initiation (1); Helix (3); Modified residue (20); Natural variant (3); Region (3); Sequence conflict (12); Turn (1),,,,3D-structure;Acetylation;Cell junction;Cell membrane;Cell projection;Complete proteome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Host-virus interaction;Membrane;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,,197,Function (1); Subcellular location (1); Subunit structure (2),,KW-0002; KW-0007; KW-0181; KW-0206; KW-0472; KW-0597; KW-0621; KW-0903; KW-0945; KW-0963; KW-0965; KW-0966; KW-1003; KW-1185,,,,,,,,,CHAIN 1 2541 Talin-1. /FTId=PRO_0000219428.,,,,,,"MOD_RES 167 167 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 405 405 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 425 425 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 446 446 Phosphoserine. {ECO:0000250|UniProtKB:P26039}.; MOD_RES 620 620 Phosphoserine. {ECO:0000250|UniProtKB:P26039}.; MOD_RES 729 729 Phosphoserine. {ECO:0000250|UniProtKB:P26039}.; MOD_RES 1021 1021 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1116 1116 Phosphotyrosine. {ECO:0000250|UniProtKB:P26039}.; MOD_RES 1142 1142 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1201 1201 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1225 1225 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1263 1263 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1323 1323 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1544 1544 N6-acetyllysine. {ECO:0000250|UniProtKB:P26039}.; MOD_RES 1849 1849 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1855 1855 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1878 1878 Phosphoserine. {ECO:0000250|UniProtKB:P26039}.; MOD_RES 2031 2031 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 2040 2040 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 2115 2115 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF078828;AF177198;AF178534;AF178081;AB028950;CH471071;BC042923;
0,Q9Y5K6,CD2AP_HUMAN,CD2AP,CD2AP,,,,Homo sapiens (Human),9606,CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains),UP000005640: Chromosome 6,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MVDYIVEYDYDAVHDDELTIRVGEIIRNVKKLQEEGWLEGELNGRRGMFPDNFVKEIKRETEFKDDSLPIKRERHGNVASLVQRISTYGLPAGGIQPHPQTKNIKKKTKKRQCKVLFEYIPQNEDELELKVGDIIDINEEVEEGWWSGTLNNKLGLFPSNFVKELEVTDDGETHEAQDDSETVLAGPTSPIPSLGNVSETASGSVTQPKKIRGIGFGDIFKEGSVKLRTRTSSSETEEKKPEKPLILQSLGPKTQSVEITKTDTEGKIKAKEYCRTLFAYEGTNEDELTFKEGEIIHLISKETGEAGWWRGELNGKEGVFPDNFAVQINELDKDFPKPKKPPPPAKAPAPKPELIAAEKKYFSLKPEEKDEKSTLEQKPSKPAAPQVPPKKPTPPTKASNLLRSSGTVYPKRPEKPVPPPPPIAKINGEVSSISSKFETEPVSKLKLDSEQLPLRPKSVDFDSLTVRTSKETDVVNFDDIASSENLLHLTANRPKMPGRRLPGRFNGGHSPTHSPEKILKLPKEEDSANLKPSELKKDTCYSPKPSVYLSTPSSASKANTTAFLTPLEIKAKVETDDVKKNSLDELRAQIIELLCIVEALKKDHGKELEKLRKDLEEEKTMRSNLEMEIEKLKKAVLSS,639,"71,451",,,,,,,,,,,,,VARIANT 581 581 N -> K (in dbSNP:rs34069459). /FTId=VAR_033672.,,,,,,1,,0,DOMAIN: The Pro-rich domain may mediate binding to SH3 domains.; DOMAIN: Potential homodimerization is mediated by the coiled coil domain. {ECO:0000269|PubMed:10339567}.,,COILED 577 638 {ECO:0000255}.,COMPBIAS 336 422 Pro-rich.,DOMAIN 1 59 SH3 1; truncated. {ECO:0000255|PROSITE-ProRule:PRU00192}.; DOMAIN 108 167 SH3 2. {ECO:0000255|PROSITE-ProRule:PRU00192}.; DOMAIN 269 330 SH3 3. {ECO:0000255|PROSITE-ProRule:PRU00192}.,MOTIF 336 352 SH3-binding. {ECO:0000255}.; MOTIF 378 397 SH3-binding. {ECO:0000255}.; MOTIF 410 422 SH3-binding. {ECO:0000255}.,REGION 1 175 Interaction with ANLN and localization to the midbody. {ECO:0000269|PubMed:15800069}.,,,,,,,,"FUNCTION: Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton (PubMed:10339567). In collaboration with CBLC, modulates the rate of RET turnover and may act as regulatory checkpoint that limits the potency of GDNF on neuronal survival. Controls CBLC function, converting it from an inhibitor to a promoter of RET degradation (By similarity). May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell (By similarity). May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis (PubMed:15800069). Plays a role in epithelial cell junctions formation (PubMed:22891260). {ECO:0000250|UniProtKB:F1LRS8, ECO:0000250|UniProtKB:Q9JLQ0, ECO:0000269|PubMed:10339567, ECO:0000269|PubMed:15800069, ECO:0000269|PubMed:22891260}.",,,,,,,,,,,,"actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]; vascular endothelial growth factor receptor binding [GO:0005172]; actin filament organization [GO:0007015]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell-cell adhesion [GO:0098609]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; positive regulation of protein localization to nucleus [GO:1900182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; vesicle organization [GO:0016050]","actin filament organization [GO:0007015]; cell-cell adhesion [GO:0098609]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; positive regulation of protein localization to nucleus [GO:1900182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; vesicle organization [GO:0016050]",beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]; vascular endothelial growth factor receptor binding [GO:0005172],actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726],GO:0001726; GO:0005172; GO:0005200; GO:0005737; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007049; GO:0007165; GO:0008013; GO:0008022; GO:0015629; GO:0016050; GO:0017124; GO:0030139; GO:0031941; GO:0032911; GO:0043161; GO:0044877; GO:0045296; GO:0048259; GO:0048471; GO:0051058; GO:0051301; GO:0065003; GO:0070062; GO:0098609; GO:1900182; GO:2000249,IPR028445; IPR035775; IPR035777; IPR035776; IPR036028; IPR001452; ,Q8WV28; P22681; Q13191; P06729; P62993; P46940; Q8WUM4; Q99816,"SUBUNIT: Homodimer. Interacts with F-actin, PKD2, NPHS1 and NPHS2. Interacts with WTIP. Interacts with DDN; interaction is direct. Interacts (via SH3 2 domain) with CBL (via phosphorylated C-terminus). Interacts with BCAR1/p130Cas (via SH3 domain). Interacts with MVB12A and ARHGAP17. Interacts with ANLN, CD2 and CBLB. Interacts with PDCD6IP and TSG101. Interacts with RIN3. Interacts directly with RET (inactive) and CBLC; upon RET activation by GDNF suggested to dissociate from RET as CBLC:CD2AP complex (Probable) (PubMed:10339567, PubMed:11067845, PubMed:15800069, PubMed:16678097, PubMed:16895919, PubMed:17020880, PubMed:17853893, PubMed:18753381, Ref.29). Interacts with CGNL1 and SH3BP1; probably part of a complex at cell junctions (PubMed:22891260). Interacts with CAPZA1 (PubMed:22891260). {ECO:0000269|PubMed:10339567, ECO:0000269|PubMed:11067845, ECO:0000269|PubMed:15800069, ECO:0000269|PubMed:16678097, ECO:0000269|PubMed:16895919, ECO:0000269|PubMed:17020880, ECO:0000269|PubMed:17853893, ECO:0000269|PubMed:18753381, ECO:0000269|PubMed:22891260, ECO:0000269|Ref.29, ECO:0000305}.",10339567; 14574404; 15489334; 17974005; 11067845; 12764198; 15800069; 16678097; 16895919; 17853893; 18753381; 18220336; 18088087; 18669648; 19690332; 20068231; 21269460; 21406692; 22891260; 22814378; 23186163; 24275569; 25218447; 28112733; 17020880; 17188587; ,10339567; 14574404; 15489334; 17974005; 11067845; 12764198; 15800069; 16678097; 16895919; 17853893; 18753381; 18220336; 18088087; 18669648; 19690332; 20068231; 21269460; 21406692; 22891260; 22814378; 23186163; 24275569; 25218447; 28112733; 17020880; 17188587; 10997929; 11733379; 12029088; 12530983; 12672817; 12690097; 12832477; 14679214; 15659563; 16630808; 16707503; 17474147; 17606992; 17713465; 17823309; 17922258; 18274541; 18396147; 18654987; 18791326; 19131354; 19146815; 19380743; 19945749; 19956976; 20360068; 20379614; 20404345; 20457601; 20515931; 20625546; 20697350; 21460841; 21519904; 21655212; 21706016; 21822214; 21911934; 21988832; 22623428; 22662192; 22706086; 22880102; 23279575; 23663663; 23681557; 24322428; 25036637; 25092125; 25261582; 25887956; 26296892; 26496610; 26519441; 26638075; 26975192; 27765817; 28164240; 28392172; 28484055; 9741631,2003-04-23,2019-02-13,1999-11-01,177,X-ray crystallography (9); NMR spectroscopy (1),STRAND 4 6 {ECO:0000244|PDB:4WCI}.; STRAND 25 30 {ECO:0000244|PDB:4WCI}.; STRAND 37 42 {ECO:0000244|PDB:4WCI}.; STRAND 45 50 {ECO:0000244|PDB:4WCI}.; STRAND 53 56 {ECO:0000244|PDB:4WCI}.; STRAND 112 115 {ECO:0000244|PDB:3U23}.; STRAND 134 142 {ECO:0000244|PDB:3U23}.; STRAND 145 150 {ECO:0000244|PDB:3U23}.; STRAND 153 158 {ECO:0000244|PDB:3U23}.; STRAND 162 164 {ECO:0000244|PDB:3U23}.,HELIX 159 161 {ECO:0000244|PDB:3U23}.; HELIX 489 492 {ECO:0000244|PDB:3AA6}.; HELIX 503 505 {ECO:0000244|PDB:3AA6}.,,,,,,5 out of 5,Beta strand (10); Chain (1); Coiled coil (1); Compositional bias (1); Cross-link (2); Domain (3); Helix (3); Modified residue (11); Motif (3); Natural variant (1); Region (1),,TISSUE SPECIFICITY: Widely expressed in fetal and adult tissues.,,3D-structure;Cell cycle;Cell division;Cell junction;Cell projection;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Isopeptide bond;Mitosis;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH3 domain;SH3-binding;Ubl conjugation,Evidence at protein level,reviewed,,,177,Domain (2); Function (1); Involvement in disease (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0498; KW-0597; KW-0621; KW-0677; KW-0728; KW-0729; KW-0832; KW-0963; KW-0965; KW-0966; KW-1017; KW-1185,,,,,"DISEASE: Focal segmental glomerulosclerosis 3 (FSGS3) [MIM:607832]: A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. {ECO:0000269|PubMed:12764198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.",,,"PTM: Phosphorylated on tyrosine residues; probably by c-Abl, Fyn and c-Src. {ECO:0000269|PubMed:10339567, ECO:0000269|PubMed:11067845, ECO:0000269|PubMed:15800069}.",CHAIN 1 639 CD2-associated protein. /FTId=PRO_0000089435.,CROSSLNK 58 58 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447}.; CROSSLNK 523 523 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,,,"MOD_RES 67 67 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 80 80 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 86 86 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 224 224 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 458 458 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 463 463 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 469 469 Phosphoserine. {ECO:0000250|UniProtKB:F1LRS8}.; MOD_RES 510 510 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 514 514 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 565 565 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 582 582 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF146277;AF164377;CH471081;BC069444;AL050105;
0,O43663,PRC1_HUMAN,PRC1,PRC1,,,,Homo sapiens (Human),9606,Protein regulator of cytokinesis 1,UP000005640: Chromosome 15,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MRRSEVLAEESIVCLQKALNHLREIWELIGIPEDQRLQRTEVVKKHIKELLDMMIAEEESLKERLIKSISVCQKELNTLCSELHVEPFQEEGETTILQLEKDLRTQVELMRKQKKERKQELKLLQEQDQELCEILCMPHYDIDSASVPSLEELNQFRQHVTTLRETKASRREEFVSIKRQIILCMEALDHTPDTSFERDVVCEDEDAFCLSLENIATLQKLLRQLEMQKSQNEAVCEGLRTQIRELWDRLQIPEEEREAVATIMSGSKAKVRKALQLEVDRLEELKMQNMKKVIEAIRVELVQYWDQCFYSQEQRQAFAPFCAEDYTESLLQLHDAEIVRLKNYYEVHKELFEGVQKWEETWRLFLEFERKASDPNRFTNRGGNLLKEEKQRAKLQKMLPKLEEELKARIELWEQEHSKAFMVNGQKFMEYVAEQWEMHRLEKERAKQERQLKNKKQTETEMLYGSAPRTPSKRRGLAPNTPGKARKLNTTTMSNATANSSIRPIFGGTVYHSPVSRLPPSGSKPVAASTCSGKKTPRTGRHGANKENLELNGSILSGGYPGSAPLQRNFSINSVASTYSEFAKDPSLSDSSTVGLQRELSKASKSDATSGILNSTNIQS,620,"71,607",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=4;  Name=1 {ECO:0000269|PubMed:9885575}; IsoId=O43663-1; Sequence=Displayed; Name=2 {ECO:0000269|PubMed:15489334}; IsoId=O43663-2; Sequence=VSP_051979, VSP_051980; Note=No experimental confirmation available. {ECO:0000244|PubMed:18669648}; Name=3; IsoId=O43663-3; Sequence=VSP_035875, VSP_035876; Note=No experimental confirmation available.; Name=4; IsoId=O43663-4; Sequence=VSP_051980; Note=No experimental confirmation available. {ECO:0000244|PubMed:18669648}; ",,,,,,,,,,"VAR_SEQ 50 90 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_035875.; VAR_SEQ 397 426 Missing (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_051979.; VAR_SEQ 558 620 GGYPGSAPLQRNFSINSVASTYSEFAKDPSLSDSSTVGLQRELSKASKSDATSGILNSTNIQS -> ARTFKGFQI (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_035876.; VAR_SEQ 584 597 Missing (in isoform 2 and isoform 4). {ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005}. /FTId=VSP_051980.","VARIANT 187 187 A -> E (in dbSNP:rs7172758). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9885575}. /FTId=VAR_047768.; VARIANT 511 511 Y -> C (in dbSNP:rs12911192). /FTId=VAR_047769.",,,,CONFLICT 416 416 E -> G (in Ref. 5; BX647317). {ECO:0000305}.,,2,,0,DOMAIN: Microtubule binding occurs via a basic patch in the central spectrin-like domain and requires also the unstructured C-terminal domain.,SIMILARITY: Belongs to the MAP65/ASE1 family. {ECO:0000305}.,COILED 96 133 {ECO:0000255}.; COILED 211 304 {ECO:0000255}.; COILED 383 463 {ECO:0000255}.,,,,"REGION 1 341 Dimerization.; REGION 342 466 Spectrin-fold.; REGION 467 620 Unstructured, Arg/Lys rich.",,,,,,,,"FUNCTION: Key regulator of cytokinesis that cross-links antiparrallel microtubules at an average distance of 35 nM. Essential for controlling the spatiotemporal formation of the midzone and successful cytokinesis. Required for KIF14 localization to the central spindle and midbody. Required to recruit PLK1 to the spindle. Stimulates PLK1 phosphorylation of RACGAP1 to allow recruitment of ECT2 to the central spindle. Acts as an oncogene for promoting bladder cancer cells proliferation, apoptosis inhibition and carcinogenic progression (PubMed:17409436). {ECO:0000269|PubMed:12082078, ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:15625105, ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:17409436, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:20691902, ECO:0000269|PubMed:9885575}.",,,,,,,BINDING 377 377 Tubulin.; BINDING 387 387 Tubulin.,,,,,contractile ring [GO:0070938]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; mitotic spindle elongation [GO:0000022]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465],cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; mitotic spindle elongation [GO:0000022]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465],identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901],contractile ring [GO:0070938]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922],GO:0000022; GO:0000922; GO:0001578; GO:0005634; GO:0005819; GO:0005829; GO:0005876; GO:0008017; GO:0008284; GO:0019894; GO:0019901; GO:0030496; GO:0032465; GO:0042802; GO:0051301; GO:0070938,IPR007145; IPR032921; ,O94972,"SUBUNIT: Homodimer (PubMed:20691902). Interacts with the C-terminal Rho-GAP domain and the basic region of RACGAP1 (PubMed:14744859). The interaction with RACGAP1 inhibits its GAP activity towards CDC42 in vitro, which may be required for maintaining normal spindle morphology (PubMed:14744859). Interacts separately via its N-terminal region with the C-terminus of CENPE, KIF4A and KIF23 during late mitosis (PubMed:15297875, PubMed:16431929). Interacts with KIF14 and KIF20A (PubMed:15625105, PubMed:16431929). Interacts with PLK1 (PubMed:19468300). Interacts with KIF20B (PubMed:17409436). {ECO:0000269|PubMed:14744859, ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:15625105, ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:17409436, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:20691902}.",9885575; 14702039; 16572171; 15489334; 17974005; 12082078; 15297875; 14744859; 15625105; 16431929; 17409436; 17438553; 17351640; 18691976; 18669648; 19369195; 19468300; 20068231; 21269460; 22814378; 23186163; 20691902,9885575; 14702039; 16572171; 15489334; 17974005; 12082078; 15297875; 14744859; 15625105; 16431929; 17409436; 17438553; 17351640; 18691976; 18669648; 19369195; 19468300; 20068231; 21269460; 22814378; 23186163; 20691902; 16189514; 16603632; 17512944; 19447967; 20360068; 20467438; 22575643; 22621898; 23444367; 23716662; 23870126; 23940115; 24120663; 25609649; 26423135; 26496610; 26638075; 27493215,2006-04-04,2019-02-13,2008-11-25,156,X-ray crystallography (4); Electron microscopy (1),STRAND 425 427 {ECO:0000244|PDB:4L6Y}.,HELIX 3 28 {ECO:0000244|PDB:4L6Y}.; HELIX 33 82 {ECO:0000244|PDB:4L6Y}.; HELIX 96 135 {ECO:0000244|PDB:4L6Y}.; HELIX 150 188 {ECO:0000244|PDB:4L6Y}.; HELIX 195 201 {ECO:0000244|PDB:4L6Y}.; HELIX 212 249 {ECO:0000244|PDB:4L6Y}.; HELIX 254 263 {ECO:0000244|PDB:4L6Y}.; HELIX 271 306 {ECO:0000244|PDB:4L6Y}.; HELIX 312 316 {ECO:0000244|PDB:4L6Y}.; HELIX 341 345 {ECO:0000244|PDB:3NRX}.; HELIX 347 373 {ECO:0000244|PDB:3NRX}.; HELIX 375 378 {ECO:0000244|PDB:3NRY}.; HELIX 385 417 {ECO:0000244|PDB:3NRX}.; HELIX 428 464 {ECO:0000244|PDB:3NRX}.,,,,,,5 out of 5,Alternative sequence (4); Beta strand (1); Binding site (2); Chain (1); Coiled coil (3); Helix (14); Modified residue (8); Mutagenesis (4); Natural variant (2); Region (3); Sequence conflict (1),,TISSUE SPECIFICITY: Overexpressed in bladder cancer cells (PubMed:17409436). {ECO:0000269|PubMed:17409436}.,,3D-structure;Alternative splicing;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Microtubule;Nucleus;Oncogene;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,MAP65/ASE1 family,156,Alternative products (1); Caution (3); Domain (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0025; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0493; KW-0539; KW-0553; KW-0597; KW-0621; KW-0963; KW-1185,,,,,,,,"PTM: Phosphorylation by CDK1 in early mitosis holds PRC1 in an inactive monomeric state, during the metaphase to anaphase transition, PRC1 is dephosphorylated, promoting interaction with KIF4A, which then translocates PRC1 along mitotic spindles to the plus ends of antiparallel interdigitating microtubules. Dephosphorylation also promotes MT-bundling activity by allowing dimerization. Phosphorylation by CDK1 prevents PLK1-binding: upon degradation of CDK1 at anaphase and dephosphorylation, it is then phosphorylated by PLK1, leading to cytokinesis. {ECO:0000269|PubMed:17351640, ECO:0000269|PubMed:17438553, ECO:0000269|PubMed:9885575}.",CHAIN 1 620 Protein regulator of cytokinesis 1. /FTId=PRO_0000229737.,,,,,,"MOD_RES 470 470 Phosphothreonine; by CDK1. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:17351640, ECO:0000269|PubMed:17438553, ECO:0000269|PubMed:9885575}.; MOD_RES 481 481 Phosphothreonine; by CDK1. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:17351640, ECO:0000269|PubMed:17438553, ECO:0000269|PubMed:9885575}.; MOD_RES 513 513 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 571 571 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 578 578 Phosphothreonine. {ECO:0000269|PubMed:17351640}.; MOD_RES 616 616 Phosphothreonine; by PLK1. {ECO:0000269|PubMed:17351640}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF044588;AK297117;BC003138;BC005140;
0,O95235,KI20A_HUMAN,KIF20A MKLP2 RAB6KIFL,KIF20A,MKLP2 RAB6KIFL,,,Homo sapiens (Human),9606,Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6),UP000005640: Chromosome 5,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MSQGILSPPAGLLSDDDVVVSPMFESTAADLGSVVRKNLLSDCSVVSTSLEDKQQVPSEDSMEKVKVYLRVRPLLPSELERQEDQGCVRIENVETLVLQAPKDSFALKSNERGIGQATHRFTFSQIFGPEVGQASFFNLTVKEMVKDVLKGQNWLIYTYGVTNSGKTHTIQGTIKDGGILPRSLALIFNSLQGQLHPTPDLKPLLSNEVIWLDSKQIRQEEMKKLSLLNGGLQEEELSTSLKRSVYIESRIGTSTSFDSGIAGLSSISQCTSSSQLDETSHRWAQPDTAPLPVPANIRFSIWISFFEIYNELLYDLLEPPSQQRKRQTLRLCEDQNGNPYVKDLNWIHVQDAEEAWKLLKVGRKNQSFASTHLNQNSSRSHSIFSIRILHLQGEGDIVPKISELSLCDLAGSERCKDQKSGERLKEAGNINTSLHTLGRCIAALRQNQQNRSKQNLVPFRDSKLTRVFQGFFTGRGRSCMIVNVNPCASTYDETLHVAKFSAIASQLVHAPPMQLGFPSLHSFIKEHSLQVSPSLEKGAKADTGLDDDIENEADISMYGKEELLQVVEAMKTLLLKERQEKLQLEMHLRDEICNEMVEQMQQREQWCSEHLDTQKELLEEMYEEKLNILKESLTSFYQEEIQERDEKIEELEALLQEARQQSVAHQQSGSELALRRSQRLAASASTQQLQEVKAKLQQCKAELNSTTEELHKYQKMLEPPPSAKPFTIDVDKKLEEGQKNIRLLRTELQKLGESLQSAERACCHSTGAGKLRQALTTCDDILIKQDQTLAELQNNMVLVKLDLRKKAACIAEQYHTVLKLQGQVSAKKRLGTNQENQQPNQQPPGKKPFLRNLLPRTPTCQSSTDCSPYARILRSRRSPLLKSGPFGKKY,890,"100,278",,ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=O95235-1; Sequence=Displayed; Name=2; IsoId=O95235-2; Sequence=VSP_056007; Note=No experimental confirmation available.; ,,,,,,,,,,VAR_SEQ 65 82 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_056007.,VARIANT 63 63 E -> K (in dbSNP:rs3734116). /FTId=VAR_049704.; VARIANT 839 839 P -> L (in dbSNP:rs3172747). /FTId=VAR_049705.,,,,,,1,,0,,SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family. {ECO:0000255|PROSITE-ProRule:PRU00283}.,COILED 611 762 {ECO:0000255}.,,DOMAIN 64 507 Kinesin motor. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,REGION 763 890 Globular. {ECO:0000255}.,,,,,,,,"FUNCTION: Mitotic kinesin required for chromosome passenger complex (CPC)-mediated cytokinesis. Following phosphorylation by PLK1, involved in recruitment of PLK1 to the central spindle. Interacts with guanosine triphosphate (GTP)-bound forms of RAB6A and RAB6B. May act as a motor required for the retrograde RAB6 regulated transport of Golgi membranes and associated vesicles along microtubules. Has a microtubule plus end-directed motility. {ECO:0000269|PubMed:12939256}.",,,,,,,,,,NP_BIND 160 167 ATP. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,cleavage furrow [GO:0032154]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; transporter activity [GO:0005215]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; vesicle-mediated transport [GO:0016192],microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; vesicle-mediated transport [GO:0016192],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; transporter activity [GO:0005215],cleavage furrow [GO:0032154]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],GO:0000281; GO:0001578; GO:0003777; GO:0005215; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016192; GO:0016887; GO:0019901; GO:0030496; GO:0032154; GO:0032465; GO:0045171; GO:0061952,IPR027326; IPR027640; IPR019821; IPR001752; IPR036961; IPR027417; ,Q7L5A3,,10233894; 10806357; 14702039; 15372022; 15489334; 12939256; 17081983; 16964243; 18220336; 18691976; 18669648; 20068231; 21406692; 23186163,10233894; 10806357; 14702039; 15372022; 15489334; 12939256; 17081983; 16964243; 18220336; 18691976; 18669648; 20068231; 21406692; 23186163; 10036229; 11060022; 11493604; 11739780; 11782313; 12198549; 12368902; 12469216; 1406973; 14504276; 15029241; 15263015; 15272311; 15326200; 15665285; 1607388; 16262723; 16571679; 17113389; 17283181; 18046453; 19116309; 19303298; 19369418; 19564404; 19758564; 20005805; 20136777; 20360068; 20462495; 20534429; 2142332; 21550981; 21988832; 22013193; 22854760; 22887948; 23750214; 24571573; 24656812; 2521221; 2522352; 25364732; 25416956; 25499221; 25953216; 25961928; 26496610; 26638075; 27036048; 27939310; 27941992; 28070829; 28081138; 28630147; 28826477; 29357359; 29704495; 29749467; 30182171; 7844144; 7929562; 8602245; 8642258; 8909537,2000-05-30,2019-02-13,1999-05-01,169,,,,,,,,,5 out of 5,Alternative sequence (1); Chain (1); Coiled coil (1); Domain (1); Initiator methionine (1); Modified residue (14); Mutagenesis (1); Natural variant (2); Nucleotide binding (1); Region (1),,,,ATP-binding;Acetylation;Alternative splicing;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Golgi apparatus;Microtubule;Motor protein;Nucleotide-binding;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family",169,Alternative products (1); Caution (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1),,KW-0007; KW-0025; KW-0067; KW-0175; KW-0181; KW-0206; KW-0333; KW-0493; KW-0505; KW-0547; KW-0597; KW-0621; KW-0653; KW-0813; KW-0963; KW-1185,,,,,,,,"PTM: Phosphorylated by PLK1 at Ser-528 during mitosis, creating a docking site for PLK1 and recruiting PLK1 at central spindle. {ECO:0000269|PubMed:12939256}.",CHAIN 2 890 Kinesin-like protein KIF20A. /FTId=PRO_0000125460.,,,,INIT_MET 1 1 Removed. {ECO:0000244|PubMed:20068231}.,,"MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 7 7 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 14 14 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 21 21 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 528 528 Phosphoserine; by PLK1. {ECO:0000244|PubMed:18669648, ECO:0000269|PubMed:12939256}.; MOD_RES 532 532 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 662 662 Phosphoserine. {ECO:0000269|PubMed:12939256}.; MOD_RES 668 668 Phosphoserine. {ECO:0000269|PubMed:12939256}.; MOD_RES 685 685 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 825 825 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 857 857 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 867 867 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 878 878 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 883 883 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF070672;AF153329;AK296879;CH471062;CH471062;BC012999;
0,O95239,KIF4A_HUMAN,KIF4A KIF4,KIF4A,KIF4,,,Homo sapiens (Human),9606,Chromosome-associated kinesin KIF4A (Chromokinesin-A),UP000005640: Chromosome X,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MKEEVKGIPVRVALRCRPLVPKEISEGCQMCLSFVPGEPQVVVGTDKSFTYDFVFDPSTEQEEVFNTAVAPLIKGVFKGYNATVLAYGQTGSGKTYSMGGAYTAEQENEPTVGVIPRVIQLLFKEIDKKSDFEFTLKVSYLEIYNEEILDLLCPSREKAQINIREDPKEGIKIVGLTEKTVLVALDTVSCLEQGNNSRTVASTAMNSQSSRSHAIFTISLEQRKKSDKNSSFRSKLHLVDLAGSERQKKTKAEGDRLKEGININRGLLCLGNVISALGDDKKGGFVPYRDSKLTRLLQDSLGGNSHTLMIACVSPADSNLEETLNTLRYADRARKIKNKPIVNIDPQTAELNHLKQQVQQLQVLLLQAHGGTLPGSITVEPSENLQSLMEKNQSLVEENEKLSRGLSEAAGQTAQMLERIILTEQANEKMNAKLEELRQHAACKLDLQKLVETLEDQELKENVEIICNLQQLITQLSDETVACMAAAIDTAVEQEAQVETSPETSRSSDAFTTQHALRQAQMSKELVELNKALALKEALARKMTQNDSQLQPIQYQYQDNIKELELEVINLQKEKEELVLELQTAKKDANQAKLSERRRKRLQELEGQIADLKKKLNEQSKLLKLKESTERTVSKLNQEIRMMKNQRVQLMRQMKEDAEKFRQWKQKKDKEVIQLKERDRKRQYELLKLERNFQKQSNVLRRKTEEAAAANKRLKDALQKQREVADKRKETQSRGMEGTAARVKNWLGNEIEVMVSTEEAKRHLNDLLEDRKILAQDVAQLKEKKESGENPPPKLRRRTFSLTEVRGQVSESEDSITKQIESLETEMEFRSAQIADLQQKLLDAESEDRPKQRWENIATILEAKCALKYLIGELVSSKIQVSKLESSLKQSKTSCADMQKMLFEERNHFAEIETELQAELVRMEQQHQEKVLYLLSQLQQSQMAEKQLEESVSEKEQQLLSTLKCQDEELEKMREVCEQNQQLLRENEIIKQKLTLLQVASRQKHLPKDTLLSPDSSFEYVPPKPKPSRVKEKFLEQSMDIEDLKYCSEHSVNEHEDGDGDDDEGDDEEWKPTKLVKVSRKNIQGCSCKGWCGNKQCGCRKQKSDCGVDCCCDPTKCRNRQQGKDSLGTVERTQDSEGSFKLEDPTEVTPGLSFFNPVCATPNSKILKEMCDVEQVLSKKTPPAPSPFDLPELKHVATEYQENKAPGKKKKRALASNTSFFSGCSPIEEEAH,1232,"139,881",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=2;  Name=1; IsoId=O95239-1; Sequence=Displayed; Name=2; IsoId=O95239-2; Sequence=VSP_013375, VSP_013376; Note=No experimental confirmation available.; ",,,,,,,,,SEQUENCE CAUTION:  Sequence=AAH49218.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305}; ,VAR_SEQ 1086 1127 CSCKGWCGNKQCGCRKQKSDCGVDCCCDPTKCRNRQQGKDSL -> VLLLTPVISALWEAEARGLLEARSSRPAWATWRDPVSTKPKN (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_013375.; VAR_SEQ 1128 1232 Missing (in isoform 2). {ECO:0000303|PubMed:15489334}. /FTId=VSP_013376.,"VARIANT 422 422 L -> W (in dbSNP:rs1199457). {ECO:0000269|PubMed:10978527, ECO:0000269|PubMed:15489334}. /FTId=VAR_021828.; VARIANT 491 491 A -> V (in dbSNP:rs2297871). /FTId=VAR_049693.; VARIANT 1193 1193 L -> S (in dbSNP:rs1046485). /FTId=VAR_049694.",,,,CONFLICT 223 223 R -> G (in Ref. 2; AAD05492). {ECO:0000305}.; CONFLICT 231 231 S -> T (in Ref. 8; AAF86334). {ECO:0000305}.; CONFLICT 286 286 V -> A (in Ref. 2; AAD05492). {ECO:0000305}.; CONFLICT 564 564 L -> H (in Ref. 8; AAF86334). {ECO:0000305}.; CONFLICT 564 564 L -> P (in Ref. 2; AAD05492). {ECO:0000305}.; CONFLICT 600 600 K -> E (in Ref. 3; CAB75427). {ECO:0000305}.; CONFLICT 668 668 K -> R (in Ref. 1 and 2). {ECO:0000305}.; CONFLICT 928 928 Q -> P (in Ref. 1; AAD51855). {ECO:0000305}.; CONFLICT 958 958 Q -> R (in Ref. 3; CAB75427). {ECO:0000305}.; CONFLICT 960 960 L -> Q (in Ref. 1; AAD51855). {ECO:0000305}.; CONFLICT 996 997 LL -> S (in Ref. 8; AAF86334). {ECO:0000305}.; CONFLICT 1003 1014 QKHLPKDTLLSP -> RTLPRIPFYLQ (in Ref. 8; AAF86334). {ECO:0000305}.; CONFLICT 1022 1022 P -> Q (in Ref. 2; AAD05492). {ECO:0000305}.; CONFLICT 1077 1077 K -> N (in Ref. 2; AAD05492). {ECO:0000305}.; CONFLICT 1138 1138 G -> S (in Ref. 2; AAD05492). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family. Chromokinesin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00283}.,COILED 350 999 {ECO:0000255}.,,DOMAIN 9 336 Kinesin motor. {ECO:0000255|PROSITE-ProRule:PRU00283}.,MOTIF 793 798 Nuclear localization signal.,REGION 663 1232 Interaction with PRC1.; REGION 1000 1232 Globular.,,,,,,,,"FUNCTION: Motor protein that translocates PRC1 to the plus ends of interdigitating spindle microtubules during the metaphase to anaphase transition, an essential step for the formation of an organized central spindle midzone and midbody and for successful cytokinesis. May play a role in mitotic chromosomal positioning and bipolar spindle stabilization. {ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:15625105}.",,,,,,,,,,NP_BIND 88 95 ATP. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,"axon cytoplasm [GO:1904115]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; organelle organization [GO:0006996]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; organelle organization [GO:0006996]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],axon cytoplasm [GO:1904115]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spindle microtubule [GO:0005876],GO:0000281; GO:0003677; GO:0003777; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0005876; GO:0006890; GO:0006996; GO:0007018; GO:0007052; GO:0008017; GO:0008089; GO:0016020; GO:0016363; GO:0016887; GO:0019886; GO:0030496; GO:0045171; GO:0051256; GO:1904115,IPR027640; IPR019821; IPR001752; IPR036961; IPR027417; ,O94880; O94880-1,"SUBUNIT: Interacts with unphosphorylated PRC1 during late mitosis. {ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:15625105}.",10978527; 14702039; 15772651; 15489334; 9168136; 11736643; 15297875; 15625105; 17081983; 16964243; 18669648; 18318008; 19413330; 20068231; 21269460; 23186163; 24812067; 28112733,10978527; 14702039; 15772651; 15489334; 9168136; 11736643; 15297875; 15625105; 17081983; 16964243; 18669648; 18318008; 19413330; 20068231; 21269460; 23186163; 24812067; 28112733; 10036229; 10747093; 10804209; 11493604; 11739780; 12198549; 12368902; 12809554; 12927788; 14504276; 15029241; 15031677; 15272311; 15326200; 1607388; 16262723; 16571679; 16880273; 17113389; 17283181; 17353931; 18046453; 18502200; 18604178; 18684836; 19116309; 19369418; 19564404; 19758564; 20005805; 20136777; 20360068; 20462495; 20467437; 20534429; 20711700; 2142332; 21550981; 21565503; 21566458; 22013193; 23416715; 23870126; 23940115; 24386490; 2521221; 2522352; 25364732; 25512391; 25609649; 25998931; 27196062; 27633014; 28160558; 28646197; 28821562; 29204984; 7844144; 7929562; 8599929; 8602245; 8642258; 8909537,1999-07-15,2019-02-13,2005-04-12,183,,,,,,,,,5 out of 5,Alternative sequence (2); Chain (1); Coiled coil (1); Cross-link (1); Domain (1); Modified residue (15); Motif (1); Natural variant (3); Nucleotide binding (1); Region (2); Sequence caution (1); Sequence conflict (16),,"TISSUE SPECIFICITY: Highly expressed in hematopoietic tissues, fetal liver, spleen, thymus and adult thymus and bone marrow. Lower levels are found in heart, testis, kidney, colon and lung. {ECO:0000269|PubMed:10978527}.",,ATP-binding;Alternative splicing;Chromosome;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;DNA-binding;Isopeptide bond;Mental retardation;Microtubule;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family, Chromokinesin subfamily",183,Alternative products (1); Caution (1); Function (1); Involvement in disease (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0067; KW-0158; KW-0175; KW-0181; KW-0206; KW-0238; KW-0493; KW-0505; KW-0539; KW-0547; KW-0597; KW-0621; KW-0832; KW-0963; KW-0991; KW-1017; KW-1185,,,,,"DISEASE: Mental retardation, X-linked 100 (MRX100) [MIM:300923]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. MRX100 clinical features include intellectual disability, epilepsy, microcephaly and cortical malformations. {ECO:0000269|PubMed:24812067}. Note=The disease may be caused by mutations affecting the gene represented in this entry.",,,,CHAIN 1 1232 Chromosome-associated kinesin KIF4A. /FTId=PRO_0000125437.,CROSSLNK 1194 1194 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,,,"MOD_RES 394 394 Phosphoserine. {ECO:0000250|UniProtKB:P33174}.; MOD_RES 799 799 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 801 801 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 810 810 Phosphoserine. {ECO:0000250|UniProtKB:P33174}.; MOD_RES 815 815 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 951 951 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 995 995 Phosphothreonine. {ECO:0000244|PubMed:18318008}.; MOD_RES 1001 1001 Phosphoserine. {ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 1013 1013 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1017 1017 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1028 1028 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1126 1126 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1181 1181 Phosphothreonine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1186 1186 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 1225 1225 Phosphoserine. {ECO:0000250|UniProtKB:P33174}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AF179308;AF071592;AJ271784;AK313133;CH471132;CH471132;BC049218;BC050548;AF277375;
0,P33176,KINH_HUMAN,KIF5B KNS KNS1,KIF5B,KNS KNS1,,,Homo sapiens (Human),9606,Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain) (UKHC),UP000005640: Chromosome 10,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MADLAECNIKVMCRFRPLNESEVNRGDKYIAKFQGEDTVVIASKPYAFDRVFQSSTSQEQVYNDCAKKIVKDVLEGYNGTIFAYGQTSSGKTHTMEGKLHDPEGMGIIPRIVQDIFNYIYSMDENLEFHIKVSYFEIYLDKIRDLLDVSKTNLSVHEDKNRVPYVKGCTERFVCSPDEVMDTIDEGKSNRHVAVTNMNEHSSRSHSIFLINVKQENTQTEQKLSGKLYLVDLAGSEKVSKTGAEGAVLDEAKNINKSLSALGNVISALAEGSTYVPYRDSKMTRILQDSLGGNCRTTIVICCSPSSYNESETKSTLLFGQRAKTIKNTVCVNVELTAEQWKKKYEKEKEKNKILRNTIQWLENELNRWRNGETVPIDEQFDKEKANLEAFTVDKDITLTNDKPATAIGVIGNFTDAERRKCEEEIAKLYKQLDDKDEEINQQSQLVEKLKTQMLDQEELLASTRRDQDNMQAELNRLQAENDASKEEVKEVLQALEELAVNYDQKSQEVEDKTKEYELLSDELNQKSATLASIDAELQKLKEMTNHQKKRAAEMMASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVARLYISKMKSEVKTMVKRCKQLESTQTESNKKMEENEKELAACQLRISQHEAKIKSLTEYLQNVEQKKRQLEESVDALSEELVQLRAQEKVHEMEKEHLNKVQTANEVKQAVEQQIQSHRETHQKQISSLRDEVEAKAKLITDLQDQNQKMMLEQERLRVEHEKLKATDQEKSRKLHELTVMQDRREQARQDLKGLEETVAKELQTLHNLRKLFVQDLATRVKKSAEIDSDDTGGSAAQKQKISFLENNLEQLTKVHKQLVRDNADLRCELPKLEKRLRATAERVKALESALKEAKENASRDRKRYQQEVDRIKEAVRSKNMARRGHSAQIAKPIRPGQHPAASPTHPSAIRGGGAFVQNSQPVAVRGGGGKQV,963,"109,685",,,,,,,,,,,,,,,,,,,1,,0,"DOMAIN: Composed of three structural domains: a large globular N-terminal domain which is responsible for the motor activity of kinesin (it hydrolyzes ATP and binds microtubule), a central alpha-helical coiled coil domain that mediates the heavy chain dimerization; and a small globular C-terminal domain which interacts with other proteins (such as the kinesin light chains), vesicles and membranous organelles.",SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family. Kinesin subfamily. {ECO:0000255|PROSITE-ProRule:PRU00283}.,COILED 329 914,,DOMAIN 8 325 Kinesin motor. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,REGION 915 963 Globular.,,,,,,,,"FUNCTION: Microtubule-dependent motor required for normal distribution of mitochondria and lysosomes. Can induce formation of neurite-like membrane protrusions in non-neuronal cells in a ZFYVE27-dependent manner (By similarity). Regulates centrosome and nuclear positioning during mitotic entry. During the G2 phase of the cell cycle in a BICD2-dependent manner, antagonizes dynein function and drives the separation of nuclei and centrosomes (PubMed:20386726). Required for anterograde axonal transportation of MAPK8IP3/JIP3 which is essential for MAPK8IP3/JIP3 function in axon elongation (By similarity). {ECO:0000250|UniProtKB:Q2PQA9, ECO:0000250|UniProtKB:Q61768, ECO:0000269|PubMed:20386726}.",,,,,,,,,,NP_BIND 85 92 ATP.,,"axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; microtubule motor activity [GO:0003777]; anterograde axonal protein transport [GO:0099641]; anterograde neuronal dense core vesicle transport [GO:1990048]; cellular response to interferon-gamma [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of voltage-gated sodium channel activity [GO:1905152]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; vesicle transport along microtubule [GO:0047496]","anterograde axonal protein transport [GO:0099641]; anterograde neuronal dense core vesicle transport [GO:1990048]; cellular response to interferon-gamma [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of voltage-gated sodium channel activity [GO:1905152]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; vesicle transport along microtubule [GO:0047496]",ATPase activity [GO:0016887]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; microtubule motor activity [GO:0003777],axonal growth cone [GO:0044295]; axon cytoplasm [GO:1904115]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982],GO:0003777; GO:0005524; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007028; GO:0008017; GO:0008432; GO:0016020; GO:0016887; GO:0021766; GO:0031340; GO:0031982; GO:0032230; GO:0035253; GO:0035617; GO:0035774; GO:0042391; GO:0042802; GO:0043268; GO:0044295; GO:0045296; GO:0045335; GO:0047496; GO:0048471; GO:0051642; GO:0071346; GO:0072383; GO:0090316; GO:0099609; GO:0099641; GO:1903078; GO:1904115; GO:1905152; GO:1990048; GO:1990049,IPR027640; IPR019821; IPR001752; IPR036961; IPR027417; ,Itself; Q9BQS8; Q8CII8; P68619,"SUBUNIT: Oligomer composed of two heavy chains and two light chains. Interacts with GRIP1 and PPP1R42 (By similarity). Interacts with SYBU (PubMed:15459722). Interacts with JAKMIP1 (PubMed:17532644). Interacts with PLEKHM2 (PubMed:15905402). Interacts with ECPAS (PubMed:20682791). Interacts with ZFYVE27 (By similarity). Found in a complex with OGT, RHOT1, RHOT2 and TRAK1 (PubMed:24995978). {ECO:0000250|UniProtKB:Q61768, ECO:0000269|PubMed:12368902, ECO:0000269|PubMed:15459722, ECO:0000269|PubMed:15905402, ECO:0000269|PubMed:17532644, ECO:0000269|PubMed:20682791, ECO:0000269|PubMed:24995978, ECO:0000269|PubMed:8606779}.",1607388; 15164054; 15489334; 15459722; 15905402; 17081983; 17532644; 19413330; 20682791; 20386726; 20068231; 21269460; 22223895; 22814378; 24995978; 24275569; 24129315; 28112733; 8606779; 12368902; 17470637,1607388; 15164054; 15489334; 15459722; 15905402; 17081983; 17532644; 19413330; 20682791; 20386726; 20068231; 21269460; 22223895; 22814378; 24995978; 24275569; 24129315; 28112733; 8606779; 12368902; 17470637; 10036229; 10913441; 11493604; 11689693; 11739780; 12191989; 12198549; 12475239; 14504276; 14592410; 14600269; 14743216; 15029241; 15161933; 15184079; 15272311; 15324660; 15326200; 15778465; 16260607; 16262723; 16385451; 16498388; 16571679; 16714477; 17043677; 17113389; 17220478; 17283181; 17353931; 17394562; 17887960; 17925227; 17979178; 18046453; 18514191; 18579780; 18615096; 18817524; 18984674; 19116309; 19242560; 19305391; 19348763; 19367725; 19369418; 19463016; 19564404; 19615732; 19675065; 19758564; 19765186; 19773350; 19913510; 20005805; 20071331; 20136777; 20195357; 20462495; 20534429; 20562859; 20711500; 20936779; 2142332; 21550981; 21656749; 21900206; 21910419; 21915095; 22013193; 22172677; 22198464; 22327624; 22404429; 22514732; 22810585; 23378251; 23416715; 23606334; 23872990; 23884313; 24072715; 24821626; 25047660; 2521221; 2522352; 25231297; 25348260; 25364732; 25378581; 25395082; 25415053; 25450690; 25516977; 25537000; 25609649; 25660542; 25665578; 25676575; 25818289; 25902401; 26268359; 26496610; 26627252; 26991731; 27327622; 27788242; 27851960; 28195215; 28284467; 28302907; 28504639; 28668932; 28877471; 28911147; 28930676; 29229862; 30015159; 30591488; 3130248; 3134048; 7844144; 7929562; 8602245; 8642258; 8909537; 9112396,1993-10-01,2019-02-13,1993-10-01,192,X-ray crystallography (9); Electron microscopy (3),STRAND 8 15 {ECO:0000244|PDB:1BG2}.; STRAND 32 34 {ECO:0000244|PDB:1BG2}.; STRAND 38 41 {ECO:0000244|PDB:1BG2}.; STRAND 44 47 {ECO:0000244|PDB:1BG2}.; STRAND 49 52 {ECO:0000244|PDB:1BG2}.; STRAND 79 84 {ECO:0000244|PDB:1BG2}.; STRAND 124 138 {ECO:0000244|PDB:1BG2}.; STRAND 141 146 {ECO:0000244|PDB:1BG2}.; STRAND 155 157 {ECO:0000244|PDB:1BG2}.; STRAND 163 165 {ECO:0000244|PDB:1BG2}.; STRAND 171 173 {ECO:0000244|PDB:1BG2}.; STRAND 204 216 {ECO:0000244|PDB:1BG2}.; STRAND 222 231 {ECO:0000244|PDB:1BG2}.; STRAND 242 244 {ECO:0000244|PDB:1BG2}.; STRAND 290 293 {ECO:0000244|PDB:1BG2}.; STRAND 295 302 {ECO:0000244|PDB:1BG2}.; STRAND 326 329 {ECO:0000244|PDB:1MKJ}.,HELIX 20 25 {ECO:0000244|PDB:1BG2}.; HELIX 58 65 {ECO:0000244|PDB:1BG2}.; HELIX 67 74 {ECO:0000244|PDB:1BG2}.; HELIX 91 95 {ECO:0000244|PDB:1BG2}.; HELIX 107 122 {ECO:0000244|PDB:1BG2}.; HELIX 176 189 {ECO:0000244|PDB:1BG2}.; HELIX 197 203 {ECO:0000244|PDB:1BG2}.; HELIX 238 241 {ECO:0000244|PDB:4HNA}.; HELIX 256 269 {ECO:0000244|PDB:1BG2}.; HELIX 277 279 {ECO:0000244|PDB:1BG2}.; HELIX 281 285 {ECO:0000244|PDB:1BG2}.; HELIX 286 288 {ECO:0000244|PDB:1BG2}.; HELIX 306 308 {ECO:0000244|PDB:1BG2}.; HELIX 309 320 {ECO:0000244|PDB:1BG2}.; HELIX 337 348 {ECO:0000244|PDB:1MKJ}.,TURN 35 37 {ECO:0000244|PDB:1BG2}.; TURN 102 104 {ECO:0000244|PDB:1BG2}.; TURN 190 193 {ECO:0000244|PDB:1BG2}.; TURN 217 219 {ECO:0000244|PDB:1BG2}.,,,,,5 out of 5,Beta strand (17); Chain (1); Coiled coil (1); Cross-link (1); Domain (1); Helix (15); Initiator methionine (1); Modified residue (3); Nucleotide binding (1); Region (1); Turn (4),,,,3D-structure;ATP-binding;Acetylation;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Isopeptide bond;Methylation;Microtubule;Motor protein;Nucleotide-binding;Phosphoprotein;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family, Kinesin subfamily",192,Domain (1); Function (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0067; KW-0175; KW-0181; KW-0206; KW-0488; KW-0493; KW-0505; KW-0547; KW-0597; KW-0832; KW-0963; KW-1017; KW-1185,,,,,,,,,CHAIN 2 963 Kinesin-1 heavy chain. /FTId=PRO_0000125351.,CROSSLNK 213 213 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,"INIT_MET 1 1 Removed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.",,"MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.; MOD_RES 933 933 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 956 956 Omega-N-methylarginine. {ECO:0000244|PubMed:24129315}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X65873;BC126279;BC126281;
0,P42345,MTOR_HUMAN,MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1,MTOR,FRAP FRAP1 FRAP2 RAFT1 RAPT1,,,Homo sapiens (Human),9606,Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1),UP000005640: Chromosome 1,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW,2549,"288,892",,,,SEQUENCE CAUTION:  Sequence=BAE06077.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305}; ,,,"SEQUENCE CAUTION:  Sequence=AAC39933.1; Type=Frameshift; Positions=956, 999; Evidence={ECO:0000305}; ",,,,,,"VARIANT 8 8 A -> S (in a lung large cell carcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041537.; VARIANT 135 135 M -> T (in a metastatic melanoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041538.; VARIANT 624 624 R -> H (in FCORD2; somatic mutation; unknown pathological significance; dbSNP:rs913197212). {ECO:0000269|PubMed:25799227}. /FTId=VAR_078824.; VARIANT 1083 1083 M -> V (in dbSNP:rs56164650). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041539.; VARIANT 1134 1134 A -> V (in dbSNP:rs28730685). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041540.; VARIANT 1178 1178 S -> F (in dbSNP:rs55975118). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041541.; VARIANT 1376 1376 D -> E (found in a patient with focal epilepsy; unknown pathological significance; dbSNP:rs975577894). {ECO:0000269|PubMed:27830187}. /FTId=VAR_078825.; VARIANT 1450 1450 Y -> D (in FCORD2; somatic mutation). {ECO:0000269|PubMed:25799227}. /FTId=VAR_078826.; VARIANT 1456 1456 W -> G (in FCORD2; somatic mutation; dbSNP:rs1085307114). {ECO:0000269|PubMed:25878179}. /FTId=VAR_078827.; VARIANT 1459 1459 A -> D (in FCORD2; somatic mutation; increased TOR signaling). {ECO:0000269|PubMed:26018084}. /FTId=VAR_078828.; VARIANT 1459 1459 A -> S (in FCORD2; somatic mutation). {ECO:0000269|PubMed:27830187}. /FTId=VAR_078829.; VARIANT 1460 1460 L -> P (in FCORD2; somatic mutation; increased TOR signaling; dbSNP:rs1057519779). {ECO:0000269|PubMed:26018084, ECO:0000269|PubMed:27830187}. /FTId=VAR_078830.; VARIANT 1483 1483 C -> R (in FCORD2; somatic mutation; increased TOR signaling; increased kinase activity; dbSNP:rs1057519914). {ECO:0000269|PubMed:25799227}. /FTId=VAR_078831.; VARIANT 1490 1490 W -> R (in SKS). {ECO:0000269|PubMed:27830187}. /FTId=VAR_078832.; VARIANT 1595 1595 M -> I (in SKS; dbSNP:rs869312671). {ECO:0000269|PubMed:27830187}. /FTId=VAR_078833.; VARIANT 1709 1709 R -> H (in FCORD2; somatic mutation; unknown pathological significance; dbSNP:rs587777895). {ECO:0000269|PubMed:25799227}. /FTId=VAR_078834.; VARIANT 1799 1799 E -> K (in SKS; results in increased mTOR signaling; dbSNP:rs863225264). {ECO:0000269|PubMed:25851998, ECO:0000269|PubMed:26542245}. /FTId=VAR_075072.; VARIANT 1832 1832 A -> T (in SKS; dbSNP:rs369088781). {ECO:0000269|PubMed:27830187}. /FTId=VAR_078835.; VARIANT 1888 1888 F -> C (in SKS; dbSNP:rs869312666). {ECO:0000269|PubMed:27830187}. /FTId=VAR_078836.; VARIANT 1977 1977 T -> K (in FCORD2; somatic mutation; dbSNP:rs587777893). {ECO:0000269|PubMed:25799227}. /FTId=VAR_078837.; VARIANT 2011 2011 M -> V (in an ovarian mucinous carcinoma sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041542.; VARIANT 2193 2193 R -> C (in FCORD2; somatic mutation). {ECO:0000269|PubMed:25799227}. /FTId=VAR_078838.; VARIANT 2215 2215 S -> F (in FCORD2; somatic mutation; increased TOR signaling; dbSNP:rs587777894). {ECO:0000269|PubMed:25799227, ECO:0000269|PubMed:26018084, ECO:0000269|PubMed:27830187}. /FTId=VAR_078839.; VARIANT 2215 2215 S -> Y (in FCORD2; also found in a colorectal adenocarcinoma sample; somatic mutation; increased TOR signaling; dbSNP:rs587777894). {ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:26018084, ECO:0000269|PubMed:27830187}. /FTId=VAR_041543.; VARIANT 2220 2220 L -> F (found in a renal cell carcinoma sample; somatic mutation). {ECO:0000269|PubMed:21248752}. /FTId=VAR_064733.; VARIANT 2327 2327 M -> I (in SKS; dbSNP:rs878855328). {ECO:0000269|PubMed:27830187}. /FTId=VAR_078840.; VARIANT 2406 2406 V -> A (found in a renal cell carcinoma sample; somatic mutation). {ECO:0000269|PubMed:21248752}. /FTId=VAR_064734.; VARIANT 2427 2427 L -> P (in FCORD2; somatic mutation; increased TOR signaling; increased kinase activity; dbSNP:rs1085307113). {ECO:0000269|PubMed:25799227}. /FTId=VAR_078841.; VARIANT 2427 2427 L -> Q (in FCORD2; somatic mutation; increased TOR signaling; increased kinase activity; dbSNP:rs1085307113). {ECO:0000269|PubMed:25799227}. /FTId=VAR_078842.; VARIANT 2476 2476 P -> L (in a glioblastoma multiforme sample; somatic mutation). {ECO:0000269|PubMed:17344846}. /FTId=VAR_041544.; VARIANT 2501 2501 I -> V (found in a patient with non-lesional nocturnal frontal epilepsy; unknown pathological significance; dbSNP:rs968817513). {ECO:0000269|PubMed:27830187}. /FTId=VAR_078843.",,,,CONFLICT 353 353 K -> N (in Ref. 2; AAC39933). {ECO:0000305}.; CONFLICT 359 359 S -> N (in Ref. 2; AAC39933). {ECO:0000305}.; CONFLICT 364 364 D -> N (in Ref. 2; AAC39933). {ECO:0000305}.; CONFLICT 390 390 M -> L (in Ref. 2; AAC39933). {ECO:0000305}.; CONFLICT 430 430 R -> L (in Ref. 2; AAC39933). {ECO:0000305}.; CONFLICT 455 457 VLD -> GVE (in Ref. 2; AAC39933). {ECO:0000305}.; CONFLICT 461 461 A -> G (in Ref. 2; AAC39933). {ECO:0000305}.; CONFLICT 482 484 VFT -> FFN (in Ref. 2; AAC39933). {ECO:0000305}.; CONFLICT 489 489 L -> V (in Ref. 2; AAC39933). {ECO:0000305}.; CONFLICT 513 513 L -> I (in Ref. 2; AAC39933). {ECO:0000305}.; CONFLICT 539 539 L -> V (in Ref. 2; AAC39933). {ECO:0000305}.; CONFLICT 553 553 R -> C (in Ref. 2; AAC39933). {ECO:0000305}.; CONFLICT 857 857 P -> L (in Ref. 3; BAE06077). {ECO:0000305}.; CONFLICT 1075 1075 I -> S (in Ref. 2; AAC39933). {ECO:0000305}.,,1,,0,DOMAIN: The kinase domain (PI3K/PI4K) is intrinsically active but has a highly restricted catalytic center. {ECO:0000269|PubMed:23636326}.; DOMAIN: The FAT domain forms three discontinuous subdomains of alpha-helical TPR repeats plus a single subdomain of HEAT repeats. The four domains pack sequentially to form a C-shaped a-solenoid that clamps onto the kinase domain (PubMed:23636326). {ECO:0000269|PubMed:23636326}.,SIMILARITY: Belongs to the PI3/PI4-kinase family. {ECO:0000305}.,,,"DOMAIN 1382 1982 FAT. {ECO:0000255|PROSITE-ProRule:PRU00534}.; DOMAIN 2182 2516 PI3K/PI4K. {ECO:0000255|PROSITE-ProRule:PRU00269}.; DOMAIN 2517 2549 FATC. {ECO:0000255|PROSITE-ProRule:PRU00534, ECO:0000255|PROSITE-ProRule:PRU00535}.",,REGION 1 651 Interaction with NBN. {ECO:0000269|PubMed:23762398}.; REGION 2012 2144 Sufficient for interaction with the FKBP1A/rapamycin complex. {ECO:0000250}.; REGION 2258 2296 Interaction with MLST8.,REPEAT 16 53 HEAT 1.; REPEAT 55 99 HEAT 2.; REPEAT 100 137 HEAT 3.; REPEAT 138 179 HEAT 4.; REPEAT 180 220 HEAT 5.; REPEAT 222 276 HEAT 6.; REPEAT 277 313 HEAT 7.; REPEAT 314 364 HEAT 8.; REPEAT 365 409 HEAT 9.; REPEAT 410 445 HEAT 10.; REPEAT 446 494 HEAT 11.; REPEAT 495 529 HEAT 12.; REPEAT 530 563 HEAT 13.; REPEAT 564 596 HEAT 14.; REPEAT 597 636 HEAT 15.; REPEAT 637 683 HEAT 16.; REPEAT 686 724 HEAT 17.; REPEAT 727 766 HEAT 18.; REPEAT 769 811 HEAT 19.; REPEAT 814 853 HEAT 20.; REPEAT 857 893 HEAT 21.; REPEAT 894 942 HEAT 22.; REPEAT 943 988 HEAT 23.; REPEAT 989 1027 HEAT 24.; REPEAT 1029 1068 HEAT 25.; REPEAT 1069 1105 HEAT 26.; REPEAT 1106 1144 HEAT 27.; REPEAT 1145 1188 HEAT 28.; REPEAT 1189 1225 HEAT 29.; REPEAT 1226 1273 HEAT 30.; REPEAT 1274 1311 HEAT 31.; REPEAT 1312 1345 HEAT 32.; REPEAT 1346 1382 TPR 1.; REPEAT 1383 1408 TPR 2.; REPEAT 1409 1442 TPR 3.; REPEAT 1443 1473 TPR 4.; REPEAT 1474 1507 TPR 5.; REPEAT 1508 1541 TPR 6.; REPEAT 1542 1574 TPR 7.; REPEAT 1575 1614 TPR 8.; REPEAT 1615 1649 TPR 9.; REPEAT 1650 1693 TPR 10.; REPEAT 1694 1731 TPR 11.; REPEAT 1732 1786 TPR 12.; REPEAT 1787 1846 TPR 13.; REPEAT 1898 1930 TPR 14.; REPEAT 1931 1970 TPR 15.; REPEAT 1971 2005 TPR 16.,,2.7.11.1,,"CATALYTIC ACTIVITY: Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",,,"FUNCTION: Serine/threonine protein kinase which is a central regulator of cellular metabolism, growth and survival in response to hormones, growth factors, nutrients, energy and stress signals. MTOR directly or indirectly regulates the phosphorylation of at least 800 proteins. Functions as part of 2 structurally and functionally distinct signaling complexes mTORC1 and mTORC2 (mTOR complex 1 and 2). Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. This includes phosphorylation of EIF4EBP1 and release of its inhibition toward the elongation initiation factor 4E (eiF4E). Moreover, phosphorylates and activates RPS6KB1 and RPS6KB2 that promote protein synthesis by modulating the activity of their downstream targets including ribosomal protein S6, eukaryotic translation initiation factor EIF4B, and the inhibitor of translation initiation PDCD4. Stimulates the pyrimidine biosynthesis pathway, both by acute regulation through RPS6KB1-mediated phosphorylation of the biosynthetic enzyme CAD, and delayed regulation, through transcriptional enhancement of the pentose phosphate pathway which produces 5-phosphoribosyl-1-pyrophosphate (PRPP), an allosteric activator of CAD at a later step in synthesis, this function is dependent on the mTORC1 complex. Regulates ribosome synthesis by activating RNA polymerase III-dependent transcription through phosphorylation and inhibition of MAF1 an RNA polymerase III-repressor. In parallel to protein synthesis, also regulates lipid synthesis through SREBF1/SREBP1 and LPIN1. To maintain energy homeostasis mTORC1 may also regulate mitochondrial biogenesis through regulation of PPARGC1A. mTORC1 also negatively regulates autophagy through phosphorylation of ULK1. Under nutrient sufficiency, phosphorylates ULK1 at 'Ser-758', disrupting the interaction with AMPK and preventing activation of ULK1. Also prevents autophagy through phosphorylation of the autophagy inhibitor DAP. mTORC1 exerts a feedback control on upstream growth factor signaling that includes phosphorylation and activation of GRB10 a INSR-dependent signaling suppressor. Among other potential targets mTORC1 may phosphorylate CLIP1 and regulate microtubules. As part of the mTORC2 complex MTOR may regulate other cellular processes including survival and organization of the cytoskeleton. Plays a critical role in the phosphorylation at 'Ser-473' of AKT1, a pro-survival effector of phosphoinositide 3-kinase, facilitating its activation by PDK1. mTORC2 may regulate the actin cytoskeleton, through phosphorylation of PRKCA, PXN and activation of the Rho-type guanine nucleotide exchange factors RHOA and RAC1A or RAC1B. mTORC2 also regulates the phosphorylation of SGK1 at 'Ser-422' (PubMed:12087098, PubMed:12150925, PubMed:12150926, PubMed:12231510, PubMed:12718876, PubMed:14651849, PubMed:15268862, PubMed:15467718, PubMed:15545625, PubMed:15718470, PubMed:18497260, PubMed:18762023, PubMed:18925875, PubMed:20516213, PubMed:20537536, PubMed:21659604, PubMed:23429703, PubMed:23429704, PubMed:25799227, PubMed:26018084). Regulates osteoclastogenesis by adjusting the expression of CEBPB isoforms (By similarity). {ECO:0000250|UniProtKB:Q9JLN9, ECO:0000269|PubMed:12087098, ECO:0000269|PubMed:12150925, ECO:0000269|PubMed:12150926, ECO:0000269|PubMed:12231510, ECO:0000269|PubMed:12718876, ECO:0000269|PubMed:14651849, ECO:0000269|PubMed:15268862, ECO:0000269|PubMed:15467718, ECO:0000269|PubMed:15545625, ECO:0000269|PubMed:15718470, ECO:0000269|PubMed:18497260, ECO:0000269|PubMed:18762023, ECO:0000269|PubMed:18925875, ECO:0000269|PubMed:20516213, ECO:0000269|PubMed:20537536, ECO:0000269|PubMed:21659604, ECO:0000269|PubMed:23429703, ECO:0000269|PubMed:23429704, ECO:0000269|PubMed:25799227, ECO:0000269|PubMed:26018084}.",,,,,,,,,,,,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]; translation regulator activity [GO:0045182]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060]","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; T-helper 1 cell lineage commitment [GO:0002296]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060]",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]; translation regulator activity [GO:0045182],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932],GO:0000139; GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0001558; GO:0001933; GO:0001934; GO:0001938; GO:0002296; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005789; GO:0005829; GO:0005979; GO:0006112; GO:0006207; GO:0006468; GO:0007050; GO:0007281; GO:0007420; GO:0007569; GO:0007584; GO:0007616; GO:0008361; GO:0008542; GO:0009267; GO:0009791; GO:0010507; GO:0010592; GO:0010628; GO:0010718; GO:0010831; GO:0012505; GO:0014042; GO:0014736; GO:0014823; GO:0016020; GO:0016241; GO:0016242; GO:0016301; GO:0016310; GO:0016605; GO:0018105; GO:0018107; GO:0019901; GO:0019904; GO:0021510; GO:0030163; GO:0030425; GO:0030838; GO:0031397; GO:0031529; GO:0031641; GO:0031669; GO:0031929; GO:0031931; GO:0031932; GO:0031998; GO:0032095; GO:0032148; GO:0032516; GO:0032868; GO:0032956; GO:0034198; GO:0035176; GO:0035264; GO:0038202; GO:0042060; GO:0042220; GO:0042802; GO:0043022; GO:0043025; GO:0043087; GO:0043200; GO:0043276; GO:0043278; GO:0043610; GO:0045182; GO:0045429; GO:0045670; GO:0045727; GO:0045792; GO:0045945; GO:0046777; GO:0046889; GO:0048255; GO:0048661; GO:0048714; GO:0050731; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051897; GO:0055013; GO:0060048; GO:0060135; GO:0060252; GO:0060999; GO:0061051; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0090335; GO:0090559; GO:0098978; GO:0099524; GO:0099547; GO:1900034; GO:1901216; GO:1901838; GO:1903691; GO:1904000; GO:1904056; GO:1904058; GO:1904193; GO:1904197; GO:1904206; GO:1904213; GO:1904690; GO:1990253,IPR011989; IPR016024; IPR024585; IPR003152; IPR009076; IPR036738; IPR011009; IPR000403; IPR036940; IPR018936; IPR003151; IPR014009; IPR026683; IPR011990; ,Itself; P31749; Q07817-1; Q8TB45; Q13541; P62942; Q8WUA4; Q9BVC4; Q9BVC4-1; Q13615; Q8TCU6; P62820; Q15382; Q6R327; Q8N122; Q96EB6; Q8NHX9; O75385,"SUBUNIT: Part of the mammalian target of rapamycin complex 1 (mTORC1) which contains MTOR, MLST8, RPTOR, AKT1S1/PRAS40 and DEPTOR. The mTORC1 complex is a 1 Md obligate dimer of two stoichiometric heterotetramers with overall dimensions of 290 A x 210 A x 135 A. It has a rhomboid shape and a central cavity, the dimeric interfaces are formed by interlocking interactions between the two MTOR and the two RPTOR subunits. The MLST8 subunit forms distal foot-like protuberances, and contacts only one MTOR within the complex, while the small PRAS40 localizes to the midsection of the central core, in close proximity to RPTOR. Part of the mammalian target of rapamycin complex 2 (mTORC2) which contains MTOR, MLST8, PRR5, RICTOR, MAPKAP1 and DEPTOR. Interacts with PLPP7 and PML. Interacts with PRR5 and RICTOR; the interaction is direct within the mTORC2 complex. Interacts with WAC; WAC positively regulates MTOR activity by promoting the assembly of the TTT complex composed of TELO2, TTI1 and TTI2 and the RUVBL complex composed of RUVBL1 and RUVBL2 into the TTT-RUVBL complex which leads to the dimerization of the mTORC1 complex and its subsequent activation (PubMed:26812014). Interacts with UBQLN1. Interacts with TTI1 and TELO2. Interacts with CLIP1; phosphorylates and regulates CLIP1. Interacts with NBN. Interacts with HTR6 (PubMed:23027611). Interacts with BRAT1. {ECO:0000269|PubMed:10089303, ECO:0000269|PubMed:11853878, ECO:0000269|PubMed:12150925, ECO:0000269|PubMed:12150926, ECO:0000269|PubMed:12231510, ECO:0000269|PubMed:12408816, ECO:0000269|PubMed:12718876, ECO:0000269|PubMed:15268862, ECO:0000269|PubMed:15467718, ECO:0000269|PubMed:17386266, ECO:0000269|PubMed:17599906, ECO:0000269|PubMed:18925875, ECO:0000269|PubMed:19446321, ECO:0000269|PubMed:20427287, ECO:0000269|PubMed:20542007, ECO:0000269|PubMed:20801936, ECO:0000269|PubMed:20810650, ECO:0000269|PubMed:23027611, ECO:0000269|PubMed:23636326, ECO:0000269|PubMed:23762398, ECO:0000269|PubMed:25657994, ECO:0000269|PubMed:26812014, ECO:0000269|PubMed:8662507}.",8008069; 9653645; 16710414; 15489334; 11426320; 7809080; 9434772; 11853878; 12150925; 12150926; 12231510; 12087098; 12408816; 11930000; 14651849; 12718876; 15268862; 15545625; 14578359; 15467718; 15905173; 15718470; 17599906; 17386266; 18925875; 18762023; 18691976; 18669648; 18497260; 19446321; 19487463; 19369195; 19608861; 19145465; 20381137; 20537536; 20810650; 20801936; 20427287; 20516213; 20068231; 21269460; 21576368; 21406692; 21659604; 23027611; 22814378; 25657994; 24247430; 23186163; 23762398; 23429704; 23429703; 24275569; 25851998; 26018084; 26542245; 25799227; 25561175; 25878179; 25944712; 25567906; 26812014; 27830187; 8662507; 10089303; 20060908; 20542007; 23636326; 17344846; 21248752,8008069; 9653645; 16710414; 15489334; 11426320; 7809080; 9434772; 11853878; 12150925; 12150926; 12231510; 12087098; 12408816; 11930000; 14651849; 12718876; 15268862; 15545625; 14578359; 15467718; 15905173; 15718470; 17599906; 17386266; 18925875; 18762023; 18691976; 18669648; 18497260; 19446321; 19487463; 19369195; 19608861; 19145465; 20381137; 20537536; 20810650; 20801936; 20427287; 20516213; 20068231; 21269460; 21576368; 21406692; 21659604; 23027611; 22814378; 25657994; 24247430; 23186163; 23762398; 23429704; 23429703; 24275569; 25851998; 26018084; 26542245; 25799227; 25561175; 25878179; 25944712; 25567906; 26812014; 27830187; 8662507; 10089303; 20060908; 20542007; 23636326; 17344846; 21248752; 10567225; 10702316; 10910062; 11438723; 11691993; 11729323; 11884412; 12000755; 12080086; 12145207; 12151408; 12167717; 12172553; 12242281; 12271141; 12370290; 12524439; 12558800; 12604610; 12807916; 12813467; 12820960; 12869586; 12906785; 12912989; 14668532; 14729629; 14743216; 14970221; 15001544; 15004009; 15028555; 15056668; 15161933; 15208671; 15218033; 15292274; 15317677; 15388791; 15452223; 15489897; 15496972; 15522880; 15576463; 15580312; 15584862; 15604215; 15605414; 15623621; 15624760; 15632115; 15632201; 15657358; 15659381; 15702344; 15708965; 15723049; 15755954; 15760475; 15802268; 15809305; 15878852; 15899889; 15953364; 16006564; 16027121; 16049009; 16098202; 16098514; 16099944; 16109716; 16141350; 16183647; 16242075; 16282343; 16286006; 16341243; 16354680; 16407298; 16427044; 16467080; 16543150; 16652388; 16786123; 16818690; 16824195; 16847060; 16870609; 16874098; 16884363; 16912159; 16912980; 16914728; 16916907; 16922504; 16927414; 16929481; 16954686; 16959214; 16962653; 16963469; 17016437; 17018601; 17028174; 17052453; 17075574; 17102641; 17110454; 17114181; 17148679; 17215282; 17253963; 17277771; 17289850; 17318075; 17329620; 17351147; 17363738; 17372934; 17409838; 17461779; 17463046; 17470430; 17482291; 17483438; 17488873; 17517883; 17545512; 17553806; 17562705; 17562865; 17565979; 17595159; 17604271; 17611497; 17616684; 17616691; 17631500; 17640392; 17656678; 17683115; 17684489; 17698027; 17721511; 17721885; 17724079; 17726467; 17889116; 17911267; 17914450; 17928295; 17935273; 17942603; 17990907; 17991864; 17993259; 17996122; 18006825; 18048359; 18056791; 18160036; 18215133; 18247380; 18250445; 18276609; 18292222; 18337562; 18339839; 18339899; 18351386; 18372248; 18395956; 18413763; 18423201; 18426977; 18434090; 18439900; 18483275; 18494264; 18511708; 18519641; 18548093; 18563337; 18566587; 18570873; 18596736; 18612547; 18622747; 18650380; 18652687; 18658153; 18660489; 18678646; 18697743; 18702307; 18704194; 18715846; 18757300; 18769127; 18769147; 18776922; 18787170; 18794342; 18807177; 18813808; 18824293; 18826385; 18831768; 18842593; 18848473; 18924132; 18926585; 18929564; 18945681; 18948269; 18953439; 18954143; 18980674; 18990449; 19018001; 19019920; 19020722; 19054297; 19074768; 19078992; 19090006; 19098000; 19107520; 19107873; 19108833; 19121088; 19147678; 19147764; 19147772; 19147966; 19155728; 19164214; 19176054; 19176518; 19176689; 19201859; 19203585; 19203829; 19211835; 19222999; 19223493; 19225151; 19225536; 19234517; 19240722; 19244117; 19258318; 19285014; 19293424; 19299575; 19301157; 19321861; 19331815; 19341427; 19357233; 19371356; 19373664; 19402821; 19414743; 19416884; 19454477; 19489223; 19509151; 19535348; 19539012; 19549760; 19553685; 19553815; 19553991; 19561084; 19564927; 19587219; 19608873; 19615795; 19619545; 19624311; 19648884; 19654299; 19657638; 19679016; 19680556; 19690328; 19698731; 19724909; 19725049; 19726679; 19739122; 19771169; 19788500; 19789507; 19789631; 19794149; 19797172; 19815051; 19838215; 19864431; 19875696; 19875983; 19881535; 19889638; 19897009; 19914247; 19935716; 19935854; 19936974; 19949304; 19954658; 19955088; 19956179; 19956839; 19956876; 19956903; 20005306; 20009539; 20019839; 20022946; 20030877; 20038818; 20048174; 20053679; 20061787; 20070283; 20080789; 20081105; 20093977; 20133820; 20137118; 20145209; 20150565; 20153512; 20157617; 20160076; 20166697; 20166753; 20176935; 20190810; 20196784; 20204306; 20207176; 20226010; 20227368; 20232298; 20232305; 20233713; 20236941; 20299603; 20308064; 20335217; 20338061; 20338997; 20339946; 20354165; 20354178; 20360610; 20368287; 20371770; 20372862; 20375166; 20375271; 20386866; 20388784; 20395440; 20410302; 20412774; 20424163; 20424326; 20427710; 20438709; 20439490; 20447721; 20453000; 20457610; 20459645; 20459775; 20460933; 20479250; 20480226; 20488790; 20491627; 20501647; 20542987; 20543138; 20562859; 20606252; 20607654; 20622004; 20628002; 20630061; 20656459; 20668229; 20673489; 20679884; 20711500; 20717925; 20727662; 20727967; 20804212; 20805015; 20805416; 20809949; 20811722; 20811725; 20817788; 20823133; 20837708; 20855840; 20857497; 20861467; 20864032; 20874802; 20884115; 20929525; 20960030; 21033251; 21035469; 21035497; 21040950; 21045808; 21046231; 21048031; 21062981; 21062993; 21071439; 21071597; 21092676; 21095582; 21113813; 21123297; 21145759; 21159731; 21170086; 21177869; 21199794; 21203441; 21212465; 21223797; 21228924; 21228927; 21239045; 21242970; 21246613; 21258367; 21264294; 21266827; 21276607; 21277936; 21283628; 21289308; 21290341; 21294052; 21304100; 21317285; 21320304; 21321085; 21321111; 21325052; 21326036; 21326806; 21329734; 21334199; 21336308; 21339740; 21360636; 21367918; 21368105; 21372221; 21373201; 21376236; 21383697; 21412012; 21415389; 21422248; 21428914; 21428925; 21430254; 21440577; 21454807; 21458454; 21460621; 21460630; 21460850; 21464729; 21471201; 21501360; 21510936; 21512002; 21513566; 21531565; 21532145; 21541441; 21548803; 21555591; 21559457; 21567173; 21577328; 21606591; 21609291; 21631271; 21665993; 21673516; 21681021; 21696297; 21701776; 21702994; 21707707; 21707714; 21718677; 21725971; 21734039; 21738705; 21744334; 21757621; 21757730; 21763898; 21763970; 21763972; 21768204; 21785113; 21793913; 21795849; 21802763; 21804606; 21821699; 21822208; 21837670; 21859551; 21861134; 21874010; 21881486; 21886838; 21887223; 21890410; 21898543; 21900206; 21914810; 21926965; 21931802; 21933144; 21939655; 21941369; 21943204; 21949121; 21949767; 21949775; 21963299; 21963359; 21965657; 21971509; 21980128; 21981924; 21987434; 22007913; 22015781; 22017875; 22017876; 22017877; 22024086; 22024166; 22025552; 22029423; 22031597; 22045983; 22053105; 22084251; 22094587; 22105511; 22127531; 22142830; 22145100; 22148961; 22173835; 22199311; 22214661; 22216185; 22248270; 22248718; 22253885; 22258093; 22268788; 22285859; 22287548; 22320958; 22328503; 22338078; 22339676; 22340595; 22343475; 22343943; 22349822; 22354785; 22357971; 22367541; 22369257; 22399302; 22399812; 22408252; 22409888; 22424946; 22452883; 22455872; 22457328; 22457331; 22457523; 22469187; 22471665; 22473959; 22483750; 22487935; 22493283; 22504275; 22504639; 22505595; 22509023; 22509811; 22544753; 22549934; 22556133; 22556409; 22562131; 22570149; 22576015; 22607554; 22612812; 22619175; 22619737; 22620485; 22627626; 22648906; 22664266; 22674982; 22684558; 22685542; 22696419; 22696681; 22729223; 22752785; 22753663; 22760498; 22761730; 22768106; 22797077; 22813852; 22815832; 22826320; 22833529; 22840496; 22841170; 22863900; 22871496; 22886792; 22895079; 22895785; 22898570; 22899290; 22902049; 22907398; 22907434; 22920721; 22924455; 22944293; 22952422; 22955108; 22958932; 22960547; 22967500; 22977662; 22980980; 22983984; 22987636; 23000302; 23022044; 23027127; 23027865; 23035115; 23061800; 23064282; 23080369; 23084634; 23091295; 23095638; 23103253; 23107319; 23110147; 23115234; 23150676; 23160380; 23162107; 23165769; 23167739; 23169238; 23173671; 23178462; 23209702; 23216249; 23246968; 23276696; 23277194; 23283505; 23284171; 23291726; 23296986; 23297824; 23297825; 23318419; 23322780; 23325216; 23332779; 23337583; 23340270; 23348097; 23358420; 23362262; 23363784; 23375848; 23394946; 23395818; 23412940; 23416715; 23416721; 23423739; 23426850; 23434734; 23440206; 23444213; 23444380; 23451476; 23454121; 23459592; 23464458; 23524405; 23524951; 23530221; 23536724; 23541542; 23544944; 23549875; 23555892; 23573198; 23585566; 23592839; 23601218; 23614736; 23623586; 23632629; 23660068; 23671028; 23684925; 23686362; 23686804; 23691056; 23693095; 23697980; 23720219; 23722547; 23728790; 23734707; 23773481; 23795962; 23797151; 23798432; 23828865; 23832540; 23841076; 23853042; 23863161; 23871289; 23872956; 23878245; 23878397; 23883112; 23886172; 23886294; 23898069; 23911927; 23913957; 23916134; 23933173; 23940798; 23941441; 23953116; 23953228; 23963361; 23977397; 23979023; 23983265; 23991038; 23991179; 23992520; 24002888; 24006489; 24018969; 24022660; 24023300; 24027431; 24036451; 24052408; 24059496; 24065188; 24067973; 24073922; 24078802; 24088187; 24088573; 24098109; 24112608; 24122995; 24164895; 24180592; 24203892; 24204783; 24205284; 24239474; 24243494; 24243565; 24247793; 24262949; 24263107; 24285179; 24287118; 24289602; 24312415; 24319109; 24323026; 24334141; 24337580; 24349524; 24350295; 24353015; 24357630; 24365180; 24375676; 24418474; 24419422; 24431075; 24462769; 24469052; 24469061; 24480319; 24481845; 24496328; 24496460; 24508774; 24509877; 24517835; 24519842; 24531144; 24535608; 24550542; 24556727; 24556942; 24562770; 24568519; 24571487; 24582588; 24582593; 24583924; 24585383; 24587347; 24587596; 24597762; 24612393; 24615084; 24615476; 24622468; 24623675; 24624456; 24630930; 24631838; 24637915; 24646917; 24648513; 24650799; 24651621; 24658605; 24662006; 24666346; 24667640; 24668416; 24675012; 24677687; 24682932; 24683191; 24687132; 24688046; 24694195; 24694739; 24695460; 24699302; 24718901; 24735948; 24735980; 24737380; 24757677; 24762959; 24767255; 24774538; 24780446; 24780459; 24781943; 24797554; 24810045; 24810336; 24810750; 24811059; 24813396; 24816861; 24853425; 24864089; 24875536; 24878609; 24886512; 24887419; 24887566; 24891456; 24899720; 24905636; 24918639; 24936148; 24948799; 24952635; 24952732; 24962700; 24964744; 24970801; 24972968; 24974886; 24985347; 24990947; 24990952; 24991762; 24994750; 25001862; 25019278; 25020061; 25023728; 25026290; 25029414; 25034463; 25043031; 25043657; 25043667; 25046358; 25051360; 25053543; 25054716; 25061101; 25063062; 25108739; 25109390; 25110431; 25119265; 25122428; 25124033; 25128458; 25128827; 25129346; 25146530; 25155956; 25156912; 25163725; 25181405; 25183163; 25194337; 25194338; 25208880; 25208915; 25215588; 25228590; 25234729; 25241761; 25254627; 25261369; 25277143; 25277454; 25283550; 25288394; 25288641; 25293974; 25294810; 25311616; 25332233; 25341684; 25343550; 25356800; 25372487; 25373346; 25375091; 25388971; 25403445; 25404014; 25416705; 25418470; 25424347; 25428582; 25431263; 25439321; 25444920; 25446900; 25448705; 25454472; 25460505; 25466966; 25475435; 25476730; 25476905; 25478811; 25480586; 25482988; 25483439; 25491778; 25495560; 25497009; 25499605; 25500904; 25509983; 25512523; 25524555; 25531317; 25531318; 25534823; 25548410; 25556834; 25578782; 25582616; 25589557; 25600244; 25601471; 25627160; 25632222; 25632225; 25637161; 25645581; 25654547; 25656579; 25659153; 25663547; 25667121; 25680114; 25685786; 25692408; 25701004; 25721338; 25726893; 25729885; 25735853; 25742482; 25747970; 25749387; 25757539; 25759478; 25762619; 25769791; 25770584; 25776026; 25776475; 25778319; 25788687; 25791428; 25796537; 25807077; 25809873; 25813405; 25816324; 25833943; 25848831; 25849206; 25849580; 25849663; 25854169; 25854175; 25855786; 25862847; 25862896; 25867326; 25877925; 25878330; 25883264; 25887293; 25893736; 25898924; 25906314; 25909227; 25915427; 25918246; 25931349; 25940091; 25952930; 25955819; 25962638; 25963655; 25972538; 25978653; 25982172; 25989725; 26010766; 26012635; 26023239; 26026101; 26045808; 26046375; 26051103; 26051179; 26061549; 26063890; 26077103; 26097572; 26108313; 26108998; 26147250; 26147685; 26149216; 26158266; 26160839; 26163618; 26169935; 26170313; 26188279; 26191214; 26191215; 26195823; 26201060; 26202144; 26206180; 26208432; 26232429; 26235873; 26238185; 26238486; 26239490; 26241026; 26246196; 26247533; 26251974; 26255626; 26261493; 26261591; 26267321; 26275051; 26280535; 26281684; 26284586; 26287940; 26292663; 26295809; 26299257; 26305116; 26306048; 26308575; 26311737; 26317520; 26318432; 26319086; 26319900; 26325371; 26330617; 26339598; 26341051; 26346135; 26357655; 26358751; 26360779; 26362858; 26367112; 26391637; 26403194; 26408181; 26416965; 26418749; 26419801; 26426522; 26427150; 26427479; 26427711; 26431550; 26432405; 26432419; 26437614; 26438156; 26447757; 26460589; 26477999; 26485560; 26487002; 26490311; 26496610; 26496775; 26499488; 26506516; 26516700; 26521691; 26522726; 26523512; 26530936; 26534958; 26536660; 26537073; 26544513; 26549638; 26577839; 26584640; 26585486; 26606243; 26617795; 26617839; 26621838; 26626074; 26639036; 26639561; 26648340; 26648451; 26652716; 26655341; 26669439; 26678875; 26686971; 26687302; 26692480; 26698679; 26707081; 26714229; 26719046; 26722032; 26722465; 26735435; 26742086; 26752047; 26753650; 26763419; 26774497; 26775690; 26779999; 26780727; 26787466; 26792725; 26818518; 26823699; 26831717; 26832959; 26848623; 26857578; 26876207; 26879375; 26884601; 26884863; 26885978; 26892465; 26895472; 26901106; 26935715; 26956871; 26956874; 26962683; 26984228; 26988032; 26993162; 27009856; 27012089; 27015560; 27018341; 27029904; 27034171; 27035650; 27036037; 27048245; 27055253; 27058415; 27069150; 27075467; 27077655; 27094611; 27095304; 27096957; 27097372; 27097373; 27098617; 27099149; 27109477; 27119232; 27129295; 27132889; 27134121; 27147575; 27150059; 27153561; 27154977; 27156070; 27159400; 27166282; 27167192; 27167344; 27174915; 27183469; 27188501; 27189717; 27198515; 27211906; 27220494; 27226604; 27235137; 27241020; 27244671; 27249692; 27263112; 27267853; 27268034; 27277722; 27277844; 27278278; 27278932; 27280401; 27283897; 27285754; 27311860; 27314664; 27315344; 27342399; 27350136; 27363263; 27385486; 27391151; 27392709; 27394002; 27412013; 27438153; 27448972; 27453478; 27462867; 27467530; 27472392; 27473087; 27491646; 27498786; 27507059; 27516388; 27517315; 27524440; 27526942; 27533080; 27553832; 27557534; 27562465; 27572296; 27590200; 27593892; 27610411; 27619662; 27621407; 27624942; 27626684; 27658023; 27663511; 27669541; 27693556; 27729611; 27733576; 27746162; 27753196; 27756877; 27784786; 27787197; 27789294; 27796683; 27811956; 27835987; 27848074; 27849335; 27853903; 27860187; 27863387; 27876894; 27879648; 27893461; 27893811; 27909983; 27911920; 27913676; 27914823; 27930338; 27932243; 27939840; 27957793; 27974704; 27980219; 27983922; 27991928; 27992581; 27996156; 28002802; 28005970; 28007777; 28026112; 28036295; 28052030; 28053105; 28064317; 28064447; 28082200; 28082737; 28086984; 28087344; 28089725; 28092463; 28094770; 28122379; 28124577; 28124643; 28147330; 28148781; 28151717; 28159681; 28170089; 28184925; 28186392; 28188923; 28192480; 28194539; 28199842; 28202675; 28223357; 28230853; 28232476; 28235484; 28257428; 28259820; 28279716; 28292441; 28332630; 28333142; 28336152; 28343070; 28349073; 28351321; 28358054; 28377226; 28395710; 28399646; 28400511; 28408137; 28408318; 28419191; 28423208; 28427795; 28433890; 28440461; 28442344; 28446188; 28446743; 28447760; 28450157; 28456658; 28459375; 28461391; 28464864; 28466106; 28468774; 28475179; 28475291; 28478460; 28482067; 28482233; 28492559; 28498460; 28499984; 28506734; 28532580; 28560385; 28569781; 28574664; 28582508; 28591687; 28600513; 28606928; 28624790; 28633336; 28639903; 28641977; 28661070; 28665915; 28685544; 28685610; 28698135; 28703798; 28711648; 28716898; 28724580; 28724614; 28731193; 28741507; 28745319; 28759011; 28765952; 28774796; 28776671; 28791373; 28800130; 28801734; 28821580; 28826600; 28835610; 28849060; 28849072; 28854163; 28864682; 28870807; 28875501; 28878358; 28899863; 28905415; 28923857; 28952842; 28993455; 29016699; 29037858; 29048631; 29076004; 29081412; 29086897; 29090958; 29094413; 29103666; 29115444; 29133593; 29133782; 29185784; 29198077; 29203244; 29208245; 29233126; 29233656; 29236692; 29253569; 29259984; 29305864; 29307829; 29328491; 29331082; 29358326; 29386088; 29393469; 29448085; 29449346; 29484434; 29484437; 29488612; 29491094; 29544697; 29566977; 29567957; 29568966; 29625033; 29657089; 29660335; 29675630; 29713761; 29713826; 29749504; 29807226; 29845289; 29862445; 29866590; 29897294; 29905853; 29916308; 29978609; 30011848; 30021100; 30053655; 30061532; 30061533; 30096787; 30110936; 30120233; 30147110; 30190183; 30218719; 30224479; 30272366; 30301809,1995-11-01,2019-02-13,1995-11-01,204,X-ray crystallography (19); NMR spectroscopy (3); Electron microscopy (6),STRAND 1501 1503 {ECO:0000244|PDB:5WBY}.; STRAND 1538 1540 {ECO:0000244|PDB:5WBY}.; STRAND 1606 1608 {ECO:0000244|PDB:4JSP}.; STRAND 1681 1684 {ECO:0000244|PDB:5WBY}.; STRAND 1896 1898 {ECO:0000244|PDB:5WBY}.; STRAND 2119 2122 {ECO:0000244|PDB:5WBY}.; STRAND 2137 2139 {ECO:0000244|PDB:5WBY}.; STRAND 2146 2148 {ECO:0000244|PDB:5WBY}.; STRAND 2152 2156 {ECO:0000244|PDB:5WBY}.; STRAND 2158 2162 {ECO:0000244|PDB:5WBY}.; STRAND 2165 2167 {ECO:0000244|PDB:5WBY}.; STRAND 2170 2176 {ECO:0000244|PDB:5WBY}.; STRAND 2181 2189 {ECO:0000244|PDB:5WBY}.; STRAND 2227 2229 {ECO:0000244|PDB:5WBY}.; STRAND 2231 2233 {ECO:0000244|PDB:5WBY}.; STRAND 2235 2238 {ECO:0000244|PDB:5WBY}.; STRAND 2243 2245 {ECO:0000244|PDB:5WBY}.; STRAND 2344 2347 {ECO:0000244|PDB:5WBY}.; STRAND 2353 2355 {ECO:0000244|PDB:5WBY}.; STRAND 2369 2371 {ECO:0000244|PDB:5WBY}.; STRAND 2512 2516 {ECO:0000244|PDB:4JT5}.,HELIX 1386 1406 {ECO:0000244|PDB:5WBY}.; HELIX 1410 1421 {ECO:0000244|PDB:5WBY}.; HELIX 1426 1439 {ECO:0000244|PDB:5WBY}.; HELIX 1446 1452 {ECO:0000244|PDB:5WBY}.; HELIX 1456 1469 {ECO:0000244|PDB:5WBY}.; HELIX 1474 1487 {ECO:0000244|PDB:5WBY}.; HELIX 1490 1498 {ECO:0000244|PDB:5WBY}.; HELIX 1506 1523 {ECO:0000244|PDB:5WBY}.; HELIX 1526 1535 {ECO:0000244|PDB:5WBY}.; HELIX 1541 1553 {ECO:0000244|PDB:5WBY}.; HELIX 1557 1577 {ECO:0000244|PDB:5WBY}.; HELIX 1587 1605 {ECO:0000244|PDB:5WBY}.; HELIX 1609 1611 {ECO:0000244|PDB:4JSX}.; HELIX 1613 1624 {ECO:0000244|PDB:5WBY}.; HELIX 1630 1640 {ECO:0000244|PDB:5WBY}.; HELIX 1650 1663 {ECO:0000244|PDB:5WBY}.; HELIX 1666 1677 {ECO:0000244|PDB:5WBY}.; HELIX 1694 1706 {ECO:0000244|PDB:5WBY}.; HELIX 1710 1729 {ECO:0000244|PDB:5WBY}.; HELIX 1738 1761 {ECO:0000244|PDB:5WBY}.; HELIX 1768 1782 {ECO:0000244|PDB:5WBY}.; HELIX 1787 1813 {ECO:0000244|PDB:5WBY}.; HELIX 1868 1893 {ECO:0000244|PDB:5WBY}.; HELIX 1900 1913 {ECO:0000244|PDB:5WBY}.; HELIX 1917 1929 {ECO:0000244|PDB:5WBY}.; HELIX 1932 1938 {ECO:0000244|PDB:5WBY}.; HELIX 1939 1943 {ECO:0000244|PDB:5WBY}.; HELIX 1951 1966 {ECO:0000244|PDB:5WBY}.; HELIX 1969 1971 {ECO:0000244|PDB:5WBY}.; HELIX 1973 1980 {ECO:0000244|PDB:5WBY}.; HELIX 1985 2020 {ECO:0000244|PDB:5WBY}.; HELIX 2025 2039 {ECO:0000244|PDB:4DRI}.; HELIX 2044 2058 {ECO:0000244|PDB:4DRI}.; HELIX 2065 2091 {ECO:0000244|PDB:4DRI}.; HELIX 2094 2111 {ECO:0000244|PDB:4DRI}.; HELIX 2123 2126 {ECO:0000244|PDB:5WBY}.; HELIX 2128 2132 {ECO:0000244|PDB:5WBY}.; HELIX 2193 2211 {ECO:0000244|PDB:5WBY}.; HELIX 2213 2217 {ECO:0000244|PDB:5WBY}.; HELIX 2246 2256 {ECO:0000244|PDB:5WBY}.; HELIX 2263 2271 {ECO:0000244|PDB:5WBY}.; HELIX 2275 2277 {ECO:0000244|PDB:5WBY}.; HELIX 2280 2292 {ECO:0000244|PDB:5WBY}.; HELIX 2298 2306 {ECO:0000244|PDB:5WBY}.; HELIX 2310 2334 {ECO:0000244|PDB:5WBY}.; HELIX 2364 2367 {ECO:0000244|PDB:5WBY}.; HELIX 2381 2386 {ECO:0000244|PDB:5WBY}.; HELIX 2395 2409 {ECO:0000244|PDB:5WBY}.; HELIX 2411 2422 {ECO:0000244|PDB:5WBY}.; HELIX 2429 2432 {ECO:0000244|PDB:5WBY}.; HELIX 2433 2435 {ECO:0000244|PDB:5WBY}.; HELIX 2493 2509 {ECO:0000244|PDB:5WBY}.; HELIX 2521 2533 {ECO:0000244|PDB:5WBY}.; HELIX 2535 2540 {ECO:0000244|PDB:5WBY}.; HELIX 2543 2545 {ECO:0000244|PDB:5WBY}.,TURN 1422 1424 {ECO:0000244|PDB:5WBY}.; TURN 1584 1586 {ECO:0000244|PDB:5WBY}.; TURN 1641 1643 {ECO:0000244|PDB:5WBY}.; TURN 1646 1648 {ECO:0000244|PDB:5WBY}.; TURN 1783 1785 {ECO:0000244|PDB:5WBY}.; TURN 1944 1947 {ECO:0000244|PDB:5WBY}.; TURN 2115 2117 {ECO:0000244|PDB:5WBY}.; TURN 2141 2143 {ECO:0000244|PDB:5WBY}.; TURN 2341 2343 {ECO:0000244|PDB:5WBY}.; TURN 2348 2350 {ECO:0000244|PDB:5WBY}.; TURN 2389 2394 {ECO:0000244|PDB:5WBY}.; TURN 2425 2428 {ECO:0000244|PDB:5WBY}.,,,,,5 out of 5,Beta strand (21); Chain (1); Domain (3); Erroneous initiation (1); Frameshift (1); Helix (55); Modified residue (12); Mutagenesis (6); Natural variant (31); Region (3); Repeat (48); Sequence conflict (14); Turn (12),,"TISSUE SPECIFICITY: Expressed in numerous tissues, with highest levels in testis. {ECO:0000269|PubMed:12408816, ECO:0000269|PubMed:7809080}.",,3D-structure;ATP-binding;Acetylation;Complete proteome;Cytoplasm;Disease mutation;Endoplasmic reticulum;Epilepsy;Golgi apparatus;Kinase;Lysosome;Membrane;Mental retardation;Microsome;Mitochondrion;Mitochondrion outer membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;TPR repeat;Transferase,Evidence at protein level,reviewed,,PI3/PI4-kinase family,204,Activity regulation (1); Catalytic activity (2); Domain (2); Function (1); Involvement in disease (2); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0067; KW-0181; KW-0225; KW-0256; KW-0333; KW-0418; KW-0458; KW-0472; KW-0492; KW-0496; KW-0539; KW-0547; KW-0597; KW-0621; KW-0677; KW-0723; KW-0802; KW-0808; KW-0887; KW-0963; KW-0991; KW-1000; KW-1185,,,,,"DISEASE: Smith-Kingsmore syndrome (SKS) [MIM:616638]: An autosomal dominant syndrome characterized by intellectual disability, macrocephaly, seizures, umbilical hernia, and facial dysmorphic features. {ECO:0000269|PubMed:25851998, ECO:0000269|PubMed:26542245, ECO:0000269|PubMed:27830187}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Focal cortical dysplasia 2 (FCORD2) [MIM:607341]: A form of focal cortical dysplasia, a malformation of cortical development that results in medically refractory epilepsy in the pediatric population and in adults. FCORD2 is a severe form, with onset usually in childhood, characterized by disrupted cortical lamination and specific cytological abnormalities. It is classified in 2 subtypes: type IIA characterized by dysmorphic neurons and lack of balloon cells; type IIB with dysmorphic neurons and balloon cells. {ECO:0000269|PubMed:25799227, ECO:0000269|PubMed:25878179, ECO:0000269|PubMed:26018084, ECO:0000269|PubMed:27830187}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Autophosphorylates when part of mTORC1 or mTORC2. Phosphorylation at Ser-1261, Ser-2159 and Thr-2164 promotes autophosphorylation. Phosphorylation in the kinase domain modulates the interactions of MTOR with RPTOR and PRAS40 and leads to increased intrinsic mTORC1 kinase activity. Phosphorylation at Thr-2173 in the ATP-binding region by AKT1 strongly reduces kinase activity. {ECO:0000269|PubMed:15905173, ECO:0000269|PubMed:19145465, ECO:0000269|PubMed:19487463, ECO:0000269|PubMed:21576368, ECO:0000269|PubMed:23429703, ECO:0000269|PubMed:23429704, ECO:0000269|PubMed:24247430}.",CHAIN 1 2549 Serine/threonine-protein kinase mTOR. /FTId=PRO_0000088808.,,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 567 567 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231}.; MOD_RES 1162 1162 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 1218 1218 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 1261 1261 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:19487463}.; MOD_RES 2159 2159 Phosphoserine. {ECO:0000269|PubMed:21576368}.; MOD_RES 2164 2164 Phosphothreonine. {ECO:0000269|PubMed:21576368}.; MOD_RES 2173 2173 Phosphothreonine; by PKB/AKT1. {ECO:0000269|PubMed:24247430}.; MOD_RES 2446 2446 Phosphothreonine; by RPS6KB1. {ECO:0000269|PubMed:15905173}.; MOD_RES 2448 2448 Phosphoserine; by RPS6KB1. {ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:15905173, ECO:0000269|PubMed:19145465}.; MOD_RES 2478 2478 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 2481 2481 Phosphoserine; by autocatalysis. {ECO:0000244|PubMed:18669648, ECO:0000269|PubMed:21576368}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,L34075;U88966;AB209995;BC117166;AJ300188;L35478;
0,Q02241,KIF23_HUMAN,KIF23 KNSL5 MKLP1,KIF23,KNSL5 MKLP1,,,Homo sapiens (Human),9606,Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1),UP000005640: Chromosome 15,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MKSARAKTPRKPTVKKGSQTNLKDPVGVYCRVRPLGFPDQECCIEVINNTTVQLHTPEGYRLNRNGDYKETQYSFKQVFGTHTTQKELFDVVANPLVNDLIHGKNGLLFTYGVTGSGKTHTMTGSPGEGGLLPRCLDMIFNSIGSFQAKRYVFKSNDRNSMDIQCEVDALLERQKREAMPNPKTSSSKRQVDPEFADMITVQEFCKAEEVDEDSVYGVFVSYIEIYNNYIYDLLEEVPFDPIKPKPPQSKLLREDKNHNMYVAGCTEVEVKSTEEAFEVFWRGQKKRRIANTHLNRESSRSHSVFNIKLVQAPLDADGDNVLQEKEQITISQLSLVDLAGSERTNRTRAEGNRLREAGNINQSLMTLRTCMDVLRENQMYGTNKMVPYRDSKLTHLFKNYFDGEGKVRMIVCVNPKAEDYEENLQVMRFAEVTQEVEVARPVDKAICGLTPGRRYRNQPRGPVGNEPLVTDVVLQSFPPLPSCEILDINDEQTLPRLIEALEKRHNLRQMMIDEFNKQSNAFKALLQEFDNAVLSKENHMQGKLNEKEKMISGQKLEIERLEKKNKTLEYKIEILEKTTTIYEEDKRNLQQELETQNQKLQRQFSDKRRLEARLQGMVTETTMKWEKECERRVAAKQLEMQNKLWVKDEKLKQLKAIVTEPKTEKPERPSRERDREKVTQRSVSPSPVPLSSNYIAQISNGQQLMSQPQLHRRSNSCSSISVASCISEWEQKIPTYNTPLKVTSIARRRQQEPGQSKTCIVSDRRRGMYWTEGREVVPTFRNEIEIEEDHCGRLLFQPDQNAPPIRLRHRRSRSAGDRWVDHKPASNMQTETVMQPHVPHAITVSVANEKALAKCEKYMLTHQELASDGEIETKLIKGDIYKTRGGGQSVQFTDIETLKQESPNGSRKRRSSTVAPAQPDGAESEWTDVETRCSVAVEMRAGSQLGPGYQHHAQPKRKKP,960,"110,059",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=Q02241-1; Sequence=Displayed; Name=2; IsoId=Q02241-2; Sequence=VSP_021801; Name=3; IsoId=Q02241-3; Sequence=VSP_057348, VSP_057349, VSP_021801; Note=No experimental confirmation available.; ",,,,,,,,,,"VAR_SEQ 1 197 Missing (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_057348.; VAR_SEQ 245 245 K -> KWNSCSTPMRNTDFV (in isoform 3). {ECO:0000303|PubMed:14702039}. /FTId=VSP_057349.; VAR_SEQ 690 793 Missing (in isoform 2 and isoform 3). {ECO:0000303|PubMed:1406973, ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334}. /FTId=VSP_021801.",VARIANT 515 515 F -> L (in dbSNP:rs17310879). /FTId=VAR_049686.,,,,,,3,,0,,SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family. {ECO:0000255|PROSITE-ProRule:PRU00283}.,COILED 535 620 {ECO:0000255}.,,DOMAIN 25 436 Kinesin motor. {ECO:0000255|PROSITE-ProRule:PRU00283}.,MOTIF 7 11 Nuclear localization signal. {ECO:0000255}.,REGION 794 911 Interaction with ARF6. {ECO:0000269|PubMed:22522702}.,,,,,,,,"FUNCTION: Component of the centralspindlin complex that serves as a microtubule-dependent and Rho-mediated signaling required for the myosin contractile ring formation during the cell cycle cytokinesis. Essential for cytokinesis in Rho-mediated signaling. Required for the localization of ECT2 to the central spindle. Plus-end-directed motor enzyme that moves antiparallel microtubules in vitro. {ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:22522702}.",,,,,,,,,,NP_BIND 112 119 ATP. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,"centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",ATPase activity [GO:0016887]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],GO:0000022; GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0006890; GO:0007018; GO:0008017; GO:0016887; GO:0019886; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149,IPR032924; IPR032384; IPR038105; IPR027640; IPR019821; IPR001752; IPR036961; IPR027417; ,P62330; P62331; Q9NR09; Q9H8V3; Q7RTP6-1; Q9H0H5; P63104,"SUBUNIT: Heterotetramer of two molecules each of RACGAP1 and KIF23. Found in the centralspindlin complex composed of RACGAP1 and KIF23. Interacts with RACGAP1; the interaction is direct. Interacts with ECT2 and PRC1. Interacts with ANXA11 during cytokinesis. Interacts with BIRC6/bruce and USP8/UBPY. Interacts with ARF6, forming heterodimers and heterotetramers. {ECO:0000269|PubMed:11782313, ECO:0000269|PubMed:15197175, ECO:0000269|PubMed:15297875, ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:18329369, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:22522702}.",1406973; 14702039; 16572171; 15489334; 11782313; 15297875; 15197175; 16213214; 16103226; 17081983; 16236794; 16964243; 18329369; 18220336; 18669648; 19413330; 19468300; 19690332; 20068231; 21269460; 21406692; 23186163; 25772364; 25755297; 28112733; 22522702,1406973; 14702039; 16572171; 15489334; 11782313; 15297875; 15197175; 16213214; 16103226; 17081983; 16236794; 16964243; 18329369; 18220336; 18669648; 19413330; 19468300; 19690332; 20068231; 21269460; 21406692; 23186163; 25772364; 25755297; 28112733; 22522702; 10036229; 11493604; 11739780; 11877456; 12198549; 12368902; 14504276; 14676191; 15029241; 15161933; 15199097; 15272311; 15324660; 15326200; 15778465; 15796717; 1607388; 16262723; 16461284; 16571679; 16790497; 17113389; 17198681; 17283181; 17353931; 17979178; 18046453; 18201571; 18511905; 19015243; 19116309; 19203582; 19369418; 19564404; 19758564; 20005805; 20136777; 20360068; 20451386; 20462495; 20508983; 20534429; 20875083; 2142332; 21550981; 21904957; 22013193; 22580824; 22945935; 23562843; 23570799; 23650552; 24128730; 2521221; 2522352; 25364732; 25658096; 25786116; 26496610; 26638075; 26674738; 26775597; 27013586; 28004812; 28951443; 7844144; 7929562; 8602245; 8642258; 8909537,1993-07-01,2019-02-13,2006-11-28,193,X-ray crystallography (1),STRAND 814 816 {ECO:0000244|PDB:3VHX}.; STRAND 819 822 {ECO:0000244|PDB:3VHX}.; STRAND 833 836 {ECO:0000244|PDB:3VHX}.; STRAND 841 846 {ECO:0000244|PDB:3VHX}.; STRAND 856 865 {ECO:0000244|PDB:3VHX}.; STRAND 871 882 {ECO:0000244|PDB:3VHX}.; STRAND 888 901 {ECO:0000244|PDB:3VHX}.,HELIX 849 854 {ECO:0000244|PDB:3VHX}.,,,,,,5 out of 5,Alternative sequence (3); Beta strand (7); Chain (1); Coiled coil (1); Cross-link (13); Domain (1); Helix (1); Modified residue (11); Motif (1); Natural variant (1); Nucleotide binding (1); Region (1),,,,3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Isopeptide bond;Microtubule;Mitosis;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family",193,Alternative products (1); Caution (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0025; KW-0067; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0493; KW-0498; KW-0505; KW-0539; KW-0547; KW-0597; KW-0621; KW-0832; KW-0963; KW-1017; KW-1185,,,,,,,,PTM: Ubiquitinated. Deubiquitinated by USP8/UBPY. {ECO:0000269|PubMed:18329369}.,CHAIN 1 960 Kinesin-like protein KIF23. /FTId=PRO_0000125434.,"CROSSLNK 571 571 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 586 586 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 624 624 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 647 647 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 662 662 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 665 665 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 741 741 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733}.; CROSSLNK 823 823 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 854 854 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 874 874 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 877 877 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 899 899 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 956 956 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.",,,,,"MOD_RES 155 155 Phosphoserine. {ECO:0000244|PubMed:17081983}.; MOD_RES 160 160 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 605 605 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 682 682 Phosphoserine. {ECO:0000250|UniProtKB:E9Q5G3}.; MOD_RES 684 684 Phosphoserine. {ECO:0000250|UniProtKB:E9Q5G3}.; MOD_RES 738 738 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 814 814 Phosphoserine. {ECO:0000244|PubMed:17081983}.; MOD_RES 867 867 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 902 902 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 911 911 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 927 927 Phosphothreonine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,X67155;AK303874;BC017705;BC051826;
0,Q96Q89,KI20B_HUMAN,KIF20B KRMP1 MPHOSPH1,KIF20B,KRMP1 MPHOSPH1,,,Homo sapiens (Human),9606,Kinesin-like protein KIF20B (Cancer/testis antigen 90) (CT90) (Kinesin family member 20B) (Kinesin-related motor interacting with PIN1) (M-phase phosphoprotein 1) (MPP1),UP000005640: Chromosome 10,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MESNFNQEGVPRPSYVFSADPIARPSEINFDGIKLDLSHEFSLVAPNTEANSFESKDYLQVCLRIRPFTQSEKELESEGCVHILDSQTVVLKEPQCILGRLSEKSSGQMAQKFSFSKVFGPATTQKEFFQGCIMQPVKDLLKGQSRLIFTYGLTNSGKTYTFQGTEENIGILPRTLNVLFDSLQERLYTKMNLKPHRSREYLRLSSEQEKEEIASKSALLRQIKEVTVHNDSDDTLYGSLTNSLNISEFEESIKDYEQANLNMANSIKFSVWVSFFEIYNEYIYDLFVPVSSKFQKRKMLRLSQDVKGYSFIKDLQWIQVSDSKEAYRLLKLGIKHQSVAFTKLNNASSRSHSIFTVKILQIEDSEMSRVIRVSELSLCDLAGSERTMKTQNEGERLRETGNINTSLLTLGKCINVLKNSEKSKFQQHVPFRESKLTHYFQSFFNGKGKICMIVNISQCYLAYDETLNVLKFSAIAQKVCVPDTLNSSQEKLFGPVKSSQDVSLDSNSNSKILNVKRATISWENSLEDLMEDEDLVEELENAEETQNVETKLLDEDLDKTLEENKAFISHEEKRKLLDLIEDLKKKLINEKKEKLTLEFKIREEVTQEFTQYWAQREADFKETLLQEREILEENAERRLAIFKDLVGKCDTREEAAKDICATKVETEETHNYVGFEDIIDSLQDNVADIKKQAEIAHLYIASLPDPQEATACLELKFNQIKAELAKTKGELIKTKEELKKRENESDSLIQELETSNKKIITQNQRIKELINIIDQKEDTINEFQNLKSHMENTFKCNDKADTSSLIINNKLICNETVEVPKDSKSKICSERKRVNENELQQDEPPAKKGSIHVSSAITEDQKKSEEVRPNIAEIEDIRVLQENNEGLRAFLLTIENELKNEKEEKAELNKQIVHFQQELSLSEKKNLTLSKEVQQIQSNYDIAIAELHVQKSKNQEQEEKIMKLSNEIETATRSITNNVSQIKLMHTKIDELRTLDSVSQISNIDLLNLRDLSNGSEEDNLPNTQLDLLGNDYLVSKQVKEYRIQEPNRENSFHSSIEAIWEECKEIVKASSKKSHQIEELEQQIEKLQAEVKGYKDENNRLKEKEHKNQDDLLKEKETLIQQLKEELQEKNVTLDVQIQHVVEGKRALSELTQGVTCYKAKIKELETILETQKVECSHSAKLEQDILEKESIILKLERNLKEFQEHLQDSVKNTKDLNVKELKLKEEITQLTNNLQDMKHLLQLKEEEEETNRQETEKLKEELSASSARTQNLKADLQRKEEDYADLKEKLTDAKKQIKQVQKEVSVMRDEDKLLRIKINELEKKKNQCSQELDMKQRTIQQLKEQLNNQKVEEAIQQYERACKDLNVKEKIIEDMRMTLEEQEQTQVEQDQVLEAKLEEVERLATELEKWKEKCNDLETKNNQRSNKEHENNTDVLGKLTNLQDELQESEQKYNADRKKWLEEKMMLITQAKEAENIRNKEMKKYAEDRERFFKQQNEMEILTAQLTEKDSDLQKWREERDQLVAALEIQLKALISSNVQKDNEIEQLKRIISETSKIETQIMDIKPKRISSADPDKLQTEPLSTSFEISRNKIEDGSVVLDSCEVSTENDQSTRFPKPELEIQFTPLQPNKMAVKHPGCTTPVTVKIPKARKRKSNEMEEDLVKCENKKNATPRTNLKFPISDDRNSSVKKEQKVAIRPSSKKTYSLRSQASIIGVNLATKKKEGTLQKFGDFLQHSPSILQSKAKKIIETMSSSKLSNVEASKENVSQPKRAKRKLYTSEISSPIDISGQVILMDQKMKESDHQIIKRRLRTKTAK,1820,"210,629",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=5;  Name=1; IsoId=Q96Q89-1; Sequence=Displayed; Name=2; IsoId=Q96Q89-2; Sequence=VSP_022620; Name=3; IsoId=Q96Q89-3; Sequence=VSP_022619; Name=4; IsoId=Q96Q89-4; Sequence=VSP_022621, VSP_022622; Name=5; IsoId=Q96Q89-5; Sequence=VSP_022618; ",,,,,,,,,SEQUENCE CAUTION:  Sequence=AAH46134.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};  Sequence=AAH58913.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};  Sequence=AAH93089.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};  Sequence=AAI08689.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};  Sequence=BAB15043.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305}; ,"VAR_SEQ 1 1308 Missing (in isoform 5). {ECO:0000303|PubMed:14702039}. /FTId=VSP_022618.; VAR_SEQ 668 707 Missing (in isoform 3). {ECO:0000303|PubMed:11230166, ECO:0000303|PubMed:12740395, ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005}. /FTId=VSP_022619.; VAR_SEQ 849 849 G -> GTTSAASSRRLRKLISKPKKGVNRTRQTEGHSLV (in isoform 2). {ECO:0000303|PubMed:11470801}. /FTId=VSP_022620.; VAR_SEQ 1664 1722 DLVKCENKKNATPRTNLKFPISDDRNSSVKKEQKVAIRPSSKKTYSLRSQASIIGVNLA -> SASPPPKECSSSPAMEQSWKENDFDKLREEGFRRSNYSELQEEIQTKGKEVENFEKNLD (in isoform 4). {ECO:0000303|Ref.9}. /FTId=VSP_022621.; VAR_SEQ 1723 1820 Missing (in isoform 4). {ECO:0000303|Ref.9}. /FTId=VSP_022622.","VARIANT 50 50 A -> G (in dbSNP:rs1129777). /FTId=VAR_030181.; VARIANT 490 490 E -> D (in dbSNP:rs17484219). {ECO:0000269|PubMed:11230166, ECO:0000269|PubMed:15489334}. /FTId=VAR_030182.; VARIANT 756 756 N -> I (in dbSNP:rs12572012). {ECO:0000269|PubMed:11470801, ECO:0000269|PubMed:12740395}. /FTId=VAR_030183.; VARIANT 789 789 H -> L (in dbSNP:rs3758388). {ECO:0000269|PubMed:11470801, ECO:0000269|PubMed:12740395}. /FTId=VAR_030184.; VARIANT 1011 1011 D -> E (in dbSNP:rs1062465). /FTId=VAR_030185.; VARIANT 1127 1127 E -> Q (in dbSNP:rs11185863). /FTId=VAR_030186.; VARIANT 1148 1148 A -> V (in dbSNP:rs117564945). {ECO:0000269|PubMed:26477546}. /FTId=VAR_075704.; VARIANT 1177 1177 C -> R (in dbSNP:rs1886996). {ECO:0000269|PubMed:10695267, ECO:0000269|PubMed:11230166, ECO:0000269|PubMed:11470801, ECO:0000269|PubMed:12740395, ECO:0000269|PubMed:14702039, ECO:0000269|Ref.9}. /FTId=VAR_030187.; VARIANT 1219 1219 N -> S (in dbSNP:rs1886997). /FTId=VAR_030188.; VARIANT 1589 1589 F -> Y (in dbSNP:rs117258675). {ECO:0000269|PubMed:26477546}. /FTId=VAR_075705.; VARIANT 1789 1789 I -> V (in dbSNP:rs3758390). /FTId=VAR_030189.",,,,CONFLICT 266 266 S -> T (in Ref. 1; BAB69456). {ECO:0000305}.; CONFLICT 296 297 KR -> NT (in Ref. 1; BAB69456). {ECO:0000305}.; CONFLICT 357 357 V -> I (in Ref. 1; BAB69456). {ECO:0000305}.; CONFLICT 388 388 M -> V (in Ref. 1; BAB69456). {ECO:0000305}.; CONFLICT 593 593 E -> K (in Ref. 6; AAI08689). {ECO:0000305}.; CONFLICT 705 707 DPQ -> ETE (in Ref. 5; AAP40331). {ECO:0000305}.; CONFLICT 753 753 E -> K (in Ref. 1; BAB69456). {ECO:0000305}.; CONFLICT 797 797 N -> S (in Ref. 3; BAB15043). {ECO:0000305}.; CONFLICT 870 870 N -> S (in Ref. 3; BAB15043). {ECO:0000305}.; CONFLICT 915 915 F -> S (in Ref. 3; BAB15043). {ECO:0000305}.; CONFLICT 1105 1105 K -> R (in Ref. 3; BAB15043). {ECO:0000305}.; CONFLICT 1302 1302 V -> E (in Ref. 10; AAC37542). {ECO:0000305}.; CONFLICT 1459 1459 R -> S (in Ref. 10; AAC37542). {ECO:0000305}.; CONFLICT 1608 1608 V -> A (in Ref. 1; BAB69456). {ECO:0000305}.; CONFLICT 1649 1649 K -> E (in Ref. 2; CAB55962 and 3; BAB15194). {ECO:0000305}.,,3,,0,,SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Kinesin family. {ECO:0000255|PROSITE-ProRule:PRU00283}.,COILED 523 603 {ECO:0000255}.; COILED 674 793 {ECO:0000255}.,COMPBIAS 1247 1251 Poly-Glu.,DOMAIN 58 479 Kinesin motor. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,REGION 1050 1107 Necessary and sufficient for interaction with SHTN1. {ECO:0000250|UniProtKB:Q80WE4}.; REGION 1560 1820 Interaction with PIN1. {ECO:0000269|PubMed:11470801}.,,,,,,,,"FUNCTION: Plus-end-directed motor enzyme that is required for completion of cytokinesis (PubMed:11470801, PubMed:12740395). Required for proper midbody organization and abscission in polarized cortical stem cells. Plays a role in the regulation of neuronal polarization by mediating the transport of specific cargos. Participates in the mobilization of SHTN1 and in the accumulation of PIP3 in the growth cone of primary hippocampal neurons in a tubulin and actin-dependent manner. In the developing telencephalon, cooperates with SHTN1 to promote both the transition from the multipolar to the bipolar stage and the radial migration of cortical neurons from the ventricular zone toward the superficial layer of the neocortex. Involved in cerebral cortex growth (By similarity). Acts as an oncogene for promoting bladder cancer cells proliferation, apoptosis inhibition and carcinogenic progression (PubMed:17409436). {ECO:0000250|UniProtKB:Q80WE4, ECO:0000269|PubMed:11470801, ECO:0000269|PubMed:12740395, ECO:0000269|PubMed:17409436}.",,,,,,,,,,NP_BIND 152 159 ATP. {ECO:0000255|PROSITE-ProRule:PRU00283}.,,"centrosome [GO:0005813]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein homodimerization activity [GO:0042803]; WW domain binding [GO:0050699]; cell cycle arrest [GO:0007050]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of neuron migration [GO:2001224]; protein localization to microtubule [GO:0035372]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic nuclear division [GO:0007088]",cell cycle arrest [GO:0007050]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of neuron migration [GO:2001224]; protein localization to microtubule [GO:0035372]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic nuclear division [GO:0007088],"ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein homodimerization activity [GO:0042803]; WW domain binding [GO:0050699]",centrosome [GO:0005813]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233],GO:0001843; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005871; GO:0005874; GO:0007018; GO:0007050; GO:0007088; GO:0008017; GO:0008284; GO:0008574; GO:0016887; GO:0030426; GO:0030496; GO:0032467; GO:0035372; GO:0042803; GO:0048471; GO:0048812; GO:0050699; GO:0051233; GO:0051301; GO:0070938; GO:0090316; GO:0097431; GO:1903438; GO:1990023; GO:2000114; GO:2001224,IPR028828; IPR027640; IPR019821; IPR001752; IPR036961; IPR027417; ,,"SUBUNIT: Oligomerizes (via kinesin motor domain) (PubMed:11470801). Associates with microtubules (PubMed:12740395). Interacts (via C-terminal globular tail region) with PIN1 (via WW domain) (PubMed:11470801). Interacts with PRC1 (PubMed:17409436). Interacts with SHTN1 (via N-terminus); the interaction is direct and promotes the association of SHTN1 to microtubules in primary neurons. {ECO:0000250|UniProtKB:Q80WE4, ECO:0000269|PubMed:11470801, ECO:0000269|PubMed:12740395, ECO:0000269|PubMed:17409436}.",11470801; 11230166; 14702039; 15164054; 12740395; 15489334; 17974005; 10695267; 8290587; 17409436; 17525332; 21406692; 23186163; 26477546,11470801; 11230166; 14702039; 15164054; 12740395; 15489334; 17974005; 10695267; 8290587; 17409436; 17525332; 21406692; 23186163; 26477546; 11493604; 11739780; 12368902; 14504276; 15029241; 15272311; 15326200; 1607388; 16262723; 16385451; 16571679; 17113389; 17353931; 19116309; 19369418; 19758564; 20005805; 20136777; 20462495; 20534429; 20711500; 21150319; 21282530; 2142332; 21550981; 22013193; 23416715; 2521221; 2522352; 25364732; 26496610; 29167382; 7844144; 7929562; 8602245,2007-01-23,2019-02-13,2010-10-05,145,,,,,,,,,5 out of 5,Alternative sequence (5); Chain (1); Coiled coil (2); Compositional bias (1); Domain (1); Modified residue (8); Natural variant (11); Nucleotide binding (1); Region (2); Sequence caution (5); Sequence conflict (16),,"TISSUE SPECIFICITY: Brain, ovary, kidney and testis (at protein level) (PubMed:12740395). Overexpressed in bladder cancer cells (at protein level) (PubMed:17409436). Expressed in testis. Overexpressed in bladder cancer cells (PubMed:17409436). {ECO:0000269|PubMed:12740395, ECO:0000269|PubMed:17409436}.",,ATP-binding;Alternative splicing;Cell cycle;Cell division;Cell projection;Coiled coil;Complete proteome;Cytoplasm;Cytoskeleton;Microtubule;Mitosis;Motor protein;Nucleotide-binding;Nucleus;Oncogene;Phosphoprotein;Polymorphism;Reference proteome,Evidence at protein level,reviewed,,"TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family",145,Alternative products (1); Function (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0025; KW-0067; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0493; KW-0498; KW-0505; KW-0539; KW-0547; KW-0553; KW-0597; KW-0621; KW-0963; KW-0966; KW-1185,,,,,,,,"PTM: Phosphorylated during mitosis by CDK1 (PubMed:11470801, PubMed:12740395). {ECO:0000269|PubMed:11470801, ECO:0000269|PubMed:12740395}.",CHAIN 1 1820 Kinesin-like protein KIF20B. /FTId=PRO_0000274053.,,,,,,"MOD_RES 488 488 Phosphoserine. {ECO:0000244|PubMed:17525332}.; MOD_RES 560 560 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 997 997 Phosphoserine. {ECO:0000250|UniProtKB:Q80WE4}.; MOD_RES 1588 1588 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1644 1644 Phosphothreonine; by CDK1. {ECO:0000269|PubMed:11470801}.; MOD_RES 1658 1658 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 1715 1715 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1740 1740 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB033337;AB033338;AL117496;AK024959;AK025628;AY282406;AY282407;BC046134;BC058913;BC093089;BC108688;AL137392;U93121;AY739715;L16782;
0,Q9H0H5,RGAP1_HUMAN,RACGAP1 KIAA1478 MGCRACGAP,RACGAP1,KIAA1478 MGCRACGAP,,,Homo sapiens (Human),9606,Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4),UP000005640: Chromosome 12,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MDTMMLNVRNLFEQLVRRVEILSEGNEVQFIQLAKDFEDFRKKWQRTDHELGKYKDLLMKAETERSALDVKLKHARNQVDVEIKRRQRAEADCEKLERQIQLIREMLMCDTSGSIQLSEEQKSALAFLNRGQPSSSNAGNKRLSTIDESGSILSDISFDKTDESLDWDSSLVKTFKLKKREKRRSTSRQFVDGPPGPVKKTRSIGSAVDQGNESIVAKTTVTVPNDGGPIEAVSTIETVPYWTRSRRKTGTLQPWNSDSTLNSRQLEPRTETDSVGTPQSNGGMRLHDFVSKTVIKPESCVPCGKRIKFGKLSLKCRDCRVVSHPECRDRCPLPCIPTLIGTPVKIGEGMLADFVSQTSPMIPSIVVHCVNEIEQRGLTETGLYRISGCDRTVKELKEKFLRVKTVPLLSKVDDIHAICSLLKDFLRNLKEPLLTFRLNRAFMEAAEITDEDNSIAAMYQAVGELPQANRDTLAFLMIHLQRVAQSPHTKMDVANLAKVFGPTIVAHAVPNPDPVTMLQDIKRQPKVVERLLSLPLEYWSQFMMVEQENIDPLHVIENSNAFSTPQTPDIKVSLLGPVTTPEHQLLKTPSSSSLSQRVRSTLTKNTPRFGSKSKSATNLGRQGNFFASPMLK,632,"71,027",,,,,,,"SEQUENCE CAUTION:  Sequence=AAH24144.1; Type=Frameshift; Positions=171, 205, 437; Evidence={ECO:0000305}; ",,,,,,,,,,CONFLICT 155 155 D -> H (in Ref. 3; BAA91347). {ECO:0000305}.; CONFLICT 518 518 L -> S (in Ref. 1; BAA90247). {ECO:0000305}.,,1,,0,"DOMAIN: The coiled coil region is indispensible for localization to the midbody during cytokinesis. {ECO:0000269|PubMed:11085985}.; DOMAIN: The phorbol-ester/DAG-type zinc finger domain mediates interaction with membranes enriched in phosphatidylinositol 3,4,5-trisphosphate and is required during mitotic cytokinesis for normal attachment of the midbody to the cell membrane.",,COILED 53 110 {ECO:0000255}.,,DOMAIN 349 539 Rho-GAP. {ECO:0000255|PROSITE-ProRule:PRU00172}.,,REGION 106 285 Interaction with SLC26A8. {ECO:0000269|PubMed:11278976}.,,ZN_FING 286 335 Phorbol-ester/DAG-type. {ECO:0000255|PROSITE-ProRule:PRU00226}.,,,,,,"FUNCTION: Component of the centralspindlin complex that serves as a microtubule-dependent and Rho-mediated signaling required for the myosin contractile ring formation during the cell cycle cytokinesis. Required for proper attachment of the midbody to the cell membrane during cytokinesis. Plays key roles in controlling cell growth and differentiation of hematopoietic cells through mechanisms other than regulating Rac GTPase activity. Also involved in the regulation of growth-related processes in adipocytes and myoblasts. May be involved in regulating spermatogenesis and in the RACGAP1 pathway in neuronal proliferation. Shows strong GAP (GTPase activation) activity towards CDC42 and RAC1 and less towards RHOA. Essential for the early stages of embryogenesis. May play a role in regulating cortical activity through RHOA during cytokinesis. May participate in the regulation of sulfate transport in male germ cells. {ECO:0000269|PubMed:10979956, ECO:0000269|PubMed:11085985, ECO:0000269|PubMed:11278976, ECO:0000269|PubMed:11782313, ECO:0000269|PubMed:14729465, ECO:0000269|PubMed:15642749, ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:16129829, ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:19468302, ECO:0000269|PubMed:23235882, ECO:0000269|PubMed:9497316}.",,,,,,,,,,,,"acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]","actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]","alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]",acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233],GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005874; GO:0006890; GO:0007018; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019886; GO:0019901; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0035556; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149,IPR002219; IPR008936; IPR000198; ,P35221; Q9H8V3; Q02241; Q9UBU8; P53350; Q16537; O75154; Q96RN1,"SUBUNIT: Heterotetramer of two molecules each of RACGAP1 and KIF23. Found in the centralspindlin complex composed of RACGAP1 and KIF23. Associates with alpha-, beta- and gamma-tubulin and microtubules. Interacts via its Rho-GAP domain with RND2. Associates with AURKB during M phase. Interacts via its Rho-GAP domain and basic region with PRC1. The interaction with PRC1 inhibits its GAP activity towards CDC42 in vitro, which may be required for maintaining normal spindle morphology. Interacts with SLC26A8 via its N-terminus. Interacts with RAB11FIP3. Interacts with ECT2; the interaction is direct, occurs at anaphase and during cytokinesis in a microtubule-dependent manner and is enhanced by phosphorylation by PLK1. Interacts with KIF23; the interaction is direct. {ECO:0000269|PubMed:11085985, ECO:0000269|PubMed:11278976, ECO:0000269|PubMed:11782313, ECO:0000269|PubMed:12590651, ECO:0000269|PubMed:12689593, ECO:0000269|PubMed:14744859, ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:16129829, ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:18511905, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:23235882}.",10979956; 11230166; 14702039; 15489334; 10819331; 9497316; 11085985; 11278976; 11782313; 12590651; 12689593; 14729465; 14744859; 16213214; 15642749; 16103226; 16129829; 17081983; 16236794; 16964243; 18511905; 18669648; 19468302; 19468300; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 28112733; 23235882,10979956; 11230166; 14702039; 15489334; 10819331; 9497316; 11085985; 11278976; 11782313; 12590651; 12689593; 14729465; 14744859; 16213214; 15642749; 16103226; 16129829; 17081983; 16236794; 16964243; 18511905; 18669648; 19468302; 19468300; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 28112733; 23235882; 10036229; 11431473; 11493604; 11739780; 11804589; 11937491; 12198549; 12368902; 12493759; 12577067; 1406973; 14504276; 15029241; 15272311; 15284113; 15324660; 15326200; 15677464; 15728185; 15778465; 15863513; 15872091; 1607388; 16118207; 16169070; 16262723; 16571679; 16790497; 17113389; 17222083; 17283181; 17353931; 17982282; 18046453; 18201571; 19015243; 19116309; 19369418; 19564404; 19758564; 19913121; 20005805; 20136777; 20360068; 20462495; 20467437; 20534429; 20628086; 2142332; 21550981; 21825042; 21851590; 21988832; 22013193; 22267324; 22580824; 22683270; 22945935; 23096218; 23225332; 23416715; 23525949; 23665020; 23696789; 24019536; 24615626; 24807907; 24857844; 25068414; 2521221; 2522352; 25305482; 25364732; 25416956; 25475728; 25486482; 25568185; 26018753; 26496610; 26508373; 26638075; 26778597; 27121792; 27216196; 27259241; 27284123; 28067790; 2825022; 29095547; 29695400; 30009820; 7844144; 7929562; 8288572; 8602245; 8642258; 8909537; 9605766,2006-03-21,2019-02-13,2001-03-01,174,X-ray crystallography (7),STRAND 289 293 {ECO:0000244|PDB:4B6D}.; STRAND 312 320 {ECO:0000244|PDB:4B6D}.; STRAND 357 360 {ECO:0000244|PDB:5C2K}.; STRAND 429 431 {ECO:0000244|PDB:5C2K}.; STRAND 508 511 {ECO:0000244|PDB:5C2K}.,HELIX 325 330 {ECO:0000244|PDB:4B6D}.; HELIX 351 353 {ECO:0000244|PDB:5C2K}.; HELIX 364 376 {ECO:0000244|PDB:5C2K}.; HELIX 390 403 {ECO:0000244|PDB:5C2K}.; HELIX 409 411 {ECO:0000244|PDB:5C2K}.; HELIX 415 427 {ECO:0000244|PDB:5C2K}.; HELIX 439 447 {ECO:0000244|PDB:5C2K}.; HELIX 451 464 {ECO:0000244|PDB:5C2K}.; HELIX 467 485 {ECO:0000244|PDB:5C2K}.; HELIX 493 504 {ECO:0000244|PDB:5C2K}.; HELIX 514 520 {ECO:0000244|PDB:5C2K}.; HELIX 523 532 {ECO:0000244|PDB:5C2K}.; HELIX 536 541 {ECO:0000244|PDB:5C2K}.,TURN 301 303 {ECO:0000244|PDB:4B6D}.; TURN 377 379 {ECO:0000244|PDB:5C2K}.; TURN 381 385 {ECO:0000244|PDB:5C2K}.; TURN 436 438 {ECO:0000244|PDB:5C2K}.; TURN 487 489 {ECO:0000244|PDB:5C2K}.; TURN 542 544 {ECO:0000244|PDB:5C2K}.,,,,,5 out of 5,Beta strand (5); Chain (1); Coiled coil (1); Cross-link (2); Domain (1); Frameshift (1); Helix (13); Modified residue (23); Mutagenesis (11); Region (1); Sequence conflict (2); Turn (6); Zinc finger (1),,"TISSUE SPECIFICITY: Highly expressed in testis, thymus and placenta. Expressed at lower levels in spleen and peripheral blood lymphocytes. In testis, expression is restricted to germ cells with the highest levels of expression found in spermatocytes. Expression is regulated in a cell cycle-dependent manner and peaks during G2/M phase. {ECO:0000269|PubMed:10979956, ECO:0000269|PubMed:11278976, ECO:0000269|PubMed:12590651, ECO:0000269|PubMed:9497316}.",,3D-structure;Acetylation;Cell cycle;Cell division;Cell membrane;Coiled coil;Complete proteome;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Developmental protein;Differentiation;GTPase activation;Ion transport;Isopeptide bond;Lipid-binding;Membrane;Metal-binding;Microtubule;Nucleus;Phosphoprotein;Reference proteome;Spermatogenesis;Transport;Ubl conjugation;Zinc;Zinc-finger,Evidence at protein level,reviewed,,,174,Domain (2); Function (1); Induction (1); Post-translational modification (1); Subcellular location (1); Subunit structure (1); Tissue specificity (1),,KW-0002; KW-0007; KW-0131; KW-0132; KW-0175; KW-0181; KW-0206; KW-0217; KW-0221; KW-0343; KW-0406; KW-0446; KW-0472; KW-0479; KW-0493; KW-0539; KW-0597; KW-0744; KW-0813; KW-0832; KW-0862; KW-0863; KW-0963; KW-0968; KW-1003; KW-1017; KW-1185,,,,,,,,"PTM: Phosphorylated at multiple sites in the midbody during cytokinesis. Phosphorylation by AURKB on Ser-387 at the midbody is, at least in part, responsible for exerting its latent GAP activity towards RhoA. Phosphorylation on multiple serine residues by PLK1 enhances its association with ECT2 and is critical for cleavage furrow formation. {ECO:0000269|PubMed:12689593, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:19468302}.",CHAIN 1 632 Rac GTPase-activating protein 1. /FTId=PRO_0000228808.,CROSSLNK 248 248 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 404 404 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.,,,,,"MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 149 149 Phosphoserine; by PLK1. {ECO:0000269|PubMed:19468300}.; MOD_RES 154 154 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 157 157 Phosphoserine; by PLK1. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:19468302}.; MOD_RES 161 161 Phosphothreonine. {ECO:0000244|PubMed:17081983}.; MOD_RES 164 164 Phosphoserine; by PLK1. {ECO:0000244|PubMed:17081983, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:19468302}.; MOD_RES 170 170 Phosphoserine; by PLK1. {ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:19468302}.; MOD_RES 203 203 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 206 206 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 214 214 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:19468302}.; MOD_RES 249 249 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 257 257 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 260 260 Phosphothreonine. {ECO:0000269|PubMed:19468302}.; MOD_RES 342 342 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 387 387 Phosphoserine; by AURKB. {ECO:0000269|PubMed:12689593}.; MOD_RES 410 410 Phosphoserine; by AURKB. {ECO:0000269|PubMed:12689593}.; MOD_RES 567 567 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 580 580 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 588 588 Phosphothreonine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 600 600 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 601 601 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 606 606 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 628 628 Phosphoserine. {ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB030251;AL136794;AK000733;CR533565;BC024144;BC032754;AB040911;
0,O76064,RNF8_HUMAN,RNF8 KIAA0646,RNF8,KIAA0646,,,Homo sapiens (Human),9606,E3 ubiquitin-protein ligase RNF8 (hRNF8) (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8),UP000005640: Chromosome 6,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MGEPGFFVTGDRAGGRSWCLRRVGMSAGWLLLEDGCEVTVGRGFGVTYQLVSKICPLMISRNHCVLKQNPEGQWTIMDNKSLNGVWLNRARLEPLRVYSIHQGDYIQLGVPLENKENAEYEYEVTEEDWETIYPCLSPKNDQMIEKNKELRTKRKFSLDELAGPGAEGPSNLKSKINKVSCESGQPVKSQGKGEVASTPSDNLDPKLTALEPSKTTGAPIYPGFPKVTEVHHEQKASNSSASQRSLQMFKVTMSRILRLKIQMQEKHEAVMNVKKQTQKGNSKKVVQMEQELQDLQSQLCAEQAQQQARVEQLEKTFQEEEQHLQGLEIAQGEKDLKQQLAQALQEHWALMEELNRSKKDFEAIIQAKNKELEQTKEEKEKMQAQKEEVLSHMNDVLENELQCIICSEYFIEAVTLNCAHSFCSYCINEWMKRKIECPICRKDIKSKTYSLVLDNCINKMVNNLSSEVKERRIVLIRERKAKRLF,485,"55,518",,"ALTERNATIVE PRODUCTS:  Event=Alternative splicing; Named isoforms=3;  Name=1; IsoId=O76064-1; Sequence=Displayed; Name=2; IsoId=O76064-2; Sequence=VSP_036671, VSP_037831; Note=May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. No experimental confirmation available.; Name=3; IsoId=O76064-3; Sequence=VSP_054037, VSP_054038; Note=No experimental confirmation available. Gene prediction based on EST data.; ",SEQUENCE CAUTION:  Sequence=EAX03945.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; ,SEQUENCE CAUTION:  Sequence=BAA31621.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305}; ,,SEQUENCE CAUTION:  Sequence=BAG60572.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305}; ,,,,,,VAR_SEQ 81 98 SLNGVWLNRARLEPLRVY -> SFPSEKAEDFTAAGERFL (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_036671.; VAR_SEQ 99 485 Missing (in isoform 2). {ECO:0000303|PubMed:14702039}. /FTId=VSP_037831.; VAR_SEQ 413 448 AVTLNCAHSFCSYCINEWMKRKIECPICRKDIKSKT -> QRDCSEDRALRAFERLPGSASLRWSGGFSLAVTPLL (in isoform 3). {ECO:0000305}. /FTId=VSP_054037.; VAR_SEQ 449 485 Missing (in isoform 3). {ECO:0000305}. /FTId=VSP_054038.,VARIANT 162 162 A -> T (in dbSNP:rs34338974). /FTId=VAR_052096.; VARIANT 473 473 I -> V (in dbSNP:rs1139944). /FTId=VAR_052097.,,,,CONFLICT 230 230 V -> A (in Ref. 6; BAD96485). {ECO:0000305}.; CONFLICT 334 334 K -> R (in Ref. 6; BAD96485). {ECO:0000305}.,,1,,0,"DOMAIN: The FHA domain specifically recognizes and binds ATM-phosphorylated MDC1 and 'Thr-4827' phosphorylated HERC2 (PubMed:18001824). This domain is required for proper recruitment to DNA damage sites after UV irradiation, ionizing radiation, or treatment with an alkylating agent (PubMed:23233665). {ECO:0000269|PubMed:18001824, ECO:0000269|PubMed:23233665}.",SIMILARITY: Belongs to the RNF8 family. {ECO:0000255|HAMAP-Rule:MF_03067}.,,COMPBIAS 276 345 Gln-rich.,DOMAIN 38 92 FHA. {ECO:0000255|HAMAP-Rule:MF_03067}.,,REGION 68 72 Required for interaction with PIWIL1. {ECO:0000255|HAMAP-Rule:MF_03067}.,,ZN_FING 403 441 RING-type. {ECO:0000255|HAMAP-Rule:MF_03067}.,2.3.2.27,,CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000255|HAMAP-Rule:MF_03067};,,,"FUNCTION: E3 ubiquitin-protein ligase that plays a key role in DNA damage signaling via 2 distinct roles: by mediating the 'Lys-63'-linked ubiquitination of histones H2A and H2AX and promoting the recruitment of DNA repair proteins at double-strand breaks (DSBs) sites, and by catalyzing 'Lys-48'-linked ubiquitination to remove target proteins from DNA damage sites. Following DNA DSBs, it is recruited to the sites of damage by ATM-phosphorylated MDC1 and catalyzes the 'Lys-63'-linked ubiquitination of histones H2A and H2AX, thereby promoting the formation of TP53BP1 and BRCA1 ionizing radiation-induced foci (IRIF). Also controls the recruitment of UIMC1-BRCC3 (RAP80-BRCC36) and PAXIP1/PTIP to DNA damage sites. Also recruited at DNA interstrand cross-links (ICLs) sites and catalyzes 'Lys-63'-linked ubiquitination of histones H2A and H2AX, leading to recruitment of FAAP20/C1orf86 and Fanconi anemia (FA) complex, followed by interstrand cross-link repair. H2A ubiquitination also mediates the ATM-dependent transcriptional silencing at regions flanking DSBs in cis, a mechanism to avoid collision between transcription and repair intermediates. Promotes the formation of 'Lys-63'-linked polyubiquitin chains via interactions with the specific ubiquitin-conjugating UBE2N/UBC13 and ubiquitinates non-histone substrates such as PCNA. Substrates that are polyubiquitinated at 'Lys-63' are usually not targeted for degradation. Also catalyzes the formation of 'Lys-48'-linked polyubiquitin chains via interaction with the ubiquitin-conjugating UBE2L6/UBCH8, leading to degradation of substrate proteins such as CHEK2, JMJD2A/KDM4A and KU80/XRCC5: it is still unclear how the preference toward 'Lys-48'- versus 'Lys-63'-linked ubiquitination is regulated but it could be due to RNF8 ability to interact with specific E2 specific ligases. For instance, interaction with phosphorylated HERC2 promotes the association between RNF8 and UBE2N/UBC13 and favors the specific formation of 'Lys-63'-linked ubiquitin chains. Promotes non-homologous end joining (NHEJ) by promoting the 'Lys-48'-linked ubiquitination and degradation the of KU80/XRCC5. Following DNA damage, mediates the ubiquitination and degradation of JMJD2A/KDM4A in collaboration with RNF168, leading to unmask H4K20me2 mark and promote the recruitment of TP53BP1 at DNA damage sites (PubMed:11322894, PubMed:14981089, PubMed:17724460, PubMed:18001824, PubMed:18001825, PubMed:18006705, PubMed:18077395, PubMed:18337245, PubMed:18948756, PubMed:19015238, PubMed:19124460, PubMed:19202061, PubMed:19203578, PubMed:19203579, PubMed:20550933, PubMed:21558560, PubMed:21857671, PubMed:21911360, PubMed:22266820, PubMed:22373579, PubMed:22531782, PubMed:22705371, PubMed:22865450, PubMed:22980979). Following DNA damage, mediates the ubiquitination and degradation of POLD4/p12, a subunit of DNA polymerase delta. In the absence of POLD4, DNA polymerase delta complex exhibits higher proofreading activity (PubMed:23233665). In addition to its function in damage signaling, also plays a role in higher-order chromatin structure by mediating extensive chromatin decondensation. Involved in the activation of ATM by promoting histone H2B ubiquitination, which indirectly triggers histone H4 'Lys-16' acetylation (H4K16ac), establishing a chromatin environment that promotes efficient activation of ATM kinase. Required in the testis, where it plays a role in the replacement of histones during spermatogenesis. At uncapped telomeres, promotes the joining of deprotected chromosome ends by inducing H2A ubiquitination and TP53BP1 recruitment, suggesting that it may enhance cancer development by aggravating telomere-induced genome instability in case of telomeric crisis. Promotes the assembly of RAD51 at DNA DSBs in the absence of BRCA1 and TP53BP1 Also involved in class switch recombination in immune system, via its role in regulation of DSBs repair. May be required for proper exit from mitosis after spindle checkpoint activation and may regulate cytokinesis. May play a role in the regulation of RXRA-mediated transcriptional activity. Not involved in RXRA ubiquitination by UBE2E2 (PubMed:11322894, PubMed:14981089, PubMed:17724460, PubMed:18001824, PubMed:18001825, PubMed:18006705, PubMed:18077395, PubMed:18337245, PubMed:18948756, PubMed:19015238, PubMed:19124460, PubMed:19202061, PubMed:19203578, PubMed:19203579, PubMed:20550933, PubMed:21558560, PubMed:21857671, PubMed:21911360, PubMed:22266820, PubMed:22373579, PubMed:22531782, PubMed:22705371, PubMed:22865450, PubMed:22980979). {ECO:0000269|PubMed:11322894, ECO:0000269|PubMed:14981089, ECO:0000269|PubMed:17724460, ECO:0000269|PubMed:18001824, ECO:0000269|PubMed:18001825, ECO:0000269|PubMed:18006705, ECO:0000269|PubMed:18077395, ECO:0000269|PubMed:18337245, ECO:0000269|PubMed:18948756, ECO:0000269|PubMed:19015238, ECO:0000269|PubMed:19124460, ECO:0000269|PubMed:19202061, ECO:0000269|PubMed:19203578, ECO:0000269|PubMed:19203579, ECO:0000269|PubMed:20550933, ECO:0000269|PubMed:21558560, ECO:0000269|PubMed:21857671, ECO:0000269|PubMed:21911360, ECO:0000269|PubMed:22266820, ECO:0000269|PubMed:22373579, ECO:0000269|PubMed:22531782, ECO:0000269|PubMed:22705371, ECO:0000269|PubMed:22865450, ECO:0000269|PubMed:22980979, ECO:0000269|PubMed:23233665}.",,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|HAMAP-Rule:MF_03067}.,,,,,,,,,,"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]","cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]",chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]",GO:0000151; GO:0000781; GO:0003682; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0007049; GO:0007286; GO:0008270; GO:0010212; GO:0030496; GO:0031625; GO:0033522; GO:0033523; GO:0034244; GO:0035093; GO:0035861; GO:0036297; GO:0042393; GO:0042802; GO:0042803; GO:0043130; GO:0043486; GO:0045190; GO:0045739; GO:0051301; GO:0051865; GO:0070534; GO:0070535; GO:0070936,IPR000253; IPR017335; IPR008984; IPR001841; IPR013083; IPR017907; ,Itself; Q9C0F1; V9HW80; Q8IX15-3; Q9Y6D9; Q14676; Q9UL42; O43251; Q9UH03; O75558; Q9BSE2; P62837; Q99986; O00401,"SUBUNIT: Homodimer. Forms a E2-E3 ubiquitin ligase complex composed of the RNF8 homodimer and a E2 heterodimer of UBE2N and UBE2V2. Interacts with class III E2s, including UBE2E1, UBE2E2, and UBE2E3 and with UBE2N. Interacts with RXRA. Interacts (via FHA domain) with ATM-phosphorylated MDC1. Interacts (via FHA domain) with 'Thr-4827' phosphorylated HERC2 (via C-terminus). Interacts with PIWIL1; leading to sequester RNF8 in the cytoplasm (By similarity). Interacts with WRAP53/TCAB1 (PubMed:25512560). {ECO:0000250|UniProtKB:Q8VC56, ECO:0000269|PubMed:11322894, ECO:0000269|PubMed:14981089, ECO:0000269|PubMed:16215985, ECO:0000269|PubMed:18001824, ECO:0000269|PubMed:18001825, ECO:0000269|PubMed:18006705, ECO:0000269|PubMed:18678647, ECO:0000269|PubMed:20023648, ECO:0000269|PubMed:22266820, ECO:0000269|PubMed:22589545, ECO:0000269|PubMed:22980979, ECO:0000269|PubMed:25512560}.; SUBUNIT: (Microbial infection) Interacts (via FHA domain) with phosphorylated human herpesvirus 1 ICP0 protein; leading to RNF8 degradation by the proteasome. {ECO:0000269|PubMed:22405594}.",9852682; 16215985; 9734811; 14702039; 14574404; 15489334; 23233665; 11322894; 14981089; 18001824; 18077395; 18006705; 17724460; 18948756; 18337245; 18678647; 18669648; 19690332; 20023648; 19203578; 19203579; 19124460; 19015238; 19202061; 20550933; 21558560; 21857671; 22865450; 22373579; 22531782; 22405594; 22705371; 22266820; 21911360; 23186163; 25512560; 18001825; 22980979; 22589545,9852682; 16215985; 9734811; 14702039; 14574404; 15489334; 23233665; 11322894; 14981089; 18001824; 18077395; 18006705; 17724460; 18948756; 18337245; 18678647; 18669648; 19690332; 20023648; 19203578; 19203579; 19124460; 19015238; 19202061; 20550933; 21558560; 21857671; 22865450; 22373579; 22531782; 22405594; 22705371; 22266820; 21911360; 23186163; 25512560; 18001825; 22980979; 22589545; 10550055; 10724175; 10866324; 10973490; 11025670; 11114888; 11493912; 11604075; 12364621; 12447390; 12697768; 12773400; 12947387; 15231747; 15468306; 15574327; 15723659; 16150728; 16189514; 16651405; 17525340; 17553757; 18171988; 18550271; 19001859; 19176521; 19261749; 19549727; 19690564; 19797077; 19913121; 20016603; 20075863; 20080757; 20081839; 20628086; 20711500; 20713529; 21282113; 21293379; 21412056; 21516116; 21635870; 21664912; 21698222; 21774837; 22179609; 22493164; 22508508; 22635276; 22661229; 22661230; 22814251; 23038782; 23115235; 23230272; 23306437; 23333306; 23442799; 23615962; 23727112; 24667604; 25304081; 25337968; 25374327; 25416956; 25417706; 25483088; 25512557; 25955491; 26381412; 26507658; 26734725; 26903517; 27259701; 27310875; 27550454; 27618486; 27993934; 28194753; 28216286; 28499869; 28507061; 28525740; 28983621; 9512523,2002-06-06,2019-02-13,1998-11-01,188,X-ray crystallography (4); NMR spectroscopy (1),STRAND 16 22 {ECO:0000244|PDB:2PIE}.; STRAND 29 32 {ECO:0000244|PDB:2PIE}.; STRAND 38 49 {ECO:0000244|PDB:2PIE}.; STRAND 64 68 {ECO:0000244|PDB:2PIE}.; STRAND 74 78 {ECO:0000244|PDB:2PIE}.; STRAND 85 87 {ECO:0000244|PDB:2PIE}.; STRAND 105 109 {ECO:0000244|PDB:2PIE}.; STRAND 119 128 {ECO:0000244|PDB:2PIE}.; STRAND 411 416 {ECO:0000244|PDB:4AYC}.; STRAND 421 423 {ECO:0000244|PDB:4AYC}.; STRAND 447 449 {ECO:0000244|PDB:4AYC}.,HELIX 56 58 {ECO:0000244|PDB:2CSW}.; HELIX 129 132 {ECO:0000244|PDB:2PIE}.; HELIX 133 135 {ECO:0000244|PDB:2PIE}.; HELIX 351 400 {ECO:0000244|PDB:4AYC}.; HELIX 424 430 {ECO:0000244|PDB:4AYC}.; HELIX 451 461 {ECO:0000244|PDB:4AYC}.; HELIX 466 480 {ECO:0000244|PDB:4AYC}.,TURN 404 406 {ECO:0000244|PDB:4AYC}.; TURN 431 433 {ECO:0000244|PDB:4AYC}.; TURN 438 440 {ECO:0000244|PDB:4AYC}.,,,,,5 out of 5,Alternative sequence (4); Beta strand (11); Chain (1); Compositional bias (1); Domain (1); Erroneous gene model prediction (1); Erroneous initiation (1); Erroneous translation (1); Helix (7); Modified residue (1); Mutagenesis (5); Natural variant (2); Region (1); Sequence conflict (2); Turn (3); Zinc finger (1),"CAUTION: According to a well-established model, RNF8 initiate H2A 'Lys-63'-linked ubiquitination leading to recruitment of RNF168 to amplify H2A 'Lys-63'-linked ubiquitination (PubMed:19203578 and PubMed:19203579). However, other data suggest that RNF168 is the priming ubiquitin ligase by mediating monoubiquitination of 'Lys-13' and 'Lys-15' of nucleosomal histone H2A (H2AK13Ub and H2AK15Ub respectively) (PubMed:22980979). These data suggest that RNF168 might be recruited to DSBs sites in a RNF8-dependent manner by binding to non-histone proteins ubiquitinated via 'Lys-63'-linked and initiates monoubiquitination of H2A, which is then amplified by RNF8 (PubMed:22980979). Additional evidences are however required to confirm these data. {ECO:0000255|HAMAP-Rule:MF_03067, ECO:0000305|PubMed:22980979}.","TISSUE SPECIFICITY: Ubiquitous. In fetal tissues, highest expression in brain, thymus and liver. In adult tissues, highest levels in brain and testis, lowest levels in peripheral blood cells. {ECO:0000269|PubMed:16215985, ECO:0000269|PubMed:9852682}.",,3D-structure;Alternative splicing;Cell cycle;Cell division;Chromatin regulator;Chromosome;Complete proteome;Cytoplasm;DNA damage;DNA repair;Direct protein sequencing;Metal-binding;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Telomere;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger,Evidence at protein level,reviewed,,RNF8 family,188,Alternative products (1); Catalytic activity (1); Caution (3); Developmental stage (1); Domain (1); Function (1); Pathway (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (2); Tissue specificity (1),,KW-0002; KW-0025; KW-0131; KW-0132; KW-0156; KW-0158; KW-0181; KW-0227; KW-0234; KW-0479; KW-0498; KW-0539; KW-0597; KW-0621; KW-0779; KW-0808; KW-0832; KW-0833; KW-0862; KW-0863; KW-0903; KW-0963; KW-1185,Protein modification; protein ubiquitination. ,,,,,,,"PTM: Autoubiquitinated through 'Lys-48' and 'Lys-63' of ubiquitin. 'Lys-63' polyubiquitination is mediated by UBE2N. 'Lys-29'-type polyubiquitination is also observed, but it doesn't require its own functional RING-type zinc finger. {ECO:0000255|HAMAP-Rule:MF_03067, ECO:0000269|PubMed:16215985}.",CHAIN 1 485 E3 ubiquitin-protein ligase RNF8. /FTId=PRO_0000056048.,,,,,,"MOD_RES 157 157 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,AB012770;AF334675;AB014546;AK298319;BT007446;AK222765;CH471081;CH471081;BC007517;
0,P54132,BLM_HUMAN,BLM RECQ2 RECQL3,BLM,RECQ2 RECQL3,,,Homo sapiens (Human),9606,"Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3)",UP000005640: Chromosome 15,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",9606,,MAAVPQNNLQEQLERHSARTLNNKLSLSKPKFSGFTFKKKTSSDNNVSVTNVSVAKTPVLRNKDVNVTEDFSFSEPLPNTTNQQRVKDFFKNAPAGQETQRGGSKSLLPDFLQTPKEVVCTTQNTPTVKKSRDTALKKLEFSSSPDSLSTINDWDDMDDFDTSETSKSFVTPPQSHFVRVSTAQKSKKGKRNFFKAQLYTTNTVKTDLPPPSSESEQIDLTEEQKDDSEWLSSDVICIDDGPIAEVHINEDAQESDSLKTHLEDERDNSEKKKNLEEAELHSTEKVPCIEFDDDDYDTDFVPPSPEEIISASSSSSKCLSTLKDLDTSDRKEDVLSTSKDLLSKPEKMSMQELNPETSTDCDARQISLQQQLIHVMEHICKLIDTIPDDKLKLLDCGNELLQQRNIRRKLLTEVDFNKSDASLLGSLWRYRPDSLDGPMEGDSCPTGNSMKELNFSHLPSNSVSPGDCLLTTTLGKTGFSATRKNLFERPLFNTHLQKSFVSSNWAETPRLGKKNESSYFPGNVLTSTAVKDQNKHTASINDLERETQPSYDIDNFDIDDFDDDDDWEDIMHNLAASKSSTAAYQPIKEGRPIKSVSERLSSAKTDCLPVSSTAQNINFSESIQNYTDKSAQNLASRNLKHERFQSLSFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLGEDCFILMPTGGGKSLCYQLPACVSPGVTVVISPLRSLIVDQVQKLTSLDIPATYLTGDKTDSEATNIYLQLSKKDPIIKLLYVTPEKICASNRLISTLENLYERKLLARFVIDEAHCVSQWGHDFRQDYKRMNMLRQKFPSVPVMALTATANPRVQKDILTQLKILRPQVFSMSFNRHNLKYYVLPKKPKKVAFDCLEWIRKHHPYDSGIIYCLSRRECDTMADTLQRDGLAALAYHAGLSDSARDEVQQKWINQDGCQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFYTYHDVTRLKRLIMMEKDGNHHTRETHFNNLYSMVHYCENITECRRIQLLAYFGENGFNPDFCKKHPDVSCDNCCKTKDYKTRDVTDDVKSIVRFVQEHSSSQGMRNIKHVGPSGRFTMNMLVDIFLGSKSAKIQSGIFGKGSAYSRHNAERLFKKLILDKILDEDLYINANDQAIAYVMLGNKAQTVLNGNLKVDFMETENSSSVKKQKALVAKVSQREEMVKKCLGELTEVCKSLGKVFGVHYFNIFNTVTLKKLAESLSSDPEVLLQIDGVTEDKLEKYGAEVISVLQKYSEWTSPAEDSSPGISLSSSRGPGRSAAEELDEEIPVSSHYFASKTRNERKRKKMPASQRSKRRKTASSGSKAKGGSATCRKISSKTKSSSIIGSSSASHTSQATSGANSKLGIMAPPKPINRPFLKPSYAFS,1417,"159,000",,,,,,,,,,,,,VARIANT 137 137 K -> R (in dbSNP:rs28384988). {ECO:0000269|Ref.3}. /FTId=VAR_022295.; VARIANT 298 298 T -> M (in dbSNP:rs28384991). {ECO:0000269|Ref.3}. /FTId=VAR_022296.; VARIANT 591 591 R -> Q (in dbSNP:rs28385012). {ECO:0000269|Ref.3}. /FTId=VAR_022297.; VARIANT 672 672 Q -> R (in BLM; dbSNP:rs747281324). {ECO:0000269|PubMed:7585968}. /FTId=VAR_006901.; VARIANT 841 841 I -> T (in BLM; dbSNP:rs767086502). /FTId=VAR_016032.; VARIANT 843 843 T -> I (in BLM; dbSNP:rs137853152). {ECO:0000269|PubMed:7585968}. /FTId=VAR_006902.; VARIANT 868 868 P -> L (in dbSNP:rs2227935). {ECO:0000269|Ref.3}. /FTId=VAR_022298.; VARIANT 878 878 C -> R (in BLM). {ECO:0000269|PubMed:10862105}. /FTId=VAR_016033.; VARIANT 891 891 G -> E (in BLM). /FTId=VAR_009138.; VARIANT 901 901 C -> Y (in BLM; dbSNP:rs758311406). /FTId=VAR_009139.; VARIANT 1036 1036 C -> F (in BLM; dbSNP:rs137853153). {ECO:0000269|PubMed:9285778}. /FTId=VAR_009140.; VARIANT 1043 1043 A -> D (in dbSNP:rs2229035). /FTId=VAR_051731.; VARIANT 1055 1055 C -> S (in BLM; dbSNP:rs367543029). {ECO:0000269|PubMed:7585968}. /FTId=VAR_006903.; VARIANT 1205 1205 V -> I (in dbSNP:rs28385141). /FTId=VAR_022299.; VARIANT 1209 1209 S -> T (in dbSNP:rs1801256). /FTId=VAR_014912.; VARIANT 1213 1213 E -> K (in dbSNP:rs28385142). {ECO:0000269|Ref.3}. /FTId=VAR_022300.; VARIANT 1321 1321 V -> I (in dbSNP:rs7167216). {ECO:0000269|Ref.3}. /FTId=VAR_022301.,,,,,,1,,0,"DOMAIN: The N-terminal region mediates dimerization and homooligomerization (PubMed:28228481). Both the helicase ATP-binding domain and the helicase C-terminal domain form intramolecular interactions with the HRDC domain in a ATP-dependent manner (PubMed:25901030). The HRDC domain is required for single-stranded DNA (ssDNA) and DNA Holliday junction binding (PubMed:20639533). {ECO:0000269|PubMed:20639533, ECO:0000269|PubMed:25901030, ECO:0000269|PubMed:28228481}.",SIMILARITY: Belongs to the helicase family. RecQ subfamily. {ECO:0000305}.,,COMPBIAS 292 299 Poly-Asp.; COMPBIAS 310 316 Poly-Ser.; COMPBIAS 557 566 Poly-Asp.,"DOMAIN 676 851 Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541, ECO:0000305|PubMed:24816114}.; DOMAIN 877 1024 Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542, ECO:0000305|PubMed:24816114}.; DOMAIN 1212 1292 HRDC. {ECO:0000255|PROSITE-ProRule:PRU00328, ECO:0000269|PubMed:20639533, ECO:0000305|PubMed:20639533}.",MOTIF 795 798 DEAH box.; MOTIF 1334 1349 Nuclear localization signal. {ECO:0000255}.,"REGION 301 600 Necessary for interaction with SPIDR. {ECO:0000269|PubMed:23509288}.; REGION 362 414 Necessary for dimerization and homooligomerization. {ECO:0000269|PubMed:28228481}.; REGION 870 873 3' overhang DNA-binding. {ECO:0000269|PubMed:25901030}.; REGION 897 899 3' overhang DNA-binding. {ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.; REGION 1000 1003 3' overhang DNA-binding. {ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.; REGION 1094 1139 DNA Holliday junction binding. {ECO:0000269|PubMed:24257077}.; REGION 1110 1112 3' overhang DNA-binding. {ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.; REGION 1121 1125 3' overhang DNA-binding. {ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.; REGION 1160 1166 3' overhang DNA-binding. {ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.; REGION 1227 1244 Necessary for ssDNA and DNA Holliday junction binding. {ECO:0000269|PubMed:20639533}.",,,3.6.4.12,,"CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12; Evidence={ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030};","COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030};  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030};",,"FUNCTION: ATP-dependent DNA helicase that unwinds single- and double-stranded DNA in a 3'-5' direction (PubMed:9388193, PubMed:24816114, PubMed:25901030). Participates in DNA replication and repair (PubMed:12019152, PubMed:21325134, PubMed:23509288). Involved in 5'-end resection of DNA during double-strand break (DSB) repair: unwinds DNA and recruits DNA2 which mediates the cleavage of 5'-ssDNA (PubMed:21325134). Negatively regulates sister chromatid exchange (SCE) (PubMed:25901030). Stimulates DNA 4-way junction branch migration and DNA Holliday junction dissolution (PubMed:25901030). Binds single-stranded DNA (ssDNA), forked duplex DNA and DNA Holliday junction (PubMed:20639533, PubMed:24257077, PubMed:25901030). {ECO:0000269|PubMed:12019152, ECO:0000269|PubMed:20639533, ECO:0000269|PubMed:21325134, ECO:0000269|PubMed:23509288, ECO:0000269|PubMed:24257077, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030, ECO:0000269|PubMed:9388193}.",,,,,,,"BINDING 982 982 ATP. {ECO:0000244|PDB:4CDG, ECO:0000244|PDB:4CGZ, ECO:0000269|PubMed:25901030}.; BINDING 1242 1242 ATP. {ECO:0000244|PDB:4CDG, ECO:0000244|PDB:4CGZ, ECO:0000269|PubMed:25901030}.",,"METAL 1036 1036 Zinc. {ECO:0000244|PDB:4CDG, ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.; METAL 1055 1055 Zinc. {ECO:0000244|PDB:4CDG, ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.; METAL 1063 1063 Zinc. {ECO:0000244|PDB:4CDG, ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.; METAL 1066 1066 Zinc. {ECO:0000244|PDB:4CDG, ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.","NP_BIND 668 672 ATP. {ECO:0000244|PDB:4CDG, ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.; NP_BIND 692 696 ATP. {ECO:0000244|PDB:4CDG, ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.","SITE 717 717 3' overhang DNA-binding. {ECO:0000269|PubMed:25901030}.; SITE 808 808 3' overhang DNA-binding. {ECO:0000269|PubMed:25901030}.; SITE 920 920 3' overhang DNA-binding; via amide nitrogen. {ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.; SITE 946 946 3' overhang DNA-binding. {ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.; SITE 968 968 3' overhang DNA-binding. {ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.; SITE 1110 1110 3' overhang DNA-binding. {ECO:0000244|PDB:4CGZ, ECO:0000244|PDB:4O3M, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030}.","chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; pronucleus [GO:0045120]; replication fork [GO:0005657]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent helicase activity [GO:0008026]; ATPase activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]; alpha-beta T cell differentiation [GO:0046632]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; G-quadruplex DNA unwinding [GO:0044806]; meiotic chromosome separation [GO:0051307]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; negative regulation of mitotic recombination [GO:0045950]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; resolution of meiotic recombination intermediates [GO:0000712]; resolution of recombination intermediates [GO:0071139]; response to X-ray [GO:0010165]; strand displacement [GO:0000732]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820]","alpha-beta T cell differentiation [GO:0046632]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; G-quadruplex DNA unwinding [GO:0044806]; meiotic chromosome separation [GO:0051307]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; negative regulation of mitotic recombination [GO:0045950]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; resolution of meiotic recombination intermediates [GO:0000712]; resolution of recombination intermediates [GO:0071139]; response to X-ray [GO:0010165]; strand displacement [GO:0000732]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820]",8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; annealing helicase activity [GO:0036310]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent helicase activity [GO:0008026]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; pronucleus [GO:0045120]; replication fork [GO:0005657],GO:0000079; GO:0000228; GO:0000400; GO:0000403; GO:0000405; GO:0000712; GO:0000724; GO:0000729; GO:0000731; GO:0000732; GO:0000800; GO:0002039; GO:0003677; GO:0003678; GO:0003697; GO:0004003; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006303; GO:0006310; GO:0006974; GO:0007095; GO:0008026; GO:0008094; GO:0008270; GO:0009378; GO:0010165; GO:0010705; GO:0016363; GO:0016605; GO:0016887; GO:0031297; GO:0032508; GO:0036310; GO:0042803; GO:0043066; GO:0043140; GO:0044806; GO:0045003; GO:0045120; GO:0045893; GO:0045910; GO:0045950; GO:0046632; GO:0046641; GO:0048478; GO:0051259; GO:0051260; GO:0051307; GO:0051782; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070244; GO:0071139; GO:0071479; GO:0072711; GO:0072757; GO:0090329; GO:0090656; GO:1901291; GO:1905168; GO:1905773,IPR012532; IPR032439; IPR032437; IPR011545; IPR002464; IPR004589; IPR014001; IPR001650; IPR010997; IPR002121; IPR027417; IPR032284; IPR018982; IPR036388; IPR036390; ,Q9BX63; P39748; P53350; O75771; Q9H9A7; P27694; P42677; P54274; Q15554; Q96RL1; Q14191,"SUBUNIT: Monomer (PubMed:28228481). Homodimer (via N-terminus) (PubMed:28228481). Homotetramer (via N-terminus); dimer of dimers (PubMed:28228481). Homohexamer (via N-terminus) (PubMed:28228481). Self-association negatively regulates DNA unwinding amplitude and rate. Oligomeric complexes dissociate into monomer in presence of ATP (PubMed:28228481). Part of the BRCA1-associated genome surveillance complex (BASC), which contains BRCA1, MSH2, MSH6, MLH1, ATM, BLM, PMS2 and the RAD50-MRE11-NBS1 protein complex. This association could be a dynamic process changing throughout the cell cycle and within subnuclear domains. Interacts with ubiquitinated FANCD2. Interacts with RMI complex. Interacts directly with RMI1 (via N-terminal region) component of RMI complex. Interacts with SUPV3L1. Found in a complex, at least composed of BLM, RAD51 and SPIDR; the complex formation is mediated by SPIDR. Interacts with TOP3A (via N-terminal region). Interacts with SPIDR (via C-terminal region); the interaction is direct and required to target BLM to sites of DNA damage. {ECO:0000269|PubMed:15257300, ECO:0000269|PubMed:15775963, ECO:0000269|PubMed:16595695, ECO:0000269|PubMed:17961633, ECO:0000269|PubMed:18923082, ECO:0000269|PubMed:18923083, ECO:0000269|PubMed:21325134, ECO:0000269|PubMed:23509288, ECO:0000269|PubMed:28228481}.",7585968; 9388193; 15489334; 9388480; 10783165; 15257300; 12019152; 15775963; 16595695; 16964243; 17961633; 18923082; 18923083; 18669648; 19690332; 19608861; 20068231; 21269460; 21325134; 23186163; 23509288; 25772364; 25755297; 28112733; 20739603; 20639533; 24257077; 24816114; 24435566; 25901030; 28228481; 9285778; 10862105,7585968; 9388193; 15489334; 9388480; 10783165; 15257300; 12019152; 15775963; 16595695; 16964243; 17961633; 18923082; 18923083; 18669648; 19690332; 19608861; 20068231; 21269460; 21325134; 23186163; 23509288; 25772364; 25755297; 28112733; 20739603; 20639533; 24257077; 24816114; 24435566; 25901030; 28228481; 9285778; 10862105; 10029069; 10072381; 10101178; 10212258; 10318934; 10435622; 10438626; 10652259; 10728666; 10734115; 10801132; 10809667; 10856253; 10859164; 10921897; 10928988; 11006276; 11080452; 11171374; 11178747; 11292842; 11301010; 11390642; 11459987; 11472631; 11532193; 11571269; 11691925; 11741924; 11751635; 11781842; 11832208; 11876000; 11916980; 11919194; 11950880; 11960380; 12034743; 12080066; 12091911; 12139939; 12181313; 12242432; 12370410; 12379650; 12433984; 12444098; 12545175; 12578958; 12606585; 12702560; 12750383; 12791985; 12818200; 12826610; 12912992; 12974384; 12975363; 14517203; 14527420; 14576316; 14576433; 14685245; 14688284; 14704203; 14716019; 14729972; 14734547; 15064730; 15140983; 15189136; 15190204; 15229185; 15289897; 15304223; 15485900; 15539948; 15579905; 15616572; 15665856; 15703751; 15707391; 15726604; 15750625; 15805243; 15829507; 15845538; 15916957; 15959913; 15965237; 15990871; 16030011; 16123081; 16148040; 16153896; 16199871; 16260499; 16322221; 16327781; 16337601; 16360315; 16412221; 16530042; 16537486; 16766518; 16766662; 16864798; 16876111; 16880735; 16885023; 17114795; 17344431; 17407155; 17457718; 17575048; 17591918; 17599064; 17603497; 17728255; 17855454; 17878217; 17928296; 17943968; 17962301; 17965729; 17977839; 17984114; 17996710; 17996711; 18003860; 18054789; 18171670; 18264947; 18270339; 18278455; 18317453; 18390547; 18401830; 18430927; 18448429; 18471088; 18539610; 18541667; 18676680; 18682526; 18708356; 18757400; 18787696; 18805091; 18923075; 18957201; 18971343; 18974064; 18978339; 19074197; 19109166; 19165145; 19170196; 19205873; 19237606; 19268590; 19329795; 19369211; 19419957; 19432957; 19442250; 19465921; 19494131; 19500012; 19542097; 19573080; 19578796; 19625176; 19632996; 19661064; 19671661; 19692168; 19714462; 19734539; 19773279; 19913121; 19917125; 19935873; 19941829; 19945966; 19956565; 20154148; 20207730; 20211839; 20215422; 20233725; 20237496; 20360068; 20445207; 20467437; 20628086; 20711169; 20719863; 20729832; 20729858; 20729859; 20800603; 20813000; 20871615; 20871616; 20965415; 21052091; 21111748; 21113733; 21123383; 21129251; 21240188; 21263215; 21300576; 21567087; 21659603; 21680713; 21712816; 21736299; 21743438; 21777809; 21804533; 21815139; 21851590; 22021381; 22024395; 22106380; 22253018; 22272300; 22356911; 22544709; 22563370; 22593209; 22645308; 22653443; 22792074; 22977173; 22989712; 23028338; 23149936; 23225144; 23253856; 23261817; 23268311; 23322570; 23345434; 23404160; 23572515; 23686288; 23708797; 23731732; 23810717; 24027577; 24076221; 24095737; 24096176; 24108125; 24118499; 24126761; 24141787; 24239288; 24371268; 24485656; 24509834; 24831703; 24858046; 24958861; 25015292; 25084169; 25113031; 25122754; 25129257; 25182961; 25218447; 25472581; 25588990; 25609649; 25766002; 25794620; 26028025; 26358404; 26496610; 26638075; 26778106; 27083049; 27100209; 27169843; 27238185; 27407146; 27427384; 27601585; 27612385; 28506294; 28673972; 28877996; 28912125; 28919440; 29017749; 29042409; 29348659; 29388204; 29523790; 8673133; 8702565; 9065463; 9443891; 9781043; 9837724; 9925639,1996-10-01,2019-02-13,1996-10-01,200,X-ray crystallography (8); NMR spectroscopy (3),STRAND 685 688 {ECO:0000244|PDB:4O3M}.; STRAND 706 713 {ECO:0000244|PDB:4O3M}.; STRAND 734 741 {ECO:0000244|PDB:4O3M}.; STRAND 755 757 {ECO:0000244|PDB:4O3M}.; STRAND 762 765 {ECO:0000244|PDB:4O3M}.; STRAND 789 795 {ECO:0000244|PDB:4O3M}.; STRAND 826 830 {ECO:0000244|PDB:4O3M}.; STRAND 851 853 {ECO:0000244|PDB:4O3M}.; STRAND 862 868 {ECO:0000244|PDB:4O3M}.; STRAND 891 894 {ECO:0000244|PDB:4O3M}.; STRAND 915 919 {ECO:0000244|PDB:4O3M}.; STRAND 941 945 {ECO:0000244|PDB:4O3M}.; STRAND 960 965 {ECO:0000244|PDB:4O3M}.; STRAND 987 993 {ECO:0000244|PDB:4O3M}.; STRAND 1074 1076 {ECO:0000244|PDB:4CDG}.; STRAND 1096 1099 {ECO:0000244|PDB:3WE2}.; STRAND 1154 1161 {ECO:0000244|PDB:4O3M}.; STRAND 1163 1166 {ECO:0000244|PDB:4CGZ}.; STRAND 1167 1173 {ECO:0000244|PDB:4O3M}.; STRAND 1188 1190 {ECO:0000244|PDB:4CDG}.; STRAND 1207 1209 {ECO:0000244|PDB:2RRD}.; STRAND 1263 1265 {ECO:0000244|PDB:2KV2}.,HELIX 365 383 {ECO:0000244|PDB:5LUP}.; HELIX 388 391 {ECO:0000244|PDB:5LUP}.; HELIX 397 411 {ECO:0000244|PDB:5LUP}.; HELIX 643 645 {ECO:0000244|PDB:4O3M}.; HELIX 652 661 {ECO:0000244|PDB:4O3M}.; HELIX 672 680 {ECO:0000244|PDB:4O3M}.; HELIX 697 705 {ECO:0000244|PDB:4O3M}.; HELIX 717 729 {ECO:0000244|PDB:4O3M}.; HELIX 743 753 {ECO:0000244|PDB:4O3M}.; HELIX 769 772 {ECO:0000244|PDB:4O3M}.; HELIX 774 785 {ECO:0000244|PDB:4O3M}.; HELIX 797 800 {ECO:0000244|PDB:4CDG}.; HELIX 811 820 {ECO:0000244|PDB:4O3M}.; HELIX 835 845 {ECO:0000244|PDB:4O3M}.; HELIX 871 873 {ECO:0000244|PDB:4O3M}.; HELIX 874 885 {ECO:0000244|PDB:4O3M}.; HELIX 898 910 {ECO:0000244|PDB:4O3M}.; HELIX 924 935 {ECO:0000244|PDB:4O3M}.; HELIX 947 950 {ECO:0000244|PDB:4CDG}.; HELIX 970 977 {ECO:0000244|PDB:4O3M}.; HELIX 995 1005 {ECO:0000244|PDB:4O3M}.; HELIX 1015 1031 {ECO:0000244|PDB:4O3M}.; HELIX 1037 1044 {ECO:0000244|PDB:4O3M}.; HELIX 1054 1057 {ECO:0000244|PDB:4O3M}.; HELIX 1059 1061 {ECO:0000244|PDB:4O3M}.; HELIX 1064 1067 {ECO:0000244|PDB:4O3M}.; HELIX 1078 1090 {ECO:0000244|PDB:4O3M}.; HELIX 1111 1119 {ECO:0000244|PDB:4O3M}.; HELIX 1139 1151 {ECO:0000244|PDB:4O3M}.; HELIX 1177 1181 {ECO:0000244|PDB:4O3M}.; HELIX 1195 1197 {ECO:0000244|PDB:4CDG}.; HELIX 1210 1233 {ECO:0000244|PDB:4O3M}.; HELIX 1237 1239 {ECO:0000244|PDB:4O3M}.; HELIX 1243 1252 {ECO:0000244|PDB:4O3M}.; HELIX 1257 1260 {ECO:0000244|PDB:4O3M}.; HELIX 1268 1283 {ECO:0000244|PDB:4O3M}.,TURN 979 983 {ECO:0000244|PDB:4CDG}.; TURN 1069 1071 {ECO:0000244|PDB:4CDG}.; TURN 1129 1136 {ECO:0000244|PDB:4O3M}.; TURN 1284 1288 {ECO:0000244|PDB:4O3M}.,,,,,5 out of 5,Beta strand (22); Binding site (2); Chain (1); Compositional bias (3); Cross-link (32); Domain (3); Helix (36); Metal binding (4); Modified residue (20); Motif (2); Mutagenesis (13); Natural variant (17); Nucleotide binding (2); Region (10); Site (6); Turn (4),,,,3D-structure;ATP-binding;Acetylation;Complete proteome;DNA damage;DNA repair;DNA replication;DNA-binding;Disease mutation;Dwarfism;Helicase;Hydrolase;Isopeptide bond;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Zinc,Evidence at protein level,reviewed,,"Helicase family, RecQ subfamily",200,Catalytic activity (1); Cofactor (1); Domain (1); Function (1); Involvement in disease (1); Post-translational modification (1); Sequence similarities (1); Subcellular location (1); Subunit structure (1),,KW-0002; KW-0007; KW-0067; KW-0181; KW-0225; KW-0227; KW-0234; KW-0235; KW-0238; KW-0242; KW-0347; KW-0378; KW-0479; KW-0539; KW-0547; KW-0597; KW-0621; KW-0832; KW-0862; KW-1017; KW-1185,,,,,"DISEASE: Bloom syndrome (BLM) [MIM:210900]: An autosomal recessive disorder. It is characterized by proportionate pre- and postnatal growth deficiency, sun-sensitive telangiectatic hypo- and hyperpigmented skin, predisposition to malignancy, and chromosomal instability. {ECO:0000269|PubMed:10862105, ECO:0000269|PubMed:7585968, ECO:0000269|PubMed:9285778}. Note=The disease is caused by mutations affecting the gene represented in this entry.",,,"PTM: Phosphorylated in response to DNA damage. Phosphorylation requires the FANCA-FANCC-FANCE-FANCF-FANCG protein complex, as well as the presence of RMI1. {ECO:0000269|PubMed:15257300, ECO:0000269|PubMed:15775963}.",CHAIN 1 1417 Bloom syndrome protein. /FTId=PRO_0000205039.,"CROSSLNK 24 24 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 31 31 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 38 38 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 56 56 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 63 63 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 87 87 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 91 91 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 105 105 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 116 116 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 129 129 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 195 195 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 205 205 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 331 331 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 344 344 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 347 347 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 451 451 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 476 476 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 484 484 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733}.; CROSSLNK 498 498 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 513 513 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 514 514 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 531 531 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 535 535 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 588 588 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 594 594 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733}.; CROSSLNK 604 604 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 1125 1125 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 1199 1199 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 1207 1207 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 1329 1329 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 1372 1372 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.; CROSSLNK 1395 1395 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:28112733}.",,,,,"MOD_RES 28 28 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 48 48 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 57 57 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 114 114 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 168 168 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 171 171 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 328 328 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 338 338 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 358 358 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 419 419 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 422 422 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 426 426 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 464 464 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 499 499 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 508 508 Phosphothreonine. {ECO:0000244|PubMed:16964243}.; MOD_RES 863 863 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 1197 1197 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1295 1295 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1296 1296 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1310 1310 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.",,,,,"cellular organisms, Eukaryota, Opisthokonta, Metazoa, Eumetazoa, Bilateria, Deuterostomia, Chordata, Craniata, Vertebrata, Gnathostomata (jawed vertebrates), Teleostomi, Euteleostomi, Sarcopterygii, Dipnotetrapodomorpha, Tetrapoda, Amniota, Mammalia, Theria, Eutheria, Boreoeutheria, Euarchontoglires, Primates, Haplorrhini, Simiiformes, Catarrhini, Hominoidea (apes), Hominidae (great apes), Homininae, Homo, Homo sapiens (Human)",Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea (apes),Hominidae (great apes),Homininae,,,Homo,,,,Homo sapiens (Human),,,,"131567, 2759, 33154, 33208, 6072, 33213, 33511, 7711, 89593, 7742, 7776, 117570, 117571, 8287, 1338369, 32523, 32524, 40674, 32525, 9347, 1437010, 314146, 9443, 376913, 314293, 9526, 314295, 9604, 207598, 9605, 9606",2759,33208,,,7711,89593,8287,40674,,,314146,9443,376913,314293,9526,314295,9604,207598,,,9605,,,,,,,,,U39817;AY886902;BC093622;BC101567;BC115030;BC115032;
